PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Carroll, MW; Matthews, DA; Hiscox, JA; Elmore, MJ; Pollakis, G; Rambaut, A; Hewson, R; Garcia-Dorival, I; Bore, JA; Koundouno, R; Abdellati, S; Afrough, B; Aiyepada, J; Akhilomen, P; Asogun, D; Atkinson, B; Badusche, M; Bah, A; Bate, S; Baumann, J; Becker, D; Becker-Ziaja, B; Bocquin, A; Borremans, B; Bosworth, A; Boettcher, JP; Cannas, A; Carletti, F; Castilletti, C; Clark, S; Colavita, F; Diederich, S; Donatus, A; Duraffour, S; Ehichioya, D; Ellerbrok, H; Fernandez-Garcia, MD; Fizet, A; Fleischmann, E; Gryseels, S; Hermelink, A; Hinzmann, J; Hopf-Guevara, U; Ighodalo, Y; Jameson, L; Kelterbaum, A; Kis, Z; Kloth, S; Kohl, C; Korva, M; Kraus, A; Kuisma, E; Kurth, A; Liedigk, B; Logue, CH; Ludtke, A; Maes, P; McCowen, J; Mely, S; Mertens, M; Meschi, S; Meyer, B; Michel, J; Molkenthin, P; Munoz-Fontela, C; Muth, D; Newman, ENC; Ngabo, D; Oestereich, L; Okosun, J; Olokor, T; Omiunu, R; Omomoh, E; Pallasch, E; Palyi, B; Portmann, J; Pottage, T; Pratt, C; Priesnitz, S; Quartu, S; Rappe, J; Repits, J; Richter, M; Rudolf, M; Sachse, A; Schmidt, KM; Schudt, G; Strecker, T; Thom, R; Thomas, S; Tobin, E; Tolley, H; Trautner, J; Vermoesen, T; Vitoriano, I; Wagner, M; Wolff, S; Yue, C; Capobianchi, MR; Kretschmer, B; Hall, Y; Kenny, JG; Rickett, NY; Dudas, G; Coltart, CEM; Kerber, R; Steer, D; Wright, C; Senyah, F; Keita, S; Drury, P; Diallo, B; de Clerck, H; Van Herp, M; Sprecher, A; Traore, A; Diakite, M; Konde, MK; Koivogui, L; Magassouba, N; Avsic-Zupanc, T; Nitsche, A; Strasser, M; Ippolito, G; Becker, S; Stoecker, K; Gabriel, M; Raoul, H; Di Caro, A; Wolfel, R; Formenty, P; Gunther, S				Carroll, Miles W.; Matthews, David A.; Hiscox, Julian A.; Elmore, Michael J.; Pollakis, Georgios; Rambaut, Andrew; Hewson, Roger; Garcia-Dorival, Isabel; Bore, Joseph Akoi; Koundouno, Raymond; Abdellati, Said; Afrough, Babak; Aiyepada, John; Akhilomen, Patience; Asogun, Danny; Atkinson, Barry; Badusche, Marlis; Bah, Amadou; Bate, Simon; Baumann, Jan; Becker, Dirk; Becker-Ziaja, Beate; Bocquin, Anne; Borremans, Benny; Bosworth, Andrew; Boettcher, Jan Peter; Cannas, Angela; Carletti, Fabrizio; Castilletti, Concetta; Clark, Simon; Colavita, Francesca; Diederich, Sandra; Donatus, Adomeh; Duraffour, Sophie; Ehichioya, Deborah; Ellerbrok, Heinz; Fernandez-Garcia, Maria Dolores; Fizet, Alexandra; Fleischmann, Erna; Gryseels, Sophie; Hermelink, Antje; Hinzmann, Julia; Hopf-Guevara, Ute; Ighodalo, Yemisi; Jameson, Lisa; Kelterbaum, Anne; Kis, Zoltan; Kloth, Stefan; Kohl, Claudia; Korva, Misa; Kraus, Annette; Kuisma, Eeva; Kurth, Andreas; Liedigk, Britta; Logue, Christopher H.; Luedtke, Anja; Maes, Piet; McCowen, James; Mely, Stephane; Mertens, Marc; Meschi, Silvia; Meyer, Benjamin; Michel, Janine; Molkenthin, Peter; Munoz-Fontela, Cesar; Muth, Doreen; Newman, Edmund N. C.; Ngabo, Didier; Oestereich, Lisa; Okosun, Jennifer; Olokor, Thomas; Omiunu, Racheal; Omomoh, Emmanuel; Pallasch, Elisa; Palyi, Bernadett; Portmann, Jasmine; Pottage, Thomas; Pratt, Catherine; Priesnitz, Simone; Quartu, Serena; Rappe, Julie; Repits, Johanna; Richter, Martin; Rudolf, Martin; Sachse, Andreas; Schmidt, Kristina Maria; Schudt, Gordian; Strecker, Thomas; Thom, Ruth; Thomas, Stephen; Tobin, Ekaete; Tolley, Howard; Trautner, Jochen; Vermoesen, Tine; Vitoriano, Ines; Wagner, Matthias; Wolff, Svenja; Yue, Constanze; Capobianchi, Maria Rosaria; Kretschmer, Birte; Hall, Yper; Kenny, John G.; Rickett, Natasha Y.; Dudas, Gytis; Coltart, Cordelia E. M.; Kerber, Romy; Steer, Damien; Wright, Callum; Senyah, Francis; Keita, Sakoba; Drury, Patrick; Diallo, Boubacar; de Clerck, Hilde; Van Herp, Michel; Sprecher, Armand; Traore, Alexis; Diakite, Mandiou; Konde, Mandy Kader; Koivogui, Lamine; Magassouba, N'Faly; Avsic-Zupanc, Tatjana; Nitsche, Andreas; Strasser, Marc; Ippolito, Giuseppe; Becker, Stephan; Stoecker, Kilian; Gabriel, Martin; Raoul, Herve; Di Caro, Antonino; Woelfel, Roman; Formenty, Pierre; Guenther, Stephan			Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa	NATURE			English	Article							INFERENCE; MODEL; VP24	West Africa is currently witnessing the most extensive Ebola virus (EBOV) outbreak so far recorded(1-3). Until now, there have been 27,013 reported cases and 11,134 deaths. The origin of the virus is thought to have been a zoonotic transmission from a bat to a two-year-old boy in December 2013 (ref. 2). From this index case the virus was spread by human-to-human contact throughout Guinea, Sierra Leone and Liberia. However, the origin of the particular virus in each country and time of transmission is not known and currently relies on epidemiological analysis, which may be unreliable owing to the difficulties of obtaining patient information. Here we trace the genetic evolution of EBOV in the current outbreak that has resulted in multiple lineages. Deep sequencing of 179 patient samples processed by the European Mobile Laboratory, the first diagnostics unit to be deployed to the epicentre of the outbreak in Guinea, reveals an epidemiological and evolutionary history of the epidemic from March 2014 to January 2015. Analysis of EBOV genome evolution has also benefited from a similar sequencing effort of patient samples from Sierra Leone. Our results confirm that the EBOV from Guinea moved into Sierra Leone, most likely in April or early May. The viruses of the Guinea/Sierra Leone lineage mixed around June/July 2014. Viral sequences covering August, September and October 2014 indicate that this lineage evolved independently within Guinea. These data can be used in conjunction with epidemiological information to test retrospectively the effectiveness of control measures, and provides an unprecedented window into the evolution of an ongoing viral haemorrhagic fever outbreak.	[Carroll, Miles W.; Elmore, Michael J.; Hewson, Roger; Afrough, Babak; Atkinson, Barry; Bate, Simon; Bosworth, Andrew; Clark, Simon; Jameson, Lisa; Kuisma, Eeva; Logue, Christopher H.; McCowen, James; Newman, Edmund N. C.; Ngabo, Didier; Pottage, Thomas; Pratt, Catherine; Thom, Ruth; Thomas, Stephen; Tolley, Howard; Vitoriano, Ines; Hall, Yper; Senyah, Francis] Publ Hlth England, Porton Down SP4 0JG, Wilts, England; [Carroll, Miles W.; Hewson, Roger; Bore, Joseph Akoi; Koundouno, Raymond; Abdellati, Said; Afrough, Babak; Aiyepada, John; Akhilomen, Patience; Asogun, Danny; Atkinson, Barry; Badusche, Marlis; Bah, Amadou; Bate, Simon; Baumann, Jan; Becker, Dirk; Becker-Ziaja, Beate; Bocquin, Anne; Borremans, Benny; Bosworth, Andrew; Boettcher, Jan Peter; Cannas, Angela; Carletti, Fabrizio; Castilletti, Concetta; Clark, Simon; Colavita, Francesca; Diederich, Sandra; Donatus, Adomeh; Duraffour, Sophie; Ehichioya, Deborah; Ellerbrok, Heinz; Fernandez-Garcia, Maria Dolores; Fizet, Alexandra; Fleischmann, Erna; Gryseels, Sophie; Hermelink, Antje; Hinzmann, Julia; Hopf-Guevara, Ute; Ighodalo, Yemisi; Jameson, Lisa; Kelterbaum, Anne; Kis, Zoltan; Kloth, Stefan; Kohl, Claudia; Korva, Misa; Kraus, Annette; Kuisma, Eeva; Kurth, Andreas; Liedigk, Britta; Logue, Christopher H.; Luedtke, Anja; Maes, Piet; McCowen, James; Mely, Stephane; Mertens, Marc; Meschi, Silvia; Meyer, Benjamin; Michel, Janine; Molkenthin, Peter; Munoz-Fontela, Cesar; Muth, Doreen; Newman, Edmund N. C.; Ngabo, Didier; Oestereich, Lisa; Okosun, Jennifer; Olokor, Thomas; Omiunu, Racheal; Omomoh, Emmanuel; Pallasch, Elisa; Palyi, Bernadett; Portmann, Jasmine; Pottage, Thomas; Pratt, Catherine; Priesnitz, Simone; Quartu, Serena; Rappe, Julie; Repits, Johanna; Richter, Martin; Rudolf, Martin; Sachse, Andreas; Schmidt, Kristina Maria; Schudt, Gordian; Strecker, Thomas; Thom, Ruth; Thomas, Stephen; Tobin, Ekaete; Tolley, Howard; Trautner, Jochen; Vermoesen, Tine; Vitoriano, Ines; Wagner, Matthias; Wolff, Svenja; Yue, Constanze; Capobianchi, Maria Rosaria; Kerber, Romy; Avsic-Zupanc, Tatjana; Nitsche, Andreas; Strasser, Marc; Ippolito, Giuseppe; Becker, Stephan; Stoecker, Kilian; Gabriel, Martin; Raoul, Herve; Di Caro, Antonino; Woelfel, Roman; Guenther, Stephan] Bernhard Nocht Inst Trop Med, European Mobile Lab Consortium, D-20359 Hamburg, Germany; [Carroll, Miles W.] Univ Southampton, South Gen Hosp, Southampton SO16 6YD, Hants, England; [Matthews, David A.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Hiscox, Julian A.; Pollakis, Georgios; Garcia-Dorival, Isabel; Bosworth, Andrew; Rickett, Natasha Y.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 2BE, Merseyside, England; [Rambaut, Andrew; Dudas, Gytis] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 2FL, Midlothian, Scotland; [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Rambaut, Andrew] Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh EH9 2FL, Midlothian, Scotland; [Hewson, Roger] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Bore, Joseph Akoi; Koundouno, Raymond; Magassouba, N'Faly] Univ Gamal Abdel Nasser Conakry, Lab Fievres Hemorrag Guinee, Conakry, Guinea; [Bore, Joseph Akoi; Koundouno, Raymond; Koivogui, Lamine] Inst Nacl Sante Publ, Conakry, Guinea; [Abdellati, Said; Vermoesen, Tine] Inst Trop Med, B-2000 Antwerp, Belgium; [Aiyepada, John; Akhilomen, Patience; Asogun, Danny; Donatus, Adomeh; Ighodalo, Yemisi; Okosun, Jennifer; Olokor, Thomas; Omiunu, Racheal; Omomoh, Emmanuel; Tobin, Ekaete] Irrua Specialist Teaching Hosp, Inst Lassa Fever Res & Control, Irrua, Edo State, Nigeria; [Badusche, Marlis; Baumann, Jan; Becker-Ziaja, Beate; Duraffour, Sophie; Ehichioya, Deborah; Liedigk, Britta; Oestereich, Lisa; Pallasch, Elisa; Rudolf, Martin; Kerber, Romy; Gabriel, Martin; Guenther, Stephan] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Badusche, Marlis; Becker, Dirk; Becker-Ziaja, Beate; Diederich, Sandra; Fleischmann, Erna; Kelterbaum, Anne; Liedigk, Britta; Luedtke, Anja; Mertens, Marc; Meyer, Benjamin; Molkenthin, Peter; Munoz-Fontela, Cesar; Muth, Doreen; Oestereich, Lisa; Pallasch, Elisa; Rudolf, Martin; Schudt, Gordian; Strecker, Thomas; Wagner, Matthias; Wolff, Svenja; Kerber, Romy; Becker, Stephan; Stoecker, Kilian; Gabriel, Martin; Woelfel, Roman; Guenther, Stephan] German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany; [Bah, Amadou] Univ Basel, Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Becker, Dirk; Kelterbaum, Anne; Schudt, Gordian; Strecker, Thomas; Wolff, Svenja; Becker, Stephan] Philipps Univ Marburg, Inst Virol, D-35043 Marburg, Germany; [Bocquin, Anne; Fizet, Alexandra; Mely, Stephane] Natl Reference Ctr Viral Hemorrhag Fevers, F-69365 Lyon, France; [Bocquin, Anne; Mely, Stephane; Raoul, Herve] US003 Inserm, Inserm Jean Merieux, Lab P4, F-69365 Lyon, France; [Borremans, Benny; Gryseels, Sophie] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Boettcher, Jan Peter; Ellerbrok, Heinz; Hermelink, Antje; Hinzmann, Julia; Hopf-Guevara, Ute; Kloth, Stefan; Kohl, Claudia; Kurth, Andreas; Michel, Janine; Richter, Martin; Sachse, Andreas; Schmidt, Kristina Maria; Yue, Constanze; Nitsche, Andreas] Robert Koch Inst, D-13353 Berlin, Germany; [Cannas, Angela; Carletti, Fabrizio; Castilletti, Concetta; Colavita, Francesca; Meschi, Silvia; Quartu, Serena; Capobianchi, Maria Rosaria; Ippolito, Giuseppe; Di Caro, Antonino] Natl Inst Infect Dis INMI Lazzaro Spallanzani, I-00149 Rome, Italy; [Diederich, Sandra; Mertens, Marc] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, D-17493 Greifswald, Insel Riems, Germany; [Duraffour, Sophie; Maes, Piet] Katholieke Univ Leuven, Rega Inst, B-3000 Leuven, Belgium; [Ehichioya, Deborah] Redeemers Univ, Mowe, Osun State, Nigeria; [Fernandez-Garcia, Maria Dolores] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid 28029, Spain; [Fizet, Alexandra] Inst Pasteur, Unite Biol Infect Virales Emergentes, F-69365 Lyon, France; [Fleischmann, Erna; Molkenthin, Peter; Wagner, Matthias; Stoecker, Kilian; Woelfel, Roman] Bundeswehr Inst Microbiol, D-80937 Munich, Germany; [Kis, Zoltan; Palyi, Bernadett] Natl Ctr Epidemiol, Natl Biosafety Lab, H-1097 Budapest, Hungary; [Korva, Misa; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, SI-1000 Ljubljana, Slovenia; [Kraus, Annette] Publ Hlth Agcy Sweden, S-17182 Solna, Sweden; [Luedtke, Anja; Munoz-Fontela, Cesar] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Meyer, Benjamin; Muth, Doreen] Univ Bonn, Inst Virol, D-53127 Bonn, Germany; [Portmann, Jasmine; Strasser, Marc] Fed Off Civil Protect, Spiez Lab, CH-3700 Spiez, Switzerland; [Priesnitz, Simone] Bundeswehr Hosp, D-22049 Hamburg, Germany; [Rappe, Julie] Inst Virol & Immunol, CH-3147 Mittelhausern, Switzerland; [Repits, Johanna] Janssen Cilag, SE-19207 Sollentuna, Sweden; [Trautner, Jochen] Thunen Inst, D-22767 Hamburg, Germany; [Kretschmer, Birte] Eurice European Res & Project Off GmbH, D-10115 Berlin, Germany; [Kenny, John G.] Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Liverpool L69 7ZB, Merseyside, England; [Coltart, Cordelia E. M.] UCL, Dept Infect & Populat Hlth, London WC1E 6JB, England; [Steer, Damien] Univ Bristol, Res IT, Bristol BS8 1HH, Avon, England; [Wright, Callum] Univ Bristol, Adv Comp Res Ctr, Bristol BS8 1HH, Avon, England; [Keita, Sakoba] Minist Hlth Guinea, Conakry, Guinea; [Drury, Patrick; Formenty, Pierre] WHO, CH-1211 Geneva 27, Switzerland; [Diallo, Boubacar] World Hlth Org, Conakry, Guinea; [de Clerck, Hilde; Van Herp, Michel; Sprecher, Armand] Med Sans Frontieres, B-1050 Brussels, Belgium; [Traore, Alexis] Direct Prefectorale Sante Gueckedou, Sect Prevent & Lutte Malad, Gueckedou, Guinea; [Diakite, Mandiou] Univ Gamal Abdel Nasser Conakry, Conakry, Guinea; [Konde, Mandy Kader] Hlth & Sustainable Dev Fdn, Conakry, Guinea	Public Health England; Bernhard Nocht Institut fur Tropenmedizin; University of Southampton; University of Bristol; University of Liverpool; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research; University of Basel; Swiss Tropical & Public Health Institute; Philipps University Marburg; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Antwerp; Robert Koch Institute; IRCCS Lazzaro Spallanzani; Friedrich Loeffler Institute; KU Leuven; Redeemers University; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Bundeswehr Institute of Microbiology (IMB); University of Ljubljana; Public Health Agency of Sweden; Heinrich Pette Institute; University of Bonn; Johnson & Johnson; Johann Heinrich von Thunen Institute; University of Liverpool; University of London; University College London; University of Bristol; University of Bristol; World Health Organization; World Health Organization; Doctors Without Borders	Carroll, MW (corresponding author), Publ Hlth England, Porton Down SP4 0JG, Wilts, England.	miles.carroll@phe.gov.uk	Pratt, Catherine/AAD-6118-2022; Colavita, Francesca/I-8848-2018; Dorival, Isabel Garcia/AAX-5807-2020; Meyer, Bernhard/Q-9413-2016; Rappe, julie/P-7313-2016; Dudas, Gytis/H-5968-2019; Rambaut, Andrew/B-2481-2009; Wölfel, Roman/AAQ-3977-2021; Meyer, Benjamin/F-3285-2018; Fernandez-Garcia, Maria Dolores/B-2029-2016; Ehichioya, Deborah/AAR-7295-2020; Castilletti, Concetta/B-6545-2016; Logue, Christopher H/ABH-3469-2020; Ippolito, Giuseppe/J-7207-2017; Kenny, John/HCI-1952-2022; Castilletti, Concetta/AAA-8408-2019; TOBIN, EKAETE/ABB-6998-2020; Maes, Piet/P-7782-2017; Strecker, Thomas/AAR-8442-2020; Richter, Martin Heinrich/AAB-1929-2022; Di Caro, Antonino/K-6854-2016; Gryseels, Sophie/K-2633-2019; Georgios, Pollakis/Y-2341-2019; Borremans, Benny/D-2241-2009	Pratt, Catherine/0000-0001-6132-2570; Colavita, Francesca/0000-0003-0640-8667; Dorival, Isabel Garcia/0000-0002-5654-5662; Rappe, julie/0000-0001-9230-0219; Dudas, Gytis/0000-0002-0227-4158; Rambaut, Andrew/0000-0003-4337-3707; Wölfel, Roman/0000-0002-8756-7821; Meyer, Benjamin/0000-0003-0601-3550; Fernandez-Garcia, Maria Dolores/0000-0003-0336-6596; Castilletti, Concetta/0000-0001-9819-236X; Kenny, John/0000-0003-2994-6169; Castilletti, Concetta/0000-0001-9819-236X; TOBIN, EKAETE/0000-0001-5059-807X; Maes, Piet/0000-0002-4571-5232; Richter, Martin Heinrich/0000-0002-8649-5248; Di Caro, Antonino/0000-0001-6027-3009; Gryseels, Sophie/0000-0002-4851-9384; Borremans, Benny/0000-0002-7779-4107; Bosworth, Andrew/0000-0003-0780-4362; Munoz-Fontela, Cesar/0000-0002-7725-2586; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Ngabo, Didier/0000-0003-1818-1439; Matthews, David/0000-0003-4611-8795; Palyi, Bernadett/0000-0003-1975-4198; Pottage, Thomas/0000-0002-8062-853X; Rickett, Natasha/0000-0002-3172-1877; Nitsche, Andreas/0000-0001-8185-3176; Thomas, Stephen/0000-0003-2368-8058; Oestereich, Lisa/0000-0003-0098-7485; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Afrough, Babak/0000-0002-6651-1239; Strecker, Thomas/0000-0002-7857-937X; Hiscox, Julian/0000-0002-6582-0275; clark, simon/0000-0003-1923-6120; Hall, Yper/0000-0002-8537-8920; Gunther, Stephan/0000-0002-6562-0230; MELY, Stephane/0000-0002-3278-3455; Ehichioya, Deborah/0000-0002-5777-685X; Atkinson, Barry/0000-0002-1348-7204; kohl, claudia/0000-0002-1480-8911; Pollakis, Georgios/0000-0002-9659-5461; Ippolito, Giuseppe/0000-0002-1076-2979; meschi, silvia/0000-0003-0924-993X; Korva, Misa/0000-0003-1501-1004	European Union [666100]; Directorate-General for International Cooperation and Development [IFS/2011/272-372]	European Union(European Commission); Directorate-General for International Cooperation and Development	The authors would like to acknowledge that the EMLab response and the subsequent EBOV genome sequencing study would not have been possible without the extensive support from the many different agencies and organisations working in the West African EBOV disease outbreak region. EMLab worked with WHO, MSF and the Guinean authorities to tackle the outbreak in the Gueckedou area where the samples from this study were collected. We thank those who helped make this possible and the Guinean authorities for their decision to release the diagnostic samples to EMLab for shipment to Europe to undergo further analysis, including sequencing. We acknowledge Air France, Brussels Airlines and Virgin Airlines for transporting EMLab personnel and equipment in and out of West Africa during the outbreak period; World Courier for shipping our EBOV-positive samples out of Guinea to Europe; and the logistics support units and pilots and drivers of WHO/United Nations in West Africa for transporting our people and equipment throughout the region, and especially the drivers who made the 28h round trip journey from Conakry to enable the EMLab unit to be established and resupplied in Gueckedou. We appreciate the work of the numerous European Embassies operating in West Africa who provided emergency support to our personnel at times of need. We thank M. Bull, J. Lewis, P. Payne and S. Leach from the Microbial Risk Assessment and Behavioural Science Team, Emergency Response Department, Public Health England; J. Tree from Public Health England for help with GenBank submission; and S. Price and I. Stewart for helping with the running of our software on BlueCrystal, University of Bristol. We thank the people of West Africa for their gratitude and optimism, and for their positive attitude to our presence that we encountered on the daily journey to the Ebola Treatment Centre in Gueckedou. We acknowledge the efforts of the late Dr Lamine Ouendeno, who was one of the first healthcare workers to die during the current EBVD outbreak. We also thank Isabel and Maurice Ouendeno for providing us with food and shelter whilst delivering our Ebola response duties. This work was carried out in the context of the project EVIDENT (Ebola virus disease: correlates of protection, determinants of outcome, and clinical management) that received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 666100 and in the context of service contract IFS/2011/272-372 funded by Directorate-General for International Cooperation and Development. The EMLab is a technical partner in the WHO Emerging and Dangerous Pathogens Laboratory Network (EDPLN), and the Global Outbreak Alert and Response Network (GOARN) and the deployments in West Africa have been coordinated and supported by the GOARN Operational Support Team at WHO/HQ.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Basler CF, 2009, J INTERF CYTOK RES, V29, P511, DOI 10.1089/jir.2009.0076; Dowall SD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0540-x; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Garcia-Dorival I, 2014, J PROTEOME RES, V13, P5120, DOI 10.1021/pr500556d; Gatherer Derek, 2015, Evid Based Med, V20, P28, DOI 10.1136/ebmed-2014-110127; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hoenen T., 2015, SCIENCE; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Mateo M, 2011, J INFECT DIS, V204, pS1011, DOI 10.1093/infdis/jir338; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Tavare S, 1986, LECT MATH LIFE SCI, V17; Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232; Wynne JW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0532-x; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	20	214	217	1	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					97	U201		10.1038/nature14594	http://dx.doi.org/10.1038/nature14594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26083749	hybrid, Green Published			2022-12-28	WOS:000359002300039
J	Abe, J; Hiyama, TB; Mukaiyama, A; Son, S; Mori, T; Saito, S; Osako, M; Wolanin, J; Yamashita, E; Kondo, T; Akiyama, S				Abe, Jun; Hiyama, Takuya B.; Mukaiyama, Atsushi; Son, Seyoung; Mori, Toshifumi; Saito, Shinji; Osako, Masato; Wolanin, Julie; Yamashita, Eiki; Kondo, Takao; Akiyama, Shuji			Atomic-scale origins of slowness in the cyanobacterial circadian clock	SCIENCE			English	Article							PHOSPHORYLATION; DYNAMICS; RHYTHM; OSCILLATION; EXPRESSION; FEEDBACK; GOVERNS; COMPLEX; KAIABC; RING	Circadian clocks generate slow and ordered cellular dynamics but consist of fast-moving bio-macromolecules; consequently, the origins of the overall slowness remain unclear. We identified the adenosine triphosphate (ATP) catalytic region [adenosine triphosphatase (ATPase)] in the amino-terminal half of the clock protein KaiC as the minimal pacemaker that controls the in vivo frequency of the cyanobacterial clock. Crystal structures of the ATPase revealed that the slowness of this ATPase arises from sequestration of a lytic water molecule in an unfavorable position and coupling of ATP hydrolysis to a peptide isomerization with high activation energy. The slow ATPase is coupled with another ATPase catalyzing autodephosphorylation in the carboxyl-terminal half of KaiC, yielding the circadian response frequency of intermolecular interactions with other clock-related proteins that influences the transcription and translation cycle.	[Abe, Jun; Hiyama, Takuya B.; Mukaiyama, Atsushi; Saito, Shinji; Wolanin, Julie; Akiyama, Shuji] Natl Inst Nat Sci, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, Okazaki, Aichi 4448585, Japan; [Mukaiyama, Atsushi; Mori, Toshifumi; Saito, Shinji; Akiyama, Shuji] Grad Univ Adv Studies, SOKENDAI, Dept Funct Mol Sci, Okazaki, Aichi 4448585, Japan; [Son, Seyoung; Osako, Masato; Kondo, Takao] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Mori, Toshifumi; Saito, Shinji] Natl Inst Nat Sci, Inst Mol Sci, Dept Theoret & Computat Mol Sci, Okazaki, Aichi 4448585, Japan; [Wolanin, Julie] PSL Res Univ, Chim ParisTech, F-75005 Paris, France; [Yamashita, Eiki] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech; Osaka University	Akiyama, S (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	akiyamas@ims.ac.jp	Mukaiyama, Atsushi/AAV-2152-2021; Saito, Shinji/B-9746-2019; Yamashita, Eiki/V-6758-2019	Saito, Shinji/0000-0003-4982-4820; Yamashita, Eiki/0000-0002-4278-0039; Mukaiyama, Atsushi/0000-0002-6736-631X; Mori, Toshifumi/0000-0003-0188-0794; Wolanin, Julie/0000-0001-7155-4295; AKIYAMA, Shuji/0000-0002-7184-189X	Academia Sinica; National Synchrotron Radiation Research Center (Taiwan, China); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Okazaki ORION project;  [25291039];  [22687010];  [26102544];  [24000016];  [26888019];  [25288011]	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan, China); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Okazaki ORION project; ; ; ; ; ; 	Diffraction data were collected at BL44XU in the SPring-8 facility under the proposals 2009A6902, 2009B6902, 2010A6502, 2010B6502, 2011A6602, 2011B6602, 2012A6702, 2012B6702, and 2013B6700. MX225-HE was financially supported by Academia Sinica and National Synchrotron Radiation Research Center (Taiwan, China). This work was supported by Grants-in-Aid for Scientific Research (25291039, 22687010, and 26102544 to S.A.; 24000016 to T.K.; 26888019 to T.M.; and 25288011 to S. Saito); the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and partly by the Okazaki ORION project. The calculations were in part performed at the Research Center for Computational Science in Okazaki, Japan. S. A. designed the experiments. A.M., J.A., J.W., and M.O. conducted ATPase experiments. S. Son screened initial crystallization conditions, and J.A. and T.B.H. further refined them. S. Son, J.A., T.B.H., and S. A. collected diffraction data and analyzed the structures with inputs from E.Y. T.M. and S. Saito conducted molecular dynamics simulations. S. A., J.A., T.B.H., A. M., T.M., S. Saito, and T.K. drafted the manuscript with input from all authors. We declare no conflicts of interest. The atomic coordinates and structure factors are deposited in the Protein Data Bank with accession codes 4TL8 (KaiC1-WT, P2<INF>1</INF>2<INF>1</INF>2<INF>1</INF>), 4TL9 (ATP gamma S-bound KaiC1-S48T), 4TLA (ADP-bound KaiC1-S48T), 4TLB (KaiC1-S146P), 4TLC (KaiC1-S146G), 4TLD (KaiC1-S157P), 4TLE (KaiC1-S157C), 4TL7 (KaiC1-WT, P3<INF>1</INF>21), and 4TL6 (KaiC1-WT, C2).	Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Akiyama S, 2012, CELL MOL LIFE SCI, V69, P2147, DOI 10.1007/s00018-012-0919-3; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Chang YG, 2012, P NATL ACAD SCI USA, V109, P16847, DOI 10.1073/pnas.1211508109; Chang YG, 2011, P NATL ACAD SCI USA, V108, P14431, DOI 10.1073/pnas.1104221108; Hanaoka M, 2012, J BIOL CHEM, V287, P26321, DOI 10.1074/jbc.M111.338251; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Karplus M, 2000, J PHYS CHEM B, V104, P11, DOI 10.1021/jp993555t; Kondo T., 2008, CLOCKS AND RHYTHMS, P47; Mukaiyama Atsushi, 2015, Biophysics (Nagoya-shi), V11, P79, DOI 10.2142/biophysics.11.79; Murayama Y, 2011, EMBO J, V30, P68, DOI 10.1038/emboj.2010.298; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Nishiwaki T, 2012, J BIOL CHEM, V287, P18030, DOI 10.1074/jbc.M112.350660; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Tseng R, 2014, J MOL BIOL, V426, P389, DOI 10.1016/j.jmb.2013.09.040; Yoshida T, 2009, P NATL ACAD SCI USA, V106, P1648, DOI 10.1073/pnas.0806741106	29	60	60	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		312	316		10.1126/science.1261040	http://dx.doi.org/10.1126/science.1261040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26113637				2022-12-28	WOS:000358218600053
J	Ruijtenberg, S; van den Heuvel, S				Ruijtenberg, Suzan; van den Heuvel, Sander			G1/S Inhibitors and the SWI/SNF Complex Control Cell-Cycle Exit during Muscle Differentiation	CELL			English	Article							DEPENDENT KINASE INHIBITOR; C-ELEGANS; DEVELOPMENTAL REGULATION; DIVISION; NEMATODE; GENES; PROGRESSION; LINEAGE; ROLES; RB	The transition from proliferating precursor cells to post-mitotic differentiated cells is crucial for development, tissue homeostasis, and tumor suppression. To study cell-cycle exit during differentiation in vivo, we developed a conditional knockout and lineage-tracing system for Caenorhabditis elegans. Combined lineage-specific gene inactivation and genetic screening revealed extensive redundancies between previously identified cell-cycle inhibitors and the SWI/SNF chromatin-remodeling complex. Muscle precursor cells missing either SWI/SNF or G1/S inhibitor function could still arrest cell division, while simultaneous inactivation of these regulators caused continued proliferation and a C. elegans tumor phenotype. Further genetic analyses support that SWI/SNF acts in concert with hlh-1 MyoD, antagonizes Polycomb-mediated transcriptional repression, and suppresses cye-1 Cyclin E transcription to arrest cell division of muscle precursors. Thus, SWI/SNF and G1/S inhibitors provide alternative mechanisms to arrest cell-cycle progression during terminal differentiation, which offers insight into the frequent mutation of SWI/SNF genes in human cancers.	[Ruijtenberg, Suzan; van den Heuvel, Sander] Univ Utrecht, Fac Sci, Dept Biol, Dev Biol, NL-3584 CH Utrecht, Netherlands	Utrecht University	van den Heuvel, S (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Dev Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	s.j.l.vandenheuvel@uu.nl	van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463	NIH Office of Research Infrastructure Programs [P40 OD010440]; Netherlands Organization for Scientific Research (NWO) [819.02.016]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Akhmanova, H. Sawa, S. Mitani, A. Hyman, A. Pozniakovsky, G. Wachsman, and B. Scheres for reagents and strains; T. Middelkoop, M. Bienko, A. van Oudenaarden, and the Hubrecht Imaging Center for assistance with smFISH experiments; C. Riedel for access to SWI/SNF ChIP data; M. Boxem for help with data analysis; F. Holstege, M. Boxem, I. The, and A. Thomas for critically reading the manuscript; and members of the van den Heuvel and Boxem groups for help and discussion. Several strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This work is part of research program 819.02.016, financed by the Netherlands Organization for Scientific Research (NWO).	Boxem M, 2002, CURR BIOL, V12, P906, DOI 10.1016/S0960-9822(02)00844-8; Boxem M, 2001, DEVELOPMENT, V128, P4349; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896; Corsi AK, 2000, DEVELOPMENT, V127, P2041; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Eroglu E, 2014, CELL, V156, P1259, DOI 10.1016/j.cell.2014.01.053; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Fukuyama M, 2003, DEV BIOL, V260, P273, DOI 10.1016/S0012-1606(03)00239-2; Gaydos LJ, 2012, CELL REP, V2, P1169, DOI 10.1016/j.celrep.2012.09.019; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hebeisen M, 2008, DEVELOPMENT, V135, P1259, DOI 10.1242/dev.014969; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Hong Y, 1998, DEVELOPMENT, V125, P3585; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Korzelius J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002362; Kuwahara Y, 2013, MOL CANCER RES, V11, P251, DOI 10.1158/1541-7786.MCR-12-0390; Lei HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015898; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Puri PL, 2012, GENE DEV, V26, P2673, DOI 10.1101/gad.207415.112; Riedel CG, 2013, NAT CELL BIOL, V15, P491, DOI 10.1038/ncb2720; Saito RM, 2004, NAT CELL BIOL, V6, P777, DOI 10.1038/ncb1154; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shibata Y, 2012, DEV BIOL, V361, P349, DOI 10.1016/j.ydbio.2011.10.035; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; The I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6906; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; van den Heuvel S, 2012, METHOD CELL BIOL, V107, P265, DOI 10.1016/B978-0-12-394620-1.00009-6; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068	37	53	55	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					300	313		10.1016/j.cell.2015.06.013	http://dx.doi.org/10.1016/j.cell.2015.06.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26144318	Bronze			2022-12-28	WOS:000358087700011
J	Jardine, JG; Ota, T; Sok, D; Pauthner, M; Kulp, DW; Kalyuzhniy, O; Skog, PD; Thinnes, TC; Bhullar, D; Briney, B; Menis, S; Jones, M; Kubitz, M; Spencer, S; Adachi, Y; Burton, DR; Schief, WR; Nemazee, D				Jardine, Joseph G.; Ota, Takayuki; Sok, Devin; Pauthner, Matthias; Kulp, Daniel W.; Kalyuzhniy, Oleksandr; Skog, Patrick D.; Thinnes, Theresa C.; Bhullar, Deepika; Briney, Bryan; Menis, Sergey; Jones, Meaghan; Kubitz, Mike; Spencer, Skye; Adachi, Yumiko; Burton, Dennis R.; Schief, William R.; Nemazee, David			Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen	SCIENCE			English	Article							B-CELL RECEPTORS; MONOCLONAL-ANTIBODIES; VACCINE DEVELOPMENT; STRUCTURAL BASIS; RATIONAL DESIGN; ENVELOPE TRIMER; IN-VITRO; POTENT; CHALLENGE; MACAQUES	A major goal of HIV-1 vaccine research is the design of immunogens capable of inducing broadly neutralizing antibodies (bnAbs) that bind to the viral envelope glycoprotein (Env). Poor binding of Env to unmutated precursors of bnAbs, including those of the VRC01 class, appears to be a major problem for bnAb induction. We engineered an immunogen that binds to VRC01-class bnAb precursors and immunized knock-in mice expressing germline-reverted VRC01 heavy chains. Induced antibodies showed characteristics of VRC01-class bnAbs, including a short CDRL3 (light-chain complementarity-determining region 3) and mutations that favored binding to near-native HIV-1 gp120 constructs. In contrast, native-like immunogens failed to activate VRC01-class precursors. The results suggest that rational epitope design can prime rare B cell precursors for affinity maturation to desired targets.	[Jardine, Joseph G.; Ota, Takayuki; Sok, Devin; Pauthner, Matthias; Kulp, Daniel W.; Kalyuzhniy, Oleksandr; Skog, Patrick D.; Thinnes, Theresa C.; Bhullar, Deepika; Briney, Bryan; Menis, Sergey; Jones, Meaghan; Kubitz, Mike; Spencer, Skye; Adachi, Yumiko; Burton, Dennis R.; Schief, William R.; Nemazee, David] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Jardine, Joseph G.; Sok, Devin; Pauthner, Matthias; Kulp, Daniel W.; Kalyuzhniy, Oleksandr; Briney, Bryan; Menis, Sergey; Jones, Meaghan; Kubitz, Mike; Spencer, Skye; Adachi, Yumiko; Burton, Dennis R.; Schief, William R.] Scripps Res Inst, NAC, IAVI, La Jolla, CA 92037 USA; [Jardine, Joseph G.; Sok, Devin; Pauthner, Matthias; Kulp, Daniel W.; Kalyuzhniy, Oleksandr; Briney, Bryan; Menis, Sergey; Jones, Meaghan; Kubitz, Mike; Spencer, Skye; Adachi, Yumiko; Burton, Dennis R.; Schief, William R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Burton, Dennis R.; Schief, William R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	burton@scripps.edu; schief@scripps.edu; nemazee@scripps.edu	Ota, Takayuki/Q-5528-2017; Schief, William/ABF-3645-2020	Ota, Takayuki/0000-0001-6249-0664; Schief, William/0000-0002-1120-0150; Kalyuzhniy, Oleksandr/0000-0002-5273-1951; Spencer, Skye/0000-0001-9570-9634; Pauthner, Matthias G./0000-0001-9212-4307	IAVI Neutralizing Antibody Consortium and Center; Collaboration for AIDS Vaccine Discovery funding for the IAVI NAC; Ragon Institute of MGH, MIT and Harvard; Helen Hay Whitney Foundation; National Institute of Allergy and Infectious Diseases [R01-AI073148, P01AI081625]; CHAVI-ID [1UM1AI100663]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI094419, R01AI073148, R01AI081625, UM1AI100663, T32AI007244] Funding Source: NIH RePORTER	IAVI Neutralizing Antibody Consortium and Center; Collaboration for AIDS Vaccine Discovery funding for the IAVI NAC; Ragon Institute of MGH, MIT and Harvard; Helen Hay Whitney Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CHAVI-ID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. R. Blane, S. Kupriyanov, and G. S. Martin for technical assistance. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the IAVI Neutralizing Antibody Consortium and Center (W.R.S. and D.R.B.); the Collaboration for AIDS Vaccine Discovery funding for the IAVI NAC (W.R.S. and D.R.B.); the Ragon Institute of MGH, MIT and Harvard (D.R.B. and W.R.S.); the Helen Hay Whitney Foundation (J.G.J.); and National Institute of Allergy and Infectious Diseases grants R01-AI073148 (D.N.), P01AI081625 (W.R.S.), and CHAVI-ID 1UM1AI100663 (W.R.S. and D.R.B.). IAVI and the Scripps Research Institute are filing a patent relating to the eOD-GT8 immunogens in this manuscript, with inventors J.G.J., D.W.K., S.M., and W.R.S. Materials and information will be provided under a material transfer agreement.	Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Morelli AB, 2012, J MED MICROBIOL, V61, P935, DOI 10.1099/jmm.0.040857-0; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	40	258	270	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					156	161		10.1126/science.aac5894	http://dx.doi.org/10.1126/science.aac5894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26089355	Green Accepted			2022-12-28	WOS:000357664300035
J	Ito, T; Handa, H				Ito, Takumi; Handa, Hiroshi			MYELOID DISEASE Another action of a thalidomide derivative	NATURE			English	Editorial Material							E3 UBIQUITIN LIGASE; LENALIDOMIDE; DEGRADATION; COMPLEX	Lenalidomide effectively treats a blood disorder caused by the 5q chromosomal deletion. A study shows that the drug binds to its target, CRBN, to promote the breakdown of an enzyme encoded by a gene in the 5q region. See Article p.183	[Ito, Takumi; Handa, Hiroshi] Tokyo Med Univ, Dept Nanoparticle Translat Res, Shinjuku Ku, Tokyo 1608402, Japan	Tokyo Medical University	Ito, T (corresponding author), Tokyo Med Univ, Dept Nanoparticle Translat Res, Shinjuku Ku, Tokyo 1608402, Japan.	hhanda@tokyo-med.ac.jp		Ito, Takumi/0000-0002-9997-2664				Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Hartmann MD, 2014, J STRUCT BIOL, V188, P225, DOI 10.1016/j.jsb.2014.10.010; Ito T, 2011, CELL MOL LIFE SCI, V68, P1569, DOI 10.1007/s00018-010-0619-9; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731	12	12	12	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					167	168		10.1038/nature14628	http://dx.doi.org/10.1038/nature14628			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4ZO	26131932				2022-12-28	WOS:000357695900025
J	Porter, MM; Adriaens, D; Hatton, RL; Meyers, MA; McKittrick, J				Porter, Michael M.; Adriaens, Dominique; Hatton, Ross L.; Meyers, Marc A.; McKittrick, Joanna			Why the seahorse tail is square	SCIENCE			English	Article							FISH; SKELETAL; ROBOTS; SKIN; HIPPOCAMPUS; EVOLUTION; LIZARDS; ANATOMY; TISSUES; BONES	Whereas the predominant shapes of most animal tails are cylindrical, seahorse tails are square prisms. Seahorses use their tails as flexible grasping appendages, in spite of a rigid bony armor that fully encases their bodies. We explore the mechanics of two three-dimensional-printed models that mimic either the natural (square prism) or hypothetical (cylindrical) architecture of a seahorse tail to uncover whether or not the square geometry provides any functional advantages. Our results show that the square prism is more resilient when crushed and provides a mechanism for preserving articulatory organization upon extensive bending and twisting, as compared with its cylindrical counterpart. Thus, the square architecture is better than the circular one in the context of two integrated functions: grasping ability and crushing resistance.	[Porter, Michael M.] Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA; [Adriaens, Dominique] Univ Ghent, Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium; [Hatton, Ross L.] Oregon State Univ, Sch Mech Ind & Mfg Engn, Corvallis, OR 97330 USA; [Meyers, Marc A.; McKittrick, Joanna] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA; [Meyers, Marc A.; McKittrick, Joanna] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Meyers, Marc A.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA	Clemson University; Ghent University; Oregon State University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Porter, MM (corresponding author), Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.	mmporte@clemson.edu	Meyers, Marc A/A-2970-2016; Porter, Michael M/A-4895-2016; Adriaens, Dominique/G-1587-2010	Meyers, Marc A/0000-0003-1698-5396; Porter, Michael M/0000-0002-1607-6531; Adriaens, Dominique/0000-0003-3610-2773; McKittrick, Joanna/0000-0002-1442-3472	Department of Mechanical Engineering, Clemson University; School of Mechanical, Industrial, and Manufacturing Engineering, Oregon State University; von Liebig Entrepreneurism Center, University of California, San Diego; National Science Foundation, Division of Materials Research, Ceramics Program [1006931]; Multi-University Research Initiative through the Air Force Office of Scientific Research [AFOSR-FA9550-15-1-0009]; Agency for Innovation by Science and Technology (IWT) [IWT/SB-111249]	Department of Mechanical Engineering, Clemson University; School of Mechanical, Industrial, and Manufacturing Engineering, Oregon State University; von Liebig Entrepreneurism Center, University of California, San Diego; National Science Foundation, Division of Materials Research, Ceramics Program(National Science Foundation (NSF)); Multi-University Research Initiative through the Air Force Office of Scientific Research; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	We thank L. Matsushige (Scripps Institute of Oceanography) for providing the seahorse specimens; E. Cory and R. Sah (University of California, San Diego) and Pieter Vanderniepen, Manu Dierick, and Luc Van Hoorebeke (Centre for X-ray Tomography of the Ghent University) for assistance in microcomputed tomography of the seahorses; C. Cassidy (University of California, San Diego) for assistance in 3D printing; R. Blob and C. Mayerl (Clemson) for assistance in high-speed videography; V. Sherman (University of California, San Diego) for assistance in compression testing the solid rings; and L. Lundgren (Clemson University), C. Neutens (Ghent University), and W. Shih and R. Ochoa (University of California, San Diego) for insightful discussions. This work was partially supported by the Department of Mechanical Engineering, Clemson University; the School of Mechanical, Industrial, and Manufacturing Engineering, Oregon State University; the von Liebig Entrepreneurism Center, University of California, San Diego; the National Science Foundation, Division of Materials Research, Ceramics Program Grant 1006931; the Multi-University Research Initiative through the Air Force Office of Scientific Research, AFOSR-FA9550-15-1-0009; and the Agency for Innovation by Science and Technology (IWT), grant IWT/SB-111249. The University of California, San Diego, holds the following provisional patent: M. Porter, J. McKittrick, M. Meyers, S. Cai, D. Adriaens, T. Praet, M. De Beule, B. Verhegghe, "Seahorse Inspired Devices" (Application Number 62044058). Data reported, detailed materials and methods, as well as additional discussion and figures are included in the supplementary materials.	Anthony R., 1913, ARCH ZOOLOGIE NOTES, V51, P11; Ashley-Ross MA, 2002, J EXP ZOOL, V293, P561, DOI 10.1002/jez.10183; Bruet BJF, 2008, NAT MATER, V7, P748, DOI 10.1038/nmat2231; Bruner E, 2008, INT J MORPHOL, V26, P247, DOI 10.4067/S0717-95022008000200002; Daltorio KA, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/3/035003; Deruntz JA., 1962, J APPL MECH, V30, P391, DOI DOI 10.1115/1.3636567; Donoghue PCJ, 2006, J EXP ZOOL PART B, V306B, P278, DOI 10.1002/jez.b.21090; EMMONS LH, 1983, AM NAT, V121, P513, DOI 10.1086/284079; Hale ME, 1996, J MORPHOL, V227, P51, DOI 10.1002/(SICI)1097-4687(199601)227:1<51::AID-JMOR4>3.0.CO;2-S; HICKMAN GC, 1979, MAMMAL REV, V9, P143, DOI 10.1111/j.1365-2907.1979.tb00252.x; Hopkins JK, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/2/021001; HWANG CS, 1953, J AERONAUT SCI, V20, P819, DOI 10.2514/8.2868; Ijspeert AJ, 2014, SCIENCE, V346, P196, DOI 10.1126/science.1254486; Kleiber D, 2011, REV FISH BIOL FISHER, V21, P205, DOI 10.1007/s11160-010-9167-5; Libby T, 2012, NATURE, V481, P181, DOI 10.1038/nature10710; Long JH, 1996, J EXP BIOL, V199, P2139; Lourie S.A., 2004, GUIDE IDENTIFICATION; Mehling JS, 2006, P IEEE RAS-EMBS INT, P423; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Neutens C, 2014, J ANAT, V224, P710, DOI 10.1111/joa.12181; Onal CD, 2013, IEEE-ASME T MECH, V18, P430, DOI 10.1109/TMECH.2012.2210239; Organ JM, 2010, ANAT REC, V293, P544, DOI 10.1002/ar.21132; PETERS HM, 1951, Z VERGL PHYSIOL, V33, P207, DOI 10.1007/BF00395584; Porter MM, 2013, ACTA BIOMATER, V9, P6763, DOI 10.1016/j.actbio.2013.02.045; Praet T., 2013, THESIS GHENT U GHENT; Praet T, 2012, INT J NUMER METH BIO, V28, P1028, DOI 10.1002/cnm.2499; Quillin KJ, 1999, J EXP BIOL, V202, P661; Sadeghi A, 2013, IEEE INT CONF ROBOT, P3457, DOI 10.1109/ICRA.2013.6631060; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; SINHA DK, 1982, INT J SOLIDS STRUCT, V18, P819, DOI 10.1016/0020-7683(82)90038-5; Sire JY, 2003, BIOL REV, V78, P219, DOI 10.1017/S1464793102006073; Summers AP, 2006, FISH PHYSIOL, V23, P141, DOI 10.1016/S1546-5098(05)23005-4; Tesch M, 2009, ADV ROBOTICS, V23, P1131, DOI 10.1163/156855309X452566; Van Cauter S., 2010, 2010 SIMULIA CUST P, P770; Van Wassenbergh S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1168; Vernerey FJ, 2014, J MECH PHYS SOLIDS, V68, P66, DOI 10.1016/j.jmps.2014.01.005; Walker I. D., 1999, 1999 IEEE/ASME International Conference on Advanced Intelligent Mechatronics (Cat. No.99TH8399), P410, DOI 10.1109/AIM.1999.803204; Walker ID, 2005, P SOC PHOTO-OPT INS, V5804, P303, DOI 10.1117/12.606201; Wright C., 2007, IEEE RSJ INTERNATION; Xu K, 2006, IEEE INT CONF ROBOT, P4148, DOI 10.1109/ROBOT.2006.1642340; Zippel KC, 1999, J MORPHOL, V239, P143, DOI 10.1002/(SICI)1097-4687(199902)239:2<143::AID-JMOR3>3.0.CO;2-O	41	84	86	17	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243							aaa6683	10.1126/science.aaa6683	http://dx.doi.org/10.1126/science.aaa6683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138983				2022-12-28	WOS:000357280800053
J	Wasser, SK; Brown, L; Mailand, C; Mondol, S; Clark, W; Laurie, C; Weir, BS				Wasser, S. K.; Brown, L.; Mailand, C.; Mondol, S.; Clark, W.; Laurie, C.; Weir, B. S.			Genetic assignment of large seizures of elephant ivory reveals Africa's major poaching hotspots	SCIENCE			English	Article							LOXODONTA-AFRICANA; TRADE; DNA; ORIGIN; LOCI	Poaching of elephants is now occurring at rates that threaten African populations with extinction. Identifying the number and location of Africa's major poaching hotspots may assist efforts to end poaching and facilitate recovery of elephant populations. We genetically assign origin to 28 large ivory seizures (>= 0.5 metric tons) made between 1996 and 2014, also testing assignment accuracy. Results suggest that the major poaching hotspots in Africa may be currently concentrated in as few as two areas. Increasing law enforcement in these two hotspots could help curtail future elephant losses across Africa and disrupt this organized transnational crime.	[Wasser, S. K.; Mailand, C.; Mondol, S.] Univ Washington, Ctr Conservat Biol, Dept Biol, Seattle, WA 98195 USA; [Brown, L.; Laurie, C.; Weir, B. S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Clark, W.] Environm Secur Subdirectorate ENS, INTERPOL, Lyon, France	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wasser, SK (corresponding author), Univ Washington, Ctr Conservat Biol, Dept Biol, Box 351800, Seattle, WA 98195 USA.	wassers@u.washington.edu	Wasser, Samuel K/I-5542-2015; Weir, Bruce S/A-2894-2013	Mondol, Samrat/0000-0003-3034-9396	U.S. Fish and Wildlife Service African Elephant Conservation Act; Bosack Kruger Charitable Foundation; U.N. Office on Drugs and Crime; World Bank; Woodtiger Fund; Paul G. Allen Family Foundation; INTERPOL; Bureau of International Narcotics and Law Enforcement Affairs of the U.S. State Department; Wildcat Foundation; Fulbright-Nehru Doctoral and Professional Fellowship; National Institute of Justice [2011-DN-13X-K541]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER	U.S. Fish and Wildlife Service African Elephant Conservation Act; Bosack Kruger Charitable Foundation; U.N. Office on Drugs and Crime; World Bank(The World Bank India); Woodtiger Fund; Paul G. Allen Family Foundation; INTERPOL; Bureau of International Narcotics and Law Enforcement Affairs of the U.S. State Department; Wildcat Foundation; Fulbright-Nehru Doctoral and Professional Fellowship; National Institute of Justice(US National Institute of Justice); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. Fish and Wildlife Service African Elephant Conservation Act, the Bosack Kruger Charitable Foundation, Paul and Yaffa Maritz, the U.N. Office on Drugs and Crime, World Bank, Woodtiger Fund, Paul G. Allen Family Foundation, INTERPOL, the Bureau of International Narcotics and Law Enforcement Affairs of the U.S. State Department, Wildcat Foundation, the Fulbright-Nehru Doctoral and Professional Fellowship, and the National Institute of Justice (grant 2011-DN-13X-K541). Disclaimer: The opinions, findings, conclusions, and recommendations expressed in this publication are those of the authors and do not necessarily reflect those of the agencies or donors that funded this work. The following governments agreed to provide and share results from their ivory seizures: Malaysia, Thailand, the Philippines, Singapore, Cameroon, Taiwan, Hong Kong, Kenya, Uganda, Sri Lanka, Malawi, and Togo. A. Torkelson, S. Tucker, and M. Winters provided lab assistance. M. Stephens provided statistical advice. C. Klumb and H. J. Kim assisted in manuscript preparation. All microsatellite data are available on DRYAD with the accession no. doi:10.5061/dryad.435p4. Ivory samples are subject to restricted access (see www.whitehouse.gov/the-press-office/2014/02/11/fact-sheet-national-strategy-combating-wildlife-trafficking-commercial-b for the U.S. regulatory conditions currently governing trade in ivory, which may also apply to availability of samples). The idea for the study was conceived by S.K.W. Samples were acquired by S.K.W. and W.C. Genotyping was conducted by C. M. Statistical analyses were done by L.B., C.L., S.K.W., S. M., and B.S.W. Manuscript preparation was done by S.K.W. and L.B. Manuscript edits were done by S.K.W., L.B., S. M., W.C., C.L., and B.S.W. All microsatellite data are available on Dryad Digital Repository (http://dx.doi.org/10.5061/dryad.435p4).	Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; Comstock KE, 2000, MOL ECOL, V9, P1004, DOI 10.1046/j.1365-294x.2000.00939-8.x; Comstock KE, 2002, MOL ECOL, V11, P2489, DOI 10.1046/j.1365-294X.2002.01615.x; Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), 2014, 421 CITES SC65; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Nyakaana S, 1998, MOL ECOL, V7, P1436; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Underwood FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076539; United Nations, 2010, GLOB CRIM; Vounatsou P, 2000, Biostatistics, V1, P177, DOI 10.1093/biostatistics/1.2.177; Wasser S, 2010, SCIENCE, V327, P1331, DOI 10.1126/science.1187811; Wasser SK, 2007, P NATL ACAD SCI USA, V104, P4228, DOI 10.1073/pnas.0609714104; Wasser SK, 2009, SCI AM, V301, P68, DOI 10.1038/scientificamerican0709-68; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; Western D., 2001, DUST KILIMANJARO; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	19	124	125	4	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					84	87		10.1126/science.aaa2457	http://dx.doi.org/10.1126/science.aaa2457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26089357	Green Accepted			2022-12-28	WOS:000357280800064
J	Smith, MR; Caron, JB				Smith, Martin R.; Caron, Jean-Bernard			Hallucigenia's head and the pharyngeal armature of early ecdysozoans	NATURE			English	Article							ECHINISCUS-VIRIDISSIMUS PETERFI; 1956 HETEROTARDIGRADA; TARDIGRADES; PHYLOGENY; SHALE; ANOMALOCARIS; ARTHROPODS; MORPHOLOGY; EVOLUTION; CONE	The molecularly defined clade Ecdysozoa(1) comprises the panarthropods (Euarthropoda, Onychophora and Tardigrada) and the cycloneuralian worms (Nematoda, Nematomorpha, Priapulida, Loricifera and Kinorhyncha). These disparate phyla are united by their means of moulting, but otherwise share few morphological characters-none of which has a meaningful fossilization potential. As such, the early evolutionary history of the group as a whole is largely uncharted. Here we redescribe the 508-million-year-old stem-group onychophoran Hallucigenia sparsa(2-6) from the mid-Cambrian Burgess Shale. We document an elongate head with a pair of simple eyes, a terminal buccal chamber containing a radial array of sclerotized elements, and a differentiated foregut that is lined with acicular teeth. The radial elements and pharyngeal teeth resemble the sclerotized circumoral elements and pharyngeal teeth expressed in tardigrades(7-9), stem-group euarthropods(10-12) and cycloneuralian worms(13). Phylogenetic results indicate that equivalent structures characterized the ancestral panarthropod and, seemingly, the ancestral ecdysozoan, demonstrating the deep homology of panarthropod and cycloneuralian mouthparts, and providing an anatomical synapomorphy for the ecdysozoan supergroup.	[Smith, Martin R.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist, Palaeobiol Sect, Toronto, ON M5S 2C6, Canada; [Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Caron, Jean-Bernard] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B2, Canada	University of Cambridge; Royal Ontario Museum; University of Toronto; University of Toronto	Smith, MR (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	ms609@cam.ac.uk	Smith, Martin Ross/B-8461-2012	Smith, Martin Ross/0000-0001-5660-1727; Caron, Jean-Bernard/0000-0002-1670-5502	Willi Hennig Society; Clare College, Cambridge; NSERC [341944]; ROM DMV Acquisition and Research Fund; Endowment Fund; ROM Burgess Shale project [60]	Willi Hennig Society; Clare College, Cambridge; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); ROM DMV Acquisition and Research Fund; Endowment Fund; ROM Burgess Shale project	We thank D. Erwin, M. Florence and P. Fenton for access to material and assistance with collections, G. Kretschmann and S. Whittaker for assistance with electron microscopy, and K. Meechan for assistance with data collection. ROM specimens were collected under Parks Canada Research and Collection permits to D. Collins. TNT is made available with the sponsorship of the Willi Hennig Society. Funding for this research was provided by Clare College, Cambridge (M.R.S.), NSERC Discovery Grant no. 341944 (J.-B.C.) and the ROM DMV Acquisition and Research Fund and Endowment Fund (J.-B.C.). This is ROM Burgess Shale project number 60.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2001, ZOOL ANZ, V240, P265, DOI 10.1078/0044-5231-00034; Caron JB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1613; Conway Morris S., 1977, SPEC PAP PAL, V20; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Dewel RA, 2006, HYDROBIOLOGIA, V558, P41, DOI 10.1007/s10750-005-1406-8; DEWEL RA, 1973, TISSUE CELL, V5, P147, DOI 10.1016/S0040-8166(73)80012-6; Dewel RA, 1996, ZOOL J LINN SOC-LOND, V116, P35; Dunn CW, 2014, ANNU REV ECOL EVOL S, V45, P371, DOI 10.1146/annurev-ecolsys-120213-091627; Elzinga RJ, 1998, INT J INSECT MORPHOL, V27, P341, DOI 10.1016/S0020-7322(98)00027-0; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff P, 2008, CLADISTICS, V24, P91; Guidetti R, 2012, ZOOMORPHOLOGY, V131, P127, DOI 10.1007/s00435-012-0149-0; HOU XG, 1995, ZOOL J LINN SOC-LOND, V114, P3, DOI 10.1006/zjls.1995.0014; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; KRISTENSEN RM, 1983, Z ZOOL SYST EVOL, V21, P163; Liu JN, 2006, CHINESE SCI BULL, V51, P358, DOI 10.1007/s11434-006-0358-3; Maas A, 2007, PALAEOGEOGR PALAEOCL, V254, P288, DOI 10.1016/j.palaeo.2007.03.019; Martin C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI [10.3389/fnins.2014.00211, 10.3389/fnana.2014.00007]; Morris S. C., 1977, Palaeontology, V20, P623; Morris SC, 2012, BIOL REV, V87, P480, DOI 10.1111/j.1469-185X.2012.00220.x; Morris SC, 2010, ACTA PALAEONTOL POL, V55, P141, DOI 10.4202/app.2009.0058; Ramskold L, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P107; RAMSKOLD L, 1992, LETHAIA, V25, P221, DOI 10.1111/j.1502-3931.1992.tb01389.x; RAMSKOLD L, 1991, NATURE, V351, P225, DOI 10.1038/351225a0; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Smith MR, 2014, NATURE, V514, P363, DOI 10.1038/nature13576; Smith MR, 2013, PALEOBIOLOGY, V39, P297, DOI 10.1666/12029; Steiner M, 2012, B GEOSCI, V87, P107, DOI 10.3140/bull.geosci.1280; Vannier J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4641; Waggoner Ben, 1999, Boletin de la SEA, V26, P115; Walcott C.D., 1911, SMITHSONIAN MISCELLA, V57, P109, DOI DOI 10.1126/SCIENCE.1091376	35	39	41	4	94	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					75	+		10.1038/nature14573	http://dx.doi.org/10.1038/nature14573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26106857	Green Accepted			2022-12-28	WOS:000357169500034
J	Jain, R; Li, DQ; Gupta, M; Manderfield, LJ; Ifkovits, JL; Wang, QH; Liu, FY; Liu, Y; Poleshko, A; Padmanabhan, A; Raum, JC; Li, L; Morrisey, EE; Lu, MM; Won, KJ; Epstein, JA				Jain, Rajan; Li, Deqiang; Gupta, Mudit; Manderfield, Lauren J.; Ifkovits, Jamie L.; Wang, Qiaohong; Liu, Feiyan; Liu, Ying; Poleshko, Andrey; Padmanabhan, Arun; Raum, Jeffrey C.; Li, Li; Morrisey, Edward E.; Lu, Min Min; Won, Kyoung-Jae; Epstein, Jonathan A.			Integration of Bmp and Wnt signaling by Hopx specifies commitment of cardiomyoblasts	SCIENCE			English	Article							PROGENITOR CELLS; SMOOTH-MUSCLE; STEM-CELLS; MULTIPOTENT; DIFFERENTIATION; MOUSE; POPULATIONS; EXPRESSION; PRECURSOR; HOMEOBOX	Cardiac progenitor cells are multipotent and give rise to cardiac endothelium, smooth muscle, and cardiomyocytes. Here, we define and characterize the cardiomyoblast intermediate that is committed to the cardiomyocyte fate, and we characterize the niche signals that regulate commitment. Cardiomyoblasts express Hopx, which functions to coordinate local Bmp signals to inhibit the Wnt pathway, thus promoting cardiomyogenesis. Hopx integrates Bmp and Wnt signaling by physically interacting with activated Smads and repressing Wnt genes. The identification of the committed cardiomyoblast that retains proliferative potential will inform cardiac regenerative therapeutics. In addition, Bmp signals characterize adult stem cell niches in other tissues where Hopx-mediated inhibition of Wnt is likely to contribute to stem cell quiescence and to explain the role of Hopx as a tumor suppressor.	[Jain, Rajan; Li, Deqiang; Gupta, Mudit; Manderfield, Lauren J.; Ifkovits, Jamie L.; Wang, Qiaohong; Liu, Feiyan; Liu, Ying; Poleshko, Andrey; Padmanabhan, Arun; Li, Li; Morrisey, Edward E.; Lu, Min Min; Epstein, Jonathan A.] Univ Penn, Inst Regenerat Med, Perelman Sch Med, Dept Cell & Dev Biol,Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Raum, Jeffrey C.; Won, Kyoung-Jae] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Epstein, JA (corresponding author), Univ Penn, Inst Regenerat Med, Perelman Sch Med, Dept Cell & Dev Biol,Penn Cardiovasc Inst, Philadelphia, PA 19104 USA.	epsteinj@upenn.edu		Won, Kyoung Jae/0000-0002-2924-9630; Poleshko, Andrey/0000-0002-6656-2941; Epstein, Jonathan/0000-0001-8637-4465	NIH [K08 HL119553-02, 5-T32-GM-007170, U01 HL100405, R01 HL071546]; Cotswold Foundation; Spain Fund for Regenerative Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546, U01HL100405, R01HL087825, K08HL119553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cotswold Foundation; Spain Fund for Regenerative Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Epstein laboratory, S. Evans, R. Schwartz, N. Palpant, and C. Murry for helpful discussions and sharing of reagents; H. Aghajanian for critical reading of the manuscript; and J. Schug and the Next Generation Sequencing Core for sequencing, ChIP-seq analysis, and microarray analysis. Data associated with this manuscript are available in Gene Expression Omnibus (GSE67254). We thank J. LeLay for help with initial ChIP-seq experiments, J. Jeong and S. Eun Kwon for help with bioinformatic analyses, the Wistar Proteomics Core for mass spectrometry analysis, the Penn Cell and Developmental Biology Microscopy Core for microscopy help, and L. Guo for artistic help with the model figure. The work was supported by NIH K08 HL119553-02 to R. J., NIH 5-T32-GM-007170 to M.G., NIH U01 HL100405, R01 HL071546, the Cotswold Foundation, and the Spain Fund for Regenerative Cardiology to J.A.E.	Cagavi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110752; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Cohen ED, 2007, J CLIN INVEST, V117, P1794, DOI 10.1172/JCI31731; De Toni A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-13; Devine WP, 2014, ELIFE, V3, DOI 10.7554/eLife.03848; Epstein JA, 2010, NEW ENGL J MED, V363, P1638, DOI 10.1056/NEJMra1003941; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Genander M, 2014, CELL STEM CELL, V15, P619, DOI 10.1016/j.stem.2014.09.009; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Karamboulas C, 2013, BBA-GEN SUBJECTS, V1830, P2481, DOI 10.1016/j.bbagen.2012.11.008; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kook H, 2006, BIOCHEMISTRY-US, V45, P10584, DOI 10.1021/bi060641s; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Li N, 2014, STEM CELL REP, V3, P876, DOI 10.1016/j.stemcr.2014.09.011; Liang XQ, 2013, CIRC RES, V113, P399, DOI 10.1161/CIRCRESAHA.113.301588; Lim S. Y., 2014, METHODS MOL BIOL; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; O'Connell DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002414; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Song JF, 2014, P NATL ACAD SCI USA, V111, P7337, DOI 10.1073/pnas.1321764111; Spaeter D, 2013, NAT CELL BIOL, V15, P1098, DOI 10.1038/ncb2824; Takeda N, 2013, DEVELOPMENT, V140, P1655, DOI 10.1242/dev.093005; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yamashita K, 2013, INT J MOL SCI, V14, P23231, DOI 10.3390/ijms141223231	39	88	89	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242							aaa6071	10.1126/science.aaa6071	http://dx.doi.org/10.1126/science.aaa6071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE9NO	26113728	Green Accepted			2022-12-28	WOS:000370964800002
J	Rugani, R; Vallortigara, G; Priftis, K; Regolin, L				Rugani, Rosa; Vallortigara, Giorgio; Priftis, Konstantinos; Regolin, Lucia			Response to Comments on "Number-space mapping in the newborn chick resembles humans' mental number line"	SCIENCE			English	Editorial Material								Mangalam and Karve raise concerns on whether our results demonstrate a mental number line, suggesting auxiliary experiments. Further data analyses show that their methodological concerns are not founded. Harshaw suggests that a side bias could have affected our results. We show that this concern is also unfounded.	[Rugani, Rosa; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Trento, Italy; [Rugani, Rosa; Priftis, Konstantinos; Regolin, Lucia] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Trento; University of Padua	Rugani, R (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Trento, Italy.	rosa.rugani@unitn.it	Priftis, Konstantinos/B-7862-2008; Rugani, Rosa/C-2219-2013; Regolin, Lucia/N-9564-2019	Priftis, Konstantinos/0000-0002-5215-4621; Rugani, Rosa/0000-0001-5294-6306; Regolin, Lucia/0000-0001-8960-0309				Daisley JN, 2009, PHILOS T R SOC B, V364, P965, DOI 10.1098/rstb.2008.0229; Dharmaretnam A, 2005, BEHAV BRAIN RES, V162, P62, DOI 10.1016/j.bbr.2005.03.012; Diekamp B, 2005, CURR BIOL, V15, pR372, DOI 10.1016/j.cub.2005.05.017; Harshaw C, 2015, SCIENCE, V348, DOI 10.1126/science.aaa9565; Mangalam M, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8577; Rugani R, 2015, SCIENCE, V347, P534, DOI 10.1126/science.aaa1379	6	9	9	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242								10.1126/science.aab0002	http://dx.doi.org/10.1126/science.aab0002			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113715				2022-12-28	WOS:000356869100032
J	Chown, SL; Clarke, A; Fraser, CI; Cary, SC; Moon, KL; McGeoch, MA				Chown, Steven L.; Clarke, Andrew; Fraser, Ceridwen I.; Cary, S. Craig; Moon, Katherine L.; McGeoch, Melodie A.			The changing form of Antarctic biodiversity	NATURE			English	Review							CLIMATE-CHANGE; MICROBIAL COMMUNITIES; OCEAN BARRIERS; VICTORIA LAND; POLAR FRONT; FOOD-WEB; SOUTHERN; DIVERSITY; BIOGEOGRAPHY; DISPERSAL	Antarctic biodiversity is much more extensive, ecologically diverse and biogeographically structured than previously thought. Understanding of how this diversity is distributed in marine and terrestrial systems, the mechanisms underlying its spatial variation, and the significance of the microbiota is growing rapidly. Broadly recognizable drivers of diversity variation include energy availability and historical refugia. The impacts of local human activities and global environmental change nonetheless pose challenges to the current and future understanding of Antarctic biodiversity. Life in the Antarctic and the Southern Ocean is surprisingly rich, and as much at risk from environmental change as it is elsewhere.	[Chown, Steven L.; Moon, Katherine L.; McGeoch, Melodie A.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Clarke, Andrew] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Fraser, Ceridwen I.; Moon, Katherine L.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 2601, Australia; [Cary, S. Craig] Univ Waikato, Int Ctr Terr Antarctic Res, Hamilton 3240, New Zealand	Monash University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Australian National University; University of Waikato	Chown, SL (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.	steven.chown@monash.edu	Chown, Steven L/H-3347-2011; Chown, Steven/ABD-7646-2021; McGeoch, Melodie A/F-8353-2011	Chown, Steven L/0000-0001-6069-5105; McGeoch, Melodie A/0000-0003-3388-2241; Fraser, Ceridwen/0000-0002-6918-8959; Cary, Stephen/0000-0002-2876-2387	Australian Research Council [DP140102815, DP150103017]; Australian Research Council Discovery Early Career Fellowship [DE140101715]; NewZealand Antarctic Research Institute; New Zealand Marsden Fund; US National Science Foundation; NERC [bas010011] Funding Source: UKRI; Natural Environment Research Council [bas010011] Funding Source: researchfish; Office of Polar Programs (OPP) [1246292] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); Australian Research Council Discovery Early Career Fellowship(Australian Research Council); NewZealand Antarctic Research Institute; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); US National Science Foundation(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by Australian Research Council grants DP140102815 to S.L.C. and DP150103017 to M.A.M., an Australian Research Council Discovery Early Career Fellowship DE140101715 to C.I.F., grants from the NewZealand Antarctic Research Institute, New Zealand Marsden Fund and the US National Science Foundation to S.C.C.,and emeritus support from the British Antarctic Survey to A.C. We thank D. J. Marshall, C. Lee and H. W. Morgan for comments that improved the work.	Ainley DG, 2014, POLAR REC, V50, P92, DOI 10.1017/S0032247412000757; Ainley DG, 2013, FISH FISH, V14, P343, DOI 10.1111/j.1467-2979.2012.00474.x; Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Anesio AM, 2011, TRENDS MICROBIOL, V19, P52, DOI 10.1016/j.tim.2010.11.002; [Anonymous], 2011, SCI DIPLOMACY ANTARC; Ansorge IJ, 2003, J MARINE SYST, V39, P1, DOI 10.1016/S0924-7963(02)00243-9; Archer SDJ, 2014, FEMS MICROBIOL ECOL, V89, P451, DOI 10.1111/1574-6941.12358; Aronson RB, 2015, J BIOGEOGR, V42, P1, DOI 10.1111/jbi.12414; Barberan A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00203; Barnes DKA, 2010, GLOBAL CHANGE BIOL, V16, P3297, DOI 10.1111/j.1365-2486.2010.02198.x; Barnes DKA, 2006, GLOBAL ECOL BIOGEOGR, V15, P121, DOI 10.1111/j.1466-822x.2006.00216.x; Barrett JE, 2006, ANTARCT SCI, V18, P535, DOI 10.1017/S0954102006000587; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Bielewicz S, 2011, ISME J, V5, P1559, DOI 10.1038/ismej.2011.23; Bowman JP, 2000, FEMS MICROBIOL LETT, V183, P81; BRADY AM, 2013, EMERGING POLITICS AN; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Braun C., 2014, ANTARCTIC FUTURES, P169, DOI [DOI 10.1007/978-94-007-6582-5_7, 10.1007/978-94-007-6582-5_7]; Broyer CD, 2014, BIOGEOGRAPHIC ATLAS; Cary SC, 2010, NAT REV MICROBIOL, V8, P129, DOI 10.1038/nrmicro2281; Casanovas P, 2013, ECOGRAPHY, V36, P209, DOI 10.1111/j.1600-0587.2012.07549.x; CEP (Committee for Environmental Protection), 2011, NONN SPEC MAN; Chan YK, 2013, P NATL ACAD SCI USA, V110, P8990, DOI 10.1073/pnas.1300643110; Christner BC, 2014, NATURE, V512, P310, DOI 10.1038/nature13667; Clarke Andrew, 2009, P250; Constable AJ, 2014, GLOBAL CHANGE BIOL, V20, P3004, DOI 10.1111/gcb.12623; Convention on Biological Diversity, 2015, NAT BIOD STRAT ACT P; Convey P, 2014, ECOL MONOGR, V84, P203, DOI 10.1890/12-2216.1; Crame JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054139; Cziko PA, 2014, P NATL ACAD SCI USA, V111, P14583, DOI 10.1073/pnas.1410256111; Davies RG, 2010, GLOBAL ECOL BIOGEOGR, V19, P98, DOI 10.1111/j.1466-8238.2009.00498.x; Diaz A, 2011, DEEP-SEA RES PT II, V58, P205, DOI 10.1016/j.dsr2.2010.10.012; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fraser CI, 2014, P NATL ACAD SCI USA, V111, P5634, DOI 10.1073/pnas.1321437111; Fraser CI, 2012, TRENDS ECOL EVOL, V27, P462, DOI 10.1016/j.tree.2012.04.011; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gordon DA, 2000, MICROB ECOL, V39, P197; Green TGA, 2011, POLAR BIOL, V34, P1643, DOI 10.1007/s00300-011-1058-2; Griffiths HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066981; Halanych KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3738; Havermans C, 2011, DEEP-SEA RES PT II, V58, P230, DOI 10.1016/j.dsr2.2010.09.028; Hawes TC, 2015, J BIOGEOGR, V42, P207, DOI 10.1111/jbi.12450; Herbold CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4875; Hughes KA, 2010, GLOBAL ENVIRON CHANG, V20, P96, DOI 10.1016/j.gloenvcha.2009.09.005; Huiskes AHL, 2014, BIOL CONSERV, V171, P278, DOI 10.1016/j.biocon.2014.01.038; Hunter RL, 2008, J HERED, V99, P137, DOI 10.1093/jhered/esm119; Janosik AM, 2010, INTEGR COMP BIOL, V50, P981, DOI 10.1093/icb/icq119; Kaiser S, 2013, MAR BIOL, V160, P2295, DOI 10.1007/s00227-013-2232-6; Kawaguchi S, 2013, NAT CLIM CHANGE, V3, DOI 10.1038/NCLIMATE1937; Kennicutt MC, 2014, NATURE, V512, P23, DOI 10.1038/512023a; Lauro FM, 2011, ISME J, V5, P879, DOI 10.1038/ismej.2010.185; Laybourn-Parry J, 2007, PHILOS T R SOC B, V362, P2273, DOI 10.1098/rstb.2006.1945; Lecointre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068787; Lee CK, 2012, ISME J, V6, P1046, DOI 10.1038/ismej.2011.170; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Lefebvre V, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002345; Lewis PN, 2004, MAR POLLUT BULL, V49, P999, DOI 10.1016/j.marpolbul.2004.07.001; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Lynch HJ, 2012, ECOLOGY, V93, P1367; Marshall DJ, 2012, ANNU REV ECOL EVOL S, V43, P97, DOI 10.1146/annurev-ecolsys-102710-145004; McGaughran Angela, 2011, Insects, V2, P62, DOI 10.3390/insects2020062; Molina-Montenegro MA, 2014, POLAR RES, V33, DOI 10.3402/polar.v33.21425; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Nielsen UN, 2013, ECOL LETT, V16, P409, DOI 10.1111/ele.12058; O'Hara TD, 2013, POLAR BIOL, V36, P321, DOI 10.1007/s00300-012-1261-9; Page TJ, 2002, POLAR BIOL, V25, P818, DOI 10.1007/s00300-002-0414-7; Pearce DA, 2009, FEMS MICROBIOL ECOL, V69, P143, DOI 10.1111/j.1574-6941.2009.00706.x; Peat HJ, 2007, J BIOGEOGR, V34, P132, DOI 10.1111/j.1365-2699.2006.01565.x; Peck Lloyd S., 2012, P157; Pennycuick C. J., 1987, COMP PHYSL LIFE WATE, V9, P371; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; Pierrat B, 2013, J BIOGEOGR, V40, P1374, DOI 10.1111/jbi.12088; Pisa S, 2014, POLAR BIOL, V37, P1469, DOI 10.1007/s00300-014-1537-3; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Poulin E, 2014, GLOBAL PLANET CHANGE, V123, P392, DOI 10.1016/j.gloplacha.2014.07.017; Puig-Marco R, 2014, MAR GENOM, V17, P73, DOI 10.1016/j.margen.2014.04.008; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Rogers Alex D., 2012, P417; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Saba GK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5318; Shaw JD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001888; Shin JI, 2014, POLAR BIOL, V37, P1579, DOI 10.1007/s00300-014-1543-5; Smith WO, 2014, ANNU REV MAR SCI, V6, P469, DOI 10.1146/annurev-marine-010213-135114; Stevens M.I., 2006, P177, DOI 10.1007/1-4020-5277-4_9; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Terauds A, 2012, DIVERS DISTRIB, V18, P726, DOI 10.1111/j.1472-4642.2012.00925.x; Thatje S, 2008, ECOLOGY, V89, P682, DOI 10.1890/07-0498.1; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; Tin T, 2009, ANTARCT SCI, V21, P3, DOI 10.1017/S0954102009001722; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Turner J, 2014, POLAR REC, V50, P237, DOI 10.1017/S0032247413000296; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; Varin T, 2012, APPL ENVIRON MICROB, V78, P549, DOI 10.1128/AEM.06354-11; Velasco-Castrillon A, 2014, POLAR BIOL, V37, P1517, DOI 10.1007/s00300-014-1544-4; Velasco-Castrillon A, 2014, SOIL BIOL BIOCHEM, V70, P272, DOI 10.1016/j.soilbio.2013.12.016; Villaescusa JA, 2010, INT MICROBIOL, V13, P67, DOI 10.2436/20.1501.01.112; Volonterio O, 2013, POLAR BIOL, V36, P1125, DOI 10.1007/s00300-013-1334-4; Vyverman W, 2010, POLAR SCI, V4, P103, DOI 10.1016/j.polar.2010.03.006; Wan E, 2010, CURR ISSUES MOL BIOL, V12, P135; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wilkins D, 2013, FEMS MICROBIOL REV, V37, P303, DOI 10.1111/1574-6976.12007; Wilson NG, 2007, MAR BIOL, V152, P895, DOI 10.1007/s00227-007-0742-9; Wilson NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080277; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Yergeau E, 2007, FEMS MICROBIOL ECOL, V59, P436, DOI 10.1111/j.1574-6941.2006.00200.x; Zablocki O, 2014, APPL ENVIRON MICROB, V80, P6888, DOI 10.1128/AEM.01525-14	110	161	167	4	212	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					427	434		10.1038/nature14505	http://dx.doi.org/10.1038/nature14505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108852	Green Accepted			2022-12-28	WOS:000356782900040
J	Holmes, D				Holmes, David			4 BIG QUESTIONS ADDICTION	NATURE			English	Editorial Material																			0	6	6	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					S63	S63		10.1038/522S63a	http://dx.doi.org/10.1038/522S63a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2OC	26107101	Bronze			2022-12-28	WOS:000356782900009
J	Shively, HL				Shively, Henry L.			Ben Franklin's Views (Reprinted from JAMA, vol 64, pg 2085-2086, 1915)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1915, JAMA, V64, P2085	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2499	2499		10.1001/jama.2014.11814	http://dx.doi.org/10.1001/jama.2014.11814			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103043				2022-12-28	WOS:000356663600027
J	Steineck, I; Cederholm, J; Eliasson, B; Rawshani, A; Eeg-Olofsson, K; Svensson, AM; Zethelius, B; Avdic, T; Landin-Olsson, M; Jendle, J; Gudbjornsdottir, S				Steineck, Isabelle; Cederholm, Jan; Eliasson, Bjorn; Rawshani, Araz; Eeg-Olofsson, Katarina; Svensson, Ann-Marie; Zethelius, Bjorn; Avdic, Tarik; Landin-Olsson, Mona; Jendle, Johan; Gudbjornsdottir, Soffia		Swedish Natl Diabet Register	Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEVERE HYPOGLYCEMIA; GLYCEMIC CONTROL; RADICAL PROSTATECTOMY; MYOCARDIAL-INFARCTION; INFUSION; MELLITUS; DISEASE; GLUCOSE; RADIOTHERAPY; METAANALYSIS	OBJECTIVE To investigate the long term effects of continuous subcutaneous insulin infusion (insulin pump therapy) on cardiovascular diseases and mortality in people with type 1 diabetes. Design Observational study. SETTING Swedish National Diabetes Register, Sweden 2005-12. PARTICIPANTS 18 168 people with type 1 diabetes, 2441 using insulin pump therapy and 15 727 using multiple daily insulin injections. MAIN OUTCOME MEASURES Cox regression analysis was used to estimate hazard ratios for the outcomes, with stratification of propensity scores including clinical characteristics, risk factors for cardiovascular disease, treatments, and previous diseases. RESULTS Follow-up was for a mean of 6.8 years until December 2012, with 114 135 person years. With multiple daily injections as reference, the adjusted hazard ratios for insulin pump treatment were significantly lower: 0.55 (95% confidence interval 0.36 to 0.83) for fatal coronary heart disease, 0.58 (0.40 to 0.85) for fatal cardiovascular disease (coronary heart disease or stroke), and 0.73 (0.58 to 0.92) for all cause mortality. Hazard ratios were lower, but not significantly so, for fatal or non-fatal coronary heart disease and fatal or non-fatal cardiovascular disease. Unadjusted absolute differences were 3.0 events of fatal coronary heart disease per 1000 person years; corresponding figures were 3.3 for fatal cardiovascular disease and 5.7 for all cause mortality. When lower body mass index and previous cardiovascular diseases were excluded, results of subgroup analyses were similar to the results from complete data. A sensitivity analysis of unmeasured confounders in all individuals showed that an unmeasured confounders with hazard ratio of 1.3 would have to be present in > 80% of the individuals treated with multiple daily injections versus not presence in those treated with pump therapy to invalidate the significantly lower hazard ratios for fatal cardiovascular disease. Data on patient education and frequency of blood glucose monitoring were missing, which might have influenced the observed association. CONCLUSION Among people with type 1 diabetes use of insulin pump therapy is associated with lower cardiovascular mortality than treatment with multiple daily insulin injections.	[Steineck, Isabelle] Aarhus Univ Hosp, Dept Endocrinol, DK-8000 Aarhus, Denmark; [Cederholm, Jan] Uppsala Univ, Dept Publ Hlth & Caring Sci Family & Prevent Med, Uppsala, Sweden; [Eliasson, Bjorn; Eeg-Olofsson, Katarina; Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, Gothenburg, Sweden; [Rawshani, Araz; Svensson, Ann-Marie; Avdic, Tarik; Gudbjornsdottir, Soffia] Natl Diabet Register, Ctr Registers, Gothenburg, Sweden; [Zethelius, Bjorn] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden; [Zethelius, Bjorn] Med Prod Agcy, Uppsala, Sweden; [Landin-Olsson, Mona] Lund Univ, Dept Clin Sci, Lund, Sweden; [Jendle, Johan] Univ Orebro, Fac Med & Hlth Sci, SE-70182 Orebro, Sweden	Aarhus University; Uppsala University; Sahlgrenska University Hospital; University of Gothenburg; Uppsala University; Medical Products Agency; Lund University; Orebro University	Steineck, I (corresponding author), Aarhus Univ Hosp, Dept Endocrinol, DK-8000 Aarhus, Denmark.	isabelle.steineck@iname.com	rawshani, araz/HGE-5637-2022; Rawshani, Araz/AAW-3229-2021; Jendle, Johan/AAN-3375-2020; Jendle, Johan/H-8310-2019; Eliasson, Bjorn/H-5783-2016	Jendle, Johan/0000-0003-1025-1682; Rawshani, Araz/0000-0003-2066-3533; Steineck, Isabelle/0000-0001-5557-0885; Eliasson, Bjorn/0000-0003-2569-4160	European Association for the study of diabetes; Swedish Association of Local Authorities and Regions	European Association for the study of diabetes; Swedish Association of Local Authorities and Regions	This study received funding from the European Association for the study of diabetes. The Swedish National Diabetes Register is funded by the Swedish Association of Local Authorities and Regions.	Abdollah F, 2012, INT J UROL, V19, P836, DOI 10.1111/j.1442-2042.2012.03052.x; Allison PD, 2010, SURVIVAL ANAL USING; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; [Anonymous], 2013, ANN REP 2013; Arbab-Zadeh A, 2012, CIRCULATION, V125, P1147, DOI 10.1161/CIRCULATIONAHA.111.047431; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Berglund P, 2014, MULTIPLE IMPUTATION; Bode BW, 1996, DIABETES CARE, V19, P324, DOI 10.2337/diacare.19.4.324; Bruttomesso D, 2002, DIABETIC MED, V19, P628, DOI 10.1046/j.1464-5491.2002.00750.x; Cederholm J, 2011, DIABETIC MED, V28, P1213, DOI 10.1111/j.1464-5491.2011.03342.x; Chow E, 2014, DIABETES, V63, P1738, DOI 10.2337/db13-0468; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; Eklind-Cervenka M, 2011, JAMA-J AM MED ASSOC, V305, P175, DOI 10.1001/jama.2010.1949; Ekstrom N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002688; Eliasson B, 2014, DIABETES RES CLIN PR, V106, pS291, DOI 10.1016/S0168-8227(14)70732-6; Faries D, 2010, ANAL OBSERVATIONAL H; Fatourechi MM, 2009, J CLIN ENDOCR METAB, V94, P729, DOI 10.1210/jc.2008-1415; Fredheim S, 2015, ACTA DIABETOL, V52, P591, DOI 10.1007/s00592-014-0697-5; Geistanger A, 2008, CLIN CHEM, V54, P1379, DOI 10.1373/clinchem.2008.103556; Gimenez M, 2012, DIABETES RES CLIN PR, V96, pE23, DOI 10.1016/j.diabres.2012.01.014; Gruden G, 2012, DIABETES CARE, V35, P1598, DOI 10.2337/dc11-1531; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; Jeitler K, 2008, DIABETOLOGIA, V51, P941, DOI 10.1007/s00125-008-0974-3; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Lung TWC, 2014, DIABETES CARE, V37, P2974, DOI 10.2337/dc14-0405; Medical Advisory Secretariat, 2009, Ont Health Technol Assess Ser, V9, P1; Mellbin LG, 2013, EUR HEART J, V34, P3137, DOI 10.1093/eurheartj/eht332; Merlo J, 2000, EUR J EPIDEMIOL, V16, P235, DOI 10.1023/A:1007634722658; Misso ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005103.pub2; Monami M, 2010, ACTA DIABETOL, V47, pS77, DOI 10.1007/s00592-009-0132-5; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Pickup JC, 2008, DIABETIC MED, V25, P765, DOI 10.1111/j.1464-5491.2008.02486.x; Pickup JC, 2012, NEW ENGL J MED, V366, P1616, DOI 10.1056/NEJMct1113948; Plotnick LP, 2003, DIABETES CARE, V26, P1142, DOI 10.2337/diacare.26.4.1142; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Snow R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003583; Sooriakumaran P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1502; Stahn A, 2014, DIABETES CARE, V37, P516, DOI 10.2337/dc13-0600; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Yeh Hsin-Chieh, 2012, Ann Intern Med, V157, P336	44	136	138	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2015	350								h3234	10.1136/bmj.h3234	http://dx.doi.org/10.1136/bmj.h3234			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NK	26100640	Green Published, hybrid			2022-12-28	WOS:000357158600005
J	Rihel, J; Bendor, D				Rihel, Jason; Bendor, Daniel			Flies Sleep on It, or Fuhgeddaboudit!	CELL			English	Editorial Material							MEMORY CONSOLIDATION; DROSOPHILA; NEED	Many studies in diverse organisms, including humans, have demonstrated a fundamental role for sleep in the formation of memories. A new study by Berry et al. indicates that, in fruit flies, sleep accomplishes this in part by preventing an active process of forgetting.	[Rihel, Jason] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Bendor, Daniel] UCL, Dept Expt Psychol, London WC1H 0AP, England	University of London; University College London; University of London; University College London	Rihel, J (corresponding author), UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England.	j.rihel@ucl.ac.uk	Rihel, Jason/G-7106-2011; Zebrafish, UCL/A-3125-2009	Rihel, Jason/0000-0003-4067-2066				Berry JA, 2015, CELL, V161, P1656, DOI 10.1016/j.cell.2015.05.027; Berry JA, 2014, PROG BRAIN RES, V208, P39, DOI 10.1016/B978-0-444-63350-7.00002-4; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011	10	1	1	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1498	1500		10.1016/j.cell.2015.06.011	http://dx.doi.org/10.1016/j.cell.2015.06.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091032	Green Submitted, Bronze			2022-12-28	WOS:000356618200006
J	[Anonymous]				[Anonymous]			GLOBAL OVERVIEW	NATURE			English	Editorial Material																			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S2	S3		10.1038/522S2a	http://dx.doi.org/10.1038/522S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083853	Bronze			2022-12-28	WOS:000356425400002
J	[Anonymous]				[Anonymous]			Appendicitis and Infectious Diseases (Reprinted from JAMA, vol 38, pg 181, 1902)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1902, JAMA, V38, P181	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2384	2384		10.1001/jama.2014.11828	http://dx.doi.org/10.1001/jama.2014.11828			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080353				2022-12-28	WOS:000356300200033
J	Sherman, SM; Castanon, A; Moss, E; Redman, CWE				Sherman, Susan M.; Castanon, Alejandra; Moss, Esther; Redman, Charles W. E.			Cervical cancer is not just a young woman's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sherman, Susan M.] Keele Univ, Sch Psychol, Keele ST5 5BG, Staffs, England; [Castanon, Alejandra] Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London, England; [Moss, Esther] Univ Hosp Leicester NHS Trust, Dept Gynaecol Oncol, Leicester, Leics, England; [Redman, Charles W. E.] Royal Stoke Univ Hosp, Dept Obstet & Gynaecol, Stoke On Trent, Staffs, England	Keele University; University of London; Queen Mary University London; University Hospitals of Leicester NHS Trust; University of Leicester; Royal Stoke University Hospital	Sherman, SM (corresponding author), Keele Univ, Sch Psychol, Keele ST5 5BG, Staffs, England.	s.m.sherman@keele.ac.uk	Moss, Esther/ABA-6987-2020; Sherman, Sue/ABH-3490-2020; Castanon, Alejandra/G-1506-2013	Moss, Esther/0000-0002-2650-0172; Castanon, Alejandra/0000-0002-1101-6548; Sherman, Susan/0000-0001-6708-3398	Cancer Research UK [16892] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Cancer Research UK, 2014, CERV CANC INC STAT; Cancer Research UK, 2012, BREAST CANC SCREEN S; Castanon A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001585; Elit L, 2014, MATURITAS, V79, P413, DOI 10.1016/j.maturitas.2014.09.012; Haguenoer K, 2014, BRIT J CANCER, V111, P2187, DOI 10.1038/bjc.2014.510; Karwalajtys T, 2006, SEX TRANSM INFECT, V82, P337, DOI 10.1136/sti.2005.019430; Lancucki L, 2012, J MED SCREEN, V19, P89, DOI 10.1258/jms.2012.012028; Low EL, 2012, EUR J CANCER, V48, P3001, DOI 10.1016/j.ejca.2012.05.004; Marlow LAV, 2012, J MED SCREEN, V19, P184, DOI 10.1258/jms.2012.012095; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; NHS Cervical Screening Programme, 2012, STAT B; NHS Cervical Screening Programme, 2012, AUD INV CERV CANC; Office of National Statistics, 2014, INT LIF TABL 2014; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; STEVENS JC, 1987, PSYCHOL AGING, V2, P36, DOI 10.1037/0882-7974.2.1.36; von Wagner C, 2013, AGE AGEING, V42, P770, DOI 10.1093/ageing/aft132; Waller J, 2004, PREV MED, V38, P745, DOI 10.1016/j.ypmed.2004.01.003	17	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2015	350								h2729	10.1136/bmj.h2729	http://dx.doi.org/10.1136/bmj.h2729			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2NQ	26077735	Green Accepted			2022-12-28	WOS:000356781600001
J	Leder, BZ; Tsai, JN; Uihlein, AV; Wallace, PM; Lee, H; Neer, RM; Burnett-Bowie, SAM				Leder, Benjamin Z.; Tsai, Joy N.; Uihlein, Alexander V.; Wallace, Paul M.; Lee, Hang; Neer, Robert M.; Burnett-Bowie, Sherri-Ann M.			Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial	LANCET			English	Article							PARATHYROID-HORMONE; FRACTURE RISK; BONE MASS; WORLDWIDE PREVALENCE; HIP FRACTURE; WOMEN; ALENDRONATE; BMD; THERAPY; DENSITY	Background Unlike most chronic diseases, osteoporosis treatments are generally limited to a single drug at a fixed dose and frequency. Nonetheless, no approved therapy is able to restore skeletal integrity in most osteoporotic patients and the long-term use of osteoporosis drugs is controversial. Thus, many patients are treated with the sequential use of two or more therapies. The DATA study showed that combined teriparatide and denosumab increased bone mineral density more than either drug alone. Discontinuing teriparatide and denosumab, however, results in rapidly declining bone mineral density. In this DATA-Switch study, we aimed to assess the changes in bone mineral density in postmenopausal osteoporotic women who transitioned between treatments. Methods This randomised controlled trial (DATA-Switch) is a preplanned extension of the denosumab and teriparatide administration study (DATA), in which 94 postmenopausal osteoporotic women were randomly assigned to receive 24 months of teriparatide (20 mg daily), denosumab (60 mg every 6 months), or both drugs. In DATA-Switch, women originally assigned to teriparatide received denosumab (teriparatide to denosumab group), those originally assigned to denosumab received teriparatide (denosumab to teriparatide group), and those originally assigned to both received an additional 24 months of denosumab alone (combination to denosumab group). Bone mineral density at the spine, hip, and wrist were measured 6 months, 12 months, 18 months, and 24 months after the drug transitions as were biochemical markers of bone turnover. The primary endpoint was the percent change in posterior-anterior spine bone mineral density over 4 years. Between-group changes were assessed by one-way analysis of variance in our modified intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT00926380. Findings Between Sept 27, 2011, and Jan 28, 2013, eligible women from the DATA study were enrolled into DATA-Switch. Of 83 potential enrollees from the DATA study, 77 completed at least one post-baseline visit. After 48 months, the primary outcome of mean spine bone mineral density increased by 18.3% (95% CI 14.9-21.8) in 27 women in the teriparatide to denosumab group, 14.0% (10.9-17.2) in 27 women the denosumab to teriparatide group, and 16.0% (14.0-18.0) in 23 women in the combination to denosumab group, although this increase did not differ significantly between groups (for between-group comparisons, p=0.13 for the teriparatide to denosumab group vs the denosumab to teriparatide group, p=0.30 for the teriparatide to denosumab group vs the combination to denosumab group, and p=0.41 for the denosumab to teriparatide group vs the combination to denosumab group). For the bone mineral density secondary outcomes, total hip bone mineral density increased more in the teriparatide to denosumab group (6.6% [95% CI 5.3-7.9]) than in the denosumab to teriparatide group (2.8% [1.3-4.2], p=0.0002), but had the greatest increase in the combination to denosumab group (8.6% [7.1-10.0]; p=0.0446 vs the teriparatide to denosumab group, p<0.0001 vs the denosumab to teriparatide group). Similarly, femoral neck bone mineral density increased more in the teriparatide to denosumab group (8.3% [95% CI 6.1-10.5]) and the combination to denosumab group (9.1% [6.1-12.0]) than in the denosumab to teriparatide group (4.9% [2.2-7.5]; p=0.0447 for teriparatide to denosumab vs denosumab to teriparatide, p=0.0336 for combination to denosumab vs denosumab to teriparatide). Differences between the combination to denosumab group and the teriparatide to denosumab group did not differ significantly (p=0.67). After 48 months, radius bone mineral density was unchanged in the teriparatide to denosumab group (0.0% [95% CI -1.3 to 1.4]), whereas it decreased by -1.8% (-5.0 to 1.3) in the denosumab to teriparatide group, and increased by 2.8% (1.2-4.4) in the combination to denosumab group (p=0.0075 for the teriparatide to denosumab group vs the combination to denosumab group; p=0.0099 for the denosumab to teriparatide group vs the combination to denosumab group). One participant in the denosumab to teriparatide group had nephrolithiasis, classified as being possibly related to treatment. Interpretation In postmenopausal osteoporotic women switching from teriparatide to denosumab, bone mineral density continued to increase, whereas switching from denosumab to teriparatide results in progressive or transient bone loss. These results should be considered when choosing the initial and subsequent management of postmenopausal osteoporotic patients.	[Leder, Benjamin Z.; Tsai, Joy N.; Uihlein, Alexander V.; Wallace, Paul M.; Neer, Robert M.; Burnett-Bowie, Sherri-Ann M.] Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA; [Lee, Hang] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Leder, BZ (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Thier 1051, Boston, MA 02114 USA.	bzleder@partners.org		Burnett-Bowie, Sherri-Ann/0000-0002-0064-096X	Amgen; Eli Lilly; National Institutes of Health; National Institutes of Health from the National Center for Research Resources [ULI RR025758]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR067847] Funding Source: NIH RePORTER	Amgen(Amgen); Eli Lilly(Eli Lilly); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding Amgen, Eli Lilly, and National Institutes of Health.; This study was funded by investigator-initiated grants from Amgen and Eli Lilly and by National Institutes of Health Grant ULI RR025758 from the National Center for Research Resources.	Austin M, 2012, J BONE MINER RES, V27, P687, DOI 10.1002/jbmr.1472; Bala Y, 2014, J BONE MINER RES, V29, P1356, DOI 10.1002/jbmr.2167; Berger C, 2009, J BONE MINER RES, V24, P361, DOI [10.1359/jbmr.081004, 10.1359/JBMR.081004]; Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623; Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Boonen S, 2008, J CLIN ENDOCR METAB, V93, P852, DOI 10.1210/jc.2007-0711; Chen PQ, 2006, J BONE MINER RES, V21, P1785, DOI 10.1359/JBMR.060802; Cosman F, 2011, J BONE MINER RES, V26, P503, DOI 10.1002/jbmr.238; Cosman F, 2009, J CLIN ENDOCR METAB, V94, P3772, DOI 10.1210/jc.2008-2719; Crandall CJ, 2014, ANN INTERN MED, V161, P711, DOI 10.7326/M14-0317; Eastell R, 2009, J BONE MINER RES, V24, P726, DOI 10.1359/JBMR.081215; Ensrud KE, 2004, J BONE MINER RES, V19, P1259, DOI 10.1359/JBMR.040326; Ettinger B, 2004, J BONE MINER RES, V19, P745, DOI 10.1359/JBMR.040117; Finkelstein JS, 2010, J CLIN ENDOCR METAB, V95, P1838, DOI 10.1210/jc.2009-1703; Garnero P, 2000, J BONE MINER RES, V15, P1526, DOI 10.1359/jbmr.2000.15.8.1526; Johnell O, 2004, OSTEOPOROSIS INT, V15, P897, DOI 10.1007/s00198-004-1627-0; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Leder BZ, 2014, J CLIN ENDOCR METAB, V99, P1694, DOI 10.1210/jc.2013-4440; Leder BZ, 2009, J CLIN ENDOCR METAB, V94, P2915, DOI 10.1210/jc.2008-2630; Miller PD, 2008, J CLIN ENDOCR METAB, V93, P3785, DOI 10.1210/jc.2008-0353; Miller PD, 2008, BONE, V43, P222, DOI 10.1016/j.bone.2008.04.007; Nancollas GH, 2006, BONE, V38, P617, DOI 10.1016/j.bone.2005.05.003; Nguyen TV, 2005, J BONE MINER RES, V20, P1195, DOI 10.1359/JBMR.050215; Obermayer-Pietsch BM, 2008, J BONE MINER RES, V23, P1591, DOI 10.1359/JBMR.080506; Papapoulos S, 2012, J BONE MINER RES, V27, P694, DOI 10.1002/jbmr.1479; Rittmaster RS, 2000, J CLIN ENDOCR METAB, V85, P2129, DOI 10.1210/jc.85.6.2129; Sorensen OH, 2003, BONE, V32, P120, DOI 10.1016/S8756-3282(02)00946-8; Sornay-Rendu E, 2005, J BONE MINER RES, V20, P1929, DOI 10.1359/JBMR.050704; Tsai JN, 2013, LANCET, V382, P50, DOI 10.1016/S0140-6736(13)60856-9; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619; Yates J, 2004, OBSTET GYNECOL, V103, P440, DOI 10.1097/01.AOG.0000114986.14806.37; Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419	36	286	295	1	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1147	1155		10.1016/S0140-6736(15)61120-5	http://dx.doi.org/10.1016/S0140-6736(15)61120-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5GE	26144908	Green Accepted			2022-12-28	WOS:000361368000029
J	Crowley, RA; Kirschner, N				Crowley, Ryan A.; Kirschner, Neil		Amer Coll Phys	The Integration of Care for Mental Health, Substance Abuse, and Other Behavioral Health Conditions into Primary Care: Executive Summary of an American College of Physicians Position Paper	ANNALS OF INTERNAL MEDICINE			English	Review							COLLABORATIVE CARE; COST-EFFECTIVENESS; OLDER-ADULTS; INTERVENTION; PSYCHIATRY; DEPRESSION; MEDICAID; OPIOIDS; PEOPLE	Behavioral health care includes care for patients around mental health and substance abuse conditions, health behavior change, life stresses and crises, and stress-related physical symptoms. Mental and substance use disorders alone are estimated to surpass all physical diseases as a major cause of worldwide disability by 2020. The literature recognizes the importance of the health care system effectively addressing behavioral health conditions. Recently, there has been a call for the use of the primary care delivery platform and the related patient-centered medical home model to effectively address these conditions. This position paper focuses on the issue of better integration of behavioral health into the primary care setting. It provides an environmental scan of the current state of conditions included in the concept of behavioral health and examines the arguments for and barriers to increased integration into primary care. It also examines various approaches of integrated care delivery and offers a series of policy recommendations that are based on the reviewed information and evidence to inform the actions of the American College of Physicians and its members regarding advocacy, research, and practice.	[Crowley, Ryan A.; Kirschner, Neil] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA	American College of Physicians	Crowley, RA (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	rcrowley@acponline.org			ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Agency for Healthcare Research and Quality, INT CHER HLTH SYST; Agency for Healthcare Research and Quality, 2010, FUT RES NEEDS INT ME; Agency for Healthcare Research and Quality, 2008, INT MENT HLTH SUBST; Agency for Healthcare Research and Quality, 2012, EXP CALL INT MENT HL; Agency for Healthcare Research and Quality, AC INT BEH HLTH PRIM; Agency for Healthcare Research and Quality, 2013, LEX BEH HLTH PRIM CA; American Academy of Family Physicians, 2011, MENT HLTH CAR SERV F; American College of Physicians, 1998, ILL DRUG AB NAT DRUG; American Psychiatric Association, 2010, PSYCH PRIM CAR INT L; American Psychological Association, 2007, APA PRINC HLTH CAR R; [Anonymous], 2010, Psychiatr Serv, V61, P1042, DOI 10.1176/ps.2010.61.10.1042; [Anonymous], 2014, CRIS SERV EFF COST E; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Bachrach D., 2014, STATE STRATEGIES INT; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Baird M, 2014, ANN FAM MED, V12, P183, DOI 10.1370/afm.1634; Barry KL, 1999, BRIEF INT BRIEF THER, V34; Bauer BJ, 2007, MIND BOD REUN IMPR C; Belfort R, 2014, INT PHYS BEH HLTH ST; Blount A., 2003, FAMILIES SYSTEMS HEA, V21, P121, DOI DOI 10.1037/1091-7527.21.2.121; Blount FA, 2009, J CLIN PSYCHOL MED S, V16, P113, DOI 10.1007/s10880-008-9142-7; Butkus R, 2014, ANN INTERN MED, V160, P858, DOI 10.7326/M14-0216; Butler M, 2008, EVIDENCE REPORTS TEC; Byrne P, 1997, J ROY SOC MED, V90, P618, DOI 10.1177/014107689709001107; California Mental Health Services Authority, 2007, WHY PURS INT BEH CAR; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Centers for Disease Control and Prevention, OV OB AD OB FACTS; Centers for Disease Control and Prevention, 1965, SMOK TOB US TRENDS C; Centers for Disease Control and Prevention, 2010, UN DRUG POIS US; Chapa T., 2004, MENTAL HLTH SERVICES; Chiles JA, 1999, CLIN PSYCHOL-SCI PR, V6, P204, DOI 10.1093/clipsy/6.2.204; Cicero TJ, 2012, NEW ENGL J MED, V367, P187, DOI 10.1056/NEJMc1204141; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Corlette S, 2014, NARROW NETWORKS NEW; Cunningham PJ, 2009, HEALTH AFFAIR, V28, pW490, DOI 10.1377/hlthaff.28.3.w490; Davis M, 2013, J AM BOARD FAM MED, V26, P588, DOI 10.3122/jabfm.2013.05.130028; DeBano L, APA NEWS STIGMA SERI; Drug Enforcement Administration Department of Justice, 2014, Fed Regist, V79, P49661; Druss BG, 2011, 11 RW JOHNS FDN; Ducat L, 2014, JAMA-J AM MED ASSOC, V312, P691, DOI 10.1001/jama.2014.8040; Fields Gary, 2014, WALL STREET J; Fleming MF, 2004, ALCOHOL RES HEALTH, V28, P57; Freeman DS, 2007, BLEND BEH HLTH PRIM; Gallo JJ, 2004, ANN FAM MED, V2, P305, DOI 10.1370/afm.116; Garfield RL, 2011, AM J PSYCHIAT, V168, P486, DOI 10.1176/appi.ajp.2010.10060792; Glover Robert W., 2012, P STAT BUDG CRIS BEH; Hartman B, 2014, MEDPAGE TODAY; Heisler E. J., 2015, MENTAL HLTH WORKFORC; Hocking Barbara, 2003, Med J Aust, V178, pS47; Hogan M., 2003, ACHIEVING PROMISE TR; Holm-Hansen C, 2009, STIGMA REDUCTION PRO; Honberg R, 2011, STAT MENT HLTH CUTS; Hung DY, 2007, MILBANK Q, V85, P69, DOI 10.1111/j.1468-0009.2007.00477.x; Hyde P.S., 2013, C NAT SUBST AB MENT; Inciardi JA, 2009, PAIN MED, V10, P537, DOI 10.1111/j.1526-4637.2009.00603.x; Institute of Medicine Committee on Crossing the Quality Chasm Adaptation to Mental Health and Addictive Disorders, 2006, IMPR QUAL HLTH CAR M; Kaiser Family Foundation, 2014, STAT STAT ACT MED EX; Kathol RG, 2014, ANN FAM MED, V12, P172, DOI 10.1370/afm.1619; Katon W, 2006, DIABETES CARE, V29, P265, DOI 10.2337/diacare.29.02.06.dc05-1572; Katon W, 2012, ARCH GEN PSYCHIAT, V69, P506, DOI 10.1001/archgenpsychiatry.2011.1548; Kinman C. R., 2015, PROVIDER PRACTICE LE; Kirschner N, 2014, ANN INTERN MED, V160, P198, DOI 10.7326/M13-2209; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Laderman M, 2014, INTEGRATING PHYS BEH; Lamb HR, 2005, J AM ACAD PSYCHIATRY, V33, P529; Letourneau LM, 2012, ADV HLTH CAR REF MAI; Mauch D., 2008, REIMBURSEMENT MENTAL; Mechanic D, 2014, HEALTH AFFAIR, V33, P1416, DOI 10.1377/hlthaff.2014.0504; Melek SP, 2014, EC IMPACT INTEGRATED; Missouri Department of Mental Health, PAV WAY HLTH HOM; Moran M, 2013, PSYCHIAT NEWS; Muhuri P.K., 2013, CBHSQ DATA REV; Nardone Mike, 2014, INTEGRATING PHYS BEH; National Alliance on Mental Illness, 2013, ESS HLTH BEN; National Alliance on Mental Illness, 2011, COV CAR MENT HLTH SE; National Alliance on Mental Illness, PSYCH TREATM; National Association of Community Health Centers, 2011, NACHC 2010 ASS BEH H; National Committee for Quality Assurance, PCMH 2011 PCMH 2014; National Council for Community Behavioral Healthcare, 2012, HIT AD READ MEAN US; National Institute of Drug Abuse, HER WHAT IS SCOP HER; National Institute of Mental Health, NUMB COUNT MENT DIS; National Institute on Drug Abuse, PRINC DRUG ADD TREAT; Nicholson NR, 2012, J PRIM PREV, V33, P137, DOI 10.1007/s10935-012-0271-2; OConnell ME, 2009, PREVENTING MENTAL, EMOTIONAL, AND BEHAVIORAL DISORDERS AMONG YOUNG PEOPLE: PROGRESS AND POSSIBILITIES, P1; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Parks J., 2006, MORBIDITY MORTALITY; Patient Centered Primary Care Collaborative, SERV TOOLS BEH HLTH; Patient-Centered Primary Care Collaborative, BEH HLTH INT PCMH; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; Pollini RA, 2011, SUBST ABUSE REHABIL, V2, P173, DOI 10.2147/SAR.S24800; Richardson LP, 2014, JAMA-J AM MED ASSOC, V312, P809, DOI 10.1001/jama.2014.9259; Rosenbaum S, 2013, USDATE FINAL RULE ME; Russell L., 2010, MENTAL HLTH CARE SER; Saliba, 2008, DEV VALIDATION REVIS; Salsberry PJ, 2005, PSYCHIAT SERV, V56, P458, DOI 10.1176/appi.ps.56.4.458; SAMHSA-HRSA Center for Integrated Health Solutions, PRIM BEH HEALTHC INT; Sharfstein SS, 2009, HEALTH AFFAIR, V28, P685, DOI 10.1377/hlthaff.28.3.685; Starfield B., 1992, PRIMARY CARE CONCEPT; Substance Abuse and Mental Health Services Administration, 2013, MED HDB INT BEH HLTH; Substance Abuse and Mental Health Services Administration, 2014, RES 2013 NAT SURV DR; Substance Abuse and Mental Health Services Administration, CAN WE LIV LONG INT; Substance Abuse and Mental Health Services Administration, HLTH CAR HLTH SYST I; Substance Abuse and Mental Health Services Administration, 2014, HLTH FIN; Substance Abuse and Mental Health Services Administration, 2013, RES 2013 NAT SURV DR; Substance Abuse and Mental Health Services Administration C. f. B. H. S. a. Q, 2014, NSDUH REP SUBST US M; The Kaiser Family Foundation The Kaiser Commission on Medicaid and the Uninsured, 2011, MENT HLTH FIN US PRI; Thornicroft G, 2007, INT REV PSYCHIATR, V19, P113, DOI 10.1080/09540260701278937; Tierney K, 2014, CREATING CONNECTIONS; Torrey E.F., 2014, TREATMENT PERSONS ME; Townley C, 2012, DEV IMPLEMENTING SEC; U.S. Food and Drug Administration, 2014, EXT REL ER LONG ACT; U.S. Preventive Services Task Force, REC PRIM CAR PRACT; UnitedHealth Foundation, PHYS IN US; University of Massachusetts Medical School, WORKF TRAIN WHOL TEA; Unutzer J, 2015, COLLABORATIVE CARE M; Wang PS, 2006, AM J PSYCHIAT, V163, P1187, DOI 10.1176/appi.ajp.163.7.1187; World Health Organisation, 2021, MENT HLTH ACT PLAN 2; World Health Organization, 2002, PHYS IN LEAD CAUS DI; World Health Organization, WORLD HLTH REP 2008; World Health Organization, ALCOHOL SMOKING SUBS; World Health Organization, SCREEN BRIEF INT ALC	121	123	124	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					298	+		10.7326/M15-0510	http://dx.doi.org/10.7326/M15-0510			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LC	26121401				2022-12-28	WOS:000360286400008
J	Bai, YH; McCoy, JG; Levin, EJ; Sobrado, P; Rajashankar, KR; Fox, BG; Zhou, M				Bai, Yonghong; McCoy, Jason G.; Levin, Elena J.; Sobrado, Pablo; Rajashankar, Kanagalaghatta R.; Fox, Brian G.; Zhou, Ming			X-ray structure of a mammalian stearoyl-CoA desaturase	NATURE			English	Article							FATTY-ACID DESATURATION; COENZYME-A DESATURASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; DIIRON PROTEINS; RIBONUCLEOTIDE REDUCTASE; SACCHAROMYCES-CEREVISIAE; MECHANISM; ENZYME; IDENTIFICATION	Stearoyl-CoA desaturase (SCD) is conserved in all eukaryotes and introduces the first double bond into saturated fatty acyl-CoAs1-4. Because the monounsaturated products of SCD are key precursors of membrane phospholipids, cholesterol esters and triglycerides, SCD is pivotal in fatty acid metabolism. Humans have two SCD homologues (SCD1 and SCD5), while mice have four (SCD1-SCD4). SCD1-deficient mice do not become obese or diabetic when fed a high-fat diet because of improved lipid metabolic profiles and insulin sensitivity(5,6). Thus, SCD1 is a pharmacological target in the treatment of obesity, diabetes and other metabolic diseases(7). SCD1 is an integral membrane protein located in the endoplasmic reticulum, and catalyses the formation of a cis-double bond between the ninth and tenth carbons of stearoyl-or palmitoyl-CoA(8,9). The reaction requires molecular oxygen, which is activated by a di-iron centre, and cytochrome b(5), which regenerates the di-iron centre(10). To understand better the structural basis of these characteristics of SCD function, here we crystallize and solve the structure of mouse SCD1 bound to stearoyl-CoA at 2.6 angstrom resolution. The structure shows a novel fold comprising four transmembrane helices capped by a cytosolic domain, and a plausible pathway for lateral substrate access and product egress. The acyl chain of the bound stearoyl-CoA is enclosed in a tunnel buried in the cytosolic domain, and the geometry of the tunnel and the conformation of the bound acyl chain provide a structural basis for the regioselectivity and stereospecificity of the desaturation reaction. The dimetal centre is coordinated by a unique spacial arrangement of nine conserved histidine residues that implies a potentially novel mechanism for oxygen activation. The structure also illustrates a possible route for electron transfer from cytochrome b5 to the di-iron centre.	[Bai, Yonghong; McCoy, Jason G.; Levin, Elena J.; Zhou, Ming] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sobrado, Pablo; Fox, Brian G.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Baylor College of Medicine; University of Wisconsin System; University of Wisconsin Madison; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Zhou, M (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	bgfox@biochem.wisc.edu; mzhou@bcm.edu			US National Institutes of Health [R01DK088057, R01GM098878, R01HL086392, U54GM095315, U54GM094584, R01GM050853]; American Heart Association [12EIA8850017]; Cancer Prevention and Research Institute of Texas [R12MZ]; National Institute of General Medical Sciences [P41GM103403]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM098878, U54GM094584, U54GM095315, P41GM103403, R01GM050853] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cancer Prevention and Research Institute of Texas; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (R01DK088057, R01GM098878, R01HL086392, U54GM095315, U54GM094584 and R01GM050853), the American Heart Association (12EIA8850017), and the Cancer Prevention and Research Institute of Texas (R12MZ). Final data were collected at Northeastern Collaborative Access Team (NE-CAT) beamlines, which are supported by a grant from the National Institute of General Medical Sciences (P41GM103403). Crystals were screened at beamline 17-ID at the Advanced Photon Source, beamlines 8.2.2 and 5.0.2 at Berkeley Center for Structural Biology at the Lawrence Berkeley Laboratory.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arnesano F, 1999, EUR J BIOCHEM, V260, P347, DOI 10.1046/j.1432-1327.1999.00167.x; Banerjee R, 2015, NATURE, V518, P431, DOI 10.1038/nature14160; Behrouzian B, 2002, CURR OPIN CHEM BIOL, V6, P577, DOI 10.1016/S1367-5931(02)00365-4; Behrouzian B, 2001, EUR J BIOCHEM, V268, P3545, DOI 10.1046/j.1432-1327.2001.02258.x; BLOCH K, 1969, ACCOUNTS CHEM RES, V2, P193, DOI 10.1021/ar50019a001; Broadwater JA, 1998, BIOCHEMISTRY-US, V37, P14664, DOI 10.1021/bi981839i; Buist PH, 1996, CHEM COMMUN, P2671, DOI 10.1039/cc9960002671; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; DAILEY HA, 1980, J BIOL CHEM, V255, P5184; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gomez FE, 2002, BIOCHEMISTRY-US, V41, P5473, DOI 10.1021/bi012177r; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LIGHT RJ, 1962, J BIOL CHEM, V237, P1793; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; Lou Y, 2010, J BIOL CHEM, V285, P19384, DOI 10.1074/jbc.M110.125377; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meesapyodsuk D, 2014, ACS CHEM BIOL, V9, P922, DOI 10.1021/cb400675d; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Moenne-Loccoz P, 1998, BIOCHEMISTRY-US, V37, P14659, DOI 10.1021/bi981838q; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 1997, P NATL ACAD SCI USA, V94, P2981, DOI 10.1073/pnas.94.7.2981; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Ujwal R, 2011, METHODS, V55, P337, DOI 10.1016/j.ymeth.2011.09.020; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; Zhang ZH, 2014, J MED CHEM, V57, P5039, DOI 10.1021/jm401516c	49	132	147	7	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					252	+		10.1038/nature14549	http://dx.doi.org/10.1038/nature14549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26098370	Green Accepted			2022-12-28	WOS:000359386900039
J	Goodman, A				Goodman, Annekathryn			The Mountains Are Angry	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goodman, Annekathryn] Massachusetts Gen Hosp, Ctr Global Hlth, Off Global Disaster Response, Boston, MA 02114 USA; [Goodman, Annekathryn] Int Med Corps, Los Angeles, CA USA	Harvard University; Massachusetts General Hospital	Goodman, A (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Off Global Disaster Response, Boston, MA 02114 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					203	205		10.1056/NEJMp1506499	http://dx.doi.org/10.1056/NEJMp1506499			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM8MS	26083120				2022-12-28	WOS:000357956200002
J	Yang, Y; Shi, SL; Niu, DW; Liu, P; Buchwald, SL				Yang, Yang; Shi, Shi-Liang; Niu, Dawen; Liu, Peng; Buchwald, Stephen L.			Catalytic asymmetric hydroamination of unactivated internal olefins to aliphatic amines	SCIENCE			English	Article							INTERMOLECULAR HYDROAMINATION; ALKENES; HYDROFORMYLATION; KETONES; HYDROSILYLATION; HYDROBORATION; AMINATION	Catalytic assembly of enantiopure aliphatic amines from abundant and readily available precursors has long been recognized as a paramount challenge in synthetic chemistry. Here, we describe a mild and general copper-catalyzed hydroamination that effectively converts unactivated internal olefins-an important yet unexploited class of abundant feedstock chemicals-into highly enantioenriched a-branched amines (>= 96% enantiomeric excess) featuring two minimally differentiated aliphatic substituents. This method provides a powerful means to access a broad range of advanced, highly functionalized enantioenriched amines of interest in pharmaceutical research and other areas.	[Yang, Yang; Shi, Shi-Liang; Niu, Dawen; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Liu, Peng] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	sbuchwal@mit.edu	Liu, Peng/A-9043-2008	Liu, Peng/0000-0002-8188-632X; Yang, Yang/0000-0002-4956-2034; Shi, Shi-Liang/0000-0002-0624-6824	National Institutes of Health [GM 58160]; University of Pittsburgh; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh(University of Pittsburgh); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the National Institutes of Health (grant GM 58160 to S.L.B.) and the University of Pittsburgh (P.L.) for financial support. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We acknowledge Y. Zhao (Swager group) for helpful discussions. We thank Y.-M. Wang and M.T. Pirnot for assistance with the preparation of the manuscript. Calculations were performed at the Center for Simulation and Modeling at the University of Pittsburgh and the Extreme Science and Engineering Discovery Environment (XSEDE) supported by the National Science Foundation.	Appella DH, 1999, J AM CHEM SOC, V121, P9473, DOI 10.1021/ja992366l; Berman AM, 2004, J AM CHEM SOC, V126, P5680, DOI 10.1021/ja049474e; Bornscheuer UT, 2006, HYDROLASES IN ORGANIC SYNTHESIS: REGIO- AND STEREOSELECTIVE BIOTRANSFORMATIONS, 2ND EDITION, P1; de Meijere A., 2004, METAL CATALYZED CROS, V2nd, DOI 10.1002/9783527619535; Deutsch C, 2008, CHEM REV, V108, P2916, DOI 10.1021/cr0684321; Dorta R, 1997, J AM CHEM SOC, V119, P10857, DOI 10.1021/ja972594k; Fandrick KR, 2011, J AM CHEM SOC, V133, P10332, DOI 10.1021/ja2028958; Gadzikwa T, 2012, J AM CHEM SOC, V134, P2860, DOI 10.1021/ja211455j; GAGNE MR, 1992, ORGANOMETALLICS, V11, P2003, DOI 10.1021/om00042a012; Gant TG, 2014, J MED CHEM, V57, P3595, DOI 10.1021/jm4007998; Hong S, 2004, ACCOUNTS CHEM RES, V37, P673, DOI 10.1021/ar040051r; Kawatsura M, 2000, J AM CHEM SOC, V122, P9546, DOI 10.1021/ja002284t; Lee D, 2004, TETRAHEDRON LETT, V45, P5415, DOI 10.1016/j.tetlet.2004.05.048; Lipshutz BH, 2003, J AM CHEM SOC, V125, P8779, DOI 10.1021/ja021391f; Miki Y, 2013, ANGEW CHEM INT EDIT, V52, P10830, DOI 10.1002/anie.201304365; Muller TE, 2008, CHEM REV, V108, P3795, DOI 10.1021/cr0306788; Niljianskul N, 2015, ANGEW CHEM INT EDIT, V54, P1638, DOI 10.1002/anie.201410326; Pereira S, 1996, J AM CHEM SOC, V118, P909, DOI 10.1021/ja952653z; Reznichenko AL, 2010, ANGEW CHEM INT EDIT, V49, P8984, DOI 10.1002/anie.201004570; Robak MT, 2010, CHEM REV, V110, P3600, DOI 10.1021/cr900382t; Roesky PW, 2003, ANGEW CHEM INT EDIT, V42, P2708, DOI 10.1002/anie.200301637; Royer J., 2010, CHIRAL AMINE SYNTHES, DOI 10.1002/anie.201005721; Rucker RP, 2012, J AM CHEM SOC, V134, P6571, DOI 10.1021/ja3023829; SAKAI N, 1994, J CHEM SOC CHEM COMM, P395, DOI 10.1039/c39940000395; Shi SL, 2015, NAT CHEM, V7, P38, DOI [10.1038/nchem.2131, 10.1038/NCHEM.2131]; van der Veen LA, 1999, ANGEW CHEM INT EDIT, V38, P336, DOI 10.1002/(SICI)1521-3773(19990201)38:3<336::AID-ANIE336>3.0.CO;2-P; Whitesides G. M., 1970, J AM CHEM SOC, V92, P1426; Won J, 2010, J PHYS CHEM A, V114, P12112, DOI 10.1021/jp1081966; Zhang ZB, 2009, J AM CHEM SOC, V131, P5372, DOI 10.1021/ja9001162; Zhao YC, 2015, J AM CHEM SOC, V137, P3221, DOI 10.1021/jacs.5b00556; Zhou JR, 2008, J AM CHEM SOC, V130, P12220, DOI 10.1021/ja803523z; Zhu SL, 2014, J AM CHEM SOC, V136, P15913, DOI 10.1021/ja509786v; Zhu SL, 2013, J AM CHEM SOC, V135, P15746, DOI 10.1021/ja4092819	33	232	231	9	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					62	66		10.1126/science.aab3753	http://dx.doi.org/10.1126/science.aab3753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138973	Green Accepted, Green Submitted			2022-12-28	WOS:000357280800058
J	Clark, J				Clark, Jocalyn			WOMEN'S HEALTH Bangladesh's ignored female sex workers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.clark@utoronto.ca		Clark, Jocalyn/0000-0002-8014-3989				Biraj A, 2012, REUTERS; FHI 360, 2014, DO FEM SEX WORK DHAK; Islam U, 2014, DKAKA TRIBUNE   0818; Population Council, 2015, SEX REPR HLTH YOUNG; Rashid T, 2015, VICE NEWS       0205; Sultana H, 2015, CULT HEALTH SEX, V17, P777, DOI 10.1080/13691058.2014.990516; UNAIDS, 2012, HIV SEX WORK COLL IN; Unicef Bangladesh, 2011, SEX AB COMM EXPL CHI; USAID Bangladesh, 2012, TRAFF WOM CHILDR	9	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2015	350								h3470	10.1136/bmj.h3470	http://dx.doi.org/10.1136/bmj.h3470			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TH	26124507				2022-12-28	WOS:000357606700003
J	Emanuel, EJ; Bedarida, G; Macci, K; Gabler, NB; Rid, A; Wendler, D				Emanuel, Ezekiel J.; Bedarida, Gabriella; Macci, Kristy; Gabler, Nicole B.; Rid, Annette; Wendler, David			Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERSE EVENTS; CLINICAL-RESEARCH; TRIALS; BENEFITS	Objective To quantify the frequency and seriousness of adverse events in non-oncology phase I studies with healthy participants. Design Meta-analysis of individual, healthy volunteer level data. Setting Phase I studies with healthy volunteers conducted between September 2004 and March 2011 at Pfizer's three dedicated phase I testing sites in Belgium, Singapore, and the United States. These included studies in which drug development was terminated. Participants 11 028 participants who received the study drug in 394 distinct non-oncology phase I studies, which involved 4620 unique individuals. A total of 2460 (53.2%) participants were involved in only one study, whereas others participated in two or more studies. Main outcome measures Adverse events classified as mild, moderate, and severe as well as serious adverse events-defined by the Food and Drug Administration as events that result in death, a life threatening event, admission to hospital, prolongation of existing hospital stay, a persistent or major disability, or a congenital anomaly or birth defect. Pfizer researchers of phase I trials determined adverse events, and serious adverse events were those filed with the FDA. Results Overall, 4000 (36.3%) participants who received the study drug experienced no adverse events and 7028 (63.7%) experienced 24 643 adverse events. Overall, 84.6% (n=20 840) of adverse events were mild and 1.0% (n=255) were severe. 34 (0.31%) serious adverse events occurred among the 11 028 participants who received the study agent, with no deaths or life threatening events. Of the 34 serious adverse events, 11 were related to the study drug and seven to study procedures, whereas 16 were unrelated to a study drug or procedure, including four that occurred when the participant was receiving a placebo. Overall, 24.1% (n=5947) of adverse events were deemed to be unrelated to the study drug. With a total of 143 (36%) studies involving placebo, 10.3% (n=2528) of all adverse events occurred among participants receiving placebo. The most common adverse events were headache (12.2%, n=3017), drowsiness (9.8%, n=2410), and diarrhea (6.9%, n=1698). Research on drugs for neuropsychiatric indications had the highest frequency of adverse events (3015 per 1000 participants). Conclusion Among 11 028 healthy participants who received study drug in non-oncology phase I studies, the majority (85%) of adverse events were mild. 34 (0.31%) serious adverse events occurred, with no life threatening events or deaths. Half of all adverse events were related to the study drug or to procedures. Extrapolation of these data to other types of phase I studies, especially with biological agents, may not be warranted.	[Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Off Provost, Philadelphia, PA 19104 USA; [Bedarida, Gabriella; Macci, Kristy] Pfizer, New Haven Clin Res Unit, New Haven, CT USA; [Gabler, Nicole B.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Rid, Annette] Kings Coll London, Dept Social Sci Hlth & Med, London WC2R 2LS, England; [Wendler, David] NIH, Ctr Clin, Dept Bioeth, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pfizer; University of Pennsylvania; Pennsylvania Medicine; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.	vp-global@upenn.edu			NIH intramural research funds; Department of Medical Ethics and Health Policy of the Perelman School of Medicine, University of Pennsylvania; Pfizer; Swiss National Science Foundation [PA00B-117505/1, PA0033-117502/2]	NIH intramural research funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medical Ethics and Health Policy of the Perelman School of Medicine, University of Pennsylvania; Pfizer(Pfizer); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded, in part by NIH intramural research funds and in part by funds from the Department of Medical Ethics and Health Policy of the Perelman School of Medicine, University of Pennsylvania. The researchers from NIH, University of Pennsylvania, and King's College London were independent of Pfizer and had no financial compensation from Pfizer. NBG was awarded a Pfizer grant that ended in 2009. The two Pfizer employees were paid by Pfizer. AR received funding from the Swiss National Science Foundation (PA00B-117505/1 and PA0033-117502/2). Pfizer provided no specific financial support for this study.	Cryder CE, 2010, SOC SCI MED, V70, P455, DOI 10.1016/j.socscimed.2009.10.047; Elliott C, 2008, NEW ENGL J MED, V358, P2316, DOI 10.1056/NEJMp0801872; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Emanuel EJ, 2007, AM J BIOETHICS, V7, P76, DOI 10.1080/15265160601111800; Fisher JA, 2009, MED RES HIRE POLITIC; Fisher JA, 2015, SCI TECHNOL HUM VAL, V40, P199, DOI 10.1177/0162243914554838; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Kass NE, 2007, CLIN PHARMACOL THER, V82, P219, DOI 10.1038/sj.clpt.6100192; Kumagai Y, 2006, CLIN PHARMACOL THER, V79, pP71, DOI 10.1016/j.clpt.2005.12.256; Lemmens Trudo, 2001, American Journal of Bioethics, V1, P51, DOI 10.1162/152651601300169095; Lutfullin A, 2005, INT J CLIN PHARM TH, V43, P217; Martin RM, 1998, BRIT J CLIN PHARMACO, V46, P505, DOI 10.1046/j.1365-2125.1998.00817.x; Nicolson TJ, 2010, TRENDS PHARMACOL SCI, V31, P108, DOI 10.1016/j.tips.2009.12.001; ORME M, 1989, BRIT J CLIN PHARMACO, V27, P125, DOI 10.1111/j.1365-2125.1989.tb05342.x; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Rosenthal E, 2006, NY TIMES; Shamoo AE, 2006, AM J BIOETHICS, V6, pW1, DOI 10.1080/15265160600686281; Sheridan C, 2006, NAT BIOTECHNOL, V24, P475, DOI 10.1038/nbt0506-475; Sibille M, 1998, EUR J CLIN PHARMACOL, V54, P13, DOI 10.1007/s002280050413; Stunkel Leanne, 2010, IRB, V32, P1	20	44	47	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2015	350								h3271	10.1136/bmj.h3271	http://dx.doi.org/10.1136/bmj.h3271			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7OD	26115663	hybrid, Green Published			2022-12-28	WOS:000357160700002
J	Brunham, RC				Brunham, Robert C.			A Chlamydia vaccine on the horizon	SCIENCE			English	Editorial Material									Univ British Columbia, Dept Med, Vancouver, BC V6X 1N4, Canada	University of British Columbia	Brunham, RC (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC V6X 1N4, Canada.	robert.brunham@bccdc.ca						Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426; GRAYSTON JT, 1975, J INFECT DIS, V132, P87, DOI 10.1093/infdis/132.1.87; IGIETSEME JU, 1991, INFECT IMMUN, V59, P1346, DOI 10.1128/IAI.59.4.1346-1351.1991; Mabey DCW, 2014, VACCINE, V32, P1572, DOI 10.1016/j.vaccine.2013.10.016; Owusu-Edusei K, 2015, EMERG INFECT DIS, V21, P960, DOI 10.3201/eid2106.141270; Stary G., 2015, SCIENCE, V348	6	5	7	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1322	1323		10.1126/science.aac6528	http://dx.doi.org/10.1126/science.aac6528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089500				2022-12-28	WOS:000356449500032
J	Sundquist, WI; Ullman, KS				Sundquist, Wesley I.; Ullman, Katharine S.			An ESCRT to seal the envelope	SCIENCE			English	Editorial Material							AURORA-B; ABSCISSION; NUCLEUS		[Sundquist, Wesley I.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Ullman, Katharine S.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; katharine.ullman@hci.utah.edu		Ullman, Katharine/0000-0003-3693-2830	NIAID NIH HHS [R01 AI051174] Funding Source: Medline; NIGMS NIH HHS [P50 GM082545] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, R01GM112080] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cashikar AG, 2014, ELIFE, V3, DOI 10.7554/eLife.02184; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Olmos Y, 2015, NATURE, V522, P236, DOI 10.1038/nature14503; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Vietri M, 2015, NATURE, V522, P231, DOI 10.1038/nature14408; Wandke C, 2013, CELL, V152, P1222, DOI 10.1016/j.cell.2013.02.046; Webster BM, 2015, NUCLEUS-PHILA, V6, P197, DOI 10.1080/19491034.2015.1035844	15	7	7	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1314	1315		10.1126/science.aac7083	http://dx.doi.org/10.1126/science.aac7083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089496				2022-12-28	WOS:000356449500027
J	Reznick, JS; Koyle, KM				Reznick, Jeffrey S.; Koyle, Kenneth M.			Combat and the Medical Mindset - The Enduring Effect of Civil War Medical Innovation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Reznick, Jeffrey S.; Koyle, Kenneth M.] US Natl Lib Med, Hist Med Div, NIH, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Reznick, JS (corresponding author), US Natl Lib Med, Hist Med Div, NIH, Bethesda, MD 20894 USA.							Brinton John H., 1914, PERSONAL MEMOIRS JH; Devine S, 2014, CIV WAR AM; Gaillard ES., 1868, MED SURG LESSONS LAT; Hammond WA., 1862, 2 SURG GEN OFF; Warner John Harley, 1997, THERAPEUTIC PERSPECT	5	1	1	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2377	2380		10.1056/NEJMp1502748	http://dx.doi.org/10.1056/NEJMp1502748			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK6RF	26083204				2022-12-28	WOS:000356354600002
J	Kapadia, BH; Berg, RA; Daley, JA; Fritz, J; Bhave, A; Mont, MA				Kapadia, Bhaveen H.; Berg, Richard A.; Daley, Jacqueline A.; Fritz, Jan; Bhave, Anil; Mont, Michael A.			Periprosthetic joint infection	LANCET			English	Review							SURGICAL-SITE INFECTIONS; TOTAL KNEE ARTHROPLASTY; TOTAL HIP-ARTHROPLASTY; LAMINAR AIR-FLOW; DEEP INFECTION; POSTOPERATIVE COMPLICATIONS; INCREASED REVISION; DIABETES-MELLITUS; 2-STAGE REVISION; TOBACCO USE	Periprosthetic joint infections are a devastating complication after arthroplasty and are associated with substantial patient morbidity. More than 25% of revisions are attributed to these infections, which are expected to increase. The increased prevalence of obesity, diabetes, and other comorbidities are some of the reasons for this increase. Recognition of the challenge of surgical site infections in general, and periprosthetic joint infections particularly, has prompted implementation of enhanced prevention measures preoperatively (glycaemic control, skin decontamination, decolonisation, etc), intraoperatively (ultraclean operative environment, blood conservation, etc), and postoperatively (refined anticoagulation, improved wound dressings, etc). Additionally, indications for surgical management have been refined. In this Review, we assess risk factors, preventive measures, diagnoses, clinical features, and treatment options for prosthetic joint infection. An international consensus meeting about such infections identified the best practices and further research needs. Orthopaedics could benefit from enhanced preventive, diagnostic, and treatment methods.	[Kapadia, Bhaveen H.; Mont, Michael A.] Sinai Hosp, Ctr Joint Preservat & Replacement, Rubin Inst Adv Orthoped, Baltimore, MD 21215 USA; [Berg, Richard A.] Sinai Hosp, Dept Infect Dis, Baltimore, MD 21215 USA; [Daley, Jacqueline A.] Sinai Hosp, Infect Prevent & Control, Baltimore, MD 21215 USA; [Bhave, Anil] Sinai Hosp, Dept Rehabil, Baltimore, MD 21215 USA; [Fritz, Jan] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA	Sinai Hospital of Baltimore; Sinai Hospital of Baltimore; Sinai Hospital of Baltimore; Sinai Hospital of Baltimore; Johns Hopkins University	Mont, MA (corresponding author), Sinai Hosp, Ctr Joint Preservat & Replacement, Rubin Inst Adv Orthoped, 2401 West Belvedere Ave, Baltimore, MD 21215 USA.	mmont@lifebridgehealth.org	Kapadia, Bhaveen/X-4068-2019	Kapadia, Bhaveen/0000-0003-1335-891X	Sage Products; DJ Orthopaedics; Janssen; Joint Active Systems; Medtronic; Stryker; TissueGene; Microport; National Institutes of Health (NIAMS); National Institutes of Health (NICHD); Tissue Gene; Ongoing Care Solutions; DJO Global; Orthosensor; Siemens AG	Sage Products(General Electric); DJ Orthopaedics; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Joint Active Systems; Medtronic(Medtronic); Stryker; TissueGene; Microport; National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Tissue Gene; Ongoing Care Solutions; DJO Global; Orthosensor; Siemens AG(Siemens AG)	BHK is on the Speakers bureau and is a paid consultant for Sage Products. MAM receives royalties from Stryker and Microport and is a paid consultant for DJ Orthopaedics, Janssen, Joint Active Systems, Medtronic, Sage Products, Stryker, TissueGene, and Microport. He has received research support from DJ Orthopaedics, Joint Active Systems, National Institutes of Health (NIAMS and NICHD), Sage Products, Stryker, Tissue Gene, and Microport, is on the editorial or governing board of American Journal of Orthopaedics; Journal of Arthroplasty; Journal of Bone and Joint Surgery-American; and Journal of Knee Surgery; Surgical Techniques International, and is a board member for the American Association of Orthopaedic Surgeons. JAD is on the Speakers bureau for 3M and Sage Products. AB receives royalties from Guardian and is a paid consultant for Ongoing Care Solutions, DJO Global, and Orthosensor. JF has received research support from Siemens AG. RAB declares no competing interests.	Aggarwal VK, 2014, J KNEE SURG, V27, P399, DOI 10.1055/s-0033-1364102; AlBuhairan B, 2008, J BONE JOINT SURG BR, V90B, P915, DOI 10.1302/0301-620X.90B7.20498; Am Dent Ass, 2003, J AM DENT ASSOC, V134, P895; American Academy of Orthopaedic Surgeons, PREV ORTH IMPL INF P; Azodi OS, 2006, J BONE JOINT SURG BR, V88B, P1316, DOI 10.1302/0301-620X.88B10.17957; Basu S, 2009, SEMIN NUCL MED, V39, P36, DOI 10.1053/j.semnuclmed.2008.08.004; Bejon P, 2010, J ANTIMICROB CHEMOTH, V65, P569, DOI 10.1093/jac/dkp469; Berbari EF, 2012, INFECT CONT HOSP EP, V33, P774, DOI 10.1086/666641; Berend KR, 2013, CLIN ORTHOP RELAT R, V471, P510, DOI 10.1007/s11999-012-2595-x; BLACKBURN WD, 1991, ARTHRITIS RHEUM, V34, P110, DOI 10.1002/art.1780340118; Blom A, 2000, ANN ROY COLL SURG, V82, P405; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Boyle JM, 2007, J CLIN IMMUNOL, V27, P497, DOI 10.1007/s10875-007-9103-1; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Bradley KA, 2011, J GEN INTERN MED, V26, P162, DOI 10.1007/s11606-010-1475-x; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Brown NM, 2012, J ARTHROPLASTY, V27, P27, DOI 10.1016/j.arth.2011.03.034; Buller LT, 2012, J ARTHROPLASTY, V27, P857, DOI 10.1016/j.arth.2012.01.003; Byren I, 2009, J ANTIMICROB CHEMOTH, V63, P1264, DOI 10.1093/jac/dkp107; Choi HR, 2011, CLIN ORTHOP RELAT R, V469, P961, DOI 10.1007/s11999-010-1679-8; Choong PFM, 2009, J BONE JOINT SURG BR, V91B, P1642, DOI 10.1302/0301-620X.91B12.23795; Cooper HJ, 2013, BONE JOINT J, V95B, P84, DOI 10.1302/0301-620X.95B11.32906; Corten K, 2011, CLIN ORTHOP RELAT R, V469, P209, DOI 10.1007/s11999-010-1459-5; CRAIG CP, 1986, INFECT CONT HOSP EP, V7, P257, DOI 10.1017/S019594170006416X; D'Apuzzo MR, 2015, CLIN ORTHOP RELAT R, V473, P57, DOI 10.1007/s11999-014-3668-9; Dale H, 2009, ACTA ORTHOP, V80, P639, DOI 10.3109/17453670903506658; Daver NG, 2007, J INFECTION, V54, P539, DOI 10.1016/j.jinf.2006.11.011; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Devoto G, 2006, CLIN CHEM, V52, P2281, DOI 10.1373/clinchem.2006.080366; Dinneen A, 2013, BONE JOINT J, V95B, P554, DOI 10.1302/0301-620X.95B4.30388; Dowsey MM, 2008, ANZ J SURG, V78, P439, DOI 10.1111/j.1445-2197.2008.04554.x; Dowsey MM, 2009, CLIN ORTHOP RELAT R, V467, P1577, DOI 10.1007/s11999-008-0551-6; Drew RH, 2000, J ANTIMICROB CHEMOTH, V46, P775, DOI 10.1093/jac/46.5.775; Edmiston Charles E Jr, 2010, AORN J, V92, P509, DOI 10.1016/j.aorn.2010.01.020; El Helou OC, 2010, EUR J CLIN MICROBIOL, V29, P961, DOI 10.1007/s10096-010-0952-9; European Centre for Disease Prevention and Control, 2013, ANT RES SURV EUR 201; Evans RP, 2011, CLIN ORTHOP RELAT R, V469, P945, DOI 10.1007/s11999-010-1688-7; Finley R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076398; Fritz J, 2014, RADIOGRAPHICS, V34, pE106, DOI 10.1148/rg.344140010; Fritz J, 2013, SEMIN MUSCULOSKEL R, V17, P316, DOI 10.1055/s-0033-1348098; Garvin KL, 1999, CLIN ORTHOP RELAT R, P110; Gastmeier P, 2012, J HOSP INFECT, V81, P73, DOI 10.1016/j.jhin.2012.04.008; Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400; Harrop JS, 2012, J AM ACAD ORTHOP SUR, V20, P94, DOI 10.5435/JAAOS-20-02-094; Hooper GJ, 2011, J BONE JOINT SURG BR, V93B, P85, DOI 10.1302/0301-620X.93B1.24862; Iorio R, 2012, J ARTHROPLASTY, V27, P726, DOI 10.1016/j.arth.2011.09.013; Itani KMF, 2012, CLIN THER, V34, P1667, DOI 10.1016/j.clinthera.2012.06.018; Jaberi FM, 2008, CLIN ORTHOP RELAT R, V466, P1368, DOI 10.1007/s11999-008-0214-7; Johnson AJ, 2013, J KNEE SURG, V26, P213, DOI 10.1055/s-0032-1329232; Kapadia BH, 2014, J ARTHROPLASTY, V29, P929, DOI 10.1016/j.arth.2013.09.017; Kapadia BH, 2014, J ARTHROPLASTY, V29, P777, DOI 10.1016/j.arth.2013.08.023; Kapadia BH, 2013, EXPERT REV MED DEVIC, V10, P215, DOI [10.1586/erd.12.76, 10.1586/ERD.12.76]; Kapadia BH, 2013, J ARTHROPLASTY, V28, P490, DOI 10.1016/j.arth.2012.07.015; Kapadia BH, 2012, J ARTHROPLASTY, V27, P1690, DOI 10.1016/j.arth.2012.03.057; Klouche S, 2010, ORTHOP TRAUMATOL-SUR, V96, P124, DOI [10.1016/j.rcot.2010.02.005, 10.1016/j.otsr.2009.11.004]; Kramer A, 2010, GMS KRANKENHHYG INTE, V5; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Kurtz SM, 2010, CLIN ORTHOP RELAT R, V468, P52, DOI 10.1007/s11999-009-1013-5; Lankester BJA, 2002, J HOSP INFECT, V50, P281, DOI 10.1053/jhin.2001.1154; Lee JP, 2013, WOUND REPAIR REGEN, V21, P211, DOI 10.1111/wrr.12024; Lora-Tamayo J, 2013, CLIN INFECT DIS, V56, P182, DOI 10.1093/cid/cis746; MADERAZO EG, 1988, CLIN ORTHOP RELAT R, P131; MAINOUS MR, 1994, SURG CLIN N AM, V74, P659, DOI 10.1016/S0039-6109(16)46335-8; Marchant MH, 2009, J BONE JOINT SURG AM, V91A, P1621, DOI 10.2106/JBJS.H.00116; Marculescu CE, 2006, CLIN INFECT DIS, V42, P471, DOI 10.1086/499234; Miner AL, 2007, INFECT CONT HOSP EP, V28, P222, DOI 10.1086/509852; Moucha Calin S, 2011, Instr Course Lect, V60, P557; Mraovic Boris, 2011, J Diabetes Sci Technol, V5, P412; Newman ET, 2014, J BONE JOINT SURG AM, V96A, P279, DOI 10.2106/JBJS.L.01041; Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1; Park JH, 2013, J BONE JOINT SURG AM, V95A, P1777, DOI 10.2106/JBJS.L.01335; Parvizi J, 2013, BONE JOINT J, V95B, P1450, DOI 10.1302/0301-620X.95B11.33135; Parvizi J, 2010, J ARTHROPLASTY, V25, P103, DOI 10.1016/j.arth.2010.04.011; Peersman G, 2001, CLIN ORTHOP RELAT R, P15, DOI 10.1097/00003086-200111000-00003; Perazzo P, 2013, BLOOD TRANSFUS-ITALY, V11, P370, DOI 10.2450/2013.0197-12; Petsatodis G, 2009, ARCH ORTHOP TRAUM SU, V129, P1645, DOI 10.1007/s00402-009-0844-6; Pour AE, 2011, J BONE JOINT SURG AM, V93A, P1448, DOI 10.2106/JBJS.J.00219; Puhto AP, 2014, J ARTHROPLASTY, V29, P1101, DOI 10.1016/j.arth.2013.12.027; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Ramirez JA, 1999, ARCH INTERN MED, V159, P2449, DOI 10.1001/archinte.159.20.2449; Rao N, 2003, CLIN ORTHOP RELAT R, P55, DOI 10.1097/01.blo.0000087321.60612.cf; Rodriguez D, 2010, CLIN MICROBIOL INFEC, V16, P1789, DOI 10.1111/j.1469-0691.2010.03157.x; Romano CL, 2012, HIP INT, V22, pS19, DOI 10.5301/HIP.2012.9566; Rosenberger LH, 2011, SURG INFECT, V12, P163, DOI 10.1089/sur.2010.083; Saltzman MD, 2009, J BONE JOINT SURG AM, V91A, P1949, DOI 10.2106/JBJS.H.00768; Schindler M, 2011, INT ORTHOP, V35, P647, DOI 10.1007/s00264-010-1014-8; SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P200; Segreti J, 1998, CLIN INFECT DIS, V27, P711, DOI 10.1086/514951; Sendi P, 2006, CLIN INFECT DIS, V43, P961, DOI 10.1086/507633; Senneville E, 2011, CLIN INFECT DIS, V53, P334, DOI 10.1093/cid/cir402; SILVERSTEIN P, 1992, AM J MED, V93, pS22, DOI 10.1016/0002-9343(92)90623-J; Sorensen LT, 2012, ARCH SURG-CHICAGO, V147, P373, DOI 10.1001/archsurg.2012.5; Srinivasa BT, 2012, AM J MED, V125, P779, DOI 10.1016/j.amjmed.2012.02.015; Stroh DA, 2012, J BONE JOINT SURG AM, V94A, P1662, DOI 10.2106/JBJS.K.01600; Sukeik M, 2011, J BONE JOINT SURG BR, V93B, P39, DOI 10.1302/0301-620X.93B1.24984; The NJR Editorial Board, 10 NJR ED BOARD; Toma O, 2011, ANESTH ANALG, V113, P730, DOI 10.1213/ANE.0b013e31821fff74; Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058; Tornero E, 2014, CLIN MICROBIOL INFEC, V20, P1219, DOI 10.1111/1469-0691.12721; Toulson C, 2009, J ARTHROPLASTY, V24, P1051, DOI 10.1016/j.arth.2008.07.004; Tsaras G, 2012, J BONE JOINT SURG AM, V94A, P1700, DOI 10.2106/JBJSJ.00756; Webster J, 2007, COCHRANE DB SYST REV, V4; Wu MH, 2011, KNEE SURG SPORT TR A, V19, P273, DOI 10.1007/s00167-010-1211-4; Yokoe DS, 2013, CLIN INFECT DIS, V57, P1282, DOI 10.1093/cid/cit516; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537; ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305	107	403	433	14	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					386	394		10.1016/S0140-6736(14)61798-0	http://dx.doi.org/10.1016/S0140-6736(14)61798-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4XI	26135702				2022-12-28	WOS:000368516500037
J	Broadhurst, MJ; Kelly, JD; Miller, A; Semper, A; Bailey, D; Groppelli, E; Simpson, A; Brooks, T; Hula, S; Nyoni, W; Sankoh, AB; Kanu, S; Jalloh, A; Ton, Q; Sarchet, N; George, P; Perkins, MD; Wonderly, B; Murray, M; Pollock, NR				Broadhurst, Mara Jana; Kelly, John Daniel; Miller, Ann; Semper, Amanda; Bailey, Daniel; Groppelli, Elisabetta; Simpson, Andrew; Brooks, Tim; Hula, Susan; Nyoni, Wilfred; Sankoh, Alhaji B.; Kanu, Santigi; Jalloh, Alhaji; Ton, Quy; Sarchet, Nicholas; George, Peter; Perkins, Mark D.; Wonderly, Betsy; Murray, Megan; Pollock, Nira R.			ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study	LANCET			English	Article								Background At present, diagnosis of Ebola virus disease requires transport of venepuncture blood to field biocontainment laboratories for testing by real-time RT-PCR, resulting in delays that complicate patient care and infection control efforts. Therefore, an urgent need exists for a point-of-care rapid diagnostic test for this disease. In this Article, we report the results of a field validation of the Corgenix ReEBOV Antigen Rapid Test kit. Methods We performed the rapid diagnostic test on fingerstick blood samples from 106 individuals with suspected Ebola virus disease presenting at two clinical centres in Sierra Leone. Adults and children who were able to provide verbal consent or assent were included; we excluded patients with haemodynamic instability and those who were unable to cooperate with fingerstick or venous blood draw. Two independent readers scored each rapid diagnostic test, with any disagreements resolved by a third. We compared point-of-care rapid diagnostic test results with clinical real-time RT-PCR results (RealStar Filovirus Screen RT-PCR kit 1.0; altona Diagnostics GmbH, Hamburg, Germany) for venepuncture plasma samples tested in a Public Health England field reference laboratory (Port Loko, Sierra Leone). Separately, we performed the rapid diagnostic test (on whole blood) and real-time RT-PCR (on plasma) on 284 specimens in the reference laboratory, which were submitted to the laboratory for testing from many clinical sites in Sierra Leone, including our two clinical centres. Findings In point-of-care testing, all 28 patients who tested positive for Ebola virus disease by RT-PCR were also positive by fingerstick rapid diagnostic test (sensitivity 100% [95% CI 87.7-100]), and 71 of 77 patients who tested negative by RT-PCR were also negative by the rapid diagnostic test (specificity 92.2% [95% CI 83.8-97.1]). In laboratory testing, all 45 specimens that tested positive by RT-PCR were also positive by the rapid diagnostic test (sensitivity 100% [95% CI 92.1-100]), and 214 of 232 specimens that tested negative by RT-PCR were also negative by the rapid diagnostic test (specifi city 92.2% [88.0-95.3]). The two independent readers agreed about 95.2% of point-of-care and 98.6% of reference laboratory rapid diagnostic test results. Cycle threshold values ranged from 15.9 to 26.3 (mean 22.6 [SD 2.6]) for the PCR-positive point-of-care cohort and from 17.5 to 26.3 (mean 21.5 [2.7]) for the reference laboratory cohort. Six of 16 banked plasma samples from rapid diagnostic test-positive and altona-negative patients were positive by an alternative real-time RT-PCR assay (the Trombley assay); three (17%) of 18 samples from individuals who were negative by both the rapid diagnostic test and altona test were also positive by Trombley. Interpretation The ReEBOV rapid diagnostic test had 100% sensitivity and 92% specifi city in both point-of-care and reference laboratory testing in this population (maximum cycle threshold 26.3). With two independent readers, the test detected all patients who were positive for Ebola virus by altona real-time RT-PCR; however, this benchmark itself had imperfect sensitivity.	[Broadhurst, Mara Jana; Kelly, John Daniel; Miller, Ann; Ton, Quy; Sarchet, Nicholas; Murray, Megan; Pollock, Nira R.] Partners Hlth, Boston, MA USA; [Kelly, John Daniel] Wellbody Alliance, Freetown, Sierra Leone; [Miller, Ann; Murray, Megan] Harvard Univ, Sch Med, Boston, MA USA; [Semper, Amanda; Bailey, Daniel; Simpson, Andrew; Brooks, Tim] Publ Hlth England, Porton Down, England; [Semper, Amanda; Brooks, Tim] NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England; [Groppelli, Elisabetta; Simpson, Andrew; Brooks, Tim; Hula, Susan; Nyoni, Wilfred] Publ Hlth England Lab, Port Loko, Sierra Leone; [Groppelli, Elisabetta] UCL, London, England; [Hula, Susan] Publ Hlth England, Bristol, Avon, England; [Nyoni, Wilfred] Publ Hlth England, Birmingham, W Midlands, England; [Sankoh, Alhaji B.; Kanu, Santigi; Jalloh, Alhaji; George, Peter] Minist Hlth & Sanitat Republ Sierra Leone, Freetown, Sierra Leone; [Ton, Quy] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Perkins, Mark D.; Wonderly, Betsy] Fdn Innovat New Diagnost, Geneva, Switzerland; [Pollock, Nira R.] Boston Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Partners Healthcare System; Harvard University; Harvard Medical School; Public Health England; University of London; University College London; Public Health England; Public Health England; Ministry of Health & Sanitation Sierra Leone; University of Washington; University of Washington Seattle; Foundation For Innovative New Diagnostics; Harvard University; Boston Children's Hospital	Pollock, NR (corresponding author), Boston Childrens Hosp, 300 Longwood Ave,Bader 761, Boston, MA 02115 USA.	nira.pollock@childrens.harvard.edu		Groppelli, Elisabetta/0000-0003-4241-2858	Abundance Foundation	Abundance Foundation	Funding Abundance Foundation.	[Anonymous], 2014, REALSTAR EB RT PCR K; Corgenix Inc, 2015, REEBOV ANT RAP TEST; FIND, 2014, SIT REV EB DIAGN OPP; Goeijenbier M, 2014, NETH J MED, V72, P442; Niedrig M, 2004, J CLIN MICROBIOL, V42, P1753, DOI 10.1128/JCM.42.4.1753-1755.2004; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; WHO, WHO EM US ASS LIST E; WHO, 2015, MAN CAR MAN PAT EB C; WHO, 2014, TARG PROD PROF ZAIR; WHO, 2015, INT GUID US RAP EB A; World Health Organization, EB SIT REP 1 APR 201; World Health Organization, 2014, LAB DIAGN EB VIR DIS; World Health Organization, 2014, LAB SAF COLL BLOOD S	14	122	128	0	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					867	874		10.1016/S0140-6736(15)61042-X	http://dx.doi.org/10.1016/S0140-6736(15)61042-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0MJ	26119838				2022-12-28	WOS:000360290000030
J	Schmidt, H; Gostin, LO; Emanuel, EJ				Schmidt, Harald; Gostin, Lawrence O.; Emanuel, Ezekiel J.			Public health, universal health coverage, and Sustainable Development Goals: can they coexist?	LANCET			English	Editorial Material							SOCIAL DETERMINANTS		[Schmidt, Harald; Emanuel, Ezekiel J.] Univ Penn, Dept Med Ethics & Hlth Policy, Philadelphia, PA 19104 USA; [Schmidt, Harald] Univ Penn, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Gostin, Lawrence O.] Georgetown Univ, WHO Collaborating Ctr Publ Hlth Law & Human Right, Washington, DC USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Georgetown University; Georgetown University	Schmidt, H (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Ethics & Hlth Policy, Philadelphia, PA 19104 USA.	schmidth@mail.med.upenn.edu		Gostin, Lawrence/0000-0001-5286-4044				Boerma T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001731; Chan M., 2012, COMMUNICATION; D?az Y., 2013, IMPACT UNIVERSAL COV; Duran A., 2010, IMPLEMENTING HLTH FI, V21, P245; Exworthy M, 2008, HEALTH POLICY PLANN, V23, P318, DOI 10.1093/heapol/czn022; Eyal N, 2008, PUBLIC HEALTH ETH-UK, V1, P180, DOI 10.1093/phe/phn026; Frenk J, 2012, LANCET, V380, P862, DOI 10.1016/S0140-6736(12)61341-5; Guerrero R, 2014, DOBLE DESCENTRALIZAC; Gwatkin DR, 2011, LANCET, V377, P2160, DOI 10.1016/S0140-6736(10)62058-2; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kickbusch I., 2008, HLTH SOC ADDRESSING; Lazarus JV, 2010, SCAND J PUBLIC HEALT, V38, P670, DOI 10.1177/1403494810372265; Maeda A, 2014, DIR DEV, P1, DOI 10.1596/978-1-4648-0297-3; Marmot M, 2013, LANCET, V382, P1227, DOI 10.1016/S0140-6736(13)61791-2; O'Connell T, 2014, LANCET, V383, P277, DOI 10.1016/S0140-6736(13)60955-1; Open Working Group of the General Assembly, 2014, A68970 OP WORK GROUP; Tangcharoensathien V, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-25; Tantivess S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f462; World Health Organisation. Geneva Switzerland, 2018, NOT FUS PROT WORK GR; World Health Organization Consultative Group on Equity and Universal Health Coverage, 2014, MAK FAIR CHOIC PATH; World Health Organization (WHO), 2005, 58 WORLD HLTH ASS GE; World Health Organization & World Bank, 2013, MON PROGR UN HLTH CO	22	98	98	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					928	930		10.1016/S0140-6736(15)60244-6	http://dx.doi.org/10.1016/S0140-6736(15)60244-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0MJ	26138141	Green Published			2022-12-28	WOS:000360290000035
J	Downs, JR; O'Malley, PG				Downs, John R.; O'Malley, Patrick G.			Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2014 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE STATIN THERAPY; CORONARY-HEART-DISEASE; 14 RANDOMIZED-TRIALS; PRIMARY PREVENTION; CHOLESTEROL LEVELS; METAANALYSIS; EFFICACY; EVENTS; SAFETY; PARTICIPANTS	Description: In December 2014, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of dyslipidemia for cardiovascular disease risk reduction in adults. This synopsis summarizes the major recommendations. Methods: On 30 September 2013, the VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline development effort that included clinical stakeholders and conformed to the Institute of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel developed key questions, systematically searched and evaluated the literature, developed a simple 1-page algorithm, and rated each of 26 recommendations by using the Grading of Recommendations Assessment, Development, and Evaluation system. Recommendations: This synopsis summarizes key features of the guideline in 5 areas: elimination of treatment targets, additional tests for risk prediction, primary and secondary prevention, and laboratory testing.	[Downs, John R.] South Texas Vet Hlth Care Syst, Med Serv 111, San Antonio, TX 78229 USA; [O'Malley, Patrick G.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Uniformed Services University of the Health Sciences - USA	Downs, JR (corresponding author), South Texas Vet Hlth Care Syst, Med Serv 111, 7400 Merton Minter, San Antonio, TX 78229 USA.	john.downs@va.gov						Agency for Healthcare Research and Quality, 2012, AHRQ PUBL; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Everett BM, 2014, AM J CARDIOL, V114, P1682, DOI 10.1016/j.amjcard.2014.08.041; Finegold JA, 2014, EUR J PREV CARDIOL, V21, P464, DOI 10.1177/2047487314525531; Gaziano JM, 2012, ARCH INTERN MED, V172, P1705, DOI 10.1001/jamainternmed.2013.1771; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Guirguis-Blake J, 2007, ANN INTERN MED, V147, P117, DOI 10.7326/0003-4819-147-2-200707170-00170; Hayward RA, 2012, CIRC-CARDIOVASC QUAL, V5, P2, DOI 10.1161/CIRCOUTCOMES.111.964676; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Khera AV, 2012, ARCH INTERN MED, V172, P1710, DOI 10.1001/2013.jamainternmed.263; Laine C, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00011; McConnell M, 2014, JAMA INTERN MED, V174, P473, DOI 10.1001/jamainternmed.2013.12872; McKenney JM, 2006, AM J CARDIOL, V97, p89C, DOI 10.1016/j.amjcard.2006.02.030; Mills EJ, 2011, EUR HEART J, V32, P1409, DOI 10.1093/eurheartj/ehr035; Naci H, 2013, CIRC-CARDIOVASC QUAL, V6, P390, DOI 10.1161/CIRCOUTCOMES.111.000071; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Nichols GA, 2007, CLIN THER, V29, P1761, DOI 10.1016/j.clinthera.2007.08.022; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Silva M, 2007, CLIN THER, V29, P253, DOI 10.1016/j.clinthera.2007.02.008; Sniderman A, 2012, J CLIN LIPIDOL, V6, P303, DOI 10.1016/j.jacl.2012.05.004; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; U. S. Department of Veterans Affairs, 2013, VA DOD CLIN PRACT GU; Yan YL, 2013, EUR J CLIN PHARMACOL, V69, P2001, DOI 10.1007/s00228-013-1570-0; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	40	75	78	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					291	+		10.7326/M15-0840	http://dx.doi.org/10.7326/M15-0840			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LC	26099117				2022-12-28	WOS:000360286400007
J	Haeder, SF; Weimer, DL; Mukamel, DB				Haeder, Simon F.; Weimer, David L.; Mukamel, Dana B.			Narrow Networks and the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Haeder, Simon F.] Univ Wisconsin, Dept Polit Sci, Madison, WI 53706 USA; [Weimer, David L.] Univ Wisconsin, Dept Polit Sci, La Follette Sch Publ Affairs, Madison, WI 53706 USA; [Mukamel, Dana B.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine	Haeder, SF (corresponding author), Univ Wisconsin, Dept Polit Sci, 110 N Hall,1050 Bascom Mall, Madison, WI 53706 USA.	haeder@wisc.edu	Haeder, Simon F./AAH-6990-2020	Haeder, Simon F./0000-0003-0077-6047				ARROW KJ, 1963, AM ECON REV, V53, P941; Bauman N, 2014, ANNU REV PUBL HEALTH, P5; Corlette S., 2015, IMPLEMENTING AFFORDA; Haeder SF, 2015, J HEALTH POLIT POLIC, V40, P281, DOI 10.1215/03616878-2882219; Haeder SF, 2015, HEALTH AFFAIR, V34, P741, DOI 10.1377/hlthaff.2014.1406	6	42	42	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					669	670		10.1001/jama.2015.6807	http://dx.doi.org/10.1001/jama.2015.6807			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP6SS	26110978				2022-12-28	WOS:000360019100012
J	Patel, SA; Winkel, M; Ali, MK; Narayan, KMV; Mehta, NK				Patel, Shivani A.; Winkel, Munir; Ali, Mohammed K.; Narayan, K. M. Venkat; Mehta, Neil K.			Cardiovascular Mortality Associated With 5 Leading Risk Factors: National and State Preventable Fractions Estimated From Survey Data	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; EXCESS DEATHS; DISEASE; OBESITY; BURDEN; ADULTS; TRENDS; LEVEL; PREVALENCE; WEIGHT	Background: Impressive decreases in cardiovascular mortality have been achieved through risk factor reduction and clinical intervention, yet cardiovascular disease remains a leading cause of death nationally. Objective: To estimate up-to-date preventable fractions of cardiovascular mortality associated with elimination and reduction of 5 leading risk factors nationally and by state in the United States. Design: Cross-sectional and cohort studies. Setting: Nationally representative and state-representative samples of the U.S. population. Participants: Adults aged 45 to 79 years. Measurements: Self-reported risk factor status in the BRFSS (Behavioral Risk Factor Surveillance System) 2009-2010 was corrected to approximate clinical definitions. The relative hazards of cardiovascular death (International Classification of Diseases, 10th Revision, codes I00 to I99) associated with risk factors were estimated using data from NHANES (National Health and Nutrition Examination Survey) (1988-1994 and 1999-2004, followed through 2006). Results: The preventable fraction of cardiovascular mortality associated with complete elimination of elevated cholesterol lev-els, diabetes, hypertension, obesity, and smoking was 54.0% for men and 49.6% for women in 2009 to 2010. When the more feasible target of reducing risk factors to the best achieved levels in the states was considered, diabetes (1.7% and 4.1%), hypertension (3.8% and 7.3%), and smoking (5.1% and 4.4%) were independently associated with the largest preventable fractions among men and women, respectively. With both targets, southern states had the largest preventable fractions, and western states had the smallest. Limitation: Self-reported state data; mortality hazards relied on baseline risk factor status. Conclusion: Major modifiable cardiovascular risk factors collectively accounted for half of cardiovascular deaths in U.S. adults aged 45 to 79 years in 2009 to 2010. Fewer than 10% of cardiovascular deaths nationally could be prevented if all states were to achieve risk factor levels observed in the best-performing states.	[Patel, Shivani A.; Ali, Mohammed K.; Narayan, K. M. Venkat; Mehta, Neil K.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Winkel, Munir] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Patel, SA (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, 1518 Clifton Rd NE,Room 6002, Atlanta, GA 30322 USA.	s.a.patel@emory.edu	Narayan, K.M. Venkat/J-9819-2012; Ali, Mohammed K/N-9833-2013	Narayan, K.M. Venkat/0000-0001-8621-5405; Patel, Shivani/0000-0003-0082-5857; Ali, Mohammed/0000-0001-7266-2503	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Robert Wood Johnson Foundation	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Byers T, 1998, PREV MED, V27, P311, DOI 10.1006/pmed.1998.0303; Centers for Disease Control and Prevention, 2014, CDC WONDER MULT CAUS; Centers for Disease Control and Prevention, 2009, BEH RISK FACT SURV S; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Fenelon A, 2012, DEMOGRAPHY, V49, P797, DOI 10.1007/s13524-012-0108-x; Flegal KM, 2004, AM J EPIDEMIOL, V160, P331, DOI 10.1093/aje/kwh222; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2009, CIRCULATION, V120, P1181, DOI 10.1161/CIRCULATIONAHA.108.835728; Ford ES, 2005, OBES RES, V13, P118, DOI 10.1038/oby.2005.15; Hahn R A, 1998, MMWR CDC Surveill Summ, V47, P35; HAHN RA, 1990, JAMA-J AM MED ASSOC, V264, P2654, DOI 10.1001/jama.264.20.2654; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LITTLE RJA, 1989, SOCIOL METHOD RES, V18, P292, DOI 10.1177/0049124189018002004; Mehta N, 2012, AM J PUBLIC HEALTH, V102, P2181, DOI 10.2105/AJPH.2011.300489; Mehta NK, 2014, EPIDEMIOLOGY, V25, P707, DOI 10.1097/EDE.0000000000000147; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Olives C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060308; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Preston SH, 2013, EPIDEMIOLOGY, V24, P158, DOI 10.1097/EDE.0b013e3182770217; Saydah S, 2014, OBESITY, V22, P1888, DOI 10.1002/oby.20761; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; Stokes A, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-6	31	131	137	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					245	+		10.7326/M14-1753	http://dx.doi.org/10.7326/M14-1753			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LC	26121190				2022-12-28	WOS:000360286400002
J	Barua, S; Greenwald, R; Grebely, J; Dore, GJ; Swan, T; Taylor, LE				Barua, Soumitri; Greenwald, Robert; Grebely, Jason; Dore, Gregory J.; Swan, Tracy; Taylor, Lynn E.			Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INJECTION-DRUG USERS; PLUS SOFOSBUVIR; GENOTYPE 1; ALCOHOL; INTERFERON; RIBAVIRIN; THERAPY; PEOPLE; HCV	The aim of this study was to systematically evaluate state Medicaid policies for the treatment of hepatitis C virus (HCV) infection with sofosbuvir in the United States. Medicaid reimbursement criteria for sofosbuvir were evaluated in all 50 states and the District of Columbia. The authors searched state Medicaid Web sites between 23 June and 7 December 2014 and extracted data in duplicate. Any differences were resolved by consensus. Data were extracted on whether sofosbuvir was covered and the criteria for coverage based on the following categories: liver disease stage, HIV co-infection, prescriber type, and drug or alcohol use. Of the 42 states with known Medicaid reimbursement criteria for sofosbuvir, 74% limit sofosbuvir access to persons with advanced fibrosis (Meta-Analysis of Histologic Data in Viral Hepatitis [METAVIR] fibrosis stage F3) or cirrhosis (F4). One quarter of states require persons co-infected with HCV and HIV to be receiving antiretroviral therapy or to have suppressed HIV RNA levels. Two thirds of states have restrictions based on prescriber type, and 88% include drug or alcohol use in their sofosbuvir eligibility criteria, with 50% requiring a period of abstinence and 64% requiring urine drug screening. Heterogeneity is present in Medicaid reimbursement criteria for sofosbuvir with respect to liver disease staging, HIV co-infection, prescriber type, and drug or alcohol use across the United States. Restrictions do not seem to conform with recommendations from professional organizations, such as the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases. Current restrictions seem to violate federal Medicaid law, which requires states to cover drugs consistent with their U.S. Food and Drug Administration labels.	Brown Univ, Providence, RI 02912 USA; Miriam Hosp, Providence, RI 02906 USA; Harvard Univ, Sch Law, Cambridge, MA 02138 USA; Univ New S Wales, Sydney, NSW, Australia; Treatment Act Grp, New York, NY USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; Harvard University; University of New South Wales Sydney	Taylor, LE (corresponding author), Brown Univ, Dept Med, Dept Med,Ctr AIDS Res Bldg, Warren Alpert Med Sch,Miriam Hosp, 164 Summit Ave,Room 156, Providence, RI 02912 USA.	LTaylor@Lifespan.org	Dore, Gregory John/ABD-5665-2021	Dore, Gregory John/0000-0002-4741-2622; Taylor, Lynn/0000-0002-0472-8125	Australian Government Department of Health and Ageing; National Health and Medical Research Council; Harvard Law School; Rhode Island Innovation Fellowship from the Rhode Island Foundation; Lifespan/Tufts/Brown Center for AIDS Research (National Institute of Allergy and Infectious Diseases) [P30AI042853]; Lifespan/Tufts/Brown Center for AIDS Research Summer Student Internship program [P30AI042853]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Harvard Law School; Rhode Island Innovation Fellowship from the Rhode Island Foundation; Lifespan/Tufts/Brown Center for AIDS Research (National Institute of Allergy and Infectious Diseases); Lifespan/Tufts/Brown Center for AIDS Research Summer Student Internship program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Kirby Institute is funded by the Australian Government Department of Health and Ageing. Dr. Grebely is supported by a National Health and Medical Research Council Career Development Fellowship. Mr. Greenwald is supported by Harvard Law School. Dr. Taylor is supported by a Rhode Island Innovation Fellowship from the Rhode Island Foundation for her "Rhode Island Defeats Hep C" project and the Lifespan/Tufts/Brown Center for AIDS Research (grant P30AI042853 from the National Institute of Allergy and Infectious Diseases). Ms. Barua was supported by the Lifespan/Tufts/Brown Center for AIDS Research Summer Student Internship program (grant P30AI042853).	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; American Association for the Study of Liver Diseases, 2015, RECOMMENDATIONS FOR; Anand BS, 2006, GASTROENTEROLOGY, V130, P1607, DOI 10.1053/j.gastro.2006.02.023; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Butt AA, 2007, GUT, V56, P385, DOI 10.1136/gut.2006.099150; Centers for Medicare & Medicaid Services, MEDICAID DRUG REBATE; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Corrao G, 1998, HEPATOLOGY, V27, P914, DOI 10.1002/hep.510270404; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Gilead Sciences, 2014, SOVALDI PACKAGE INSE; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Graham CS, 2015, UNDERSTANDING THE RE; Grebely J, 2007, J GASTROEN HEPATOL, V22, P1519, DOI 10.1111/j.1440-1746.2007.05032.x; Grebely J, 2011, SEMIN LIVER DIS, V31, P331, DOI 10.1055/s-0031-1297922; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Henry J., 2015, STATE HEALTH FACTS M; Hutchinson SJ, 2005, CLIN GASTROENTEROL H, V3, P1150, DOI 10.1016/S1542-3565(05)00407-6; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kottilil S, 2014, ANN INTERN MED, V161, P443, DOI 10.7326/M14-0741; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Le Lan C, 2012, J HEPATOL, V56, P334, DOI 10.1016/j.jhep.2011.05.021; Lettmeier B, 2008, J HEPATOL, V49, P528, DOI 10.1016/j.jhep.2008.04.021; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Matthews G, 2005, CLIN INFECT DIS, V40, pS325, DOI 10.1086/427448; Mauss S, 2004, HEPATOLOGY, V40, P120, DOI 10.1002/hep.20279; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pawlotsky JM, 2014, J HEPATOL, V61, P373, DOI 10.1016/j.jhep.2014.05.001; Reau NS, 2014, HEPATOLOGY, V59, P1246, DOI 10.1002/hep.27039; Robaeys G, 2013, CLIN INFECT DIS, V57, pS129, DOI 10.1093/cid/cit302; Rosman AS, 1996, AM J GASTROENTEROL, V91, P498; Singal AK, 2007, J CLIN GASTROENTEROL, V41, P761, DOI 10.1097/MCG.0b013e3180381584; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Sylvestre DL, 2005, J SUBST ABUSE TREAT, V29, P159, DOI 10.1016/j.jsat.2005.06.002; [U. S. Department of Health and Human Services National Institutes of Health NIH Consensus Development Program Office of Disease Prevention], 2002, MANAGEMENT OF HEPATI; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; [WHO W. H. Organization], 2014, GUID SCREEN CAR TREA; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3	48	322	322	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					215	+		10.7326/M15-0406	http://dx.doi.org/10.7326/M15-0406			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO6EX	26120969				2022-12-28	WOS:000359251100010
J	Shaw, LJ; Giambrone, AE; Blaha, MJ; Knapper, JT; Berman, DS; Bellam, N; Quyyumi, A; Budoff, MJ; Callister, TQ; Min, JK				Shaw, Leslee J.; Giambrone, Ashley E.; Blaha, Michael J.; Knapper, Joseph T.; Berman, Daniel S.; Bellam, Naveen; Quyyumi, Arshed; Budoff, Matthew J.; Callister, Tracy Q.; Min, James K.			Long-Term Prognosis After Coronary Artery Calcification Testing in Asymptomatic Patients A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR RISK-FACTORS; COMPUTED-TOMOGRAPHY; HEART-DISEASE; CALCIUM SCORES; OUTCOMES; EVENTS; ATHEROSCLEROSIS; QUANTIFICATION; IMPROVEMENT	Background: The extent of coronary artery calcification (CAC) and near-term adverse clinical outcomes are strongly related through 5 years of follow-up. Objective: To describe the ability of CAC scores to predict long-term mortality in persons without symptoms of coronary artery disease. Design: Observational cohort. Setting: Single-center, outpatient cardiology laboratory. Patients: 9715 asymptomatic patients. Measurements: Coronary artery calcification scoring and binary risk factor data were collected. The primary end point was time to all-cause mortality (median follow-up, 14.6 years). Univariable and multivariable Cox proportional hazards models were used to compare survival distributions. The net reclassification improvement statistic was calculated. Results: In Cox models adjusted for risk factors for coronary artery disease, the CAC score was highly predictive of all-cause mortality (P < 0.001). Overall 15-year mortality rates ranged from 3% to 28% for CAC scores from 0 to 1000 or greater (P < 0.001). The relative hazard for all-cause mortality ranged from 1.68 for a CAC score of 1 to 10 (P < 0.001) to 6.26 for a score of 1000 or greater (P < 0.001). The categorical net reclassification improvement using cut points of less than 7.5% to 22.5% or greater was 0.21 (95% Cl, 0.16 to 0.32). Limitations: Data collection was limited to a single center with generalizability limitations. Only binary risk factor data were available, and CAC was only measured once. Conclusion: The extent of CAC accurately predicts 15-year mortality in a large cohort of asymptomatic patients. Long-term estimates of mortality provide a unique opportunity to examine the value of novel biomarkers, such as CAC, in estimating important patient outcomes.	Emory Univ, Sch Med, Atlanta, GA 30322 USA; Weill Cornell Med Coll, New York, NY USA; Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Harbor UCLA Med Ctr, Los Angeles, CA USA; Tennessee Heart & Vasc Inst, Hendersonville, TN USA	Emory University; Cornell University; Johns Hopkins University; Johns Hopkins Medicine; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Tennessee Heart & Vascular	Shaw, LJ (corresponding author), Emory Univ, Sch Med, Emory Clin Cardiovasc Res Inst, 1462 Clifton Rd Northeast,Room 529, Atlanta, GA 30322 USA.	leslee.shaw@emory.edu	Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946	U.S. Food and Drug Administration/National Institutes of Health; American Heart Association; Aetna; Pfizer; Luitpold Pharmaceuticals; General Electric Healthcare; National Heart, Lung, and Blood Institute; National Research Foundation of Korea	U.S. Food and Drug Administration/National Institutes of Health; American Heart Association(American Heart Association); Aetna; Pfizer(Pfizer); Luitpold Pharmaceuticals; General Electric Healthcare(General ElectricGE Healthcare); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Foundation of Korea(National Research Foundation of Korea)	Dr. Blaha reports grants from the U.S. Food and Drug Administration/National Institutes of Health, American Heart Association, and Aetna and personal fees from Pfizer and Luitpold Pharmaceuticals outside the submitted work. Dr. Budoff reports grants from General Electric Healthcare during the conduct of the study. Dr. Min reports grants from the National Heart, Lung, and Blood Institute and National Research Foundation of Korea and other from Michael Wolk Heart Foundation and General Electric Healthcare during the conduct of the study, as well as other from Vital Images, Philips Healthcare, Arineta, AstraZeneca, Bristol-Myers Squibb, and HeartFlow outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-0612.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Bellasi A, 2007, AM J CARDIOL, V100, P409, DOI 10.1016/j.amjcard.2007.03.037; Berard E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095671; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Mao SS, 2009, J COMPUT ASSIST TOMO, V33, P175, DOI 10.1097/RCT.0b013e31817579ee; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; Menotti A, 2001, EUR HEART J, V22, P573, DOI 10.1053/euhj.2000.2402; Nasir K, 2007, J AM COLL CARDIOL, V50, P953, DOI 10.1016/j.jacc.2007.03.066; Oudkerk M, 2008, EUR RADIOL, V18, P2785, DOI 10.1007/s00330-008-1095-6; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Penston J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6395; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Raggi P, 2008, J AM COLL CARDIOL, V52, P17, DOI 10.1016/j.jacc.2008.04.004; Rozanski A, 2007, J AM COLL CARDIOL, V49, P1352, DOI 10.1016/j.jacc.2006.12.035; Rozanski A, 2011, J AM COLL CARDIOL, V57, P1622, DOI 10.1016/j.jacc.2011.01.019; Schenker MP, 2008, CIRCULATION, V117, P1693, DOI 10.1161/CIRCULATIONAHA.107.717512; Schmermund A, 2002, AM J CARDIOL, V90, P168, DOI 10.1016/S0002-9149(02)02445-1; Shaw LJ, 2006, EUR HEART J, V27, P968, DOI 10.1093/eurheartj/ehi750; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Social Security Administration, ACT LIF TABL; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Wayhs R, 2002, J AM COLL CARDIOL, V39, P225, DOI 10.1016/S0735-1097(01)01737-5; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	35	130	133	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1					14	21		10.7326/M14-0612	http://dx.doi.org/10.7326/M14-0612			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	26148276				2022-12-28	WOS:000357442000002
J	Bull, JJ				Bull, James J.			EVOLUTION Reptile sex determination goes wild	NATURE			English	Editorial Material								Wild populations of an Australian lizard have sex chromosomes and also exhibit temperature-controlled sexual development, providing insight into how these two sex-determining mechanisms may evolve back and forth.	[Bull, James J.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Bull, James J.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Bull, James J.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Bull, JJ (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	bull@utexas.edu						Gamble T, 2015, MOL BIOL EVOL, V32, P1296, DOI 10.1093/molbev/msv023; Holleley CE, 2015, NATURE, V523, P79, DOI 10.1038/nature14574; Janes DE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0809; JANZEN FJ, 1991, Q REV BIOL, V66, P149, DOI 10.1086/417143; Ohno S., 1967, SEX CHROMOSOMES SEX; Quinn AE, 2009, MOL GENET GENOMICS, V281, P665, DOI 10.1007/s00438-009-0437-7; Radder RS, 2008, BIOL LETTERS, V4, P176, DOI 10.1098/rsbl.2007.0583; Schwanz LE, 2013, J EVOLUTION BIOL, V26, P2544, DOI 10.1111/jeb.12258	8	3	3	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					43	44		10.1038/523043a	http://dx.doi.org/10.1038/523043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135445				2022-12-28	WOS:000357169500026
J	Langen, M; Agi, E; Altschuler, DJ; Wu, LNF; Altschuler, SJ; Hiesinger, PR				Langen, Marion; Agi, Egemen; Altschuler, Dylan J.; Wu, Lani F.; Altschuler, Steven J.; Hiesinger, Peter Robin			The Developmental Rules of Neural Superposition in Drosophila	CELL			English	Article							VISUAL-SYSTEM DEVELOPMENT; SYNAPTIC SPECIFICITY; GROWTH; ORGANIZATION; MECHANISMS; PATTERNS; RETINA; CONNECTIONS; FLY	Complicated neuronal circuits can be genetically encoded, but the underlying developmental algorithms remain largely unknown. Here, we describe a developmental algorithm for the specification of synaptic partner cells through axonal sorting in the Drosophila visual map. Our approach combines intravital imaging of growth cone dynamics in developing brains of intact pupae and data-driven computational modeling. These analyses suggest that three simple rules are sufficient to generate the seemingly complex neural superposition wiring of the fly visual map without an elaborate molecular matchmaking code. Our computational model explains robust and precise wiring in a crowded brain region despite extensive growth cone overlaps and provides a framework for matching molecular mechanisms with the rules they execute. Finally, ordered geometric axon terminal arrangements that are not required for neural superposition are a side product of the developmental algorithm, thus elucidating neural circuit connectivity that remained unexplained based on adult structure and function alone.	[Langen, Marion; Altschuler, Dylan J.; Wu, Lani F.; Altschuler, Steven J.; Hiesinger, Peter Robin] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Langen, Marion; Wu, Lani F.; Altschuler, Steven J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Agi, Egemen; Hiesinger, Peter Robin] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Agi, Egemen; Hiesinger, Peter Robin] Free Univ Berlin, Inst Biol, Div Neurobiol, D-14195 Berlin, Germany; [Agi, Egemen; Hiesinger, Peter Robin] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Altschuler, SJ (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	steven.altschuler@ucsf.edu; robin.hiesinger@fu-berlin.de		Langen, Marion/0000-0001-6109-6593	Green Center for Systems Biology Postdoctoral Fellowship at UT Southwestern; NIH [RO1EY018884, RO1EY023333, R01CA133253, R01GM071794, CA185404, CA184984]; Institute of Computational Health Sciences at UC San Francisco; Muscular Dystrophy Association [MDA275948]; Freie Universitat Berlin; NeuroCure Cluster of Excellence, Berlin; NATIONAL CANCER INSTITUTE [R01CA185404, P30CA142543, R01CA184984, R01CA133253] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023333, R01EY018884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071794] Funding Source: NIH RePORTER	Green Center for Systems Biology Postdoctoral Fellowship at UT Southwestern; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Computational Health Sciences at UC San Francisco; Muscular Dystrophy Association(Muscular Dystrophy Association); Freie Universitat Berlin; NeuroCure Cluster of Excellence, Berlin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the P.R.H. lab and S.J.A/L.F.W lab, Tom Clandinin, Ian Meinertzhagen, Orkun Akin, Larry Zipursky, and Rama Ranganathan for helpful discussions. We thank Tom Clandinin, Ernst Hafen, and Developmental Studies Hybridoma Bank at the University of Iowa for reagents. We also thank Kate Luby-Phelps and the Imaging Core Facility at UT Southwestern Medical Center for help with two-photon microscopy. This work was supported by a Green Center for Systems Biology Postdoctoral Fellowship at UT Southwestern (to M.L.), the NIH (RO1EY018884 and RO1EY023333 to P.R.H.; R01CA133253 and R01GM071794 to S.J.A.; and CA185404 and CA184984 to L.F.W.), the Institute of Computational Health Sciences at UC San Francisco (to L.F.W. and S.J.A.), and the Muscular Dystrophy Association (MDA275948) and the Freie Universitat Berlin and the NeuroCure Cluster of Excellence, Berlin (to P.R.H.).	Agi E, 2014, J NEUROGENET, V28, P216, DOI 10.3109/01677063.2014.922557; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; CAUDY M, 1986, J NEUROSCI, V6, P1781; Chan CC, 2011, DEV NEUROBIOL, V71, P1227, DOI 10.1002/dneu.20940; Chen PL, 2008, NEURON, V58, P26, DOI 10.1016/j.neuron.2008.01.007; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; HORRIDGE GA, 1970, PROC R SOC SER B-BIO, V175, P69, DOI 10.1098/rspb.1970.0012; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; KRANTZ DE, 1990, EMBO J, V9, P1969, DOI 10.1002/j.1460-2075.1990.tb08325.x; Land MF, 2005, CURR BIOL, V15, pR319, DOI 10.1016/j.cub.2005.04.041; Langen M, 2013, ELIFE, V2, DOI 10.7554/eLife.00337; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; MEINERTZHAGEN IA, 1976, PHILOS T ROY SOC B, V274, P555, DOI 10.1098/rstb.1976.0064; Meinertzhagen Ian A., 1993, P1363; Nilsson D.-E., 1989, P30; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Rivera-Alba M, 2011, CURR BIOL, V21, P2000, DOI 10.1016/j.cub.2011.10.022; Schwabe T, 2014, CURR BIOL, V24, P1304, DOI 10.1016/j.cub.2014.04.047; Schwabe T, 2013, CELL, V154, P351, DOI 10.1016/j.cell.2013.06.011; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; TRUJILLOCENOZ O, 1973, J ULTRA MOL STRUCT R, V42, P554, DOI 10.1016/S0022-5320(73)80027-9; VIGIER P, 1907, CR HEBD ACAD SCI, V63, P532; Vigier P., 1907, CR HEBD ACAD SCI, V63, P633; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5; Yogev S, 2014, ANNU REV CELL DEV BI, V30, P417, DOI 10.1146/annurev-cellbio-100913-012953; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	32	49	49	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					120	133		10.1016/j.cell.2015.05.055	http://dx.doi.org/10.1016/j.cell.2015.05.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26119341	Green Accepted, Bronze			2022-12-28	WOS:000357542300014
J	Rutter, P				Rutter, Paul			PERSONAL VIEW End pharmacists' monopoly on selling certain drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Wolverhampton Univ, Sch Pharm, Wolverhampton WV1 1SB, England	University of Wolverhampton	Rutter, P (corresponding author), Wolverhampton Univ, Sch Pharm, Wolverhampton WV1 1SB, England.	paul.rutter@wlv.ac.uk	rutter, paul/AAG-7043-2019	Rutter, Paul/0000-0003-4106-1515				Akhtar S, 2015, RES SOC ADMIN PHARM, V11, P472, DOI 10.1016/j.sapharm.2014.09.003; [Anonymous], 2008, WHICH PHARM GET TEST; Driesen Annelies, 2009, Int J Pharm Pract, V17, P215; Medicines and Healthcare Products Regulatory Agency, 2015, OR DICL PRES LEG STA; Paudyal V, 2014, RES SOC ADMIN PHARM, V10, P88, DOI 10.1016/j.sapharm.2013.04.007; Paudyal V, 2011, HEALTH POLICY, V101, P253, DOI 10.1016/j.healthpol.2011.05.010; Pillay N, 2010, SELFCARE, V1, P105; Rutter PM, 2013, SELF CARE, V4, P125; Tisman A., 2010, RISING TIDE OTC EURO; World Self Medication Industry, 2014, RESP SELF CAR SELF M; World Self Medication Industry, 2009, SWITCH PRESCR NONPR	11	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2015	351								h3415	10.1136/bmj.h3415	http://dx.doi.org/10.1136/bmj.h3415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TQ	26136348	Green Accepted			2022-12-28	WOS:000357607800004
J	Hawks, J; de Ruiter, DJ; Berger, LR				Hawks, John; de Ruiter, Darryl J.; Berger, Lee R.			Comment on "Early Homo at 2.8 Ma from Ledi-Geraru, Afar, Ethiopia"	SCIENCE			English	Editorial Material								Villmoare et al. (Reports, 20 March 2015, p. 1352) report on a hominin mandible from the Ledi-Geraru research area, Ethiopia, which they claim to be the earliest known representative of the genus Homo. However, certain measurements and observations for Australopithecus sediba mandibles presented are incorrect or are not included in critical aspects of the study. When correctly used, these data demonstrate that specimen LD 350-1 cannot be unequivocally assigned to the genus Homo.	[Hawks, John] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Hawks, John; de Ruiter, Darryl J.; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA	University of Wisconsin System; University of Wisconsin Madison; University of Witwatersrand; Texas A&M University System; Texas A&M University College Station	Hawks, J (corresponding author), Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA.	jhawks@wisc.edu	Hawks, John/H-5737-2015	Hawks, John/0000-0003-3187-3755; de Ruiter, Darryl/0000-0003-1183-0352				Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343	3	11	12	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241								10.1126/science.aab0591	http://dx.doi.org/10.1126/science.aab0591			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7XK	26089505				2022-12-28	WOS:000356449500037
J	Hatch, EM; Hetzer, MW				Hatch, Emily M.; Hetzer, Martin W.			Linking Micronuclei to Chromosome Fragmentation	CELL			English	Editorial Material							CHROMOTHRIPSIS; REARRANGEMENTS	Human cancer cells bear complex chromosome rearrangements that can be potential drivers of cancer development. However, the molecular mechanisms underlying these rearrangements have been unclear. Zhang et al. use a new technique combining live-cell imaging and single-cell sequencing to demonstrate that chromosomes mis-segregated to micronuclei frequently undergo chromothripsis-like rearrangements in the subsequent cell cycle.	[Hatch, Emily M.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Hatch, Emily/0000-0002-3393-4075	NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Kloosterman WP, 2013, CURR OPIN CELL BIOL, V25, P341, DOI 10.1016/j.ceb.2013.02.008; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; TOLBERT PE, 1992, MUTAT RES, V271, P69, DOI 10.1016/0165-1161(92)90033-I; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Zhang C.-Z., 2015, NATURE, DOI 10.1038/nature14493; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113	10	27	31	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1502	1504		10.1016/j.cell.2015.06.005	http://dx.doi.org/10.1016/j.cell.2015.06.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091034	Bronze			2022-12-28	WOS:000356618200008
J	Liu, Z; Guan, DB; Moore, S; Lee, H; Su, J; Zhang, Q				Liu, Zhu; Guan, Dabo; Moore, Scott; Lee, Henry; Su, Jun; Zhang, Qiang			Steps to China's carbon peak	NATURE			English	Editorial Material									[Liu, Zhu] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Guan, Dabo] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Liu, Zhu; Moore, Scott; Lee, Henry] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Su, Jun] Tsinghua Univ, Sch Publ Policy & Management, Beijing 100084, Peoples R China; [Guan, Dabo; Zhang, Qiang] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of East Anglia; Harvard University; Tsinghua University; Tsinghua University	Liu, Z (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China.	liuzhu@iae.ac.cn; dabo.guan@uea.ac.uk	Guan, Dabo/K-5534-2017; Liu, Zhu/A-4634-2013; Guan, Dabo/Y-2406-2019; Zhang, Qiang/D-9034-2012	Guan, Dabo/0000-0003-3773-3403; Liu, Zhu/0000-0002-8968-7050; Guan, Dabo/0000-0003-3773-3403; 	ESRC [ES/L016028/1] Funding Source: UKRI; Economic and Social Research Council [ES/L016028/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110; Guan DB, 2014, NAT CLIM CHANGE, V4, P1017, DOI 10.1038/NCLIMATE2388; Guan DB, 2012, NAT CLIM CHANGE, V2, P672, DOI [10.1038/NCLIMATE1560, 10.1038/nclimate1560]; Li JA, 2011, SCIENCE, V334, P886; Liu Z, 2012, ENERGY, V45, P1059, DOI 10.1016/j.energy.2012.06.007; National Development and Reform Commission of China, 2014, INT PLAN CARB TRAD C	6	176	192	24	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					279	281		10.1038/522279a	http://dx.doi.org/10.1038/522279a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085256	Bronze, Green Submitted			2022-12-28	WOS:000356425400027
J	Berry, S; Berry, J; Ramchandani, R; Spencer, N				Berry, Simon; Berry, Jane; Ramchandani, Rohit; Spencer, Nick			Should we welcome multinational companies' involvement in programmes to improve child health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Berry, Simon; Berry, Jane] ColaLife, Keepers Zambia Fdn, Lusaka, Zambia; [Ramchandani, Rohit] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Spencer, Nick] Univ Warwick, Sch Hlth & Social Studies, Child Hlth, Coventry CV4 7AL, W Midlands, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Warwick	Berry, S (corresponding author), ColaLife, Keepers Zambia Fdn, Lusaka, Zambia.	simon@colalife.org; N.J.Spencer@warwick.ac.uk		Ramchandani, Rohit/0000-0003-4111-7670				ActionAid, SABMILLER GUID TAX D; [Anonymous], 2014, EVALUATION REPORT CO; Choonara I, 2014, ARCH DIS CHILD, V99, P605, DOI 10.1136/archdischild-2013-305257; Gill CJ, 2013, LANCET, V381, P1487, DOI 10.1016/S0140-6736(13)60314-1; Leontopoulus N., COCA COLA ZERO TAX G; Muoi Nguyen Pham, 2012, WALL STREET J; Prahalad C. K., 2005, FORTUNE BOTTOM PYRAM; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; World Bank, 2014, LEV TRENDS CHILD MOR	9	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2015	350								h3046	10.1136/bmj.h3046	http://dx.doi.org/10.1136/bmj.h3046			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2OZ	26085507				2022-12-28	WOS:000356785200002
J	Thorlund, JB; Juhl, CB; Roos, EM; Lohmander, LS				Thorlund, J. B.; Juhl, C. B.; Roos, E. M.; Lohmander, L. S.			Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DEEP-VEIN THROMBOSIS; PATIENT REPORTED OUTCOMES; MOLECULAR-WEIGHT HEPARIN; MEDIAL MENISCAL TEARS; VENOUS THROMBOEMBOLISM; CONTROLLED-TRIAL; PARTIAL MENISCECTOMY; NONOPERATIVE TREATMENT; AMBULATORY SURGERY; HIP OSTEOARTHRITIS	OBJECTIVE To determine benefits and harms of arthroscopic knee surgery involving partial meniscectomy, debridement, or both for middle aged or older patients with knee pain and degenerative knee disease. DESIGN Systematic review and meta-analysis. MAIN OUTCOME MEASURES Pain and physical function. DATA SOURCES Systematic searches for benefits and harms were carried out in Medline, Embase, CINAHL, Web of Science, and the Cochrane Central Register of Controlled Trials (CENTRAL) up to August 2014. Only studies published in 2000 or later were included for harms. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials assessing benefit of arthroscopic surgery involving partial meniscectomy, debridement, or both for patients with or without radiographic signs of osteoarthritis were included. For harms, cohort studies, register based studies, and case series were also allowed. RESULTS The search identified nine trials assessing the benefits of knee arthroscopic surgery in middle aged and older patients with knee pain and degenerative knee disease. The main analysis, combining the primary endpoints of the individual trials from three to 24 months postoperatively, showed a small difference in favour of interventions including arthroscopic surgery compared with control treatments for pain (effect size 0.14, 95% confidence interval 0.03 to 0.26). This difference corresponds to a benefit of 2.4 (95% confidence interval 0.4 to 4.3) mm on a 0-100 mm visual analogue scale. When analysed over time of follow-up, interventions including arthroscopy showed a small benefit of 3-5 mm for pain at three and six months but not later up to 24 months. No significant benefit on physical function was found (effect size 0.09, -0.05 to 0.24). Nine studies reporting on harms were identified. Harms included symptomatic deep venous thrombosis (4.13 (95% confidence interval 1.78 to 9.60) events per 1000 procedures), pulmonary embolism, infection, and death. CONCLUSIONS The small inconsequential benefit seen from interventions that include arthroscopy for the degenerative knee is limited in time and absent at one to two years after surgery. Knee arthroscopy is associated with harms. Taken together, these findings do not support the practise of arthroscopic surgery for middle aged or older patients with knee pain with or without signs of osteoarthritis. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42014009145.	[Thorlund, J. B.; Juhl, C. B.; Roos, E. M.; Lohmander, L. S.] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, DK-5230 Odense M, Denmark; [Juhl, C. B.] Copenhagen Univ Hosp, Dept Orthoped, Gentofte, Denmark; [Lohmander, L. S.] Odense Univ Hosp, Dept Orthoped & Traumatol, DK-5000 Odense, Denmark; [Lohmander, L. S.] Lund Univ, Dept Orthoped, Clin Sci Lund, S-22100 Lund, Sweden	University of Southern Denmark; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Lund University	Thorlund, JB (corresponding author), Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Campusvej 55, DK-5230 Odense M, Denmark.	jthorlund@health.sdu.dk	Roos, Ewa M/A-5416-2012; Thorlund, Jonas B/A-4278-2014; Lohmander, Stefan/AAL-8314-2021; Thorlund, Jonas Bloch/N-1593-2019	Roos, Ewa M/0000-0001-5425-2199; Thorlund, Jonas B/0000-0001-7789-8224; Lohmander, Stefan/0000-0002-5424-9448; Thorlund, Jonas Bloch/0000-0001-7789-8224	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	LSL is supported by the Swedish Research Council. The funder had no role in any part of the study or in any decision about publication.	Ahlb?ck S., 1968, ACTA RADIOL STOCKH S, V277, P7, DOI DOI 10.1556/AALIM.2015.0002; [Anonymous], 2006, Technol Eval Cent Assess Program Exec Summ, V21, P1; Aydogan NH, 2008, SAUDI MED J, V29, P397; Bannuru RR, 2014, OSTEOARTHR CARTILAGE, V22, pS24, DOI 10.1016/j.joca.2014.02.068; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P1398, DOI 10.2106/JBJS.I.00539; Bergqvist D, 2002, ARCH INTERN MED, V162, P2173, DOI 10.1001/archinte.162.19.2173; Biedert RM, 2000, KNEE SURG SPORT TR A, V8, P104, DOI 10.1007/s001670050195; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Bliddal H, 2009, EXPERT OPIN PHARMACO, V10, P1793, DOI 10.1517/14656560903018911; Bohensky M, 2012, INTERN MED J, V42, P29; Bohensky MA, 2014, KNEE, V21, P491, DOI 10.1016/j.knee.2013.11.009; Bohensky MA, 2013, ARTHROSCOPY, V29, P716, DOI 10.1016/j.arthro.2012.11.020; Bohensky MA, 2012, MED J AUSTRALIA, V197, P399, DOI 10.5694/mja11.11645; Brophy RH, 2014, J BONE JOINT SURG AM, V96A, P801, DOI 10.2106/JBJS.M.00105; Camporese G, 2008, ANN INTERN MED, V149, P73, DOI 10.7326/0003-4819-149-2-200807150-00003; CHANG RW, 1993, ARTHRITIS RHEUM, V36, P289, DOI 10.1002/art.1780360302; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Crevoisier X, 2001, ARTHROSCOPY, V17, P732, DOI 10.1053/jars.2001.20099; Cullen K, 2009, AMBULATORY SURG US 2; Dahl OE, 2000, ACTA ORTHOP SCAND, V71, P47, DOI 10.1080/00016470052943883; Delis KT, 2001, THROMB HAEMOSTASIS, V86, P817; Dias L, 2013, 4REG AN PAIN MED C 3, P38; ElAttrache N, 2014, ARTHROSCOPY, V30, P542, DOI 10.1016/j.arthro.2014.02.010; Engbaek J, 2006, ACTA ANAESTH SCAND, V50, P911, DOI 10.1111/j.1399-6576.2006.01090.x; Englund M, 2007, ARTHRITIS RHEUM, V56, P4048, DOI 10.1002/art.23071; Englund M, 2001, RHEUMATOLOGY, V40, P631, DOI 10.1093/rheumatology/40.6.631; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Ettema HB, 2006, J THROMB HAEMOST, V4, P1411, DOI 10.1111/j.1538-7836.2006.01948.x; Gauffin H, 2014, OSTEOARTHR CARTILAGE, V22, P1808, DOI 10.1016/j.joca.2014.07.017; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Greene JW, 2013, SPORTS MED ARTHROSC, V21, P69, DOI 10.1097/JSA.0b013e31828a7e76; Guermazi A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5339; Hame SL, 2012, AM J SPORT MED, V40, P1402, DOI 10.1177/0363546512443043; Harris IA, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-143; Hawker G, 2008, J BONE JOINT SURG AM, V90A, P2337, DOI 10.2106/JBJS.G.01671; Hedges L.V., 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; Herrlin SV, 2013, KNEE SURG SPORT TR A, V21, P358, DOI 10.1007/s00167-012-1960-3; Hetsroni I, 2011, J BONE JOINT SURG BR, V93B, P47, DOI 10.1302/0301-620X.93B1.25498; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hitzeman N, 2008, AM FAM PHYSICIAN, V78, P331; Hoppener MR, 2006, ACTA ORTHOP, V77, P767, DOI 10.1080/17453670610012962; Ilahi OA, 2005, ARTHROSCOPY, V21, P727, DOI 10.1016/j.arthro.2005.03.007; Jameson SS, 2011, J BONE JOINT SURG BR, V93B, P1327, DOI 10.1302/0301-620X.93B10.27078; Juhl C, 2014, ARTHRITIS RHEUMATOL, V66, P622, DOI 10.1002/art.38290; Juhl C, 2012, ARTHRITIS, DOI 10.1155/2012/136245; [康建国 Kang Jianguo], 2005, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V31, P802; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Kim S, 2011, J BONE JOINT SURG AM, V93A, P994, DOI 10.2106/JBJS.I.01618; Kim TK, 2002, AM J SPORT MED, V30, P619, DOI 10.1177/03635465020300042501; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Krych AJ, 2014, NEW ENGL J MED, V370, P1259, DOI 10.1056/NEJMc1401128; Laupaffarakasem W, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005118.pub2; Lazic S, 2014, KNEE, V21, P631, DOI 10.1016/j.knee.2014.02.014; Lim HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096745; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Lohmander LS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7835; Lubowitz JH, 2014, ARTHROSCOPY, V30, P654, DOI 10.1016/j.arthro.2014.04.007; Lubowitz JH, 2013, ARTHROSCOPY, V29, P1597, DOI 10.1016/j.arthro.2013.07.268; Luetmer MT, 2011, AM J NEURORADIOL, V32, P647, DOI 10.3174/ajnr.A2371; Maletis GB, 2012, J BONE JOINT SURG AM, V94A, P714, DOI 10.2106/JBJS.J.01759; Mauck KF, 2013, J THROMB HAEMOST, V11, P1279, DOI 10.1111/jth.12283; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; MERCHAN ECR, 1993, ARTHROSCOPY, V9, P663, DOI 10.1016/S0749-8063(05)80503-1; Michot M, 2002, ARTHROSCOPY, V18, P257, DOI 10.1053/jars.2002.30013; Mitchell JM, 2010, ARCH SURG-CHICAGO, V145, P732, DOI 10.1001/archsurg.2010.149; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Moseley JB, 1996, AM J SPORT MED, V24, P28, DOI 10.1177/036354659602400106; Ng W M, 2005, Med J Malaysia, V60 Suppl C, P14; Osteras H, 2012, J BODYW MOV THER, V16, P456, DOI 10.1016/j.jbmt.2012.04.003; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Price A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2382; Pugely AJ, 2013, J BONE JOINT SURG AM, V95A, P193, DOI [10.2106/JBJS.K.01682, 10.2106/JBJS.L.01440]; Ramos J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005259.pub3; Reigstad O, 2006, KNEE SURG SPORT TR A, V14, P473, DOI 10.1007/s00167-005-0694-x; Moreno HAR, 2009, CURR ORTHOP PRACT, V20, P665, DOI 10.1097/BCO.0b013e3181a5ef0a; Rossi MJ, 2014, ARTHROSCOPY, V30, P536, DOI 10.1016/j.arthro.2014.02.013; Salzler MJ, 2014, AM J SPORT MED, V42, P292, DOI 10.1177/0363546513510677; Sgaglione NA, 2004, SPORTS MED ARTHROSC, V12, P148, DOI 10.1097/00132585-200409000-00002; Shannon FJ, 2001, INT ORTHOP, V25, P242, DOI 10.1007/s002640000212; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Thorlund JB, 2014, ACTA ORTHOP, V85, P287, DOI 10.3109/17453674.2014.919558; Tubach F, 2005, ANN RHEUM DIS, V64, P34, DOI 10.1136/ard.2004.023028; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; Tzoanos GN, 2011, ARTHROSCOPY, P27; Vermesan D, 2013, EUR REV MED PHARMACO, V17, P3192; Wai EK, 2002, J BONE JOINT SURG AM, V84A, P17, DOI 10.2106/00004623-200201000-00003; Wartolowska K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3253; Widuchowski Jerzy, 2003, Chir Narzadow Ruchu Ortop Pol, V68, P105; Wirth T, 2001, ARTHROSCOPY, V17, P393, DOI 10.1053/jars.2001.21247; Yacub JN, 2009, AM J PHYS MED REHAB, V88, P635, DOI 10.1097/PHM.0b013e3181ae0c9d; Yeranosian MG, 2013, ARTHROSCOPY, V29, P1355, DOI 10.1016/j.arthro.2013.05.007; Yim JH, 2013, AM J SPORT MED, V41, P1565, DOI 10.1177/0363546513488518; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	103	196	200	2	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2015	350								h2747	10.1136/bmj.h2747	http://dx.doi.org/10.1136/bmj.h2747			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2OJ	26080045	hybrid, Green Published			2022-12-28	WOS:000356783600001
J	Gellad, WF; Flynn, KE; Alexander, GC				Gellad, Walid F.; Flynn, Kathryn E.; Alexander, G. Caleb			Evaluation of Flibanserin Science and Advocacy at the FDA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gellad, Walid F.] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA; [Gellad, Walid F.] Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing, Pittsburgh, PA USA; [Gellad, Walid F.] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; [Flynn, Kathryn E.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Flynn, Kathryn E.] Med Coll Wisconsin, Ctr Patient Care & Outcomes Res, Milwaukee, WI 53226 USA; [Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Baltimore, MD USA; [Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Alexander, G. Caleb] Johns Hopkins Med, Dept Med, Gen Internal Med Sect, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Medical College of Wisconsin; Medical College of Wisconsin; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Gellad, WF (corresponding author), Div Gen Internal Med, Univ Dr 151C, Pittsburgh, PA 15240 USA.	walid.gellad@pitt.edu	Flynn, Kathryn E/M-5346-2013	Flynn, Kathryn E/0000-0002-4427-3583				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Gnanasakthy A, 2012, VALUE HEALTH, V15, P437, DOI 10.1016/j.jval.2011.11.032; Pollack A., VIAGRA WOMEN GETS PU; Qato DM, 2011, JAMA-J AM MED ASSOC, V306, P1595, DOI 10.1001/jama.2011.1457; Tavernise S, AID WOMEN BOTTOM LIN; US Food and Drug Administration, FDA BRIEF DOC JOINT	6	30	30	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					869	870		10.1001/jama.2015.8405	http://dx.doi.org/10.1001/jama.2015.8405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26148201				2022-12-28	WOS:000360392100008
J	Buyon, JP; Kim, MY; Guerra, MM; Laskin, CA; Petri, M; Lockshin, MD; Sammaritano, L; Branch, DW; Porter, TF; Sawitzke, A; Merrill, JT; Stephenson, MD; Cohn, E; Garabet, L; Salmon, JE				Buyon, Jill P.; Kim, Mimi Y.; Guerra, Marta M.; Laskin, Carl A.; Petri, Michelle; Lockshin, Michael D.; Sammaritano, Lisa; Branch, D. Ware; Porter, T. Flint; Sawitzke, Allen; Merrill, Joan T.; Stephenson, Mary D.; Cohn, Elisabeth; Garabet, Lamya; Salmon, Jane E.			Predictors of Pregnancy Outcomes in Patients With Lupus A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIAC MANIFESTATIONS; HEART-BLOCK; ERYTHEMATOSUS; WOMEN; RISK; COMPLEMENT; ANTIBODIES; HYDROXYCHLOROQUINE; CLASSIFICATION; ACTIVATION	Background: Because systemic lupus erythematosus (SLE) affects women of reproductive age, pregnancy is a major concern. Objective: To identify predictors of adverse pregnancy outcomes (APOs) in patients with inactive or stable active SLE. Design: Prospective cohort. Setting: Multicenter. Patients: 385 patients (49% non-Hispanic white; 31% with prior nephritis) with SLE in the PROMISSE (Predictors of Pregnancy Outcome: Biomarkers in Antiphospholipid Antibody Syndrome and Systemic Lupus Erythematosus) study. Exclusion criteria were urinary protein-creatinine ratio greater than 1000 mg/g, creatinine level greater than 1.2 mg/dL, prednisone use greater than 20 mg/d, and multifetal pregnancy. Measurements: APOs included fetal or neonatal death; birth before 36 weeks due to placental insufficiency, hypertension, or preeclampsia; and small-for-gestational-age (SGA) neonate (birthweight below the fifth percentile). Disease activity was assessed with the Systemic Lupus Erythematosus Pregnancy Disease Activity Index and the Physician's Global Assessment (PGA). Results: APOs occurred in 19.0% (95% CI, 15.2% to 23.2%) of pregnancies; fetal death occurred in 4%, neonatal death occurred in 1%, preterm delivery occurred in 9%, and SGA neonate occurred in 10%. Severe flares in the second and third trimesters occurred in 2.5% and 3.0%, respectively. Baseline predictors of APOs included presence of lupus anticoagulant (LAC) (odds ratio [OR], 8.32 [CI, 3.59 to 19.26]), antihypertensive use (OR, 7.05 [CI, 3.05 to 16.31]), PGA score greater than 1 (OR, 4.02 [CI, 1.84 to 8.82]), and low platelet count (OR, 1.33 [CI, 1.09 to 1.63] per decrease of 50 x 10(9) cells/L). Non-Hispanic white race was protective (OR, 0.45 [CI, 0.24 to 0.84]). Maternal flares, higher disease activity, and smaller increases in C3 level later in pregnancy also predicted APOs. Among women without baseline risk factors, the APO rate was 7.8%. For those who either were LAC-positive or were LAC-negative but nonwhite or Hispanic and using antihypertensives, the APO rate was 58.0% and fetal or neonatal mortality was 22.0%. Limitation: Patients with high disease activity were excluded. Conclusion: In pregnant patients with inactive or stable mild/moderate SLE, severe flares are infrequent and, absent specific risk factors, outcomes are favorable.	NYU, Sch Med, Hosp Special Surg, Albert Einstein Coll Med, New York, NY 10016 USA; Weill Cornell Med Coll, New York, NY USA; Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; Intermt Healthcare, Salt Lake City, UT USA; Oestfold Hosp Trust, Fredrikstad, Norway; Univ Toronto, Toronto, ON, Canada; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Univ Illinois, Chicago, IL USA	New York University; Yeshiva University; Cornell University; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; University of Toronto; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Johns Hopkins University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Buyon, JP (corresponding author), NYU, Langone Med Ctr, 550 First Ave,MSB 607, New York, NY 10016 USA.		Merrill, Joan/HDL-9141-2022	Buyon, Jill/0000-0002-3852-7129	National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049772, R01AR043727, R55AR043727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Primary Funding Source: National Institutes of Health.	ABRAMSON SB, 1992, AM J REPROD IMMUNOL, V28, P183, DOI 10.1111/j.1600-0897.1992.tb00787.x; Al Arfaj AS, 2010, LUPUS, V19, P1665, DOI 10.1177/0961203310378669; Bramham K, 2011, J RHEUMATOL, V38, P1906, DOI 10.3899/jrheum.100997; Brucato A, 2001, ARTHRITIS RHEUM-US, V44, P1832, DOI 10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C; Buyon JP, 1999, LUPUS, V8, P677, DOI 10.1191/096120399680411272; Clowse MEB, 2013, ANN RHEUM DIS, V72, P1536, DOI 10.1136/annrheumdis-2012-202449; Clowse MEB, 2011, J RHEUMATOL, V38, P1012, DOI 10.3899/jrheum.100746; Clowse MEB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.012; Fischer-Betz R, 2013, RHEUMATOLOGY, V52, P1070, DOI 10.1093/rheumatology/kes425; Friedman DM, 2008, CIRCULATION, V117, P485, DOI 10.1161/CIRCULATIONAHA.107.707661; Georgiou PE, 2000, RHEUMATOLOGY, V39, P1014, DOI 10.1093/rheumatology/39.9.1014; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Izmirly PM, 2012, CIRCULATION, V126, P76, DOI 10.1161/CIRCULATIONAHA.111.089268; Izmirly PM, 2010, ANN RHEUM DIS, V69, P1827, DOI 10.1136/ard.2009.119263; James G., 2017, INTRO STAT LEARNING; Ko HS, 2011, INT J MED SCI, V8, P577, DOI 10.7150/ijms.8.577; Levy RA, 2001, LUPUS, V10, P401, DOI 10.1191/096120301678646137; Liu JT, 2012, J MATERN-FETAL NEO M, V25, P261, DOI 10.3109/14767058.2011.572310; Lockshin MD, 1989, ARTHRITIS RHEUM, V32, P665; Lockshin MD, 2012, ARTHRITIS RHEUM-US, V64, P2311, DOI 10.1002/art.34402; LYNCH A, 1994, ANN INTERN MED, V120, P470, DOI 10.7326/0003-4819-120-6-199403150-00004; MacDorman Marian F, 2012, Natl Vital Stat Rep, V60, P1; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Ostensen M, 2004, BEST PRACT RES CL RH, V18, P219, DOI 10.1016/j.berh.2004.01.002; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; PETRI M, 1991, ARTHRITIS RHEUM, V34, P1538; PETRI M, 1993, J RHEUMATOL, V20, P650; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; RuizIrastorza G, 1996, BRIT J RHEUMATOL, V35, P133; Saavedra MA, 2012, CLIN RHEUMATOL, V31, P813, DOI 10.1007/s10067-012-1941-4; Shand AW, 2013, ANN RHEUM DIS, V72, P547, DOI 10.1136/annrheumdis-2011-201210; Silva CAA, 2002, LUPUS, V11, P419, DOI 10.1191/0961203302lu219oa; Smyth A, 2013, ADV CHRONIC KIDNEY D, V20, P402, DOI 10.1053/j.ackd.2013.06.004; Smyth A, 2010, CLIN J AM SOC NEPHRO, V5, P2060, DOI 10.2215/CJN.00240110; WONG KL, 1991, ARCH INTERN MED, V151, P269, DOI 10.1001/archinte.151.2.269	36	276	293	1	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					153	+		10.7326/M14-2235	http://dx.doi.org/10.7326/M14-2235			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO6EX	26098843	Green Accepted			2022-12-28	WOS:000359251100004
J	Canary, LA; Klevens, RM; Holmberg, SD				Canary, Lauren A.; Klevens, R. Monina; Holmberg, Scott D.			Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; LIVER-DISEASE; INFECTION		[Canary, Lauren A.; Klevens, R. Monina; Holmberg, Scott D.] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Canary, LA (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Fdn, Mailstop G-37, Atlanta, GA 30329 USA.	lcanary@cdc.gov		Canary, Lauren/0000-0002-4297-2102				Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Grebely J, 2014, ANTIVIR RES, V104, P62, DOI 10.1016/j.antiviral.2014.01.002; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Kim WR, 2001, HEPATOLOGY, V33, P201, DOI 10.1053/jhep.2001.20798; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Leidner AJ, 2015, HEPATOLOGY, V61, P1860, DOI 10.1002/hep.27736; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004	7	111	111	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					226	+		10.7326/M15-0320	http://dx.doi.org/10.7326/M15-0320			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO6EX	26121095				2022-12-28	WOS:000359251100012
J	Wang, LF; Zhou, Y; Xu, L; Xiao, R; Lu, XY; Chen, L; Chong, J; Li, HR; He, C; Fu, XD; Wang, D				Wang, Lanfeng; Zhou, Yu; Xu, Liang; Xiao, Rui; Lu, Xingyu; Chen, Liang; Chong, Jenny; Li, Hairi; He, Chuan; Fu, Xiang-Dong; Wang, Dong			Molecular basis for 5-carboxycytosine recognition by RNA polymerase II elongation complex	NATURE			English	Article							STRUCTURAL BASIS; DNA METHYLATION; SUBSTRATE-SPECIFICITY; TET PROTEINS; TRANSCRIPTION; 5-FORMYLCYTOSINE; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; REVEALS; MECHANISM	DNA methylation at selective cytosine residues (5-methylcytosine (5mC)) and their removal by TET-mediated DNA demethylation are critical for setting up pluripotent states in early embryonic development(1,2). TET enzymes successively convert 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC), with 5fC and 5caC subject to removal by thymine DNA glycosylase (TDG) in conjunction with base excision repair(1-6). Early reports indicate that 5fC and 5caC could be stably detected on enhancers, promoters and gene bodies, with distinct effects on gene expression, but the mechanisms have remained elusive(7,8). Here we determined the X-ray crystal structure of yeast elongating RNA polymerase II (Pol II) in complex with a DNA template containing oxidized 5mCs, revealing specific hydrogen bonds between the 5-carboxyl group of 5caC and the conserved epi-DNA recognition loop in the polymerase. This causes a positional shift for incoming nucleoside 5'-triphosphate (NTP), thus compromising nucleotide addition. To test the implication of this structural insight in vivo, we determined the global effect of increased 5fC/5caC levels on transcription, finding that such DNA modifications indeed retarded Pol II elongation on gene bodies. These results demonstrate the functional impact of oxidized 5mCs on gene expression and suggest a novel role for Pol II as a specific and direct epigenetic sensor during transcription elongation.	[Wang, Lanfeng; Xu, Liang; Chong, Jenny; Wang, Dong] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Zhou, Yu; Xiao, Rui; Chen, Liang; Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Lu, Xingyu; He, Chuan] Univ Chicago, Dept Chem, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Lu, Xingyu; He, Chuan] Univ Chicago, Inst Biophys Dynam, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Wang, D (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	xdfu@ucsd.edu; dongwang@ucsd.edu	Chen, Liang/G-2990-2013; Zhou, Yu/AAP-9964-2021	Chen, Liang/0000-0002-6748-9416; Xiao, Rui/0000-0002-9477-1054; Zhou, Yu/0000-0002-2102-9377	National Institutes of Health (NIH) [GM102362]; Kimmel Scholars award from the Sidney Kimmel Foundation for Cancer Research; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego; NIH [HG006827, GM052872, HG004659]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827, R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102362, R01GM052872] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Scholars award from the Sidney Kimmel Foundation for Cancer Research; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.W. acknowledges the National Institutes of Health (NIH) (GM102362), a Kimmel Scholars award from the Sidney Kimmel Foundation for Cancer Research, and start-up funds from the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego. This work was also supported by NIH grant HG006827 and the Howard Hughes Medical Institute to C.H., and NIH grants GM052872 and HG004659 to X.-D.F. We are grateful to C. Kaplan for providing Saccharomyces cerevisiae Pol II Rpb2 Q531H and Q531A mutant strains.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hashimoto H, 2014, GENE DEV, V28, P2304, DOI 10.1101/gad.250746.114; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang Y, 2012, NAT STRUCT MOL BIOL, V19, P1061, DOI 10.1038/nsmb.2437; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Iyer LM, 2014, P NATL ACAD SCI USA, V111, P1676, DOI 10.1073/pnas.1321818111; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Silva DA, 2014, P NATL ACAD SCI USA, V111, P7665, DOI 10.1073/pnas.1315751111; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; van Luenen HGAM, 2012, CELL, V150, P909, DOI 10.1016/j.cell.2012.07.030; Walmacq C, 2012, MOL CELL, V46, P18, DOI 10.1016/j.molcel.2012.02.006; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang D, 2010, P NATL ACAD SCI USA, V107, P9584, DOI 10.1073/pnas.1002565107; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]	38	109	112	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					621	+		10.1038/nature14482	http://dx.doi.org/10.1038/nature14482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26123024	Green Accepted, Green Submitted			2022-12-28	WOS:000358655200051
J	Shi, NN; Tsai, CC; Camino, F; Bernard, GD; Yu, NF; Wehner, R				Shi, Norman Nan; Tsai, Cheng-Chia; Camino, Fernando; Bernard, Gary D.; Yu, Nanfang; Wehner, Ruediger			Keeping cool: Enhanced optical reflection and radiative heat dissipation in Saharan silver ants	SCIENCE			English	Article							REFRACTIVE-INDEX; DESERT; FILMS	Saharan silver ants, Cataglyphis bombycina, forage under extreme temperature conditions in the African desert. We show that the ants' conspicuous silvery appearance is created by a dense array of triangular hairs with two thermoregulatory effects. They enhance not only the reflectivity of the ant's body surface in the visible and near-infrared range of the spectrum, where solar radiation culminates, but also the emissivity of the ant in the mid-infrared. The latter effect enables the animals to efficiently dissipate heat back to the surroundings via blackbody radiation under full daylight conditions. This biological solution for a thermoregulatory problem may lead to the development of biomimetic coatings for passive radiative cooling of objects.	[Shi, Norman Nan; Tsai, Cheng-Chia; Yu, Nanfang] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA; [Camino, Fernando] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Bernard, Gary D.] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Wehner, Ruediger] Univ Zurich, Brain Res Inst, Zurich, Switzerland	Columbia University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Washington; University of Washington Seattle; University of Zurich	Yu, NF (corresponding author), Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA.	ny2214@columbia.edu; rwehner@zool.uzh.ch	BERNARD, GARY D/L-6655-2014; Yu, Nanfang/AAA-2634-2020	BERNARD, GARY D/0000-0001-7460-5123; Tsai, Cheng-Chia/0000-0001-5662-6908	NSF [PHY-1411445, ECCS-1307948]; Air Force Office of Scientific Research, Multidisciplinary University Research Initiative program [FA9550-14-1-0389]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-SC0012704]; Division Of Physics [1411445] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research, Multidisciplinary University Research Initiative program(MURI); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge intriguing discussions with N. Pierce; help with experiments from Z. Li, M.-H. Kim, B. Patterson, and M. Y. Sfeir; and R. F. Foelix for kindly preparing and providing Fig. 1B. The work was supported by NSF (grants PHY-1411445 and ECCS-1307948) and the Air Force Office of Scientific Research, Multidisciplinary University Research Initiative program (grant FA9550-14-1-0389). Research was carried out in part at the Center for Functional Nanomaterials, Brookhaven National Laboratory, which is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under contract no. DE-SC0012704. Data reported in this paper are archived at http://datadryad.org/resource/doi:10.5061/dryad.2bm50. Author contributions are as follows: R.W. and G.D.B. initiated the study, N.N.S., C.-C. Tsai, and N. Y. designed the study and conducted the analyses, and all authors contributed to developing the study and to drafting the manuscript.	BERDAHL P, 1984, APPL OPTICS, V23, P370, DOI 10.1364/AO.23.000370; Bohren C. F., 1998, ABSORPTION SCATTERIN; Coulson K. L., 1975, SOLAR TERRESTRIAL RA; GEHRING WJ, 1995, P NATL ACAD SCI USA, V92, P2994, DOI 10.1073/pnas.92.7.2994; GRANQVIST CG, 1980, APPL PHYS LETT, V36, P139, DOI 10.1063/1.91406; Howell J.R., 2020, THERMAL RAD HEAT TRA; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; MINOT MJ, 1976, J OPT SOC AM, V66, P515, DOI 10.1364/JOSA.66.000515; Monteith J., 2007, PRINCIPLES ENV PHYS; Raman AP, 2014, NATURE, V515, P540, DOI 10.1038/nature13883; Rephaeli E, 2013, NANO LETT, V13, P1457, DOI 10.1021/nl4004283; Schuller JA, 2009, NAT PHOTONICS, V3, P658, DOI 10.1038/NPHOTON.2009.188; Sun CH, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2870080; WEHNER R, 1992, NATURE, V357, P586, DOI 10.1038/357586a0; Wehner R., 1989, JB AKAD WISS LIT MAI, V89, P101; Wehner R, 2011, PHYSIOL ENTOMOL, V36, P271, DOI 10.1111/j.1365-3032.2011.00795.x; Xi JQ, 2007, NAT PHOTONICS, V1, P176, DOI 10.1038/nphoton.2007.26	17	294	301	68	573	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		298	301		10.1126/science.aab3564	http://dx.doi.org/10.1126/science.aab3564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26089358				2022-12-28	WOS:000358218600049
J	Inaba, M; Buszczak, M; Yamashita, YM				Inaba, Mayu; Buszczak, Michael; Yamashita, Yukiko M.			Nanotubes mediate niche-stem-cell signalling in the Drosophila testis	NATURE			English	Article							INTRAFLAGELLAR TRANSPORT; MITOTIC KINESINS; SELF-RENEWAL; MAINTENANCE; DIVISION; CILIA; SPERMATOGENESIS; CILIOGENESIS; ACTIVATION; LINEAGE	Stem cell niches provide resident stem cells with signals that specify their identity. Niche signals act over a short range such that only stem cells but not their differentiating progeny receive the self-renewing signals(1). However, the cellular mechanisms that limit niche signalling to stem cells remain poorly understood. Here we show that the Drosophila male germline stem cells form previously unrecognized structures, microtubule-based nanotubes, which extend into the hub, a major niche component. Microtubule-based nanotubes are observed specifically within germline stem cell populations, and require intraflagellar transport proteins for their formation. The bone morphogenetic protein (BMP) receptor Tkv localizes to microtubule-based nanotubes. Perturbation of microtubule-based nanotubes compromises activation of Dpp signalling within germline stem cells, leading to germline stem cell loss. Moreover, Dpp ligand and Tkv receptor interaction is necessary and sufficient for microtubule-based nanotube formation. We propose that microtubule-based nanotubes provide a novel mechanism for selective receptor-ligand interaction, contributing to the short-range nature of niche-stem-cell signalling.	[Inaba, Mayu; Yamashita, Yukiko M.] Univ Michigan, Life Sci Inst, Dept Cell & Dev Biol, Sch Med, Ann Arbor, MI 48109 USA; [Inaba, Mayu; Yamashita, Yukiko M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Inaba, Mayu; Buszczak, Michael] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Texas System; University of Texas Southwestern Medical Center Dallas	Buszczak, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	michael.buszczak@utsouthwestern.edu; yukikomy@umich.edu		Buszczak, Michael/0000-0001-6361-3654; Yamashita, Yukiko/0000-0001-5541-0216	Howard Hughes Medical Institute; MacArthur Foundation; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); MacArthur Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Kornberg, S. Roy, T. Avidor-Reiss, E. Laufer, A. Rodal, D. Sharp, S. Noselli, A. C. Spradling, T. E. Haerry, E. R. Gavis, C.-Y. Lee, T. Xie, B. McCabe, K. S. McKim, Bloomington Drosophila Stock Center, Vienna Drosophila Resource Center and the Developmental Studies Hybridoma Bank for reagents; S. Roy, T. Kornberg, G. Boekhoff-Falk and D. King for comments and advice; K. Luby-Phelps, A. Bugde and M. Acar for advice for imaging/image data processing; and the Yamashita and Buszczak laboratory members for discussion. The research in the Yamashita laboratory is supported by the Howard Hughes Medical Institute. Y.M.Y. is supported by the MacArthur Foundation.	[Anonymous], 1997, IMAGEJ; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Kuzhandaivel A, 2014, CELL REP, V7, P672, DOI 10.1016/j.celrep.2014.03.052; Michel M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1426; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Radford SJ, 2012, GENETICS, V192, P431, DOI 10.1534/genetics.112.143503; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Roy S, 2014, SCIENCE, V343, P852, DOI 10.1126/science.1244624; Salzmann V, 2013, CELL MOL BIOENG, V6, P441, DOI 10.1007/s12195-013-0295-6; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Wharton K, 1996, GENETICS, V142, P493; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yagi R, 2010, P NATL ACAD SCI USA, V107, P16166, DOI 10.1073/pnas.1005957107; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	36	123	124	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					329	+		10.1038/nature14602	http://dx.doi.org/10.1038/nature14602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26131929	Green Accepted			2022-12-28	WOS:000357950900038
J	Brown, CT; Hug, LA; Thomas, BC; Sharon, I; Castelle, CJ; Singh, A; Wilkins, MJ; Wrighton, KC; Williams, KH; Banfield, JF				Brown, Christopher T.; Hug, Laura A.; Thomas, Brian C.; Sharon, Itai; Castelle, Cindy J.; Singh, Andrea; Wilkins, Michael J.; Wrighton, Kelly C.; Williams, Kenneth H.; Banfield, Jillian F.			Unusual biology across a group comprising more than 15% of domain Bacteria	NATURE			English	Article							RIBOSOMAL-RNA; UNCULTURED BACTERIA; SINGLE-CELL; PROTEIN; GENES; ALIGNMENT; PREDICTION; SEQUENCES; ORGANISMS; INSIGHTS	A prominent feature of the bacterial domain is a radiation of major lineages that are defined as candidate phyla because they lack isolated representatives. Bacteria from these phyla occur in diverse environments(1) and are thought to mediate carbon and hydrogen cycles(2). Genomic analyses of a few representatives suggested that metabolic limitations have prevented their cultivation(2-6). Here we reconstructed 8 complete and 789 draft genomes from bacteria representing >35 phyla and documented features that consistently distinguish these organisms from other bacteria. We infer that this group, which may comprise >(1)5% of the bacterial domain, has shared evolutionary history, and describe it as the candidate phyla radiation (CPR). All CPR genomes are small and most lack numerous biosynthetic pathways. Owing to divergent 16S ribosomal RNA (rRNA) gene sequences, 50-100% of organisms sampled from specific phyla would evade detection in typical cultivation-independent surveys. CPR organisms often have self-splicing introns and proteins encoded within their rRNA genes, a feature rarely reported in bacteria. Furthermore, they have unusual ribosome compositions. All are missing a ribosomal protein often absent in symbionts, and specific lineages are missing ribosomal proteins and biogenesis factors considered universal in bacteria. This implies different ribosome structures and biogenesis mechanisms, and underlines unusual biology across a large part of the bacterial domain.	[Brown, Christopher T.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Hug, Laura A.; Thomas, Brian C.; Sharon, Itai; Castelle, Cindy J.; Singh, Andrea; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Wilkins, Michael J.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Wilkins, Michael J.; Wrighton, Kelly C.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Williams, Kenneth H.; Banfield, Jillian F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Wilkins, Michael/A-9358-2013; Williams, Kenneth Hurst/O-5181-2014; Sharon, Itai/M-4472-2019; Wrighton, Kelly C/ABD-6621-2021	Williams, Kenneth Hurst/0000-0002-3568-1155; Sharon, Itai/0000-0003-0705-2316; Wrighton, Kelly C/0000-0003-0434-4217; Wilkins, Michael/0000-0002-3595-0853; Castelle, Cindy/0000-0002-0751-9804; Banfield, Jill/0000-0001-8203-8771; Brown, Chris/0000-0002-7758-6447	US Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231, DE-SC0004918]; Natural Sciences and Engineering Research Council postdoctoral fellowship; DOE	US Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council postdoctoral fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); DOE(United States Department of Energy (DOE))	We thank J. Cate and S. Moore for input into the ribosomal protein analysis, J. Doudna and E. Nawrocki for suggestions on the rRNA insertion analysis, and M. Markillie and R. Taylor for assistance with RNA sequencing. Research was supported by the US Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research under award number DE-AC02-05CH11231 (Sustainable Systems Scientific Focus Area and DOE-JGI) and award number DE-SC0004918 (Systems Biology Knowledge Base Focus Area). L.A.H. was partially supported by a Natural Sciences and Engineering Research Council postdoctoral fellowship. DNA sequencing was conducted at the DOE Joint Genome Institute, a DOE Office of Science User Facility, via the Community Science Program. RNA sequencing was performed at the DOE-supported Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akanuma G, 2012, J BACTERIOL, V194, P6282, DOI 10.1128/JB.01544-12; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andronescu M, 2007, BIOINFORMATICS, V23, pI19, DOI 10.1093/bioinformatics/btm223; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Baker BJ, 2003, APPL ENVIRON MICROB, V69, P5512, DOI 10.1128/AEM.69.9.5512-5518.2003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Dick G.J., 2013, MICROBE, V8, P353, DOI 10.1128/microbe.8.353.1; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evguenieva-Hackenberg E, 2005, MOL MICROBIOL, V57, P318, DOI 10.1111/j.1365-2958.2005.04662.x; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI 10.4056/sigs.1433550; Gong J, 2014, SYST APPL MICROBIOL, V37, P35, DOI 10.1016/j.syapm.2013.08.007; Harris JK, 2004, APPL ENVIRON MICROB, V70, P845, DOI 10.1128/AEM.70.2.845-849.2004; Hug LA, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-22; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lagkouvardos I, 2014, APPL ENVIRON MICROB, V80, P440, DOI 10.1128/AEM.02655-13; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372; Luef B, 2013, ISME J, V7, P338, DOI 10.1038/ismej.2012.103; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; McLean Jeffrey S, 2013, Proc Natl Acad Sci U S A, V110, pE2390, DOI 10.1073/pnas.1219809110; Nawrocki E.P., 2009, STRUCTURAL RNA HOMOL, DOI 10.7936/K78050MP; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nevskaya N, 2005, NUCLEIC ACIDS RES, V33, P478, DOI 10.1093/nar/gki194; NOWOTNY V, 1982, P NATL ACAD SCI-BIOL, V79, P7238, DOI 10.1073/pnas.79.23.7238; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Raghavan R, 2008, J BACTERIOL, V190, P5934, DOI 10.1128/JB.00602-08; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Salman V, 2012, P NATL ACAD SCI USA, V109, P4203, DOI 10.1073/pnas.1120192109; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Ultsch A., 2005, 46 U MARB DEP MATH C; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Wrighton KC, 2014, ISME J, V8, P1452, DOI 10.1038/ismej.2013.249; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	62	613	624	10	280	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					208	U173		10.1038/nature14486	http://dx.doi.org/10.1038/nature14486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26083755	Green Submitted			2022-12-28	WOS:000357695900034
J	Richards, TA; Gomes, SL				Richards, Thomas A.; Gomes, Suely L.			PROTISTOLOGY How to build a microbial eye	NATURE			English	Editorial Material							CHLAMYDOMONAS-REINHARDTII; PHOTOTAXIS; EVOLUTION; EYESPOT; LIGHT	Dissection of the subcellular eye of microorganisms called warnowiid dinoflagellates reveals that this structure is composed of elements of two cellular organelles - the plastid and the mitochondrion. See Letter p.204	[Richards, Thomas A.] Univ Exeter, Dept Biosci, Exeter EX4 4QD, Devon, England; [Gomes, Suely L.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil	University of Exeter; Universidade de Sao Paulo	Richards, TA (corresponding author), Univ Exeter, Dept Biosci, Exeter EX4 4QD, Devon, England.	t.a.richards@exeter.ac.uk; sulgomes@iq.usp.br	Lopes Gomes, Suely/HGC-5280-2022; Gomes, Suely Lopes/D-8938-2012	Gomes, Suely Lopes/0000-0002-3367-9676; Richards, Thomas/0000-0002-9692-0973	BBSRC [BB/G00885X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G00885X/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Galen G, 1968, USEFULNESS PARTS BOD; Gavelis GS, 2015, NATURE, V523, P204, DOI 10.1038/nature14593; Hayakawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118415; Jekely G, 2009, PHILOS T R SOC B, V364, P2795, DOI 10.1098/rstb.2009.0072; Kepler J., 1604, ASTRONOMIAE PA UNPUB; LOVETT JS, 1975, BACTERIOL REV, V39, P345, DOI 10.1128/MMBR.39.4.345-404.1975; LUCAS IAN, 1982, BRIT PHYCOL J, V17, P13, DOI 10.1080/00071618200650031; Ntefidou M, 2003, PLANT PHYSIOL, V133, P1517, DOI 10.1104/pp.103.034223; Schmidt M, 2006, PLANT CELL, V18, P1908, DOI 10.1105/tpc.106.041749; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399	14	4	5	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					166	167		10.1038/nature14630	http://dx.doi.org/10.1038/nature14630			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4ZO	26131934				2022-12-28	WOS:000357695900024
J	Pi-Sunyer, X; Astrup, A; Fujioka, K; Greenway, F; Halpern, A; Krempf, M; Lau, DCW; le Roux, CW; Ortiz, RV; Jensen, CB; Wilding, JPH				Pi-Sunyer, Xavier; Astrup, Arne; Fujioka, Ken; Greenway, Frank; Halpern, Alfredo; Krempf, Michel; Lau, David C. W.; le Roux, Carel W.; Violante Ortiz, Rafael; Jensen, Christine Bjorn; Wilding, John P. H.		SCALE Obesity Prediabet NN8022-183	A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-STYLE INTERVENTION; QUALITY-OF-LIFE; OBESE; OVERWEIGHT; MAINTENANCE; PARAMETERS; RELEASE	BACKGROUND Obesity is a chronic disease with serious health consequences, but weight loss is difficult to maintain through lifestyle intervention alone. Liraglutide, a glucagon-like peptide-1 analogue, has been shown to have potential benefit for weight management at a once-daily dose of 3.0 mg, injected subcutaneously. METHODS We conducted a 56-week, double-blind trial involving 3731 patients who did not have type 2 diabetes and who had a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of at least 30 or a BMI of at least 27 if they had treated or untreated dyslipidemia or hypertension. We randomly assigned patients in a 2: 1 ratio to receive once-daily subcutaneous injections of liraglutide at a dose of 3.0 mg (2487 patients) or placebo (1244 patients); both groups received counseling on lifestyle modification. The coprimary end points were the change in body weight and the proportions of patients losing at least 5% and more than 10% of their initial body weight. RESULTS At baseline, the mean (+/- SD) age of the patients was 45.1 +/- 12.0 years, the mean weight was 106.2 +/- 21.4 kg, and the mean BMI was 38.3 +/- 6.4; a total of 78.5% of the patients were women and 61.2% had prediabetes. At week 56, patients in the liraglutide group had lost a mean of 8.4 +/- 7.3 kg of body weight, and those in the placebo group had lost a mean of 2.8 +/- 6.5 kg (a difference of -5.6 kg; 95% confidence interval, -6.0 to -5.1; P<0.001, with last-observation-carried-forward imputation). A total of 63.2% of the patients in the liraglutide group as compared with 27.1% in the placebo group lost at least 5% of their body weight (P<0.001), and 33.1% and 10.6%, respectively, lost more than 10% of their body weight (P<0.001). The most frequently reported adverse events with liraglutide were mild or moderate nausea and diarrhea. Serious events occurred in 6.2% of the patients in the liraglutide group and in 5.0% of the patients in the placebo group. CONCLUSIONS In this study, 3.0 mg of liraglutide, as an adjunct to diet and exercise, was associated with reduced body weight and improved metabolic control. (Funded by Novo Nordisk; SCALE Obesity and Prediabetes NN8022-1839 ClinicalTrials.gov number, NCT01272219.)	[Pi-Sunyer, Xavier] Columbia Univ, Div Endocrinol, New York, NY 10032 USA; [Pi-Sunyer, Xavier] Columbia Univ, Obes Res Ctr, New York, NY 10032 USA; [Astrup, Arne] Univ Copenhagen, Dept Nutr Exercise & Sports, Frederiksberg, Denmark; [Jensen, Christine Bjorn] Novo Nordisk AS, Soborg, Denmark; [Fujioka, Ken] Scripps Clin, Div Endocrinol, Dept Nutr & Metab Res, La Jolla, CA 92037 USA; [Greenway, Frank] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Halpern, Alfredo] Univ Sao Paulo, Sch Med, Hosp Clin, Obes & Metab Syndrome Unit,Div Endocrinol & Metab, Sao Paulo, Brazil; [Krempf, Michel] CHU Nantes, Clin Endocrinol & Nutr, F-44035 Nantes 01, France; [Lau, David C. W.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Lau, David C. W.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [le Roux, Carel W.] Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin 2, Ireland; [Violante Ortiz, Rafael] Inst Mexicano Seguro Social, Dept Endocrinol, Cuidad Madero, Mexico; [Wilding, John P. H.] Univ Liverpool, Dept Obes & Endocrinol, Liverpool L69 3BX, Merseyside, England	Columbia University; Columbia University; University of Copenhagen; Novo Nordisk; Scripps Research Institute; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Universidade de Sao Paulo; Nantes Universite; CHU de Nantes; University of Calgary; University of Calgary; University College Dublin; Instituto Mexicano del Seguro Social; University of Liverpool	Pi-Sunyer, X (corresponding author), Columbia Univ, Med Ctr, Obes Res Ctr, Berrie Bldg,1150 St Nicholas Ave, New York, NY 10032 USA.	fxp1@cumc.columbia.edu	Buscemi, Silvio/K-9662-2016; Jensen, Christine Bjoern/AAG-7900-2020; Finucane, Francis/G-6031-2012; Geloneze, Bruno/F-4231-2010; Wilding, John/ABB-6443-2020; Carmen, Team1/Y-7382-2019; Santini, Ferruccio/J-9272-2018; Lyudmila, Suplotova A/J-3596-2014; Wilding, John PH/A-7106-2008; Astrup, Arne/B-1407-2015	Buscemi, Silvio/0000-0003-0730-7649; Finucane, Francis/0000-0002-5374-7090; Geloneze, Bruno/0000-0002-0557-4578; Wilding, John/0000-0003-2839-8404; Carmen, Team1/0000-0003-4234-1746; Santini, Ferruccio/0000-0002-1706-0822; Lyudmila, Suplotova A/0000-0001-9253-8075; Wilding, John PH/0000-0003-2839-8404; Lab, Carmen/0000-0002-5935-3236; Madsbad, Sten/0000-0002-5017-1815; Klemsdal, Tor Ole/0000-0001-5442-9134; Le Roux, Carel/0000-0001-5521-5445; Bilz, Stefan/0000-0002-7716-2791; Krempf, Michel/0000-0002-4353-9511; Carraro, Raffaele/0000-0002-5874-8076; Astrup, Arne/0000-0001-8968-8996; Rotella, Carlo Maria/0000-0001-9462-2334	Novo Nordisk [NN8022-1839]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER	Novo Nordisk(Novo Nordisk); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by Novo Nordisk; SCALE Obesity and Prediabetes NN8022-1839 ClinicalTrials.gov number, NCT01272219.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Brod M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-19; Childs BP, 2005, DIABETES CARE, V28, P1245; Dombrowski S U, 2014, BMJ, V348, pg2646, DOI 10.1136/bmj.g2646; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Erlinger S, 2000, EUR J GASTROEN HEPAT, V12, P1347, DOI 10.1097/00042737-200012120-00015; Fabricatore AN, 2009, OBES REV, V10, P333, DOI 10.1111/j.1467-789X.2009.00567.x; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; International Conference on Harmonisation Expert Working Group, ICH HARM TRIP GUID G; Jensen MD, 2014, OBESITY, V22, pS5, DOI 10.1002/oby.20821; Keller J, 2012, REGUL PEPTIDES, V179, P77, DOI 10.1016/j.regpep.2012.08.005; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Lean MEJ, 2014, INT J OBESITY, V38, P689, DOI 10.1038/ijo.2013.149; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Mertens IL, 2000, OBES RES, V8, P270, DOI 10.1038/oby.2000.32; National Academy of Sciences, 2010, PREV TREATM MISS DAT; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Robinson LE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001986; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; TENNER S, 1994, AM J GASTROENTEROL, V89, P1863; van Can J, 2014, INT J OBESITY, V38, P784, DOI 10.1038/ijo.2013.162; Wadden TA, 2013, INT J OBESITY, V37, pS1, DOI 10.1038/ijo.2013.89; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Warkentin LM, 2014, OBES REV, V15, P169, DOI 10.1111/obr.12113	32	924	959	9	134	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					11	22		10.1056/NEJMoa1411892	http://dx.doi.org/10.1056/NEJMoa1411892			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL8IS	26132939	Bronze, Green Published			2022-12-28	WOS:000357218700004
J	Tresini, M; Warmerdam, DO; Kolovos, P; Snijder, L; Vrouwe, MG; Demmers, JAA; van IJcken, WFJ; Grosveld, FG; Medema, RH; Hoeijmakers, JHJ; Mullenders, LHF; Vermeulen, W; Marteijn, JA				Tresini, Maria; Warmerdam, Daniel O.; Kolovos, Petros; Snijder, Loes; Vrouwe, Mischa G.; Demmers, Jeroen A. A.; van IJcken, Wilfred F. J.; Grosveld, Frank G.; Medema, Rene H.; Hoeijmakers, Jan H. J.; Mullenders, Leon H. F.; Vermeulen, Wim; Marteijn, Jurgen A.			The core spliceosome as target and effector of non-canonical ATM signalling	NATURE			English	Article							DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; ATAXIA-TELANGIECTASIA; TRANSCRIPTION; ACTIVATION; PHOSPHORYLATION; CHROMATIN; PROTEOME	In response to DNA damage, tissue homoeostasis is ensured by protein networks promoting DNA repair, cell cycle arrest or apoptosis. DNA damage response signalling pathways coordinate these processes, partly by propagating gene-expression-modulating signals. DNA damage influences not only the abundance of messenger RNAs, but also their coding information through alternative splicing. Here we show that transcription-blocking DNA lesions promote chromatin displacement of late-stage spliceosomes and initiate a positive feedback loop centred on the signalling kinase ATM. We propose that initial spliceosome displacement and subsequent R-loop formation is triggered by pausing of RNA polymerase at DNA lesions. In turn, R-loops activate ATM, which signals to impede spliceosome organization further and augment ultraviolet-irradiation-triggered alternative splicing at the genome-wide level. Our findings define R-loop-dependent ATM activation by transcription-blocking lesions as an important event in the DNA damage response of non-replicating cells, and highlight a key role for spliceosome displacement in this process.	[Tresini, Maria; Snijder, Loes; Hoeijmakers, Jan H. J.; Vermeulen, Wim; Marteijn, Jurgen A.] Erasmus Univ, Med Ctr, Dept Genet, Canc Genom Netherlands, NL-3015 CN Rotterdam, Netherlands; [Warmerdam, Daniel O.; Medema, Rene H.] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Kolovos, Petros; Grosveld, Frank G.] Erasmus Univ, Med Ctr, Dept Cell Biol, NL-3015 CN Rotterdam, Netherlands; [Vrouwe, Mischa G.; Mullenders, Leon H. F.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2333 ZC Leiden, Netherlands; [Demmers, Jeroen A. A.] Erasmus Univ, Med Ctr, Erasmus MC Prote Ctr, NL-3015 CN Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus Univ, Med Ctr, Erasmus Ctr Biom, NL-3015 CN Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Tresini, M (corresponding author), Erasmus Univ, Med Ctr, Dept Genet, Canc Genom Netherlands, NL-3015 CN Rotterdam, Netherlands.	m.tresini@erasmusmc.nl; w.vermeulen@erasmusmc.nl; j.marteijn@erasmsumc.nl	Vermeulen, Wim/W-8708-2019; van ijcken, willem/N-9805-2018; Hoeijmakers, Jan/AAX-6972-2021; Demmers, Jeroen AA/F-4046-2016; Marteijn, Jurgen A/B-5696-2014	Vermeulen, Wim/0000-0003-3616-734X; van ijcken, willem/0000-0002-0421-8301; Demmers, Jeroen AA/0000-0002-8757-9611; Marteijn, Jurgen A/0000-0001-9321-518X; Tresini, Maria/0000-0001-7711-3204; Warmerdam, Daniel/0000-0003-1606-7448; Medema, Rene/0000-0002-6754-0381; Kolovos, Petros/0000-0002-0787-6158	Netherlands Organization for Scientific Research (NWO) ZonMW TOP Grant [912.08.031, 912.12.132]; Netherlands Organization for Scientific Research (NWO) ZonMW Horizon Zenith Grant [935.11.042]; Netherlands Organization for Scientific Research (NWO) ZonMW ALW Grant [854.11.002, 823.02.013]; Association for International Cancer Research [10-594]; European Research Council [233424, 340988]; ErasmusMC fellowship; Worldwide Cancer Research [10-0594] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO) ZonMW TOP Grant; Netherlands Organization for Scientific Research (NWO) ZonMW Horizon Zenith Grant; Netherlands Organization for Scientific Research (NWO) ZonMW ALW Grant; Association for International Cancer Research; European Research Council(European Research Council (ERC)European Commission); ErasmusMC fellowship; Worldwide Cancer Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the Optical Imaging Center of ErasmusMC for technical support; M. Reijns and A. Jackson for the S9.6 antibody; L. Marufu for technical assistance; and N. G. J. Jaspers for intellectual input. This work was funded by the Netherlands Organization for Scientific Research (NWO) ZonMW TOP Grants 912.08.031 and 912.12.132, Horizon Zenith 935.11.042, ALW 854.11.002 and 823.02.013, the Association for International Cancer Research 10-594, European Research Council Advanced Investigator Grants 233424 and 340988, and an ErasmusMC fellowship.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Alexander R, 2010, BIOCHEM SOC T, V38, P1251, DOI 10.1042/BST0381251; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; Dutertre M, 2011, RNA BIOL, V8, P740, DOI 10.4161/rna.8.5.16016; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Galiveti CR, 2010, RNA, V16, P450, DOI 10.1261/rna.1755810; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; Houtsmuller AB, 2001, HISTOCHEM CELL BIOL, V115, P13, DOI 10.1007/s004180000234; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lenzken Silvia C, 2013, Int J Cell Biol, V2013, P153634, DOI 10.1155/2013/153634; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; Paronetto MP, 2011, MOL CELL, V43, P353, DOI 10.1016/j.molcel.2011.05.035; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rino J, 2007, PLOS COMPUT BIOL, V3, P2019, DOI 10.1371/journal.pcbi.0030201; Schor Ignacio E, 2013, Cancer Treat Res, V158, P1, DOI 10.1007/978-3-642-31659-3_1; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Sirbu BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012724; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valadkhan S, 2010, PROTEOMICS, V10, P4128, DOI 10.1002/pmic.201000354; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Zhou HL, 2014, NUCLEIC ACIDS RES, V42, P701, DOI 10.1093/nar/gkt875	45	159	162	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					53	+		10.1038/nature14512	http://dx.doi.org/10.1038/nature14512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26106861	Green Accepted			2022-12-28	WOS:000357169500029
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION What is significance?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick Philip, 2015, BMJ, V350, ph3229, DOI 10.1136/bmj.h3229; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5196; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5420; Wiegersma M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7378	4	0	0	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2015	350								h3475	10.1136/bmj.h3475	http://dx.doi.org/10.1136/bmj.h3475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7OD	26116134				2022-12-28	WOS:000357160700006
J	Leonard, KE				Leonard, Kenneth E.			Perspective Beyond the neural circuits	NATURE			English	Editorial Material									SUNY Buffalo, Res Inst Addict, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Leonard, KE (corresponding author), SUNY Buffalo, Res Inst Addict, Buffalo, NY 14260 USA.	kleonard@ria.buffalo.edu	Leonard, Kenneth/AAS-4814-2021	Leonard, Kenneth E./0000-0001-6658-1264				Benishek LA, 2014, ADDICTION, V109, P1426, DOI 10.1111/add.12589; Hunter-Reel D, 2009, ADDICTION, V104, P1281, DOI 10.1111/j.1360-0443.2009.02611.x; Mattson RE, 2010, J FAM VIOLENCE, V25, P33, DOI 10.1007/s10896-009-9267-y; O'Farrell TJ, 2012, J MARITAL FAM THER, V38, P122, DOI 10.1111/j.1752-0606.2011.00242.x; Stout RL, 2012, J STUD ALCOHOL DRUGS, V73, P489, DOI 10.15288/jsad.2012.73.489; Wise RA, 2014, NEUROPSYCHOPHARMACOL, V39, P254, DOI 10.1038/npp.2013.261	6	7	7	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					S56	S56		10.1038/522S56a	http://dx.doi.org/10.1038/522S56a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26107097				2022-12-28	WOS:000356782900005
J	McAlister, C				McAlister, Chryssa			Breaking the Silence of the Switch - Increasing Transparency about Trainee Participation in Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CATARACT-SURGERY		Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada	University of Toronto	McAlister, C (corresponding author), Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada.							Gan KD, 2009, CAN J OPHTHALMOL, V44, P651, DOI 10.3129/i09-075; Knifed E, 2008, AM J SURG, V196, P788, DOI 10.1016/j.amjsurg.2007.12.058; Kocher MS, 2002, J BONE JOINT SURG AM, V84A, P148, DOI 10.2106/00004623-200201000-00029; Porta CR, 2012, ARCH SURG-CHICAGO, V147, P57, DOI 10.1001/archsurg.2011.235; Rogers GM, 2009, J CATARACT REFR SURG, V35, P1956, DOI 10.1016/j.jcrs.2009.05.046	5	25	25	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2477	2479		10.1056/NEJMp1502901	http://dx.doi.org/10.1056/NEJMp1502901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2QD	26107052				2022-12-28	WOS:000356788200004
J	Shubik, M				Shubik, Martin			John Forbes Nash Jr. (1928-2015)	SCIENCE			English	Biographical-Item									Yale Univ, Covles Fdn, New Haven, CT 06520 USA	Yale University	Shubik, M (corresponding author), Yale Univ, Covles Fdn, New Haven, CT 06520 USA.	martin.shubik@yale.edu						NASH JF, PUBLICATIN LIST	1	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1324	1324		10.1126/science.aac7085	http://dx.doi.org/10.1126/science.aac7085			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089501				2022-12-28	WOS:000356449500033
J	[Anonymous]				[Anonymous]			Achieving a cleaner, more sustainable, and healthier future	LANCET			English	Editorial Material															World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)			0	10	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					E27	E27		10.1016/S0140-6736(15)61080-7	http://dx.doi.org/10.1016/S0140-6736(15)61080-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3VO	26111436				2022-12-28	WOS:000364194700001
J	Hall, MA				Hall, Mark A.			King v. Burwell - ACA Armageddon Averted	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hall, Mark A.] Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA; [Hall, Mark A.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Hall, MA (corresponding author), Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA.			Hall, Mark A./0000-0001-6277-144X				Bagley N, 2015, NEW ENGL J MED, V372, P101, DOI 10.1056/NEJMp1414191	1	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					497	499		10.1056/NEJMp1504077	http://dx.doi.org/10.1056/NEJMp1504077			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO2LM	26132865				2022-12-28	WOS:000358987700002
J	Ashley-Ross, MA				Ashley-Ross, Miriam A.			When it's hip to be square	SCIENCE			English	Editorial Material							SEAHORSE		Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University	Ashley-Ross, MA (corresponding author), Wake Forest Univ, Dept Biol, Box 7325, Winston Salem, NC 27109 USA.	rossma@wfu.edu						Hale ME, 1996, J MORPHOL, V227, P51, DOI 10.1002/(SICI)1097-4687(199601)227:1<51::AID-JMOR4>3.0.CO;2-S; Kuiter R. H., 2009, SEAHORSE THEIR RELAT; Neutens C, 2014, J ANAT, V224, P710, DOI 10.1111/joa.12181; Playter R, 2006, PROC SPIE, V6230, DOI 10.1117/12.684087; Porter MM, 2015, SCIENCE, V349, DOI 10.1126/science.aaa6683; Porter MM, 2013, ACTA BIOMATER, V9, P6763, DOI 10.1016/j.actbio.2013.02.045; Praet T, 2012, INT J NUMER METH BIO, V28, P1028, DOI 10.1002/cnm.2499; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Vogel S., 2013, COMP BIOMECHANICS LI	9	0	0	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					30	+		10.1126/science.aab1508	http://dx.doi.org/10.1126/science.aab1508			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138964				2022-12-28	WOS:000357280800043
J	Magnard, JL; Roccia, A; Caissard, JC; Vergne, P; Sun, PL; Hecquet, R; Dubois, A; Hibrand-Saint Oyant, L; Jullien, F; Nicole, F; Raymond, O; Huguet, S; Baltenweck, R; Meyer, S; Claudel, P; Jeauffre, J; Rohmer, M; Foucher, F; Hugueney, P; Bendahmane, M; Baudino, S				Magnard, Jean-Louis; Roccia, Aymeric; Caissard, Jean-Claude; Vergne, Philippe; Sun, Pulu; Hecquet, Romain; Dubois, Annick; Hibrand-Saint Oyant, Laurence; Jullien, Frederic; Nicole, Florence; Raymond, Olivier; Huguet, Stephanie; Baltenweck, Raymonde; Meyer, Sophie; Claudel, Patricia; Jeauffre, Julien; Rohmer, Michel; Foucher, Fabrice; Hugueney, Philippe; Bendahmane, Mohammed; Baudino, Sylvie			Biosynthesis of monoterpene scent compounds in roses	SCIENCE			English	Article							METHYLERYTHRITOL PHOSPHATE-PATHWAY; NUDIX HYDROLASE FAMILY; FLORAL FRAGRANCE; CHINESE ROSES; FRUITS; ARABIDOPSIS; SYNTHASES; SUBSTRATE; VERSATILE; PROTEINS	The scent of roses (Rosa x hybrida) is composed of hundreds of volatile molecules. Monoterpenes represent up to 70% percent of the scent content in some cultivars, such as the Papa Meilland rose. Monoterpene biosynthesis in plants relies on plastid-localized terpene synthases. Combining transcriptomic and genetic approaches, we show that the Nudix hydrolase RhNUDX1, localized in the cytoplasm, is part of a pathway for the biosynthesis of free monoterpene alcohols that contribute to fragrance in roses. The RhNUDX1 protein shows geranyl diphosphate diphosphohydrolase activity in vitro and supports geraniol biosynthesis in planta.	[Magnard, Jean-Louis; Roccia, Aymeric; Caissard, Jean-Claude; Sun, Pulu; Hecquet, Romain; Jullien, Frederic; Nicole, Florence; Baudino, Sylvie] Univ Lyon St Etienne, Lab BVpam, EA3061, F-42000 St Etienne, France; [Roccia, Aymeric; Vergne, Philippe; Dubois, Annick; Raymond, Olivier; Bendahmane, Mohammed] Univ Lyon 1, Lab Reprod & Dev Plantes UMR Inst Natl Rech Agron, Ecole Normale Super Lyon, CNRS, F-69364 Lyon 07, France; [Hibrand-Saint Oyant, Laurence; Jeauffre, Julien; Foucher, Fabrice] Univ Angers, INRA, Inst Rech Hort & Semences, AGROCAMPUS OUEST,SFR QUASAV 4207, F-49071 Beaucouze, France; [Huguet, Stephanie] Univ Evry Val Essonne, Genom Fonct Arabidopsis, ERL CNRS 8196, Unite Rech Genom Vegetale,UMR INRA 1165, Evry, France; [Baltenweck, Raymonde; Meyer, Sophie; Claudel, Patricia; Hugueney, Philippe] Univ Strasbourg, INRA, UMR Sante Vigne & Qualite Vin 1131, F-68000 Colmar, France; [Rohmer, Michel] Univ Strasbourg, CNRS, UMR 7177, Inst Le Bel, F-67070 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Baudino, S (corresponding author), Univ Lyon St Etienne, Lab BVpam, EA3061, 23 Rue Dr Michelon, F-42000 St Etienne, France.	philippe.hugueney@colmar.inra.fr; mohammed.bendahmane@ens-lyon.fr; sylvie.baudino@univ-st-etienne.fr	Jullien, Frederic/AAF-5473-2020; Dubois, Annick/AAX-2219-2021; Foucher, Fabrice/AAJ-5069-2021; Hugueney, Philippe/AAU-5903-2020; Bendahmane, Mohammed/AAX-1296-2020; Raymond, Olivier/AAO-5868-2020	Dubois, Annick/0000-0002-3646-3811; Foucher, Fabrice/0000-0002-3693-7183; Hugueney, Philippe/0000-0002-1641-9274; Bendahmane, Mohammed/0000-0003-1661-1060; Raymond, Olivier/0000-0002-9664-5377; Baltenweck, Raymonde/0000-0002-8228-1517; MAGNARD, Jean-Louis/0000-0001-8312-2633; Sun, Pulu/0000-0001-7495-0226; Florence, Nicole/0000-0002-1853-7055; CAISSARD, Jean-Claude/0000-0001-7938-3101; JULLIEN, Frederic/0000-0001-9858-729X; Baudino, Sylvie/0000-0002-3367-172X	Region Rhone-Alpes; CNRS [GDR 2827]; ENS Lyon; INRA, France	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); CNRS(Centre National de la Recherche Scientifique (CNRS)); ENS Lyon; INRA, France	We thank E. Pichersky (University of Michigan) for providing the GES cDNA clone; D. Busso (CEA-FAR) for gateway expression vectors; G. Ingram (ENS Lyon), B. Camara (Universite de Strasbourg), J. Szecsi (ENS Lyon), and P. Beyer (University of Freiburg) for critical reading of the manuscript; N. Boyer, I. Desbouchages, P. Angelot, A. Lacroix, the Lyon Botanical Garden, and Meilland Richardier for providing plant material; F. Gros, T. Thouroude, and A. Bony for technical assistance; S. Palle for confocal imaging assistance; and L. Legendre for help with antibody production. This work was supported by funding from the Region Rhone-Alpes, CNRS (GDR 2827), ENS Lyon, and INRA, France. Sequence data from this article can be found in the GenBank/European Molecular Biology Laboratory databases under accession number JQ820249. All raw and normalized transcriptomic data are available through the CATdb database [AFFY_ROSE_2012_06 (25)] and from the Gene Expression Omnibus repository [National Center for Biotechnology Information, no. GSE 45236 (26)]. The supplementary materials contain additional data.	Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bergougnoux V, 2007, PLANTA, V226, P853, DOI 10.1007/s00425-007-0531-1; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Borda AM, 2011, POSTHARVEST BIOL TEC, V59, P245, DOI 10.1016/j.postharvbio.2010.09.008; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Dubois A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-638; Dunphy PJ, 2006, PHYTOCHEMISTRY, V67, P1110, DOI 10.1016/j.phytochem.2006.03.023; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FRANCIS MJO, 1969, PHYTOCHEMISTRY, V8, P1705, DOI 10.1016/S0031-9422(00)85957-9; Frick S, 2013, P NATL ACAD SCI USA, V110, P4194, DOI 10.1073/pnas.1221489110; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gutensohn M, 2013, PLANT J, V75, P351, DOI 10.1111/tpj.12212; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Hampel D, 2006, J AGR FOOD CHEM, V54, P1473, DOI 10.1021/jf0523972; Hampel D, 2007, J AGR FOOD CHEM, V55, P9296, DOI 10.1021/jf071311x; Iijima Y, 2004, PLANT PHYSIOL, V134, P370, DOI 10.1104/pp.103.032946; Joichi A, 2005, FLAVOUR FRAG J, V20, P152, DOI 10.1002/ffj.1388; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; Kraszewska E, 2008, ACTA BIOCHIM POL, V55, P663; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Scalliet G, 2008, P NATL ACAD SCI USA, V105, P5927, DOI 10.1073/pnas.0711551105; Shang YJ, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-1; Vainstein A, 2001, PLANT PHYSIOL, V127, P1383, DOI 10.1104/pp.127.4.1383; Yoshimura K, 2015, BIOSCI BIOTECH BIOCH, V79, P354, DOI 10.1080/09168451.2014.987207	26	106	113	15	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					81	83		10.1126/science.aab0696	http://dx.doi.org/10.1126/science.aab0696			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138978	Green Published			2022-12-28	WOS:000357280800063
J	Monsell, A; Asopa, V				Monsell, Adam; Asopa, Vipin			SPOT DIAGNOSIS A painful hand after a fall	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Monsell, Adam; Asopa, Vipin] North Middlesex Univ Hosp, Orthopaed, London N18 1QX, England		Monsell, A (corresponding author), North Middlesex Univ Hosp, Orthopaed, London N18 1QX, England.	adam.monsell@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2015	351								h3388	10.1136/bmj.h3388	http://dx.doi.org/10.1136/bmj.h3388			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3UA	26141734				2022-12-28	WOS:000357609000003
J	Shang, CP; Liu, ZH; Chen, ZJ; Shi, YC; Wang, Q; Liu, S; Li, DP; Cao, P				Shang, Congping; Liu, Zhihui; Chen, Zijun; Shi, Yingchao; Wang, Qian; Liu, Su; Li, Dapeng; Cao, Peng			A parvalbumin-positive excitatory visual pathway to trigger fear responses in mice	SCIENCE			English	Article							SUPERIOR COLLICULUS; NEURAL CIRCUITS; NEURONS; CORTEX; AMYGDALA; DEFENSE; MEMORY; RAT; CAT	The fear responses to environmental threats play a fundamental role in survival. Little is known about the neural circuits specifically processing threat-relevant sensory information in the mammalian brain. We identified parvalbumin-positive (PV+) excitatory projection neurons in mouse superior colliculus (SC) as a key neuronal subtype for detecting looming objects and triggering fear responses. These neurons, distributed predominantly in the superficial SC, divergently projected to different brain areas, including the parabigeminal nucleus (PBGN), an intermediate station leading to the amygdala. Activation of the PV+ SC-PBGN pathway triggered fear responses, induced conditioned aversion, and caused depression-related behaviors. Approximately 20% of mice subjected to the fear-conditioning paradigm developed a generalized fear memory.	[Shang, Congping; Liu, Zhihui; Chen, Zijun; Shi, Yingchao; Wang, Qian; Liu, Su; Li, Dapeng; Cao, Peng] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Shang, Congping; Chen, Zijun; Shi, Yingchao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cao, P (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	pcao@ibp.ac.cn	Shang, Congping/O-7381-2016	Liu, Zhihui/0000-0002-9198-9090; Cao, Peng/0000-0001-7739-6857	Thousand Young Talents Program of China	Thousand Young Talents Program of China(Chinese Academy of Sciences)	We thank T. Sudhot, K. Deisseroth, Y. Wang, B. Li, and M. Luo for providing plasmids, instruments, and technical support for this study. This work was supported by the Thousand Young Talents Program of China. We declare no conflicts of interest. All data are archived in the Institute of Biophysics, Chinese Academy of Sciences.	Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cohen JD, 2010, J NEUROSCI, V30, P8502, DOI 10.1523/JNEUROSCI.1497-10.2010; Comoli E, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00009; Cork RJ, 1998, J COMP NEUROL, V394, P205; Corneil BD, 2014, NEURON, V82, P1230, DOI 10.1016/j.neuron.2014.05.040; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; Descalzo VF, 2005, J NEUROPHYSIOL, V93, P1111, DOI 10.1152/jn.00658.2004; DesJardin JT, 2013, J NEUROSCI, V33, P150, DOI 10.1523/JNEUROSCI.2924-12.2013; Feinberg EH, 2015, NATURE, V519, P229, DOI 10.1038/nature14103; Fotowat H, 2011, ANNU REV NEUROSCI, V34, P1, DOI 10.1146/annurev-neuro-061010-113632; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Krusemark EA, 2013, J NEUROSCI, V33, P587, DOI [10.1523/JNEUROSCI.1379-12.2013, 10.1523/JNEUROSCI.1835-13.2013]; Liu YJ, 2011, BRAIN BEHAV EVOLUT, V77, P193, DOI 10.1159/000327045; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Mize RR, 1996, PROG BRAIN RES, V112, P35; Morin LP, 2014, J COMP NEUROL, V522, P3733, DOI 10.1002/cne.23635; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; ONO T, 1985, Neuroscience Research, V2, P221, DOI 10.1016/0168-0102(85)90002-1; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; SAHIBZADA N, 1986, J NEUROSCI, V6, P723; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yilmaz M, 2013, CURR BIOL, V23, P2011, DOI 10.1016/j.cub.2013.08.015; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhao XY, 2014, NEURON, V84, P202, DOI 10.1016/j.neuron.2014.08.037	32	163	167	8	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1472	1477		10.1126/science.aaa8694	http://dx.doi.org/10.1126/science.aaa8694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113723				2022-12-28	WOS:000356869100042
J	Stone, M				Stone, Michael			Topology, spin, and light	SCIENCE			English	Editorial Material									Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Stone, M (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	m-stone5@illinois.edu						BialynickiBirula I, 1996, PROG OPTICS, V36, P245, DOI 10.1016/S0079-6638(08)70316-0; Bliokh KY, 2015, SCIENCE, V348, P1448, DOI 10.1126/science.aaa9519; CALLAN CG, 1985, NUCL PHYS B, V250, P427, DOI 10.1016/0550-3213(85)90489-4; O'Connor D., NAT COMMUN, V5, P5327; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Stephanov MA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.162001; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405	9	6	6	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1432	1433		10.1126/science.aac4368	http://dx.doi.org/10.1126/science.aac4368			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113707				2022-12-28	WOS:000356869100022
J	Cepko, C; Punzo, C				Cepko, Connie; Punzo, Claudio			CELL METABOLISM Sugar for sight	NATURE			English	Editorial Material							CONE SURVIVAL; DYSFUNCTION; EXPRESSION; DEATH; MODEL		[Cepko, Connie] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Cepko, Connie] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Cepko, Connie] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Punzo, Claudio] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01655 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Cepko, C (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu; claudio.punzo@umassmed.edu	Punzo, Claudio/AAJ-8291-2021	Punzo, Claudio/0000-0001-5207-0041				Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; GRAYMORE C, 1959, Br J Ophthalmol, V43, P34, DOI 10.1136/bjo.43.1.34; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Hori K, 2000, INVEST OPHTH VIS SCI, V41, P3128; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Trapani I, 2015, HUM GENE THER, V26, P193, DOI 10.1089/hum.2015.030; Venkatesh A, 2015, J CLIN INVEST, V125, P1446, DOI 10.1172/JCI79766; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Yu DY, 2000, INVEST OPHTH VIS SCI, V41, P3999	15	12	12	1	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					425	426		10.1038/522428a	http://dx.doi.org/10.1038/522428a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108850				2022-12-28	WOS:000356782900038
J	Horton, DE; Johnson, NC; Singh, D; Swain, DL; Rajaratnam, B; Diffenbaugh, NS				Horton, Daniel E.; Johnson, Nathaniel C.; Singh, Deepti; Swain, Daniel L.; Rajaratnam, Bala; Diffenbaugh, Noah S.			Contribution of changes in atmospheric circulation patterns to extreme temperature trends	NATURE			English	Article							ARCTIC SEA-ICE; PLANETARY-WAVES; AMPLIFICATION; CLIMATE; UNCERTAINTY; WINTERS	Surface weather conditions are closely governed by the large-scale circulation of the Earth's atmosphere. Recent increases in the occurrence of some extreme weather phenomena(1,2) have led to multiple mechanistic hypotheses linking changes in atmospheric circulation to increasing probability of extreme events(3-5). However, observed evidence of long-term change in atmospheric circulation remains inconclusive(6-8). Here we identify statistically significant trends in the occurrence of atmospheric circulation patterns, which partially explain observed trends in surface temperature extremes over seven mid-latitude regions of the Northern Hemisphere. Using self-organizing map cluster analysis(9-12), we detect robust circulation pattern trends in a subset of these regions during both the satellite observation era (1979-2013) and the recent period of rapid Arctic sea-ice decline (1990-2013). Particularly substantial influences include the contribution of increasing trends in anticyclonic circulations to summer and autumn hot extremes over portions of Eurasia and North America, and the contribution of increasing trends in northerly flow to winter cold extremes over central Asia. Our results indicate that although a substantial portion of the observed change in extreme temperature occurrence has resulted from regional-and global-scale thermodynamic changes, the risk of extreme temperatures over some regions has also been altered by recent changes in the frequency, persistence and maximum duration of regional circulation patterns.	[Horton, Daniel E.; Singh, Deepti; Swain, Daniel L.; Rajaratnam, Bala; Diffenbaugh, Noah S.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Horton, Daniel E.; Rajaratnam, Bala; Diffenbaugh, Noah S.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Johnson, Nathaniel C.] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Johnson, Nathaniel C.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Johnson, Nathaniel C.] Princeton Univ, Cooperat Inst Climate Sci, Princeton, NJ 08540 USA; [Rajaratnam, Bala] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California San Diego; Scripps Institution of Oceanography; Princeton University; Stanford University	Horton, DE (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.	danethan@stanford.edu	Horton, Daniel E./AAH-1472-2020; Swain, Daniel/I-9394-2019; Diffenbaugh, Noah S/I-5920-2014; Johnson, Nathaniel C/L-8045-2015	Horton, Daniel E./0000-0002-2065-4517; Swain, Daniel/0000-0003-4276-3092; Diffenbaugh, Noah S/0000-0002-8856-4964; Johnson, Nathaniel C/0000-0003-4906-178X	NSF CAREER Award [0955283]; DOE Integrated Assessment Research Program [DE-SC005171DE-SC005171]; G.J. Lieberman Fellowship; NOAA [NA14OAR4310189]; US Air Force Office of Scientific Research [FA9550-13-1-0043]; US National Science Foundation [DMS-0906392, DMS-CMG-1025465, AGS-1003823, DMS-1106642, DMS-CAREER-1352656]; Defense Advanced Research Projects Agency [DARPA YFA N66001-111-4131]; UPS Foundation (SMC-DBNKY)	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); DOE Integrated Assessment Research Program; G.J. Lieberman Fellowship; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); UPS Foundation (SMC-DBNKY)	Work by D.E.H., D.S., D.L.S. and N.S.D. was supported by NSF CAREER Award 0955283, DOE Integrated Assessment Research Program Grant No. DE-SC005171DE-SC005171, and a G.J. Lieberman Fellowship to D.S. Contributions from N.C.J. were supported by NOAA's Climate Program Office's Modeling, Analysis, Predictions, and Projections program award NA14OAR4310189. B.R. acknowledges support from the US Air Force Office of Scientific Research (FA9550-13-1-0043), the US National Science Foundation (DMS-0906392, DMS-CMG-1025465, AGS-1003823, DMS-1106642, and DMS-CAREER-1352656), the Defense Advanced Research Projects Agency (DARPA YFA N66001-111-4131), and the UPS Foundation (SMC-DBNKY). We thank B. Santer, J. Cattiaux, D. Touma, and J. S. Mankin for discussions that improved the manuscript. Computational resources for data processing and analysis were provided by the Center for Computational Earth and Environmental Science in the School of Earth, Energy, and Environmental Sciences at Stanford University.	ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Barnes EA, 2014, GEOPHYS RES LETT, V41, P638, DOI 10.1002/2013GL058745; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cassano JJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000332; Cattiaux J, 2013, CLIM DYNAM, V41, P2889, DOI 10.1007/s00382-013-1731-y; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; Cohen JL, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014007; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Deser C, 2014, J CLIMATE, V27, P2271, DOI 10.1175/JCLI-D-13-00451.1; Diffenbaugh N, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P137; Diffenbaugh NS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043888; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Donat MG, 2013, J GEOPHYS RES-ATMOS, V118, P2098, DOI 10.1002/jgrd.50150; Driouech F, 2010, GLOBAL PLANET CHANGE, V72, P1, DOI 10.1016/j.gloplacha.2010.03.004; Francis JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051000; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Inoue J, 2012, J CLIMATE, V25, P2561, DOI 10.1175/JCLI-D-11-00449.1; IPCC, 2018, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Johnson NC, 2008, J CLIMATE, V21, P6354, DOI 10.1175/2008JCLI2380.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/BAMS-83-11-1631(2002)083<1631:NAR>2.3.CO;2, 10.1175/Bams-83-11-1631]; Kohonen T., 2001, SELF ORG MAPS, V3rd ed.; Lee S, 2013, SCIENCE, V339, P563, DOI 10.1126/science.1225154; Liu JP, 2012, P NATL ACAD SCI USA, V109, P4074, DOI 10.1073/pnas.1114910109; Miralles DG, 2014, NAT GEOSCI, V7, P345, DOI [10.1038/NGEO2141, 10.1038/ngeo2141]; Mori M, 2014, NAT GEOSCI, V7, P869, DOI 10.1038/NGEO2277; Palmer T, 2014, SCIENCE, V344, P803, DOI 10.1126/science.1255147; Petoukhov V, 2013, P NATL ACAD SCI USA, V110, P5336, DOI 10.1073/pnas.1222000110; Screen JA, 2014, NAT CLIM CHANGE, V4, P704, DOI 10.1038/nclimate2271; Screen JA, 2014, NAT CLIM CHANGE, V4, P577, DOI [10.1038/NCLIMATE2268, 10.1038/nclimate2268]; Screen JA, 2014, CLIM DYNAM, V43, P333, DOI 10.1007/s00382-013-1830-9; Screen JA, 2013, P NATL ACAD SCI USA, V110, pE2327, DOI 10.1073/pnas.1304867110; Screen JA, 2013, GEOPHYS RES LETT, V40, P959, DOI 10.1002/grl.50174; Screen JA, 2013, J CLIMATE, V26, P1230, DOI 10.1175/JCLI-D-12-00063.1; Shepherd TG, 2014, NAT GEOSCI, V7, P703, DOI 10.1038/NGEO2253; Simmonds I, 2015, ANN GLACIOL, V56, P18, DOI 10.3189/2015AoG69A909; Skific N, 2009, J CLIMATE, V22, P4135, DOI 10.1175/2009JCLI2645.1; Wallace JM, 2014, SCIENCE, V343, P729, DOI 10.1126/science.343.6172.729; ZWIERS FW, 1995, J CLIMATE, V8, P336, DOI 10.1175/1520-0442(1995)008<0336:TSCIAI>2.0.CO;2	42	330	336	29	260	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					465	+		10.1038/nature14550	http://dx.doi.org/10.1038/nature14550			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108856				2022-12-28	WOS:000356782900047
J	Vandrey, R; Raber, JC; Raber, ME; Douglass, B; Miller, C; Bonn-Miller, MO				Vandrey, Ryan; Raber, Jeffrey C.; Raber, Mark E.; Douglass, Brad; Miller, Cameron; Bonn-Miller, Marcel O.			Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Vandrey, Ryan] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA; [Raber, Jeffrey C.; Raber, Mark E.] Werc Shop Lab, Pasadena, CA USA; [Douglass, Brad; Miller, Cameron] Werc Shop Lab, Bellevue, WA USA; [Bonn-Miller, Marcel O.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine	Vandrey, R (corresponding author), Johns Hopkins Univ, Sch Med, Behav Pharmacol Res Unit, 5510 Nathan Shock Dr, Baltimore, MD 21224 USA.	rvandrey@jhmi.edu						Favrat B, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-17; Grella CE, 2014, J PSYCHOACTIVE DRUGS, V46, P263, DOI 10.1080/02791072.2014.944960; Monte AA, 2015, JAMA-J AM MED ASSOC, V313, P241, DOI 10.1001/jama.2014.17057; Russo EB, 2011, BRIT J PHARMACOL, V163, P1344, DOI 10.1111/j.1476-5381.2011.01238.x; Vermersch Patrick, 2011, Expert Rev Neurother, V11, P15; Walsh Z, 2013, INT J DRUG POLICY, V24, P511, DOI 10.1016/j.drugpo.2013.08.010	6	219	221	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2491	2493		10.1001/jama.2015.6613	http://dx.doi.org/10.1001/jama.2015.6613			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103034	Bronze			2022-12-28	WOS:000356663600019
J	Frenking, G				Frenking, Gernot			INORGANIC CHEMISTRY Peculiar boron startles again	NATURE			English	Editorial Material							MAIN-GROUP COMPOUNDS; DATIVE BONDS; CARBODICARBENE; CARBENES; SUBOXIDE; ARROWS; ALLENE		Univ Marburg, Fachbereich Chem, D-35039 Marburg, Germany	Philipps University Marburg	Frenking, G (corresponding author), Univ Marburg, Fachbereich Chem, Hans Meerwein Str, D-35039 Marburg, Germany.	frenking@chemie.uni-marburg.de						Braunschweig H, 2015, NATURE, V522, P327, DOI 10.1038/nature14489; Celik MA, 2012, CHEM-EUR J, V18, P5676, DOI 10.1002/chem.201103965; Dahcheh F, 2014, ANGEW CHEM INT EDIT, V53, P13159, DOI 10.1002/anie.201408371; Diels O, 1906, BER DTSCH CHEM GES, V39, P689, DOI 10.1002/cber.190603901103; Dyker CA, 2008, ANGEW CHEM INT EDIT, V47, P3206, DOI 10.1002/anie.200705620; Frenking G, 2014, ANGEW CHEM INT EDIT, V53, P6040, DOI 10.1002/anie.201311022; Frenking G, 2009, PURE APPL CHEM, V81, P597, DOI 10.1351/PAC-CON-08-11-03; Furstner A, 2008, ANGEW CHEM INT EDIT, V47, P3210, DOI 10.1002/anie.200705798; Himmel D, 2014, ANGEW CHEM INT EDIT, V53, P6047, DOI 10.1002/anie.201403078; Himmel D, 2014, ANGEW CHEM INT EDIT, V53, P370, DOI 10.1002/anie.201300461; JENSEN P, 1986, J MOL SPECTROSC, V118, P248, DOI 10.1016/0022-2852(86)90239-0; Kinjo R, 2011, SCIENCE, V333, P610, DOI 10.1126/science.1207573; Soleilhavoup M, 2015, ACCOUNTS CHEM RES, V48, P256, DOI 10.1021/ar5003494	13	17	17	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					297	298		10.1038/522297a	http://dx.doi.org/10.1038/522297a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085268				2022-12-28	WOS:000356425400044
J	Hu, DX; Wu, LX; Cai, WJ; Sen Gupta, A; Ganachaud, A; Qiu, B; Gordon, AL; Lin, XP; Chen, ZH; Hu, SJ; Wang, GJ; Wang, QY; Sprintall, J; Qu, TD; Kashino, Y; Wang, F; Kessler, WS				Hu, Dunxin; Wu, Lixin; Cai, Wenju; Sen Gupta, Alex; Ganachaud, Alexandre; Qiu, Bo; Gordon, Arnold L.; Lin, Xiaopei; Chen, Zhaohui; Hu, Shijian; Wang, Guojian; Wang, Qingye; Sprintall, Janet; Qu, Tangdong; Kashino, Yuji; Wang, Fan; Kessler, William S.			Pacific western boundary currents and their roles in climate	NATURE			English	Review							NORTH EQUATORIAL CURRENT; SEA-SURFACE TEMPERATURE; EAST AUSTRALIAN CURRENT; MINDANAO CURRENT; INDONESIAN THROUGHFLOW; KUROSHIO EXTENSION; SOUTH-PACIFIC; INTERANNUAL VARIABILITY; TROPICAL PACIFIC; DECADAL VARIABILITY	Pacific Ocean western boundary currents and the interlinked equatorial Pacific circulation system were among the first currents of these types to be explored by pioneering oceanographers. The widely accepted but poorly quantified importance of these currents-in processes such as the El Nino/Southern Oscillation, the Pacific Decadal Oscillation and the Indonesian Throughflow-has triggered renewed interest. Ongoing efforts are seeking to understand the heat and mass balances of the equatorial Pacific, and possible changes associated with greenhouse-gas-induced climate change. Only a concerted international effort will close the observational, theoretical and technical gaps currently limiting a robust answer to these elusive questions.	[Hu, Dunxin; Hu, Shijian; Wang, Qingye; Wang, Fan] Chinese Acad Sci, Inst Oceanol, Key Lab Ocean Circulat & Waves, Qingdao 266071, Peoples R China; [Wu, Lixin; Cai, Wenju; Lin, Xiaopei; Chen, Zhaohui] Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao 266003, Peoples R China; [Cai, Wenju; Wang, Guojian] CSIRO Oceans & Atmosphere Flagship, Aspendale, Vic 3195, Australia; [Sen Gupta, Alex] Univ New S Wales, Australian Res Council ARC Ctr Excellence Climate, Sydney, NSW 2052, Australia; [Ganachaud, Alexandre] UPS OMP PCA, LEGOS UMR5566, IRD, F-31400 Toulouse, France; [Qiu, Bo] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Gordon, Arnold L.] Columbia Univ, Earth Inst, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Sprintall, Janet] Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Qu, Tangdong] Univ Hawaii, SOEST, Dept Oceanog, IPRC, Honolulu, HI 96822 USA; [Kashino, Yuji] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Ctr Earth Informat Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Kessler, William S.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA	Chinese Academy of Sciences; Institute of Oceanology, CAS; Ocean University of China; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New South Wales Sydney; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hawaii System; University of Hawaii Manoa; Columbia University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); National Oceanic Atmospheric Admin (NOAA) - USA	Cai, WJ (corresponding author), Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao 266003, Peoples R China.	lxwu@ouc.edu.cn; wenju.cai@csiro.au	Gordon, Arnold L/H-1049-2011; Gupta, Alexander R Sen/B-7995-2011; Wang, Fan/J-5119-2012; Wang, Guojian/AAF-9297-2020; Hu, Shijian/Q-6838-2016; Qiu, Bo/D-9569-2017; Cai, Wenju/C-2864-2012; Ganachaud, Alexandre S/B-7556-2013	Gordon, Arnold L/0000-0001-6480-6095; Gupta, Alexander R Sen/0000-0001-5226-871X; Wang, Fan/0000-0001-5932-7567; Wang, Guojian/0000-0002-8881-7394; Hu, Shijian/0000-0002-6142-7441; Cai, Wenju/0000-0001-6520-0829; Hu, Dunxin/0000-0002-9285-8287; Kashino, Yuji/0000-0001-8841-6526	Australian Climate Change Science Program; CSIRO Office of the Chief Executive Science Leader award; CSIRO Office of the Chief Executive postdoctoral awards; National Science Foundation of China (NSFC) [41130859, 41490640, 41306001]; National Basic Research Program of China (MOST) [2013CB956200]; CAS Program XDA [11010101]; NSFC [41330963, 41421005, 41406016]; MOST [2013CB956202, 2012CB417401]; NSFC/Shangdong [U1406401]; CNRS/INSU/LEFE project MoorSPICE; National Aeronautics and Space Administration (NASA) [NNX13AO38G]; Tropical Ocean Climate Study of Japan Agency for Marine-Earth Science and Technology; Directorate For Geosciences [1029487] Funding Source: National Science Foundation	Australian Climate Change Science Program; CSIRO Office of the Chief Executive Science Leader award; CSIRO Office of the Chief Executive postdoctoral awards; National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (MOST)(National Basic Research Program of China); CAS Program XDA; NSFC(National Natural Science Foundation of China (NSFC)); MOST; NSFC/Shangdong; CNRS/INSU/LEFE project MoorSPICE; National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Tropical Ocean Climate Study of Japan Agency for Marine-Earth Science and Technology; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	W.C. and G.W. are supported by the Australian Climate Change Science Program, a CSIRO Office of the Chief Executive Science Leader award, and CSIRO Office of the Chief Executive postdoctoral awards. L.W., Z.C. and X.L. are supported by projects (41130859,41490640, 41306001) of the National Science Foundation of China (NSFC), and a project (2013CB956200) of the National Basic Research Program of China (MOST). D.H. is supported by CAS Program XDA 11010101, and NSFC Grants 41330963 and 41421005. S.H. is supported by NSFC Grant 41406016. Q.W. is supported by MOST Grant 2013CB956202. F.W. is supported by MOST Grant 2012CB417401 and NSFC/Shangdong Grant U1406401, A.G. is supported by CNRS/INSU/LEFE project MoorSPICE. This is PMEL Contribution Number 4207, and Lamont-Doherty Earth Observatory Contribution Number 7875. J.S. is supported by the National Aeronautics and Space Administration (NASA) under award no. NNX13AO38G. Y.K. is supported by the Tropical Ocean Climate Study of Japan Agency for Marine-Earth Science and Technology. This is a contribution to the CLIVAR SPICE and NPOCE programmes. We thank A. Purich and T. Cowan for their comments before submission. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, and we thank the climate modelling groups for producing and making available their model output. The US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Alexander MA, 2002, J CLIMATE, V15, P2205, DOI 10.1175/1520-0442(2002)015<2205:TABTIO>2.0.CO;2; ALEXANDER MA, 1995, J PHYS OCEANOGR, V25, P122, DOI 10.1175/1520-0485(1995)025<0122:AMFTRO>2.0.CO;2; Beal LM, 2011, NATURE, V472, P429, DOI 10.1038/nature09983; Cai W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024911; Cai W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024701; Cai WJ, 2007, J CLIMATE, V20, P681, DOI 10.1175/JCLI4028.1; Cai WJ, 2012, NATURE, V488, P365, DOI 10.1038/nature11358; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; Chen ZH, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007814; Davis RE, 2012, J PHYS OCEANOGR, V42, P2001, DOI 10.1175/JPO-D-12-022.1; Feng JQ, 2014, J GEOPHYS RES-OCEANS, V119, P4029, DOI 10.1002/2013JC009683; FINE RA, 1994, J GEOPHYS RES-OCEANS, V99, P25063, DOI 10.1029/94JC02277; Firing E, 2005, DEEP-SEA RES PT II, V52, P605, DOI 10.1016/j.dsr2.2004.12.007; Frankignoul C, 2007, J CLIMATE, V20, P592, DOI 10.1175/JCLI4021.1; Ganachaud A. S., 2014, J GEOPHYS RES, V119, P2642; Ganachaud A, 2013, CLIMATIC CHANGE, V119, P163, DOI 10.1007/s10584-012-0631-1; Gasparin F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052575; Godfrey JS, 1996, J GEOPHYS RES-OCEANS, V101, P12217, DOI 10.1029/95JC03860; Gordon AL, 2010, DYNAM ATMOS OCEANS, V50, P115, DOI 10.1016/j.dynatmoce.2009.12.002; Gordon A.L, 2005, OCEANOGRAPHY, V18, P15, DOI [10.5670/oceanog.2005.01, DOI 10.5670/OCEANOG.2005.01]; Gordon AL, 2003, NATURE, V425, P824, DOI 10.1038/nature02038; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Gordon AL, 1996, NATURE, V379, P146, DOI 10.1038/379146a0; Gordon AL, 2014, J GEOPHYS RES-OCEANS, V119, P4251, DOI 10.1002/2014JC009882; Gordon AL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052021; GOURIOU Y, 1993, J GEOPHYS RES-OCEANS, V98, P22495, DOI 10.1029/93JC02513; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Grenier M, 2014, J GEOPHYS RES-OCEANS, V119, P3948, DOI 10.1002/2013JC009670; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Hill KL, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2009JC005926; HOLLAND GJ, 1986, MON WEATHER REV, V114, P594, DOI 10.1175/1520-0493(1986)114<0594:IVOTAS>2.0.CO;2; Hotta D, 2011, J CLIMATE, V24, P3377, DOI 10.1175/2010JCLI3910.1; Hu D., 2011, NW PACIFIC OCEAN CIR; Hu D., 1991, J OCEANOL LIMNOL, V9, P1, DOI [10.1007/BF02849784, DOI 10.1007/BF02849784]; Hu DX, 2013, J PHYS OCEANOGR, V43, P1417, DOI 10.1175/JPO-D-12-0165.1; Huang R. H., 1988, CHINESE J ATMOS SCI, V14, P95; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; Johnson GC, 2002, PROG OCEANOGR, V52, P31, DOI 10.1016/S0079-6611(02)00021-6; Kashino Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023880; Kashino Y, 2009, J OCEANOGR, V65, P325, DOI 10.1007/s10872-009-0030-z; Kelly KA, 2010, J CLIMATE, V23, P5644, DOI 10.1175/2010JCLI3346.1; Kessler WS, 2007, J PHYS OCEANOGR, V37, P1610, DOI 10.1175/JPO3046.1; Kessler WS, 2013, J PHYS OCEANOGR, V43, P956, DOI 10.1175/JPO-D-12-0113.1; Kim YY, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002013; KLEIN SA, 1995, J CLIMATE, V8, P1140, DOI 10.1175/1520-0442(1995)008<1140:OTRALC>2.0.CO;2; Konda M, 2010, J CLIMATE, V23, P5206, DOI 10.1175/2010JCLI3391.1; Kwon YO, 2010, J CLIMATE, V23, P3249, DOI 10.1175/2010JCLI3343.1; Lau NC, 2001, J CLIMATE, V14, P2846, DOI 10.1175/1520-0442(2001)014<2846:IOEOSV>2.0.CO;2; Li WH, 2012, NAT GEOSCI, V5, P830, DOI [10.1038/NGEO1590, 10.1038/ngeo1590]; LINDSTROM E, 1987, NATURE, V330, P533, DOI 10.1038/330533a0; Liu ZY, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000172; LUKAS R, 1991, J GEOPHYS RES-OCEANS, V96, P7089, DOI 10.1029/91JC00062; MCCREARY JP, 1994, J PHYS OCEANOGR, V24, P466; Melet A, 2013, OCEAN DYNAM, V63, P1, DOI 10.1007/s10236-012-0582-0; Nakamura H, 2004, GEOPHYS MONOGR SER, V147, P329; Nakamura H, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/1999JC000085; NORRIS JR, 1994, J CLIMATE, V7, P1915, DOI 10.1175/1520-0442(1994)007<1915:IVISCA>2.0.CO;2; Oliver ECJ, 2014, J GEOPHYS RES-OCEANS, V119, P2788, DOI 10.1002/2013JC009591; Park SS, 2006, J CLIMATE, V19, P6243, DOI 10.1175/JCLI3957.1; Qiu B, 1996, J GEOPHYS RES-OCEANS, V101, P12315, DOI 10.1029/95JC03204; Qiu B, 1999, J PHYS OCEANOGR, V29, P1599, DOI 10.1175/1520-0485(1999)029<1599:IVITIP>2.0.CO;2; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; Qiu B, 2009, J PHYS OCEANOGR, V39, P404, DOI 10.1175/2008JPO3988.1; Qu TD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028350; Qu TD, 2004, J PHYS OCEANOGR, V34, P2104, DOI 10.1175/1520-0485(2004)034<2104:NIOAIW>2.0.CO;2; Qu TD, 2003, J PHYS OCEANOGR, V33, P5, DOI 10.1175/1520-0485(2003)033<0005:TBOTNE>2.0.CO;2; Qu TD, 2002, J PHYS OCEANOGR, V32, P2492, DOI 10.1175/1520-0485-32.9.2492; Qu TD, 1997, DEEP-SEA RES PT I, V44, P413, DOI 10.1016/S0967-0637(96)00121-5; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Roemmich D, 2007, J PHYS OCEANOGR, V37, P162, DOI 10.1175/JPO3004.1; Sasaki YN, 2012, J CLIMATE, V25, P6627, DOI 10.1175/JCLI-D-11-00727.1; Seager R, 2001, J CLIMATE, V14, P4249, DOI 10.1175/1520-0442(2001)014<4249:WDSITL>2.0.CO;2; Sen Gupta A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051447; Shi G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032436; Song Q, 2004, J PHYS OCEANOGR, V34, P772, DOI 10.1175/1520-0485(2004)034<0772:SOTITI>2.0.CO;2; Speich S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031583; SPICE Community, 2012, CLIVAR NEWSLETTER EX, V58, P28; SPRINTALL J, 1995, J GEOPHYS RES-OCEANS, V100, P15865, DOI 10.1029/95JC01664; Sprintall J, 2014, NAT GEOSCI, V7, P487, DOI [10.1038/NGEO2188, 10.1038/ngeo2188]; Stommel H., 1972, KUROSHIO ITS PHYS AS; Sugimoto S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021410; Taguchi B, 2005, J CLIMATE, V18, P2979, DOI 10.1175/JCLI3449.1; Taguchi B, 2007, J CLIMATE, V20, P2357, DOI 10.1175/JCLI4142.1; Taguchi B, 2009, J CLIMATE, V22, P6536, DOI 10.1175/2009JCLI2910.1; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Tokinaga H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025102; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Ueki I, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001611; van Sebille E, 2014, J GEOPHYS RES-OCEANS, V119, P1365, DOI 10.1002/2013JC009525; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Vranes K, 2002, DEEP-SEA RES PT II, V49, P1391, DOI 10.1016/S0967-0645(01)00150-3; Wang GJ, 2014, J GEOPHYS RES-OCEANS, V119, P2974, DOI 10.1002/2013JC009589; WIJFFELS S, 1995, J GEOPHYS RES-OCEANS, V100, P18421, DOI 10.1029/95JC01347; Wu CR, 2013, PROG OCEANOGR, V110, P49, DOI 10.1016/j.pocean.2012.12.001; Wu CR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033942; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; Yamagata T., 1999, BEYOND EL NINO, P49; Zhai FG, 2014, GEOPHYS RES LETT, V41, P3172, DOI 10.1002/2014GL059934; Zhang LL, 2014, J GEOPHYS RES-OCEANS, V119, P3617, DOI 10.1002/2013JC009693	100	340	381	29	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					299	308		10.1038/nature14504	http://dx.doi.org/10.1038/nature14504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085269				2022-12-28	WOS:000356425400045
J	Kheirbek, MA				Kheirbek, Mazen A.			Finding the Roots of Adult Neurogenesis	CELL			English	Editorial Material							NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; MAMMALIAN BRAIN; HIPPOCAMPUS	In select areas of the brain, neural stem cells produce new neurons throughout life. An elegant new study in this issue of Cell reveals the origins of a stem cell population that persists into adulthood and uncovers a surprising relationship between neurons born in the mature brain and those generated early in development.	[Kheirbek, Mazen A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Kheirbek, Mazen A.] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Kheirbek, MA (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	mk3156@cumc.columbia.edu	Kheirbek, Mazen A/J-3656-2015	Kheirbek, Mazen A/0000-0001-9157-7363	NIMH NIH HHS [K01 MH099371] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099371] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Calzolari F, 2015, NAT NEUROSCI, V18, P490, DOI 10.1038/nn.3963; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; GOLDEN JA, 1995, P NATL ACAD SCI USA, V92, P5704, DOI 10.1073/pnas.92.12.5704; Li GN, 2013, NEURON, V78, P658, DOI 10.1016/j.neuron.2013.03.019; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001	9	5	5	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1500	1502		10.1016/j.cell.2015.06.010	http://dx.doi.org/10.1016/j.cell.2015.06.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091033	Green Accepted, Bronze			2022-12-28	WOS:000356618200007
J	[Anonymous]				[Anonymous]			West Asia	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S22	S23		10.1038/522S22a	http://dx.doi.org/10.1038/522S22a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083855	Bronze			2022-12-28	WOS:000356425400008
J	McDonald, CF				McDonald, Christine F.			Review: Pulmonary rehabilitation improves health-related QoL and exercise capacity in COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Austin Hlth, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health	McDonald, CF (corresponding author), Austin Hlth, Heidelberg, Vic, Australia.		McDonald, Christine Faye/AAU-9083-2021					Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067	3	3	3	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC4	10.7326/ACPJC-2015-162-12-004	http://dx.doi.org/10.7326/ACPJC-2015-162-12-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075781				2022-12-28	WOS:000356516300005
J	Salminen, P; Paajanen, H; Rautio, T; Nordstrom, P; Aarnio, M; Rantanen, T; Tuominen, R; Hurme, S; Virtanen, J; Mecklin, JP; Sand, J; Jartti, A; Rinta-Kiikka, I; Gronroos, JM				Salminen, Paulina; Paajanen, Hannu; Rautio, Tero; Nordstrom, Pia; Aarnio, Markku; Rantanen, Tuomo; Tuominen, Risto; Hurme, Saija; Virtanen, Johanna; Mecklin, Jukka-Pekka; Sand, Juhani; Jartti, Airi; Rinta-Kiikka, Irina; Gronroos, Juha M.			Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis The APPAC Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEGATIVE APPENDECTOMIES; NONOPERATIVE MANAGEMENT; SUSPECTED APPENDICITIS; 1ST-LINE THERAPY; CT; METAANALYSIS; DIAGNOSIS; PERFORATION; OUTCOMES; ADULTS	IMPORTANCE An increasing amount of evidence supports the use of antibiotics instead of surgery for treating patients with uncomplicated acute appendicitis. OBJECTIVE To compare antibiotic therapy with appendectomy in the treatment of uncomplicated acute appendicitis confirmed by computed tomography (CT). DESIGN, SETTING, AND PARTICIPANTS The Appendicitis Acuta (APPAC) multicenter, open-label, noninferiority randomized clinical trial was conducted from November 2009 until June 2012 in Finland. The trial enrolled 530 patients aged 18 to 60 years with uncomplicated acute appendicitis confirmed by a CT scan. Patients were randomly assigned to early appendectomy or antibiotic treatment with a 1-year follow-up period. INTERVENTIONS Patients randomized to antibiotic therapy received intravenous ertapenem (1 g/d) for 3 days followed by 7 days of oral levofloxacin (500 mg once daily) and metronidazole (500 mg 3 times per day). Patients randomized to the surgical treatment group were assigned to undergo standard open appendectomy. MAIN OUTCOMES AND MEASURES The primary end point for the surgical intervention was the successful completion of an appendectomy. The primary end point for antibiotic-treated patients was discharge from the hospital without the need for surgery and no recurrent appendicitis during a 1-year follow-up period. RESULTS There were 273 patients in the surgical group and 257 in the antibiotic group. Of 273 patients in the surgical group, all but 1 underwent successful appendectomy, resulting in a success rate of 99.6%(95% CI, 98.0% to 100.0%). In the antibiotic group, 70 patients (27.3%; 95% CI, 22.0% to 33.2%) underwent appendectomy within 1 year of initial presentation for appendicitis. Of the 256 patients available for follow-up in the antibiotic group, 186 (72.7%; 95% CI, 66.8% to 78.0%) did not require surgery. The intention-to-treat analysis yielded a difference in treatment efficacy between groups of -27.0%(95% CI, -31.6% to infinity) (P = .89). Given the prespecified noninferiority margin of 24%, we were unable to demonstrate noninferiority of antibiotic treatment relative to surgery. Of the 70 patients randomized to antibiotic treatment who subsequently underwent appendectomy, 58 (82.9%; 95% CI, 72.0% to 90.8%) had uncomplicated appendicitis, 7(10.0%; 95% CI, 4.1% to 19.5%) had complicated acute appendicitis, and 5 (7.1%; 95% CI, 2.4% to 15.9%) did not have appendicitis but received appendectomy for suspected recurrence. There were no intra-abdominal abscesses or other major complications associated with delayed appendectomy in patients randomized to antibiotic treatment. CONCLUSIONS AND RELEVANCE Among patients with CT-proven, uncomplicated appendicitis, antibiotic treatment did not meet the prespecified criterion for noninferiority compared with appendectomy. Most patients randomized to antibiotic treatment for uncomplicated appendicitis did not require appendectomy during the 1-year follow-up period, and those who required appendectomy did not experience significant complications.	[Salminen, Paulina; Gronroos, Juha M.] Turku Univ Hosp, Div Digest Surg & Urol, Dept Acute, FIN-20520 Turku, Finland; [Salminen, Paulina; Gronroos, Juha M.] Turku Univ Hosp, Div Digest Surg & Urol, Dept Digest Surg, FIN-20520 Turku, Finland; [Salminen, Paulina; Gronroos, Juha M.] Turku Univ, Dept Surg, Turku, Finland; [Paajanen, Hannu] Mikkeli Cent Hosp, Dept Surg, Mikkeli, Finland; [Paajanen, Hannu; Rantanen, Tuomo; Mecklin, Jukka-Pekka] Univ Eastern Finland, Inst Clin Med, Joensuu, Finland; [Rautio, Tero] Oulu Univ Hosp, Dept Surg, Oulu, Finland; [Nordstrom, Pia; Sand, Juhani] Tampere Univ Hosp, Div Surg Gastroenterol & Oncol, Tampere, Finland; [Aarnio, Markku; Mecklin, Jukka-Pekka] Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland; [Rantanen, Tuomo] Kuopio Univ Hosp, Dept Surg, SF-70210 Kuopio, Finland; [Rantanen, Tuomo] Seinajoki Cent Hosp, Dept Surg, Seinajoki, Finland; [Tuominen, Risto] Univ Turku, Dept Publ Hlth, Turku, Finland; [Tuominen, Risto] Hosp Dist Southwest Finland, Primary Hlth Care Unit, Turku, Finland; [Hurme, Saija] Univ Turku, Dept Biostat, Turku, Finland; [Virtanen, Johanna] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland; [Jartti, Airi] Oulu Univ Hosp, Dept Radiol, Oulu, Finland; [Rinta-Kiikka, Irina] Tampere Univ Hosp, Dept Radiol, Tampere, Finland	University of Turku; University of Turku; University of Turku; University of Eastern Finland; University of Oulu; Tampere University; Tampere University Hospital; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland; Seinajoki Central Hospital; University of Turku; University of Turku; University of Turku; University of Turku; University of Oulu; Tampere University; Tampere University Hospital	Salminen, P (corresponding author), Kiinamyllynkatu 4-8, Turku 20520, Finland.	paulina.salminen@tyks.fi	Mecklin, Jukka-Pekka/AAC-9650-2019; Salminen, Paulina Taru Pipsa (T.P.)/ABB-8883-2020; Mecklin, Jukka-Pekka/AAB-5378-2020	Salminen, Paulina Taru Pipsa (T.P.)/0000-0001-6435-9264; Mecklin, Jukka-Pekka/0000-0003-4895-2249	government research grant (EVO Foundation)	government research grant (EVO Foundation)	The APPAC trial was supported by a government research grant (EVO Foundation) awarded to Turku University Hospital.	Andersson RE, 2013, CURR INFECT DIS REP, V15, P10, DOI 10.1007/s11908-012-0303-3; Andersson RE, 2012, WORLD J SURG, V36, P2037, DOI 10.1007/s00268-012-1647-4; Ansaloni L, 2011, DIGEST SURG, V28, P210, DOI 10.1159/000324595; Aprahamian CJ, 2007, J PEDIATR SURG, V42, P934, DOI 10.1016/j.jpedsurg.2007.01.024; Charfi S, 2014, INT J COLORECTAL DIS, V29, P1009, DOI 10.1007/s00384-014-1934-7; COLDREY E, 1956, BRIT MED J, V2, P1458, DOI 10.1136/bmj.2.5007.1458; Coursey CA, 2010, RADIOLOGY, V254, P460, DOI 10.1148/radiol.09082298; Fitz RH, 1886, AM J MED SCI, V92, P321; Hansson J, 2009, BRIT J SURG, V96, P473, DOI 10.1002/bjs.6482; Hansson J, 2012, WORLD J SURG, V36, P2028, DOI [10.1007/s00268-012-1641-x, 10.1007/s00268-012-1647-4]; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Jones K, 2004, AM J SURG, V188, P748, DOI 10.1016/j.amjsurg.2004.08.044; Kim K, 2012, NEW ENGL J MED, V366, P1596, DOI 10.1056/NEJMoa1110734; Lahaye MJ, 2015, EUR RADIOL, V25, P1464, DOI 10.1007/s00330-014-3531-0; Leung TTW, 2009, ANN SURG, V250, P51, DOI 10.1097/SLA.0b013e3181ad64a7; Liu K, 2011, SURGERY, V150, P673, DOI 10.1016/j.surg.2011.08.018; Livingston EH, 2011, ARCH SURG-CHICAGO, V146, P308, DOI 10.1001/archsurg.2011.2; Margenthaler JA, 2003, ANN SURG, V238, P59, DOI 10.1097/01.SLA.0000074961.50020.f8; Mason RJ, 2012, SURG INFECT, V13, P74, DOI 10.1089/sur.2011.058; McBurney C., 1889, NY STATE MED J, V50, P676; Paajanen H, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-3; Raja AS, 2010, RADIOLOGY, V256, P460, DOI 10.1148/radiol.10091570; Raman SS, 2008, NEW ENGL J MED, V358, P972, DOI 10.1056/NEJMc0707000; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Sauerland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001546.pub3; Shindoh J, 2010, J GASTROINTEST SURG, V14, P309, DOI 10.1007/s11605-009-1094-1; Solomkin JS, 2010, SURG INFECT, V11, P79, DOI 10.1089/sur.2009.9930; Styrud J, 2006, WORLD J SURG, V30, P1033, DOI 10.1007/s00268-005-0304-6; Varadhan KK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2156; Varadhan KK, 2010, WORLD J SURG, V34, P199, DOI 10.1007/s00268-009-0343-5; Vons C, 2011, LANCET, V377, P1573, DOI 10.1016/S0140-6736(11)60410-8; Wilms IMHA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008359.pub2; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	34	396	412	2	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2340	2348		10.1001/jama.2015.6154	http://dx.doi.org/10.1001/jama.2015.6154			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080338	Bronze			2022-12-28	WOS:000356300200019
J	Simmons, KB; Rodriguez, MI				Simmons, Katharine B.; Rodriguez, Maria I.			Reducing unintended pregnancy through provider training	LANCET			English	Editorial Material							REVERSIBLE CONTRACEPTION; IMMEDIATE; INSERTION		[Simmons, Katharine B.; Rodriguez, Maria I.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University	Simmons, KB (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA.	simmonka@ohsu.edu		Rodriguez, Maria Isabel/0000-0002-3127-2581				Bednarek PH, 2011, NEW ENGL J MED, V364, P2208, DOI 10.1056/NEJMoa1011600; Goodman S, 2008, CONTRACEPTION, V78, P143, DOI 10.1016/j.contraception.2008.03.003; Guttmacher Institute, 2013, UN PREGN US, P1; Guttmacher Institute, 2014, CONTR US US, P1; Harper CC, 2015, LANCET, V386, P562, DOI 10.1016/S0140-6736(14)62460-0; Kavanaugh ML, 2010, CONTRACEPTION, V82, P331, DOI 10.1016/j.contraception.2010.04.010; Langston AM, 2014, CONTRACEPTION, V89, P103, DOI 10.1016/j.contraception.2013.10.014; Peipert JF, 2011, OBSTET GYNECOL, V117, P1105, DOI 10.1097/AOG.0b013e31821188ad; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Thompson KMJ, 2011, CONTRACEPTION, V83, P41, DOI 10.1016/j.contraception.2010.06.008; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; U.S. Department of Health and Human Services. Centers for Disease Control and Prevention, EFF FAM PLANN METH; WHO, 2014, ENS HUM RIGHTS PROV, P34; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855	14	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					514	516		10.1016/S0140-6736(14)62444-2	http://dx.doi.org/10.1016/S0140-6736(14)62444-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO8PG	26091740				2022-12-28	WOS:000359431900009
J	Sidibe, M				Sidibe, Michel			The sustainable development agenda and the end of AIDS	LANCET			English	Editorial Material							HEALTH		UNAIDS, CH-1211 Geneva, Switzerland	UNAIDS	Sidibe, M (corresponding author), UNAIDS, CH-1211 Geneva, Switzerland.	sidibem@unaids.org						Buse K, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0098-8; Heywood M, 2009, J HUM RIGHTS PRACT, V1, P14, DOI 10.1093/jhuman/hun006; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Piot P, 2015, LANCET; Taylor AL, 2014, PUBLIC HEALTH, V128, P151, DOI 10.1016/j.puhe.2013.08.022; UNAIDS, 2014, THE GAP REP	7	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					108	110		10.1016/S0140-6736(15)61041-8	http://dx.doi.org/10.1016/S0140-6736(15)61041-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM5QC	26117718				2022-12-28	WOS:000357742200006
J	Susstrunk, R; Huber, SD				Suesstrunk, Roman; Huber, Sebastian D.			Observation of phononic helical edge states in a mechanical topological insulator	SCIENCE			English	Article							HGTE QUANTUM-WELLS; MODES	A topological insulator, as originally proposed for electrons governed by quantum mechanics, is characterized by a dichotomy between the interior and the edge of a finite system: The bulk has an energy gap, and the edges sustain excitations traversing this gap. However, it has remained an open question whether the same physics can be observed for systems obeying Newton's equations of motion. We conducted experiments to characterize the collective behavior of mechanical oscillators exhibiting the phenomenology of the quantum spin Hall effect. The phononic edge modes are shown to be helical, and we demonstrate their topological protection via the stability of the edge states against imperfections. Our results may enable the design of topological acoustic metamaterials that can capitalize on the stability of the surface phonons as reliable wave guides.	[Suesstrunk, Roman; Huber, Sebastian D.] ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Huber, SD (corresponding author), ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland.	sebastian.huber@phys.ethz.ch	Huber, Sebastian/L-8987-2013	Huber, Sebastian/0000-0003-3558-351X	Swiss National Foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF))	We thank T. Donner, T. Esslinger, P. Maletinsky, E. P. L. van Nieuwenburg, M. Tovmasyan, and O. Zilberberg for discussions. Special thanks go to C. Daraio for pointing out the technological relevance of our work. Supported by the Swiss National Foundation.	Albert VV, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.173902; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Berg N, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021913; Bernevig B.A., 2013, TOPOLOGICAL INSULATO; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; Chen BGG, 2014, P NATL ACAD SCI USA, V111, P13004, DOI 10.1073/pnas.1405969111; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Kane CL, 2014, NAT PHYS, V10, P39, DOI [10.1038/nphys2835, 10.1038/NPHYS2835]; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Kovacic I., 2011, DUFFING EQUATION NON; Li BW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.184301; Liu ZY, 2000, SCIENCE, V289, P1734, DOI 10.1126/science.289.5485.1734; Mellnik AR, 2014, NATURE, V511, P449, DOI 10.1038/nature13534; Mong RSK, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011036; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Paulose J, 2015, NAT PHYS, V11, P153, DOI 10.1038/NPHYS3185; Prodan E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.248101; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Rayleigh L., 1889, THEORY SOUND; Rayleigh L., 1910, PHILOS MAG, V20, P1001; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Spadoni A, 2010, P NATL ACAD SCI USA, V107, P7230, DOI 10.1073/pnas.1001514107	29	630	634	8	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					47	50		10.1126/science.aab0239	http://dx.doi.org/10.1126/science.aab0239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138969	Green Submitted			2022-12-28	WOS:000357280800054
J	Tholl, D; Gershenzon, J				Tholl, Dorothea; Gershenzon, Jonathan			The flowering of a new scent pathway in rose	SCIENCE			English	Editorial Material							BIOSYNTHESIS		[Tholl, Dorothea] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Gershenzon, Jonathan] Max Planck Inst Chem Ecol, Dept Biochem, D-07745 Jena, Germany	Virginia Polytechnic Institute & State University; Max Planck Society	Tholl, D (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA.	tholl@vt.edu	Gershenzon, Jonathan/K-1331-2013	Gershenzon, Jonathan/0000-0002-1812-1551				Byers KJRP, 2014, PLANT J, V80, P1031, DOI 10.1111/tpj.12702; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Francis M. J. O., 1969, PHYTOCHEMISTRY, V67, P1110; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Iijima Y, 2004, PLANT PHYSIOL, V134, P370, DOI 10.1104/pp.103.032946; Jirschitzka J, 2012, P NATL ACAD SCI USA, V109, P10304, DOI 10.1073/pnas.1200473109; Magnard JL, 2015, SCIENCE, V349, P81, DOI 10.1126/science.aab0696; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Scalliet G, 2008, P NATL ACAD SCI USA, V105, P5927, DOI 10.1073/pnas.0711551105; Sohrabi R, 2015, PLANT CELL, V27, P874, DOI 10.1105/tpc.114.132209	12	10	13	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					28	29		10.1126/science.aac6509	http://dx.doi.org/10.1126/science.aac6509			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138963				2022-12-28	WOS:000357280800042
J	McCarthy, M				McCarthy, Michael			California ends vaccine exemptions on grounds of belief-will other states follow?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mxmc@mac.com						Lillvis DF, 2014, MILBANK Q, V92, P475, DOI 10.1111/1468-0009.12075; McCarthy M., 2013, BMJ-BRIT MED J, V347, pf6109; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h865	3	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2015	351								h3635	10.1136/bmj.h3635	http://dx.doi.org/10.1136/bmj.h3635			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TX	26139597				2022-12-28	WOS:000357608600008
J	Yoshizato, T; Dumitriu, B; Hosokawa, K; Makishima, H; Yoshida, K; Townsley, D; Sato-Otsubo, A; Sato, Y; Liu, D; Suzuki, H; Wu, CO; Shiraishi, Y; Clemente, MJ; Kataoka, K; Shiozawa, Y; Okuno, Y; Chiba, K; Tanaka, H; Nagata, Y; Katagiri, T; Kon, A; Sanada, M; Scheinberg, P; Miyano, S; Maciejewski, JP; Nakao, S; Young, NS; Ogawa, S				Yoshizato, T.; Dumitriu, B.; Hosokawa, K.; Makishima, H.; Yoshida, K.; Townsley, D.; Sato-Otsubo, A.; Sato, Y.; Liu, D.; Suzuki, H.; Wu, C. O.; Shiraishi, Y.; Clemente, M. J.; Kataoka, K.; Shiozawa, Y.; Okuno, Y.; Chiba, K.; Tanaka, H.; Nagata, Y.; Katagiri, T.; Kon, A.; Sanada, M.; Scheinberg, P.; Miyano, S.; Maciejewski, J. P.; Nakao, S.; Young, N. S.; Ogawa, S.			Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PIG-A GENE; MYELODYSPLASTIC SYNDROMES; DNMT3A MUTATIONS; CELLS; SURVIVAL; AGE; MOSAICISM; EVOLUTION; SPECTRUM; ASXL1	BACKGROUND In patients with acquired aplastic anemia, destruction of hematopoietic cells by the immune system leads to pancytopenia. Patients have a response to immunosuppressive therapy, but myelodysplastic syndromes and acute myeloid leukemia develop in about 15% of the patients, usually many months to years after the diagnosis of aplastic anemia. METHODS We performed next-generation sequencing and array-based karyotyping using 668 blood samples obtained from 439 patients with aplastic anemia. We analyzed serial samples obtained from 82 patients. RESULTS Somatic mutations in myeloid cancer candidate genes were present in one third of the patients, in a limited number of genes and at low initial variant allele frequency. Clonal hematopoiesis was detected in 47% of the patients, most frequently as acquired mutations. The prevalence of the mutations increased with age, and mutations had an age-related signature. DNMT3A-mutated and ASXL1-mutated clones tended to increase in size over time; the size of BCOR- and BCORL1-mutated and PIGA-mutated clones decreased or remained stable. Mutations in PIGA and BCOR and BCORL1 correlated with a better response to immunosuppressive therapy and longer and a higher rate of overall and progression-free survival; mutations in a subgroup of genes that included DNMT3A and ASXL1 were associated with worse outcomes. However, clonal dynamics were highly variable and might not necessarily have predicted the response to therapy and long-term survival among individual patients. CONCLUSIONS Clonal hematopoiesis was prevalent in aplastic anemia. Some mutations were related to clinical outcomes. A highly biased set of mutations is evidence of Darwinian selection in the failed bone marrow environment. The pattern of somatic clones in individual patients over time was variable and frequently unpredictable. (Funded by Grant-in-Aid for Scientific Research and others.)	[Yoshizato, T.; Yoshida, K.; Sato-Otsubo, A.; Sato, Y.; Suzuki, H.; Kataoka, K.; Shiozawa, Y.; Nagata, Y.; Kon, A.; Sanada, M.; Ogawa, S.] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; [Hosokawa, K.; Katagiri, T.; Nakao, S.] Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Transplantat Biol, Div Canc Med, Kanazawa, Ishikawa, Japan; [Shiraishi, Y.; Chiba, K.; Tanaka, H.; Miyano, S.] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Okuno, Y.] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Dumitriu, B.; Hosokawa, K.; Townsley, D.; Liu, D.; Scheinberg, P.; Young, N. S.] NHLBI, Hematol Branch, Bethesda, MD 20892 USA; [Wu, C. O.] NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; [Makishima, H.; Clemente, M. J.; Maciejewski, J. P.] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH USA	Kyoto University; Kanazawa University; University of Tokyo; Nagoya University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cleveland Clinic Foundation	Ogawa, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	youngns@mail.nih.gov; sogawa-tky@umin.ac.jp	Kataoka, Keisuke/AAS-2546-2020; Okuno, Yusuke/C-9082-2009; Ogawa, Seishi/AAE-7088-2019; Scheinberg, Phillip/H-5251-2012; Suzuki, Hiromichi/AAO-4664-2021; Yoshizato, Tetsuichi/AAD-7308-2019	Kataoka, Keisuke/0000-0002-8263-9902; Okuno, Yusuke/0000-0003-3139-9272; Scheinberg, Phillip/0000-0002-9047-4538; Suzuki, Hiromichi/0000-0002-8858-0294; Yoshizato, Tetsuichi/0000-0003-4283-2983; Miyano, Satoru/0000-0002-1753-6616; Yoshida, Kenichi/0000-0003-4612-2778; Hosokawa, Kohei/0000-0002-3423-1523; Clemente, Michael/0000-0003-4345-3934	KAKENHI from Ministry of Health, Labor, and Welfare of Japan [22134006, 23249052, 26253060, 26221308]; Japan Society for the Promotion of Science through Funding Program for World-Leading Innovative Research and Development on Science and Technology; Intramural Research Program of the National Heart, Lung, and Blood Institute; Aplastic Anemia and MDS International Foundation; Scott Hamilton Cancer Alliance for Research Education and Survivorship Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002315] Funding Source: NIH RePORTER	KAKENHI from Ministry of Health, Labor, and Welfare of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science through Funding Program for World-Leading Innovative Research and Development on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Program of the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Aplastic Anemia and MDS International Foundation; Scott Hamilton Cancer Alliance for Research Education and Survivorship Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by Grant-in-Aid for Scientific Research (KAKENHI 22134006, 23249052, 26253060, and 26221308) from the Ministry of Health, Labor, and Welfare of Japan and the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative Research and Development on Science and Technology, the Intramural Research Program of the National Heart, Lung, and Blood Institute, a grant from the Aplastic Anemia and MDS International Foundation, and a research grant from the Scott Hamilton Cancer Alliance for Research Education and Survivorship Foundation.	Abdel-Wahab O, 2013, J EXP MED, V210, P2641, DOI 10.1084/jem.20131141; Afable MG, 2011, BLOOD, V117, P6876, DOI 10.1182/blood-2010-11-314393; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Damm F, 2013, BLOOD, V122, P3169, DOI 10.1182/blood-2012-11-469619; Dumitriu B, 2015, BLOOD, V125, P706, DOI 10.1182/blood-2014-10-607572; Gargiulo L, 2013, BLOOD, V121, P2753, DOI 10.1182/blood-2012-11-469353; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Heuser M, 2014, HAEMATOLOGICA, V99, pE165, DOI 10.3324/haematol.2013.101642; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Katagiri T, 2011, BLOOD, V118, P6601, DOI 10.1182/blood-2011-07-365189; Kulasekararaj AG, 2014, BLOOD, V124, P2698, DOI 10.1182/blood-2014-05-574889; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lane AA, 2013, LEUKEMIA, V27, P968, DOI 10.1038/leu.2013.30; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Maciejewski JP, 1996, BLOOD, V88, P1983, DOI 10.1182/blood.V88.6.1983.bloodjournal8861983; Mikhailova N, 1996, HAEMATOLOGICA, V81, P418; Mortazavi Y, 2000, EUR J HAEMATOL, V64, P385, DOI 10.1034/j.1600-0609.2000.90150.x; Mortazavi Y, 2003, BLOOD, V101, P2833, DOI 10.1182/blood-2002-07-2095; Murakami Y, 2002, BLOOD, V100, P4116, DOI 10.1182/blood-2002-06-1669; Nafa K, 1998, BLOOD CELL MOL DIS, V24, P370, DOI 10.1006/bcmd.1998.0203; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Scheinberg P, 2012, BLOOD, V120, P1185, DOI 10.1182/blood-2011-12-274019; Scheinberg P, 2011, NEW ENGL J MED, V365, P430, DOI 10.1056/NEJMoa1103975; Scheinberg P, 2010, JAMA-J AM MED ASSOC, V304, P1358, DOI 10.1001/jama.2010.1376; Scheinberg P, 2009, BRIT J HAEMATOL, V144, P206, DOI 10.1111/j.1365-2141.2008.07450.x; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Simon N, 2011, J STAT SOFTW, V39, P1; Socie G, 2000, SEMIN HEMATOL, V37, P91; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yasuda T, 2014, LEUKEMIA, V28, P426, DOI 10.1038/leu.2013.278; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	41	364	392	5	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					35	47		10.1056/NEJMoa1414799	http://dx.doi.org/10.1056/NEJMoa1414799			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL8IS	26132940	Green Accepted, Green Published			2022-12-28	WOS:000357218700006
J	Errico, A				Errico, Alessia			Judge by actions, not words	NATURE			English	Editorial Material												alessia.errico@googlemail.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					393	393		10.1038/522393a	http://dx.doi.org/10.1038/522393a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108815	Bronze			2022-12-28	WOS:000356782900059
J	Srokosz, MA; Bryden, HL				Srokosz, M. A.; Bryden, H. L.			Observing the Atlantic Meridional Overturning Circulation yields a decade of inevitable surprises	SCIENCE			English	Review							SEA-LEVEL RISE; WESTERN BOUNDARY CURRENT; TEMPORAL VARIABILITY; NORTH-AMERICAN; 26-DEGREES N; GULF-STREAM; EAST-COAST; CLIMATE; TRANSPORTS; ATMOSPHERE	The importance of the Atlantic Meridional Overturning Circulation (AMOC) heat transport for climate is well acknowledged. Climate models predict that the AMOC will slow down under global warming, with substantial impacts, but measurements of ocean circulation have been inadequate to evaluate these predictions. Observations over the past decade have changed that situation, providing a detailed picture of variations in the AMOC. These observations reveal a surprising degree of AMOC variability in terms of the intraannual range, the amplitude and phase of the seasonal cycle, the interannual changes in strength affecting the ocean heat content, and the decline of the AMOC over the decade, both of the latter two exceeding the variations seen in climate models.	[Srokosz, M. A.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Bryden, H. L.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton; NERC National Oceanography Centre; University of Southampton	Srokosz, MA (corresponding author), Univ Southampton, Natl Oceanog Ctr, Waterfront Campus, Southampton, Hants, England.	mas@noc.ac.uk		Bryden, Harry/0000-0002-8216-6359	NERC; NSF; National Oceanic and Atmospheric Administration (NOAA); Natural Environment Research Council [noc010012] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This review would not have been possible without the outstanding work of those who have been involved in making the AMOC observations at 26.5 degrees N for the past decade, together with continuing funding from NERC, NSF, and the National Oceanic and Atmospheric Administration (NOAA). We thank D. Smeed for the time series in Fig. 2. We pay tribute to all the scientists, technicians, and crew involved in the many U.K. and U.S. cruises that have taken place to deploy and recover the observing array and in the subsequent analysis of the data acquired. We are grateful to two anonymous reviewers whose comments helped to improve this review.	Alley RB, 2003, PHILOS T R SOC A, V361, P1831, DOI 10.1098/rsta.2003.1236; Alley RB, 2007, ANNU REV EARTH PL SC, V35, P241, DOI 10.1146/annurev.earth.35.081006.131524; Ansorge I. J., 2014, EOS, V95, P53, DOI [10.1002/2014EO060001, DOI 10.1002/2014E0060001]; Atkinson CP, 2010, OCEAN SCI, V6, P837, DOI 10.5194/os-6-837-2010; Ba J, 2014, CLIM DYNAM, V43, P2333, DOI 10.1007/s00382-014-2056-1; Bamber J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052552; Baringer MO, 2001, GEOPHYS RES LETT, V28, P3179, DOI 10.1029/2001GL013246; Bintanja R, 2014, NATURE, V509, P479, DOI 10.1038/nature13259; Brayshaw DJ, 2009, J CLIMATE, V22, P3146, DOI 10.1175/2008JCLI2594.1; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Bryden HL, 2014, OCEAN SCI, V10, P683, DOI 10.5194/os-10-683-2014; Bryden HL, 2009, OCEAN SCI, V5, P421, DOI 10.5194/os-5-421-2009; Bryden HL, 2011, J MAR RES, V69, P39; Bryden HL, 2005, NATURE, V438, P655, DOI 10.1038/nature04385; Chen XY, 2014, SCIENCE, V345, P897, DOI 10.1126/science.1254937; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; Cunningham SA, 2013, GEOPHYS RES LETT, V40, P6202, DOI 10.1002/2013GL058464; Danabasoglu G, 2014, OCEAN MODEL, V73, P76, DOI 10.1016/j.ocemod.2013.10.005; de Vries P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021450; Drijfhout SS, 2011, CLIM DYNAM, V37, P1575, DOI 10.1007/s00382-010-0930-z; Duchez A, 2014, J CLIMATE, V27, P6439, DOI 10.1175/JCLI-D-13-00052.1; Elipot S, 2014, J PHYS OCEANOGR, V44, P517, DOI 10.1175/JPO-D-13-026.1; Elipot S, 2013, J PHYS OCEANOGR, V43, P744, DOI 10.1175/JPO-D-12-067.1; Ezer T, 2015, GLOBAL PLANET CHANGE, V129, P23, DOI 10.1016/j.gloplacha.2015.03.002; Ezer T, 2013, GEOPHYS RES LETT, V40, P5439, DOI 10.1002/2013GL057952; Fischer J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045321; Garzoli SL, 2013, DEEP-SEA RES PT I, V71, P21, DOI 10.1016/j.dsr.2012.09.003; Goddard PB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7346; HALL MM, 1982, DEEP-SEA RES, V29, P339, DOI 10.1016/0198-0149(82)90099-1; Hawkins E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047208; Hobbs WR, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007039; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Jackson LC, 2015, CLIM DYNAM, V45, P3299, DOI 10.1007/s00382-015-2540-2; Johns WE, 2011, J CLIMATE, V24, P2429, DOI 10.1175/2010JCLI3997.1; Kanzow T, 2010, J CLIMATE, V23, P5678, DOI 10.1175/2010JCLI3389.1; Kanzow T, 2009, J PHYS OCEANOGR, V39, P3091, DOI 10.1175/2009JPO4185.1; Kanzow T, 2007, SCIENCE, V317, P938, DOI 10.1126/science.1141293; Kopp RE, 2013, GEOPHYS RES LETT, V40, P3981, DOI 10.1002/grl.50781; Kuhlbrodt T, 2007, REV GEOPHYS, V45, DOI 10.1029/2004RG000166; Levermann A, 2005, CLIM DYNAM, V24, P347, DOI 10.1007/s00382-004-0505-y; Lozier MS, 2012, ANNU REV MAR SCI, V4, P291, DOI 10.1146/annurev-marine-120710-100740; Maidens A, 2013, MON WEATHER REV, V141, P3801, DOI 10.1175/MWR-D-13-00033.1; McCarthy G, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052933; McCarthy GD, 2015, PROG OCEANOGR, V130, P91, DOI 10.1016/j.pocean.2014.10.006; McCarthy GD, 2015, NATURE, V521, P508, DOI 10.1038/nature14491; Meinen CS, 2013, J GEOPHYS RES-OCEANS, V118, P6461, DOI 10.1002/2013JC009228; Mercier H, 2015, PROG OCEANOGR, V132, P250, DOI 10.1016/j.pocean.2013.11.001; Mielke C, 2013, GEOPHYS RES LETT, V40, P1159, DOI 10.1002/grl.50233; Myhre G., 2013, CONTRIBUTION WORKING; National Research Council Committee on Abrupt Climate Change, 2002, ABR CLIM CHANG IN SU; Nghiem SV, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053611; NOAA, 2014, THE ATLANTIC HURRICA; Rahmstorf S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023655; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rahmstorf S, 2015, NAT CLIM CHANGE, V5, P475, DOI [10.1038/nclimate2554, 10.1038/NCLIMATE2554]; Rayner D, 2011, DEEP-SEA RES PT II, V58, P1744, DOI 10.1016/j.dsr2.2010.10.056; Roberts CD, 2014, GEOPHYS RES LETT, V41, P3204, DOI 10.1002/2014GL059473; Roberts CD, 2013, GEOPHYS RES LETT, V40, P5164, DOI 10.1002/grl.50930; Robson J, 2014, NAT GEOSCI, V7, P2, DOI 10.1038/ngeo2050; Rossby T, 2014, GEOPHYS RES LETT, V41, P114, DOI 10.1002/2013GL058636; Scaife AA, 2014, GEOPHYS RES LETT, V41, P2514, DOI 10.1002/2014GL059637; Send U, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049801; Smeed DA, 2014, OCEAN SCI, V10, P29, DOI 10.5194/os-10-29-2014; Srokosz M, 2012, B AM METEOROL SOC, V93, P1663, DOI 10.1175/BAMS-D-11-00151.1; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Taws SL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048978; Toole JM, 2011, DEEP-SEA RES PT II, V58, P1768, DOI 10.1016/j.dsr2.2010.10.058; Trenberth KE, 2001, J CLIMATE, V14, P3433, DOI 10.1175/1520-0442(2001)014<3433:EOMAAO>2.0.CO;2; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P911, DOI [10.1038/NCLIMATE2341, 10.1038/nclimate2341]; Valdes P, 2011, NAT GEOSCI, V4, P414, DOI 10.1038/ngeo1200; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; von Appen WJ, 2014, DEEP-SEA RES PT I, V92, P75, DOI 10.1016/j.dsr.2014.06.002; Weaver AJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053763; Willis JK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042372; Woollings T, 2012, NAT GEOSCI, V5, P313, DOI [10.1038/ngeo1438, 10.1038/NGEO1438]; Wunsch C, 2008, NAT GEOSCI, V1, P165, DOI 10.1038/ngeo126; Yin JJ, 2013, GEOPHYS RES LETT, V40, P5514, DOI 10.1002/2013GL057992; Yin JJ, 2009, NAT GEOSCI, V2, P262, DOI 10.1038/NGEO462	80	131	133	7	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241							1255575	10.1126/science.1255575	http://dx.doi.org/10.1126/science.1255575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089521	Green Accepted			2022-12-28	WOS:000356449500041
J	Akbani, R; Akdemir, KC; Aksoy, BA; Albert, M; Ally, A; Amin, SB; Arachchi, H; Arora, A; Auman, JT; Ayala, B; Baboud, J; Balasundaram, M; Balu, S; Barnabas, N; Bartlett, J; Bartlett, P; Bastian, BC; Baylin, SB; Behera, M; Belyaev, D; Benz, C; Bernard, B; Beroukhim, R; Bir, N; Black, AD; Bodenheimer, T; Boice, L; Boland, GM; Bono, R; Bootwalla, MS; Bosenberg, M; Bowen, J; Bowlby, R; Bristow, CA; Brockway-Lunardi, L; Brooks, D; Brzezinski, J; Bshara, W; Buda, E; Burns, WR; Butterfield, YSN; Button, M; Calderone, T; Cappellini, GA; Carter, C; Carter, SL; Cherney, L; Cherniack, AD; Chevalier, A; Chin, L; Cho, J; Cho, RJ; Choi, YL; Chu, A; Chudamani, S; Cibulskis, K; Ciriello, G; Clarke, A; Coons, S; Cope, L; Crain, D; Curley, E; Danilova, L; D'Atri, S; Davidsen, T; Davies, MA; Delman, KA; Demchok, JA; Deng, QA; Deribe, YL; Dhalla, N; Dhir, R; DiCara, D; Dinikin, M; Dubina, M; Ebrom, JS; Egea, S; Eley, G; Engel, J; Eschbacher, JM; Fedosenko, KV; Felau, I; Fennell, T; Ferguson, ML; Fisher, S; Flaherty, KT; Frazer, S; Frick, J; Fulidou, V; Gabriel, SB; Gao, J; Gardner, J; Garraway, LA; Gastier-Foster, JM; Gaudioso, C; Gehlenborg, N; Genovese, G; Gerken, M; Gershenwald, JE; Getz, G; Gomez-Fernandez, C; Gribbin, T; Grimsby, J; Gross, B; Guin, R; Gutschner, T; Hadjipanayis, A; Halaban, R; Hanf, B; Haussler, D; Haydu, LE; Hayes, DN; Hayward, NK; Heiman, DI; Herbert, L; Herman, JG; Hersey, P; Hoadley, KA; Hodis, E; Holt, RA; Hoon, DSB; Hoppough, S; Hoyle, AP; Huang, FW; Huang, M; Huang, S; Hutter, CM; Ibbs, M; Iype, L; Jacobsen, A; Jakrot, V; Janning, A; Jeck, WR; Jefferys, SR; Jensen, MA; Jones, CD; Jones, SJM; Ju, Z; Kakavand, H; Kang, H; Kefford, RF; Khuri, FR; Kim, J; Kirkwood, JM; Klode, J; Korkut, A; Korski, K; Krauthammer, M; Kucherlapati, R; Kwong, LN; Kycler, W; Ladanyi, M; Lai, PH; Laird, PW; Lander, E; Lawrence, MS; Lazar, AJ; Qazniak, R; Lee, D; Lee, JE; Lee, J; Lee, K; Lee, S; Lee, W; Leporowska, E; Leraas, KM; Li, HI; Lichtenberg, TM; Lichtenstein, L; Lin, P; Ling, SY; Liu, J; Liu, O; Liu, W; Long, GV; Lu, Y; Ma, S; Ma, Y; Mackiewicz, A; Mahadeshwar, HS; Malke, J; Mallery, D; Manikhas, GM; Mann, GJ; Marra, MA; Matejka, B; Mayo, M; Mehrabi, S; Meng, S; Meyerson, M; Mieczkowski, PA; Miller, JP; Miller, ML; Mills, GB; Moiseenko, F; Moore, RA; Morris, S; Morrison, C; Morton, DL; Moschos, S; Mose, LE; Muller, FL; Mungall, AJ; Murawa, D; Murawa, P; Murray, BA; Nezi, L; Ng, S; Nicholson, D; Noble, MS; Osunkoya, A; Owonikoko, TK; Ozenberger, BA; Pagani, E; Paklina, OV; Pantazi, A; Parfenov, M; Parfitt, J; Park, PJ; Park, WY; Parker, JS; Passarelli, F; Penny, R; Perou, CM; Pihl, TD; Potapova, O; Prieto, VG; Protopopov, A; Quinn, MJ; Radenbaugh, A; Rai, K; Ramalingam, SS; Raman, AT; Ramirez, NC; Ramirez, R; Rao, U; Rathmell, WK; Ren, XJ; Reynolds, SM; Roach, J; Robertson, AG; Ross, MI; Roszik, J; Russo, G; Saksena, G; Saller, C; Samuels, Y; Sander, C; Sander, C; Sandusky, G; Santoso, N; Saul, M; Saw, RPM; Schadendorf, D; Schein, JE; Schultz, N; Schumacher, SE; Schwallier, C; Scolyer, RA; Seidman, J; Sekhar, PC; Sekhon, HS; Senbabaoglu, Y; Seth, S; Shannon, KF; Sharpe, S; Sharpless, NE; Shaw, KRM; Shelton, C; Shelton, T; Shen, R; Sheth, M; Shi, Y; Shiau, CJ; Shmulevich, I; Sica, GL; Simons, JV; Sinha, R; Sipahimalani, P; Sofia, HJ; Soloway, MG; Song, XZ; Sougnez, C; Spillane, AJ; Spychaa, A; Stretch, JR; Stuart, J; Suchorska, WM; Sucker, A; Sumer, SO; Sun, YC; Synott, M; Tabak, B; Tabler, TR; Tam, A; Tan, DH; Tang, JB; Tarnuzzer, R; Tarvin, K; Tatka, H; Taylor, BS; Teresiak, M; Thiessen, N; Thompson, JF; Thorne, L; Thorsson, V; Trent, JM; Triche, TJ; Tsai, KY; Tsou, P; Van den Berg, DJ; Van Allen, EM; Veluvolu, U; Verhaak, RG; Voet, D; Voronina, O; Walter, V; Walton, JS; Wan, YH; Wang, YL; Wang, ZN; Waring, S; Watson, IR; Weinhold, N; Weinstein, JN; Weisenberger, DJ; White, P; Wilkerson, MD; Wilmott, JS; Wise, L; Wiznerowicz, M; Woodman, SE; Wu, CJ; Wu, CC; Wu, JY; Wu, Y; Xi, RB; Xu, AW; Yang, D; Yang, LM; Yang, LX; Zack, TI; Zen-Klusen, JC; Zhang, HL; Zhang, JH; Zhang, W; Zhao, XB; Zhu, JC; Zhu, K; Zimmer, L; Zmuda, E; Zou, LH				Akbani, Rehan; Akdemir, Kadir C.; Aksoy, B. Arman; Albert, Monique; Ally, Adrian; Amin, Samirkumar B.; Arachchi, Harindra; Arora, Arshi; Auman, J. Todd; Ayala, Brenda; Baboud, Julien; Balasundaram, Miruna; Balu, Saianand; Barnabas, Nandita; Bartlett, John; Bartlett, Pam; Bastian, Boris C.; Baylin, Stephen B.; Behera, Madhusmita; Belyaev, Dmitry; Benz, Christopher; Bernard, Brady; Beroukhim, Rameen; Bir, Natalie; Black, Aaron D.; Bodenheimer, Tom; Boice, Lori; Boland, Genevieve M.; Bono, Riccardo; Bootwalla, Moiz S.; Bosenberg, Marcus; Bowen, Jay; Bowlby, Reanne; Bristow, Christopher A.; Brockway-Lunardi, Laura; Brooks, Denise; Brzezinski, Jakub; Bshara, Wiam; Buda, Elizabeth; Burns, William R.; Butterfield, Yaron S. N.; Button, Michael; Calderone, Tiffany; Cappellini, Giancarlo Antonini; Carter, Candace; Carter, Scott L.; Cherney, Lynn; Cherniack, Andrew D.; Chevalier, Aaron; Chin, Lynda; Cho, Juok; Cho, Raymond J.; Choi, Yoon-La; Chu, Andy; Chudamani, Sudha; Cibulskis, Kristian; Ciriello, Giovanni; Clarke, Amanda; Coons, Stephen; Cope, Leslie; Crain, Daniel; Curley, Erin; Danilova, Ludmila; D'Atri, Stefania; Davidsen, Tanja; Davies, Michael A.; Delman, Keith A.; Demchok, John A.; Deng, Qixia A.; Deribe, Yonathan Lissanu; Dhalla, Noreen; Dhir, Rajiv; DiCara, Daniel; Dinikin, Michael; Dubina, Michael; Ebrom, J. Stephen; Egea, Sophie; Eley, Greg; Engel, Jay; Eschbacher, Jennifer M.; Fedosenko, Konstantin V.; Felau, Ina; Fennell, Timothy; Ferguson, Martin L.; Fisher, Sheila; Flaherty, Keith T.; Frazer, Scott; Frick, Jessica; Fulidou, Victoria; Gabriel, Stacey B.; Gao, Jianjiong; Gardner, Johanna; Garraway, Levi A.; Gastier-Foster, Julie M.; Gaudioso, Carmelo; Gehlenborg, Nils; Genovese, Giannicola; Gerken, Mark; Gershenwald, Jeffrey E.; Getz, Gad; Gomez-Fernandez, Carmen; Gribbin, Thomas; Grimsby, Jonna; Gross, Benjamin; Guin, Ranabir; Gutschner, Tony; Hadjipanayis, Angela; Halaban, Ruth; Hanf, Benjamin; Haussler, David; Haydu, Lauren E.; Hayes, D. Neil; Hayward, Nicholas K.; Heiman, David I.; Herbert, Lynn; Herman, James G.; Hersey, Peter; Hoadley, Katherine A.; Hodis, Eran; Holt, Robert A.; Hoon, Dave S. B.; Hoppough, Susan; Hoyle, Alan P.; Huang, Franklin W.; Huang, Mei; Huang, Sharon; Hutter, Carolyn M.; Ibbs, Matthew; Iype, Lisa; Jacobsen, Anders; Jakrot, Valerie; Janning, Alyssa; Jeck, William R.; Jefferys, Stuart R.; Jensen, Mark A.; Jones, Corbin D.; Jones, Steven J. M.; Ju, Zhenlin; Kakavand, Hojabr; Kang, Hyojin; Kefford, Richard F.; Khuri, Fadlo R.; Kim, Jaegil; Kirkwood, John M.; Klode, Joachim; Korkut, Anil; Korski, Konstanty; Krauthammer, Michael; Kucherlapati, Raju; Kwong, Lawrence N.; Kycler, Witold; Ladanyi, Marc; Lai, Phillip H.; Laird, Peter W.; Lander, Eric; Lawrence, Michael S.; Lazar, Alexander J.; Qazniak, Radoslaw; Lee, Darlene; Lee, Jeffrey E.; Lee, Junehawk; Lee, Kenneth; Lee, Semin; Lee, William; Leporowska, Ewa; Leraas, Kristen M.; Li, Haiyan I.; Lichtenberg, Tara M.; Lichtenstein, Lee; Lin, Pei; Ling, Shiyun; Liu, Jia; Liu, Ouida; Liu, Wenbin; Long, Georgina V.; Lu, Yiling; Ma, Singer; Ma, Yussanne; Mackiewicz, Andrzej; Mahadeshwar, Harshad S.; Malke, Jared; Mallery, David; Manikhas, Georgy M.; Mann, Graham J.; Marra, Marco A.; Matejka, Brenna; Mayo, Michael; Mehrabi, Sousan; Meng, Shaowu; Meyerson, Matthew; Mieczkowski, Piotr A.; Miller, John P.; Miller, Martin L.; Mills, Gordon B.; Moiseenko, Fedor; Moore, Richard A.; Morris, Scott; Morrison, Carl; Morton, Donald L.; Moschos, Stergios; Mose, Lisle E.; Muller, Florian L.; Mungall, Andrew J.; Murawa, Dawid; Murawa, Pawel; Murray, Bradley A.; Nezi, Luigi; Ng, Sam; Nicholson, Dana; Noble, Michael S.; Osunkoya, Adeboye; Owonikoko, Taofeek K.; Ozenberger, Bradley A.; Pagani, Elena; Paklina, Oxana V.; Pantazi, Angeliki; Parfenov, Michael; Parfitt, Jeremy; Park, Peter J.; Park, Woong-Yang; Parker, Joel S.; Passarelli, Francesca; Penny, Robert; Perou, Charles M.; Pihl, Todd D.; Potapova, Olga; Prieto, Victor G.; Protopopov, Alexei; Quinn, Michael J.; Radenbaugh, Amie; Rai, Kunal; Ramalingam, Suresh S.; Raman, Ayush T.; Ramirez, Nilsa C.; Ramirez, Ricardo; Rao, Uma; Rathmell, W. Kimryn; Ren, Xiaojia; Reynolds, Sheila M.; Roach, Jeffrey; Robertson, A. Gordon; Ross, Merrick I.; Roszik, Jason; Russo, Giandomenico; Saksena, Gordon; Saller, Charles; Samuels, Yardena; Sander, Chris; Sander, Cindy; Sandusky, George; Santoso, Netty; Saul, Melissa; Saw, Robyn P. M.; Schadendorf, Dirk; Schein, Jacqueline E.; Schultz, Nikolaus; Schumacher, Steven E.; Schwallier, Charles; Scolyer, Richard A.; Seidman, Jonathan; Sekhar, Pedamallu Chandra; Sekhon, Harmanjatinder S.; Senbabaoglu, Yasin; Seth, Sahil; Shannon, Kerwin F.; Sharpe, Samantha; Sharpless, Norman E.; Shaw, Kenna R. Mills; Shelton, Candace; Shelton, Troy; Shen, Ronglai; Sheth, Margi; Shi, Yan; Shiau, Carolyn J.; Shmulevich, Ilya; Sica, Gabriel L.; Simons, Janae V.; Sinha, Rileen; Sipahimalani, Payal; Sofia, Heidi J.; Soloway, Matthew G.; Song, Xingzhi; Sougnez, Carrie; Spillane, Andrew J.; Spychaa, Arkadiusz; Stretch, Jonathan R.; Stuart, Joshua; Suchorska, Wiktoria M.; Sucker, Antje; Sumer, S. Onur; Sun, Yichao; Synott, Maria; Tabak, Barbara; Tabler, Teresa R.; Tam, Angela; Tan, Donghui; Tang, Jiabin; Tarnuzzer, Roy; Tarvin, Katherine; Tatka, Honorata; Taylor, Barry S.; Teresiak, Marek; Thiessen, Nina; Thompson, John F.; Thorne, Leigh; Thorsson, Vesteinn; Trent, Jeffrey M.; Triche, Timothy J., Jr.; Tsai, Kenneth Y.; Tsou, Peiling; Van den Berg, David J.; Van Allen, Eliezer M.; Veluvolu, Umadevi; Verhaak, Roeland G.; Voet, Douglas; Voronina, Olga; Walter, Vonn; Walton, Jessica S.; Wan, Yunhu; Wang, Yuling; Wang, Zhining; Waring, Scot; Watson, Ian R.; Weinhold, Nils; Weinstein, John N.; Weisenberger, Daniel J.; White, Peter; Wilkerson, Matthew D.; Wilmott, James S.; Wise, Lisa; Wiznerowicz, Maciej; Woodman, Scott E.; Wu, Chang-Jiun; Wu, Chia-Chin; Wu, Junyuan; Wu, Ye; Xi, Ruibin; Xu, Andrew Wei; Yang, Da; Yang, Liming; Yang, Lixing; Zack, Travis I.; Zen-Klusen, Jean C.; Zhang, Hailei; Zhang, Jianhua; Zhang, Wei; Zhao, Xiaobei; Zhu, Jingchun; Zhu, Kelsey; Zimmer, Lisa; Zmuda, Erik; Zou, Lihua		Canc Genome Atlas Network	Genomic Classification of Cutaneous Melanoma	CELL			English	Article							TERT PROMOTER MUTATIONS; STAGE-III MELANOMA; METASTATIC MELANOMA; ADJUVANT THERAPY; RAF INHIBITION; NODE BIOPSY; CANCER; RESISTANCE; LANDSCAPE; SAFETY	We describe the landscape of genomic alterations in cutaneous melanomas through DNA, RNA, and protein-based analysis of 333 primary and/or metastatic melanomas from 331 patients. We establish a framework for genomic classification into one of four sub-types based on the pattern of the most prevalent significantly mutated genes: mutant BRAF, mutant RAS, mutant NF1, and Triple-WT (wild-type). Integrative analysis reveals enrichment of KIT mutations and focal amplifications and complex structural rearrangements as a feature of the Triple-WT subtype. We found no significant outcome correlation with genomic classification, but samples assigned a transcriptomic subclass enriched for immune gene expression associated with lymphocyte infiltrate on pathology review and high LCK protein expression, a T cell marker, were associated with improved patient survival. This clinicopathological and multidimensional analysis suggests that the prognosis of melanoma patients with regional metastases is influenced by tumor stroma immunobiology, offering insights to further personalize therapeutic decision-making.	NCI, Canc Genome Atlas Program Off, NIH, Bethesda, MD 20892 USA; [Akbani, Rehan; Akdemir, Kadir C.; Aksoy, B. Arman; Albert, Monique; Ally, Adrian; Amin, Samirkumar B.; Arachchi, Harindra; Arora, Arshi; Auman, J. Todd; Ayala, Brenda; Baboud, Julien; Balasundaram, Miruna; Balu, Saianand; Barnabas, Nandita; Bartlett, John; Bartlett, Pam; Bastian, Boris C.; Baylin, Stephen B.; Behera, Madhusmita; Belyaev, Dmitry; Benz, Christopher; Bernard, Brady; Beroukhim, Rameen; Bir, Natalie; Black, Aaron D.; Bodenheimer, Tom; Boice, Lori; Boland, Genevieve M.; Bono, Riccardo; Bootwalla, Moiz S.; Bosenberg, Marcus; Bowen, Jay; Bowlby, Reanne; Bristow, Christopher A.; Brockway-Lunardi, Laura; Brooks, Denise; Brzezinski, Jakub; Bshara, Wiam; Buda, Elizabeth; Burns, William R.; Butterfield, Yaron S. N.; Button, Michael; Calderone, Tiffany; Cappellini, Giancarlo Antonini; Carter, Candace; Carter, Scott L.; Cherney, Lynn; Cherniack, Andrew D.; Chevalier, Aaron; Chin, Lynda; Cho, Juok; Cho, Raymond J.; Choi, Yoon-La; Chu, Andy; Chudamani, Sudha; Cibulskis, Kristian; Ciriello, Giovanni; Clarke, Amanda; Coons, Stephen; Cope, Leslie; Crain, Daniel; Curley, Erin; Danilova, Ludmila; D'Atri, Stefania; Davidsen, Tanja; Davies, Michael A.; Delman, Keith A.; Demchok, John A.; Deng, Qixia A.; Deribe, Yonathan Lissanu; Dhalla, Noreen; Dhir, Rajiv; DiCara, Daniel; Dinikin, Michael; Dubina, Michael; Ebrom, J. Stephen; Egea, Sophie; Eley, Greg; Engel, Jay; Eschbacher, Jennifer M.; Fedosenko, Konstantin V.; Felau, Ina; Fennell, Timothy; Ferguson, Martin L.; Fisher, Sheila; Flaherty, Keith T.; Frazer, Scott; Frick, Jessica; Fulidou, Victoria; Gabriel, Stacey B.; Gao, Jianjiong; Gardner, Johanna; Garraway, Levi A.; Gastier-Foster, Julie M.; Gaudioso, Carmelo; Gehlenborg, Nils; Genovese, Giannicola; Gerken, Mark; Gershenwald, Jeffrey E.; Getz, Gad; Gomez-Fernandez, Carmen; Gribbin, Thomas; Grimsby, Jonna; Gross, Benjamin; Guin, Ranabir; Gutschner, Tony; Hadjipanayis, Angela; Halaban, Ruth; Hanf, Benjamin; Haussler, David; Haydu, Lauren E.; Hayes, D. Neil; Hayward, Nicholas K.; Heiman, David I.; Herbert, Lynn; Herman, James G.; Hersey, Peter; Hoadley, Katherine A.; Hodis, Eran; Holt, Robert A.; Hoon, Dave S. B.; Hoppough, Susan; Hoyle, Alan P.; Huang, Franklin W.; Huang, Mei; Huang, Sharon; Hutter, Carolyn M.; Ibbs, Matthew; Iype, Lisa; Jacobsen, Anders; Jakrot, Valerie; Janning, Alyssa; Jeck, William R.; Jefferys, Stuart R.; Jensen, Mark A.; Jones, Corbin D.; Jones, Steven J. M.; Ju, Zhenlin; Kakavand, Hojabr; Kang, Hyojin; Kefford, Richard F.; Khuri, Fadlo R.; Kim, Jaegil; Kirkwood, John M.; Klode, Joachim; Korkut, Anil; Korski, Konstanty; Krauthammer, Michael; Kucherlapati, Raju; Kwong, Lawrence N.; Kycler, Witold; Ladanyi, Marc; Lai, Phillip H.; Laird, Peter W.; Lander, Eric; Lawrence, Michael S.; Lazar, Alexander J.; Qazniak, Radoslaw; Lee, Darlene; Lee, Jeffrey E.; Lee, Junehawk; Lee, Kenneth; Lee, Semin; Lee, William; Leporowska, Ewa; Leraas, Kristen M.; Li, Haiyan I.; Lichtenberg, Tara M.; Lichtenstein, Lee; Lin, Pei; Ling, Shiyun; Liu, Jia; Liu, Ouida; Liu, Wenbin; Long, Georgina V.; Lu, Yiling; Ma, Singer; Ma, Yussanne; Mackiewicz, Andrzej; Mahadeshwar, Harshad S.; Malke, Jared; Mallery, David; Manikhas, Georgy M.; Mann, Graham J.; Marra, Marco A.; Matejka, Brenna; Mayo, Michael; Mehrabi, Sousan; Meng, Shaowu; Meyerson, Matthew; Mieczkowski, Piotr A.; Miller, John P.; Miller, Martin L.; Mills, Gordon B.; Moiseenko, Fedor; Moore, Richard A.; Morris, Scott; Morrison, Carl; Morton, Donald L.; Moschos, Stergios; Mose, Lisle E.; Muller, Florian L.; Mungall, Andrew J.; Murawa, Dawid; Murawa, Pawel; Murray, Bradley A.; Nezi, Luigi; Ng, Sam; Nicholson, Dana; Noble, Michael S.; Osunkoya, Adeboye; Owonikoko, Taofeek K.; Ozenberger, Bradley A.; Pagani, Elena; Paklina, Oxana V.; Pantazi, Angeliki; Parfenov, Michael; Parfitt, Jeremy; Park, Peter J.; Park, Woong-Yang; Parker, Joel S.; Passarelli, Francesca; Penny, Robert; Perou, Charles M.; Pihl, Todd D.; Potapova, Olga; Prieto, Victor G.; Protopopov, Alexei; Quinn, Michael J.; Radenbaugh, Amie; Rai, Kunal; Ramalingam, Suresh S.; Raman, Ayush T.; Ramirez, Nilsa C.; Ramirez, Ricardo; Rao, Uma; Rathmell, W. Kimryn; Ren, Xiaojia; Reynolds, Sheila M.; Roach, Jeffrey; Robertson, A. Gordon; Ross, Merrick I.; Roszik, Jason; Russo, Giandomenico; Saksena, Gordon; Saller, Charles; Samuels, Yardena; Sander, Chris; Sander, Cindy; Sandusky, George; Santoso, Netty; Saul, Melissa; Saw, Robyn P. M.; Schadendorf, Dirk; Schein, Jacqueline E.; Schultz, Nikolaus; Schumacher, Steven E.; Schwallier, Charles; Scolyer, Richard A.; Seidman, Jonathan; Sekhar, Pedamallu Chandra; Sekhon, Harmanjatinder S.; Senbabaoglu, Yasin; Seth, Sahil; Shannon, Kerwin F.; Sharpe, Samantha; Sharpless, Norman E.; Shaw, Kenna R. Mills; Shelton, Candace; Shelton, Troy; Shen, Ronglai; Sheth, Margi; Shi, Yan; Shiau, Carolyn J.; Shmulevich, Ilya; Sica, Gabriel L.; Simons, Janae V.; Sinha, Rileen; Sipahimalani, Payal; Sofia, Heidi J.; Soloway, Matthew G.; Song, Xingzhi; Sougnez, Carrie; Spillane, Andrew J.; Spychaa, Arkadiusz; Stretch, Jonathan R.; Stuart, Joshua; Suchorska, Wiktoria M.; Sucker, Antje; Sumer, S. Onur; Sun, Yichao; Synott, Maria; Tabak, Barbara; Tabler, Teresa R.; Tam, Angela; Tan, Donghui; Tang, Jiabin; Tarnuzzer, Roy; Tarvin, Katherine; Tatka, Honorata; Taylor, Barry S.; Teresiak, Marek; Thiessen, Nina; Thompson, John F.; Thorne, Leigh; Thorsson, Vesteinn; Trent, Jeffrey M.; Triche, Timothy J., Jr.; Tsai, Kenneth Y.; Tsou, Peiling; Van den Berg, David J.; Van Allen, Eliezer M.; Veluvolu, Umadevi; Verhaak, Roeland G.; Voet, Douglas; Voronina, Olga; Walter, Vonn; Walton, Jessica S.; Wan, Yunhu; Wang, Yuling; Wang, Zhining; Waring, Scot; Watson, Ian R.; Weinhold, Nils; Weinstein, John N.; Weisenberger, Daniel J.; White, Peter; Wilkerson, Matthew D.; Wilmott, James S.; Wise, Lisa; Wiznerowicz, Maciej; Woodman, Scott E.; Wu, Chang-Jiun; Wu, Chia-Chin; Wu, Junyuan; Wu, Ye; Xi, Ruibin; Xu, Andrew Wei; Yang, Da; Yang, Liming; Yang, Lixing; Zack, Travis I.; Zen-Klusen, Jean C.; Zhang, Hailei; Zhang, Jianhua; Zhang, Wei; Zhao, Xiaobei; Zhu, Jingchun; Zhu, Kelsey; Zimmer, Lisa; Zmuda, Erik; Zou, Lihua; Canc Genome Atlas Network] NCI, Canc Genome Atlas Program Off, NIH, Bethesda, MD 20892 USA	International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Watson, IR (corresponding author), NCI, Canc Genome Atlas Program Off, NIH, 31 Ctr Dr,Bldg 31,Suite 3A20, Bethesda, MD 20892 USA.	lchin@mdanderson.org; jgershen@mdanderson.org; irwatson@mdanderson.org	Gao, JianJiong/B-5673-2016; Akbani, Rehan/AAG-1490-2019; Kucherlapati, Raju/ABC-8807-2021; Zimmer, Lisa/AAP-8495-2021; Lazar, Alexander J/A-3416-2008; Schultz, Nikolaus/ABE-6347-2020; Ladanyi, Marc/AAG-8585-2019; Marra, Marco A/B-5987-2008; Parker, Joel/AAG-1108-2019; Moiseenko, Fedor/E-1775-2014; Boland, Genevieve/AAP-2767-2021; Mungall, Andrew J./U-7067-2018; hayward, nick/AAV-8802-2020; Davies, Michael/GWV-2527-2022; Gershenwald, Jeff/AAX-4367-2020; Jakrot, Valerie/AAH-2291-2019; Holt, Robert A/C-3303-2009; Gutschner, Tony/I-3944-2019; Shannon, Kerwin/AAP-8209-2021; Schein, Jacquie E/G-3674-2015; Ramalingam, Suresh/AAV-7478-2020; Walter, Vonn/AAI-3450-2021; Skanderup, Anders Jacobsen/K-1081-2013; Amin, Samirkumar B/H-3184-2019; Hoon, Dave SB/C-7146-2018; Ibbs, Matthew/AAU-1511-2021; Cherniack, Andrew/AAC-5310-2019; Wu, Chia-Chin/ABD-5516-2021; Dubina, Michael/E-1888-2014; Raman, Ayush/AAR-6165-2021; Lee, Semin/S-2629-2016; Suchorska, Wiktoria/CAG-0479-2022; White, Peter/E-4301-2011; D'Atri, Stefania/K-6039-2016; Scolyer, Richard/AAE-8511-2019; Wilmott, James/AGA-8227-2022; Khuri, Fadlo R./AAU-4942-2020; Long, Georgina V/C-1771-2013; Perou, Charles M/H-9934-2014; Cibulskis, Kristian/AAC-7380-2019; Weisenberger, Daniel/AAA-8314-2020; Nezi, Luigi/AAB-1957-2019; Seth, Sahil/I-5809-2019; Cho, Raymond/AAO-8125-2020; Cherniack, Andrew D./AAY-8132-2020; Van Den Berg, David J/G-8598-2017; Schadendorf, Dirk/AAE-8206-2019; Verhaak, Roel/ABE-7058-2020; wang, edwin/G-5372-2010; Jones, Steven J/C-3621-2009; Russo, Giandomenico/K-9566-2016; Miller, John J/GZG-5663-2022; hayward, nicholas k/C-1367-2015; Laird, Peter W/G-8683-2012; Lawrence, Michael/AAC-8202-2020; Mann, Graham/G-4758-2014	Gao, JianJiong/0000-0002-5739-1781; Zimmer, Lisa/0000-0002-3680-3521; Lazar, Alexander J/0000-0002-6395-4499; Marra, Marco A/0000-0001-7146-7175; Moiseenko, Fedor/0000-0003-2544-9042; Mungall, Andrew J./0000-0002-0905-2742; Gershenwald, Jeff/0000-0003-4519-5369; Holt, Robert A/0000-0002-7259-1247; Gutschner, Tony/0000-0002-1722-3134; Walter, Vonn/0000-0001-6114-6714; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Amin, Samirkumar B/0000-0002-3207-9505; Hoon, Dave SB/0000-0003-1915-3683; Ibbs, Matthew/0000-0003-2510-3447; Wu, Chia-Chin/0000-0002-5208-6016; Dubina, Michael/0000-0002-6606-3309; Raman, Ayush/0000-0003-2872-2307; Lee, Semin/0000-0002-9015-6046; White, Peter/0000-0002-5218-5903; Scolyer, Richard/0000-0002-8991-0013; Wilmott, James/0000-0002-6750-5244; Khuri, Fadlo R./0000-0002-8638-7618; Long, Georgina V/0000-0001-8894-3545; Perou, Charles M/0000-0001-9827-2247; Weisenberger, Daniel/0000-0001-8303-2603; Nezi, Luigi/0000-0002-4670-7656; Seth, Sahil/0000-0003-4579-3959; Cho, Raymond/0000-0001-6090-6603; Cherniack, Andrew D./0000-0003-0470-0111; Van Den Berg, David J/0000-0002-5404-5218; Jones, Steven J/0000-0003-3394-2208; Russo, Giandomenico/0000-0002-7718-9687; hayward, nicholas k/0000-0003-4760-1033; Laird, Peter W/0000-0001-9117-3641; Lee, Junehawk/0000-0001-8908-0884; Park, Peter/0000-0001-9378-960X; Miller, Martin L/0000-0003-3161-8690; Rai, Kunal/0000-0003-2321-6894; Weinstein, John/0000-0001-9401-6908; Mann, Graham/0000-0003-1301-405X; Suchorska, Wiktoria/0000-0003-4742-2465; Jensen, Mark/0000-0001-5215-101X; Bootwalla, Moiz/0000-0001-6158-7114; Paklina, Oxana/0000-0001-6373-1888; Tsai, Kenneth/0000-0001-5325-212X; Jakrot, Valerie/0000-0002-8578-5964; Ciriello, Giovanni/0000-0003-2021-8683; Yang, Da/0000-0002-8336-9457; Thompson, John/0000-0002-2816-2496; Sharpless, Norman/0000-0001-7078-9455; Klode, joachim/0000-0001-9239-7014; Roszik, Jason/0000-0002-4561-6170; Heiman, David/0000-0001-7895-4259; Krauthammer, Michael/0000-0002-4808-1845; Auman, James/0000-0002-9328-8829; Samuels, Yardena/0000-0002-3349-7266; Bowen, Jay/0000-0001-6861-9043; Hoadley, Katherine/0000-0002-1216-477X; Xi, Ruibin/0000-0001-7545-7361; Park, Woong-Yang/0000-0003-4234-0380; Stuart, Joshua/0000-0002-2171-565X; Meyerson, Matthew/0000-0002-9133-8108; Shannon, Kerwin/0000-0001-8538-3132; Kakavand, Hojabr/0000-0002-3458-7853; Kefford, Richard/0000-0001-9251-9229; Muller, Florian/0000-0001-7568-2948; Mieczkowski, Piotr/0000-0003-2418-0096; Bastian, Boris/0000-0003-1836-6062; Sinha, Rileen/0000-0001-5497-5055; Tarnuzzer, Roy/0000-0002-3725-4173; Genovese, Giannicola/0000-0003-1392-9954; Gehlenborg, Nils/0000-0003-0327-8297; Cibulskis, Kristian/0000-0003-1343-1582; D'Atri, Stefania/0000-0001-9852-7377; Saul, Melissa/0000-0002-6712-5102; Triche, Tim/0000-0001-5665-946X; Watson, Ian/0000-0002-6025-3080	NIH [U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, P30 CA016672]; Bayer AG; Novartis; Zymo Research; NATIONAL CANCER INSTITUTE [P50CA121974, U24CA143882, U24CA143866, U24CA144025, U24CA143883, U24CA143799, U24CA143848, U24CA143835, U24CA143840, P30CA016672, R01CA163896, U24CA180951, U24CA143858, U24CA143845, U24CA143867, U24CA143843] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003273, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; Versus Arthritis [21141] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer AG(Bayer AG); Novartis(Novartis); Zymo Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Versus Arthritis(Versus Arthritis)	We thank all patients and families who contributed to this study. We are grateful to Chris Gunter for manuscript editing and Ina Felau and Margi Sheth for project management. This article is dedicated to the memory of Donald L. Morton, M.D., a pioneer in melanoma oncology, who passed away on January 10, 2014. This study was supported by NIH grants: U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, and P30 CA016672.; A.D.C. and M.M. receive research funding from Bayer AG. M.M. is a founder of, equity holder in, and consultant for Foundation Medicine, a next-generation sequencing-based cancer diagnostics company. L.A.G. received a commercial research grant from Novartis and is a consultant/advisory board member for Novartis, Foundation Medicine, and Boehringer Ingelheim. L.A.G. also has equity interest in Foundation Medicine. D.J.W. is a consultant for Zymo Research Corporation, which distributes commercially available products for DNA methylation-based experiments. Zymo Research neither supported this work nor has an interest in the outcome of this research. O.P and O.V. are co-founders and shareholders of Cureline, Inc., which received a contract payment from the NIH for this work. J.E.G. is an advisory board member for Merck.	ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; Ascierto PA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-116; Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Baade P, 2012, INT J CANCER, V130, P170, DOI 10.1002/ijc.25996; Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Criscione VD, 2010, J INVEST DERMATOL, V130, P793, DOI 10.1038/jid.2009.328; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; DRAPER GJ, 1986, BRIT J CANCER, V53, P661, DOI 10.1038/bjc.1986.110; Dutton-Regester K, 2014, ONCOTARGET, V5, P2912, DOI 10.18632/oncotarget.2048; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; Field MG, 2014, CURR OPIN OPHTHALMOL, V25, P234, DOI 10.1097/ICU.0000000000000051; Frederick DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101286; Gershenwald JE, 2011, NEW ENGL J MED, V364, P1738, DOI 10.1056/NEJMct1002967; Gold HL, 2014, MOL CANCER RES, V12, P433, DOI 10.1158/1541-7786.MCR-13-0422; GUPTA TD, 1963, SURG GYNECOL OBSTET, V117, P341; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jayaraman SS, 2014, J INVEST DERMATOL, V134, P213, DOI 10.1038/jid.2013.276; Ji ZY, 2013, CLIN CANCER RES, V19, P4383, DOI 10.1158/1078-0432.CCR-13-0074; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kusters-Vandevelde HVN, 2010, ACTA NEUROPATHOL, V119, P317, DOI 10.1007/s00401-009-0611-3; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lopez GY, 2010, BIOCHEM BIOPH RES CO, V398, P585, DOI 10.1016/j.bbrc.2010.06.125; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; Maertens O, 2013, CANCER DISCOV, V3, P338, DOI 10.1158/2159-8290.CD-12-0313; Mann GJ, 2013, J INVEST DERMATOL, V133, P509, DOI 10.1038/jid.2012.283; McArthur GA, 2013, J CLIN ONCOL, V31, P499, DOI 10.1200/JCO.2012.45.5568; Mihm MC, 1996, LAB INVEST, V74, P43; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Nissan MH, 2014, CANCER RES, V74, P2340, DOI 10.1158/0008-5472.CAN-13-2625; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Rakosy Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054958; Ranzani M, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12316; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; SantaCruz DJ, 1997, J CUTAN PATHOL, V24, P533, DOI 10.1111/j.1600-0560.1997.tb01457.x; Shields JM, 2007, CANCER RES, V67, P1502, DOI 10.1158/0008-5472.CAN-06-3311; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sun DQ, 2014, J MED CHEM, V57, P1454, DOI 10.1021/jm401753e; Terheyden P, 2010, J INVEST DERMATOL, V130, P314, DOI 10.1038/jid.2009.197; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Watson IR, 2014, CANCER RES, V74, P4845, DOI 10.1158/0008-5472.CAN-14-1232-T; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103	68	1718	1743	7	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1681	1696		10.1016/j.cell.2015.05.044	http://dx.doi.org/10.1016/j.cell.2015.05.044			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091043	Green Accepted, Bronze			2022-12-28	WOS:000356618200023
J	Sinha, SS; Eagle, KA				Sinha, Shashank S.; Eagle, Kim A.			Noncardiac surgery <= 2 y after coronary stent placement was linked to perioperative MI and all-cause mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sinha, Shashank S.; Eagle, Kim A.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sinha, SS (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Alshawabkeh LI, 2011, HELL J CARDIOL, V52, P141; Gandhi NK, 2011, CATHETER CARDIO INTE, V77, P972, DOI 10.1002/ccd.22744; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC11	10.7326/ACPJC-2015-162-12-011	http://dx.doi.org/10.7326/ACPJC-2015-162-12-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075776				2022-12-28	WOS:000356516300012
J	Helliwell, P; Coates, L				Helliwell, Philip; Coates, Laura			Interleukin-17 inhibition in psoriatic arthritis	LANCET			English	Editorial Material							TRIAL		[Helliwell, Philip; Coates, Laura] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Chapel Allerton Hosp, Leeds LS7 4SA, W Yorkshire, England	Chapel Allerton Hospital; University of Leeds	Helliwell, P (corresponding author), Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Chapel Allerton Hosp, Leeds LS7 4SA, W Yorkshire, England.	p.helliwell@leeds.ac.uk			National Institute for Health Research [CL-2011-02-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Coates LC, 2013, ARTHRITIS RHEUM-US, V65, pS346; Griffiths C. E., 2015, LANCET; Kavanaugh AF, 2006, J RHEUMATOL, V33, P1417; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; McInnes IB, 2015, LANCET; MEASE P, 2014, ARTHRITIS RHEUMA S10, V66, pS423; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Ritchlin CT, 2009, ANN RHEUM DIS, V68, P1387, DOI 10.1136/ard.2008.094946; Ritchlin C, 2014, ANN RHEUM DIS, V73, P990, DOI 10.1136/annrheumdis-2013-204655; ROBERTS MET, 1976, ANN RHEUM DIS, V35, P206, DOI 10.1136/ard.35.3.206; Saad AA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2670; Sokoll KB, 2001, J RHEUMATOL, V28, P1842	12	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1114	1116		10.1016/S0140-6736(15)61170-9	http://dx.doi.org/10.1016/S0140-6736(15)61170-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5GE	26135705				2022-12-28	WOS:000361368000009
J	Gonzales, G				Gonzales, Gilbert			Association of the New York State Marriage Equality Act With Changes in Health Insurance Coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Gonzales, G (corresponding author), Univ Minnesota, Div Hlth Policy & Management, 2221 Univ Ave SE, Minneapolis, MN 55455 USA.	gonza440@umn.edu						Buchmueller TC, 2012, J POLICY ANAL MANAG, V31, P388, DOI 10.1002/pam.21603; DeSilver D, MANY SAME SEX MARRIA; Gonzales G, 2014, AM J PUBLIC HEALTH, V104, pE95, DOI 10.2105/AJPH.2013.301577; Lofquist D, SAME SEX COUPLE HOUS; United States Census Bureau, AM COMM SURV DES MET	5	11	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					727	728		10.1001/jama.2015.7950	http://dx.doi.org/10.1001/jama.2015.7950			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26115522	Bronze			2022-12-28	WOS:000360019100023
J	Pfender, S; Kuznetsov, V; Pasternak, M; Tischer, T; Santhanam, B; Schuh, M				Pfender, Sybille; Kuznetsov, Vitaliy; Pasternak, Michal; Tischer, Thomas; Santhanam, Balaji; Schuh, Melina			Live imaging RNAi screen reveals genes essential for meiosis in mammalian oocytes	NATURE			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; ENCLOSED MOUSE OOCYTES; GREATWALL KINASE; IN-VITRO; ANEUPLOIDY; CELLS; FERTILIZATION; KINETOCHORES; INSIGHTS; ANAPHASE	During fertilization, an egg and a sperm fuse to form a new embryo. Eggs develop from oocytes in a process called meiosis. Meiosis inhuman oocytes is highly error-prone(1,2), and defective eggs are the leading cause of pregnancy loss and several genetic disorders such as Down's syndrome(3-5). Which genes safeguard accurate progression through meiosis is largely unclear. Here we develop high-content phenotypic screening methods for the systematic identification of mammalian meiotic genes. We targeted 774 genes by RNA interference within follicle-enclosed mouse oocytes to block protein expression from an early stage of oocyte development onwards. We then analysed the function of several genes simultaneously by high-resolution imaging of chromosomes and microtubules in live oocytes and scored each oocyte quantitatively for 50 phenotypes, generating a comprehensive resource of meiotic gene function. The screen generated an unprecedented annotated data set of meiotic progression in 2,241 mammalian oocytes, which allowed us to analyse systematically which defects are linked to abnormal chromosome segregation during meiosis, identifying progression into anaphase with misaligned chromosomes as well as defects in spindle organization as risk factors. This study demonstrates how high-content screens can be performed in oocytes, and allows systematic studies of meiosis in mammals.	[Pfender, Sybille; Kuznetsov, Vitaliy; Pasternak, Michal; Tischer, Thomas; Santhanam, Balaji; Schuh, Melina] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Schuh, M (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	mschuh@mrc-lmb.cam.ac.uk		Tischer, Thomas/0000-0002-6845-2762; Pasternak, Michal/0000-0001-5407-4273	Boehringer-Ingelheim Fonds; EMBO [ALTF700-2014]; European Research Council [337415]; European Community [241548]; Medical Research Council [MC_U105185859, MC_U105192711, 1274326] Funding Source: researchfish; MRC [MC_U105185859, MC_U105192711] Funding Source: UKRI	Boehringer-Ingelheim Fonds(Boehringer Ingelheim); EMBO(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff of the MRC Laboratory of Molecular Biology's Animal and Microscopy Facilities for technical assistance; J. Ellenberg, L. Jaffe and M. Freudzon for technical advice on culturing siRNA-injected follicles in vitro; J. Ellenberg and M. Madan Babu for discussions; G. Chalancon for help with data analyses; E. Voets for the Mastl construct; and members of the Schuh laboratory and S. Munro for comments on the manuscript. S.P. and M.P. received PhD fellowships from Boehringer-Ingelheim Fonds. T.T. is supported by an EMBO Long Term Fellowship (ALTF700-2014). The research leading to these results has received financial support from the European Research Council under grant agreement no. 337415 and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 241548.	Adhikari D, 2014, J CELL BIOL, V206, P843, DOI 10.1083/jcb.201406033; Alvarez-Fernandez M, 2013, P NATL ACAD SCI USA, V110, P17374, DOI 10.1073/pnas.1310745110; BLEIL JD, 1980, P NATL ACAD SCI-BIOL, V77, P1029, DOI 10.1073/pnas.77.2.1029; Brar GA, 2008, NAT REV GENET, V9, P899, DOI 10.1038/nrg2454; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; EPPIG JJ, 1989, BIOL REPROD, V41, P268, DOI 10.1095/biolreprod41.2.268; Fragouli E, 2011, MOL HUM REPROD, V17, P286, DOI 10.1093/molehr/gar024; Ge L, 2008, MOL REPROD DEV, V75, P136, DOI 10.1002/mrd.20753; Griffin Jeanine, 2006, J Exp Clin Assist Reprod, V3, P2, DOI 10.1186/1743-1050-3-2; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Jaffe Laurinda A., 2009, V518, P157, DOI 10.1007/978-1-59745-202-1_12; Jiang ZZ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.126; Jones KT, 2013, DEVELOPMENT, V140, P3719, DOI 10.1242/dev.090589; Kasippillai T, 2013, J CLIN ENDOCR METAB, V98, pE1534, DOI 10.1210/jc.2013-1102; Kuliev A, 2011, REPROD BIOMED ONLINE, V22, P2, DOI 10.1016/j.rbmo.2010.08.014; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; Mehlmann LM, 2005, DEV BIOL, V288, P397, DOI 10.1016/j.ydbio.2005.09.030; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Wang P, 2013, J CELL BIOL, V202, P277, DOI 10.1083/jcb.201211141; Xu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049303; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhou P, 2010, BIOL REPROD, V82, P759, DOI 10.1095/biolreprod.109.082206	30	56	57	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					239	+		10.1038/nature14568	http://dx.doi.org/10.1038/nature14568			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26147080	Green Submitted, Green Accepted			2022-12-28	WOS:000359386900036
J	Morone, F; Makse, HA				Morone, Flaviano; Makse, Hernan A.			Influence maximization in complex networks through optimal percolation	NATURE			English	Article								The whole frame of interconnections in complex networks hinges on a specific set of structural nodes, much smaller than the total size, which, if activated, would cause the spread of information to the whole network(1), or, if immunized, would prevent the diffusion of a large scale epidemic(2,3). Localizing this optimal, that is, minimal, set of structural nodes, called influencers, is one of the most important problems in network science(4,5). Despite the vast use of heuristic strategies to identify influential spreaders(6-14), the problem remains unsolved. Here we map the problem onto optimal percolation in random networks to identify the minimal set of influencers, which arises by minimizing the energy of a many-body system, where the form of the interactions is fixed by the non-backtracking matrix(15) of the network. Big data analyses reveal that the set of optimal influencers is much smaller than the one predicted by previous heuristic centralities. Remarkably, a large number of previously neglected weakly connected nodes emerges among the optimal influencers. These are topologically tagged as low-degree nodes surrounded by hierarchical coronas of hubs, and are uncovered only through the optimal collective interplay of all the influencers in the network. The present theoretical framework may hold a larger degree of universality, being applicable to other hard optimization problems exhibiting a continuous transition from a known phase(16).	[Morone, Flaviano; Makse, Hernan A.] CUNY City Coll, Levich Inst, New York, NY 10031 USA; [Morone, Flaviano; Makse, Hernan A.] CUNY City Coll, Dept Phys, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY)	Makse, HA (corresponding author), CUNY City Coll, Levich Inst, New York, NY 10031 USA.	hmakse@lev.ccny.cuny.edu			NIH-NIGMS [1R21GM107641]; NSF-PoLS [PHY-1305476]; ARL; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM107641] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF-PoLS; ARL(United States Department of DefenseUS Army Research Laboratory (ARL)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH-NIGMS 1R21GM107641 and NSF-PoLS PHY-1305476. Additional support was provided by ARL. We thank L. Bo, S. Havlin and R. Mari for discussions and Grandata for providing the data on mobile phone calls.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Altarelli F, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021024; Altarelli F, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/09/P09011; Angel O, 2015, T AM MATH SOC, V367, P4287; Boettcher S, 2001, PHYS REV LETT, V86, P5211, DOI 10.1103/PhysRevLett.86.5211; Bollobas B., 2006, PERCOLATION; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chen YP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058701; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Coja-Oghlan A, 2009, COMB PROBAB COMPUT, V18, P881, DOI 10.1017/S096354830900981X; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hashimoto K., 1989, ADV STUD PURE MATH, V15, P211, DOI DOI 10.1016/B978-0-12-330580-0.50015-X; Kempe D., 2003, P 9 ACM SIGKDD INT C, P137, DOI DOI 10.1145/956750.956769; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/NPHYS1746, 10.1038/nphys1746]; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Krzakala F, 2013, P NATL ACAD SCI USA, V110, P20935, DOI 10.1073/pnas.1312486110; Mezard M, 2003, J STAT PHYS, V111, P1, DOI 10.1023/A:1022221005097; Newman MEJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042822; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pei S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05547; Pei S, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12002; Radicchi F, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.010801; Richardson M., 2002, P 8 ACM SIGKDD INT C, P61, DOI DOI 10.1145/775047.775057; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	30	610	635	24	361	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					65	U122		10.1038/nature14604	http://dx.doi.org/10.1038/nature14604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26131931	Green Submitted			2022-12-28	WOS:000359002300032
J	Avorn, J				Avorn, Jerry			In Opposition to Liberty: We Need a "Sovereign" to Govern Drug Claims	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA USA; [Avorn, Jerry] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	avorn@post.harvard.edu						Avorn J., 2013, NY TIMES, pA27; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Clarke T, 2015, FDA TO HOLD PUBLIC M; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hobbes T., 1651, LEVIATHAN; Kesselheim AS, 2015, N ENGL J MED	7	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					229	+		10.7326/M15-1429	http://dx.doi.org/10.7326/M15-1429			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO6EX	26121615				2022-12-28	WOS:000359251100013
J	Sterling, AC; Moore, RL; Falconer, DA; Adams, M				Sterling, Alphonse C.; Moore, Ronald L.; Falconer, David A.; Adams, Mitzi			Small-scale filament eruptions as the driver of X-ray jets in solar coronal holes	NATURE			English	Article							MASS EJECTIONS; FLUX EMERGENCE; BLOWOUT JET; QUIET SUN; MAGNETIC RECONNECTION; BRIGHT POINTS; ALFVEN WAVES; HOT-PLASMA; FLARES; HINODE	Solar X-ray jets are thought to be made by a burst of reconnection of closed magnetic field at the base of a jet with ambient open field(1,2). In the accepted version of the 'emerging-flux' model, such a reconnection occurs at a plasma current sheet between the open field and the emerging closed field, and also forms a localized X-ray brightening that is usually observed at the edge of the jet's base(1,3). Here we report high-resolution X-ray and extreme-ultraviolet observations of 20 randomly selected X-ray jets that form in coronal holes at the Sun's poles. In each jet, contrary to the emerging-flux model, a miniature version of the filament eruptions that initiate coronal mass ejections(4-7) drives the jet-producing reconnection. The X-ray bright point occurs by reconnection of the 'legs' of the minifilament-carrying erupting closed field, analogous to the formation of solar flares in larger-scale eruptions. Previous observations have found that some jets are driven by base-field eruptions(8-11), but only one such study, of only one jet, provisionally questioned the emerging-flux model(12). Our observations support the view that solar filament eruptions are formed by a fundamental explosive magnetic process that occurs on a vast range of scales, from the biggest mass ejections and flare eruptions down to X-ray jets, and perhaps even down to smaller jets that may power coronal heating(10,13,14). A similar scenario has previously been suggested, but was inferred from different observations and based on a different origin of the erupting minifilament(15).	[Sterling, Alphonse C.; Moore, Ronald L.; Falconer, David A.; Adams, Mitzi] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Moore, Ronald L.; Falconer, David A.] Univ Alabama, Ctr Space Plasma & Aeron Res, Huntsville, AL 35899 USA	National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Alabama System; University of Alabama Huntsville	Sterling, AC (corresponding author), NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA.	alphonse.sterling@nasa.gov; ron.moore@nasa.gov			Heliophysics Division of NASA's Science Mission Directorate through the Living With A Star Targeted Research and Technology Program(LWS TRT); Hinode Project	Heliophysics Division of NASA's Science Mission Directorate through the Living With A Star Targeted Research and Technology Program(LWS TRT); Hinode Project	A.C.S. and R.L.M. were supported by funding from the Heliophysics Division of NASA's Science Mission Directorate through the Living With A Star Targeted Research and Technology Program(LWS TR&T), and the Hinode Project. Both benefited from TR&T discussions and from discussions with S. K. Antiochos. We thank D. M. Zarro for assistance with video development. A.C.S. benefited from discussions held at the International Space Science Institute (ISSI; Switzerland) International Team on Solar Coronal Jets (led by N. Raouafi). Hinode is a Japanese mission developed and launched by the Institute of Space and Astronautical Science (ISAS) of the Japan Aerospace Exploration Agency (JAXA), with the National Astronomical Observatory Japan (NAOJ) as a domestic partner, and NASA and the Science and Technology Facilities Council (UK) as international partners. It is operated by these agencies in cooperation with the European Space Agency and Norwegian Space Agency.	Adams M, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/11; Archontis V, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/2/L21; Bernasconi PN, 2005, SOL PHYS, V228, P97, DOI 10.1007/s11207-005-2766-y; Chandrashekhar K, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322408; Chen PF, 2011, LIVING REV SOL PHYS, V8, DOI 10.12942/lrsp-2011-1; Cirtain JW, 2007, SCIENCE, V318, P1580, DOI 10.1126/science.1147050; Crooker NU, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000236; De Pontieu B, 2011, SCIENCE, V331, P55, DOI 10.1126/science.1197738; Fang F, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L19; Freeland SL, 1998, SOL PHYS, V182, P497, DOI 10.1023/A:1005038224881; HIRAYAMA T, 1974, SOL PHYS, V34, P323, DOI 10.1007/BF00153671; Hong JC, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/73; Huang Z, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220079; Innes DE, 2013, SOL PHYS, V282, P453, DOI 10.1007/s11207-012-0199-y; Innes DE, 2009, ASTRON ASTROPHYS, V495, P319, DOI 10.1051/0004-6361:200811011; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Kusano K, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/31; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; Lin J, 2001, J GEOPHYS RES-SPACE, V106, P25053, DOI 10.1029/2001JA000046; Liu C, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/1/L18; MOORE RL, 1977, ASTROPHYS J, V218, P286, DOI 10.1086/155681; Moore RL, 2001, ASTROPHYS J, V552, P833, DOI 10.1086/320559; Moore RL, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/134; Moore RL, 2010, ASTROPHYS J, V720, P757, DOI 10.1088/0004-637X/720/1/757; Moreno-Insertis F, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/20; Nishizuka N, 2008, ASTROPHYS J LETT, V683, pL83, DOI 10.1086/591445; Nistico G, 2009, SOL PHYS, V259, P87, DOI 10.1007/s11207-009-9424-8; Pariat E, 2009, ASTROPHYS J, V691, P61, DOI 10.1088/0004-637X/691/1/61; Raouafi NE, 2010, ASTROPHYS J, V718, P981, DOI 10.1088/0004-637X/718/2/981; Savcheva A, 2009, ASTROPHYS J LETT, V702, pL32, DOI 10.1088/0004-637X/702/1/L32; Savcheva A, 2007, PUBL ASTRON SOC JPN, V59, pS771, DOI 10.1093/pasj/59.sp3.S771; Schrijver CJ, 2010, ASTROPHYS J, V710, P1480, DOI 10.1088/0004-637X/710/2/1480; Shen YD, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/164; SHIBATA K, 1992, PUBL ASTRON SOC JPN, V44, pL173; Shibata K, 2001, EARTH PLANETS SPACE, V53, P473, DOI 10.1186/BF03353258; Shibata K, 1998, ASTROPHYS SPACE SCI, V264, P129, DOI 10.1023/A:1002413214356; SHIBATA K, 1995, ASTROPHYS J, V451, pL83, DOI 10.1086/309688; Shibata K, 2007, SCIENCE, V318, P1591, DOI 10.1126/science.1146708; Shimojo M, 1996, PUBL ASTRON SOC JPN, V48, P123, DOI 10.1093/pasj/48.1.123; Sterling AC, 2005, ASTROPHYS J, V630, P1148, DOI 10.1086/432044; Sterling AC, 2001, J GEOPHYS RES-SPACE, V106, P25227, DOI 10.1029/2000JA004001; Sterling AC, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/1/L3; Wang JX, 2000, ASTROPHYS J, V530, P1071, DOI 10.1086/308377; YOKOYAMA T, 1995, NATURE, V375, P42, DOI 10.1038/375042a0; Young PR, 2014, SOL PHYS, V289, P3313, DOI 10.1007/s11207-014-0484-z	45	189	190	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					437	U130		10.1038/nature14556	http://dx.doi.org/10.1038/nature14556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26147079	Green Accepted			2022-12-28	WOS:000358378900031
J	Becker, LB; Aufderheide, TP; Graham, R				Becker, Lance B.; Aufderheide, Tom P.; Graham, Robert			Strategies to Improve Survival From Cardiac Arrest A Report From the Institute of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESUSCITATION		[Becker, Lance B.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Aufderheide, Tom P.] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Graham, Robert] George Washington Univ, Washington, DC USA	University of Pennsylvania; Medical College of Wisconsin; George Washington University	Becker, LB (corresponding author), Univ Penn, Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	lance.becker@uphs.upenn.edu						Chan P., PUBLIC HLTH BURDEN I; Chatalas H, DIVISION EMERGENCY M; Daya MR, CURRENT BURDEN CARDI; Kaji AH, 2014, AM J CARDIOL, V114, P1024, DOI 10.1016/j.amjcard.2014.06.031; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Ornato JP, 2010, CIRCULATION, V122, P1876, DOI 10.1161/CIRCULATIONAHA.110.963991; Vellano K, CARDIAC ARREST REGIS; Weisfeldt ML, 2010, J AM COLL CARDIOL, V55, P1712, DOI 10.1016/j.jacc.2009.11.077	8	45	47	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					223	224		10.1001/jama.2015.8454	http://dx.doi.org/10.1001/jama.2015.8454			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26132709				2022-12-28	WOS:000358228000011
J	Chang, YG; Cohen, SE; Phong, C; Myers, WK; Kim, YI; Tseng, R; Lin, J; Zhang, L; Boyd, JS; Lee, Y; Kang, S; Lee, D; Li, S; Britt, RD; Rust, MJ; Golden, SS; LiWang, A				Chang, Yong-Gang; Cohen, Susan E.; Phong, Connie; Myers, William K.; Kim, Yong-Ick; Tseng, Roger; Lin, Jenny; Zhang, Li; Boyd, Joseph S.; Lee, Yvonne; Kang, Shannon; Lee, David; Li, Sheng; Britt, R. David; Rust, Michael J.; Golden, Susan S.; LiWang, Andy			A protein fold switch joins the circadian oscillator to clock output in cyanobacteria	SCIENCE			English	Article							PSEUDO-RECEIVER DOMAIN; SYNECHOCOCCUS-ELONGATUS; KAIC PHOSPHORYLATION; HISTIDINE KINASE; GENE-EXPRESSION; NMR STRUCTURE; CIKA; MECHANISM; RHYTHMS; ROBUST	Organisms are adapted to the relentless cycles of day and night, because they evolved timekeeping systems called circadian clocks, which regulate biological activities with similar to 24-hour rhythms. The clock of cyanobacteria is driven by a three-protein oscillator composed of KaiA, KaiB, and KaiC, which together generate a circadian rhythm of KaiC phosphorylation. We show that KaiB flips between two distinct three-dimensional folds, and its rare transition to an active state provides a time delay that is required to match the timing of the oscillator to that of Earth's rotation. Once KaiB switches folds, it binds phosphorylated KaiC and captures KaiA, which initiates a phase transition of the circadian cycle, and it regulates components of the clock-output pathway, which provides the link that joins the timekeeping and signaling functions of the oscillator.	[Chang, Yong-Gang; Tseng, Roger; Zhang, Li; LiWang, Andy] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Cohen, Susan E.; Kim, Yong-Ick; Boyd, Joseph S.; Golden, Susan S.; LiWang, Andy] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA; [Phong, Connie; Lin, Jenny; Rust, Michael J.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Myers, William K.; Britt, R. David] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Tseng, Roger; LiWang, Andy] Univ Calif, Quantitat & Syst Biolog, Merced, CA 95343 USA; [Lee, Yvonne; Kang, Shannon; Golden, Susan S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Lee, David; Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [LiWang, Andy] Univ Calif, Chem & Chem Biol, Merced, CA 95343 USA; [LiWang, Andy] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA	University of California System; University of California Merced; University of California System; University of California San Diego; University of Chicago; University of California System; University of California Davis; University of California System; University of California Merced; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Merced; University of California System; University of California Merced	LiWang, A (corresponding author), Univ Calif, Sch Nat Sci, Merced, CA 95343 USA.	aliwang@ucmerced.edu	LiWang, Andy/AAE-5205-2020; Kim, Yong-Ick/K-3535-2019	LiWang, Andy/0000-0003-4741-6946; Kim, Yong-Ick/0000-0001-5491-616X; Myers, William/0000-0001-5935-9112; Lee, David/0000-0001-7232-0968; Heisler, Joel/0000-0002-2703-3035	Air Force Office of Scientific Research [13RSL012]; NIH [GM107521, GM100116, GM062419, AI081982, AI101436]; Burroughs-Wellcome Career Award at the Scientific Interface; American Cancer Society Postdoctoral Fellowship [PF-12-262-01-MPC]; NSF; EPSRC [EP/L011972/1, EP/D048559/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D048559/1, EP/L011972/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081982, R01AI101436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100116, R01GM107369, R01GM107521, R01GM062419] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); American Cancer Society Postdoctoral Fellowship(American Cancer Society); NSF(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Greenspan, J.-P. Changeux, M. Paddock, Y. Shen, R. Peterson, S. Chou, and N.-W. Kuo for discussions and A. Chavan for figure preparation. Work was supported by Air Force Office of Scientific Research grant 13RSL012 and NIH grant GM107521 to A.L., a Burroughs-Wellcome Career Award at the Scientific Interface to M.J.R., NIH grants GM100116 and GM062419 to S.S.G. and AI081982 and AI101436 for support of the University of California-San Diego HDX-MS Laboratory, American Cancer Society Postdoctoral Fellowship PF-12-262-01-MPC to S.E.C., and NSF Graduate Research Fellowship to R.T. The data reported in this paper are tabulated in the supplementary materials.	Chang YG, 2012, P NATL ACAD SCI USA, V109, P16847, DOI 10.1073/pnas.1211508109; Dong GG, 2010, CURR OPIN GENET DEV, V20, P619, DOI 10.1016/j.gde.2010.09.002; Dong GG, 2010, CELL, V140, P529, DOI 10.1016/j.cell.2009.12.042; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gao TY, 2007, PROTEIN SCI, V16, P465, DOI 10.1110/ps.062532007; Garces RG, 2004, EMBO J, V23, P1688, DOI 10.1038/sj.emboj.7600190; Gutu A, 2013, MOL CELL, V50, P288, DOI 10.1016/j.molcel.2013.02.022; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Loza-Correa M, 2014, ENVIRON MICROBIOL, V16, P359, DOI 10.1111/1462-2920.12223; Markson JS, 2013, CELL, V155, P1396, DOI 10.1016/j.cell.2013.11.005; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Phong C, 2013, P NATL ACAD SCI USA, V110, P1124, DOI 10.1073/pnas.1212113110; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Snijder J, 2014, P NATL ACAD SCI USA, V111, P1379, DOI 10.1073/pnas.1314326111; Tseng R, 2014, J MOL BIOL, V426, P389, DOI 10.1016/j.jmb.2013.09.040; Vakonakis I, 2004, J MOL BIOL, V342, P9, DOI 10.1016/j.jmb.2004.07.010; Vakonakis L, 2004, P NATL ACAD SCI USA, V101, P1479, DOI 10.1073/pnas.0305516101; Villarreal SA, 2013, J MOL BIOL, V425, P3311, DOI 10.1016/j.jmb.2013.06.018; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Zhang XF, 2006, MOL MICROBIOL, V60, P658, DOI 10.1111/j.1365-2958.2006.05138.x	30	98	99	5	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		324	328		10.1126/science.1260031	http://dx.doi.org/10.1126/science.1260031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26113641	Green Accepted			2022-12-28	WOS:000358218600056
J	Wertz, A; Trenholm, S; Yonehara, K; Hillier, D; Raics, Z; Leinweber, M; Szalay, G; Ghanem, A; Keller, G; Rozsa, B; Conzelmann, KK; Roska, B				Wertz, Adrian; Trenholm, Stuart; Yonehara, Keisuke; Hillier, Daniel; Raics, Zoltan; Leinweber, Marcus; Szalay, Gergely; Ghanem, Alexander; Keller, Georg; Rozsa, Balazs; Conzelmann, Karl-Klaus; Roska, Botond			Single-cell-initiated monosynaptic tracing reveals layer-specific cortical network modules	SCIENCE			English	Article							STIMULUS SELECTIVITY; RECEPTIVE-FIELDS; VISUAL-CORTEX; NEURONS; MOUSE; ORGANIZATION; SUBTYPES	Individual cortical neurons can selectively respond to specific environmental features, such as visual motion or faces. How this relates to the selectivity of the presynaptic network across cortical layers remains unclear. We used single-cell-initiated, monosynaptically restricted retrograde transsynaptic tracing with rabies viruses expressing GCaMP6s to image, in vivo, the visual motion-evoked activity of individual layer 2/3 pyramidal neurons and their presynaptic networks across layers in mouse primary visual cortex. Neurons within each layer exhibited similar motion direction preferences, forming layer-specific functional modules. In one-third of the networks, the layer modules were locked to the directionpreference of the postsynaptic neuron, whereas for other networks the direction preference varied by layer. Thus, there exist feature-locked and feature-variant cortical networks.	[Wertz, Adrian; Trenholm, Stuart; Yonehara, Keisuke; Hillier, Daniel; Raics, Zoltan; Leinweber, Marcus; Keller, Georg; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Szalay, Gergely; Rozsa, Balazs] Hungarian Acad Sci, Inst Expt Med, Photon Imaging Ctr 2, Budapest, Hungary; [Conzelmann, Karl-Klaus] Univ Munich, Max von Pettenkofer Inst, Munich, Germany; [Conzelmann, Karl-Klaus] Univ Munich, Gene Ctr, Munich, Germany; [Roska, Botond] Univ Basel, Dept Ophthalmol, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Munich; University of Munich; University of Basel	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Roska, Botond/AAD-7268-2021; Conzelmann, Karl-Klaus/L-7239-2013; Ghanem, Alexander/AAL-9902-2020; Balazs, Rozsa/C-6306-2015	Trenholm, Stuart/0000-0001-5792-0957; Yonehara, Keisuke/0000-0001-9541-6671; Hillier, Daniel/0000-0003-0453-9049; Balazs, Rozsa/0000-0003-1427-7003; Keller, Georg/0000-0002-1401-0117; Leinweber, Marcus/0000-0002-6583-7739; Conzelmann, Karl-Klaus/0000-0002-8614-3656	Human Frontier Science Program Postdoctoral Fellowship [LT000173/2013]; Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad; European Molecular Biology Organization Postdoctoral Fellowship; Swiss National Science Foundation grant; Swiss-Hungarian, Hungarian-French, Central-Hungarian Region, Research and Technological Innovation Fund; European Union; German Research Foundation Neuronal Circuits grant [SFB 870]; Gebert-Ruf Foundation; Swiss National Science Foundation; European Research Council; National Centres of Competence in Research Molecular Systems Engineering; Sinergia; Swiss-Hungarian	Human Frontier Science Program Postdoctoral Fellowship(Human Frontier Science Program); Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Molecular Biology Organization Postdoctoral Fellowship; Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); Swiss-Hungarian, Hungarian-French, Central-Hungarian Region, Research and Technological Innovation Fund; European Union(European Commission); German Research Foundation Neuronal Circuits grant; Gebert-Ruf Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); National Centres of Competence in Research Molecular Systems Engineering; Sinergia; Swiss-Hungarian	We thank R. da Silveira for helpful discussions about possible functional roles for feature-locked and -variant networks. We thank S. Oakeley and A. Drinnenberg for commenting on the manuscript and members of the Facility for Advanced Imaging and Microscopy at the Friedrich Miescher Institute (FMI) for assistance with anatomical data acquisition and image processing. Original data are curated and stored in the server of FMI. All materials described in this paper, with the exception of the rabies virus, can be obtained for noncommercial purposes after signing a material transfer agreement (MTA) with FMI. The rabies virus can be obtained for noncommercial purposes after signing an MTA with the Ludwig-Maximilians-University Munich. The plasmids can be obtained from Addgene (addgene.org). We acknowledge the following grants: Human Frontier Science Program Postdoctoral Fellowship (LT000173/2013) to S.T.; Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad to K.Y.; European Molecular Biology Organization Postdoctoral Fellowship to D.H.; Swiss National Science Foundation grant to G.K.; Swiss-Hungarian, Hungarian-French, Central-Hungarian Region, Research and Technological Innovation Fund and European Union 3x3D Imaging grants to B. Rozsa; German Research Foundation Neuronal Circuits grant (SFB 870) to K.-K.C. and A.G.; Gebert-Ruf Foundation, Swiss National Science Foundation, European Research Council, National Centres of Competence in Research Molecular Systems Engineering, Sinergia, Swiss-Hungarian, and European Union 3X3D Imaging grants to B. Roska. Author contributions: In vivo electroporation and virus tracing techniques were optimized by A.W. Experiments were designed by A.W., S.T., and B. Roska. Experiments were performed by A.W. and S.T. Image data analysis was performed by A.W. Immunohistochemistry was performed by A.W. and S.T. Morphological data analysis was performed by S.T. Stimulation software was written by Z.R. Two-photon microscopes were developed by B. Rozsa and optimized by G.S. and D.H. Rabies virus was developed by A.G. and K.-K.C. Plasmids were made by K.Y. The intrinsic imaging was performed by A.W., M.L., and G.K. The paper was written by A.W., S.T., and B. Roska.	Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Freiwald WA, 2009, NAT NEUROSCI, V12, P1187, DOI 10.1038/nn.2363; Gavornik JP, 2014, NAT NEUROSCI, V17, P732, DOI 10.1038/nn.3683; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/NMETH.1851, 10.1038/nmeth.1851]; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Liu YJ, 2013, CURR BIOL, V23, P1746, DOI 10.1016/j.cub.2013.07.033; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mazurek M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00092; Okun M, 2015, NATURE, V521, P511, DOI 10.1038/nature14273; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schuett S, 2002, J NEUROSCI, V22, P6549; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Velez-Fort M, 2014, NEURON, V83, P1431, DOI 10.1016/j.neuron.2014.08.001; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	27	123	125	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					70	74		10.1126/science.aab1687	http://dx.doi.org/10.1126/science.aab1687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138975				2022-12-28	WOS:000357280800060
J	Ma, XY				Ma, Xiaoya			PALAEONTOLOGY Hallucigenia's head	NATURE			English	Editorial Material									[Ma, Xiaoya] Yunnan Univ, Kunming 650091, Peoples R China; [Ma, Xiaoya] Nat Hist Museum, London SW7 5BD, England	Yunnan University; Natural History Museum London	Ma, XY (corresponding author), Yunnan Univ, Kunming 650091, Peoples R China.	x.ma@nhm.ac.uk			Natural Environment Research Council [NE/L011751/1] Funding Source: researchfish; NERC [NE/L011751/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Conway-Morris S., 1977, SPEC PAP PALAEONTOL, V20, P1; Dewel RA, 2006, HYDROBIOLOGIA, V558, P41, DOI 10.1007/s10750-005-1406-8; Edgecombe Gregory D., 2013, P393; Hou XG, 2004, LETHAIA, V37, P235, DOI 10.1080/00241160410006555; RAMSKOLD L, 1991, NATURE, V351, P225, DOI 10.1038/351225a0; Smith MR, 2015, NATURE, V523, P75, DOI 10.1038/nature14573; Smith MR, 2014, NATURE, V514, P363, DOI 10.1038/nature13576; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Vannier J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4641	10	0	1	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					38	39		10.1038/nature14627	http://dx.doi.org/10.1038/nature14627			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26106859				2022-12-28	WOS:000357169500022
J	Nosek, BA; Alter, G; Banks, GC; Borsboom, D; Bowman, SD; Breckler, SJ; Buck, S; Chambers, CD; Chin, G; Christensen, G; Contestabile, M; Dafoe, A; Eich, E; Freese, J; Glennerster, R; Goroff, D; Green, DP; Hesse, B; Humphreys, M; Ishiyama, J; Karlan, D; Kraut, A; Lupia, A; Mabry, P; Madon, TA; Malhotra, N; Mayo-Wilson, E; McNutt, M; Miguel, E; Paluck, EL; Simonsohn, U; Soderberg, C; Spellman, BA; Turitto, J; VandenBos, G; Vazire, S; Wagenmakers, EJ; Wilson, R; Yarkoni, T				Nosek, B. A.; Alter, G.; Banks, G. C.; Borsboom, D.; Bowman, S. D.; Breckler, S. J.; Buck, S.; Chambers, C. D.; Chin, G.; Christensen, G.; Contestabile, M.; Dafoe, A.; Eich, E.; Freese, J.; Glennerster, R.; Goroff, D.; Green, D. P.; Hesse, B.; Humphreys, M.; Ishiyama, J.; Karlan, D.; Kraut, A.; Lupia, A.; Mabry, P.; Madon, T. A.; Malhotra, N.; Mayo-Wilson, E.; McNutt, M.; Miguel, E.; Paluck, E. Levy; Simonsohn, U.; Soderberg, C.; Spellman, B. A.; Turitto, J.; VandenBos, G.; Vazire, S.; Wagenmakers, E. J.; Wilson, R.; Yarkoni, T.			Promoting an open research culture	SCIENCE			English	Editorial Material							FILE DRAWER; PUBLICATION; INCENTIVES; PSYCHOLOGY; PREVALENCE; SCIENCE; TRUTH					nosek@virginia.edu	Wagenmakers, Eric-Jan/AAH-7065-2019; Simonsohn, Uri/ABF-2344-2020; Green, Donald P./E-4565-2010; Mayo-Wilson, Evan/J-6289-2019	Wagenmakers, Eric-Jan/0000-0003-1596-1034; Simonsohn, Uri/0000-0002-8601-7211; Green, Donald P./0000-0002-8850-438X; Mayo-Wilson, Evan/0000-0001-6126-2459; Bowman, Sara/0000-0002-5741-8868; Borsboom, Denny/0000-0001-9720-4162; Christensen, Garret/0000-0003-2558-1609; McNutt, Marcia/0000-0003-0117-7716; Buck, Stuart/0000-0002-8111-3239; Miguel, Edward/0000-0001-6927-709X; Mabry, Patricia/0000-0002-6374-8679; karlan, dean/0000-0003-0164-1398; Alter, George/0000-0003-3823-4972; Madon, Temina/0000-0003-2427-3655; Soderberg, Courtney/0000-0003-1227-7042; Chambers, Chris/0000-0001-6058-4114; Nosek, Brian/0000-0001-6797-5476; Vazire, Simine/0000-0002-3933-9752; Spellman, Barbara/0000-0003-2823-1292	BBSRC [BB/K008277/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K008277/1] Funding Source: researchfish; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NIA NIH HHS [R24 AG048124] Funding Source: Medline; NICHD NIH HHS [P2C HD047879] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R24AG048124] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson MS, 2007, J EMPIR RES HUM RES, V2, P3, DOI 10.1525/jer.2007.2.4.3; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Chambers CD, 2013, CORTEX, V49, P609, DOI 10.1016/j.cortex.2012.12.016; Eich E, 2014, PSYCHOL SCI, V25, P3, DOI 10.1177/0956797613512465; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; McNutt M, 2014, SCIENCE, V343, P231, DOI 10.1126/science.1250475; Miguel E, 2014, SCIENCE, V343, P30, DOI 10.1126/science.1245317; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; O'Boyle EH, 2017, J MANAGE, V43, P376, DOI 10.1177/0149206314527133; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078	14	1191	1204	9	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1422	1425		10.1126/science.aab2374	http://dx.doi.org/10.1126/science.aab2374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3RW	26113702	Green Accepted, Green Submitted			2022-12-28	WOS:000356869100017
J	White, MD; Payne, KAP; Fisher, K; Marshall, SA; Parker, D; Rattray, NJW; Trivedi, DK; Goodacre, R; Rigby, SEJ; Scrutton, NS; Hay, S; Leys, D				White, Mark D.; Payne, Karl A. P.; Fisher, Karl; Marshall, Stephen A.; Parker, David; Rattray, Nicholas J. W.; Trivedi, Drupad K.; Goodacre, Royston; Rigby, Stephen E. J.; Scrutton, Nigel S.; Hay, Sam; Leys, David			UbiX is a flavin prenyltransferase required for bacterial ubiquinone biosynthesis	NATURE			English	Article							ISOPENTENYL DIPHOSPHATE ISOMERASE; COENZYME-Q; ACID DECARBOXYLASE; FLAVOENZYMES; CATALYSTS; IDENTIFICATION; CARBOXYLASES; PATHWAYS; PAD1	Ubiquinone (also known as coenzyme Q) is a ubiquitous lipid-soluble redox cofactor that is an essential component of electron transfer chains(1). Eleven genes have been implicated in bacterial ubiquinone biosynthesis, including ubiX and ubiD, which are responsible for decarboxylation of the 3-octaprenyl-4-hydroxy-benzoate precursor(2). Despite structural and biochemical characterization of UbiX as a flavin mononucleotide (FMN)-binding protein, no decarboxylase activity has been detected(3,4). Here we report that UbiX produces a novel flavin-derived cofactor required for the decarboxylase activity of UbiD(5). UbiX acts as a flavin prenyltransferase, linking a dimethylallyl moiety to the flavin N5 and C6 atoms. This adds a fourth non-aromatic ring to the flavin isoalloxazine group. In contrast to other prenyltransferases(6,7), UbiX is metal-independent and requires dimethylallyl-monophosphate as substrate. Kinetic crystallography reveals that the prenyltransferase mechanism of UbiX resembles that of the terpene synthases(8). The active site environment is dominated by pi systems, which assist phosphate-C1' bond breakage following FMN reduction, leading to formation of the N5-C1' bond. UbiX then acts as a chaperone for adduct reorientation, via transient carbocation species, leading ultimately to formation of the dimethylallyl C3'-C6 bond. Our findings establish the mechanism for formation of a new flavin-derived cofactor, extending both flavin and terpenoid biochemical repertoires.	[White, Mark D.; Payne, Karl A. P.; Fisher, Karl; Marshall, Stephen A.; Rattray, Nicholas J. W.; Trivedi, Drupad K.; Goodacre, Royston; Rigby, Stephen E. J.; Scrutton, Nigel S.; Hay, Sam; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Ctr Synthet Biol Fine & Special Chem, Manchester M1 7DN, Lancs, England; [Parker, David] Westhollow Technol Ctr, Innovat Biodomain Shell Int Explorat & Prod, Houston, TX 77082 USA	University of Manchester	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Ctr Synthet Biol Fine & Special Chem, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Hay, Sam/D-5974-2012; Rattray, Nicholas/AAX-7283-2021; Goodacre, Roy/AAO-3194-2021; Trivedi, Drupad/I-3904-2017; Goodacre, Roy/J-1600-2012	Hay, Sam/0000-0003-3274-0938; Goodacre, Roy/0000-0003-2230-645X; Trivedi, Drupad/0000-0001-7969-0195; Goodacre, Roy/0000-0003-2230-645X; Rattray, Nicholas/0000-0002-3528-6905; Marshall, Stephen/0000-0001-7678-4989; payne, karl/0000-0002-6331-6374; White, Mark/0000-0002-1431-0339	BBSRC [BB/K017802/1, BB/M017702/1]; Royal Society; Biotechnology and Biological Sciences Research Council [BB/M017702/1, BB/K017802/1, BB/H021523/1, BB/E013007/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish; BBSRC [BB/H021523/1, BB/E013007/1] Funding Source: UKRI; EPSRC [EP/J020192/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by BBSRC grants (BB/K017802/1 with Shell and BB/M017702/1). We thank Diamond Light Source for access to beamlines (proposal number MX8997) that contributed to the results presented here. S.H. is a BBSRC David Phillips research fellow. N.S.S. is an EPSRC Established Career Fellow and Royal Society Wolfson Award holder. The authors acknowledge the assistance given by IT Services and the use of the Computational Shared Facility and the Protein Structure Facility at The University of Manchester.	Abu Laban N, 2010, ENVIRON MICROBIOL, V12, P2783, DOI 10.1111/j.1462-2920.2010.02248.x; Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Berthelot K, 2012, BIOCHIMIE, V94, P1621, DOI 10.1016/j.biochi.2012.03.021; Chang WC, 2013, CURR OPIN CHEM BIOL, V17, P571, DOI 10.1016/j.cbpa.2013.06.020; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; Doud EH, 2011, J AM CHEM SOC, V133, P1270, DOI 10.1021/ja109578b; Erb TJ, 2011, APPL ENVIRON MICROB, V77, P8466, DOI 10.1128/AEM.05702-11; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Frisch X.M.J., 2010, GAUSSIAN 09; Fu GX, 2011, BIOCHEMISTRY-US, V50, P6292, DOI 10.1021/bi200831a; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; Guex Y. N, 1997, ELECTROPHORESIS, V18, P2714; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kopec J, 2011, ACTA CRYSTALLOGR F, V67, P1184, DOI 10.1107/S174430911102923X; Lenaz G, 2009, BBA-BIOENERGETICS, V1787, P563, DOI 10.1016/j.bbabio.2009.02.019; Liang PH, 2009, BIOCHEMISTRY-US, V48, P6562, DOI 10.1021/bi900371p; Lin FM, 2015, ACS CHEM BIOL, V10, P1137, DOI 10.1021/cb5008103; Lupa B, 2005, GENOMICS, V86, P342, DOI 10.1016/j.ygeno.2005.05.002; Mukai N, 2010, J BIOSCI BIOENG, V109, P564, DOI 10.1016/j.jbiosc.2009.11.011; Nagai T, 2011, P NATL ACAD SCI USA, V108, P20461, DOI 10.1073/pnas.1115749108; Payne K. A. P., 2015, NATURE; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; Smanski MJ, 2012, CURR OPIN CHEM BIOL, V16, P132, DOI 10.1016/j.cbpa.2012.03.002; Sobrado P, 2012, INT J MOL SCI, V13, P14219, DOI 10.3390/ijms131114219; Sun HG, 2012, J BIOL CHEM, V287, P4602, DOI 10.1074/jbc.M111.312538; VanNice JC, 2014, J BACTERIOL, V196, P1055, DOI 10.1128/JB.01230-13; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	30	120	122	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					502	+		10.1038/nature14559	http://dx.doi.org/10.1038/nature14559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26083743	Green Accepted			2022-12-28	WOS:000356782900055
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Solving the mystery of health inequality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Ost A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005	1	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2015	350								h3389	10.1136/bmj.h3389	http://dx.doi.org/10.1136/bmj.h3389			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NX	26108214				2022-12-28	WOS:000357160000019
J	Honigsbaum, M				Honigsbaum, Mark			Jean-Jacques Muyembe-Tamfum: Africa's veteran Ebola hunter	LANCET			English	Biographical-Item														honigsbaum, mark/0000-0002-1891-8763	Wellcome Trust [103159] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2455	2455		10.1016/S0140-6736(15)61128-X	http://dx.doi.org/10.1016/S0140-6736(15)61128-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	26122060				2022-12-28	WOS:000356532500013
J	Li, X; Rohrer, F; Hofzumahaus, A; Brauers, T; Haseler, R; Bohn, B; Broch, S; Fuchs, H; Gomm, S; Holland, F; Jager, J; Kaiser, J; Keutsch, FN; Lohse, I; Lu, KD; Tillmann, R; Wegener, R; Wolfe, GM; Mentel, TF; Kiendler-Scharr, A; Wahner, A				Li, Xin; Rohrer, Franz; Hofzumahaus, Andreas; Brauers, Theo; Haeseler, Rolf; Bohn, Birger; Broch, Sebastian; Fuchs, Hendrik; Gomm, Sebastian; Holland, Frank; Jaeger, Julia; Kaiser, Jennifer; Keutsch, Frank N.; Lohse, Insa; Lu, Keding; Tillmann, Ralf; Wegener, Robert; Wolfe, Glenn M.; Mentel, Thomas F.; Kiendler-Scharr, Astrid; Wahner, Andreas			Response to Comment on "Missing gas-phase source of HONO inferred from Zeppelin measurements in the troposphere"	SCIENCE			English	Editorial Material							PHOTOLYSIS; OH	Ye et al. have determined a maximum nitrous acid (HONO) yield of 3% for the reaction HO2 center dot H2O + NO2, which is much lower than the yield used in our work. This finding, however, does not affect our main result that HONO in the investigated Po Valley region is mainly from a gas-phase source that consumes nitrogen oxides.	[Li, Xin; Rohrer, Franz; Hofzumahaus, Andreas; Brauers, Theo; Haeseler, Rolf; Bohn, Birger; Broch, Sebastian; Fuchs, Hendrik; Gomm, Sebastian; Holland, Frank; Jaeger, Julia; Lohse, Insa; Lu, Keding; Tillmann, Ralf; Wegener, Robert; Mentel, Thomas F.; Kiendler-Scharr, Astrid; Wahner, Andreas] Forschungszentrum Julich, Inst Energie & Klimaforsch, Troposphare IEK 8, D-52425 Julich, Germany; [Kaiser, Jennifer; Keutsch, Frank N.; Wolfe, Glenn M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	Helmholtz Association; Research Center Julich; University of Wisconsin System; University of Wisconsin Madison	Rohrer, F (corresponding author), Forschungszentrum Julich, Inst Energie & Klimaforsch, Troposphare IEK 8, D-52425 Julich, Germany.	x.li@fz-juelich.de; f.rohrer@fz-juelich.de	Fuchs, Hendrik/I-9157-2012; Kiendler-Scharr, Astrid/E-8439-2011; Wegener, Robert/I-8925-2012; Tillmann, Ralf/AAM-5619-2021; Bohn, Birger/J-4130-2012; Holland, Frank/J-8812-2012; Li, Xin/F-9498-2011; Wegener, Robert/P-6892-2019; Wahner, Andreas/J-4129-2012; Hofzumahaus, Andreas/I-9420-2012; Rohrer, Franz/I-2052-2012; Lu, Keding/A-7282-2012; Tillmann, Ralf/I-9203-2012	Fuchs, Hendrik/0000-0003-1263-0061; Kiendler-Scharr, Astrid/0000-0003-3166-2253; Wegener, Robert/0000-0003-2042-9333; Tillmann, Ralf/0000-0003-0648-6622; Bohn, Birger/0000-0003-4177-3934; Holland, Frank/0000-0002-2278-4761; Wegener, Robert/0000-0003-2042-9333; Wahner, Andreas/0000-0001-8948-1928; Hofzumahaus, Andreas/0000-0003-2876-0880; Rohrer, Franz/0000-0003-3436-3419; Lu, Keding/0000-0001-9425-9520; Tillmann, Ralf/0000-0003-0648-6622; Broch, Sebastian/0000-0001-6768-9058				Acker K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024643; Alicke B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000579; Grilli R, 2013, GEOPHYS RES LETT, V40, P791, DOI 10.1002/grl.50154; Kleffmann J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022524; Li X, 2014, SCIENCE, V344, P292, DOI 10.1126/science.1248999; Lu KD, 2012, ATMOS CHEM PHYS, V12, P1541, DOI 10.5194/acp-12-1541-2012; Pitts Jr J. N., 2000, CHEM UPPER LOWER ATM; Rubach F., 2013, THESIS U WUPPERTAL G; Ye CX, 2015, SCIENCE, V348, DOI 10.1126/science.aaa1992; Zhou XL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018620	10	8	8	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241								10.1126/science.aaa3777	http://dx.doi.org/10.1126/science.aaa3777			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089508				2022-12-28	WOS:000356449500040
J	Biousse, V; Newman, NJ				Biousse, Valerie; Newman, Nancy J.			Ischemic Optic Neuropathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GIANT-CELL ARTERITIS; RISK-FACTORS; CLINICAL-FEATURES; VISUAL-LOSS; PATHOGENESIS; MANAGEMENT; STEROIDS; RATIO		[Biousse, Valerie; Newman, Nancy J.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Biousse, Valerie; Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Newman, Nancy J.] Emory Univ, Sch Med, Dept Neurol Surg, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Biousse, V (corresponding author), Emory Univ, Sch Med, Neuroophthalmol Unit, Emory Eye Ctr, 1365 B Clifton Rd NE, Atlanta, GA 30322 USA.	vbiouss@emory.edu	Newman, Nancy/AAB-2532-2021		GenSight Biologics; Research to Prevent Blindness; Santhera Pharmaceuticals; Trius Therapeutics/Cubist Pharmaceuticals	GenSight Biologics; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Santhera Pharmaceuticals; Trius Therapeutics/Cubist Pharmaceuticals	Dr. Biousse reports receiving consulting fees from GenSight Biologics and grant support from Research to Prevent Blindness; and Dr. Newman, receiving consulting fees from GenSight Biologics, Santhera Pharmaceuticals, and Trius Therapeutics/Cubist Pharmaceuticals and grant support from Research to Prevent Blindness. No other potential conflict of interest relevant to this article was reported.	Archer EL, 2013, J CLIN SLEEP MED, V9, P613, DOI 10.5664/jcsm.2766; Arnold AC, 2003, J NEURO-OPHTHALMOL, V23, P157, DOI 10.1097/00041327-200306000-00012; Atkins EJ, 2010, SURV OPHTHALMOL, V55, P47, DOI 10.1016/j.survophthal.2009.06.008; BECK RW, 1987, OPHTHALMOLOGY, V94, P1503; Bernstein SL, 2011, PROG RETIN EYE RES, V30, P167, DOI 10.1016/j.preteyeres.2011.02.003; BURDE RM, 1993, AM J OPHTHALMOL, V116, P759, DOI 10.1016/S0002-9394(14)73478-6; Campbell UB, 2015, J SEX MED, V12, P139, DOI 10.1111/jsm.12726; Dasgupta B, 2010, RHEUMATOLOGY, V49, P1594, DOI 10.1093/rheumatology/keq039a; DICKERSIN K, 1995, JAMA-J AM MED ASSOC, V273, P625, DOI 10.1001/jama.1995.03520320035038; DORO S, 1985, ARCH OPHTHALMOL-CHIC, V103, P1143; Fivgas GD, 1999, AM J OPHTHALMOL, V127, P104, DOI 10.1016/S0002-9394(98)00312-2; Hattenhauer MG, 1997, AM J OPHTHALMOL, V123, P103, DOI 10.1016/S0002-9394(14)70999-7; Hayreh SS, 2008, GRAEF ARCH CLIN EXP, V246, P1029, DOI 10.1007/s00417-008-0805-8; Hayreh SS, 2013, GRAEF ARCH CLIN EXP, V251, P1873, DOI 10.1007/s00417-013-2399-z; Hayreh SS, 2012, J NEURO-OPHTHALMOL, V32, P278, DOI 10.1097/WNO.0b013e3182688218; Hayreh SS, 1997, AM J OPHTHALMOL, V123, P285, DOI 10.1016/S0002-9394(14)70123-0; Hayreh SS, 2004, EYE, V18, P1188, DOI 10.1038/sj.eye.6701562; HAYREH SS, 1994, AM J OPHTHALMOL, V118, P766, DOI 10.1016/S0002-9394(14)72557-7; Hayreh SS, 1998, AM J OPHTHALMOL, V125, P521, DOI 10.1016/S0002-9394(99)80193-7; He M, 2010, SEMIN OPHTHALMOL, V25, P225, DOI 10.3109/08820538.2010.518450; Jacobson DM, 1997, ARCH OPHTHALMOL-CHIC, V115, P1403, DOI 10.1001/archopht.1997.01100160573008; Kaufman D, 2000, ARCH OPHTHALMOL-CHIC, V118, P793; Lee AG, 2010, J NEURO-OPHTHALMOL, V30, P193, DOI 10.1097/WNO.0b013e3181e1f71f; Lee LA, 2012, ANESTHESIOLOGY, V116, P15, DOI 10.1097/ALN.0b013e31823d012a; LIU GT, 1994, OPHTHALMOLOGY, V101, P1779; McCulley TJ, 2003, AM J OPHTHALMOL, V136, P1171, DOI 10.1016/S0002-9394(03)00676-7; Melson Mark R, 2007, Rev Neurol Dis, V4, P128; Miller NR, 2014, INVEST OPHTH VIS SCI, V55, P7047, DOI 10.1167/iovs.14-14063; Murphy MA, 2005, J NEURO-OPHTHALMOL, V25, P232, DOI 10.1097/01.wno.0000177290.09649.38; Newman NJ, 2008, AM J OPHTHALMOL, V145, P604, DOI 10.1016/j.ajo.2007.09.016; Newman NJ, 2002, AM J OPHTHALMOL, V134, P317, DOI 10.1016/S0002-9394(02)01639-2; Newman NJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1366; Nicholson JD, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00122; Preechawat P, 2007, AM J OPHTHALMOL, V144, P953, DOI 10.1016/j.ajo.2007.07.031; Sadda SR, 2001, AM J OPHTHALMOL, V132, P743, DOI 10.1016/S0002-9394(01)01199-0; Salomon O, 1999, OPHTHALMOLOGY, V106, P739, DOI 10.1016/S0161-6420(99)90159-8; Salvarani C, 2012, NAT REV RHEUMATOL, V8, P509, DOI 10.1038/nrrheum.2012.97; Singh AG, 2015, J RHEUMATOL, V42, P309, DOI 10.3899/jrheum.140188; Van Stavern G P, 2001, Ophthalmol Clin North Am, V14, P61; Warner MA, 2012, ANESTHESIOLOGY, V116, P274, DOI 10.1097/ALN.0b013e31823c104d	40	146	152	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2428	2436		10.1056/NEJMra1413352	http://dx.doi.org/10.1056/NEJMra1413352			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK6RF	26083207				2022-12-28	WOS:000356354600009
J	Ramirez, S; Liu, X; MacDonald, CJ; Moffa, A; Zhou, J; Redondo, RL; Tonegawa, S				Ramirez, Steve; Liu, Xu; MacDonald, Christopher J.; Moffa, Anthony; Zhou, Joanne; Redondo, Roger L.; Tonegawa, Susumu			Activating positive memory engrams suppresses depression-like behaviour	NATURE			English	Article							NUCLEUS-ACCUMBENS; HIPPOCAMPAL NEUROGENESIS; OPTOGENETIC STIMULATION; PREFRONTAL CORTEX; MAJOR DEPRESSION; REWARD CIRCUITRY; STRESS; MECHANISMS; AMYGDALA; DISORDERS	Stress is considered a potent environmental risk factor for many behavioural abnormalities, including anxiety and mood disorders(1,2). Animal models can exhibit limited but quantifiable behavioural impairments resulting from chronic stress, including deficits in motivation, abnormal responses to behavioural challenges, and anhedonia(3-5). The hippocampus is thought to negatively regulate the stress response and to mediate various cognitive and mnemonic aspects of stress-induced impairments(2,3,5), although the neuronal underpinnings sufficient to support behavioural improvements are largely unknown. Here we acutely rescue stress-induced depression-related behaviours in mice by optogenetically reactivating dentate gyrus cells that were previously active during a positive experience. A brain-wide histological investigation, coupled with pharmacological and projection-specific optogenetic blockade experiments, identified glutamatergic activity in the hippocampus-amygdala-nucleus-accumbens pathway as a candidate circuit supporting the acute rescue. Finally, chronically reactivating hippocampal cells associated with a positive memory resulted in the rescue of stress-induced behavioural impairments and neurogenesis at time points beyond the light stimulation. Together, our data suggest that activating positive memories artificially is sufficient to suppress depression-like behaviours and point to dentate gyrus engram cells as potential therapeutic nodes for intervening with maladaptive behavioural states.	[Ramirez, Steve; MacDonald, Christopher J.; Moffa, Anthony; Zhou, Joanne; Redondo, Roger L.; Tonegawa, Susumu] MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Cambridge, MA 02139 USA; [Ramirez, Steve; MacDonald, Christopher J.; Moffa, Anthony; Zhou, Joanne; Redondo, Roger L.; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Redondo, Roger L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu		Zhou, Joanne/0000-0002-6226-4701	RIKEN Brain Science Institute; Howard Hughes Medical Institute	RIKEN Brain Science Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank B. Chen, D. S. Roy, and J. Kim for help with the experiments, T. J. Ryan and T. Kitamura for the TRE-ArchT-eGFP construct, J. Sarinana and E. Hueske for comments and extensive discussions on the manuscript, and all the members of the Tonegawa laboratory for their support. We dedicate this study to the memory of Xu Liu, who made major contributions to memory engram research. This work was supported by RIKEN Brain Science Institute and Howard Hughes Medical Institute.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Brody AL, 2001, ARCH GEN PSYCHIAT, V58, P631, DOI 10.1001/archpsyc.58.7.631; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Huff ML, 2013, P NATL ACAD SCI USA, V110, P3597, DOI 10.1073/pnas.1219593110; Hyman SE, 2014, NEUROPSYCHOPHARMACOL, V39, P220, DOI 10.1038/npp.2013.181; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Xiu JB, 2014, NAT NEUROSCI, V17, P1552, DOI 10.1038/nn.3813	32	179	187	11	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					335	+		10.1038/nature14514	http://dx.doi.org/10.1038/nature14514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085274	Green Accepted			2022-12-28	WOS:000356425400052
J	Absher, JR				Absher, John R.			In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Absher, John R.] Absher Neurol, Greenville, SC 29607 USA; [Absher, John R.] Alliance Neuro Res LLC, Greenville, SC USA		Absher, JR (corresponding author), Absher Neurol, Greenville, SC 29607 USA.		Absher, John/P-3138-2019					Boulton C, 2012, J CLIN PHARMACOL, V52, P1879, DOI 10.1177/0091270011427908; Marrie RA, 2014, NEUROLOGY, V83, P929, DOI 10.1212/WNL.0000000000000753; Mehling M, 2011, ANN NEUROL, V69, P408, DOI 10.1002/ana.22352; Redelings MD, 2006, NEUROEPIDEMIOLOGY, V26, P102, DOI 10.1159/000090444	4	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC8	10.7326/ACPJC-2015-162-12-008	http://dx.doi.org/10.7326/ACPJC-2015-162-12-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075785				2022-12-28	WOS:000356516300009
J	Acedillo, RR; Garg, AX; James, MT				Acedillo, Rey R.; Garg, Amit X.; James, Matthew T.			In hospitalized patients, an electronic alert for acute kidney injury did not differ from usual care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Acedillo, Rey R.; Garg, Amit X.] Univ Western Ontario, London, ON, Canada; [James, Matthew T.] Univ Calgary, Calgary, AB, Canada	Western University (University of Western Ontario); University of Calgary	Acedillo, RR (corresponding author), Univ Western Ontario, London, ON, Canada.							Gjelstad S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4403; National Clinical Guideline Centre (UK), 2013, AC KIDN INJ PREV DET; Scheepers-Hoeks AMJ, 2013, ARTIF INTELL MED, V59, P33, DOI 10.1016/j.artmed.2013.05.002	3	0	0	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC6	10.7326/ACPJC-2015-162-12-006	http://dx.doi.org/10.7326/ACPJC-2015-162-12-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075783				2022-12-28	WOS:000356516300007
J	Zeid, S; Bustreo, F; Barakat, MT; Maurer, P; Gilmore, K				Zeid, Sarah; Bustreo, Flavia; Barakat, Maha Taysir; Maurer, Peter; Gilmore, Kate			For every woman, every child, everywhere: a universal agenda for the health of women, children, and adolescents	LANCET			English	Editorial Material									[Zeid, Sarah] Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva, Switzerland; [Bustreo, Flavia] WHO, CH-1211 Geneva, Switzerland; [Barakat, Maha Taysir] Hlth Author Abu Dhabi, Abu Dhabi, U Arab Emirates; [Maurer, Peter] Int Comm Red Cross, Geneva, Switzerland; [Gilmore, Kate] UN Populat Fund, New York, NY USA	World Health Organization; United Nations Population Fund	Zeid, S (corresponding author), Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva, Switzerland.	pmnch@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Lewis J., 2001, 5 EUR SOC ASS C 2001; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Organisation for Economic Cooperation and Development, 2015, STAT FRAG 2015 M POS; Plan International, 2013, BEC I AM GIRL STAT W; UNICEF WHO The World Bank UN, 2014, LEV TRENDS CHILD MOR; WHO UNICEF UNFPA World Bank Group and the United Nations Population Division, 2013, TRENDS MAT MORT 1990	6	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1919	1920		10.1016/S0140-6736(15)60766-8	http://dx.doi.org/10.1016/S0140-6736(15)60766-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1YR	26090626				2022-12-28	WOS:000354541700004
J	Kornberg, TB				Kornberg, Thomas B.			Nanotubes in the niche	NATURE			English	Editorial Material							SELF-RENEWAL; STEM-CELLS; DROSOPHILA; TRANSPORT		Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kornberg, TB (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	tkornberg@ucsf.edu						Bischoff M, 2013, NAT CELL BIOL, V15, P1269, DOI 10.1038/ncb2856; Browne EN, 1909, J EXP ZOOL, V7, P1, DOI 10.1002/jez.1400070102; Guo Z, 2009, DEVELOPMENT, V136, P3627, DOI 10.1242/dev.036939; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Huang H, 2015, ELIFE, V4, DOI 10.7554/eLife.06114; Inaba M, 2015, NATURE, V523, P329, DOI 10.1038/nature14602; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Roy S, 2014, SCIENCE, V343, P852, DOI 10.1126/science.1244624; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Spemann H., 1924, DEV BIOL, V109, P599; Stanganello E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6846; Zheng Q, 2011, DEV BIOL, V357, P202, DOI 10.1016/j.ydbio.2011.06.022	13	4	4	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					292	293		10.1038/nature14631	http://dx.doi.org/10.1038/nature14631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26131936				2022-12-28	WOS:000357950900026
J	Shaw, A; Bradley, MD; Elyan, S; Kurian, KM				Shaw, Abigail; Bradley, Marcus D.; Elyan, Sean; Kurian, Kathreena M.			CASE REVIEW Tumour biomarkers: diagnostic, prognostic, and predictive	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							E-CADHERIN; RECEPTOR STATUS; CANCER BIOMARKERS; K-RAS; BREAST; METASTASES; ESTROGEN; CLASSIFICATION; CARCINOMAS; SURVIVAL		[Shaw, Abigail] Univ Bristol, Sch Med, Bristol BS8 1TH, Avon, England; [Bradley, Marcus D.] Inst Clin Neurosci, Bristol, Avon, England; [Elyan, Sean] Cheltenham Gen Hosp, Gloucestershire Oncol Ctr, Cheltenham, Glos, England; [Kurian, Kathreena M.] Southmead Hosp, Dept Neuropathol, Bristol, Avon, England	University of Bristol; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; Southmead Hospital	Shaw, A (corresponding author), Univ Bristol, Sch Med, Bristol BS8 1TH, Avon, England.	as0370@my.bristol.ac.uk		Kurian, Kathreena/0000-0003-0303-3716				Berghoff A, 2012, BRIT J CANCER, V106, P440, DOI 10.1038/bjc.2011.597; Bhatt AN, 2010, INDIAN J MED RES, V132, P129; Bracke ME, 1996, CURR TOP MICROBIOL, V213, P123; Cancer Research UK, CANC INC COMM CANC; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Clarke M, 1998, LANCET, V351, P1451; Conley BA, 2004, DIS MARKERS, V20, P35, DOI 10.1155/2004/202031; Enmark E, 1999, J INTERN MED, V246, P133, DOI 10.1046/j.1365-2796.1999.00545.x; Grann VR, 2005, CANCER-AM CANCER SOC, V103, P2241, DOI 10.1002/cncr.21030; Hajdu SI, 2006, ANN CLIN LAB SCI, V36, P222; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jelovac D, 2012, CURR TREAT OPTION ON, V13, P230, DOI 10.1007/s11864-012-0186-4; Jeschke U, 2007, ANTICANCER RES, V27, P1969; Jiang YX, 2010, BIOMARK MED, V4, P535, DOI 10.2217/BMM.10.74; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Lekanidi K, 2013, CLIN RADIOL, V68, P1070, DOI 10.1016/j.crad.2013.05.091; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Lower EE, 2005, BREAST CANCER RES TR, V90, P65, DOI 10.1007/s10549-004-2756-z; Madu CO, 2010, J CANCER, V1, P150; Meyer Helmut E., 2007, Cancer Genomics & Proteomics, V4, P263; Mishra Alok, 2010, Cancers (Basel), V2, P190, DOI 10.3390/cancers2010190; National Cancer Institute, CANC GEN ATL; National Cancer Institute, NAT CANC I DICT CANC; National Institute for Health and Care Excellence, 2009, EARL LOC ADV BREAST; National Institute of Health and Care Excellence, 2014, ADV BREAST CANC UPD; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Rhodes A, 2000, J CLIN PATHOL, V53, P688, DOI 10.1136/jcp.53.9.688; Singhai R, 2011, N AM J MED SCI, V3, P227, DOI 10.4297/najms.2011.3227; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Veronesi U, 2009, BREAST J, V15, P291, DOI 10.1111/j.1524-4741.2009.00719.x; Wellcome Trust Sanger Institute, CANC GEN PROJ; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x	38	11	11	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2015	351								h3449	10.1136/bmj.h3449	http://dx.doi.org/10.1136/bmj.h3449			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3UA	26141725				2022-12-28	WOS:000357609000004
J	Callaway, E				Callaway, Ewen			COMPUTERS READ THE FOSSIL RECORD	NATURE			English	Editorial Material																		Peters SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113523; 2012, NATURE, V483, P134	2	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					115	116		10.1038/523115a	http://dx.doi.org/10.1038/523115a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135452	Bronze			2022-12-28	WOS:000357169500043
J	Goodman, A				Goodman, Annekathryn			HPV testing as a screen for cervical cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HUMAN-PAPILLOMAVIRUS DNA; RISK HUMAN-PAPILLOMAVIRUS; LIQUID-BASED CYTOLOGY; INTRAEPITHELIAL NEOPLASIA; FOLLOW-UP; COST-EFFECTIVENESS; POOLED ANALYSIS; UNITED-STATES; WOMEN; PREVALENCE	Human papillomavirus (HPV) has been identified as a necessary factor in the development of pre-invasive and invasive cancers of the lower genital tract, of which cervical cancer is the most prevalent. A molecular understanding of malignant transformation and epidemiologic information has led to the development of many strategies for detection and early intervention. Newer tests for oncogenic subtypes of HPV have made it possible to predict the risk of future development of cervical cancer. This review summarizes the current understanding of HPV related disease and examines the role of HPV testing as a screening tool for cervical cancer. It summarizes the data from prospective and randomized controlled trials on HPV screening from Europe and North America and includes smaller studies from low and middle income countries where cervical cancer is the most common cancer in women.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gynecol Oncol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Goodman, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gynecol Oncol, Boston, MA 02114 USA.	agoodman@partners.org						Ahdieh L, 2001, J INFECT DIS, V184, P682, DOI 10.1086/323081; Aklimunnessa K, 2006, JPN J CLIN ONCOL, V36, P511, DOI 10.1093/jjco/hyl060; American Congress of Obstetricians and Gynecologists (ACOG), 2008, MAN ABN CERV CANC TE, V99; An HJ, 2011, GYNECOL ONCOL, V120, P284, DOI 10.1016/j.ygyno.2010.10.024; Andrae Bengt, 2012, BMJ, V344, pe900, DOI 10.1136/bmj.e900; Arbyn M, 2008, EUROPEAN GUIDELINES; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bernal-Silva S, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-31; Castle PE, 2012, J CLIN ONCOL, V30, P3044, DOI 10.1200/JCO.2011.38.8389; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Coleman DV, 2006, CYTOPATHOLOGY, V17, P127, DOI 10.1111/j.1365-2303.2006.00310.x; Coquillard G, 2011, GYNECOL ONCOL, V120, P89, DOI 10.1016/j.ygyno.2010.09.013; Coupe VMH, 2007, BJOG-INT J OBSTET GY, V114, P416, DOI 10.1111/j.1471-0528.2007.01265.x; Cox JT, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.020; Cubie HA, 2014, J CLIN PATHOL, V67, P458, DOI 10.1136/jclinpath-2013-202014; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; del Pino M, 2011, GYNECOL ONCOL, V122, P515, DOI 10.1016/j.ygyno.2011.05.012; Dillner J, 2013, CURR OPIN OBSTET GYN, V25, P11, DOI 10.1097/GCO.0b013e32835c5d10; Dochez C, 2014, VACCINE, V32, P1595, DOI 10.1016/j.vaccine.2013.10.081; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Eklund C, 2014, J CLIN MICROBIOL, V52, P449, DOI 10.1128/JCM.02453-13; Elfstrom KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g130; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Globocan, CERV CANC EST INC MO; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS78, DOI 10.1097/LGT.0b013e31828543c5; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Kawana Kei, 2012, Open Virol J, V6, P264, DOI 10.2174/1874357901206010264; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; Kulasingam SL, 2013, J LOW GENIT TRACT DI, V17, P193, DOI 10.1097/LGT.0b013e3182616241; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Liu SH, 2014, CANCER EPIDEM BIOMAR, V23, P200, DOI 10.1158/1055-9965.EPI-13-0666; Louvanto K, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.033; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Natphopsuk S, 2013, ASIAN PAC J CANCER P, V14, P6961, DOI 10.7314/APJCP.2013.14.11.6961; Natphopsuk S, 2012, ASIAN PAC J CANCER P, V13, P5489, DOI 10.7314/APJCP.2012.13.11.5489; Naucler P, 2009, JNCI-J NATL CANCER I, V101, P88, DOI 10.1093/jnci/djn444; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Ogilvie GS, 2012, BRIT J CANCER, V107, P1917, DOI 10.1038/bjc.2012.489; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Pan QJ, 2014, GYNECOL ONCOL, V133, P172, DOI 10.1016/j.ygyno.2014.03.008; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Rositch AF, 2014, CANCER-AM CANCER SOC, V120, P2032, DOI 10.1002/cncr.28548; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schmeink CE, 2010, OBSTET GYNECOL, V116, P67, DOI 10.1097/AOG.0b013e3181e238f0; Smelov V, 2015, INT J CANCER, V136, P1171, DOI 10.1002/ijc.29085; Smith EM, 2003, CANCER DETECT PREV, V27, P472, DOI 10.1016/S0361-090X(03)00104-1; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; SOOST HJ, 1991, ACTA CYTOL, V35, P8; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Suba EJ, 2001, CANCER-AM CANCER SOC, V91, P928, DOI 10.1002/1097-0142(20010301)91:5<928::AID-CNCR1082>3.0.CO;2-S; Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12; Thomsen LT, 2014, OBSTET GYNECOL, V123, P57, DOI 10.1097/AOG.0000000000000056; Vicus D, 2014, GYNECOL ONCOL, V133, P167, DOI 10.1016/j.ygyno.2014.02.037; Vintermyr OK, 2014, GYNECOL ONCOL, V133, P159, DOI 10.1016/j.ygyno.2014.03.004; WHO, 2013, WHO GUID SCREEN TREA; Wright TC, 2011, AM J CLIN PATHOL, V136, P578, DOI 10.1309/AJCPTUS5EXAS6DKZ; Zazove P, 1998, J CLIN MICROBIOL, V36, P2708, DOI 10.1128/JCM.36.9.2708-2713.1998; Zoodsma M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.031351; Zorzi M, 2013, BJOG-INT J OBSTET GY, V120, P1260, DOI 10.1111/1471-0528.12272; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	75	128	139	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2015	350								h2372	10.1136/bmj.h2372	http://dx.doi.org/10.1136/bmj.h2372			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TN	26126623				2022-12-28	WOS:000357607400001
J	Lamont, K; Scott, NW; Jones, GT; Bhattacharya, S				Lamont, Kathleen; Scott, Neil W.; Jones, Gareth T.; Bhattacharya, Sohinee			Risk of recurrent stillbirth: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUBSEQUENT PREGNANCY; FETAL-DEATH; CLASSIFICATION; OUTCOMES; SMOKING; OBESITY; TRENDS; COMPLICATIONS	OBJECTIVE To determine the risk of recurrent stillbirth. DESIGN Systematic review and meta-analysis of cohort and case-control studies. DATA SOURCES Embase, Medline, Cochrane Library, PubMed, CINAHL, and Scopus searched systematically with no restrictions on date, publication, or language to identify relevant studies. Supplementary efforts included searching relevant internet resources as well as hand searching the reference lists of included studies. Where published information was unclear or inadequate, corresponding authors were contacted for more information. STUDY SELECTION Cohort and case-control studies from high income countries were potentially eligible if they investigated the association between stillbirth in an initial pregnancy and risk of stillbirth in a subsequent pregnancy. Stillbirth was defined as fetal death occurring at more than 20 weeks' gestation or a birth weight of at least 400 g. Two reviewers independently screened titles to identify eligible studies based on inclusion and exclusion criteria agreed a priori, extracted data, and assessed the methodological quality using scoring criteria from the critical appraisal skills programme. Random effects meta-analyses were used to combine the results of the included studies. Subgroup analysis was performed on studies that examined unexplained stillbirth. RESULTS 13 cohort studies and three case-control studies met the inclusion criteria and were included in the meta-analysis. Data were available on 3 412 079 women with pregnancies beyond 20 weeks duration, of who 3 387 538 (99.3%) had had a previous live birth and 24 541 (0.7%) a stillbirth. A total of 14 283 stillbirths occurred in subsequent pregnancies, 606/24 541 (2.5%) in women with a history of stillbirth and 13 677/3 387 538 (0.4%) among women with no such history (pooled odds ratio 4.83, 95% confidence interval 3.77 to 6.18). 12 studies specifically assessed the risk of stillbirth in second pregnancies. Compared with women who had a live birth in their first pregnancy, those who experienced a stillbirth were almost five times more likely to experience a stillbirth in their second pregnancy (odds ratio 4.77, 95% confidence interval 3.70 to 6.15). The pooled odds ratio using the adjusted effect measures from the primary studies was 3.38 (95% confidence interval 2.61 to 4.38). Four studies examined the risk of recurrent unexplained stillbirth. Methodological differences between these studies precluded pooling the results. CONCLUSIONS The risk of stillbirth in subsequent pregnancies is higher in women who experience a stillbirth in their first pregnancy. This increased risk remained after adjusted analysis. Evidence surrounding the recurrence risk of unexplained stillbirth remains controversial.	[Lamont, Kathleen; Jones, Gareth T.; Bhattacharya, Sohinee] Univ Aberdeen, Epidemiol Grp, Inst Appl Hlth Sci, Aberdeen, Scotland; [Scott, Neil W.] Univ Aberdeen, Inst Appl Hlth Sci, Med Stat Team, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Bhattacharya, S (corresponding author), Aberdeen Matern Hosp, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland.	sohinee.bhattacharya@abdn.ac.uk	Jones, Gareth/T-1755-2019	Jones, Gareth/0000-0003-0016-7591; Scott, Neil/0000-0002-8067-9660	University of Aberdeen	University of Aberdeen	The University of Aberdeen acted as sponsors for this research project, but the findings and their interpretation in this study are the authors' own.	[Anonymous], 2013, CRITICAL APPRAISAL S; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bhattacharya S, 2010, BJOG-INT J OBSTET GY, V117, P1243, DOI 10.1111/j.1471-0528.2010.02641.x; Black M, 2008, BJOG-INT J OBSTET GY, V115, P269, DOI 10.1111/j.1471-0528.2007.01562.x; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2469, DOI 10.1001/jama.2011.1798; Chan A, 2004, J PAEDIATR CHILD H, V40, P340, DOI 10.1111/j.1440-1754.2004.00398.x; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Cnattingius S, 2002, SEMIN PERINATOL, V26, P25, DOI 10.1053/sper.2002.29841; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Cochrane Collaboration, 2013, EV BAS HLTH CAR SYST; Cochrane Collaboration, 2012, REV MAN REVMAN; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Flenady V, 2009, PSANZ CLIN PRACTICE; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-22; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Getahun D, 2009, OBSTET GYNECOL, V201; Gordon A, 2012, OBSTET GYNECOL, V119, P509, DOI 10.1097/AOG.0b013e31824781f8; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hogberg L, 2007, BJOG-INT J OBSTET GY, V114, P699, DOI 10.1111/j.1471-0528.2007.01340.x; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; lancet.com, 2011, STILLB; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Light R.J., 1984, SUMMING SCI REV RES; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; MANTEL N, 1959, J NATL CANCER I, V22, P719; Measey MA, 2009, AUST NZ J OBSTET GYN, V49, P151, DOI 10.1111/j.1479-828X.2009.00982.x; Melve KK, 2010, AM J EPIDEMIOL, V172, P1123, DOI 10.1093/aje/kwq259; Mohsin M, 2008, BJOG-INT J OBSTET GY, V115, P1428, DOI 10.1111/j.1471-0528.2008.01864.x; NIJKAMP J, 2013, AM J OBSTET GYNECO S, V208, pS63; Nijkamp JW, 2013, EUR J OBSTET GYN R B, V166, P37, DOI 10.1016/j.ejogrb.2012.10.008; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Ofir K, 2013, J PERINAT MED, V41, P543, DOI 10.1515/jpm-2013-0013; Patterson JA, 2014, AUST NZ J PUBL HEAL, V38, P384, DOI 10.1111/1753-6405.12179; ProQuest, 2013, THESIS; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Robson S, 2001, AUST NZ J OBSTET GYN, V41, P29, DOI 10.1111/j.1479-828X.2001.tb01290.x; SAMUELOFF A, 1993, J REPROD MED, V38, P883; Sharma PP, 2006, OBSTET GYNECOL, V107, P391, DOI 10.1097/01.AOG.0000196501.32272.44; Silver RM, 2007, OBSTET GYNECOL, V109, P153, DOI 10.1097/01.AOG.0000248537.89739.96; Silver RM, 2011, STILLBIRTH: PREDICTION, PREVENTION AND MANAGEMENT, P187; Smith G, 2012, AM J OBSTET GYNECOL, V206, pS64, DOI 10.1016/j.ajog.2011.10.133; Stacey T, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-3; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; UKCRN, 2013, UK CLIN RES NETW STU; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; WHITFIELD CR, 1986, BRIT J OBSTET GYNAEC, V93, P694, DOI 10.1111/j.1471-0528.1986.tb08054.x; World Bank, 2013, COUNTR LEND GROUPS	53	110	115	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2015	350								h3080	10.1136/bmj.h3080	http://dx.doi.org/10.1136/bmj.h3080			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NX	26109551	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000357160000001
J	Dror, RO; Mildorf, TJ; Hilger, D; Manglik, A; Borhani, DW; Arlow, DH; Philippsen, A; Villanueva, N; Yang, ZY; Lerch, MT; Hubbell, WL; Kobilka, BK; Sunahara, RK; Shaw, DE				Dror, Ron O.; Mildorf, Thomas J.; Hilger, Daniel; Manglik, Aashish; Borhani, David W.; Arlow, Daniel H.; Philippsen, Ansgar; Villanueva, Nicolas; Yang, Zhongyu; Lerch, Michael T.; Hubbell, Wayne L.; Kobilka, Brian K.; Sunahara, Roger K.; Shaw, David E.			Structural basis for nucleotide exchange in heterotrimeric G proteins	SCIENCE			English	Article							BETA(2) ADRENERGIC-RECEPTOR; ALPHA-SUBUNIT; COUPLED RECEPTORS; HELICAL DOMAIN; CRYSTAL-STRUCTURE; ACTIVATION; TRANSDUCIN; BINDING; INTERDOMAIN; FLEXIBILITY	G protein-coupled receptors (GPCRs) relay diverse extracellular signals into cells by catalyzing nucleotide release from heterotrimeric G proteins, but the mechanism underlying this quintessential molecular signaling event has remained unclear. Here we use atomic-level simulations to elucidate the nucleotide-release mechanism. We find that the G protein a subunit Ras and helical domains-previously observed to separate widely upon receptor binding to expose the nucleotide-binding site-separate spontaneously and frequently even in the absence of a receptor. Domain separation is necessary but not sufficient for rapid nucleotide release. Rather, receptors catalyze nucleotide release by favoring an internal structural rearrangement of the Ras domain that weakens its nucleotide affinity. We use double electron-electron resonance spectroscopy and protein engineering to confirm predictions of our computationally determined mechanism.	[Dror, Ron O.; Mildorf, Thomas J.; Borhani, David W.; Arlow, Daniel H.; Philippsen, Ansgar; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Hilger, Daniel; Manglik, Aashish; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Villanueva, Nicolas; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Yang, Zhongyu; Lerch, Michael T.; Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Yang, Zhongyu; Lerch, Michael T.; Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Shaw, David E.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	D. E. Shaw Research; Stanford University; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University	Dror, RO (corresponding author), Stanford Univ, Dept Comp Sci, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	ron.dror@deshawresearch.com; david.shaw@deshawresearch.com	Hilger, Daniel/C-7297-2019; Borhani, David/O-2692-2019; Lerch, Michael/AAC-8551-2019; Sunahara, Roger/AAJ-8667-2020; Cote, Rick H/G-3363-2013	Hilger, Daniel/0000-0001-5179-1357; Borhani, David/0000-0002-8486-8792; Lerch, Michael/0000-0002-2406-9972; Cote, Rick H/0000-0002-1573-6526; Villanueva, Nicolas/0000-0002-9856-1417; Dror, Ron/0000-0002-6418-2793; Kobilka, Brian/0000-0001-5958-3990	NIH [R01GM083118, R01EY05216]; Jules Stein Professor Endowment; National Eye Institute Core Grant [P30EY00331]; Research to Prevent Blindness; German Academic Exchange Service (DAAD); NATIONAL EYE INSTITUTE [R01EY005216, P30EY000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118, T32GM008294] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Stein Professor Endowment; National Eye Institute Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Pan for assistance with TAMD, K. Palmo for help with force field parameterization, J. Valcourt and H. Green for advice on figures, and M. Kirk for editorial assistance. Portions of this work were funded by NIH grants R01GM083118 (B.K.K. and R.K.S.) and R01EY05216 (W.L.H.), the Jules Stein Professor Endowment (W.L.H.), National Eye Institute Core Grant P30EY00331 (W.L.H.), and a Research to Prevent Blindness unrestricted grant (to the Jules Stein Eye Institute). D.H. was supported by the German Academic Exchange Service (DAAD). Author contributions: R.O.D. conceived this study and, with D.E.S., oversaw MD simulations and analysis. R.O.D., T.J.M., and D.H.A. designed MD simulations. T.J.M. performed MD simulations and, with D.W.B., modeled proteins based on crystal structures. T.J.M. analyzed MD simulations, with guidance from R.O.D. T.J.M. and A.P. performed molecular visualization. D.H. developed a minimal cysteine construct for Gs, prepared spin-labeled protein, and assisted Z.Y. and M.T.L. in obtaining and analyzing DEER data. A. M. and D.H. designed the HD-tether construct, and A. M. performed the kinetics experiments. W.L.H. and B.K.K. supervised experimental work. R.O.D., T.J.M., N.V., and R.K.S. interpreted and synthesized data. R.O.D., T.J.M., D.W.B., and D.E.S. wrote the manuscript, with input from D.H., A. M., B.K.K., and R.K.S. R.O.D. and D.E.S. supervised the overall research.	Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Ceruso MA, 2004, J MOL BIOL, V338, P469, DOI 10.1016/j.jmb.2004.02.064; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Dohlman HG, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003013; Elgeti M, 2013, J AM CHEM SOC, V135, P12305, DOI 10.1021/ja405133k; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Khafizov K, 2009, PROTEINS, V75, P919, DOI 10.1002/prot.22303; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Louet M, 2011, J MOL BIOL, V411, P298, DOI 10.1016/j.jmb.2011.05.034; Marin EP, 2001, J BIOL CHEM, V276, P23873, DOI 10.1074/jbc.M101197200; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; Mello LV, 1998, BIOCHEMISTRY-US, V37, P3137, DOI 10.1021/bi971402v; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2009, P NATL ACAD SCI USA, V106, P10660, DOI 10.1073/pnas.0900072106; Shnerb T, 2007, BIOCHEMISTRY-US, V46, P10875, DOI 10.1021/bi700585w; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Van Eps N, 2015, P NATL ACAD SCI USA, V112, P1404, DOI 10.1073/pnas.1423878112; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108	28	173	175	2	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1361	1365		10.1126/science.aaa5264	http://dx.doi.org/10.1126/science.aaa5264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089515	Green Accepted			2022-12-28	WOS:000356449500051
J	Farrar, J				Farrar, Jeremy			Science, Medicine, and Society A View From the Wellcome Trust	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Wellcome Trust Res Labs, London NW1 2BE, England		Farrar, J (corresponding author), Wellcome Trust Res Labs, Gibbs Bldg,215 Euston Rd, London NW1 2BE, England.	j.farrar@wellcome.ac.uk	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				CAMERON D, 1983, INT J EPIDEMIOL, V12, P393, DOI 10.1093/ije/12.4.393; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Loudon I, 2013, J ROY SOC MED, V106, P461, DOI 10.1177/0141076813507844; Wellcome Trust, 2014, WELLC TRUST ANN REP; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	5	1	2	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2315	2316		10.1001/jama.2015.2004	http://dx.doi.org/10.1001/jama.2015.2004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080334				2022-12-28	WOS:000356300200010
J	Robinson, L; Tang, E; Taylor, JP				Robinson, Louise; Tang, Eugene; Taylor, John-Paul			Dementia: timely diagnosis and early intervention	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ALZHEIMERS ASSOCIATION WORKGROUPS; REVISED ACE-R; PRIMARY-CARE; COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE; LEWY BODIES; GUIDELINES; RECOMMENDATIONS; METAANALYSIS; MANAGEMENT		[Robinson, Louise; Tang, Eugene] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Taylor, John-Paul] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Robinson, L (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	a.l.robinson@ncl.ac.uk	Taylor, John Paul/D-1480-2009	Taylor, John Paul/0000-0001-7958-6558; Tang, Eugene/0000-0003-1030-9311; Robinson, Louise/0000-0003-0209-2503	National Institute for Health Research professorship [NIHR-RP-011-043]; National Institute for Health Research [NIHR-RP-011-043, ACF-2012-01-012] Funding Source: researchfish	National Institute for Health Research professorship; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank Tim Beanland, knowledge services manager at the Alzheimer's Society, London for advice. LR is supported by a National Institute for Health Research professorship (NIHR-RP-011-043).	Alzheimer Europe, 2013, NAT DEM STRAT DIAGN; Bamford C, 2007, FAM PRACT, V24, P108, DOI 10.1093/fampra/cml068; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231; Cameron ID, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5202; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Ferri C, 2011, WORLD ALZHEIMER REPO; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gibson G, 2014, DEMENTIA LONDON; Hort J, 2010, EUR J NEUROL, V17, P1236, DOI 10.1111/j.1468-1331.2010.03040.x; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Iliffe S, 2009, INT J GERIATR PSYCH, V24, P895, DOI 10.1002/gps.2204; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Knapp M, 2013, INT J GERIATR PSYCH, V28, P551, DOI 10.1002/gps.3864; Kostopoulou O, 2008, FAM PRACT, V25, P400, DOI 10.1093/fampra/cmn071; Larner AJ, 2014, INT PSYCHOGERIATR, V26, P555, DOI 10.1017/S1041610213002329; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meeuwsen EJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3086; Milne A, 2008, INT PSYCHOGERIATR, V20, P911, DOI 10.1017/S1041610208007394; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; National Institute for Health and Care Excellence, 2006, DEM SUPP PEOPL DEM T; National Institute for Health and Care Excellence, 2011, DON GAL RIV MEM TREA; Prince M, 2013, POLICY BRIEF HEADS G; Prince M., 2014, DEMENTIA RISK REDUCT; Prince M., 2014, DEMENTIA UK; Ritchie C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008782.pub4; Robinson L, 2012, AGE AGEING, V41, P263, DOI 10.1093/ageing/afr148; Robinson L, 2011, INT PSYCHOGERIATR, V23, P1026, DOI 10.1017/S1041610210002437; Rossor MN, 2010, LANCET NEUROL, V9, P793, DOI 10.1016/S1474-4422(10)70159-9; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; van der Steen JT, 2010, J ALZHEIMERS DIS, V22, P37, DOI 10.3233/JAD-2010-100744; Walker Z, 2015, BRIT J PSYCHIAT, V206, P145, DOI 10.1192/bjp.bp.114.148643; Yokomizo JE, 2014, INT PSYCHOGERIATR, V26, P1783, DOI 10.1017/S1041610214001082; Zhang S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010386.pub2	41	215	215	2	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2015	350								h3029	10.1136/bmj.h3029	http://dx.doi.org/10.1136/bmj.h3029			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2OJ	26079686	hybrid, Green Published			2022-12-28	WOS:000356783600003
J	Bhadelia, N				Bhadelia, Nahid			Rapid diagnostics for Ebola in emergency settings	LANCET			English	Editorial Material							VIRUS DISEASE; EPIDEMIC		Boston Univ, Sch Med, Natl Emerging Infect Dis Labs, Sect Infect Dis,Boston Med Ctr, Boston, MA 02118 USA	Boston Medical Center; Boston University	Bhadelia, N (corresponding author), Boston Univ, Sch Med, Natl Emerging Infect Dis Labs, Sect Infect Dis,Boston Med Ctr, Boston, MA 02118 USA.	nahid.bhadelia@bmc.org	Bhadelia, Nahid/HCH-3580-2022	Bhadelia, Nahid/0000-0003-4512-2741				Blackley DJ, 2015, MMWR-MORBID MORTAL W, V64, P175; Broadhurst MJ, 2015, LANCET; Dhillon RS, 2015, LANCET INFECT DIS, V15, P147, DOI 10.1016/S1473-3099(14)71035-7; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Janvier F, 2015, J CLIN VIROL, V67, P36, DOI 10.1016/j.jcv.2015.04.001; O'Shea MK, 2015, CLIN INFECT DIS, V61, P795, DOI 10.1093/cid/civ399; Perkins MD, 2015, NAT BIOTECHNOL, V33, P464, DOI 10.1038/nbt.3215; Strecker T, 2015, CLIN INFECT DIS, V61, P669, DOI 10.1093/cid/civ397; WHO, 2015, EB SIT REP JUN 3 201; WHO, 2015, 1 ANT RAP TEST EB EM; WHO Ebola Response Team, 2014, N ENGL J MED, V371, P1481	12	4	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					833	835		10.1016/S0140-6736(15)61119-9	http://dx.doi.org/10.1016/S0140-6736(15)61119-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0MJ	26119839	Bronze			2022-12-28	WOS:000360290000005
J	Fokom-Domgue, J; Combescure, C; Fokom-Defo, V; Tebeu, PM; Vassilakos, P; Kengne, AP; Petignat, P				Fokom-Domgue, Joel; Combescure, Christophe; Fokom-Defo, Victoire; Tebeu, Pierre Marie; Vassilakos, Pierre; Kengne, Andre Pascal; Petignat, Patrick			Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VISUAL INSPECTION METHODS; HIV-INFECTED WOMEN; ACETIC-ACID; NEOPLASIA; LESIONS; BIAS; MULTICENTER; POPULATION; PREVENTION; BENEFITS	OBJECTIVE To assess and compare the accuracy of visual inspection with acetic acid (VIA), visual inspection with Lugol's iodine (VILI), and human papillomavirus (HPV) testing as alternative standalone methods for primary cervical cancer screening in sub-Saharan Africa. DESIGN Systematic review and meta-analysis of diagnostic test accuracy studies. DATA SOURCES Systematic searches of multiple databases including Medline, Embase, and Scopus for studies published between January 1994 and June 2014. REVIEW METHODS Inclusion criteria for studies were: alternative methods to cytology used as a standalone test for primary screening; study population not at particular risk of cervical cancer (excluding studies focusing on HIV positive women or women with gynaecological symptoms); women screened by nurses; reference test (colposcopy and directed biopsies) performed at least in women with positive screening results. Two reviewers independently screened studies for eligibility and extracted data for inclusion, and evaluated study quality using the quality assessment of diagnostic accuracy studies 2 (QUADAS-2) checklist. Primary outcomes were absolute accuracy measures (sensitivity and specificity) of screening tests to detect cervical intraepithelial neoplasia grade 2 or worse (CIN2+). RESULTS 15 studies of moderate quality were included (n= 61 381 for VIA, n= 46 435 for VILI, n= 11 322 for HPV testing). Prevalence of CIN2+ did not vary by screening test and ranged from 2.3% (95% confidence interval 1.5% to 3.3%) in VILI studies to 4.9% (2.7% to 7.8%) in HPV testing studies. Positivity rates of VILI, VIA, and HPV testing were 16.5% (9.8% to 24.7%), 16.8% (11.0% to 23.6%), and 25.8% (17.4% to 35.3%), respectively. Pooled sensitivity was higher for VILI (95.1%; 90.1% to 97.7%) than VIA (82.4%; 76.3% to 87.3%) in studies where the reference test was performed in all women (P< 0.001). Pooled specificity of VILI and VIA were similar (87.2% (78.1% to 92.8%) v 87.4% (77.1% to 93.4%); P< 0.85). Pooled sensitivity and specificity were similar for HPV testing versus VIA (both P >= 0.23) and versus VILI (both P >= 0.16). Accuracy of VIA and VILI increased with sample size and time period. CONCLUSIONS For primary screening of cervical cancer in sub-Saharan Africa, VILI is a simple and affordable alternative to cytology that demonstrates higher sensitivity than VIA. Implementation studies are needed to assess the effect of these screening strategies on the incidence and outcomes of cervical cancer in the region.	[Fokom-Domgue, Joel; Tebeu, Pierre Marie] Univ Yaounde, Dept Gynecol & Obstet, Fac Med & Biomed Sci, Yaounde, Cameroon; [Fokom-Domgue, Joel; Petignat, Patrick] Univ Hosp Geneva, Div Gynecol, Dept Gynecol & Obstet, CH-1211 Geneva 14, Switzerland; [Combescure, Christophe] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland; [Fokom-Defo, Victoire] Yaounde Cent Hosp, Div Infect & Chron Dis, Dept Internal Med, Yaounde, Cameroon; [Vassilakos, Pierre] Geneva Fdn Med Educ & Res, Geneva, Switzerland; [Kengne, Andre Pascal] South African Med Res Council, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Yaounde I; University of Geneva; University of Geneva; South African Medical Research Council; University of Cape Town	Fokom-Domgue, J (corresponding author), Univ Yaounde, Dept Gynecol & Obstet, Fac Med & Biomed Sci, Yaounde, Cameroon.	fokom.domgue@gmail.com	Fokom-Domgue, Joel/AAI-8191-2020; Kengne, Andre Pascal/ABB-3696-2020	Fokom-Domgue, Joel/0000-0002-4722-9262; Kengne, Andre Pascal/0000-0002-5183-131X; Petignat, Patrick/0000-0002-6835-533X	International Solidarity of Geneva	International Solidarity of Geneva	Statistical analyses were funded by the International Solidarity of Geneva. However, researchers are fully independent from funders. The organisation that financed statistical analyses did not have a role in study design, data collection, data analysis, data interpretation, and writing of the manuscript. The corresponding author had the final responsibility for the decision to submit the report.	Adefuye PO, 2013, VACCINE, V31, pF53, DOI 10.1016/j.vaccine.2012.06.070; Ajenifuja KO, 2013, INT J GYNECOL CANCER, V23, P507, DOI 10.1097/IGC.0b013e318280f395; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Blumenthal PD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.031; Bradford L, 2013, CLIN OBSTET GYNECOL, V56, P76, DOI 10.1097/GRF.0b013e31828237ac; Cronje HS, 2003, AM J OBSTET GYNECOL, V188, P395, DOI 10.1067/mob.2003.153; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; De Vuyst H, 2005, INT J GYNECOL OBSTET, V89, P120, DOI 10.1016/j.ijgo.2005.01.035; Denny L, 2000, CANCER-AM CANCER SOC, V89, P826, DOI 10.1002/1097-0142(20000815)89:4&lt;826::AID-CNCR15&gt;3.0.CO;2-5; Denny L, 2002, CANCER-AM CANCER SOC, V94, P1699, DOI 10.1002/cncr.10381; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doebler P, 2012, PSYCHOL METHODS, V17, P418, DOI 10.1037/a0028091; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fokom-Domgue J, 2014, PREV MED, V65, P138, DOI 10.1016/j.ypmed.2014.05.014; Gaffikin L, 1999, LANCET, V353, P869; Gasparrini A, 2012, STAT MED, V31, P3821, DOI 10.1002/sim.5471; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Hadzic B, 1999, Med Pregl, V52, P151; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04704; Huchko MJ, 2014, B WORLD HEALTH ORGAN, V92, P195, DOI 10.2471/BLT.13.122051; Ibrahim A, 2012, INT J WOMENS HEALTH, V4, P67, DOI 10.2147/IJWH.S28406; Jackson D, 2011, STAT MED, V30, P2481, DOI 10.1002/sim.4172; Jeronimo J, 2014, INT J GYNECOL CANCER, V24, P576, DOI 10.1097/IGC.0000000000000084; Kang LN, 2014, J CLIN MICROBIOL, V52, P1954, DOI 10.1128/JCM.03432-13; Katz IT, 2006, NEW ENGL J MED, V354, P1110, DOI 10.1056/NEJMp068031; Kohn MA, 2013, ACAD EMERG MED, V20, P1194, DOI 10.1111/acem.12255; Kuhn L, 2000, JNCI-J NATL CANCER I, V92, P818, DOI 10.1093/jnci/92.10.818; Labani S, 2014, EUR J OBSTET GYN R B, V176, P75, DOI 10.1016/j.ejogrb.2014.03.006; Mahmud SM, 2012, GYNECOL ONCOL, V124, P286, DOI 10.1016/j.ygyno.2011.10.031; Mandelblatt JS, 2002, JNCI-J NATL CANCER I, V94, P1469, DOI 10.1093/jnci/94.19.1469; Megevand E, 1996, AM J OBSTET GYNECOL, V174, P923, DOI 10.1016/S0002-9378(96)70327-7; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moodley JR, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-135; Murillo R, 2010, INT J GYNECOL OBSTET, V109, P230, DOI 10.1016/j.ijgo.2010.01.019; Muwonge R, 2010, INT J GYNECOL OBSTET, V111, P68, DOI 10.1016/j.ijgo.2010.04.024; Ngoma T, 2010, INT J GYNECOL OBSTET, V109, P100, DOI 10.1016/j.ijgo.2009.11.025; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Pretorius RG, 2007, INT J CANCER, V121, P2218, DOI 10.1002/ijc.22991; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sangiva-Lugoma G, 2006, INT J CANCER, V119, P1389, DOI 10.1002/ijc.21972; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2004, INT J CANCER, V112, P341, DOI 10.1002/ijc.20396; Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS, P1; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1; Womack SD, 2000, BRIT J OBSTET GYNAEC, V107, P33, DOI 10.1111/j.1471-0528.2000.tb11576.x; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	57	63	63	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2015	351								h3084	10.1136/bmj.h3084	http://dx.doi.org/10.1136/bmj.h3084			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3UA	26142020	hybrid, Green Published			2022-12-28	WOS:000357609000001
J	McCoy, SW				McCoy, Scott W.			Landscapes in the lab	SCIENCE			English	Editorial Material									Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	McCoy, SW (corresponding author), Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA.	scottmccoy@unr.edu						Davis W M, 1892, Science, V20, P245; Gilbert GK, 1909, J GEOL, V17, P344, DOI 10.1086/621620; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; MONTGOMERY DR, 1992, SCIENCE, V255, P826, DOI 10.1126/science.255.5046.826; Paola C, 2009, EARTH-SCI REV, V97, P1, DOI 10.1016/j.earscirev.2009.05.003; Perron J., 2008, J GEOPHYS RES, V113, P1; Perron JT, 2009, NATURE, V460, P502, DOI 10.1038/nature08174; Sweeney KE, 2015, SCIENCE, V349, P51, DOI 10.1126/science.aab0017	8	1	1	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					32	33		10.1126/science.aac5794	http://dx.doi.org/10.1126/science.aac5794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138966				2022-12-28	WOS:000357280800045
J	Levine, JH; Simonds, EF; Bendall, SC; Davis, KL; Amir, EAD; Tadmor, MD; Litvin, O; Fienberg, HG; Jager, A; Zunder, ER; Finck, R; Gedman, AL; Radtke, I; Downing, JR; Pe'er, D; Nolan, GP				Levine, Jacob H.; Simonds, Erin F.; Bendall, Sean C.; Davis, Kara L.; Amir, El-ad D.; Tadmor, Michelle D.; Litvin, Oren; Fienberg, Harris G.; Jager, Astraea; Zunder, Eli R.; Finck, Rachel; Gedman, Amanda L.; Radtke, Ina; Downing, James R.; Pe'er, Dana; Nolan, Garry P.			Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; MASS CYTOMETRY; HETEROGENEITY; CANCER; DECONVOLUTION	Acute myeloid leukemia (AML) manifests as phenotypically and functionally diverse cells, often within the same patient. Intratumor phenotypic and functional heterogeneity have been linked primarily by physical sorting experiments, which assume that functionally distinct subpopulations can be prospectively isolated by surface phenotypes. This assumption has proven problematic, and we therefore developed a data-driven approach. Using mass cytometry, we profiled surface and intracellular signaling proteins simultaneously in millions of healthy and leukemic cells. We developed PhenoGraph, which algorithmically defines phenotypes in high-dimensional single-cell data. PhenoGraph revealed that the surface phenotypes of leukemic blasts do not necessarily reflect their intracellular state. Using hematopoietic progenitors, we defined a signaling-based measure of cellular phenotype, which led to isolation of a gene expression signature that was predictive of survival in independent cohorts. This study presents new methods for large-scale analysis of single-cell heterogeneity and demonstrates their utility, yielding insights into AML pathophysiology.	[Levine, Jacob H.; Amir, El-ad D.; Tadmor, Michelle D.; Litvin, Oren; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Levine, Jacob H.; Amir, El-ad D.; Tadmor, Michelle D.; Litvin, Oren; Pe'er, Dana] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Simonds, Erin F.; Davis, Kara L.; Fienberg, Harris G.; Jager, Astraea; Zunder, Eli R.; Finck, Rachel; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Bendall, Sean C.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Gedman, Amanda L.; Radtke, Ina; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	Columbia University; Columbia University; Stanford University; Stanford University; St Jude Children's Research Hospital	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	dpeer@biology.columbia.edu; gnolan@stanford.edu	Downing, James R./N-8102-2018; Nolan, Garry/AAE-7903-2019; Bendall, Sean/AGG-0126-2022	Pe'er, Dana/0000-0002-9259-8817; Zunder, Eli/0000-0002-0356-1685; Bendall, Sean/0000-0003-1341-2453; Simonds, Erin/0000-0002-3497-4861; Nolan, Garry/0000-0002-8862-9043	DRCRF Fellowships [DRG 2190-14, DRG-2017-09]; NIH [1R00-GM104148, DP1-HD084071, DP2-OD002414, R01-CA164729 U54-CA121852, 1R01CA130826, 5U54CA143907, HHSN272200700038C, N01-HV-00242, P01 CA034233, U19 AI057229, U54CA149145]; Stand Up To Cancer Phillip A. Sharp Award [SU2C-AACR-PS04]; CIRM [DR1-01477, RB2-01592]; EC [HEALTH.2010.1.2-1]; US FDA [HHSF223201210194C]; US DOD [W81XWH-12-1-0591]; Entertainment Industry Foundation; Rachford and Carlota Harris Endowed Professorship; Packard Fellowship for Science and Engineering; Div Of Molecular and Cellular Bioscience [1149728] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD084071] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA034233, U54CA143907, U54CA149145, R01CA130826, U54CA121852, R01CA164729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798, R00GM104148] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414] Funding Source: NIH RePORTER	DRCRF Fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer Phillip A. Sharp Award; CIRM(California Institute for Regenerative Medicine); EC(European CommissionEuropean Commission Joint Research Centre); US FDA(United States Department of Health & Human Services); US DOD(United States Department of Defense); Entertainment Industry Foundation; Rachford and Carlota Harris Endowed Professorship; Packard Fellowship for Science and Engineering; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Behbehani, W. Fantl, B.J. Chen, and L. Zelnik for helpful discussion. E.F.S. and S.C.B. are supported by DRCRF Fellowships (DRG 2190-14 & DRG-2017-09) and NIH 1R00-GM104148 to S.C.B. Grants from NIH (DP1-HD084071, DP2-OD002414, R01-CA164729 U54-CA121852), Stand Up To Cancer Phillip A. Sharp Award SU2C-AACR-PS04 and Packard Fellowship for Science and Engineering supported D.P. Grants from NIH (1R01CA130826, 5U54CA143907, HHSN272200700038C, N01-HV-00242, P01 CA034233, U19 AI057229 and U54CA149145), CIRM (DR1-01477 and RB2-01592), EC (HEALTH.2010.1.2-1), US FDA (HHSF223201210194C), US DOD (W81XWH-12-1-0591), the Entertainment Industry Foundation, and the Rachford and Carlota Harris Endowed Professorship supported G.P.N. G.P.N., S.C.B, H.G.F., and E.F.S. have a personal financial interest in the company Fluidigm, the manufacturer of the mass cytometer used in this manuscript.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gibbs KD, 2011, BLOOD, V117, P4226, DOI 10.1182/blood-2010-07-298232; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Toren A, 2005, STEM CELLS, V23, P1142, DOI 10.1634/stemcells.2004-0317; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	29	888	905	4	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					184	197		10.1016/j.cell.2015.05.047	http://dx.doi.org/10.1016/j.cell.2015.05.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26095251	Green Accepted, Bronze			2022-12-28	WOS:000357542300019
J	Chang, LF; Zhang, ZG; Yang, J; McLaughlin, SH; Barford, D				Chang, Leifu; Zhang, Ziguo; Yang, Jing; McLaughlin, Stephen H.; Barford, David			Atomic structure of the APC/C and its mechanism of protein ubiquitination	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; E3 LIGASE; CRYSTAL-STRUCTURE; CHAIN ELONGATION; CONJUGATING ENZYME; MITOTIC REGULATION; ACTIVATION; REVEALS; SUBUNIT; PHOSPHORYLATION	The anaphase-promoting complex (APC/C) is a multimeric RING E3 ubiquitin ligase that controls chromosome segregation and mitotic exit. Its regulation by coactivator subunits, phosphorylation, the mitotic checkpoint complex and interphase early mitotic inhibitor 1 (Emi1) ensures the correct order and timing of distinct cell-cycle transitions. Here we use cryo-electron microscopy to determine atomic structures of APC/C-coactivator complexes with either Emi1 or a UbcH10-ubiquitin conjugate. These structures define the architecture of all APC/C subunits, the position of the catalytic module and explain how Emi1 mediates inhibition of the two E2s UbcH10 and Ube2S. Definition of Cdh1 interactions with the APC/C indicates how they are antagonized by Cdh1 phosphorylation. The structure of the APC/C with UbcH10-ubiquitin reveals insights into the initiating ubiquitination reaction. Our results provide a quantitative framework for the design of future experiments to investigate APC/C functions in vivo.	[Chang, Leifu; Zhang, Ziguo; Yang, Jing; McLaughlin, Stephen H.; Barford, David] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Barford, D (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	dbarford@mrc-lmb.cam.ac.uk		Zhang, Ziguo/0000-0002-7268-9631; McLaughlin, Stephen/0000-0001-9135-6253; Yang, Jing/0000-0002-8984-4503; Barford, David/0000-0001-8810-950X	Cancer Research UK; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_UP_1201/6] Funding Source: researchfish; MRC [MC_UP_1201/6] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Cancer Research UK grant to D.B. We thank W.J. Chazin and members of the Barford group for discussions, and X. Bai and S. Scheres for their help with RELION; C. Savva and S. Chen for EM facilities; P. Emsley for help with COOT; G. Murshudov for help with REFMAC; G. McMullan for assistance in movie data capture; J. Grimmett and T. Darling for computing; and A. Boland for advice with COOT and PyMol.	Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brown NG, 2014, MOL CELL, V56, P246, DOI 10.1016/j.molcel.2014.09.009; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Frye JJ, 2013, NAT STRUCT MOL BIOL, V20, P827, DOI 10.1038/nsmb.2593; Han D, 2009, J BIOL CHEM, V284, P15137, DOI 10.1074/jbc.M804887200; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; He J, 2012, STRUCTURE, V20, P513, DOI 10.1016/j.str.2011.12.015; Hegemann B, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001993; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Izawa D, 2015, NATURE, V517, P631, DOI 10.1038/nature13911; Izawa D, 2012, J CELL BIOL, V199, P27, DOI 10.1083/jcb.201205170; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kelly A, 2014, MOL CELL, V56, P232, DOI 10.1016/j.molcel.2014.09.010; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Meyer HJ, 2011, SEMIN CELL DEV BIOL, V22, P544, DOI 10.1016/j.semcdb.2011.03.009; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; SIKORSKI RS, 1993, MOL CELL BIOL, V13, P1212, DOI 10.1128/MCB.13.2.1212; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Soss SE, 2013, BIOCHEMISTRY-US, V52, P2991, DOI 10.1021/bi3015949; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Van Voorhis VA, 2014, CURR BIOL, V24, P1556, DOI 10.1016/j.cub.2014.05.052; Wang WP, 2013, NAT CELL BIOL, V15, P797, DOI 10.1038/ncb2755; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010; Zhang ZG, 2013, J MOL BIOL, V425, P4236, DOI 10.1016/j.jmb.2013.04.004; Zhang ZG, 2013, BIOCHEM J, V449, P365, DOI 10.1042/BJ20121374; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	73	150	153	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					450	+		10.1038/nature14471	http://dx.doi.org/10.1038/nature14471			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26083744	Green Accepted			2022-12-28	WOS:000356782900043
J	Lee, JS; Hnilova, M; Maes, M; Lin, YCL; Putarjunan, A; Han, SK; Avila, J; Torii, KU				Lee, Jin Suk; Hnilova, Marketa; Maes, Michal; Lin, Ya-Chen Lisa; Putarjunan, Aarthi; Han, Soon-Ki; Avila, Julian; Torii, Keiko U.			Competitive binding of antagonistic peptides fine-tunes stomatal patterning	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; SECRETORY PEPTIDE; ARABIDOPSIS; KINASE; DENSITY; PROTEIN; DIFFERENTIATION; ACTIVATION; STOMAGEN; ORGAN	During development, cells interpret complex and often conflicting signals to make optimal decisions. Plant stomata, the cellular interface between a plant and the atmosphere, develop according to positional cues, which include a family of secreted peptides called epidermal patterning factors (EPFs). How these signalling peptides orchestrate pattern formation at a molecular level remains unclear. Here we report in Arabidopsis that Stomagen (also called EPF-LIKE9) peptide, which promotes stomatal development, requires ERECTA (ER)-family receptor kinases and interferes with the inhibition of stomatal development by the EPIDERMAL PATTERNING FACTOR 2 (EPF2)-ER module. Both EPF2 and Stomagen directly bind to ER and its co-receptor TOO MANY MOUTHS. Stomagen peptide competitively replaced EPF2 binding to ER. Furthermore, application of EPF2, but not Stomagen, elicited rapid phosphorylation of downstream signalling components in vivo. Our findings demonstrate how a plant receptor agonist and antagonist define inhibitory and inductive cues to fine-tune tissue patterning on the plant epidermis.	[Lee, Jin Suk; Lin, Ya-Chen Lisa; Han, Soon-Ki; Avila, Julian; Torii, Keiko U.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Lee, Jin Suk; Maes, Michal; Lin, Ya-Chen Lisa; Putarjunan, Aarthi; Han, Soon-Ki; Avila, Julian; Torii, Keiko U.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Hnilova, Marketa] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Torii, KU (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	ktorii@u.washingotn.edu	TORII, KEIKO U./A-6041-2013	TORII, KEIKO U./0000-0002-6168-427X; Maes, Michal/0000-0002-7406-3982; Avila, Julian/0000-0001-9388-3946	Grants-in-Aid for Scientific Research [26113507] Funding Source: KAKEN; Howard Hughes Medical Institute Funding Source: Medline	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abrash EB, 2011, PLANT CELL, V23, P2864, DOI 10.1105/tpc.111.086637; Abrash EB, 2010, DEVELOPMENT, V137, P447, DOI 10.1242/dev.040931; Bemis SM, 2013, J EXP BOT, V64, P5323, DOI 10.1093/jxb/ert270; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Fukuda H, 2011, PLANT CELL PHYSIOL, V52, P1, DOI 10.1093/pcp/pcq193; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Hanada K, 2013, P NATL ACAD SCI USA, V110, P2395, DOI 10.1073/pnas.1213958110; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Hunt L, 2010, NEW PHYTOL, V186, P609, DOI 10.1111/j.1469-8137.2010.03200.x; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Jewaria PK, 2013, PLANT CELL PHYSIOL, V54, P1253, DOI 10.1093/pcp/pct076; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Pillitteri LJ, 2008, PLANT CELL PHYSIOL, V49, P934, DOI 10.1093/pcp/pcn067; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pillitteri LJ, 2011, PLANT CELL, V23, P3260, DOI 10.1105/tpc.111.088583; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Uchida N, 2012, P NATL ACAD SCI USA, V109, P6337, DOI 10.1073/pnas.1117537109; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	33	169	182	11	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					435	+		10.1038/nature14561	http://dx.doi.org/10.1038/nature14561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26083750	Green Accepted			2022-12-28	WOS:000356782900041
J	Roumiantsev, S; Shah, U; Westra, SJ; Misdraji, J				Roumiantsev, Serguei; Shah, Uzma; Westra, Sjirk J.; Misdraji, Joseph			Case 20-2015: A Newborn Girl with Hypotension, Coagulopathy, Anemia, and Hyperbilirubinemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALLOIMMUNE LIVER-DISEASE; NEONATAL HEMOCHROMATOSIS; MITOCHONDRIAL HEPATOPATHIES; FAILURE; EXPERIENCE; MANAGEMENT; METABOLISM; DIAGNOSIS; HEPATITIS; INFANTS		[Roumiantsev, Serguei] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Westra, Sjirk J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Misdraji, Joseph] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Roumiantsev, Serguei] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Westra, Sjirk J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Misdraji, Joseph] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Roumiantsev, S (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.		Misdraji, Joseph/AGX-4779-2022; Misdraji, Joseph/AAD-4588-2019; Roumiantsev, Sergey/L-1428-2018	Roumiantsev, Sergey/0000-0002-7418-0222; Westra, Sjirk/0000-0002-9952-6891; Roumiantsev, Sergei/0000-0003-0355-3076				[Anonymous], 2005, N ENGL J MED, V353, P189; Bonilla S, 2012, J HEPATOL, V56, P1351, DOI 10.1016/j.jhep.2012.01.010; COTTIER H, 1957, Schweiz Med Wochenschr, V87, P39; D'Alton ME, 2014, OBSTET GYNECOL, V123, P896; DEBAULNY HO, 2002, SEMIN NEONATOL, V7, P17; Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002; HAYES AM, 1992, AM J ROENTGENOL, V159, P623, DOI 10.2214/ajr.159.3.1503038; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Hill BJ, 2005, AM J ROENTGENOL, V184, P993, DOI 10.2214/ajr.184.3.01840993; Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710; Leonard JV, 2006, ACTA PAEDIATR, V95, P6, DOI 10.1080/08035250500349413; Levy PA, 2010, J DEV BEHAV PEDIATR, V31, P622, DOI 10.1097/DBP.0b013e3181eedf01; Rand EB, 2009, J PEDIATR-US, V155, P566, DOI 10.1016/j.jpeds.2009.04.012; Remington JS, 2011, INFECT DIS FETUS NEW; Rodrigues F, 2005, LIVER TRANSPLANT, V11, P1417, DOI 10.1002/lt.20497; Rubod C, 2007, OBSTET GYNECOL, V110, P256, DOI 10.1097/01.AOG.0000271212.66040.70; Shanmugam NP, 2011, EUR J PEDIATR, V170, P573, DOI 10.1007/s00431-010-1309-1; Smith SR, 2004, ARCH OTOLARYNGOL, V130, P760, DOI 10.1001/archotol.130.6.760; SOCOL ML, 1994, AM J OBSTET GYNECOL, V170, P991, DOI 10.1016/S0002-9378(94)70092-3; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; St Pierre TG, 2014, MAGN RESON MED, V71, P2215, DOI 10.1002/mrm.24854; Sundaram SS, 2011, J PEDIATR-US, V159, P813, DOI 10.1016/j.jpeds.2011.04.016; Udell IW, 2005, LIVER TRANSPLANT, V11, P998, DOI 10.1002/lt.20461; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; Whitington PF, 2007, SEMIN LIVER DIS, V27, P243, DOI 10.1055/s-2007-985069; Whitington PF, 2011, J PEDIATR-US, V159, P612, DOI 10.1016/j.jpeds.2011.03.048; Whitington PF, 2004, LANCET, V364, P1690, DOI 10.1016/S0140-6736(04)17356-X; Williams H, 2009, TLS-TIMES LIT SUPPL, P20; Zoller H, 2012, J HEPATOL, V56, P1226, DOI 10.1016/j.jhep.2012.02.012	29	4	4	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2542	2553		10.1056/NEJMcpc1404334	http://dx.doi.org/10.1056/NEJMcpc1404334			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2QD	26107055				2022-12-28	WOS:000356788200011
J	Roze, JC; Cambonie, G; Marchand-Martin, L; Gournay, V; Durrmeyer, X; Durox, M; Storme, L; Porcher, R; Ancel, PY				Roze, Jean-Christophe; Cambonie, Gilles; Marchand-Martin, Laetitia; Gournay, Veronique; Durrmeyer, Xavier; Durox, Melanie; Storme, Laurent; Porcher, Raphael; Ancel, Pierre-Yves		Hemodynamic EPIPAGE 2 Study Grp	Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSTRUMENTAL VARIABLE METHODS; PLACEBO-CONTROLLED TRIAL; PROPENSITY SCORE; PREMATURE-INFANTS; ECHOCARDIOGRAPHIC ASSESSMENT; MECHANICAL VENTILATION; TREATMENT OPTIONS; DOUBLE-BLIND; IBUPROFEN; SHUNT	IMPORTANCE There is currently no consensus for the screening and treatment of patent ductus arteriosus (PDA) in extremely preterm infants. Less pharmacological closure and more supportive management have been observed without evidence to support these changes. OBJECTIVE To evaluate the association between early screening echocardiography for PDA and in-hospital mortality. DESIGN, SETTING, AND PARTICIPANTS Comparison of screened and not screened preterm infants enrolled in the EPIPAGE 2 national prospective population-based cohort study that included all preterm infants born at less than 29 weeks of gestation and hospitalized in 68 neonatal intensive care units in France from April through December 2011. Two main analyses were performed to adjust for potential selection bias, one using propensity score matching and one using neonatal unit preference for early screening echocardiography as an instrumental variable. EXPOSURES Early screening echocardiography before day 3 of life. MAIN OUTCOMES AND MEASURES The primary outcome was death between day 3 and discharge. The secondary outcomes were major neonatal morbidities (pulmonary hemorrhage, severe bronchopulmonary dysplasia, severe cerebral lesions, and necrotizing enterocolitis). RESULTS Among the 1513 preterm infants with data available to determine exposure, 847 were screened for PDA and 666 were not; 605 infants from each group could be paired. Exposed infants were treated for PDA more frequently during their hospitalization than nonexposed infants (55.1% vs 43.1%; odds ratio [OR], 1.62 [95% CI, 1.31 to 2.00]; absolute risk reduction [ARR] in events per 100 infants, -12.0 [95% CI, -17.3 to -6.7). Exposed infants had a lower hospital death rate (14.2% vs 18.5%; OR, 0.73 [95% CI, 0.54 to 0.98]; ARR, 4.3 [95% CI, 0.3 to 8.3]) and a lower rate of pulmonary hemorrhage (5.6% vs 8.9%; OR, 0.60 [95% CI, 0.38 to 0.95]; ARR, 3.3 [95% CI, 0.4 to 6.3]). No differences in rates of necrotizing enterocolitis, severe bronchopulmonary dysplasia, or severe cerebral lesions were observed. In the overall cohort, instrumental variable analysis yielded an adjusted OR for in-hospital mortality of 0.62 [95% CI, 0.37 to 1.04]. CONCLUSIONS AND RELEVANCE In this national population-based cohort of extremely preterm infants, screening echocardiography before day 3 of life was associated with lower in-hospital mortality and likelihood of pulmonary hemorrhage but not with differences in necrotizing enterocolitis, severe bronchopulmonary dysplasia, or severe cerebral lesions. However, results of the instrumental variable analysis leave some ambiguity in the interpretation, and longer-term evaluation is needed to provide clarity.	[Roze, Jean-Christophe] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Roze, Jean-Christophe] Nantes Univ Hosp, Ctr Invest Clin CIC004, Epidemiol Clin, Nantes, France; [Cambonie, Gilles] Montpellier Univ Hosp, Montpellier Dept Neonatal Med, Montpellier, France; [Marchand-Martin, Laetitia; Durrmeyer, Xavier; Durox, Melanie; Ancel, Pierre-Yves] Paris Descartes Univ, Obstet Perinatal & Pediat Epidemiol Team, Epidemiol & Stat Sorbonne Paris Cite Res Ctr, INSERM,U1153, Paris, France; [Gournay, Veronique] Nantes Univ Hosp, Pediat Cardiol Unit, Nantes, France; [Storme, Laurent] Lille Univ Hosp, Dept Neonatal Med, Lille, France; [Porcher, Raphael] Paris Descartes Univ, Epidemiol & Stat Sorbonne Paris Cite Res Ctr, METHODS Team, INSERM,U1153, Paris, France; [Ancel, Pierre-Yves] Cochin Hotel Dieu Hosp, AP HP, Ctr Invest Clin CIC P1419, Paris, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Roze, JC (corresponding author), Univ Nantes, Univ Hosp Nantes, Dept Neonatal Med, 36 Blvd Jean Monnet, F-44093 Nantes, France.	jcroze@chu-nantes.fr	Durrmeyer, Xavier/AAB-7519-2020; Rozé, Jean-Christophe/AAS-1314-2021	Durrmeyer, Xavier/0000-0002-6303-7252; Marchand-Martin, Laetitia/0000-0002-8036-8387; PATURAL, Hugues/0000-0002-5359-6544; Roze, Jean-Christophe/0000-0003-3367-512X; burguet, antoine/0000-0001-5140-2884; Porcher, Raphael/0000-0002-5277-4679; ANCEL, pierre-yves/0000-0001-9632-7494; CAMBONIE, GILLES/0000-0002-1360-7915	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research; National Institute of Cancer; National Solidarity Fund for Autonomy; National Research Agency through the French Equipex Program of Investments in the Future [ANR-11-EQPX-0038]; PremUp Foundation	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research(Institut National de la Sante et de la Recherche Medicale (Inserm)); National Institute of Cancer; National Solidarity Fund for Autonomy; National Research Agency through the French Equipex Program of Investments in the Future; PremUp Foundation	This study was supported by the French Institute of Public Health Research/Institute of Public Health and its partners the French Health Ministry, the National Institute of Health and Medical Research, the National Institute of Cancer, and the National Solidarity Fund for Autonomy; grant ANR-11-EQPX-0038 from the National Research Agency through the French Equipex Program of Investments in the Future; and the PremUp Foundation.	Ancel PY, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-97; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Baiocchi M, 2014, STAT MED, V33, P2297, DOI 10.1002/sim.6128; BOUND J, 1995, J AM STAT ASSOC, V90, P443, DOI 10.2307/2291055; Clyman RI, 2000, NEW ENGL J MED, V343, P728, DOI 10.1056/NEJM200009073431009; Clyman RI, 2012, SEMIN PERINATOL, V36, P123, DOI 10.1053/j.semperi.2011.09.022; Concato J, 2004, LANCET, V363, P1660, DOI 10.1016/S0140-6736(04)16285-5; El Hajjar M, 2005, ARCH DIS CHILD-FETAL, V90, pF419, DOI 10.1136/adc.2003.027698; EVANS N, 1994, J PEDIATR-US, V125, P778, DOI 10.1016/S0022-3476(94)70078-8; Evans N, 2011, SEMIN FETAL NEONAT M, V16, P61, DOI 10.1016/j.siny.2010.06.005; Gayat E, 2012, PHARM STAT, V11, P222, DOI 10.1002/pst.537; Gournay V, 2004, LANCET, V364, P1939, DOI 10.1016/S0140-6736(04)17476-X; Gournay V, 1998, ACTA PAEDIATR, V87, P419; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Hamrick SEG, 2010, PEDIATRICS, V125, P1020, DOI 10.1542/peds.2009-3506; Heuchan AM, 2014, ARCH DIS CHILD-FETAL, V99, pE431, DOI 10.1136/archdischild-2014-306176; Jones LJ, 2011, ARCH DIS CHILD-FETAL, V96, pF45, DOI 10.1136/adc.2009.168682; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF188, DOI 10.1136/fn.82.3.F188; KLUCKOW M, 1995, J PEDIATR-US, V127, P774, DOI 10.1016/S0022-3476(95)70172-9; Kluckow M, 2014, ARCH DIS CHILD-FETAL, V99, pF99, DOI 10.1136/archdischild-2013-304695; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; McCurnin D, 2008, PEDIATRICS, V121, P945, DOI 10.1542/peds.2007-2051; Noori S, 2009, PEDIATRICS, V123, pE138, DOI 10.1542/peds.2008-2418; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Rolland A, 2015, ARCH DIS CHILD-FETAL, V100, pF55, DOI 10.1136/archdischild-2014-306339; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Sellmer A, 2013, ARCH DIS CHILD-FETAL, V98, pF505, DOI 10.1136/archdischild-2013-303816; Sosenko IRS, 2012, J PEDIATR-US, V160, DOI 10.1016/j.jpeds.2011.12.031; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Su BH, 1997, ARCH DIS CHILD-FETAL, V77, pF36, DOI 10.1136/fn.77.1.F36; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009	34	78	78	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2441	2448		10.1001/jama.2015.6734	http://dx.doi.org/10.1001/jama.2015.6734			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103028	Bronze			2022-12-28	WOS:000356663600013
J	Stary, G; Olive, A; Radovic-Moreno, AF; Gondek, D; Alvarez, D; Basto, PA; Perro, M; Vrbanac, VD; Tager, AM; Shi, JJ; Yethon, JA; Farokhzad, OC; Langer, R; Starnbach, MN; von Andrian, UH				Stary, Georg; Olive, Andrew; Radovic-Moreno, Aleksandar F.; Gondek, David; Alvarez, David; Basto, Pamela A.; Perro, Mario; Vrbanac, Vladimir D.; Tager, Andrew M.; Shi, Jinjun; Yethon, Jeremy A.; Farokhzad, Omid C.; Langer, Robert; Starnbach, Michael N.; von Andrian, Ulrich H.			A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells	SCIENCE			English	Article							CD103(+) DENDRITIC CELLS; RESIDENT MEMORY; FIELD TRIAL; MEDIATED PROTECTION; IMMUNE-RESPONSES; ORAL TOLERANCE; INFECTION; MIGRATION; EFFECTOR; ANTIGEN	Genital Chlamydia trachomatis (Ct) infection induces protective immunity that depends on interferon-g-producing CD4 T cells. By contrast, we report that mucosal exposure to ultraviolet light (UV)-inactivated Ct (UV-Ct) generated regulatory T cells that exacerbated subsequent Ct infection. We show that mucosal immunization with UV-Ct complexed with charge-switching synthetic adjuvant particles (cSAPs) elicited long-lived protection in conventional and humanized mice. UV-Ct-cSAP targeted immunogenic uterine CD11b(+)CD103(-) dendritic cells (DCs), whereas UV-Ct accumulated in tolerogenic CD11b(-)CD103(+) DCs. Regardless of vaccination route, UV-Ct-cSAP induced systemic memory T cells, but only mucosal vaccination induced effector T cells that rapidly seeded uterine mucosa with resident memory T cells (T-RM cells). Optimal Ct clearance required both TRM seeding and subsequent infection-induced recruitment of circulating memory T cells. Thus, UV-Ct-cSAP vaccination generated two synergistic memory T cell subsets with distinct migratory properties.	[Stary, Georg; Olive, Andrew; Gondek, David; Alvarez, David; Perro, Mario; Starnbach, Michael N.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Radovic-Moreno, Aleksandar F.; Basto, Pamela A.; Langer, Robert] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Radovic-Moreno, Aleksandar F.; Basto, Pamela A.; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Vrbanac, Vladimir D.; Tager, Andrew M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Yethon, Jeremy A.] Sanofi Pasteur, Cambridge, MA 02139 USA; [Shi, Jinjun; Farokhzad, Omid C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Nanomed & Biomat,Dept Anesthesiol, Boston, MA 02115 USA; [Farokhzad, Omid C.] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [von Andrian, Ulrich H.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Sanofi-Aventis; Harvard University; Brigham & Women's Hospital; Harvard Medical School; King Abdulaziz University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	georg_stary@hms.harvard.edu; uva@hms.harvard.edu	Perro, Mario/AAB-5554-2021; Stary, Georg/M-8978-2014	Perro, Mario/0000-0003-1375-8155; Olive, Andrew/0000-0003-3441-3113; Stary, Georg/0000-0003-1746-4250; Basto, Pamela/0000-0002-5446-7963; Shi, Jinjun/0000-0001-9200-5068; Farokhzad, Omid/0000-0003-2009-270X	NIH [AI078897, AI069259, AI095261, AI111595, U54-CA119349, U54-CA151884, R37-EB000244, 1 R01-EB015419-01, R00 CA160350, T32 HL066987, P30-AI060354, R01 AI062827, R01 AI39558]; Harvard Innovation Award from Sanofi Pasteur; Ragon Institute of MGH, MIT and Harvard; David Koch Prostate Cancer Foundation; MGH Humanized Mouse Program by the Harvard University CFAR; Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Diseases (NIH) [U19 AI113187]; Max Kade foundation; MIT Portugal Program; National Science Foundation (NSF-GRFP); NATIONAL CANCER INSTITUTE [U54CA119349, U54CA151884, R00CA160350] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P01AI078897, R01AI069259, R01AI039558, R01AI072252, R01AI111595, U19AI095261, R01AI062827, P01AI112521, U19AI113187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244, R01EB015419, R37EB000244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Innovation Award from Sanofi Pasteur; Ragon Institute of MGH, MIT and Harvard; David Koch Prostate Cancer Foundation; MGH Humanized Mouse Program by the Harvard University CFAR; Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Diseases (NIH); Max Kade foundation; MIT Portugal Program; National Science Foundation (NSF-GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank E. Nigro for secretarial assistance, L. B. Jones for technical support, and the members of the von Andrian laboratory for discussion. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Supported by NIH grants AI078897, AI069259, AI095261, and AI111595, a Harvard Innovation Award from Sanofi Pasteur, and the Ragon Institute of MGH, MIT and Harvard (U.H.v.A.); NIH grants U54-CA119349, U54-CA151884, and R37-EB000244 and the David Koch Prostate Cancer Foundation (R.L. and O.C.F.); NIH grant 1 R01-EB015419-01 (O.C.F.); NIH grant R00 CA160350 (J.S.); NIH grant T32 HL066987 (D.A.); NIH grant P30-AI060354 and the MGH Humanized Mouse Program by the Harvard University CFAR (A.M.T.); and NIH grant R01 AI062827, NIH grant R01 AI39558, and the Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Diseases (NIH grant U19 AI113187) (M.N.S.). G.S. is a Max Kade foundation postdoctoral research exchange grant recipient. A.F.R.-M. acknowledges support from the MIT Portugal Program and the National Science Foundation (NSF-GRFP). G.S., A.R.F.-M., P.A.B., M.N.S., R.L., O.C.F., and U.H.v.A. are inventors on a patent application entitled "Nanoparticle-Based Compositions" (U.S. Application number PCT2014/029000; International Publication No. WO2014/153087) filed by Harvard University together with MIT and Brigham and Women's Hospital (BWH) that relates to the use of cSAP for mucosal vaccination. A.R.F.-M., R.L., and O.C.F. are inventors on a patent application entitled "pH Sensitive Biodegradable Polymeric Particles for Drug Delivery" (U.S. Application no. PCT2011/0065807) filed by BWH together with MIT that relates to the engineering of charge-switching particles. O.C.F., R.L., and U.H.v.A. disclose financial interests in BIND Therapeutics, Selecta Biosciences, and Blend Therapeutics, three biotechnology companies developing nanocarrier technologies for medical applications. BIND, Selecta, and Blend did not support the research in this study. Selecta and Blend have obtained licenses to a portion of the intellectual property described in this study. O.C.F., R.L., and U.H.v.A. are scientific founders and members of the Scientific Advisory Board and O.C.F. and R.L. are directors of Selecta Biosciences. O.C.F., R.L. and U.H.v.A. are members of the Scientific Advisory Board and O.C.F. and R.L. are scientific founders and directors of Blend Therapeutics. The following reagents used in the paper are subject to MTA: NR-1 transgenic mice, cSAP, cSP, and SAP. All reasonable requests for collaboration involving materials used in the research will be fulfilled, provided that a written agreement is executed in advance between BWH, MIT, or Harvard Medical School and the requester (and his or her affiliated institution). Such inquiries or requests for additional data should be directed to the corresponding author.	Bakken IJ, 2008, CURR OPIN INFECT DIS, V21, P77, DOI 10.1097/QCO.0b013e3282f3d972; Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Bernstein-Hanley I, 2006, GENES IMMUN, V7, P122, DOI 10.1038/sj.gene.6364285; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BIENENSTOCK J, 1984, ANN ALLERGY, V53, P535; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; BRUNHAM RC, 1983, INFECT IMMUN, V39, P1491, DOI 10.1128/IAI.39.3.1491-1494.1983; Brunham RC, 2013, J INFECT DIS, V207, P1796, DOI 10.1093/infdis/jit095; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Davila SJ, 2014, J IMMUNOL, V192, P4284, DOI 10.4049/jimmunol.1303238; Denning TL, 2005, J IMMUNOL, V174, P7487, DOI 10.4049/jimmunol.174.12.7487; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Farris CM, 2010, INFECT IMMUN, V78, P4374, DOI 10.1128/IAI.00622-10; Gallichan WS, 1996, J EXP MED, V184, P1879, DOI 10.1084/jem.184.5.1879; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; GRAYSTON JT, 1962, ANN NY ACAD SCI, V98, P352, DOI 10.1111/j.1749-6632.1962.tb30558.x; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; Hawkins RA, 2000, INFECT IMMUN, V68, P5587, DOI 10.1128/IAI.68.10.5587-5594.2000; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Ilyinskii PO, 2014, VACCINE, V32, P2882, DOI 10.1016/j.vaccine.2014.02.027; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kantele A, 1999, J IMMUNOL, V162, P5173; Lawson LB, 2011, CURR OPIN IMMUNOL, V23, P414, DOI 10.1016/j.coi.2011.03.009; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Mabey DCW, 2014, VACCINE, V32, P1572, DOI 10.1016/j.vaccine.2013.10.016; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; NICHOLS RL, 1966, AM J TROP MED HYG, V15, P639, DOI 10.4269/ajtmh.1966.15.639; NICHOLS RL, 1969, AM J TROP MED HYG, V18, P723, DOI 10.4269/ajtmh.1969.18.723; Olive AJ, 2011, MUCOSAL IMMUNOL, V4, P208, DOI 10.1038/mi.2010.58; Radovic-Moreno AF, 2012, ACS NANO, V6, P4279, DOI 10.1021/nn3008383; Roan NR, 2006, P NATL ACAD SCI USA, V103, P12069, DOI 10.1073/pnas.0603866103; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; SCHACHTER J, 1985, REV INFECT DIS, V7, P713; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; SOWA S, 1969, J HYG-CAMB, V67, P699, DOI 10.1017/S0022172400042157; Tifrea DF, 2013, INFECT IMMUN, V81, P1741, DOI 10.1128/IAI.00734-12; van Ginkel FW, 2005, INFECT IMMUN, V73, P6892, DOI 10.1128/IAI.73.10.6892-6902.2005; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; WOOLRIDGE RL, 1967, AM J OPHTHALMOL, V63, P1645, DOI 10.1016/0002-9394(67)94158-X; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	64	237	253	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241							aaa8205	10.1126/science.aaa8205	http://dx.doi.org/10.1126/science.aaa8205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089520	Green Accepted, Green Submitted			2022-12-28	WOS:000356449500042
J	Aljishi, M; Barrow, C				Aljishi, Manaf; Barrow, Catherine			Cutaneous T-Cell Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Aljishi, Manaf; Barrow, Catherine] Capital & Coast Dist Hlth Board, Wellington, New Zealand		Aljishi, M (corresponding author), Capital & Coast Dist Hlth Board, Wellington, New Zealand.	manaf.aljishi@gmail.com	Tham, Ivan WK/H-6188-2016; Niewold, Timothy B/D-2669-2018	Tham, Ivan WK/0000-0002-9476-4276; Aljishi, Manaf/0000-0002-3331-3922					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2437	2437		10.1056/NEJMicm1406401	http://dx.doi.org/10.1056/NEJMicm1406401			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK6RF	26083208				2022-12-28	WOS:000356354600010
J	Ananthakrishnan, S				Ananthakrishnan, Shubha			Trimethoprim-sulfamethoxazole was linked to sudden death in older patients using spironolactone	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INDUCED HYPERKALEMIA		Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Ananthakrishnan, S (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.							Antoniou T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5228; Hirsch JS, 2014, SEMIN NEPHROL, V34, P307, DOI 10.1016/j.semnephrol.2014.04.006; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; VELAZQUEZ H, 1993, ANN INTERN MED, V119, P296, DOI 10.7326/0003-4819-119-4-199308150-00008	4	0	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC13	10.7326/ACPJC-2015-162-12-013	http://dx.doi.org/10.7326/ACPJC-2015-162-12-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075778				2022-12-28	WOS:000356516300014
J	Wang, LW; Omari, A; Emmett, L; Jansz, PC; Huilgol, R; Rainer, S; Subbiah, RN				Wang, Louis W.; Omari, Abdullah; Emmett, Louise; Jansz, Paul C.; Huilgol, Ravi; Rainer, Stephen; Subbiah, Rajesh N.			Granulomatous sarcoid aortitis: a serious complication of a well-known multisystem disease	LANCET			English	Editorial Material									[Wang, Louis W.] St Vincents Hosp, Dept Cardiol, Sydney, NSW 2010, Australia; [Omari, Abdullah] St Vincents Hosp, Dept Vasc Med, Sydney, NSW 2010, Australia; [Emmett, Louise] St Vincents Hosp, Dept Nucl Med, Sydney, NSW 2010, Australia; [Jansz, Paul C.] St Vincents Hosp, Dept Cardiothorac Surg, Sydney, NSW 2010, Australia; [Huilgol, Ravi] St Vincents Hosp, Dept Vasc Surg, Sydney, NSW 2010, Australia; [Rainer, Stephen] St Vincents Hosp, Dept Pathol, Sydney, NSW 2010, Australia; [Wang, Louis W.; Subbiah, Rajesh N.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia	St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; Victor Chang Cardiac Research Institute	Wang, LW (corresponding author), St Vincents Hosp, Dept Cardiol, 390 Victoria St, Sydney, NSW 2010, Australia.	louis.wang@unsw.edu.au		Emmett, Louise/0000-0002-4895-7384; Jansz, Paul/0000-0002-4721-5549				Gornik HL, 2008, CIRCULATION, V117, P3039, DOI 10.1161/CIRCULATIONAHA.107.760686; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Weiler V, 2000, ANN RHEUM DIS, V59, P850, DOI 10.1136/ard.59.11.850	3	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					2014	2014		10.1016/S0140-6736(15)60649-3	http://dx.doi.org/10.1016/S0140-6736(15)60649-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1YR	26090647				2022-12-28	WOS:000354541700035
J	Flock, T; Ravarani, CNJ; Sun, DW; Venkatakrishnan, AJ; Kayikci, M; Tate, CG; Veprintsev, DB; Babu, MM				Flock, Tilman; Ravarani, Charles N. J.; Sun, Dawei; Venkatakrishnan, A. J.; Kayikci, Melis; Tate, Christopher G.; Veprintsev, Dmitry B.; Babu, M. Madan			Universal allosteric mechanism for G alpha activation by GPCRs	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; G-PROTEIN ACTIVATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SIGNAL-TRANSDUCTION; BINDING-SITE; WEB SERVER; EVOLUTION; RAS; HELIX	G protein-coupled receptors (GPCRs) allosterically activate heterotrimeric G proteins and trigger GDP release. Given that there are similar to 800 human GPCRs and 16 different G alpha genes, this raises the question of whether a universal allosteric mechanism governs G alpha activation. Here we show that different GPCRs interact with and activate G alpha proteins through a highly conserved mechanism. Comparison of G alpha with the small G protein Ras reveals how the evolution of short segments that undergo disorder-to-order transitions can decouple regions important for allosteric activation from receptor binding specificity. This might explain how the GPCR-G alpha system diversified rapidly, while conserving the allosteric activation mechanism.	[Flock, Tilman; Ravarani, Charles N. J.; Venkatakrishnan, A. J.; Kayikci, Melis; Tate, Christopher G.; Babu, M. Madan] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Sun, Dawei; Veprintsev, Dmitry B.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Sun, Dawei; Veprintsev, Dmitry B.] Swiss Fed Inst Technol, Dept Biol, CH-8039 Zurich, Switzerland	MRC Laboratory Molecular Biology; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Flock, T (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	tflock@mrc-lmb.cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Veprintsev, Dmitry B/H-2228-2012; Mohan, Babu P./I-7362-2019	Veprintsev, Dmitry B/0000-0002-3583-5409; /0000-0003-3398-0968; Sun, Dawei/0000-0002-2010-6051	Medical Research Council [MC_U105185859, MC_U105197215]; Swiss National Science Foundation [141898, 133810, 31-135754]; MRC Centenary Award; AFR scholarship from Luxembourg National Research Fund; Boehringer Ingelheim Fond; MRC [MC_U105185859, MC_U105197215] Funding Source: UKRI; Medical Research Council [1274107] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC Centenary Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AFR scholarship from Luxembourg National Research Fund(Luxembourg National Research Fund); Boehringer Ingelheim Fond(Boehringer Ingelheim); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank U. F. Lang, C. Chothia, R. Weatheritt, S. Balaji, H. Harbrecht, A. Morgunov, G. Murshudov and N. S. Latysheva for their comments on this work. This work was supported by the Medical Research Council (MC_U105185859; M.M.B., T.F., M.K., A.J.V. and C.N.J.R.; MC_U105197215; C.G.T.), the Swiss National Science Foundation grants 141898, 133810, 31-135754 (D.B.V.), the MRC Centenary Award (A.J.V.), the AFR scholarship from the Luxembourg National Research Fund (C.N.J.R.) and the Boehringer Ingelheim Fond (T.F.). M.M.B. is also a Lister Institute Research Prize Fellow.	Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anantharaman V, 2011, GENE, V475, P63, DOI 10.1016/j.gene.2010.12.001; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P3345, DOI 10.1093/nar/gkg528; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; CHOTHIA C, 1985, J MOL BIOL, V182, P151, DOI 10.1016/0022-2836(85)90033-6; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; de la Vega Michelle, 2011, Small GTPases, V2, P192; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Doncheva NT, 2011, TRENDS BIOCHEM SCI, V36, P179, DOI 10.1016/j.tibs.2011.01.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Jia M, 2012, J BIOL CHEM, V287, P36766, DOI 10.1074/jbc.M112.391607; Johnston CA, 2008, J BIOL CHEM, V283, P21550, DOI 10.1074/jbc.M803023200; Kasprzyk A., 2011, DATABASE-OXFORD, V2011, DOI DOI 10.1093/DATABASE/BAR049; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li D, 2014, J CLIN ENDOCR METAB, V99, pE1774, DOI 10.1210/jc.2014-1029; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Maeda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098714; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Mnpotra JS, 2014, J BIOL CHEM, V289, P20259, DOI 10.1074/jbc.M113.539916; Morikawa T, 2007, ACTA CRYSTALLOGR F, V63, P139, DOI 10.1107/S1744309107003363; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Slessareva JE, 2003, J BIOL CHEM, V278, P50530, DOI 10.1074/jbc.M304417200; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sun D., NATURE STRUCT MOL BI; Sun DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078878; Tanaka T, 1998, J BIOL CHEM, V273, P3247, DOI 10.1074/jbc.273.6.3247; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vohra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071711; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Zhang XW, 2013, CURR OPIN STRUC BIOL, V23, P954, DOI 10.1016/j.sbi.2013.07.004	76	189	196	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					173	+		10.1038/nature14663	http://dx.doi.org/10.1038/nature14663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26147082	Green Accepted			2022-12-28	WOS:000359386900022
J	Jordan, DM; Frangakis, SG; Golzio, C; Cassa, CA; Kurtzberg, J; Davis, EE; Sunyaev, SR; Katsanis, N				Jordan, Daniel M.; Frangakis, Stephan G.; Golzio, Christelle; Cassa, Christopher A.; Kurtzberg, Joanne; Davis, Erica E.; Sunyaev, Shamil R.; Katsanis, Nicholas		Task Force Neonatal Genomics	Identification of cis-suppression of human disease mutations by comparative genomics	NATURE			English	Article							INCOMPATIBILITIES; EPISTASIS; EVOLUTION; EXOME; VARIANTS	Patterns of amino acid conservation have served as a tool for understanding protein evolution(1). The same principles have also found broad application in human genomics, driven by the need to interpret the pathogenic potential of variants in patients(2). Here we performed a systematic comparative genomics analysis of human disease-causing missense variants. We found that an appreciable fraction of disease-causing alleles are fixed in the genomes of other species, suggesting a role for genomic context. We developed a model of genetic interactions that predicts most of these to be simple pairwise compensations. Functional testing of this model on two known human disease genes(3,4) revealed discrete cis amino acid residues that, although benign on their own, could rescue the human mutations in vivo. This approach was also applied to ab initio gene discovery to support the identification of a de novo disease driver in BTG2 that is subject to protective cis-modification in more than 50 species. Finally, on the basis of our data and models, we developed a computational tool to predict candidate residues subject to compensation. Taken together, our data highlight the importance of cis-genomic context as a contributor to protein evolution; they provide an insight into the complexity of allele effect on phenotype; and they are likely to assist methods for predicting allele pathogenicity(5,6).	[Jordan, Daniel M.; Cassa, Christopher A.; Sunyaev, Shamil R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Jordan, Daniel M.; Cassa, Christopher A.; Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Frangakis, Stephan G.; Golzio, Christelle; Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Kurtzberg, Joanne] Duke Univ, Dept Pediat, Div Pediat Blood & Marrow Transplantat, Durham, NC 27701 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University; Duke University	Sunyaev, SR (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	ssunyaev@rics.bwh.harvard.edu; nicholas.katsanis@dm.duke.edu	Jordan, Daniel/M-6842-2019; Frangakis, Stephan/GLQ-5773-2022	Jordan, Daniel/0000-0002-5318-8225; Davis, Erica/0000-0002-2412-8397; Willer, Jason/0000-0002-5869-3992; Golzio, Christelle/0000-0002-4420-3921; Cassa, Christopher/0000-0002-5771-9177; Katsanis, Sara/0000-0002-5044-8765	NARSAD;  [R01HD04260];  [R01DK072301];  [R01DK075972];  [R01 GM078598];  [R01 MH101244];  [R01 DK095721];  [U01 HG006500];  [R01EY021872]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021872] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG007229, U01HG006500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095721, R01DK072301, P50DK096415, R01DK075972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER	NARSAD(NARSAD); ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Y. Liu and D. Balick for helpful discussions, M. Kousi for assistance with the NCL mutational list, and M. Talkowski, A. Kondrashov and G. Lyon for critical review of the manuscript. This work was supported by grants R01HD04260, R01DK072301 and R01DK075972 (N.K.); R01 GM078598, R01 MH101244, R01 DK095721 and U01 HG006500 (S.R.S.); R01EY021872 (E.E.D.); and a NARSAD Young Investigator Award (C.G.). N.K. is a Distinguished Brumley Professor.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahola V, 2008, BIOINFORMATICS, V24, P2165, DOI 10.1093/bioinformatics/btn414; Alfoldi J, 2013, GENOME RES, V23, P1063, DOI 10.1101/gr.157503.113; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Corbett-Detig RB, 2013, NATURE, V504, P135, DOI 10.1038/nature12678; Ferrer-Costa C, 2007, J MOL BIOL, V365, P249, DOI 10.1016/j.jmb.2006.09.053; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fraisse C, 2014, J EVOLUTION BIOL, V27, P688, DOI 10.1111/jeb.12339; Gao LZ, 2003, TRENDS GENET, V19, P678, DOI 10.1016/j.tig.2003.10.002; Giudicessi JR, 2013, TRANSL RES, V161, P1, DOI 10.1016/j.trsl.2012.08.005; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Katsanis N, 2012, FUTUR NEUROL, V7, P655, DOI 10.2217/FNL.12.74; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kimura M, 1984, NEUTRAL THEORY MOL E; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kulathinal RJ, 2004, SCIENCE, V306, P1553, DOI 10.1126/science.1100522; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; McCandlish DM, 2013, NATURE, V497, pE1, DOI 10.1038/nature12219; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Mottaz A, 2010, BIOINFORMATICS, V26, P851, DOI 10.1093/bioinformatics/btq028; Niederriter A. R., 2012, JOVE-J VIS EXP, V78; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Soylemez O, 2012, GENOME BIOL EVOL, V4, P1213, DOI 10.1093/gbe/evs096; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weinreich DM, 2013, CURR OPIN GENET DEV, V23, P700, DOI 10.1016/j.gde.2013.10.007; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107	36	68	68	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					225	+		10.1038/nature14497	http://dx.doi.org/10.1038/nature14497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26123021	Green Accepted			2022-12-28	WOS:000359386900033
J	Barouch, DH; Alter, G; Broge, T; Linde, C; Ackerman, ME; Brown, EP; Borducchi, EN; Smith, KM; Nkolola, JP; Liu, JY; Shields, J; Parenteau, L; Whitney, JB; Abbink, P; Ng'ang'a, DM; Seaman, MS; Lavine, CL; Perry, JR; Li, WJ; Colantonio, AD; Lewis, MG; Chen, B; Wenschuh, H; Reimer, U; Piatak, M; Lifson, JD; Handley, SA; Virgin, HW; Koutsoukos, M; Lorin, C; Voss, G; Weijtens, M; Pau, MG; Schuitemaker, H				Barouch, Dan H.; Alter, Galit; Broge, Thomas; Linde, Caitlyn; Ackerman, Margaret E.; Brown, Eric P.; Borducchi, Erica N.; Smith, Kaitlin M.; Nkolola, Joseph P.; Liu, Jinyan; Shields, Jennifer; Parenteau, Lily; Whitney, James B.; Abbink, Peter; Ng'ang'a, David M.; Seaman, Michael S.; Lavine, Christy L.; Perry, James R.; Li, Wenjun; Colantonio, Arnaud D.; Lewis, Mark G.; Chen, Bing; Wenschuh, Holger; Reimer, Ulf; Piatak, Michael; Lifson, Jeffrey D.; Handley, Scott A.; Virgin, Herbert W.; Koutsoukos, Marguerite; Lorin, Clarisse; Voss, Gerald; Weijtens, Mo; Pau, Maria G.; Schuitemaker, Hanneke			Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys	SCIENCE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; HIGHLY PATHOGENIC SIV; HIV-1 VACCINE; HIGH-THROUGHPUT; ANTIBODIES; RESPONSES; VECTORS; BREADTH	Preclinical studies of viral vector-based HIV-1 vaccine candidates have previously shown partial protection against neutralization-resistant virus challenges in rhesus monkeys. In this study, we evaluated the protective efficacy of adenovirus serotype 26 (Ad26) vector priming followed by purified envelope (Env) glycoprotein boosting. Rhesus monkeys primed with Ad26 vectors expressing SIVsmE543 Env, Gag, and Pol and boosted with AS01B-adjuvanted SIVmac32H Env gp140 demonstrated complete protection in 50% of vaccinated animals against a series of repeated, heterologous, intrarectal SIVmac251 challenges that infected all controls. Protective efficacy correlated with the functionality of Env-specific antibody responses. Comparable protection was also observed with a similar Ad/Env vaccine against repeated, heterologous, intrarectal SHIV-SF162P3 challenges. These data demonstrate robust protection by Ad/Env vaccines against acquisition of neutralization-resistant virus challenges in rhesus monkeys.	[Barouch, Dan H.; Brown, Eric P.; Borducchi, Erica N.; Smith, Kaitlin M.; Nkolola, Joseph P.; Liu, Jinyan; Shields, Jennifer; Parenteau, Lily; Whitney, James B.; Abbink, Peter; Ng'ang'a, David M.; Seaman, Michael S.; Lavine, Christy L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.; Alter, Galit; Broge, Thomas; Linde, Caitlyn] MIT, Massachusetts Gen Hosp, Ragan Inst, Cambridge, MA 02139 USA; [Barouch, Dan H.; Alter, Galit; Broge, Thomas; Linde, Caitlyn] Harvard Univ, Cambridge, MA 02139 USA; [Ackerman, Margaret E.; Brown, Eric P.] Thayer Sch Engn Dartmouth, Hanover, NH 03755 USA; [Li, Wenjun] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Colantonio, Arnaud D.] New England Primate Res Ctr, Southborough, MA 01772 USA; [Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Chen, Bing] Childrens Hosp, Boston, MA 02115 USA; [Wenschuh, Holger; Reimer, Ulf] JPT Peptide Technol GmbH, D-12489 Berlin, Germany; [Piatak, Michael; Lifson, Jeffrey D.] Frederick Natl Lab, Leidos Biomed Res, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Handley, Scott A.; Virgin, Herbert W.] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Koutsoukos, Marguerite; Lorin, Clarisse; Voss, Gerald] GSK Vaccines, B-1330 Rixensart, Belgium; [Weijtens, Mo; Pau, Maria G.; Schuitemaker, Hanneke] Janssen Infect Dis & Vaccines, NL-2301 Leiden, Netherlands	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Dartmouth College; University of Massachusetts System; University of Massachusetts Worcester; BIOQUAL Inc.; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); GlaxoSmithKline	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Li, Wenjun/F-5634-2015; Barouch, Dan/Y-3918-2019	Li, Wenjun/0000-0001-5335-7386; Brown, Eric/0000-0002-8438-6136; Virgin, Herbert/0000-0001-8580-7628; Reimer, Ulf/0000-0002-3375-6889	NIH [AI060354, AI078526, AI080289, AI084794, AI095985, AI096040, AI102660, AI102691, OD011170, HHSN261200800001E]; Bill and Melinda Gates Foundation [OPP1032817]; Ragon Institute of MGH, MIT, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102660, R01AI102691, R37AI080289, R01AI080289, P30AI060354, U19AI096040, R01AI084794, U19AI078526, U19AI095985] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011170] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ragon Institute of MGH, MIT, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Pensiero, M. Marovich, M. Beck, J. Kramer, S. Westmoreland, P. Johnson, W. Wagner, J. Yalley, C. Gittens, C. Cosgrove, M. Kumar, J. Schmitz, H. Peng, J. Hendriks, D. van Manen, W. Bosche, V. Cyril, Y. Li, F. Stephens, R. Hamel, K. Kelly, and L. Dunne for generous advice, assistance, and reagents. The SIVmac239 peptides were obtained from the NIH AIDS Research and Reference Reagent Program. The data presented in this paper are tabulated in the main paper and in the supplementary materials. The authors declare no competing financial interests. D. H. B. is a named co-inventor on vector, antigen, and protein patents (PCT/EP2007/052463, PCT/US2009/060494, PCT/US2009/064999). Correspondence and requests for materials should be addressed to D. H. B. (dbarouch@bidmc.harvard.edu). Vectors, antigens, proteins, adjuvants, and viruses are subject to Material Transfer Agreements. We acknowledge support from the NIH (AI060354, AI078526, AI080289, AI084794, AI095985, AI096040, AI102660, AI102691, OD011170, and HHSN261200800001E), the Bill and Melinda Gates Foundation (OPP1032817), and the Ragon Institute of MGH, MIT, and Harvard.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Ackerman ME, 2013, CURR HIV RES, V11, P365, DOI 10.2174/1570162X113116660058; Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barouch DH, 2013, NEW ENGL J MED, V369, P2073, DOI 10.1056/NEJMp1312711; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Boesch AW, 2014, MABS-AUSTIN, V6, P915, DOI 10.4161/mabs.28808; Brown EP, 2012, J IMMUNOL METHODS, V386, P117, DOI 10.1016/j.jim.2012.09.007; Chen B, 2000, J BIOL CHEM, V275, P34946, DOI 10.1074/jbc.M004905200; Chung AW, 2014, FUTURE VIROL, V9, P397, DOI 10.2217/fvl.14.19; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Lau KS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001338; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Li HL, 2011, J VIROL, V85, P11007, DOI 10.1128/JVI.05346-11; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Masch A, 2010, METHODS MOL BIOL, V669, P161, DOI 10.1007/978-1-60761-845-4_13; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roederer M, 2014, NATURE, V505, P502, DOI 10.1038/nature12893; Stephenson KE, 2015, J IMMUNOL METHODS, V416, P105, DOI 10.1016/j.jim.2014.11.006; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003	36	236	255	7	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		320	324		10.1126/science.aab3886	http://dx.doi.org/10.1126/science.aab3886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26138104	Green Accepted			2022-12-28	WOS:000358218600055
J	Kimura, W; Xiao, F; Canseco, DC; Muralidhar, S; Thet, S; Zhang, HM; Abderrahman, Y; Chen, R; Garcia, JA; Shelton, JM; Richardson, JA; Ashour, AM; Asaithamby, A; Liang, HQ; Xing, C; Lu, ZG; Zhang, CC; Sadek, HA				Kimura, Wataru; Xiao, Feng; Canseco, Diana C.; Muralidhar, Shalini; Thet, SuWannee; Zhang, Helen M.; Abderrahman, Yezan; Chen, Rui; Garcia, Joseph A.; Shelton, John M.; Richardson, James A.; Ashour, Abdelrahman M.; Asaithamby, Aroumougame; Liang, Hanquan; Xing, Chao; Lu, Zhigang; Zhang, Cheng Cheng; Sadek, Hesham A.			Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; HIF-ALPHA; RNA-SEQ; RENEWAL; PROLIFERATION; HYDROXYLATION; REGENERATION	Although the adult mammalian heart is incapable of meaningful functional recovery following substantial cardiomyocyte loss, it is now clear that modest cardiomyocyte turnover occurs in adult mouse and human hearts(1,2), mediated primarily by proliferation of pre-existing cardiomyocytes(3-5). However, fate mapping of these cycling cardiomyocytes has not been possible thus far owing to the lack of identifiable genetic markers(6). In several organs, stem or progenitor cells reside in relatively hypoxic microenvironments where the stabilization of the hypoxia-inducible factor 1 alpha (Hif-1 alpha) subunit is critical for their maintenance and function(7-10). Here we report fate mapping of hypoxic cells and their progenies by generating a transgenic mouse expressing a chimaeric protein in which the oxygen-dependent degradation (ODD) domain of Hif-1 alpha is fused to the tamoxifen-inducible CreERT2 recombinase. In mice bearing the creERT2-ODD transgene driven by either the ubiquitous CAG promoter or the cardiomyocyte-specific a myosin heavy chain promoter, we identify a rare population of hypoxic cardiomyocytes that display characteristics of proliferative neonatal cardiomyocytes, such as smaller size, mononucleation and lower oxidative DNA damage. Notably, these hypoxic cardiomyocytes contributed widely to new cardiomyocyte formation in the adult heart. These results indicate that hypoxia signalling is an important hallmark of cycling cardiomyocytes, and suggest that hypoxia fate mapping can be a powerful tool for identifying cycling cells in adult mammals.	[Kimura, Wataru; Xiao, Feng; Canseco, Diana C.; Muralidhar, Shalini; Thet, SuWannee; Abderrahman, Yezan; Chen, Rui; Garcia, Joseph A.; Shelton, John M.; Ashour, Abdelrahman M.; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA; [Kimura, Wataru] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki 3058577, Japan; [Zhang, Helen M.; Lu, Zhigang; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zhang, Helen M.; Lu, Zhigang; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Garcia, Joseph A.] VA North Texas Hlth Care Syst, Dept Med, Dallas, TX 75216 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Asaithamby, Aroumougame] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Liang, Hanquan; Xing, Chao] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tsukuba; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sadek, HA (corresponding author), Univ Texas SW Med Ctr Dallas, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA.	hesham.sadek@utsouthwestern.edu	Zhang, Cheng/GRS-8698-2022	Lu, Zhigang/0000-0002-2880-7848; Garcia, Joseph/0000-0002-5621-7538; Kimura, Wataru/0000-0001-6548-6353; Xing, Chao/0000-0002-1838-0502	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL115275, R01 HL108104] Funding Source: Medline; BLRD VA [I01 BX000446] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BLRD VA		Ali SR, 2014, P NATL ACAD SCI USA, V111, P8850, DOI 10.1073/pnas.1408233111; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Culver JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053546; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Johansson B, 2008, INT J CARDIOL, V126, P252, DOI 10.1016/j.ijcard.2007.04.003; Jopling C, 2012, CIRCULATION, V126, P3017, DOI 10.1161/CIRCULATIONAHA.112.107888; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Parmacek MS, 2009, NEW ENGL J MED, V361, P86, DOI 10.1056/NEJMcibr0903347; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sanada F, 2014, CIRC RES, V114, P41, DOI 10.1161/CIRCRESAHA.114.302500; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang YL, 2005, GENE THER, V12, P1163, DOI 10.1038/sj.gt.3302513; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uchida S, 2013, STEM CELL REP, V1, P397, DOI 10.1016/j.stemcr.2013.09.004; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Zhang CC, 2014, ANTIOXID REDOX SIGN, V20, P1891, DOI 10.1089/ars.2012.5019	29	211	217	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					226	U243		10.1038/nature14582	http://dx.doi.org/10.1038/nature14582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26098368				2022-12-28	WOS:000357695900038
J	Zamble, D				Zamble, Deborah			It costs more than a nickel	SCIENCE			English	Editorial Material							TRAFFICKING; PROTEINS; LACTATE; THEMES		[Zamble, Deborah] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Zamble, Deborah] Univ Toronto, Dept Biochem, Toronto, ON M5S 3H6, Canada	University of Toronto; University of Toronto	Zamble, D (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	deborah.zamble@utoronto.ca		Zamble, Deborah/0000-0002-8976-3375				Can M, 2014, CHEM REV, V114, P4149, DOI 10.1021/cr400461p; Chivers PT, 2015, METALLOMICS, V7, P590, DOI 10.1039/c4mt00310a; de Reuse H, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00094; Desguin B, 2015, SCIENCE, V349, P66, DOI 10.1126/science.aab2272; Desguin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4615; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Goffin P, 2005, J BACTERIOL, V187, P6750, DOI 10.1128/JB.187.19.6750-6761.2005; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Maroney MJ, 2014, CHEM REV, V114, P4206, DOI 10.1021/cr4004488; Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296; Sydor AM, 2013, METAL IONS LIFE SCI, V12, P375, DOI 10.1007/978-94-007-5561-1_11; van Koten G, 2013, TOP ORGANOMETAL CHEM, V40, P1, DOI 10.1007/978-3-642-31081-2_1; Zambelli B, 2011, ACCOUNTS CHEM RES, V44, P520, DOI 10.1021/ar200041k	13	3	3	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					35	36		10.1126/science.aac5854	http://dx.doi.org/10.1126/science.aac5854			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138967				2022-12-28	WOS:000357280800047
J	Anheier, NC				Anheier, Norm C.			NANOTECHNOLOGY Colourful particles for spectrometry	NATURE			English	Editorial Material									Pacific NW Natl Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Anheier, NC (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	norm.anheier@pnnl.gov						Bao J, 2015, NATURE, V523, P67, DOI 10.1038/nature14576; EKIMOV AI, 1981, JETP LETT+, V34, P345; Faraday M., 1857, PHILOS T ROY SOC LON, V147, P145, DOI [10.1098/rstl.1857.001, DOI 10.1098/RSTL.1857.0011]; Kaltenegger L, 2010, ASTROBIOLOGY, V10, P89, DOI 10.1089/ast.2009.0381; Kershaw SV, 2013, CHEM SOC REV, V42, P3033, DOI 10.1039/c2cs35331h; Newton I., 1704, OPTICKS; Wiens R., 2011, GEOCHEM NEWS, V145, P41	7	3	3	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					39	40		10.1038/523039a	http://dx.doi.org/10.1038/523039a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135442				2022-12-28	WOS:000357169500023
J	Miniati, F; Beresnyak, A				Miniati, Francesco; Beresnyak, Andrey			Self-similar energetics in large clusters of galaxies	NATURE			English	Article							LARGE-SCALE STRUCTURE; SEED MAGNETIC-FIELDS; TURBULENT MOTIONS; ROTATION MEASURES; POWER SPECTRUM; ADAPTIVE MESH; SHOCK-WAVES; REFINEMENT; GENERATION; STATISTICS	Massive galaxy clusters are filled with a hot, turbulent and magnetized intra-cluster medium. Still forming under the action of gravitational instability, they grow in mass by accretion of supersonic flows. These flows partially dissipate into heat through a complex network of large-scale shocks(1), while residual transonic (near-sonic) flows create giant turbulent eddies and cascades(2,3). Turbulence heats the intra-cluster medium(4) and also amplifies magnetic energy by way of dynamo action(5-8). However, the pattern regulating the transformation of gravitational energy into kinetic, thermal, turbulent and magnetic energies remains unknown. Here we report that the energy components of the intra-cluster medium are ordered according to a permanent hierarchy, in which the ratio of thermal to turbulent to magnetic energy densities remains virtually unaltered throughout the cluster's history, despite evolution of each individual component and the drive towards equipartition of the turbulent dynamo. This result revolves around the approximately constant efficiency of turbulence generation from the gravitational energy that is freed during mass accretion, revealed by our computational model of cosmological structure formation(3,9). The permanent character of this hierarchy reflects yet another type of self-similarity in cosmology(10-13), while its structure, consistent with current data(14-18), encodes information about the efficiency of turbulent heating and dynamo action.	[Miniati, Francesco] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [Beresnyak, Andrey] KTH Royal Inst Technol, Nordita, SE-10691 Stockholm, Sweden; [Beresnyak, Andrey] Stockholm Univ, SE-10691 Stockholm, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; Nordic Institute for Theoretical Physics; Royal Institute of Technology; Stockholm University	Miniati, F (corresponding author), ETH, Dept Phys, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland.	fm@phys.ethz.ch			Swiss National Supercomputing Center (CSCS) [S419, S506]	Swiss National Supercomputing Center (CSCS)	This work was supported by a grant from the Swiss National Supercomputing Center (CSCS) under project IDs S419 and S506.	Beresnyak A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.035002; Beresnyak A., ASTROPHYS J UNPUB; Bernet ML, 2008, NATURE, V454, P302, DOI 10.1038/nature07105; Bertone S, 2006, MON NOT R ASTRON SOC, V370, P319, DOI 10.1111/j.1365-2966.2006.10474.x; Bonafede A, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913696; Cho J, 2009, ASTROPHYS J, V693, P1449, DOI 10.1088/0004-637X/693/2/1449; Clarke TE, 2001, ASTROPHYS J, V547, pL111, DOI 10.1086/318896; COLELLA P, 1990, J COMPUT PHYS, V87, P171, DOI 10.1016/0021-9991(90)90233-Q; Donnert J, 2009, MON NOT R ASTRON SOC, V392, P1008, DOI 10.1111/j.1365-2966.2008.14132.x; Eisenstein DJ, 1998, ASTROPHYS J, V498, P137, DOI 10.1086/305535; Eke VR, 2001, ASTROPHYS J, V554, P114, DOI 10.1086/321345; Gaspari M, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322295; Govoni F, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913665; Gregori G, 2012, NATURE, V481, P480, DOI 10.1038/nature10747; Guidetti D, 2008, ASTRON ASTROPHYS, V483, P699, DOI 10.1051/0004-6361:20078576; HARRISON ER, 1970, PHYS REV D, V1, P2726, DOI 10.1103/PhysRevD.1.2726; KAISER N, 1986, MON NOT R ASTRON SOC, V222, P323, DOI 10.1093/mnras/222.2.323; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Kuchar P, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/200913918; Kulsrud RM, 1997, ASTROPHYS J, V480, P481, DOI 10.1086/303987; Landau L.D., 1987, PHYS TODAY, V6; Miniati F, 2000, ASTROPHYS J, V542, P608, DOI 10.1086/317027; Miniati F, 2007, J COMPUT PHYS, V227, P400, DOI 10.1016/j.jcp.2007.07.035; Miniati F, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/60; Miniati F, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/21; Miniati F, 2011, ASTROPHYS J SUPPL S, V195, DOI 10.1088/0067-0049/195/1/5; Miniati F, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/73; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Ryu D, 2008, SCIENCE, V320, P909, DOI 10.1126/science.1154923; SCHLUTER A, 1950, Z NATURFORSCH A, V5, P237; Stephens IW, 2014, NATURE, V514, P597, DOI 10.1038/nature13850; SUBRAMANIAN K, 1994, MON NOT R ASTRON SOC, V271, pL15, DOI 10.1093/mnras/271.1.L15; Vazza F, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016015; Zamaninasab M, 2014, NATURE, V510, P126, DOI 10.1038/nature13399; Zhuravleva I, 2014, NATURE, V515, P85, DOI 10.1038/nature13830	36	51	51	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					59	+		10.1038/nature14552	http://dx.doi.org/10.1038/nature14552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135447	Green Submitted			2022-12-28	WOS:000357169500030
J	Miller, MR; Levy, ML				Miller, Martin R.; Levy, Mark L.			TOO MUCH MEDICINE Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMERICAN-THORACIC-SOCIETY; LUNG-FUNCTION; REFERENCE VALUES; LOWER LIMIT; COPD; RISK; DEFINITIONS; PREVALENCE; STRATEGIES; SPIROMETRY		[Miller, Martin R.] Univ Birmingham, Inst Occupat & Environm Med, Birmingham B15 2TT, W Midlands, England; [Levy, Mark L.] Harrow Clin Commissioning Grp, London, England	University of Birmingham	Miller, MR (corresponding author), Univ Birmingham, Inst Occupat & Environm Med, Birmingham B15 2TT, W Midlands, England.	m.r.miller@bham.ac.uk						Albrecht E, 2014, EUR RESPIR J, V43, P983, DOI 10.1183/09031936.00046213; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Bhatt SP, 2014, THORAX, V69, P409, DOI 10.1136/thoraxjnl-2012-202810; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Han JN, 2015, COPD, V12, P115, DOI 10.3109/15412555.2014.974741; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Health and Social Care Information Centre, HLTH SURV ENGL; Hu Y, 2006, THORAX, V61, P290, DOI 10.1136/thx.2005.051524; Johannessen A, 2006, AM J RESP CRIT CARE, V173, P1316, DOI 10.1164/rccm.200601-023OC; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Lamprecht B, 2011, PULM MED, V2011, DOI 10.1155/2011/780215; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Mannino DM, 2007, THORAX, V62, P237, DOI 10.1136/thx.2006.068379; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; McKenzie DK, 2003, MED J AUST S, V178, pS1, DOI DOI 10.5694/J.1326-5377.2003.TB05213.X; Miller Martin R, 2007, Int J Chron Obstruct Pulmon Dis, V2, P657; Nacul L, 2011, J PUBLIC HEALTH-UK, V33, P108, DOI 10.1093/pubmed/fdq031; National Institute for Health and Care Excellence, 2010, CHRON OBSTR PULM DIS; Neupane M, HOUSEHOLD AIR POLLUT; Omland O, 2014, SCAND J WORK ENV HEA, V40, P19, DOI 10.5271/sjweh.3400; Oyebode O, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-24; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quanjer PH, 2010, PRIM CARE RESP J, V19, P288, DOI 10.4104/pcrj.2010.00052; Rennard SI, 2013, AM J RESP CRIT CARE, V187, P1036, DOI 10.1164/rccm.201212-2321ED; Schermer TRJ, 2008, EUR RESPIR J, V32, P945, DOI 10.1183/09031936.00170307; Scholes S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005685; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Singh S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3215; Stanciole AE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e608; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; van Dijk W, 2015, ANN FAM MED, V13, P41, DOI 10.1370/afm.1714; World Health Organization, 2004, GLOB BURD DIS 2004 U	41	54	54	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2015	351								h3021	10.1136/bmj.h3021	http://dx.doi.org/10.1136/bmj.h3021			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TQ	26136356				2022-12-28	WOS:000357607800003
J	Johnston, AWB				Johnston, Andrew W. B.			Who can cleave DMSP?	SCIENCE			English	Editorial Material							DIMETHYL SULFIDE; LYASE		Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Johnston, AWB (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk	Johnston, Andrew W B/D-1859-2009		BBSRC [BB/H002642/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002642/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alcolombri U, 2015, SCIENCE, V348, P1466, DOI 10.1126/science.aab1586; CANTONI GL, 1956, J BIOL CHEM, V222, P171; CHALLENGER F, 1948, J CHEM SOC, P1591, DOI 10.1039/jr9480001591; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; deSouza MP, 1996, PLANTA, V199, P433, DOI 10.1007/BF00195736; Haas P, 1935, BIOCHEM J, V29, P1297, DOI 10.1042/bj0291297; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Moran MA, 2012, ANNU REV MAR SCI, V4, P523, DOI 10.1146/annurev-marine-120710-100827; Nevitt GA, 2011, INTEGR COMP BIOL, V51, P819, DOI 10.1093/icb/icr093; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215	12	11	11	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1430	1431		10.1126/science.aac5661	http://dx.doi.org/10.1126/science.aac5661			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113706				2022-12-28	WOS:000356869100021
J	Gonen, S; DiMaio, F; Gonen, T; Baker, D				Gonen, Shane; DiMaio, Frank; Gonen, Tamir; Baker, David			Design of ordered two-dimensional arrays mediated by noncovalent protein-protein interfaces	SCIENCE			English	Article							ATOMIC-LEVEL ACCURACY; COMPUTATIONAL DESIGN; NANOMATERIALS; ASSEMBLIES; SYMMETRY; CRYSTALS; LATTICES; MODELS; DNA	We describe a general approach to designing two-dimensional (2D) protein arrays mediated by noncovalent protein-protein interfaces. Protein homo-oligomers are placed into one of the seventeen 2D layer groups, the degrees of freedom of the lattice are sampled to identify configurations with shape-complementary interacting surfaces, and the interaction energy is minimized using sequence design calculations. We used the method to design proteins that self-assemble into layer groups P 3 2 1, P 4 21 2, and P 6. Projection maps of micrometer-scale arrays, assembled both in vitro and in vivo, are consistent with the design models and display the target layer group symmetry. Such programmable 2D protein lattices should enable new approaches to structure determination, sensing, and nanomaterial engineering.	[Gonen, Shane; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Gonen, Shane; DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Gonen, Shane; DiMaio, Frank; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Gonen, Shane; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Gonen, T (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	gonent@janelia.hhmi.org; dabaker@uw.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Gonen, Shane/0000-0002-4829-3151	HHMI's Janelia Research Campus visitor program; University of Washington's Biochemistry Department and Biological Physics, Structure, and Design program; U.S. Defense Threat Reduction Agency; U.S. Air Force Office of Scientific Research; Howard Hughes Medical Institute; Direct For Mathematical & Physical Scien [1332907] Funding Source: National Science Foundation	HHMI's Janelia Research Campus visitor program; University of Washington's Biochemistry Department and Biological Physics, Structure, and Design program; U.S. Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank D. Shi and J. de la Cruz for help with EM, S. Sanchez-Martinez for help with protein expression, J. Bale and N. King for support and helpful discussions, and W. Sheffler for Rosetta code. We would also like to thank members of both the Baker and Gonen labs for scripts and useful discussions. We thank HHMI's Janelia Research Campus visitor program, the University of Washington's Biochemistry Department and Biological Physics, Structure, and Design program, U.S. Defense Threat Reduction Agency, U.S. Air Force Office of Scientific Research, and the Howard Hughes Medical Institute for funding and support. S.G., F.D., T.G., and D.B. are inventors on a provisional patent application that covers the method for the design of self-assembling 2D protein material. Supporting materials, methods and the design models and sample design files are available in the supplementary materials. Author contributions: S.G. and F.D. worked on the docking and design. S.G. worked on design optimization. F.D. wrote Rosetta code. S.G., F.D., and D.B. computationally analyzed the designs. S.G. worked on the biochemistry, electron microscopy, and data analysis. S.G. and T.G. analyzed the EM data. All authors designed the research and wrote, edited, and contributed to the manuscript.	Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Baneyx F, 2014, CURR OPIN BIOTECH, V28, P39, DOI 10.1016/j.copbio.2013.11.001; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; CASPAR DLD, 1977, J CELL BIOL, V74, P605, DOI 10.1083/jcb.74.2.605; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; Hendsch ZS, 1996, BIOCHEMISTRY-US, V35, P7621, DOI 10.1021/bi9605191; Kellogg EH, 2012, J PHYS CHEM B, V116, P11405, DOI 10.1021/jp3044303; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Nannenga B. L., 2013, CURR PROTOC PROTEIN; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Pum D, 2013, INT J MOL SCI, V14, P2484, DOI 10.3390/ijms14022484; Rash JE, 2004, NEUROSCIENCE, V129, P915, DOI 10.1016/j.neuroscience.2004.06.076; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Shi D, 2013, ELIFE, V2, DOI 10.7554/eLife.01345; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; WUKOVITZ SW, 1995, NAT STRUCT BIOL, V2, P1062, DOI 10.1038/nsb1295-1062; Zhang J, 2014, CURR OPIN STRUC BIOL, V27, P79, DOI 10.1016/j.sbi.2014.05.009	26	161	165	4	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1365	1368		10.1126/science.aaa9897	http://dx.doi.org/10.1126/science.aaa9897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089516				2022-12-28	WOS:000356449500052
J	Hogue, TS; Pincetl, S				Hogue, Terri S.; Pincetl, Stephanie			Are you watering your lawn?	SCIENCE			English	Editorial Material							LOS-ANGELES; URBAN WATER		[Hogue, Terri S.] Colorado Sch Mines, Dept Civil & Environm Engn, Golden, CO 80401 USA; [Pincetl, Stephanie] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA	Colorado School of Mines; University of California System; University of California Los Angeles	Hogue, TS (corresponding author), Colorado Sch Mines, Dept Civil & Environm Engn, Golden, CO 80401 USA.	thogue@mines.edu						Balling RC, 2007, J APPL METEOROL CLIM, V46, P1130, DOI 10.1175/JAM2518.1; Beal C., 2014, 2014 REV SMART METER; Boyle T, 2013, WATER-SUI, V5, P1052, DOI 10.3390/w5031052; Carandang C., 2015, THESIS COLORADO SCH; Ferraro PJ, 2013, REV ECON STAT, V95, P64, DOI 10.1162/REST_a_00344; Giurco DP, 2010, WATER-SUI, V2, P461, DOI 10.3390/w2030461; Gleick P.H., 2003, WASTE NOT WANT NOT P; Gurung TR, 2015, J CLEAN PROD, V87, P642, DOI 10.1016/j.jclepro.2014.09.054; Hilaire RS, 2008, HORTSCIENCE, V43, P2081, DOI 10.21273/HORTSCI.43.7.2081; Kaplan S, 2014, ENVIRON MANAGE, V53, P855, DOI 10.1007/s00267-014-0245-7; Mini C, 2015, RESOUR CONSERV RECY, V94, P136, DOI 10.1016/j.resconrec.2014.10.005; Mini C, 2014, WATER POLICY, V16, P1054, DOI 10.2166/wp.2014.029; Neal B., 2014, WATER MANAGEMENT, V167, P435; NPR, 2015, HIST DROUGHT GRIPS B	14	20	21	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1319	1320		10.1126/science.aaa6909	http://dx.doi.org/10.1126/science.aaa6909			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089498				2022-12-28	WOS:000356449500030
J	Karan, S; Jiang, ZW; Livingston, AG				Karan, Santanu; Jiang, Zhiwei; Livingston, Andrew G.			Sub-10 nm polyamide nanofilms with ultrafast solvent transport for molecular separation	SCIENCE			English	Article							HIGH-FLUX MEMBRANES; INTERFACIAL POLYMERIZATION; HYDROXIDE NANOSTRANDS; THIN-FILMS; NANOFILTRATION; PERMEATION	Membranes with unprecedented solvent permeance and high retention of dissolved solutes are needed to reduce the energy consumed by separations in organic liquids. We used controlled interfacial polymerization to form free-standing polyamide nanofilms less than 10 nanometers in thickness, and incorporated them as separating layers in composite membranes. Manipulation of nanofilm morphology by control of interfacial reaction conditions enabled the creation of smooth or crumpled textures; the nanofilms were sufficiently rigid that the crumpled textures could withstand pressurized filtration, resulting in increased permeable area. Composite membranes comprising crumpled nanofilms on alumina supports provided high retention of solutes, with acetonitrile permeances up to 112 liters per square meter per hour per bar. This is more than two orders of magnitude higher than permeances of commercially available membranes with equivalent solute retention.	[Karan, Santanu; Jiang, Zhiwei; Livingston, Andrew G.] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England	Imperial College London	Livingston, AG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, South Kensington Campus, London SW7 2AZ, England.	a.livingston@imperial.ac.uk	Livingston, Andrew G/A-7697-2015; Karan, Santanu/I-2632-2015	Livingston, Andrew G/0000-0002-7916-3026; Livingston, Andrew/0000-0003-0074-1426; Karan, Santanu/0000-0002-9140-9121	UK Engineering and Physical Sciences Research Council [EP/J014974/1]; BP International Centre for Advanced Materials; Engineering and Physical Sciences Research Council [EP/J014974/1] Funding Source: researchfish; EPSRC [EP/J014974/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BP International Centre for Advanced Materials; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by UK Engineering and Physical Sciences Research Council platform grant EP/J014974/1 and the BP International Centre for Advanced Materials. We thank J. T. Cabral for his suggestions on determining the modulus values of the nanofilms.	Buekenhoudt A, 2013, J MEMBRANE SCI, V439, P36, DOI 10.1016/j.memsci.2013.03.032; CADOTTE JE, 1980, DESALINATION, V32, P25, DOI 10.1016/S0011-9164(00)86003-8; CHAI GY, 1994, J MEMBRANE SCI, V93, P175, DOI 10.1016/0376-7388(94)80006-5; Chung JY, 2011, NANO LETT, V11, P3361, DOI 10.1021/nl201764b; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Freger V, 2003, LANGMUIR, V19, P4791, DOI 10.1021/la020920q; Gorgojo P, 2014, ADV FUNCT MATER, V24, P4729, DOI 10.1002/adfm.201400400; Ichinose I, 2004, J AM CHEM SOC, V126, P7162, DOI 10.1021/ja049141h; Johnson PM, 2012, J POLYM SCI POL PHYS, V50, P168, DOI 10.1002/polb.23002; Karan S, 2013, J MEMBRANE SCI, V448, P270, DOI 10.1016/j.memsci.2013.07.068; Karan S, 2012, SCIENCE, V335, P444, DOI 10.1126/science.1212101; Marchetti P, 2014, CHEM REV, V114, P10735, DOI 10.1021/cr500006j; Solomon MFJ, 2012, J MEMBRANE SCI, V423, P371, DOI 10.1016/j.memsci.2012.08.030; Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175; Szekely G, 2014, GREEN CHEM, V16, P4440, DOI 10.1039/c4gc00701h; Vanhook SJ, 1997, J FLUID MECH, V345, P45, DOI 10.1017/S0022112097006101	16	1033	1063	146	1639	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1347	1351		10.1126/science.aaa5058	http://dx.doi.org/10.1126/science.aaa5058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089512				2022-12-28	WOS:000356449500047
J	Woodroffe, R; Redpath, SM				Woodroffe, Rosie; Redpath, Stephen M.			When the hunter becomes the hunted	SCIENCE			English	Editorial Material							WOLVES		[Woodroffe, Rosie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Redpath, Stephen M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 2TZ, Scotland	Zoological Society of London; University of Aberdeen	Woodroffe, R (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	rosie.woodroffe@ioz.ac.uk; s.redpath@abdn.ac.uk	Redpath, Stephen/B-4640-2012	Redpath, Stephen/0000-0001-5399-9477				Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Bourne J., 2007, BOVINE TB SCI EVIDEN; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Ellis-Felege SN, 2012, J APPL ECOL, V49, P661, DOI 10.1111/j.1365-2664.2012.02126.x; Gibeau M.L, 2012, WILDL PROF, V6, P62; Hervieux D, 2014, CAN J ZOOL, V92, P1029, DOI 10.1139/cjz-2014-0142; Holt AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002400; Macdonald DW., 1980, RABIES WILDLIFE BIOL; Novaro Andres J., 2005, P268; Redpath S.M., 2015, CONFLICTS CONSERVATI; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Trewby ID, 2008, BIOL LETTERS, V4, P170, DOI 10.1098/rsbl.2007.0516; Woodroffe R., 2005, CONSERV BIOL	15	41	41	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1312	1314		10.1126/science.aaa8465	http://dx.doi.org/10.1126/science.aaa8465			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089495	Green Submitted			2022-12-28	WOS:000356449500026
J	Horanyi, M; Szalay, JR; Kempf, S; Schmidt, J; Grun, E; Srama, R; Sternovsky, Z				Horanyi, M.; Szalay, J. R.; Kempf, S.; Schmidt, J.; Gruen, E.; Srama, R.; Sternovsky, Z.			A permanent, asymmetric dust cloud around the Moon	NATURE			English	Article							PLANETARY SATELLITES; LUNAR ATMOSPHERE; EJECTA; EXOSPHERE; IMPACTS	Interplanetary dust particles hit the surfaces of airless bodies in the Solar System, generating charged(1) and neutral(2) gas clouds, as well as secondary ejecta dust particles(3). Gravitationally bound ejecta clouds that form dust exospheres were recognized by in situ dust instruments around the icy moons of Jupiter(4) and Saturn(5), but have hitherto not been observed near bodies with refractory regolith surfaces. High-altitude Apollo 15 and 17 observations of a 'horizon glow' indicated a putative population of high-density small dust particles near the lunar terminators(6,7), although later orbital observations(8,9) yielded upper limits on the abundance of such particles that were a factor of about 10(4) lower than that necessary to produce the Apollo results. Here we report observations of a permanent, asymmetric dust cloud around the Moon, caused by impacts of high-speed cometary dust particles on eccentric orbits, as opposed to particles of asteroidal origin following near-circular paths striking the Moon at lower speeds. The density of the lunar ejecta cloud increases during the annual meteor showers, especially the Geminids, because the lunar surface is exposed to the same stream of interplanetary dust particles. We expect all airless planetary objects to be immersed in similar tenuous clouds of dust.	[Horanyi, M.; Szalay, J. R.; Kempf, S.; Gruen, E.; Sternovsky, Z.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA; [Horanyi, M.; Szalay, J. R.; Kempf, S.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Horanyi, M.; Szalay, J. R.; Kempf, S.; Gruen, E.; Sternovsky, Z.] Univ Colorado, Inst Modeling Plasma Atmospheres & Cosm Dust IMPA, Boulder, CO 80303 USA; [Schmidt, J.] Univ Oulu, Astron & Space Phys, FI-90014 Oulu, Finland; [Gruen, E.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Srama, R.] Univ Stuttgart, Inst Raumfahrtsyst, Raumfahrtzentrum Baden Wurttemberg, D-70569 Stuttgart, Germany; [Sternovsky, Z.] Univ Colorado, Aerosp Engn Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Oulu; Max Planck Society; University of Stuttgart; University of Colorado System; University of Colorado Boulder	Horanyi, M (corresponding author), Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA.	horanyi@colorado.edu	Sternovsky, Zoltan/D-7297-2018	Sternovsky, Zoltan/0000-0002-9658-1350; KEMPF, SASCHA/0000-0001-5236-3004; Szalay, Jamey/0000-0003-2685-9801	NASA; NASA's Solar System Exploration Research Virtual Institute (SSERVI)	NASA(National Aeronautics & Space Administration (NASA)); NASA's Solar System Exploration Research Virtual Institute (SSERVI)	The LADEE/LDEX project was supported by NASA. Tests and calibrations were done at the dust accelerator facility of the University of Colorado, supported by NASA's Solar System Exploration Research Virtual Institute (SSERVI). We are grateful for engineering and technical support from the Laboratory for Atmospheric and Space Physics (LASP), especially from M. Lankton (project manager), S. Gagnard and D. Gathright (mission operations), and D. James (calibration).	Allegrini F, 2013, PLANET SPACE SCI, V85, P232, DOI 10.1016/j.pss.2013.06.014; Auer S, 2001, ASTR AST LI, P385; AUER S, 1968, EARTH PLANET SC LETT, V4, P178; Buhl E, 2014, ICARUS, V237, P131, DOI 10.1016/j.icarus.2014.04.039; Collette A, 2014, ICARUS, V227, P89, DOI 10.1016/j.icarus.2013.09.009; DIETZEL H, 1973, J PHYS E SCI INSTRUM, V6, P209, DOI 10.1088/0022-3735/6/3/008; Dikarev V, 2005, ADV SPACE RES, V35, P1282, DOI 10.1016/j.asr.2005.05.014; Drolshagen G., 2009, 241 IADC; Elphic RC, 2014, SPACE SCI REV, V185, P3, DOI 10.1007/s11214-014-0113-z; Feldman PD, 2014, ICARUS, V233, P106, DOI 10.1016/j.icarus.2014.01.039; Glenar DA, 2014, J GEOPHYS RES-PLANET, V119, P2548, DOI 10.1002/2014JE004702; Glenar DA, 2011, PLANET SPACE SCI, V59, P1695, DOI 10.1016/j.pss.2010.12.003; GRUN E, 1985, ICARUS, V62, P244, DOI 10.1016/0019-1035(85)90121-6; HARTMANN WK, 1985, ICARUS, V63, P69, DOI 10.1016/0019-1035(85)90021-1; Horanyi M, 2014, SPACE SCI REV, V185, P93, DOI 10.1007/s11214-014-0118-7; IGLSEDER H, 1995, ADV SPACE RES-SERIES, V17, P177; Koschny D, 2001, ICARUS, V154, P402, DOI 10.1006/icar.2001.6708; Krivov AV, 2003, PLANET SPACE SCI, V51, P251, DOI 10.1016/S0032-0633(02)00147-2; Kruger H, 1999, NATURE, V399, P558, DOI 10.1038/21136; Kruger H, 2000, PLANET SPACE SCI, V48, P1457, DOI 10.1016/S0032-0633(00)00092-1; Markwardt CB, 2009, ASTR SOC P, V411, P251; McCoy J E, 1976, LUNAR PLANET SCI, V7, P1087; McNamara H, 2005, EARTH MOON PLANETS, V95, P123, DOI 10.1007/s11038-005-9044-8; Nesvorny D, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/129; Poppe A. R., 2014, 45 LUN PLAN SCI C, V45, P1393; Rennilson J. J., 1974, Moon, V10, P121, DOI 10.1007/BF00655715; Saito Y, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036077; Saul L, 2013, PLANET SPACE SCI, V84, P1, DOI 10.1016/j.pss.2013.02.004; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Sremcevic M, 2005, PLANET SPACE SCI, V53, P625, DOI 10.1016/j.pss.2004.10.001; Sremcevic M, 2003, PLANET SPACE SCI, V51, P455, DOI 10.1016/S0032-0633(03)00050-3; Stern SA, 1999, REV GEOPHYS, V37, P453, DOI 10.1029/1999RG900005; ZOOK HA, 1991, GEOPHYS RES LETT, V18, P2117, DOI 10.1029/91GL02235	33	129	138	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					324	+		10.1038/nature14479	http://dx.doi.org/10.1038/nature14479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085272				2022-12-28	WOS:000356425400049
J	Bates, ER				Bates, Eric R.			In STEMI, manual thrombectomy before PCI did not reduce CV-related outcomes but increased stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; THROMBUS ASPIRATION		Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Jaffe R, 2010, JACC-CARDIOVASC INTE, V3, P695, DOI 10.1016/j.jcin.2010.05.004; Lagerqvist B, 2014, NEW ENGL J MED, V371, P1111, DOI 10.1056/NEJMoa1405707; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC2	10.7326/ACPJC-2015-162-12-002	http://dx.doi.org/10.7326/ACPJC-2015-162-12-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075779				2022-12-28	WOS:000356516300003
J	Watts, G				Watts, Geoff			Richard Michael Suzman Obituary	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1942	1942		10.1016/S0140-6736(15)60951-5	http://dx.doi.org/10.1016/S0140-6736(15)60951-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	26090633				2022-12-28	WOS:000354541700017
J	Watts, N; Adger, WN; Agnolucci, P; Blackstock, A; Byass, P; Cai, WJ; Chaytor, S; Colbourn, T; Collins, M; Cooper, A; Cox, PM; Depledge, J; Drummond, P; Ekins, P; Galaz, V; Grace, D; Graham, H; Grubb, M; Haines, A; Hamilton, I; Hunter, A; Jiang, XJ; Li, MX; Kelman, I; Liang, L; Lott, M; Lowe, R; Luo, Y; Mace, G; Maslin, M; Nilsson, M; Oreszczyn, T; Pye, S; Quinn, T; Svensdotter, M; Venevsky, S; Warner, K; Xu, B; Yang, J; Yin, YY; Yu, CQ; Zhang, Q; Gong, P; Montgomery, H; Costello, A				Watts, Nick; Adger, W. Neil; Agnolucci, Paolo; Blackstock, Ason; Byass, Peter; Cai, Wenjia; Chaytor, Sarah; Colbourn, Tim; Collins, Mat; Cooper, Adam; Cox, Peter M.; Depledge, Joanna; Drummond, Paul; Ekins, Paul; Galaz, Victor; Grace, Delia; Graham, Hilary; Grubb, Michael; Haines, Andy; Hamilton, Ian; Hunter, Alasdair; Jiang, Xujia; Li, Moxuan; Kelman, Ilan; Liang, Lu; Lott, Melissa; Lowe, Robert; Luo, Yong; Mace, Georgina; Maslin, Mark; Nilsson, Maria; Oreszczyn, Tadj; Pye, Steve; Quinn, Tara; Svensdotter, My; Venevsky, Sergey; Warner, Koko; Xu, Bing; Yang, Jun; Yin, Yongyuan; Yu, Chaoqing; Zhang, Qiang; Gong, Peng; Montgomery, Hugh; Costello, Anthony			Health and climate change: policy responses to protect public health	LANCET			English	Review							GREENHOUSE-GAS EMISSIONS; SEA-LEVEL RISE; EXPLAINING EXTREME EVENTS; INFECTIOUS-DISEASES; AIR-QUALITY; CO-BENEFITS; GLOBAL HEALTH; WINTER MORTALITY; ENVIRONMENTAL-CHANGE; TECHNOLOGY ADOPTION	The 2015 Lancet Commission on Health and Climate Change has been formed to map out the impacts of climate change, and the necessary policy responses, in order to ensure the highest attainable standards of health for populations worldwide. This Commission is multidisciplinary and international in nature, with strong collaboration between academic centres in Europe and China. The central finding from the Commission's work is that tackling climate change could be the greatest global health opportunity of the 21st century. The key messages from the Commission are summarised below, accompanied by ten underlying recommendations to accelerate action in the next 5 years.	[Watts, Nick; Colbourn, Tim; Kelman, Ilan; Costello, Anthony] UCL, Inst Global Hlth, Mortimer St, London WC1E 6BT, England; [Agnolucci, Paolo; Drummond, Paul; Ekins, Paul; Grubb, Michael; Lott, Melissa] UCL, Inst Sustainable Resources, London WC1E 6BT, England; [Blackstock, Ason; Cooper, Adam] UCL, Dept Sci Technol Engn & Publ Policy, London WC1E 6BT, England; [Chaytor, Sarah] UCL, Publ Policy, London WC1E 6BT, England; [Hamilton, Ian; Lowe, Robert; Oreszczyn, Tadj; Pye, Steve] UCL, Energy Inst, London WC1E 6BT, England; [Mace, Georgina] UCL, Ctr Biodivers & Environm Res, London WC1E 6BT, England; [Maslin, Mark] UCL, Dept Geog, London WC1E 6BT, England; [Montgomery, Hugh] UCL, Inst Human Hlth & Performance, London WC1E 6BT, England; [Adger, W. Neil] Univ Exeter, Coll Life & Environm Sci, Geog, Exeter, Devon, England; [Collins, Mat; Cox, Peter M.; Hunter, Alasdair] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Quinn, Tara] Univ Exeter, Environm & Sustainabil Inst, Exeter, Devon, England; [Byass, Peter; Nilsson, Maria] Umea Univ, Ctr Global Hlth Res, Umea, Sweden; [Cai, Wenjia; Jiang, Xujia; Li, Moxuan; Liang, Lu; Luo, Yong; Venevsky, Sergey; Xu, Bing; Yang, Jun; Yin, Yongyuan; Yu, Chaoqing; Zhang, Qiang; Gong, Peng] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Depledge, Joanna] Univ Cambridge, Dept Polit & Int Studies, Cambridge, England; [Galaz, Victor; Svensdotter, My] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Grace, Delia] Int Livestock Res Inst, Nairobi, Kenya; [Graham, Hilary] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Warner, Koko] UN Univ Inst Environm & Human Secur, Bonn, Germany	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Exeter; University of Exeter; University of Exeter; Umea University; Tsinghua University; University of Cambridge; Stockholm University; CGIAR; International Livestock Research Institute (ILRI); University of York - UK; University of London; London School of Hygiene & Tropical Medicine	Watts, N (corresponding author), UCL, Inst Global Hlth, Mortimer St, London WC1E 6BT, England.	nicholas.watts.12@ucl.ac.uk	Hamilton, Ian/O-6234-2014; Yang, Jun/AAH-4967-2021; Colbourn, Tim/AAE-6645-2019; wang, fenfei/N-9905-2015; Venevsky, Sergey/AAB-7141-2022; Zhang, Qiang/D-9034-2012; Adger, Neil/F-7676-2010; Cai, Wenjia/HDL-7837-2022; Gong, Peng/AAM-1516-2021; Mace, Georgina M/I-3072-2016; Hamilton, Ian/O-6756-2019; LUO, Yong/AAP-3596-2021; Montgomery, Hugh/L-1229-2019; Collins, Matthew/F-8473-2011; Cox, Peter Michae;/B-3299-2012; Yang, Jun/E-2519-2011; Montgomery, Hugh/C-2592-2008	Hamilton, Ian/0000-0003-2582-2361; Yang, Jun/0000-0003-0824-749X; Colbourn, Tim/0000-0002-6917-6552; Adger, Neil/0000-0003-4244-2854; Gong, Peng/0000-0003-1513-3765; Mace, Georgina M/0000-0001-8965-5211; Hamilton, Ian/0000-0003-2582-2361; Collins, Matthew/0000-0003-3785-6008; Cox, Peter Michae;/0000-0002-0679-2219; Yang, Jun/0000-0003-0824-749X; Haines, Andy/0000-0002-8053-4605; Montgomery, Hugh/0000-0001-8797-5019; Kelman, Ilan/0000-0002-4191-6969; Maslin, Mark/0000-0001-9957-3463	ClimateWorks Foundation; European Climate Foundation; Microsoft Research Asia; Norwegian Agency for Development Cooperation (NORAD); National Environment Research Council through an Impact Acceleration award [NE/L012782/1]; Stordalen Foundation; University College London's Grand Challenge for Global Health; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Environmental Change and Health at the London School of Hygiene and Tropical Medicine; Public Health England (PHE); University of Exeter; University College London; Met Office; Ludgate Investment; Carbon Tracker Initiative; Swiss Re; Z/Yen; Overseas Development Institute; Committee on Climate Change; CDP; UK Energy Research Centre; Organization for Economic Cooperation and Development; EPSRC [EP/I02929X/1, EP/K011839/1] Funding Source: UKRI; ESRC [ES/L003015/1] Funding Source: UKRI; NERC [NE/L012782/1] Funding Source: UKRI; Economic and Social Research Council [ES/L003015/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I02929X/1, EP/K011839/1] Funding Source: researchfish; Natural Environment Research Council [NE/L012782/1] Funding Source: researchfish	ClimateWorks Foundation; European Climate Foundation; Microsoft Research Asia(Microsoft); Norwegian Agency for Development Cooperation (NORAD)(CGIAR); National Environment Research Council through an Impact Acceleration award; Stordalen Foundation; University College London's Grand Challenge for Global Health; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Environmental Change and Health at the London School of Hygiene and Tropical Medicine; Public Health England (PHE); University of Exeter; University College London(General Electric); Met Office; Ludgate Investment; Carbon Tracker Initiative; Swiss Re; Z/Yen; Overseas Development Institute; Committee on Climate Change; CDP; UK Energy Research Centre; Organization for Economic Cooperation and Development; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Central funding for the Commission was provided by ClimateWorks Foundation, the European Climate Foundation, Microsoft Research Asia, the Norwegian Agency for Development Cooperation (NORAD), the National Environment Research Council through an Impact Acceleration award to the University of Exeter (NE/L012782/1), Martin Rushton-Turner, the Stordalen Foundation, and University College London's Grand Challenge for Global Health. In-kind support was also provided from Tsinghua University, University College London (UCL), and the Stockholm Resilience Centre through the Dynamic Drivers of Disease in Africa Consortium (DDDAC). The contributions of WNA and PMC were supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Environmental Change and Health at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (PHE), and in collaboration with the University of Exeter, University College London, and the Met Office. Whilst carrying out its work, the Commission received invaluable technical advice and input from a number of individuals including Michele Acuto (UCL), John Ashton (E3G), Sukaina Bharwani (Stockholm Environment Institute-Oxford), Isobel Braithwaite (Global Climate and Health Alliance), Michael Depledge (University of Exeter), Helen Fry (University College London), Josh Karliner (Health Care Without Harm), and Duan Maosheng (Tsinsghua University). Olivia Stevenson (University College London) provided ongoing guidance and policy expertise to the Commission. Neil Morisetti (University College London) provided ongoing guidance and strategic input throughout the Commission's process. Elaine Fletcher and Marina Maiero from WHO's Department of Public Health, Environmental and Social Determinants of Health, and Bettina Menne from WHO's Regional Office for Europe provided both formal and informal advice and assistance to the Commission. The Commission also worked with various practitioner commissioners who reviewed its progress independently, and provided policy insight and guidance on how the final report could be most useful to decision makers. The practitioner commissioners included Diarmid Campbell-Lendrum (WHO), Matthew Pencharz (Greater London Authority), Virginia Murray (PHE), and Martin Frick (German Federal Foreign Office). In particular, the Commission would like to thank Diarmid Campbell-Lendrum, who leads WHO's efforts on health and climate change, for his advice and ongoing work in understanding the health impacts and adaptation responses to climate change, which provided a foundation for much of our report. Various experts in the fields of finance and economics provided invaluable guidance during the initial preparation stages for section 4, for which the authors are most grateful. These include Bernie Bulkin (Ludgate Investment), Mark Campanale (Carbon Tracker Initiative), Martin Rushton-Turner (Swiss Re), Michael Mainelli (Z/Yen), Andrew Scott (Overseas Development Institute), Adrian Gault (Committee on Climate Change), Paul Dickinson (CDP, formerly Carbon Disclosure Project), Jim Watson (UK Energy Research Centre), and Simon Buckle (Organization for Economic Cooperation and Development). Administrative, communications, and design support was provided by Ron Finaly, and by Ayesha Ally, Anila Babla, Faye Basset, Rosie Bartlett, Helen Hopkins, Kate Hoyland, and Maxine Lenza at UCL.		0	865	873	40	566	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1861	1914		10.1016/S0140-6736(15)60854-6	http://dx.doi.org/10.1016/S0140-6736(15)60854-6			54	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3VO	26111439	Green Submitted			2022-12-28	WOS:000364194700037
J	Schwarz, LA; Miyamichi, K; Gao, XJJ; Beier, KT; Weissbourd, B; DeLoach, KE; Ren, J; Ibanes, S; Malenka, RC; Kremer, EJ; Luo, LQ				Schwarz, Lindsay A.; Miyamichi, Kazunari; Gao, Xiaojing J.; Beier, Kevin T.; Weissbourd, Brandon; DeLoach, Katherine E.; Ren, Jing; Ibanes, Sandy; Malenka, Robert C.; Kremer, Eric J.; Luo, Liqun			Viral-genetic tracing of the input-output organization of a central noradrenaline circuit	NATURE			English	Article							LOCUS-COERULEUS NEURONS; CANINE ADENOVIRUS VECTORS; DOUBLE-LABELING TECHNIQUE; BRAIN-STEM NEURONS; AFFERENT-PROJECTIONS; RETROGRADE TRANSPORT; CRE-RECOMBINASE; BASAL GANGLIA; CELL-BODIES; SYSTEM	Deciphering how neural circuits are anatomically organized with regard to input and output is instrumental in understanding how the brain processes information. For example, locus coeruleus noradrenaline (also known as norepinephrine) (LC-NE) neurons receive input from and send output to broad regions of the brain and spinal cord, and regulate diverse functions including arousal, attention, mood and sensory gating(1-8). However, it is unclear how LC-NE neurons divide up their brain-wide projection patterns and whether different LC-NE neurons receive differential input. Here we developed a set of viral-genetic tools to quantitatively analyse the input-output relationship of neural circuits, and applied these tools to dissect the LC-NE circuit in mice. Rabies-virus-based input mapping indicated that LC-NE neurons receive convergent synaptic input from many regions previously identified as sending axons to the locus coeruleus, as well as from newly identified presynaptic partners, including cerebellar Purkinje cells. The 'tracing the relationship between input and output' method (or TRIO method) enables trans-synaptic input tracing from specific subsets of neurons based on their projection and cell type. We found that LC-NE neurons projecting to diverse output regions receive mostly similar input. Projection-based viral labelling revealed that LC-NE neurons projecting to one output region also project to all brain regions we examined. Thus, the LC-NE circuit overall integrates information from, and broadcasts to, many brain regions, consistent with its primary role in regulating brain states. At the same time, we uncovered several levels of specificity in certain LC-NE sub-circuits. These tools for mapping output architecture and input-output relationship are applicable to other neuronal circuits and organisms. More broadly, our viral-genetic approaches provide an efficient intersectional means to target neuronal populations based on cell type and projection pattern.	[Schwarz, Lindsay A.; Miyamichi, Kazunari; Gao, Xiaojing J.; Beier, Kevin T.; Weissbourd, Brandon; DeLoach, Katherine E.; Ren, Jing; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schwarz, Lindsay A.; Miyamichi, Kazunari; Gao, Xiaojing J.; Beier, Kevin T.; Weissbourd, Brandon; DeLoach, Katherine E.; Ren, Jing; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Miyamichi, Kazunari] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Beier, Kevin T.; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Ibanes, Sandy; Kremer, Eric J.] Inst Genet Mol Montpellier, CNRS 5535, F-34293 Montpellier, France; [Kremer, Eric J.] Univ Montpellier, F-34000 Montpellier, France	Howard Hughes Medical Institute; Stanford University; Stanford University; University of Tokyo; Stanford University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu	Ren, Jing/ABA-8444-2020; Kremer, Eric J/D-3734-2013; Schwarz, Lindsay/N-8125-2018; Kremer, EJ/P-9838-2019; Miyamichi, Kazunari/AAO-3705-2021; Gao, Xiaojing/K-2376-2016	Schwarz, Lindsay/0000-0002-0613-5518; Kremer, EJ/0000-0001-6114-7530; Luo, Liqun/0000-0001-5467-9264; Gao, Xiaojing/0000-0002-3094-1456; Ren, Jing/0000-0002-6665-7457; Beier, Kevin/0000-0002-4934-1338	Ruth L. Kirschstein National Service Research Award from NIMH; Stanford Bio-X Enlight Foundation Interdisciplinary Fellowship; Stanford Graduate Fellowship; NSF Graduate Research Fellowship; EU FP7 BrainVector [286071]; HHMI Collaborative Innovation Award; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, F32DA038913] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Service Research Award from NIMH; Stanford Bio-X Enlight Foundation Interdisciplinary Fellowship; Stanford Graduate Fellowship(Stanford University); NSF Graduate Research Fellowship(National Science Foundation (NSF)); EU FP7 BrainVector; HHMI Collaborative Innovation Award(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Makki for initiating the locus coeruleus project, Stanford and UNC Viral Cores for producing AAVs, K. Touhara for support, D. Berns for suggesting the TRIO acronym, and members of the Luo laboratory, L. de Lecea and S. Hestrin for critiques. L. A. S. is supported by a Ruth L. Kirschstein National Service Research Award from NIMH, X.J.G. is supported by a Stanford Bio-X Enlight Foundation Interdisciplinary Fellowship, B.W. is supported by a Stanford Graduate Fellowship and an NSF Graduate Research Fellowship, E.J.K. is supported by EU FP7 BrainVector (no. 286071), K.M. was a Research Specialist and L. L. is an investigator of HHMI. This work is supported by an HHMI Collaborative Innovation Award.	ASTONJONES G, 1981, J NEUROSCI, V1, P876; ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; CEDARBAUM JM, 1978, J COMP NEUROL, V178, P1, DOI 10.1002/cne.901780102; Chandler DJ, 2014, P NATL ACAD SCI USA, V111, P6816, DOI 10.1073/pnas.1320827111; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gompf HS, 2010, J NEUROSCI, V30, P14543, DOI 10.1523/JNEUROSCI.3037-10.2010; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; LUPPI PH, 1995, NEUROSCIENCE, V65, P119, DOI 10.1016/0306-4522(94)00481-J; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MASON ST, 1979, J COMP NEUROL, V187, P703, DOI 10.1002/cne.901870405; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; NAGAI T, 1981, NEUROSCI LETT, V23, P117, DOI 10.1016/0304-3940(81)90027-6; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; Robertson SD, 2013, NAT NEUROSCI, V16, P1016, DOI 10.1038/nn.3458; ROOM P, 1981, BRAIN RES, V221, P219, DOI 10.1016/0006-8993(81)90773-3; Salinas S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000442; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Saunders A, 2015, NATURE, V521, P85, DOI 10.1038/nature14179; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; STEINDLER DA, 1981, BRAIN RES, V223, P367, DOI 10.1016/0006-8993(81)91149-5; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Swanson L. W, 2011, BRAIN ARCHITECTURE U; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; Szabadi E, 2013, J PSYCHOPHARMACOL, V27, P659, DOI 10.1177/0269881113490326; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; VanBockstaele EJ, 1996, J COMP NEUROL, V364, P523, DOI 10.1002/(SICI)1096-9861(19960115)364:3<523::AID-CNE10>3.0.CO;2-Q; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Weissbourd B, 2014, NEURON, V83, P645, DOI 10.1016/j.neuron.2014.06.024; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Zhang XM, 2004, GENESIS, V40, P45, DOI 10.1002/gene.20062	39	370	375	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					88	U180		10.1038/nature14600	http://dx.doi.org/10.1038/nature14600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26131933	Green Accepted			2022-12-28	WOS:000359002300037
J	Zhou, M; Wang, W; Karapetyan, S; Mwimba, M; Marquees, J; Buchler, NE; Dong, XN				Zhou, Mian; Wang, Wei; Karapetyan, Sargis; Mwimba, Musoki; Marques, Jorge; Buchler, Nicolas E.; Dong, Xinnian			Redox rhythm reinforces the circadian clock to gate immune response	NATURE			English	Article							TRANSCRIPTION FACTOR; SALICYLIC-ACID; ARABIDOPSIS; GENE; NPR1; PROTEIN; GLUTATHIONE; INDUCTION; COMPONENT; DISTINCT	Recent studies have shown that in addition to the transcriptional circadian clock, many organisms, including Arabidopsis, have a circadian redox rhythm driven by the organism's metabolic activities(1-3). It has been hypothesized that the redox rhythm is linked to the circadian clock, but the mechanism and the biological significance of this link have only begun to be investigated(4-7). Here we report that the master immune regulator NPR1 (non-expressor of pathogenesis-related gene 1) of Arabidopsis is a sensor of the plant's redox state and regulates transcription of core circadian clock genes even in the absence of pathogen challenge. Surprisingly, acute perturbation in the redox status triggered by the immune signal salicylic acid does not compromise the circadian clock but rather leads to its reinforcement. Mathematical modelling and subsequent experiments show that NPR1 reinforces the circadian clock without changing the period by regulating both the morning and the evening clock genes. This balanced network architecture helps plants gate their immune responses towards the morning and minimize costs on growth at night. Our study demonstrates how a sensitive redox rhythm interacts with a robust circadian clock to ensure proper responsiveness to environmental stimuli without compromising fitness of the organism.	[Zhou, Mian; Wang, Wei; Mwimba, Musoki; Marques, Jorge; Dong, Xinnian] Duke Univ, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Durham, NC 27708 USA; [Zhou, Mian; Wang, Wei; Mwimba, Musoki; Marques, Jorge; Buchler, Nicolas E.; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Karapetyan, Sargis; Buchler, Nicolas E.] Duke Univ, Dept Phys, Durham, NC 27708 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University	Dong, XN (corresponding author), Duke Univ, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Durham, NC 27708 USA.	nb69@duke.edu; xdong@duke.edu	Zhou, Mian/I-9261-2017; Wang, Wei/I-5230-2015; Marqués, Jorge/J-6276-2016; Buchler, Nicolas/H-3988-2019	Wang, Wei/0000-0002-3780-5158; Marqués, Jorge/0000-0002-1684-115X; Buchler, Nicolas/0000-0003-3940-3432; Karapetyan, Sargis/0000-0003-0020-310X	National Institutes of Health (NIH) [1R01-GM099839-01, 2R01-GM069594-09]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3032]; Defense Advanced Research Projects Agency (DARPA) Biochronicity Grant [DARPA-BAA-11-66]; NIH [DP2 OD008654-01]; Burroughs Wellcome Fund CASI Award [BWF 1005769.01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069594, R01GM099839] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008654] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Defense Advanced Research Projects Agency (DARPA) Biochronicity Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund CASI Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. McClung for sharing the TOC1p: LUC, LHYp: LUC and CAB2p: LUC transgenic lines; S. H. Wu for providing the toc1-101 mutant; A. Millar for discussion on the project and advice on the modelling; S. Spoel for suggestions on an experiment; and P. Benfey for critiquing the manuscript. This work was supported by grants from the National Institutes of Health (NIH) (1R01-GM099839-01, 2R01-GM069594-09) and by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (through grant GBMF3032) to X.D., and a Defense Advanced Research Projects Agency (DARPA) Biochronicity Grant (DARPA-BAA-11-66), NIH Director's New Innovator Award (DP2 OD008654-01), and Burroughs Wellcome Fund CASI Award (BWF 1005769.01) to N.E.B.	Baldwin Ian T, 2013, Plant Signal Behav, V8, pe24410, DOI 10.4161/psb.24410; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Dodd AN, 2014, NEW PHYTOL, V201, P168, DOI 10.1111/nph.12489; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Edwards KD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.81; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Finkenstadt B, 2008, BIOINFORMATICS, V24, P2901, DOI 10.1093/bioinformatics/btn562; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Goodspeed D, 2012, P NATL ACAD SCI USA, V109, P4674, DOI 10.1073/pnas.1116368109; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Jahan MS, 2008, BIOSCI BIOTECH BIOCH, V72, P2795, DOI 10.1271/bbb.80407; Kim WY, 2010, METHOD ENZYMOL, V471, P357, DOI 10.1016/S0076-6879(10)71019-3; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; McClung CR, 2011, ADV GENET, V74, P105, DOI 10.1016/B978-0-12-387690-4.00004-0; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nagel DH, 2012, CURR BIOL, V22, pR648, DOI 10.1016/j.cub.2012.07.025; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Pokhilko A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-23; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rand DA, 2004, J ROY SOC INTERFACE, V1, P119, DOI 10.1098/rsif.2004.0014; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shin J, 2012, PLANT CELL, V24, P2470, DOI 10.1105/tpc.111.095430; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wang Y, 2011, PLANT CELL, V23, P486, DOI 10.1105/tpc.110.081661; Zhang C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003370; Zhong HH, 1996, MOL GEN GENET, V251, P196	43	113	128	5	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					472	U221		10.1038/nature14449	http://dx.doi.org/10.1038/nature14449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26098366	Green Accepted, Green Submitted			2022-12-28	WOS:000358378900039
J	Thery, C				Thery, Clotilde			CANCER Diagnosis by extracellular vesicles	NATURE			English	Editorial Material							PANCREATIC-CANCER; GLYPICAN-1; EXOSOMES; CELLS; BIOMARKERS; GROWTH; PLASMA	The detection of a single molecule anchored to circulating extracellular vesicles allows late-stage pancreatic cancer to be identified from just one drop of a patient's blood. See Article p.177	Inst Curie, Immun & Canc Unit, Exosomes & Tumor Growth Team, F-75249 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Thery, C (corresponding author), Inst Curie, Immun & Canc Unit, Exosomes & Tumor Growth Team, F-75249 Paris 05, France.	clotilde.thery@curie.fr	thery, clotilde/F-6373-2013	thery, clotilde/0000-0001-8294-6884				Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Gould SJ, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20389; Jakobsen KR, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26659; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Madhavan B, 2015, INT J CANCER, V136, P2616, DOI 10.1002/ijc.29324; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Whipple CA, 2012, ONCOGENE, V31, P2535, DOI 10.1038/onc.2011.430; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874	14	108	111	5	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					161	162		10.1038/nature14626	http://dx.doi.org/10.1038/nature14626			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4ZO	26106856				2022-12-28	WOS:000357695900021
J	Ferry, G				Ferry, Georgina			Medical periodicals: mining the past	LANCET			English	Editorial Material												mgf@georginaferry.com			Arts and Humanities Research Council [AH/L007010/1] Funding Source: researchfish; AHRC [AH/L007010/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))			0	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2569	2570		10.1016/S0140-6736(15)61151-5	http://dx.doi.org/10.1016/S0140-6736(15)61151-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL4NQ	26122152				2022-12-28	WOS:000356930000015
J	Ehrenreich, D; Bourrier, V; Wheatley, PJ; Etangs, ALD; Hebrard, G; Udry, S; Bonfils, X; Delfosse, X; Desert, JM; Sing, DK; Vidal-Madjar, A				Ehrenreich, David; Bourrier, Vincent; Wheatley, Peter J.; Etangs, Alain Lecavelier des; Hebrard, Guillaume; Udry, Stephane; Bonfils, Xavier; Delfosse, Xavier; Desert, Jean-Michel; Sing, David K.; Vidal-Madjar, Alfred			A giant comet-like cloud of hydrogen escaping the warm Neptune-mass exoplanet GJ 436b	NATURE			English	Article							ENERGETIC NEUTRAL ATOMS; HUBBLE-SPACE-TELESCOPE; HD 209458B; TRANSMISSION SPECTRUM; EXTRASOLAR PLANETS; ATMOSPHERIC ESCAPE; STARS; EVAPORATION; EVOLUTION; RADIATION	Exoplanets orbiting close to their parent stars may lose some fraction of their atmospheres because of the extreme irradiation(1-6). Atmospheric mass loss primarily affects low-mass exoplanets, leading to the suggestion that hot rocky planets(7-9) might have begun as Neptune-like(10-16), but subsequently lost all of their atmospheres; however, no confident measurements have hitherto been available. The signature of this loss could be observed in the ultraviolet spectrum, when the planet and its escaping atmosphere transit the star, giving rise to deeper and longer transit signatures than in the optical spectrum(17). Here we report that in the ultraviolet the Neptune-mass exoplanet GJ 436b (also known as Gliese 436b) has transit depths of 56.3 +/- 63.5% (1 sigma), far beyond the 0.69% optical transit depth. The ultraviolet transits repeatedly start about two hours before, and end more than three hours after the approximately one hour optical transit, which is substantially different from one previous claim(6) (based on an inaccurate ephemeris). We infer from this that the planet is surrounded and trailed by a large exospheric cloud composed mainly of hydrogen atoms. We estimate a mass-loss rate in the range of about 10(8)-10(9) grams per second, which is far too small to deplete the atmosphere of a Neptune-like planet in the lifetime of the parent star, but would have been much greater in the past.	[Ehrenreich, David; Bourrier, Vincent; Udry, Stephane] Observ Univ Geneve, CH-1290 Versoix, Switzerland; [Wheatley, Peter J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Etangs, Alain Lecavelier des; Hebrard, Guillaume; Vidal-Madjar, Alfred] CNRS, UMR 7095, Inst Astrophys Paris, F-75014 Paris, France; [Etangs, Alain Lecavelier des; Hebrard, Guillaume; Vidal-Madjar, Alfred] Univ Paris 06, Sorbonne Univ, UMR 7095, Inst Astrophys Paris, F-75014 Paris, France; [Hebrard, Guillaume] CNRS, Observ Haute Provence, F-04870 St Michel lObservatoire, France; [Hebrard, Guillaume] OAMP, F-04870 St Michel lObservatoire, France; [Bonfils, Xavier; Delfosse, Xavier] Univ Grenoble Alpes, IPAG, F-38000 Grenoble, France; [Bonfils, Xavier; Delfosse, Xavier] CNRS, IPAG, F-38000 Grenoble, France; [Desert, Jean-Michel] Univ Colorado, Dept Astrophys & Planetary Sci, CASA, Boulder, CO 80309 USA; [Sing, David K.] Univ Exeter, Astrophys Grp, Sch Phys, Exeter EX4 4QL, Devon, England	University of Geneva; University of Warwick; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Centre National de la Recherche Scientifique (CNRS); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); University of Colorado System; University of Colorado Boulder; University of Exeter	Ehrenreich, D (corresponding author), Observ Univ Geneve, 51 Chemin Maillettes, CH-1290 Versoix, Switzerland.	david.ehrenreich@unige.ch	Lecavelier des Etangs, Alain/GLU-6503-2022	Lecavelier des Etangs, Alain/0000-0002-5637-5253; udry, Stephane/0000-0001-7576-6236; Wheatley, Peter/0000-0003-1452-2240; Ehrenreich, David/0000-0001-9704-5405; Bonfils, Xavier/0000-0001-9003-8894; Sing, David/0000-0001-6050-7645	NASA [NAS 5-26555]; Swiss National Science Foundation (SNSF); CNES; French Agence Nationale de la Recherche (ANR) [ANR-12-BS05-0012]; Fondation Simone et Cino Del Duca; European Research Council (ERC) under ERC [337591-ExTrA];  [11817];  [12034];  [12965]; STFC [ST/I001719/1, ST/L000733/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001719/1, ST/L000733/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); CNES(Centre National D'etudes Spatiales); French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation Simone et Cino Del Duca; European Research Council (ERC) under ERC(European Research Council (ERC)); ; ; ; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work is based on observations made with the NASA/ESA Hubble Space Telescope, obtained at the Space Telescope Science Institute, which is operated by the Association of Universities for Researchin Astronomy, Inc., under NASA contract NAS 5-26555. These observations are associated with programmes #11817, #12034 and #12965. The scientific results reported in this article are based on observations made by the Chandra X-ray Observatory. This work was carried out in the framework of the National Centre for Competence in Research 'PlanetS' supported by the Swiss National Science Foundation (SNSF). D.E., V.B. and S.U. acknowledge the financial support of the SNSF. V.B., A.L.d.E., X.B. and X.D. acknowledge the support of CNES, the French Agence Nationale de la Recherche (ANR) under program ANR-12-BS05-0012 'Exo-Atmos', the Fondation Simone et Cino Del Duca, and the European Research Council (ERC) under ERC Grant Agreement no. 337591-ExTrA.	Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Bourrier V, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201323064; Bourrier V, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321551; Bourrier V, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220533; Chadney JM, 2015, ICARUS, V250, P357, DOI 10.1016/j.icarus.2014.12.012; Davis TA, 2009, MON NOT R ASTRON SOC, V396, P1012, DOI 10.1111/j.1365-2966.2009.14763.x; des Etangs AL, 2007, ASTRON ASTROPHYS, V461, P1185, DOI 10.1051/0004-6361:20065014; des Etangs AL, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201219363; des Etangs AL, 2004, ASTRON ASTROPHYS, V418, pL1, DOI 10.1051/0004-6361:20040106; Ehrenreich D, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219981; Ehrenreich D, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016356; Ehrenreich D, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016162; Ekenback A, 2010, ASTROPHYS J, V709, P670, DOI 10.1088/0004-637X/709/2/670; Fossati L, 2010, ASTROPHYS J LETT, V714, pL222, DOI 10.1088/2041-8205/714/2/L222; France K, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/149; Holmstrom M, 2008, NATURE, V451, P970, DOI 10.1038/nature06600; Jackson B, 2010, MON NOT R ASTRON SOC, V407, P910, DOI 10.1111/j.1365-2966.2010.17012.x; Knutson HA, 2014, NATURE, V505, P66, DOI 10.1038/nature12887; Knutson HA, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/27; Koskinen TT, 2007, NATURE, V450, P845, DOI 10.1038/nature06378; Kulow JR, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/132; Lanotte AA, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201424373; Leger A, 2011, ICARUS, V213, P1, DOI 10.1016/j.icarus.2011.02.004; Linsky JL, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/61; Linsky JL, 2010, ASTROPHYS J, V717, P1291, DOI 10.1088/0004-637X/717/2/1291; Lopez ED, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/59; Pepe F, 2013, NATURE, V503, P377, DOI 10.1038/nature12768; Pont F, 2009, MON NOT R ASTRON SOC, V393, pL6, DOI 10.1111/j.1745-3933.2008.00582.x; Poppenhaeger K, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/201014245; Ribas I, 2005, ASTROPHYS J, V622, P680, DOI 10.1086/427977; Sanz-Forcada J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116594; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448	34	285	291	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					459	+		10.1038/nature14501	http://dx.doi.org/10.1038/nature14501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108854	Green Submitted			2022-12-28	WOS:000356782900045
J	Johnston, A; Bartels, O				Johnston, Andrew; Bartels, Oliver			EBOLA UK doctors head home from Ebola frontline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Johnston, Andrew] Queen Elizabeth Hosp Birmingham, Royal Ctr Def Med, Birmingham, England; [Bartels, Oliver] Kerry Town Ebola Treatment Unit, Kerry Town, Sierra Leone	Royal Centre for Defence Medicine; University of Birmingham	Johnston, A (corresponding author), Queen Elizabeth Hosp Birmingham, Royal Ctr Def Med, Birmingham, England.	amcdjohnston@gmail.com	Johnston, Andy/GOK-2428-2022	Johnston, Andrew McDonald/0000-0002-0220-0589				Johnston A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7721; WHO, 2015, EB SIT REP	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2015	350								h3424	10.1136/bmj.h3424	http://dx.doi.org/10.1136/bmj.h3424			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7OB	26111833				2022-12-28	WOS:000357160500005
J	Elliott, A; Nerima, B; Bagaya, B; Kambugu, A; Joloba, M; Cose, S; Pantaleo, G; Yazdanbakhsh, M; Mabey, D; Dunne, D; Moffett, A; Rwakishaya, EK; Kaleebu, P; Mbidde, EK				Elliott, Alison; Nerima, Barbara; Bagaya, Bernard; Kambugu, Andrew; Joloba, Moses; Cose, Stephen; Pantaleo, Guiseppe; Yazdanbakhsh, Maria; Mabey, David; Dunne, David; Moffett, Ashley; Rwakishaya, Eli Katunguka; Kaleebu, Pontiano; Mbidde, Edward Katongole			Capacity for science in sub-Saharan Africa	LANCET			English	Editorial Material							PREECLAMPSIA; PREGNANCY; REGION; COHORT; HEALTH; WOMEN; RISK		[Elliott, Alison; Cose, Stephen; Kaleebu, Pontiano] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Elliott, Alison; Cose, Stephen; Mabey, David; Kaleebu, Pontiano] London Sch Hyg & Trop Med, London WC1, England; [Nerima, Barbara; Bagaya, Bernard; Kaleebu, Pontiano; Mbidde, Edward Katongole] Uganda Virus Res Inst, Entebbe, Uganda; [Bagaya, Bernard; Joloba, Moses] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Kambugu, Andrew] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Pantaleo, Guiseppe] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Dunne, David; Moffett, Ashley] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Rwakishaya, Eli Katunguka] Makerere Univ, Directorate Res & Grad Studies, Kampala, Uganda; [Rwakishaya, Eli Katunguka] Kyambogo Univ, Kampala, Uganda	University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute; Makerere University; Makerere University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge; Makerere University	Elliott, A (corresponding author), MRC UVRI Uganda Res Unit AIDS, POB 49, Entebbe, Uganda.	alison.elliott@mrcuganda.org	Pantaleo, Giuseppe/K-6163-2016; Dunne, David William/AAC-2530-2020; Yazdanbakhsh, Maria/AAI-3996-2020	Yazdanbakhsh, Maria/0000-0002-7666-1441; Dunne, David/0000-0002-8940-9886; Mabey, David/0000-0002-0031-8276; Elliott, Alison/0000-0003-2818-9549; Cose, Stephen/0000-0002-5156-037X; Ssentalo Bagaya, Bernard/0000-0002-3847-2615; Joloba, Moses/0000-0002-0334-9983	British Heart Foundation [PG/09/077/27964] Funding Source: Medline; Medical Research Council [MR/K019708/1] Funding Source: Medline; MRC [MR/K019708/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; European Commission, HOR 2020; Mpairwe H, 2014, PEDIAT ALLERG IMM-UK, V25, P481, DOI 10.1111/pai.12251; Mpairwe H, 2011, PEDIAT ALLERG IMM-UK, V22, P305, DOI 10.1111/j.1399-3038.2010.01122.x; Nachega JB, 2012, INT J EPIDEMIOL, V41, P1829, DOI 10.1093/ije/dys189; Nakanjako D, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-26; Nakimuli A, 2015, P NATL ACAD SCI USA, V112, P845, DOI 10.1073/pnas.1413453112; Nakimuli A, 2014, AM J OBSTET GYNECOL, V210, P510, DOI 10.1016/j.ajog.2013.10.879; Ndebele P, 2014, J EMPIR RES HUM RES, V9, P24, DOI 10.1525/jer.2014.9.2.24; Ramsay M, 2012, FEBS LETT, V586, P2813, DOI 10.1016/j.febslet.2012.07.061; Wellcome Trust, DEV EXC LEAD TRAIN S	11	14	14	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2435	2437		10.1016/S0140-6736(15)61111-4	http://dx.doi.org/10.1016/S0140-6736(15)61111-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK9AR	26122054				2022-12-28	WOS:000356532500004
J	Ulvestad, A; Singer, A; Clark, JN; Cho, HM; Kim, JW; Harder, R; Maser, J; Meng, YS; Shpyrko, OG				Ulvestad, A.; Singer, A.; Clark, J. N.; Cho, H. M.; Kim, J. W.; Harder, R.; Maser, J.; Meng, Y. S.; Shpyrko, O. G.			Topological defect dynamics in operando battery nanoparticles	SCIENCE			English	Article							RECHARGEABLE LITHIUM BATTERIES; ION BATTERIES; DISLOCATIONS; LIXMN2O4; CONTRAST; CATHODES; SILICON	Topological defects can markedly alter nanomaterial properties. This presents opportunities for "defect engineering," where desired functionalities are generated through defect manipulation. However, imaging defects in working devices with nanoscale resolution remains elusive. We report three-dimensional imaging of dislocation dynamics in individual battery cathode nanoparticles under operando conditions using Bragg coherent diffractive imaging. Dislocations are static at room temperature and mobile during charge transport. During the structural phase transformation, the lithium-rich phase nucleates near the dislocation and spreads inhomogeneously. The dislocation field is a local probe of elastic properties, and we find that a region of the material exhibits a negative Poisson's ratio at high voltage. Operando dislocation imaging thus opens a powerful avenue for facilitating improvement and rational design of nanostructured materials.	[Ulvestad, A.; Singer, A.; Kim, J. W.; Shpyrko, O. G.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Clark, J. N.] SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA; [Clark, J. N.] Deutsch Elektronensynchrotron DESY, Ctr Free Electron Laser Sci CFEL, D-22607 Hamburg, Germany; [Cho, H. M.; Meng, Y. S.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Harder, R.; Maser, J.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	University of California System; University of California San Diego; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of California System; University of California San Diego; United States Department of Energy (DOE); Argonne National Laboratory	Meng, YS (corresponding author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.	shmeng@ucsd.edu; oshpyrko@physics.ucsd.edu	Ulvestad, Andrew/K-8888-2015; Singer, Andrej/M-3948-2015; Kim, Jong Woo/B-5369-2017	Ulvestad, Andrew/0000-0003-4611-2561; Kim, Jong Woo/0000-0001-7942-0398; Singer, Andrej/0000-0002-2965-9242	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-SC0001805]; U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0012583]; Volkswagen Foundation; DOE Office of Science [DE-AC02-06CH11357]; Advanced Photon Source	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Volkswagen Foundation(Volkswagen); DOE Office of Science(United States Department of Energy (DOE)); Advanced Photon Source	This work was supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, under contract DE-SC0001805. H.M.C. and Y.S.M. acknowledge support on the in situ CXDI cell design, materials synthesis, electrochemical and materials characterization from the NorthEast Center for Chemical Energy Storage (NECCES), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Basic Energy Sciences under Award no. DE-SC0012583. O.G.S. and Y.S.M. are grateful to the University of California-San Diego Chancellor's Interdisciplinary Collaborators Award that made this collaboration possible. J.N.C. gratefully acknowledges financial support from the Volkswagen Foundation. This research used resources of the Advanced Photon Source, a U.S. DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. We thank the staff at Argonne National Laboratory and the Advanced Photon Source for their support. The data are deposited at Sector 34-ID-C of the Advanced Photon Source.	Abbey B, 2013, JOM-US, V65, P1183, DOI 10.1007/s11837-013-0702-4; [Anonymous], 1976, XRAY DIFFRACTION TOP; Bacon D.J., 2011, INTRO DISLOCATIONS; Carr LD, 2010, NAT NANOTECHNOL, V5, P316, DOI 10.1038/nnano.2010.93; Christensen J, 2006, J ELECTROCHEM SOC, V153, pA1019, DOI 10.1149/1.2185287; Clark JN, 2013, SCIENCE, V341, P56, DOI 10.1126/science.1236034; Cloetens P, 2002, PROC SPIE, V4503, P82, DOI 10.1117/12.452867; DOLLINS CC, 1970, ACTA METALL MATER, V18, P1209, DOI 10.1016/0001-6160(70)90111-2; Evans KE, 2000, ADV MATER, V12, P617, DOI 10.1002/(SICI)1521-4095(200005)12:9<617::AID-ADMA617>3.0.CO;2-3; Fichtner M, 2011, PHYS CHEM CHEM PHYS, V13, P21186, DOI 10.1039/c1cp22547b; Greaves GN, 2011, NAT MATER, V10, P823, DOI [10.1038/NMAT3134, 10.1038/nmat3134]; Huang HYS, 2012, J ELECTROCHEM SOC, V159, pA815, DOI 10.1149/2.090206jes; Huggins R. A., 2008, ADV BATTERIES MAT SC; Hytch MJ, 2003, NATURE, V423, P270, DOI 10.1038/nature01638; Kim JH, 2004, CHEM MATER, V16, P906, DOI 10.1021/cm035050s; LANG AR, 1958, J APPL PHYS, V29, P597, DOI 10.1063/1.1723234; Lang AR, 1999, J PHYS D APPL PHYS, V32, pA97, DOI 10.1088/0022-3727/32/10A/321; Le Bolloc'h D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.116401; Lee S, 2013, J ELECTROCHEM SOC, V160, pA968, DOI 10.1149/2.147306jes; Liu H, 2014, SCIENCE, V344, DOI 10.1126/science.1252817; NEWKIRK JB, 1958, PHYS REV, V110, P1465, DOI 10.1103/PhysRev.110.1465; Poulsen H. H., 2004, 3 DIMENSIONAL XRAY D; Ramchandran G. N., 1945, P INDIANA ACAD SCI, V19, P280; Saravanan K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08027; Shin N, 2013, NANO LETT, V13, P1928, DOI 10.1021/nl3042728; Singer A, 2014, NANO LETT, V14, P5295, DOI 10.1021/nl502332b; Takahashi Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.121201; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Ulvestad A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866030; Ulvestad A, 2014, NANO LETT, V14, P5123, DOI 10.1021/nl501858u; Valant M, 2010, ADV FUNCT MATER, V20, P644, DOI 10.1002/adfm.200901762; Van der Ven A, 2000, SOLID STATE IONICS, V135, P21, DOI 10.1016/S0167-2738(00)00326-X; Wang HF, 1999, J ELECTROCHEM SOC, V146, P473, DOI 10.1149/1.1391631; Whittingham MS, 2004, CHEM REV, V104, P4271, DOI 10.1021/cr020731c; Williams GJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.175501; Xu B, 2010, J POWER SOURCES, V195, P4971, DOI 10.1016/j.jpowsour.2010.02.060; Yang MC, 2011, CHEM MATER, V23, P2832, DOI 10.1021/cm200042z	37	238	239	16	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1344	1347		10.1126/science.aaa1313	http://dx.doi.org/10.1126/science.aaa1313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089511				2022-12-28	WOS:000356449500046
J	Keith, L; van Ginneken, E				Keith, Lilana; van Ginneken, Ewout			MIGRANT HEALTH Restricting access to the NHS for undocumented migrants is bad policy at high cost	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Keith, Lilana] Platform Int Cooperat Undocumented Migrants, Brussels, Belgium; [van Ginneken, Ewout] Berlin Univ Technol, Berlin, Germany	Technical University of Berlin	Keith, L (corresponding author), Platform Int Cooperat Undocumented Migrants, Brussels, Belgium.	lilana.keith@picum.org						[Anonymous], 2015, PICUM B; Chauvin P, 2015, ACCESS HEALTHCARE PE; Coram Children's Legal Centre, ACC SEC HEALTHC MIGR; Coram Children's Legal Centre, ACC PRIM HEALTHC MIG; Department of Health, VIS MIGR NHS COST RE; Fuentes FJM, 2011, IMMIGRATION WELFARE; Stimpson JP, 2010, HEALTH AFFAIR, V29, P544, DOI 10.1377/hlthaff.2009.0400; Swedish Agency for Public Management, 2015, VARD TILL PAPP; UK Draft Statutory Instruments, IMM HLTH CHARG ORD 2	9	16	16	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2015	350								h3056	10.1136/bmj.h3056	http://dx.doi.org/10.1136/bmj.h3056			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2OJ	26080047	Green Published			2022-12-28	WOS:000356783600004
J	Watts, G				Watts, Geoff			David Lawrence Sackett Obituary	LANCET			English	Biographical-Item																		SACKETT D, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2348	2348		10.1016/S0140-6736(15)61094-7	http://dx.doi.org/10.1016/S0140-6736(15)61094-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	26088633				2022-12-28	WOS:000356003700017
J	Shrager, JB				Shrager, Joseph B.			Endobronchial valves in a highly parsed emphysema population	LANCET			English	Editorial Material							VOLUME-REDUCTION SURGERY; OBSTRUCTIVE PULMONARY-DISEASE; CLINICAL-TRIAL		Stanford Univ, Sch Med, Div Thorac Surg, Dept Cardiothorac Surg, Stanford, CA 94305 USA	Stanford University	Shrager, JB (corresponding author), Stanford Univ, Sch Med, Div Thorac Surg, Dept Cardiothorac Surg, Stanford, CA 94305 USA.	shrager@stanford.edu						BRANTIGAN O C, 1957, Am Surg, V23, P789; COOPER JD, 1995, J THORAC CARDIOV SUR, V109, P106, DOI 10.1016/S0022-5223(95)70426-4; Cooper JD, 1996, J THORAC CARDIOV SUR, V112, P1319, DOI 10.1016/S0022-5223(96)70147-2; Davey C, 2015, LANCET; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Geddes D, 2000, NEW ENGL J MED, V343, P329; Goldstein RS, 2003, THORAX, V58, P405, DOI 10.1136/thorax.58.5.405; Hillerdal G, 2005, CHEST, V128, P3489, DOI 10.1378/chest.128.5.3489; Miller JD, 2006, ANN THORAC SURG, V81, P314, DOI 10.1016/j.athoracsur.2005.07.055; Ninane V, 2012, EUR RESPIR J, V39, P1319, DOI 10.1183/09031936.00019711; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Wood DE, 2014, J BRONCHOL INTERN PU, V21, P288, DOI 10.1097/LBR.0000000000000110	13	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1022	1023		10.1016/S0140-6736(15)60156-8	http://dx.doi.org/10.1016/S0140-6736(15)60156-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26116486	hybrid			2022-12-28	WOS:000361189200008
J	Fu, Q; Hajdinjak, M; Moldovan, OT; Constantin, S; Mallick, S; Skoglund, P; Patterson, N; Rohland, N; Lazaridis, I; Nickel, B; Viola, B; Prufer, K; Meyer, M; Kelso, J; Reich, D; Paabo, S				Fu, Qiaomei; Hajdinjak, Mateja; Moldovan, Oana Teodora; Constantin, Silviu; Mallick, Swapan; Skoglund, Pontus; Patterson, Nick; Rohland, Nadin; Lazaridis, Iosif; Nickel, Birgit; Viola, Bence; Pruefer, Kay; Meyer, Matthias; Kelso, Janet; Reich, David; Paeaebo, Svante			An early modern human from Romania with a recent Neanderthal ancestor	NATURE			English	Article							GENOME SEQUENCE; ANCIENT; DNA; CAVE; ADMIXTURE; ORIGINS; HISTORY; SYSTEMS; EUROPE	Neanderthals are thought to have disappeared in Europe approximately 39,000-41,000 years ago but they have contributed 1-3% of the DNA of present-day people in Eurasia(1). Here we analyse DNA from a 37,000-42,000-year-old(2) modern human from Pestera cu Oase, Romania. Although the specimen contains small amounts of human DNA, we use an enrichment strategy to isolate sites that are informative about its relationship to Neanderthals and present-day humans. We find that on the order of 6-9% of the genome of the Oase individual is derived from Neanderthals, more than any other modern human sequenced to date. Three chromosomal segments of Neanderthal ancestry are over 50 centimorgans in size, indicating that this individual had a Neanderthal ancestor as recently as four to six generations back. However, the Oase individual does not share more alleles with later Europeans than with East Asians, suggesting that the Oase population did not contribute substantially to later humans in Europe.	[Fu, Qiaomei] Chinese Acad Sci, IVPP, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Fu, Qiaomei; Mallick, Swapan; Skoglund, Pontus; Rohland, Nadin; Lazaridis, Iosif; Reich, David] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; [Fu, Qiaomei; Hajdinjak, Mateja; Nickel, Birgit; Viola, Bence; Pruefer, Kay; Meyer, Matthias; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Moldovan, Oana Teodora] Emil Racovita Inst Speleol, Cluj Branch, Cluj Napoca 400006, Romania; [Constantin, Silviu] Emil Racovita Inst Speleol, Dept Geospeleol & Paleontol, Bucharest 010986 12, Romania; [Mallick, Swapan; Patterson, Nick; Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mallick, Swapan; Viola, Bence] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Viola, Bence] Univ Toronto, Dept Anthropol, Toronto, ON M5S 2S2, Canada; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Harvard University; Harvard Medical School; Max Planck Society; Emil Racovita Institute of Speleology; Romanian Academy of Sciences; Emil Racovita Institute of Speleology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Max Planck Society; University of Toronto; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Reich, D (corresponding author), Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu; paabo@eva.mpg.de	Constantin, Silviu/D-1650-2010; Kelso, Janet/N-1812-2019; Moldovan, Oana/A-6646-2011	Constantin, Silviu/0000-0003-3737-2652; Kelso, Janet/0000-0002-3618-322X; Moldovan, Oana/0000-0002-1262-0675; Viola, Bence/0000-0001-8052-707X; Skoglund, Pontus/0000-0002-3021-5913; Hajdinjak, Mateja/0000-0002-4064-0331	Chinese Academy of Sciences [XDA05130202]; Special Foundation of the President of the Chinese Academy of Sciences; Romanian National Research Council [PCCE 31/2010]; US National Science Foundation HOMINID [BCS-1032255]; US National Institutes of Health [GM100233]; Howard Hughes Medical Institute; Presidential Innovation Fund of the Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); Special Foundation of the President of the Chinese Academy of Sciences(Chinese Academy of Sciences); Romanian National Research Council; US National Science Foundation HOMINID(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Presidential Innovation Fund of the Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Trinkaus for facilitating the sampling of Oase 1, J. Krause for help with sampling and initial DNA analyses, A. Aximu for help with DNA hybridization captures and library preparation, and E. Trinkaus and L. Vigilant for critical reading of the manuscript. Q.F. is funded in part by the Chinese Academy of Sciences (XDA05130202) and the Special Foundation of the President of the Chinese Academy of Sciences (2015-2016). O.T.M. and S.C. are supported by the Romanian National Research Council through project PCCE 31/2010 (Karst Climate Archives). D.R. is supported by US National Science Foundation HOMINID grant BCS-1032255, US National Institutes of Health grant GM100233, and the Howard Hughes Medical Institute. The laboratory work was funded by the Presidential Innovation Fund of the Max Planck Society.	Ackermann RR, 2010, EVOL ANTHROPOL, V19, P258, DOI 10.1002/evan.20288; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Constantin S, 2014, QUATERN INT, V339, P25, DOI 10.1016/j.quaint.2013.10.012; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Frayer D., 1992, CONTINUITY REPLACEME; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Kim BY, 2015, AM J HUM GENET, V96, P454, DOI 10.1016/j.ajhg.2014.12.029; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rougier H, 2007, P NATL ACAD SCI USA, V104, P1165, DOI 10.1073/pnas.0610538104; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Trinkaus E., 2013, LIFE DEATH PESTERA O; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Vernot B, 2015, AM J HUM GENET, V96, P448, DOI 10.1016/j.ajhg.2015.01.006; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110	41	375	396	6	301	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					216	+		10.1038/nature14558	http://dx.doi.org/10.1038/nature14558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26098372	Green Accepted, Green Submitted			2022-12-28	WOS:000359386900031
J	Schoch, RR; Sues, HD				Schoch, Rainer R.; Sues, Hans-Dieter			A Middle Triassic stem-turtle and the evolution of the turtle body plan	NATURE			English	Article							SHELL; ORIGIN; PHYLOGENY; ELEMENTS; BONE	The origin and early evolution of turtles have long been major contentious issues in vertebrate zoology(1-11). This is due to conflicting character evidence from molecules and morphology and a lack of transitional fossils from the critical time interval. The similar to 220-million-year-old stem-turtle Odontochelys from China(12) has a partly formed shell and many turtle-like features in its post-cranial skeleton. Unlike the 214-million-year-old Proganochelys from Germany and Thailand, it retains marginal teeth and lacks a carapace. Odontochelys is separated by a large temporal gap from the similar to 260-million-year-old Eunotosaurus from South Africa, which has been hypothesized as the earliest stem-turtle(4,5). Here we report a new reptile, Pappochelys, that is structurally and chronologically intermediate between Eunotosaurus and Odontochelys and dates from the Middle Triassic period (similar to 240 million years ago). The three taxa share anteroposteriorly broad trunk ribs that are T-shaped in cross-section and bear sculpturing, elongate dorsal vertebrae, and modified limb girdles. Pappochelys closely resembles Odontochelys in various features of the limb girdles. Unlike Odontochelys, it has a cuirass of robust paired gastralia in place of a plastron. Pappochelys provides new evidence that the plastron partly formed through serial fusion of gastralia(3,13). Its skull has small upper and ventrally open lower temporal fenestrae, supporting the hypothesis of diapsid affinities of turtles(2,7-10,14,15).	[Schoch, Rainer R.] Staatliches Museum Nat Kunde Stuttgart, Rosenstein 1, D-70191 Stuttgart, Germany; [Sues, Hans-Dieter] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Schoch, RR (corresponding author), Staatliches Museum Nat Kunde Stuttgart, Rosenstein 1, D-70191 Stuttgart, Germany.	rainer.schoch@smns-bw.de; suesh@si.edu		Sues, Hans-Dieter/0000-0002-9911-7254				Bever G. S., 2014, SOC VERT PALEONT ABS, V2014, P91; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; deBraga M, 1997, ZOOL J LINN SOC-LOND, V120, P281, DOI 10.1111/j.1096-3642.1997.tb01280.x; GAFFNEY ES, 1990, B AM MUS NAT HIST, P5; Gilbert SF, 2007, INTEGR COMP BIOL, V47, P401, DOI 10.1093/icb/icm020; Gilbert SF, 2001, EVOL DEV, V3, P47, DOI 10.1046/j.1525-142x.2001.003002047.x; Gow Chris E., 1997, Palaeontologia Africana, V34, P33; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Hirasawa T, 2015, J EXP ZOOL PART B, V324, P194, DOI 10.1002/jez.b.22579; Hirasawa T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3107; Joyce WG, 2004, J PALEONTOL, V78, P989, DOI 10.1666/0022-3360(2004)078<0989:DAPFTC>2.0.CO;2; Joyce WG, 2003, P ROY SOC LOND B BIO, V271, P1, DOI DOI 10.1098/RSPB.2003.2523); Lee MSY, 2013, J EVOLUTION BIOL, V26, P2729, DOI 10.1111/jeb.12268; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Li C, 2014, GEOL MAG, V151, P100, DOI 10.1017/S001675681300023X; Lu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079348; Lyson TR, 2013, CURR BIOL, V23, P1113, DOI 10.1016/j.cub.2013.05.003; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; M?ller J., 2004, RECENT ADV ORIGIN EA, P379; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Rieppel Olivier, 2013, P51; Scheyer TM, 2007, P ROY SOC B-BIOL SCI, V274, P1885, DOI 10.1098/rspb.2007.0499; Schoch Rainer R., 2002, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V318, P1; Watson DMS, 1914, P ZOOL SOC LOND, V1914, P1011; Zangerl R, 1939, J MORPHOL, V65, P383, DOI 10.1002/jmor.1050650302	25	101	103	5	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					584	+		10.1038/nature14472	http://dx.doi.org/10.1038/nature14472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26106865				2022-12-28	WOS:000358655200043
J	Joshi, PK; Esko, T; Mattsson, H; Eklund, N; Gandin, I; Nutile, T; Jackson, AU; Schurmann, C; Smith, AV; Zhang, WH; Okada, Y; Stancakova, A; Faul, JD; Zhao, W; Bartz, TM; Concas, MP; Franceschini, N; Enroth, S; Vitart, V; Trompet, S; Guo, XQ; Chasman, DI; O'Connel, JR; Corre, T; Nongmaithem, SS; Chen, Y; Mangino, M; Ruggiero, D; Michela, T; Farmaki, AE; Kacprowski, T; Bjonnes, A; van der Spek, A; Wu, Y; Giri, AK; Yanek, LR; Wang, LH; Hofer, E; Rietveld, CA; McLeod, O; Cornelis, MC; Pattaro, C; Verweij, N; Baumbach, C; Abdellaoui, A; Warren, HR; Vuckovic, D; Mei, H; Bouchard, C; Perry, JRB; Cappellani, S; Mirza, SS; Benton, MC; Broeckel, U; Medland, SE; Lind, P; Malerba, G; Drong, A; Yengo, L; Bielak, LF; Zhi, DG; van der Most, PJ; Shriner, D; Magi, R; Hemani, G; Karaderi, T; Wang, ZM; Liu, T; Demuth, I; Zhao, JH; Meng, WH; Lataniotis, L; van der Laan, SW; Bradfield, JP; Wood, AR; Bonnefond, A; Ahluwalia, TS; Hall, L; Salvi, E; Yazar, S; Carstensen, L; de Haan, HG; Abney, M; Afzal, U; Allison, MA; Amin, N; Asselbergs, FW; Bakker, SJL; Barr, RG; Baumeister, SE; Benjamin, DJ; Bergmann, S; Boerwinkle, E; Bottinger, EP; Campbell, A; Chakravarti, A; Chan, YL; Chanock, SJ; Chen, C; Chen, YDI; Collins, FS; Connell, J; Correa, A; Cupples, LA; Smith, GD; Davies, G; Dorr, M; Ehret, G; Ellis, SB; Feenstra, B; Feitosa, MF; Ford, I; Fox, CS; Frayling, TM; Friedrich, N; Geller, F; Scotland, G; Gillham-Nasenya, I; Gottesman, O; Graff, M; Grodstein, F; Gu, C; Haley, C; Hammond, CJ; Harris, SE; Harris, TB; Hastie, ND; Heard-Costa, NL; Heikkila, K; Hocking, LJ; Homuth, G; Hottenga, JJ; Huang, JY; Huffman, JE; Hysi, PG; Ikram, MA; Ingelsson, E; Joensuu, A; Johansson, A; Jousilahti, P; Jukema, JW; Kahonen, M; Kamatani, Y; Kanoni, S; Kerr, SM; Khan, NM; Koellinger, P; Koistinen, HA; Kooner, MK; Kubo, M; Kuusisto, J; Lahti, J; Launer, LJ; Lea, RA; Lehne, B; Lehtimaki, T; Liewald, DCM; Lind, L; Loh, M; Lokki, ML; London, SJ; Loomis, SJ; Loukola, A; Lu, YC; Lumley, T; Lundqvist, A; Mannisto, S; Marques-Vidal, P; Masciullo, C; Matchan, A; Mathias, RA; Matsuda, K; Meigs, JB; Meisinger, C; Meitinger, T; Menni, C; Mentch, FD; Mihailov, E; Milani, L; Montasser, ME; Montgomery, G; Morrison, A; Myers, RH; Nadukuru, R; Navarro, P; Nelis, M; Nieminen, MS; Nolte, IM; O'Connor, GT; Ogunniyi, A; Padmanabhan, S; Palmas, WR; Pankow, JS; Patarcic, I; Pavani, F; Peyser, PA; Pietilainen, K; Poulter, N; Prokopenko, I; Ralhan, S; Redmond, P; Rich, SS; Rissanen, H; Robino, A; Rose, LM; Rose, R; Sala, C; Salako, B; Salomaa, V; Sarin, AP; Saxena, R; Schmidt, H; Scott, LJ; Scott, WR; Sennblad, B; Seshadri, S; Sever, P; Shrestha, S; Smith, BH; Smith, JA; Soranzo, N; Sotoodehnia, N; Southam, L; Stanton, AV; Stathopoulou, MG; Strauch, K; Strawbridge, RJ; Suderman, MJ; Tandon, N; Tang, ST; Taylor, KD; Tayo, BO; Toglhofer, AM; Tomaszewski, M; Tsernikova, N; Tuomilehto, J; Uitterlinden, AG; Vaidya, D; Vlieg, AV; van Setten, J; Vasankari, T; Vedantam, S; Vlachopoulou, E; Vozzi, D; Vuoksimaa, E; Waldenberger, M; Ware, EB; Wentworth-Shields, W; Whitfield, JB; Wild, S; Willemsen, G; Yajnik, CS; Yao, J; Zaza, G; Zhu, XF; Salem, RM; Melbye, M; Bisgaard, H; Samani, NJ; Cusi, D; Mackey, DA; Cooper, RS; Froguel, P; Pasterkamp, G; Grant, SFA; Hakonarson, H; Ferrucci, L; Scott, RA; Morris, AD; Palmer, CNA; Dedoussis, G; Deloukas, P; Bertram, L; Lindenberger, U; Berndt, SI; Lindgren, CM; Timpson, NJ; Tonjes, A; Munroe, PB; Sorensen, TIA; Rotimi, CN; Arnett, DK; Oldehinkel, AJ; Kardia, SLR; Balkau, B; Gambaro, G; Morris, AP; Eriksson, JG; Wright, MJ; Martin, NG; Hunt, SC; Starr, JM; Deary, IJ; Griffiths, LR; Tiemeier, H; Pirastu, N; Kaprio, J; Wareham, NJ; Peerusse, L; Wilson, JG; Girotto, G; Caulfield, MJ; Raitakari, O; Boomsma, DI; Gieger, C; van der Harst, P; Hicks, AA; Kraft, P; Sinisalo, J; Knekt, P; Johannesson, M; Magnusson, PKE; Hamsten, A; Schmidt, R; Borecki, IB; Vartiainen, E; Becker, DM; Bharadwaj, D; Mohlke, KL; Boehnke, M; van Duijn, CM; Sanghera, DK; Teumer, A; Zeggini, E; Metspalu, A; Gasparini, P; Ulivi, S; Ober, C; Toniolo, D; Rudan, I; Porteous, DJ; Ciullo, M; Spector, TD; Hayward, C; Dupuis, J; Loos, RJF; Wright, AF; Chandak, GR; Vollenweider, P; Shuldiner, AR; Ridker, PM; Rotter, JI; Sattar, N; Gyllensten, U; North, KE; Pirastu, M; Psaty, BM; Weir, DR; Laakso, M; Gudnason, V; Takahashi, A; Chambers, JC; Kooner, JS; Strachan, DP; Campbell, H; Hirschhorn, JN; Perola, M; Polasek, O; Wilson, JF				Joshi, Peter K.; Esko, Tonu; Mattsson, Hannele; Eklund, Niina; Gandin, Ilaria; Nutile, Teresa; Jackson, Anne U.; Schurmann, Claudia; Smith, Albert V.; Zhang, Weihua; Okada, Yukinori; Stancakova, Alena; Faul, Jessica D.; Zhao, Wei; Bartz, Traci M.; Concas, Maria Pina; Franceschini, Nora; Enroth, Stefan; Vitart, Veronique; Trompet, Stella; Guo, Xiuqing; Chasman, Daniel I.; O'Connel, Jeffrey R.; Corre, Tanguy; Nongmaithem, Suraj S.; Chen, Yuning; Mangino, Massimo; Ruggiero, Daniela; Traglia, Michela; Farmaki, Aliki-Eleni; Kacprowski, Tim; Bjonnes, Andrew; van der Spek, Ashley; Wu, Ying; Giri, Anil K.; Yanek, Lisa R.; Wang, Lihua; Hofer, Edith; Rietveld, Cornelius A.; McLeod, Olga; Cornelis, Marilyn C.; Pattaro, Cristian; Verweij, Niek; Baumbach, Clemens; Abdellaoui, Abdel; Warren, Helen R.; Vuckovic, Dragana; Mei, Hao; Bouchard, Claude; Perry, John R. B.; Cappellani, Stefania; Mirza, Saira S.; Benton, Miles C.; Broeckel, Ulrich; Medland, Sarah E.; Lind, PenelopeA.; Malerba, Giovanni; Drong, Alexander; Yengo, Loic; Bielak, Lawrence F.; Zhi, Degui; van der Most, Peter J.; Shriner, Daniel; Maegi, Reedik; Hemani, Gibran; Karaderi, Tugce; Wang, Zhaoming; Liu, Tian; Demuth, Ilja; Zhao, Jing Hua; Meng, Weihua; Lataniotis, Lazaros; van der Laan, Sander W.; Bradfield, Jonathan P.; Wood, Andrew R.; Bonnefond, Amelie; Ahluwalia, Tarunveer S.; Hall, LeanneM.; Salvi, Erika; Yazar, Seyhan; Carstensen, Lisbeth; de Haan, Hugoline G.; Abney, Mark; Afzal, Uzma; Allison, Matthew A.; Amin, Najaf; Asselbergs, Folkert W.; Bakker, Stephan J. L.; Barr, R. Graham; Baumeister, Sebastian E.; Benjamin, Daniel J.; Bergmann, Sven; Boerwinkle, Eric; Bottinger, Erwin P.; Campbell, Archie; Chakravarti, Aravinda; Chan, Yingleong; Chanock, Stephen J.; Chen, Constance; Chen, Y. -D. Ida; Collins, Francis S.; Connell, John; Correa, Adolfo; Cupples, L. Adrienne; Smith, George Davey; Davies, Gail; Doerr, Marcus; Ehret, Georg; Ellis, Stephen B.; Feenstra, Bjarke; Feitosa, Mary F.; Ford, Ian; Fox, Caroline S.; Frayling, Timothy M.; Friedrich, Nele; Geller, Frank; Scotland, Generation; Gillham-Nasenya, Irina; Gottesman, Omri; Graff, Misa; Grodstein, Francine; Gu, Charles; Haley, Chris; Hammond, Christopher J.; Harris, Sarah E.; Harris, Tamara B.; Hastie, Nicholas D.; Heard-Costa, Nancy L.; Heikkila, Kauko; Hocking, Lynne J.; Homuth, Georg; Hottenga, Jouke-Jan; Huang, Jinyan; Huffman, Jennifer E.; Hysi, Pirro G.; Ikram, M. Arfan; Ingelsson, Erik; Joensuu, Anni; Johansson, Asa; Jousilahti, Pekka; Jukema, J. Wouter; Kahonen, Mika; Kamatani, Yoichiro; Kanoni, Stavroula; Kerr, Shona M.; Khan, Nazir M.; Koellinger, Philipp; Koistinen, Heikki A.; Kooner, Manraj K.; Kubo, Michiaki; Kuusisto, Johanna; Lahti, Jari; Launer, Lenore J.; Lea, Rodney A.; Lehne, Benjamin; Lehtimaki, Terho; Liewald, David C. M.; Lind, Lars; Loh, Marie; Lokki, Marja-Liisa; London, Stephanie J.; Loomis, Stephanie J.; Loukola, Anu; Lu, Yingchang; Lumley, Thomas; Lundqvist, Annamari; Mannisto, Satu; Marques-Vidal, Pedro; Masciullo, Corrado; Matchan, Angela; Mathias, Rasika A.; Matsuda, Koichi; Meigs, James B.; Meisinger, Christa; Meitinger, Thomas; Menni, Cristina; Mentch, Frank D.; Mihailov, Evelin; Milani, Lili; Montasser, May E.; Montgomery, GrantW.; Morrison, Alanna; Myers, Richard H.; Nadukuru, Rajiv; Navarro, Pau; Nelis, Mari; Nieminen, Markku S.; Nolte, Ilja M.; O'Connor, George T.; Ogunniyi, Adesola; Padmanabhan, Sandosh; Palmas, Walter R.; Pankow, James S.; Patarcic, Inga; Pavani, Francesca; Peyser, Patricia A.; Pietilainen, Kirsi; Poulter, Neil; Prokopenko, Inga; Ralhan, Sarju; Redmond, Paul; Rich, Stephen S.; Rissanen, Harri; Robino, Antonietta; Rose, Lynda M.; Rose, Richard; Sala, Cinzia; Salako, Babatunde; Salomaa, Veikko; Sarin, Antti-Pekka; Saxena, Richa; Schmidt, Helena; Scott, Laura J.; Scott, William R.; Sennblad, Bengt; Seshadri, Sudha; Sever, Peter; Shrestha, Smeeta; Smith, Blair H.; Smith, Jennifer A.; Soranzo, Nicole; Sotoodehnia, Nona; Southam, Lorraine; Stanton, Alice V.; Stathopoulou, Maria G.; Strauch, Konstantin; Strawbridge, Rona J.; Suderman, Matthew J.; Tandon, Nikhil; Tang, Sian-Tsun; Taylor, Kent D.; Tayo, Bamidele O.; Toeglhofer, Anna Maria; Tomaszewski, Maciej; Tsernikova, Natalia; Tuomilehto, Jaakko; Uitterlinden, Andre G.; Vaidya, Dhananjay; Vlieg, Astrid van Hylckama; van Setten, Jessica; Vasankari, Tuula; Vedantam, Sailaja; Vlachopoulou, Efthymia; Vozzi, Diego; Vuoksimaa, Eero; Waldenberger, Melanie; Ware, Erin B.; Wentworth-Shields, William; Whitfield, John B.; Wild, Sarah; Willemsen, Gonneke; Yajnik, Chittaranjan S.; Yao, Jie; Zaza, Gianluigi; Zhu, Xiaofeng; Salem, Rany M.; Melbye, Mads; Bisgaard, Hans; Samani, Nilesh J.; Cusi, Daniele; Mackey, David A.; Cooper, Richard S.; Froguel, Philippe; Pasterkamp, Gerard; Grant, Struan F. A.; Hakonarson, Hakon; Ferrucci, Luigi; Scott, Robert A.; Morris, Andrew D.; Palmer, Colin N. A.; Dedoussis, George; Deloukas, Panos; Bertram, Lars; Lindenberger, Ulman; Berndt, Sonja I.; Lindgren, Cecilia M.; Timpson, Nicholas J.; Toenjes, Anke; Munroe, Patricia B.; Sorensen, Thorkild I. A.; Rotimi, Charles N.; Arnett, Donna K.; Oldehinkel, Albertine J.; Kardia, Sharon L. R.; Balkau, Beverley; Gambaro, Giovanni; Morris, Andrew P.; Eriksson, Johan G.; Wright, Margie J.; Martin, Nicholas G.; Hunt, Steven C.; Starr, John M.; Deary, Ian J.; Griffiths, Lyn R.; Tiemeier, Henning; Pirastu, Nicola; Kaprio, Jaakko; Wareham, Nicholas J.; Perusse, Louis; Wilson, James G.; Girotto, Giorgia; Caulfield, Mark J.; Raitakari, Olli; Boomsma, Dorret I.; Gieger, Christian; van der Harst, Pim; Hicks, Andrew A.; Kraft, Peter; Sinisalo, Juha; Knekt, Paul; Johannesson, Magnus; Magnusson, Patrik K. E.; Hamsten, Anders; Schmidt, Reinhold; Borecki, Ingrid B.; Vartiainen, Erkki; Becker, Diane M.; Bharadwaj, Dwaipayan; Mohlke, Karen L.; Boehnke, Michael; van Duijn, Cornelia M.; Sanghera, Dharambir K.; Teumer, Alexander; Zeggini, Eleftheria; Metspalu, Andres; Gasparini, Paolo; Ulivi, Sheila; Ober, Carole; Toniolo, Daniela; Rudan, Igor; Porteous, David J.; Ciullo, Marina; Spector, Tim D.; Hayward, Caroline; Dupuis, Josee; Loos, Ruth J. F.; Wright, Alan F.; Chandak, Giriraj R.; Vollenweider, Peter; Shuldiner, Alan R.; Ridker, Paul M.; Rotter, Jerome I.; Sattar, Naveed; Gyllensten, Ulf; North, Kari E.; Pirastu, Mario; Psaty, Bruce M.; Weir, David R.; Laakso, Markku; Gudnason, Vilmundur; Takahashi, Atsushi; Chambers, John C.; Kooner, Jaspal S.; Strachan, David P.; Campbell, Harry; Hirschhorn, Joel N.; Perola, Markus; Polasek, Ozren; Wilson, James F.		BioBank Japan Project	Directional dominance on stature and cognition in diverse human populations	NATURE			English	Article							GENETIC-VARIANTS; BLOOD-PRESSURE; ASSOCIATION; INTELLIGENCE; HOMOZYGOSITY; ARCHITECTURE; TRAITS	Homozygosity has long been associated with rare, often devastating, Mendelian disorders(1), and Darwin was one of the first to recognize that inbreeding reduces evolutionary fitness(2). However, the effect of the more distant parental relatedness that is common in modern human populations is less well understood. Genomic data now allow us to investigate the effects of homozygosity on traits of public health importance by observing contiguous homozygous segments (runs of homozygosity), which are inferred to be homozygous along their complete length. Given the low levels of genome-wide homozygosity prevalent in most human populations, information is required on very large numbers of people to provide sufficient power(3,4). Here we use runs of homozygosity to study 16 health-related quantitative traits in 354,224 individuals from 102 cohorts, and find statistically significant associations between summed runs of homozygosity and four complex traits: height, forced expiratory lung volume in one second, general cognitive ability and educational attainment (P < 1 x 10(-300), 2.1 x 10(-6), 2.5 x 10(-10) and 1.8 x 10(-10), respectively). In each case, increased homozygosity was associated with decreased trait value, equivalent to the offspring of first cousins being 1.2 cm shorter and having 10 months' less education. Similar effect sizes were found across four continental groups and populations with different degrees of genome-wide homozygosity, providing evidence that homozygosity, rather than confounding, directly contributes to phenotypic variance. Contrary to earlier reports in substantially smaller samples(5,6), no evidence was seen of an influence of genome-wide homozygosity on blood pressure and low density lipoprotein cholesterol, or ten other cardio-metabolic traits. Since directional dominance is predicted for traits under directional evolutionary selection(7), this study provides evidence that increased stature and cognitive function have been positively selected in human evolution, whereas many important risk factors for late-onset complex diseases may not have been.	[Joshi, Peter K.; Rudan, Igor; Campbell, Harry; Polasek, Ozren; Wilson, James F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh EH8 9AG, Midlothian, Scotland; [Esko, Tonu; Maegi, Reedik; Mihailov, Evelin; Milani, Lili; Nelis, Mari; Tsernikova, Natalia; Morris, Andrew P.; Metspalu, Andres; Perola, Markus] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Esko, Tonu; Chan, Yingleong; Vedantam, Sailaja; Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Cambridge, MA 02141 USA; [Esko, Tonu; Chan, Yingleong; Vedantam, Sailaja; Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Cambridge, MA 02141 USA; [Esko, Tonu; Chan, Yingleong; Vedantam, Sailaja; Salem, Rany M.; Lindgren, Cecilia M.; Hirschhorn, Joel N.] Cambridge Ctr 7, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02242 USA; [Esko, Tonu; Chan, Yingleong; Vedantam, Sailaja; Salem, Rany M.; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Mattsson, Hannele; Eklund, Niina; Joensuu, Anni; Sarin, Antti-Pekka; Perola, Markus] Natl Inst Hlth & Welf, Unit Publ Hlth Genom, FI-00251 Helsinki, Finland; [Mattsson, Hannele; Joensuu, Anni; Pietilainen, Kirsi; Sarin, Antti-Pekka; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, FI-00014 Helsinki, Finland; [Gandin, Ilaria; Vuckovic, Dragana; Pirastu, Nicola; Girotto, Giorgia] Univ Trieste, Dept Med Sci, I-34149 Trieste, Italy; [Nutile, Teresa; Ruggiero, Daniela; Ciullo, Marina] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80131 Naples, Italy; [Jackson, Anne U.; Scott, Laura J.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Jackson, Anne U.; Scott, Laura J.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Schurmann, Claudia; Bottinger, Erwin P.; Ellis, Stephen B.; Gottesman, Omri; Lu, Yingchang; Nadukuru, Rajiv; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Schurmann, Claudia; Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Zhang, Weihua; Afzal, Uzma; Lehne, Benjamin; Loh, Marie; Scott, William R.; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Zhang, Weihua; Afzal, Uzma; Kooner, Manraj K.; Scott, William R.; Chambers, John C.; Kooner, Jaspal S.] Ealing Hosp NHS Trust, Dept Cardiol, Southall UB1 3HW, Middx, England; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Bunkyo Ku, Tokyo 1138510, Japan; [Okada, Yukinori; Kamatani, Yoichiro; Takahashi, Atsushi; BioBank Japan Project] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Stancakova, Alena] Univ Eastern Finland, Dept Med, Kuopio 70210, Finland; [Faul, Jessica D.; Weir, David R.] Univ Michigan, Inst Social Res, Ann Arbor, MI 48104 USA; [Zhao, Wei; Bielak, Lawrence F.; Peyser, Patricia A.; Smith, Jennifer A.; Ware, Erin B.; Kardia, Sharon L. R.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bartz, Traci M.] Univ Washington, Dept Biostat, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Bartz, Traci M.] Univ Washington, Dept Med, Seattle, WA 98101 USA; [Concas, Maria Pina; Pirastu, Mario] CNR, Inst Populat Genet, I-07100 Sassari, Italy; [Franceschini, Nora; Graff, Misa; North, Kari E.] Univ N Carolina, Epidemiol, Chapel Hill, NC 27599 USA; [Enroth, Stefan; Johansson, Asa; Gyllensten, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Biomed Ctr, SciLifeLab Uppsala, SE-75108 Uppsala, Sweden; [Vitart, Veronique; Haley, Chris; Hastie, Nicholas D.; Huffman, Jennifer E.; Kerr, Shona M.; Navarro, Pau; Hayward, Caroline; Wright, Alan F.; Wilson, James F.] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Trompet, Stella] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, NL-2300 RC Leiden, Netherlands; [Guo, Xiuqing; Chen, Y. -D. Ida; Taylor, Kent D.; Yao, Jie; Rotter, Jerome I.] Los Angeles Biomed Res Inst, Inst Translat Gen & Populat Sci, Torrance, CA 90502 USA; [Guo, Xiuqing; Chen, Y. -D. Ida; Taylor, Kent D.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Chasman, Daniel I.; Rose, Lynda M.; Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02215 USA; [O'Connel, Jeffrey R.; Montasser, May E.; Shuldiner, Alan R.] Univ Maryland, Div Endocrinol Diabet & Nutr, Sch Med, Baltimore, MD 21201 USA; [O'Connel, Jeffrey R.; Montasser, May E.; Shuldiner, Alan R.] Univ Maryland, Program Personalised & Genom Med, Dept Med, Sch Med, Baltimore, MD 21201 USA; [Corre, Tanguy; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Corre, Tanguy; Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Nongmaithem, Suraj S.; Shrestha, Smeeta; Chandak, Giriraj R.] CSIR Ctr Cellular & Mol Biol, Genom Res Complex Dis GRC Grp, Hyderabad 500007, Andhra Pradesh, India; [Chen, Yuning; Cupples, L. Adrienne; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Mangino, Massimo; Gillham-Nasenya, Irina; Hammond, Christopher J.; Hysi, Pirro G.; Menni, Cristina; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Mangino, Massimo] Guys & St Thomas Fdn Trust, NIHR Biomed Res Ctr, London SE1 7EH, England; [Traglia, Michela; Masciullo, Corrado; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Farmaki, Aliki-Eleni; Dedoussis, George] Harokopio Univ Athens, Dept Nutr & Dietet, Athens 17671, Greece; [Kacprowski, Tim; Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17475 Greifswald, Germany; [Bjonnes, Andrew; Saxena, Richa] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [van der Spek, Ashley; Mirza, Saira S.; Amin, Najaf; Ikram, M. Arfan; Uitterlinden, Andre G.; Tiemeier, Henning; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Giri, Anil K.; Khan, Nazir M.; Bharadwaj, Dwaipayan] CSIR Inst Genom & Integrat Biol, Genom & Mol Med, New Delhi 110025, India; [Yanek, Lisa R.; Mathias, Rasika A.; Vaidya, Dhananjay; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program,Div Gen Internal Med, Baltimore, MD 21287 USA; [Wang, Lihua; Feitosa, Mary F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Clin Div Neurogeriatr, Dept Neurol, A-8036 Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, A-8036 Graz, Austria; [Rietveld, Cornelius A.; Koellinger, Philipp] Erasmus Univ, Erasmus Sch Econ, NL-3000 DR Rotterdam, Netherlands; [McLeod, Olga; Sennblad, Bengt; Strawbridge, Rona J.; Hamsten, Anders] Karolinska Univ Hosp, Atherosclerosis Res Unit, Dept Med Solna, Karolinska Inst, S-17176 Stockholm, Sweden; [Cornelis, Marilyn C.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Cornelis, Marilyn C.; Grodstein, Francine] Harvard Univ, Sch Publ Hlth, Nutr, Boston, MA 02215 USA; [Pattaro, Cristian; Pavani, Francesca; Hicks, Andrew A.] European Acad Bozen Bolzano EURAC, Ctr Biomed, I-39100 Bolzano, Italy; [Verweij, Niek; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Baumbach, Clemens; Waldenberger, Melanie; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Baumbach, Clemens; Meisinger, Christa; Waldenberger, Melanie; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Baumbach, Clemens; Strauch, Konstantin; Gieger, Christian] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany; [Abdellaoui, Abdel; Hottenga, Jouke-Jan; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Warren, Helen R.; Munroe, Patricia B.; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol, London EC1M 6BQ, England; [Warren, Helen R.; Munroe, Patricia B.; Caulfield, Mark J.] Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, London EC1M 6BQ, England; [Mei, Hao; Correa, Adolfo] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Bouchard, Claude] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Perry, John R. B.; Zhao, Jing Hua; Scott, Robert A.; Wareham, Nicholas J.] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Cappellani, Stefania; Robino, Antonietta; Vozzi, Diego; Pirastu, Nicola; Gasparini, Paolo; Ulivi, Sheila] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34137 Trieste, Italy; [Benton, Miles C.; Lea, Rodney A.; Griffiths, Lyn R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Broeckel, Ulrich] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Medland, Sarah E.; Lind, PenelopeA.] QIMR Berghofer Med Res Inst, Quantitat Genet, Brisbane, Qld 4006, Australia; [Malerba, Giovanni] Univ Verona, Dipartimento Sci Vita & Riprod, I-37134 Verona, Italy; [Drong, Alexander; Karaderi, Tugce; Ingelsson, Erik; Southam, Lorraine; Lindgren, Cecilia M.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Yengo, Loic; Bonnefond, Amelie; Froguel, Philippe] Univ Lille 2, EGID, CNRS, UMR 199, F-59000 Lille, France; [Zhi, Degui] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [van der Most, Peter J.; Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Shriner, Daniel; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Hemani, Gibran; Smith, George Davey; Suderman, Matthew J.; Timpson, Nicholas J.; Sorensen, Thorkild I. A.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Wang, Zhaoming; Chanock, Stephen J.; Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA; [Wang, Zhaoming] SAIC Frederick Inc, Canc Genom Res Lab, Frederick Natl Lab Canc Res, Ft Detrick, MD 21702 USA; [Liu, Tian; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, D-14195 Berlin, Germany; [Liu, Tian; Bertram, Lars] Max Planck Inst Mol Genet, Vertebrate Genom, D-14195 Berlin, Germany; [Demuth, Ilja] Charite, Charite Res Grp Geriatr, D-13347 Berlin, Germany; [Demuth, Ilja] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Meng, Weihua] Univ Dundee, Div Populat Hlth Sci, Med Res Inst, Ninewells Hosp & Sch Med, Dundee DD2 4BF, Scotland; [Lataniotis, Lazaros; Kanoni, Stavroula; Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [van der Laan, Sander W.; van Setten, Jessica; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Div Heart & Lungs, Expt Cardiol, NL-3584 CX Utrecht, Netherlands; [Bradfield, Jonathan P.; Mentch, Frank D.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Wood, Andrew R.; Frayling, Timothy M.] Univ Exeter, Genet Complex Traits, Sch Med, Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [Ahluwalia, Tarunveer S.; Bisgaard, Hans] Univ Copenhagen, COPSAC, Prospect Studies Asthma Childhood, Herlev & Gentofte Hosp, DK-2820 Copenhagen, Denmark; [Ahluwalia, Tarunveer S.; Sorensen, Thorkild I. A.] Univ Copenhagen, Sect Metab Genet, Fac Hlth & Med Sci, Novo Nordisk Ctr Basic Metab Res, DK-2100 Copenhagen, Denmark; [Hall, LeanneM.; Tomaszewski, Maciej; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, BHF Cardiovasc Res Ctr, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Salvi, Erika; Cusi, Daniele] Univ Milan, Dept Hlth Sci, I-20142 Milan, Italy; [Yazar, Seyhan; Mackey, David A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Carstensen, Lisbeth; Feenstra, Bjarke; Geller, Frank; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [de Haan, Hugoline G.; Vlieg, Astrid van Hylckama] Leiden Univ, Med Ctr, Clin Epidemiol, NL-2300 RC Leiden, Netherlands; [Abney, Mark; Wentworth-Shields, William; Ober, Carole] Univ Chicago, Dept HumanGenet, Chicago, IL 60637 USA; [Allison, Matthew A.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, NL-3584 CX Utrecht, Netherlands; [Asselbergs, Folkert W.; van der Harst, Pim] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, NL-3501 DG Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth, Inst Cardiovasc Sci, London WC1E 6BT, England; [Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [Barr, R. Graham; Palmas, Walter R.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Baumeister, Sebastian E.; Teumer, Alexander] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Benjamin, Daniel J.] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Benjamin, Daniel J.] Univ So Calif, Dept Econ, Los Angeles, CA 90089 USA; [Benjamin, Daniel J.] Univ So Calif, Ctr Econ & Social Res, Los Angeles, CA 90089 USA; [Boerwinkle, Eric; Morrison, Alanna] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA; [Campbell, Archie; Scotland, Generation; Harris, Sarah E.; Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Chakravarti, Aravinda; Ehret, Georg] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Sch Med, Baltimore, MD 21205 USA; [Chen, Constance; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Collins, Francis S.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Connell, John] Ninewells Hosp & Med Sch, Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland; [Cupples, L. Adrienne; Fox, Caroline S.; Heard-Costa, Nancy L.; O'Connor, George T.; Seshadri, Sudha; Dupuis, Josee] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Davies, Gail; Redmond, Paul; Deary, Ian J.] Univ Edinburgh, Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Davies, Gail; Harris, Sarah E.; Liewald, David C. M.; Starr, John M.; Deary, Ian J.; Porteous, David J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, D-17475 Greifswald, Germany; [Ehret, Georg] Univ Hosp Geneva, Cardiol, CH-1211 Geneva, Switzerland; [Ford, Ian] Univ Glasgow, Robertson Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Friedrich, Nele] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Gu, Charles] Washington Univ, Div Biostat, St Louis, MO 63110 USA; [Haley, Chris] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Harris, Tamara B.; Launer, Lenore J.] NIA, NIH, Bethesda, MD 20892 USA; [Heard-Costa, Nancy L.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Heikkila, Kauko; Loukola, Anu; Vuoksimaa, Eero; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, FI-00014 Helsinki, Finland; [Hocking, Lynne J.] Univ Aberdeen, Div Appl Med, Musculoskeletal Res Programme, Aberdeen AB25 2ZD, Scotland; [Huang, Jinyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hematol, State Key Lab Med Genom,Rui Jin Hosp, Shanghai 200025, Peoples R China; [Ikram, M. Arfan] Erasmus MC, Dept Radiol, NL-3000 CA Rotterdam, Netherlands; [Ingelsson, Erik] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, SE-17121 Uppsala, Sweden; [Johansson, Asa] Uppsala Univ, Uppsala Clin Res Ctr, SE-75237 Uppsala, Sweden; [Jousilahti, Pekka; Mannisto, Satu; Salomaa, Veikko; Eriksson, Johan G.; Vartiainen, Erkki] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, FI-00271 Helsinki, Finland; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol C5 P, NL-2300 RC Leiden, Netherlands; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FI-33521 Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, FI-33521 Tampere, Finland; [Koistinen, Heikki A.; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, FI-00271 Helsinki, Finland; [Koistinen, Heikki A.; Pietilainen, Kirsi] Univ Helsinki, Cent Hosp, Div Endocrinol, Dept Med, FI-00029 Helsinki, Finland; [Koistinen, Heikki A.] Biomedicum 2U, Minerva Fdn Inst Med Res, FI-00290 Helsinki, Finland; [Kubo, Michiaki] Lab Genotyping Dev RCfIMS, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Laakso, Markku] Univ Eastern Finland, Dept Med, FI-70210 Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, FI-70210 Kuopio, Finland; [Kuusisto, Johanna; Lahti, Jari] Univ Helsinki, Inst Behav Sci, FI-00014 Helsinki, Finland; [Lahti, Jari] Univ Helsinki, Folkhalsan Reasearch Ctr, FI-00014 Helsinki, Finland; [Lehtimaki, Terho] Univ Tampere, Fimlab Labs, Dept Clin Chem, FI-33520 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, FI-33520 Tampere, Finland; [Lind, Lars] Univ Hosp, Dept Med Sci, S-75185 Uppsala, Sweden; [Lokki, Marja-Liisa; Vlachopoulou, Efthymia] Univ Helsinki, Haartman Inst, Transplantat Lab, FI-00014 Helsinki, Finland; [London, Stephanie J.] NIEHS, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Loomis, Stephanie J.] Massachusetts Eye & Ear, Ophthalmol, Boston, MA 02114 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1142, New Zealand; [Lundqvist, Annamari; Rissanen, Harri; Knekt, Paul] Natl Inst Hlth & Welf, Dept Hlth Funct Capac & Welf, FI-00271 Helsinki, Finland; [Marques-Vidal, Pedro; Vollenweider, Peter] Univ Hosp, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Matchan, Angela; Soranzo, Nicole; Southam, Lorraine; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Human Genet, Cambridge CB10 1HH, England; [Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21224 USA; [Matsuda, Koichi] Univ Tokyo, Lab Mol Med, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Meigs, James B.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Meitinger, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Klinikum Rechts Isar, D-81675 Munich, Germany; [Montgomery, GrantW.] QIMR Berghofer Med Res Inst, Mol Epidemiol, Brisbane, Qld 4006, Australia; [Myers, Richard H.] Boston Univ, Sch Med, Genome Sci Inst, Boston, MA 02118 USA; [Nieminen, Markku S.; Sinisalo, Juha] Univ Helsinki, Cent Hosp, HUCH Heart & Lung Ctr, FI-00029 Helsinki, Finland; [O'Connor, George T.] Boston Univ, Sch Med, Pulm Ctr, Boston, MA 02118 USA; [O'Connor, George T.] Boston Univ, Dept Med, Boston, MA 02118 USA; [Ogunniyi, Adesola; Salako, Babatunde] Univ Ibadan, Dept Med, Ibadan, Nigeria; [Padmanabhan, Sandosh] Univ Glasgow, ICAMS, Glasgow G12 8TA, Lanark, Scotland; [Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Patarcic, Inga; Polasek, Ozren] Univ Split, Ctr Global Hlth, Split 21000, Croatia; [Patarcic, Inga; Polasek, Ozren] Univ Split, Dept Publ Hlth, Sch Med, Split 21000, Croatia; [Pietilainen, Kirsi] Univ Helsinki, Obes Res Unit, Res Programs Unit, Diabet & Obes, FI-00014 Helsinki, Finland; [Poulter, Neil; Sever, Peter] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1LA, England; [Prokopenko, Inga; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London SW7 2AZ, England; [Ralhan, Sarju] Hero DMC Heart Inst, Dept Cardiol & Cardio Thorac Surg, Civil Lines, Ludhiana 141001, Punjab, India; [Rich, Stephen S.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Rose, Richard] Indiana Univ Bloomington, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Schmidt, Helena; Toeglhofer, Anna Maria] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Sennblad, Bengt] Karolinska Inst, Sci Life Lab, SE-17121 Stockholm, Sweden; [Smith, Blair H.] Univ Dundee, Dundee DD2 4DB, Scotland; [Sotoodehnia, Nona] Univ Washington, Div Cardiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Stanton, Alice V.] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin 2, Ireland; [Stathopoulou, Maria G.] UMR INSERM U1122, F-54000 Nancy, France; [Stathopoulou, Maria G.] Univ Lorraine, INSERM, IGE PCV Interact Geneenvironm Physiopathol Cardio, F-54000 Nancy, France; [Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Tandon, Nikhil] All India Inst Med Sci, Dept Endocrinol, New Delhi 110029, India; ImpColl London, Natl Heart & Lung Inst, London W12 0NN, England; [Tang, Sian-Tsun; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Tayo, Bamidele O.; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Tomaszewski, Maciej; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Tsernikova, Natalia; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, A-3500 Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Res Grp, Jeddah 21589, Saudi Arabia; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Vaidya, Dhananjay] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Vasankari, Tuula] Finnish Lung Hlth Assoc, FI-00250 Helsinki, Finland; [Whitfield, John B.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld 4006, Australia; [Yajnik, Chittaranjan S.] KEM Hosp & Res Ctr, Diabet Unit, Pune 411011, Maharashtra, India; [Zaza, Gianluigi] Univ Verona, Dept Med, Renal Unit, I-37124 Verona, Italy; [Zhu, Xiaofeng] CaseWestern Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Melbye, Mads] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Ferrucci, Luigi] NIA, Translat Gerontol Branch, Baltimore, MD 21225 USA; [Morris, Andrew D.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH16 4UX, Midlothian, Scotland; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Sch Med, Med Res Inst, Ctr Pharmacogenet & Pharmacogen, Dundee DD1 9SY, Scotland; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21589, Saudi Arabia; [Bertram, Lars] Univ London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, England; [Toenjes, Anke] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, DK-2000 Copenhagen, Denmark; [Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Balkau, Beverley] INSERM, Epidemiol Diabet Obes & Chron Kidney Dis Lifecour, CESP Ctr Res Epidemiol & Populat Hlth, U1018, F-94807 Villejuif, France; [Gambaro, Giovanni] Univ Cattolica Sacro Cuore, Dipartimento Sci Med, I-00168 Rome, Italy; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3GA, Merseyside, England; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FI-00014 Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, FI-65130 Vaasa, Finland; [Eriksson, Johan G.] Univ Helsinki, Folkhalsan Reasearch Ctr, FI-00014 Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, FI-00290 Helsinki, Finland; [Wright, Margie J.] QIMR Berghofer Med Res Inst, Neuroimaging Genet, Brisbane, Qld 4006, Australia; [Hunt, Steven C.] Univ Utah, Cardiovasc Genet Div, Salt Lake City, UT 84117 USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Tiemeier, Henning] Erasmus MC, Dept Psychiat, NL-3000 CA Rotterdam, Netherlands; [Kaprio, Jaakko] Natl Inst Hlth & Welf THL, FI-00271 Helsinki, Finland; [Perusse, Louis] Univ Laval, Dept Kinesiol, Quebec City, PQ 2300, Canada; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Raitakari, Olli] Univ Turku, Dept Clin Physiol & Nucl Med, FI-20521 Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, FI-20521 Turku, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FI-20521 Turku, Finland; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet & Biostat, St Louis, MO 63108 USA; [Becker, Diane M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA; [Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73104 USA; [Gasparini, Paolo] Sidra Med & Res Ctr, Doha, Qatar; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Chandak, Giriraj R.] Genome Inst Singapore, Singapore 138672, Singapore; [Shuldiner, Alan R.] Univ Maryland, Sch Med, Dept Med, Program Personalised & Genom Med, Baltimore, MD 21201 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol & Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Chambers, John C.; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Healthcare NHS Trust, London W2 1NY, England; [Strachan, David P.] Univ London, Populat Hlth Res Inst, London SW17 0RE, England; [Ahluwalia, Tarunveer S.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Loh, Marie] ASTAR, Translat Lab Genet Med TLGM, Singapore 138648, Singapore; [Wild, Sarah] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Bertram, Lars] Med Univ Lubeck, Inst Neurogenet, D-23562 Lubeck, Germany; [Bertram, Lars] Med Univ Lubeck, Inst Integrat & Expt Genom, D-23562 Lubeck, Germany; [Bharadwaj, Dwaipayan] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	University of Edinburgh; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Finland National Institute for Health & Welfare; University of Helsinki; University of Trieste; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icelandic Heart Association; University of Iceland; Imperial College London; Tokyo Medical & Dental University (TMDU); RIKEN; University of Eastern Finland; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Consiglio Nazionale delle Ricerche (CNR); University of North Carolina; University of North Carolina Chapel Hill; SciLifeLab; Uppsala University; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Lausanne; Swiss Institute of Bioinformatics; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Boston University; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harokopio University Athens; Greifswald Medical School; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; University of North Carolina; University of North Carolina Chapel Hill; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Johns Hopkins University; Washington University (WUSTL); Medical University of Graz; Medical University of Graz; Erasmus University Rotterdam; Karolinska Institutet; Karolinska University Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; European Academy of Bozen-Bolzano; University of Groningen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Vrije Universiteit Amsterdam; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Mississippi; University of Mississippi Medical Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Cambridge; IRCCS Burlo Garofolo; Queensland University of Technology (QUT); Medical College of Wisconsin; QIMR Berghofer Medical Research Institute; University of Verona; University of Oxford; Wellcome Centre for Human Genetics; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; University of Alabama System; University of Alabama Birmingham; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Bristol; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Dundee; University of London; Queen Mary University London; Utrecht University; Utrecht University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Exeter; University of Copenhagen; University of Copenhagen; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Milan; University of Western Australia; Statens Serum Institut; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Chicago; University of California System; University of California San Diego; Utrecht University; Utrecht University Medical Center; University of London; University College London; University of Groningen; Columbia University; Greifswald Medical School; Cornell University; University of Southern California; University of Southern California; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Edinburgh; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Dundee; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Edinburgh; University of Edinburgh; Greifswald Medical School; University of Geneva; University of Glasgow; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Greifswald Medical School; Washington University (WUSTL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Boston University; University of Helsinki; University of Aberdeen; Chinese Academy of Sciences; Shanghai Jiao Tong University; Erasmus University Rotterdam; Erasmus MC; Uppsala University; Uppsala University; Finland National Institute for Health & Welfare; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tampere University; Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Tampere University; Tampere University; Uppsala University; Uppsala University Hospital; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Massachusetts Eye & Ear Infirmary; University of Auckland; Finland National Institute for Health & Welfare; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Wellcome Trust Sanger Institute; Johns Hopkins University; University of Tokyo; Harvard University; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; QIMR Berghofer Medical Research Institute; Boston University; University of Helsinki; Helsinki University Central Hospital; Boston University; Boston University; University of Ibadan; University of Glasgow; University of Minnesota System; University of Minnesota Twin Cities; University of Split; University of Split; University of Helsinki; Imperial College London; Imperial College London; Dayanand Medical College & Hospital; University of Virginia; Indiana University System; Indiana University Bloomington; Medical University of Graz; Karolinska Institutet; University of Dundee; University of Washington; University of Washington Seattle; Royal College of Surgeons - Ireland; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Munich; All India Institute of Medical Sciences (AIIMS) New Delhi; Imperial College London; Imperial College London; Loyola University Chicago; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Tartu; Danube University Krems; King Abdulaziz University; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; QIMR Berghofer Medical Research Institute; University of Verona; Case Western Reserve University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Edinburgh; University of Dundee; King Abdulaziz University; Imperial College London; Leipzig University; University of Copenhagen; Bispebjerg Hospital; University of Alabama System; University of Alabama Birmingham; University of Groningen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Liverpool; University of Helsinki; Vaasa Central Hospital; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; QIMR Berghofer Medical Research Institute; Utah System of Higher Education; University of Utah; University of Edinburgh; Erasmus University Rotterdam; Erasmus MC; Finland National Institute for Health & Welfare; Laval University; University of Mississippi; University of Mississippi Medical Center; University of Turku; University of Turku; University of Turku; University of Groningen; Stockholm School of Economics; Karolinska Institutet; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Sidra Medical & Research Center; Icahn School of Medicine at Mount Sinai; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Glasgow; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Imperial College London; University of London; Steno Diabetes Center; Agency for Science Technology & Research (A*STAR); University of Edinburgh; University of Lubeck; University of Lubeck; Jawaharlal Nehru University, New Delhi	Joshi, PK (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.		Verweij, Niek/A-4499-2017; Gudnason, Vilmundur/K-6885-2015; Karaderi, Tugce/W-8729-2019; Prokopenko, Inga/H-3241-2014; Polasek, Ozren/B-6002-2011; Kacprowski, Tim/K-8650-2013; Gasparini, Paolo/B-6173-2014; Marques-Vidal, Pedro M/C-9449-2009; Medland, Sarah/AAT-7595-2020; Saxena, Richa/AAG-7279-2020; Meigs, James/P-3927-2019; Kacprowski, Tim/N-9692-2019; Bouchard, Claude/AAE-2035-2019; Strawbridge, Rona/H-5422-2012; Loos, Ruth J F/Q-2862-2016; Wilson, James F/A-5704-2009; Yazar, Seyhan/U-4032-2018; Fox, Laura J/C-6249-2016; Zaza, Gianluigi/K-3827-2018; Campbell, Harry/E-2959-2010; Ford, Ian/ABE-6145-2020; Enroth, Stefan/C-7396-2009; Bertram, Lars/K-3889-2015; Loos, Ruth/GON-5877-2022; Wright, Margaret Jane/A-4560-2016; Johansson, Åsa/AAG-6799-2021; Vaidya, Dhananjay/AAL-5684-2020; EHRET, Georg B/A-9532-2009; Waldenberger, Melanie/B-5355-2014; Boomsma, Dorret I/AAX-4470-2020; Kaprio, Jaakko/A-1820-2008; zhang, weihua/GXV-1334-2022; Meitinger, Thomas/O-1318-2015; Nelis, Mari/ABG-7775-2020; Lind, Penelope A/B-2553-2009; Chen, Yuning/ABE-1239-2020; Lind, Penelope A/ABC-5341-2021; Johansson, Åsa/G-5270-2011; Davey Smith, George/A-7407-2013; Verweij, Niek/ABC-6249-2021; van Hylckama Vlieg, Astrid/A-3323-2017; Berndt, Sonja I/J-8423-2016; Drong, Alexander/AAG-1115-2020; Campbell, Archie/AAZ-1757-2021; Montgomery, Grant W/B-7148-2008; Deloukas, Panos/B-2922-2013; Stanton, Alice V/F-4697-2012; Ciullo, Marina/AAE-3041-2020; Tiemeier, Henning/H-6534-2019; Navarro, Pau/AAJ-8091-2021; Pirastu, Nicola/AHB-6226-2022; Ahluwalia, Tarunveer Singh/C-5549-2009; Wood, Andrew R/AAB-3807-2019; Schmidt, Reinhold/E-1137-2014; Attrill, Lauren/V-1688-2018; Colaus, PsyColaus/K-6607-2013; Padmanabhan, Sandosh/S-3963-2016; Ikram, M. Arfan/AAM-5225-2021; Feitosa, Mary F/K-8044-2012; Shrestha, Smeeta/AAF-4819-2020; Rudan, Igor/I-1467-2012; Schurmann, Claudia/L-1204-2016; Zhu, Xiaofeng/O-6874-2019; Mägi, Reedik/AAJ-9679-2021; Lahti, Jari/P-2283-2019; Gandin, Ilaria/B-2634-2017; Magnusson, Patrik KE/C-4458-2017; Meisinger, Christine/B-5358-2014; Kamatani, Yoichiro/N-5513-2015; Smith, Albert Vernon/K-5150-2015; Timpson, Nicholas John/O-7548-2015; Malerba, Giovanni/T-3278-2019; Teumer, Alexander/S-7438-2019; Yengo, Loic/D-2692-2017; Sala, Cinzia Felicita/AAN-1900-2020; Bouchard, Claude/A-7637-2009; Toniolo, Daniela/AAE-2969-2019; ruggiero, daniela/K-5638-2016; Concas, Maria Pina/K-2266-2018; Wang, Zhaoming/R-5527-2018; Lahti, Jari/P-7987-2018; Traglia, Michela/AAX-5816-2020; Deary, Ian J/C-6297-2009; Rotter, Jerome/AAY-6598-2021; Asselbergs, Folkert W./ABD-6752-2021; Hicks, Andrew Anthony/E-9518-2017; Milani, Lili/N-1097-2019; Bonnefond, Amélie/O-2784-2017; Mackey, David A/H-5340-2014; Perusse, Louis/A-3444-2012; Jukema, J. Wouter/ABD-6503-2021; van der Laan, Sander W./N-1330-2019; Study, GoDARTS/K-9448-2016; Porteous, David/AAA-3446-2021; London, Stephanie/C-3734-2019; Johannesson, Magnus/E-9680-2011; Kubo, Michiaki/N-7947-2015; Stancakova, Alena/AAN-6723-2020; Khan, Nazir M/D-1514-2019; Kanoni, Stavroula/AAN-7161-2021; FROGUEL, Philippe/O-6799-2017; Raitakari, Olli/AAQ-7389-2021; Medland, Sarah E/C-7630-2013; Stathopoulou, Maria/H-7324-2016; Dedoussis, George/AAN-7252-2021; HUANG, Jinyan/AAK-3065-2020; Prokopenko, Inga/AAU-9895-2020; Bisgaard, Hans/N-4761-2016; Palmer, Colin NA/C-7053-2008; Dörr, Marcus/F-1919-2010; Kraft, Peter/GQH-8448-2022; Salvi, Erika/AAA-1415-2019; Baumeister, Sebastian-Edgar/P-7894-2019; Heikkilä, Kauko/E-5578-2019; Mangino, Massimo/F-5134-2011; Lehtimäki, Terho/AAD-1094-2022; Demuth, Ilja/ABD-5352-2021; Gudnason, Vilmundur/AAE-7126-2019; Robino, Antonietta/K-9398-2016; Girotto, Giorgia/I-9452-2018; Gu, C. Charles/A-7934-2010; Smith, Blair/G-2834-2012; Koistinen, Heikki/J-7313-2016	Gudnason, Vilmundur/0000-0001-5696-0084; Karaderi, Tugce/0000-0001-9763-8139; Prokopenko, Inga/0000-0003-1624-7457; Polasek, Ozren/0000-0002-5765-1862; Kacprowski, Tim/0000-0002-5393-2413; Marques-Vidal, Pedro M/0000-0002-4548-8500; Medland, Sarah/0000-0003-1382-380X; Meigs, James/0000-0002-2439-2657; Kacprowski, Tim/0000-0002-5393-2413; Strawbridge, Rona/0000-0001-8506-3585; Loos, Ruth J F/0000-0002-8532-5087; Wilson, James F/0000-0001-5751-9178; Yazar, Seyhan/0000-0003-0994-6196; Campbell, Harry/0000-0002-6169-6262; Enroth, Stefan/0000-0002-5056-9137; Bertram, Lars/0000-0002-0108-124X; Wright, Margaret Jane/0000-0001-7133-4970; Johansson, Åsa/0000-0002-2915-4498; Vaidya, Dhananjay/0000-0002-7164-1601; EHRET, Georg B/0000-0002-5730-0675; Waldenberger, Melanie/0000-0003-0583-5093; Kaprio, Jaakko/0000-0002-3716-2455; Nelis, Mari/0000-0001-9748-1020; Lind, Penelope A/0000-0002-3887-2598; Chen, Yuning/0000-0002-7358-7055; Lind, Penelope A/0000-0002-3887-2598; Johansson, Åsa/0000-0002-2915-4498; Davey Smith, George/0000-0002-1407-8314; Verweij, Niek/0000-0002-4303-7685; Montgomery, Grant W/0000-0002-4140-8139; Deloukas, Panos/0000-0001-9251-070X; Ciullo, Marina/0000-0002-9621-9984; Tiemeier, Henning/0000-0002-4395-1397; Navarro, Pau/0000-0001-5576-8584; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Wood, Andrew R/0000-0003-1726-948X; Feitosa, Mary F/0000-0002-0933-2410; Shrestha, Smeeta/0000-0002-6560-4230; Rudan, Igor/0000-0001-6993-6884; Schurmann, Claudia/0000-0003-4158-9192; Lahti, Jari/0000-0002-4310-5297; Gandin, Ilaria/0000-0003-3196-2491; Magnusson, Patrik KE/0000-0002-7315-7899; Smith, Albert Vernon/0000-0003-1942-5845; Timpson, Nicholas John/0000-0002-7141-9189; Teumer, Alexander/0000-0002-8309-094X; Yengo, Loic/0000-0002-4272-9305; Bouchard, Claude/0000-0002-0048-491X; Toniolo, Daniela/0000-0001-9545-6032; ruggiero, daniela/0000-0003-3898-7827; Concas, Maria Pina/0000-0003-3598-2537; Wang, Zhaoming/0000-0001-7556-3869; Lahti, Jari/0000-0002-4310-5297; Deary, Ian J/0000-0002-1733-263X; Asselbergs, Folkert W./0000-0002-1692-8669; Hicks, Andrew Anthony/0000-0001-6320-0411; Milani, Lili/0000-0002-5323-3102; Bonnefond, Amélie/0000-0001-9976-3005; Mackey, David A/0000-0001-7914-4709; Perusse, Louis/0000-0001-6440-9698; Jukema, J. Wouter/0000-0002-3246-8359; van der Laan, Sander W./0000-0001-6888-1404; Porteous, David/0000-0003-1249-6106; London, Stephanie/0000-0003-4911-5290; Johannesson, Magnus/0000-0001-8759-6393; Stancakova, Alena/0000-0002-1375-0252; Khan, Nazir M/0000-0002-1637-7641; Kanoni, Stavroula/0000-0002-1691-9615; FROGUEL, Philippe/0000-0003-2972-0784; Medland, Sarah E/0000-0003-1382-380X; Stathopoulou, Maria/0000-0003-4376-2083; Dedoussis, George/0000-0002-7798-6221; HUANG, Jinyan/0000-0002-8053-0209; Bisgaard, Hans/0000-0003-4131-7592; Palmer, Colin NA/0000-0002-6415-6560; Dörr, Marcus/0000-0001-7471-475X; Salvi, Erika/0000-0002-2724-2291; Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Heikkilä, Kauko/0000-0002-9256-8028; Mangino, Massimo/0000-0002-2167-7470; Lehtimäki, Terho/0000-0002-2555-4427; Demuth, Ilja/0000-0002-4340-2523; Gudnason, Vilmundur/0000-0001-5696-0084; Smith, Jennifer Ann/0000-0002-3575-5468; Allison, Matthew/0000-0003-0777-8272; Robino, Antonietta/0000-0003-2152-2353; Salem, Rany/0000-0001-8816-6862; Girotto, Giorgia/0000-0003-4507-6589; Vuoksimaa, Eero/0000-0002-6534-3667; Gasparini, Paolo/0000-0002-0859-0856; Sanghera, Dharambir/0000-0001-7203-8655; /0000-0003-0941-1458; Saxena, Richa/0000-0003-2233-1065; Scott, William/0000-0001-5467-114X; Amin, Najaf/0000-0002-8944-1771; Ober, Carole/0000-0003-4626-9809; Kerr, Shona/0000-0002-4137-1495; Lea, Rodney/0000-0002-1148-5862; Dupuis, Josee/0000-0003-2871-3603; Meisinger, Christa/0000-0002-9026-6544; Loh, Marie/0000-0003-3626-8466; Vuckovic, Dragana/0000-0001-9343-6142; s, hema/0000-0002-3440-9475; Morrison, Alanna/0000-0001-6381-4296; Ware, Erin/0000-0003-4731-8158; Meitinger, Thomas/0000-0002-8838-8403; Heard-Costa, Nancy/0000-0001-9730-0306; Van Duijn, Cornelia/0000-0002-2374-9204; Joshi, Peter/0000-0002-6361-5059; cappellani, stefania/0000-0002-1126-5202; Esko, Tonu/0000-0003-1982-6569; Eriksson, Johan/0000-0002-2516-2060; Tomaszewski, Maciej/0000-0001-8215-6567; nongmaithem, suraj/0000-0001-5390-0449; Gu, C. Charles/0000-0002-8527-8145; NUTILE, TERESA/0000-0001-7062-8352; Campbell, Archie/0000-0003-0198-5078; Loukola, Anu-Maria/0000-0003-0542-5967; Hysi, Pirro/0000-0001-5752-2510; Magi, Reedik/0000-0002-2964-6011; Griffiths, Lyn/0000-0002-6774-5475; de Haan, Hugoline/0000-0003-1126-4776; Pankow, James/0000-0001-7076-483X; Menni, Cristina/0000-0001-9790-0571; Cupples, L. Adrienne/0000-0003-0273-7965; Zhu, Xiaofeng/0000-0003-0037-411X; Hemani, Gibran/0000-0003-0920-1055; Geller, Frank/0000-0002-9238-3269; Lindgren, Cecilia/0000-0002-4903-9374; Pietilainen, Kirsi/0000-0002-8522-1288; Smith, Blair/0000-0002-5362-9430; Kahonen, Mika/0000-0002-4510-7341; Zeggini, Eleftheria/0000-0003-4238-659X; Rich, Stephen/0000-0003-3872-7793; Haley, Chris/0000-0002-9811-0210; Sinisalo, Juha/0000-0002-0169-5137; Willemsen, Gonneke/0000-0003-3755-0236; Pirastu, Nicola/0000-0002-5363-3886; Chandak, Giriraj Ratan/0000-0002-3095-9453; vozzi, diego/0000-0002-2902-8184; Padmanabhan, Sandosh/0000-0003-3869-5808; Gieger, Christian/0000-0001-6986-9554; Suderman, Matthew/0000-0002-2715-9930; Caulfield, Mark/0000-0001-9295-3594; Stanton, Alice/0000-0002-4961-165X; Mannisto, Satu/0000-0002-8668-3046; Bharadwaj, Dwaipayan/0000-0001-5268-8482; melbye, mads/0000-0001-8264-6785; Seshadri, Sudha/0000-0001-6135-2622; Soranzo, Nicole/0000-0003-1095-3852; Shuldiner, Alan/0000-0001-9921-4305; Koistinen, Heikki/0000-0001-7870-070X; Zaza, Gianluigi/0000-0002-6004-6196; Hocking, Lynne J/0000-0002-2414-2826; Benton, Miles/0000-0003-3442-965X; Munroe, Patricia/0000-0002-4176-2947; Grant, Struan/0000-0003-2025-5302; Koellinger, Philipp/0000-0001-7413-0412; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Faul, Jessica/0000-0002-6969-6478; Joensuu, Anni/0000-0002-7547-7458; Gambaro, Giovanni/0000-0001-5733-2370; Pattaro, Cristian/0000-0002-4119-0109; Malerba, Giovanni/0000-0001-8705-8560	UK Medical Research Council (MRC); MRC Human Genetics Unit "QTL in Health and Disease" programme; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [MC_U106179472, MC_PC_U127592696, G0700704, G9521010, MC_UU_12015/1, MC_UU_12013/3, G1001799, MR/N01104X/1, MC_PC_U127561128, MR/K002414/1, G0701863, G0601966, MC_UU_12013/1, MC_UU_12015/2, G0700931, MC_U127561128] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [MC_U106179471, G0601966, MC_UU_12015/1, G1001799, MC_U106179472, MC_UU_12013/3, MC_UU_12013/1, MR/K026992/1, G0700704, MR/N01104X/1, MC_PC_13046, MC_PC_13048, MR/K002414/1, MC_PC_U127561128, MC_PC_15018, G9521010, 1201677, G9815508, MC_UU_12015/2, MC_U127561128, MC_PC_U127592696, MR/K006584/1, G0700931, G0701863] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10059, NF-SI-0512-10113, SRF/01/010, NF-SI-0514-10027, NF-SI-0512-10135] Funding Source: researchfish; Novo Nordisk Fonden [NNF10OC1013354] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4, CZD/16/6/2, CZB/4/505, ETM/55, CZB/4/710] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056465] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524, R01HL085197, R01HL104135, R01HL091357, R01HL117078, R01HL077612, R01HL055673] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362, R01HG002899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK093757, P30DK063491, R01DK072193, U01DK078616, R01DK078616, R01DK075787, R01DK089256, U01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES043012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740, R01AG033193, U01AG049505, P30AG017265, ZIAAG007270, R01AG008122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013373] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05670, 25293168] Funding Source: KAKEN	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Human Genetics Unit "QTL in Health and Disease" programme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); Chief Scientist Office; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This paper is the work of the ROHgen consortium. We thank the participants in all ROHgen studies; cohort-specific acknowledgements are detailed in Supplementary Table 6. This work was funded by a UK Medical Research Council (MRC) PhD studentship to P.K.J.; and J.F.W. and O.P. acknowledge support from the MRC Human Genetics Unit "QTL in Health and Disease" programme. We thank W. G. Hill for discussions and comments on the manuscript and K. Lindsay for administrative assistance.	Abdellaoul A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118935; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; DARWIN C, 1876, EFFECTS CROSSING SEL; Darwin C, 1968, VARIATION ANIMALS PL; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; Galton F., 1889, NATURAL INHERITANCE; Garrod AE, 1902, LANCET, V2, P1616; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Hedges LV, 2014, STAT METHODS META AN; Hoffman JI, 2014, P NATL ACAD SCI USA, V111, P3775, DOI 10.1073/pnas.1318945111; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Marioni RE, 2014, INTELLIGENCE, V44, P26, DOI 10.1016/j.intell.2014.02.006; Marioni RE, 2014, BEHAV GENET, V44, P91, DOI 10.1007/s10519-014-9644-z; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; McQuillan R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002655; MORTON NE, 1978, P NATL ACAD SCI USA, V75, P3906, DOI 10.1073/pnas.75.8.3906; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nalls MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000415; NEEL JV, 1970, AM J HUM GENET, V22, P263; Pemberton TJ, 2014, HUM HERED, V77, P37, DOI 10.1159/000362878; Powell JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003502; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ronnegard L, 2010, R J, V2, P20; Rudan I, 2003, GENETICS, V163, P1011; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wright A, 2003, TRENDS GENET, V19, P97, DOI 10.1016/S0168-9525(02)00033-1; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Wright S., 1977, EVOLUTION GENETICS P, V3	44	101	101	3	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					459	U176		10.1038/nature14618	http://dx.doi.org/10.1038/nature14618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26131930	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000358378900036
J	Lo, S; Horton, R				Lo, Selina; Horton, Richard			AIDS and global health: the path to sustainable development	LANCET			English	Editorial Material									[Lo, Selina] The Lancet, Beijing 100738, Peoples R China; [Horton, Richard] The Lancet, London, England		Lo, S (corresponding author), The Lancet, Beijing 100738, Peoples R China.							Biehl J, 2009, LANCET, V373, P2182, DOI 10.1016/S0140-6736(09)61172-7; Global Commission on HIV and the Law, 2012, HIV LAW RISKS RIGHTS; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Piot P, 2015, LANCET; Sidibe M, 2015, LANCET; UNAIDS, 2014, THE GAP REP	7	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					106	108		10.1016/S0140-6736(15)61040-6	http://dx.doi.org/10.1016/S0140-6736(15)61040-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM5QC	26117721				2022-12-28	WOS:000357742200005
J	Sweeney, KE; Roering, JJ; Ellis, C				Sweeney, K. E.; Roering, J. J.; Ellis, C.			Experimental evidence for hillslope control of landscape scale	SCIENCE			English	Article							DRAINAGE DENSITY; CLIMATE; UPLIFT; MODEL	Landscape evolution theory suggests that climate sets the scale of landscape dissection by modulating the competition between diffusive processes that sculpt convex hillslopes and advective processes that carve concave valleys. However, the link between the relative dominance of hillslope and valley transport processes and landscape scale is difficult to demonstrate in natural landscapes due to the episodic nature of erosion. Here, we report results from laboratory experiments combining diffusive and advective processes in an eroding landscape. We demonstrate that rainsplash-driven disturbances in our experiments are a robust proxy for hillslope transport, such that increasing hillslope transport efficiency decreases drainage density. Our experimental results demonstrate how the coupling of climate-driven hillslope- and valley-forming processes, such as bioturbation and runoff, dictates the scale of eroding landscapes.	[Sweeney, K. E.; Roering, J. J.] 1272 Univ Oregon, Dept Geol Sci, Univ Oregon, Eugene, OR 97403 USA; [Ellis, C.] Univ Minnesota, St Anthony Falls Lab, Coll Sci & Engn, Minneapolis, MN 55414 USA; [Ellis, C.] Univ Minnesota, Natl Ctr Earth Surface Dynam, Coll Sci & Engn, Minneapolis, MN 55414 USA	University of Oregon; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sweeney, KE (corresponding author), 1272 Univ Oregon, Dept Geol Sci, Univ Oregon, Eugene, OR 97403 USA.	kristin.e.sweeney@gmail.com			National Science Foundation [EAR 1252177]; Directorate For Geosciences [1252177] Funding Source: National Science Foundation; Division Of Earth Sciences [1251375] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by a National Science Foundation grant (EAR 1252177) to J.J.R. and C.E. We thank D. Furbish and A. Singh for fruitful discussions, S. Grieve and M. Hurst for assistance with the calculation of hillslope metrics, and the technical staff of St. Anthony Falls Laboratory for support during experiments. All authors designed the experiments and wrote the manuscript, C.E. built and troubleshot the experimental apparatus, and K.E.S. conducted the experiments and analyzed the data. Comments from two anonymous reviewers greatly improved the manuscript. Topographic data are available from the National Center for Earth Dynamics Data Repository at https://repository.nced.umn.edu.	Bonnet S, 2003, GEOLOGY, V31, P123, DOI 10.1130/0091-7613(2003)031<0123:LRTCCI>2.0.CO;2; Bonnet S, 2009, NAT GEOSCI, V2, P766, DOI 10.1038/NGEO666; Chadwick OA, 2013, GEOLOGY, V41, P1171, DOI 10.1130/G34721.1; Davis W M, 1892, Science, V20, P245; DIETRICH WE, 1992, GEOLOGY, V20, P675, DOI 10.1130/0091-7613(1992)020<0675:ETALSM>2.3.CO;2; Dixon JL, 2009, GEOLOGY, V37, P975, DOI 10.1130/G30045A.1; Furbish DJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000498; Gabet EJ, 2000, EARTH SURF PROC LAND, V25, P1419, DOI 10.1002/1096-9837(200012)25:13&lt;1419::AID-ESP148&gt;3.0.CO;2-1; Gilbert GK, 1909, J GEOL, V17, P344, DOI 10.1086/621620; Hasbargen LE, 2000, GEOLOGY, V28, P1067, DOI 10.1130/0091-7613(2000)28<1067:LIIAED>2.0.CO;2; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; Hurst MD, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002057; Kirkby M.J., 1971, SPECIAL PUBLICATION, V3, P5; Lague D, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001785; Matsuoka N, 1998, PERMAFROST PERIGLAC, V9, P121, DOI 10.1002/(SICI)1099-1530(199804/06)9:2&lt;121::AID-PPP281&gt;3.0.CO;2-C; Moglen GE, 1998, WATER RESOUR RES, V34, P855, DOI 10.1029/97WR02709; MONTGOMERY DR, 1989, WATER RESOUR RES, V25, P1907, DOI 10.1029/WR025i008p01907; Paola C, 2009, EARTH-SCI REV, V97, P1, DOI 10.1016/j.earscirev.2009.05.003; Passalacqua P, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001254; Perron JT, 2009, NATURE, V460, P502, DOI 10.1038/nature08174; Perron JT, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000977; Perron J. Taylor, 2012, EARTH SURF PROCESS L, V37, P52; RINALDO A, 1995, NATURE, V374, P632, DOI 10.1038/374632a0; Roering JJ, 2001, J GEOPHYS RES-SOL EA, V106, P16499, DOI 10.1029/2001JB000323; Roering JJ, 2007, EARTH PLANET SC LETT, V264, P245, DOI 10.1016/j.epsl.2007.09.035; Roering JJ, 2010, EARTH PLANET SC LETT, V298, P183, DOI 10.1016/j.epsl.2010.07.040; SMITH TR, 1972, WATER RESOUR RES, V8, P1506, DOI 10.1029/WR008i006p01506; Stock J, 2003, WATER RESOUR RES, V39, DOI 10.1029/2001WR001057; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; Turowski JM, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000306; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Wobus C, 2006, GEOL SOC AM SPEC PAP, V398, P55, DOI 10.1130/2006.2398(04)	33	48	51	5	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					51	53		10.1126/science.aab0017	http://dx.doi.org/10.1126/science.aab0017			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138970				2022-12-28	WOS:000357280800055
J	Weissman, P				Weissman, Paul			PLANETARY SCIENCE Sink holes and dust jets on comet 67P	NATURE			English	Editorial Material								Analyses of images taken by the Rosetta spacecraft reveal the complex landscape of a comet in rich detail. Close-up views of the surface indicate that some dust jets are being emitted from active pits undergoing sublimation.	NASA, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Weissman, P (corresponding author), NASA, Jet Prop Lab, Pasadena, CA 91109 USA.	weissman@jpl.nasa.gov						Donn B., 1986, 20th ESLAB Symposium on the Exploration of Halley's Comet. Proceedings of the International Symposium (ESA-SP-250), P523; Kirk R., 2015, 46 LUN PLAN SCI C; Rotundi A, 2015, SCIENCE, V347, DOI 10.1126/science.aaa3905; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Vincent JB, 2015, NATURE, V523, P63, DOI 10.1038/nature14564; WEISSMAN PR, 1986, NATURE, V320, P242, DOI 10.1038/320242a0	6	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					42	43		10.1038/523042a	http://dx.doi.org/10.1038/523042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135444				2022-12-28	WOS:000357169500025
J	Gardham, D				Gardham, Duncan			DOCTORS AND ISLAMIC STATE Islamic State creates jihadi health service	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												duncan.gardham@gmail.com							0	7	7	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2015	350								h3487	10.1136/bmj.h3487	http://dx.doi.org/10.1136/bmj.h3487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TN	26130227				2022-12-28	WOS:000357607400009
J	Ahmed, N; Pillay, A; Lawler, M; Bobat, R; Archary, M				Ahmed, Nadia; Pillay, Ashendri; Lawler, Melissa; Bobat, Raziya; Archary, Moherndran			Donovanosis causing lymphadenitis, mastoiditis, and meningitis in a child	LANCET			English	Editorial Material									[Ahmed, Nadia] Mortimer Market Ctr, Dept Genitourinary Med, London WC1E 6JB, England; [Pillay, Ashendri; Lawler, Melissa; Archary, Moherndran] King Edward VIII Hosp, Dept Paediat Infect Dis, Kwa Zulu, South Africa; [Bobat, Raziya] Univ KwaZulu Natal, Dept Paediat, Durban, South Africa	University of Kwazulu Natal	Ahmed, N (corresponding author), Mortimer Market Ctr, Dept Genitourinary Med, London WC1E 6JB, England.	nadia.ahmed2@nhs.net		Archary, Moherndran/0000-0003-3082-9234				Govender D, 1999, PEDIATR SURG INT, V15, P129, DOI 10.1007/s003830050533; O'Farrell N, 2002, SEX TRANSM INFECT, V78, P452, DOI 10.1136/sti.78.6.452; RAMACHANDER M, 1967, INDIAN J DERMATOL VE, V33, P237	3	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2644	2644		10.1016/S0140-6736(15)60992-8	http://dx.doi.org/10.1016/S0140-6736(15)60992-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	26122163				2022-12-28	WOS:000356930000030
J	Ackland, GJ				Ackland, Graeme J.			Bearing down on hydrogen	SCIENCE			English	Editorial Material							TRANSITION		Univ Edinburgh, Sch Phys & Astron, Ctr Sci Extreme Condit, Edinburgh EH9 3FD, Midlothian, Scotland	University of Edinburgh	Ackland, GJ (corresponding author), Univ Edinburgh, Sch Phys & Astron, Ctr Sci Extreme Condit, Edinburgh EH9 3FD, Midlothian, Scotland.	gjackland@ed.ac.uk	Ackland, Graeme/H-2215-2015	Ackland, Graeme/0000-0002-1205-7675	EPSRC [EP/J004839/1, EP/K01465X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K01465X/1, EP/J004839/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Babaev E, 2004, NATURE, V431, P666, DOI 10.1038/nature02910; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3064; Howie RT, 2015, NAT MATER, V14, P495, DOI [10.1038/NMAT4213, 10.1038/nmat4213]; Howie RT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.125501; Knudson MD, 2015, SCIENCE, V348, P1455, DOI 10.1126/science.aaa7471; Magdau IB, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174110; Marques M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.095502; Matzen MK, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1891746; Morales MA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.065702; Morales MA, 2010, P NATL ACAD SCI USA, V107, P12799, DOI 10.1073/pnas.1007309107; Pickard CJ, 2007, NAT PHYS, V3, P473, DOI 10.1038/nphys625; Tamblyn I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.065702; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590	14	2	2	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1429	1430		10.1126/science.aac6626	http://dx.doi.org/10.1126/science.aac6626			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113705	Green Accepted			2022-12-28	WOS:000356869100020
J	Hinde, K; Lewis, ZT				Hinde, Katie; Lewis, Zachery T.			Mother's littlest helpers	SCIENCE			English	Editorial Material							HUMAN-MILK; INFANTS; MICROBIOME		[Hinde, Katie] Harvard Univ, Dept Human Evolutionary Biol, Boston, MA 02115 USA; [Lewis, Zachery T.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	Harvard University; University of California System; University of California Davis	Hinde, K (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Boston, MA 02115 USA.	khinde@fas.harvard.edu		Hinde, Katie/0000-0002-0528-866X				AlFaleh Khalid, 2014, Evid Based Child Health, V9, P584, DOI 10.1002/ebch.1976; Allen-Blevins Cary R., 2015, Evolution Medicine and Public Health, P106, DOI 10.1093/emph/eov007; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Donovan SM, 2014, FEBS LETT, V588, P4112, DOI 10.1016/j.febslet.2014.07.008; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Geddes DT, 2008, EARLY HUM DEV, V84, P471, DOI 10.1016/j.earlhumdev.2007.12.008; Hinde K, 2012, J SCI FOOD AGR, V92, P2219, DOI 10.1002/jsfa.5720; Houghteling PD, 2015, J PEDIATR GASTR NUTR, V60, P294, DOI 10.1097/MPG.0000000000000597; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; Johnson TJ, 2015, NEONATOLOGY, V107, P271, DOI 10.1159/000370058; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; Martin Melanie A., 2013, BUILDING BABIES, P233, DOI DOI 10.1007/978-1-4614-4060-4_11; Rook GAW, 2014, CLIN EXP IMMUNOL, V177, P1, DOI 10.1111/cei.12269; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Urashima T., 2014, EVOLUTIONARY BIOL GE, DOI [10.1007/978-3-319-07623-2_1, DOI 10.1007/978-3-319-07623-2_1]	15	38	39	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1427	1428		10.1126/science.aac7436	http://dx.doi.org/10.1126/science.aac7436			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113704				2022-12-28	WOS:000356869100019
J	Datar, N				Datar, Nikhil			PERSONAL VIEW India's abortion law puts women at risk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Datar, Nikhil] Cloudnine Hosp, Obstet & Gynaecol, Bombay, Maharashtra, India; [Datar, Nikhil] Lifewave Hosp, Bombay, Maharashtra, India		Datar, N (corresponding author), Cloudnine Hosp, Obstet & Gynaecol, Bombay, Maharashtra, India.	drnikhil70@hotmail.com						FIGO Committee for the Study of Ethical Aspects of Human Reproduction and Women's Health, 2012, ETH ISS OBST GYN; Konar H., 2006, DC DUTTAS TXB OBSTET; Ministry of Health and Family Welfare. Government of India, 2014, NOT 12015 49 2008 MC; Nuffield Council on Bioethics, 2006, GUID INT CAR EXTR PR; Shah S., 1966, REPORT COMMITTE STUD; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2015	350								h3294	10.1136/bmj.h3294	http://dx.doi.org/10.1136/bmj.h3294			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7OB	26113630				2022-12-28	WOS:000357160500002
J	Hamilton, W; Hajioff, S; Graham, J; Schmidt-Hansen, M				Hamilton, William; Hajioff, Steve; Graham, John; Schmidt-Hansen, Mia			Suspected cancer (part 1-children and young adults): visual overview of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hamilton, William] Univ Exeter, Exeter EX1 2LU, Devon, England; [Hajioff, Steve] London Borough Hillingdon, Uxbridge UB8 1UW, Middx, England; [Graham, John; Schmidt-Hansen, Mia] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales	University of Exeter	Hamilton, W (corresponding author), Univ Exeter, Exeter EX1 2LU, Devon, England.	w.hamilton@exeter.ac.uk		Graham, John/0000-0003-3381-9787; Hamilton, William/0000-0003-1611-1373					0	4	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2015	350								h3036	10.1136/bmj.h3036	http://dx.doi.org/10.1136/bmj.h3036			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NR	26104677	Green Submitted			2022-12-28	WOS:000357159400001
J	Haynes, BF; Bradley, T				Haynes, Barton F.; Bradley, Todd			Broadly Neutralizing Antibodies and the Development of Vaccines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV-1 ANTIBODY; IN-VIVO; PROTECTION		[Haynes, Barton F.; Bradley, Todd] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA; [Haynes, Barton F.; Bradley, Todd] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.	Hayne002@mc.duke.edu	Bradley, Todd/AAB-3550-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI100645] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746	7	12	13	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2419	2420		10.1001/jama.2015.2427	http://dx.doi.org/10.1001/jama.2015.2427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103022				2022-12-28	WOS:000356663600005
J	Stern, T; Cifu, AS				Stern, Todd; Cifu, Adam S.			Perioperative beta-Blocker Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED-CONTROLLED-TRIAL; NONCARDIAC SURGERY; CARDIOVASCULAR MORBIDITY; MYOCARDIAL-INFARCTION; RISK PATIENTS; MORTALITY; BISOPROLOL		[Stern, Todd; Cifu, Adam S.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Bouri S, 2014, HEART, V100, P456, DOI 10.1136/heartjnl-2013-304262; Chopra V, 2012, AM J MED, V125, P953, DOI 10.1016/j.amjmed.2012.03.014; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Dunkelgrun M, 2009, ANN SURG, V249, P921, DOI 10.1097/SLA.0b013e3181a77d00; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944; London MJ, 2013, JAMA-J AM MED ASSOC, V309, P1704, DOI 10.1001/jama.2013.4135; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402	8	4	6	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2486	2487		10.1001/jama.2015.3086	http://dx.doi.org/10.1001/jama.2015.3086			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103033				2022-12-28	WOS:000356663600018
J	Molnar, AO; Fergusson, D; Tsampalieros, AK; Bennett, A; Fergusson, N; Ramsay, T; Knoll, GA				Molnar, Amber O.; Fergusson, Dean; Tsampalieros, Anne K.; Bennett, Alexandria; Fergusson, Nicholas; Ramsay, Timothy; Knoll, Greg A.			Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MYCOPHENOLATE-MOFETIL; CYCLOSPORINE-A; BRAND-NAME; THERAPEUTIC EQUIVALENCE; RENAL-TRANSPLANTATION; RECIPIENTS; CONVERSION; BIOEQUIVALENCE; TACROLIMUS; FORMULATION	OBJECTIVE To compare the clinical efficacy and bioequivalence of generic immunosuppressive drugs in patients with solid organ transplants. DESIGN Systematic review and meta-analysis of all studies comparing generic with innovator immunosuppressive drugs. DATA SOURCES Medline and Embase from 1980 to September 2014. REVIEW METHODS A literature search was performed for all studies comparing a generic to an innovator immunosuppressive drug in solid organ transplantation. Two reviewers independently extracted data and assessed quality of studies. Meta-analyses of prespecified outcomes were performed when deemed appropriate. Outcomes included patient survival, allograft survival, acute rejection, adverse events and bioequivalence. RESULTS 1679 citations were screened, of which 50 studies met eligibility criteria (17 randomized trials, 15 non-randomized interventional studies, and 18 observational studies). Generics were compared with Neoral (cyclosporine) (32 studies), Prograf (tacrolimus) (12 studies), and Cellcept (mycophenolate mofetil) (six studies). Pooled analysis of randomized controlled trials in patients with kidney transplants that reported bioequivalence criteria showed that Neoral (two studies) and Prograf (three studies) were not bioequivalent with generic preparations according to criteria of the European Medicines Agency. The single Cellcept trial also did not meet bioequivalence. Acute rejection was rare but did not differ between groups. For Neoral, the pooled Peto odds ratio was 1.23 (95% confidence interval 0.64 to 2.36) for kidney randomized controlled trials and 0.66 (0.40 to 1.08) for observational studies. For kidney observational studies, the pooled Peto odds ratios were 0.98 (0.37 to 2.60) for Prograf and 0.49 (0.09 to 2.56) for Cellcept. Meta-analyses for nonrenal solid organ transplants were not performed because of a lack of data. There were insufficient data reported on patient or graft survival. Pooling of results was limited by inconsistent study methods and reporting of outcomes. Many studies did not report standard criteria used to determine bioequivalence. While rates of acute rejection seemed similar and were relatively rare, few studies were designed to properly compare clinical outcomes. Most studies had short follow-up times and included stable patients without a history of rejection. CONCLUSIONS High quality data showing bioequivalence and clinical efficacy of generic immunosuppressive drugs in patients with transplants are lacking. Given the serious consequences of rejection and allograft failure, well designed studies on bioequivalence and safety of generic immunosuppression in transplant recipients are needed.	[Molnar, Amber O.; Fergusson, Dean; Tsampalieros, Anne K.; Bennett, Alexandria; Fergusson, Nicholas; Ramsay, Timothy; Knoll, Greg A.] Univ Ottawa, Div Nephrol, Dept Med, Kidney Res Ctr, Ottawa, ON K1H 8L6, Canada; [Molnar, Amber O.; Tsampalieros, Anne K.; Bennett, Alexandria; Fergusson, Nicholas] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON K1H 8L6, Canada; [Fergusson, Dean] Childrens Hosp Eastern Ontario, Div Nephrol, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario	Knoll, GA (corresponding author), Ottawa Hosp, Riverside Campus,1967 Riverside Dr, Ottawa, ON K1H 7W9, Canada.	gknoll@ottawahospital.on.ca	Molnar, Amber/K-6093-2019; Bennett, Alexandria/ABB-4639-2020	Bennett, Alexandria/0000-0002-5977-2094; Fergusson, Dean/0000-0002-3389-2485; Knoll, Greg/0000-0001-5442-9310; Fergusson, Nicholas/0000-0001-9862-9584; Ramsay, Tim/0000-0001-8478-8170	KRESCENT Program	KRESCENT Program(Canadian Institutes of Health Research (CIHR))	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. AOM received salary support from the KRESCENT Program.	Al Ameri MN, 2011, TRANSPL INT, V24, P770, DOI 10.1111/j.1432-2277.2011.01268.x; Al Wakeel JS, 2008, TRANSPL P, V40, P2245, DOI 10.1016/j.transproceed.2008.06.044; Al Wakeel JS, 2008, TRANSPL P, V40, P2252, DOI 10.1016/j.transproceed.2008.06.043; Allard Julie, 2014, Can J Kidney Health Dis, V1, P23, DOI 10.1186/s40697-014-0023-8; Alloway RR, 2012, AM J TRANSPLANT, V12, P2825, DOI 10.1111/j.1600-6143.2012.04174.x; Alloway RR, 2003, AM J TRANSPLANT, V3, P1211, DOI 10.1046/j.1600-6143.2003.00212.x; Banahan BF, 1997, ARCH INTERN MED, V157, P2080, DOI 10.1001/archinte.157.18.2080; Ben Abdallah T, 2010, EXP CLIN TRANSPLANT, V8, P292; Carnahan W, 2003, TRANSPLANT P, V35, P1308, DOI 10.1016/S0041-1345(03)00423-8; CHMP Pharmacokinetics Working Party (PKWP), 2011, QUEST ANSW POST SPEC; Christians U, 2000, THER DRUG MONIT, V22, P330, DOI 10.1097/00007691-200006000-00017; Connor A, 2012, TRANSPLANTATION, V93, pE45, DOI 10.1097/TP.0b013e318256dd13; Danguilan RA, 2014, TRANSPL P, V46, P415, DOI 10.1016/j.transproceed.2013.11.116; Danish Health Medicines Authority, 2011, GEN SUBST TERM OR ME; David-Neto E, 2004, THER DRUG MONIT, V26, P53, DOI 10.1097/00007691-200402000-00012; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; Deeks JJ, 2010, STAT ALGORITHMS REV, V5; Dhungel V, 2013, OPEN J ORGAN TRANSPL, V3, P19; Diarra DA, 2010, KIDNEY INT, V77, pS8, DOI 10.1038/ki.2009.505; Durlik M, 2003, TRANSPLANT P, V35, P1304, DOI 10.1016/S0041-1345(03)00516-5; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Figueiras MJ, 2009, PSYCHOL HEALTH MED, V14, P311, DOI 10.1080/13548500802613043; First MR, 1998, CLIN TRANSPLANT, V12, P518; Fisher RA, 1999, TRANSPLANT P, V31, P394, DOI 10.1016/S0041-1345(98)01676-5; Fradette C, 2005, THER DRUG MONIT, V27, P592, DOI 10.1097/01.ftd.0000174005.51383.2f; Gaston R, 1999, TRANSPLANT P, V31, P326, DOI 10.1016/S0041-1345(98)01647-9; Godman B, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00106; Hakonsen H, 2009, CURR MED RES OPIN, V25, P2515, DOI 10.1185/03007990903192223; Harrison JJ, 2012, TRANSPLANTATION, V93, P657, DOI 10.1097/TP.0b013e3182445e9d; Health Canada, 2012, GUID DOC COMP BIOAV; Heavner MS, 2013, AM J HEALTH-SYST PH, V70, P1507, DOI 10.2146/ajhp120783; Henney JF, 2000, JAMA-J AM MED ASSOC, V284, P1234, DOI 10.1001/jama.284.10.1234-b; Hibberd AD, 2006, TRANSPLANTATION, V81, P711, DOI 10.1097/01.tp.0000181198.98232.0c; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kahn D, 2010, SAUDI J KIDNEY DIS T, V21, P426; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Khatami SMR, 2015, EXP CLIN TRANSPLANT, V13, P233, DOI 10.6002/ect.2013.0139; Kim SC, 1998, TRANSPLANT P, V30, P3547, DOI 10.1016/S0041-1345(98)01129-4; Klintmalm GB, 2011, AM J TRANSPLANT, V11, P1765, DOI 10.1111/j.1600-6143.2011.03616.x; Knoll GA, 2010, AM J KIDNEY DIS, V56, P219, DOI 10.1053/j.ajkd.2010.05.004; Kraeuter M, 2013, DRUG DES DEV THER, V7, P1421, DOI 10.2147/DDDT.S54245; Leet A, 2009, J HEART LUNG TRANSPL, V28, P894, DOI 10.1016/j.healun.2009.05.015; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Marfo Kwaku, 2013, P T, V38, P484; Masri MA, 2005, TRANSPL P, V37, P2988, DOI 10.1016/j.transproceed.2005.07.055; Masri MA, 2004, TRANSPL P, V36, P80, DOI 10.1016/j.transproceed.2003.11.007; Masri MA, 1996, TRANSPL P, V28, P1318; McDevitt-Potter LM, 2011, TRANSPLANTATION, V92, P653, DOI 10.1097/TP.0b013e31822a79ad; Medicines and Health Products Regulatory Agency, 2012, DRUG SAFETY UPDATE; Meredith P, 2003, CLIN THER, V25, P2875, DOI 10.1016/S0149-2918(03)80340-5; Meyer, 2001, J CLIN PSYCHIAT, V62, P23; Meyer MC, 2001, J CLIN PSYCHIAT, V62, P4; Min SI, 2013, NEPHROL DIAL TRANSPL, V28, P3110, DOI 10.1093/ndt/gft300; Momper JD, 2011, AM J TRANSPLANT, V11, P1861, DOI 10.1111/j.1600-6143.2011.03615.x; Namgoong JM, 2013, TRANSPL P, V45, P3035, DOI 10.1016/j.transproceed.2013.08.026; NATION RL, 1994, PHARMACOL THERAPEUT, V62, P41, DOI 10.1016/0163-7258(94)90004-3; Pamugas GEP, 2012, TRANSPL P, V44, P101, DOI 10.1016/j.transproceed.2011.12.002; Perlik Frantisek, 2005, Biomedical Papers (Olomouc), V149, P309; Qazi YA, 2006, CLIN TRANSPLANT, V20, P313, DOI 10.1111/j.1399-0012.2005.00483.x; Robertsen I, 2015, TRANSPLANTATION, V99, P528, DOI 10.1097/TP.0000000000000384; Rosenborg S, 2014, CLIN KIDNEY J, V7, P151, DOI 10.1093/ckj/sfu015; Roza A, 2002, TRANSPLANTATION, V74, P1013, DOI 10.1097/00007890-200210150-00020; Rutkowski B, 2011, ANN TRANSPL, V16, P74; Sabatini S, 1999, AM J KIDNEY DIS, V33, P389, DOI 10.1016/S0272-6386(99)70318-5; Sayyah M, 2007, TRANSPL P, V39, P1214, DOI 10.1016/j.transproceed.2007.02.012; Sharma A, 2006, TRANSPLANT P, V38, P2051, DOI 10.1016/j.transproceed.2006.07.004; Spasovski G, 2008, TRANSPL INT, V21, P392, DOI 10.1111/j.1432-2277.2007.00612.x; Spence MM, 2012, PHARMACOTHERAPY, V32, P981, DOI 10.1002/phar.1130; Stephan A, 1998, TRANSPLANT P, V30, P3533, DOI 10.1016/S0041-1345(98)01125-7; Sunder-Plassmann G, 2012, TRANSPL INT, V25, P680, DOI 10.1111/j.1432-2277.2012.01475.x; Taber DJ, 2005, TRANSPLANTATION, V80, P1633, DOI 10.1097/01.tp.0000188688.15639.03; Talaulikar GS, 2004, NEPHROLOGY, V9, P418, DOI 10.1111/j.1440-1797.2004.00335.x; Toman Jiri, 2002, Biomedical Papers (Olomouc), V146, P87; Trofe-Clark J, 2012, AM J TRANSPLANT, V12, P792, DOI 10.1111/j.1600-6143.2011.03875.x; Tsang WK, 2003, HONG KONG J NEPHROL, V5, P40; Uber PA, 2009, J HEART LUNG TRANSPL, V28, P655, DOI 10.1016/j.healun.2009.05.001; US Food and Drug Administration, 2009, FDA PROC APPR GEN DR; van Gelder T, 2011, TRANSPL INT, V24, P1135, DOI 10.1111/j.1432-2277.2011.01378.x; Videla C, 2007, TRANSPL P, V39, P602, DOI 10.1016/j.transproceed.2006.12.034; Vitko S, 2010, KIDNEY INT, V77, pS12, DOI 10.1038/ki.2009.506; Wells GA, 2013, RES SYNTH METHODS, V4, P63, DOI 10.1002/jrsm.1077; Yu YD, 2012, HEPATO-GASTROENTEROL, V59, P357, DOI 10.5754/hge11472	83	53	55	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2015	350								h3163	10.1136/bmj.h3163	http://dx.doi.org/10.1136/bmj.h3163			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NK	26101226	Green Published, hybrid			2022-12-28	WOS:000357158600004
J	May, M; Brody, H				May, Mike; Brody, Herb			Untitled	NATURE			English	Editorial Material																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S1	S1		10.1038/522S1a	http://dx.doi.org/10.1038/522S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26083849	Bronze			2022-12-28	WOS:000356425400001
J	Foglia, EE; Nolen, TL; DeMauro, SB; Das, A; Bell, EF; Stoll, BJ; Schmidt, B				Foglia, Elizabeth E.; Nolen, Tracy L.; DeMauro, Sara B.; Das, Abhik; Bell, Edward F.; Stoll, Barbara J.; Schmidt, Barbara		Eunice Kennedy Shriver Natl Inst	Short-term Outcomes of Infants Enrolled in Randomized Clinical Trials vs Those Eligible but Not Enrolled	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Foglia, Elizabeth E.; DeMauro, Sara B.; Schmidt, Barbara] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Nolen, Tracy L.] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Das, Abhik] RTI Int, Social Stat & Environm Sci Unit, Rockville, MD USA; [Bell, Edward F.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Stoll, Barbara J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	University of Pennsylvania; Research Triangle Institute; Research Triangle Institute; University of Iowa; Emory University	Foglia, EE (corresponding author), Hosp Univ Penn, Div Neonatol, 3400 Spruce St, Philadelphia, PA 19104 USA.	foglia@email.chop.edu	Das, Abhik/AAF-1883-2020; DeMauro, Sara/ABD-6568-2021	Das, Abhik/0000-0003-2722-0479; DeMauro, Sara/0000-0003-1647-4000; Nolen, Tracy/0000-0003-2512-343X; Bell, Edward/0000-0002-5568-0889	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD053124, U10HD027871, UG1HD087229, U10HD053109, U10HD068270, U10HD040689, U10HD027904, U10HD053119, U10HD021373, U10HD068278, UG1HD021364, UG1HD053109, UG1HD053089, U10HD068263, U10HD027880, U10HD027856, U10HD027851, U10HD053089, U10HD036790, UG1HD034216, U10HD034216, UG1HD027880, U10HD040461, U10HD068244, UG1HD068270, U10HD068284, U10HD027853, U10HD021385, U10HD021364, U10HD040492] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD040498, U10HD021397, U10HD040521] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000044, M01RR000080, M01RR000054, M01RR000997, M01RR007122, M01RR000633, M01RR000070, M01RR006022, M01RR000064, M01RR000125, M01RR008084, M01RR000750, M01RR016587, M01RR000039, M01RR000032] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001449] Funding Source: Medline; NCRR NIH HHS [M01 RR007122, M01 RR016587, M01 RR000750, M01 RR000032, M01 RR000044, M01 RR008084, M01 RR000080, M01 RR000039, M01 RR000997, M01 RR000125, M01 RR000054, M01 RR006022, M01 RR000633, M01 RR000070, M01 RR000064] Funding Source: Medline; NICHD NIH HHS [U10 HD040521, U10 HD068284, UG1 HD053109, U10 HD068278, UG1 HD087229, U10 HD021385, UG1 HD027880, U10 HD068270, U10 HD053089, U10 HD068263, U10 HD053124, U10 HD027871, U10 HD053119, UG1 HD068278, UG1 HD027851, U10 HD027856, U10 HD021373, U10 HD040689, UG1 HD034216, U10 HD027880, U10 HD040498, U10 HD036790, U10 HD034216, UG1 HD068270, U10 HD040492, U10 HD053109, U10 HD021364, U10 HD068244, U10 HD021397, U10 HD027851, UG1 HD040492, UG1 HD021364, U10 HD027853, U10 HD040461, U10 HD027904, UG1 HD053089] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Fernandes N, 2014, CAN MED ASSOC J, V186, pE596, DOI 10.1503/cmaj.131693; Rich W, 2012, PEDIATRICS, V129, P480, DOI 10.1542/peds.2011-2121; Rueegger CM, 2014, NEONATOLOGY, V106, P114, DOI 10.1159/000362784; Schmidt B, 1999, J PEDIATR-US, V134, P151, DOI 10.1016/S0022-3476(99)70428-2; Shankaran S, 2014, JAMA-J AM MED ASSOC, V312, P2629, DOI 10.1001/jama.2014.16058; Vist GE, 2008, COCHRANE DB SYST REV, V16, DOI DOI 10.1002/14651858.MR000009.PUB4	6	9	10	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2377	2379		10.1001/jama.2015.5734	http://dx.doi.org/10.1001/jama.2015.5734			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080344	Green Accepted, Bronze			2022-12-28	WOS:000356300200025
J	Schattner, A				Schattner, Ami			Review: In rheumatoid arthritis, adding rituximab to methotrexate improves clinical outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Schattner, A (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel.		Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Finckh A, 2007, ARTHRITIS RHEUM, V56, P1417, DOI 10.1002/art.22520; Listing J, 2015, ANN RHEUM DIS, V74, P415, DOI 10.1136/annrheumdis-2013-204021	2	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC9	10.7326/ACPJC-2015-162-12-009	http://dx.doi.org/10.7326/ACPJC-2015-162-12-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075786				2022-12-28	WOS:000356516300010
J	Stoopler, ET; Sollecito, TP				Stoopler, Eric T.; Sollecito, Thomas P.			Recurrent Oral Ulcers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							APHTHOUS STOMATITIS		[Stoopler, Eric T.; Sollecito, Thomas P.] Univ Penn, Dept Oral Med, Sch Dent Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Stoopler, ET (corresponding author), Univ Penn, Dept Oral Med, Sch Dent Med, 240 S 40th St, Philadelphia, PA 19104 USA.	ets@dental.upenn.edu						Akintoye Sunday O, 2014, Dent Clin North Am, V58, P281, DOI 10.1016/j.cden.2013.12.002; Albanidou-Farmaki E, 2008, INT J IMMUNOGENET, V35, P427, DOI 10.1111/j.1744-313X.2008.00801.x; Altenburg A, 2008, Skin Therapy Lett, V13, P1; Chattopadhyay A, 2007, COMMUNITY DENT ORAL, V35, P152, DOI 10.1111/j.1600-0528.2007.00329.x; Compilato D, 2010, J EUR ACAD DERMATOL, V24, P667, DOI 10.1111/j.1468-3083.2009.03482.x; Huling LB, 2012, J ORAL PATHOL MED, V41, P149, DOI 10.1111/j.1600-0714.2011.01102.x; Lopez-Jornet P, 2014, INT J DERMATOL, V53, P159, DOI 10.1111/j.1365-4632.2012.05751.x; Mimura MAM, 2009, CLINICS, V64, P193, DOI 10.1590/S1807-59322009000300008; MEILLER TF, 1991, ORAL SURG ORAL MED O, V72, P425, DOI 10.1016/0030-4220(91)90553-O; Scully C, 2006, NEW ENGL J MED, V355, P165, DOI 10.1056/NEJMcp054630	10	5	6	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2373	2374		10.1001/jama.2015.1637	http://dx.doi.org/10.1001/jama.2015.1637			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080343				2022-12-28	WOS:000356300200024
J	Glund, S; Stangier, J; Schmohl, M; Gansser, D; Norris, S; van Ryn, J; Lang, B; Ramael, S; Moschetti, V; Gruenenfelder, F; Reilly, P; Kreuzer, J				Glund, Stephan; Stangier, Joachim; Schmohl, Michael; Gansser, Dietmar; Norris, Stephen; van Ryn, Joanne; Lang, Benjamin; Ramael, Steven; Moschetti, Viktoria; Gruenenfelder, Fredrik; Reilly, Paul; Kreuzer, Joerg			Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial	LANCET			English	Article							DIRECT THROMBIN INHIBITOR; VITAMIN-K; WARFARIN; ANTIDOTE; ASSAYS	Background Idarucizumab is a monoclonal antibody fragment that binds dabigatran with high affinity in a 1: 1 molar ratio. We investigated the safety, tolerability, and efficacy of increasing doses of idarucizumab for the reversal of anticoagulant effects of dabigatran in a two-part phase 1 study (rising-dose assessment and dose-finding, proof-of-concept investigation). Here we present the results of the proof-of-concept part of the study. Methods In this randomised, placebo-controlled, double-blind, proof-of-concept phase 1 study, we enrolled healthy volunteers (aged 18-45 years) with a body-mass index of 18.5-29.9 kg/m(2) into one of four dose groups at SGS Life Sciences Clinical Research Services, Belgium. Participants were randomly assigned within groups in a 3: 1 ratio to idarucizumab or placebo using a pseudorandom number generator and a supplied seed number. Participants and care providers were masked to treatment assignment. All participants received oral dabigatran etexilate 220 mg twice daily for 3 days and a final dose on day 4. Idarucizumab (1 g, 2 g, or 4 g 5-min infusion, or 5 g plus 2.5 g in two 5-min infusions given 1 h apart) was administered about 2 h after the final dabigatran etexilate dose. The primary endpoint was incidence of drug-related adverse events, analysed in all randomly assigned participants who received at least one dose of dabigatran etexilate. Reversal of diluted thrombin time (dTT), ecarin clotting time (ECT), activated partial thromboplastin time (aPTT), and thrombin time (TT) were secondary endpoints assessed by measuring the area under the effect curve from 2 h to 12 h (AUEC 2-12) after dabigatran etexilate ingestion on days 3 and 4. This trial is registered with ClinicalTrials.gov, number NCT01688830. Findings Between Feb 23, and Nov 29, 2013, 47 men completed this part of the study. 12 were enrolled into each of the 1 g, 2 g, or 5 g plus 2.5 g idarucizumab groups (nine to idarucizumab and three to placebo in each group), and 11 were enrolled into the 4 g idarucizumab group (eight to idarucizumab and three to placebo). Drug-related adverse events were all of mild intensity and reported in seven participants: one in the 1 g idarucizumab group (infusion site erythema and hot flushes), one in the 5 g plus 2.5 g idarucizumab group (epistaxis); one receiving placebo (infusion site haematoma), and four during dabigatran etexilate pretreatment (three haematuria and one epistaxis). Idarucizumab immediately and completely reversed dabigatran-induced anticoagulation in a dose-dependent manner; the mean ratio of day 4 AUEC 2-12 to day 3 AUEC 2-12 for dTT was 1.01 with placebo, 0.26 with 1 g idarucizumab (74% reduction), 0.06 with 2 g idarucizumab (94% reduction), 0.02 with 4 g idarucizumab (98% reduction), and 0.01 with 5 g plus 2.5 g idarucizumab (99% reduction). No serious or severe adverse events were reported, no adverse event led to discontinuation of treatment, and no clinically relevant difference in incidence of adverse events was noted between treatment groups. Interpretation These phase 1 results show that idarucizumab was associated with immediate, complete, and sustained reversal of dabigatran-induced anticoagulation in healthy men, and was well tolerated with no unexpected or clinically relevant safety concerns, supporting further testing. Further clinical studies are in progress.	[Glund, Stephan; Stangier, Joachim; Schmohl, Michael; Gansser, Dietmar; van Ryn, Joanne; Lang, Benjamin] Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germany; [Norris, Stephen; Reilly, Paul] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Moschetti, Viktoria; Gruenenfelder, Fredrik; Kreuzer, Joerg] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Ramael, Steven] SGS Life Sci Clin Res Serv, Clin Pharmacol Unit, Antwerp, Belgium	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Glund, S (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany.	stephan.glund@boehringer-ingelheim.com			Boehringer Ingelheim Pharma GmbH Co KG	Boehringer Ingelheim Pharma GmbH Co KG(Boehringer Ingelheim)	The study was funded by Boehringer Ingelheim Pharma GmbH & Co KG. Medical writing assistance, supported financially by Boehringer Ingelheim Pharma GmbH & Co KG, was provided by Lakshmi Venkatraman, of PAREXEL (Hyderabad, India) during the preparation of this Article.	Ansell JE, 2014, NEW ENGL J MED, V371, P2141, DOI 10.1056/NEJMc1411800; ANTMAN EM, 1990, CIRCULATION, V81, P1744, DOI 10.1161/01.CIR.81.6.1744; Blech S, 2008, DRUG METAB DISPOS, V36, P386, DOI 10.1124/dmd.107.019083; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Glund S, 2015, THROMB HAEMOSTASIS, V113, P943, DOI 10.1160/TH14-12-1080; Gosselin R, 2014, AM J CLIN PATHOL, V141, P262, DOI 10.1309/AJCPRNUMI4PVSJ7Q; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Grottke O, 2014, J AM COLL CARDIOL, V63, pA295, DOI 10.1016/S0735-1097(14)60295-3; Hanley JP, 2004, J CLIN PATHOL, V57, P1132, DOI 10.1136/jcp.2003.008904; Heidbuchel H, 2013, EUR HEART J, V34, P2094, DOI 10.1093/eurheartj/eht134; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Majeed A, 2013, CIRCULATION, V128, P2325, DOI 10.1161/CIRCULATIONAHA.113.002332; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; Schulman S, 2014, CIRCULATION, V129, P764, DOI 10.1161/CIRCULATIONAHA.113.004450; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Seeger JD, 2014, CIRCULATION, V130; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; van Ryn J, 2014, ANESTHESIOLOGY, V120, P1429, DOI 10.1097/ALN.0000000000000255; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Vang ML, 2011, ACTA ANAESTH SCAND, V55, P507, DOI 10.1111/j.1399-6576.2011.02414.x; Villines TC, 2014, CIRCULATION, V130; Watson HG, 2001, BRIT J HAEMATOL, V115, P145, DOI 10.1046/j.1365-2141.2001.03070.x; Wolzt M, 2011, THROMB HAEMOSTASIS, V105, P1080, DOI 10.1160/TH10-11-0705	27	247	262	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					680	690		10.1016/S0140-6736(15)60732-2	http://dx.doi.org/10.1016/S0140-6736(15)60732-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26088268				2022-12-28	WOS:000359849200035
J	Simon-Loriere, E; Faye, O; Faye, O; Koivogui, L; Magassouba, N; Keita, S; Thiberge, JM; Diancourt, L; Bouchier, C; Vandenbogaert, M; Caro, V; Fall, G; Buchmann, JP; Matranga, CB; Sabeti, PC; Manuguerra, JC; Holmes, EC; Sall, AA				Simon-Loriere, Etienne; Faye, Ousmane; Faye, Oumar; Koivogui, Lamine; Magassouba, Nfaly; Keita, Sakoba; Thiberge, Jean-Michel; Diancourt, Laure; Bouchier, Christiane; Vandenbogaert, Matthias; Caro, Valerie; Fall, Gamou; Buchmann, Jan P.; Matranga, Christan B.; Sabeti, Pardis C.; Manuguerra, Jean-Claude; Holmes, Edward C.; Sall, Amadou A.			Distinct lineages of Ebola virus in Guinea during the 2014 West African epidemic	NATURE			English	Article							TRANSMISSION; PLATFORM; ORIGIN; GALAXY	An epidemic of Ebola virus disease of unprecedented scale has been ongoing for more than a year in West Africa. As of 29 April 2015, there have been 26,277 reported total cases (of which 14,895 have been laboratory confirmed) resulting in 10,899 deaths(1). The source of the outbreak was traced to the prefecture of Gueckedou in the forested region of southeastern Guinea(2,3). The virus later spread to the capital, Conakry, and to the neighbouring countries of Sierra Leone, Liberia, Nigeria, Senegal and Mali(1). In March 2014, when the first cases were detected in Conakry, the Institut Pasteur of Dakar, Senegal, deployed a mobile laboratory in Donka hospital to provide diagnostic services to the greater Conakry urban area and other regions of Guinea. Through this process we sampled 85 Ebola viruses (EBOV) from patients infected from July to November 2014, and report their full genome sequences here. Phylogenetic analysis reveals the sustained transmission of three distinct viral lineages co-circulating in Guinea, including the urban setting of Conakry and its surroundings. One lineage is unique to Guinea and closely related to the earliest sampled viruses of the epidemic. A second lineage contains viruses probably reintroduced from neighbouring Sierra Leone on multiple occasions, while a third lineage later spread from Guinea to Mali. Each lineage is defined by multiple mutations, including non-synonymous changes in the virion protein 35 (VP35), glycoprotein (GP) and RNA-dependent-RNA polymerase (L) proteins. The viral GP is characterized by a glycosylation site modification and mutations in the mucin-like domain that could modify the outer shape of the virion. These data illustrate the ongoing ability of EBOV to develop lineage-specific and potentially phenotypically important variation.	[Simon-Loriere, Etienne] Inst Pasteur, Funct Genet Infect Dis Unit, F-75724 Paris 15, France; [Simon-Loriere, Etienne] CNRS, URA3012, F-75015 Paris, France; [Faye, Ousmane; Faye, Oumar; Fall, Gamou; Sall, Amadou A.] Inst Pasteur, Arbovirus & Viral Hemorrhag Fever Unit, Dakar, Senegal; [Koivogui, Lamine] Inst Natl Sante Publ Guinee, Conakry, Guinea; [Magassouba, Nfaly] Univ Gamal Abdel Nasser, Projet Fievres Hemorrag Guinee, Conakry, Guinea; [Keita, Sakoba] Minist Hlth, Conakry, Guinea; [Thiberge, Jean-Michel; Diancourt, Laure; Vandenbogaert, Matthias; Caro, Valerie; Manuguerra, Jean-Claude] Inst Pasteur, Unite Environm & Risques Infect, Cellule Intervent Biol Urgence, F-75724 Paris 15, France; [Bouchier, Christiane] Inst Pasteur, Genom Platform, F-75724 Paris 15, France; [Buchmann, Jan P.; Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Charles Perkins Ctr, Sch Biol Sci, Sydney, NSW 2006, Australia; [Buchmann, Jan P.; Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Matranga, Christan B.; Sabeti, Pardis C.] Broad Inst, Cambridge, MA 02142 USA; [Sabeti, Pardis C.] Harvard Univ, FAS Ctr Syst Biol, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Sydney; University of Sydney; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Simon-Loriere, E (corresponding author), Inst Pasteur, Funct Genet Infect Dis Unit, F-75724 Paris 15, France.	etienne.simon-loriere@pasteur.fr; edward.holmes@sydney.edu.au; asall@pasteur.sn	Faye, Oumar/T-7168-2019; Holmes, Edward/Y-2789-2019; Buchmann, Jan Piotr/S-1727-2019; Holmes, Edward/GVR-9499-2022; Sabeti, Pardis/GQH-8610-2022; faye, Ousmane/GMW-6500-2022	Faye, Oumar/0000-0002-3478-1322; Holmes, Edward/0000-0001-9596-3552; Buchmann, Jan Piotr/0000-0002-6842-1229; , Etienne/0000-0001-8420-7743; Matranga, Christian/0000-0002-9037-5468; Vandenbogaert, Mathias/0000-0002-3073-9688	Pasteur Ebola Task Force (PETF); French government's Investissement d'Avenir programme; Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]; Institut Pasteur de Dakar; NHMRC Australia fellowship	Pasteur Ebola Task Force (PETF); French government's Investissement d'Avenir programme(French National Research Agency (ANR)); Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases'; Institut Pasteur de Dakar; NHMRC Australia fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Pasteur Ebola Task Force (PETF) and has also received funding from the French government's Investissement d'Avenir programme, Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (grant number ANR-10-LABX-62-IBEID) and Institut Pasteur de Dakar. We are grateful to all members of the PETF for their support, and in particular F. Rey and K. Victoir. High-throughput sequencing was performed on the Genomics Platform of Institut Pasteur, member of 'France Genomique' consortium (ANR10-INBS-09-08). We thank L. Ma for technical assistance and Institut Pasteur Clinical Research Department for their help with ethical approval procedures. E.C.H. is supported by an NHMRC Australia fellowship.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Blankenberg D., 2010, CURR PROTOCOLS MOL B; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Devaux CA, 2015, INFECT GENET EVOL, V29, P26, DOI 10.1016/j.meegid.2014.10.028; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duchene S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0732; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faye O, 2015, LANCET INFECT DIS, V15, P320, DOI 10.1016/S1473-3099(14)71075-8; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7; Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792; Sayburn A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5161; Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202	21	72	75	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					102	U210		10.1038/nature14612	http://dx.doi.org/10.1038/nature14612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26106863	hybrid			2022-12-28	WOS:000359002300040
J	Rosenfield, K; Jaff, MR; White, CJ; Rocha-Singh, K; Mena-Hurtado, C; Metzger, DC; Brodmann, M; Pilger, E; Zeller, T; Krishnan, P; Gammon, R; Muller-Hulsbeck, S; Nehler, MR; Benenati, JF; Scheinert, D				Rosenfield, Kenneth; Jaff, Michael R.; White, Christopher J.; Rocha-Singh, Krishna; Mena-Hurtado, Carlos; Metzger, D. Christopher; Brodmann, Marianne; Pilger, Ernst; Zeller, Thomas; Krishnan, Prakash; Gammon, Roger; Mueller-Huelsbeck, Stefan; Nehler, Mark R.; Benenati, James F.; Scheinert, Dierk		Levant 2 Investigators	Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUPERFICIAL FEMORAL-ARTERY; NITINOL STENT IMPLANTATION; RESILIENT RANDOMIZED-TRIAL; POPLITEAL ARTERIES; ELUTING STENTS; FOLLOW-UP; LESIONS; ANGIOPLASTY; RESTENOSIS; FRACTURES	BACKGROUND The treatment of peripheral artery disease with percutaneous transluminal angioplasty is limited by the occurrence of vessel recoil and restenosis. Drug-coated angioplasty balloons deliver antiproliferative agents directly to the artery, potentially improving vessel patency by reducing restenosis. METHODS In this single-blind, randomized trial conducted at 54 sites, we assigned, in a 2: 1 ratio, 476 patients with symptomatic intermittent claudication or ischemic pain while at rest and angiographically significant atherosclerotic lesions to angioplasty with a paclitaxel-coated balloon or to standard angioplasty. The primary efficacy end point was primary patency of the target lesion at 12 months (defined as freedom from binary restenosis or from the need for target-lesion revascularization). The primary safety end point was a composite of freedom from perioperative death from any cause and freedom at 12 months from limb-related death (i.e., death from a medical complication related to a limb), amputation, and reintervention. RESULTS The two groups were well matched at baseline; 42.9% of the patients had diabetes, and 34.7% were current smokers. At 12 months, the rate of primary patency among patients who had undergone angioplasty with the drug-coated balloon was superior to that among patients who had undergone conventional angioplasty (65.2% vs. 52.6%, P=0.02). The proportion of patients free from primary safety events was 83.9% with the drug-coated balloon and 79.0% with standard angioplasty (P=0.005 for noninferiority). There were no significant between-group differences in functional outcomes or in the rates of death, amputation, thrombosis, or reintervention. CONCLUSIONS Among patients with symptomatic femoropopliteal peripheral artery disease, percutaneous transluminal angioplasty with a paclitaxel-coated balloon resulted in a rate of primary patency at 12 months that was higher than the rate with angioplasty with a standard balloon. The drug-coated balloon was noninferior to the standard balloon with respect to safety.	[Rosenfield, Kenneth; Jaff, Michael R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [White, Christopher J.] Ochsner Med Ctr, New Orleans, LA USA; [Rocha-Singh, Krishna] St Johns Hosp, Prairie Heart Inst, Springfield, IL USA; [Mena-Hurtado, Carlos] Yale Univ, Sch Med, New Haven, CT USA; [Metzger, D. Christopher] Wellmont Cardiovasc Associates Heart Inst, Kingsport, TN USA; [Brodmann, Marianne; Pilger, Ernst] Med Univ Graz, Graz, Austria; [Zeller, Thomas] Univ Heart Ctr Freiburg Bad Krozingen, Bad Krozingen, Germany; [Mueller-Huelsbeck, Stefan] Diakonissenanstalt Flensburg, Flensburg, Germany; [Scheinert, Dierk] Park Krankenhaus Leipzig, Leipzig, Germany; [Scheinert, Dierk] Univ Klinikum Leipzig, Leipzig, Germany; [Krishnan, Prakash] Mt Sinai Med Ctr, New York, NY 10029 USA; [Gammon, Roger] Austin Heart, Austin, TX USA; [Nehler, Mark R.] Univ Colorado, Med Ctr, Denver, CO 80202 USA; [Benenati, James F.] Baptist Cardiac & Vasc Inst, Miami, FL USA	Harvard University; Massachusetts General Hospital; Ochsner Health System; Yale University; Medical University of Graz; Universitats Herzzentrum Freiburg; Leipzig University; Icahn School of Medicine at Mount Sinai; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Baptist Cardiac & Vascular Institute	Rosenfield, K (corresponding author), Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	krosenfield1@partners.org	White, Christopher J/J-6686-2012; Ketelsen, Dominik/A-1143-2012	White, Christopher J/0000-0001-8618-7539; Ketelsen, Dominik/0000-0002-7333-8024; krishnan, prakash/0000-0003-2871-3689; Kashyap, Vikram/0000-0003-1780-979X	Lutonix-Bard	Lutonix-Bard	Funded by Lutonix-Bard; LEVANT 2 ClinicalTrials.gov number, NCT01412541.	Bosiers M, 2009, J ENDOVASC THER, V16, P261, DOI 10.1583/08-2676.1; Dake MD, 2013, J AM COLL CARDIOL, V61, P2417, DOI 10.1016/j.jacc.2013.03.034; Dake MD, 2011, J ENDOVASC THER, V18, P613, DOI 10.1583/11-3560.1; Duda SH, 2005, J VASC INTERV RADIOL, V16, P331, DOI 10.1097/01.RVI.0000151260.74519.CA; Duda SH, 2002, CIRCULATION, V106, P1505, DOI 10.1161/01.CIR.0000029746.10018.36; Duda SH, 2006, J ENDOVASC THER, V13, P701, DOI 10.1583/05-1704.1; Iida O, 2009, JACC-CARDIOVASC INTE, V2, P665, DOI 10.1016/j.jcin.2009.04.014; Krankenberg H, 2007, CIRCULATION, V116, P285, DOI 10.1161/CIRCULATIONAHA.107.689141; Laird JR, 2012, J ENDOVASC THER, V19, P1, DOI 10.1583/11-3627.1; Laird JR, 2010, CIRC-CARDIOVASC INTE, V3, P267, DOI 10.1161/CIRCINTERVENTIONS.109.903468; Matsumura JS, 2013, J VASC SURG, V58, P73, DOI 10.1016/j.jvs.2012.12.066; Milewski K, 2011, EUROINTERVENTION, V7, P362, DOI 10.4244/EIJV7I3A61; Radke PW, 2011, EUROINTERVENTION, V7, P730, DOI 10.4244/EIJV7I6A116; Rocha-Singh KJ, 2007, CATHETER CARDIO INTE, V69, P910, DOI 10.1002/ccd.21104; Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026; Scheinert D, 2014, JACC-CARDIOVASC INTE, V7, P11, DOI 10.1016/j.jcin.2013.05.022; Scheinert D, 2011, J ENDOVASC THER, V18, P745, DOI 10.1583/11-3500.1; Schillinger M, 2007, CIRCULATION, V115, P2745, DOI 10.1161/CIRCULATIONAHA.107.688341; Schlager O, 2005, J ENDOVASC THER, V12, P676, DOI 10.1583/05-1672.1; Soga Y, 2010, J VASC SURG, V52, P608, DOI 10.1016/j.jvs.2010.03.050; Tepe G, 2008, NEW ENGL J MED, V358, P689, DOI 10.1056/NEJMoa0706356; Werk M, 2008, CIRCULATION, V118, P1358, DOI 10.1161/CIRCULATIONAHA.107.735985; Werk M, 2012, CIRC-CARDIOVASC INTE, V5, P831, DOI 10.1161/CIRCINTERVENTIONS.112.971630; Yazdani SK, 2014, CATHETER CARDIO INTE, V83, P132, DOI 10.1002/ccd.24995	24	425	453	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					145	153		10.1056/NEJMoa1406235	http://dx.doi.org/10.1056/NEJMoa1406235			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26106946				2022-12-28	WOS:000357598600007
J	Fernandes, VM; Desplan, C				Fernandes, Vilaiwan M.; Desplan, Claude			NEUROBIOLOGY Inversion in the worm	NATURE			English	Editorial Material							MOTONEURON	Combinations of spatially and temporally restricted transcription factors are shown to coordinate movement in nematode worms by controlling the formation of synaptic connections to and from motor neurons. SEE LETTER p.83	[Fernandes, Vilaiwan M.; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA	New York University	Fernandes, VM (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.	cd38@nyu.edu	Fernandes, Vil/ABE-3183-2021	Fernandes, Vil/0000-0002-1991-7252; Desplan, Claude/0000-0002-6914-1413	NEI NIH HHS [R01 EY013012] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013012] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aurelio O, 2002, SCIENCE, V295, P686, DOI 10.1126/science.1066642; Cinar H, 2005, CURR BIOL, V15, P340, DOI 10.1016/j.cub.2005.02.025; Eastman C, 1999, J NEUROSCI, V19, P6225; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; Howell K, 2015, NATURE, V523, P83, DOI 10.1038/nature14545; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; WALTHALL WW, 1995, J NEUROSCI, V15, P1035; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0	10	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					44	45		10.1038/523044a	http://dx.doi.org/10.1038/523044a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135446	Green Accepted			2022-12-28	WOS:000357169500027
J	Holleley, CE; O'Meally, D; Sarre, SD; Graves, JAM; Ezaz, T; Matsubara, K; Azad, B; Zhang, XW; Georges, A				Holleley, Clare E.; O'Meally, Denis; Sarre, Stephen D.; Graves, Jennifer A. Marshall; Ezaz, Tariq; Matsubara, Kazumi; Azad, Bhumika; Zhang, Xiuwen; Georges, Arthur			Sex reversal triggers the rapid transition from genetic to temperature-dependent sex	NATURE			English	Article							ADAPTIVE SIGNIFICANCE; DETERMINING SYSTEMS; POGONA-VITTICEPS; CLIMATE-CHANGE; DRAGON LIZARD; CHROMOSOME; PARTHENOGENESIS; DIFFERENTIATION; COOCCURRENCE; SEQUENCES	Sex determination in animals is amazingly plastic. Vertebrates display contrasting strategies ranging from complete genetic control of sex (genotypic sex determination) to environmentally determined sex (for example, temperature-dependent sex determination)(1). Phylogenetic analyses suggest frequent evolutionary transitions between genotypic and temperature-dependent sex determination in environmentally sensitive lineages, including reptiles(2). These transitions are thought to involve a genotypic system becoming sensitive to temperature, with sex determined by gene-environment interactions(3). Most mechanistic models of transitions invoke a role for sex reversal(3-5). Sex reversal has not yet been demonstrated in nature for any amniote, although it occurs in fish(6) and rarely in amphibians(7,8). Here we make the first report of reptile sex reversal in the wild, in the Australian bearded dragon (Pogona vitticeps), and use sex-reversed animals to experimentally induce a rapid transition from genotypic to temperature-dependent sex determination. Controlled mating of normal males to sex-reversed females produces viable and fertile offspring whose phenotypic sex is determined solely by temperature (temperature-dependent sex determination). The W sex chromosome is eliminated from this lineage in the first generation. The instantaneous creation of a lineage of ZZ temperature-sensitive animals reveals a novel, climate-induced pathway for the rapid transition between genetic and temperature-dependent sex determination, and adds to concern about adaptation to rapid global climate change.	[Holleley, Clare E.; O'Meally, Denis; Sarre, Stephen D.; Graves, Jennifer A. Marshall; Ezaz, Tariq; Matsubara, Kazumi; Azad, Bhumika; Zhang, Xiuwen; Georges, Arthur] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Graves, Jennifer A. Marshall] La Trobe Univ, Sch Life Sci, Melbourne, Vic 3086, Australia	University of Canberra; La Trobe University	Holleley, CE (corresponding author), Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia.	clare@holleley.net; georges@aerg.canberra.edu.au	O'Meally, Denis/A-3746-2012; Georges, Arthur/D-2153-2009; Holleley, Clare E/C-4629-2011; Ezaz, Tariq/D-9875-2011	O'Meally, Denis/0000-0001-7749-9506; Georges, Arthur/0000-0003-2428-0361; Holleley, Clare E/0000-0002-5257-0019; Sarre, Stephen D./0000-0002-7158-2517; Ezaz, Tariq/0000-0003-4763-1347; Graves, Jennifer/0000-0001-6480-7856	Australian Research Council Discovery Grant [DP110104377]	Australian Research Council Discovery Grant(Australian Research Council)	We thank the following persons and institutions: W. Ruscoe and J. Richardson (animal husbandry); A. Quinn, M. Young and J. Richardson (field collections); A. Kilian and Diversity Arrays Technology (SNP genotyping); A. Livernois (sequencing assistance); B. Gruber and N. Garlapati (geographic information system); A. T. Adamack (modelling advice); A. Dobos and P. E. Geertz (graphic design); J. Deakin, R. Thompson and the Kioloa Science Writers Workshop (revisions of the manuscript). We particularly thank reviewer J. J. Bull for suggesting the modelling approach in Extended Data Fig. 4. Funding was from Australian Research Council Discovery Grant DP110104377 to A.G. and T.E. This research was conducted under appropriate approvals from the Victorian, New South Wales and Queensland authorities, and with approvals from the Animal Ethics Committee of the University of Canberra.	Alho JS, 2010, MOL ECOL, V19, P1763, DOI 10.1111/j.1365-294X.2010.04607.x; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Booth W, 2012, BIOL LETTERS, V8, P983, DOI 10.1098/rsbl.2012.0666; Booth W, 2011, BIOL LETTERS, V7, P253, DOI 10.1098/rsbl.2010.0793; Boyle M, 2014, ECOL EVOL, V4, P4522, DOI 10.1002/ece3.1316; Brown Danny, 2009, Biawak, V3, P26; Bull J.J., 1983, EVOLUTION SEX DETERM; BULL JJ, 1981, HEREDITY, V47, P173, DOI 10.1038/hdy.1981.74; CHAN STH, 1983, FISH PHYSIOL, V9, P171; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; Cioffi MB, 2010, SEX DEV, V4, P176, DOI 10.1159/000309726; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Ezaz T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-899; Ezaz T, 2008, CYTOTECHNOLOGY, V58, P135, DOI 10.1007/s10616-009-9182-3; Harlow Peter S., 1996, Herpetological Review, V27, P71; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Matsubara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095226; McGaugh SE, 2011, J EVOLUTION BIOL, V24, P784, DOI 10.1111/j.1420-9101.2010.02211.x; MIURA I, 1994, ZOOL SCI, V11, P797; Mork L, 2014, DEV BIOL, V386, P264, DOI 10.1016/j.ydbio.2013.11.026; MROSOVSKY N, 1991, Amphibia-Reptilia, V12, P169, DOI 10.1163/156853891X00149; Quinn AE, 2010, HEREDITY, V104, P410, DOI 10.1038/hdy.2009.133; Quinn AE, 2007, SCIENCE, V316, P411, DOI 10.1126/science.1135925; Quinn AE, 2011, BIOL LETTERS, V7, P443, DOI 10.1098/rsbl.2010.1126; Radder RS, 2008, BIOL LETTERS, V4, P176, DOI 10.1098/rsbl.2007.0583; Raman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101673; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Sarre SD, 2011, ANNU REV GENOM HUM G, V12, P391, DOI 10.1146/annurev-genom-082410-101518; Saunders PA, 2014, EVOLUTION, V68, P2119, DOI 10.1111/evo.12387; Schwanz LE, 2013, J EVOLUTION BIOL, V26, P2544, DOI 10.1111/jeb.12258; Shine R, 2002, ECOL LETT, V5, P486, DOI 10.1046/j.1461-0248.2002.00351.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Wang C, 2015, ZOOL SCI, V32, P151, DOI 10.2108/zs140246; Warner DA, 2008, NATURE, V451, P566, DOI 10.1038/nature06519; Warner DA, 2005, EVOLUTION, V59, P2209; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a; Young MJ, 2013, CHROMOSOME RES, V21, P361, DOI 10.1007/s10577-013-9362-z	41	211	219	8	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					79	+		10.1038/nature14574	http://dx.doi.org/10.1038/nature14574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135451				2022-12-28	WOS:000357169500035
J	Howell, K; White, JG; Hobert, O				Howell, Kelly; White, John G.; Hobert, Oliver			Spatiotemporal control of a novel synaptic organizer molecule	NATURE			English	Article							HETEROCHRONIC GENE LIN-14; MOTOR-NEURONS; RECEPTOR; PROTEIN; GABA; IDENTIFICATION; TRANSMISSION; MOTONEURON; ENCODES; PATTERN	Synapse formation is a process tightly controlled in space and time. How gene regulatory mechanisms specify spatial and temporal aspects of synapse formation is not well understood. In the nematode Caenorhabditis elegans, two subtypes of the D-type inhibitory motor neuron (MN) classes, the dorsal D (DD) and ventral D (VD) neurons, extend axons along both the dorsal and ventral nerve cords(1). The embryonically generated DD motor neurons initially innervate ventral muscles in the first (L1) larval stage and receive their synaptic input from cholinergic motor neurons in the dorsal cord. They rewire by the end of the L1 moult to innervate dorsal muscles and to be innervated by newly formed ventral cholinergic motor neurons(1). VD motor neurons develop after the L1 moult; they take over the innervation of ventral muscles and receive their synaptic input from dorsal cholinergic motor neurons. We show here that the spatiotemporal control of synaptic wiring of the D-type neurons is controlled by an intersectional transcriptional strategy in which the UNC-30 Pitx-type homeodomain transcription factor acts together, in embryonic and early larval stages, with the temporally controlled LIN-14 transcription factor to prevent premature synapse rewiring of the DD motor neurons and, together with the UNC-55 nuclear hormone receptor, to prevent aberrant VD synaptic wiring in later larval and adult stages. A key effector of this intersectional transcription factor combination is a novel synaptic organizer molecule, the single immunoglobulin domain protein OIG-1. OIG-1 is perisynaptically localized along the synaptic outputs of the D-type motor neurons in a temporally controlled manner and is required for appropriate selection of both pre-and post-synaptic partners.	[Howell, Kelly; Hobert, Oliver] Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, Med Ctr, New York, NY 10032 USA; [White, John G.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Columbia University; Howard Hughes Medical Institute; MRC Laboratory Molecular Biology	Howell, K (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, Med Ctr, 630 W 168th St, New York, NY 10032 USA.	kh2512@columbia.edu; or38@columbia.edu			National Institutes of Health [R01NS039996-05, R01NS050266-03]; Howard Hughes Medical Institute; UK Medical Research Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039996, R01NS050266] Funding Source: NIH RePORTER; Medical Research Council [MC_U105178783] Funding Source: researchfish; MRC [MC_U105178783] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the TransgeneOme project, the CGC, J. L. Bessereau, M. Gendrel, S. Y. Kerk for reagents, Q. Chen for microinjection, E. Southgate and N. Thomson for electron microscopy analyses, S. Brenner for first noting the neural defects of unc-30(e191), E. Yemini for assistance with worm tracking, and D. Miller, S. He, I. Greenwald and members of the Hobert laboratory for comments on this manuscript. This work was funded by the National Institutes of Health (R01NS039996-05 and R01NS050266-03), the Howard Hughes Medical Institute and the UK Medical Research Council.	Araya CL, 2014, NATURE, V512, P400, DOI 10.1038/nature13497; Aurelio O, 2002, SCIENCE, V295, P686, DOI 10.1126/science.1066642; Bamber BA, 1999, J NEUROSCI, V19, P5348; Cinar H, 2005, CURR BIOL, V15, P340, DOI 10.1016/j.cub.2005.02.025; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Eastman C, 1999, J NEUROSCI, V19, P6225; Gally C, 2003, J NEUROSCI, V23, P2591; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; Hobert O., 2013, WORMBOOK; Hong Y, 2000, MOL CELL BIOL, V20, P2285, DOI 10.1128/MCB.20.6.2285-2295.2000; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Kim Joanne S M, 2010, Commun Integr Biol, V3, P251; Kim JSM, 2010, DEVELOPMENT, V137, P93, DOI 10.1242/dev.041459; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li J, 2010, CURR BIOL, V20, P1875, DOI 10.1016/j.cub.2010.09.055; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Melkman T, 2005, DEVELOPMENT, V132, P1935, DOI 10.1242/dev.01788; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Petersen SC, 2011, J NEUROSCI, V31, P15362, DOI 10.1523/JNEUROSCI.3181-11.2011; Petrash HA, 2013, J NEUROSCI, V33, P5524, DOI 10.1523/JNEUROSCI.4384-12.2013; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; Shan G, 2005, DEV BIOL, V280, P494, DOI 10.1016/j.ydbio.2005.01.032; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; WALTHALL WW, 1995, J NEUROSCI, V15, P1035; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]; Zhou HM, 1998, J NEUROSCI, V18, P10438	34	39	42	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					83	+		10.1038/nature14545	http://dx.doi.org/10.1038/nature14545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26083757	Green Accepted			2022-12-28	WOS:000357169500036
J	Mirtschink, P; Krishnan, J; Grimm, F; Sarre, A; Horl, M; Kayikci, M; Fankhauser, N; Christinat, Y; Cortijo, C; Feehan, O; Vukolic, A; Sossalla, S; Stehr, SN; Ule, J; Zamboni, N; Pedrazzini, T; Krek, W				Mirtschink, Peter; Krishnan, Jaya; Grimm, Fiona; Sarre, Alexandre; Hoerl, Manuel; Kayikci, Melis; Fankhauser, Niklaus; Christinat, Yann; Cortijo, Cedric; Feehan, Owen; Vukolic, Ana; Sossalla, Samuel; Stehr, Sebastian N.; Ule, Jernej; Zamboni, Nicola; Pedrazzini, Thierry; Krek, Wilhelm			HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease	NATURE			English	Article							CARDIAC-HYPERTROPHY; MASS-SPECTROMETRY; MESSENGER-RNA; CELLS; FAILURE; PATHWAY; KETOHEXOKINASE; EXPRESSION; MICE; QUANTIFICATION	Fructose is a major component of dietary sugar and its overconsumption exacerbates key pathological features of metabolic syndrome. The central fructose-metabolising enzyme is ketohexokinase (KHK), which exists in two isoforms: KHK-A and KHK-C, generated through mutually exclusive alternative splicing of KHK pre-mRNAs. KHK-C displays superior affinity for fructose compared with KHK-A and is produced primarily in the liver, thus restricting fructose metabolism almost exclusively to this organ. Here we show that myocardial hypoxia actuates fructose metabolism in human and mouse models of pathological cardiac hypertrophy through hypoxia-inducible factor 1 alpha (HIF1 alpha) activation of SF3B1 and SF3B1-mediated splice switching of KHK-A to KHK-C. Heart-specific depletion of SF3B1 orgenetic ablation of Khk, but not Khk-A alone, in mice, suppresses pathological stress-induced fructose metabolism, growth and contractile dysfunction, thus defining signalling components and molecular underpinnings of a fructose metabolism regulatory system crucial for pathological growth.	[Mirtschink, Peter; Krishnan, Jaya; Grimm, Fiona; Fankhauser, Niklaus; Christinat, Yann; Cortijo, Cedric; Feehan, Owen; Vukolic, Ana; Krek, Wilhelm] ETH, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Sarre, Alexandre; Pedrazzini, Thierry] Univ Lausanne, Dept Med, CH-1011 Lausanne, Switzerland; [Hoerl, Manuel; Zamboni, Nicola] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Kayikci, Melis; Ule, Jernej] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Sossalla, Samuel] Univ Med Gottingen, Klin Kardiol & Pneumol, D-37075 Gottingen, Germany; [Sossalla, Samuel] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Hamburg, Germany; [Stehr, Sebastian N.] Univ Hosp Jena, Dept Anesthesiol & Crit Care Med, D-07747 Jena, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; MRC Laboratory Molecular Biology; University of Gottingen; German Centre for Cardiovascular Research; Friedrich Schiller University of Jena	Krek, W (corresponding author), ETH, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland.	wilhelm.krek@biol.ethz.ch	Sossalla, Samuel/AAF-3611-2020; Zamboni, Nicola/K-3042-2012; Ule, Jernej/C-6315-2013	Zamboni, Nicola/0000-0003-1271-1021; Ule, Jernej/0000-0002-2452-4277; Fankhauser, Niklaus/0000-0002-0023-3993; Sossalla, Samuel/0000-0001-8034-2673; Krishnan, Jaya/0000-0002-5698-7671; Grimm, Fiona/0000-0001-5249-619X; Christinat, Yann/0000-0002-4977-1362	Sinergia (Swiss National Science Foundation); Swiss Heart Foundation; MRC [MC_U105185859, MC_U105185858] Funding Source: UKRI; Medical Research Council [MC_U105185858, MC_U105185859] Funding Source: researchfish	Sinergia (Swiss National Science Foundation); Swiss Heart Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Georgiev, T. Simka, S. Xu, C. Bischoff, J. M. Dominguez, W. Kovacs and M. Piontek and other members of the Krek laboratory for discussions, help and technical assistance. We are grateful to M. Stoffel for performing tail vein injections. K. Chien, A. Asipu and R. J. Johnson provided mouse lines. This work was supported by grants from Sinergia (Swiss National Science Foundation) to W. K., T.P. and J. U. and the Swiss Heart Foundation to W. K.	Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Casonato A, 2004, J LAB CLIN MED, V144, P254, DOI 10.1016/j.lab.2004.08.002; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Diggle CP, 2010, PHYSIOL GENOMICS, V42A, P235, DOI 10.1152/physiolgenomics.00128.2010; Diggle CP, 2009, J HISTOCHEM CYTOCHEM, V57, P763, DOI 10.1369/jhc.2009.953190; Dolatshad H, 2015, LEUKEMIA, V29, P1092, DOI [10.1038/leu.2014.331, 10.1038/leu.2015.178]; Falcao-Pires I, 2011, CIRCULATION, V124, P1151, DOI 10.1161/CIRCULATIONAHA.111.025270; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Fukuzawa J, 2000, HYPERTENSION, V35, P1191, DOI 10.1161/01.HYP.35.6.1191; Gao Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06098; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Haefliger JA, 2006, J CLIN INVEST, V116, P405, DOI 10.1172/JCI23327; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Kawasaki T, 2002, DIABETES CARE, V25, P353, DOI 10.2337/diacare.25.2.353; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Kuroda H, 2009, J VIROL METHODS, V157, P113, DOI 10.1016/j.jviromet.2008.11.021; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Nemir M, 2014, EUR HEART J, V35, P2174, DOI 10.1093/eurheartj/ehs269; Radin N S, 1981, Methods Enzymol, V72, P5; Ramasamy R, 2010, CIRC RES, V106, P1449, DOI 10.1161/CIRCRESAHA.109.213447; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiota M, 1998, DIABETES, V47, P867, DOI 10.2337/diabetes.47.6.867; Son NHP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046549; Troilo A, 2014, EMBO REP, V15, P77, DOI 10.1002/embr.201337688; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Yip GW, 2009, J HUM HYPERTENS, V23, P295, DOI 10.1038/jhh.2008.141	48	106	109	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					444	+		10.1038/nature14508	http://dx.doi.org/10.1038/nature14508			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26083752	Green Accepted, Green Submitted			2022-12-28	WOS:000356782900042
J	Maret-Ouda, J; Brusselaers, N; Lagergren, J				Maret-Ouda, John; Brusselaers, Nele; Lagergren, Jesper			UNCERTAINTIES What is the most effective treatment for severe gastro-oesophageal reflux disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROTON-PUMP INHIBITORS; LAPAROSCOPIC NISSEN FUNDOPLICATION; ANTIREFLUX SURGERY; MEDICAL-MANAGEMENT; TRIAL; ESOMEPRAZOLE; ASSOCIATION; GUIDELINES; ESOPHAGUS; GERD		[Maret-Ouda, John; Brusselaers, Nele] Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, S-17176 Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Sect Gastrointestinal Canc, Div Canc Studies, Guys & St Thomas NHS Fdn Trust,Upper Gastrointest, London SE1 7EH, England; [Lagergren, Jesper] Kings Coll London, Sect Gastrointestinal Canc, Div Canc Studies, Guys & St Thomas NHS Fdn Trust,Surg, London SE1 7EH, England	Karolinska Institutet; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lagergren, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Surg, Norra Stationsgatan 67, S-17176 Stockholm, Sweden.	jesper.lagergren@ki.se	Brusselaers, Nele/I-3501-2012	Brusselaers, Nele/0000-0003-0137-447X				Anvari M, 2006, SURG INNOV, V13, P238, DOI 10.1177/1553350606296389; Anvari M, 2011, SURG ENDOSC, V25, P2547, DOI 10.1007/s00464-011-1585-5; Attwood SE, 2008, J GASTROINTEST SURG, V12, P1646, DOI 10.1007/s11605-008-0645-1; Chang EY, 2007, ANN SURG, V246, P11, DOI 10.1097/01.sla.0000261459.10565.e9; Epstein D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2576; Ford AC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2481; Galmiche JP, 2011, JAMA-J AM MED ASSOC, V305, P1969, DOI 10.1001/jama.2011.626; Grant AM, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17220; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Kwok CS, 2012, AM J GASTROENTEROL, V107, P1011, DOI 10.1038/ajg.2012.108; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Leontiadis GI, 2012, AM J GASTROENTEROL, V107, P1020, DOI 10.1038/ajg.2012.174; Lundell L, 2008, GUT, V57, P1207, DOI 10.1136/gut.2008.148833; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Mahon D, 2005, BRIT J SURG, V92, P695, DOI 10.1002/bjs.4934; Moayyedi P, 2013, CAN J GASTROENTEROL, V27, P593, DOI 10.1155/2013/321379; Singh S, 2014, GUT, V63, P1229, DOI 10.1136/gutjnl-2013-305997; Stefanidis D, 2010, SURG ENDOSC, V24, P2647, DOI 10.1007/s00464-010-1267-8; Sultan N, 2008, CAN J GASTROENTEROL, V22, P761, DOI 10.1155/2008/821385; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Watson TJ, 2008, J GASTROINTEST SURG, V12, P1654; Wileman SM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003243.pub2	22	14	14	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2015	350								h3169	10.1136/bmj.h3169	http://dx.doi.org/10.1136/bmj.h3169			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NX	26108963	Green Published			2022-12-28	WOS:000357160000002
J	Ammirati, E; Stucchi, M; Brambatti, M; Spano, F; Bonacina, E; Recalcati, F; Cerea, G; Vanzulli, A; Frigerio, M; Oliva, F				Ammirati, Enrico; Stucchi, Miriam; Brambatti, Michela; Spano, Francesca; Bonacina, Edgardo; Recalcati, Fabio; Cerea, Giulio; Vanzulli, Angelo; Frigerio, Maria; Oliva, Fabrizio			Eosinophilic myocarditis: a paraneoplastic event	LANCET			English	Editorial Material									[Ammirati, Enrico; Stucchi, Miriam; Brambatti, Michela; Spano, Francesca; Bonacina, Edgardo; Recalcati, Fabio; Frigerio, Maria; Oliva, Fabrizio] Osped Niguarda Ca Granda, De Gasperis Cardio Ctr, Milan, Italy; [Cerea, Giulio] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Falk Div Med Oncol, Milan, Italy; [Vanzulli, Angelo] Osped Niguarda Ca Granda, Dept Radiol, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Ammirati, E (corresponding author), Azienda Osped Osped Niguarda Ca Granda, Angelo De Gasperis Cardiothorac & Vasc Dept, I-20162 Milan, Italy.	enrico.ammirati@ospedaleniguarda.it	Ammirati, Enrico/AAA-9961-2020; Vanzulli, Angelo/X-4175-2019	Ammirati, Enrico/0000-0002-1676-5257; Vanzulli, Angelo/0000-0002-2452-3370; Brambatti, Michela/0000-0001-9605-8220	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056267] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baandrup U, 2012, HERZ, V37, P849, DOI 10.1007/s00059-012-3701-2; DESREUMAUX P, 1993, BLOOD, V82, P1553; Fozing T, 2014, CIRC-HEART FAIL, V7, P692, DOI 10.1161/CIRCHEARTFAILURE.114.001130; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X	4	17	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2546	2546		10.1016/S0140-6736(15)60903-5	http://dx.doi.org/10.1016/S0140-6736(15)60903-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	26122067				2022-12-28	WOS:000356532500029
J	Glaser, A; Mian, Z; von Hippel, F				Glaser, Alexander; Mian, Zia; von Hippel, Frank			After the Iran deal: Multinational enrichment	SCIENCE			English	Editorial Material									[Glaser, Alexander; Mian, Zia; von Hippel, Frank] Princeton Univ, Program Sci & Global Secur, Princeton, NJ 08544 USA	Princeton University	Mian, Z (corresponding author), Princeton Univ, Program Sci & Global Secur, Princeton, NJ 08544 USA.	zia@princeton.edu						Albright D., 2015, ISIS ANAL IAEA IRAN; [Anonymous], 2015, COMMUNICATION   0502; Glaser A., 2009, 9 ICNND; IAEA, 2002, SAF GLOSS, P23; IAEA, 2013, INFCIRC855 IAEA; Organization of Atomic Energy of Iran, 2014, BUSH POW PLANT FUEL; Sanger David, 2015, NEW YORK TIMES; *US STAT DEP, 1946, REP INT CONTR AT EN; von Hippel F.N., 2013, INT PAN FISS MAT OCT	9	3	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1320	1322		10.1126/science.aac5989	http://dx.doi.org/10.1126/science.aac5989			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7XK	26089499				2022-12-28	WOS:000356449500031
J	Dudzinski, DM; Prabhakar, AM; Ptaszek, LM; Vlahakes, GJ				Dudzinski, David M.; Prabhakar, Anand M.; Ptaszek, Leon M.; Vlahakes, Gus J.			Case 19-2015: A 71-Year-Old Man with Chest Pain and Shortness of Breath	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVERTER-DEFIBRILLATOR REGISTRY; CARDIOVASCULAR DATA REGISTRY; COMPUTED-TOMOGRAPHY; LEAD PERFORATION; INSIGHTS; COMPLICATIONS; MORTALITY		[Dudzinski, David M.; Ptaszek, Leon M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Prabhakar, Anand M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Vlahakes, Gus J.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Dudzinski, David M.; Ptaszek, Leon M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Prabhakar, Anand M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Vlahakes, Gus J.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Dudzinski, DM (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Bintcliffe O, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2928; Cheng A, 2010, J AM COLL CARDIOL, V56, P1651, DOI 10.1016/j.jacc.2010.06.037; Chidambaram Sundar, 2013, Indian Heart J, V65, P666, DOI 10.1016/j.ihj.2013.10.013; Dewland TA, 2011, J AM COLL CARDIOL, V58, P1007, DOI 10.1016/j.jacc.2011.04.039; Dudzinski DM, 2012, CURR PROB CARDIOLOGY, V37, P75, DOI 10.1016/j.cpcardiol.2011.10.002; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Henrikson CA, 2006, PACE, V29, P509, DOI 10.1111/j.1540-8159.2006.00385.x; Hsu JC, 2013, CIRC-CARDIOVASC QUAL, V6, P582, DOI 10.1161/CIRCOUTCOMES.113.000299; Lee DS, 2010, J AM COLL CARDIOL, V55, P774, DOI 10.1016/j.jacc.2009.11.029; Mansoor AM, 2015, NEW ENGL J MED, V372, pE3, DOI 10.1056/NEJMicm1310957; Pang BJ, 2014, PACE, V37, P537, DOI 10.1111/pace.12307; Swap CJ, 2005, JAMA-J AM MED ASSOC, V294, P2623, DOI 10.1001/jama.294.20.2623; van Rees JB, 2011, J AM COLL CARDIOL, V58, P995, DOI 10.1016/j.jacc.2011.06.007; Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580; Yavari A, 2009, EUROPACE, V11, P252, DOI 10.1093/europace/eun381	15	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2438	2446		10.1056/NEJMcpc1415757	http://dx.doi.org/10.1056/NEJMcpc1415757			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK6RF	26083209				2022-12-28	WOS:000356354600011
J	Garris, CS; Pittet, MJ				Garris, Christopher S.; Pittet, Mikael J.			ER Stress in Dendritic Cells Promotes Cancer	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR; XBP1; IMMUNITY	XBP1 is part of the ER stress response, and when activated in cancer cells, it fosters tumor growth. In this issue of Cell, Cubillos-Ruiz et al. demonstrate that XBP1 in tumor-infiltrating dendritic cells blunts anti-tumor immunity. These findings further imply XBP1 as a relevant target for cancer therapy.	[Garris, Christopher S.; Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA; [Garris, Christopher S.; Pittet, Mikael J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Garris, Christopher S.] Harvard Univ, Sch Med, Grad Program Immunol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA.	mpittet@mgh.harvard.edu	Pittet, Mikael/ABD-6300-2021					Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	9	12	14	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1492	1493		10.1016/j.cell.2015.06.006	http://dx.doi.org/10.1016/j.cell.2015.06.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091029	Bronze			2022-12-28	WOS:000356618200003
J	Laughlin, G				Laughlin, Gregory			ASTRONOMY A Mars-sized exoplanet	NATURE			English	Editorial Material									Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Laughlin, G (corresponding author), Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA.	laughlin@ucolick.org						Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Gautier III T. N., 2010, PREPRINT; Grant R, 1852, HIST PHYS ASTRONOMY; Jontof-Hutter D, 2015, NATURE, V522, P321, DOI 10.1038/nature14494; Marcy GW, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/20; Ricker GR, 2015, J ASTRON TELESC INST, V1, DOI 10.1117/1.JATIS.1.1.014003	7	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					290	291		10.1038/522290a	http://dx.doi.org/10.1038/522290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085265				2022-12-28	WOS:000356425400038
J	Park, DJ; Dudas, G; Wohl, S; Goba, A; Whitmer, SLM; Andersen, KG; Sealfon, RS; Ladner, JT; Kugelman, JR; Matranga, CB; Winnicki, SM; Qu, J; Gire, SK; Gladden-Young, A; Jalloh, S; Nosamiefan, D; Yozwiak, NL; Moses, LM; Jiang, PP; Lin, AE; Schaffner, SF; Bird, B; Towner, J; Mamoh, M; Gbakie, M; Kanneh, L; Kargbo, D; Massally, JLB; Kamara, FK; Konuwa, E; Sellu, J; Jalloh, AA; Mustapha, I; Foday, M; Yillah, M; Erickson, BR; Sealy, T; Blau, D; Paddock, C; Brault, A; Amman, B; Basile, J; Bearden, S; Belser, J; Bergeron, E; Campbell, S; Chakrabarti, A; Dodd, K; Flint, M; Gibbons, A; Goodman, C; Klena, J; McMullan, L; Morgan, L; Russell, B; Salzer, J; Sanchez, A; Wang, D; Jungreis, I; Tomkins-Tinch, C; Kislyuk, A; Lin, MF; Chapman, S; MacInnis, B; Matthews, A; Bochicchio, J; Hensley, LE; Kuhn, JH; Nusbaum, C; Schieffelin, JS; Birren, BW; Forget, M; Nichol, ST; Palacios, GF; Ndiaye, D; Happi, C; Gevao, SM; Vandi, MA; Kargbo, B; Holmes, EC; Bedford, T; Gnirke, A; Stroher, U; Rambaut, A; Garry, RF; Sabeti, PC				Park, Daniel J.; Dudas, Gytis; Wohl, Shirlee; Goba, Augustine; Whitmer, Shannon L. M.; Andersen, Kristian G.; Sealfon, Rachel S.; Ladner, Jason T.; Kugelman, Jeffrey R.; Matranga, Christian B.; Winnicki, Sarah M.; Qu, James; Gire, Stephen K.; Gladden-Young, Adrianne; Jalloh, Simbirie; Nosamiefan, Dolo; Yozwiak, Nathan L.; Moses, Lina M.; Jiang, Pan-Pan; Lin, Aaron E.; Schaffner, Stephen F.; Bird, Brian; Towner, Jonathan; Mamoh, Mambu; Gbakie, Michael; Kanneh, Lansana; Kargbo, David; Massally, James L. B.; Kamara, Fatima K.; Konuwa, Edwin; Sellu, Josephine; Jalloh, Abdul A.; Mustapha, Ibrahim; Foday, Momoh; Yillah, Mohamed; Erickson, Bobbie R.; Sealy, Tara; Blau, Dianna; Paddock, Christopher; Brault, Aaron; Amman, Brian; Basile, Jane; Bearden, Scott; Belser, Jessica; Bergeron, Eric; Campbell, Shelley; Chakrabarti, Ayan; Dodd, Kimberly; Flint, Mike; Gibbons, Aridth; Goodman, Christin; Klena, John; McMullan, Laura; Morgan, Laura; Russell, Brandy; Salzer, Johanna; Sanchez, Angela; Wang, David; Jungreis, Irwin; Tomkins-Tinch, Christopher; Kislyuk, Andrey; Lin, Michael F.; Chapman, Sinead; MacInnis, Bronwyn; Matthews, Ashley; Bochicchio, James; Hensley, Lisa E.; Kuhn, Jens H.; Nusbaum, Chad; Schieffelin, John S.; Birren, Bruce W.; Forget, Marc; Nichol, Stuart T.; Palacios, Gustavo F.; Ndiaye, Daouda; Happi, Christian; Gevao, Sahr M.; Vandi, Mohamed A.; Kargbo, Brima; Holmes, Edward C.; Bedford, Trevor; Gnirke, Andreas; Stroeher, Ute; Rambaut, Andrew; Garry, Robert F.; Sabeti, Pardis C.			Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone	CELL			English	Article							RNA VIRUSES; SELECTION; OUTBREAK; DATABASE	The 2013-2015 Ebola virus disease (EVD) epidemic is caused by the Makona variant of Ebola virus (EBOV). Early in the epidemic, genome sequencing provided insights into virus evolution and transmission and offered important information for outbreak response. Here, we analyze sequences from 232 patients sampled over 7 months in Sierra Leone, along with 86 previously released genomes from earlier in the epidemic. We confirm sustained human-to-human transmission within Sierra Leone and find no evidence for import or export of EBOV across national borders after its initial introduction. Using high-depth replicate sequencing, we observe both host-to-host transmission and recurrent emergence of intrahost genetic variants. We trace the increasing impact of purifying selection in suppressing the accumulation of nonsynonymous mutations over time. Finally, we note changes in the mucin-like domain of EBOV glycoprotein that merit further investigation. These findings clarify the movement of EBOV within the region and describe viral evolution during prolonged human-to-human transmission.	[Park, Daniel J.; Wohl, Shirlee; Sealfon, Rachel S.; Matranga, Christian B.; Winnicki, Sarah M.; Qu, James; Gire, Stephen K.; Gladden-Young, Adrianne; Nosamiefan, Dolo; Yozwiak, Nathan L.; Jiang, Pan-Pan; Lin, Aaron E.; Schaffner, Stephen F.; Tomkins-Tinch, Christopher; Chapman, Sinead; MacInnis, Bronwyn; Matthews, Ashley; Bochicchio, James; Nusbaum, Chad; Birren, Bruce W.; Gnirke, Andreas; Sabeti, Pardis C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Dudas, Gytis; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3FL, Midlothian, Scotland; [Wohl, Shirlee; Winnicki, Sarah M.; Gire, Stephen K.; Yozwiak, Nathan L.; Jiang, Pan-Pan; Lin, Aaron E.; Schaffner, Stephen F.; Matthews, Ashley] Harvard Univ, Cambridge, MA 02138 USA; [Goba, Augustine; Jalloh, Simbirie; Mamoh, Mambu; Gbakie, Michael; Kanneh, Lansana; Kargbo, David; Massally, James L. B.; Kamara, Fatima K.; Konuwa, Edwin; Sellu, Josephine; Jalloh, Abdul A.; Mustapha, Ibrahim; Foday, Momoh; Yillah, Mohamed] Kenema Govt Hosp, Kenema, Sierra Leone; [Whitmer, Shannon L. M.; Bird, Brian; Towner, Jonathan; Erickson, Bobbie R.; Sealy, Tara; Blau, Dianna; Paddock, Christopher; Brault, Aaron; Amman, Brian; Basile, Jane; Bearden, Scott; Belser, Jessica; Bergeron, Eric; Campbell, Shelley; Chakrabarti, Ayan; Dodd, Kimberly; Flint, Mike; Gibbons, Aridth; Goodman, Christin; Klena, John; McMullan, Laura; Morgan, Laura; Russell, Brandy; Salzer, Johanna; Sanchez, Angela; Wang, David; Nichol, Stuart T.; Stroeher, Ute] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Whitmer, Shannon L. M.; Bird, Brian; Towner, Jonathan; Erickson, Bobbie R.; Sealy, Tara; Blau, Dianna; Paddock, Christopher; Brault, Aaron; Amman, Brian; Basile, Jane; Bearden, Scott; Belser, Jessica; Bergeron, Eric; Campbell, Shelley; Chakrabarti, Ayan; Dodd, Kimberly; Flint, Mike; Gibbons, Aridth; Goodman, Christin; Klena, John; McMullan, Laura; Morgan, Laura; Russell, Brandy; Salzer, Johanna; Sanchez, Angela; Wang, David; Nichol, Stuart T.; Stroeher, Ute] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Andersen, Kristian G.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Sealfon, Rachel S.; Jungreis, Irwin] MIT, Cambridge, MA 02139 USA; [Ladner, Jason T.; Kugelman, Jeffrey R.; Palacios, Gustavo F.] US Army, Med Res Inst Infect Dis, Frederick, MD 21702 USA; [Moses, Lina M.; Schieffelin, John S.; Garry, Robert F.] Tulane Univ, New Orleans, LA 70112 USA; [Kislyuk, Andrey; Lin, Michael F.] DNAnexus, Mountain View, CA 94040 USA; [Hensley, Lisa E.; Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, Div Clin Res, NIH, Frederick, MD 21702 USA; [Forget, Marc] Med Sans Frontieres, B-1050 Brussels, Belgium; [Ndiaye, Daouda] Univ Cheikh Anta Diop, Dakar, Senegal; [Happi, Christian] Redeemers Univ Nigeria, Redemption City, Ogun State, Nigeria; [Gevao, Sahr M.] Univ Sierra Leone, Freetown, Sierra Leone; [Vandi, Mohamed A.; Kargbo, Brima] Sierra Leone Minist Hlth & Sanitat, Freetown, Sierra Leone; [Holmes, Edward C.] Univ Sydney, Johns Hopkins Dr, Camperdown, NSW 2050, Australia; [Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Rambaut, Andrew] Univ Edinburgh, Ctr Immunol Infect & Evolut, Ashworth Labs, Edinburgh EH9 3FL, Midlothian, Scotland; [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Edinburgh; Harvard University; Kenema Government Hospital; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Scripps Research Institute; Massachusetts Institute of Technology (MIT); Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Doctors Without Borders; University Cheikh Anta Diop Dakar; Ministry of Health & Sanitation Sierra Leone; University of Sydney; Fred Hutchinson Cancer Center; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Park, DJ (corresponding author), Broad Inst Harvard & MIT, 75 Ames St, Cambridge, MA 02142 USA.	dpark@broadinstitute.org; a.rambaut@ed.ac.uk; pardis@broadinstitute.org	Rambaut, Andrew/B-2481-2009; Bergeron, Eric/N-9566-2019; McMullan, Laura/AAI-1404-2021; Palacios, Gustavo/I-7773-2015; Kuhn, Jens H./B-7615-2011; Flint, Mike/L-8355-2019; Sabeti, Pardis/GQH-8610-2022; Dudas, Gytis/H-5968-2019; Lin, Aaron/AAL-1625-2021; Holmes, Edward/GVR-9499-2022; Towner, Jonathan/ABC-3780-2020; Ladner, Jason/G-3486-2011; Schaffner, Stephen F/D-1189-2011	Rambaut, Andrew/0000-0003-4337-3707; Bergeron, Eric/0000-0003-3398-8628; McMullan, Laura/0000-0003-2748-5151; Palacios, Gustavo/0000-0001-5062-1938; Kuhn, Jens H./0000-0002-7800-6045; Dudas, Gytis/0000-0002-0227-4158; Ladner, Jason/0000-0001-7751-4366; Matranga, Christian/0000-0002-9037-5468; Wohl, Shirlee/0000-0002-0311-3348; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Hensley, Lisa/0000-0003-1188-4342; Schaffner, Stephen/0000-0001-6699-3568; Happi, Christian/0000-0002-3056-6705; Basile, Alison Jane/0000-0002-5646-1557; Garry, Robert/0000-0002-5683-3250; Flint, Michael/0000-0002-5373-787X; Tomkins-Tinch, Christopher/0000-0002-9114-6421; Holmes, Edward/0000-0001-9596-3552; Lin, Aaron/0000-0001-7400-4125; Moses, Lina/0000-0003-4292-647X	European Union grant FP7 [278433-PREDEMICS]; European Research Council [260864]; Natural Environment Research Council [D76739X]; NIH [U54 GM111274, GM080177, 1U01HG007480-01]; National Science Foundation Graduate Research Fellowship [DGE 1144152]; National Health and Medical Research Council, Australia; Defense Threat Reduction Agency (USAMRIID); NIH/NIAID (Broad Institute) [U19AI110818]; Bill and Melinda Gates Foundation (Broad Institute) [OPP1123407]; US National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700016I]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400028C]; NIAID (Harvard/Tulane) [HHSN272200900049C]; Zalgen Labs; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007234, U01HG007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM111274, T32GM080177] Funding Source: NIH RePORTER	European Union grant FP7; European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Defense Threat Reduction Agency (USAMRIID)(United States Department of DefenseDefense Threat Reduction Agency); NIH/NIAID (Broad Institute); Bill and Melinda Gates Foundation (Broad Institute)(Bill & Melinda Gates Foundation); US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID (Harvard/Tulane); Zalgen Labs; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by European Union grant FP7/2007-2013 278433-PREDEMICS and European Research Council grant 260864 (A.R.); Natural Environment Research Council grant D76739X (G.D.); NIH U54 GM111274 (T.B.); NIH grant GM080177 (S.W.); NIH grant 1U01HG007480-01 (C.H.); National Science Foundation Graduate Research Fellowship Grant No. DGE 1144152 (A.E.L.); the National Health and Medical Research Council, Australia (E.C.H.); the Defense Threat Reduction Agency (USAMRIID); NIH/NIAID U19AI110818 (Broad Institute); the Bill and Melinda Gates Foundation OPP1123407 (Broad Institute); and NIAID HHSN272200900049C (Harvard/Tulane). This work was funded, in part, through Battelle Memorial Institute's prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under contract number HHSN272200700016I. Subcontractors to Battelle Memorial Institute who performed this work are: J.H.K., an employee of Tunnell Government Services, Inc. R.F.G. is co-founder of Zalgen Labs.; The Virus Pathogen Database and Analysis Resource (ViPR) has been wholly funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN272201400028C.	Alizon S, 2014, VIRULENCE, V5, P825, DOI 10.4161/21505594.2014.976514; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Becquart P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096360; Bedford T, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-220; Carpenter JA, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-75; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Emmett K. J., 2015, PLOS CURR; Folarin OA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0515-y; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Kuhn JH, 2014, VIRUSES-BASEL, V6, P4760, DOI 10.3390/v6114760; Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Olal D, 2012, J VIROL, V86, P2809, DOI 10.1128/JVI.05549-11; Park D., 2015, VIRAL NGS V1 0 0; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; Sanchez A, 1998, VIROLOGY, V240, P138, DOI 10.1006/viro.1997.8902; Stadler T., 2014, PLOS CURR; Tong Y.-G., 2015, NATURE; Volz E., 2014, PLOS CURR, V6; Wertheim JO, 2009, J VIROL, V83, P4690, DOI 10.1128/JVI.02358-08; WHO, 2015, EB SIT REP; Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a; Zahn RC, 2007, J VIROL, V81, P457, DOI 10.1128/JVI.00067-06	30	195	201	1	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1516	1526		10.1016/j.cell.2015.06.007	http://dx.doi.org/10.1016/j.cell.2015.06.007			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091036	Green Published, hybrid			2022-12-28	WOS:000356618200010
J	[Anonymous]				[Anonymous]			Central & South Asia	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S24	S25		10.1038/522S24a	http://dx.doi.org/10.1038/522S24a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083856	Bronze			2022-12-28	WOS:000356425400009
J	Smith, SA; Tamhane, S				Smith, Steven A.; Tamhane, Shrikant			Review: Intensive blood pressure control reduces retinopathy in diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Smith, Steven A.; Tamhane, Shrikant] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Smith, SA (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC7	10.7326/ACPJC-2015-162-12-007	http://dx.doi.org/10.7326/ACPJC-2015-162-12-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075784				2022-12-28	WOS:000356516300008
J	Marchalik, D				Marchalik, Daniel			The art of medicine Saving the professionalism course	LANCET			English	Editorial Material									Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA	Georgetown University	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com		Marchalik, Daniel/0000-0002-6912-1252					0	2	2	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2346	2347		10.1016/S0140-6736(15)61093-5	http://dx.doi.org/10.1016/S0140-6736(15)61093-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1XV	26088632				2022-12-28	WOS:000356003700016
J	Holmes, D				Holmes, David			Profile Andrzej Wiecek: east meets west in nephrology	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1937	1937		10.1016/S0140-6736(15)60947-3	http://dx.doi.org/10.1016/S0140-6736(15)60947-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	26090630				2022-12-28	WOS:000354541700014
J	Ong, ACM; Devuyst, O; Knebelmann, B; Walz, G				Ong, Albert C. M.; Devuyst, Olivier; Knebelmann, Bertrand; Walz, Gerd		ERA-EDTA Working Grp Inherited Kid	Autosomal dominant polycystic kidney disease: the changing face of clinical management	LANCET			English	Article							LEFT-VENTRICULAR MASS; PRIMARY CILIA; RENAL-FUNCTION; CYST GROWTH; ADPKD; GENE; PROGRESSION; MUTATIONS; RECEPTOR; VOLUME	Autosomal dominant polycystic kidney disease is the most common inherited kidney disease and accounts for 7-10% of all patients on renal replacement therapy worldwide. Although first reported 500 years ago, this disorder is still regarded as untreatable and its pathogenesis is poorly understood despite much study. During the past 40 years, however, remarkable advances have transformed our understanding of how the disease develops and have led to rapid changes in diagnosis, prognosis, and treatment, especially during the past decade. This Review will summarise the key findings, highlight recent developments, and look ahead to the changes in clinical practice that will likely arise from the adoption of a new management framework for this major kidney disease.	[Ong, Albert C. M.] Univ Sheffield, Sch Med, Acad Nephrol Unit, Sheffield S10 2RX, S Yorkshire, England; [Ong, Albert C. M.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield Kidney Inst, Sheffield, S Yorkshire, England; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Devuyst, Olivier] Catholic Univ Louvain, Div Nephrol, B-1200 Brussels, Belgium; [Knebelmann, Bertrand] Univ Paris 05, Hop Necker, AP HP, Ctr Reference Malad Renales Hereditaires MARHEA, Paris, France; [Walz, Gerd] Univ Freiburg, Med Ctr, Dept Nephrol, Freiburg, Germany	University of Sheffield; University of Sheffield; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Freiburg	Ong, ACM (corresponding author), Univ Sheffield, Sch Med, Acad Nephrol Unit, Kidney Genet Grp, Sheffield S10 2RX, S Yorkshire, England.	a.ong@sheffield.ac.uk	Maxwell, Patrick H/C-5557-2008; Ong, Albert/AAN-9430-2021; Torra, Roser/A-9983-2008	Maxwell, Patrick H/0000-0002-0338-2679; Ong, Albert/0000-0002-7211-5400; Torra, Roser/0000-0001-8714-2332; Devuyst, Olivier/0000-0003-3744-4767	ERA-EDTA (EuroCYST); European Union (EU-FP7) [317246]; European Union (TranCYST); European Union (FP7) [305608]; European Union (EURenOmics); Kidney Research UK; Medical Research Council; Fonds National de la Recherche Scientifique; Fonds de la Recherche Scientifique Medicale; Swiss National Science Foundation project grant [310030-146490]; Association pour l'Information et la Recherche sur les Maladies Renales Genetiques; Fondation Maladies Rares; Deutsche Forschungsgemeinschaft [SFB 1140]; Otsuka Corporation; Pfizer; Raptor; Roche; Amgen; Genzyme; Advicenne; National Institute for Health Research [NF-SI-0514-10122] Funding Source: researchfish; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish	ERA-EDTA (EuroCYST); European Union (EU-FP7); European Union (TranCYST); European Union (FP7)(European Commission); European Union (EURenOmics); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Swiss National Science Foundation project grant(Swiss National Science Foundation (SNSF)); Association pour l'Information et la Recherche sur les Maladies Renales Genetiques; Fondation Maladies Rares; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Otsuka Corporation(Otsuka Pharmaceutical); Pfizer(Pfizer); Raptor; Roche(Roche Holding); Amgen(Amgen); Genzyme(Sanofi-AventisGenzyme Corporation); Advicenne; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors have received consultancy fees from Otsuka Corporation (ACMO, OD, BK, GW), Pfizer (ACMO), Raptor (BK), Roche (BK), Amgen (BK), Genzyme (BK), and Advicenne (BK). ACMO, OD, and GW are steering group members of the EuroCYST Consortium; ACMO and OD are board members of TranCYST; and OD is a member of the Rare Disease Initiative zurich (radiz) KFSP of the University of Zurich. Research in the authors' laboratories is supported by the ERA-EDTA (EuroCYST to ACMO, OD, GW); European Union (EU-FP7/2007-2013 grant agreement number 317246 and TranCYST [ACMO and OD]; FP7/2007-2013 grant agreement number 305608 and EURenOmics [OD]); Kidney Research UK (ACMO); Medical Research Council (ACMO); Fonds National de la Recherche Scientifique and the Fonds de la Recherche Scientifique Medicale (OD); the Swiss National Science Foundation project grant 310030-146490 (OD); Association pour l'Information et la Recherche sur les Maladies Renales Genetiques (BK); Fondation Maladies Rares (BK); and Deutsche Forschungsgemeinschaft SFB 1140 (GW).	Bergmann C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080; Boyer O, 2007, PEDIATR NEPHROL, V22, P380, DOI 10.1007/s00467-006-0327-8; Braun WE, 2014, CLIN J AM SOC NEPHRO, V9, P881, DOI 10.2215/CJN.02650313; Cadnapaphornchai MA, 2008, KIDNEY INT, V74, P1192, DOI 10.1038/ki.2008.397; Cadnapaphornchai MA, 2014, CLIN J AM SOC NEPHRO, V9, P889, DOI 10.2215/CJN.08350813; Cai YQ, 2014, J CLIN INVEST, V124, P5129, DOI 10.1172/JCI67273; Caroli A, 2013, LANCET, V382, P1485, DOI 10.1016/S0140-6736(13)61407-5; Caroli A, 2011, AM J PATHOL, V179, P619, DOI 10.1016/j.ajpath.2011.04.036; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; CHAN KW, 1993, PATHOLOGY, V25, P229, DOI 10.3109/00313029309066577; Chang MY, 2006, NEPHROL DIAL TRANSPL, V21, P2078, DOI 10.1093/ndt/gfl150; Chang MY, 2013, BRIT J CLIN PHARMACO, V76, P524, DOI 10.1111/bcp.12136; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Chapman AB, 2012, CLIN J AM SOC NEPHRO, V7, P479, DOI 10.2215/CJN.09500911; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Corradi V, 2015, MINERVA MED, V106, P53; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; DALGAARD O. Z., 1957, ACTA MED SCAND SUPPL, V158, P1; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Devuyst O, 2014, LANCET, V383, P1844, DOI 10.1016/S0140-6736(14)60659-0; Devuyst O, 2012, NEPHROL DIAL TRANSPL, V27, P67, DOI 10.1093/ndt/gfr764; Devuyst O, 2011, NEPHROL DIAL TRANSPL, V26, P2423, DOI 10.1093/ndt/gfr380; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Ecder T, 2009, NAT REV NEPHROL, V5, P221, DOI 10.1038/nrneph.2009.13; Erickson KF, 2013, ANN INTERN MED, V159, P382, DOI 10.7326/0003-4819-159-6-201309170-00004; Fogazzi GB, 1998, NEPHROL DIAL TRANSPL, V13, P1039, DOI 10.1093/ndt/13.4.1039; Gall ECL, 2014, NAT REV NEPHROL, V10, P485, DOI 10.1038/nrneph.2014.132; GARDNER KD, 1969, NEW ENGL J MED, V281, P985, DOI 10.1056/NEJM196910302811804; Gevers TJG, 2013, NAT REV GASTRO HEPAT, V10, P101, DOI 10.1038/nrgastro.2012.254; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goto H, 2013, CELL MOL LIFE SCI, V70, P3893, DOI 10.1007/s00018-013-1302-8; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; GRANTHAM JJ, 1994, AM J KIDNEY DIS, V23, P210, DOI 10.1016/S0272-6386(12)80974-7; Happe H, 2014, NAT REV NEPHROL, V10, P587, DOI 10.1038/nrneph.2014.137; Harris PC, 2006, J AM SOC NEPHROL, V17, P3013, DOI 10.1681/ASN.2006080835; Harris PC, 2014, J CLIN INVEST, V124, P2315, DOI 10.1172/JCI72272; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Helies-Toussaint C, 2000, AM J PHYSIOL-RENAL, V279, pF185, DOI 10.1152/ajprenal.2000.279.1.F185; IGLESIAS CG, 1983, AM J KIDNEY DIS, V2, P630; Irazabal MV, 2015, J AM SOC NEPHROL, V26, P160, DOI 10.1681/ASN.2013101138; Kim E, 2007, NAT MED, V13, P1409, DOI 10.1038/nm1207-1409; King BF, 2003, KIDNEY INT, V64, P2214, DOI 10.1046/j.1523-1755.2003.00326.x; Lentine KL, 2010, CLIN J AM SOC NEPHRO, V5, P1471, DOI 10.2215/CJN.00780110; Lienkamp S, 2012, DIFFERENTIATION, V83, pS49, DOI 10.1016/j.diff.2011.11.012; MANGOOKARIM R, 1989, FASEB J, V3, P2629, DOI 10.1096/fasebj.3.14.2480260; Mao ZG, 2015, NEPHROL DIAL TRANSPL, V30, P197, DOI 10.1093/ndt/gfu044; Menezes LF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003053; Merrick D, 2012, DEV CELL, V22, P197, DOI 10.1016/j.devcel.2011.10.028; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Ong ACM, 2005, KIDNEY INT, V67, P1234, DOI 10.1111/j.1523-1755.2005.00201.x; Paterson AD, 2005, J AM SOC NEPHROL, V16, P755, DOI 10.1681/ASN.2004090758; Paul BM, 2014, KIDNEY INT, V85, P383, DOI 10.1038/ki.2013.227; Pei Y, 2015, J AM SOC NEPHROL, V26, P746, DOI 10.1681/ASN.2014030297; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Persu A, 2004, KIDNEY INT, V66, P2132, DOI 10.1111/j.1523-1755.2004.66003.x; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; Petzold K, 2014, NEPHROL DIAL TRANSPL, V29, P26, DOI 10.1093/ndt/gfu091; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; Rees S, 2014, J AM SOC NEPHROL, V25, P232, DOI 10.1681/ASN.2013010077; Rosansky SJ, 2014, KIDNEY INT, V85, P723, DOI 10.1038/ki.2013.506; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Rossetti S, 2012, J AM SOC NEPHROL, V23, P915, DOI 10.1681/ASN.2011101032; Rossetti S, 2009, KIDNEY INT, V75, P848, DOI 10.1038/ki.2008.686; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Schrier RW, 2014, J AM SOC NEPHROL, V25, P2399, DOI 10.1681/ASN.2013111184; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shamshirsaz A, 2005, KIDNEY INT, V68, P2218, DOI 10.1111/j.1523-1755.2005.00678.x; Simms RJ, 2015, TRANSPLANTATION, V99, P1023, DOI 10.1097/TP.0000000000000466; Simms RJ, 2014, NEPHROL DIAL TRANSPL, V29, P106, DOI 10.1093/ndt/gfu106; Slaats GG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004594; Spithoven EM, 2014, NEPHROL DIAL TRANSPL, V29, P15, DOI 10.1093/ndt/gfu017; Streets AJ, 2013, HUM MOL GENET, V22, P1924, DOI 10.1093/hmg/ddt031; Sussman CR, 2014, J AM SOC NEPHROL, V25, P2222, DOI 10.1681/ASN.2013040421; Ho TA, 2012, KIDNEY INT, V82, P1121, DOI 10.1038/ki.2012.225; Torres VE, 1998, NEPHROL DIAL TRANSPL, V13, P2690, DOI 10.1093/ndt/13.10.2690; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; WARD CJ, 1994, CELL, V77, P881; Wetmore JB, 2014, J AM SOC NEPHROL, V25, P2335, DOI 10.1681/ASN.2013101122; Wilson PD, 2011, BBA-MOL BASIS DIS, V1812, P1239, DOI 10.1016/j.bbadis.2011.05.008; ZERRES K, 1993, J MED GENET, V30, P583, DOI 10.1136/jmg.30.7.583	91	192	202	0	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1993	2002		10.1016/S0140-6736(15)60907-2	http://dx.doi.org/10.1016/S0140-6736(15)60907-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	26090645				2022-12-28	WOS:000354541700033
J	Douketis, JD; Spyropoulos, AC; Kaatz, S; Becker, RC; Caprini, JA; Dunn, AS; Garcia, DA; Jacobson, A; Jaffer, AK; Kong, DF; Schulman, S; Turpie, AGG; Hasselblad, V; Ortel, TL				Douketis, James D.; Spyropoulos, Alex C.; Kaatz, Scott; Becker, Richard C.; Caprini, Joseph A.; Dunn, Andrew S.; Garcia, David A.; Jacobson, Alan; Jaffer, Amir K.; Kong, David F.; Schulman, Sam; Turpie, Alexander G. G.; Hasselblad, Vic; Ortel, Thomas L.		Bridge Investigators	Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; TERM ORAL ANTICOAGULANTS; VITAMIN-K-ANTAGONISTS; TEMPORARY INTERRUPTION; WARFARIN INTERRUPTION; CLINICAL-OUTCOMES; MANAGEMENT; THERAPY; SURGERY; DABIGATRAN	BACKGROUND It is uncertain whether bridging anticoagulation is necessary for patients with atrial fibrillation who need an interruption in warfarin treatment for an elective operation or other elective invasive procedure. We hypothesized that forgoing bridging anticoagulation would be noninferior to bridging with low-molecular-weight heparin for the prevention of perioperative arterial thromboembolism and would be superior to bridging with respect to major bleeding. METHODS We performed a randomized, double-blind, placebo-controlled trial in which, after perioperative interruption of warfarin therapy, patients were randomly assigned to receive bridging anticoagulation therapy with low-molecular-weight heparin (100 IU of dalteparin per kilogram of body weight) or matching placebo administered subcutaneously twice daily, from 3 days before the procedure until 24 hours before the procedure and then for 5 to 10 days after the procedure. Warfarin treatment was stopped 5 days before the procedure and was resumed within 24 hours after the procedure. Follow-up of patients continued for 30 days after the procedure. The primary outcomes were arterial thromboembolism (stroke, systemic embolism, or transient ischemic attack) and major bleeding. RESULTS In total, 1884 patients were enrolled, with 950 assigned to receive no bridging therapy and 934 assigned to receive bridging therapy. The incidence of arterial thromboembolism was 0.4% in the no-bridging group and 0.3% in the bridging group (risk difference, 0.1 percentage points; 95% confidence interval [CI], -0.6 to 0.8; P = 0.01 for noninferiority). The incidence of major bleeding was 1.3% in the no-bridging group and 3.2% in the bridging group (relative risk, 0.41; 95% CI, 0.20 to 0.78; P = 0.005 for superiority). CONCLUSIONS In patients with atrial fibrillation who had warfarin treatment interrupted for an elective operation or other elective invasive procedure, forgoing bridging anticoagulation was noninferior to perioperative bridging with low-molecular-weight heparin for the prevention of arterial thromboembolism and decreased the risk of major bleeding.	[Douketis, James D.] Duke Univ, Med Ctr, Box 3422, Durham, NC 27710 USA; [Douketis, James D.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Kaatz, Scott; Turpie, Alexander G. G.] McMaster Univ, Hamilton Hlth Sci Ctr, Hamilton, ON, Canada; [Spyropoulos, Alex C.] Mt Sinai Med Ctr, Long Isl Jewish Sch Med, Hofstra North Shore, Manhasset, NY USA; [Kaatz, Scott] Hurley Med Ctr, Flint, MI USA; [Becker, Richard C.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Caprini, Joseph A.] NorthShore Univ Healthsyst, Evanston, IL USA; [Jaffer, Amir K.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Garcia, David A.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Jacobson, Alan] Vet Affairs Loma Linda Healthcare Syst, Loma Linda, CA USA; [Kong, David F.; Hasselblad, Vic] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Ortel, Thomas L.] Duke Univ, Ctr Med, Dept Med, Durham, NC USA	Duke University; McMaster University; McMaster University; Hofstra University; University System of Ohio; University of Cincinnati; NorthShore University Health System; Rush University; University of Washington; University of Washington Seattle; Duke University; Duke University	Ortel, TL (corresponding author), Duke Univ, Med Ctr, Box 3422, Durham, NC 27710 USA.	thomas.ortel@duke.edu	Douketis, James/AAO-5659-2021; Faltas, Bishoy Morris/J-5739-2019; Schulman, Sam/I-7559-2019; caprini, joseph/AAH-4750-2019	Faltas, Bishoy Morris/0000-0002-6432-1693; Schulman, Sam/0000-0002-8512-9043; Ritchie, Bruce/0000-0003-4754-1050	National Heart, Lung, and Blood Institute of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087229, U01HL086755] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health; BRIDGE ClinicalTrials.gov number, NCT00786474.	[Anonymous], 2010, STATXACT VERS 9 CYT; Ansell JE, 2003, ARCH INTERN MED, V163, P881, DOI 10.1001/archinte.163.8.881; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Baron TH, 2013, NEW ENGL J MED, V368, P2113, DOI 10.1056/NEJMra1206531; Beyer-Westendorf J, 2014, EUR HEART J, V35, P1888, DOI 10.1093/eurheartj/eht557; Birnie DH, 2013, NEW ENGL J MED, V368, P2084, DOI 10.1056/NEJMoa1302946; Cheung CC, 2015, AM J MED, V128, P532, DOI 10.1016/j.amjmed.2014.11.030; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Desai NR, 2014, AM J MED, V127, P1075, DOI 10.1016/j.amjmed.2014.05.013; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Douketis JD, 2015, THROMB HAEMOSTASIS, V113, P625, DOI 10.1160/TH14-04-0305; Douketis JD, 2012, CIRCULATION, V125, pE496, DOI 10.1161/CIRCULATIONAHA.111.084517; Douketis JD, 2005, THROMB HAEMOSTASIS, V94, P528, DOI 10.1160/TH05-01-0064; Douketis JD, 2004, ARCH INTERN MED, V164, P1319, DOI 10.1001/archinte.164.12.1319; Douketis JD, 2012, CHEST S, V141; Dunn AS, 2007, J THROMB HAEMOST, V5, P2211, DOI 10.1111/j.1538-7836.2007.02729.x; Dunn AS, 2003, ARCH INTERN MED, V163, P901, DOI 10.1001/archinte.163.8.901; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gallego P, 2012, CIRCULATION, V126, P1573, DOI 10.1161/CIRCULATIONAHA.112.135681; Garcia D, 2014, BLOOD, V124, P3692, DOI 10.1182/blood-2014-08-595496; Garcia DA, 2008, ARCH INTERN MED, V168, P63, DOI 10.1001/archinternmed.2007.23; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; GRIP L, 1991, EUR HEART J, V12, P1225, DOI 10.1093/eurheartj/12.11.1225; Halbritter KM, 2005, J THROMB HAEMOST, V3, P2823, DOI 10.1111/j.1538-7836.2005.01674.x; Healey JS, 2012, CIRCULATION, V126, pE160, DOI 10.1161/CIR.0b013e31826e4424; Healey JS, 2012, CIRCULATION, V126, P343, DOI 10.1161/CIRCULATIONAHA.111.090464; Kaatz S, 2010, J THROMB HAEMOST, V8, P884, DOI 10.1111/j.1538-7836.2010.03781.x; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; Kosir MA, 1998, J SURG RES, V74, P96, DOI 10.1006/jsre.1997.5233; Kovacs MJ, 2004, CIRCULATION, V110, P1658, DOI 10.1161/01.CIR.0000142859.77578.C9; Malato A, 2010, J THROMB HAEMOST, V8, P107, DOI 10.1111/j.1538-7836.2009.03649.x; O'Donnell MJ, 2007, ANN INTERN MED, V146, P184, DOI 10.7326/0003-4819-146-3-200702060-00007; Olesen JB, 2015, EUROPACE, V17, P187, DOI 10.1093/europace/euu225; Palareti G, 1996, CLIN PHARMACOKINET, V30, P300, DOI 10.2165/00003088-199630040-00003; Patel JP, 2014, BRIT J HAEMATOL, V164, P619, DOI 10.1111/bjh.12644; Pengo V, 2009, CIRCULATION, V119, P2920, DOI 10.1161/CIRCULATIONAHA.108.823211; Piazza Gregory, 2003, Crit Pathw Cardiol, V2, P96, DOI 10.1097/01.hpc.0000077042.02114.15; Schulman S, 2014, J THROMB HAEMOST, V12, P1254, DOI 10.1111/jth.12613; Sherwood MW, 2014, CIRCULATION, V129, P1850, DOI 10.1161/CIRCULATIONAHA.113.005754; Siegal D, 2012, CIRCULATION, V126, P1630, DOI 10.1161/CIRCULATIONAHA.112.105221; Spyropoulos AC, 2006, J THROMB HAEMOST, V4, P1246, DOI 10.1111/j.1538-7836.2006.01908.x; Spyropoulos AC, 2012, THROMB HAEMOSTASIS, V108, P213, DOI 10.1160/TH12-04-0217; Steinberg BA, 2015, CIRCULATION, V131, P488, DOI 10.1161/CIRCULATIONAHA.114.011777; Wysokinski WE, 2008, MAYO CLIN PROC, V83, P639, DOI 10.4065/83.6.639; Xu Yan, 2013, CMAJ Open, V1, pE115, DOI 10.9778/cmajo.20130032	47	663	680	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					823	833		10.1056/NEJMoa1501035	http://dx.doi.org/10.1056/NEJMoa1501035			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP8VC	26095867	Green Accepted			2022-12-28	WOS:000360171700008
J	Bao, J; Bawendi, MG				Bao, Jie; Bawendi, Moungi G.			A colloidal quantum dot spectrometer	NATURE			English	Article							CDSE; NANOCRYSTALS; RESOLUTION; LIGHT; REGRESSION; DESIGN; FILTER; MODEL; SIZE	Spectroscopy is carried out in almost every field of science, whenever light interacts with matter(1). Although sophisticated instruments with impressive performance characteristics are available, much effort continues to be invested in the development of miniaturized, cheap and easy-to-use systems(1-13). Current microspectrometer designs mostly use interference filters(2-5) and interferometric optics(3) that limit their photon efficiency, resolution and spectral range(2,3). Here we show that many of these limitations can be overcome by replacing interferometric optics with a two-dimensional absorptive filter array composed of colloidal quantum dots(14-17). Instead of measuring different bands of a spectrum individually after introducing temporal or spatial separations with gratings or interference-based narrow-band filters, a colloidal quantum dot spectrometer measures a light spectrum based on the wavelength multiplexing principle(18): multiple spectral bands are encoded and detected simultaneously with one filter and one detector(9-12), respectively, with the array format allowing the process to be efficiently repeated many times using different filters with different encoding so that sufficient information is obtained to enable computational reconstruction of the target spectrum. We illustrate the performance of such a quantum dot microspectrometer, made from 195 different types of quantum dots with absorption features that cover a spectral range of 300 nanometres, by measuring shifts in spectral peak positions as small as one nanometre. Given this performance, demonstrable avenues for further improvement, the ease with which quantum dots can be processed and integrated, and their numerous finely tuneable bandgaps that cover a broad spectral range, we expect that quantum dot micro-spectrometers will be useful in applications where minimizing size, weight, cost and complexity of the spectrometer are critical.	[Bao, Jie] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China; [Bao, Jie; Bawendi, Moungi G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Bao, Jie] CALTECH, Dept Phys, Pasadena, CA 91125 USA	Tsinghua University; Massachusetts Institute of Technology (MIT); California Institute of Technology	Bao, J (corresponding author), Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China.	bao@tsinghua.edu.cn			ARO through the Institute for Soldier Nanotechnologies [W911NF-07-D-0004]; Tsinghua University; Division of Physics, Mathematics and Astronomy at the California Institute of Technology	ARO through the Institute for Soldier Nanotechnologies; Tsinghua University; Division of Physics, Mathematics and Astronomy at the California Institute of Technology	The inception, experiments and initial analysis in this work was funded by the ARO through the Institute for Soldier Nanotechnologies (W911NF-07-D-0004). During further analysis and modelling, J.B. was supported by Tsinghua University and the Division of Physics, Mathematics and Astronomy at the California Institute of Technology.	Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Bacon CP, 2004, REV SCI INSTRUM, V75, P1, DOI 10.1063/1.1633025; Bangalore AS, 1996, ANAL CHEM, V68, P4200, DOI 10.1021/ac9607121; BRUS LE, 1983, J CHEM PHYS, V79, P5566, DOI 10.1063/1.445676; Cao YC, 2004, J AM CHEM SOC, V126, P14336, DOI 10.1021/ja0459678; Chen O, 2008, ANGEW CHEM INT EDIT, V47, P8638, DOI 10.1002/anie.200804266; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Chuang CHM, 2014, NAT MATER, V13, P796, DOI [10.1038/nmat3984, 10.1038/NMAT3984]; Ciric-Marjanovic G, 2011, J POLYM SCI POL CHEM, V49, P3387, DOI 10.1002/pola.24775; DEMRO JC, 1995, P SOC PHOTO-OPT INS, V2480, P280, DOI 10.1117/12.210883; EFROS AL, 1982, SOV PHYS SEMICOND+, V16, P772; Emadi A, 2012, OPT EXPRESS, V20, P489, DOI 10.1364/OE.20.000489; Gan XT, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4724177; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; James J. F., 1969, DESIGN OPTICAL SPECT; Kim L, 2008, NANO LETT, V8, P4513, DOI 10.1021/nl8025218; Kim TH, 2011, NAT PHOTONICS, V5, P176, DOI 10.1038/NPHOTON.2011.12; Knipp D, 2005, IEEE T ELECTRON DEV, V52, P419, DOI 10.1109/TED.2005.843880; Kurokawa U, 2011, IEEE SENS J, V11, P1556, DOI 10.1109/JSEN.2010.2103054; Laux E, 2008, NAT PHOTONICS, V2, P161, DOI 10.1038/nphoton.2008.1; Le Coarer E, 2007, NAT PHOTONICS, V1, P473, DOI 10.1038/nphoton.2007.138; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; NORRIS DJ, 1994, PHYS REV LETT, V72, P2612, DOI 10.1103/PhysRevLett.72.2612; Oliver J, 2012, OPT EXPRESS, V20, P2613, DOI 10.1364/OE.20.002613; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Pervez NK, 2010, OPT EXPRESS, V18, P8277, DOI 10.1364/OE.18.008277; Qu LH, 2001, NANO LETT, V1, P333, DOI 10.1021/nl0155532; Redding B, 2013, NAT PHOTONICS, V7, P746, DOI [10.1038/nphoton.2013.190, 10.1038/NPHOTON.2013.190]; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Rogach A.L., 2008, SEMICONDUCTOR NANOCR, P1; Sharma SN, 2003, J PHYS CHEM B, V107, P10088, DOI 10.1021/jp034109f; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Vigneau E, 1997, J CHEMOMETR, V11, P239, DOI 10.1002/(SICI)1099-128X(199705)11:3<239::AID-CEM470>3.0.CO;2-A; Wang SW, 2007, OPT LETT, V32, P632, DOI 10.1364/OL.32.000632; Waring D. R., 1990, CHEM APPL DYES; Wolffenbuttel RF, 2004, IEEE T INSTRUM MEAS, V53, P197, DOI 10.1109/TIM.2003.821490; Xu T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1058	38	315	340	32	596	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					67	+		10.1038/nature14576	http://dx.doi.org/10.1038/nature14576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135449				2022-12-28	WOS:000357169500032
J	Conrad, J				Conrad, Jan			Reproducibility: Don't cry wolf	NATURE			English	Editorial Material									Stockholm Univ, Oskar Klein Ctr Cosmoparticle Phys, Astroparticle Phys, S-10691 Stockholm, Sweden	Oskar Klein Centre; Stockholm University	Conrad, J (corresponding author), Stockholm Univ, Oskar Klein Ctr Cosmoparticle Phys, Astroparticle Phys, S-10691 Stockholm, Sweden.	conrad@fysik.su.se						Ade PAR, 2015, ASTRON ASTROPHYS, V576, DOI 10.1051/0004-6361/201424088; Ade PAR, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.101301; Ade PAR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.241101; Ellis G, 2014, NATURE, V516, P321, DOI 10.1038/516321a; Fermi LAT Collaboration & DES Collaboration, 2015, PREPRINT; Geringer-Sameth A., 2015, PREPRINT; Overbye D., 2015, NY TIMES	7	3	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					27	28		10.1038/523027a	http://dx.doi.org/10.1038/523027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135433	Bronze			2022-12-28	WOS:000357169500013
J	Fuhs, SR; Meisenhelder, J; Aslanian, A; Ma, L; Zagorska, A; Stankova, M; Binnie, A; Al-Obeidi, F; Mauger, J; Lemke, G; Yates, JR; Hunter, T				Fuhs, Stephen Rush; Meisenhelder, Jill; Aslanian, Aaron; Ma, Li; Zagorska, Anna; Stankova, Magda; Binnie, Alan; Al-Obeidi, Fahad; Mauger, Jacques; Lemke, Greg; Yates, John R., III; Hunter, Tony			Monoclonal 1-and 3-Phosphohistidine Antibodies: New Tools to Study Histidine Phosphorylation	CELL			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; PHOSPHOHISTIDINE; PROTEINS; DYNAMIN; METASTASIS; SUPPRESSOR; CELLS; FOCUS; RAS; GTP	Histidine phosphorylation (pHis) is well studied in bacteria; however, its role in mammalian signaling remains largely unexplored due to the lack of pHis-specific antibodies and the lability of the phosphoramidate (P-N) bond. Both imidazole nitrogens can be phosphorylated, forming 1-phosphohistidine (1-pHis) or 3-phosphohistidine (3-pHis). We have developed monoclonal antibodies (mAbs) that specifically recognize 1-pHis or 3-pHis; they do not cross-react with phosphotyrosine or the other pHis isomer. Assays based on the isomer-specific autophosphorylation of NME1 and phosphoglycerate mutase were used with immunoblotting and sequencing IgG variable domains to screen, select, and characterize anti-1-pHis and anti-3-pHis mAbs. Their sequence independence was determined by blotting synthetic peptide arrays, and they have been tested for immunofluorescence staining and immunoaffinity purification, leading to putative identification of pHis-containing proteins. These reagents should be broadly useful for identification of pHis substrates and functional study of pHis using a variety of immunological, proteomic, and biological assays.	[Fuhs, Stephen Rush; Meisenhelder, Jill; Aslanian, Aaron; Ma, Li; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Zagorska, Anna; Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Stankova, Magda; Binnie, Alan; Al-Obeidi, Fahad; Mauger, Jacques] Sanofi, Tucson Innovat Ctr, Tucson, AZ 85755 USA; [Aslanian, Aaron; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Sanofi-Aventis; Scripps Research Institute	Hunter, T (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu			USPHS [CA80100, CA82683, CA194584]; Helmsley Center for Genomic Medicine; NIH [2 T32 CA009370, R01 NS085296]; Salk Institute Innovation Grant; Human Frontiers Science Program; Genentech Foundation Fellowship for Cancer Research; NCRR [5P41RR011823-17]; NIGMS [8P41GM103533-17];  [P30CA14195]; NATIONAL CANCER INSTITUTE [R01CA080100, P30CA014195, R01CA082683, R01CA194584, T32CA009370] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085296] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Helmsley Center for Genomic Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Salk Institute Innovation Grant; Human Frontiers Science Program(Human Frontier Science Program); Genentech Foundation Fellowship for Cancer Research; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Joseph Kim and Ronghua Li at Sanofi for peptide synthesis and William Brondyk (Genzyme) and Jean-Dominique Guitton (Sanofi) for large-scale mAb purification. This work was supported by USPHS grants (CA80100, CA82683, and CA194584) (to T.H.) and made use of the Peptide Synthesis and Biophotonics Cores (supported by P30CA14195). The Helmsley Center for Genomic Medicine also provided support. S.R.F. received funding from an NIH training grant (2 T32 CA009370) and a Salk Institute Innovation Grant. T.H. is a Frank and Else Schilling American Cancer Society Professor and holds the Renato Dulbecco Chair in Cancer Research. A.Z. received support from the Human Frontiers Science Program. L.M. received a Genentech Foundation Fellowship for Cancer Research. G.L. received support from the NIH (R01 NS085296). J.R.Y. received support from an NCRR grant (5P41RR011823-17) and an NIGMS grant (8P41GM103533-17).	Attwood PV, 2007, AMINO ACIDS, V32, P145, DOI 10.1007/s00726-006-0443-6; Besant PG, 2012, BIOCHEM SOC T, V40, P290, DOI 10.1042/BST20110605; Boissan M, 2014, SCIENCE, V344, P1510, DOI 10.1126/science.1253768; BOYER PD, 1962, J BIOL CHEM, V237, P3306; Cai XJ, 2014, MOL BIOL CELL, V25, P1244, DOI 10.1091/mbc.E13-04-0180; Conery AR, 2010, P NATL ACAD SCI USA, V107, P15461, DOI 10.1073/pnas.1010633107; FRACKELTON AR, 1983, MOL CELL BIOL, V3, P1343, DOI 10.1128/MCB.3.8.1343; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fraser ME, 2000, J MOL BIOL, V299, P1325, DOI 10.1006/jmbi.2000.3807; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Gonzalez-Sanchez MB, 2013, BIOCHEM SOC T, V41, P1089, DOI 10.1042/BST20130072; Hamby CV, 2000, INT J CANCER, V88, P547, DOI 10.1002/1097-0215(20001115)88:4<547::AID-IJC5>3.0.CO;2-L; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; Kee JM, 2015, ORG LETT, V17, P187, DOI 10.1021/ol503320p; Kee JM, 2013, NAT CHEM BIOL, V9, P416, DOI [10.1038/NCHEMBIO.1259, 10.1038/nchembio.1259]; Kee JM, 2012, ACS CHEM BIOL, V7, P44, DOI 10.1021/cb200445w; Kee JM, 2010, J AM CHEM SOC, V132, P14327, DOI 10.1021/ja104393t; Lapek JD, 2015, N-S ARCH PHARMACOL, V388, P161, DOI 10.1007/s00210-014-1063-4; Matthews H, 1995, PHARMACOL THERAPEUT, V67, P232; McAllister TE, 2012, ORG BIOMOL CHEM, V10, P4043, DOI 10.1039/c2ob25517k; McAllister TE, 2011, CHEM COMMUN, V47, P1297, DOI 10.1039/c0cc04238b; MORERA S, 1994, J MOL BIOL, V243, P873, DOI 10.1006/jmbi.1994.1689; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PESIS KH, 1988, FEBS LETT, V239, P151, DOI 10.1016/0014-5793(88)80563-5; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Thakur RK, 2011, N-S ARCH PHARMACOL, V384, P397, DOI 10.1007/s00210-011-0631-0; Tso PH, 2013, CELL SIGNAL, V25, P1064, DOI 10.1016/j.cellsig.2013.02.010; WAGNER PD, 1995, J BIOL CHEM, V270, P21758, DOI 10.1074/jbc.270.37.21758; Wieland T, 2010, METHOD ENZYMOL, V471, P379, DOI 10.1016/S0076-6879(10)71020-X; Zhang X, 2008, CURR PROTOC IMMUNOL, V14	36	123	126	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					198	210		10.1016/j.cell.2015.05.046	http://dx.doi.org/10.1016/j.cell.2015.05.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140597	Green Accepted, Bronze			2022-12-28	WOS:000357542300020
J	Kaptchuk, TJ; Miller, FG				Kaptchuk, Ted J.; Miller, Franklin G.			Placebo Effects in Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kaptchuk, Ted J.] Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA; [Kaptchuk, Ted J.] Harvard Univ, Sch Med, Boston, MA USA; [Miller, Franklin G.] NIH, Ctr Clin, Dept Bioeth, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kaptchuk, TJ (corresponding author), Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA.							Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Hall KT, 2015, TRENDS MOL MED, V21, P285, DOI 10.1016/j.molmed.2015.02.009; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319	5	255	259	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					8	9		10.1056/NEJMp1504023	http://dx.doi.org/10.1056/NEJMp1504023			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL8IS	26132938				2022-12-28	WOS:000357218700003
J	Fredrickson, JK				Fredrickson, James K.			Ecological communities by design	SCIENCE			English	Editorial Material							ADAPTATION; CONSORTIA		Pacific NW Natl Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Fredrickson, JK (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	jim.fredrickson@pnnl.gov						Asfahl KL, 2015, ISME J, V9, P1734, DOI 10.1038/ismej.2014.259; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; He XS, 2014, ISME J, V8, P564, DOI 10.1038/ismej.2013.172; He XS, 2010, MICROB ECOL, V60, P655, DOI 10.1007/s00248-010-9708-4; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Johnson DR, 2012, ISME J, V6, P1985, DOI 10.1038/ismej.2012.46; Lee KWK, 2014, ISME J, V8, P894, DOI 10.1038/ismej.2013.194; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Minty JJ, 2013, P NATL ACAD SCI USA, V110, P14592, DOI 10.1073/pnas.1218447110; Pande S, 2014, ISME J, V8, P953, DOI 10.1038/ismej.2013.211; Sison-Mangus MP, 2014, ISME J, V8, P63, DOI 10.1038/ismej.2013.138; Waite AJ, 2012, P NATL ACAD SCI USA, V109, P19079, DOI 10.1073/pnas.1210190109; Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108297	14	48	51	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1425	1427		10.1126/science.aab0946	http://dx.doi.org/10.1126/science.aab0946			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3RW	26113703				2022-12-28	WOS:000356869100018
J	Dolgin, E				Dolgin, Elie			TECHNOLOGY Barriers to misuse	NATURE			English	Editorial Material																		Butler SF, 2013, J PAIN, V14, P351, DOI 10.1016/j.jpain.2012.08.008; Degenhardt L., 2015, DRUG ALCOHOL DEPEND; Kirson NY, 2014, PAIN MED, V15, P1450, DOI 10.1111/pme.12489	3	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					S60	S61		10.1038/522S60a	http://dx.doi.org/10.1038/522S60a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2OC	26107099	Bronze			2022-12-28	WOS:000356782900007
J	Vaduganathan, M; Johnson, JH				Vaduganathan, Muthiah; Johnson, Jacob H.			Ping-Pong Gaze	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vaduganathan, Muthiah; Johnson, Jacob H.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Vaduganathan, M (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	mvaduganathan@partners.org							0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					E34	E34		10.1056/NEJMicm1408161	http://dx.doi.org/10.1056/NEJMicm1408161			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2QD	26107068				2022-12-28	WOS:000356788200001
J	Mozaffarian, D; Ludwig, DS				Mozaffarian, Dariush; Ludwig, David S.			The 2015 US Dietary Guidelines Lifting the Ban on Total Dietary Fat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERUM-LIPIDS		[Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA USA	Tufts University; Harvard University; Boston Children's Hospital	Mozaffarian, D (corresponding author), 150 Harrison Ave, Boston, MA 02111 USA.	dariush.mozaffarian@tufts.edu	Mozaffarian, Dariush/ABC-2822-2020	Ludwig, David/0000-0003-3307-8544	NHLBI NIH HHS [R01 HL115189] Funding Source: Medline; NIDDK NIH HHS [K24DK082730, K24 DK082730] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], WE CAN WAYS ENH CHIL; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Dietary Guidelines Advisory Committee, 2015, RAPP ACT 2015 REP PE; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mozaffarian D, 2014, BRAUNWALDS HEART DIS; United States Department of Agriculture, 2015, SMART SNACKS SCH USD	8	96	98	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2421	2422		10.1001/jama.2015.5941	http://dx.doi.org/10.1001/jama.2015.5941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103023	Green Accepted			2022-12-28	WOS:000356663600006
J	Whiting, PF; Wolff, RF; Deshpande, S; Di Nisio, M; Duffy, S; Hernandez, AV; Keurentjes, JC; Lang, S; Misso, K; Ryder, S; Schmidlkofer, S; Westwood, M; Kleijnen, J				Whiting, Penny F.; Wolff, Robert F.; Deshpande, Sohan; Di Nisio, Marcello; Duffy, Steven; Hernandez, Adrian V.; Keurentjes, J. Christiaan; Lang, Shona; Misso, Kate; Ryder, Steve; Schmidlkofer, Simone; Westwood, Marie; Kleijnen, Jos			Cannabinoids for Medical Use A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CHEMOTHERAPY-INDUCED NAUSEA; CENTRAL NEUROPATHIC PAIN; RANDOMIZED CONTROLLED-TRIAL; BRACHIAL-PLEXUS AVULSION; PLACEBO-CONTROLLED TRIAL; MULTIPLE-SCLEROSIS CAMS; DOUBLE-BLIND; CANCER-CHEMOTHERAPY; TOURETTE-SYNDROME; MEDICINAL EXTRACTS	IMPORTANCE Cannabis and cannabinoid drugs are widely used to treat disease or alleviate symptoms, but their efficacy for specific indications is not clear. OBJECTIVE To conduct a systematic review of the benefits and adverse events (AEs) of cannabinoids. DATA SOURCES Twenty-eight databases from inception to April 2015. STUDY SELECTION Randomized clinical trials of cannabinoids for the following indications: nausea and vomiting due to chemotherapy, appetite stimulation in HIV/AIDS, chronic pain, spasticity due to multiple sclerosis or paraplegia, depression, anxiety disorder, sleep disorder, psychosis, glaucoma, or Tourette syndrome. DATA EXTRACTION AND SYNTHESIS Study quality was assessed using the Cochrane risk of bias tool. All review stages were conducted independently by 2 reviewers. Where possible, data were pooled using random-effects meta-analysis. MAIN OUTCOMES AND MEASURES Patient-relevant/disease-specific outcomes, activities of daily living, quality of life, global impression of change, and AEs. RESULTS A total of 79 trials (6462 participants) were included; 4 were judged at low risk of bias. Most trials showed improvement in symptoms associated with cannabinoids but these associations did not reach statistical significance in all trials. Compared with placebo, cannabinoids were associated with a greater average number of patients showing a complete nausea and vomiting response (47% vs 20%; odds ratio [OR], 3.82 [95% CI, 1.55-9.42]; 3 trials), reduction in pain (37% vs 31%; OR, 1.41 [95% CI, 0.99-2.00]; 8 trials), a greater average reduction in numerical rating scale pain assessment (on a 0-10-point scale; weighted mean difference [WMD], -0.46 [95% CI, -0.80 to -0.11]; 6 trials), and average reduction in the Ashworth spasticity scale (WMD, -0.36 [95% CI, -0.69 to -0.05]; 7 trials). There was an increased risk of short-term AEs with cannabinoids, including serious AEs. Common AEs included dizziness, dry mouth, nausea, fatigue, somnolence, euphoria, vomiting, disorientation, drowsiness, confusion, loss of balance, and hallucination. CONCLUSIONS AND RELEVANCE There was moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity. There was low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV infection, sleep disorders, and Tourette syndrome. Cannabinoids were associated with an increased risk of short-term AEs.	[Whiting, Penny F.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Whiting, Penny F.] Bristol NHS Fdn Trust, Univ Hosp, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Bristol, Avon, England; [Whiting, Penny F.; Wolff, Robert F.; Deshpande, Sohan; Duffy, Steven; Lang, Shona; Misso, Kate; Ryder, Steve; Westwood, Marie; Kleijnen, Jos] Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England; [Di Nisio, Marcello] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Di Nisio, Marcello] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Hernandez, Adrian V.] Univ Peruana Ciencias Aplicadas UPC, Sch Med, Lima, Peru; [Hernandez, Adrian V.] Cleveland Clin, Dept Quantitat Hlth Sci, Hlth Outcomes & Clin Epidemiol Sect, Lerner Res Inst, Cleveland, OH 44106 USA; [Keurentjes, J. Christiaan] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Schmidlkofer, Simone] Cepicon GmbH, Inst Epidemiol & Kongenitale Erkrankungen, Hamburg, Germany; [Kleijnen, Jos] Maastricht Univ, Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands	University of Bristol; Kleijnen Systematic Reviews; G d'Annunzio University of Chieti-Pescara; University of Amsterdam; Academic Medical Center Amsterdam; Universidad Peruana de Ciencias Aplicadas (UPC); Cleveland Clinic Foundation; Radboud University Nijmegen; Maastricht University	Whiting, PF (corresponding author), Univ Hosp Bristol NHS Fdn Trust, NIHR CLAHRC West, Ninth Floor, Bristol BS1 2NT, Avon, England.	penny.whiting@bristol.ac.uk	Lang, Shona Helen/M-8397-2019; Duffy, Steven/E-2327-2016; Hernandez, Adrian V./ABD-4616-2021; Misso, Kate/D-2060-2016; Wolff, Robert F/E-2322-2016	Lang, Shona Helen/0000-0002-4883-8393; Duffy, Steven/0000-0001-7335-8167; Hernandez, Adrian V./0000-0002-9999-4003; Misso, Kate/0000-0002-4924-4327; Wolff, Robert F/0000-0003-3270-7791; Whiting, Penny/0000-0003-1138-5682	Swiss Federal Office of Public Health (FOPH) [14.001443/204.0001/-1257]	Swiss Federal Office of Public Health (FOPH)	This funded by the Swiss Federal Office of Public Health (FOPH) under grant agreement 14.001443/204.0001/-1257.	Abrams DI, 2007, NEUROLOGY, V68, P515, DOI 10.1212/01.wnl.0000253187.66183.9c; Abrams DI, 2003, ANN INTERN MED, V139, P258, DOI 10.7326/0003-4819-139-4-200308190-00008; Abrams DI, 2005, IACM 3 C CANN MED SE; AHMEDZAI S, 1983, BRIT J CANCER, V48, P657, DOI 10.1038/bjc.1983.247; [Anonymous], INT C HARM TECHN REQ; BEAL JE, 1995, J PAIN SYMPTOM MANAG, V10, P89, DOI 10.1016/0885-3924(94)00117-4; Bergamaschi MM, 2011, NEUROPSYCHOPHARMACOL, V36, P1219, DOI 10.1038/npp.2011.6; Berman, 2007, BRIT PAIN SOC ANN SC; Berman J, 2003, ANAESTHESIA, V58, P938, DOI 10.1046/j.1365-2044.2003.03408_3.x; Berman JS, 2004, PAIN, V112, P299, DOI 10.1016/j.pain.2004.09.013; Blake DR, 2006, RHEUMATOLOGY, V45, P50, DOI 10.1093/rheumatology/kei183; Boers M, 2010, J CLIN EPIDEMIOL, V63, P813, DOI 10.1016/j.jclinepi.2010.01.002; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boychuk DG, 2015, J ORAL FACIAL PAIN H, V29, P7, DOI 10.11607/ofph.1274; Brigham and Women's Hospital; Solvay Pharmaceuticals, STUD EV EFF DRON MAR; Broder LE, 1982, P AM ASSOC CANC RES, V23, P514; Brook JS, 2010, NICOTINE TOB RES, V12, P474, DOI 10.1093/ntr/ntq027; Burns TL, 2006, ANN PHARMACOTHER, V40, P251, DOI 10.1345/aph.1G217; Cambridge Laboratories Ltd, RAND CROSS DOUBL BLI; Campbell FA, 2001, BMJ-BRIT MED J, V323, P13, DOI 10.1136/bmj.323.7303.13; Canadian Agency for Drugs and Technologies in Health, 2013, CADTH PEER REV CHECK; Canadian Agency for Drugs and Technologies in Health (CADTH), 2010, CANN COAN REV CLIN E; Canadian Agency for Drugs and Technologies in Health (CADTH), 2010, CANN MAN NEUR PAIN R; Center for Medicinal Cannabis Research, EFF SMOK MAR NEUR PA; Center for Medicinal Cannabis Research, MED CANN PAINF HIV N; Center for Medicinal Cannabis Research, SHORT TERM EFF MED C; Center for Medicinal Cannabis Research, EFF INH CANN DIAB PA; Center for Medicinal Cannabis Research, MAR HIV REL PER NEUR; Centre for Reviews and Dissemination, SYST REV CRDS GUID U; Chan HS, 1984, P AN M AM SOC CLIN, V3, P108; CHAN HSL, 1987, PEDIATRICS, V79, P946; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Collin C, 2010, NEUROL RES, V32, P451, DOI 10.1179/016164109X12590518685660; Collin C, 2006, 22 C ECTRIMS SEPT 27; Corey-Bloom J, 2008, NEUROLOGY, V70, pA86; Corey-Bloom J, 2012, CAN MED ASSOC J, V184, P1143, DOI 10.1503/cmaj.110837; Curtis A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006565.pub2; DALZELL AM, 1986, ARCH DIS CHILD, V61, P502, DOI 10.1136/adc.61.5.502; Davis MP, 2008, EXPERT OPIN INV DRUG, V17, P85, DOI 10.1517/13543784.17.1.85; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duran M, 2010, BRIT J CLIN PHARMACO, V70, P656, DOI 10.1111/j.1365-2125.2010.03743.x; EINHORN LH, 1981, J CLIN PHARMACOL, V21, pS64, DOI 10.1002/j.1552-4604.1981.tb02576.x; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Ellis RJ, 2009, NEUROPSYCHOPHARMACOL, V34, P672, DOI 10.1038/npp.2008.120; Fitzcharles MA, 2009, ARTHRITIS RHEUM, V60, P1429; Frank B, 2008, BRIT MED J, V336, P199, DOI 10.1136/bmj.39429.619653.80; Freeman RM, 2006, INT UROGYNECOL J, V17, P636, DOI 10.1007/s00192-006-0086-x; FRYTAK S, 1979, P AM ASSOC CANC RES, V20, P391; FRYTAK S, 1979, ANN INTERN MED, V91, P825, DOI 10.7326/0003-4819-91-6-825; GEORGE M, 1983, BIOMED PHARMACOTHER, V37, P24; Gesellschaft fuer klinische Forschung e.V, MULT SCLER EXTR CANN; Grunberg SM, 2012, J CLIN ONCOL, V30; Guerra, 2012, BR J NEUROSCI NURS, V8, P71, DOI DOI 10.12968/BJNN.2012.8.2.71; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; GW Pharma Ltd, DOUBL BLIND RAND PLA; GW Pharma Ltd, DOUBL BLIND RAND PLA; GW Pharmaceuticals Ltd, STUD EV EFF SAT REL; GW Pharmaceuticals Ltd, SAT VERS PLAC ADD EX; GW Pharmaceuticals Ltd, STUD SAT PAIN REL DU; GW Pharmaceuticals Ltd, STUD SAT TREATM CENT; GW Pharmaceuticals Ltd, STUD CANN BAS MED EX; GW Pharmaceuticals Ltd, STUD SAT REL PER NEU; GW Pharmaceuticals Ltd, STUD SAT PAIN REL PA; GW Pharmaceuticals Ltd, STUD SAT PAIN REL PE; GW Pharmaceuticals Ltd, STUD SAT REL SPAST S; GW Pharmaceuticals Ltd, INV DELT 9 TETR THC; GWPharmaceuticals Ltd, STUD EV EFF CANN BAS; Hagenbach U, 2003, IACM 2 C CANN MED SE; Harden-Harrison MM, 2012, SUPPORT CARE CANCER, V20, pS209; Hazekamp A, 2013, J PSYCHOACTIVE DRUGS, V45, P199, DOI 10.1080/02791072.2013.805976; Hazekamp A, 2013, EUR J CLIN PHARMACOL, V69, P1575, DOI 10.1007/s00228-013-1503-y; HEIM ME, 1984, CANCER CHEMOTH PHARM, V13, P123; HERMAN TS, 1979, NEW ENGL J MED, V300, P1295, DOI 10.1056/NEJM197906073002302; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hobart JC, 2012, MULT SCLER J, V18, P247; HUTCHEON AW, 1983, EUR J CANCER CLIN ON, V19, P1087, DOI 10.1016/0277-5379(83)90032-9; Institut fur Klinische Forschung Germany; Weleda AG, MULTIPLE SCLEROSIS E; Iskedjian M, 2007, CURR MED RES OPIN, V23, P17, DOI 10.1185/030079906X158066; Issa MA, 2014, CLIN J PAIN, V30, P472, DOI 10.1097/AJP.0000000000000022; Jawahar R, 2013, DRUGS, V73, P1711, DOI 10.1007/s40265-013-0125-0; Jhangiani H, 2005, BLOOD, V106, p477B, DOI 10.1182/blood.V106.11.5555.5555; JOHANSSON R, 1982, CANCER TREAT REV, V9, P25, DOI 10.1016/S0305-7372(82)80032-7; Johnson JR, 2010, J PAIN SYMPTOM MANAG, V39, P167, DOI 10.1016/j.jpainsymman.2009.06.008; JONES SE, 1982, CANCER TREAT REV, V9, P45, DOI 10.1016/S0305-7372(82)80035-2; Karst M, 2003, JAMA-J AM MED ASSOC, V290, P1757, DOI 10.1001/jama.290.13.1757; Killestein J, 2002, NEUROLOGY, V58, P1404, DOI 10.1212/WNL.58.9.1404; Killestein J, 2000, MULT SCLER S1, V6, pS28, DOI [10.1177/135245850000600101, DOI 10.1177/135245850000600101]; Kung T, 2011, J RHEUMATOL, V38, P1171; Lakhan SE, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-59; LANE M, 1991, J PAIN SYMPTOM MANAG, V6, P352, DOI 10.1016/0885-3924(91)90026-Z; Lane M, 1989, P AN M AM SOC CLIN, V8, P326; Langford RM, 2013, J NEUROL, V260, P984, DOI 10.1007/s00415-012-6739-4; Leocani L, 2014, COMMUNICATION, V20, P498, DOI 10.1177/1352458514547846; LEVITT M, 1982, CANCER TREAT REV, V9, P49, DOI 10.1016/S0305-7372(82)80036-4; Leweke FM, 2008, EUR NEUROPSYCHOPHARM, V18, pS171, DOI 10.1016/S0924-977X(08)70156-1; Leweke FM, 2009, EUR PSYCHIAT, V24; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Leweke FM, 2012, BIOL PSYCHIAT, V71, p63S; Leweke FMM, 2011, SCHIZOPHRENIA BULL, V37, P313; Leweke FM, 2010, NEUROPSYCHOPHARMA S1, V35, pS280, DOI [10.1038/npp.2010.217, DOI 10.1038/NPP.2010.217]; LONG A, 1982, P AM SOC CLIN ONCOL, V1; Lynch ME, 2015, J NEUROIMMUNE PHARM, V10, P293, DOI 10.1007/s11481-015-9600-6; Lynch Mary, SATIVEX TREATMENT CH; Lynch ME, 2014, J PAIN SYMPTOM MANAG, V47, P166, DOI 10.1016/j.jpainsymman.2013.02.018; Lynch ME, 2011, BRIT J CLIN PHARMACO, V72, P735, DOI 10.1111/j.1365-2125.2011.03970.x; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Martin-Sanchez E, 2009, PAIN MED, V10, P1353, DOI 10.1111/j.1526-4637.2009.00703.x; MCCABE M, 1981, P AM ASSOC CANC RES, V22, P416; MCCABE M, 1988, INVEST NEW DRUG, V6, P243; McGill University Health Center, NAB VERS AM IMPR QUA; McGowan J, 2010, EVID BASED LIB INF P, V5, P149, DOI 10.18438/B8SG8R; Medical Research Council (MRC), MULT RAND CONTR TRIA; Meiri E, 2007, CURR MED RES OPIN, V23, P533, DOI 10.1185/030079907X167525; Montreal General Hospital, PIL STUD SMOK CANN C; Muller-Vahl KR, 2003, J CLIN PSYCHIAT, V64, P459, DOI 10.4088/JCP.v64n0417; Muller-Vahl KR, 2003, NEUROPSYCHOPHARMACOL, V28, P384, DOI 10.1038/sj.npp.1300047; Muller-Vahl KR, 2002, PHARMACOPSYCHIATRY, V35, P57, DOI 10.1055/s-2002-25028; Muller-Vahl KR, 2001, PHARMACOPSYCHIATRY, V34, P19, DOI 10.1055/s-2001-15191; Narang S, 2008, J PAIN, V9, P254, DOI 10.1016/j.jpain.2007.10.018; NIEDERLE N, 1986, KLIN WOCHENSCHR, V64, P362, DOI 10.1007/BF01728184; NIIRANEN A, 1985, AM J CLIN ONCOL-CANC, V8, P336, DOI 10.1097/00000421-198508000-00013; NOYES R, 1975, J CLIN PHARMACOL, V15, P139, DOI 10.1002/j.1552-4604.1975.tb02348.x; Nurmikko TJ, 2005, NEUROLOGY, V64, pA374; Nurmikko TJ, 2007, PAIN, V133, P210, DOI 10.1016/j.pain.2007.08.028; O ffice of National Drug Control Policy, MAR RES CTR STAT LAW; Orr L E, 1980, Arch Intern Med, V140, P1431; ORR LE, 1981, J CLIN PHARMACOL, V21, pS76, DOI 10.1002/j.1552-4604.1981.tb02578.x; Parsai S, 2014, PHARMACOTHERAPY, V34, pE287; Phillips RS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007786.pub2; Phillips TJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014433; Pinsger M, 2012, EUR SPINE J, V21, P2366, DOI [10.1007/s00586-012-2522-6, DOI 10.1007/S00586-012-2522-6]; Pinsger M, 2006, WIEN KLIN WOCHENSCHR, V118, P327, DOI 10.1007/s00508-006-0611-4; Pittler MH, 2008, CLIN J PAIN, V24, P731, DOI 10.1097/AJP.0b013e3181759231; POMEROY M, 1986, CANCER CHEMOTH PHARM, V17, P285; Pooyania S, 2010, ARCH PHYS MED REHAB, V91, P703, DOI 10.1016/j.apmr.2009.12.025; Portenoy RK, 2012, J PAIN, V13, P438, DOI 10.1016/j.jpain.2012.01.003; Poznyak V, 2014, ALCOHOL ALCOHOL S1, V49, pi14, DOI [10.1093/alcalc/agu052.58i, DOI 10.1093/ALCALC/AGU052.58]; Prasad B, 2011, AM J RESP CRIT CARE, V183; Rathbone J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004837.pub2; Richards BL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008921.pub2; Robson P, 2005, IACM 3 C CANN MED; Rocha FCM, 2008, EUR J CANCER CARE, V17, P431, DOI 10.1111/j.1365-2354.2008.00917.x; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Rog DJ, 2006, NEUROLOGY, V66, pA31; Rohleder C, 2012, EARLY INTERV PSYCHIA, V6, P7; Salim K, 2005, NEUROPHARMACOLOGY, V48, P1164, DOI 10.1016/j.neuropharm.2005.02.010; SALLAN SE, 1980, NEW ENGL J MED, V302, P135, DOI 10.1056/NEJM198001173020302; Schoeler T, 2013, EUR NEUROPSYCHOPHARM, V23, pS216, DOI 10.1016/S0924-977X(13)70334-1; Selvarajah D, 2006, DIABETOLOGIA, V49, P671; Selvarajah D, 2010, DIABETES CARE, V33, P128, DOI 10.2337/dc09-1029; Serpell M, 2014, EUR J PAIN, V18, P999, DOI 10.1002/j.1532-2149.2013.00445.x; Shakespeare D T, 2001, Cochrane Database Syst Rev, pCD001332, DOI 10.1002/14651858.CD001332; SHEIDLER VR, 1984, J CLIN PHARMACOL, V24, P155, DOI 10.1002/j.1552-4604.1984.tb01824.x; Skrabek RQ, 2008, J PAIN, V9, P164, DOI 10.1016/j.jpain.2007.09.002; SMALL E, 1976, TAXON, V25, P405, DOI 10.2307/1220524; Solvay Pharmaceuticals, DRON VERS STAND OND; Stanley Medical Research Institute Coordinating Centre for Clinical Trials Cologne. University of Cologne, CLIN TRIAL ANT PROP; STEELE N, 1980, CANCER TREAT REP, V64, P219; STRUWE M, 1993, ANN PHARMACOTHER, V27, P827, DOI 10.1177/106002809302700701; Svendsen KB, 2004, BMJ-BRIT MED J, V329, P253, DOI 10.1136/bmj.38149.566979.AE; Svendsen Kristina Bacher, 2005, Ugeskr Laeger, V167, P2772; Timpone JG, 1997, AIDS RES HUM RETROV, V13, P305, DOI 10.1089/aid.1997.13.305; Tomida I, 2006, J GLAUCOMA, V15, P349, DOI 10.1097/01.ijg.0000212260.04488.60; Tramer MR, 2001, BMJ-BRIT MED J, V323, P16, DOI 10.1136/bmj.323.7303.16; Turcotte D, 2015, PAIN MED, V16, P149, DOI 10.1111/pme.12569; UNGERLEIDER JT, 1982, CANCER, V50, P636; United Nations, 1962, SINGL CONV NARC DRUG; University of California Davis. Center for Medicinal Cannabis Research VA Northern California Health Care System, EFF VAP MAR NEUR PAI; University of Cologne, EV ANT EFF CANN AC S; University of Manitoba Valeant Canada Limited, RAND DOUBL BLIND CRO; Van Amerongen G, 2014, MULT SCLER S1, V20, P478, DOI [10.1177/1352458514547846, DOI 10.1177/1352458514547846]; van den Elsen GAH, 2014, AGEING RES REV, V14, P56, DOI 10.1016/j.arr.2014.01.007; Vaney C, 2004, MULT SCLER, V10, P417, DOI 10.1191/1352458504ms1048oa; Ventegodt Soren, 2003, ScientificWorldJournal, V3, P694; WADA JK, 1982, CANCER TREAT REV, V9, P39, DOI 10.1016/S0305-7372(82)80034-0; Wade DT, 2010, MULT SCLER J, V16, P707, DOI 10.1177/1352458510367462; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Waldon K, 2013, BEHAV NEUROL, V26, P265, DOI [10.3233/BEN-2012-120269, 10.1155/2013/626410]; Wallace M, 2013, J PAIN, V14, pS62, DOI 10.1016/j.jpain.2013.01.587; Wallace MS, 2015, J PAIN, V16, P616, DOI 10.1016/j.jpain.2015.03.008; Ware M, 2009, J RHEUMATOL, V36, P2607; Ware MA, 2010, CAN MED ASSOC J, V182, pE694, DOI 10.1503/cmaj.091414; Ware MA, 2010, ANESTH ANALG, V110, P604, DOI 10.1213/ANE.0b013e3181c76f70; Wilsey B, 2008, J PAIN, V9, P506, DOI 10.1016/j.jpain.2007.12.010; Wilsey B, 2013, J PAIN, V14, P136, DOI 10.1016/j.jpain.2012.10.009; Winnipeg Regional Health Authority; Valeant Canada Limited, TRIAL ASS EFF NAB PA; Young CA, 2003, 4 C EUR FED IASP CHA; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1; Zajicek J, 2009, MULT SCLER, V15, pS274; Zajicek J, 2009, IACM 5 C CANN MED OC; Zajicek JP, 2012, J NEUROL NEUROSUR PS, V83, P1125, DOI 10.1136/jnnp-2012-302468; Zajicek JP, 2005, J NEUROL NEUROSUR PS, V76, P1664, DOI 10.1136/jnnp.2005.070136; Zammit S, 2008, BRIT J PSYCHIAT, V193, P357, DOI 10.1192/bjp.bp.107.046375	194	1198	1224	30	382	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2456	2473		10.1001/jama.2015.6358	http://dx.doi.org/10.1001/jama.2015.6358			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103030	Green Published			2022-12-28	WOS:000356663600015
J	Wear, A				Wear, Andrew			Making us as cruel as dogs: plague in 16th and 17th century England	LANCET			English	Editorial Material									UCL, Dept Hist, London WC1E 6BT, England	University of London; University College London	Wear, A (corresponding author), UCL, Dept Hist, London WC1E 6BT, England.	a.wear@ucl.ac.uk						Cippola Carlo M., 1976, PUBLIC HLTH MED PROF; Cohn Samuel K., 2002, BLACK DEATH TRANSFOR; Moote AL., 2004, GREAT PLAGUE STORY L; Slack P., 1990, IMPACT PLAGUE TUDOR; Wear, 2000, KNOWLEDGE PRACTICE E, P508	5	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2456	2457		10.1016/S0140-6736(15)61129-1	http://dx.doi.org/10.1016/S0140-6736(15)61129-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK9AR	26122061	Bronze			2022-12-28	WOS:000356532500014
J	Dow, LE; O'Rourke, KP; Simon, J; Tschaharganeh, DF; van Es, JH; Clevers, H; Lowe, SW				Dow, Lukas E.; O'Rourke, Kevin P.; Simon, Janelle; Tschaharganeh, Darjus F.; van Es, Johan H.; Clevers, Hans; Lowe, Scott W.			Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer	CELL			English	Article							MULTIPLE INTESTINAL NEOPLASIA; STEM-CELLS; TUMOR DORMANCY; ADENOMATOUS POLYPOSIS; WNT/BETA-CATENIN; MOUSE MODEL; HUMAN COLON; WNT; PROGRESSION; MUTATION	The adenomatous polyposis coli (APC) tumor suppressor is mutated in the vast majority of human colorectal cancers (CRC) and leads to deregulated Wnt signaling. To determine whether Apc disruption is required for tumor maintenance, we developed a mouse model of CRC whereby Apc can be conditionally suppressed using a doxycycline-regulated shRNA. Apc suppression produces adenomas in both the small intestine and colon that, in the presence of Kras and p53 mutations, can progress to invasive carcinoma. In established tumors, Apc restoration drives rapid and widespread tumor-cell differentiation and sustained regression without relapse. Tumor regression is accompanied by the reestablishment of normal crypt-villus homeostasis, such that once aberrantly proliferating cells reacquire self-renewal and multi-lineage differentiation capability. Our study reveals that CRC cells can revert to functioning normal cells given appropriate signals and provide compelling in vivo validation of the Wnt pathway as a therapeutic target for treatment of CRC.	[Dow, Lukas E.; O'Rourke, Kevin P.; Simon, Janelle; Tschaharganeh, Darjus F.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [O'Rourke, Kevin P.] Weill Cornell Rockefeller Sloan Kettering Tri Ins, New York, NY 10065 USA; [van Es, Johan H.; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [van Es, Johan H.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	lowes@mskcc.org	van+Es, Johan/ABD-5411-2021	Dow, Lukas/0000-0001-7048-1418	NIH/NCI [CA-013106]; National Health and Medical Research Council (NHMRC) Overseas Biomedical Fellowship; K22 Career Development Award from the NCI/NIH [CA 181280-01]; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH [T32GM07739]; NATIONAL CANCER INSTITUTE [P30CA008748, F30CA200110, R01CA195787, P01CA013106, K22CA181280, U01CA168409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research Council (NHMRC) Overseas Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia); K22 Career Development Award from the NCI/NIH; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Danielle Grace, Sha Tian, and Meredith Taylor for technical assistance with animal colonies, and other members of the Lowe laboratory for advice and discussions. Microscopy was performed at the MSKCC Molecular Cytology Core Facility with help from Yevgeniy Romin, Vitaly Boyko, and Sho Fujisawa. This work was supported by a program project grant from the NIH/NCI (CA-013106). L.E.D. was supported by a National Health and Medical Research Council (NHMRC) Overseas Biomedical Fellowship and a K22 Career Development Award from the NCI/NIH (CA 181280-01). K.P.O. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH under award number T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. S.W.L. is the Geoffrey Beene Chair of Cancer Biology and an investigator of the Howard Hughes Medical Institute. L.E.D. and S.W.L. are scientific advisory board members, and hold equity in Mirimus Inc., a company that has licensed technology related to this work.	Albuquerque C, 2010, GENE CHROMOSOME CANC, V49, P746, DOI 10.1002/gcc.20786; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bellovin DI, 2013, ADV EXP MED BIOL, V734, P91, DOI 10.1007/978-1-4614-1445-2_6; Brannon AR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0454-7; Cancer Genome Atlas N., 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Christie M, 2013, ONCOGENE, V32, P4675, DOI 10.1038/onc.2012.486; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Debies MT, 2008, J CLIN INVEST, V118, P51, DOI 10.1172/JCI33320; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Dow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095236; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Felsher DW, 2008, APMIS, V116, P629, DOI 10.1111/j.1600-0463.2008.01037.x; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; GRODEN J, 1995, CANCER RES, V55, P1531; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jang JW, 2006, MOL CELL BIOL, V26, P8109, DOI 10.1128/MCB.00404-06; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Juan J, 2014, GENE DEV, V28, P561, DOI 10.1101/gad.233627.113; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Leedham SJ, 2013, GUT, V62, P83, DOI 10.1136/gutjnl-2011-301601; Lim JWE, 2012, ELECTROPHORESIS, V33, P1873, DOI 10.1002/elps.201100687; Marino S, 2000, GENE DEV, V14, P994; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Ongen H, 2014, NATURE, V512, P87, DOI 10.1038/nature13602; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Robanus-Maandag EC, 2010, CARCINOGENESIS, V31, P946, DOI 10.1093/carcin/bgq046; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; SARRE RG, 1987, GUT, V28, P306, DOI 10.1136/gut.28.3.306; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Zeineldin M, 2013, CANCER RES, V73, P2389, DOI 10.1158/0008-5472.CAN-12-4607; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	51	318	324	2	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1539	1552		10.1016/j.cell.2015.05.033	http://dx.doi.org/10.1016/j.cell.2015.05.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091037	Green Accepted, Bronze			2022-12-28	WOS:000356618200012
J	Wei, JW; Shimazu, J; Makinistoglu, MP; Maurizi, A; Kajimura, D; Zong, HH; Takarada, T; Lezaki, T; Pessin, JE; Hinoi, E; Karsenty, G				Wei, Jianwen; Shimazu, Junko; Makinistoglu, Munevver P.; Maurizi, Antonio; Kajimura, Daisuke; Zong, Haihong; Takarada, Takeshi; Lezaki, Takashi; Pessin, Jeffrey E.; Hinoi, Eiichi; Karsenty, Gerard			Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation	CELL			English	Article							ACTIVATED PROTEIN-KINASE; CLEIDOCRANIAL DYSPLASIA; TRANSCRIPTION FACTOR; ENERGY-METABOLISM; COLLAGEN GENES; YEAST SNF1; EXPRESSION; CBFA1; OSF2/CBFA1; KNOCKOUT	The synthesis of type I collagen, the main component of bone matrix, precedes the expression of Runx2, the earliest determinant of osteoblast differentiation. We hypothesized that the energetic needs of osteoblasts might explain this apparent paradox. We show here that glucose, the main nutrient of osteoblasts, is transported in these cells through Glut1, whose expression precedes that of Runx2. Glucose uptake favors osteoblast differentiation by suppressing the AMPK-dependent proteasomal degradation of Runx2 and promotes bone formation by inhibiting another function of AMPK. While RUNX2 cannot induce osteoblast differentiation when glucose uptake is compromised, raising blood glucose levels restores collagen synthesis in Runx2-null osteoblasts and initiates bone formation in Runx2-deficient embryos. Moreover, RUNX2 favors Glut1 expression, and this feedforward regulation between RUNX2 and Glut1 determines the onset of osteoblast differentiation during development and the extent of bone formation throughout life. These results reveal an unexpected intricacy between bone and glucose metabolism.	[Wei, Jianwen; Shimazu, Junko; Makinistoglu, Munevver P.; Maurizi, Antonio; Kajimura, Daisuke; Karsenty, Gerard] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Zong, Haihong; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10461 USA; [Takarada, Takeshi; Lezaki, Takashi; Hinoi, Eiichi] Kanazawa Univ, Mol Pharmacol Lab, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Columbia University; Yeshiva University; Albert Einstein College of Medicine; Kanazawa University	Karsenty, G (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@cumc.columbia.edu	Maurizi, Antonio/AAI-7728-2020	Takarada, Takeshi/0000-0002-2363-7704; Maurizi, Antonio/0000-0002-7027-4694; Karsenty, Gerard/0000-0002-9253-7627	NIH [R01AR045548]; Columbia University Mandl Connective Tissue Research Fellowship; Honjo International Scholarship; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033823, R01DK104727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University Mandl Connective Tissue Research Fellowship; Honjo International Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. P. Ducy, J. Wrana, J. Shim, and L. Glimcher for their critical reading of the manuscript and reagents. This work was supported by the NIH (R01AR045548) (to G.K.), a Columbia University Mandl Connective Tissue Research Fellowship (to J.W.), and a Honjo International Scholarship (to J.S.).	Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; CHAPPARD D, 1987, ACTA HISTOCHEM, V81, P183, DOI 10.1016/S0065-1281(87)80012-0; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Groesbeck DK, 2006, DEV MED CHILD NEUROL, V48, P978, DOI 10.1111/j.1469-8749.2006.tb01269.x; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Puppin C, 2005, J HUM GENET, V50, P679, DOI 10.1007/s10038-005-0311-3; Reiter AK, 2005, AM J PHYSIOL-ENDOC M, V288, pE980, DOI 10.1152/ajpendo.00333.2004; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tessa Alessandra, 2003, Hum Mutat, V22, P104, DOI 10.1002/humu.9155; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; WOODS A, 1994, J BIOL CHEM, V269, P19509; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	30	258	275	5	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1576	1591		10.1016/j.cell.2015.05.029	http://dx.doi.org/10.1016/j.cell.2015.05.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091038	Green Accepted, Bronze			2022-12-28	WOS:000356618200015
J	[Anonymous]				[Anonymous]			North & West Europe	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S10	S12		10.1038/522S10a	http://dx.doi.org/10.1038/522S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083850	Bronze			2022-12-28	WOS:000356425400004
J	Brooke, BS; Goodney, PP; Kraiss, LW; Gottlieb, DJ; Samore, MH; Finlayson, SRG				Brooke, Benjamin S.; Goodney, Philip P.; Kraiss, Larry W.; Gottlieb, Daniel J.; Samore, Matthew H.; Finlayson, Samuel R. G.			Readmission destination and risk of mortality after major surgery: an observational cohort study	LANCET			English	Article							AORTIC-ANEURYSM REPAIR; SURGICAL-PROCEDURES; INPATIENT SURGERY; PROPENSITY SCORE; CARE; VOLUME; CONTINUITY; QUALITY	Background Hospital readmissions are common after major surgery, although it is unknown whether patients achieve improved outcomes when they are readmitted to, and receive care at, the index hospital where their surgical procedure was done. We examined the association between readmission destination and mortality risk in the USA in Medicare beneficiaries after a range of common operations. Methods By use of claims data from Medicare beneficiaries in the USA between Jan 1, 2001, and Nov 15, 2011, we assessed patients who needed hospital readmission within 30 days after open abdominal aortic aneurysm repair, infrainguinal arterial bypass, aortobifemoral bypass, coronary artery bypass surgery, oesophagectomy, colectomy, pancreatectomy, cholecystectomy, ventral hernia repair, craniotomy, hip replacement, or knee replacement. We used logistic regression models incorporating inverse probability weighting and instrumental variable analysis to measure associations between readmission destination (index vs non-index hospital) and risk of 90 day mortality for patients who underwent surgery who needed hospital readmission. Findings 9 440 503 patients underwent one of 12 major operations, and the number of patients readmitted or transferred back to the index hospital where their operation was done varied from 186 336 (65.8%) of 283 131 patients who were readmitted after coronary artery bypass grafting, to 142 142 (83.2%) of 170 789 patients who were readmitted after colectomy. Readmission was more likely to be to the index hospital than to a non-index hospital if the readmission was for a surgical complication (189 384 [23%] of 834 070 patients readmitted to index hospital vs 36 792 [13%] of 276 976 patients readmitted non-index hospital, p<0.0001). Readmission to the index hospital was associated with a 26% lower risk of 90 day mortality than was readmission to a non-index hospital, with inverse probability weighting used to control for selection bias (odds ratio [OR] 0.74, 95% CI 0.66-0.83). This effect was significant (p<0.0001) for all procedures in inverse probability-weighted models, and was largest for patients who were readmitted after pancreatectomy (OR 0.56, 95% CI 0.45-0.69) and aortobifemoral bypass (OR 0.69, 95% CI 0.61-0.77). By use of hospital-level variation among regional index hospital readmission rates as an instrument, instrumental variable analysis showed that the patients with the highest probability of returning to the index hospital had 8% lower risk of mortality (OR 0.92 95% CI 0.91-0.94) than did patients who were less likely to be readmitted to the index hospital. Interpretation In the USA, patients who are readmitted to hospital after various major operations consistently achieve improved survival if they return to the hospital where their surgery took place. These findings might have important implications for cost-effectiveness-driven regional centralisation of surgical care.	[Brooke, Benjamin S.; Kraiss, Larry W.; Finlayson, Samuel R. G.] Univ Utah, Dept Surg, Sch Med, Salt Lake City, UT 84132 USA; [Samore, Matthew H.] Univ Utah, Div Epidemiol, Sch Med, Salt Lake City, UT 84132 USA; [Brooke, Benjamin S.; Samore, Matthew H.] VA Salt Lake City Hlth Care Syst, IDEAS Ctr, Salt Lake City, UT USA; [Goodney, Philip P.] Dartmouth Hitchcock Med Ctr, Vasc Surg Sect, Lebanon, NH 03766 USA; [Gottlieb, Daniel J.] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Dartmouth College; Dartmouth College	Brooke, BS (corresponding author), Univ Utah, Dept Surg, Sch Med, Salt Lake City, UT 84132 USA.	benjamin.brooke@hsc.utah.edu			National Heart Lung and Blood Institute [K08 HL05676]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS021581] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG046830] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by BSB and SRGF. PPG was supported by a Career Development Award (K08 HL05676) from the National Heart Lung and Blood Institute.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 2004, J AM COLL SURGEONS, V198, P626, DOI 10.1016/j.jamcollsurg.2003.11.017; Brooke BS, 2014, JAMA SURG, V149, P821, DOI 10.1001/jamasurg.2014.157; Centers for Medicare and Medicaid Services, READM RED PROGR; Centers for Medicare and Medicaid Services, MED APPR FAC; Deloitte Center for Health Solutions, MED TOUR CONS SEARCH; Fontanarosa PB, 2013, JAMA-J AM MED ASSOC, V309, P398, DOI 10.1001/jama.2013.42; Fry DE, 2014, AM J SURG, V207, P326, DOI 10.1016/j.amjsurg.2013.09.007; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Greenblatt DY, 2012, ANN SURG, V256, P595, DOI 10.1097/SLA.0b013e31826b4bfe; Greenblatt DY, 2010, ANN SURG, V251, P659, DOI 10.1097/SLA.0b013e3181d3d27c; Hall MH, 2014, ANN THORAC SURG, V97, P1488, DOI 10.1016/j.athoracsur.2013.12.049; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hollenbeck BK, 2005, NAT CLIN PRACT UROL, V2, P461, DOI 10.1038/ncpuro0322; Hussey PS, 2014, JAMA INTERN MED, V174, P742, DOI 10.1001/jamainternmed.2014.245; Ingraham Angela M, 2010, Adv Surg, V44, P251; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; Radley DC, 2008, J CLIN EPIDEMIOL, V61, P580, DOI 10.1016/j.jclinepi.2007.08.001; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Santry Charlotte, 2011, Health Serv J, V121, P13; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saunders RS, 2014, J VASC SURG, V59, P1502, DOI 10.1016/j.jvs.2013.12.015; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Tsai TC, 2015, JAMA SURG, V150, P59, DOI 10.1001/jamasurg.2014.2071; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; Wal-Mart McKenzie K., 2014, LOWES USE CORPORATE	30	118	118	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					884	895		10.1016/S0140-6736(15)60087-3	http://dx.doi.org/10.1016/S0140-6736(15)60087-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0MJ	26093917	Green Accepted			2022-12-28	WOS:000360290000032
J	Treschan, TA; Beiderlinden, M				Treschan, Tanja A.; Beiderlinden, Martin			Antidotes for anticoagulants: a long way to go	LANCET			English	Editorial Material							DABIGATRAN; REVERSAL; EDOXABAN; VIVO		[Treschan, Tanja A.] Univ Dusseldorf, Dusseldorf Univ Hosp, Dept Anaesthesiol, D-40225 Dusseldorf, Germany; [Beiderlinden, Martin] Marien Hosp, Dept Anaesthesiol, Osnabruck, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; St. Marien Hospital	Treschan, TA (corresponding author), Univ Dusseldorf, Dusseldorf Univ Hosp, Dept Anaesthesiol, D-40225 Dusseldorf, Germany.	tanja.treschan@med.uni-duesseldorf.de	Meyer-Treschan, Tanja A./S-6624-2017	Meyer-Treschan, Tanja A./0000-0001-9363-1028				Ansell JE, 2014, NEW ENGL J MED, V371, P2141, DOI 10.1056/NEJMc1411800; Bouchard J, 2015, CLIN TOXICOL, V53, P156, DOI 10.3109/15563650.2015.1004580; Dager WE, 2013, CRIT CARE MED, V41, pE42, DOI 10.1097/CCM.0b013e31827caaa3; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Glund S, 2015, LANCET; Greinacher A, 2015, THROMB HAEMOSTASIS, V113, P931, DOI 10.1160/TH14-11-0982; Halim AB, 2014, THROMB RES, V134, P909, DOI 10.1016/j.thromres.2014.07.036; Levy JH, 2013, ANESTHESIOLOGY, V118, P1466, DOI 10.1097/ALN.0b013e318289bcba; Levy JH, 2010, ANESTHESIOLOGY, V113, P726, DOI 10.1097/ALN.0b013e3181ebdb15; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Majeed A, 2013, CIRCULATION, V128, P2325, DOI 10.1161/CIRCULATIONAHA.113.002332; Sheffield WP, 2014, J THROMB HAEMOST, V12, P1110, DOI 10.1111/jth.12601	12	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					634	636		10.1016/S0140-6736(15)61086-8	http://dx.doi.org/10.1016/S0140-6736(15)61086-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26088267				2022-12-28	WOS:000359849200011
J	Uthman, OA; Okwundu, C; Gbenga, K; Volmink, J; Dowdy, D; Zumla, A; Nachega, JB				Uthman, Olalekan A.; Okwundu, Charles; Gbenga, Kayode; Volmink, Jimmy; Dowdy, David; Zumla, Alimuddin; Nachega, Jean B.			Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							SUB-SAHARAN AFRICA; DELAYED INITIATION; PATIENTS LOST; FOLLOW-UP; OUTCOMES; DISEASE; IMPACT; HETEROGENEITY; INDIVIDUALS; MANAGEMENT	Background: Initiation of antiretroviral therapy (ART) during tuberculosis (TB) treatment remains challenging. Purpose: To assess evidence from randomized, controlled trials of the timing of ART initiation in HIV-infected adults with newly diagnosed pulmonary TB. Data Sources: PubMed, EMBASE, Cochrane Central Register of Controlled Trials, conference abstracts, and ClinicalTrials.gov (from January 1980 to May 2015). Study Selection: Randomized, controlled trials evaluating early versus delayed ART initiation (1 to 4 weeks vs. 8 to 12 weeks after initiation of TB treatment) or deferred ART initiation (after the end of TB treatment). Data Extraction: Three reviewers independently extracted data and assessed risk of bias. The main outcome measures were all-cause mortality and the TB-associated immune reconstitution inflammatory syndrome (TB-IRIS). Data Synthesis: The 8 included trials (n = 4568) were conducted in Africa, Asia, and the United States and were generally at low risk of bias for the assessed domains. Overall, early ART reduced mortality compared with delayed ART (relative risk [RR], 0.81 [95% CL, 0.66 to 0.99]; I-2 = 0%). In a prespecified subgroup analysis, early ART reduced mortality compared with delayed ART among patients with baseline CD4(+) 1-cell counts less than 0.050 x 10(9) cells/L (RR, 0.71 [Cl, 0.54 to 0.93]; I-2 = 0%). However, a mortality benefit from early ART Was not found among those with CD4(+) T-cell counts greater than 0.050 x 10(9) cells/L (RR, 1.05 [Cl, 0.68 to 1.61]; I-2 = 56%). Early ART was associated with a higher incidence of TB-IRIS than delayed ART (RR, 2.31 [Cl, 1.87 to 2.86]; I-2 = 19%). Limitation: Few trials provided sufficient data for subgroup analysis. Conclusion: Early ART in HIV-infected adults with newly diagnosed TB improves survival in those with CD4(+) T-cell counts less than 0.050 x 10(9) cells/L, although this is associated with a 2-fold higher frequency of TB-IRIS. In patients with CD4(+) T-cell counts greater. than 0.050 x 10(9) cells/L, evidence is insufficient to support or refute a survival benefit conferred by early versus delayed ART initiation.	Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Grp, Liverpool L3 5QA, Merseyside, England; Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; South African Med Res Council, Tygerberg, South Africa; Univ Med Ctr Utrecht, Utrecht, Netherlands; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; UCL, London, England; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	University of Warwick; Liverpool School of Tropical Medicine; University of Liverpool; Stellenbosch University; South African Medical Research Council; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Uthman, OA (corresponding author), Univ Warwick, Warwick Ctr Appl Hlth Res & Delivery, Med Teaching Ctr, Div Hlth Sci,Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	olalekan.uthman@warwick.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020; Uthman, Olalekan/N-5584-2019	ZUMLA, Alimuddin/0000-0002-5111-5735; Uthman, Olalekan/0000-0002-8567-3081; Nachega, Jean/0000-0002-2862-4443	Swedish Council for Working Life and Social Research Marie Curie International Postdoctoral fellowship [2012-0064]; National Institute for Allergy and Infectious Disease of the National Institutes of Health; AIDS Clinical Trial Group; Stellenbosch University Clinical Trial Unit [2UM1AI069521-08]; Medical Education Partnership Initiative through the U.S. President Emergency Plan for AIDS Relief [T84HA21652-01-00]; European Developing Countries Clinical Trial Partnership Senior Fellowship Award [TA-08-40200-021]; Wellcome Trust Southern Africa Consortium for Research Excellence [WT087537MA]; European Commission; National Institutes of Health Research Biomedical Research Centre; Stellenbosch University; South African Medical Research Council; Department for International Development (DFID) [201400] Funding Source: researchfish	Swedish Council for Working Life and Social Research Marie Curie International Postdoctoral fellowship; National Institute for Allergy and Infectious Disease of the National Institutes of Health; AIDS Clinical Trial Group; Stellenbosch University Clinical Trial Unit; Medical Education Partnership Initiative through the U.S. President Emergency Plan for AIDS Relief; European Developing Countries Clinical Trial Partnership Senior Fellowship Award; Wellcome Trust Southern Africa Consortium for Research Excellence(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health Research Biomedical Research Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stellenbosch University; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID)	Dr. Uthman acknowledges support from the Swedish Council for Working Life and Social Research Marie Curie International Postdoctoral fellowship (2012-0064). Dr. Nachega receives research grant support from the National Institute for Allergy and Infectious Disease of the National Institutes of Health, the AIDS Clinical Trial Group, and Stellenbosch University Clinical Trial Unit (2UM1AI069521-08); the Medical Education Partnership Initiative through the U.S. President Emergency Plan for AIDS Relief (T84HA21652-01-00); the European Developing Countries Clinical Trial Partnership Senior Fellowship Award (TA-08-40200-021); and the Wellcome Trust Southern Africa Consortium for Research Excellence (WT087537MA). Dr. Zumla receives support from the European Commission Seventh Framework Programme (Rapid Identification of Respiratory Tract Infections Project) and the National Institutes of Health Research Biomedical Research Centre. Dr. Volmink receives support from Stellenbosch University and the South African Medical Research Council.	ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7; Amogne W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122587; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Chu R, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-19; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/eri.11.21, 10.1586/ERI.11.21]; LUCAS SB, 1994, BRIT MED J, V308, P1531, DOI 10.1136/bmj.308.6943.1531; Maartens G, 2009, ANTIVIR THER, V14, P1039, DOI 10.3851/IMP1455; Manosuthi W, 2012, JAIDS-J ACQ IMM DEF, V60, P377, DOI 10.1097/QAI.0b013e31825b5e06; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Mfinanga SG, 2014, LANCET INFECT DIS, V14, P563, DOI 10.1016/S1473-3099(14)70733-9; Nachega JB, 2012, PATIENT PREFER ADHER, V6, P887, DOI 10.2147/PPA.S38897; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P134; Naidoo K, 2013, CURR OPIN INFECT DIS, V26, P35, DOI 10.1097/QCO.0b013e32835ba8f9; PERRIENS JH, 1995, NEW ENGL J MED, V332, P779, DOI 10.1056/NEJM199503233321204; Piggott DA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/103917; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schroll JB, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-22; Sinha S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-168; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230	34	62	65	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1					32	39		10.7326/M14-2979	http://dx.doi.org/10.7326/M14-2979			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	26148280				2022-12-28	WOS:000357442000004
J	Kohane, IS				Kohane, Isaac S.			Ten things we have to do to achieve precision medicine	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kohane, IS (corresponding author), Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA.	isaac_kohane@harvard.edu						Barzi A, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv005; Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Curl P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107255; Dagogo-Jack S, 2010, NAT REV ENDOCRINOL, V6, P589, DOI 10.1038/nrendo.2010.126; Davenport TH, 2002, HARVARD BUS REV, V80, P107; Dressler LG, 2012, GENET MED, V14, P215, DOI 10.1038/gim.2011.10; Fry E., 2015, APPLE GOOGLE LEAD TE; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; Manrai AK, 2014, JAMA INTERN MED, V174, P991, DOI 10.1001/jamainternmed.2014.1059; Masys DR, 2012, J BIOMED INFORM, V45, P419, DOI 10.1016/j.jbi.2011.12.005; McNutt M, 2014, SCIENCE, V346, P679, DOI 10.1126/science.aaa1724; Mnookin S., 2014, NEW YORKER, P32; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Office of the Press Secretary, 2015, FACT SHEET PRES OB P; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Schadt EE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002132; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228	18	83	85	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					37	38		10.1126/science.aab1328	http://dx.doi.org/10.1126/science.aab1328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL9FG	26138968				2022-12-28	WOS:000357280800048
J	Mota, B; Herculano-Houzel, S				Mota, Bruno; Herculano-Houzel, Suzana			Cortical folding scales universally with surface area and thickness, not number of neurons	SCIENCE			English	Article							CELLULAR SCALING RULES; MAMMALIAN CEREBRAL-CORTEX; WHITE-MATTER; PRIMATE BRAINS; EXPANSION; GYRIFICATION; EVOLUTION; CONNECTIVITY; NEOCORTEX; RODENT	Larger brains tend to have more folded cortices, but what makes the cortex fold has remained unknown. We show that the degree of cortical folding scales uniformly across lissencephalic and gyrencephalic species, across individuals, and within individual cortices as a function of the product of cortical surface area and the square root of cortical thickness. This relation is derived from the minimization of the effective free energy associated with cortical shape according to a simple physical model, based on known mechanisms of axonal elongation. This model also explains the scaling of the folding index of crumpled paper balls. We discuss the implications of this finding for the evolutionary and developmental origin of folding, including the newfound continuum between lissencephaly and gyrencephaly, and for pathologies such as human lissencephaly.	[Mota, Bruno] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil; [Herculano-Houzel, Suzana] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Herculano-Houzel, Suzana] INCT MCT, Inst Nacl Neurociencia Translac, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Herculano-Houzel, S (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	suzanahh@gmail.com	Mota, Bruno/AAW-6044-2020	Mota, Bruno/0000-0002-6950-4106	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; INCT/MCT; James S. McDonnell Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INCT/MCT; James S. McDonnell Foundation	Supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, INCT/MCT, and the James S. McDonnell Foundation. Data reported in the paper are presented in the supplementary materials.	Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; ELIAS H, 1971, Zeitschrift fuer Saeugetierkunde, V36, P147; Gabi M, 2010, BRAIN BEHAV EVOLUT, V76, P32, DOI 10.1159/000319872; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00046; Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V78, P302, DOI 10.1159/000330825; Herculano-Houzel S, 2010, P NATL ACAD SCI USA, V107, P19008, DOI 10.1073/pnas.1012590107; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; KANTOR Y, 1987, PHYS REV A, V35, P3056, DOI 10.1103/PhysRevA.35.3056; Kazu RS, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00128; Kelava I, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00016; Lewitus E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002000; Lewitus E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00424; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mayhew TM, 1996, J ANAT, V188, P53; Neves K, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00005; Pillay P, 2007, EUR J NEUROSCI, V25, P2705, DOI 10.1111/j.1460-9568.2007.05524.x; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; REEP RL, 1990, BRAIN BEHAV EVOLUT, V35, P185, DOI 10.1159/000115866; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Ribeiro PFM, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00028; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Sarko DK, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.008.2009; Smith DH, 2001, TISSUE ENG, V7, P131, DOI 10.1089/107632701300062714; Smith DH, 2009, PROG NEUROBIOL, V89, P231, DOI 10.1016/j.pneurobio.2009.07.006; Tallinen T, 2014, P NATL ACAD SCI USA, V111, P12667, DOI 10.1073/pnas.1406015111; Toro R, 2005, CEREB CORTEX, V15, P1900, DOI 10.1093/cercor/bhi068; Ventura-Antunes L, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00003; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006	32	129	129	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					74	77		10.1126/science.aaa9101	http://dx.doi.org/10.1126/science.aaa9101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138976				2022-12-28	WOS:000357280800061
J	Gore, F; Schwartz, EC; Brangers, BC; Aladi, S; Stujenske, JM; Likhtik, E; Russo, MJ; Gordon, JA; Salzman, CD; Axel, R				Gore, Felicity; Schwartz, Edmund C.; Brangers, Baylor C.; Aladi, Stanley; Stujenske, Joseph M.; Likhtik, Ekaterina; Russo, Marco J.; Gordon, Joshua A.; Salzman, C. Daniel; Axel, Richard			Neural Representations of Unconditioned Stimuli in Basolateral Amygdala Mediate Innate and Learned Responses	CELL			English	Article							LONG-TERM POTENTIATION; PRIMATE AMYGDALA; CONDITIONED FEAR; PIRIFORM CORTEX; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; EVOKED ACTIVITY; REWARD-SEEKING; NEURONS; EMOTION	Stimuli that possess inherently rewarding or aversive qualities elicit emotional responses and also induce learning by imparting valence upon neutral sensory cues. Evidence has accumulated implicating the amygdala as a critical structure in mediating these processes. We have developed a genetic strategy to identify the representations of rewarding and aversive unconditioned stimuli (USs) in the basolateral amygdala (BLA) and have examined their role in innate and learned responses. Activation of an ensemble of US-responsive cells in the BLA elicits innate physiological and behavioral responses of different valence. Activation of this US ensemble can also reinforce appetitive and aversive learning when paired with differing neutral stimuli. Moreover, we establish that the activation of US-responsive cells in the BLA is necessary for the expression of a conditioned response. Neural representations of conditioned and unconditioned stimuli therefore ultimately connect to US-responsive cells in the BLA to elicit both innate and learned responses.	[Gore, Felicity; Schwartz, Edmund C.; Brangers, Baylor C.; Aladi, Stanley; Stujenske, Joseph M.; Russo, Marco J.; Salzman, C. Daniel; Axel, Richard] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Axel, Richard] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Likhtik, Ekaterina; Gordon, Joshua A.; Salzman, C. Daniel] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Gordon, Joshua A.; Salzman, C. Daniel] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; New York State Psychiatry Institute	Salzman, CD (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	cds2005@columbia.edu; ra27@columbia.edu		Axel, Richard/0000-0002-3141-4076; Russo, Marco/0000-0001-8064-6685; Gore, Felicity/0000-0003-4425-5534	Howard Hughes Medical institute; Marthers Foundation; Jane Coffin Childs fellowship; NIMH [R01-MH082017]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082017, R01MH081968] Funding Source: NIH RePORTER	Howard Hughes Medical institute(Howard Hughes Medical Institute); Marthers Foundation; Jane Coffin Childs fellowship; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Pare and L. Abbott for critical comments on the manuscript; K. Deisseroth for ChR2 and NpHR reagents; Monica Mendelsohn and Nataliya Zabello for help with mice; Phyllis Kisloff for assistance in preparing the manuscript; and Miriam Gutierrez for laboratory support. This work was supported by the Howard Hughes Medical institute and the Marthers Foundation. E.C.S. was supported by a Jane Coffin Childs fellowship. C.D.S. was supported by the NIMH (R01-MH082017).	Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; AMARAL D G, 1992, P1; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Barot SK, 2008, P NATL ACAD SCI USA, V105, P20959, DOI 10.1073/pnas.0808996106; BELKIN DA, 1968, AM ZOOL, V8, P775; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Bermudez MA, 2010, J NEUROPHYSIOL, V104, P3424, DOI 10.1152/jn.00540.2010; Blundell P, 2001, J NEUROSCI, V21, P9018, DOI 10.1523/JNEUROSCI.21-22-09018.2001; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Davis M, 1998, J CLIN NEUROPHYSIOL, V15, P378, DOI 10.1097/00004691-199809000-00002; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Guzowski J F, 2001, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0108s15; Hatfield T, 1996, J NEUROSCI, V16, P5256; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; HOLLAND PC, 1990, COGNITION, V37, P105, DOI 10.1016/0010-0277(90)90020-K; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Knapska E, 2007, PHYSIOL REV, V87, P1113, DOI 10.1152/physrev.00037.2006; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Livneh U, 2012, J NEUROSCI, V32, P8598, DOI 10.1523/JNEUROSCI.0323-12.2012; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Merritt LL, 2008, J PHARMACOL EXP THER, V326, P483, DOI 10.1124/jpet.108.138321; Morrison SE, 2011, NEURON, V71, P1127, DOI 10.1016/j.neuron.2011.07.016; MURAMOTO K, 1993, NEUROSCIENCE, V52, P621, DOI 10.1016/0306-4522(93)90411-8; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pickens CL, 2004, NEUROSCI BIOBEHAV R, V28, P651, DOI 10.1016/j.neubiorev.2004.09.003; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; RUSSCHEN FT, 1985, BRAIN RES, V329, P241, DOI 10.1016/0006-8993(85)90530-X; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; SARTER M, 1985, BEHAV NEUROSCI, V99, P342, DOI 10.1037/0735-7044.99.2.342; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Schwabe K, 2004, NEUROSCIENCE, V126, P727, DOI 10.1016/j.neuroscience.2004.04.022; Seymour B, 2008, NEURON, V58, P662, DOI 10.1016/j.neuron.2008.05.020; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	72	133	137	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					134	145		10.1016/j.cell.2015.06.027	http://dx.doi.org/10.1016/j.cell.2015.06.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140594	Green Accepted, Bronze			2022-12-28	WOS:000357542300015
J	Nussbaumer-Ochsner, Y; Thurnheer, R				Nussbaumer-Ochsner, Yvonne; Thurnheer, Robert			Subglottic Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nussbaumer-Ochsner, Yvonne; Thurnheer, Robert] Cantonal Hosp Muensterlingen, Muensterlingen, Switzerland		Nussbaumer-Ochsner, Y (corresponding author), Cantonal Hosp Muensterlingen, Muensterlingen, Switzerland.	yvonne.nussbaumer@hispeed.ch							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					73	73		10.1056/NEJMicm1404785	http://dx.doi.org/10.1056/NEJMicm1404785			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL8IS	26132943				2022-12-28	WOS:000357218700009
J	Nguyen, THD; Galej, WP; Bai, XC; Savva, CG; Newman, AJ; Scheres, SHW; Nagai, K				Thi Hoang Duong Nguyen; Galej, Wojciech P.; Bai, Xiao-chen; Savva, Christos G.; Newman, Andrew J.; Scheres, Sjors H. W.; Nagai, Kiyoshi			The architecture of the spliceosomal U4/U6.U5 tri-snRNP	NATURE			English	Article							PRE-MESSENGER-RNA; SMALL NUCLEAR RIBONUCLEOPROTEINS; PROTEIN-PROTEIN INTERACTIONS; EM STRUCTURE DETERMINATION; SPLICING FACTOR PRP8; U5 SNRNP; ELECTRON-MICROSCOPY; ACTIVE-SITE; CRYO-EM; CRYSTAL-STRUCTURE	U4/U6.U5 tri-snRNP is a 1.5-megadalton pre-assembled spliceosomal complex comprising U5 small nuclear RNA (snRNA), extensively base-paired U4/U6 snRNAs and more than 30 proteins, including the key components Prp8, Brr2 and Snu114. The tri-snRNP combines with a precursor messenger RNA substrate bound to U1 and U2 small nuclear ribonucleoprotein particles (snRNPs), and transforms into a catalytically active spliceosome after extensive compositional and conformational changes triggered by unwinding of the U4 and U6 (U4/U6) snRNAs. Here we use cryo-electron microscopy single-particle reconstruction of Saccharomyces cerevisiae tri-snRNP at 5.9 angstrom resolution to reveal the essentially complete organization of its RNA and protein components. The single-stranded region of U4 snRNA between its 39 stem-loop and the U4/U6 snRNA stem I is loaded into the Brr2 helicase active site ready for unwinding. Snu114 and the amino-terminal domain of Prp8 position U5 snRNA to insert its loop I, which aligns the exons for splicing, into the Prp8 active site cavity. The structure provides crucial insights into the activation process and the active site of the spliceosome.	[Thi Hoang Duong Nguyen; Galej, Wojciech P.; Bai, Xiao-chen; Savva, Christos G.; Newman, Andrew J.; Scheres, Sjors H. W.; Nagai, Kiyoshi] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Nguyen, THD (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	knguyen@mrc-lmb.cam.ac.uk; kn@mrc-lmb.cam.ac.uk	Scheres, Sjors H.W./AAY-2265-2021; Bai, Xiao-chen/HGV-1244-2022	Scheres, Sjors H.W./0000-0002-0462-6540; Bai, Xiao-chen/0000-0002-4234-5686; Galej, Wojciech/0000-0001-8859-5229; Nguyen, Thi Hoang Duong/0000-0002-2180-3430	Herchel Smith Research Studentship; European Union; Medical Research Council [MC_U105184330, MC_UP_A025_1013]; MRC [MC_UP_A025_1013, MC_U105184330] Funding Source: UKRI	Herchel Smith Research Studentship; European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Chen, G. McMullan, J. Grimmett and T. Darling for smooth running of the EM and computing facilities; P. da Fonseca, N. Unwin, I. Sanchez Fernandez, A. Amunts, P. Emsley, G. Murshudov and A. Brown for advice; A. Easter and L. Passmore for reagents; M. Skehel for mass spectrometry; and J. Li, Y. Kondo and the members of the spliceosome group for help and advice throughout the project. We are grateful to R. Henderson, D. Barford, S. Fica, P.-C. Lin and L. Stritt matter for critical reading of the manuscript. We thank V. Ramakrishnan, J. Lowe and R. Henderson for their continuing support and encouragements. T.H.D.N. was supported in part by a Herchel Smith Research Studentship. X.-c.B. was supported by a European Union Marie Curie Fellowship. The project was supported by the Medical Research Council (MC_U105184330 to K.N. and MC_UP_A025_1013 to S.H.W.S.).	Ayadi L, 1998, J MOL BIOL, V284, P673, DOI 10.1006/jmbi.1998.2183; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Bartels C, 2003, J BIOL CHEM, V278, P28324, DOI 10.1074/jbc.M303043200; Ben-Yehuda S, 2000, GENETICS, V154, P61; Boon KL, 2007, NAT STRUCT MOL BIOL, V14, P1077, DOI 10.1038/nsmb1303; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chanfreau G, 1997, GENE DEV, V11, P2741, DOI 10.1101/gad.11.20.2741; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Collins CA, 1999, GENE DEV, V13, P1970, DOI 10.1101/gad.13.15.1970; Dagher SF, 2001, RNA, V7, P1284, DOI 10.1017/S1355838201016077; Dix I, 1998, RNA, V4, P1674, DOI 10.1017/S1355838298412998; Dobbyn HC, 2007, BIOCHEM BIOPH RES CO, V360, P857, DOI 10.1016/j.bbrc.2007.06.163; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; GALISSON F, 1993, NUCLEIC ACIDS RES, V21, P1555, DOI 10.1093/nar/21.7.1555; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gottschalk A, 1999, EMBO J, V18, P4535, DOI 10.1093/emboj/18.16.4535; Grainger RJ, 2009, RNA, V15, P2161, DOI 10.1261/rna.1908309; Hacker I, 2008, NAT STRUCT MOL BIOL, V15, P1206, DOI 10.1038/nsmb.1506; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Korneta I, 2012, NUCLEIC ACIDS RES, V40, P7046, DOI 10.1093/nar/gks347; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuhn AN, 2000, GENETICS, V155, P1667; Kuhn AN, 1999, MOL CELL, V3, P65, DOI 10.1016/S1097-2765(00)80175-6; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li ZR, 1996, RNA, V2, P879; Lin JZ, 2015, CELL, V160, P219, DOI 10.1016/j.cell.2014.11.049; Liu L, 2007, NAT STRUCT MOL BIOL, V14, P519, DOI 10.1038/nsmb1240; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Makarov EM, 2000, J MOL BIOL, V298, P567, DOI 10.1006/jmbi.2000.3685; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; McMullan G, 2009, ULTRAMICROSCOPY, V109, P1144, DOI 10.1016/j.ultramic.2009.05.005; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Rother M, 2011, BIOINFORMATICS, V27, P2441, DOI 10.1093/bioinformatics/btr400; Sander B, 2006, MOL CELL, V24, P267, DOI 10.1016/j.molcel.2006.08.021; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schreieck A, 2014, NAT STRUCT MOL BIOL, V21, P175, DOI 10.1038/nsmb.2753; Schultz A, 2006, J BIOL CHEM, V281, P28278, DOI 10.1074/jbc.M603350200; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Siatecka M, 1999, GENE DEV, V13, P1983, DOI 10.1101/gad.13.15.1983; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Stevens SW, 2001, RNA, V7, P1543; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Turner IA, 2006, RNA, V12, P375, DOI 10.1261/rna.2229706; Umen JG, 1996, GENETICS, V143, P723; van Nues RW, 2001, GENETICS, V157, P1451; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wu XH, 2010, BIOCHEMISTRY-US, V49, P10237, DOI 10.1021/bi101321y; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou LJ, 2014, NATURE, V506, P116, DOI 10.1038/nature12803	75	157	158	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					47	+		10.1038/nature14548	http://dx.doi.org/10.1038/nature14548			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26106855	Green Accepted			2022-12-28	WOS:000357169500028
J	Shuttleworth, S; Frampton, S				Shuttleworth, Sally; Frampton, Sally			Constructing Scientific Communities: Citizen Science	LANCET			English	Editorial Material									[Shuttleworth, Sally; Frampton, Sally] Univ Oxford St Annes Coll, Oxford OX2 6HS, England	University of Oxford	Shuttleworth, S (corresponding author), Univ Oxford St Annes Coll, Oxford OX2 6HS, England.	sally.shuttleworth@st-annes.ox.ac.uk			Arts and Humanities Research Council [AH/L007010/1] Funding Source: researchfish; AHRC [AH/L007010/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))			0	9	10	1	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2568	2568		10.1016/S0140-6736(15)61150-3	http://dx.doi.org/10.1016/S0140-6736(15)61150-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL4NQ	26122151				2022-12-28	WOS:000356930000014
J	Bourzac, K				Bourzac, Katherine			NEUROSCIENCE Rewiring the brain	NATURE			English	Editorial Material																		Chanraud S, 2013, CEREB CORTEX, V23, P97, DOI 10.1093/cercor/bhr381; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Seif T, 2015, NEUROPSYCHOPHARMACOL	5	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					S50	S52		10.1038/522S50a	http://dx.doi.org/10.1038/522S50a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26107095	Bronze			2022-12-28	WOS:000356782900003
J	Hayashi, MT; Cesare, AJ; Rivera, T; Karlseder, J				Hayashi, Makoto T.; Cesare, Anthony J.; Rivera, Teresa; Karlseder, Jan			Cell death during crisis is mediated by mitotic telomere deprotection	NATURE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; DNA-DAMAGE RESPONSE; DYSFUNCTIONAL TELOMERES; ATM; SENESCENCE; IMMORTALIZATION; CRISPR-CAS9; ACTIVATION; INHIBITOR; TRF2	Tumour formation is blocked by two barriers: replicative senescence and crisis(1). Senescence is triggered by short telomeres and is bypassed by disruption of tumour-suppressive pathways. After senescence bypass, cells undergo crisis, during which almost all of the cells in the population die. Cells that escape crisis harbour unstable genomes and other parameters of transformation. The mechanism of cell death during crisis remains unexplained. Here we show that human cells in crisis undergo spontaneous mitotic arrest, resulting in death during mitosis or in the following cell cycle. This phenotype is induced by loss of p53 function, and is suppressed by telomerase overexpression. Telomere fusions triggered mitotic arrest in p53-compromised non-crisis cells, indicating that such fusions are the underlying cause of cell death. Exacerbation of mitotic telomere deprotection by partial TRF2 (also known as TERF2) knockdown(2) increased the ratio of cells that died duringmitotic arrest and sensitized cancer cells to mitotic poisons. We propose a crisis pathway wherein chromosome fusions induce mitotic arrest, resulting in mitotic telomere deprotection and cell death, thereby eliminating precancerous cells from the population.	[Hayashi, Makoto T.; Cesare, Anthony J.; Rivera, Teresa; Karlseder, Jan] Salk Inst Biol Studies, Mol & Cell Biol Dept, La Jolla, CA 92037 USA; [Hayashi, Makoto T.] Kyoto Univ, Dept Gene Mech, Grad Sch Biostudies, Hakubi Ctr Adv Res,Sakyo Ku, Kyoto 6068501, Japan; [Cesare, Anthony J.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	Salk Institute; Kyoto University; Children's Medical Research Institute - Australia; University of Sydney	Karlseder, J (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Dept, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	karlseder@salk.edu	Cesare, Anthony/N-7415-2019; Hayashi, Makoto/K-7155-2019; Cesare, Anthony J/F-4691-2010	Cesare, Anthony/0000-0002-0864-1254; Hayashi, Makoto/0000-0001-6360-7131; Cesare, Anthony J/0000-0002-0864-1254	Human Frontier Science Program; Japan Society for the Promotion of Science; NIH NRSA [5T32CA009370]; Glenn Center for Research on Aging; CIRM [TG2-01158]; Salk Institute Cancer Center Core Grant [P30CA014195]; NIH [R01GM087476, R01CA174942]; Donald and Darlene Shiley Chair; Highland Street Foundation; Fritz B. Burns Foundation; Emerald Foundation; NATIONAL CANCER INSTITUTE [T32CA009370, R01CA174942, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087476] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Center for Research on Aging; CIRM(California Institute for Regenerative Medicine); Salk Institute Cancer Center Core Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald and Darlene Shiley Chair; Highland Street Foundation; Fritz B. Burns Foundation; Emerald Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All data are archived at the Salk Institute. We thank the Salk Institute's J. Fitzpatrick of the Waitt Advanced Biophotonics Center and members of GT3 Core, C. O'Shea, G. Wahl, F. Zhang, and D. Sabatini for support and Karlseder laboratory members for comments. M.T.H. was supported by the Human Frontier Science Program and the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad. A.J.C. was supported by a NIH NRSA T32 Fellowship (5T32CA009370). T.R. was supported by the Glenn Center for Research on Aging and CIRM training grant TG2-01158. The Salk Institute Cancer Center Core Grant (P30CA014195), the NIH (R01GM087476, R01CA174942), the Donald and Darlene Shiley Chair, the Highland Street Foundation, the Fritz B. Burns Foundation, the Emerald Foundation and the Glenn Center for Research on Aging support J.K.	Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Batista LFZ, 2013, CURR OPIN GENET DEV, V23, P526, DOI 10.1016/j.gde.2013.07.006; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006; Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725; Dalton WB, 2009, FUTURE ONCOL, V5, P1363, DOI 10.2217/FON.09.118; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Gartner M, 2005, CHEMBIOCHEM, V6, P1173, DOI 10.1002/cbic.200500005; Gisselsson D, 2005, GENE CHROMOSOME CANC, V42, P22, DOI 10.1002/gcc.20094; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoque MT, 2002, J BIOL CHEM, V277, P42306, DOI 10.1074/jbc.M206836200; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088	30	75	79	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					492	+		10.1038/nature14513	http://dx.doi.org/10.1038/nature14513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108857	Green Accepted			2022-12-28	WOS:000356782900053
J	Ye, CX; Zhou, XL; Pu, D; Stutz, J; Festa, J; Spolaor, M; Cantrell, C; Mauldin, RL; Weinheimer, A; Haggerty, J				Ye, Chunxiang; Zhou, Xianliang; Pu, Dennis; Stutz, Jochen; Festa, James; Spolaor, Max; Cantrell, Christopher; Mauldin, Roy L.; Weinheimer, Andrew; Haggerty, Julie			Comment on "Missing gas-phase source of HONO inferred from Zeppelin measurements in the troposphere"	SCIENCE			English	Editorial Material								Li et al. (Reports, 18 April 2014, p. 292) proposed a unity nitrous acid (HONO) yield for reaction between nitrogen dioxide and the hydroperoxyl-water complex and suggested a substantial overestimation in HONO photolysis contribution to hydroxyl radical budget. Based on airborne observations of all parameters in this chemical system, we have determined an upper-limit HONO yield of 0.03 for the reaction.	[Ye, Chunxiang; Zhou, Xianliang] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA; [Zhou, Xianliang; Pu, Dennis] SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA; [Stutz, Jochen; Festa, James; Spolaor, Max] Univ Calif Los Angeles, Los Angeles, CA USA; [Cantrell, Christopher; Mauldin, Roy L.] Univ Colorado, Boulder, CO 80309 USA; [Mauldin, Roy L.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Weinheimer, Andrew; Haggerty, Julie] Natl Ctr Atmosphere Res, Earth Syst Lab, Boulder, CO USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder; University of Helsinki; National Center Atmospheric Research (NCAR) - USA	Zhou, XL (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.	xianliang.zhou@health.ny.gov	Stutz, Jochen/K-7159-2014; Cantrell, Christopher/GXH-7594-2022; YE, CHUNXIANG/J-6973-2013	YE, CHUNXIANG/0000-0002-5417-2671	Div Atmospheric & Geospace Sciences [1216166, 1215712] Funding Source: National Science Foundation	Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Acker K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024643; Browne EC, 2013, ATMOS CHEM PHYS, V13, P4543, DOI 10.5194/acp-13-4543-2013; Grilli R, 2013, GEOPHYS RES LETT, V40, P791, DOI 10.1002/grl.50154; Haseler R., 2009, ATMOS MEAS TECH DISC, V2, P2027, DOI [DOI 10.5194/AMTD-2-2027-2009, 10.5194/amtd-2-2027-2009]; Hornbrook RS, 2011, ATMOS MEAS TECH, V4, P735, DOI 10.5194/amt-4-735-2011; Kleffmann J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022524; Kleffmann J, 2007, CHEMPHYSCHEM, V8, P1137, DOI 10.1002/cphc.200700016; Li X, 2014, SCIENCE, V344, P292, DOI 10.1126/science.1248999; Pitts Jr J. N., 2000, CHEM UPPER LOWER ATM; Ridley B, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004769; Roberts JM, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008667; Shetter RE, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001320; Zhang N, 2012, ATMOS CHEM PHYS, V12, P8285, DOI 10.5194/acp-12-8285-2012; Zhang N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038999; Zhou XL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018620	15	20	20	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241								10.1126/science.aaa1992	http://dx.doi.org/10.1126/science.aaa1992			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089507				2022-12-28	WOS:000356449500039
J	Joos, F				Joos, Fortunat			GLOBAL WARMING Growing feedback from ocean carbon to climate	NATURE			English	Editorial Material							EMISSIONS; MARINE; MODEL		[Joos, Fortunat] Univ Bern, Inst Phys, Div Climate & Environm Phys, CH-3012 Bern, Switzerland; [Joos, Fortunat] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Joos, F (corresponding author), Univ Bern, Inst Phys, Div Climate & Environm Phys, CH-3012 Bern, Switzerland.	joos@climate.unibe.ch	Joos, Fortunat/B-4118-2018	Joos, Fortunat/0000-0002-9483-6030				Bauska TK, 2015, NAT GEOSCI, V8, P383, DOI [10.1038/ngeo2422, 10.1038/NGEO2422]; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Heimann M., 2015, NOVA ACTA LEOPOLDINA, V121, P97; Heinze C, 2015, EARTH SYST DYNAM, V6, P327, DOI 10.5194/esd-6-327-2015; Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1; Joos F, 1999, SCIENCE, V284, P464, DOI 10.1126/science.284.5413.464; Koven CD, 2015, P NATL ACAD SCI USA, V112, P3752, DOI 10.1073/pnas.1415123112; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Randerson J. T., 2015, GLOB BIOGEOCHEM CYCL; Schilt A, 2014, NATURE, V516, P234, DOI 10.1038/nature13971; Steinacher M, 2013, NATURE, V499, P197, DOI 10.1038/nature12269; Stocker BD, 2013, NAT CLIM CHANGE, V3, P666, DOI [10.1038/NCLIMATE1864, 10.1038/nclimate1864]; Stocker TF, 2013, SCIENCE, V339, P280, DOI 10.1126/science.1232468	14	8	9	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					295	296		10.1038/522295a	http://dx.doi.org/10.1038/522295a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085267				2022-12-28	WOS:000356425400042
J	Tagliabracci, VS; Wiley, SE; Guo, X; Kinch, LN; Durrant, E; Wen, JZ; Xiao, JY; Cui, JX; Nguyen, KB; Engel, JL; Coon, JJ; Grishin, N; Pinna, LA; Pagliarini, DJ; Dixon, JE				Tagliabracci, Vincent S.; Wiley, Sandra E.; Guo, Xiao; Kinch, Lisa N.; Durrant, Eric; Wen, Jianzhong; Xiao, Junyu; Cui, Jixin; Nguyen, Kim B.; Engel, James L.; Coon, Joshua J.; Grishin, Nick; Pinna, Lorenzo A.; Pagliarini, David J.; Dixon, Jack E.			A Single Kinase Generates the Majority of the Secreted Phosphoproteome	CELL			English	Article							GOLGI CASEIN KINASE; MASS-SPECTROMETRY; BREAST-CANCER; HUMAN GENOME; PHOSPHORYLATION; PROTEINS; SPECIFICITY; FAMILY; GLYCOSYLATION; METASTASIS	The existence of extracellular phosphoproteins has been acknowledged for over a century. However, research in this area has been undeveloped largely because the kinases that phosphorylate secreted proteins have escaped identification. Fam20C is a kinase that phosphorylates S-x-E/pS motifs on proteins in milk and in the extracellular matrix of bones and teeth. Here, we show that Fam20C generates the majority of the extracellular phosphoproteome. Using CRISPR/Cas9 genome editing, mass spectrometry, and biochemistry, we identify more than 100 secreted phosphoproteins as genuine Fam20C substrates. Further, we show that Fam20C exhibits broader substrate specificity than previously appreciated. Functional annotations of Fam20C substrates suggest roles for the kinase beyond biomineralization, including lipid homeostasis, wound healing, and cell migration and adhesion. Our results establish Fam20C as the major secretory pathway protein kinase and serve as a foundation for new areas of investigation into the role of secreted protein phosphorylation in human biology and disease.	[Tagliabracci, Vincent S.; Wiley, Sandra E.; Durrant, Eric; Wen, Jianzhong; Xiao, Junyu; Cui, Jixin; Nguyen, Kim B.; Engel, James L.; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guo, Xiao; Pagliarini, David J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Guo, Xiao; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Kinch, Lisa N.; Grishin, Nick] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Grishin, Nick] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Pinna, Lorenzo A.] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Pinna, Lorenzo A.] Venetian Inst Mol Med, I-35129 Padua, Italy; [Dixon, Jack E.] Univ Calif San Diego, Dept Cell & Mol Med, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Padua; Veneto Institute Molecular Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	jedixon@mail.ucsd.edu	Xiao, Junyu/ABE-2192-2020; Wen, Jianzhong/AAI-4976-2020	Wiley, Sandra/0000-0003-3979-2474; Pinna, Lorenzo A./0000-0002-8856-4956; Kinch, Lisa/0000-0003-3041-2615; Pagliarini, David J./0000-0002-0001-0087; Xiao, Junyu/0000-0003-1822-1701	NIH [DK018849-36, DK018024-37, K99DK099254, R01DK098672, GM094575]; Welch Foundation [I-1505]; AIRC [IG 10312]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849, R01DK018024, K99DK099254, R37DK018024, R01DK098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575, T32GM007752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Greg Taylor, Carolyn Worby, Peter van der Geer, and Jenna Jewell for valuable input. This work was supported by grants from the NIH (DK018849-36 and DK018024-37 to J.E.D, K99DK099254 to V.S.T., R01DK098672 to D.J.P., GM094575 to N.V.G.), the Welch Foundation (I-1505 to N.V.G.), and the AIRC (IG 10312 to L.A.P.).	Aziz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014534; Aziz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014547; Bahl JMC, 2008, ANAL CHEM, V80, P6308, DOI 10.1021/ac800835y; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bordoli MR, 2014, CELL, V158, P1033, DOI 10.1016/j.cell.2014.06.048; Brunati AM, 2000, BIOCHEM J, V351, P765, DOI 10.1042/0264-6021:3510765; Carrascal M, 2010, J PROTEOME RES, V9, P876, DOI 10.1021/pr900780s; Chan HC, 2010, J DENT RES, V89, P695, DOI 10.1177/0022034510365662; Chen C., 2010, CURR PROTOC MOL BIOL; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dewpura T, 2008, FEBS J, V275, P3480, DOI 10.1111/j.1742-4658.2008.06495.x; Dudkiewicz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066427; Gagnoux-Palacios L, 2001, J CELL BIOL, V153, P835, DOI 10.1083/jcb.153.4.835; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Georges RB, 2011, CANCER BIOL THER, V12, P69, DOI 10.4161/cbt.12.1.15719; Hammarsten O., 1883, Z PHYSL CHEM, V7, P227; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jiang W, 2008, NEOPLASIA, V10, P1335, DOI 10.1593/neo.08694; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; Lindberg I, 2015, J BONE MINER RES, V30, P431, DOI 10.1002/jbmr.2354; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MEGGIO F, 1989, EUR J BIOCHEM, V186, P459, DOI 10.1111/j.1432-1033.1989.tb15229.x; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; O'Neill AK, 2011, J BIOL CHEM, V286, P43559, DOI 10.1074/jbc.M111.294603; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Sodek KL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-223; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Tagliabracci VS, 2013, BIOCHEM SOC T, V41, P1061, DOI 10.1042/BST20130059; Tagliabracci VS, 2013, TRENDS BIOCHEM SCI, V38, P121, DOI 10.1016/j.tibs.2012.11.008; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tennant-Eyles AJ, 2011, BIOCHEM BIOPH RES CO, V406, P471, DOI 10.1016/j.bbrc.2011.02.076; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; von Renesse A, 2014, J MED GENET, V51, P275, DOI 10.1136/jmedgenet-2013-102236; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Wen JZ, 2014, P NATL ACAD SCI USA, V111, P15723, DOI 10.1073/pnas.1417993111; Xiao JY, 2013, P NATL ACAD SCI USA, V110, P10574, DOI 10.1073/pnas.1309211110; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Zawadzka AM, 2014, MOL CELL PROTEOMICS, V13, P1034, DOI 10.1074/mcp.M113.035485; Zhou WD, 2009, J PROTEOME RES, V8, P5523, DOI 10.1021/pr900603n	51	189	279	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1619	1632		10.1016/j.cell.2015.05.028	http://dx.doi.org/10.1016/j.cell.2015.05.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091039	Green Accepted, Bronze			2022-12-28	WOS:000356618200018
J	Krauss, BS; Calligaris, L; Green, SM; Barbi, E				Krauss, Baruch S.; Calligaris, Lorenzo; Green, Steven M.; Barbi, Egidio			Current concepts in management of pain in children in the emergency department	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; PEDIATRIC PAIN; INTRANASAL FENTANYL; INTRAVENOUS CANNULATION; PROCEDURAL SEDATION; VAPOCOOLANT SPRAY; ABDOMINAL-PAIN; CEREBRAL-PALSY; ANALGESIA; ACETAMINOPHEN	Pain is common in children presenting to emergency departments with episodic illnesses, acute injuries, and exacerbation of chronic disorders. We review recognition and assessment of pain in infants and children and discuss the manifestations of pain in children with chronic illness, recurrent pain syndromes, and cognitive impairment, including the difficulties of pain management in these patients. Non-pharmacological interventions, as adjuncts to pharmacological management for acute anxiety and pain, are described by age and development. We discuss the pharmacological management of acute pain and anxiety, reviewing invasive and non-invasive routes of administration, pharmacology, and adverse effects.	[Krauss, Baruch S.] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Krauss, Baruch S.] Harvard Univ, Sch Med, Boston, MA USA; [Calligaris, Lorenzo; Barbi, Egidio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Green, Steven M.] Loma Linda Univ, Med Ctr, Dept Emergency Med, Loma Linda, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; IRCCS Burlo Garofolo; Loma Linda University	Krauss, BS (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	baruch.krauss@childrens.harvard.edu	Barbi, Egidio/K-4016-2018; Krauss, Baruch/U-6182-2019	Barbi, Egidio/0000-0002-6343-846X; 				Akorn, EMLA CREAM US PACK I; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], LEX DRUGS DRUG DAT; Association of Paediatric Anaesthetists of Great Britain and Ireland, 2012, PAEDIATR ANAESTH, V22, P11; Balottin U, 2013, CEPHALALGIA, V33, P112, DOI 10.1177/0333102412468386; Barbi E, 2003, BRIT MED J, V327, P681, DOI 10.1136/bmj.327.7416.681; Bauman BH, 2005, EMERG MED CLIN N AM, V23, P393, DOI 10.1016/j.emc.2004.12.008; Bendall JC, 2011, PREHOSP EMERG CARE, V15, P158, DOI 10.3109/10903127.2010.541980; Berde CB, 2002, NEW ENGL J MED, V347, P1094, DOI 10.1056/NEJMra012626; Bianciotto M, 2013, ARCH DIS CHILD, V98, P218, DOI 10.1136/archdischild-2012-302100; Borland M, 2007, ANN EMERG MED, V49, P335, DOI 10.1016/j.annemergmed.2006.06.016; Borland M, 2011, EMERG MED AUSTRALAS, V23, P202, DOI 10.1111/j.1742-6723.2011.01391.x; Boyd RJ, 2005, EMERG MED J, V22, P30, DOI 10.1136/emj.2002.003574; Breau LM, 2003, ARCH PEDIAT ADOL MED, V157, P1219, DOI 10.1001/archpedi.157.12.1219; Breau LM, 2009, PAIN RES MANAG, V14, P116, DOI 10.1155/2009/642352; Chiaretti A, 2013, EUR REV MED PHARMACO, V17, P112; Ciszkowski C, 2009, NEW ENGL J MED, V361, P827, DOI 10.1056/NEJMc0904266; Cohen Lindsey L, 2008, Pediatrics, V122 Suppl 3, pS134, DOI 10.1542/peds.2008-1055f; Cohen LL, 2001, J PEDIATR PSYCHOL, V26, P367, DOI 10.1093/jpepsy/26.6.367; Cole J, 2009, EMERG MED AUSTRALAS, V21, P395, DOI 10.1111/j.1742-6723.2009.01216.x; Cooper C, 2004, J BONE MINER RES, V19, P1976, DOI 10.1359/JBMR.040902; Corwin DJ, 2012, PEDIATR EMERG CARE, V28, P524, DOI 10.1097/PEC.0b013e3182587d27; Costello M, 2006, CLIN PEDIATR, V45, P628, DOI 10.1177/0009922806291013; Di Lorenzo C, 2005, J PEDIATR GASTR NUTR, V40, P245, DOI 10.1097/01.MPG.0000155367.44628.21; Diamanti A, 2010, AM J EMERG MED, V28, P189, DOI 10.1016/j.ajem.2008.11.016; Downing A, 2006, EMERG MED J, V23, P391, DOI 10.1136/emj.2005.025411; Drendel AL, 2011, PEDIATR EMERG CARE, V27, P773, DOI 10.1097/PEC.0b013e31822877f7; Duff AJA, 2003, ARCH DIS CHILD, V88, P931, DOI 10.1136/adc.88.10.931; Eidelman A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005364.pub2; Eisen S, 2007, ARCH DIS CHILD, V92, P828, DOI 10.1136/adc.2007.123372; Eslick GD, 2010, PEDIATR CLIN N AM, V57, P1211, DOI 10.1016/j.pcl.2010.09.013; Farion KJ, 2008, CAN MED ASSOC J, V179, P31, DOI 10.1503/cmaj.070874; Finley GA, 2014, CAN J ANESTH, V61, P180, DOI 10.1007/s12630-013-0076-7; Fitzgerald M, 2003, PAIN INFANTS CHILDRE, V2nd, P19; Flavell JH, 1997, CHILD DEV, V68, P39, DOI 10.1111/j.1467-8624.1997.tb01923.x; Flavell JH, 2001, PSYCHOL SCI, V12, P430, DOI 10.1111/1467-9280.00379; FRANK NC, 1995, J PEDIATR PSYCHOL, V20, P277, DOI 10.1093/jpepsy/20.3.277; Gaffney A, 2003, PAIN INFANTS CHILDRE; Galinski M, 2011, AM J EMERG MED, V29, P1062, DOI 10.1016/j.ajem.2010.06.031; Gibb IA, 2008, ARCH DIS CHILD, V93, P241, DOI 10.1136/adc.2007.126896; GOLDMAN A, 2003, PAIN INFANTS CHILDRE, P539; Goldschneider KR, 2012, PAIN RES MANAG, V17, P386, DOI 10.1155/2012/854159; Grant PS, 2006, AM J EMERG MED, V24, P806, DOI 10.1016/j.ajem.2006.05.004; Green SM, 2011, ANN EMERG MED, V57, P449, DOI 10.1016/j.annemergmed.2010.11.030; Grindlay J, 2009, EMERG MED AUSTRALAS, V21, P4, DOI 10.1111/j.1742-6723.2009.01153.x; Harrison D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008408.pub2; Hearst D, 2009, PEDIATR ANESTH, V19, P1014, DOI 10.1111/j.1460-9592.2009.03146.x; Heimer L, 2006, NEUROSCI BIOBEHAV R, V30, P126, DOI 10.1016/j.neubiorev.2005.06.006; Hennequin H, 2000, LANCET, V356, P1882, DOI 10.1016/S0140-6736(00)03259-1; Hoving MA, 2009, EUR J PAEDIATR NEURO, V13, P240, DOI 10.1016/j.ejpn.2008.04.013; Hryhorczuk AL, 2012, RADIOLOGY, V263, P778, DOI 10.1148/radiol.12111726; Johnston CC, 2003, PAIN INFANTS CHILDRE, P105; Kagan J., 2005, YOUNG MIND GROWING B; Kassab M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008411.pub2; Kendall JM, 2001, BMJ-BRIT MED J, V322, P261, DOI 10.1136/bmj.322.7281.261; Kennedy Robert M, 2004, Paediatr Drugs, V6, P11; Konner M., 2010, EVOLUTION CHILDHOOD; Krauss B, 2006, LANCET, V367, P766, DOI 10.1016/S0140-6736(06)68230-5; Kuttner L, 2010, A CHILD IN PAIN; Lander JA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004236.pub2; Lavonas EJ, 2010, PEDIATRICS, V126, pE1430, DOI 10.1542/peds.2009-3352; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liebelt E.L., 2000, CLIN PEDIATR EMERG M, V1, P260, DOI [10.1016/S1522-8401(00)90038-7, DOI 10.1016/S1522-8401(00)90038-7]; Mafrica F, 2006, THESCIENTIFICWORLDJO, V6, P140, DOI 10.1100/tsw2006.27; Mak WY, 2011, EXPERT OPIN PHARMACO, V12, P865, DOI 10.1517/14656566.2011.542751; Manworren Renee C B, 2003, Pediatr Nurs, V29, P140; Marzuillo P, 2014, ACTA PAEDIATR, V103, P1110, DOI 10.1111/apa.12738; Marzuillo P, 2014, EUR J PEDIATR, V173, P415, DOI 10.1007/s00431-013-2239-5; Massaro M, 2013, EUR J PEDIATR, V172, P9, DOI 10.1007/s00431-012-1720-x; Massaro M, 2014, ACTA PAEDIATR, V103, pE495, DOI 10.1111/apa.12748; Mednick L, 2010, TXB PEDIAT PSYCHOSOM; Merry AF, 2010, BRIT J ANAESTH, V104, P80, DOI 10.1093/bja/aep338; Michiels EA, ANN EMERG M IN PRESS; Migita RT, 2006, ARCH PEDIAT ADOL MED, V160, P46, DOI 10.1001/archpedi.160.1.46; Misurac JM, 2013, J PEDIATR-US, V162, P1153, DOI 10.1016/j.jpeds.2012.11.069; Morgane PJ, 2006, NEUROSCI BIOBEHAV R, V30, P119, DOI 10.1016/j.neubiorev.2005.04.020; Murthy BVS, 2000, BRIT J ANAESTH, V84, P346, DOI 10.1093/oxfordjournals.bja.a013437; Nader R, 2004, CLIN J PAIN, V20, P88, DOI 10.1097/00002508-200403000-00005; Nelson K, 1996, 5 7 YEAR SHIFT AGE R; Neri E, 2013, ARCH DIS CHILD, V98, P721, DOI 10.1136/archdischild-2012-303527; O'Connor RE, 2011, ANN EMERG MED, V58, P365, DOI 10.1016/j.annemergmed.2011.06.020; Parkinson KN, 2013, ARCH DIS CHILD, V98, P434, DOI 10.1136/archdischild-2012-303482; Perez RS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-20; Perquin CW, 2000, PAIN, V87, P51, DOI 10.1016/S0304-3959(00)00269-4; Piaget J., 2003, PSYCHOL INTELLIGENCE; Pillow BH, 2008, J GENET PSYCHOL, V169, P297, DOI 10.3200/GNTP.169.4.297-321; Pitts Stephen R, 2008, Natl Health Stat Report, P1; Porter FL, 1999, J DEV BEHAV PEDIATR, V20, P253, DOI 10.1097/00004703-199908000-00008; Priestley S, 2003, ANN EMERG MED, V42, P34, DOI 10.1067/mem.2003.207; Primavera G, 2010, PEDIATRICS, V125, pE155, DOI 10.1542/peds.2009-0295; Racoosin JA, 2013, NEW ENGL J MED, V368, P2155, DOI 10.1056/NEJMp1302454; Ramelet Anne-Sylvie, 2004, Aust Crit Care, V17, P33, DOI 10.1016/S1036-7314(05)80048-7; Rask CU, 2012, DAN MED J, V59; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Rattaz C, 2013, PAIN, V154, P2007, DOI 10.1016/j.pain.2013.06.011; Resch K, 1998, ANN EMERG MED, V32, P693, DOI 10.1016/S0196-0644(98)70069-1; Saunders M, 2010, ACAD EMERG MED, V17, P1155, DOI 10.1111/j.1553-2712.2010.00905.x; Schechter NL, 1999, J DEV BEHAV PEDIATR, V20, P209, DOI 10.1097/00004703-199908000-00001; Smith C, 2012, CAN FAM PHYSICIAN, V58, P645; Smith & Nephew, AM 40MG G GEL UK PRO; Somers LJ, 2001, EMERG MED J, V18, P159, DOI 10.1136/emj.18.3.159; Sonneveld LP, 2013, J PEDIATR GASTR NUTR, V56, P475, DOI 10.1097/MPG.0b013e31828b5145; Synera, SYN PATCH US PACK IN; Taylor SE, 2013, EMERG MED AUSTRALAS, V25, P316, DOI 10.1111/1742-6723.12103; The Joint Commission, 2022, E DIT HOSP ACCR REQ; Todd KH, 2007, J PAIN, V8, P460, DOI 10.1016/j.jpain.2006.12.005; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tsao JC, 2012, PAIN RES MANAG, V17, P103, DOI 10.1155/2012/592108; van Staa A, 2011, PATIENT PREFER ADHER, V5, DOI 10.2147/PPA.S17184; Voepel-Lewis T, 2011, ANESTH ANALG, V112, P415, DOI 10.1213/ANE.0b013e318203f495; Walker DM, 2008, CURR OPIN PEDIATR, V20, P248, DOI 10.1097/MOP.0b013e3282ff6308; Ward RM, 2001, PEDIATRICS, V108, P1020; Weisner TS, 1996, 5 7 YEAR SHIFT AGE R; White SH, 1996, 5 7 YEAR SHIFT AGE R; Wilson JA, 1997, J ACCID EMERG MED, V14, P70; Young KD, 2005, ANN EMERG MED, V45, P160, DOI 10.1016/j.annemergmed.2004.09.019; Zelter LK, 2011, NELSON TXB PEDIAT	117	95	97	1	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					83	92		10.1016/S0140-6736(14)61686-X	http://dx.doi.org/10.1016/S0140-6736(14)61686-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26095580	Green Submitted			2022-12-28	WOS:000367457300030
J	Davey, C; Zoumot, Z; Jordan, S; McNulty, WH; Carr, DH; Hind, MD; Hansell, DM; Rubens, MB; Banya, W; Polkey, MI; Shah, PL; Hopkinson, NS				Davey, Claire; Zoumot, Zaid; Jordan, Simon; McNulty, William H.; Carr, Dennis H.; Hind, Matthew D.; Hansell, David M.; Rubens, Michael B.; Banya, Winston; Polkey, Michael I.; Shah, Pallav L.; Hopkinson, Nicholas S.			Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial	LANCET			English	Article							MINIMAL IMPORTANT DIFFERENCE; COPD ASSESSMENT TEST; MULTICENTER; HYPERINFLATION; VALIDATION; EXERCISE	Background Lung volume reduction surgery improves survival in selected patients with emphysema, and has generated interest in bronchoscopic approaches that might achieve the same effect with less morbidity and mortality. Previous trials with endobronchial valves have yielded modest group benefits because when collateral ventilation is present it prevents lobar atelectasis. Methods We did a single-centre, double-blind sham-controlled trial in patients with both heterogeneous emphysema and a target lobe with intact interlobar fissures on CT of the thorax. We enrolled stable outpatients with chronic obstructive pulmonary disease who had a forced expiratory volume in 1 s (FEV1) of less than 50% predicted, significant hyperinflation (total lung capacity >100% and residual volume >150%), a restricted exercise capacity (6 min walking distance <450 m), and substantial breathlessness (MRC dyspnoea score >= 3). Participants were randomised (1: 1) by computer-generated sequence to receive either valves placed to achieve unilateral lobar occlusion (bronchoscopic lung volume reduction) or a bronchoscopy with sham valve placement (control). Patients and researchers were masked to treatment allocation. The study was powered to detect a 15% improvement in the primary endpoint, the FEV 1 3 months after the procedure. Analysis was on an intention-to-treat basis. The trial is registered at controlled-trials. com, ISRCTN04761234. Findings 50 patients (62% male, FEV 1 [% predicted] mean 31.7% [ SD 10.2]) were enrolled to receive valves (n=25) or sham valve placement (control n=25) between March 1, 2012, and Sept 30, 2013. In the bronchoscopic lung volume reduction group, FEV 1 increased by a median 8.77% (IQR 2.27-35.85) versus 2.88% (0-8.51) in the control group (Mann-Whitney p=0.0326). There were two deaths in the bronchoscopic lung volume reduction group and one control patient was unable to attend for follow-up assessment because of a prolonged pneumothorax. Interpretation Unilateral lobar occlusion with endobronchial valves in patients with heterogeneous emphysema and intact interlobar fissures produces significant improvements in lung function. There is a risk of significant complications and further trials are needed that compare valve placement with lung volume reduction surgery. Copyright (C) Davey et al. Open Access article distributed under the terms of CC BY.	[Davey, Claire; Zoumot, Zaid; Jordan, Simon; McNulty, William H.; Carr, Dennis H.; Hind, Matthew D.; Hansell, David M.; Rubens, Michael B.; Banya, Winston; Polkey, Michael I.; Shah, Pallav L.; Hopkinson, Nicholas S.] Royal Brompton & Harefield NHS Fdn Trust, Biomed Res Unit, NIHR Resp Dis, London, England; [Davey, Claire; Zoumot, Zaid; Jordan, Simon; McNulty, William H.; Carr, Dennis H.; Hind, Matthew D.; Hansell, David M.; Rubens, Michael B.; Banya, Winston; Polkey, Michael I.; Shah, Pallav L.; Hopkinson, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, London, England	Royal Brompton & Harefield NHS Foundation Trust; Imperial College London	Hopkinson, NS (corresponding author), Royal Brompton Hosp, Fulham Rd, London SW3 6NP, England.	n.hopkinson@ic.ac.uk	Hind, Matthew/AAC-4384-2021; Shah, Pallav L/AAB-2758-2019	Shah, Pallav L/0000-0002-9052-4638; Hind, Matthew/0000-0002-9966-9446; McNulty, William/0000-0002-1315-7942	Efficacy and Mechanism Evaluation Programme - Medical Research Council (MRC); Efficacy and Mechanisms Evaluation (EME) Programme; Medical Research Council (MRC); National Institute for Health Research (NIHR); Chief Scientist Office in Scotland; National Institute for Social Care and Health Research Clinical Research Centre in Wales; Health and Social Care Research and Development Division, Public Health Agency in Northern Ireland; NIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London; NIHR Senior Investigator Award; Medical Research Council [MC_PC_12032] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10157] Funding Source: researchfish; MRC [MC_PC_12032] Funding Source: UKRI	Efficacy and Mechanism Evaluation Programme - Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Efficacy and Mechanisms Evaluation (EME) Programme; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Chief Scientist Office in Scotland; National Institute for Social Care and Health Research Clinical Research Centre in Wales; Health and Social Care Research and Development Division, Public Health Agency in Northern Ireland; NIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London; NIHR Senior Investigator Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Efficacy and Mechanism Evaluation Programme, funded by the Medical Research Council (MRC) and managed by the National Institute for Health Research (NIHR) on behalf of the MRC-NIHR partnership.; This project was supported by a grant from the Efficacy and Mechanisms Evaluation (EME) Programme. The EME Programme is funded by the Medical Research Council (MRC) and National Institute for Health Research (NIHR) with contributions from the Chief Scientist Office in Scotland, National Institute for Social Care and Health Research Clinical Research Centre in Wales, and the Health and Social Care Research and Development Division, Public Health Agency in Northern Ireland. The Programme is managed by the NIHR Evaluation, Trials and Studies Coordinating Centre based at the University of Southampton. The study was supported by the NIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London who part fund the salary of MIP and wholly fund the salary of ZZ. DMH is the recipient of an NIHR Senior Investigator Award. The endobronchial valves were provided free of charge by the manufacturers PulmonX. Our thanks to members of the Data Monitoring Committee: Michael Roughton (Chair; R Squared Statistics, London, UK), Tudor P Toma (Lewisham Hospital, London, UK), and Philip Ind (Imperial College NHS Trust, London, UK). The views expressed in this publication are those of the authors and not necessarily those of the MRC, National Health Service, NIHR, or the Department of Health.	Boutou AK, 2013, EUR RESPIR J, V42, P616, DOI 10.1183/09031936.00146012; Casaburi Richard, 2005, COPD, V2, P131; CLARK EH, 1978, CLIN SCI MOL MED, V54, P627, DOI 10.1042/cs0540627; Clark SJ, 2014, CLIN MED, V14, P122, DOI 10.7861/clinmedicine.14-2-122; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Davey C, 2015, THORAX, V70, P288, DOI 10.1136/thoraxjnl-2014-205127; Dodd JW, 2011, THORAX, V66, P425, DOI 10.1136/thx.2010.156372; Emery MJ, 2010, AM J RESP CRIT CARE, V182, P1282, DOI 10.1164/rccm.201001-0102OC; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Geddes D, 2000, NEW ENGL J MED, V343, P239, DOI 10.1056/NEJM200007273430402; Hartman JE, 2012, EUR RESPIR J, V40, P1137, DOI 10.1183/09031936.00219111; Herth FJF, 2013, EUR RESPIR J, V41, P302, DOI 10.1183/09031936.00015312; Hopkinson NS, 2011, EUR RESPIR J, V37, P1346, DOI 10.1183/09031936.00100110; Hopkinson NS, 2005, AM J RESP CRIT CARE, V171, P453, DOI 10.1164/rccm.200407-961OC; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kelly JL, 2012, RESPIRATION, V84, P193, DOI 10.1159/000336549; Kon SSC, 2014, LANCET RESP MED, V2, P195, DOI 10.1016/S2213-2600(14)70001-3; McNulty W, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000023; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Ninane V, 2012, EUR RESPIR J, V39, P1319, DOI 10.1183/09031936.00019711; Puhan MA, 2011, EUR RESPIR J, V37, P784, DOI 10.1183/09031936.00063810; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Schunemann HJ, 2003, J CLIN EPIDEMIOL, V56, P1170, DOI 10.1016/S0895-4356(03)00115-X; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shah PL, 2011, LANCET, V378, P997, DOI 10.1016/S0140-6736(11)61050-7; Shah PL, 2014, THORAX, V69, P280, DOI 10.1136/thoraxjnl-2013-203743; Shah PL, 2013, LANCET RESP MED, V1, P233, DOI 10.1016/S2213-2600(13)70047-X; Valipour A, 2014, EUR RESPIR J, V43, P387, DOI 10.1183/09031936.00133012; Zoumot Z, 2014, THORAX, V69, P973, DOI 10.1136/thoraxjnl-2014-205667	29	224	227	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1066	1073		10.1016/S0140-6736(15)60001-0	http://dx.doi.org/10.1016/S0140-6736(15)60001-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26116485	Green Published, hybrid			2022-12-28	WOS:000361189200026
J	Gladstone, DJ; Geerts, WH; Douketis, J; Ivers, N; Healey, JS; Leblanc, K				Gladstone, David J.; Geerts, William H.; Douketis, James; Ivers, Noah; Healey, Jeff S.; Leblanc, Kori			How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DABIGATRAN ADHERENCE; THERAPY; WARFARIN; RISK		Univ Toronto, Dept Med, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Sunnybrook Reg Stroke Prevent Clin, Hurvitz Brain Sci Program, Dr Thomas & Harriet Black Rapid TIA Clin, Toronto, ON M4N 3M5, Canada; Sunnybrook Hlth Sci Ctr, Anticoagulant Management Clin, Toronto, ON M4N 3M5, Canada; [Geerts, William H.] Sunnybrook Hlth Sci Ctr, Thromboembolism Serv, Toronto, ON M4N 3M5, Canada; Univ Toronto, Stroke Program, Toronto, ON, Canada; Womens Coll Hosp, Womens Coll Res Inst, Family Practice Hlth Ctr, Toronto, ON, Canada; Womens Coll Hosp, Inst Hlth Syst Solut & Virtual Care, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada; Univ Hlth Network, OpenLab, Toronto, ON, Canada; McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; Canadian Stroke Prevent Intervent Network, Hamilton, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; Population Health Research Institute	Gladstone, DJ (corresponding author), Sunnybrook Hlth Sci Ctr, Reg Stroke Prevent Clin, A442-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.gladstone@sunnybrook.ca	Douketis, James/AAO-5659-2021; Ivers, Noah/O-7643-2018	Gladstone, David/0000-0003-0612-5544; Ivers, Noah/0000-0003-2500-2435				Arima H, 2012, STROKE, V43, P1675, DOI 10.1161/STROKEAHA.112.651448; CRAIG HM, 1985, RES NURS HEALTH, V8, P61, DOI 10.1002/nur.4770080112; Di Minno A, 2014, THROMB RES, V133, P699, DOI 10.1016/j.thromres.2014.01.016; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Ewen S, 2014, CLIN RES CARDIOL, V103, P173, DOI 10.1007/s00392-013-0616-8; Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344; Gladstone DJ, 2015, ANTICOAGULANT MONITO; Gorst-Rasmussen A, 2015, J THROMB HAEMOST, V13, P495, DOI 10.1111/jth.12845; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; Rosenbaum L, 2015, NEW ENGL J MED, V372, P183, DOI 10.1056/NEJMms1409015; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Shore S, 2015, JAMA-J AM MED ASSOC, V313, P1443, DOI 10.1001/jama.2015.2761; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Spyropoulos AC, 2012, BLOOD, V120, P2954, DOI 10.1182/blood-2012-06-415943	14	27	27	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2015	163	5					382	U138		10.7326/M15-0143	http://dx.doi.org/10.7326/M15-0143			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0OM	26121536				2022-12-28	WOS:000360296000010
J	Attardo, A; Fitzgerald, JE; Schnitzer, MJ				Attardo, Alessio; Fitzgerald, James E.; Schnitzer, Mark J.			Impermanence of dendritic spines in live adult CA1 hippocampus	NATURE			English	Article							LONG-TERM POTENTIATION; IN-VIVO; STRUCTURAL PLASTICITY; PYRAMIDAL CELLS; REMOTE MEMORIES; RESOLUTION; DYNAMICS; STABILITY; NEOCORTEX; SYNAPSES	The mammalian hippocampus is crucial for episodic memory formation(1) and transiently retains information for about 3-4 weeks in adult mice and longer in humans(2). Although neuroscientists widely believe that neural synapses are elemental sites of information storage(3), there has been no direct evidence that hippocampal synapses persist for time intervals commensurate with the duration of hippocampal-dependent memory. Here we tested the prediction that the lifetimes of hippocampal synapses match the longevity of hippocampal memory. By using time-lapse two-photon microendoscopy(4) in the CA1 hippocampal area of live mice, we monitored the turnover dynamics of the pyramidal neurons' basal dendritic spines, postsynaptic structures whose turnover dynamics are thought to reflect those of excitatory synaptic connections(5,6). Strikingly, CA1 spine turnover dynamics differed sharply from those seen previously in the neocortex(7-9). Mathematical modelling revealed that the data best matched kinetic models with a single population of spines with a mean lifetime of approximately 1-2 weeks. This implies similar to 100% turnover in similar to 2-3 times this interval, a near full erasure of the synaptic connectivity pattern. Although N-methyl-D-aspartate (NMDA) receptor blockade stabilizes spines in the neocortex(10,11), in CA1 it transiently increased the rate of spine loss and thus lowered spine density. These results reveal that adult neocortical and hippocampal pyramidal neurons have divergent patterns of spine regulation and quantitatively support the idea that the transience of hippocampal-dependent memory directly reflects the turnover dynamics of hippocampal synapses.	[Attardo, Alessio; Fitzgerald, James E.; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; [Attardo, Alessio; Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Schnitzer, MJ (corresponding author), Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA.	mschnitz@stanford.edu	Fitzgerald, James E/E-6569-2012; Attardo, Alessio/ABE-5208-2021	Fitzgerald, James E/0000-0002-0949-4188; Attardo, Alessio/0000-0003-0665-6011	National Institute of Mental Health; National Institute on Aging; Ellison Foundation; National Science Foundation; Stanford Center for Mind, Brain, and Computation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH092809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG038771] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Foundation(Lawrence Ellison Foundation); National Science Foundation(National Science Foundation (NSF)); Stanford Center for Mind, Brain, and Computation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Li, J. Lecoq and E. T. W. Ho for technical assistance, R. P. J. Barretto and B. Messerschmidt for advice, and A. Holtmaat for providing published data sets. The National Institute of Mental Health, The National Institute on Aging, and the Ellison Foundation provided grants (M.J.S.). Fellowships from the National Science Foundation and The Stanford Center for Mind, Brain, and Computation provided graduate research support (J.E.F.).	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Bourne JN, 2011, HIPPOCAMPUS, V21, P354, DOI 10.1002/hipo.20768; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Gu LG, 2014, J NEUROSCI, V34, P13948, DOI 10.1523/JNEUROSCI.1464-14.2014; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Sanders J, 2012, J NEUROSCI, V32, P12570, DOI 10.1523/JNEUROSCI.1131-12.2012; Sorra KE, 1998, J NEUROSCI, V18, P658; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wu XE, 2009, NEURON, V62, P31, DOI 10.1016/j.neuron.2009.02.021; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	34	197	199	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					592	+		10.1038/nature14467	http://dx.doi.org/10.1038/nature14467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26098371	Green Accepted			2022-12-28	WOS:000358655200045
J	Reddy, KS				Reddy, K. Srinath			INTERNATIONAL HEALTH CARE SYSTEMS India's Aspirations for Universal Health Coverage	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Publ Hlth Fdn India, New Delhi, India	Public Health Foundation of India	Reddy, KS (corresponding author), Publ Hlth Fdn India, New Delhi, India.			Reddy, K Srinath/0000-0003-3416-3548				[Anonymous], 2014, CONC NOT SM IN PRESS; Ministry of Health and Family Welfare, 2014, NAT HLTH PO IN PRESS; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Swachh Bharat Abhiyan, 2014, TIMES INDIA     1002	5	31	32	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					1	5		10.1056/NEJMp1414214	http://dx.doi.org/10.1056/NEJMp1414214			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL8IS	26132937				2022-12-28	WOS:000357218700001
J	Salomon, WE; Jolly, SM; Moore, MJ; Zamore, PD; Serebrov, V				Salomon, William E.; Jolly, Samson M.; Moore, Melissa J.; Zamore, Phillip D.; Serebrov, Victor			Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides	CELL			English	Article							SILENCING COMPLEX; CRYSTAL-STRUCTURE; MICRORNA TARGETS; RNA RECOGNITION; PAZ DOMAIN; HUMAN RISC; TRANSLATIONAL REPRESSION; POLYRIBOADENYLIC ACID; POLYRIBOURIDYLIC ACID; STRUCTURAL INSIGHTS	Argonaute proteins repress gene expression and defend against foreign nucleic acids using short RNAs or DNAs to specify the correct target RNA or DNA sequence. We have developed single-molecule methods to analyze target binding and cleavage mediated by the Argonaute: guide complex, RISC. We find that both eukaryotic and prokaryotic Argonaute proteins reshape the fundamental properties of RNA: RNA, RNA: DNA, and DNA: DNA hybridization-a small RNA or DNA bound to Argonaute as a guide no longer follows the well-established rules by which oligonucleotides find, bind, and dissociate from complementary nucleic acid sequences. Argonautes distinguish substrates from targets with similar complementarity. Mouse AGO2, for example, binds tighter to miRNA targets than its RNAi cleavage product, even though the cleaved product contains more base pairs. By re-writing the rules for nucleic acid hybridization, Argonautes allow oligonucleotides to serve as specificity determinants with thermodynamic and kinetic properties more typical of RNA-binding proteins than of RNA or DNA.	[Salomon, William E.; Jolly, Samson M.; Moore, Melissa J.; Zamore, Phillip D.; Serebrov, Victor] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA Therapeut Inst, Worcester, MA 01605 USA; [Salomon, William E.; Jolly, Samson M.; Moore, Melissa J.; Zamore, Phillip D.; Serebrov, Victor] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA Therapeut Inst, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu; victor.serebrov@umassmed.edu		Zamore, Phillip/0000-0002-4505-9618; Serebrov, Victor/0000-0002-5800-3103	NIH [GM053007, GM62862, GM65236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R01GM065236, T32GM107000, R01GM053007, R37GM062862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the M.J.M. and P.D.Z. laboratories for discussions and comments on the manuscript; Jeff Gelles and Larry Friedman for experimental and analytical advice; and Johnson Chung for scripts to create overlay movies. This work was supported in part by NIH grants GM053007 and GM053007 to M.J.M. and GM62862 and GM65236 to P.D.Z.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Cava F, 2009, EXTREMOPHILES, V13, P213, DOI 10.1007/s00792-009-0226-6; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Deerberg A, 2013, P NATL ACAD SCI USA, V110, P17850, DOI 10.1073/pnas.1217838110; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Egli M., 1984, PRINCIPLES NUCL ACID; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Faehnle CR, 2013, CELL REP, V3, P1901, DOI 10.1016/j.celrep.2013.05.033; Flores-Jasso CF, 2013, RNA, V19, P271, DOI 10.1261/rna.036921.112; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Friedman L.J., 2015, MULTIWAVELENGTH SING; Friedman LJ, 2006, BIOPHYS J, V91, P1023, DOI 10.1529/biophysj.106.084004; Friedman LJ, 2013, P NATL ACAD SCI USA, V110, P9740, DOI 10.1073/pnas.1300221110; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; GRYAZNOV S, 1994, TETRAHEDRON LETT, V35, P2489, DOI 10.1016/S0040-4039(00)77151-6; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hauptmann J, 2013, NAT STRUCT MOL BIOL, V20, P814, DOI 10.1038/nsmb.2577; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Jung SR, 2013, J AM CHEM SOC, V135, P16865, DOI 10.1021/ja403138d; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu Y, 2011, MOL CELL, V44, P502, DOI 10.1016/j.molcel.2011.09.011; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; NYGAARD AP, 1964, J MOL BIOL, V9, P125, DOI 10.1016/S0022-2836(64)80095-4; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; ROSS PD, 1960, P NATL ACAD SCI USA, V46, P1360, DOI 10.1073/pnas.46.10.1360; ROSS PD, 1962, J AM CHEM SOC, V84, P4503, DOI 10.1021/ja00882a026; Sabin LR, 2013, MOL CELL, V49, P783, DOI 10.1016/j.molcel.2013.02.010; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang W, 2014, MOL CELL, V56, P708, DOI 10.1016/j.molcel.2014.10.016; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Zhang ZJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01775	65	159	161	3	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					84	95		10.1016/j.cell.2015.06.029	http://dx.doi.org/10.1016/j.cell.2015.06.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140592	Green Accepted, Bronze			2022-12-28	WOS:000357542300011
J	Mangalam, M; Karve, SM				Mangalam, Madhur; Karve, Shraddha Madhav			Comment on "Number-space mapping in the newborn chick resembles humans' mental number line"	SCIENCE			English	Editorial Material							LATERAL ASYMMETRIES	Rugani et al. (Reports, 30 January 3015, p. 534) tested 3-day-old domestic chicks using an innovative experimental setup and demonstrate the presence of the mental number line. We raise concerns regarding this conclusion by highlighting the possible loopholes in the experimental design and the data analysis procedures. We further suggest auxiliary experiments that can substantiate the authors' claim.	[Mangalam, Madhur] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Karve, Shraddha Madhav] Indian Inst Sci Educ & Res Pune, Pune 411008, Maharashtra, India	University System of Georgia; University of Georgia; Indian Institute of Science Education & Research (IISER) Pune	Mangalam, M (corresponding author), Univ Georgia, Dept Psychol, Athens, GA 30602 USA.	madhur.mangalam@uga.edu						Dehaene S., 2011, NUMBER SENSE MIND CR; Dharmaretnam A, 2005, BEHAV BRAIN RES, V162, P62, DOI 10.1016/j.bbr.2005.03.012; Haun DBM, 2010, TRENDS COGN SCI, V14, P552, DOI 10.1016/j.tics.2010.09.006; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; Regolin L, 1996, BEHAV PROCESS, V37, P67, DOI 10.1016/0376-6357(95)00076-3; Rugani R, 2015, SCIENCE, V347, P534, DOI 10.1126/science.aaa1379; Vallortigara G, 1996, BEHAV BRAIN RES, V74, P135, DOI 10.1016/0166-4328(95)00037-2	7	5	5	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242								10.1126/science.aaa8577	http://dx.doi.org/10.1126/science.aaa8577			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113713				2022-12-28	WOS:000356869100030
J	Temprana, E; Myslivets, E; Kuo, BPP; Liu, L; Ataie, V; Alic, N; Radic, S				Temprana, E.; Myslivets, E.; Kuo, B. P. -P.; Liu, L.; Ataie, V.; Alic, N.; Radic, S.			Overcoming Kerr-induced capacity limit in optical fiber transmission	SCIENCE			English	Article							SOLITONS; WDM	Nonlinear optical response of silica imposes a fundamental limit on the information transfer capacity in optical fibers. Communication beyond this limit requires higher signal power and suppression of nonlinear distortions to prevent irreversible information loss. The nonlinear interaction in silica is a deterministic phenomenon that can, in principle, be completely reversed. However, attempts to remove the effects of nonlinear propagation have led to only modest improvements, and the precise physical mechanism preventing nonlinear cancellation remains unknown. We demonstrate that optical carrier stability plays a critical role in canceling Kerr-induced distortions and that nonlinear wave interaction in silica can be substantially reverted if optical carriers possess a sufficient degree of mutual coherence. These measurements indicate that fiber information capacity can be notably increased over previous estimates.	[Temprana, E.; Myslivets, E.; Kuo, B. P. -P.; Liu, L.; Ataie, V.; Radic, S.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Alic, N.; Radic, S.] Univ Calif San Diego, Qualcomm Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Alic, N (corresponding author), Univ Calif San Diego, Qualcomm Inst, La Jolla, CA 92093 USA.	nalic@ucsd.edu			Google Inc.	Google Inc.(Google Incorporated)	We thank Sumitomo Electric Industries for fibers used in the experiments, and Google Inc. for support of this work. The University of California has filed a patent on the method and applications of frequency-referenced carriers for compensation of nonlinear impairments in transmission.	Agrawal G.P., 2006, NONLINEAR FIBER OPTI, V4th; Agrell E, 2014, J LIGHTWAVE TECHNOL, V32, P2862, DOI 10.1109/JLT.2014.2328518; Alic N, 2014, J LIGHTWAVE TECHNOL, V32, P2690, DOI 10.1109/JLT.2014.2332234; Andrekson PA, 2007, LASER PHOTONICS REV, V1, P231, DOI 10.1002/lpor.200710014; Berber SM, 2004, IEEE T INSTRUM MEAS, V53, P575, DOI 10.1109/TIM.2003.820492; Bergano  N.S., 2002, FIBER OPTIC TELECOMM, P154; BERGANO NS, 1995, J LIGHTWAVE TECHNOL, V13, P879, DOI 10.1109/50.387805; CHRAPLYVY AR, 1990, J LIGHTWAVE TECHNOL, V8, P1548, DOI 10.1109/50.59195; Dou L., 2012, P ECOC2012; Essiambre RJ, 2010, J LIGHTWAVE TECHNOL, V28, P662, DOI 10.1109/JLT.2009.2039464; Fontaine N.K., 2013, P ECOC2013; Goda K, 2009, NATURE, V458, P1145, DOI 10.1038/nature07980; GORDON JP, 1986, OPT LETT, V11, P665, DOI 10.1364/OL.11.000665; GORDON JP, 1990, OPT LETT, V15, P1351, DOI 10.1364/OL.15.001351; Hemmati H., 2013, FIBER OPTIC TELECO B, P121; Ip E, 2008, J LIGHTWAVE TECHNOL, V26, P3416, DOI 10.1109/JLT.2008.927791; KAPLAN AE, 1981, OPT LETT, V6, P590, DOI 10.1364/OL.6.000590; Li X, 2008, OPT EXPRESS, V16, P880, DOI 10.1364/OE.16.000880; Liu X, 2013, NAT PHOTONICS, V7, P560, DOI [10.1038/NPHOTON.2013.109, 10.1038/nphoton.2013.109]; McKinstrie CJ, 2007, OPT PHOTONICS NEWS, V18, P34, DOI 10.1364/OPN.18.3.000034; Mecozzi A, 2012, J LIGHTWAVE TECHNOL, V30, P2011, DOI 10.1109/JLT.2012.2190582; Mitra PP, 2001, NATURE, V411, P1027, DOI 10.1038/35082518; Myslivets E, 2012, OPT EXPRESS, V20, P3331, DOI 10.1364/OE.20.003331; Prilepsky JE, 2013, OPT EXPRESS, V21, P24344, DOI 10.1364/OE.21.024344; Proakis JG., 2007, DIGITAL COMMUNICATIO; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Solis-Trapala K., 2014, P OFC2014; Taghavi MH, 2006, IEEE T INFORM THEORY, V52, P5008, DOI 10.1109/TIT.2006.883540; Toyoda K, 2012, OPT EXPRESS, V20, P19815, DOI 10.1364/OE.20.019815; Turitsyn KS, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.203901; Yang J, 2003, STUD APPL MATH, V111, P359, DOI 10.1111/1467-9590.t01-1-00238; Yoshida T., 2014, P OFC2014	33	149	154	7	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1445	1448		10.1126/science.aab1781	http://dx.doi.org/10.1126/science.aab1781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113716				2022-12-28	WOS:000356869100034
J	Owens, B				Owens, Brian			Addiction	NATURE			English	Editorial Material																			0	0	0	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					S45	S45		10.1038/522S45a	http://dx.doi.org/10.1038/522S45a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26107092	Bronze			2022-12-28	WOS:000356782900001
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Medicine is a bit of a giggle	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Scott SK, 2014, TRENDS COGN SCI, V18, P618, DOI 10.1016/j.tics.2014.09.002	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2015	350								h3378	10.1136/bmj.h3378	http://dx.doi.org/10.1136/bmj.h3378			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NK	26101212	Bronze			2022-12-28	WOS:000357158600009
J	[Anonymous]				[Anonymous]			East & Southeast Asia	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S14	S16		10.1038/522S14a	http://dx.doi.org/10.1038/522S14a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083851	Bronze			2022-12-28	WOS:000356425400005
J	Dieleman, JL; Graves, C; Johnson, E; Templin, T; Birger, M; Hamavid, H; Freeman, M; Leach-Kemon, K; Singh, L; Haakenstad, A; Murray, CJL				Dieleman, Joseph L.; Graves, Casey; Johnson, Elizabeth; Templin, Tara; Birger, Maxwell; Hamavid, Hannah; Freeman, Michael; Leach-Kemon, Katherine; Singh, Lavanya; Haakenstad, Annie; Murray, Christopher J. L.			Sources and Focus of Health Development Assistance, 1990-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; CHRONIC DISEASES; HUMAN-RESOURCES; MORTALITY; NEWBORN; CRISIS; HIV	IMPORTANCE The governments of high-income countries and private organizations provide billions of dollars to developing countries for health. This type of development assistance can have a critical role in ensuring that life-saving health interventions reach populations in need. OBJECTIVES To identify the amount of development assistance that countries and organizations provided for health and to determine the health areas that received these funds. EVIDENCE REVIEW Budget, revenue, and expenditure data on the primary agencies and organizations (n = 38) that provided resources to developing countries (n = 146-183, depending on the year) for health from 1990 through 2014 were collected. For each channel (the international agency or organization that directed the resources toward the implementing institution or government), the source and recipient of the development assistance were determined and redundant accounting of the same dollar, which occurs when channels transfer funds among each other, was removed. This research derived the flow of resources from source to intermediary channel to recipient. Development assistance for health (DAH) was divided into 11 mutually exclusive health focus areas, such that every dollar of development assistance was assigned only 1 health focus area. FINDINGS Since 1990, $458.0 billion of development assistance has been provided to maintain or improve health in developing countries. The largest source of funding was the US government, which provided $143.1 billion between 1990 and 2014, including $12.4 billion in 2014. Of resources that originated with the US government, 70.6% were provided through US government agencies, and 41.0% were allocated for human immunodeficiency virus (HIV)/AIDS. The second largest source of development assistance for health was private philanthropic donors, including the Bill and Melinda Gates Foundation and other private foundations, which provided $69.9 billion between 1990 and 2014, including $6.2 billion in 2014. These resources were provided primarily through private foundations and nongovernmental organizations and were allocated for a diverse set of health focus areas. Since 1990, 28.0% of all DAH was allocated for maternal health and newborn and child health; 23.2% for HIV/AIDS, 4.3% for malaria, 2.8% for tuberculosis, and 1.5% for noncommunicable diseases. Between 2000 and 2010, DAH increased 11.3% annually. However, since 2010, total DAH has not increased as substantially. CONCLUSIONS AND RELEVANCE Funding for health in developing countries has increased substantially since 1990, with a focus on HIV/AIDS, maternal health, and newborn and child health. Funding from the US government has played a substantial role in this expansion. Funding for noncommunicable diseases has been limited. Understanding how funding patterns have changed across time and the priorities of sources of international funding across distinct channels, recipients, and health focus areas may help identify where funding gaps persist and where cost-effective interventions could save lives.	[Dieleman, Joseph L.; Graves, Casey; Johnson, Elizabeth; Templin, Tara; Birger, Maxwell; Hamavid, Hannah; Leach-Kemon, Katherine; Singh, Lavanya; Haakenstad, Annie; Murray, Christopher J. L.] Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Freeman, Michael] Univ Washington, Informat Sch, Seattle, WA 98195 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Dieleman, JL (corresponding author), Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	dieleman@uw.edu			Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by a grant from the Bill and Melinda Gates Foundation.	Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bhutta Z, 2014, LANCET, V384, P308; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Council on Foreign Relations, EM GLOB HLTH CRIS; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Gavi, GAV MISS; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; GLOBAL FUND, 2014, GLOB FUND FIGHT AIDS; Gostin LO, 2014, LANCET, V384, P1323, DOI 10.1016/S0140-6736(14)61791-8; Grepin KA, 2012, HEALTH POLICY PLANN, V27, P527, DOI 10.1093/heapol/czr076; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Institute for Health Metrics and Evaluation, FIN GLOB HLTH 2013 T; International Aid Transparency Initiative, ANN REP 2014; International Monetary Fund, WORLD EC OUTL DAT; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jamison DT., 2006, PRIORITIES HLTH; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Maher D, PRIORITIES DEV COUNT; Marmot MG, 2012, JAMA-J AM MED ASSOC, V307, P2033, DOI 10.1001/jama.2012.3534; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Murray CJL, 2015, JAMA-J AM MED ASSOC, V313, P359, DOI 10.1001/jama.2014.16376; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nugent R, HAVE ALL DONORS GONE; Organisation for Economic Co-Operation and Development, DEV AGGR OFF PRIV FL; Organisation for Economic Co-operation and Development, REC TRENDS OFF DEV A; Organisation for Economic Co-Operation and Development, DEV IND AID PROJ CRS; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Tarp F, 2000, FOREIGN AID DEV LESS; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UKAid, LOND SUMM FAM PLANN; UN Office for Coordination of Humanitarian Affairs (OCHA), 2014, FIN TRACK SERV EM EB; UN Secretary General, GLOB STRAT WOM CHILD; United States Agency for International Development, PVO REG; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; World Bank, PROJ OP; World Health Organization, GLOB HLTH EXP DAT IN; World Health Organization, PACK ESS NONC PEN DI	45	57	57	2	81	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2359	2368		10.1001/jama.2015.5825	http://dx.doi.org/10.1001/jama.2015.5825			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080340	Bronze, Green Submitted			2022-12-28	WOS:000356300200021
J	Scovronick, N; Dora, C; Fletcher, E; Haines, A; Shindell, D				Scovronick, Noah; Dora, Carlos; Fletcher, Elaine; Haines, Andy; Shindell, Drew			Reduce short-lived climate pollutants for multiple benefits	LANCET			English	Editorial Material									[Scovronick, Noah] Univ Witwatersrand, Global Change & Sustainabil Res Inst, Johannesburg, South Africa; [Dora, Carlos; Fletcher, Elaine] WHO, Dept Publ Hlth Environm & Social Determinants Hlt, CH-1211 Geneva, Switzerland; [Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England; [Shindell, Drew] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	University of Witwatersrand; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Duke University	Haines, A (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England.	andy.haines@lshtm.ac.uk	Shindell, Drew/D-4636-2012	Shindell, Drew/0000-0003-1552-4715; Scovronick, Noah/0000-0003-1410-3337; Haines, Andy/0000-0002-8053-4605	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Blanco G, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P351; Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Climate and Clean Air Coalition, 2014, TIM ACT RED SHORT LI; Hallstrom E, 2015, J CLEAN PROD, V91, P1, DOI 10.1016/j.jclepro.2014.12.008; Heller MC, 2013, ENVIRON SCI TECHNOL, V47, P12632, DOI 10.1021/es4025113; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Seto KC, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P923; Shindell DT, 2015, CLIMATIC CHANGE, V130, P313, DOI 10.1007/s10584-015-1343-0; UN Environment Programme/World Meteorological Organization, 2011, INT ASS BLACK CARB T; United States Environmental Protection Agency, 2013, INT SCI ASS OZ REL P; WHO, 2011, HLTH GREEN EC HLTH C	13	14	15	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					E28	E30		10.1016/S0140-6736(15)61043-1	http://dx.doi.org/10.1016/S0140-6736(15)61043-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26111440				2022-12-28	WOS:000364194700002
J	Joyner, MJ; Paneth, N				Joyner, Michael J.; Paneth, Nigel			Seven Questions for Personalized Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Joyner, Michael J.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	Mayo Clinic; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine	Joyner, MJ (corresponding author), Mayo Clin, Dept Anesthesiol, 200 First St SW, Rochester, MN 55905 USA.	joyner.michael@mayo.edu						Bloss CS, 2014, J MED GENET, V51, P83, DOI 10.1136/jmedgenet-2013-101909; Dzau VJ, 2015, LANCET, V385, P2118, DOI 10.1016/S0140-6736(15)60722-X; Grant RW, 2013, DIABETES CARE, V36, P13, DOI 10.2337/dc12-0884; Konstan MW, 2007, AM J RESP CRIT CARE, V176, P1084, DOI 10.1164/rccm.200702-181OC; Lum DWK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076648; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P1330, DOI 10.1001/jamainternmed.2014.2368; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547	7	145	147	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					999	1000		10.1001/jama.2015.7725	http://dx.doi.org/10.1001/jama.2015.7725			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26098474				2022-12-28	WOS:000360840700008
J	Tailo, M; D'Antona, F; Vesperini, E; Di Criscienzo, M; Ventura, P; Milone, AP; Bellini, A; Dotter, A; Decressin, T; D'Ercole, A; Caloi, V; Capuzzo-Dolcetta, R				Tailo, Marco; D'Antona, Francesca; Vesperini, Enrico; Di Criscienzo, Marcella; Ventura, Paolo; Milone, Antonino P.; Bellini, Andrea; Dotter, Aaron; Decressin, Thibaut; D'Ercole, Annibale; Caloi, Vittoria; Capuzzo-Dolcetta, Roberto			Rapidly rotating second-generation progenitors for the 'blue hook' stars of omega Centauri	NATURE			English	Article							HORIZONTAL-BRANCH STARS; LOW-MASS STARS; ANGULAR-MOMENTUM EVOLUTION; GLOBULAR-CLUSTER STARS; DWARF COOLING CURVE; ULTRAVIOLET EXTINCTION; STELLAR POPULATIONS; INTERNAL-ROTATION; ATOMIC DIFFUSION; GIANT BRANCH	Horizontal branch stars belong to an advanced stage in the evolution of the oldest stellar galactic population, occurring either as field halo stars or grouped in globular clusters. The discovery of multiple populations in clusters(1,2) that were previously believed to have single populations gave rise to the currently accepted theory that the hottest horizontal branch members (the 'blue hook' stars, which had late helium-core flash ignition(3), followed by deep mixing(4,5)) are the progeny of a helium-rich 'second generation' of stars(6,7). It is not known why such a supposedly rare event(8,9) (a late flash followed by mixing) is so common that the blue hook of omega Centauri contains approximately 30 per cent of the horizontal branch stars in the cluster(10), or why the blue hook luminosity range in this massive cluster cannot be reproduced by models. Here we report that the presence of helium core masses up to about 0.04 solar masses larger than the core mass resulting from evolution is required to solve the luminosity range problem. We model this by taking into account the dispersion in rotation rates achieved by the progenitors, whose pre-main-sequence accretion disk suffered an early disruption in the dense environment of the cluster's central regions, where second-generation stars form(11). Rotation may also account for frequent late-flash-mixing events in massive globular clusters.	[Tailo, Marco; D'Antona, Francesca; Di Criscienzo, Marcella; Ventura, Paolo; Decressin, Thibaut] INAF Osservatorio Astron Roma, I-00040 Rome, Italy; [Tailo, Marco; Capuzzo-Dolcetta, Roberto] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Vesperini, Enrico] Indiana Univ, Dept Astron, Bloomington, IN 47405 USA; [Milone, Antonino P.; Dotter, Aaron] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT 2611, Australia; [Bellini, Andrea] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [D'Ercole, Annibale] INAF Osservatorio Astron Bologna, I-40127 Bologna, Italy; [Caloi, Vittoria] IAPS, INAF, I-00133 Rome, Italy	Istituto Nazionale Astrofisica (INAF); Sapienza University Rome; Indiana University System; Indiana University Bloomington; Australian National University; Space Telescope Science Institute; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF)	D'Antona, F (corresponding author), INAF Osservatorio Astron Roma, I-00040 Rome, Italy.	franca.dantona@gmail.com	Bellini, Andrea/O-4139-2019	Bellini, Andrea/0000-0003-3858-637X; Tailo, Marco/0000-0002-1128-098X; Ventura, Paolo/0000-0002-5026-6400; Milone, Antonino P./0000-0001-7506-930X; Capuzzo Dolcetta, Roberto/0000-0002-6871-9519; d'ercole, annibale/0000-0002-5531-5320	Australian Research Council [DE150101816]; PRIN INAF "Multiple populations in globular clusters: their role in the Galaxy assembly''; PRIN MIUR, project "The Chemical and Dynamical Evolution of the Milky Way and Local Group Galaxies''; UE Program (FP7) of Astronomy Fellowships in Italy (ASTROFit) [267251]; INAF-OAR; STScI grant [AR-12656];  [NASANNX13AF45G]	Australian Research Council(Australian Research Council); PRIN INAF "Multiple populations in globular clusters: their role in the Galaxy assembly''; PRIN MIUR, project "The Chemical and Dynamical Evolution of the Milky Way and Local Group Galaxies''(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); UE Program (FP7) of Astronomy Fellowships in Italy (ASTROFit); INAF-OAR; STScI grant; 	A.P.M. acknowledges support by the Australian Research Council through Discovery Early Career Researcher Award DE150101816. E.V. acknowledges support from grant NASANNX13AF45G. P.V. and F.D'A. acknowledge support from PRIN INAF 2011 "Multiple populations in globular clusters: their role in the Galaxy assembly'' (principal investigator E. Carretta), and P.V. acknowledges support from PRIN MIUR 2010-2011, project "The Chemical and Dynamical Evolution of the Milky Way and Local Group Galaxies'' (principal investigator F. Matteucci). T.D. acknowledges support from the UE Program (FP7/2007-2013) under grant agreement number 267251 of Astronomy Fellowships in Italy (ASTROFit). M.D.C. acknowledges support from INAF-OAR. A.B. acknowledges support from STScI grant AR-12656.	Anderson J, 2010, ASTROPHYS J, V710, P1032, DOI 10.1088/0004-637X/710/2/1032; Armitage PJ, 1996, MON NOT R ASTRON SOC, V280, P458, DOI 10.1093/mnras/280.2.458; Bekki K, 2010, ASTROPHYS J LETT, V724, pL99, DOI 10.1088/2041-8205/724/1/L99; Bellini A, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/2/L32; Bellini A, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/32; Bellini A, 2009, ASTRON ASTROPHYS, V507, P1393, DOI 10.1051/0004-6361/200912757; Binney J., 2008, GALACTIC DYNAMICS; Bouvier J, 1997, ASTRON ASTROPHYS, V326, P1023; Brown TM, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/85; Brown TM, 2010, ASTROPHYS J, V718, P1332, DOI 10.1088/0004-637X/718/2/1332; Brown TM, 2001, ASTROPHYS J, V562, P368, DOI 10.1086/323862; Caloi V, 2007, ASTRON ASTROPHYS, V463, P949, DOI 10.1051/0004-6361:20066074; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Cassisi S, 2003, ASTROPHYS J, V582, pL43, DOI 10.1086/346200; Cassisi S, 2009, ASTROPHYS J, V702, P1530, DOI 10.1088/0004-637X/702/2/1530; CASTELLANI M, 1993, ASTROPHYS J, V407, P649, DOI 10.1086/172547; Castelli F., 2004, NEW GRIDS ATLAS9 MOD; Charbonnel C, 2005, SCIENCE, V309, P2189, DOI 10.1126/science.1116849; D'Antona F, 2008, MON NOT R ASTRON SOC, V390, P693, DOI 10.1111/j.1365-2966.2008.13760.x; D'Antona F, 2007, MON NOT R ASTRON SOC, V379, P1431, DOI 10.1111/j.1365-2966.2007.12019.x; D'Antona F, 2013, MON NOT R ASTRON SOC, V434, P1138, DOI 10.1093/mnras/stt1057; D'Antona F, 2002, ASTRON ASTROPHYS, V395, P69, DOI 10.1051/0004-6361:20021220; D'Ercole A, 2008, MON NOT R ASTRON SOC, V391, P825, DOI 10.1111/j.1365-2966.2008.13915.x; DCruz NL, 1996, ASTROPHYS J, V466, P359, DOI 10.1086/177515; Di Criscienzo M, 2015, MON NOT R ASTRON SOC, V446, P1469, DOI 10.1093/mnras/stu2167; Gallet F, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321302; Gratton RG, 2012, ASTRON ASTROPHYS REV, V20, P1, DOI 10.1007/s00159-012-0050-3; Latour M, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/106; MENGEL JG, 1976, ASTROPHYS SPACE SCI, V41, P407, DOI 10.1007/BF00646189; Michaud G, 2008, ASTROPHYS J, V675, P1223, DOI 10.1086/527541; Michaud G, 2007, ASTROPHYS J, V670, P1178, DOI 10.1086/522488; Moehler S, 2000, ASTRON ASTROPHYS, V360, P120; Moehler S, 2007, ASTRON ASTROPHYS, V475, pL5, DOI 10.1051/0004-6361:20078509; Moehler S, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015020; ODONNELL JE, 1994, ASTROPHYS J, V422, P158, DOI 10.1086/173713; Palacios A, 2003, ASTRON ASTROPHYS, V399, P603, DOI 10.1051/0004-6361:20021759; Piotto G, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/3/91; Piotto G, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/39; Salaris M, 2008, ASTROPHYS J LETT, V678, pL25, DOI 10.1086/588467; Spada F, 2011, MON NOT R ASTRON SOC, V416, P447, DOI 10.1111/j.1365-2966.2011.19052.x; Sweigart A. V., 1997, 3 C FAINT BLUE STARS, P3; Ventura P, 2011, MON NOT R ASTRON SOC, V410, P2760, DOI 10.1111/j.1365-2966.2010.17651.x; Ventura P, 2008, ASTROPHYS SPACE SCI, V316, P93, DOI 10.1007/s10509-007-9672-8; Weiss A, 2000, ASTRON ASTROPHYS, V356, P181; WHITNEY JH, 1994, ASTRON J, V108, P1350, DOI 10.1086/117157	46	29	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					318	+		10.1038/nature14516	http://dx.doi.org/10.1038/nature14516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26098367	Green Submitted			2022-12-28	WOS:000357950900035
J	Piot, P; Karim, SSA; Hecht, R; Legido-Quigley, H; Buse, K; Stover, J; Resch, S; Ryckman, T; Mogedal, S; Dybul, M; Goosby, E; Watts, C; Kilonzo, N; McManus, J; Sidibe, M				Piot, Peter; Karim, Salim S. Abdool; Hecht, Robert; Legido-Quigley, Helena; Buse, Kent; Stover, John; Resch, Stephen; Ryckman, Theresa; Mogedal, Sigrun; Dybul, Mark; Goosby, Eric; Watts, Charlotte; Kilonzo, Nduku; McManus, Joanne; Sidibe, Michel		UNAIDS-Lancet Commission	Defeating AIDS-advancing global health	LANCET			English	Review							INTIMATE-PARTNER VIOLENCE; INJECTING-DRUG-USERS; RURAL SOUTH-AFRICA; MIDDLE-INCOME COUNTRIES; TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; HIV-PREVENTION; PUBLIC-HEALTH; ANTIRETROVIRAL THERAPY; FRAMEWORK CONVENTION		[Piot, Peter; Legido-Quigley, Helena; Watts, Charlotte] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Karim, Salim S. Abdool] Ctr AIDS Programme Res South Africa, Durban, South Africa; [Hecht, Robert; Ryckman, Theresa] Results Dev Inst, Washington, DC USA; [Buse, Kent; Sidibe, Michel] UNAIDS, Geneva, Switzerland; [Stover, John] Avenir Hlth, Glastonbury, CT USA; [Resch, Stephen] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Mogedal, Sigrun] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Dybul, Mark] Global Fund Fight Aids TB & Malaria, Geneva, Switzerland; [Goosby, Eric] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [Kilonzo, Nduku] Natl AIDS Control Council, Nairobi, Kenya	University of London; London School of Hygiene & Tropical Medicine; National University of Singapore; UNAIDS; Harvard University; Harvard T.H. Chan School of Public Health; Norwegian Knowledge Centre for Health Services; University of California System; University of California San Francisco	Piot, P (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	director@lshtm.ac.uk	Karim, Salim Abdool/P-3117-2019; Buse, Kent/AAK-6688-2020; Karim, Salim Abdool/AAE-7118-2019; Ryckman, Theresa/GRR-2033-2022	Karim, Salim Abdool/0000-0002-4986-2133; Buse, Kent/0000-0002-5485-0110; Khachani, Dr Imane/0000-0002-6745-9225; Ryckman, Theresa/0000-0003-3214-3228	Joint United Nations Programme on HIV/AIDS (UNAIDS); UNAIDS; Ministry of Health, Jamaica; CINU Mexico; Department for International Development (DFID) [201447] Funding Source: researchfish	Joint United Nations Programme on HIV/AIDS (UNAIDS); UNAIDS; Ministry of Health, Jamaica; CINU Mexico; Department for International Development (DFID)	This Commission was supported financially by the Joint United Nations Programme on HIV/AIDS (UNAIDS). The funding covered travel, accommodation, and meals for the two face-to-face meetings of the Commission as well as these costs for Working Group meetings and regional, country and other consultations. UNAIDS also supported the development of background papers, research assistance time and writing for the Working Group papers, consultation synthesis and the Commission's final Report.; The Commission thanks participants at the Regional Dialogue for the Caribbean, held in Kingston under the auspices of Fenton Ferguson (Ministry of Health, Jamaica). Thanks to CINU Mexico who supported the Regional Dialogue for Latin America held in Panama. Thanks to high-level panel members including Marcela Suazo (UNFPA), Pedro Cahn (Huesped Foundation, Buenos Aires, Argentina), Alessandra Nilo (GESTOS-HIV, Communication and Gender), Cesar A Nunez (UNAIDS) and Ruben Mayorga (UNAIDS). The Commission thanks participants at the consultation in New York for their insights as well as participants at the consultation held in Washington DC-with special thanks to the Kaiser Family Foundation for co-hosting and to Chris Beyrer (Johns Hopkins University and The International AIDS Society) for cochairing the discussion. The Commission also thanks all those who participated in the Regional Dialogue for Eastern Europe and Central Asia, which was held online. In addition to these consultations, for insights provided to the process, the Commission thanks members of the UNAIDS Scientific Expert Panel and the UNAIDS Human Rights Reference Group, with special thanks to cochairs of the latter, Michaela Clayton (AIDS and Rights Alliance for Southern Africa (ARASA)) and Jonathan Cohen (Open Society Public Health Program) who conveyed a letter from the group to the chairs of the Commission providing instructive language on human rights. Thanks also to the United Nations Secretary-General's Special Envoys on HIV/AIDS, Edward Greene (United Nations), Michel Kazatchkine (United Nations) and J V R Prasada Rao (United Nations) who engaged throughout the Commission process and who provided insightful contributions through participation in Working Groups, consultations and meetings of the Commission. Thanks also to Commissioners Cristina Jade Pena (Elizabeth Glaser Pediatric AIDS Foundation), Ed Ngoksin, Jacquelyne Alesi, and Lorrie Fair who provided a letter to the Commission chairs after the first face-to-face meeting of the Commission, communicating the youth voice on a range of issues. Thanks also to Commissioner Michael Kirby (formerly High Court of Australia) who provided extensive guidance to the cochairs.	Abbott Frederick, 2014, USING COMPETITION LA; Aghaizu A, 2013, HIV UK 2013 REP DAT; American Psychological Association, ADD HIV AIDS INF TEA; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Auerbach J, 2009, ADDRESSING SOCIAL DR; Auerbach J, 2009, HEALTH AFFAIR, V28, P1655, DOI 10.1377/hlthaff.28.6.1655; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; AVAC, 2014, HIV PREV RES DEV INV; Avenir Health, UN COSTS DAT; Avila C, 2013, UNIVERSLA COVERAGE E; Babor T, 2003, ADDICTION, V98, P1343; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bautista-Arredondo S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0599-9; Beyrer C, 2013, CURR OPIN HIV AIDS, V8, P306, DOI 10.1097/COH.0b013e328361f53a; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bill & Melinda Gates Foundation, WHAT WE DO HIV STAR; Bollinger L, 2014, BACKGROUND PAPER UPD; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bor J, 2012, HEALTH AFFAIR, V31, P1459, DOI 10.1377/hlthaff.2012.0407; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Brandt AM, 2013, NEW ENGL J MED, V368, P2149, DOI 10.1056/NEJMp1305297; Burua A, 2008, HIV AIDS IMKPLEMENTE; Buse K, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0098-8; Case KK, 2014, AIDS, V28, pS411, DOI 10.1097/QAD.0000000000000487; Centers for Disease Control, 1981, MMWR-MORBID MORTAL W, V30, P250; Chamie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084317; Chandrashekar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106582; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cluver L, 2013, LANCET GLOB HEALTH, V1, pE362, DOI 10.1016/S2214-109X(13)70115-3; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cornwall A, 2008, SOC SCI MED, V66, P2173, DOI 10.1016/j.socscimed.2008.01.038; Cousens S, 2011, J EPIDEMIOL COMMUN H, V65, P576, DOI 10.1136/jech.2008.082610; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; De Boni R, 2014, CURR OPIN HIV AIDS, V9, P192, DOI 10.1097/COH.0000000000000031; Delvaux T, 2008, TROP MED INT HEALTH, V13, P970, DOI 10.1111/j.1365-3156.2008.02105.x; Department of AIDS Control Government of India, 2012, NAT AIDS CONTR PROGR; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Druce N, 2006, STRENGTHENING LINKAG; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Ellman T, 2015, NEW ENGL J MED, V372, P303, DOI 10.1056/NEJMp1414730; Ellsberg M, 2014, LANCET, V14, P61703; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Fonck K, 2005, AIDS BEHAV, V9, P335, DOI 10.1007/s10461-005-9007-0; Friedman EA, 2013, HEALTH HUM RIGHTS, V15, P71; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Global Commission on HIV and the Law, 2012, HIV LAW RISKS RIGHTS; Goosby E., 2013, STRENGTHENING EFFECT; Gostin LO, 2013, B WORLD HEALTH ORGAN, V91, P790, DOI 10.2471/BLT.12.114447; Government of Kenya, 2013, KENY HIV INVESTEMENT; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; GROSECLOSE SL, 1995, J ACQ IMMUN DEF SYND, V10, P82; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Handa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085473; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hargreaves JR, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-4; Harm Reduction International, 2020, GLOBAL STATE HARM RE; Harmonization for Health in Africa, 2011, INV HLTH AFR CAS STR; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Head MG, 2013, LANCET INFECT DIS, V13, P55, DOI 10.1016/S1473-3099(12)70261-X; Hecht R, 2012, IND STRATEGIC OPTION; Heywood M, 2010, J LAW MED ETHICS, V38, P640, DOI 10.1111/j.1748-720X.2010.00517.x; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Human Sciences Research Council, 2014, S AFR NAT HIV PREV I; Hurley SF, 1997, LANCET, V349, P1797, DOI 10.1016/S0140-6736(96)11380-5; Independent Expert Advisory Group on a Data Revolution for Sustainable Development, 2014, WORLD COUNTS MOB DAT; Independent Expert Review Group on Information and Accountability for Women's and Children's Health, 2014, IERG PROPOSES RAD NE; Institute for Health Metrics and Evaluation (IHME), 2013, GLOB BURD DIS GBD CO; International AIDS Society, HIV INC ROS 13 5 FOL; International Monetary Fund, 2014, WORLD EC OUTL DAT; Itaborahy LP, 2013, STATE SPONSORED HOMO; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Johnson AS, 2014, JAMA-J AM MED ASSOC, V312, P432, DOI 10.1001/jama.2014.8534; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Kaiser Family Foundation, US FED FUND HIV AIDS; Kalra A., 2015, REUTERS; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; KARIM QA, 1992, AIDS, V6, P1535, DOI 10.1097/00002030-199212000-00018; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, NATURE, V474, P29, DOI 10.1038/474029a; Kasenga F, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1883; Kates J, 2014, FINANCING RESPONSE; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Kenya Ministry of Health, 2014, KEN HIV PREV REV ROA; Kickbusch I, 2012, HEALTH PROMOT INT, V27, P427, DOI 10.1093/heapro/das057; Kidd R, 2007, UNDERSTANDING; Krishnan V, 2015, IS IND AIDS PROGRAMM; Kron J., 2012, NY TIMES; Kyegombe N, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19232; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Lievens T., 2011, SUST FIN HIV AIDS OV; Likatavicius G, 2008, SEX TRANSM INFECT, V84, P499, DOI 10.1136/sti.2008.031419; Lipscombe CK, 2013, CARD PUB L POLY ETHI, V11, P529; Low C, 2013, AIDS CARE, V25, pS97, DOI 10.1080/09540121.2012.748879; MacKellar DA, 2011, SEX TRANSM DIS, V38, P755, DOI 10.1097/OLQ.0b013e31820d5a77; MacQuarrie K, 2009, HIV RELATED; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Maurice J, 2013, LANCET, V382, pE25, DOI 10.1016/S0140-6736(13)62404-6; McCord A, 2013, SOCIAL PROTECTION HI; Melaku Z, 2011, 6 IAS C HIV PATH TRE; Ministerio da Saude, CONS NAC SAUD; Ministry of Health Government of Malawi, 2014, MAL NAT HLTH ACC SUB; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mwangemi F, 2010, HLTH SYSTEM STRENGTH; NACC, 2014, EST TRUST FUND ENS S; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; National Department of Health South Africa, 2014, 2012 NAT ANT SENT HI; National Institute for Health and Care Excellence, 2014, INT DEC SUPP IN; National Institutes of Health, 2014, TRANS NIH AIDS RES B; Nyamayemombe C, 2010, ZIMBABWE WORKING PAP, V4; Nyblade L, 2006, CAN WE MEASURE HIV A; Oomman N, 2013, GUIDEING PRINCIPLES; Organisation for Economic Co-operation and Development, 2013, AID POOR COUNTRIES S; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Pham QD, 2014, AIDS, V28, P2751, DOI 10.1097/QAD.0000000000000494; Pillay D, 2007, J INFECT DIS, V195, P924, DOI 10.1086/512090; Poteat T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028760; Prasada Rao JVR, 2014, 20 INT AIDS C MELB A; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Public Health England, HIV UK 2014 REP; Rasschaert Freya, 2011, J Int AIDS Soc, V14 Suppl 1, pS3, DOI 10.1186/1758-2652-14-S1-S3; Raymond A, 2014, J INT AIDS SOC, V17, P13, DOI 10.7448/IAS.17.4.19507; Remme M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19228; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Resch S, 2015, LANCET GLOB HEALTH, V3, pE52, DOI 10.1016/S2214-109X(14)70342-0; Rosenquist R, 2013, GLOB HLTH GOV, P6; Sanson-Fisher RW, 2007, AM J PREV MED, V33, P155, DOI 10.1016/j.amepre.2007.04.007; Santelli JS, 2013, JAIDS-J ACQ IMM DEF, V63, P393, DOI 10.1097/QAI.0b013e3182926795; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sekandi JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-730; Sendziuk P, 2007, CAN BULL MED HIST, V24, P113, DOI 10.3138/cbmh.24.1.113; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Sheikh K, 2014, HEALTH POLICY PLANN, V29, P1, DOI 10.1093/heapol/czu082; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O, 2014, S AFRICAN NATL HIV P; Steen TW, 2007, JAIDS-J ACQ IMM DEF, V44, P484, DOI 10.1097/QAI.0b013e318030ffa9; Sumner A, 2010, GLOB POV NEW BOTTOM; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Tagar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108304; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; The aids2031 Consortium, 2011, AIDS TAKING LONG TER; The Global Fund, 2014, GLOB FUND GUID GRAN; The Global Fund to Fight AIDS, EQ ACC IN; The Global Fund to fight AIDS TB and Malaria, WILL PAY POL; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2015, COUNT FIN WILL PAY; The Kirby Institute, 2013, ANN SURV REP; The World Bank, DAT GNI PER CAP GROW; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Treatment Action Campaign, 2010, FIGHT OU LIV HIST TR; Tucker JD, 2011, CURR OPIN INFECT DIS, V24, P50, DOI 10.1097/QCO.0b013e32834204bf; UNAIDS, 2012, ISS BRIEF 2012 POT I; UNAIDS, 2014, LANDM HIV DIAGN ACC; UNAIDS, 2014, COUNT RREP UNAIDS GL; UNAIDS, 2012, AB 12 SHAP FUT AFR; UNAIDS, 2014, 2014 PROGR REP GLOB; UNAIDS, 2014, AMB TREATM TARG WRIT; UNAIDS, 2013, 2013 PROGR SREP GLOB; UNAIDS, 2014, AIDSINFO EP STAT HIV; UNAIDS, GLOB AIDS RESP PROGR; UNAIDS, 2012, GLOB REP UNAIDS REP, P34; UNAIDS, 2014, 20 INT AIDS C; UNAIDS, 2013, 2013 GLOB FACT SHEET; UNAIDS, 2013, SHORT TECHN UPD SEL; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2014, THE GAP REPORT, P123; UNAIDS Programme Coordinating Board, 2013, UNAIDS LANC COMM WOR; UNAIDS-Lancet Commission, 2014, LOND M DISC PAP AIDS; UNDP, 2010, GOOD PRACT GUID IMPR; UNDP, 2010, PUN LAWS LIM ACC HIV; UNITAID, 2013, HIV AIDS DIAGN LANDS; United Nations Office on Drugs and Crime, WORLD DRUG REP 2014; US Centers for Disease Prevention and Control, HIV AFR AM; US Department of State, 2010, 2009 COUNTR REP HUM; Van Renterghem H, AIDS 2012 19 INT AID; Vassall A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110562; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Vietnam Ministry of Health, 2014, OPT VIET NAMS HIV RE; Wagman JA, 2015, LANCET GLOB HEALTH, V3, pE23, DOI 10.1016/S2214-109X(14)70344-4; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Whiteside A, 2014, AJAR-AFR J AIDS RES, V13, P101, DOI 10.2989/16085906.2014.927780; WHO, NAT HLTH ACC EST NAT; WHO, 2005, MULT STUDY WOM HLTH; WHO, 2013, CONS GUID US ANT DRG; WHO, 2006, PUBL HLTH INN INT PR; WHO, GLOB HLTH OBS DAT HI; WHO, 2014, GLOB UPD HLTH SECT; WHO, 2014, GLOB UPD HLHT SECT R; WHO, 2002, ALC DEV SOC PUBL HLT; WHO and African Health Observatory, ATL AFR HLTH STAT 20; Winter JA, 2003, DISABIL STUDIES Q IN, V23, DOI DOI 10.18061/DSQ.V23I1.399; World Bank, MAL TANZ RES SHOWS P; World Health Organization, 2021, VIOL WOM PREV EST 20; Yamin Alicia Ely, 2014, Health Hum Rights, V16, pE1	218	190	194	1	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					171	218		10.1016/S0140-6736(15)60658-4	http://dx.doi.org/10.1016/S0140-6736(15)60658-4			48	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM5QC	26117719				2022-12-28	WOS:000357742200034
J	Oliver, D				Oliver, David			DUTY OF CANDOUR The hardest word: managers and leaders should say sorry too	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Oliver, David] British Geriatr Soc, London, England		Oliver, D (corresponding author), Kings Fund, London, England.	d.oliver@kingsfund.org.uk						Department of Health, HARD TRUTHS JOURN PU; Department of Health, 2014, PROM LEARN COMM ACT; Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7334; Foundation Trust Network, 2012, BRIEF READM POL ADD; Francis R., 2013, REPORT MID STAFFORDH; General Medical Council Nursing and Midwifery Council, OPENN HON THINGS WRO; King's Fund, FRANC INQ REP RES; King's Fund, CULT LEAD NHS KINGS; Nuffield Trust, 2014, FRANC REP ON YEAR; Parliamentary and Health Service Ombudsman, LIST LEARN OMB REV C	10	4	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2015	351								h3644	10.1136/bmj.h3644	http://dx.doi.org/10.1136/bmj.h3644			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3UA	26141688				2022-12-28	WOS:000357609000009
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION A comparison of sampling error and standard error	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Anderson AS, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1823; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h831; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6051; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5196	4	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2015	351								h3577	10.1136/bmj.h3577	http://dx.doi.org/10.1136/bmj.h3577			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3UA	26141598				2022-12-28	WOS:000357609000005
J	Rommereim, LM; Subramanian, N				Rommereim, Leah M.; Subramanian, Naeha			AIMing 2 Curtail Cancer	CELL			English	Editorial Material							MELANOMA; CELLS; INFLAMMASOME; ABSENT	The dysregulation of the relationship between gut microbiota and innate immune homeostasis can lead to a range of complex diseases. In this issue, Man et al. reveal that the intracellular innate sensor AIM2 regulates microbial and stem cell homeostasis in the gut to protect against colorectal cancer.	[Rommereim, Leah M.; Subramanian, Naeha] Inst Syst Biol, Seattle, WA 98101 USA	Institute for Systems Biology (ISB)	Subramanian, N (corresponding author), Inst Syst Biol, Seattle, WA 98101 USA.	nsubrama@systemsbiology.org		Rommereim, Leah/0000-0003-3834-4549; Subramanian, Naeha/0000-0003-3754-0521				Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Dihlmann S, 2014, INT J CANCER, V135, P2387, DOI 10.1002/ijc.28891; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Janowski AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00370; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Luddy KA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00429; Patsos G, 2010, INT J CANCER, V126, P1838, DOI 10.1002/ijc.24905	9	4	5	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					18	20		10.1016/j.cell.2015.06.041	http://dx.doi.org/10.1016/j.cell.2015.06.041			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140588	Bronze			2022-12-28	WOS:000357542300004
J	Wu, B; Buxbaum, AR; Katz, ZB; Yoon, YJ; Singer, RH				Wu, Bin; Buxbaum, Adina R.; Katz, Zachary B.; Yoon, Young J.; Singer, Robert H.			Quantifying Protein-mRNA Interactions in Single Live Cells	CELL			English	Article							FLUORESCENCE FLUCTUATION SPECTROSCOPY; INTRACELLULAR-LOCALIZATION; BRIGHTNESS ANALYSIS; BINDING PROTEIN; IN-VIVO; TRANSLATION; REVEALS; OLIGOMERIZATION; VISUALIZATION; EXPRESSION	Specific binding proteins are crucial for the correct spatiotemporal expression of mRNA. To understand this process, a method is required to characterize RNA-protein interactions in single living cells with subcellular resolution. We combined endogenous single RNA and protein detection with two-photon fluorescence fluctuation analysis to measure the average number of proteins bound to mRNA at specific locations within live cells. We applied this to quantify the known binding of zipcode binding protein 1 (ZBP1) and ribosomes to beta-actin mRNA within subcellular compartments of primary fibroblasts and neurons. ZBP1-mRNA binding did not occur in nuclei, contrary to previous conclusions. ZBP1 interaction with beta-actin mRNA was enhanced perinuclearly in neurons compared to fibroblasts. Cytoplasmic ZBP1 and ribosome binding to the mRNA were anti-correlated depending on their location in the cell. These measurements support a mechanism whereby ZBP1 inhibits translation of localizing mRNA until its release from the mRNA peripherally, allowing ribosome binding.	[Wu, Bin; Buxbaum, Adina R.; Katz, Zachary B.; Yoon, Young J.; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Wu, Bin; Buxbaum, Adina R.; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Singer, RH (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu		buxbaum, adina/0000-0002-3452-5986	NIH [R01 NS083085]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Jeffrey A. Chao for the construct of ZBP1<INF>F478A, F479A</INF> mutant and Xiuhua Meng for cloning the plasmids used in the manuscript. The translation initiation inhibitor hippuristanol is a generous gift from Dr. Jerry Pelletier. This work was supported by NIH grant R01 NS083085 to R.H.S.	Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Chao JA, 2008, NAT STRUCT MOL BIOL, V15, P103, DOI 10.1038/nsmb1327; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Chen Y, 2005, BIOPHYS J, V88, P2177, DOI 10.1529/biophysj.104.048413; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Digman MA, 2005, BIOPHYS J, V88, pL33, DOI 10.1529/biophysj.105.061788; Digman MA, 2011, ANNU REV PHYS CHEM, V62, P645, DOI 10.1146/annurev-physchem-032210-103424; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Hutten S, 2014, RNA BIOL, V11, P992, DOI 10.4161/rna.32091; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Katz ZB, 2012, GENE DEV, V26, P1885, DOI 10.1101/gad.190413.112; Kim SA, 2005, BIOPHYS J, V88, P4319, DOI 10.1529/biophysj.104.055319; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Lapidus K, 2007, J CELL SCI, V120, P3173, DOI 10.1242/jcs.000638; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Li JH, 2012, BIOPHYS J, V103, P1657, DOI 10.1016/j.bpj.2012.09.015; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Macdonald PJ, 2010, BIOPHYS J, V99, P979, DOI 10.1016/j.bpj.2010.05.017; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Park HY, 2012, CELL REPORTS, V1, P179, DOI 10.1016/j.celrep.2011.12.009; PETERSEN NO, 1993, BIOPHYS J, V65, P1135, DOI 10.1016/S0006-3495(93)81173-1; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Ross JA, 2011, BIOPHYS J, V100, pL15, DOI 10.1016/j.bpj.2010.12.3703; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sankaran J, 2009, BIOPHYS J, V97, P2630, DOI 10.1016/j.bpj.2009.08.025; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Wu B, 2005, BIOPHYS J, V89, P2721, DOI 10.1529/biophysj.105.063685; Wu B, 2006, BIOPHYS J, V91, P2687, DOI 10.1529/biophysj.106.086181; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017; Wu B, 2010, P NATL ACAD SCI USA, V107, P4117, DOI 10.1073/pnas.0905670107; Wu B, 2009, BIOPHYS J, V96, P2391, DOI 10.1016/j.bpj.2008.12.3902; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59	47	65	66	0	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					211	220		10.1016/j.cell.2015.05.054	http://dx.doi.org/10.1016/j.cell.2015.05.054			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140598	Bronze, Green Accepted			2022-12-28	WOS:000357542300021
J	Bates, AS; Al-Hamali, S				Bates, Anthony Simon; Al-Hamali, Salem			SPOT DIAGNOSIS An occult cause of dyspnoea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UPPER AIRWAY-OBSTRUCTION		[Bates, Anthony Simon; Al-Hamali, Salem] Gen Hosp Kettering, Kettering NN16 8UZ, England		Bates, AS (corresponding author), Gen Hosp Kettering, Kettering NN16 8UZ, England.	anthony.simon.bates@gmail.com						Bright P, 1998, AM J RESP CRIT CARE, V157, P1885, DOI 10.1164/ajrccm.157.6.9705022; GARCIAPACHON E, 1994, RESPIRATION, V61, P121; Gittoes NJL, 1996, BRIT MED J, V312, P484, DOI 10.1136/bmj.312.7029.484; Jennings A, 2001, ENDOCRIN METAB CLIN, V30, P401, DOI 10.1016/S0889-8529(05)70192-4	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2015	350								h2976	10.1136/bmj.h2976	http://dx.doi.org/10.1136/bmj.h2976			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7OD	26115956				2022-12-28	WOS:000357160700001
J	Bhullar, A; Shamsudin, N				Bhullar, Anisha; Shamsudin, Norashikin			Nevus Comedonicus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bhullar, Anisha; Shamsudin, Norashikin] Univ Putra Malaysia, Serdang, Malaysia	Universiti Putra Malaysia	Bhullar, A (corresponding author), Univ Putra Malaysia, Serdang, Malaysia.	anishabhullar@gmail.com							0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2541	2541		10.1056/NEJMicm1406555	http://dx.doi.org/10.1056/NEJMicm1406555			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2QD	26107054				2022-12-28	WOS:000356788200010
J	Capak, PL; Carilli, C; Jones, G; Casey, CM; Riechers, D; Sheth, K; Carollo, CM; Ilbert, O; Karim, A; LeFevre, O; Lilly, S; Scoville, N; Smolcic, V; Yan, L				Capak, P. L.; Carilli, C.; Jones, G.; Casey, C. M.; Riechers, D.; Sheth, K.; Carollo, C. M.; Ilbert, O.; Karim, A.; LeFevre, O.; Lilly, S.; Scoville, N.; Smolcic, V.; Yan, L.			Galaxies at redshifts 5 to 6 with systematically low dust content and high [C II] emission	NATURE			English	Article							STAR-FORMING GALAXIES; SIMILAR-TO 7; UV ATTENUATION; ULTRAVIOLET; ALMA; GAS; STARBURSTS; ABSORPTION; EVOLUTION; CONTINUUM	The rest-frame ultraviolet properties of galaxies during the first three billion years of cosmic time (redshift z > 4) indicate a rapid evolution in the dust obscuration of such galaxies(1-3). This evolution implies a change in the average properties of the interstellar medium, but the measurements are systematically uncertain owing to untested assumptions(4,5) and the inability to detect heavily obscured regions of the galaxies. Previous attempts to measure the interstellar medium directly in normal galaxies at these red-shifts have failed for a number of reasons(6-9), with two notable exceptions(10,11). Here we report measurements of the forbidden C II emission (that is, [C II]) from gas, and the far-infrared emission from dust, in nine typical star-forming galaxies about one billion years after the Big Bang (z approximate to 5-6). We find that these galaxies have thermal emission that is less than 1/12 that of similar systems about two billion years later, and enhanced [C II] emission relative to the far-infrared continuum, confirming a strong evolution in the properties of the interstellar medium in the early Universe. The gas is distributed over scales of one to eight kiloparsecs, and shows diverse dynamics within the sample. These results are consistent with early galaxies having significantly less dust than typical galaxies seen at z < 3 and being comparable in dust content to local low-metallicity systems(12).	[Capak, P. L.; Yan, L.] CALTECH, Ctr Infrared Proc & Anal, Pasadena, CA 91125 USA; [Capak, P. L.; Scoville, N.; Yan, L.] CALTECH, Pasadena, CA 91125 USA; [Carilli, C.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Carilli, C.] Univ Cambridge, Cavendish Lab, Astrophys Grp, Cambridge CB3 0HE, England; [Jones, G.] New Mexico Inst Min & Technol, Socorro, NM 87801 USA; [Casey, C. M.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Riechers, D.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Sheth, K.; Lilly, S.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Carollo, C. M.] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Ilbert, O.; LeFevre, O.] Aix Marseille Univ, CNRS, LAM, UMR 7326, F-13388 Marseille, France; [Karim, A.] Argelander Inst Astron, D-53121 Bonn, Germany; [Smolcic, V.] Univ Zagreb, Dept Phys, Zagreb 10002, Croatia	California Institute of Technology; California Institute of Technology; National Radio Astronomy Observatory (NRAO); University of Cambridge; New Mexico Institute of Mining Technology; University of Texas System; University of Texas Austin; Cornell University; National Radio Astronomy Observatory (NRAO); Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; University of Bonn; University of Zagreb	Capak, PL (corresponding author), CALTECH, Ctr Infrared Proc & Anal, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	capak@astro.caltech.edu	Jones, Gareth/AAD-7663-2022; Capak, Peter/AAK-4282-2020; Ilbert, Olivier/AAK-4578-2020	Jones, Gareth/0000-0002-0267-9024; Capak, Peter/0000-0003-3578-6843; Ilbert, Olivier/0000-0002-7303-4397; Casey, Caitlin/0000-0002-0930-6466	NASA; European Union [337595]	NASA(National Aeronautics & Space Administration (NASA)); European Union(European Commission)	Support for this work was provided by NASA through an award issued by JPL/Caltech. We thank the ALMA staff for facilitating the observations and aiding in the calibration and reduction process. ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. This work is based in part on observations made with the Spitzer Space Telescope and the W.M. Keck Observatory, along with archival data from the NASA/ESA Hubble Space Telescope, the Subaru Telescope, the Canada-France-Hawaii-Telescope and the ESO Vista telescope obtained from the NASA/IPAC Infrared Science Archive. V.S. acknowledges funding by the European Union's Seventh Framework programme under grant agreement 337595 (ERC Starting Grant, 'CoSMass').	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Boquien M, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118624; Bouwens RJ, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/34; Bouwens RJ, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/83; Bouwens RJ, 2010, ASTROPHYS J LETT, V708, pL69, DOI 10.1088/2041-8205/708/2/L69; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Buat V, 2002, ASTRON ASTROPHYS, V393, P33, DOI 10.1051/0004-6361:20020925; Capak PL, 2011, NATURE, V470, P233, DOI 10.1038/nature09681; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Casey CM, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/95; Casey CM, 2012, MON NOT R ASTRON SOC, V425, P3094, DOI 10.1111/j.1365-2966.2012.21455.x; Charlot S, 2000, ASTROPHYS J, V539, P718, DOI 10.1086/309250; De Looze I, 2011, MON NOT R ASTRON SOC, V416, P2712, DOI 10.1111/j.1365-2966.2011.19223.x; Diaz-Santos T, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/1/L17; Diaz-Santos T, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/68; Finkelstein SL, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/164; Gordon KD, 2003, ASTROPHYS J, V594, P279, DOI 10.1086/376774; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Ilbert O, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321100; Israel FP, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201016336; Koekemoer AM, 2007, ASTROPHYS J SUPPL S, V172, P196, DOI 10.1086/520086; Kong X, 2004, MON NOT R ASTRON SOC, V349, P769, DOI 10.1111/j.1365-2966.2004.07556.x; Leauthaud A, 2007, ASTROPHYS J SUPPL S, V172, P219, DOI 10.1086/516598; Leitherer C, 2002, ASTROPHYS J SUPPL S, V140, P303, DOI 10.1086/342486; Leitherer C, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/37; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Maiolino R., 2015, ASSEMBLY NORMAL GALA; Malhotra S, 1997, ASTROPHYS J, V491, pL27, DOI 10.1086/311044; Meurer GR, 1999, ASTROPHYS J, V521, P64, DOI 10.1086/307523; Ota K, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/34; Ouchi M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/102; Pettini M, 1998, ASTROPHYS J, V508, P539, DOI 10.1086/306431; Reddy N, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/154; Reddy NA, 2010, ASTROPHYS J, V712, P1070, DOI 10.1088/0004-637X/712/2/1070; Riechers DA, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/84; Rogers AB, 2014, MON NOT R ASTRON SOC, V440, P3714, DOI 10.1093/mnras/stu558; Schaerer D, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424649; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Scoville N, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/108; Speagle JS, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/15; Steinhardt CL, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L25; Wang R, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/44; Watson D, 2015, NATURE, V519, P327, DOI 10.1038/nature14164	44	313	314	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					455	+		10.1038/nature14500	http://dx.doi.org/10.1038/nature14500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108853	Green Submitted, Green Accepted			2022-12-28	WOS:000356782900044
J	Gornall, J				Gornall, Jonathan			TOBACCO Why e-cigarettes are dividing the public health community	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEBATE					jgornall@mac.com						Abrams D, 2014, COMMUNICATION; Abrams D, 2014, NICOTINE SCI PO 0626; Alexanderson K, 2014, COMMUNICATION; [Anonymous], 2006, AM FIN OP; [Anonymous], 2014, BAT SUSTAINABILITY F; Arnott D., 2015, AAAS 2015 ANN M SAN, P13; Ashton JR, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5484; Bridgman K., 2015, AAAS 2015 ANN M SAN, P13; British American Tobacco, BAT 2014 ANN REP; Fagerstrom K, 2013, NICOTINE SCI PO 1214; Fagerstrom KO, 2014, ADDICT BEHAV, V39, P507, DOI 10.1016/j.addbeh.2013.11.002; Glantz S., 2015, METAANALYSIS AVAILAB; Gornall J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2052; Jollye L, 2014, LANCET, V384, P1576, DOI 10.1016/S0140-6736(14)61985-1; McKee M, 2014, LANCET, V384, P2107, DOI 10.1016/S0140-6736(14)62366-7; McKee Martin, 2013, BMJ, V347, pf5780, DOI 10.1136/bmj.f5780; NICE, TOB HARM RED MIN PRO; NICE, GUID P45 MEMB PROGR; Robinson D, 2014, FINANCIAL TIMES; Tverdal A, 2006, TOB CONTROL, V15, P472, DOI 10.1136/tc.2006.016246; US Preventive Services Task Force, 2015, TOB SMOK CESS AD PRE; WHO, 2015, TOB FACT SHEET	22	26	26	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2015	350								h3317	10.1136/bmj.h3317	http://dx.doi.org/10.1136/bmj.h3317			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NX	26109314				2022-12-28	WOS:000357160000009
J	Stern, RJ; Murphy, EJ				Stern, Rachel J.; Murphy, Elizabeth J.			Metformin as Initial Oral Therapy in Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALGORITHM; ASSOCIATION; MANAGEMENT; STATEMENT; MELLITUS; DRUGS		[Stern, Rachel J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Internal Med, Primary Care Residency, San Francisco, CA USA; [Murphy, Elizabeth J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Murphy, Elizabeth J.] San Francisco Gen Hosp, Div Endocrinol, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Stern, RJ (corresponding author), San Francisco Gen Hosp, 1001 Potrero Ave,Ward 13,Bldg 10,Third Floor, San Francisco, CA 94110 USA.	rachel.stern@ucsf.edu						Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Berkowitz SA, 2014, JAMA INTERN MED, V174, P1955, DOI 10.1001/jamainternmed.2014.5294; Eurich DT, 2007, BMJ-BRIT MED J, V335, P497, DOI 10.1136/bmj.39314.620174.80; Garber AJ, 2013, ENDOCR PRACT, V19, P100, DOI 10.4158/EP12325.OR; Hampp C, 2014, DIABETES CARE, V37, P1367, DOI 10.2337/dc13-2289; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540	8	6	6	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2484	2485		10.1001/jama.2015.2765	http://dx.doi.org/10.1001/jama.2015.2765			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103032				2022-12-28	WOS:000356663600017
J	Dosenovic, P; von Boehmer, L; Escolano, A; Jardine, J; Freund, NT; Gitlin, AD; McGuire, AT; Kulp, DW; Oliveira, T; Scharf, L; Pietzsch, J; Gray, MD; Cupo, A; van Gils, MJ; Yao, KH; Liu, C; Gazumyan, A; Seaman, MS; Bjorkman, PJ; Sanders, RW; Moore, JP; Stamatatos, L; Schief, WR; Nussenzweig, MC				Dosenovic, Pia; von Boehmer, Lotta; Escolano, Amelia; Jardine, Joseph; Freund, Natalia T.; Gitlin, Alexander D.; McGuire, Andrew T.; Kulp, Daniel W.; Oliveira, Thiago; Scharf, Louise; Pietzsch, John; Gray, Matthew D.; Cupo, Albert; van Gils, Marit J.; Yao, Kai-Hui; Liu, Cassie; Gazumyan, Anna; Seaman, Michael S.; Bjoerkman, Pamela J.; Sanders, Rogier W.; Moore, John P.; Stamatatos, Leonidas; Schief, William R.; Nussenzweig, Michel C.			Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice	CELL			English	Article							B-CELL RECEPTORS; ENVELOPE TRIMER; SOMATIC HYPERMUTATION; VACCINE; VIRUS; GP120; SITE; RECOMBINATION; GLYCOPROTEIN; AFFINITY	A subset of individuals infected with HIV-1 develops broadly neutralizing antibodies (bNAbs) that can prevent infection, but it has not yet been possible to elicit these antibodies by immunization. To systematically explore how immunization might be tailored to produce them, we generated mice expressing the predicted germline or mature heavy chains of a potent bNAb to the CD4 binding site (CD4bs) on the HIV-1 envelope glycoprotein (Env). Immunogens specifically designed to activate B cells bearing germline antibodies are required to initiate immune responses, but they do not elicit bNAbs. In contrast, native-like Env trimers fail to activate B cells expressing germline antibodies but elicit bNAbs by selecting for a restricted group of light chains bearing specific somatic mutations that enhance neutralizing activity. The data suggest that vaccination to elicit anti-HIV-1 antibodies will require immunization with a succession of related immunogens.	[Dosenovic, Pia; von Boehmer, Lotta; Escolano, Amelia; Freund, Natalia T.; Gitlin, Alexander D.; Oliveira, Thiago; Pietzsch, John; Yao, Kai-Hui; Liu, Cassie; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Gazumyan, Anna; Bjoerkman, Pamela J.; Nussenzweig, Michel C.] Scripps Res Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Jardine, Joseph; Kulp, Daniel W.; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [McGuire, Andrew T.; Gray, Matthew D.; Stamatatos, Leonidas] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Scharf, Louise; Bjoerkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Cupo, Albert; Sanders, Rogier W.; Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [van Gils, Marit J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Seaman, Michael S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98109 USA; [Jardine, Joseph; Kulp, Daniel W.; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Jardine, Joseph; Kulp, Daniel W.; Schief, William R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Schief, William R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA	Rockefeller University; Howard Hughes Medical Institute; Scripps Research Institute; Scripps Research Institute; Fred Hutchinson Cancer Center; California Institute of Technology; Cornell University; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Schief, WR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	schief@scripps.edu; nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Oliveira, Thiago Y/HGA-3848-2022; van Gils, Marit J./H-4791-2019; Dosenovic, Pia/S-6894-2018; Schief, William/ABF-3645-2020; Oliveira, Thiago Y/ABF-5186-2020	Oliveira, Thiago Y/0000-0002-2654-0879; van Gils, Marit J./0000-0003-3422-8161; Dosenovic, Pia/0000-0002-0426-4586; Schief, William/0000-0002-1120-0150; Oliveira, Thiago Y/0000-0002-2654-0879; von Boehmer, Lotta/0000-0001-8018-1814; McGuire, Andrew/0000-0003-1841-6859; Liu, Cassie/0000-0003-3907-9409; Gitlin, Alexander/0000-0002-9229-0919	NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [UM1 AI100663]; Bill and MelindaGates Foundation [OPP1033115, 1032144]; NIH [AI037526, U19 AI109632, HIVRAD/P01 AI094419-01, HIVRAD/P01 AI082362, HIVRAD/P01 AI100148]; International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center; BMGF CAVD; Aids Fonds Netherlands [2012041]; Swedish Research Council; Rockefeller University Center for Clinical and Translational Science grant from the National Center for Advancing Translational Sciences (NCATS) [UL1 TR000043/KL2TR000151]; MSTP [T32GM07739]; Canadian Institutes of Health Research Fellowship; Netherlands Organization for Scientific Research (NWO); European Research Council [ERC-StG-2011-280829-SHEV]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043, KL2TR000151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109632, P01AI082362, P01AI094419, UM1AI100663, R37AI037526, R01AI037526, P01AI100148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); Bill and MelindaGates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center; BMGF CAVD; Aids Fonds Netherlands; Swedish Research Council(Swedish Research CouncilEuropean Commission); Rockefeller University Center for Clinical and Translational Science grant from the National Center for Advancing Translational Sciences (NCATS); MSTP; Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chingwen Yang, Dorjee Shola, and Rada Norinsky for their contribution in the generation of the knockin mice; Thomas Eisenreich, David Bosque, and Susan Hinklein for assistance with the mice; Klara Velinzon and Neena Thomas for assistance with single-cell FACS sorting; Zoran Jankovic for laboratory support; Alex Robles for technical assistance with the HIV-1 TZMbl neutralization assays; and Anthony West for advice regarding the selection of the HIV-1 virus panels. This work was supported by grants from NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) UM1 AI100663 (M.C.N., W.R.S., and R.W.S.), Bill and Melinda Gates Foundation grant OPP1033115(M.C.N.), NIH grant AI037526 (M.C.N.), the International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center (W.R.S.), and by BMGF CAVD funding for the IAVI NAC Center (W.R.S.). This work was also supported by NIH grant U19 AI109632 (M.C.N. and L.S.), HIVRAD/P01 AI094419-01 (L.S.), HIVRAD/P01 AI082362 (J.P.M. and R.W.S.), HIVRAD/P01 AI100148 (P.J.B. and M.C.N.), Bill and Melinda Gates Foundation grant 1032144 (M.S.S.), and the Aids Fonds Netherlands, grant 2012041 (M.J.v.G.). P.D. is supported by an international postdoctoral fellowship from the Swedish Research Council. L.v.B. is supported by The Rockefeller University Center for Clinical and Translational Science grant UL1 TR000043/KL2TR000151 from the National Center for Advancing Translational Sciences (NCATS). A.D.G. is supported by MSTP grant T32GM07739 to the Weill Cornell/ Rockefeller/ Sloan-Kettering Tri-Institutional MD-PhD Program. A.M. is supported by a Canadian Institutes of Health Research Fellowship. R.W.S. is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV). M.C.N. and P.J.B. are Howard Hughes Medical Institute Investigators.	BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chung NPY, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-33; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Jardine J.G., 2015, SCIENCE; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002	42	184	191	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1505	1515		10.1016/j.cell.2015.06.003	http://dx.doi.org/10.1016/j.cell.2015.06.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091035	Green Accepted, Bronze			2022-12-28	WOS:000356618200009
J	Isaacs, D				Isaacs, David			Doctors should boycott working in Australia's immigration centres and must continue to speak out on mistreatment of detainees-despite the law	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DETENTION		[Isaacs, David] Univ Sydney, Westmead, NSW 21245, Australia; [Isaacs, David] Childrens Hosp Westmead, Dept Infect Dis & Microbiol, Westmead, NSW 21245, Australia	University of Sydney; University of Sydney	Isaacs, D (corresponding author), Univ Sydney, Locked Bag 4001, Westmead, NSW 21245, Australia.	david.isaacs@health.nsw.gov.au						[Anonymous], 2015, ABC NEWS; Australian Department of Immigration and Border Protection, 2015, REV REC ALL REG PROC; Australian Human Rights Commission, 2014, FORG CHILDR NAT INQ; Berger D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2907; Human Rights Law Centre, 2015, UN FINDS AUSTR TREAT; Isaacs D, 2015, J PAEDIATR CHILD H, V51, P353, DOI 10.1111/jpc.12872; Isaacs M., 2014, THE UNDESIRABLES; Paxton G, 2015, J PAEDIATR CHILD H, V51, P365, DOI 10.1111/jpc.12873	8	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2015	350								h3269	10.1136/bmj.h3269	http://dx.doi.org/10.1136/bmj.h3269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2OZ	26084966				2022-12-28	WOS:000356785200006
J	Zeng, M; Mao, XH; Li, JX; Tong, WD; Wang, B; Zhang, YJ; Guo, G; Zhao, ZJ; Li, L; Wu, DL; Lu, DS; Tan, ZM; Liang, HY; Wu, C; Li, DH; Luo, P; Zeng, H; Zhang, WJ; Zhang, JY; Guo, BT; Zhu, FC; Zou, QM				Zeng, Ming; Mao, Xu-Hu; Li, Jing-Xin; Tong, Wen-De; Wang, Bin; Zhang, Yi-Ju; Guo, Gang; Zhao, Zhi-Jing; Li, Liang; Wu, De-Lin; Lu, Dong-Shui; Tan, Zhong-Ming; Liang, Hao-Yu; Wu, Chao; Li, Da-Han; Luo, Ping; Zeng, Hao; Zhang, Wei-Jun; Zhang, Jin-Yu; Guo, Bo-Tao; Zhu, Feng-Cai; Zou, Quan-Ming			Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							COLI ENTEROTOXIN ADJUVANT; UREASE; IMMUNIZATION; VOLUNTEERS; PROTECTION; INFECTION; MICE; ANTIBODIES	Background Helicobacter pylori is one of the most common gastric pathogens, affecting at least half the world's population, and is strongly associated with gastritis, peptic ulcer, gastric adenocarcinoma, and lymphoma. We aimed to assess the efficacy, safety, and immunogenicity of a three-dose oral recombinant H pylori vaccine in children in China. Methods We did this randomised, double-blind, placebo-controlled, phase 3 trial at one centre in Ganyu County, Jiangsu Province, China. Healthy children aged 6-15 years without past or present H pylori infection were randomly assigned (1: 1), via computer-generated randomisation codes in blocks of ten, to receive the H pylori vaccine or placebo. Participants, their guardians, and study investigators were masked to treatment allocation. The primary efficacy endpoint was the occurrence of H pylori infection within 1 year after vaccination. We did analysis in the per-protocol population. This trial is registered with ClinicalTrials.gov, number NCT02302170. Findings Between Dec 2, 2004, and March 19, 2005, we randomly assigned 4464 participants to either the vaccine group (n=2232) or the placebo group (n=2232), of whom 4403 (99%) participants completed the three-dose vaccination schedule and were included in the per-protocol efficacy analysis. We extended follow-up to 3 years. We recorded 64 events of H pylori infection within the first year (14 events in 2074.3 person-years at risk in the vaccine group vs 50 events in 2089.6 person-years at risk in the placebo group), resulting in a vaccine efficacy of 71.8% (95% CI 48.2-85.6). 157 (7%) participants in the vaccine group and 161 (7%) participants in the placebo group reported at least one adverse reaction. Serious adverse events were reported in five (<1%) participants in the vaccine group and seven (<1%) participants in the placebo group, but none was considered to be vaccination related. Interpretation The oral recombinant H pylori vaccine was effective, safe, and immunogenic in H pylori-naive children. This vaccine could substantially reduce the incidence of H pylori infection; however, follow up over a longer period is needed to confirm the protection of the vaccine against H pylori-associated diseases.	[Li, Jing-Xin; Zhang, Yi-Ju; Li, Liang; Tan, Zhong-Ming; Zhu, Feng-Cai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Zeng, Ming; Wang, Bin; Zhao, Zhi-Jing; Liang, Hao-Yu] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Mao, Xu-Hu; Guo, Gang; Lu, Dong-Shui; Wu, Chao; Luo, Ping; Zeng, Hao; Zhang, Wei-Jun; Zhang, Jin-Yu; Guo, Bo-Tao; Zou, Quan-Ming] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China; [Tong, Wen-De] Kangwei Biol Technol, Chongqing, Peoples R China; [Wu, De-Lin; Li, Da-Han] Ganyu Cty Ctr Dis Control & Prevent, Lianyungang, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; National Institute of Food & Drug Control - China; Army Medical University	Zhu, FC (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China.	jszfc@vip.sina.com; qmzou2007@163.com	Zeng, Ming/GXF-3628-2022	Zeng, Ming/0000-0003-2836-9240	Chongqing Kangwei Biological Technology	Chongqing Kangwei Biological Technology	Chongqing Kangwei Biological Technology.	Aebischer T, 2008, GUT, V57, P1065, DOI 10.1136/gut.2007.145839; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Banerjee S, 2002, GUT, V51, P634, DOI 10.1136/gut.51.5.634; Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; Cave DR, 1997, GASTROENTEROLOGY, V113, pS9, DOI 10.1016/S0016-5085(97)80004-2; Chinese Medical Association Digestive Disease Branch, 2004, MOD DIGEST INTERVEN, V9, P59; Corthesy B, 2005, J INFECT DIS, V192, P1441, DOI 10.1086/444425; da Hora VP, 2011, VACCINE, V29, P1538, DOI 10.1016/j.vaccine.2010.11.091; Del Giudice G, 2009, EXPERT REV VACCINES, V8, P1037, DOI 10.1586/ERV.09.62; DiPetrillo MD, 1999, VACCINE, V18, P449, DOI 10.1016/S0264-410X(99)00246-7; Ermak TH, 1998, J EXP MED, V188, P2277, DOI 10.1084/jem.188.12.2277; Garhart CA, 2003, INFECT IMMUN, V71, P3628, DOI 10.1128/IAI.71.6.3628-3633.2003; [郭桐生 Guo Tongsheng], 2003, [中国生物制品学杂志, Chinese Journal of Biologicals], V16, P215; Kotloff KL, 2001, INFECT IMMUN, V69, P3581, DOI 10.1128/IAI.69.6.3581-3590.2001; Leal-Herrera Y, 1999, AM J TROP MED HYG, V60, P587, DOI 10.4269/ajtmh.1999.60.587; Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Megraud F, 2005, CELL, V123, P975, DOI 10.1016/j.cell.2005.11.032; Michetti P, 1999, GASTROENTEROLOGY, V116, P804, DOI 10.1016/S0016-5085(99)70063-6; Parsonnet J, 2005, NEW ENGL J MED, V353, P2421, DOI 10.1056/NEJMp058270; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Plotkin SA, 2001, PEDIATR INFECT DIS J, V20, P63, DOI 10.1097/00006454-200101000-00013; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; Sougioultzis S, 2002, VACCINE, V21, P194, DOI 10.1016/S0264-410X(02)00467-X; WARREN JR, 1983, LANCET, V1, P1273; Zhang W., 2010, MOD DIG INTERVEN, V15, P265, DOI DOI 10.3969/J.ISSN.1672-2159.2010.05.001	30	147	174	1	78	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1457	1464		10.1016/S0140-6736(15)60310-5	http://dx.doi.org/10.1016/S0140-6736(15)60310-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5UU	26142048				2022-12-28	WOS:000362877300028
J	Pardo-Saganta, A; Tata, PR; Law, BM; Saez, B; Chow, RDW; Prabhu, M; Gridley, T; Rajagopal, J				Pardo-Saganta, Ana; Tata, Purushothama Rao; Law, Brandon M.; Saez, Borja; Chow, Ryan Dz-Wei; Prabhu, Mythili; Gridley, Thomas; Rajagopal, Jayaraj			Parent stem cells can serve as niches for their daughter cells	NATURE			English	Article							SIGNALING CONTROLS; AIRWAY EPITHELIUM; TRANSGENIC MICE; MOUSE TRACHEA; IN-VIVO; LUNG; MAINTENANCE; CLARA; DIFFERENTIATION; REGENERATION	Stem cells integrate inputs from multiple sources. Stem cell niches provide signals that promote stem cell maintenance(1,2), while differentiated daughter cells are known to provide feedback signals to regulate stem cell replication and differentiation(3-6). Recently, stem cells have been shown to regulate themselves using an autocrine mechanism(7). The existence of a 'stem cell niche' was first postulated by Schofield in 1978 to define local environments necessary for the maintenance of haematopoietic stem cells1. Since then, an increasing body of work has focused on defining stem cell niches(1-6). Yet little is known about how progenitor cell and differentiated cell numbers and proportions are maintained. In the airway epithelium, basal cells function as stem/progenitor cells that can both self-renew and produce differentiated secretory cells and ciliated cells(8,9). Secretory cells also act as transit-amplifying cells that eventually differentiate into post-mitotic ciliated cells(9,10). Here we describe a mode of cell regulation in which adult mammalian stem/progenitor cells relay a forward signal to their own progeny. Surprisingly, this forward signal is shown to be necessary for daughter cell maintenance. Using a combination of cell ablation, lineage tracing and signalling pathway modulation, we show that airway basal stem/progenitor cells continuously supply a Notch ligand to their daughter secretory cells. Without these forward signals, the secretory progenitor cell pool fails to be maintained and secretory cells execute a terminal differentiation program and convert into ciliated cells. Thus, a parent stem/progenitor cell can serve as a functional daughter cell niche.	[Pardo-Saganta, Ana; Tata, Purushothama Rao; Law, Brandon M.; Saez, Borja; Chow, Ryan Dz-Wei; Prabhu, Mythili; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Pardo-Saganta, Ana; Tata, Purushothama Rao; Law, Brandon M.; Chow, Ryan Dz-Wei; Prabhu, Mythili; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [Pardo-Saganta, Ana; Tata, Purushothama Rao; Law, Brandon M.; Chow, Ryan Dz-Wei; Prabhu, Mythili; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Pediat, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Pardo-Saganta, Ana; Tata, Purushothama Rao; Law, Brandon M.; Saez, Borja; Chow, Ryan Dz-Wei; Prabhu, Mythili; Rajagopal, Jayaraj] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Saez, Borja] Harvard Univ, Stem Cell & Regenerat Biol Dept, Cambridge, MA 02138 USA; [Gridley, Thomas] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Maine Medical Center	Rajagopal, J (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	jrajagopal@mgh.harvard.edu	Chow, Ryan/ABF-1119-2021; Saez, Borja/L-7411-2015	Chow, Ryan/0000-0002-1872-6307; Saez, Borja/0000-0001-7908-7089; Pardo-Saganta, Ana/0000-0002-5926-6255; Tata, Purushothama Rao/0000-0003-4837-0337	New York Stem Cell Foundation; National Institutes of Health-National Heart, Lung, and Blood Institute Early Career Research New Faculty (P30) award [5P30HL101287-02]; NIH-NHLBI [RO1HL118185]; Harvard Stem Cell Institute (HSCI) Junior Investigator Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118185, P30HL101287] Funding Source: NIH RePORTER	New York Stem Cell Foundation; National Institutes of Health-National Heart, Lung, and Blood Institute Early Career Research New Faculty (P30) award; NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Harvard Stem Cell Institute (HSCI) Junior Investigator Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Glick for providing the CK5rtTA mice, B. Hogan for providing CK5creER and SCGB1A1creER mice and Y.-Y. Kong for sharing the Mib1 floxed mice. B. Z. Stanger provided the RBPjk floxed mice and shared protocols for the immunohistochemical detection of Notch components. We also thank B. Stripp for providing the goat anti-SCGB1A1 antibody. We wish to extend our thanks to all of the members of the Rajagopal laboratory and the HSCI flow cytometry core facility. This research was supported by the New York Stem Cell Foundation (J.R. is a New York Stem Cell Foundation-Robertson Investigator), by a National Institutes of Health-National Heart, Lung, and Blood Institute Early Career Research New Faculty (P30) award (5P30HL101287-02), an RO1 (RO1HL118185) from NIH-NHLBI (to J.R.) and a Harvard Stem Cell Institute (HSCI) Junior Investigator Grant (to J.R.). J.R. is also the Maroni Research Scholar at Massachusetts General Hospital.	Alon U, 2007, INTRO SYSTEMS BIOL D; Ambler CA, 2010, DEVELOPMENT, V137, P3569, DOI 10.1242/dev.050310; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Kim JK, 2012, AM J RESP CELL MOL, V47, P864, DOI 10.1165/rcmb.2012-0164OC; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Mori M, 2015, DEVELOPMENT, V142, P258, DOI 10.1242/dev.116855; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pan JH, 2014, STEM CELLS, V32, P3245, DOI 10.1002/stem.1814; Pardo-Saganta A, 2015, CELL STEM CELL, V16, P184, DOI 10.1016/j.stem.2015.01.002; Pardo-Saganta A, 2013, AM J RESP CELL MOL, V48, P364, DOI 10.1165/rcmb.2012-0146OC; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; Tan FE, 2013, DEVELOPMENT, V140, P4277, DOI 10.1242/dev.094102; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Weber T, 2011, GLIA, V59, P615, DOI 10.1002/glia.21129; Xu JX, 2010, GENESIS, V48, P390, DOI 10.1002/dvg.20626	37	104	105	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					597	+		10.1038/nature14553	http://dx.doi.org/10.1038/nature14553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26147083	Green Accepted			2022-12-28	WOS:000358655200046
J	Minajigi, A; Froberg, JE; Wei, CY; Sunwoo, H; Kesner, B; Colognori, D; Lessing, D; Payer, B; Boukhali, M; Haas, W; Lee, JT				Minajigi, Anand; Froberg, John E.; Wei, Chunyao; Sunwoo, Hongjae; Kesner, Barry; Colognori, David; Lessing, Derek; Payer, Bernhard; Boukhali, Myriam; Haas, Wilhelm; Lee, Jeannie T.			A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation	SCIENCE			English	Article							PATERNAL X-CHROMOSOME; HI-C REVEALS; INACTIVE-X; REGULATORY ELEMENTS; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; DOSAGE COMPENSATION; BINDING; GENOME; CTCF	The inactive X chromosome (Xi) serves as a model to understand gene silencing on a global scale. Here, we perform "identification of direct RNA interacting proteins" (iDRiP) to isolate a comprehensive protein interactome for Xist, an RNA required for Xi silencing. We discover multiple classes of interactors-including cohesins, condensins, topoisomerases, RNA helicases, chromatin remodelers, and modifiers-that synergistically repress Xi transcription. Inhibiting two or three interactors destabilizes silencing. Although Xist attracts some interactors, it repels architectural factors. Xist evicts cohesins from the Xi and directs an Xi-specific chromosome conformation. Upon deleting Xist, the Xi acquires the cohesin-binding and chromosomal architecture of the active X. Our study unveils many layers of Xi repression and demonstrates a central role for RNA in the topological organization of mammalian chromosomes.	[Minajigi, Anand; Froberg, John E.; Wei, Chunyao; Sunwoo, Hongjae; Kesner, Barry; Colognori, David; Lessing, Derek; Payer, Bernhard; Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Minajigi, Anand; Froberg, John E.; Wei, Chunyao; Sunwoo, Hongjae; Kesner, Barry; Colognori, David; Lessing, Derek; Payer, Bernhard; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Minajigi, Anand; Froberg, John E.; Wei, Chunyao; Sunwoo, Hongjae; Kesner, Barry; Colognori, David; Lessing, Derek; Payer, Bernhard; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Boukhali, Myriam; Haas, Wilhelm] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Boukhali, Myriam; Haas, Wilhelm] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Payer, Bernhard/F-7353-2010	Payer, Bernhard/0000-0002-4694-2082; Colognori, David/0000-0001-6995-7079; Froberg, John/0000-0003-3391-7619	NIH [R01-DA-38695, R03-MH97478]; Rett Syndrome Research Trust; International Rett Syndrome Foundation; National Science Foundation; MGH Fund for Medical Discovery	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rett Syndrome Research Trust; International Rett Syndrome Foundation; National Science Foundation(National Science Foundation (NSF)); MGH Fund for Medical Discovery	We thank S. Gygi for access to computational resources for proteomic analysis and all members of the Lee and Haas laboratories for valuable discussions. This work was supported by grants from NIH (R01-DA-38695 and R03-MH97478), the Rett Syndrome Research Trust, and the International Rett Syndrome Foundation to J.T.L.; a National Science Foundation predoctoral award to J.E.F.; and the MGH Fund for Medical Discovery to H.S. J.T.L. is an Investigator of the HHMI. J.T.L., A.M., J.E.F., C.W., and the Massachusetts General Hospital have filed patent applications (USSN 62/144,219 and 62/168,528) that relate to leveraging the Xist interactome to reactivate the Xi. The GEO accession code for data in the paper is GSE67516. RNA-seq, ChIP-seq, and HiC-seq data are deposited in GEO.	Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Bhatnagar S, 2014, P NATL ACAD SCI USA, V111, P12591, DOI 10.1073/pnas.1413620111; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Calabrese JM, 2012, CELL, V151, P951, DOI 10.1016/j.cell.2012.10.037; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Disteche CM, 2012, ANNU REV GENET, V46, P537, DOI 10.1146/annurev-genet-110711-155454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feig C, 2013, EMBO J, V32, P3114, DOI 10.1038/emboj.2013.248; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hall LL, 2009, J CELL BIOL, V186, P491, DOI 10.1083/jcb.200811143; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kung JT, 2015, MOL CELL, V57, P361, DOI 10.1016/j.molcel.2014.12.006; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin S, 2011, MOL CELL BIOL, V31, P3094, DOI 10.1128/MCB.01449-10; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Plath K, 2004, J CELL BIOL, V167, P1025, DOI 10.1083/jcb.200409026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Singh V, 2013, CURR CANCER DRUG TAR, V13, P379, DOI 10.2174/15680096113139990077; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Tolonen AC, 2014, JOVE-J VIS EXP, DOI 10.3791/51416; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; Wutz A, 2012, DEV CELL, V23, P680, DOI 10.1016/j.devcel.2012.09.017; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yildirim E, 2012, NAT STRUCT MOL BIOL, V19, P56, DOI 10.1038/nsmb.2195; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	66	306	310	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI				aab2276	10.1126/science.aab2276	http://dx.doi.org/10.1126/science.aab2276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26089354	Green Accepted			2022-12-28	WOS:000358218600044
J	Tan, BS; Hsu, YT; Zeng, B; Hatnean, MC; Harrison, N; Zhu, Z; Hartstein, M; Kiourlappou, M; Srivastava, A; Johannes, MD; Murphy, TP; Park, JH; Balicas, L; Lonzarich, GG; Balakrishnan, G; Sebastian, SE				Tan, B. S.; Hsu, Y. -T.; Zeng, B.; Hatnean, M. Ciomaga; Harrison, N.; Zhu, Z.; Hartstein, M.; Kiourlappou, M.; Srivastava, A.; Johannes, M. D.; Murphy, T. P.; Park, J. -H.; Balicas, L.; Lonzarich, G. G.; Balakrishnan, G.; Sebastian, Suchitra E.			Unconventional Fermi surface in an insulating state	SCIENCE			English	Article							INDUCED SUPERCONDUCTIVITY; SMB6; GAP; VALENCE; EXCITATIONS; PRESSURE; MASS	Insulators occur in more than one guise; a recent finding was a class of topological insulators, which host a conducting surface juxtaposed with an insulating bulk. Here, we report the observation of an unusual insulating state with an electrically insulating bulk that simultaneously yields bulk quantum oscillations with characteristics of an unconventional Fermi liquid. We present quantum oscillation measurements of magnetic torque in high-purity single crystals of the Kondo insulator SmB6, which reveal quantum oscillation frequencies characteristic of a large three-dimensional conduction electron Fermi surface similar to the metallic rare earth hexaborides such as PrB6 and LaB6. The quantum oscillation amplitude strongly increases at low temperatures, appearing strikingly at variance with conventional metallic behavior.	[Tan, B. S.; Hsu, Y. -T.; Hartstein, M.; Kiourlappou, M.; Srivastava, A.; Lonzarich, G. G.; Sebastian, Suchitra E.] Univ Cambridge, Cavendish Lab, Cambridge CB3 OHE, England; [Zeng, B.; Murphy, T. P.; Park, J. -H.; Balicas, L.] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Hatnean, M. Ciomaga; Balakrishnan, G.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Harrison, N.; Zhu, Z.] Los Alamos Natl Lab, Natl High Magnet Field Lab, Los Alamos, NM 87504 USA; [Johannes, M. D.] Naval Res Lab, Ctr Computat Mat Sci, Washington, DC 20375 USA	University of Cambridge; State University System of Florida; Florida State University; University of Warwick; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Sebastian, SE (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 OHE, England.	suchitra@phy.cam.ac.uk	Ciomaga Hatnean, Monica/L-8759-2013; Balicas, Luis/A-3110-2008; Balakrishnan, Geetha/P-5977-2016	Ciomaga Hatnean, Monica/0000-0003-2870-8847; Balakrishnan, Geetha/0000-0002-5890-1149; Harrison, Neil/0000-0001-5456-7756; Kiourlappou, Maria/0000-0003-1792-9206	Royal Society; Winton Programme for the Physics of Sustainability; European Research Council (ERC) under the European Union [337425]; U.S. Department of Energy (DOE)-Basic Energy Sciences (BES) [DE-SC0002613]; Engineering and Physical Sciences Research Council (EPSRC) [EP/L014963/1]; DOE Office of Science, BES-Materials Science and Engineering "Science of 100 Tesla" program; Office of Naval Research (ONR) through the Naval Research Laboratory's Basic Research Program; EPSRC [EP/K012894/1]; NSF [DMR-1157490]; state of Florida; Engineering and Physical Sciences Research Council [1492065, EP/L014963/1, EP/K012894/1] Funding Source: researchfish; EPSRC [EP/L014963/1] Funding Source: UKRI	Royal Society(Royal Society of London); Winton Programme for the Physics of Sustainability; European Research Council (ERC) under the European Union(European Research Council (ERC)); U.S. Department of Energy (DOE)-Basic Energy Sciences (BES)(United States Department of Energy (DOE)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DOE Office of Science, BES-Materials Science and Engineering "Science of 100 Tesla" program(United States Department of Energy (DOE)); Office of Naval Research (ONR) through the Naval Research Laboratory's Basic Research Program(Office of Naval Research); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF(National Science Foundation (NSF)); state of Florida; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	B.S.T., Y.-T.H., M.H., M.K., A.S., and S.E.S. acknowledge support from the Royal Society, the Winton Programme for the Physics of Sustainability, and the European Research Council (ERC) under the European Union's Seventh Framework Programme (grant FP/2007-2013)/ERC Grant Agreement 337425. B.Z. and L.B. acknowledge support from the U.S. Department of Energy (DOE)-Basic Energy Sciences (BES) through award DE-SC0002613. M.C.H. and G.B. acknowledge support from Engineering and Physical Sciences Research Council (EPSRC) grant EP/L014963/1. N.H. and Z.Z. acknowledge support from the DOE Office of Science, BES-Materials Science and Engineering "Science of 100 Tesla" program. M.D.J. acknowledges support for this project by the Office of Naval Research (ONR) through the Naval Research Laboratory's Basic Research Program. G.G.L. acknowledges support from EPSRC grant EP/K012894/1. A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by NSF Cooperative Agreement DMR-1157490 and the state of Florida. We acknowledge valuable inputs from G. Baskaran, D. Benkert, A. K. Cheetham, D. Chowdhury, P. Coleman, N. R. Cooper, M. P. M. Dean, O. Ertem, J. Flouquet, R. H. Friend, R. Golombok, C. Harris, S. A. Hartnoll, T. Kasuya, G. Khaliullin, E.-A. Kim, J. Knolle, P. A. Lee, P. B. Littlewood, C. Liu, K. Miyake, J. E. Moore, O. Petrenko, S. Sachdev, A. Shekhter, N. Shitsevalova, Q. Si, A. Thomson, S. Todadri, C. M. Varma, and J. Zaanen. We thank magnet laboratory personnel, including J. Billings, R. Carrier, E. S. Choi, B. L. Dalton, D. Freeman, L. J. Gordon, M. Hicks, C. H. Mielke, J. M. Petty, and J. N. Piotrowski, for their assistance. Data will be made available at the institutional data repository www.data.cam.ac.uk/data-repository.	Aeppli G., 1992, COMMENTS COND MAT PH, V16, P155; ALEKSEEV PA, 1993, PHYSICA B, V186-88, P384, DOI 10.1016/0921-4526(93)90580-Y; AONO M, 1979, SURF SCI, V86, P631, DOI 10.1016/0039-6028(79)90443-6; Barla A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.166401; BEHLER S, 1991, Z PHYS B CON MAT, V82, P355, DOI 10.1007/BF01357179; Biswas PK, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.161107; COHEN RL, 1970, PHYS REV LETT, V24, P383, DOI 10.1103/PhysRevLett.24.383; COLEMAN P, 1993, PHYSICA B, V186-88, P362, DOI 10.1016/0921-4526(93)90574-P; COOLEY C, 1995, PHYS REV LETT, V74, P1629, DOI 10.1103/PhysRevLett.74.1629; Derr J, 2006, J PHYS-CONDENS MAT, V18, P2089, DOI 10.1088/0953-8984/18/6/021; Derr J, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.193107; ELLIOTT M, 1980, J PHYS F MET PHYS, V10, P2681, DOI 10.1088/0305-4608/10/12/010; Flachbart K, 2006, PHYSICA B, V378-80, P610, DOI 10.1016/j.physb.2006.01.344; Flouquet J, 2005, PROGR LOW TEMPERATUR, V15, P139; Grigera SA, 2004, SCIENCE, V306, P1154, DOI 10.1126/science.1104306; Hatnean M. Ciomaga, 2013, SCI REP, V3, P3071; Hegger H, 2000, PHYS REV LETT, V84, P4986, DOI 10.1103/PhysRevLett.84.4986; Hewson A. C., 1997, KONDO PROBLEM HEAVY, V2; KASUYA T, 1994, J PHYS SOC JPN, V63, P397, DOI 10.1143/JPSJ.63.397; Kleinert H., 1988, GAUGE FIELDS CONDENS; Levy F, 2005, SCIENCE, V309, P1343, DOI 10.1126/science.1115498; Li G, 2014, SCIENCE, V346, P1208, DOI 10.1126/science.1250366; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; Matsumoto Y, 2011, SCIENCE, V331, P316, DOI 10.1126/science.1197531; McCollam A, 2008, PHYSICA B, V403, P717, DOI 10.1016/j.physb.2007.10.021; MENTH A, 1969, PHYS REV LETT, V22, P295, DOI 10.1103/PhysRevLett.22.295; MIYAKE K, 1993, PHYSICA B, V186-88, P115, DOI 10.1016/0921-4526(93)90509-5; Mizumaki M, 2009, J PHYS CONF SER, V176, DOI 10.1088/1742-6596/176/1/012034; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; MORILLO J, 1983, SOLID STATE COMMUN, V48, P315, DOI 10.1016/0038-1098(83)90730-5; MOTT NF, 1974, PHILOS MAG, V30, P403, DOI 10.1080/14786439808206566; NANBA T, 1993, PHYSICA B, V186-88, P440, DOI 10.1016/0921-4526(93)90598-Z; NYHUS P, 1995, PHYS REV B, V52, P14308, DOI 10.1103/PhysRevB.52.R14308; Paschen S, 2004, NATURE, V432, P881, DOI 10.1038/nature03129; Pfleiderer C, 2001, NATURE, V414, P427, DOI 10.1038/35106527; Priztas G., 2014, JPS C P, V3; REINDERS PHP, 1986, PHYS REV LETT, V57, P1631, DOI 10.1103/PhysRevLett.57.1631; Schofield AJ, 1999, CONTEMP PHYS, V40, P95, DOI 10.1080/001075199181602; Sebastian SE, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102501; Shishido H, 2005, J PHYS SOC JPN, V74, P1103, DOI 10.1143/JPSJ.74.1103; Shoenberg D., 1984, MAGNETIC OSCILLATION; Si QM, 2013, PHYS STATUS SOLIDI B, V250, P425, DOI 10.1002/pssb.201300005; TAILLEFER L, 1988, PHYS REV LETT, V60, P1570, DOI 10.1103/PhysRevLett.60.1570; Varma CM, 2002, PHYS REP, V361, P267, DOI 10.1016/S0370-1573(01)00060-6; VONLOHNEYSEN H, 1994, PHYS REV LETT, V72, P3262, DOI 10.1103/PhysRevLett.72.3262	49	185	186	3	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		287	290		10.1126/science.aaa7974	http://dx.doi.org/10.1126/science.aaa7974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26138105	Green Submitted, Bronze			2022-12-28	WOS:000358218600046
J	Melo, SA; Luecke, LB; Kahlert, C; Fernandez, AF; Gammon, ST; Kaye, J; LeBleu, VS; Mittendorf, EA; Weitz, J; Rahbari, N; Reissfelder, C; Pilarsky, C; Fraga, MF; Piwnica-Worms, D; Kalluri, R				Melo, Sonia A.; Luecke, Linda B.; Kahlert, Christoph; Fernandez, Agustin F.; Gammon, Seth T.; Kaye, Judith; LeBleu, Valerie S.; Mittendorf, Elizabeth A.; Weitz, Juergen; Rahbari, Nuh; Reissfelder, Christoph; Pilarsky, Christian; Fraga, Mario F.; Piwnica-Worms, David; Kalluri, Raghu			Glypican-1 identifies cancer exosomes and detects early pancreatic cancer	NATURE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; DUCTAL ADENOCARCINOMA; BREAST-CANCER; GROWTH; PROGRESSION; METASTASIS; VESICLES; CELLS; SERUM; MOUSE	Exosomes are lipid-bilayer-enclosed extracellular vesicles that contain proteins and nucleic acids. They are secreted by all cells and circulate in the blood. Specific detection and isolation of cancer-cell-derived exosomes in the circulation is currently lacking. Using mass spectrometry analyses, we identify a cell surface proteoglycan, glypican-1 (GPC1), specifically enriched on cancer-cell-derived exosomes. GPC11 circulating exosomes (crExos) were monitored and isolated using flow cytometry from the serum of patients and mice with cancer. GPC11 crExos were detected in the serum of patients with pancreatic cancer with absolute specificity and sensitivity, distinguishing healthy subjects and patients with a benign pancreatic disease from patients with early-and late-stage pancreatic cancer. Levels of GPC11 crExos correlate with tumour burden and the survival of pre-and post-surgical patients. GPC11 crExos from patients and from mice with spontaneous pancreatic tumours carry specific KRAS mutations, and reliably detect pancreatic intraepithelial lesions in mice despite negative signals by magnetic resonance imaging. GPC11 crExos may serve as a potential non-invasive diagnostic and screening tool to detect early stages of pancreatic cancer to facilitate possible curative surgical therapy.	[Melo, Sonia A.; Luecke, Linda B.; Kahlert, Christoph; Kaye, Judith; LeBleu, Valerie S.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77054 USA; [Fernandez, Agustin F.; Fraga, Mario F.] Univ Oviedo, Canc Epigenet Lab, Inst Oncol Asturias IUOPA, HUCA, E-33006 Oviedo, Spain; [Gammon, Seth T.; Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77054 USA; [Mittendorf, Elizabeth A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Weitz, Juergen; Rahbari, Nuh; Reissfelder, Christoph; Pilarsky, Christian] Tech Univ Dresden, Dept Gastrointestinal Thorac & Vasc Surg, Med Fak Carl Gustav Carus, D-01307 Dresden, Germany; [Fraga, Mario F.] CNB CSIC, Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid 28049, Spain	University of Texas System; UTMD Anderson Cancer Center; Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77054 USA.	rkalluri@mdanderson.org	Weitz, Juergen/L-7136-2018; Fernandez, Agustin F./N-7302-2014; Fraga, Mario F/H-7824-2017; Kalluri, Raghu/E-2677-2015; MELO, SONIA/H-8972-2013	Fernandez, Agustin F./0000-0002-3792-4085; Fraga, Mario F/0000-0001-8450-2603; Pilarsky, Christian/0000-0002-7968-3283; Gammon, Seth/0000-0001-8647-0975; Kalluri, Raghu/0000-0002-2190-547X; Reissfelder, Christoph/0000-0003-4591-1046; MELO, SONIA/0000-0002-2291-4263	Cancer Prevention and Research Institute of Texas; UT MD Anderson Cancer Center; National Institutes of Health (NIH) [CA-155370, CA-151925, DK 081576]; Metastasis Research Center at the MD Anderson Cancer Center [P30CA016672]; NIH/NCI [P30CA016672]; UT MDACC Khalifa Bin Zayed Al Nahya Foundation; NIH [P50-CA094056, P30CA16672, P30-CA016672, 5U24-CA126577]; Institutional Core Grant for High Resolution Electron Microscopy Facility [CA16672]; Deutsche Forschungsgemeinschaf (DFG); NATIONAL CANCER INSTITUTE [U01CA151925, P50CA094056, R01CA155370, P30CA016672, U24CA126577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081576] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; UT MD Anderson Cancer Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metastasis Research Center at the MD Anderson Cancer Center; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UT MDACC Khalifa Bin Zayed Al Nahya Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Core Grant for High Resolution Electron Microscopy Facility; Deutsche Forschungsgemeinschaf (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work supported by the Cancer Prevention and Research Institute of Texas and UT MD Anderson Cancer Center. R.K. is also supported by National Institutes of Health (NIH) grants CA-155370, CA-151925, DK 081576 and Metastasis Research Center at the MD Anderson Cancer Center (P30CA016672). V.S.L. is supported by the NIH/NCI under the award number P30CA016672 and the UT MDACC Khalifa Bin Zayed Al Nahya Foundation. D.P.-W. and S.T.G. are supported by the NIH P50-CA094056. Institutional Core Grant CA16672 for High Resolution Electron Microscopy Facility. The Flow Cytometry MDACC core facility is partially funded by NIH P30CA16672. The MDACC Small Animal Imaging Facility is partially funded by NIH grants P30-CA016672 and 5U24-CA126577. S.A.M. is a Human Frontiers Science Program Fellow. C.K. is funded by a Research Fellowship of the Deutsche Forschungsgemeinschaf (DFG). We thank P. A. Kurywchak and S. Kamerkar for the help with the sucrose gradients and K. Dunner Jr for the help with the transmission electron microscopy.	Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Ballehaninna UK, 2013, TUMOR BIOL, V34, P3279, DOI 10.1007/s13277-013-1033-3; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Bilimoria KY, 2007, ANN SURG, V246, P173, DOI 10.1097/SLA.0b013e3180691579; Brand RE, 2011, CLIN CANCER RES, V17, P805, DOI 10.1158/1078-0432.CCR-10-0248; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen WW, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.28; Conlon KC, 1996, ANN SURG, V223, P273, DOI 10.1097/00000658-199603000-00007; DAVID G, 1990, J CELL BIOL, V111, P3165, DOI 10.1083/jcb.111.6.3165; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DELVILLANO BC, 1983, CLIN CHEM, V29, P549; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Jazieh KA, 2014, SEMIN RADIAT ONCOL, V24, P67, DOI 10.1016/j.semradonc.2013.11.007; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Lee ES, 2014, WORLD J GASTROENTERO, V20, P7864, DOI 10.3748/wjg.v20.i24.7864; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Matsuda K, 2001, CANCER RES, V61, P5562; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Murphy SJ, 2013, GASTROENTEROLOGY, V145, P1098, DOI 10.1053/j.gastro.2013.07.049; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Okano K, 2014, WORLD J GASTROENTERO, V20, P11230, DOI 10.3748/wjg.v20.i32.11230; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Rachagani S, 2011, BRIT J CANCER, V104, P1038, DOI 10.1038/bjc.2011.31; Rickes S, 2002, SCAND J GASTROENTERO, V37, P1313, DOI 10.1080/003655202761020605; Rothstein DM, 2001, J IMMUNOL, V166, P322, DOI 10.4049/jimmunol.166.1.322; Schmid A, 2013, MOL IMAGING BIOL, V15, P186, DOI 10.1007/s11307-012-0548-0; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Su G, 2006, AM J PATHOL, V168, P2014, DOI 10.2353/ajpath.2006.050800; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Whipple CA, 2012, ONCOGENE, V31, P2535, DOI 10.1038/onc.2011.430; Wilson ID, 2005, J PROTEOME RES, V4, P591, DOI 10.1021/pr049769r; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yong E, 2014, NATURE, V511, P524, DOI 10.1038/511524a	50	1682	1807	54	1026	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					177	U82		10.1038/nature14581	http://dx.doi.org/10.1038/nature14581			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26106858	Green Accepted			2022-12-28	WOS:000357695900027
J	Marteau, TM; Mantzari, E				Marteau, Theresa M.; Mantzari, Eleni			PUBLIC HEALTH The case for pay to quit	NATURE			English	Editorial Material							FINANCIAL INCENTIVES; SMOKING-CESSATION; ACCEPTABILITY; INTERVENTION; BEHAVIORS		[Marteau, Theresa M.; Mantzari, Eleni] Univ Cambridge, Behav & Hlth Res Unit, Cambridge CB2 0SR, England	University of Cambridge	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Cambridge CB2 0SR, England.	tm388@cam.ac.uk		Marteau, Theresa/0000-0003-3025-1129				Cahill K., 2015, INCENTIVES SMOKING C; Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756; Halpern SD, 2015, NEW ENGL J MED, V372, P2108, DOI 10.1056/NEJMoa1414293; Ierfino D, 2015, ADDICTION, V110, P680, DOI 10.1111/add.12817; JARVIS MJ, 1999, SOCIAL DETERMINANTS, P240; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Mantzari E, 2015, PREV MED, V75, P75, DOI 10.1016/j.ypmed.2015.03.001; Peto R, 1996, BRIT MED BULL, V52, P12, DOI 10.1093/oxfordjournals.bmb.a011519; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Promberger M, 2011, J MED ETHICS, V37, P682, DOI 10.1136/jme.2010.039347; Sandel M.J, 2012, WHAT MONEY CANT BUY; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Volpp KG, 2014, JAMA-J AM MED ASSOC, V311, P909, DOI 10.1001/jama.2014.418	13	8	8	1	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					40	41		10.1038/523040a	http://dx.doi.org/10.1038/523040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL7RN	26135443				2022-12-28	WOS:000357169500024
J	Wang, TT; Maamary, J; Tan, GS; Bournazos, S; Davis, CW; Krammer, F; Schlesinger, SJ; Palese, P; Ahmed, R; Ravetch, JV				Wang, Taia T.; Maamary, Jad; Tan, Gene S.; Bournazos, Stylianos; Davis, Carl W.; Krammer, Florian; Schlesinger, Sarah J.; Palese, Peter; Ahmed, Rafi; Ravetch, Jeffrey V.			Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy	CELL			English	Article							FC-GAMMA-RIII; ANTIINFLAMMATORY ACTIVITY; RHEUMATOID-ARTHRITIS; EFFECTOR FUNCTIONS; GLOBULAR HEAD; ANTIBODIES; IGG1; SIALYLATION; MECHANISM; VIRUS	Protective vaccines elicit high-affinity, neutralizing antibodies by selection of somatically hypermutated B cell antigen receptors (BCR) on immune complexes (ICs). This implicates Fc-Fc receptor (FcR) interactions in affinity maturation, which, in turn, are determined by IgG subclass and Fc glycan composition within ICs. Trivalent influenza virus vaccination elicited regulation of anti-hemagglutinin (HA) IgG subclass and Fc glycans, with abundance of sialylated Fc glycans (sFc) predicting quality of vaccine response. We show that sFcs drive BCR affinity selection by binding the Type-II FcR CD23, thus upregulating the inhibitory Fc gamma RIIB on activated B cells. This elevates the threshold requirement for BCR signaling, resulting in B cell selection for higher affinity BCR. Immunization with sFc HA ICs elicited protective, high-affinity IgGs against the conserved stalk of the HA. These results reveal a novel, endogenous pathway for affinity maturation that can be exploited for eliciting high-affinity, broadly neutralizing antibodies through immunization with sialylated immune complexes.	[Wang, Taia T.; Maamary, Jad; Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Tan, Gene S.; Krammer, Florian; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Davis, Carl W.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Davis, Carl W.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Schlesinger, Sarah J.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Emory University; Emory University; Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA.	ravetch@rockefeller.edu	Bournazos, Stylianos/ABH-1578-2021; Krammer, Florian/H-3237-2019; Ravetch, Jeffrey/Z-1596-2019	Krammer, Florian/0000-0003-4121-776X; Ravetch, Jeffrey/0000-0003-2024-9041; Tan, Gene/0000-0002-0975-0719; Palese, Peter/0000-0002-0337-5823	National Institute of Allergy And Infectious Diseases of the NIH [U19AI111825, U19AI109946]; Rockefeller University Clinical Scholar; Iris and Junming Le Foundation; Rockefeller University Center for Clinical and Translational Science grant from the National Center for Advancing Translational Sciences, NIH [UL1 TR000043]; Clinical and Translational Science Award program; Centers of Excellence for Influenza Research and Surveillance [HHSN266200700010C]; Rockefeller University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111825, U19AI109946] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rockefeller University Clinical Scholar; Iris and Junming Le Foundation; Rockefeller University Center for Clinical and Translational Science grant from the National Center for Advancing Translational Sciences, NIH; Clinical and Translational Science Award program; Centers of Excellence for Influenza Research and Surveillance; Rockefeller University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Rockefeller University Hospital and all hospital staff involved in conducting the clinical study, in particular, Marina Caskey for helpful discussions, Noreen Buckley and Arlene Hurley for assistance in several aspects of protocol implementation and helpful discussions, and Joel Correa da Rosa for statistical assistance. We thank Sheng Zhang at the Cornell Proteomics and Mass Spectrometry Facility for helpful discussions and Robert Sherwood at the Cornell Proteomics and Mass Spectrometry Facility for helpful discussions and excellent technical support. T.T.W. thanks Barry Coller and the Rockefeller University KL2 Clinical Scholars Program for training and support. Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the NIH under Award Number U19AI111825 (J.V.R.) and U19AI109946 (P.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. T.T.W. was supported as a Rockefeller University Clinical Scholar in part by the Iris and Junming Le Foundation, the Rockefeller University Center for Clinical and Translational Science grant # UL1 TR000043 from the National Center for Advancing Translational Sciences, NIH and the Clinical and Translational Science Award program. F.K. was supported in part by the Centers of Excellence for Influenza Research and Surveillance, contract # HHSN266200700010C. Support and infrastructure were also provided by The Rockefeller University.	Ahmed AA, 2014, J MOL BIOL, V426, P3166, DOI 10.1016/j.jmb.2014.07.006; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Dalle S, 2011, MOL CANCER THER, V10, P178, DOI 10.1158/1535-7163.MCT-10-0385; de Man YA, 2014, CURR OPIN RHEUMATOL, V26, P329, DOI 10.1097/BOR.0000000000000045; Dinca Luminita, 1993, Viral Immunology, V6, P75, DOI 10.1089/vim.1993.6.75; Espy C, 2011, ARTHRITIS RHEUM-US, V63, P2105, DOI 10.1002/art.30362; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; Hodoniczky J, 2005, BIOTECHNOL PROGR, V21, P1644, DOI 10.1021/bp050228w; Junttila TT, 2010, CANCER RES, V70, P4481, DOI 10.1158/0008-5472.CAN-09-3704; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; NOSSAL GJV, 1992, CELL, V68, P1, DOI 10.1016/0092-8674(92)90198-L; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Scherer HU, 2010, ARTHRITIS RHEUM-US, V62, P1620, DOI 10.1002/art.27414; Selman MHJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014563; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sondermann P, 2013, P NATL ACAD SCI USA, V110, P9868, DOI 10.1073/pnas.1307864110; TOMANA M, 1988, ARTHRITIS RHEUM, V31, P333, DOI 10.1002/art.1780310304; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; Verma N, 2012, J VIROL, V86, P5515, DOI 10.1128/JVI.07085-11; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE1297, DOI 10.1073/pnas.1422481112; World Health Organization, 2002, WHO MAN AN INFL DIAG; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wuhrer M, 2015, J PROTEOME RES, V14, P1657, DOI 10.1021/pr500780a	43	118	120	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					160	169		10.1016/j.cell.2015.06.026	http://dx.doi.org/10.1016/j.cell.2015.06.026			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140596	Bronze, Green Accepted			2022-12-28	WOS:000357542300017
J	Miyata, H; Ezoe, S; Hori, M; Inoue, M; Oguro, K; Okamoto, T; Onishi, K; Onozaki, K; Sakakibara, T; Takeuchi, K; Tokuda, Y; Yamamoto, Y; Yamazaki, M; Shibuya, K				Miyata, Hiroaki; Ezoe, Satoshi; Hori, Manami; Inoue, Machiko; Oguro, Kazumasa; Okamoto, Toshihisa; Onishi, Kensuke; Onozaki, Kohei; Sakakibara, Takeshi; Takeuchi, Kazuhisa; Tokuda, Yasuharu; Yamamoto, Yuji; Yamazaki, Mayuka; Shibuya, Kenji		Hlth Care Advisory Panel	Japan's vision for health care in 2035	LANCET			English	Editorial Material							COST		[Miyata, Hiroaki] Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo, Japan; [Ezoe, Satoshi] Minist Hlth Labour & Welf, Canc Control & Hlth Promot Div, Hlth Serv Bur, Tokyo, Japan; [Hori, Manami] Tokai Univ, Course Human Welf Environm, Dept Human Dev, Sch Humanities & Culture, Hiratsuka, Kanagawa 25912, Japan; [Inoue, Machiko] Hamamatsu Univ Sch Med, Dept Family & Community Med, Shizuoka, Japan; [Oguro, Kazumasa] Hosei Univ, Fac Econ, Tokyo, Japan; [Okamoto, Toshihisa] Minist Hlth Labour & Welf, Off Drug Induced Damages, Gen Affairs Div, Pharmaceut & Food Safety Bur, Tokyo, Japan; [Onishi, Kensuke] Asia Pacific Alliance Disaster Management, Tokyo, Japan; [Onozaki, Kohei] Hlth & Global Policy Inst, Tokyo, Japan; [Sakakibara, Takeshi] Minist Hlth Labour & Welf, Heath Insurance Bur, Gen Affairs Div, Tokyo, Japan; [Takeuchi, Kazuhisa] Minist Hlth Labour & Welf, Welf Manpower Promot Off, Welf Promot Div, Social Welf & War Victims Relief Bur, Tokyo, Japan; [Tokuda, Yasuharu] Japan Community Healthcare Org, Tokyo, Japan; [Yamamoto, Yuji] Sony Comp Sci Labs Inc, Tokyo, Japan; [Yamazaki, Mayuka] Harvard Business Sch Japan Res Ctr, Tokyo, Japan; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Grad Sch Med, Tokyo 1130033, Japan	Keio University; Tokai University; Hamamatsu University School of Medicine; Hosei University; Sony Corporation; University of Tokyo	Shibuya, K (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Grad Sch Med, Tokyo 1130033, Japan.	shibuyak@m.u-tokyo.ac.jp	Inoue, Machiko/T-4884-2019	Inoue, Machiko/0000-0002-0799-5894; Shibuya, Kenji/0000-0003-2528-7530				Anand S, 2012, LANCET, V379, P9, DOI 10.1016/S0140-6736(11)61148-3; [Anonymous], 2015, NATURE, V519, pS56; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Health Care 2035 Advisory Panel, 2015, JAP VIS HLTH CAR 203; Integrated Community Care System, 2014, POL BRIEF LONG TERM; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Reich MR, 2011, LANCET, V378, P1051, DOI 10.1016/S0140-6736(11)60274-2; Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2; Takeuchi H, 2014, ANN SURG, V260, P259, DOI 10.1097/SLA.0000000000000644	10	23	24	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2549	2550		10.1016/S0140-6736(15)61135-7	http://dx.doi.org/10.1016/S0140-6736(15)61135-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL4NQ	26122147				2022-12-28	WOS:000356930000004
J	Clarke, CF; Allan, CM				Clarke, Catherine F.; Allan, Christopher M.			BIOCHEMISTRY Unexpected role for vitamin B2	NATURE			English	Editorial Material							ESCHERICHIA-COLI; COENZYME-Q; UBIX; BIOSYNTHESIS		[Clarke, Catherine F.; Allan, Christopher M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu			Direct For Biological Sciences [1330803] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Crane FL, 2007, MITOCHONDRION, V7, pS2, DOI 10.1016/j.mito.2007.02.011; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Krenske EH, 2013, J AM CHEM SOC, V135, P17638, DOI 10.1021/ja409928z; LEPPIK RA, 1976, BIOCHIM BIOPHYS ACTA, V436, P800, DOI 10.1016/0005-2736(76)90407-7; Lin FM, 2015, ACS CHEM BIOL, V10, P1137, DOI 10.1021/cb5008103; Mukai N, 2010, J BIOSCI BIOENG, V109, P564, DOI 10.1016/j.jbiosc.2009.11.011; Payne KAP, 2015, NATURE, V522, P497, DOI 10.1038/nature14560; Vinokur JM, 2014, BIOCHEMISTRY-US, V53, P4161, DOI 10.1021/bi500566q; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; White MD, 2015, NATURE, V522, P502, DOI 10.1038/nature14559	10	5	5	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					424	425		10.1038/nature14536	http://dx.doi.org/10.1038/nature14536			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26083748				2022-12-28	WOS:000356782900035
J	Gupta, S				Gupta, Sujata			CONTINGENCY MANAGEMENT Why it pays to quit	NATURE			English	Editorial Material							FINANCIAL INCENTIVES; SMOKING-CESSATION; TRIAL											Benishek LA, 2014, ADDICTION, V109, P1426, DOI 10.1111/add.12589; Halpern SD, 2015, N ENGL J MED; Higgins ST, 2012, PREV MED, V55, pS2, DOI 10.1016/j.ypmed.2012.04.008; Higgins ST, 2012, PREV MED, V55, pS33, DOI 10.1016/j.ypmed.2011.12.016; Petry Nancy M, 2003, Sci Pract Perspect, V2, P55; Silverman K, 2004, J CONSULT CLIN PSYCH, V72, P839, DOI 10.1037/0022-006X.72.5.839; STITZER ML, 1992, J CONSULT CLIN PSYCH, V60, P927, DOI 10.1037/0022-006X.60.6.927; Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134	8	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					S57	S59		10.1038/522S57a	http://dx.doi.org/10.1038/522S57a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2OC	26107098				2022-12-28	WOS:000356782900006
J	Shepherd, TG				Shepherd, Theodore G.			CLIMATE SCIENCE The dynamics of temperature extremes	NATURE			English	Editorial Material							ATMOSPHERIC CIRCULATION; UNCERTAINTY; WEATHER		Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England	University of Reading	Shepherd, TG (corresponding author), Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England.	theodore.shepherd@reading.ac.uk						Barnes EA, 2013, GEOPHYS RES LETT, V40, P4734, DOI 10.1002/grl.50880; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; Deser C, 2014, J CLIMATE, V27, P2271, DOI 10.1175/JCLI-D-13-00451.1; Horton DE, 2015, NATURE, V522, P465, DOI 10.1038/nature14550; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Miralles DG, 2014, NAT GEOSCI, V7, P345, DOI [10.1038/NGEO2141, 10.1038/ngeo2141]; Mori M, 2014, NAT GEOSCI, V7, P869, DOI 10.1038/NGEO2277; Screen JA, 2014, NAT CLIM CHANGE, V4, P704, DOI 10.1038/nclimate2271; Shepherd TG, 2014, NAT GEOSCI, V7, P703, DOI 10.1038/NGEO2253	9	18	19	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					422	424		10.1038/522425a	http://dx.doi.org/10.1038/522425a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108848	Green Submitted			2022-12-28	WOS:000356782900034
J	Kahn, JS				Kahn, James S.			I'm Sorry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kahn, James S.] VA Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA 94304 USA; [Kahn, James S.] Stanford Sch Med, Dept Med, Palo Alto, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Kahn, JS (corresponding author), VA Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA 94304 USA.	james.kahn@va.gov							0	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2427	2428		10.1001/jama.2014.6507	http://dx.doi.org/10.1001/jama.2014.6507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103024				2022-12-28	WOS:000356663600009
J	Pokorney, SD; Miller, AL; Chen, AY; Thomas, L; Fonarow, GC; de Lemos, JA; Al-Khatib, SM; Peterson, ED; Wang, TY				Pokorney, Sean D.; Miller, Amy L.; Chen, Anita Y.; Thomas, Laine; Fonarow, Gregg C.; de Lemos, James A.; Al-Khatib, Sana M.; Peterson, Eric D.; Wang, Tracy Y.			Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OLDER PATIENTS; AGE; PREVENTION; INPATIENT; SURVIVAL; DISEASE; IMPACT; RISK; CARE	IMPORTANCE Implantable cardioverter-defibrillators (ICDs) are not recommended within 40 days of myocardial infarction (MI); thus, ICD implantation might not be considered during the post-MI care transition. OBJECTIVE To examine ICD implantation rates and associated mortality among older MI patients with low ejection fraction (EF). DESIGN, SETTING, AND PARTICIPANTS Retrospective observational study of Medicare beneficiaries with an EF of 35% or less after MI, treated at 441 US hospitals between 2007 and 2010, excluding patients with prior ICD implantation. Follow-up data were available through December 2010. EXPOSURES ICD implantation within 1 year of MI vs no ICD implantation within 1 year of MI. MAIN OUTCOMES AND MEASURES Patient characteristics associated with receiving an ICD within 1 year after discharge and 2-year mortality associated with ICD implantation. RESULTS Among 10 318 MI patients with EF of 35% or lower, the cumulative 1-year ICD implantation rate was 8.1%(95% CI, 7.6%-8.7%). Patients with ICD implantation were more likely to have prior coronary artery bypass graft procedures, higher peak troponin levels, in-hospital cardiogenic shock, and cardiology follow-up within 2 weeks after discharge relative to patients who did not receive an ICD within 1 year. Implantation of ICD was associated with lower 2-year mortality (15.3 events per 100 patient-years [128 deaths in 838 patient-years] vs 26.4 events per 100 patient-years [3033 deaths in 11 479 patient-years]; adjusted HR, 0.64; 95% CI, 0.53-0.78). [GRAPHICS] CONCLUSIONS AND RELEVANCE In this large registry study of older patients who experienced MI from 2007-2010, fewer than 1 in 10 eligible patients with low EF received an ICD within 1 year after MI, although ICD implantation was associated with lower risk-adjusted mortality at 2 years. Additional research is needed to determine evidence-based approaches to increase ICD implantation among eligible patients.	[Pokorney, Sean D.; Al-Khatib, Sana M.; Peterson, Eric D.; Wang, Tracy Y.] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; [Pokorney, Sean D.; Chen, Anita Y.; Thomas, Laine; Al-Khatib, Sana M.; Peterson, Eric D.; Wang, Tracy Y.] Duke Clin Res Inst, Durham, NC USA; [Miller, Amy L.] Brigham & Womens Hosp, Dept Cardiovasc Electrophysiol, Boston, MA 02115 USA; [Fonarow, Gregg C.] Ronald Reagan UCLA Med Ctr, Ahmanson Cardiomyopathy Ctr, Los Angeles, CA USA; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	Duke University; Duke University; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pokorney, SD (corresponding author), Duke Univ, Med Ctr, Div Cardiol, 2301 Erwin Rd,DUMC 3845, Durham, NC 27710 USA.	sean.pokorney@duke.edu	Peterson, Eric David/ABF-5033-2021; Fonarow, Gregg C/D-5988-2014; de Lemos, James/ABD-6669-2021	Fonarow, Gregg C/0000-0002-3192-8093; 	Agency for Healthcare Research and Quality [U19HS021092]; Boston Scientific; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021092] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Boston Scientific(Boston Scientific); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by a grant from the Agency for Healthcare Research and Quality (U19HS021092). Additional support for this study was provided by an independent investigator-initiated research grant from Boston Scientific to the Duke Clinical Research Institute.	Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Chan PS, 2009, CIRC-CARDIOVASC QUAL, V2, P16, DOI 10.1161/CIRCOUTCOMES.108.807123; GARDIN JM, 1995, CIRCULATION, V91, P1739, DOI 10.1161/01.CIR.91.6.1739; Gauri AJ., 2006, AM J MED, V119, DOI [DOI 10.1016/J.AMJMED.2005.08.021, 10.1016/j.amjmed.2005.08.021]; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Hess PL, 2013, J CARDIOVASC ELECTR, V24, P664, DOI 10.1111/jce.12100; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Krahn AD, 2004, AM HEART J, V147, P837, DOI 10.1016/j.ahj.2003.12.017; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; LaPointe NMA, 2011, CIRC-CARDIOVASC QUAL, V4, P146, DOI [10.1161/CIRCOUTCOMES.111.958603, 10.1161/CIRCOUTCOMES.110.958603]; Miller AL, 2013, AM HEART J, V166, P737, DOI 10.1016/j.ahj.2013.07.019; Miller AL, 2012, ARCH INTERN MED, V172, P64, DOI 10.1001/archinternmed.2011.466; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Narayanan K, 2013, CIRCULATION, V128, P1733, DOI 10.1161/CIRCULATIONAHA.113.002539; Pellegrini CN, 2008, EUROPACE, V10, P1296, DOI 10.1093/europace/eun253; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; Peterson ED, 2009, CIRC-CARDIOVASC QUAL, V2, P491, DOI 10.1161/CIRCOUTCOMES.108.847145; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Roe MT, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.010; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Santangeli P, 2010, ANN INTERN MED, V153, P592, DOI 10.7326/0003-4819-153-9-201011020-00009; Sjoblom J, 2014, CIRCULATION, V130, P743, DOI 10.1161/CIRCULATIONAHA.114.009924; Solomon SD, 2001, ANN INTERN MED, V134, P451, DOI 10.7326/0003-4819-134-6-200103200-00009; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yung D, 2013, CIRCULATION, V127, P2383, DOI 10.1161/CIRCULATIONAHA.113.001442	27	42	46	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2433	2440		10.1001/jama.2015.6409	http://dx.doi.org/10.1001/jama.2015.6409			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103027	Bronze			2022-12-28	WOS:000356663600012
J	Nasr, H; Scriven, JM				Nasr, H.; Scriven, J. M.			PRACTICE POINTER Superficial thrombophlebitis (superficial venous thrombosis)	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEEP-VEIN THROMBOSIS; EPIDEMIOLOGY; DIAGNOSIS		[Nasr, H.; Scriven, J. M.] Heart England NHS Fdn Trust, Dept Vasc Surg, Birmingham B9 5SS, W Midlands, England	Heart of England NHS Foundation Trust	Scriven, JM (corresponding author), Heart England NHS Fdn Trust, Dept Vasc Surg, Birmingham B9 5SS, W Midlands, England.	mark.scriven@heartofengland.nhs.uk						BAKER CC, 1979, AM J SURG, V138, P97, DOI 10.1016/0002-9610(79)90248-4; Belcaro G, 1999, ANGIOLOGY, V50, P523, DOI 10.1177/000331979905000701; BERGQVIST D, 1986, BRIT MED J, V292, P658, DOI 10.1136/bmj.292.6521.658-a; Chengelis DL, 1996, J VASC SURG, V24, P745, DOI 10.1016/S0741-5214(96)70007-1; De Maeseneer MGR, 2005, ACTA CHIR BELG, V105, P145, DOI 10.1080/00015458.2005.11679688; Decousus Herve, 2010, N Engl J Med, V363, P1222, DOI 10.1056/NEJMoa0912072; Decousus H, 2011, THROMB RES, V127, pS81, DOI 10.1016/S0049-3848(11)70022-6; Decousus H, 2010, ANN INTERN MED, V152, P218, DOI 10.7326/0003-4819-152-4-201002160-00006; Di Nisio M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004982.pub5; Diaconu Camelia, 2010, J Med Life, V3, P96; Dua Anahita, 2013, Perspect Vasc Surg Endovasc Ther, V25, P5, DOI 10.1177/1531003513506266; Gillet JL, 2007, J MAL VASCUL, V32, P90, DOI 10.1016/j.jmv.2007.01.111; Leon L, 2005, EUR J VASC ENDOVASC, V29, P10, DOI 10.1016/j.ejvs.2004.09.021; LOFGREN EP, 1981, SURGERY, V90, P49; Lozano Francisco S, 2003, Vasc Endovascular Surg, V37, P415, DOI 10.1177/153857440303700605; LUTTER KS, 1991, SURGERY, V110, P42; Markovic M D, 1997, Srp Arh Celok Lek, V125, P261; Martinelli I, 1999, THROMB HAEMOSTASIS, V82, P1215; National Institute for Health and Care Excellence, 2013, VAR VEINS LEGS DIAGN; Rosendaal FR, 1997, THROMB HAEMOSTASIS, V78, P1; Wichers IM, 2005, HAEMATOLOGICA, V90, P672	21	25	26	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2015	350								h2039	10.1136/bmj.h2039	http://dx.doi.org/10.1136/bmj.h2039			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NK	26099257				2022-12-28	WOS:000357158600001
J	Stephan, BCM; Tzourio, C; Auriacombe, S; Amieva, H; Dufouil, C; Alperovitch, A; Kurth, T				Stephan, Blossom C. M.; Tzourio, Christophe; Auriacombe, Sophie; Amieva, Helene; Dufouil, Carole; Alperovitch, Annick; Kurth, Tobias			Usefulness of data from magnetic resonance imaging to improve prediction of dementia: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHITE-MATTER HYPERINTENSITIES; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS ASSOCIATION WORKGROUPS; FOLLOW-UP; INTEGRATED DISCRIMINATION; NEUROPSYCHOLOGICAL TESTS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RISK SCORE; DISEASE	OBJECTIVE To determine whether the addition of data derived from magnetic resonance imaging (MRI) of the brain to a model incorporating conventional risk variables improves prediction of dementia over 10 years of follow-up. DESIGN Population based cohort study of individuals aged >= 65. SETTING The Dijon magnetic resonance imaging study cohort from the Three-City Study, France. PARTICIPANTS 1721 people without dementia who underwent an MRI scan at baseline and with known dementia status over 10 years' follow-up. MAIN OUTCOME MEASURE Incident dementia (all cause and Alzheimer's disease). RESULTS During 10 years of follow-up, there were 119 confirmed cases of dementia, 84 of which were Alzheimer's disease. The conventional risk model incorporated age, sex, education, cognition, physical function, lifestyle (smoking, alcohol use), health (cardiovascular disease, diabetes, systolic blood pressure), and the apolipoprotein genotype (C statistic for discrimination performance was 0.77, 95% confidence interval 0.71 to 0.82). No significant differences were observed in the discrimination performance of the conventional risk model compared with models incorporating data from MRI including white matter lesion volume (C statistic 0.77, 95% confidence interval 0.72 to 0.82; P= 0.48 for difference of C statistics), brain volume (0.77, 0.72 to 0.82; P= 0.60), hippocampal volume (0.79, 0.74 to 0.84; P= 0.07), or all three variables combined (0.79, 0.75 to 0.84; P= 0.05). Inclusion of hippocampal volume or all three MRI variables combined in the conventional model did, however, lead to significant improvement in reclassification measured by using the integrated discrimination improvement index (P= 0.03 and P= 0.04) and showed increased net benefit in decision curve analysis. Similar results were observed when the outcome was restricted to Alzheimer's disease. CONCLUSIONS Data from MRI do not significantly improve discrimination performance in prediction of all cause dementia beyond a model incorporating demographic, cognitive, health, lifestyle, physical function, and genetic data. There were, however, statistical improvements in reclassification, prognostic separation, and some evidence of clinical utility.	[Stephan, Blossom C. M.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tzourio, Christophe; Dufouil, Carole; Alperovitch, Annick; Kurth, Tobias] INSERM, U897, Res Ctr Epidemiol & Biostat, Team Neuroepidemiol, F-33000 Bordeaux, France; [Tzourio, Christophe; Dufouil, Carole; Kurth, Tobias] Univ Bordeaux, Coll Hlth Sci, F-33000 Bordeaux, France; [Auriacombe, Sophie] CMRR, Memory Consultat, Univ Hosp, Dept Neurol, F-33000 Bordeaux, France; [Amieva, Helene] INSERM, U897, Res Ctr Epidemiol & Biostat, Team Epidemiol & Neuropsychol Brain Aging, F-33000 Bordeaux, France	Newcastle University - UK; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Kurth, T (corresponding author), INSERM, U897, Res Ctr Epidemiol & Biostat, Team Neuroepidemiol, F-33000 Bordeaux, France.	tobias.kurth@u-bordeaux.fr	Dufouil, Carole/F-5751-2014; Dufouil, Carole/J-4968-2012; AURIACOMBE, Sophie/T-5596-2019; Kurth, Tobias/A-9243-2012; Tzourio, christophe/B-4015-2009; Amieva, Helene/T-4170-2019; Tzourio, christophe/L-6344-2019	Dufouil, Carole/0000-0003-2442-4476; Kurth, Tobias/0000-0001-7169-2620; Tzourio, christophe/0000-0002-6517-2984; Amieva, Helene/0000-0002-0119-7242; Tzourio, christophe/0000-0002-6517-2984	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"; MRC [G0701539] Funding Source: UKRI; Medical Research Council [G0701539] Funding Source: researchfish	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne(Region Bourgogne-Franche-ComteRegion Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Three-City (3C) Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the University of Bordeaux, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C-Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques." The funding organisations played no role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, or in preparation, review, or approval of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Alzheimer's Disease International, 2009, WORLD ALZHEIMER REPO; American Psychiatric Association, 1994, DIAGN STAT MAN MEN D; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Barnes DE, 2014, ALZHEIMERS DEMENT, V10, P656, DOI 10.1016/j.jalz.2013.11.006; Barnes DE, 2010, ALZHEIMERS DEMENT, V6, P138, DOI 10.1016/j.jalz.2010.01.005; Begg CB, 2013, CLIN TRIALS, V10, P690, DOI 10.1177/1740774513496490; Benton AL, 1965, MANUEL APPL CLINIQUE; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Chary E, 2013, ALZHEIMERS DEMENT, V9, P562, DOI 10.1016/j.jalz.2012.05.2188; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Dufouil C, 2009, STROKE, V40, P2219, DOI 10.1161/STROKEAHA.108.540633; Exalto LG, 2013, LANCET DIABETES ENDO, V1, P183, DOI 10.1016/S2213-8587(13)70048-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Godin O, 2008, BIOL PSYCHIAT, V63, P663, DOI 10.1016/j.biopsych.2007.09.006; Godin O, 2010, J ALZHEIMERS DIS, V20, P453, DOI 10.3233/JAD-2010-1389; Harrison SL, 2015, J CLIN EXP NEUROPSYC, V37, P253, DOI 10.1080/13803395.2014.1002759; Hilden J, 2014, STAT MED, V33, P3405, DOI 10.1002/sim.5804; Hogan DB, 2000, CAN J NEUROL SCI, V27, P18, DOI 10.1017/S0317167100051921; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Kerr KF, 2011, AM J EPIDEMIOL, V174, P364, DOI 10.1093/aje/kwr086; LAWTON MP, 1988, PSYCHOPHARMACOL BULL, V24, P609; Madureira S, 2010, DEMENT GERIATR COGN, V29, P325, DOI 10.1159/000278333; Maillard P, 2008, NEURORADIOLOGY, V50, P31, DOI 10.1007/s00234-007-0312-3; Maillard P, 2009, NEURORADIOLOGY, V51, P209, DOI 10.1007/s00234-008-0489-0; Matthews FE, 2008, J AM GERIATR SOC, V56, P1424, DOI 10.1111/j.1532-5415.2008.01820.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nakata E, 2009, NEUROEPIDEMIOLOGY, V33, P103, DOI 10.1159/000222092; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Nielsen H, 1999, INT J GERIATR PSYCH, V14, P957, DOI 10.1002/(SICI)1099-1166(199911)14:11<957::AID-GPS43>3.0.CO;2-B; Ohara T, 2011, J AM GERIATR SOC, V59, P1074, DOI 10.1111/j.1532-5415.2011.03405.x; Okereke OI, 2012, ALZ DIS ASSOC DIS, V26, P225, DOI 10.1097/WAD.0b013e318231cd30; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Peres K, 2006, NEUROLOGY, V67, P461, DOI 10.1212/01.wnl.0000228228.70065.f1; Perneczky R, 2006, INT J GERIATR PSYCH, V21, P158, DOI 10.1002/gps.1444; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P835, DOI 10.1001/archneurol.2010.136; Restaino M, 2013, AGE AGEING, V42, P649, DOI 10.1093/ageing/aft082; Richard E, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002541; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Rubin DB, 1987, MULTIPLE IMPUTATION; Song Xiaowei, 2011, Neurology, V77, P227, DOI 10.1212/WNL.0b013e318225c6bc; Song XW, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0054-5; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stephan BCM, 2010, NAT REV NEUROL, V6, P318, DOI 10.1038/nrneurol.2010.54; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.2307/2336057; Tierney MC, 2010, J ALZHEIMERS DIS, V22, P1231, DOI 10.3233/JAD-2010-100516; Tierney MC, 2005, NEUROLOGY, V64, P1853, DOI 10.1212/01.WNL.0000163773.21794.0B; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wechsler D, 1975, WECHSLER MEMORY SCAL; Zahuranec DB, 2012, CEREBROVASC DIS, V34, P86, DOI 10.1159/000339684	55	31	31	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2015	350								h2863	10.1136/bmj.h2863	http://dx.doi.org/10.1136/bmj.h2863			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NK	26099688	Green Published, hybrid			2022-12-28	WOS:000357158600002
J	Watts, G				Watts, Geoff			Ciaran Bernard John Woodman Obituary	LANCET			English	Biographical-Item																		WOODMAN CBJ, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2458	2458		10.1016/S0140-6736(15)61130-8	http://dx.doi.org/10.1016/S0140-6736(15)61130-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	26122062				2022-12-28	WOS:000356532500015
J	Lane, R				Lane, Richard			Profile Larry Jameson: at the helm of the USA's oldest medical school	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1939	1939		10.1016/S0140-6736(15)60949-7	http://dx.doi.org/10.1016/S0140-6736(15)60949-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	26090631	Bronze			2022-12-28	WOS:000354541700015
J	Dimick, JB; Miller, DC				Dimick, Justin B.; Miller, David C.			Hospital readmission after surgery: no place like home	LANCET			English	Editorial Material							MORTALITY; OUTCOMES		[Dimick, Justin B.; Miller, David C.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Dimick, Justin B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Miller, David C.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dimick, JB (corresponding author), Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA.	jdimick@umich.edu						Brooke BS, 2015, LANCET; Chou SY, 2014, MED CARE, V52, P250, DOI 10.1097/MLR.0000000000000082; Dimick JB, 2015, JAMA-J AM MED ASSOC, V313, P512, DOI 10.1001/jama.2014.14179; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Ghaferi AA, 2011, MED CARE, V49, P1076, DOI 10.1097/MLR.0b013e3182329b97; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17	7	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					837	839		10.1016/S0140-6736(15)60462-7	http://dx.doi.org/10.1016/S0140-6736(15)60462-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0MJ	26093916				2022-12-28	WOS:000360290000007
J	Hasan, N; Curran, S; Jhass, A; Poduval, S; Legido-Quigley, H; Crisp, N				Hasan, Nadeem; Curran, Sarah; Jhass, Arnoupe; Poduval, Shoba; Legido-Quigley, Helena; Crisp, Nigel			The UK's strong contribution to health globally	LANCET			English	Editorial Material									[Hasan, Nadeem; Curran, Sarah; Jhass, Arnoupe; Poduval, Shoba; Legido-Quigley, Helena; Crisp, Nigel] London Sch Hyg & Trop Med, London WC1, England; [Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; House Lords, London SW1A 0PW, England	University of London; London School of Hygiene & Tropical Medicine; National University of Singapore	Crisp, N (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	crisp@parliament.uk		Crisp, Nigel/0000-0002-9452-095X; Jhass, Arnoupe/0000-0003-3936-2976				All-Party Parliamentary Group on Global Health, 2015, UKS CONTR HLTH GLOB; Association of Medical Research Charities, 2014, CHAR AR HEART UK MED; Department for International Development, 2014, DEP INT DEV ANN REP; HM Government, 2014, STRENGTH OPP LANDSC; Thomson Reuters, 2015, INCITIES RES EV OBJ; Times Higher Education, 2015, WORLD U RANK 2014 15	6	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					117	118		10.1016/S0140-6736(15)61162-X	http://dx.doi.org/10.1016/S0140-6736(15)61162-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM5QC	26135704				2022-12-28	WOS:000357742200011
J	Sanders, RW; van Gils, MJ; Derking, R; Sok, D; Ketas, TJ; Burger, JA; Ozorowski, G; Cupo, A; Simonich, C; Goo, L; Arendt, H; Kim, HJ; Lee, JH; Pugach, P; Williams, M; Debnath, G; Moldt, B; van Breemen, MJ; Isik, G; Medina-Ramirez, M; Back, JW; Koff, WC; Julien, JP; Rakasz, EG; Seaman, MS; Guttman, M; Lee, KK; Klasse, PJ; LaBranche, C; Schief, WR; Wilson, IA; Overbaugh, J; Burton, DR; Ward, AB; Montefiori, DC; Dean, H; Moore, JP				Sanders, Rogier W.; van Gils, Marit J.; Derking, Ronald; Sok, Devin; Ketas, Thomas J.; Burger, Judith A.; Ozorowski, Gabriel; Cupo, Albert; Simonich, Cassandra; Goo, Leslie; Arendt, Heather; Kim, Helen J.; Lee, Jeong Hyun; Pugach, Pavel; Williams, Melissa; Debnath, Gargi; Moldt, Brian; van Breemen, Marielle J.; Isik, Gozde; Medina-Ramirez, Max; Back, Jaap Willem; Koff, Wayne C.; Julien, Jean-Philippe; Rakasz, Eva G.; Seaman, Michael S.; Guttman, Miklos; Lee, Kelly K.; Klasse, Per Johan; LaBranche, Celia; Schief, William R.; Wilson, Ian A.; Overbaugh, Julie; Burton, Dennis R.; Ward, Andrew B.; Montefiori, David C.; Dean, Hansi; Moore, John P.			HIV-1 neutralizing antibodies induced by native-like envelope trimers	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GLYCOPROTEIN TRIMERS; IMMUNOGEN DESIGN; ENV TRIMERS; VACCINE; RESPONSES; SUBTYPE; BINDING; POTENT; CLADE	A challenge for HIV-1 immunogen design is the difficulty of inducing neutralizing antibodies (NAbs) against neutralization-resistant (tier 2) viruses that dominate human transmissions. We show that a soluble recombinant HIV-1 envelope glycoprotein trimer that adopts a native conformation, BG505 SOSIP.664, induced NAbs potently against the sequence-matched tier 2 virus in rabbits and similar but weaker responses in macaques. The trimer also consistently induced cross-reactive NAbs against more sensitive (tier 1) viruses. Tier 2 NAbs recognized conformational epitopes that differed between animals and in some cases overlapped with those recognized by broadly neutralizing antibodies (bNAbs), whereas tier 1 responses targeted linear V3 epitopes. A second trimer, B41 SOSIP. 664, also induced a strong autologous tier 2 NAb response in rabbits. Thus, native-like trimers represent a promising starting point for the development of HIV-1 vaccines aimed at inducing bNAbs.	[Sanders, Rogier W.; Ketas, Thomas J.; Cupo, Albert; Pugach, Pavel; Williams, Melissa; Debnath, Gargi; Klasse, Per Johan; Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Sanders, Rogier W.; van Gils, Marit J.; Derking, Ronald; Burger, Judith A.; van Breemen, Marielle J.; Isik, Gozde; Medina-Ramirez, Max] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Sok, Devin; Moldt, Brian; Schief, William R.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sok, Devin; Ozorowski, Gabriel; Kim, Helen J.; Lee, Jeong Hyun; Moldt, Brian; Julien, Jean-Philippe; Schief, William R.; Wilson, Ian A.; Burton, Dennis R.; Ward, Andrew B.] Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat, La Jolla, CA 92037 USA; [Sok, Devin; Ozorowski, Gabriel; Kim, Helen J.; Lee, Jeong Hyun; Moldt, Brian; Julien, Jean-Philippe; Schief, William R.; Wilson, Ian A.; Burton, Dennis R.; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Sok, Devin; Ozorowski, Gabriel; Kim, Helen J.; Lee, Jeong Hyun; Moldt, Brian; Julien, Jean-Philippe; Schief, William R.; Wilson, Ian A.; Burton, Dennis R.; Ward, Andrew B.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Kim, Helen J.; Lee, Jeong Hyun; Julien, Jean-Philippe; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Simonich, Cassandra; Goo, Leslie; Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Arendt, Heather; Koff, Wayne C.; Schief, William R.; Dean, Hansi] Int AIDS Vaccine Initiat, New York, NY 10004 USA; [Back, Jaap Willem] Pepscan Therapeut, NL-8243 RC Lelystad, Netherlands; [Rakasz, Eva G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Seaman, Michael S.; Schief, William R.; Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Boston, MA 02114 USA; [Guttman, Miklos; Lee, Kelly K.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [LaBranche, Celia; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Cornell University; University of Amsterdam; Academic Medical Center Amsterdam; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Fred Hutchinson Cancer Center; International AIDS Vaccine Initiative; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Washington; University of Washington Seattle; Duke University; Scripps Research Institute	Sanders, RW (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	rws2002@med.cornell.edu; jpm2003@med.cornell.edu	van Gils, Marit J./H-4791-2019; Rakasz, Eva G/H-9197-2019; Back, JW/B-3641-2009; Ozorowski, Gabriel/HCH-0634-2022; Schief, William/ABF-3645-2020; Ward, Andrew B/F-9203-2014; B, Jw/N-7879-2019; Ward, Andrew/ABD-7728-2021; Klasse, P.J./AEX-0142-2022	van Gils, Marit J./0000-0003-3422-8161; Back, JW/0000-0002-1310-4373; Schief, William/0000-0002-1120-0150; Ward, Andrew B/0000-0001-7153-3769; B, Jw/0000-0002-1310-4373; Ward, Andrew/0000-0001-7153-3769; Klasse, P.J./0000-0001-8222-278X; Lee, Jeong Hyun/0000-0001-7371-845X; Simonich, Cassandra/0000-0001-6100-4652; Isik, Gozde/0000-0002-1329-6782; Julien, Jean-Philippe/0000-0001-7602-3995	NIH [P01 AI082362, R37 AI036082, R01 AI084817, R01 AI076105, P51OD011106]; NIAID-NIH [HHSN27201100016C]; Scripps CHAVI-ID [UM1 AI100663]; Aids Fonds Netherlands [2011032, 2012041]; Canadian Institutes of Health Research (CIHR) Fellowship; Vidi grant from the Netherlands Organization for Scientific Research (NWO); Starting Investigator Grant from the European Research Council [ERC-StG-2011-280829-SHEV]; IAVI; USAID; Bill & Melinda Gates Foundation; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082362, R56AI084817, R01AI076105, R37AI036082, R01AI084817, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Scripps CHAVI-ID; Aids Fonds Netherlands; Canadian Institutes of Health Research (CIHR) Fellowship(Canadian Institutes of Health Research (CIHR)); Vidi grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Starting Investigator Grant from the European Research Council(European Research Council (ERC)); IAVI; USAID(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grants P01 AI082362, R37 AI036082, R01 AI084817, R01 AI076105, NIAID-NIH Contract HHSN27201100016C, by Scripps CHAVI-ID (UM1 AI100663), by NIH grant P51OD011106, and by Aids Fonds Netherlands grants 2011032 and 2012041. J.-P.J. is a recipient of a Canadian Institutes of Health Research (CIHR) Fellowship. R.W.S. is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV). This work was partially funded by IAVI with the generous support of USAID and the Bill & Melinda Gates Foundation; a full list of IAVI donors is available at www.iavi.org. The contents of this manuscript are the responsibility of the authors and do not necessarily reflect the views of USAID or the U.S. Government. We thank K. Sliepen, J. Korzun, M. Golabek, K. de los Reyes, L. Kong, K. Weisgrau, N. Pomplun, J. Hsueh, K. L. Saye-Francisco, A. Ramos for technical support; S. Schmidt, J. Gorman and N. Doria-Rose for advice; and G. Stewart-Jones, D. Kubitz, P. Kwong, J. Mascola, B. Haynes, A. McKnight, H. Katinger, S. Zolla-Pazner, P. Poignard, and M. Nussenzweig for reagents. The International AIDS Vaccine Initiative has previously filed a patent relating to the BG505 SOSIP.664 trimer: U.S. Provisional Application no. 61/772,739, titled "HIV-1 envelope glycoprotein," with inventors M. Caulfield, A.C., H. D., S. Hoffenberg, C. R. King, P. J. K., A. Marozsan, J. P. M., R. S., A.B.W., I.A.W., and J.-P.J. This does not alter our adherence to all Science policies on sharing data and materials.	Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Blish CA, 2010, J VIROL, V84, P2573, DOI 10.1128/JVI.01687-09; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Derdeyn CA, 2014, CURR OPIN HIV AIDS, V9, P210, DOI 10.1097/COH.0000000000000057; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Forsell MNE, 2005, J VIROL, V79, P10902, DOI 10.1128/JVI.79.17.10902-10914.2005; Go EP, 2014, J PROTEOME RES, V13, P4012, DOI 10.1021/pr5003643; Go EP, 2011, J PROTEOME RES, V10, P578, DOI 10.1021/pr100764a; Goo L, 2014, NAT MED, V20, P655, DOI 10.1038/nm.3565; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Guttman M, 2013, J VIROL, V87, P11462, DOI 10.1128/JVI.01681-13; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Ketas TJ, 2012, VIROLOGY, V422, P22, DOI 10.1016/j.virol.2011.09.019; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Langedijk JPM, 2011, ANAL BIOCHEM, V417, P149, DOI 10.1016/j.ab.2011.06.002; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Malherbe DC, 2014, J VIROL, V88, P12949, DOI 10.1128/JVI.01812-14; Maraskovsky E, 2009, IMMUNOL CELL BIOL, V87, P371, DOI 10.1038/icb.2009.21; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Tran K, 2014, P NATL ACAD SCI USA, V111, pE738, DOI 10.1073/pnas.1319512111; Uchtenhagen H, 2014, J IMMUNOL, V192, P5802, DOI 10.4049/jimmunol.1301898; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41	60	383	407	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244							aac4223	10.1126/science.aac4223	http://dx.doi.org/10.1126/science.aac4223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26089353	Green Accepted			2022-12-28	WOS:000357664300033
J	Breneman, AW; Halford, A; Millan, R; McCarthy, M; Fennell, J; Sample, J; Woodger, L; Hospodarsky, G; Wygant, JR; Cattell, CA; Goldstein, J; Malaspina, D; Kletzing, CA				Breneman, A. W.; Halford, A.; Millan, R.; McCarthy, M.; Fennell, J.; Sample, J.; Woodger, L.; Hospodarsky, G.; Wygant, J. R.; Cattell, C. A.; Goldstein, J.; Malaspina, D.; Kletzing, C. A.			Global-scale coherence modulation of radiation-belt electron loss from plasmaspheric hiss	NATURE			English	Article								Over 40 years ago it was suggested that electron loss in the region of the radiation belts that overlaps with the region of high plasma density called the plasmasphere, within four to five Earth radii(1,2), arises largely from interaction with an electromagnetic plasma wave called plasmaspheric hiss(3-5) . This interaction strongly influences the evolution of the radiation belts during a geomagnetic storm, and over the course of many hours to days helps to return the radiation-belt structure to its 'quiet' pre-storm configuration. Observations have shown that the long-term electron-loss rate is consistent with this theory but the temporal and spatial dynamics of the loss process remain to be directly verified. Here we report simultaneous measurements of structured radiation-belt electron losses and the hiss phenomenon that causes the losses. Losses were observed in the form of bremsstrahlung X-rays generated by hiss-scattered electrons colliding with the Earth's atmosphere after removal from the radiation belts. Our results show that changes of up to an order of magnitude in the dynamics of electron loss arising from hiss occur on timescales as short as one to twenty minutes, in association with modulations in plasma density and magnetic field. Furthermore, these loss dynamics are coherent with hiss dynamics on spatial scales comparable to the size of the plasmasphere. This nearly global-scale coherence was not predicted and may affect the short-term evolution of the radiation belts during active times.	[Breneman, A. W.; Wygant, J. R.; Cattell, C. A.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Halford, A.; Millan, R.; Woodger, L.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [McCarthy, M.] Univ Washington, Earth & Space Sci, Seattle, WA 98195 USA; [Fennell, J.] Aerosp Corp, Los Angeles, CA 90009 USA; [Sample, J.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Hospodarsky, G.; Kletzing, C. A.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Goldstein, J.] SW Res Inst, San Antonio, TX 78238 USA; [Malaspina, D.] Univ Colorado, Lab Atmospher & Space Phys LASP, Boulder, CO 80303 USA	University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; University of Washington; University of Washington Seattle; Aerospace Corporation - USA; University of California System; University of California Berkeley; University of Iowa; Southwest Research Institute; University of Colorado System; University of Colorado Boulder	Breneman, AW (corresponding author), Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA.	awbrenem@gmail.com	Halford, Alexa/AAH-2098-2019; Hospodarsky, George B/A-7996-2015	Halford, Alexa/0000-0002-5383-4602; Hospodarsky, George B/0000-0001-9200-9878; Kletzing, Craig/0000-0002-4136-3348; Cattell, Cynthia/0000-0002-3805-320X				Blake JB, 2013, SPACE SCI REV, V179, P383, DOI 10.1007/s11214-013-9991-8; CARPENTER DL, 1963, J GEOPHYS RES, V68, P1675, DOI 10.1029/JZ068i006p01675; Chen LJ, 2014, GEOPHYS RES LETT, V41, P5702, DOI 10.1002/2014GL060628; Claudepierre SG, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015399; Dai L, 2013, GEOPHYS RES LETT, V40, P4127, DOI 10.1002/grl.50800; Escoubet CP, 1997, SPACE SCI REV, V79, P11, DOI 10.1023/A:1004923124586; GRINGAUZ KI, 1963, PLANET SPACE SCI, V11, P281, DOI 10.1016/0032-0633(63)90030-8; HUGHES WJ, 1978, NATURE, V275, P43, DOI 10.1038/275043a0; KENNEL CF, 1966, J GEOPHYS RES, V71, P1, DOI 10.1029/JZ071i001p00001; Kletzing CA, 2013, SPACE SCI REV, V179, P127, DOI 10.1007/s11214-013-9993-6; Li W, 2013, GEOPHYS RES LETT, V40, P3798, DOI 10.1002/grl.50787; LYONS LR, 1972, J GEOPHYS RES, V77, P3455, DOI 10.1029/JA077i019p03455; LYONS LR, 1973, J GEOPHYS RES, V78, P2142, DOI 10.1029/JA078i013p02142; Mann IR, 2008, SPACE SCI REV, V141, P413, DOI 10.1007/s11214-008-9457-6; Mauk BH, 2013, SPACE SCI REV, V179, P3, DOI 10.1007/s11214-012-9908-y; Millan RM, 2007, J ATMOS SOL-TERR PHY, V69, P362, DOI 10.1016/j.jastp.2006.06.019; Millan RM, 2013, SPACE SCI REV, V179, P503, DOI 10.1007/s11214-013-9971-z; Millan RM, 2011, J ATMOS SOL-TERR PHY, V73, P1425, DOI 10.1016/j.jastp.2011.01.006; Ni BB, 2014, GEOPHYS RES LETT, V41, P1854, DOI 10.1002/2014GL059389; PINTO O, 1992, J ATMOS TERR PHYS, V54, P1129, DOI 10.1016/0021-9169(92)90137-A; Santolik O, 2003, RADIO SCI, V38, DOI 10.1029/2000RS002523; Summers D, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011993; Summers D, 2014, J GEOPHYS RES-SPACE, V119, P9134, DOI 10.1002/2014JA020437; Tsurutani BT, 2015, J GEOPHYS RES-SPACE, V120, P414, DOI 10.1002/2014JA020518; TSYGANENKO NA, 1989, PLANET SPACE SCI, V37, P5, DOI 10.1016/0032-0633(89)90066-4	25	71	71	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					193	U321		10.1038/nature14515	http://dx.doi.org/10.1038/nature14515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26123022				2022-12-28	WOS:000357695900030
J	Baross, JA; Martin, WF				Baross, John A.; Martin, William F.			The Ribofilm as a Concept for Life's Origins	CELL			English	Editorial Material							METABOLISM; CARBON	Recent phylogenetic data indicating that the first archaea were methane- producing galvanizes cross- disciplinary evidence supporting the hypothesis that life arose via thermodynamically directed events at hydrothermal vents. The new developments lead us to propose the concept of a ribofilm in which RNA's origin- of- life role is more akin to a slowly changing platform than a spontaneous self- replicator.	[Baross, John A.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Baross, John A.] Univ Washington, Astrobiol Program, Seattle, WA 98195 USA; [Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Heinrich Heine University Dusseldorf	Baross, JA (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	jbaross@u.washington.edu; bill@hhu.de	Martin, William F./O-5446-2015	Martin, William F./0000-0003-1478-6449				Amend JP, 2009, ACS SYM SER, V1025, P63; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Hordijk W, 2012, J THEOR BIOL, V295, P132, DOI 10.1016/j.jtbi.2011.11.024; Leman L, 2004, SCIENCE, V306, P283, DOI 10.1126/science.1102722; Liu YC, 2012, TRENDS MICROBIOL, V20, P251, DOI 10.1016/j.tim.2012.02.002; McCollom TM, 2013, ELEMENTS, V9, P129, DOI 10.2113/gselements.9.2.129; Raymann K, 2015, P NATL ACAD SCI USA, V112, P6670, DOI 10.1073/pnas.1420858112; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Schrenk MO, 2013, REV MINERAL GEOCHEM, V75, P575, DOI 10.2138/rmg.2013.75.18; Sojo V, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001926; Sousa FL, 2014, BBA-BIOENERGETICS, V1837, P964, DOI 10.1016/j.bbabio.2014.02.001; Ueno Y, 2006, NATURE, V440, P516, DOI 10.1038/nature04584	13	18	18	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					13	15		10.1016/j.cell.2015.06.038	http://dx.doi.org/10.1016/j.cell.2015.06.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140586	Bronze			2022-12-28	WOS:000357542300002
J	Santiago, M; Machicado, V				Santiago, Mittermayer; Machicado, Viviane			Jaccoud's Arthropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Santiago, Mittermayer] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil; [Machicado, Viviane] Hosp Santa Izabel, Salvador, BA, Brazil	Escola Bahiana de Medicina e Saude Publica	Santiago, M (corresponding author), Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.	mitter@pq.cnpq.br	Machicado, Viviane/AAK-9303-2020						0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					E1	E1		10.1056/NEJMicm1410743	http://dx.doi.org/10.1056/NEJMicm1410743			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL8IS	26132963				2022-12-28	WOS:000357218700010
J	Williams, EG; Auwerx, J				Williams, Evan G.; Auwerx, Johan			The Convergence of Systems and Reductionist Approaches in Complex Trait Analysis	CELL			English	Review							PHENOME-WIDE ASSOCIATION; GENOME-WIDE; CAENORHABDITIS-ELEGANS; GENETIC-ANALYSIS; ARABIDOPSIS-THALIANA; HETEROGENEOUS STOCK; FUNCTIONAL-ANALYSIS; RESOURCE; MICE; POPULATION	Research into the genetic and environmental factors behind complex trait variation has traditionally been segregated into distinct scientific camps. The reductionist approach aims to decrypt phenotypic variability bit by bit, founded on the underlying hypothesis that genome-to-phenome relations are largely constructed from the additive effects of their molecular players. In contrast, the systems approach aims to examine large-scale interactions of many components simultaneously, on the premise that interactions in gene networks can be both linear and non-linear. Both approaches are complementary, and they are becoming increasingly intertwined due to developments in gene editing tools, omics technologies, and population resources. Together, these strategies are beginning to drive the next era in complex trait research, paving the way to improve agriculture and toward more personalized medicine.	[Williams, Evan G.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.	admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Williams, Evan/M-7539-2017	Williams, Evan/0000-0002-9746-376X; Auwerx, Johan/0000-0002-5065-5393	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation [31003A-140780]; Sinergia grant mechanism [CSRII3-136201]; AgingX program of the Swiss Initiative for Systems Biology [51RTP0-151019]; NIH [R01AG043930]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia grant mechanism; AgingX program of the Swiss Initiative for Systems Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Xu Wang and Dr. Robert W. Williams for discussions on systems biology and cross-species approaches. J.A. is the Nestle Chair in Energy Metabolism, and the J.A. laboratory is supported by grants from the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation (31003A-140780), the Sinergia grant mechanism (CSRII3-136201), the AgingX program of the Swiss Initiative for Systems Biology (51RTP0-151019), and the NIH (R01AG043930).	Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arru L, 2003, THEOR APPL GENET, V106, P668, DOI 10.1007/s00122-002-1115-x; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Ayyadevara S, 2001, GENETICS, V157, P655; Bailey D. W., 1981, RECOMBINANT INBRED S; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bastian F, 2008, LECT N BIOINFORMAT, V5109, P124, DOI 10.1007/978-3-540-69828-9_12; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Bogardus C, 2002, ANN NY ACAD SCI, V967, P1; BURR B, 1988, GENETICS, V118, P519; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Clark AG, 2000, EVOL BIOL, V32, P205; Cronin RM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00250; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Danhauser K, 2012, AM J HUM GENET, V91, P1082, DOI 10.1016/j.ajhg.2012.10.006; DARVASI A, 1995, GENETICS, V141, P1199; Datta K, 2012, PLANT BIOTECHNOL J, V10, P579, DOI 10.1111/j.1467-7652.2012.00688.x; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Elmer GI, 2010, PSYCHOPHARMACOLOGY, V208, P309, DOI 10.1007/s00213-009-1732-z; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; GELMAN R, 1988, GENETICS, V118, P693; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; JIANG XC, 1992, J CLIN INVEST, V90, P1290, DOI 10.1172/JCI115993; Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khan D, 2014, PLANT SCI, V223, P146, DOI 10.1016/j.plantsci.2014.03.016; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Kingsmore SF, 2007, BIOMARK INSIGHTS, V2, P283; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Ledford H, 2012, NATURE, V482, P145, DOI 10.1038/482145a; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; LI TK, 1984, ALCOHOL CLIN EXP RES, V8, P485; Liu SC, 1996, GENETICS, V142, P247; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Park SJ, 2014, NAT GENET, V46, P1337, DOI 10.1038/ng.3131; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Rost HL, 2014, NAT BIOTECHNOL, V32, P219, DOI 10.1038/nbt.2841; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schilling RK, 2014, PLANT BIOTECHNOL J, V12, P378, DOI 10.1111/pbi.12145; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; SMITH L, 1987, BIO-TECHNOL, V5, P933, DOI 10.1038/nbt0987-933; SOUSSI T, 1994, INT J CANCER, V57, P1, DOI 10.1002/ijc.2910570102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAYLOR BA, 1973, P SOC EXP BIOL MED, V143, P629, DOI 10.3181/00379727-143-37380; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; WASINGER VC, 1995, ELECTROPHORESIS, V16, P1090, DOI 10.1002/elps.11501601185; Williams R. W., 2001, GENOME BIOL, V2; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039; Xu JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-656; Xu XM, 2011, CURR OPIN BIOTECH, V22, P300, DOI 10.1016/j.copbio.2010.11.007; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Yuan J, 2002, CROP SCI, V42, P271, DOI 10.2135/cropsci2002.0271; Zamir D, 2014, SCIENCE, V345, P1124, DOI 10.1126/science.1258941; Zhao L, 2009, PLANT BIOTECHNOL J, V7, P550, DOI 10.1111/j.1467-7652.2009.00423.x	87	40	41	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					23	32		10.1016/j.cell.2015.06.024	http://dx.doi.org/10.1016/j.cell.2015.06.024			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140590	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000357542300006
J	Woolston, C				Woolston, Chris			LEISURE ACTIVITIES The power of a pastime	NATURE			English	Editorial Material																		Root-Bernstein R., 2008, J PSYCHOL SCI TECHNO, V1, P51, DOI DOI 10.1891/1939-7054.1.2.51	1	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					117	119		10.1038/nj7558-117a	http://dx.doi.org/10.1038/nj7558-117a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26151070	Bronze			2022-12-28	WOS:000357169500045
J	Ruger, JP; Ruger, TW; Annas, GJ				Ruger, Jennifer Prah; Ruger, Theodore W.; Annas, George J.			The Elusive Right to Health Care under US Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ruger, Jennifer Prah] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ruger, Jennifer Prah] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Ruger, Theodore W.] Univ Penn, Sch Law, Philadelphia, PA 19104 USA; [Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Boston University	Ruger, JP (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							Annas GJ, 2014, NEW ENGL J MED, V371, P862, DOI 10.1056/NEJMhle1408081; Annas GJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1003944; [Anonymous], 2015, NY TIMES; Department of Health and Human Services Centers for Medicare and Medicaid Services, CMS MAN SYST PUB, P100; Ruger JP, 2012, NEW ENGL J MED, V366, P681, DOI 10.1056/NEJMp1200751; Ruger JP, 2010, HLTH SOCIAL JUSTICE; Ruger Theodore W., 2012, L CONT PROBS, V75, P215; RUGER TW, 2011, YALE LJ ONLINE, V120, P347	8	9	9	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2558	2563		10.1056/NEJMhle1412262	http://dx.doi.org/10.1056/NEJMhle1412262			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2QD	26107056				2022-12-28	WOS:000356788200013
J	Jack, A				Jack, Andrew			Why the panic? South Korea's MERS response questioned	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, FirstFT, London, England		Jack, A (corresponding author), Financial Times, FirstFT, London, England.	andrew.jack@ft.com						Sang-Hun C., 2015, NY TIMES; Song J-a, 2015, FINANCIAL TIMES; World Health Organization, 2014, MIDDL E RESP SYNDR C; World Health Organization (WHO), 2019, MIDDLE E RESP SYNDRO	4	16	16	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2015	350								h3403	10.1136/bmj.h3403	http://dx.doi.org/10.1136/bmj.h3403			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NX	26108610				2022-12-28	WOS:000357160000020
J	Krimpenfort, P; Berns, A				Krimpenfort, Paul; Berns, Anton			Wnt Down, Tumors Wind Up?	CELL			English	Editorial Material							CANCER; INHIBITION; MICE	In mouse intestinal tumors induced by the inhibition of APC, the restoration of APC function causes complete tumor regression with normal differentiation and return of stem cell function irrespective of whether tumors also carried mutations in Kras and p53. These findings by Dow et al. validate the Wnt pathway as an exquisite target for intervention.	[Krimpenfort, Paul; Berns, Anton] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Berns, Anton] Skolkovo Inst Sci & Technol, Skolkovo Innovat Ctr, Moscow 143026, Russia	Netherlands Cancer Institute; Skolkovo Institute of Science & Technology	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.berns@nki.nl						Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336	10	2	3	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1494	1496		10.1016/j.cell.2015.06.008	http://dx.doi.org/10.1016/j.cell.2015.06.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091030	Bronze			2022-12-28	WOS:000356618200004
J	Veale, D; Bewley, A				Veale, David; Bewley, Anthony			PRACTICE POINTER Body dysmorphic disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; EFFICACY		[Veale, David] South London & Maudsley NHS Fdn Trust, London, England; [Veale, David] Kings Coll London, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Bewley, Anthony] St Bartholomews Hosp, London, England	South London & Maudsley NHS Trust; University of London; King's College London; University of London; Queen Mary University London	Veale, D (corresponding author), South London & Maudsley NHS Fdn Trust, London, England.	david.veale@kcl.ac.uk	Veale, David M/F-5670-2010	Veale, David M/0000-0002-1717-4766				Aguilar-Duran S, 2014, CLIN EXP DERMATOL, V39, P577, DOI 10.1111/ced.12360; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2005, OBS COMP DIS COR INT; Buhlmann U, 2010, PSYCHIAT RES, V178, P171, DOI 10.1016/j.psychres.2009.05.002; Carter L, 2001, BMJ; Conrado LA, 2010, J AM ACAD DERMATOL, V63, P235, DOI 10.1016/j.jaad.2009.09.017; Crerand CE, 2010, ANN PLAS SURG, V65, P11, DOI 10.1097/SAP.0b013e3181bba08f; Hollander E, 1999, ARCH GEN PSYCHIAT, V56, P1033, DOI 10.1001/archpsyc.56.11.1033; Koran LM, 2008, CNS SPECTRUMS, V13, P316, DOI 10.1017/S1092852900016436; Phillips KA, 2006, PSYCHIAT RES, V141, P305, DOI 10.1016/j.psychres.2005.09.014; Phillips KA, 2005, J CLIN PSYCHIAT, V66, P717, DOI 10.4088/JCP.v66n0607; Phillips KA, 2005, PSYCHOSOMATICS, V46, P317, DOI 10.1176/appi.psy.46.4.317; Phillips KA, 2005, AM J PSYCHIAT, V162, P377, DOI 10.1176/appi.ajp.162.2.377; Phillips KA, 2002, ARCH GEN PSYCHIAT, V59, P381, DOI 10.1001/archpsyc.59.4.381; Phillips KA, 2001, PSYCHOSOMATICS, V42, P504, DOI 10.1176/appi.psy.42.6.504; Phillips KA, 2014, PSYCHOTHER PSYCHOSOM, V83, P325, DOI 10.1159/000366035; Tignol J, 2007, EUR PSYCHIAT, V22, P520, DOI 10.1016/j.eurpsy.2007.05.003; Veale D, 1996, BRIT J PSYCHIAT, V169, P196, DOI 10.1192/bjp.169.2.196; Veale D, 2001, BEHAV RES THER, V39, P1381, DOI 10.1016/S0005-7967(00)00102-9; Veale D, 2014, PSYCHOTHER PSYCHOSOM, V83, P341, DOI 10.1159/000360740; Veale D, 2014, INT UROGYNECOL J, V25, P831, DOI 10.1007/s00192-013-2297-2	21	15	15	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2015	350								h2278	10.1136/bmj.h2278	http://dx.doi.org/10.1136/bmj.h2278			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2PK	26088615				2022-12-28	WOS:000356786300002
J	[Anonymous]				[Anonymous]			A guide to the Nature Index	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S30	S30		10.1038/522S30a	http://dx.doi.org/10.1038/522S30a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083859	Bronze			2022-12-28	WOS:000356425400012
J	Satcher, D; Hook, EW; Coleman, E				Satcher, David; Hook, Edward W., III; Coleman, Eli			Sexual Health in America Improving Patient Care and Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERVENTIONS		[Satcher, David] Morehouse Sch Med, Satcher Hlth Leadership Inst, Atlanta, GA 30310 USA; [Hook, Edward W., III] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA; [Coleman, Eli] Univ Minnesota, Sch Med, Dept Family Med & Community Hlth, Minneapolis, MN 55454 USA	Morehouse School of Medicine; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities	Coleman, E (corresponding author), Univ Minnesota, Sch Med, Dept Family Med & Community Hlth, Program Human Sexual, 1300 S Second St,Ste 180, Minneapolis, MN 55454 USA.	colem001@umn.edu						Becasen JS, 2015, J SEX RES, V52, P433, DOI 10.1080/00224499.2014.947399; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Hogben M, 2015, J SEX RES, V52, P444, DOI 10.1080/00224499.2014.973100; Ivankovich MB, 2013, PUBLIC HEALTH REP, V128, P102, DOI 10.1177/00333549131282S112; Mustanski B, 2015, J SEX RES, V52, P220, DOI 10.1080/00224499.2013.867924; Swartzendruber A, 2010, JAMA-J AM MED ASSOC, V304, P1005, DOI 10.1001/jama.2010.1252; U.S. Department of Health and Human Services, 2001, SURG GEN CALL ACT PR	7	46	46	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					765	766		10.1001/jama.2015.6831	http://dx.doi.org/10.1001/jama.2015.6831			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP6SA	26087251				2022-12-28	WOS:000360017200010
J	Lee, LK; Monuteaux, MC; Burghardt, LC; Fleegler, EW; Nigrovic, LE; Meehan, WP; Schutzman, SA; Mannix, R				Lee, Lois K.; Monuteaux, Michael C.; Burghardt, Lindsey C.; Fleegler, Eric W.; Nigrovic, Lise E.; Meehan, William P.; Schutzman, Sara A.; Mannix, Rebekah			Motor Vehicle Crash Fatalities in States With Primary Versus Secondary Seat Belt Laws A Time-Series Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY ENFORCEMENT; DISPARITIES	Background: Motor vehicle crashes (MVCs) remain a leading cause of injury-related deaths in the United States. Primary seat belt laws allow vehicle occupants to be ticketed solely for not wearing seat belts, and secondary laws allow ticketing only for failure to wear seat belts in the setting of other violations. Objective: To determine the association between MVC fatality rates and primary versus secondary seat belt laws. Design: Retrospective time-series analysis. Setting: United States, 2001 to 2010. Participants: MVC fatalities in occupants aged 10 years or older identified in the Fatality Analysis Reporting System. Measurements: Population-based rates of fatal crashes. Results: There were 283 183 MVC fatalities in occupants aged 10 years or older from 2001 to 2010 (overall rate, 13.0 per 100 000 persons). In 2001, the mean fatality rate was 14.6 per 100 000 persons, 16 states had primary seat belt laws, and 33 states had secondary laws. In 2010, the mean fatality rate was 9.7 per 100 000 persons, 30 states had primary seat belt laws, and 19 states had secondary laws. In the multivariate regression model, states with primary seat belt laws had lower MVC fatality rates than states with secondary laws (adjusted incidence rate ratio, 0.83 [95% CI, 0.78 to 0.90]). Limitation: Only fatalities were analyzed from the database, and the degree of law enforcement could not be ascertained. Conclusion: States with primary seat belt laws had lower rates of MVC fatalities than those with secondary laws. Adoption of primary seat belt laws may offer optimal occupant protection.	Boston Childrens Hosp, Boston, MA 02115 USA; Milton Pediat Associates, Milton, MA USA	Harvard University; Boston Children's Hospital	Lee, LK (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	lois.lee@childrens.harvard.edu; Michael.monuteaux@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020; Monuteaux, Michael C/O-5032-2018	Nigrovic, Lise/0000-0002-6369-3997; Mannix, Rebekah/0000-0003-3608-2792				Baxandall P, 2013, MOVING ROAD STATE BY; Beck L. F., 2011, Morbidity and Mortality Weekly Report, V59, P1681; Briggs NC, 2006, AM J PREV MED, V31, P135, DOI 10.1016/j.amepre.2006.03.024; Carpenter CS, 2008, J HEALTH ECON, V27, P642, DOI 10.1016/j.jhealeco.2007.09.010; Committee on Injury Violence and Poison Prevention, 2011, Pediatrics, V127, P788, DOI 10.1542/peds.2011-0213; Conner KA, 2010, J SAFETY RES, V41, P17, DOI 10.1016/j.jsr.2009.10.005; Crandall CS, 2001, AM J EPIDEMIOL, V153, P219, DOI 10.1093/aje/153.3.219; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Durbin DR, 2011, PEDIATRICS, V127, pE1050, DOI 10.1542/peds.2011-0215; Elder RW, 2004, AM J PREV MED, V27, P57, DOI 10.1016/j.amepre.2004.03.002; Elder RW, 2004, J STUD ALCOHOL, V65, P297, DOI 10.15288/jsa.2004.65.297; EVANS L, 1986, ACCIDENT ANAL PREV, V18, P229, DOI 10.1016/0001-4575(86)90007-2; EVANS L, 1990, ACCIDENT ANAL PREV, V22, P167, DOI 10.1016/0001-4575(90)90067-U; Fielding JE, 2001, AM J PREV MED, V21, P16; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Foss RD, 2001, JAMA-J AM MED ASSOC, V286, P1588, DOI 10.1001/jama.286.13.1588; Garcia-Espana JF, 2012, AM J PUBLIC HEALTH, V102, P1128, DOI 10.2105/AJPH.2011.300493; Grabowski DC, 2004, JAMA-J AM MED ASSOC, V291, P2840, DOI 10.1001/jama.291.23.2840; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Hedlund J, 2004, J SAFETY RES, V35, P231, DOI 10.1016/j.jsr.2004.03.006; Hemenway D, 2009, WHILE WE WERE SLEEPI; Houston DJ, 2006, AM J PUBLIC HEALTH, V96, P1949, DOI 10.2105/AJPH.2005.074385; Insurance Institute for Highway Safety, 2012, SAF BELT CHILD RESTR; Kuhn M., 2008, INCREASING SEAT BELT; Liu C, 2014, PUBLICATION NATL HIG; National Highway Traffic Safety Administration, 2000, OBS SAF BELT US DEC; National Highway Traffic Safety Administration, FAT AN REP SYST FARS; National Highway Traffic Safety Administration, 2010, TRAFF TECH TECHN TRA; National Highway Traffic Safety Administration, 2005, NAT HIGHW TRAFF SAF; National Highway Traffic Safety Administration, 2004, MOT VEH OCC SAF SURV; Rivara FP, 1999, AM J PREV MED, V16, P30, DOI 10.1016/S0749-3797(98)00113-5; Shults RA, 2004, J SAFETY RES, V35, P189, DOI 10.1016/j.jsr.2004.03.002; Shults RA, 2004, J SAFETY RES, V35, P447, DOI 10.1016/j.jsr.2004.06.001; Shults RA, 2012, J SAFETY RES, V43, P417, DOI 10.1016/j.jsr.2012.10.010; Strine TW, 2010, ACCIDENT ANAL PREV, V42, P1066, DOI 10.1016/j.aap.2009.12.014; Tison J, 2008, PUBLICATION NATL HIG; U. S. Department of Health and Human Services, 2014, HLTH PEOPL 2020 2020; Wagenaar AC, 2007, J SAFETY RES, V38, P493, DOI 10.1016/j.jsr.2007.06.001; WEINBERG CR, 1993, AM J EPIDEMIOL, V137, P1; Welsch R. E, 2004, REGRESSION DIAGNOSTI; Ye TJ, 2010, OCCUPANT RESTRAINT U	41	26	27	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					184	+		10.7326/M14-2368	http://dx.doi.org/10.7326/M14-2368			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO6EX	26098590				2022-12-28	WOS:000359251100007
J	Liang, B; Li, ZL; Jenni, S; Rahmeh, AA; Morin, BM; Grant, T; Grigorieff, N; Harrison, SC; Whelan, SPJ				Liang, Bo; Li, Zongli; Jenni, Simon; Rahmeh, Amal A.; Morin, Benjamin M.; Grant, Timothy; Grigorieff, Nikolaus; Harrison, Stephen C.; Whelan, Sean P. J.			Structure of the L Protein of Vesicular Stomatitis Virus from Electron Cryomicroscopy	CELL			English	Article							NUCLEOPROTEIN-RNA COMPLEX; CIS-ACTING SIGNALS; CRYSTAL-STRUCTURE; GENOME REPLICATION; POLYMERASE; TRANSCRIPTION; INITIATION; MECHANISM; METHYLTRANSFERASE; TERMINATION	The large (L.) proteins of non-segmented, negativestrand RNA viruses, a group that includes Ebola and rabies viruses, catalyze RNA-dependent RNA polymerization with viral ribonucleoprotein as template, a non-canonical sequence of capping and methylation reactions, and polyadenylation of viral messages. We have determined by electron cryomicroscopy the structure of the vesicular stomatitis virus (VSV) L protein. The density map, at a resolution of 3.8 angstrom, has led to an atomic model for nearly all of the 2109-residue polypeptide chain, which comprises three enzymatic domains (RNA-dependent RNA polymerase [RdRp], polyribonucleotidyl transferase [PRNTase], and methyltransferase) and two structural domains. The RdRp resembles the corresponding enzymatic regions of dsRNA virus polymerases and influenza virus polymerase. A loop from the PRNTase (capping) domain projects into the catalytic site of the RdRp, where it appears to have the role of a priming loop and to couple product elongation to large-scale conformational changes in L.	[Liang, Bo; Rahmeh, Amal A.; Morin, Benjamin M.; Whelan, Sean P. J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 20115 USA; [Li, Zongli] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 20115 USA; [Liang, Bo; Jenni, Simon; Harrison, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 20115 USA; [Li, Zongli; Harrison, Stephen C.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 20115 USA; [Grant, Timothy; Grigorieff, Nikolaus] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Whelan, SPJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 20115 USA.	sean_whelan@hms.harvard.edu	Liang, Bo/H-2476-2011; Li, Zongli/AAB-9100-2020	Liang, Bo/0000-0002-5617-9228; Whelan, Sean/0000-0003-1564-8590; Rahmeh, Amal/0000-0003-0985-7978; Liang, Bo/0000-0003-0719-4074; Grigorieff, Nikolaus/0000-0002-1506-909X; Grant, Tim/0000-0002-4855-8703	NIH (New England Regional Center of Excellent for Biodefense and Emerging Infectious Diseases) [GM62580, AI059371, AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI059371, U54AI057159, R01AI059371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	NIH (New England Regional Center of Excellent for Biodefense and Emerging Infectious Diseases); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Robin Ross for protein expression and purification and Thomas Walz for advice and encouragement. The research was supported by NIH grants GM62580 (to S.C.H.), AI059371 (to S.P.J.W.), and AI057159 (New England Regional Center of Excellent for Biodefense and Emerging Infectious Diseases). N.G. and S.C.H. are Investigators in the Howard Hughes Medical Institute.	ABRAHAM G, 1976, P NATL ACAD SCI USA, V73, P1504, DOI 10.1073/pnas.73.5.1504; Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; BALTIMOR.D, 1970, P NATL ACAD SCI USA, V66, P572, DOI 10.1073/pnas.66.2.572; Barr JN, 1997, J VIROL, V71, P8718, DOI 10.1128/JVI.71.11.8718-8725.1997; Barr JN, 2001, J VIROL, V75, P6901, DOI 10.1128/JVI.75.15.6901-6913.2001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ding HT, 2006, J VIROL, V80, P2808, DOI 10.1128/JVI.80.6.2808-2814.2006; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; EMERSON SU, 1973, J VIROL, V12, P1325, DOI 10.1128/JVI.12.6.1325-1335.1973; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galloway SE, 2008, J VIROL, V82, P12280, DOI 10.1128/JVI.01225-08; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Green TJ, 2009, P NATL ACAD SCI USA, V106, P11713, DOI 10.1073/pnas.0903228106; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; HERCYK N, 1988, VIROLOGY, V163, P222, DOI 10.1016/0042-6822(88)90253-X; HUNT DM, 1984, J VIROL, V52, P515, DOI 10.1128/JVI.52.2.515-521.1984; IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krumm SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008517; LAFERLA FM, 1989, J VIROL, V63, P3852, DOI 10.1128/JVI.63.9.3852-3857.1989; Li JR, 2009, J VIROL, V83, P1930, DOI 10.1128/JVI.02162-08; Lij J, 2008, J VIROL, V82, P775, DOI 10.1128/JVI.02107-07; Liuzzi M, 2005, J VIROL, V79, P13105, DOI 10.1128/JVI.79.20.13105-13115.2005; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morin B, 2014, J BIOL CHEM, V289, P9961, DOI 10.1074/jbc.M113.542761; Morin B, 2012, EMBO J, V31, P1320, DOI 10.1038/emboj.2011.483; Ogino T, 2007, MOL CELL, V25, P85, DOI 10.1016/j.molcel.2006.11.013; PATTON JT, 1984, J VIROL, V49, P303, DOI 10.1128/JVI.49.2.303-309.1984; PELUSO RW, 1983, P NATL ACAD SCI-BIOL, V80, P3198, DOI 10.1073/pnas.80.11.3198; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Rahmeh AA, 2012, P NATL ACAD SCI USA, V109, P14628, DOI 10.1073/pnas.1209147109; Rahmeh AA, 2010, P NATL ACAD SCI USA, V107, P20075, DOI 10.1073/pnas.1013559107; Rahmeh AA, 2009, J VIROL, V83, P11043, DOI 10.1128/JVI.01426-09; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; ROSE JK, 1977, J VIROL, V21, P683, DOI 10.1128/JVI.21.2.683-693.1977; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Stillman EA, 1999, J VIROL, V73, P7199, DOI 10.1128/JVI.73.9.7199-7209.1999; Stillman EA, 1997, J VIROL, V71, P2127, DOI 10.1128/JVI.71.3.2127-2137.1997; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Tekes G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002073; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang JT, 2007, J VIROL, V81, P11499, DOI 10.1128/JVI.01057-07; Whelan SPJ, 2002, P NATL ACAD SCI USA, V99, P9178, DOI 10.1073/pnas.152155599; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	48	169	172	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					314	327		10.1016/j.cell.2015.06.018	http://dx.doi.org/10.1016/j.cell.2015.06.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26144317	Green Accepted, Bronze			2022-12-28	WOS:000358087700012
J	Tan, KW; Jung, B; Werner, JG; Rhoades, ER; Thompson, MO; Wiesner, U				Tan, Kwan Wee; Jung, Byungki; Werner, Joerg G.; Rhoades, Elizabeth R.; Thompson, Michael O.; Wiesner, Ulrich			Transient laser heating induced hierarchical porous structures from block copolymer-directed self-assembly	SCIENCE			English	Article							THIN-FILMS; RESOLUTION; SILICON; ARRAYS; ORDER; SIZE	Development of rapid processes combining hierarchical self-assembly with mesoscopic shape control has remained a challenge. This is particularly true for high-surface-area porous materials essential for applications including separation and detection, catalysis, and energy conversion and storage. We introduce a simple and rapid laser writing method compatible with semiconductor processing technology to control three-dimensionally continuous hierarchically porous polymer network structures and shapes. Combining self-assembly of mixtures of block copolymers and resols with spatially localized transient laser heating enables pore size and pore size distribution control in all-organic and highly conducting inorganic carbon films with variable thickness. The method provides all-laser-controlled pathways to complex high-surface-area structures, including fabrication of microfluidic devices with high-surface-area channels and complex porous crystalline semiconductor nanostructures.	[Tan, Kwan Wee; Jung, Byungki; Werner, Joerg G.; Thompson, Michael O.; Wiesner, Ulrich] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Werner, Joerg G.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Rhoades, Elizabeth R.] Cornell Univ, Cornell NanoScale Sci & Technol Facil, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Wiesner, U (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	ubw1@cornell.edu	Tan, Kwan W./D-6942-2011	Tan, Kwan W./0000-0002-8289-6503; Werner, Jorg G./0000-0001-7845-086X; Thompson, Michael/0000-0002-4933-009X	National Science Foundation (NSF) Single Investigator Award [DMR-1409105]; Singapore Energy Innovation Programme Office; NSF Materials Research Science and Engineering Centers (MRSEC) program [DMR-1120296]; NSF [ECCS-0335765]	National Science Foundation (NSF) Single Investigator Award; Singapore Energy Innovation Programme Office; NSF Materials Research Science and Engineering Centers (MRSEC) program; NSF(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF) Single Investigator Award (DMR-1409105). K.W.T. gratefully acknowledges the Singapore Energy Innovation Programme Office for a National Research Foundation graduate fellowship. This work made use of research facilities at the Cornell Center for Materials Research (CCMR), with support from the NSF Materials Research Science and Engineering Centers (MRSEC) program (DMR-1120296); Cornell NanoScale Science and Technology Facility (CNF), a member of the National Nanotechnology Infrastructure Network, which is supported by the NSF (grant ECCS-0335765); Nanobiotechnology Center shared research facilities at Cornell University; and Center for Energy and Sustainability at Cornell University. We acknowledge experimental assistance from P. Carubia and T. Yuasa for attenuated total reflectance FTIR spectroscopy measurements; D. Lynch for electrical conductivity measurements; Y. Sun and Q. Zhang for microfluidic device fabrication; and T. Corso (CorSolutions LLC) for microfluidic probe station setup. We also gratefully acknowledge the expertise and experimental assistance from M. Goodman and P. Braun (University of Illinois at Urbana Champaign) for amorphous silicon chemical vapor deposition. We thank L. Estroff, Y. Gu, T. Porri, H. Sai, and M. Weathers for helpful discussions. A patent application related to this research has been filed by Cornell University.	[Anonymous], 2012, QUANT CONT OPP MES S; Arora H, 2010, SCIENCE, V330, P214, DOI 10.1126/science.1193369; BATES FS, 1991, SCIENCE, V251, P898, DOI 10.1126/science.251.4996.898; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Deng GD, 2014, CHEM COMMUN, V50, P12684, DOI 10.1039/c4cc02471k; El-Kady MF, 2012, SCIENCE, V335, P1326, DOI 10.1126/science.1216744; Fischer J, 2013, LASER PHOTONICS REV, V7, P22, DOI 10.1002/lpor.201100046; Gan ZS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3061; GRISDALE RO, 1953, J APPL PHYS, V24, P1288, DOI 10.1063/1.1721148; Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046; Jung B, 2012, ACS NANO, V6, P5830, DOI 10.1021/nn300008a; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Li LJ, 2009, SCIENCE, V324, P910, DOI 10.1126/science.1168996; Lin J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6714; Maruo S, 2008, LASER PHOTONICS REV, V2, P100, DOI 10.1002/lpor.200710039; Meng Y, 2006, CHEM MATER, V18, P4447, DOI 10.1021/cm060921u; Park S, 2009, SCIENCE, V323, P1030, DOI 10.1126/science.1168108; Peinemann KV, 2007, NAT MATER, V6, P992, DOI 10.1038/nmat2038; Rinne SA, 2008, NAT PHOTONICS, V2, P52, DOI 10.1038/nphoton.2007.252; Sai H, 2013, SCIENCE, V341, P530, DOI 10.1126/science.1238159; Silverstein R., 1977, SPECTROMETRIC IDENTI; Singer JP, 2013, ADV MATER, V25, P6100, DOI 10.1002/adma.201302777; Templin M, 1997, SCIENCE, V278, P1795, DOI 10.1126/science.278.5344.1795; THOMPSON MO, 1984, PHYS REV LETT, V52, P2360, DOI 10.1103/PhysRevLett.52.2360; Warren SC, 2008, SCIENCE, V320, P1748, DOI 10.1126/science.1159950; Werner JG, 2014, ACS NANO, V8, P731, DOI 10.1021/nn405392t; YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988; Yang PD, 1998, NATURE, V396, P152; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548	30	118	119	16	405	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					54	58		10.1126/science.aab0492	http://dx.doi.org/10.1126/science.aab0492			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138971				2022-12-28	WOS:000357280800056
J	Ortega, P; Lehner, F; Swingedouw, D; Masson-Delmotte, V; Raible, CC; Casado, M; Yiou, P				Ortega, Pablo; Lehner, Flavio; Swingedouw, Didier; Masson-Delmotte, Valerie; Raible, Christoph C.; Casado, Mathieu; Yiou, Pascal			A model-tested North Atlantic Oscillation reconstruction for the past millennium	NATURE			English	Article							MEDIEVAL WARM PERIOD; TREE GROWTH; SUMMER TEMPERATURES; ARCTIC OSCILLATION; PINATUBO ERUPTION; ELLESMERE-ISLAND; CLIMATE-CHANGE; SYSTEM MODEL; NAO INDEX; ICE-AGE	The North Atlantic Oscillation (NAO) is the major source of variability in winter atmospheric circulation in the Northern Hemisphere, with large impacts on temperature, precipitation and storm tracks(1), and therefore also on strategic sectors such as insurance(2), renewable energy production(3), crop yields(4) and water management(5). Recent developments in dynamical methods offer promise to improve seasonal NAO predictions(6), but assessing potential predictability on multi-annual timescales requires documentation of past low-frequency variability in the NAO. A recent bi-proxy NAO reconstruction(7) spanning the past millennium suggested that long-lasting positive NAO conditions were established during medieval times, explaining the particularly warm conditions in Europe during this period; however, these conclusions are debated. Here, we present a yearly NAO reconstruction for the past millennium, based on an initial selection of 48 annually resolved proxy records distributed around the Atlantic Ocean and built through an ensemble of multivariate regressions. We validate the approach in six past-millenniumclimate simulations, and show that our reconstruction outperforms the bi-proxy index. The final reconstruction shows no persistent positive NAO during the medieval period, but suggests that positive phases were dominant during the thirteenth and fourteenth centuries. The reconstruction also reveals that a positive NAO emerges two years after strong volcanic eruptions, consistent with results obtained from models and satellite observations for the Mt Pinatubo eruption in the Philippines(8,9).	[Ortega, Pablo; Masson-Delmotte, Valerie; Casado, Mathieu; Yiou, Pascal] CEA Saclay, UMR CEA CNRS UVSQ 8212, LSCE IPSL, F-91191 Gif Sur Yvette, France; [Lehner, Flavio; Raible, Christoph C.] Univ Bern, Inst Phys, Climate & Environm Phys, CH-3012 Bern, Switzerland; [Lehner, Flavio; Raible, Christoph C.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Swingedouw, Didier] Univ Bordeaux 1, EPOC, F-33615 Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; University of Bern; University of Bern; UDICE-French Research Universities; Universite de Bordeaux	Ortega, P (corresponding author), Univ Reading, Dept Meteorol, NCAS Climate, Reading RG6 6BB, Berks, England.	pablo.ortega@lsce.ipsl.fr	Swingedouw, Didier/M-5471-2019; Ortega, Pablo/ABE-7884-2020; Raible, Christoph/M-8309-2016; Ortega, Pablo/B-2829-2017; Masson-Delmotte, Valerie L/G-1995-2011; Swingedouw, Didier/D-1408-2010	Swingedouw, Didier/0000-0002-0583-0850; Ortega, Pablo/0000-0002-4135-9621; Raible, Christoph/0000-0003-0176-0602; Ortega, Pablo/0000-0002-4135-9621; Masson-Delmotte, Valerie L/0000-0001-8296-381X; Swingedouw, Didier/0000-0002-0583-0850; Casado, Mathieu/0000-0002-8185-415X; Lehner, Flavio/0000-0003-4632-9701	French ANR CEPS project Green Greenland [ANR-10-CEPL-0008]; NCCR-Climate - Swiss National Science Foundation [200020 147174]; Swedish Research Council [C0629701]	French ANR CEPS project Green Greenland(French National Research Agency (ANR)); NCCR-Climate - Swiss National Science Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work of P.O., D.S., V.M.-D. and M.C. has been financially supported by the French ANR CEPS project Green Greenland (ANR-10-CEPL-0008). F.L. and C.R. acknowledge the support of the NCCR-Climate, funded by the Swiss National Science Foundation (grant number 200020 147174). P.Y. acknowledges funding from the Swedish Research Council (grant number C0629701). We thank the paleoclimate community, in particular the PAGES2k Network, and all the institutions involved in the CMIP5/PMIP3 initiative for making available proxy data and model outputs. We also thank F. Gonzalez-Rouco and M. Montoya for discussions at an earlier stage of the analysis; M. Khodri for feedback on the volcanic reconstructions; and E. Hawkins for help and advice on the statistical analysis.	Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/NGEO1797, 10.1038/ngeo1797]; Anchukaitis KJ, 2013, J CLIMATE, V26, P3001, DOI 10.1175/JCLI-D-11-00139.1; Andersen KK, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006765; Baehr J, 2004, J MAR RES, V62, P283, DOI 10.1357/0022240041446191; Box JE, 2002, INT J CLIMATOL, V22, P1829, DOI 10.1002/joc.852; Briffa KR, 2008, PHILOS T R SOC B, V363, P2271, DOI 10.1098/rstb.2007.2199; Buntgen U, 2013, P NATL ACAD SCI USA, V110, P1773, DOI 10.1073/pnas.1211485110; Buntgen U, 2012, CLIMATIC CHANGE, V114, P651, DOI 10.1007/s10584-012-0450-4; Bunn AG, 2005, HOLOCENE, V15, P481, DOI 10.1191/0959683605hl827rp; Buntgen U, 2006, J CLIMATE, V19, P5606, DOI 10.1175/JCLI3917.1; Casado M, 2013, CLIM PAST, V9, P871, DOI 10.5194/cp-9-871-2013; Chen W, 2012, ADV ATMOS SCI, V29, P217, DOI 10.1007/s00376-011-1095-3; Collins M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016504; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Cook ER, 2002, J CLIMATE, V15, P1754, DOI 10.1175/1520-0442(2002)015<1754:AWVMRO>2.0.CO;2; Cook TL, 2009, J PALEOLIMNOL, V41, P77, DOI 10.1007/s10933-008-9252-0; Crowley TJ, 2013, EARTH SYST SCI DATA, V5, P187, DOI 10.5194/essd-5-187-2013; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; CUFFEY KM, 1995, SCIENCE, V270, P455, DOI 10.1126/science.270.5235.455; Davini P, 2014, CLIM DYNAM, V43, P1497, DOI 10.1007/s00382-013-1970-y; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Esper J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030844; Esper J, 2012, NAT CLIM CHANGE, V2, P862, DOI [10.1038/NCLIMATE1589, 10.1038/nclimate1589]; FISHER DA, 1995, HOLOCENE, V5, P19, DOI 10.1177/095968369500500103; Gao CC, 2008, J GEOPHYS RES-ATMOS, V113, DOI [10.1029/2008JD010239, 10.1029/2009JD012133]; Glueck MF, 2001, INT J CLIMATOL, V21, P1453, DOI 10.1002/joc.684; Gomez-Navarro JJ, 2013, GEOPHYS RES LETT, V40, P3232, DOI 10.1002/grl.50628; Gonzalez-Rouco JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024693; GRAF HF, 1993, CLIM DYNAM, V9, P81, DOI 10.1007/BF00210011; Graumlich LJ, 2003, CLIMATIC CHANGE, V59, P245, DOI 10.1023/A:1024474627079; Graybill D. A., 1994, NV516 INT TREE RING; Graybill D. A., 1994, UT508 INT TREE RING; Griffies SM, 1997, CLIM DYNAM, V13, P459, DOI 10.1007/s003820050177; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Hawkins E, 2011, CLIM DYNAM, V37, P407, DOI 10.1007/s00382-010-0810-6; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Huth R, 2007, J ATMOS SOL-TERR PHY, V69, P1095, DOI 10.1016/j.jastp.2007.03.006; Jones PD, 2014, J GEOPHYS RES-ATMOS, V119, P6497, DOI 10.1002/2014JD021561; Jones PD, 1999, INT J CLIMATOL, V19, P347, DOI 10.1002/(SICI)1097-0088(19990330)19:4<347::AID-JOC363>3.0.CO;2-S; Jungclaus JH, 2014, CLIM PAST, V10, P2201, DOI 10.5194/cp-10-2201-2014; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kettlewell PS, 1999, J CEREAL SCI, V29, P205, DOI 10.1006/jcrs.1999.0258; Kuttel M, 2010, CLIM DYNAM, V34, P1115, DOI 10.1007/s00382-009-0577-9; Lamb HH, 1965, PALAEOGEOGR PALAEOCL, V1, P13, DOI DOI 10.1016/0031-0182(65)90004-0; Landrum L, 2013, J CLIMATE, V26, P1085, DOI 10.1175/JCLI-D-11-00326.1; Larsen DJ, 2011, QUATERNARY SCI REV, V30, P2715, DOI 10.1016/j.quascirev.2011.05.026; Lavigne F, 2013, P NATL ACAD SCI USA, V110, P16742, DOI 10.1073/pnas.1307520110; Lehner F, 2012, QUATERNARY SCI REV, V45, P85, DOI 10.1016/j.quascirev.2012.04.025; Lopez-Moreno JI, 2007, WATER RESOUR RES, V43, DOI 10.1029/2007WR005864; Luterbacher J, 2001, ATMOS SCI LETT, V2, P114, DOI 10.1006/asle.2001.0044; Luterbacher J, 2002, CLIM DYNAM, V18, P545, DOI 10.1007/s00382-001-0196-6; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; McCabe-Glynn S, 2013, NAT GEOSCI, V6, P617, DOI [10.1038/ngeo1862, 10.1038/NGEO1862]; Miller H., 2000, ACCUMULATION RATE ST; Moore JJ, 2001, J PALEOLIMNOL, V25, P503, DOI 10.1023/A:1011181301514; Moreno A, 2012, QUATERNARY SCI REV, V43, P16, DOI 10.1016/j.quascirev.2012.04.007; Naurzbaev MM, 2002, HOLOCENE, V12, P727, DOI 10.1191/0959683602hl586rp; Olsen J, 2012, NAT GEOSCI, V5, P808, DOI [10.1038/NGEO1589, 10.1038/ngeo1589]; OVERLAND JE, 1982, MON WEATHER REV, V110, P1, DOI 10.1175/1520-0493(1982)110<0001:ASTFPC>2.0.CO;2; Phipps SJ, 2012, GEOSCI MODEL DEV, V5, P649, DOI 10.5194/gmd-5-649-2012; Pinto JG, 2012, CLIM RES, V54, P1, DOI 10.3354/cr01111; Pozo-Vazquez D., 2011, ADV GLOBAL CHANGE RE, V46; Proctor CJ, 2000, CLIM DYNAM, V16, P815, DOI 10.1007/s003820000077; Raible CC, 2014, CLIM PAST, V10, P537, DOI 10.5194/cp-10-537-2014; Salzer MW, 2005, CLIMATIC CHANGE, V70, P465, DOI 10.1007/s10584-005-5922-3; Scaife AA, 2014, GEOPHYS RES LETT, V41, P2514, DOI 10.1002/2014GL059637; Schmidt GA, 2014, J ADV MODEL EARTH SY, V6, P141, DOI 10.1002/2013MS000265; Schmutz C, 2000, GEOPHYS RES LETT, V27, P1135, DOI 10.1029/1999GL011045; Schurer AP, 2014, NAT GEOSCI, V7, P104, DOI [10.1038/NGEO2040, 10.1038/ngeo2040]; Schweingruber F. H., 1977, SWIT177 INT TREE RIN; Seim A, 2012, CLIM RES, V51, P217, DOI 10.3354/cr01076; Shindell DT, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004151; Siebert L., 2010, VOLCANOES WORLD, V3; Sigl M, 2014, NAT CLIM CHANGE, V4, P693, DOI 10.1038/nclimate2293; Smerdon JE, 2012, WIRES CLIM CHANGE, V3, P63, DOI 10.1002/wcc.149; Stahle D. W., 2005, FL001 INT TREE RING; Stahle D. W., 1996, LA001 INT TREE RING; Stahle D. W., 1996, AR050 INT TREE RING; STAHLE DW, 1994, CLIMATIC CHANGE, V26, P199, DOI 10.1007/BF01092414; Stenchikov G, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002090; Sueyoshi T, 2013, GEOSCI MODEL DEV, V6, P819, DOI 10.5194/gmd-6-819-2013; Tosh R., 1994, CA051 INT TREE RING; Touchan R, 2011, INT J CLIMATOL, V31, P896, DOI 10.1002/joc.2117; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Vieira LEA, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201015843; Vinther BM, 2010, QUATERNARY SCI REV, V29, P522, DOI 10.1016/j.quascirev.2009.11.002; Vinther BM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018220; Wilhelm B, 2012, QUATERNARY RES, V78, P1, DOI 10.1016/j.yqres.2012.03.003; Woodhouse C. A., 2006, CO572 INT TREE RING; Young GHF, 2012, CLIM DYNAM, V39, P495, DOI 10.1007/s00382-011-1246-3; Zhang J., 2012, EUR GEOSC UN GEN ASS; Zhou TJ, 2011, CHINESE SCI BULL, V56, P3028, DOI 10.1007/s11434-011-4641-6	93	185	191	8	128	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					71	+		10.1038/nature14518	http://dx.doi.org/10.1038/nature14518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135450				2022-12-28	WOS:000357169500033
J	Zhou, F; Roy, S				Zhou, Feng; Roy, Sudipto			SnapShot: Motile Cilia	CELL			English	Editorial Material							MULTICILIATED CELLS; CILIOGENESIS; MUTATIONS	Motile cilia are hair-like organelles that protrude from the cell surface and are conserved throughout eukaryotes. Motile cilia beat rhythmically and function in cellular and organismal locomotion and in driving fluid transport over epithelia. In vertebrates, their roles are varied, and their dysfunction in humans is associated with disease.	[Zhou, Feng; Roy, Sudipto] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Roy, Sudipto] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Roy, Sudipto] Natl Univ Singapore, Dept Pediat, Singapore 119228, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Zhou, F (corresponding author), Inst Mol & Cell Biol, Singapore 138673, Singapore.				Agency for Science, Technology, and Research (A*STAR) of Singapore	Agency for Science, Technology, and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	The authors gratefully acknowledge funding provided by the Agency for Science, Technology, and Research (A*STAR) of Singapore.	Al Jord A, 2014, NATURE, V516, P104, DOI 10.1038/nature13770; Babu D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130052; Brooks ER, 2014, CURR BIOL, V24, pR973, DOI 10.1016/j.cub.2014.08.047; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Narasimhan V, 2015, HUM MUTAT, V36, P307, DOI 10.1002/humu.22738; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Wallmeier J, 2014, NAT GENET, V46, P646, DOI 10.1038/ng.2961	9	17	17	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1							224.e1	10.1016/j.cell.2015.06.048	http://dx.doi.org/10.1016/j.cell.2015.06.048			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140599	Bronze			2022-12-28	WOS:000357542300024
J	Abbara, A; Orcutt, M; Gabbar, O				Abbara, Aula; Orcutt, Miriam; Gabbar, Omar			DOCTORS IN THE FIRING LINE Syria's lost generation of doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Abbara, Aula] London Deanery, London, England; [Orcutt, Miriam] Newcastle Upon Tyne NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Gabbar, Omar] Univ Hosp, Leicester, Leics, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust; University Hospitals of Leicester NHS Trust	Abbara, A (corresponding author), London Deanery, London, England.	aula.abbara@gmail.com	Orcutt, Miriam/L-1363-2019	Orcutt, Miriam/0000-0003-4677-1962				[Anonymous], 2015, SYR MED COMM ASS	1	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2015	350								h3479	10.1136/bmj.h3479	http://dx.doi.org/10.1136/bmj.h3479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TN	26130331				2022-12-28	WOS:000357607400005
J	Brummelkamp, TR; van Steensel, B				Brummelkamp, Thijn R.; van Steensel, Bas			A HUSH for transgene expression	SCIENCE			English	Editorial Material							MOUSE		[Brummelkamp, Thijn R.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Brummelkamp, Thijn R.] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [van Steensel, Bas] Erasmus Univ, Med Ctr, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Brummelkamp, TR (corresponding author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.brummelkamp@nki.nl; b.v.steensel@nki.nl						Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Daxinger L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r96; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Eissenberg JC, 2014, TRENDS GENET, V30, P103, DOI 10.1016/j.tig.2014.01.002; Harten SK, 2014, MAMM GENOME, V25, P293, DOI 10.1007/s00335-014-9516-0; Schlesinger S, 2015, MOL CELL BIOL, V35, P770, DOI 10.1128/MCB.01293-14; Tchasovnikarova IA, 2015, SCIENCE, V348, P1481, DOI 10.1126/science.aaa7227	8	4	4	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1433	1434		10.1126/science.aac6529	http://dx.doi.org/10.1126/science.aac6529			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113708				2022-12-28	WOS:000356869100023
J	Potenza, M				Potenza, Marc			Perspective: Behavioural addictions matter	NATURE			English	Editorial Material							DISORDER; DSM-5		Yale Univ, Ctr Excellence Gambling Res, New Haven, CT 06520 USA	Yale University	Potenza, M (corresponding author), Yale Univ, Ctr Excellence Gambling Res, New Haven, CT 06520 USA.	marc.potenza@yale.edu						Hormes JM, 2014, ADDICTION, V109, P2079, DOI 10.1111/add.12713; Petry NM, 2013, ADDICTION, V108, P1186, DOI 10.1111/add.12162; Potenza MN, 2006, ADDICTION, V101, P142, DOI 10.1111/j.1360-0443.2006.01591.x; Reid RC, 2012, J SEX MED, V9, P2868, DOI 10.1111/j.1743-6109.2012.02936.x	4	21	21	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					S62	S62		10.1038/522S62a	http://dx.doi.org/10.1038/522S62a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2OC	26107100	Bronze			2022-12-28	WOS:000356782900008
J	Vampa, G; Hammond, TJ; Thire, N; Schmidt, BE; Legare, F; McDonald, CR; Brabec, T; Corkum, PB				Vampa, G.; Hammond, T. J.; Thire, N.; Schmidt, B. E.; Legare, F.; McDonald, C. R.; Brabec, T.; Corkum, P. B.			Linking high harmonics from gases and solids	NATURE			English	Article							GENERATION; DYNAMICS; FIELD; IONIZATION	When intense light interacts with an atomic gas, recollision between an ionizing electron and its parent ion(1) creates high-order harmonics of the fundamental laser frequency(2). This sub-cycle effect generates coherent soft X-rays(3) and attosecond pulses(4), and provides a means to image molecular orbitals(5). Recently, high harmonics have been generated from bulk crystals(6,7), but what mechanism(8-12) dominates the emission remains uncertain. To resolve this issue, we adapt measurement methods from gas-phase research(13,14) to solid zinc oxide driven by mid-infrared laser fields of 0.25 volts per angstrom. We find that when we alter the generation process with a second-harmonic beam, the modified harmonic spectrum bears the signature of a generalized recollision between an electron and its associated hole(11). In addition, we find that solid-state high harmonics are perturbed by fields so weak that they are present in conventional electronic circuits, thus opening a route to integrate electronics with attosecond and high-harmonic technology. Future experiments will permit the band structure of a solid(15) to be tomographically reconstructed.	[Vampa, G.; Hammond, T. J.; McDonald, C. R.; Brabec, T.; Corkum, P. B.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Thire, N.; Schmidt, B. E.; Legare, F.] INRS EMT, Varennes, PQ J3X 1S2, Canada; [Corkum, P. B.] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada	University of Ottawa; University of Quebec; Institut national de la recherche scientifique (INRS); National Research Council Canada	Corkum, PB (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.	gvamp015@uottawa.ca; paul.corkum@nrc.ca		Corkum, Paul/0000-0003-3394-5572	US AFOSR; NSERC; FRQNT; MDEIE; CFI	US AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQNT; MDEIE; CFI(Canada Foundation for Innovation)	We thank A. Laramee from the Advanced Laser Light Source for technical support during the experiment and M. Clerici for lending some equipment. We acknowledge financial support from the US AFOSR, NSERC, FRQNT, MDEIE and CFI.	BRUNEL F, 1990, J OPT SOC AM B, V7, P521, DOI 10.1364/JOSAB.7.000521; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Dudovich N, 2006, NAT PHYS, V2, P781, DOI 10.1038/nphys434; Eremets MI, 2011, NAT MATER, V10, P927, DOI [10.1038/NMAT3175, 10.1038/nmat3175]; Gertsvolf M, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/13/131002; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Golde D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075330; Golde D, 2011, PHYS STATUS SOLIDI B, V248, P863, DOI 10.1002/pssb.201000840; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Hawkins PG, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.013405; He X, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.033410; Higuchi T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.213901; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Kemper AF, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/023003; Krausz F, 2014, NAT PHOTONICS, V8, P205, DOI 10.1038/nphoton.2014.28; LHUILLIER A, 1993, PHYS REV LETT, V70, P774, DOI 10.1103/PhysRevLett.70.774; Niikura H, 2003, NATURE, V421, P826, DOI 10.1038/nature01430; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Schultze M, 2014, SCIENCE, V346, P1348, DOI 10.1126/science.1260311; Schultze M, 2013, NATURE, V493, P75, DOI 10.1038/nature11720; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]; Shafir D, 2012, NATURE, V485, P343, DOI 10.1038/nature11025; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Spielmann C, 1997, SCIENCE, V278, P661, DOI 10.1126/science.278.5338.661; Stuart BC, 1996, PHYS REV B, V53, P1749, DOI 10.1103/PhysRevB.53.1749; Ulstrup S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.257401; Vampa G, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.064302; Vampa G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.073901; Vu QT, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217403; Worner HJ, 2010, NATURE, V466, P604, DOI 10.1038/nature09185; Zaks B, 2012, NATURE, V483, P580, DOI 10.1038/nature10864	33	449	456	15	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					462	+		10.1038/nature14517	http://dx.doi.org/10.1038/nature14517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108855	Green Published			2022-12-28	WOS:000356782900046
J	Sato, T; Clevers, H				Sato, Toshiro; Clevers, Hans			SnapShot: Growing Organoids from Stem Cells	CELL			English	Editorial Material							IN-VITRO; EXPANSION; LIVER	Tissue stem cells require unique niche microenvironments. In the presence of specific combinations of niche factors, mouse and human epithelial tissues from stomach, small intestine, colon, pancreas duct, and liver bile duct efficiently form stereotypic organoids. The platform of epitheloid organoids can also be employed for in vitro generation of digestive tissue from human pluripotent stem cells. Organoids hold great promise for basic and translational research.	[Sato, Toshiro] Keio Univ, Sch Med, Dept Gastroenterol, Tokyo 1608582, Japan; [Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Keio University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Sato, T (corresponding author), Keio Univ, Sch Med, Dept Gastroenterol, Tokyo 1608582, Japan.		Sato, Toshiro/J-3522-2014	Sato, Toshiro/0000-0001-8353-8137				Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691	10	89	100	4	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7							1700.e1	10.1016/j.cell.2015.06.028	http://dx.doi.org/10.1016/j.cell.2015.06.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091044	Bronze			2022-12-28	WOS:000356618200025
J	[Anonymous]				[Anonymous]			Africa	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S28	S29		10.1038/522S28a	http://dx.doi.org/10.1038/522S28a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083858	Bronze			2022-12-28	WOS:000356425400011
J	Cole, TB				Cole, Thomas B.			Untitled Otis Dozier	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2306	2307		10.1001/jama.2014.11807	http://dx.doi.org/10.1001/jama.2014.11807			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080324				2022-12-28	WOS:000356300200034
J	Admasu, K; Debessa, K				Admasu, Kesetebirhan; Debessa, Kare			Action to protect human health from climate change: an African perspective	LANCET			English	Editorial Material									[Admasu, Kesetebirhan] Govt Ethiopia, Fed Minist Hlth, Addis Ababa, Ethiopia; [Debessa, Kare] Govt Ethiopia, Fed Minist Environm & Forest, Addis Ababa, Ethiopia	Federal Ministry of Health - Ethiopia (FMOH)	Admasu, K (corresponding author), Govt Ethiopia, Fed Minist Hlth, Addis Ababa, Ethiopia.	moh@ethionet.et						Dessalegn M, 2013, VOICES SOURCE STRUGG; Emmelin Anders, 2008, Glob Health Action, V2, DOI [10.3402/gha.v1i0.1829, 10.3402/gha.v2i0.1829]; Federal Democratic Republic of Ethiopia, 2011, ETH CLIM RES GREEN E; Hagos S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-884; Horton R, 2014, LANCET, V383, P847, DOI 10.1016/S0140-6736(14)60409-8; International Energy Agency, 2014, AFR EN OUTL; United Nations Development Programme, 2014, ETH STRENGTH CLIM IN; United Nations Environment Programme, 2015, AFR MIN CALL AD MIT; United Nations Environment Programme, 2015, AFR AD GAP 2; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6	10	5	6	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					E31	E33		10.1016/S0140-6736(15)61139-4	http://dx.doi.org/10.1016/S0140-6736(15)61139-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3VO	26111435				2022-12-28	WOS:000364194700003
J	Perl, TM; Price, CS				Perl, Trish M.; Price, Connie Savor			Orchestrated Scientific Collaboration: Critical to the Control of MERS- CoV	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Univ Colorado, Sch Med, Aurora, CO USA	Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus	Perl, TM (corresponding author), Johns Hopkins Med, Dept Epidemiol & Infect Prevent, 600 North Wolfe St,Osler 327A, Baltimore, MD 21287 USA.	tperl@jhmi.edu						[Anonymous], 2013, GUARDIAN; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Laursen L, 2013, NAT BIOTECHNOL, V31, P671, DOI 10.1038/nbt0813-671; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Sanburn J, 2013, TOP 10 UNDERREPORTED; Zimmerman RK, 2014, INFLUENZA OTHER RESP, V8, P397, DOI 10.1111/irv.12247	6	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					313	+		10.7326/M15-1395	http://dx.doi.org/10.7326/M15-1395			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LC	26098095				2022-12-28	WOS:000360286400012
J	McKinney, EF; Lee, JC; Jayne, DRW; Lyons, PA; Smith, KGC				McKinney, Eoin F.; Lee, James C.; Jayne, David R. W.; Lyons, Paul A.; Smith, Kenneth G. C.			T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection	NATURE			English	Article							ACUTE HEPATITIS-C; GENE-EXPRESSION; PREDICTS PROGNOSIS; ACTIVITY INDEX; DISEASE; INTERFERON; SIGNATURE; RESPONSES; BIOLOGY	The clinical course of autoimmune and infectious disease varies greatly, even between individuals with the same condition. An understanding of the molecular basis for this heterogeneity could lead to significant improvements in both monitoring and treatment. During chronic infection the process of T-cell exhaustion inhibits the immune response, facilitating viral persistence(1). Here we show that a transcriptional signature reflecting CD8 T-cell exhaustion is associated with poor clearance of chronic viral infection, but conversely predicts better prognosis in multiple autoimmune diseases. The development of CD8 T-cell exhaustion during chronic infection is driven both by persistence of antigen and by a lack of accessory 'help' signals. In autoimmunity, we find that where evidence of CD4 T-cell co-stimulation is pronounced, that of CD8 T-cell exhaustion is reduced. We can reproduce the exhaustion signature by modifying the balance of persistent stimulation of T-cell antigen receptors and specific CD2-induced co-stimulation provided to human CD8 T cells in vitro, suggesting that each process plays a role in dictating outcome in autoimmune disease. The 'non-exhausted' T-cell state driven by CD2-induced co-stimulation is reduced by signals through the exhaustion-associated inhibitory receptor PD-1, suggesting that induction of exhaustion may be a therapeutic strategy in autoimmune and inflammatory disease. Using expression of optimal surrogate markers of co-stimulation/exhaustion signatures in independent data sets, we confirm an association with good clinical outcome or response to therapy in infection (hepatitis C virus) and vaccination (yellow fever, malaria, influenza), but poor outcome in autoimmune and inflammatory disease (type 1 diabetes, anti-neutrophil cytoplasmic antibody-associated vasculitis, systemic lupus erythematosus, idiopathic pulmonary fibrosis and dengue haemorrhagic fever). Thus, T-cell exhaustion plays a central role in determining outcome in autoimmune disease and targeted manipulation of this process could lead to new therapeutic opportunities.	[McKinney, Eoin F.; Lee, James C.; Jayne, David R. W.; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; [McKinney, Eoin F.; Lee, James C.; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	McKinney, EF (corresponding author), Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 0QQ, England.	efm30@cam.ac.uk; kgcs2@cam.ac.uk	Lee, James/ABD-5920-2020	Lee, James/0000-0001-5711-9385; McKinney, Eoin/0000-0003-3516-3072; Smith, Kenneth/0000-0003-3829-4326; Jayne, David/0000-0002-1712-0637	National Institute of Health Research (NIHR); Cambridge Biomedical Research Centre; Wellcome Trust [094227/Z/10/Z, 083650/Z/07/Z, 079895]; Lister Prize Fellowship; Lupus Research Institute; Beit Foundation [104064/Z/14/Z]; MRC [G0400929, MR/L019027/1] Funding Source: UKRI; Medical Research Council [G0400929, MR/L019027/1] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); Wellcome Trust(Wellcome Trust); Lister Prize Fellowship; Lupus Research Institute; Beit Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The National Institute of Health Research (NIHR), Cambridge Biomedical Research Centre and funded by the Wellcome Trust (project 094227/Z/10/Z and program grants 083650/Z/07/Z), a Lister Prize Fellowship (K.G.C.S) and the Lupus Research Institute (Distinguished Innovator Award, K.G.C.S). E.F.M. is a Wellcome-Beit Research Fellow supported by the Wellcome Trust and Beit Foundation (104064/Z/14/Z). The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895). We thank A. Kaser and J. Todd for reviewing the manuscript, staff of the NIHR Cambridge Biomedical Research Centre Cell Phenotyping hub and the patients who provided samples.	[Anonymous], 2003, ING PATHW AN; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bienkowska JR, 2009, GENOMICS, V94, P423, DOI 10.1016/j.ygeno.2009.08.008; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cramp ME, 2000, GASTROENTEROLOGY, V118, P346, DOI 10.1016/S0016-5085(00)70217-4; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elo LL, 2010, J AUTOIMMUN, V35, P70, DOI 10.1016/j.jaut.2010.03.001; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; HARVEY RF, 1980, LANCET, V1, P1134; Herazo-Maya JD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005964; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lauer GM, 2005, J VIROL, V79, P12979, DOI 10.1128/JVI.79.20.12979-12988.2005; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Long TH, 2010, J VIROL, V84, P12982, DOI 10.1128/JVI.01224-10; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Shum AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006998; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stone JH, 2001, ARTHRITIS RHEUM, V44, P912, DOI 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Taylor MW, 2007, J VIROL, V81, P3391, DOI 10.1128/JVI.02640-06; Toonen EJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033199; Urbani S, 2006, HEPATOLOGY, V44, P126, DOI 10.1002/hep.21242; Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Walmsley RS, 1998, GUT, V43, P29, DOI 10.1136/gut.43.1.29; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499	55	381	394	8	121	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					612	+		10.1038/nature14468	http://dx.doi.org/10.1038/nature14468			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26123020	Green Submitted, Green Accepted			2022-12-28	WOS:000358655200049
J	Murray, T; Nettles, M; Selmes, N; Cathles, LM; Burton, JC; James, TD; Edwards, S; Martin, I; O'Farrell, T; Aspey, R; Rutt, I; Bauge, T				Murray, T.; Nettles, M.; Selmes, N.; Cathles, L. M.; Burton, J. C.; James, T. D.; Edwards, S.; Martin, I.; O'Farrell, T.; Aspey, R.; Rutt, I.; Bauge, T.			Reverse glacier motion during iceberg calving and the cause of glacial earthquakes	SCIENCE			English	Article							GREENLAND	Nearly half of Greenland's mass loss occurs through iceberg calving, but the physical mechanisms operating during calving are poorly known and in situ observations are sparse. We show that calving at Greenland's Helheim Glacier causes a minutes-long reversal of the glacier's horizontal flow and a downward deflection of its terminus. The reverse motion results from the horizontal force caused by iceberg capsize and acceleration away from the glacier front. The downward motion results from a hydrodynamic pressure drop behind the capsizing berg, which also causes an upward force on the solid Earth. These forces are the source of glacial earthquakes, globally detectable seismic events whose proper interpretation will allow remote sensing of calving processes occurring at increasing numbers of outlet glaciers in Greenland and Antarctica.	[Murray, T.; Selmes, N.; James, T. D.; Rutt, I.] Swansea Univ, Coll Sci, Dept Geog, Glaciol Grp, Swansea SA2 8PP, W Glam, Wales; [Nettles, M.] Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10964 USA; [Cathles, L. M.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Burton, J. C.] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Edwards, S.; Martin, I.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [O'Farrell, T.; Aspey, R.] Univ Sheffield, Dept Elect & Elect Engn, Sheffield S1 3JD, S Yorkshire, England; [Bauge, T.] Thales UK, Res & Technol, Reading RG2 0SB, Berks, England	Swansea University; Columbia University; University of Michigan System; University of Michigan; Emory University; Newcastle University - UK; University of Sheffield; Thales Group	Murray, T (corresponding author), Swansea Univ, Coll Sci, Dept Geog, Glaciol Grp, Swansea SA2 8PP, W Glam, Wales.	t.murray@swansea.ac.uk	Selmes, Nick/N-3634-2013; James, Timothy/C-9219-2013; Nettles, Meredith/A-8638-2012; Burton, Justin C/M-9735-2016; O'Farrell, Timothy/D-8784-2015	Selmes, Nick/0000-0002-6557-1379; James, Timothy/0000-0003-4082-7822; Nettles, Meredith/0000-0003-4613-4162; Burton, Justin C/0000-0002-4797-8968; O'Farrell, Timothy/0000-0002-7870-4097; Murray, Tavi/0000-0001-6714-6512; Martin, Ian/0000-0002-5703-4709	Natural Environment Research Council UK [NE/I007148/1]; Royal Society Leverhulme Trust Senior Research Fellowship; Climate Change Consortium of Wales (C3W); U.S. NSF [EAR-1249167]; Michigan Society of Fellows; NSF [ANT-0944193, ANT-0424589]; NASA [NNX10AT68G]; Natural Environment Research Council [NE/I007148/1] Funding Source: researchfish; NERC [NE/I007148/1] Funding Source: UKRI; Division Of Earth Sciences [1261833] Funding Source: National Science Foundation	Natural Environment Research Council UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society Leverhulme Trust Senior Research Fellowship; Climate Change Consortium of Wales (C3W); U.S. NSF(National Science Foundation (NSF)); Michigan Society of Fellows; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the Natural Environment Research Council UK grant NE/I007148/1. T.M. is currently supported by a Royal Society Leverhulme Trust Senior Research Fellowship. T.D.J. was supported by the Climate Change Consortium of Wales (C3W). M.N. was supported by U.S. NSF grant EAR-1249167. L.M.C. is currently supported by the Michigan Society of Fellows. J.B. and L.M.C. were supported and the laboratory equipment was developed with support from NSF grant ANT-0944193. A. Everett is thanked for assistance in the field and L. Kaluzienski for assistance with laboratory data. We thank the staff of the Civil Engineering and Geosciences workshop, Newcastle University, for GPS sensor construction. We acknowledge the use of bed data from the Center for Remote Sensing of Ice Sheets, generated with support from NSF grant ANT-0424589 and NASA grant NNX10AT68G, and the use of seismic data from the Incorporated Research Institutions for Seismology (IRIS)-U.S. Geological Survey Global Seismographic Network, Geoscope, Geofon, Mednet, and the Greenland Ice Sheet Monitoring Network. A 2013 lidar survey flown by the Natural Environment Resource Council Airborne Remote Sensing Facility was used in the processing of photographs. Seismic waveforms are available from the IRIS Data Management Center (NSF EAR-1261681); GPS data are available from UNAVCO (NSF EAR-1261833).	Amundson JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035281; Amundson JM, 2012, ANN GLACIOL, V53, P106, DOI 10.3189/2012/AoG60A012; Burton JC, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002055; Ekstrom G, 2006, SCIENCE, V311, P1756, DOI 10.1126/science.1122112; Ekstrom G, 2003, SCIENCE, V302, P622, DOI 10.1126/science.1088057; EKSTROM G, 1989, J GEOPHYS RES-SOLID, V94, P15499, DOI 10.1029/JB094iB11p15499; Ekstrom G, 2006, B SEISMOL SOC AM, V96, P1201, DOI 10.1785/0120050175; Enderlin EM, 2014, GEOPHYS RES LETT, V41, P866, DOI 10.1002/2013GL059010; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2011, J GLACIOL, V57, P389, DOI 10.3189/002214311796905631; James TD, 2014, NAT GEOSCI, V7, P594, DOI 10.1038/NGEO2204; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000837; Luckman A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025428; Martin I, 2014, IEEE SENS J, V14, P3926, DOI 10.1109/JSEN.2014.2348534; Murray T, 2015, J GEOPHYS RES-EARTH, V120, P964, DOI 10.1002/2015JF003531; Nettles M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036127; Nettles M, 2010, ANNU REV EARTH PL SC, V38, P467, DOI 10.1146/annurev-earth-040809-152414; Tsai VC, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000596; Tsai VC, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000944; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Veitch SA, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2012JF002412; Walter F, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002132	23	33	33	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		305	308		10.1126/science.aab0460	http://dx.doi.org/10.1126/science.aab0460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26113640	Green Accepted, Green Submitted			2022-12-28	WOS:000358218600051
J	Salas, RN				Salas, Renee N.			Humanity, Teamwork, and Art in Post-Earthquake Nepal	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Salas, Renee N.] Massachusetts Gen Hosp, Dept Emergency Med, Div Wilderness Med, Boston, MA 02114 USA; [Salas, Renee N.] Harvard Univ, Sch Med, Dept Emergency Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Salas, RN (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Div Wilderness Med, Boston, MA 02114 USA.								0	3	3	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					205	207		10.1056/NEJMp1506643	http://dx.doi.org/10.1056/NEJMp1506643			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM8MS	26083121	Bronze			2022-12-28	WOS:000357956200003
J	Harnik, IG				Harnik, Ian G.			Gastroesophageal Reflux Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PROTON-PUMP INHIBITORS; ESOPHAGEAL PH; MANAGEMENT; DIAGNOSIS; METAANALYSIS; SYMPTOMS; TRIAL; FUNDOPLICATION; QUESTIONNAIRE; OMEPRAZOLE											Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Boeckxstaens GE, 2014, GASTROENTEROL CLIN N, V43, P15, DOI 10.1016/j.gtc.2013.11.001; Bytzer P, 2012, CLIN GASTROENTEROL H, V10, P1360, DOI 10.1016/j.cgh.2012.06.030; Chen M, 2012, CARDIOVASC THER, V30, pe227, DOI 10.1111/j.1755-5922.2011.00289.x; de Bortoli N, 2012, WORLD J GASTROENTERO, V18, P4363, DOI 10.3748/wjg.v18.i32.4363; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Dent J, 2010, GUT, V59, P714, DOI 10.1136/gut.2009.200063; Estores DS, 2014, GASTROENTEROL CLIN N, V43, P27, DOI 10.1016/j.gtc.2013.11.002; Fackler WK, 2002, GASTROENTEROLOGY, V122, P625, DOI 10.1053/gast.2002.31876; Fass R, 2006, CLIN GASTROENTEROL H, V4, P50, DOI 10.1016/S1542-3565(05)00860-8; Ganz RA, 2013, NEW ENGL J MED, V368, P719, DOI 10.1056/NEJMoa1205544; GARCIARODRIGUEZ LA, 2005, GUT S7, V54, pA75; Gerson LB, 2012, ALIMENT PHARM THER, V35, P803, DOI 10.1111/j.1365-2036.2012.05016.x; Gerson Lauren B, 2012, Gastroenterol Hepatol (N Y), V8, P763; Gralnek IM, 2006, CLIN GASTROENTEROL H, V4, P1452, DOI 10.1016/j.cgh.2006.09.013; Grant AM, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17220; Haastrup P, 2014, FAM PRACT, V31, P625, DOI 10.1093/fampra/cmu050; Hallan A, 2015, AM J GASTROENTEROL, V110, P393, DOI 10.1038/ajg.2015.18; Howlader N, SEER CANC STAT REV; Hunter JG, 2015, GASTROENTEROLOGY, V148, P324, DOI 10.1053/j.gastro.2014.10.009; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Ip S, 2011, COMP EFFECTIVENESS M; Jacobson BC, 2006, NEW ENGL J MED, V354, P2340, DOI 10.1056/NEJMoa054391; JOHNSSON F, 1987, SCAND J GASTROENTERO, V22, P714, DOI 10.3109/00365528709011148; Johnston BT, 1996, AM J GASTROENTEROL, V91, P1181; Kahrilas PJ, 2008, GASTROENTEROLOGY, V135, P1392, DOI 10.1053/j.gastro.2008.08.044; Kaltenbach T, 2006, ARCH INTERN MED, V166, P965, DOI 10.1001/archinte.166.9.965; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Khan M, 2007, COCHRANE DB SYST REV, V2; Khan M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003244.pub2; Lichtenstein DR, 2007, GASTROINTEST ENDOSC, V66, P219, DOI 10.1016/j.gie.2007.05.027; Lipka S, 2014, CLIN GASTROENTEROL H; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Ngamruengphong S, 2011, AM J GASTROENTEROL, V106, P1209, DOI 10.1038/ajg.2011.113; Numans ME, 2004, ANN INTERN MED, V140, P518, DOI 10.7326/0003-4819-140-7-200404060-00011; Pace F, 2007, ALIMENT PHARM THER, V26, P195, DOI 10.1111/j.1365-2036.2007.03381.x; RICHTER JE, 1982, ANN INTERN MED, V97, P93, DOI 10.7326/0003-4819-97-1-93; Shaheen NJ, 2012, ANN INTERN MED, V157, P808, DOI 10.7326/0003-4819-157-11-201212040-00008; Shakhatreh MH, 2015, CLIN GASTROENTEROL H, V13, P280, DOI 10.1016/j.cgh.2014.06.029; Shaw MJ, 2001, AM J GASTROENTEROL, V96, P52; Sigterman KE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002095.pub5; Simon Thomas J., 1995, Am J Ther, V2, P304, DOI 10.1097/00045391-199505000-00003; Smith Jaclyn A, 2013, Cough, V9, P12, DOI 10.1186/1745-9974-9-12; Song H, 2014, COCHRANE DB SYST REV, V12; Sontag SJ, 2006, J CLIN GASTROENTEROL, V40, P398, DOI 10.1097/00004836-200605000-00007; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Vaezi MF, 2008, GASTROENTEROLOGY, V135; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Vakil NB, 2013, EUR J GASTROEN HEPAT, V25, P2, DOI 10.1097/MEG.0b013e328358bf74; VAN DE, 2002, COCHRANE DB SYST REV; van der Woude CJ, 2014, GUT, V63, P1014, DOI 10.1136/gutjnl-2013-305418; VIGNERI S, 1995, NEW ENGL J MED, V333, P1106, DOI 10.1056/NEJM199510263331703; Wileman SM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003243.pub2; Witteman BPL, 2015, AM J GASTROENTEROL, V110, P531, DOI 10.1038/ajg.2015.28; Yadlapati R, 2015, CLIN GASTROENTEROL H, V13, P874, DOI 10.1016/j.cgh.2014.11.012	55	7	7	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1							ITC1	10.7326/AITC201507070	http://dx.doi.org/10.7326/AITC201507070			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	26148292				2022-12-28	WOS:000357442000019
J	Dusselier, M; Van Wouwe, P; Dewaele, A; Jacobs, PA; Sels, BF				Dusselier, Michiel; Van Wouwe, Pieter; Dewaele, Annelies; Jacobs, Pierre A.; Sels, Bert F.			Shape-selective zeolite catalysis for bioplastics production	SCIENCE			English	Article							LACTIC-ACID; BIOMASS; CONVERSION	Biodegradable and renewable polymers, such as polylactic acid, are benign alternatives for petrochemical-based plastics. Current production of polylactic acid via its key building block lactide, the cyclic dimer of lactic acid, is inefficient in terms of energy, time, and feedstock use. We present a direct zeolite-based catalytic process, which converts lactic acid into lactide. The shape-selective properties of zeolites are essential to attain record lactide yields, outperforming those of the current multistep process by avoiding both racemization and side-product formation. The highly productive process is strengthened by facile recovery and practical reactivation of the catalyst, which remains structurally fit during at least six consecutive reactions, and by the ease of solvent and side-product recycling.	[Dusselier, Michiel; Van Wouwe, Pieter; Dewaele, Annelies; Jacobs, Pierre A.; Sels, Bert F.] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, B-3001 Heverlee, Belgium	KU Leuven	Dusselier, M (corresponding author), CALTECH, Chem Engn, 1200 East Calif Blvd,MSC 210-4, Pasadena, CA 91125 USA.	michiel.dusselier@gmail.com; bert.sels@biw.kuleuven.be	Dusselier, Michiel J./N-3190-2016		Research Foundation-Flanders (FWO); Belgian American Educational Foundation; Research Council of KU Leuven [IDO KP/14/003]	Research Foundation-Flanders (FWO)(FWO); Belgian American Educational Foundation; Research Council of KU Leuven(KU Leuven)	M.D. acknowledges Research Foundation-Flanders (FWO) for financial support and the Belgian American Educational Foundation for his honorary fellowship. B.F.S thanks the Research Council of KU Leuven, IDO KP/14/003. Patent applications are pending for inventors M.D and B.F.S (EP/WO). All data are available in the supplementary materials.	Abdel-Rahman MA, 2013, BIOTECHNOL ADV, V31, P877, DOI 10.1016/j.biotechadv.2013.04.002; Cheng YT, 2012, ANGEW CHEM INT EDIT, V51, P11097, DOI 10.1002/anie.201205230; CORMA A, 1995, CHEM REV, V95, P559, DOI 10.1021/cr00035a006; Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d; Dusselier M, 2013, ACS CATAL, V3, P1786, DOI 10.1021/cs400298n; Dusselier M, 2013, ENERG ENVIRON SCI, V6, P1415, DOI 10.1039/c3ee00069a; Emel'yanenko VN, 2010, RUSS J PHYS CHEM A+, V84, P1491, DOI 10.1134/S0036024410090074; Gerhardt WW, 2006, BIOMACROMOLECULES, V7, P1735, DOI 10.1021/bm060024j; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; Gruber P, 1993, US Patent No, Patent No. 5247058; Holm MS, 2010, SCIENCE, V328, P602, DOI 10.1126/science.1183990; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Jacobs PA, 2014, ANGEW CHEM INT EDIT, V53, P8621, DOI 10.1002/anie.201400922; Jones CW, 1998, NATURE, V393, P52, DOI 10.1038/29959; Lange JP, 2009, CHEMSUSCHEM, V2, P437, DOI 10.1002/cssc.200800216; Law KL, 2014, SCIENCE, V345, P144, DOI 10.1126/science.1254065; Mueller M., 1988, European patent, Patent No. [261572A1, 261572]; O'Brien W. G., 1996, WO patent, Patent No. [9606092A1, 9606092]; Roman-Leshkov Y, 2007, NATURE, V447, P982, DOI 10.1038/nature05923; Sharninghausen LS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6084; Shen L, 2010, BIOFUEL BIOPROD BIOR, V4, P25, DOI 10.1002/bbb.189; Smit B, 2008, NATURE, V451, P671, DOI 10.1038/nature06552; Traa, 2008, HDB HETEROGENEOUS CA, DOI DOI 10.1002/9783527610044.HETCAT0130; Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930; Vink ETH, 2003, POLYM DEGRAD STABIL, V80, P403, DOI 10.1016/S0141-3910(02)00372-5; Vispute TP, 2010, SCIENCE, V330, P1222, DOI 10.1126/science.1194218; Vu DT, 2005, FLUID PHASE EQUILIBR, V236, P125, DOI 10.1016/j.fluid.2005.06.021; WEISZ PB, 1980, PURE APPL CHEM, V52, P2091, DOI 10.1351/pac198052092091	29	210	219	33	626	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					78	80		10.1126/science.aaa7169	http://dx.doi.org/10.1126/science.aaa7169			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138977				2022-12-28	WOS:000357280800062
J	Gumz, ML; Rabinowitz, L; Wingo, CS				Gumz, Michelle L.; Rabinowitz, Lawrence; Wingo, Charles S.			An Integrated View of Potassium Homeostasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HYPOKALEMIC PERIODIC PARALYSIS; CIRCADIAN TIMING SYSTEM; BLOOD-PRESSURE CONTROL; H+-K+-ATPASES; RENAL EXCRETION; SERUM POTASSIUM; CLOCK; EXPRESSION; MOUSE; RHYTHMS		[Gumz, Michelle L.; Wingo, Charles S.] Univ Florida, Dept Med, Gainesville, FL USA; [Gumz, Michelle L.] Univ Florida, Dept Mol Biol & Biochem, Gainesville, FL USA; [Wingo, Charles S.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Wingo, Charles S.] North Florida South Georgia Vet Hlth Syst, Gainesville, FL USA; [Wingo, Charles S.] Malcom Randall Vet Affairs VA Med Ctr, Gainesville, FL USA; [Rabinowitz, Lawrence] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Davis	Wingo, CS (corresponding author), Malcom Randall VA Med Ctr, Nephrol Sect, 111G,1601 Archer Rd, Gainesville, FL 32608 USA.		Gumz, Michelle/AGX-2097-2022	Gumz, Michelle/0000-0002-1342-0878	ZS Pharma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085193, R03DK098460, R01DK082680] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001472] Funding Source: NIH RePORTER	ZS Pharma; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Dr. Wingo reports receiving consulting fees from ZS Pharma. No other potential conflict of interest relevant to this article was reported.	Agarwal A, 1999, NEW ENGL J MED, V340, P154; [Anonymous], 2011, ZONING, V301, pR421; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; Asmar A, 2012, AM J KIDNEY DIS, V60, P492, DOI 10.1053/j.ajkd.2012.01.031; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bass J, 2011, NATURE, V469, P476, DOI 10.1038/469476a; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bettinelli A, 2000, PEDIATR NEPHROL, V14, P940, DOI 10.1007/PL00013418; CALO L, 1995, NEPHRON, V69, P253, DOI 10.1159/000188466; Cheng CJ, 2013, SEMIN NEPHROL, V33, P237, DOI 10.1016/j.semnephrol.2013.04.004; Cope TE, 2013, J EMERG MED, V45, P338, DOI 10.1016/j.jemermed.2012.11.107; Crambert G, 2014, AM J PHYSIOL-RENAL, V306, pF693, DOI 10.1152/ajprenal.00605.2013; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; El Moghrabi S, 2010, P NATL ACAD SCI USA, V107, P13526, DOI 10.1073/pnas.0913070107; Elabida B, 2011, KIDNEY INT, V80, P256, DOI 10.1038/ki.2011.15; ELLIOTT AL, 1972, J PHYSIOL-LONDON, V221, P227, DOI 10.1113/jphysiol.1972.sp009750; ERNSBERGER P, 1981, LIFE SCI, V28, P1387, DOI 10.1016/0024-3205(81)90413-6; Fontaine B, 1996, KIDNEY INT, V49, P9, DOI 10.1038/ki.1996.2; Gordon D L, 1998, Endocr Pract, V4, P142; Goyal A, 2012, JAMA-J AM MED ASSOC, V307, P157, DOI 10.1001/jama.2011.1967; Graziani G, 2010, QJM-INT J MED, V103, P741, DOI 10.1093/qjmed/hcq123; Greenlee M, 2009, ANN INTERN MED, V150, P619, DOI 10.7326/0003-4819-150-9-200905050-00008; Greenlee MM, 2011, J AM SOC NEPHROL, V22, P49, DOI 10.1681/ASN.2010030311; GREKIN RJ, 1980, HYPERTENSION, V2, P326, DOI 10.1161/01.HYP.2.3.326; Gumz ML, 2013, SEMIN NEPHROL, V33, P229, DOI 10.1016/j.semnephrol.2013.04.003; Gumz ML, 2010, AM J PHYSIOL-RENAL, V298, pF12, DOI 10.1152/ajprenal.90723.2008; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Hermida RC, 2013, NAT REV NEPHROL, V9, P358, DOI 10.1038/nrneph.2013.79; Hermida RC, 2011, J AM SOC NEPHROL, V22, P2313, DOI 10.1681/ASN.2011040361; HULTER HN, 1978, AM J PHYSIOL, V235, pF298, DOI 10.1152/ajprenal.1978.235.4.F298; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klevecz RR, 2007, COLD SPRING HARB SYM, V72, P421, DOI 10.1101/sqb.2007.72.040; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kumar V, 2014, TROP DOCT, V44, P33, DOI 10.1177/0049475513512643; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Lin SH, 2012, J AM SOC NEPHROL, V23, P985, DOI 10.1681/ASN.2012010046; Linus S, 2014, COMPREHENSIVE CLIN N, P118; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Malnic G., 2013, SELDIN GIEBISCHS KID, V5th, P1659, DOI [10.1016/B978-0-12-381462-3.00049-5, DOI 10.1016/B978-0-12-381462-3.00049-5]; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; MILLS JN, 1966, PHYSIOL REV, V46, P128, DOI 10.1152/physrev.1966.46.1.128; MILLS JN, 1961, J PHYSIOL-LONDON, V156, P415, DOI 10.1113/jphysiol.1961.sp006684; MOOREEDE MC, 1977, AM J PHYSIOL, V233, pR230, DOI 10.1152/ajpregu.1977.233.5.R230; MOOREEDE MC, 1975, J APPL PHYSIOL, V38, P163, DOI 10.1152/jappl.1975.38.1.163; MOOREEDE MC, 1986, AM J PHYSIOL, V250, pR737, DOI 10.1152/ajpregu.1986.250.5.R737; MOOREEDE MC, 1977, AM J PHYSIOL, V232, pF128, DOI 10.1152/ajprenal.1977.232.2.F128; Mount DB, 2012, BRENNER RECTORS KIDN, P640; Nikolaeva S, 2012, J AM SOC NEPHROL, V23, P1019, DOI 10.1681/ASN.2011080842; Oh KS, 2011, AM J PHYSIOL-REG I, V301, pR421, DOI 10.1152/ajpregu.00095.2011; Oh YT, 2013, AM J PHYSIOL-REG I, V304, pR1166, DOI 10.1152/ajpregu.00495.2012; PAN YJ, 1982, HYPERTENSION, V4, P279, DOI 10.1161/01.HYP.4.2.279; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Ptacek LJ, 1997, NEUROMUSCULAR DISORD, V7, P250, DOI 10.1016/S0960-8966(97)00046-1; RABELINK TJ, 1990, KIDNEY INT, V38, P942, DOI 10.1038/ki.1990.295; RABINOWITZ L, 1993, FRONT NEUROENDOCRIN, V14, P1, DOI 10.1006/frne.1993.1001; Salhi A, 2012, FASEB J, V26, P2859, DOI 10.1096/fj.11-199711; SCHWARTZ WB, 1955, NEW ENGL J MED, V253, P601, DOI 10.1056/NEJM195510062531405; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Silver RB, 1999, AM J PHYSIOL-RENAL, V276, pF799, DOI 10.1152/ajprenal.1999.276.6.F799; Silver RB, 1996, AM J PHYSIOL-RENAL, V270, pF539, DOI 10.1152/ajprenal.1996.270.3.F539; Sinha AD, 2013, SEMIN NEPHROL, V33, P290, DOI 10.1016/j.semnephrol.2013.04.009; Smyth A, 2014, KIDNEY INT, V86, P1205, DOI 10.1038/ki.2014.214; Stow LR, 2012, HYPERTENSION, V59, P1151, DOI 10.1161/HYPERTENSIONAHA.112.190892; STOYNEV AG, 1982, PHYSIOL BEHAV, V29, P35, DOI 10.1016/0031-9384(82)90362-6; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Torlen K, 2012, CLIN J AM SOC NEPHRO, V7, P1272, DOI 10.2215/CJN.00960112; van den Wildenberg MJ, 2015, AM J KIDNEY DIS, V65, P607, DOI 10.1053/j.ajkd.2014.09.026; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Walsh S, 2011, QJM-INT J MED, V104, P939, DOI 10.1093/qjmed/hcr095; WINGO CS, 1995, AM J PHYSIOL-RENAL, V269, pF1, DOI 10.1152/ajprenal.1995.269.1.F1; Yilmaz H, 2013, RHEUMATOL INT, V33, P1879, DOI 10.1007/s00296-011-2322-z; Youn JH, 2013, SEMIN NEPHROL, V33, P248, DOI 10.1016/j.semnephrol.2013.04.005; Youn JH, 2009, ANNU REV PHYSIOL, V71, P381, DOI 10.1146/annurev.physiol.010908.163241; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zheng D, 2008, AM J PHYSIOL-CELL PH, V294, pC126, DOI 10.1152/ajpcell.00464.2007; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106	85	143	146	4	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					60	72		10.1056/NEJMra1313341	http://dx.doi.org/10.1056/NEJMra1313341			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL8IS	26132942	Green Accepted			2022-12-28	WOS:000357218700008
J	Langendonk, JG; Balwani, M; Anderson, KE; Bonkovsky, HL; Anstey, AV; Bissell, DM; Bloomer, J; Edwards, C; Neumann, NJ; Parker, C; Phillips, JD; Lim, HW; Hamzavi, I; Deybach, JC; Kauppinen, R; Rhodes, LE; Frank, J; Murphy, GM; Karstens, FPJ; Sijbrands, EJG; de Rooij, FWM; Lebwohl, M; Naik, H; Goding, CR; Wilson, JHP; Desnick, RJ				Langendonk, J. G.; Balwani, M.; Anderson, K. E.; Bonkovsky, H. L.; Anstey, A. V.; Bissell, D. M.; Bloomer, J.; Edwards, C.; Neumann, N. J.; Parker, C.; Phillips, J. D.; Lim, H. W.; Hamzavi, I.; Deybach, J. -C.; Kauppinen, R.; Rhodes, L. E.; Frank, J.; Murphy, G. M.; Karstens, F. P. J.; Sijbrands, E. J. G.; de Rooij, F. W. M.; Lebwohl, M.; Naik, H.; Goding, C. R.; Wilson, J. H. P.; Desnick, R. J.			Afamelanotide for Erythropoietic Protoporphyria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MELANOCYTE-STIMULATING HORMONE; LIVER-DISEASE; MELANIN; ANALOG; PHOTOSENSITIVITY; PHOTOPROTECTION; METABOLISM; PORPHYRIAS	BACKGROUND Erythropoietic protoporphyria is a severe photodermatosis that is associated with acute phototoxicity. Patients with this condition have excruciating pain and a markedly reduced quality of life. We evaluated the safety and efficacy of an alpha-melanocyte-stimulating hormone analogue, afamelanotide, to decrease pain and improve quality of life. METHODS We conducted two multicenter, randomized, double-blind, placebo-controlled trials of subcutaneous implants containing 16 mg of afamelanotide. Patients in the European Union (74 patients) and the United States (94 patients) were randomly assigned, in a 1:1 ratio, to receive a subcutaneous implant containing either afamelanotide or placebo every 60 days (a total of five implants in the European Union study and three in the U.S study). The type and duration of sun exposure, number and severity of phototoxic reactions, and adverse events were recorded over the respective 180-day and 270-day study periods. Quality of life was assessed with the use of validated questionnaires. A subgroup of U.S. patients underwent photoprovocation testing. The primary efficacy end point was the number of hours of direct exposure to sunlight without pain. RESULTS In the U.S. study, the duration of pain-free time after 6 months was longer in the afamelanotide group (median, 69.4 hours, vs. 40.8 hours in the placebo group; P = 0.04). In the European Union study, the duration of pain-free time after 9 months was also longer in the afamelanotide group than in the placebo group (median, 6.0 hours vs. 0.8 hours; P = 0.005), and the number of phototoxic reactions was lower in the the afamelanotide group (77 vs. 146, P = 0.04). In both trials, quality of life improved with afamelanotide therapy. Adverse events were mostly mild; serious adverse events were not thought to be related to the study drug. CONCLUSIONS Afamelanotide had an acceptable side-effect and adverse-event profile and was associated with an increased duration of sun exposure without pain and improved quality of life in patients with erythropoietic protoporphyria. (Funded by Clinuvel Pharmaceuticals and others; ClinicalTrials.gov numbers, NCT01605136 and NCT00979745.)	[Langendonk, J. G.; Karstens, F. P. J.; Sijbrands, E. J. G.; de Rooij, F. W. M.; Wilson, J. H. P.] Erasmus MC, Ctr Lysosomal & Metab Dis, Dept Internal Med, Rotterdam, Netherlands; [Frank, J.] Maastricht Univ, Med Ctr, Dept Dermatol, Maastricht, Netherlands; [Balwani, M.; Naik, H.; Desnick, R. J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Lebwohl, M.] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Anderson, K. E.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Anderson, K. E.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Anderson, K. E.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Bonkovsky, H. L.] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27109 USA; [Anstey, A. V.; Edwards, C.] Royal Gwent Hosp, Newport, Gwent, Wales; [Rhodes, L. E.] Univ Manchester, Salford Royal Hosp, Ctr Dermatol, Manchester, Lancs, England; [Goding, C. R.] Univ Oxford, Nuffield Dept Med, Ludwig Inst Canc Res, Oxford, England; [Bissell, D. M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bloomer, J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Neumann, N. J.; Frank, J.] Univ Dusseldorf, Dept Dermatol, Dusseldorf, Germany; [Parker, C.; Phillips, J. D.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Lim, H. W.; Hamzavi, I.] Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA; [Deybach, J. -C.] Univ Paris Diderot, INSERM Unite 1149, Hop Univ Paris Nord Val de Seine, AP HP,Hop Louis Nourier, Colombes, France; [Kauppinen, R.] Univ Helsinki Hosp, Dept Med, Helsinki, Finland; [Kauppinen, R.] Univ Helsinki Hosp, Dept Dermatol, Helsinki, Finland; [Murphy, G. M.] Beaumont Hosp, Dept Dermatol, Dublin 9, Ireland	Erasmus University Rotterdam; Erasmus MC; Maastricht University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Wake Forest University; Royal Gwent Hospital; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Ludwig Institute for Cancer Research; University of Oxford; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Heinrich Heine University Dusseldorf; Utah System of Higher Education; University of Utah; Henry Ford Health System; Henry Ford Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Desnick, RJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 5th Ave & 100th St, New York, NY 10029 USA.	robert.desnick@mssm.edu	Lim, HW/GRY-3517-2022; Hamzavi, Iltefat/AAW-7320-2021; Bonkovsky, Herbert L./AAH-1892-2021; Rhodes, Lesley E/H-5324-2015; Sijbrands, Eric/A-1065-2009	Bonkovsky, Herbert L./0000-0001-7387-3230; Rhodes, Lesley E/0000-0002-9107-6654; Sijbrands, Eric/0000-0001-8857-7389; Goding, Colin/0000-0002-1614-3909; Anderson, Karl/0000-0002-6499-8573; Naik, Hetanshi/0000-0002-5894-7390; Kauppinen, Raili/0000-0002-8799-3425	Clinuvel Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL117199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK020503, K23DK095946] Funding Source: NIH RePORTER	Clinuvel Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by Clinuvel Pharmaceuticals and others; ClinicalTrials.gov numbers, NCT01605136 and NCT00979745.	Anderson KE, 2006, ONLINE METABOLIC MOL, P95; Anstey AV, 2007, GUT, V56, P1009, DOI 10.1136/gut.2006.097576; Balwani Manisha, 2013, Mol Med, V19, P26, DOI 10.2119/molmed.2012.00340; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Biolcati G, 2015, BRIT J DERMATOL, V172, P1601, DOI 10.1111/bjd.13598; BLOOMER JR, 1988, HEPATOLOGY, V8, P402, DOI 10.1002/hep.1840080235; Bonkovsky HL, 2013, COMPR PHYSIOL, V3, P365, DOI 10.1002/cphy.c120006; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; CASTRUCCI AMD, 1984, COMP BIOCHEM PHYS B, V78, P519, DOI 10.1016/0305-0491(84)90090-7; Fabrikant J, 2013, J DRUGS DERMATOL, V12, P775; Gouya L, 2006, AM J HUM GENET, V78, P2, DOI 10.1086/498620; Harms J, 2009, NEW ENGL J MED, V360, P306, DOI 10.1056/NEJMc0805682; Harms JH, 2009, PHOTOCHEM PHOTOBIOL, V85, P1434, DOI 10.1111/j.1751-1097.2009.00595.x; Hauser JE, 2006, PIGM CELL RES, V19, P303, DOI 10.1111/j.1600-0749.2006.00315.x; Haylett AK, 2011, BRIT J DERMATOL, V164, P407, DOI 10.1111/j.1365-2133.2010.10104.x; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; Holme SA, 2006, BRIT J DERMATOL, V155, P574, DOI 10.1111/j.1365-2133.2006.07472.x; KAIDBEY KH, 1979, J AM ACAD DERMATOL, V1, P249, DOI 10.1016/S0190-9622(79)70018-1; KOLLIAS N, 1991, J PHOTOCH PHOTOBIO B, V9, P135, DOI 10.1016/1011-1344(91)80147-A; Lecha M, 2003, PHOTODERMATOL PHOTO, V19, P142, DOI 10.1034/j.1600-0781.2002.00009.x; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Luger TA, 2000, ANN NY ACAD SCI, V917, P232; McGuire BM, 2005, LIVER TRANSPLANT, V11, P1590, DOI 10.1002/lt.20620; Minder EI, 2009, CELL MOL BIOL, V55, P84; Minder EI, 2015, EXPERT REV CLIN PHAR, V8, P43, DOI 10.1586/17512433.2014.956089; Murphy Gillian M, 2003, Dermatol Ther, V16, P57, DOI 10.1046/j.1529-8019.2003.01609.x; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Pago RA., 2014, GENEREVIEWS; Pathak MA, 1995, MELANIN: ITS ROLE IN HUMAN PHOTOPROTECTION, P125; Porter RM, 2014, EXP DERMATOL, V23, P543, DOI 10.1111/exd.12467; SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754; Thunell S, 2000, SCAND J CLIN LAB INV, V60, P561; TODD DJ, 1994, BRIT J DERMATOL, V131, P751, DOI 10.1111/j.1365-2133.1994.tb08577.x; Tollanes MC, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-93; Wahlin S, 2011, J INTERN MED, V269, P278, DOI 10.1111/j.1365-2796.2010.02236.x; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003	37	125	130	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					48	59		10.1056/NEJMoa1411481	http://dx.doi.org/10.1056/NEJMoa1411481			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL8IS	26132941	Green Accepted, Bronze			2022-12-28	WOS:000357218700007
J	Vincent, JB; Bodewits, D; Besse, S; Sierks, H; Barbieri, C; Lamy, P; Rodrigo, R; Koschny, D; Rickman, H; Keller, HU; Agarwal, J; A'Hearn, MF; Auger, AT; Barucci, MA; Bertaux, JL; Bertini, I; Capanna, C; Cremonese, G; Da Deppo, V; Davidsson, B; Debei, S; De Cecco, M; El-Maarry, MR; Ferri, F; Fornasier, S; Fulle, M; Gaskell, R; Giacomini, L; Groussin, O; Guilbert-Lepoutre, A; Gutierrez-Marques, P; Gutierrez, PJ; Guttler, C; Hoekzema, N; Hofner, S; Hviid, SF; Ip, WH; Jorda, L; Knollenberg, J; Kovacs, G; Kramm, R; Kuhrt, E; Kuppers, M; La Forgia, F; Lara, LM; Lazzarin, M; Lee, V; Leyrat, C; Lin, ZY; Moreno, JJL; Lowry, S; Magrin, S; Maquet, L; Marchi, S; Marzari, F; Massironi, M; Michalik, H; Moissl, R; Mottola, S; Naletto, G; Oklay, N; Pajola, M; Preusker, F; Scholten, F; Thomas, N; Toth, I; Tubiana, C				Vincent, Jean-Baptiste; Bodewits, Dennis; Besse, Sebastien; Sierks, Holger; Barbieri, Cesare; Lamy, Philippe; Rodrigo, Rafael; Koschny, Detlef; Rickman, Hans; Keller, Horst Uwe; Agarwal, Jessica; A'Hearn, Michael F.; Auger, Anne-Therese; Barucci, M. Antonella; Bertaux, Jean-Loup; Bertini, Ivano; Capanna, Claire; Cremonese, Gabriele; Da Deppo, Vania; Davidsson, Bjoern; Debei, Stefano; De Cecco, Mariolino; El-Maarry, Mohamed Ramy; Ferri, Francesca; Fornasier, Sonia; Fulle, Marco; Gaskell, Robert; Giacomini, Lorenza; Groussin, Olivier; Guilbert-Lepoutre, Aurelie; Gutierrez-Marques, P.; Gutierrez, Pedro J.; Guettler, Carsten; Hoekzema, Nick; Hoefner, Sebastian; Hviid, Stubbe F.; Ip, Wing-Huen; Jorda, Laurent; Knollenberg, Joerg; Kovacs, Gabor; Kramm, Rainer; Kuehrt, Ekkehard; Kueppers, Michael; La Forgia, Fiorangela; Lara, Luisa M.; Lazzarin, Monica; Lee, Vicky; Leyrat, Cedric; Lin, Zhong-Yi; Lopez Moreno, Jose J.; Lowry, Stephen; Magrin, Sara; Maquet, Lucie; Marchi, Simone; Marzari, Francesco; Massironi, Matteo; Michalik, Harald; Moissl, Richard; Mottola, Stefano; Naletto, Giampiero; Oklay, Nilda; Pajola, Maurizio; Preusker, Frank; Scholten, Frank; Thomas, Nicolas; Toth, Imre; Tubiana, Cecilia			Large heterogeneities in comet 67P as revealed by active pits from sinkhole collapse	NATURE			English	Article							DEEP IMPACT; 67P/CHURYUMOV-GERASIMENKO ACTIVITY; 9P/TEMPEL 1; DUST COMA; SURFACE; NUCLEI; EVOLUTION; MORPHOLOGY; OUTBURSTS; CAMERA	Pits have been observed on many cometary nuclei mapped by spacecraft(1-4). It has been argued that cometary pits are a signature of endogenic activity, rather than impact craters such as those on planetary and asteroid surfaces. Impact experiments(5,6) andmodels(7,8) cannot reproduce the shapes of most of the observed cometary pits, and the predicted collision rates imply that few of the pits are related to impacts(8,9). Alternative mechanisms like explosive activity(10) have been suggested, but the driving process remains unknown. Here we report that pits on comet 67P/Churyumov-Gerasimenko are active, and probably created by a sinkhole process, possibly accompanied by outbursts. We argue that after formation, pits expand slowly in diameter, owing to sublimation-driven retreat of the walls. Therefore, pits characterize how eroded the surface is: a fresh cometary surface will have a ragged structure with many pits, while an evolved surface will look smoother. The size and spatial distribution of pits imply that large heterogeneities exist in the physical, structural or compositional properties of the first few hundred metres below the current nucleus surface.	[Vincent, Jean-Baptiste; Sierks, Holger; Agarwal, Jessica; A'Hearn, Michael F.; Gutierrez-Marques, P.; Guettler, Carsten; Hoekzema, Nick; Hoefner, Sebastian; Kovacs, Gabor; Kramm, Rainer; Oklay, Nilda; Pajola, Maurizio; Tubiana, Cecilia] Max Planck Inst Sonnensyst Forsch, Justus von Liebig Weg 3, D-37077 Gottingen, Germany; [Bodewits, Dennis; A'Hearn, Michael F.; Guilbert-Lepoutre, Aurelie] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Besse, Sebastien; Koschny, Detlef] European Space Res & Technol Ctr ESA, Sci Support Off, NL-2201 AZ Noordwijk, Netherlands; [Barbieri, Cesare; La Forgia, Fiorangela; Lazzarin, Monica] Univ Padua, Dept Phys & Astron, I-35122 Padua, Italy; [Lamy, Philippe; Auger, Anne-Therese; Capanna, Claire; Groussin, Olivier; Jorda, Laurent] CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille 13, France; [Lamy, Philippe; Auger, Anne-Therese; Capanna, Claire; Groussin, Olivier; Jorda, Laurent] Aix Marseille Univ, F-13388 Marseille 13, France; [Rodrigo, Rafael; Davidsson, Bjoern] CSIC, INTA, Ctr Astrobiol, Madrid 28850, Spain; [Rodrigo, Rafael] Int Space Sci Inst, CH-3012 Bern, Switzerland; [Rickman, Hans] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Rickman, Hans] PAS Space Res Ctr, PL-00716 Warsaw, Poland; [Keller, Horst Uwe] Tech Univ Carolo Wilhelmina Braunschweig, IGEP, D-38106 Braunschweig, Germany; [A'Hearn, Michael F.] Akad Wissensch Gottingen, D-37077 Gottingen, Germany; [Barucci, M. Antonella; Fornasier, Sonia; Leyrat, Cedric] Univ Paris Diderot, Univ Paris 06, LESIA Observ Paris, CNRS, F-92195 Meudon, France; [Bertaux, Jean-Loup] UVSQ, CNRS, IPSL, LATMOS, F-78280 Guyancourt, France; [Bertini, Ivano; Ferri, Francesca; Giacomini, Lorenza; Naletto, Giampiero; Pajola, Maurizio] Univ Padua, Ctr Ateneo Studi Attivita Spaziali Giuseppe Colom, I-35131 Padua, Italy; [Cremonese, Gabriele] Osserv Astron Padova, INAF, I-35122 Padua, Italy; [Da Deppo, Vania; Naletto, Giampiero] CNR, IFN UOS Padova LUXOR, I-35131 Padua, Italy; [Debei, Stefano] Univ Padua, Dept Ind Engn, I-35131 Padua, Italy; [De Cecco, Mariolino] Univ Trento, I-38100 Trento, Italy; [El-Maarry, Mohamed Ramy; Thomas, Nicolas] Univ Bern, Phys Inst, CH-3012 Bern, Switzerland; [Fulle, Marco] INAF Osservatorio Astron, I-34014 Trieste, Italy; [Gaskell, Robert] Planetary Sci Inst, Tucson, AZ 85719 USA; [Gutierrez, Pedro J.; Lara, Luisa M.; Lopez Moreno, Jose J.] Inst Astrofis Andalucia CSIC, Granada 18008, Spain; [Hviid, Stubbe F.; Knollenberg, Joerg; Kuehrt, Ekkehard; Mottola, Stefano; Preusker, Frank; Scholten, Frank] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetenforsch, D-12489 Berlin, Germany; [Ip, Wing-Huen; Lee, Vicky; Lin, Zhong-Yi] Natl Cent Univ, Grad Inst Astron, Chungli 32054, Taiwan; [Kueppers, Michael; Maquet, Lucie; Moissl, Richard] European Space Astron Ctr ESA, Operat Dept, Madrid 28691, Spain; [Lowry, Stephen] Univ Kent, Sch Phys Sci, Canterbury CT2 7NZ, Kent, England; [Magrin, Sara; Marzari, Francesco] Univ Padua, Deptartment Phys & Astron, I-35131 Padua, Italy; [Marchi, Simone] Southwest Res Inst, Solar Syst Explorat Res Virtual Inst, Boulder, CO 80302 USA; [Massironi, Matteo] Univ Padua, Dipartimento Geosci, I-35131 Padua, Italy; [Michalik, Harald] Tech Univ Carolo Wilhelmina Braunschweig, Inst Datentech & Kommunikat Netze, D-38106 Braunschweig, Germany; [Naletto, Giampiero] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Toth, Imre] Hungarian Acad Sci, Konkoly Observ, H-1525 Budapest, Hungary	Max Planck Society; University System of Maryland; University of Maryland College Park; University of Padua; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Uppsala University; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Braunschweig University of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; University of Padua; Istituto Nazionale Astrofisica (INAF); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); University of Padua; University of Trento; University of Bern; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Helmholtz Association; German Aerospace Centre (DLR); National Central University; European Space Agency; University of Kent; University of Padua; Southwest Research Institute; University of Padua; Braunschweig University of Technology; University of Padua; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences	Vincent, JB (corresponding author), Max Planck Inst Sonnensyst Forsch, Justus von Liebig Weg 3, D-37077 Gottingen, Germany.	vincent@mps.mpg.de	Jorda, Laurent/AAA-1718-2021; Kovacs, Gabor/H-5819-2012; Moreno, Jose Juan Lopez/M-5537-2019; Gutiérrez, Pedro J/AAJ-6177-2020; Lee, Jui-Chi/ABG-8244-2021; La Forgia, Fiorangela/AAD-7477-2019; Kovacs, Gabor/E-4688-2010; Marzari, Francesco/X-2440-2019; Da Deppo, Vania/D-2897-2012; Rickman, Hans/X-7631-2018; Maquet, Lucie/ABF-7742-2020; El-Maarry, M. Ramy/K-1360-2018; Tubiana, Cecilia/AAG-8209-2019; Lara, Luisa M/F-5614-2012; Pajola, Maurizio/N-5574-2018; Naletto, Giampiero/S-6329-2016; Thomas, Nicolas/G-4693-2015	Kovacs, Gabor/0000-0002-6431-0556; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Gutiérrez, Pedro J/0000-0002-7332-6269; La Forgia, Fiorangela/0000-0003-3924-1867; Kovacs, Gabor/0000-0002-6431-0556; Da Deppo, Vania/0000-0001-6273-8738; Rickman, Hans/0000-0002-9603-6619; El-Maarry, M. Ramy/0000-0002-8262-0320; Tubiana, Cecilia/0000-0001-8475-9898; Lara, Luisa M/0000-0002-7184-920X; Pajola, Maurizio/0000-0002-3144-1277; Naletto, Giampiero/0000-0003-2007-3138; Lee, Jui-Chi/0000-0001-6686-546X; Thomas, Nicolas/0000-0002-0146-0071; Massironi, Matteo/0000-0002-7757-8818; Lowry, Stephen/0000-0002-5605-4329; Besse, Sebastien/0000-0002-1052-5439; Ferri, Francesca/0000-0003-2395-5275; fulle, marco/0000-0001-8435-5287; Cremonese, Gabriele/0000-0001-9021-1140; Debei, Stefano/0000-0002-6757-6616; Maquet, Lucie/0000-0002-3443-5841; De Cecco, Mariolino/0000-0003-1562-0328; JORDA, Laurent/0000-0001-8735-3308; Bertini, Ivano/0000-0002-0616-2444	Germany (DLR); France (CNES); Italy (ASI); Spain (MEC); Sweden (SNSB); ESA Technical Directorate; NASA JPL contract [1267923]	Germany (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); France (CNES)(Centre National D'etudes Spatiales); Italy (ASI)(Agenzia Spaziale Italiana (ASI)); Spain (MEC)(Spanish Government); Sweden (SNSB); ESA Technical Directorate; NASA JPL contract	OSIRIS was built by a consortium of the Max-Planck-Institut fur Sonnensystemforschung, Katlenburg-Lindau, Germany, the CISAS, University of Padova, Italy, the Laboratoire d'Astrophysique de Marseille, France, the Instituto de Astrofisica de Andalucia, CSIC, Granada, Spain, the Research and Scientific Support Department of the European Space Agency, Noordwijk, The Netherlands, the Instituto Nacional de Tecnica Aeroespacial, Madrid, Spain, the Universidad Politechnica de Madrid, Spain, the Department of Physics and Astronomy of Uppsala University, Sweden, and the Institut fur Datentechnik und Kommunikationsnetze der Technischen Universitat Braunschweig, Germany. The support of the national funding agencies of Germany (DLR), France (CNES), Italy (ASI), Spain (MEC), Sweden (SNSB), and the ESA Technical Directorate is acknowledged. This work was also supported by NASA JPL contract 1267923 to the University of Maryland (M.F.A'H. and D.B.). M.F.A'H. is a Gauss Professor at the Akademie der Wissenschaften zu Gottingen and Max-Planck-Institut fur Sonnensystemforschung (Germany). This research has made use of NASA's Astrophysics Data System Bibliographic Services. We thank H. J. Melosh for reviews and criticism.	A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; Basilevsky AT, 2006, PLANET SPACE SCI, V54, P808, DOI 10.1016/j.pss.2006.05.001; Belton MJS, 2008, ICARUS, V198, P189, DOI 10.1016/j.icarus.2008.07.009; Belton MJS, 2013, ICARUS, V222, P477, DOI 10.1016/j.icarus.2012.03.007; Belton MJS, 2010, ICARUS, V210, P881, DOI 10.1016/j.icarus.2010.07.007; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; Crifo JF, 2002, EARTH MOON PLANETS, V90, P227, DOI 10.1023/A:1021501509992; De Sanctis MC, 2010, ASTRON J, V140, P1, DOI 10.1088/0004-6256/140/1/1; Farnham TL, 2007, ICARUS, V187, P26, DOI 10.1016/j.icarus.2006.10.036; Feaga LM, 2007, ICARUS, V190, P345, DOI [10.1016/j.icarus.2007.04.009, 10.1016/j.icarus.2007.04.038]; Feldman PD, 2007, ICARUS, V187, P113, DOI 10.1016/j.icarus.2006.07.027; GHORMLEY JA, 1968, J CHEM PHYS, V48, P503, DOI 10.1063/1.1667954; Groussin O, 2013, ICARUS, V222, P580, DOI 10.1016/j.icarus.2012.10.003; Hillman Y, 2012, ICARUS, V221, P147, DOI 10.1016/j.icarus.2012.07.014; Holsapple KA, 2007, ICARUS, V187, P345, DOI 10.1016/j.icarus.2006.08.029; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; KELLER HU, 1988, NATURE, V331, P227, DOI 10.1038/331227a0; KIRK RL, 2005, LUNAR PLANET SCI, V36, P2244; Lara LM, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015515; Marboeuf U, 2014, ICARUS, V242, P225, DOI 10.1016/j.icarus.2014.07.001; MARSDEN BG, 1973, ASTRON J, V78, P211, DOI 10.1086/111402; Prialnik D, 2004, SPACE SCI S, P359; Richardson JE, 2013, ICARUS, V222, P492, DOI 10.1016/j.icarus.2012.04.019; Schultz PH, 2013, ICARUS, V222, P502, DOI 10.1016/j.icarus.2012.06.018; Sekanina Z., 1987, ESA SPECIAL PUBLICAT, V278, P315; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Snodgrass C, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201322020; Soderblom LA, 2002, SCIENCE, V296, P1087, DOI 10.1126/science.1069527; TANCREDI G, 1994, ASTRON ASTROPHYS, V286, P659; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Thomas P, 2013, ICARUS, V222, P453, DOI 10.1016/j.icarus.2012.02.037; Tozzi GP, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201116577; Tubiana C, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424735; Vincent JB, 2015, PLANET SPACE SCI, V107, P53, DOI 10.1016/j.pss.2014.06.008; Waltham T, 2007, SINKHOLES SUBSIDENCE; Weissman PR, 2004, SPACE SCI S, P337; White W.B., 1988, GEOMORPHOLOGY HYDROL; Wilkening L. L, 1982, IAU C 61 COMET DISCO, P85	39	135	139	0	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					63	+		10.1038/nature14564	http://dx.doi.org/10.1038/nature14564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26135448	Green Submitted			2022-12-28	WOS:000357169500031
J	Freger, V				Freger, Viatcheslav			Outperforming nature's membranes	SCIENCE			English	Editorial Material							REVERSE-OSMOSIS MEMBRANES; MOLECULAR-DYNAMICS; NANOFILTRATION; WATER		Technion Israel Inst Technol, Wolfson Dept Chem Engn, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Freger, V (corresponding author), Technion Israel Inst Technol, Wolfson Dept Chem Engn, IL-32000 Haifa, Israel.	vfreger@tx.technion.ac.il	Freger, Viatcheslav/B-4182-2017	Freger, Viatcheslav/0000-0001-8067-052X				Drazevic E, 2014, WATER RES, V49, P444, DOI 10.1016/j.watres.2013.10.029; Freger V, 2005, LANGMUIR, V21, P1884, DOI 10.1021/la048085v; Fujioka T, 2015, J MEMBRANE SCI, V486, P106, DOI 10.1016/j.memsci.2015.02.007; Harder E, 2009, J PHYS CHEM B, V113, P10177, DOI 10.1021/jp902715f; Karan S, 2015, SCIENCE, V348, P1347, DOI 10.1126/science.aaa5058; Keasling JD, 2012, NATURE, V492, P188, DOI 10.1038/492188a; Kolev V, 2014, POLYMER, V55, P1420, DOI 10.1016/j.polymer.2013.12.045; Marchetti P, 2014, CHEM REV, V114, P10735, DOI 10.1021/cr500006j; Semiat R, 2010, DESALIN WATER TREAT, V15, P228, DOI 10.5004/dwt.2010.1758; Shen YX, 2014, J MEMBRANE SCI, V454, P359, DOI 10.1016/j.memsci.2013.12.019; Szymczyk A, 2007, J MEMBRANE SCI, V287, P102, DOI 10.1016/j.memsci.2006.10.025; Yaroshchuk AE, 2001, SEP PURIF TECHNOL, V22-3, P143, DOI 10.1016/S1383-5866(00)00159-3	12	19	20	3	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1317	+		10.1126/science.aab3727	http://dx.doi.org/10.1126/science.aab3727			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089497				2022-12-28	WOS:000356449500029
J	Huber, RC; Ferreira, AS; Thompson, R; Kilbride, D; Knutson, NS; Devi, LS; Toso, DB; Challa, JR; Zhou, ZH; Rubin, Y; Schwartz, BJ; Tolbert, SH				Huber, Rachel C.; Ferreira, Amy S.; Thompson, Robert; Kilbride, Daniel; Knutson, Nicholas S.; Devi, Lekshmi Sudha; Toso, Daniel B.; Challa, J. Reddy; Zhou, Z. Hong; Rubin, Yves; Schwartz, Benjamin J.; Tolbert, Sarah H.			Long-lived photoinduced polaron formation in conjugated polyelectrolyte-fullerene assemblies	SCIENCE			English	Article							CHARGE-TRANSFER; BULK-HETEROJUNCTION; SOLAR-CELLS; POLYMER; STATE; DYNAMICS; EXCITONS	The efficiency of biological photosynthesis results from the exquisite organization of photoactive elements that promote rapid movement of charge carriers out of a critical recombination range. If synthetic organic photovoltaic materials could mimic this assembly, charge separation and collection could be markedly enhanced. We show that micelle-forming cationic semiconducting polymers can coassemble in water with cationic fullerene derivatives to create photoinduced electron-transfer cascades that lead to exceptionally long-lived polarons. The stability of the polarons depends on the organization of the polymer-fullerene assembly. Properly designed assemblies can produce separated polaronic charges that are stable for days or weeks in aqueous solution.	[Huber, Rachel C.; Ferreira, Amy S.; Thompson, Robert; Kilbride, Daniel; Knutson, Nicholas S.; Devi, Lekshmi Sudha; Challa, J. Reddy; Rubin, Yves; Schwartz, Benjamin J.; Tolbert, Sarah H.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Toso, Daniel B.; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Toso, Daniel B.; Zhou, Z. Hong] Univ Calif Los Angeles, Biomed Engn Program, Los Angeles, CA 90095 USA; [Zhou, Z. Hong; Schwartz, Benjamin J.; Tolbert, Sarah H.] Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90095 USA; [Tolbert, Sarah H.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rubin, Y (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	rubin@chem.ucla.edu; schwartz@chem.ucla.edu; tolbert@chem.ucla.edu	Rubin, Yves/B-4398-2012; Tolbert, Sarah H./L-2321-2016; Zhou, Z Hong/HDN-0747-2022	Rubin, Yves/0000-0003-0187-9689; Challa, Jagannadha Reddy/0000-0001-8076-2811; Schwartz, Benjamin/0000-0003-3257-9152	NSF [CHE-1112569, CHE-1048804]; Center for Molecularly Engineered Energy Materials, an Energy Frontier Research Center - U.S. Department of Energy (DOE) [DE-AC06-76RLO-1830]; Clean Green IGERT [NSF DGE-0903720]; DOE [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NIH [1S10RR23057]; CNSI at UCLA; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1112569] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Center for Molecularly Engineered Energy Materials, an Energy Frontier Research Center - U.S. Department of Energy (DOE); Clean Green IGERT; DOE(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNSI at UCLA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NSF under grant CHE-1112569 and by the Center for Molecularly Engineered Energy Materials, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE) under Contract DE-AC06-76RLO-1830. A.S.F acknowledges support from The Clean Green IGERT (NSF DGE-0903720). This work made use of facilities support by the NSF under equipment grant CHE-1048804. Portions of this work were conducted at the Stanford Synchrotron Radiation Lightsource (SSRL), which is supported under DOE Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). We acknowledge the use of instruments at the Electron Imaging Center for NanoMachines supported by the NIH (1S10RR23057 to Z.H.Z.) and CNSI at UCLA.	Arzhantsev S, 2005, APPL SPECTROSC, V59, P206, DOI 10.1366/0003702053085007; Beaucage G, 1996, J APPL CRYSTALLOGR, V29, P134, DOI 10.1107/S0021889895011605; Cassell AM, 1999, ANGEW CHEM INT EDIT, V38, P2403, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2403::AID-ANIE2403>3.0.CO;2-J; Ceuster J., 2001, PHYS REV B, V64; CHIANG CK, 1977, PHYS REV LETT, V39, P1098, DOI 10.1103/PhysRevLett.39.1098; Choudhary S, 2012, CARBOHYD POLYM, V87, P524, DOI 10.1016/j.carbpol.2011.08.025; Clark APZ, 2013, ACS NANO, V7, P962, DOI 10.1021/nn304437k; Costa T, 2014, J PHYS CHEM B, V118, P613, DOI 10.1021/jp409577y; Gelinas S, 2011, J PHYS CHEM C, V115, P7114, DOI 10.1021/jp200466y; Guldi DM, 2000, ACCOUNTS CHEM RES, V33, P695, DOI 10.1021/ar990144m; Jeng U, 2009, NUCL INSTRUM METH A, V600, P294, DOI 10.1016/j.nima.2008.11.048; KATO T, 1991, CHEM PHYS LETT, V186, P35, DOI 10.1016/0009-2614(91)80188-4; Kelley EG, 2011, SOFT MATTER, V7, P7094, DOI [10.1039/C1SM05506B, 10.1039/c1sm05506b]; Krinichnyi VI, 2008, SOL ENERG MAT SOL C, V92, P942, DOI 10.1016/j.solmat.2008.02.040; Li YC, 2006, LANGMUIR, V22, P11009, DOI 10.1021/la0612769; Lungenschmied C, 2007, SOL ENERG MAT SOL C, V91, P379, DOI 10.1016/j.solmat.2006.10.013; Miura T, 2015, J PHYS CHEM LETT, V6, P267, DOI 10.1021/jz502495u; Osterbacka R, 2000, SCIENCE, V287, P839, DOI 10.1126/science.287.5454.839; Paquin F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.197401; Park YI, 2014, POLYMER, V55, P855, DOI 10.1016/j.polymer.2013.11.050; Piris J, 2009, J PHYS CHEM C, V113, P14500, DOI 10.1021/jp904229q; RUTHERFORD AW, 1989, TRENDS BIOCHEM SCI, V14, P227, DOI 10.1016/0968-0004(89)90032-7; Savenije TJ, 2011, PHYS CHEM CHEM PHYS, V13, P16579, DOI 10.1039/c1cp21607d; Shaw PE, 2008, ADV MATER, V20, P3516, DOI 10.1002/adma.200800982; Verhoeven JW, 2006, J PHOTOCH PHOTOBIO C, V7, P40, DOI 10.1016/j.jphotochemrev.2006.04.001; Yasuda T, 2012, ORG ELECTRON, V13, P1802, DOI 10.1016/j.orgel.2012.05.037	26	45	46	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1340	1343		10.1126/science.aaa6850	http://dx.doi.org/10.1126/science.aaa6850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089510	Green Accepted			2022-12-28	WOS:000356449500045
J	Villmoare, B; Kimbel, WH; Seyoum, C; Campisano, CJ; DiMaggio, E; Rowan, J; Braun, DR; Arrowsmith, JR; Reed, KE				Villmoare, Brian; Kimbel, William H.; Seyoum, Chalachew; Campisano, Christopher J.; DiMaggio, Erin; Rowan, John; Braun, David R.; Arrowsmith, J. Ramon; Reed, Kaye E.			Response to Comment on "Early Homo at 2.8 Ma from Ledi-Geraru, Afar, Ethiopia"	SCIENCE			English	Editorial Material							AUSTRALOPITHECUS-SEDIBA	Hawks et al. argue that our analysis of Australopithecus sediba mandibles is flawed and that specimen LD 350-1 cannot be distinguished from this, or any other, Australopithecus species. Our reexamination of the evidence confirms that LD 350-1 falls outside of the pattern that A. sediba shares with Australopithecus and thus is reasonably assigned to the genus Homo.	[Villmoare, Brian] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Kimbel, William H.; Seyoum, Chalachew; Campisano, Christopher J.; Rowan, John; Reed, Kaye E.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Kimbel, William H.; Seyoum, Chalachew; Campisano, Christopher J.; Rowan, John; Reed, Kaye E.] Arizona State Univ, Inst Human Origins, Tempe, AZ 85287 USA; [DiMaggio, Erin] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Villmoare, Brian; Braun, David R.] George Washington Univ, Ctr Adv Study Hominin Paleobiol, Washington, DC 20052 USA; [Arrowsmith, J. Ramon] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA; [Villmoare, Brian] UCL, Dept Anthropol, London WC1H 0BW, England; [Seyoum, Chalachew] Author Res & Conservat Cultural Heritage, Addis Ababa, Ethiopia	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Washington University; Arizona State University; Arizona State University-Tempe; University of London; University College London	Villmoare, B (corresponding author), Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA.	brian.villmoare@unlv.edu; wkimbel.iho@asu.edu	Villmoare, Brian/W-4391-2019	Campisano, Christopher/0000-0001-9530-6130; DiMaggio, Erin/0000-0002-3157-5160	Division Of Behavioral and Cognitive Sci [1157351] Funding Source: National Science Foundation	Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Berger LR, 2012, J ANTHROPOL SCI, V90, P117, DOI 10.4436/jass.90009; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Hawks J, 2015, SCIENCE, V348, DOI 10.1126/science.aab0591; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343	5	5	5	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241								10.1126/science.aab1122	http://dx.doi.org/10.1126/science.aab1122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7XK	26089506				2022-12-28	WOS:000356449500038
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Time to give patients informed choice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Dyer C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1414	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2015	350								h3311	10.1136/bmj.h3311	http://dx.doi.org/10.1136/bmj.h3311			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2PK	26088598	Bronze			2022-12-28	WOS:000356786300007
J	Niphakis, MJ; Lum, KM; Cognetta, AB; Correia, BE; Ichu, TA; Olucha, J; Brown, SJ; Kundu, S; Piscitelli, F; Rosen, H; Cravatt, BF				Niphakis, Micah J.; Lum, Kenneth M.; Cognetta, Armand B., III; Correia, Bruno E.; Ichu, Taka-Aki; Olucha, Jose; Brown, Steven J.; Kundu, Soumajit; Piscitelli, Fabiana; Rosen, Hugh; Cravatt, Benjamin F.			A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells	CELL			English	Article							TARGET IDENTIFICATION; THERAPEUTIC TARGETS; RECEPTORS; CYCLOOXYGENASES; ENGAGEMENT; INHIBITORS; PROTEOMICS; ENZYMES; BIOLOGY; DESIGN	Lipids play central roles in physiology and disease, where their structural, metabolic, and signaling functions often arise from interactions with proteins. Here, we describe a set of lipid-based chemical proteomic probes and their global interaction map in mammalian cells. These interactions involve hundreds of proteins from diverse functional classes and frequently occur at sites of drug action. We determine the target profiles for several drugs across the lipid-interaction proteome, revealing that its ligandable content extends far beyond traditionally defined categories of druggable proteins. In further support of this finding, we describe a selective ligand for the lipid-binding protein nucleobindin-1 (NUCB1) and show that this compound perturbs the hydrolytic and oxidative metabolism of endocannabinoids in cells. The described chemical proteomic platform thus provides an integrated path to both discover and pharmacologically characterize a wide range of proteins that participate in lipid pathways in cells.	[Niphakis, Micah J.; Lum, Kenneth M.; Cognetta, Armand B., III; Correia, Bruno E.; Ichu, Taka-Aki; Olucha, Jose; Brown, Steven J.; Kundu, Soumajit; Piscitelli, Fabiana; Rosen, Hugh; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Niphakis, Micah J.; Lum, Kenneth M.; Cognetta, Armand B., III; Correia, Bruno E.; Ichu, Taka-Aki; Olucha, Jose; Brown, Steven J.; Kundu, Soumajit; Piscitelli, Fabiana; Rosen, Hugh; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Niphakis, MJ (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	mniphak@gmail.com; cravatt@scripps.edu	Piscitelli, Fabiana/A-7100-2014	Piscitelli, Fabiana/0000-0001-9343-4622; Ichu, Taka/0000-0002-9967-2661; Cognetta, Armand/0000-0003-0773-0674	NIH [CA132630, DA032541]; NSS (PhD) A*STAR; NATIONAL CANCER INSTITUTE [R01CA132630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA032541] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSS (PhD) A*STAR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G.M. Simon and M.M. Dix for assistance with proteomics (data analysis and technical assistance, respectively); L. Bar-Peled for assistance with shRNA studies; M.W. Buczynski and K.L. Hsu for guidance with LC-MS methods; and M.L. Matthews for assistance with recombinant protein expression and purification. This work was supported by NIH grants CA132630 (B.F.C.) and DA032541 (M.J.N.), and a predoctoral fellowship provided by NSS (PhD) A*STAR (K.M.L.).	Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Ballif BA, 1996, P NATL ACAD SCI USA, V93, P5544, DOI 10.1073/pnas.93.11.5544; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Evans JF, 2010, NAT CHEM BIOL, V6, P476, DOI 10.1038/nchembio.394; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; Gubbens J, 2009, CHEM BIOL, V16, P3, DOI 10.1016/j.chembiol.2008.11.009; Haberkant P, 2013, ANGEW CHEM INT EDIT, V52, P4033, DOI 10.1002/anie.201210178; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Heal WP, 2011, CHEM SOC REV, V40, P246, DOI 10.1039/c0cs00004c; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kimura I, 2008, J BIOL CHEM, V283, P4323, DOI 10.1074/jbc.M706679200; Laggner C, 2005, J MED CHEM, V48, P4754, DOI 10.1021/jm049073+; Leclerc P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002229; Lee J, 2013, CURR OPIN CHEM BIOL, V17, P118, DOI 10.1016/j.cbpa.2012.12.022; Li ZQ, 2013, ANGEW CHEM INT EDIT, V52, P8551, DOI 10.1002/anie.201300683; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Mechoulam R, 1998, EUR J PHARMACOL, V359, P1, DOI 10.1016/S0014-2999(98)00649-9; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Muro E, 2014, MOL BIOL CELL, V25, P1819, DOI 10.1091/mbc.E13-09-0516; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Rowland MM, 2011, BIOCHEMISTRY-US, V50, P11143, DOI 10.1021/bi201636s; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Saghatelian A, 2006, BIOCHEMISTRY-US, V45, P9007, DOI 10.1021/bi0608008; Samad TA, 2002, TRENDS MOL MED, V8, P390, DOI 10.1016/S1471-4914(02)02383-3; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Su Y, 2013, CURR OPIN CHEM BIOL, V17, P768, DOI 10.1016/j.cbpa.2013.06.005; Tate EW, 2015, CURR OPIN CHEM BIOL, V24, P48, DOI 10.1016/j.cbpa.2014.10.016; Trapani L, 2011, IUBMB LIFE, V63, P964, DOI 10.1002/iub.522; Urbano M, 2013, BIOORG MED CHEM LETT, V23, P6377, DOI 10.1016/j.bmcl.2013.09.058	43	140	143	4	118	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1668	1680		10.1016/j.cell.2015.05.045	http://dx.doi.org/10.1016/j.cell.2015.05.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091042	Bronze, Green Accepted			2022-12-28	WOS:000356618200022
J	Meester, RGS; Doubeni, CA; Lansdorp-Vogelaar, I; Jensen, CD; van der Meulen, MP; Levin, TR; Quinn, VP; Schottinger, JE; Zauber, AG; Corley, DA; van Ballegooijen, M				Meester, Reinier G. S.; Doubeni, Chyke A.; Lansdorp-Vogelaar, Iris; Jensen, Christopher D.; van der Meulen, Miriam P.; Levin, Theodore R.; Quinn, Virginia P.; Schottinger, Joanne E.; Zauber, Ann G.; Corley, Douglas A.; van Ballegooijen, Marjolein			Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening A Microsimulation Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL-OCCULT-BLOOD; SOCIETY-TASK-FORCE; ASYMPTOMATIC ADULTS; QUALITY INDICATORS; POLYPECTOMY RATE; COLONOSCOPY; RISK; SURVEILLANCE; ENDOSCOPY; POPULATION	IMPORTANCE Colonoscopy is the most commonly used colorectal cancer screening test in the United States. Its quality, as measured by adenoma detection rates (ADRs), varies widely among physicians, with unknown consequences for the cost and benefits of screening programs. OBJECTIVE To estimate the lifetime benefits, complications, and costs of an initial colonoscopy screening program at different levels of adenoma detection. DESIGN, SETTING, AND PARTICIPANTS Microsimulation modeling with data from a community-based health care system on ADR variation and cancer risk among 57 588 patients examined by 136 physicians from 1998 through 2010. EXPOSURES Using modeling, no screening was compared with screening initiation with colonoscopy according to ADR quintiles (averages 15.3%, quintile 1; 21.3%, quintile 2; 25.6%, quintile 3; 30.9%, quintile 4; and 38.7%, quintile 5) at ages 50, 60, and 70 years with appropriate surveillance of patients with adenoma. MAIN OUTCOMES AND MEASURES Estimated lifetime colorectal cancer incidence and mortality, number of colonoscopies, complications, and costs per 1000 patients, all discounted at 3% per year and including 95% confidence intervals from multiway probabilistic sensitivity analysis. RESULTS In simulation modeling, among unscreened patients the lifetime risk of colorectal cancer incidence was 34.2 per 1000 (95% CI, 25.9-43.6) and risk of mortality was 13.4 per 1000 (95% CI, 10.0-17.6). Among screened patients, simulated lifetime incidence decreased with lower to higher ADRs (26.6; 95% CI, 20.0-34.3 for quintile 1 vs 12.5; 95% CI, 9.3-16.5 for quintile 5) as did mortality (5.7; 95% CI, 4.2-7.7 for quintile 1 vs 2.3; 95% CI, 1.7-3.1 for quintile 5). Compared with quintile 1, simulated lifetime incidence was on average 11.4%(95% CI, 10.3%-11.9%) lower for every 5 percentage-point increase of ADRs and for mortality, 12.8% (95% CI, 11.1%-13.7%) lower. Complications increased from 6.0 (95% CI, 4.0-8.5) of 2777 colonoscopies (95% CI, 2626-2943) in quintile 1 to 8.9 (95% CI, 6.1-12.0) complications of 3376 (95% CI, 3081-3681) colonoscopies in quintile 5. Estimated net screening costs were lower from quintile 1 (US $2.1 million, 95% CI, $1.8-$2.4 million) to quintile 5 (US $1.8 million, 95% CI, $1.3-$2.3 million) due to averted cancer treatment costs. Results were stable across sensitivity analyses. CONCLUSIONS AND RELEVANCE In this microsimulation modeling study, higher adenoma detection rates in screening colonoscopy were associated with lower lifetime risks of colorectal cancer and colorectal cancer mortality without being associated with higher overall costs. Future research is needed to assess whether increasing adenoma detection would be associated with improved patient outcomes.	[Meester, Reinier G. S.] Erasmus MC Univ Med Ctr, Netherlands Inst Hlth Sci, NL-3000 CA Rotterdam, Netherlands; [Meester, Reinier G. S.; Lansdorp-Vogelaar, Iris; van der Meulen, Miriam P.; van Ballegooijen, Marjolein] Erasmus MC Univ Med Ctr, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Doubeni, Chyke A.] Univ Penn, Dept Family Med & Community Hlth, Perelman Sch Med, Philadelphia, PA 19104 USA; [Doubeni, Chyke A.] Univ Penn, Dept Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Doubeni, Chyke A.] Univ Penn, Leonard Davis Ctr Hlth Econ, Perelman Sch Med, Philadelphia, PA 19104 USA; [Doubeni, Chyke A.] Univ Penn, Publ Hlth Initiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jensen, Christopher D.; Levin, Theodore R.; Corley, Douglas A.] Kaiser Permanente, Div Res, Oakland, CA USA; [Quinn, Virginia P.; Schottinger, Joanne E.] Kaiser Permanente So Calif, Res & Evaluat, Pasadena, CA 91101 USA; [Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Kaiser Permanente; Kaiser Permanente; Memorial Sloan Kettering Cancer Center	Meester, RGS (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	r.meester@erasmusmc.nl			National Cancer Institute, National Institutes of Health [U54 CA163262, U01 CA152959, U01 CA151736, U24 CA171524]; NATIONAL CANCER INSTITUTE [U01CA152959, U01CA151736, U54CA163262, U24CA171524, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by grants U54 CA163262, U01 CA152959, U01 CA151736, and U24 CA171524 from the National Cancer Institute, National Institutes of Health.	Adler A, 2013, GUT, V62, P236, DOI 10.1136/gutjnl-2011-300167; American Joint Committee on Cancer AJCC, 1997, AJCC CANC STAGING MA; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Austin GL, 2013, AM J GASTROENTEROL, V108, P296, DOI 10.1038/ajg.2012.195; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Baxter NN, 2011, GASTROENTEROLOGY, V140, P65, DOI 10.1053/j.gastro.2010.09.006; Brenner H, 2014, GASTROENTEROLOGY, V146, P709, DOI 10.1053/j.gastro.2013.09.001; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Cooper GS, 2012, CANCER-AM CANCER SOC, V118, P3044, DOI 10.1002/cncr.26602; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Doubeni CA, 2013, ANN INTERN MED, V158, P312, DOI 10.7326/0003-4819-158-5-201303050-00003; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Gohel TD, 2014, CLIN GASTROENTEROL H, V12, P1137, DOI 10.1016/j.cgh.2013.11.023; Hewett DG, 2010, AM J GASTROENTEROL, V105, P1925, DOI 10.1038/ajg.2010.247; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Jensen CD, 2015, CLIN GASTROENTEROL H, V13, P739, DOI 10.1016/j.cgh.2014.10.020; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Ladabaum U, 2014, AM J GASTROENTEROL, V109, P1513, DOI 10.1038/ajg.2014.64; Leffler DA, 2010, ARCH INTERN MED, V170, P1752, DOI 10.1001/archinternmed.2010.373; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; MANNING WG, 1996, COST EFFECTIVENESS H, P247; National Cancer Institute, 2014, SEER STAT FACT SHEET; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Rex DK, 2015, AM J GASTROENTEROL, V110, P72, DOI 10.1038/ajg.2014.385; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Robertson DJ, 2014, GUT, V63, P949, DOI 10.1136/gutjnl-2012-303796; Sheffield KM, 2013, JAMA INTERN MED, V173, P542, DOI 10.1001/jamainternmed.2013.2912; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Williams JE, 2012, GASTROINTEST ENDOSC, V75, P576, DOI 10.1016/j.gie.2011.12.012; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; ZAUBER AG, 2007, COST EFFECTIVENESS C	39	55	58	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2349	2358		10.1001/jama.2015.6251	http://dx.doi.org/10.1001/jama.2015.6251			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080339	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000356300200020
J	Inouye, SK				Inouye, Sharon K.			Enhancing Cognitive Aging: Clinical Highlights of a Report From the Institute of Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Inouye, Sharon K.] Harvard Univ, Sch Med, Boston, MA USA; [Inouye, Sharon K.] Hebrew SeniorLife, Boston, MA 02459 USA	Harvard University; Harvard Medical School; Harvard University; Hebrew SeniorLife	Inouye, SK (corresponding author), Hebrew SeniorLife, Inst Aging Res, Aging Brain Ctr, 1200 Ctr St, Boston, MA 02459 USA.	AgingBrainCenter@hsl.harvard.edu	Inouye, Sharon/R-7216-2019		NIA NIH HHS [R01 AG044518, P01AG031720, R01AG044518, P01 AG031720, K07AG041835, K07 AG041835] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG044518, K07AG041835, P01AG031720] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Administration on Aging, 2013, PROF OLD AM 2013; American Society of Consultant Pharmacists, 2015, ASCP FACT SHEET; Cordell CB, 2013, ALZHEIMERS DEMENT, V9, P141, DOI 10.1016/j.jalz.2012.09.011; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Grossmann I, 2010, P NATL ACAD SCI USA, V107, P7246, DOI 10.1073/pnas.1001715107; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inst Med, 2015, COGNITIVE AGING: PROGRESS IN UNDERSTANDING AND OPPORTUNITIES FOR ACTION, P1; National Committee for the Prevention of Elder Abuse Virginia Tech MetLife Mature Market Institute, 2011, METLIFE STUD ELD FIN; Stiernstedt O.J.M, 2014, CONSENSUS BRAIN TRAI	9	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					307	+		10.7326/M15-1228	http://dx.doi.org/10.7326/M15-1228			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LC	26099073	Green Accepted			2022-12-28	WOS:000360286400010
J	Govorunova, EG; Sineshchekov, OA; Janz, R; Liu, XQ; Spudich, JL				Govorunova, Elena G.; Sineshchekov, Oleg A.; Janz, Roger; Liu, Xiaoqin; Spudich, John L.			Natural light-gated anion channels: A family of microbial rhodopsins for advanced optogenetics	SCIENCE			English	Article							CHLORIDE CHANNEL; CHANNELRHODOPSIN; EXCITATION	Light-gated rhodopsin cation channels from chlorophyte algae have transformed neuroscience research through their use as membrane-depolarizing optogenetic tools for targeted photoactivation of neuron firing. Photosuppression of neuronal action potentials has been limited by the lack of equally efficient tools for membrane hyperpolarization. We describe anion channel rhodopsins (ACRs), a family of light-gated anion channels from cryptophyte algae that provide highly sensitive and efficient membrane hyperpolarization and neuronal silencing through light-gated chloride conduction. ACRs strictly conducted anions, completely excluding protons and larger cations, and hyperpolarized the membrane of cultured animal cells with much faster kinetics at less than one-thousandth of the light intensity required by the most efficient currently available optogenetic proteins. Natural ACRs provide optogenetic inhibition tools with unprecedented light sensitivity and temporal precision.	[Govorunova, Elena G.; Sineshchekov, Oleg A.; Spudich, John L.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Janz, Roger; Liu, Xiaoqin] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Spudich, JL (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA.	john.l.spudich@uth.tmc.edu		Janz, Roger/0000-0002-9872-0596; Govorunova, Elena/0000-0003-0522-9683	NIH [R01GM027750, R21MH098288, S10RR022531]; UTHealth BRAIN Initiative grant; Hermann Eye Fund; Endowed Chair from the Robert A. Welch Foundation [AU-0009]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH098288] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTHealth BRAIN Initiative grant; Hermann Eye Fund; Endowed Chair from the Robert A. Welch Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	E.G.G., O.A.S., J.L.S., and The University of Texas Health Science Center at Houston have filed a provisional patent application that relates to ACRs. We thank E. S. Boyden [Massachusetts Institute of Technology (MIT), Boston] for the archaeorhodopsin-3 expression construct and C. Lois (MIT) for the pCMV-VSVG and p Delta 8.9 plasmids. This work was supported by NIH grants R01GM027750, R21MH098288, and S10RR022531, and a UTHealth BRAIN Initiative grant, the Hermann Eye Fund, and Endowed Chair AU-0009 from the Robert A. Welch Foundation.	Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Bregestovski P, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.015.2009; Chow BY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003101; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Govorunova EG, 2013, J BIOL CHEM, V288, P29911, DOI 10.1074/jbc.M113.505495; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Spudich JL, 2014, BBA-BIOENERGETICS, V1837, P546, DOI 10.1016/j.bbabio.2013.06.006; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	25	346	361	13	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					647	650		10.1126/science.aaa7484	http://dx.doi.org/10.1126/science.aaa7484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26113638	Green Accepted			2022-12-28	WOS:000359092900043
J	Windham, BG; Deere, B; Griswold, ME; Wang, WM; Bezerra, DC; Shibata, D; Butler, K; Knopman, D; Gottesman, RF; Heiss, G; Mosley, TH				Windham, B. Gwen; Deere, Bradley; Griswold, Michael E.; Wang, Wanmei; Bezerra, Daniel C.; Shibata, Dean; Butler, Kenneth; Knopman, David; Gottesman, Rebecca F.; Heiss, Gerardo; Mosley, Thomas H., Jr.			Small Brain Lesions and Incident Stroke and Mortality A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							WHITE-MATTER LESIONS; SMALL VESSEL DISEASE; ENLARGED PERIVASCULAR SPACES; VIRCHOW-ROBIN SPACES; MIDDLE-AGED ADULTS; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; ELDERLY-PEOPLE; OLDER-ADULTS; INFARCTS	Background: Although cerebral lesions 3 mm or larger on imaging are associated with incident stroke, lesions smaller than 3 mm are typically ignored. Objective: To examine stroke risks associated with subclinical brain lesions (<3 mm only, >= 3 mm only, and both sizes) and white matter hyperintensities (WMHs). Design: Community cohort from the ARIC (Atherosclerosis Risk in Communities) Study. Setting: Two ARIC sites with magnetic resonance imaging (MRI) data from 1993 to 1995. Participants: 1884 adults aged 50 to 73 years with MRI, no prior stroke, and average follow-up of 14.5 years. Measurements: Lesions on MRI (by size), WMH score (scale of 0 to 9), incident stroke, all-cause mortality, and stroke-related mortality. Hazard ratios (HRs) were estimated with proportional hazards models. Results: Compared with no lesions, stroke risk tripled with lesions smaller than 3 mm only (HR, 3.47 [95% Cl, 1.86 to 6.49]), doubled with lesions 3 mm or larger only (HR, 1.94 [Cl, 1.22 to 3.07]), was 8-fold higher with lesions of both sizes (HR, 8.59 [Cl, 4.69 to 15.73]), and doubled with a WMH score of at least 3 (HR, 2.14 [Cl, 1.45 to 3.16]). Risk for stroke-related death tripled with lesions smaller than 3 mm only (HR, 3.05 [Cl, 1.04 to 8.94]) and was 7 times higher with lesions of both sizes (HR, 6.97 [Cl, 2.03 to 23.93]). Limitation: Few strokes (especially hemorrhagic) and few participants with lesions smaller than 3 mm only or lesions of both sizes. Conclusion: Very small cerebrovascular lesions may be associated with increased risks for stroke and death; presence of lesions smaller than 3 mm and 3 mm or larger may result in a particularly striking risk increase. Larger studies are needed to confirm findings and provide more precise estimates.	[Windham, B. Gwen] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Univ Washington, Med Ctr, Seattle, WA 98195 USA; Mayo Clin, Rochester, MN USA; Univ N Carolina, Chapel Hill, NC USA	University of Mississippi; University of Mississippi Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Washington; University of Washington Seattle; Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill	Windham, BG (corresponding author), Univ Mississippi, Med Ctr, 2500 North State St, Jackson, MS 39216 USA.	gwindham@umc.edu	Gottesman, Rebecca/ABA-8468-2020; Butler, Kenneth Ray/S-3328-2019		National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL075572] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.	Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; Bezerra DC, 2012, NEUROLOGY, V78, P102, DOI 10.1212/WNL.0b013e31823efc42; Bokura Hirokazu, 2006, J Stroke Cerebrovasc Dis, V15, P57, DOI 10.1016/j.jstrokecerebrovasdis.2005.11.001; Bryan RN, 1999, AM J NEURORADIOL, V20, P1273; Buyck JF, 2009, STROKE, V40, P2327, DOI 10.1161/STROKEAHA.109.548222; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Debette S, 2010, STROKE, V41, P600, DOI 10.1161/STROKEAHA.109.570044; Deramecourt V, 2012, NEUROLOGY, V78, P1043, DOI 10.1212/WNL.0b013e31824e8e7f; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; Folsom AR, 2012, ANN NEUROL, V71, P552, DOI 10.1002/ana.22690; Fu JH, 2010, CEREBROVASC DIS, V30, P51, DOI 10.1159/000313614; Gerdes VEA, 2006, ATHEROSCLEROSIS, V186, P166, DOI 10.1016/j.atherosclerosis.2005.07.008; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Kalantarian S, 2014, ANN INTERN MED, V161, P650, DOI 10.7326/M14-0538; Knopman DS, 2011, NEUROLOGY, V76, P1879, DOI 10.1212/WNL.0b013e31821d753f; Kobayashi S, 1997, STROKE, V28, P1932, DOI 10.1161/01.STR.28.10.1932; Kuller LH, 2004, STROKE, V35, P1821, DOI 10.1161/01.STR.0000132193.35955.69; Liao DP, 1997, NEUROEPIDEMIOLOGY, V16, P149, DOI 10.1159/000368814; Liao DP, 1996, STROKE, V27, P2262, DOI 10.1161/01.STR.27.12.2262; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; Longstreth WT, 2001, ARCH NEUROL-CHICAGO, V58, P2074, DOI 10.1001/archneur.58.12.2074; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; Ohira T, 2006, STROKE, V37, P2493, DOI 10.1161/01.STR.0000239694.19359.88; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Potter GM, 2015, INT J STROKE, V10, P376, DOI 10.1111/ijs.12054; Price TR, 1997, STROKE, V28, P1158, DOI 10.1161/01.STR.28.6.1158; Robins M., 1981, STROKE, V12, pI45; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rouhl RPW, 2008, J NEUROL, V255, P692, DOI 10.1007/s00415-008-0777-y; van der Flier WM, 2005, STROKE, V36, P2116, DOI 10.1161/01.STR.0000179092.59909.42; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong TY, 2002, JAMA-J AM MED ASSOC, V288, P67, DOI 10.1001/jama.288.1.67; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	41	37	38	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1					22	31		10.7326/M14-2057	http://dx.doi.org/10.7326/M14-2057			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	26148278	Green Accepted			2022-12-28	WOS:000357442000003
J	Chandradoss, SD; Schirle, NT; Szczepaniak, M; MacRae, IJ; Joo, C				Chandradoss, Stanley D.; Schirle, Nicole T.; Szczepaniak, Malwina; MacRae, Ian J.; Joo, Chirlmin			A Dynamic Search Process Underlies MicroRNA Targeting	CELL			English	Article							SINGLE-MOLECULE; STRUCTURAL BASIS; SMALL RNAS; ARGONAUTE; DNA; GUIDE; DIFFUSION; RECOGNITION; CLEAVAGE; MECHANISMS	Argonaute proteins play a central role in mediating post-transcriptional gene regulation by microRNAs (miRNAs). Argonautes use the nucleotide sequences in miRNAs as guides for identifying target messenger RNAs for repression. Here, we used single-molecule FRET to directly visualize how human Argonaute-2 (Ago2) searches for and identifies target sites in RNAs complementary to its miRNA guide. Our results suggest that Ago2 initially scans for target sites with complementarity to nucleotides 2-4 of the miRNA. This initial transient interaction propagates into a stable association when target complementarity extends to nucleotides 2-8. This stepwise recognition process is coupled to lateral diffusion of Ago2 along the target RNA, which promotes the target search by enhancing the retention of Ago2 on the RNA. The combined results reveal the mechanisms that Argonaute likely uses to efficiently identify miRNA target sites within the vast and dynamic agglomeration of RNA molecules in the living cell.	[Chandradoss, Stanley D.; Szczepaniak, Malwina; Joo, Chirlmin] Delft Univ Technol, Kavli Inst NanoSci, Dept BioNanoSci, NL-2628 CJ Delft, Netherlands; [Schirle, Nicole T.; MacRae, Ian J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	Delft University of Technology; Scripps Research Institute	MacRae, IJ (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	macrae@scripps.edu; c.joo@tudelft.nl	MacRae, Ian/CAF-5564-2022; Joo, Chirlmin/B-9294-2008	Joo, Chirlmin/0000-0003-2803-0335; Chandradoss, Stanley D/0000-0001-7790-1374; Szczepaniak, Malwina/0000-0002-1230-9190	NIH [R01 GM104475]; European Research Council under the European Union's Seventh Framework Programme/ERC [309509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104475] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anna Haagsma, Margreet Docter, Pawel Tulinski and Inge Geuzebroek for their technical support. We thank Anna Haagsma, Mohamed Fareh, Inha Heo, Margreet Docter, and Sung Hyun Kim for their critical reading this manuscript and V. Narry Kim, Jessica Sheu-Gruttadauria, Robert A. Luenberger, and Mahipal Ganji for stimulating conversations. I.J.M. and N.T.S. were supported by NIH grant R01 GM104475. C.J. was funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no (309509).	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Chandradoss SD, 2014, JOVE-J VIS EXP, DOI 10.3791/50549; Cisse II, 2012, NAT STRUCT MOL BIOL, V19, P623, DOI 10.1038/nsmb.2294; Faehnle CR, 2013, CELL REP, V3, P1901, DOI 10.1016/j.celrep.2013.05.033; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; Jung SR, 2013, J AM CHEM SOC, V135, P16865, DOI 10.1021/ja403138d; Karunatilaka KS, 2010, NATURE, V467, P935, DOI 10.1038/nature09422; Kim H, 2014, NATURE, V506, P334, DOI 10.1038/nature13039; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klehs K, 2014, CHEMPHYSCHEM, V15, P637, DOI 10.1002/cphc.201300874; Koh HR, 2013, P NATL ACAD SCI USA, V110, P151, DOI 10.1073/pnas.1212917110; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee G, 2012, SCIENCE, V336, P1726, DOI 10.1126/science.1216848; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leith JS, 2012, P NATL ACAD SCI USA, V109, P16552, DOI 10.1073/pnas.1120452109; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Nakanishi K, 2013, CELL REP, V3, P1893, DOI 10.1016/j.celrep.2013.06.010; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Ragunathan K, 2012, ELIFE, V1, DOI 10.7554/eLife.00067; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Selvin P R, 2007, SINGLE MOL TECHNIQUE; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Xia Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054620; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yeom KH, 2011, EMBO REP, V12, P690, DOI 10.1038/embor.2011.100; Zander A, 2014, RNA BIOL, V11, P45, DOI 10.4161/rna.27446	58	158	161	0	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					96	107		10.1016/j.cell.2015.06.032	http://dx.doi.org/10.1016/j.cell.2015.06.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140593	Bronze, Green Accepted			2022-12-28	WOS:000357542300012
J	Man, SM; Zhu, QF; Zhu, LQ; Liu, ZP; Karki, R; Malik, A; Sharma, D; Li, LY; Malireddi, RKS; Gurung, P; Neale, G; Olsen, SR; Carter, RA; McGoldrick, DJ; Wu, G; Finkelstein, D; Vogel, P; Gilbertson, RJ; Kanneganti, TD				Man, Si Ming; Zhu, Qifan; Zhu, Liqin; Liu, Zhiping; Karki, Rajendra; Malik, Ankit; Sharma, Deepika; Li, Liyuan; Malireddi, R. K. Subbarao; Gurung, Prajwal; Neale, Geoffrey; Olsen, Scott R.; Carter, Robert A.; McGoldrick, Daniel J.; Wu, Gang; Finkelstein, David; Vogel, Peter; Gilbertson, Richard J.; Kanneganti, Thirumala-Devi			Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer	CELL			English	Article							COLORECTAL-CANCER; MELANOMA 2; NEGATIVE REGULATION; COLON INFLAMMATION; ACTIVATION; PROTEINS; BINDING; TUMORIGENESIS; ABSENT; RECOGNITION	Colorectal cancer is a leading cause of cancer-related deaths. Mutations in the innate immune sensor AIM2 are frequently identified in patients with colorectal cancer, but how AIM2 modulates colonic tumorigenesis is unknown. Here, we found that Aim2-deficient mice were hypersusceptible to colonic tumor development. Production of inflammasome-associated cytokines and other inflammatory mediators was largely intact in Aim2-deficient mice; however, intestinal stem cells were prone to uncontrolled proliferation. Aberrant Wnt signaling expanded a population of tumor-initiating stem cells in the absence of AIM2. Susceptibility of Aim2-deficient mice to colorectal tumorigenesis was enhanced by a dysbiotic gut microbiota, which was reduced by reciprocal exchange of gut microbiota with healthy wild-type mice. These findings uncover a synergy between a specific host genetic factor and gut microbiota in determining the susceptibility to colorectal cancer. Therapeutic modulation of AIM2 expression and microbiota has the potential to prevent colorectal cancer.	[Man, Si Ming; Zhu, Qifan; Liu, Zhiping; Karki, Rajendra; Malik, Ankit; Sharma, Deepika; Malireddi, R. K. Subbarao; Gurung, Prajwal; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Zhu, Qifan] Univ Tennessee, Integrated Biomed Sci Program, Hlth Sci Ctr, Memphis, TN 38163 USA; [Zhu, Liqin; Li, Liyuan; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Liu, Zhiping] Gannan Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Ganzhou 341000, Jiangxi, Peoples R China; [Neale, Geoffrey; Olsen, Scott R.] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Carter, Robert A.; McGoldrick, Daniel J.; Wu, Gang; Finkelstein, David] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Gannan Medical University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Malireddi, RKSubbarao/C-5804-2013; Man, Si Ming/AAE-9168-2019; Liu, Zhiping/O-3510-2019; Gilbertson, Richard James/ABE-1346-2021; Wu, Gang/M-8012-2014; Man, Si Ming/O-6223-2015; Kanneganti, Thirumala-Devi/M-9435-2018; Karki, Rajendra/H-6647-2019; Zhu, Liqin/N-8126-2018; Malik, Ankit/I-1817-2019; Vogel, Peter/N-2490-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447; Man, Si Ming/0000-0002-5079-2857; Liu, Zhiping/0000-0002-5109-4153; Gilbertson, Richard James/0000-0001-7539-9472; Wu, Gang/0000-0002-1678-5864; Man, Si Ming/0000-0002-5079-2857; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Karki, Rajendra/0000-0003-4436-9128; Zhu, Liqin/0000-0002-2346-150X; Malik, Ankit/0000-0001-7175-6575; Vogel, Peter/0000-0002-7535-0545; Gurung, Prajwal/0000-0002-7451-9433	NIH [AR056296, CA163507, AI101935]; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; National Health and Medical Research Council of Australia (R.G. Menzies Early Career Fellowship); NATIONAL CANCER INSTITUTE [R01CA163507, P30CA021765, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; National Health and Medical Research Council of Australia (R.G. Menzies Early Career Fellowship)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank V.M. Dixit (Genentech) for the Aim2-deficient mice. This work was supported by the NIH (AR056296, CA163507, and AI101935 to T.-D.K.), the American Lebanese Syrian Associated Charities (to T.-D.K.), St. Jude Children's Research Hospital (Neoma Boadway Endowed Fellowship to S.M.M. and Paul Barrett Endowed Fellowship to P.G.), and the National Health and Medical Research Council of Australia (R.G. Menzies Early Career Fellowship to S.M.M.).	Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bonte D, 2008, NEOPLASIA, V10, P920, DOI 10.1593/neo.08216; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Dihlmann S, 2014, INT J CANCER, V135, P2387, DOI 10.1002/ijc.28891; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Patsos G, 2010, INT J CANCER, V126, P1838, DOI 10.1002/ijc.24905; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Schulmann K, 2005, GASTROENTEROLOGY, V128, P590, DOI 10.1053/j.gastro.2004.12.051; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Sparks AB, 1998, CANCER RES, V58, P1130; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vonlanthen J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-46; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Woerner SM, 2007, GENE CHROMOSOME CANC, V46, P1080, DOI 10.1002/gcc.20493; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zhao LA, 2010, FEBS J, V277, P4195, DOI 10.1111/j.1742-4658.2010.07808.x; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051	48	212	226	3	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					45	58		10.1016/j.cell.2015.06.001	http://dx.doi.org/10.1016/j.cell.2015.06.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26095253	Green Accepted, Bronze			2022-12-28	WOS:000357542300008
J	Soccio, RE; Chen, ER; Rajapurkar, SR; Safabakhsh, P; Marinis, JM; Dispirito, JR; Emmett, MJ; Briggs, ER; Fang, B; Everett, LJ; Lim, HW; Won, KJ; Steger, DJ; Wu, Y; Civelek, M; Voight, BF; Lazar, MA				Soccio, Raymond E.; Chen, Eric R.; Rajapurkar, Satyajit R.; Safabakhsh, Pegah; Marinis, Jill M.; Dispirito, Joanna R.; Emmett, Matthew J.; Briggs, Erika R.; Fang, Bin; Everett, Logan J.; Lim, Hee-Woong; Won, Kyoung-Jae; Steger, David J.; Wu, Ying; Civelek, Mete; Voight, Benjamin F.; Lazar, Mitchell A.			Genetic Variation Determines PPAR gamma Function and Anti-diabetic Drug Response In Vivo	CELL			English	Article							INSULIN-RESISTANCE; TRANSCRIPTION FACTORS; BINDING; DISEASE; ENHANCERS; REVEALS; MOUSE; THIAZOLIDINEDIONE; ASSOCIATION; ADIPOCYTES	SNPs affecting disease risk often reside in non-coding genomic regions. Here, we show that SNPs are highly enriched at mouse strain-selective adipose tissue binding sites for PPAR gamma, a nuclear receptor for antidiabetic drugs. Many such SNPs alter binding motifs for PPAR gamma or cooperating factors and functionally regulate nearby genes whose expression is strain selective and imbalanced in heterozygous F1 mice. Moreover, genetically determined binding of PPAR gamma accounts for mouse strain-specific transcriptional effects of TZD drugs, providing proof of concept for personalized medicine related to nuclear receptor genomic occupancy. In human fat, motif-altering SNPs cause differential PPAR gamma binding, provide a molecular mechanism for some expression quantitative trait loci, and are risk factors for dysmetabolic traits in genome-wide association studies. One PPAR gamma motif-altering SNP is associated with HDL levels and other metabolic syndrome parameters. Thus, natural genetic variation in PPAR gamma genomic occupancy determines individual disease risk and drug response.	[Soccio, Raymond E.; Chen, Eric R.; Rajapurkar, Satyajit R.; Safabakhsh, Pegah; Marinis, Jill M.; Dispirito, Joanna R.; Emmett, Matthew J.; Briggs, Erika R.; Fang, Bin; Everett, Logan J.; Steger, David J.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Soccio, Raymond E.; Chen, Eric R.; Rajapurkar, Satyajit R.; Safabakhsh, Pegah; Marinis, Jill M.; Dispirito, Joanna R.; Emmett, Matthew J.; Briggs, Erika R.; Fang, Bin; Everett, Logan J.; Lim, Hee-Woong; Won, Kyoung-Jae; Steger, David J.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Lim, Hee-Woong; Won, Kyoung-Jae; Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Wu, Ying] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Civelek, Mete] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lim, HW/GRY-3517-2022; Lazar, Mitchell A/AAF-3738-2019; Soccio, Raymond/M-7517-2019; Lim, Hee Woong/AAX-6835-2021; Everett, Logan/AAK-1523-2021	Lim, Hee Woong/0000-0001-8599-1808; Emmett, Matthew/0000-0002-8855-423X; Chen, Eric/0000-0002-6712-9488; Won, Kyoung Jae/0000-0002-2924-9630; Voight, Benjamin/0000-0002-6205-9994; Civelek, Mete/0000-0002-8141-0284	NIH [R01-DK49780, K08-DK094968, R01-DK101478, R21-DK098769, K99-HL121172, P01-HL028481]; JPB Foundation; NIDDK Nuclear Receptor Signaling Atlas (NURSA); Functional Genomics Core of the Penn Diabetes Research Center [P30-DK19525];  [AHA-13SDG14330006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL121172, P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R21DK098769, F30DK104513, R01DK098542, R01DK049780, P01DK049210, K08DK094968, R01DK101478] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NIDDK Nuclear Receptor Signaling Atlas (NURSA); Functional Genomics Core of the Penn Diabetes Research Center; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Klaus Kaestner, Struan Grant, Mingyao Li, Patrick Seale, Doris Stoffers, and Dan Rader for valuable discussions and Markku Laakso, Karen Mohlke, and Aldons J. Lusis for access to the METSIM eQTL data. Valuable assistance was provided by Manashree Damle (computational) and Jennifer Jager (GRO-seq). We also thank the Functional Genomics Core of the Penn Diabetes Research Center (P30-DK19525). For human adipose tissue samples, we thank Marion Vetter, Nicole Jochym, Gary Korus, and Amy Cha. This work was supported by NIH grants (R01-DK49780 to M.A.L., K08-DK094968 to R.E.S., R01-DK101478 to B.F.V., R21-DK098769 to K.-J.W., K99-HL121172 and P01-HL028481 supporting M.C. and Y.W.), as well as the JPB Foundation (M.A.L.) and AHA-13SDG14330006 (B.F.V.), along with initial pilot funding from the NIDDK Nuclear Receptor Signaling Atlas (NURSA). M.A.L. is on scientific advisory boards for Pfizer Inc. and Eli Lilly and Company.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Cusanovich DA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004226; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Long JZ, 2011, NAT CHEM BIOL, V7, P763, DOI 10.1038/nchembio.659; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mizzi C, 2014, PHARMACOGENOMICS, V15, P1223, DOI [10.2217/PGS.14.102, 10.2217/pgs.14.102]; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Sadee W, 2014, HUM GENET, V133, P1199, DOI 10.1007/s00439-014-1476-7; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165; Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005; Soccio RE, 2011, MOL ENDOCRINOL, V25, P694, DOI 10.1210/me.2010-0454; Stancakova A., 2012, DIABETES, V61, P1895; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Su Z, 2008, INT J OBESITY, V32, P1180, DOI 10.1038/ijo.2008.56; Sur I, 2013, CANCER RES, V73, P4180, DOI 10.1158/0008-5472.CAN-13-0789; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	50	94	97	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					33	44		10.1016/j.cell.2015.06.025	http://dx.doi.org/10.1016/j.cell.2015.06.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140591	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000357542300007
J	Bliokh, KY; Smirnova, D; Nori, F				Bliokh, Konstantin Y.; Smirnova, Daria; Nori, Franco			Quantum spin Hall effect of light	SCIENCE			English	Article							TOPOLOGICAL PHASE; PHOTONS	Maxwell's equations, formulated 150 years ago, ultimately describe properties of light, from classical electromagnetism to quantum and relativistic aspects. The latter ones result in remarkable geometric and topological phenomena related to the spin-1 massless nature of photons. By analyzing fundamental spin properties of Maxwell waves, we show that free-space light exhibits an intrinsic quantum spin Hall effect-surface modes with strong spin-momentum locking. These modes are evanescent waves that form, for example, surface plasmon-polaritons at vacuum-metal interfaces. Our findings illuminate the unusual transverse spin in evanescent waves and explain recent experiments that have demonstrated the transverse spin-direction locking in the excitation of surface optical modes. This deepens our understanding of Maxwell's theory, reveals analogies with topological insulators for electrons, and offers applications for robust spin-directional optical interfaces.	[Bliokh, Konstantin Y.; Nori, Franco] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Bliokh, Konstantin Y.; Smirnova, Daria] Australian Natl Univ, Res Sch Phys & Engn, Nonlinear Phys Ctr, Canberra, ACT 0200, Australia; [Nori, Franco] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	RIKEN; Australian National University; University of Michigan System; University of Michigan	Bliokh, KY (corresponding author), RIKEN, Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	k.bliokh@gmail.com; fnori@riken.jp	Bliokh, Konstantin/A-4024-2013; Smirnova, Daria A./Q-3636-2017; Nori, Franco/B-1222-2009	Bliokh, Konstantin/0000-0003-1104-8627; Smirnova, Daria A./0000-0001-8033-3427; Nori, Franco/0000-0003-3682-7432	RIKEN iTHES Project, Multidisciplinary University Research Initiative Center for Dynamic Magneto-Optics [FA9550-14-1-0040]; Japan Society for the Promotion of Science-Russian Foundation for Basic Research [12-02-92100]; Australian Research Council	RIKEN iTHES Project, Multidisciplinary University Research Initiative Center for Dynamic Magneto-Optics; Japan Society for the Promotion of Science-Russian Foundation for Basic Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Australian Research Council(Australian Research Council)	We are grateful to A. Furusaki, Y. Bliokh, E. Ostrovskaya, Y. Kivshar, and A. Khanikaev for fruitful discussions. This work was partially supported by the RIKEN iTHES Project, Multidisciplinary University Research Initiative Center for Dynamic Magneto-Optics (award number FA9550-14-1-0040), the Australian Research Council, Japan Society for the Promotion of Science-Russian Foundation for Basic Research contract 12-02-92100 and a Grant-in-Aid for Scientific Research (A).	Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Bliokh KY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4300; Bliokh KY, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.061801; Bliokh KY, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.063825; Bliokh KY, 2008, NAT PHOTONICS, V2, P748, DOI 10.1038/nphoton.2008.229; Bliokh KY, 2004, PHYS LETT A, V333, P181, DOI 10.1016/j.physleta.2004.10.035; CHIAO RY, 1986, PHYS REV LETT, V57, P933, DOI 10.1103/PhysRevLett.57.933; Fernandez-Corbaton I, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.060401; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Haldane FDM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013904; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; JACKIW R, 1976, PHYS REV D, V13, P3398, DOI 10.1103/PhysRevD.13.3398; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Khanikaev AB, 2013, NAT MATER, V12, P233, DOI [10.1038/nmat3520, 10.1038/NMAT3520]; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; O'Connor D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6327; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Rikken GLJA, 1996, NATURE, V381, P54, DOI 10.1038/381054a0; Rodriguez-Fortuno FJ, 2013, SCIENCE, V340, P328, DOI 10.1126/science.1233739; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; Sheng DN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.036808; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Sollner  I., 2014, ARXIV14064295V3; Stone M., 1992, QUANTUM HALL EFFECT; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Zayats AV, 2005, PHYS REP, V408, P131, DOI 10.1016/j.physrep.2004.11.001	33	486	491	25	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1448	1451		10.1126/science.aaa9519	http://dx.doi.org/10.1126/science.aaa9519			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113717	Green Submitted			2022-12-28	WOS:000356869100035
J	Phimister, EG				Phimister, Elizabeth G.			TREM2 and Risk of Alzheimer's Disease - Friend or Foe?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Phimister, Elizabeth G.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Phimister, Elizabeth G.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Phimister, EG (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049	8	39	41	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2564	2565		10.1056/NEJMcibr1503954	http://dx.doi.org/10.1056/NEJMcibr1503954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2QD	26107057				2022-12-28	WOS:000356788200014
J	Sarewitz, D				Sarewitz, Daniel			CRISPR: Science can't solve it	NATURE			English	Editorial Material									[Sarewitz, Daniel] Arizona State Univ, Sci & Soc, Tempe, AZ 85281 USA; [Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcome, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Sarewitz, D (corresponding author), Arizona State Univ, Sci & Soc, Tempe, AZ 85281 USA.	daniel.sarewitz@asu.edu						Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Hicks DJ, 2015, STUD HIST PHI PART C, V50, P1, DOI 10.1016/j.shpsc.2015.02.002; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Marris C, 2001, PUBLIC PERCEPTIONS A; Peterson James C., 1984, CITIZEN PARTICIPATIO; Scheufele DA, 2007, NAT NANOTECHNOL, V2, P732, DOI 10.1038/nnano.2007.392; WEINBERG AM, 1972, MINERVA, V10, P209, DOI 10.1007/BF01682418	8	69	69	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					412	413		10.1038/522413a	http://dx.doi.org/10.1038/522413a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26108836	Bronze			2022-12-28	WOS:000356782900022
J	Szalavitz, M				Szalavitz, Maia			GENETICS No more addictive personality	NATURE			English	Editorial Material							ANTISOCIAL BEHAVIORAL SYNDROMES; NATIONAL EPIDEMIOLOGIC SURVEY; USE DISORDERS; ALCOHOL; DEPENDENCE											Fowler CD, 2014, NEUROPHARMACOLOGY, V76, P533, DOI 10.1016/j.neuropharm.2013.09.008; Giordano GN, 2014, ADDICTION, V109, P1119, DOI 10.1111/add.12537; Goldstein RB, 2007, DRUG ALCOHOL DEPEN, V90, P145, DOI 10.1016/j.drugalcdep.2007.02.023; Goldstein RB, 2007, ALCOHOL CLIN EXP RES, V31, P814, DOI 10.1111/j.1530-0277.2007.00364.x; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Luczak SE, 2006, PSYCHOL BULL, V132, P607, DOI 10.1037/0033-2909.132.4.607	6	9	9	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					S48	S49		10.1038/522S48a	http://dx.doi.org/10.1038/522S48a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26107094				2022-12-28	WOS:000356782900002
J	Baragana, B; Hallyburton, I; Lee, MCS; Norcross, NR; Grimaldi, R; Otto, TD; Proto, WR; Blagborough, AM; Meister, S; Wirjanata, G; Ruecker, A; Upton, LM; Abraham, TS; Almeida, MJ; Pradhan, A; Porzelle, A; Martinez, MS; Bolscher, JM; Woodland, A; Norval, S; Zuccotto, F; Thomas, J; Simeons, F; Stojanovski, L; Osuna-Cabello, M; Brock, PM; Churcher, TS; Sala, KA; Zakutansky, SE; Jimenez-Diaz, MB; Sanz, LM; Riley, J; Basak, R; Campbell, M; Avery, VM; Sauerwein, RW; Dechering, KJ; Noviyanti, R; Campo, B; Frearson, JA; Angulo-Barturen, I; Ferrer-Bazaga, S; Gamo, FJ; Wyatt, PG; Leroy, D; Siegl, P; Delves, MJ; Kyle, DE; Wittlin, S; Marfurt, J; Price, RN; Sinden, RE; Winzeler, EA; Charman, SA; Bebrevska, L; Gray, DW; Campbell, S; Fairlamb, AH; Willis, PA; Rayner, JC; Fidock, DA; Read, KD; Gilbert, IH				Baragana, Beatriz; Hallyburton, Irene; Lee, Marcus C. S.; Norcross, Neil R.; Grimaldi, Raffaella; Otto, Thomas D.; Proto, William R.; Blagborough, Andrew M.; Meister, Stephan; Wirjanata, Grennady; Ruecker, Andrea; Upton, Leanna M.; Abraham, Tara S.; Almeida, Mariana J.; Pradhan, Anupam; Porzelle, Achim; Santos Martinez, Maria; Bolscher, Judith M.; Woodland, Andrew; Norval, Suzanne; Zuccotto, Fabio; Thomas, John; Simeons, Frederick; Stojanovski, Laste; Osuna-Cabello, Maria; Brock, Paddy M.; Churcher, Tom S.; Sala, Katarzyna A.; Zakutansky, Sara E.; Belen Jimenez-Diaz, Maria; Maria Sanz, Laura; Riley, Jennifer; Basak, Rajshekhar; Campbell, Michael; Avery, Vicky M.; Sauerwein, Robert W.; Dechering, Koen J.; Noviyanti, Rintis; Campo, Brice; Frearson, Julie A.; Angulo-Barturen, Inigo; Ferrer-Bazaga, Santiago; Javier Gamo, Francisco; Wyatt, Paul G.; Leroy, Didier; Siegl, Peter; Delves, Michael J.; Kyle, Dennis E.; Wittlin, Sergio; Marfurt, Jutta; Price, Ric N.; Sinden, Robert E.; Winzeler, Elizabeth A.; Charman, Susan A.; Bebrevska, Lidiya; Gray, David W.; Campbell, Simon; Fairlamb, Alan H.; Willis, Paul A.; Rayner, Julian C.; Fidock, David A.; Read, Kevin D.; Gilbert, Ian H.			A novel multiple-stage antimalarial agent that inhibits protein synthesis	NATURE			English	Article							ELONGATION-FACTOR 2; PLASMODIUM-FALCIPARUM; NEXT-GENERATION; MALARIA CONTROL; DRUG DISCOVERY; TRANSMISSION; POPULATIONS; VIVAX; IDENTIFICATION; GAMETOCYTES	There is an urgent need for new drugs to treat malaria, with broad therapeutic potential and novel modes of action, to widen the scope of treatment and to overcome emerging drug resistance. Here we describe the discovery of DDD107498, a compound with a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite, with good pharmacokinetic properties and an acceptable safety profile. DDD107498 demonstrates potential to address a variety of clinical needs, including single-dose treatment, transmission blocking and chemoprotection. DDD107498 was developed from a screening programme against blood-stage malaria parasites; its molecular target has been identified as translation elongation factor 2 (eEF2), which is responsible for the GTP-dependent translocation of the ribosome along messenger RNA, and is essential for protein synthesis. This discovery of eEF2 as a viable antimalarial drug target opens up new possibilities for drug discovery.	[Baragana, Beatriz; Hallyburton, Irene; Norcross, Neil R.; Grimaldi, Raffaella; Porzelle, Achim; Woodland, Andrew; Norval, Suzanne; Zuccotto, Fabio; Thomas, John; Simeons, Frederick; Stojanovski, Laste; Osuna-Cabello, Maria; Riley, Jennifer; Frearson, Julie A.; Wyatt, Paul G.; Gray, David W.; Fairlamb, Alan H.; Read, Kevin D.; Gilbert, Ian H.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland; [Lee, Marcus C. S.; Abraham, Tara S.; Almeida, Mariana J.; Basak, Rajshekhar; Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Otto, Thomas D.; Rayner, Julian C.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England; [Blagborough, Andrew M.; Ruecker, Andrea; Upton, Leanna M.; Brock, Paddy M.; Churcher, Tom S.; Sala, Katarzyna A.; Zakutansky, Sara E.; Delves, Michael J.; Sinden, Robert E.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Meister, Stephan; Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Proto, William R.; Wirjanata, Grennady; Marfurt, Jutta; Price, Ric N.] Charles Darwin Univ, Menzies Sch Hlth Res, Global Hlth & Trop Med Div, Darwin, NT 0811, Australia; [Pradhan, Anupam; Kyle, Dennis E.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33612 USA; [Santos Martinez, Maria; Belen Jimenez-Diaz, Maria; Maria Sanz, Laura; Angulo-Barturen, Inigo; Ferrer-Bazaga, Santiago; Javier Gamo, Francisco] GlaxoSmithKline, Madrid 28760, Spain; [Bolscher, Judith M.; Sauerwein, Robert W.; Dechering, Koen J.] TropIQ Hlth Sci, NL-6525 GA Nijmegen, Netherlands; [Campbell, Michael; Charman, Susan A.] Monash Univ, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia; [Avery, Vicky M.] Griffith Univ, Eskitis Inst, Nathan, Qld 4111, Australia; [Noviyanti, Rintis] Eijkman Inst Mol Biol, Malaria Pathogenesis Lab, Jakarta 10430, Indonesia; [Campo, Brice; Leroy, Didier; Siegl, Peter; Bebrevska, Lidiya; Campbell, Simon; Willis, Paul A.] Med Malaria Venture, CH-1215 Geneva 15, Switzerland; [Wittlin, Sergio] Swiss Trop & Publ Hlth Inst, CH-4051 Basel, Switzerland; [Price, Ric N.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford OX3 7LJ, England; [Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA	University of Dundee; Columbia University; Wellcome Trust Sanger Institute; Imperial College London; University of California System; University of California San Diego; Charles Darwin University; Menzies School of Health Research; State University System of Florida; University of South Florida; GlaxoSmithKline; Monash University; Griffith University; Eijkman Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Oxford; Columbia University	Gilbert, IH (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland.	k.read@dundee.ac.uk; i.h.gilbert@dundee.ac.uk	Otto, Thomas/ABE-7632-2020; Avery, Vicky M/A-5449-2010; Ferrer-Bazaga, Santiago/AAA-7749-2021; Fairlamb, Alan/A-5272-2009; Sauerwein, Robert/C-8519-2013; Zuccotto, Fabio/E-7144-2017; Gray, David W/F-6674-2011; Winzeler, Elizabeth/AAP-6752-2020; Charman, Susan A/E-2221-2011; Meister, Stephan/M-6608-2014	Avery, Vicky M/0000-0003-4914-2299; Ferrer-Bazaga, Santiago/0000-0002-6672-551X; Fairlamb, Alan/0000-0001-5134-0329; Zuccotto, Fabio/0000-0002-3888-7423; Gray, David W/0000-0001-9512-3828; Winzeler, Elizabeth/0000-0002-4049-2113; Charman, Susan A/0000-0003-1753-8213; Rayner, Julian/0000-0002-9835-1014; Churcher, Thomas/0000-0002-8442-0525; Fidock, David/0000-0001-6753-8938; Ruecker, Andrea/0000-0003-3804-9670; Noviyanti, Rintis/0000-0003-1383-3274; Delves, Michael/0000-0001-8526-4782; Pradhan, Anupam/0000-0002-8805-6177; Otto, Thomas/0000-0002-1246-7404; Lee, Marcus/0000-0002-4973-0915; Hallyburton, Irene/0000-0003-4883-5560; Kyle, Dennis/0000-0002-0238-965X; Price, Richard/0000-0003-2000-2874; Gilbert, Ian/0000-0002-5238-1314; Brock, Paddy/0000-0002-1035-1619; Baragana, Beatriz/0000-0002-0959-1113; Meister, Stephan/0000-0003-2436-7037; Wirjanata, Grennady/0000-0002-6858-8547	Medicines for Malaria Venture; Wellcome Trust [100476, 091625, 098051]; Bill and Melinda Gates Foundation [OPP1043501]; National Institutes of Health [R01 AI103058]; European Union (EVIMalaR); European Regional Development Fund; UK Research Partnership Investment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103058, R01AI090141] Funding Source: NIH RePORTER; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish	Medicines for Malaria Venture; Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union (EVIMalaR); European Regional Development Fund(European Commission); UK Research Partnership Investment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Medicines for Malaria Venture, the Wellcome Trust (100476 (I.H.G., A.H.F.), 091625 (R.N.P.) and 098051 (J.C.R., W.P., T.D.O.)), the Bill and Melinda Gates Foundation (OPP1043501 (M.D., R.S.)), the National Institutes of Health (R01 AI103058 to E.A.W. and D.A.F.) and the European Union (EVIMalaR (T.D.O.)). Drug Discovery Unit infrastructure was supported by the European Regional Development Fund 2007-2013 and UK Research Partnership Investment Fund awards to M. Ferguson, whom we also thank for continued support. We thank C. Sibley for discussions. We acknowledge the East Scotland Blood Transfusion Service, Ninewells Hospital, Dundee, for erythrocyte supply to Dundee. We thank L. D. Shultz and The Jackson Laboratory for providing access to non-obese diabetic SCID IL2R gamma c null mice through their collaboration with the GlaxoSmithKline Tres Cantos Medicines Development Campus. The following are acknowledged for technical assistance: all members of the Drug Discovery Unit (Dundee), M. Berriman, J. Kamber, E. Kenangalem, A. LaCrue, O. Montagnat, J. Rini Poespoprodjo, M. Sanders, S. Sax, C. Scheurer, L. Trianty, M. Tunnicliff (detailed in Supplementary Information).	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Biswas S, 2011, INT J PARASITOL, V41, P417, DOI 10.1016/j.ijpara.2010.11.003; Blagborough AM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2840; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Burrows JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-187; Capa L, 1998, ANTIMICROB AGENTS CH, V42, P2694, DOI 10.1128/AAC.42.10.2694; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Cox G, 2012, P NATL ACAD SCI USA, V109, P2102, DOI 10.1073/pnas.1117275109; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Delves MJ, 2013, ANTIMICROB AGENTS CH, V57, P3268, DOI 10.1128/AAC.00325-13; Delves MJ, 2012, INT J PARASITOL, V42, P999, DOI 10.1016/j.ijpara.2012.08.009; Ding XC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-292; Flannery EL, 2013, J MED CHEM, V56, P7761, DOI 10.1021/jm400325j; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jimenez-Diaz MB, 2009, CYTOM PART A, V75A, P225, DOI 10.1002/cyto.a.20647; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Sanz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030949; Shastry M, 2001, MICROBIOL-UK, V147, P383, DOI 10.1099/00221287-147-2-383; Upton LM, 2015, ANTIMICROB AGENTS CH, V59, P490, DOI 10.1128/AAC.03942-14; Wells TNC, 2011, RSC DRUG DISCOV, V14, P1, DOI 10.1039/9781849733496-00001; WHO, 2013, WORLD MALARIA REPORT 2013, P1	36	251	256	0	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					315	+		10.1038/nature14451	http://dx.doi.org/10.1038/nature14451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085270	Green Submitted, Green Accepted			2022-12-28	WOS:000356425400047
J	Braunschweig, H; Dewhurst, RD; Hupp, F; Nutz, M; Radacki, K; Tate, CW; Vargas, A; Ye, Q				Braunschweig, Holger; Dewhurst, Rian D.; Hupp, Florian; Nutz, Marco; Radacki, Krzysztof; Tate, Christopher W.; Vargas, Alfredo; Ye, Qing			Multiple complexation of CO and related ligands to a main-group element	NATURE			English	Article							BORON TRIPLE BOND; DATIVE BONDS; SOLID-STATE; ACTIVATION; REACTIVITY; COMPOUND; CARBENES; CARBONYL; ARROWS; ADDUCT	The ability of an atom or molecular fragment to bind multiple carbon monoxide (CO) molecules to form multicarbonyl adducts is a fundamental trait of transition metals. Transition-metal carbonyl complexes are vital to industry, appear naturally in the active sites of a number of enzymes (such as hydrogenases), are promising therapeutic agents(1), and have even been observed in interstellar dust clouds(2). Despite the wealth of established transition-metal multicarbonyl complexes(3), no elements outside groups 4 to 12 of the periodic table have yet been shown to react directly with two or more CO units to form stable multicarbonyl adducts. Here we present the synthesis of a borylene dicarbonyl complex, the first multicarbonyl complex of a main-group element prepared using CO. The compound is additionally stable towards ambient air and moisture. The synthetic strategy used-liberation of a borylene ligand from a transition metal using donor ligands-is broadly applicable, leading to a number of unprecedented monovalent boron species with different Lewis basic groups. The similarity of these compounds to conventional transition-metal carbonyl complexes is demonstrated by photolytic liberation of CO and subsequent intramolecular carbon-carbon bond activation.	[Braunschweig, Holger; Dewhurst, Rian D.; Hupp, Florian; Nutz, Marco; Radacki, Krzysztof; Tate, Christopher W.; Ye, Qing] Univ Wurzburg, Inst Anorgan Chem, D-97074 Wurzburg, Germany; [Vargas, Alfredo] Univ Sussex, Sch Life Sci, Dept Chem, Brighton BN1 9QJ, E Sussex, England	University of Wurzburg; University of Sussex	Braunschweig, H (corresponding author), Univ Wurzburg, Inst Anorgan Chem, D-97074 Wurzburg, Germany.	h.braunschweig@uni-wuerzburg.de	Ye, Qing/J-2736-2014; Braunschweig, Holger/W-8600-2019; Vargas, Alfredo/N-6711-2015; Dewhurst, Rian D/B-7062-2009	Ye, Qing/0000-0002-7238-0407; Braunschweig, Holger/0000-0001-9264-1726; Vargas, Alfredo/0000-0001-7491-791X; Dewhurst, Rian D/0000-0001-5978-811X; Radacki, Krzysztof/0000-0003-3088-6327	European Research Council	European Research Council(European Research Council (ERC)European Commission)	This work was supported by a European Research Council Advanced Grant to H.B.	Bernhardi I, 1999, ANGEW CHEM INT EDIT, V38, P2232, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2232::AID-ANIE2232>3.0.CO;2-2; Braunschweig H, 2013, NAT CHEM, V5, P1025, DOI [10.1038/NCHEM.1778, 10.1038/nchem.1778]; Braunschweig H, 2012, SCIENCE, V336, P1420, DOI 10.1126/science.1221138; Braunschweig H, 2010, CHEM REV, V110, P3924, DOI 10.1021/cr900333n; Celik MA, 2012, CHEM-EUR J, V18, P5676, DOI 10.1002/chem.201103965; Dahcheh F, 2014, ANGEW CHEM INT EDIT, V53, P13159, DOI 10.1002/anie.201408371; Ellern A, 2001, Z ANORG ALLG CHEM, V627, P73, DOI 10.1002/1521-3749(200101)627:1<73::AID-ZAAC73>3.0.CO;2-A; Finze M, 2002, J AM CHEM SOC, V124, P15385, DOI 10.1021/ja0209924; Frenking G, 2014, ANGEW CHEM INT EDIT, V53, P6040, DOI 10.1002/anie.201311022; Frey GD, 2007, SCIENCE, V316, P439, DOI 10.1126/science.1141474; GLORE JD, 1973, INORG CHEM, V12, P2175, DOI 10.1021/ic50127a048; Grigsby WJ, 1996, J AM CHEM SOC, V118, P7981, DOI 10.1021/ja960918j; Himmel D, 2014, ANGEW CHEM INT EDIT, V53, P6047, DOI 10.1002/anie.201403078; Himmel D, 2014, ANGEW CHEM INT EDIT, V53, P370, DOI 10.1002/anie.201300461; Khan S, 2012, CHEM COMMUN, V48, P2169, DOI 10.1039/c2cc17449a; Kinjo R, 2011, SCIENCE, V333, P610, DOI 10.1126/science.1207573; Kong LB, 2014, ANGEW CHEM INT EDIT, V53, P9280, DOI 10.1002/anie.201405201; Lavallo V, 2006, ANGEW CHEM INT EDIT, V45, P3488, DOI 10.1002/anie.200600987; Martin D, 2011, CHEM SCI, V2, P389, DOI 10.1039/c0sc00388c; Mondal KC, 2013, ANGEW CHEM INT EDIT, V52, P2963, DOI 10.1002/anie.201208307; PARRY J, 1995, J AM CHEM SOC, V117, P2649, DOI 10.1021/ja00114a030; Power PP, 2010, NATURE, V463, P171, DOI 10.1038/nature08634; Puschmann FF, 2011, ANGEW CHEM INT EDIT, V50, P8420, DOI 10.1002/anie.201102930; Ruiz DA, 2014, CHEM COMMUN, V50, P7837, DOI 10.1039/c4cc03497j; Simpson PV, 2014, INORGANIC CHEMICAL BIOLOGY: PRINCIPLES, TECHNIQUES AND APPLICATIONS, P309; Spikes GH, 2005, J AM CHEM SOC, V127, P12232, DOI 10.1021/ja053247a; The Cambridge Crystallographic Database, 2013, CAMBRIDGE CRYSTALLOG; Tielens AGGM, 1996, ASTROPHYS J, V461, P210, DOI 10.1086/177049; Tonner R, 2007, ANGEW CHEM INT EDIT, V46, P8695, DOI 10.1002/anie.200701632; Wang YZ, 2012, DALTON T, V41, P337, DOI 10.1039/c1dt11165e	30	200	199	3	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					327	330		10.1038/nature14489	http://dx.doi.org/10.1038/nature14489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085273				2022-12-28	WOS:000356425400050
J	Kaji, AH; Lewis, RJ				Kaji, Amy H.; Lewis, Roger J.			Noninferiority Trials Is a New Treatment Almost as Effective as Another?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kaji, Amy H.; Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Kaji, Amy H.; Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Torrance, CA USA; [Kaji, Amy H.; Lewis, Roger J.] Los Angeles Biomed Res Inst, Los Angeles, CA USA; [Lewis, Roger J.] Berry Consultants LLC, Austin, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lewis, RJ (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Box 21, Torrance, CA 90509 USA.	roger@emedharbor.edu						Kaji AH, 2010, ANN EMERG MED, V55, P408, DOI 10.1016/j.annemergmed.2010.01.024; Mulla SM, 2012, JAMA-J AM MED ASSOC, V308, P2605, DOI 10.1001/2012.jama.11235; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154; Tamayo-Sarver JH, 2005, ACAD EMERG MED, V12, P536, DOI 10.1197/j.aem.2005.01.010; Wilms IMHA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008359.pub2; Young KD, 1997, ANN EMERG MED, V30, P307, DOI 10.1016/S0196-0644(97)70166-5	7	50	48	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2371	2372		10.1001/jama.2015.6645	http://dx.doi.org/10.1001/jama.2015.6645			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080342				2022-12-28	WOS:000356300200023
J	Lim, LS				Lim, Lionel S.			Review: In patients with dementia who live in care homes, some nondrug interventions reduce agitation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Griffin Hosp, Derby, CT 06418 USA		Lim, LS (corresponding author), Griffin Hosp, Derby, CT 06418 USA.			Livingston, Gill/0000-0001-6741-5516; Lim, Lionel/0000-0002-0730-8767				American Geriatrics Society, 10 THINGS PHYS PAT S; [Anonymous], 2015, ALZH DIS FACTS FIG; Van der Mussele S, 2015, AGING MENT HEALTH, V19, P247, DOI 10.1080/13607863.2014.924900	3	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC3	10.7326/ACPJC-2015-162-12-003	http://dx.doi.org/10.7326/ACPJC-2015-162-12-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075780				2022-12-28	WOS:000356516300004
J	Snyder, A				Snyder, Alison			Alexander Rich Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2248	2248		10.1016/S0140-6736(15)61056-X	http://dx.doi.org/10.1016/S0140-6736(15)61056-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	26088490				2022-12-28	WOS:000355943500017
J	McInnes, IB; Mease, PJ; Kirkham, B; Kavanaugh, A; Ritchlin, CT; Rahman, P; van der Heijde, D; Landewe, R; Conaghan, PG; Gottlieb, AB; Richards, H; Pricop, L; Ligozio, G; Patekar, M; Mpofu, S				McInnes, Iain B.; Mease, Philip J.; Kirkham, Bruce; Kavanaugh, Arthur; Ritchlin, Christopher T.; Rahman, Proton; Van der Heijde, Desiree; Landewe, Robert; Conaghan, Philip G.; Gottlieb, Alice B.; Richards, Hanno; Pricop, Luminita; Ligozio, Gregory; Patekar, Manmath; Mpofu, Shephard		FUTURE 2 Study Grp	Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							DISEASE-ACTIVITY; EFFICACY; SAFETY; CELLS; MULTICENTER; USTEKINUMAB; SYMPTOMS; SIGNS	Background Interleukin 17A is a proinflammatory cytokine that is implicated in the pathogenesis of psoriatic arthritis. We assessed the efficacy and safety of subcutaneous secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis. Methods In this phase 3, double-blind, placebo-controlled study undertaken at 76 centres in Asia, Australia, Canada, Europe, and the USA, adults (aged >= 18 years old) with active psoriatic arthritis were randomly allocated in a 1: 1: 1: 1 ratio with computer-generated blocks to receive subcutaneous placebo or secukinumab 300 mg, 150 mg, or 75 mg once a week from baseline and then every 4 weeks from week 4. Patients and investigators were masked to treatment assignment. The primary endpoint was the proportion of patients achieving at least 20% improvement in the American College of Rheumatology response criteria (ACR20) at week 24. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01752634. Findings Between April 14, and Nov 25, 2013, 397 patients were randomly assigned to receive secukinumab 300 mg (n=100), 150 mg (n=100), 75 mg (n=99), or placebo (n=98). A significantly higher proportion of patients achieved an ACR20 at week 24 with secukinumab 300 mg (54 [54%] patients; odds ratio versus placebo 6.81, 95% CI 3.42-13.56; p<0.0001), 150 mg (51 [51%] patients; 6.52, 3.25-13.08; p<0.0001), and 75 mg (29 [29%] patients; 2.32, 1.14-4.73; p=0.0399) versus placebo (15 [15%] patients). Up to week 16, the most common adverse events were upper respiratory tract infections (four [4%], eight [8%], ten [10%], and seven [7%] with secukinumab 300 mg, 150 mg, 75 mg, and placebo, respectively) and nasopharyngitis (six [6%], four [4%], six [6%], and eight [8%], respectively). Serious adverse events were reported by five (5%), one (1%), and four (4%) patients in the secukinumab 300 mg, 150 mg, and 75 mg groups, respectively, compared with two (2%) in the placebo group. No deaths were reported. Interpretation Subcutaneous secukinumab 300 mg and 150 mg improved the signs and symptoms of psoriatic arthritis, suggesting that secukinumab is a potential future treatment option for patients with this disorder.	[McInnes, Iain B.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Mease, Philip J.] Swedish Med Ctr, Seattle, WA USA; [Mease, Philip J.] Univ Washington, Seattle, WA 98195 USA; [Kirkham, Bruce] Guys & St Thomas NHS Fdn Trust, London, England; [Kavanaugh, Arthur] San Diego Sch Med, Dept Internal Med, Div Rheumatol Allergy & Immunol, San Diego, CA USA; [Ritchlin, Christopher T.] Univ Rochester, Allergy Immunol & Rheumatol Div, Rochester, NY USA; [Rahman, Proton] Mem Univ, St John, NF, Canada; [Van der Heijde, Desiree] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Landewe, Robert] Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands; [Landewe, Robert] Atrium Med Ctr, Heerlen, Netherlands; [Conaghan, Philip G.] NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Conaghan, Philip G.] Univ Leeds, Leeds, W Yorkshire, England; [Gottlieb, Alice B.] Tufts Med Ctr, Dept Dermatol, Boston, MA USA; [Richards, Hanno; Mpofu, Shephard] Novartis Pharmaceut, Basel, Switzerland; [Pricop, Luminita; Ligozio, Gregory] Novartis Pharmaceut, E Hanover, NJ USA; [Patekar, Manmath] Novartis Healthcare, Hyderabad, Andhra Pradesh, India	University of Glasgow; Swedish Medical Center; University of Washington; University of Washington Seattle; Guy's & St Thomas' NHS Foundation Trust; University of Rochester; Memorial University Newfoundland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Atrium Medical Center; Leeds Biomedical Research Centre; University of Leeds; Tufts Medical Center; Novartis; Novartis	McInnes, IB (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	Iain.McInnes@glasgow.ac.uk	Kaul, Arvind/AAM-2628-2021; van der Heijde, Désirée/I-6774-2019; Mann, Herman Felix/G-5871-2014; LANDEWE, ROBERT B.M./ABD-7388-2021; Chinoy, Hector/C-7832-2013	van der Heijde, Désirée/0000-0002-5781-158X; Mann, Herman Felix/0000-0002-4243-235X; LANDEWE, ROBERT B.M./0000-0002-0577-6620; ritchlin, christopher/0000-0002-2602-1219; Yakupova, Svetlana/0000-0002-8590-4839; Szepietowski, Jacek/0000-0003-0766-6342; Chinoy, Hector/0000-0001-6492-1288; Conaghan, Philip/0000-0002-3478-5665	Novartis; Novartis Pharma; MRC [MR/L01629X/1] Funding Source: UKRI; Medical Research Council [MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [CL-2006-06-010] Funding Source: researchfish	Novartis(Novartis); Novartis Pharma; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding Novartis.; Novartis provided funding for FUTURE 2. We thank the patients who participated in the study, the study investigators, and John Gallagher, a medical consultant for Novartis Pharma. The initial manuscript draft was written by Chris Strutynskyj-Stannard, with assistance from Joanne Swainston and Jessica Breen, medical writers from Seren Communications, an Ashfield Company, part of UDG Healthcare, the funding for which was provided by Novartis Pharma.	Antoni C, 2005, ANN RHEUM DIS, V64, P1150, DOI 10.1136/ard.2004.032268; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; FitzGerald O, 2014, ARTHRITIS RHEUMATOL, V66, P1077, DOI 10.1002/art.38370; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Gaffen SL, 2011, IMMUNOL RES, V50, P181, DOI 10.1007/s12026-011-8226-x; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Kavanaugh A, 2014, ANN RHEUM DIS, V73, P1020, DOI 10.1136/annrheumdis-2013-205056; Kavanaugh A, 2009, ARTHRITIS RHEUM-US, V60, P976, DOI 10.1002/art.24403; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Klein U, 2013, J INVEST DERMATOL, V133, pS172; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; McInnes IB, 2013, LANCET, V382, P780, DOI 10.1016/S0140-6736(13)60594-2; Mease PJ, 2014, ANN RHEUM DIS, V73, P48, DOI 10.1136/annrheumdis-2013-203696; Mease P, 2014, ARTHRITIS RHEUMATOL, V66, pS423; Mease PJ, 2004, ARTHRITIS RHEUM-US, V50, P2264, DOI 10.1002/art.20335; Mease PJ, 2005, ARTHRITIS RHEUM-US, V52, P3279, DOI 10.1002/art.21306; Menon B, 2014, ARTHRITIS RHEUMATOL, V66, P1272, DOI 10.1002/art.38376; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; Raychaudhuri SP, 2012, MOL CELL BIOCHEM, V359, P419, DOI 10.1007/s11010-011-1036-6; Ritchlin C, 2014, ANN RHEUM DIS, V73, P990, DOI 10.1136/annrheumdis-2013-204655; Rosen CF, 2012, RHEUMATOLOGY, V51, P571, DOI 10.1093/rheumatology/ker365; Strand V, 2008, AM J MANAG CARE, V14, P239; Weisman S, 2003, J Dermatolog Treat, V14, P158, DOI 10.1080/09546630310013360; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459	25	582	609	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1137	1146		10.1016/S0140-6736(15)61134-5	http://dx.doi.org/10.1016/S0140-6736(15)61134-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5GE	26135703	Green Accepted			2022-12-28	WOS:000361368000028
J	Gostin, LO; Lucey, D				Gostin, Lawrence O.; Lucey, Daniel			Middle East Respiratory Syndrome A Global Health Challenge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYNDROME CORONAVIRUS; OUTBREAK		[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Lucey, Daniel] Georgetown Univ, Sch Med, Washington, DC USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Al-Abdallat MM, 2014, CLIN INFECT DIS, V59, P1225, DOI 10.1093/cid/ciu359; Fiddler DP, WHO OWNS MERS; Lucey DR, 2014, CLIN INFECT DIS, V59, P1234, DOI 10.1093/cid/ciu638; Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3; Sang-Hun C., FEARS MERS VIRUS PRO; Sang-Hun C., MERS VIRUSS PATH ONE; World Health Organization, 66 WORLD HLTH ASS CL; World Health Organization, MIDDL E RESP SYNDR C	8	6	8	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					771	772		10.1001/jama.2015.7646	http://dx.doi.org/10.1001/jama.2015.7646			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26084030				2022-12-28	WOS:000360017200013
J	Onofrey, S; Aneja, J; Haney, GA; Nagami, EH; DeMaria, A; Lauer, GM; Hills-Evans, K; Barton, K; Kulaga, S; Bowen, MJ; Cocoros, N; McGovern, BH; Church, DR; Kim, AY				Onofrey, Shauna; Aneja, Jasneet; Haney, Gillian A.; Nagami, Ellen H.; DeMaria, Alfred, Jr.; Lauer, Georg M.; Hills-Evans, Kelsey; Barton, Kerri; Kulaga, Stephanie; Bowen, Melinda J.; Cocoros, Noelle; McGovern, Barbara H.; Church, Daniel R.; Kim, Arthur Y.			Underascertainment of Acute Hepatitis C Virus Infections in the US Surveillance System	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE VIRAL-HEPATITIS; INJECTION-DRUG USERS; UNITED-STATES; YOUNG-ADULTS; MASSACHUSETTS; EPIDEMIOLOGY; DIAGNOSIS; RISK	Background: In 2010, the incidence of hepatitis C virus (HCV) infection in the United States was estimated to be 17 000 cases annually, based on 850 acute HCV cases reported to the Centers for Disease Control and Prevention by local public health authorities. Absence of symptomatic disease and lack of a specific laboratory test for acute infection complicates diagnosis and surveillance. Objective: To validate estimates of the incidence of acute HCV infection by determining the reporting rate of clinical diagnoses of acute infection to the Massachusetts Department of Public Health (MDPH) and Centers for Disease Control and Prevention. Design: Case series and chart review. Setting: Two hospitals and the state correctional health care system in Massachusetts. Patients: 183 patients clinically diagnosed with acute HCV infection from 2001 to 2011 and participating in a research study. Measurements: Rate of electronic case reporting of acute HCV infection to the MDPH and rate of subsequent confirmation according to national case definitions. Results: 149 of 183 (81.4%) clinical cases of acute HCV infection were reported to the MDPH for surveillance classification. The MDPH investigated 43 of these reports as potential acute cases of HCV infection based on their surveillance requirements; ultimately, only 1 met the national case definition and was counted in nationwide statistics published by the Centers for Disease Control and Prevention. Discordance in clinical and surveillance classification was often related to missing clinical or laboratory data at the MDPH as well as restrictive definitions, including requirements for negative hepatitis A and B laboratory results. Limitation: Findings may not apply to other jurisdictions because of differences in resources for surveillance. Conclusion: Clinical diagnoses of acute HCV infection were grossly underascertained by formal surveillance reporting. Incomplete clinician reporting, problematic case definitions, limitations of diagnostic testing, and imperfect data capture remain major limitations to accurate case ascertainment despite automated electronic laboratory reporting. These findings may have implications for national estimates of the incidence of HCV infection.	[Onofrey, Shauna; Haney, Gillian A.; Barton, Kerri; Church, Daniel R.] Massachusetts Dept Publ Hlth, Jamaica Plain, MA 02130 USA; [Aneja, Jasneet; Kulaga, Stephanie; Kim, Arthur Y.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Nagami, Ellen H.; McGovern, Barbara H.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [DeMaria, Alfred, Jr.] Massachusetts Dept Publ Hlth, Bur Infect Dis, William A Hinton State Lab Inst, Jamaica Plain, MA 02130 USA; [Lauer, Georg M.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Hills-Evans, Kelsey] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Bowen, Melinda J.] Massachusetts Partnership Correct Hlth Care, Westborough, MA 01581 USA; [Cocoros, Noelle] Harvard Univ, Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02215 USA; [Kim, Arthur Y.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Massachusetts Department of Public Health; Harvard University; Massachusetts General Hospital; Tufts University; Massachusetts Department of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Kim, AY (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, 55 Fruit St,Cox 5, Boston, MA 02114 USA.	shauna.onofrey@state.ma.us; akim1@mgh.harvard.edu	Lauer, Georg/J-1467-2018	Lauer, Georg/0000-0002-9792-4271; Cocoros, Noelle/0000-0001-7090-2761	National Institutes of Health.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066345, U19AI082630, R01AI105035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031056, R01DA033541] Funding Source: NIH RePORTER	National Institutes of Health.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health.	ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; [Anonymous], VIR HEP STAT SURV; Boesecke C, 2012, INFECT DIS CLIN N AM, V26, P995, DOI 10.1016/j.idc.2012.08.011; Center for Behavioral Health Statistics and Quality, 2012, MMWR MORB MORTAL WKL, V44; Centers for Disease Control and Prevention, VIR HEP HEP C INF; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P358; Centers for Disease Control and Prevention (CDC), 2008, MMWR-MORBID MORTAL W, V57, P517; Church D., 2011, Morbidity and Mortality Weekly Report, V60, P1457; Colvin HM, 2010, HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, P1; Cox AL, 2009, GASTROENTEROLOGY, V136, P26, DOI 10.1053/j.gastro.2008.11.049; Deacon RM, 2011, COMMUN DIS INTELL, V35, P16; Edlin BR, 2011, NATURE, V474, pS18, DOI 10.1038/474S18a; Hagan H, 2002, J URBAN HEALTH, V79, P579, DOI 10.1093/jurban/79.4.579; Hajarizadeh B, 2012, J HEPATOL, V57, P1349, DOI 10.1016/j.jhep.2012.07.007; Hart-Malloy R, 2013, AM J PUBLIC HEALTH, V103, P1402, DOI 10.2105/AJPH.2013.301231; Iqbal K, 2012, PUBLIC HEALTH REP, V127, P591, DOI 10.1177/003335491212700609; Kim AY, 2013, HEPATOLOGY, V57, P944, DOI 10.1002/hep.26113; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Klevens R. M., 2010, Morbidity and Mortality Weekly Report, V59, P1407; Klevens RM, 2014, AM J PUBLIC HEALTH, V104, P482, DOI 10.2105/AJPH.2013.301601; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; McGovern BH, 2006, CLIN INFECT DIS, V42, P1663, DOI 10.1086/504327; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Onofrey Shauna, 2011, Morbidity and Mortality Weekly Report, V60, P537; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Sacks-Davis R, 2012, EPIDEMIOL INFECT, V140, P1925, DOI 10.1017/S0950268812001033; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Ticehurst JR, 2007, J CLIN MICROBIOL, V45, P2426, DOI 10.1128/JCM.02448-06; Troppy S, 2014, PUBLIC HEALTH REP, V129, P132, DOI 10.1177/003335491412900206; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Williams IT, 2011, ARCH INTERN MED, V171, P242, DOI 10.1001/archinternmed.2010.511	33	27	27	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					254	+		10.7326/M14-2939	http://dx.doi.org/10.7326/M14-2939			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LC	26121304	Green Accepted			2022-12-28	WOS:000360286400003
J	Pollack Jr, CV; Reilly, PA; Eikelboom, J; Glund, S; Verhamme, P; Bernstein, RA; Dubiel, R; Huisman, MV; Hylek, EM; Kamphuisen, PW; Kreuzer, J; Levy, JH; Sellke, FW; Stangier, J; Steiner, T; Wang, B; Kam, CW; Weitz, JI				Pollack, Charles V., Jr.; Reilly, Paul A.; Eikelboom, John; Glund, Stephan; Verhamme, Peter; Bernstein, Richard A.; Dubiel, Robert; Huisman, Menno V.; Hylek, Elaine M.; Kamphuisen, Pieter W.; Kreuzer, Jrg; Levy, Jerrold H.; Sellke, Frank W.; Stangier, Joachim; Steiner, Thorsten; Wang, Bushi; Kam, Chak-Wah; Weitz, Jeffrey I.			Idarucizumab for Dabigatran Reversal	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIDOTE; WARFARIN; STROKE; SAFETY	BACKGROUND Specific reversal agents for non-vitamin K antagonist oral anticoagulants are lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran. METHODS We undertook this prospective cohort study to determine the safety of 5 g of intravenous idarucizumab and its capacity to reverse the anticoagulant effects of dabigatran in patients who had serious bleeding (group A) or required an urgent procedure (group B). The primary end point was the maximum percentage reversal of the anticoagulant effect of dabigatran within 4 hours after the administration of idarucizumab, on the basis of the determination at a central laboratory of the dilute thrombin time or ecarin clotting time. A key secondary end point was the restoration of hemostasis. RESULTS This interim analysis included 90 patients who received idarucizumab (51 patients in group A and 39 in group B). Among 68 patients with an elevated dilute thrombin time and 81 with an elevated ecarin clotting time at baseline, the median maximum percentage reversal was 100% (95% confidence interval, 100 to 100). Idarucizumab normalized the test results in 88 to 98% of the patients, an effect that was evident within minutes. Concentrations of unbound dabigatran remained below 20 ng per milliliter at 24 hours in 79% of the patients. Among 35 patients in group A who could be assessed, hemostasis, as determined by local investigators, was restored at a median of 11.4 hours. Among 36 patients in group B who underwent a procedure, normal intraoperative hemostasis was reported in 33, and mildly or moderately abnormal hemostasis was reported in 2 patients and 1 patient, respectively. One thrombotic event occurred within 72 hours after idarucizumab administration in a patient in whom anticoagulants had not been reinitiated. CONCLUSIONS Idarucizumab completely reversed the anticoagulant effect of dabigatran within minutes. (Funded by Boehringer Ingelheim; RE-VERSE AD ClinicalTrials.gov number, NCT02104947.)	[Pollack, Charles V., Jr.] Penn Hosp, Philadelphia, PA 19107 USA; [Reilly, Paul A.; Dubiel, Robert; Wang, Bushi] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Eikelboom, John; Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON, Canada; [Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Glund, Stephan; Stangier, Joachim] Univ Heidelberg Hosp, Boehringer Ingelheim Pharma, Biberach, Germany; [Kreuzer, Jrg] Univ Heidelberg Hosp, Ingelheim, Frankfurt, Germany; [Steiner, Thorsten] Univ Heidelberg Hosp, Klinikum Frankfurt Hochst, Heidelberg, Germany; [Verhamme, Peter] Univ Leuven, Leuven, Belgium; [Bernstein, Richard A.] Northwestern Univ, Chicago, IL 60611 USA; [Huisman, Menno V.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Kamphuisen, Pieter W.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Hylek, Elaine M.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Levy, Jerrold H.] Duke Univ, Med Ctr, Durham, NC USA; [Sellke, Frank W.] Brown Med Sch, Providence, RI USA; [Sellke, Frank W.] Rhode Isl Hosp, Providence, RI USA; [Kam, Chak-Wah] Tuen Mun Hosp, Tuen Mun, NT, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Boehringer Ingelheim; McMaster University; McMaster University; Boehringer Ingelheim; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; KU Leuven; Northwestern University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Boston University; Duke University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Tuen Mun Hospital	Pollack Jr, CV (corresponding author), Thomas Jefferson Univ, Scott Mem Lib, 1020 Walnut St,Rm 616, Philadelphia, PA 19107 USA.	charles.-pollack@jefferson.-edu	Weitz, Jeffrey/AAD-1929-2019; Eikelboom, John/AAG-6117-2019; Steiner, Thorsten/L-2868-2018	Weitz, Jeffrey/0000-0002-1092-7550; Eikelboom, John/0000-0003-4126-1285; Steiner, Thorsten/0000-0002-5080-8222	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Funded by Boehringer Ingelheim; RE-VERSE AD ClinicalTrials.gov number, NCT02104947.	Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dennis M, 2012, STROKE, V43, P851, DOI 10.1161/STROKEAHA.111.639708; Glund S, 2015, LANCET; Glund S, 2015, THROMB HAEMOSTASIS, V113, P943, DOI 10.1160/TH14-12-1080; Glund S, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.344.344; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; Yeh CH, 2014, BLOOD, V124, P1020, DOI 10.1182/blood-2014-03-563056	14	911	926	2	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					511	520		10.1056/NEJMoa1502000	http://dx.doi.org/10.1056/NEJMoa1502000			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26095746				2022-12-28	WOS:000358987700005
J	McCance-Katz, EF; Valdiserri, RO				McCance-Katz, Elinore F.; Valdiserri, Ronald O.			Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From Fiction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS		Subst Abuse & Mental Hlth Serv Adm, US Dept HHS, Rockville, MD 20857 USA; US Dept HHS, Off HIV AIDS & Infect Dis Policy, Washington, DC 20201 USA		McCance-Katz, EF (corresponding author), Subst Abuse & Mental Hlth Serv Adm, 1 Choke Cherry Rd,Room 8-1057, Rockville, MD 20857 USA.	emccancekatz@gmail.com						American Association for the Study of Liver Diseases, 2014, RECOMMENDATIONS FOR; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Bart G, 2012, J ADDICT DIS, V31, P207, DOI 10.1080/10550887.2012.694598; Dimova RB, 2013, CLIN INFECT DIS, V56, P806, DOI 10.1093/cid/cis1007; Ellwood M, 2014, RESTRICTIONS TO HCV; Grebely J, 2010, J GASTROEN HEPATOL, V25, P1281, DOI 10.1111/j.1440-1746.2010.06238.x; Litwin AH, 2009, J SUBST ABUSE TREAT, V37, P32, DOI 10.1016/j.jsat.2008.09.009; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Venteicher W., 2014, MOST ILLINOIS MEDICA	9	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					224	+		10.7326/M15-0007	http://dx.doi.org/10.7326/M15-0007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO6EX	26120801				2022-12-28	WOS:000359251100011
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The zombie statistic behind the push for seven day working	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2012, GUARDIAN; [Anonymous], 2012, BBC NEWS; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; McCartney M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8276; Royal College of Physicians, 2012, EV CONS INP AC HOSP	5	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2015	351								h3575	10.1136/bmj.h3575	http://dx.doi.org/10.1136/bmj.h3575			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MA	26149420	Bronze			2022-12-28	WOS:000357954200002
J	Desguin, B; Zhang, T; Soumillion, P; Hols, P; Hu, J; Hausinger, RP				Desguin, Benoit; Zhang, Tuo; Soumillion, Patrice; Hols, Pascal; Hu, Jian; Hausinger, Robert P.			A tethered niacin-derived pincer complex with a nickel-carbon bond in lactate racemase	SCIENCE			English	Article							SCS-PINCER; PURIFICATION; METABOLISM	Lactic acid racemization is involved in lactate metabolism and cell wall assembly of many microorganisms. Lactate racemase (Lar) requires nickel, but the nickel-binding site and the role of three accessory proteins required for its activation remain enigmatic. We combined mass spectrometry and x-ray crystallography to show that Lar from Lactobacillus plantarum possesses an organometallic nickel-containing prosthetic group. A nicotinic acid mononucleotide derivative is tethered to Lys(184) and forms a tridentate pincer complex that coordinates nickel through one metal-carbon and two metal-sulfur bonds, with His(200) as another ligand. Although similar complexes have been previously synthesized, there was no prior evidence for the existence of pincer cofactors in enzymes. The wide distribution of the accessory proteins without Lar suggests that it may play a role in other enzymes.	[Desguin, Benoit; Hausinger, Robert P.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Zhang, Tuo; Hu, Jian; Hausinger, Robert P.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Soumillion, Patrice; Hols, Pascal] Catholic Univ Louvain, Inst Life Sci, B-1348 Louvain La Neuve, Belgium; [Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Universite Catholique Louvain; Michigan State University	Hu, J (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	hujian1@msu.edu; hausinge@msu.edu	, jonah/AAH-2478-2020	Hausinger, Robert/0000-0002-3643-2054; Desguin, Benoit/0000-0002-5004-6918	Belgian National Fund for Scientific Research (FNRS); Universite Catholique de Louvain-Fonds Speciaux de Recherche; Michigan State University	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Catholique de Louvain-Fonds Speciaux de Recherche; Michigan State University	We thank E. L. Hegg, A. D. Jones, and O. Riant for fruitful discussions; L. Chen at the Michigan State University Mass Spectrometry and Metabolomics Core for instructions and help with data collection; and J. Brunzelle and Z. Wawrzak at the Life Sciences Collaborative Access Team of Advanced Proton Source for assistance with data collection. The LarA structure has been deposited with the Protein Data Bank (accession code 4YNS). The work of P.H. and P.S. was supported by grants from the Belgian National Fund for Scientific Research (FNRS) and the Universite Catholique de Louvain-Fonds Speciaux de Recherche. R.P.H. acknowledges support from Michigan State University.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; CANTWELL A, 1974, Biochemistry, V13, P287, DOI 10.1021/bi00699a009; DENNIS D, 1963, BIOCHEM Z, V338, P485; Desguin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4615; HIYAMA T, 1968, J BIOCHEM-TOKYO, V64, P99, DOI 10.1093/oxfordjournals.jbchem.a128870; KATAGIRI H, 1961, AGR BIOL CHEM TOKYO, V25, P281, DOI 10.1080/00021369.1961.10857808; Kruithof CA, 2008, ORGANOMETALLICS, V27, P4928, DOI 10.1021/om800324w; Peterson SM, 2015, DALTON T, V44, P747, DOI 10.1039/c4dt02718c; RAGSDALE SW, 1985, P NATL ACAD SCI USA, V82, P6811, DOI 10.1073/pnas.82.20.6811; Randaccio L, 2010, MOLECULES, V15, P3228, DOI 10.3390/molecules15053228; Shima S, 2012, DALTON T, V41, P767, DOI 10.1039/c1dt11093d; Singleton JT, 2003, TETRAHEDRON, V59, P1837, DOI 10.1016/S0040-4020(02)01511-9; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; van Koten G, 2013, TOP ORGANOMETAL CHEM, V40, P1, DOI 10.1007/978-3-642-31081-2_1; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; Zargarian D, 2013, TOP ORGANOMETAL CHEM, V40, P131, DOI 10.1007/978-3-642-31081-2_5; Zhang GY, 2009, APPL ENVIRON MICROB, V75, P1080, DOI 10.1128/AEM.01416-08	18	61	61	4	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					66	69		10.1126/science.aab2272	http://dx.doi.org/10.1126/science.aab2272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138974				2022-12-28	WOS:000357280800059
J	Bruun, E; Givoni, M				Bruun, Eric; Givoni, Moshe			Sustainable mobility: Six research routes to steer transport policy	NATURE			English	Editorial Material									[Givoni, Moshe] Tel Aviv Univ, Dept Geog & Human Environm, Transport Res Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University	Bruun, E (corresponding author), Aalto Univ, Dept Civil & Environm Engn, Espoo, Finland.	eric.bruun@gmx.com; givonim@post.tau.ac.il	Bruun, Eric/G-2209-2013					Banister D., 2013, MOVING LOW CARBON MO; Bruun E. C., 2014, CHARACTERIZING INFLU; Burns LD, 2013, NATURE, V497, P181, DOI 10.1038/497181a; Givoni M, 2013, TRANSPORT REV, V33, P1, DOI 10.1080/01441647.2012.744779; Givoni M, 2012, J TRANSP GEOGR, V22, P306, DOI 10.1016/j.jtrangeo.2012.01.024; Givoni M, 2012, URBAN STUD, V49, P1089, DOI 10.1177/0042098011417017; Kenworthy J. R., 2010, INTRO SUSTAINABLE TR; Newman P., 2015, END AUTOMOBILE DEPEN, DOI DOI 10.5822/978-1-61091-613-4_4	8	24	24	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					29	31		10.1038/523029a	http://dx.doi.org/10.1038/523029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL7RN	26135434	Bronze			2022-12-28	WOS:000357169500014
J	Truitt, ML; Conn, CS; Shi, Z; Pang, XM; Tokuyasu, T; Coady, AM; Seo, Y; Barna, M; Ruggero, D				Truitt, Morgan L.; Conn, Crystal S.; Shi, Zhen; Pang, Xiaming; Tokuyasu, Taku; Coady, Alison M.; Seo, Youngho; Barna, Maria; Ruggero, Davide			Differential Requirements for eIF4E Dose in Normal Development and Cancer	CELL			English	Article							CAP-BINDING PROTEIN; TRANSLATIONAL LANDSCAPE; INITIATION-FACTORS; C-MYC; PHOSPHORYLATION; EIF-4E; RAS; RECRUITMENT; EXPRESSION; MECHANISM	eIF4E, the major cap- binding protein, has long been considered limiting for translating the mammalian genome. However, the eIF4E dose requirement at an organismal level remains unexplored. By generating an Eif4e haploinsufficient mouse, we found that a 50% reduction in eIF4E expression, while compatible with normal development and global protein synthesis, significantly impeded cellular transformation. Genome- wide translational profiling uncovered a translational program induced by oncogenic transformation and revealed a critical role for the dose of eIF4E, specifically in translating a network of mRNAs enriched for a unique 5' UTR signature. In particular, we demonstrate that the dose of eIF4E is essential for translating mRNAs that regulate reactive oxygen species, fueling transformation and cancer cell survival in vivo. Our findings indicate eIF4E is maintained at levels in excess for normal development that are hijacked by cancer cells to drive a translational program supporting tumorigenesis.	[Truitt, Morgan L.; Conn, Crystal S.; Pang, Xiaming; Ruggero, Davide] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA; [Ruggero, Davide] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Truitt, Morgan L.; Conn, Crystal S.; Pang, Xiaming; Tokuyasu, Taku; Coady, Alison M.; Seo, Youngho; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Seo, Youngho] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA; [Shi, Zhen; Barna, Maria] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Shi, Zhen; Barna, Maria] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Stanford University; Stanford University	Barna, M (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	mbarna@stanford.edu; davide.ruggero@ucsf.edu	Conn, Crystal S/ABF-8464-2020; Seo, Youngho/D-5705-2013	Conn, Crystal S/0000-0003-3209-0445; Seo, Youngho/0000-0001-5908-6636; Coady, Alison/0000-0003-1871-5576	NIH Director's New Innovator Award [7DP2OD00850902]; NIH [R01CA140456, R01CA154916, R01CA184624, 1F32CA189696, P30CA82103]; Alfred P. Sloan Research Fellowship; Mallinckrodt Foundation Award; Pew Scholars Award; American Cancer Society grant [PF-14-212-01-RMC]; Life Science Research Foundation Postdoctoral Fellowship; Onyx Oncology Innovation Alliance Award; NATIONAL CANCER INSTITUTE [R01CA154916, F32CA189696, R01CA140456, R01CA184624, P30CA082103] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008509] Funding Source: NIH RePORTER	NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Mallinckrodt Foundation Award; Pew Scholars Award; American Cancer Society grant(American Cancer Society); Life Science Research Foundation Postdoctoral Fellowship; Onyx Oncology Innovation Alliance Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the D.R. and M.B. labs for critical discussion and Adam Olshen for reading the manuscript. This work was supported by the NIH Director's New Innovator Award (7DP2OD00850902) (to M.B.), NIH grants (R01CA140456, R01CA154916, and R01CA184624 to D.R.; 1F32CA189696 to C.S.C.; and P30CA82103 to T.T.), the Alfred P. Sloan Research Fellowship (to M.B), the Mallinckrodt Foundation Award (to M.B.), a Pew Scholars Award (to M.B.), an American Cancer Society grant (PF-14-212-01-RMC) (to C.S.C.), and the Life Science Research Foundation Postdoctoral Fellowship (to Z.S). This work was supported in part by the Onyx Oncology Innovation Alliance Award (to D.R.). D.R. is a Leukemia and Lymphoma Society Scholar. M.B. is a Pew Scholar and Alfred P. Sloan Research Fellow. D.R. is a shareholder of eFFECTOR Therapeutics, Inc., and a member of its scientific advisory board.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Blackshear PJ, 1997, J BIOL CHEM, V272, P31510, DOI 10.1074/jbc.272.50.31510; Cunningham JT, 2014, CELL, V157, P1088, DOI 10.1016/j.cell.2014.03.052; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DEBENEDETTI A, 1991, MOL CELL BIOL, V11, P5435, DOI 10.1128/MCB.11.11.5435; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; HIREMATH LS, 1985, J BIOL CHEM, V260, P7843; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Rau M, 1996, J BIOL CHEM, V271, P8983, DOI 10.1074/jbc.271.15.8983; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shi ZZ, 2000, P NATL ACAD SCI USA, V97, P5101, DOI 10.1073/pnas.97.10.5101; Stumpf CR, 2013, MOL CELL, V52, P574, DOI 10.1016/j.molcel.2013.09.018; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004	42	205	208	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					59	71		10.1016/j.cell.2015.05.049	http://dx.doi.org/10.1016/j.cell.2015.05.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26095252	Bronze, Green Accepted			2022-12-28	WOS:000357542300009
J	Alberts, B; Cicerone, RJ; Fienberg, SE; Kamb, A; McNutt, M; Nerem, RM; Schekman, R; Shiffrin, R; Stodden, V; Suresh, S; Zuber, MT; Pope, BK; Jamieson, KH				Alberts, Bruce; Cicerone, Ralph J.; Fienberg, Stephen E.; Kamb, Alexander; McNutt, Marcia; Nerem, Robert M.; Schekman, Randy; Shiffrin, Richard; Stodden, Victoria; Suresh, Subra; Zuber, Maria T.; Pope, Barbara Kline; Jamieson, Kathleen Hall			Self-correction in science at work	SCIENCE			English	Editorial Material							INCENTIVES		[Alberts, Bruce] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cicerone, Ralph J.] Natl Acad Sci, Washington, DC 20418 USA; [Fienberg, Stephen E.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Kamb, Alexander] Amgen Inc, Discovery Res, Thousand Oaks, CA 91320 USA; [McNutt, Marcia] Amer Assoc Advancement Sci, Sci, Washington, DC 20005 USA; [Nerem, Robert M.] Georgia Inst Technol, Atlanta, GA 30332 USA; [Schekman, Randy] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Schekman, Randy] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Shiffrin, Richard] Indiana Univ, Bloomington, IN USA; [Stodden, Victoria] Univ Illinois, Champaign, IL USA; [Suresh, Subra] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Zuber, Maria T.] MIT, Cambridge, MA 02139 USA; [Pope, Barbara Kline] Natl Acad Sci, Natl Res Council, Natl Acad Press, Natl Acad Engn,Inst Med, Washington, DC 20418 USA; [Jamieson, Kathleen Hall] Annenberg Retreat Sunnylands, Rancho Mirage, CA USA; [Jamieson, Kathleen Hall] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; National Academies of Sciences, Engineering & Medicine; Carnegie Mellon University; Amgen; University System of Georgia; Georgia Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Indiana University System; Indiana University Bloomington; University of Illinois System; University of Illinois Urbana-Champaign; Carnegie Mellon University; Massachusetts Institute of Technology (MIT); National Academies of Sciences, Engineering & Medicine; University of Pennsylvania	McNutt, M (corresponding author), Amer Assoc Advancement Sci, Sci, Washington, DC 20005 USA.	mmcnutt@aaas.org		Pope, Barbara/0000-0002-0575-3605; McNutt, Marcia/0000-0003-0117-7716	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		[Anonymous], 2013, ECONOMIST; Committee on Science Engineering and Public Policy of the National Academy of Sciences National Academy of Engineering and Institute of Medicine, INT SCI IN PRESS; Editorial Board, 2014, NATURE, V511, P5; Franzoni C, 2011, SCIENCE, V333, P702, DOI 10.1126/science.1197286; Institute of Medicine, 2014, DISC FRAM CLIN TRIAL, DOI 10.17226/18610; Karlan D, 2014, J ECON BEHAV ORGAN, V106, P402, DOI 10.1016/j.jebo.2014.06.013; Lacetera N, 2010, J ECON BEHAV ORGAN, V76, P225, DOI 10.1016/j.jebo.2010.08.007; Merton R., 1973, SOCIOL SCI, P276; National Academy of Sciences, 1992, RESP SCI; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Pfeiffer T., 2012, J R SOC INTERFACE, V2012; Popper Karl R., 1963, CONJECTURES REFUTAT, P293	14	73	73	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1420	1422		10.1126/science.aab3847	http://dx.doi.org/10.1126/science.aab3847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3RW	26113701				2022-12-28	WOS:000356869100016
J	Bernstein, R				Bernstein, Rachel			The health of those who study health	SCIENCE			English	Editorial Material																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1506	1506		10.1126/science.348.6242.1506	http://dx.doi.org/10.1126/science.348.6242.1506			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3RW	26113726				2022-12-28	WOS:000356869100047
J	Powell, K				Powell, Kendall			Nursing research: Nurses know best	NATURE			English	Editorial Material																			0	11	12	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					507	509		10.1038/nj7557-507a	http://dx.doi.org/10.1038/nj7557-507a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2OC	26114201	Bronze			2022-12-28	WOS:000356782900056
J	Ubel, PA				Ubel, Peter A.			Medical Facts versus Value Judgments - Toward Preference-Sensitive Guidelines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER		[Ubel, Peter A.] Duke Univ, Sch Med, Fuqua Sch Business, Durham, NC 27708 USA; [Ubel, Peter A.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA	Duke University; Duke University	Ubel, PA (corresponding author), Duke Univ, Sch Med, Fuqua Sch Business, Durham, NC 27708 USA.							Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; HAMMOND KR, 1976, SCIENCE, V194, P389, DOI 10.1126/science.194.4263.389; National Comprehensive Cancer Network, 2014, NCCN GUID PAT PROST; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003	5	32	32	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2475	2477		10.1056/NEJMp1504245	http://dx.doi.org/10.1056/NEJMp1504245			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2QD	26107051				2022-12-28	WOS:000356788200003
J	Strandburg-Peshkin, A; Farine, DR; Couzin, ID; Crofoot, MC				Strandburg-Peshkin, Ariana; Farine, Damien R.; Couzin, Iain D.; Crofoot, Margaret C.			Shared decision-making drives collective movement in wild baboons	SCIENCE			English	Article							CHACMA BABOONS; ANIMAL GROUPS; LEADERSHIP; CONSENSUS; PRIMATE	Conflicts of interest about where to go and what to do are a primary challenge of group living. However, it remains unclear how consensus is achieved in stable groups with stratified social relationships. Tracking wild baboons with a high-resolution global positioning system and analyzing their movements relative to one another reveals that a process of shared decision-making governs baboon movement. Rather than preferentially following dominant individuals, baboons are more likely to follow when multiple initiators agree. When conflicts arise over the direction of movement, baboons choose one direction over the other when the angle between them is large, but they compromise if it is not. These results are consistent with models of collective motion, suggesting that democratic collective action emerging from simple rules is widespread, even in complex, socially stratified societies.	[Strandburg-Peshkin, Ariana; Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Farine, Damien R.; Crofoot, Margaret C.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Farine, Damien R.; Crofoot, Margaret C.] Smithsonian Trop Res Inst, Panama City, Panama; [Farine, Damien R.] Univ Oxford, Dept Zool, Edward Grey Inst Field Ornithol, Oxford, England; [Couzin, Iain D.] Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany; [Couzin, Iain D.] Univ Konstanz, Chair Biodivers & Collect Behav, Dept Biol, Constance, Germany	Princeton University; University of California System; University of California Davis; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Oxford; Max Planck Society; University of Konstanz	Strandburg-Peshkin, A (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	astrandb@princeton.edu; damien.farine@zoo.ox.ac.uk; mccrofoot@ucdavis.edu	Couzin, Iain D./Q-6862-2018; Farine, Damien R./Y-2454-2019	Couzin, Iain D./0000-0001-8556-4558; Farine, Damien R./0000-0003-2208-7613	NSF [EAGER-IOS-1250895, PHY-0848755, IOS-1355061, EAGER-IOS-1251585]; Max Planck Institute for Ornithology; Smithsonian Tropical Research Institute; Princeton University; NIH [T32HG003284]; Biotechnology and Biological Sciences Research Council [BB/L006081/1]; Office of Naval Research [N00014-09-1-1074, N00014-14-1-0635]; Army Research Office [W911NG-11-1-0385, W911NF-14-1-0431]; Human Frontier Science Program [RGP0065/2012]; BBSRC [BB/L006081/1] Funding Source: UKRI; Direct For Biological Sciences [1355061] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1251585] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003284] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Max Planck Institute for Ornithology(Max Planck Society); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Princeton University(Princeton University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Naval Research(Office of Naval Research); Army Research Office; Human Frontier Science Program(Human Frontier Science Program); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Kenya National Science and Technology Council, Kenyan Wildlife Service, and Mpala Research Centre for permission to conduct research. All procedures received Institutional Animal Care and Use Committee approval (2012.0601.2015). We thank M. Wikelski, E. Bermingham, D. Rubenstein, and M. Kinnaird for logistical support; R. Kays, S. Murray, M. Mutinda, R. Lessnau, S. Alavi, J. Nairobi, F. Kuemmeth, W. Heidrich, and I. Brugere for assistance; and T. Berger-Wolf, J. Silk, J. Fischer, B. Sheldon, L. Aplin, D. Pappano, M. Grobis, B. Rosenthal, A. Hein, B. Ziebart, L. Polansky, and J. Li for feedback. We acknowledge funding from NSF (grant EAGER-IOS-1250895), the Max Planck Institute for Ornithology, the Smithsonian Tropical Research Institute, and Princeton University. A. S.-P. and D.R.F. received additional support from NIH (grant T32HG003284), NSF (a Graduate Research Fellowship to A. S.-P.), and the Biotechnology and Biological Sciences Research Council (grant BB/L006081/1 to B. C. Sheldon). I.D.C. acknowledges support from NSF (grants PHY-0848755, IOS-1355061, and EAGER-IOS-1251585), the Office of Naval Research (grants N00014-09-1-1074 and N00014-14-1-0635), the Army Research Office (grants W911NG-11-1-0385 and W911NF-14-1-0431), and the Human Frontier Science Program (grant RGP0065/2012). Data are deposited at www.datarepository.movebank.org/(doi.org/10.5441/001/1.kn0816jn).	Altmann J., 1980, BABOON MOTHERS INFAN; Altmann SA, 1998, FORAGING SURVIVAL YE; Byrne R. W., 2000, MOVE, P501; Cheney DL., 2008, BABOON METAPHYSICS; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Johnson SE, 2004, HUM NATURE-INT BIOS, V15, P45, DOI 10.1007/s12110-004-1003-y; King AJ, 2011, ANIM BEHAV, V82, P1337, DOI 10.1016/j.anbehav.2011.09.017; King AJ, 2011, INT J PRIMATOL, V32, P1245, DOI 10.1007/s10764-011-9526-7; King AJ, 2009, ANIM BEHAV, V78, P1381, DOI 10.1016/j.anbehav.2009.09.009; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King Andrew J., 2009, Communicative & Integrative Biology, V2, P147; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1875, DOI 10.1007/s00265-010-0999-8; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064	22	289	292	10	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1358	1361		10.1126/science.aaa5099	http://dx.doi.org/10.1126/science.aaa5099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089514	Green Accepted, Green Submitted			2022-12-28	WOS:000356449500050
J	Chrencik, JE; Roth, CB; Terakado, M; Kurata, H; Omi, R; Kihara, Y; Warshaviak, D; Nakade, S; Asmar-Rovira, G; Mileni, M; Mizuno, H; Griffith, MT; Rodgers, C; Han, GW; Velasquez, J; Chun, J; Stevens, RC; Hanson, MA				Chrencik, Jill E.; Roth, Christopher B.; Terakado, Masahiko; Kurata, Haruto; Omi, Rie; Kihara, Yasuyuki; Warshaviak, Dora; Nakade, Shinji; Asmar-Rovira, Guillermo; Mileni, Mauro; Mizuno, Hirotaka; Griffith, Mark T.; Rodgers, Caroline; Han, Gye Won; Velasquez, Jeffrey; Chun, Jerold; Stevens, Raymond C.; Hanson, Michael A.			Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; MOLECULAR-DYNAMICS; MEMBRANE-PROTEINS; CANNABINOID CB1; LPA(1); CELLS; AUTOTAXIN; BRAIN; PH; VZG-1/LP(A1)/EDG-2	Lipid biology continues to emerge as an area of significant therapeutic interest, particularly as the result of an enhanced understanding of the wealth of signaling molecules with diverse physiological properties. This growth in knowledge is epitomized by lysophosphatidic acid (LPA), which functions through interactions with at least six cognate G protein- coupled receptors. Herein, we present three crystal structures of LPA(1) in complex with antagonist tool compounds selected and designed through structural and stability analyses. Structural analysis combined with molecular dynamics identified a basis for ligand access to the LPA(1) binding pocket from the extracellular space contrasting with the proposed access for the sphingosine 1-phosphate receptor. Characteristics of the LPA(1) binding pocket raise the possibility of promiscuous ligand recognition of phosphorylated endocannabinoids. Cell-based assays confirmed this hypothesis, linking the distinct receptor systems through metabolically related ligands with potential functional and therapeutic implications for treatment of disease.	[Chrencik, Jill E.; Roth, Christopher B.; Asmar-Rovira, Guillermo; Mileni, Mauro; Griffith, Mark T.; Rodgers, Caroline; Hanson, Michael A.] Receptos, Dept Struct Discovery, San Diego, CA 92121 USA; [Terakado, Masahiko; Kurata, Haruto; Omi, Rie] Ono Pharmaceut Co Ltd, Med Chem Res Labs, Osaka 6188585, Japan; [Warshaviak, Dora] Schrodinger Inc, New York, NY 10036 USA; [Han, Gye Won; Velasquez, Jeffrey; Stevens, Raymond C.] Univ So Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Han, Gye Won; Velasquez, Jeffrey; Stevens, Raymond C.] Univ So Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Kihara, Yasuyuki; Mizuno, Hirotaka; Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Nakade, Shinji; Mizuno, Hirotaka] Ono Pharmaceut Co Ltd, Exploratory Res Labs, Ibaraki 3004247, Japan; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China	Ono Pharmaceutical Co Ltd; University of Southern California; University of Southern California; Scripps Research Institute; Ono Pharmaceutical Co Ltd; ShanghaiTech University	Hanson, MA (corresponding author), GPCR Consortium, San Marcos, CA 92078 USA.	mhanson@gpcrconsortium.org	Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022; Stevens, Raymond/K-7272-2015; Chun, Jerold/Y-4670-2019; Han, Gye Won/GLQ-8673-2022	Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Kurata, Haruto/0000-0002-9009-3428; Terakado, Masahiko/0000-0002-4740-1667	National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; NIH [MH051699, NS082092, NS084398, U54 GM094618, GPCR-235]; ShanghaiTech University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051699, R01MH051699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084398, R56NS082092] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ShanghaiTech University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Angela Walker for critical review of this manuscript and J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and NIGMS grant Y1-GM-1104. This work was supported in part by the NIH grants MH051699, NS082092 and NS084398 to J.C., and U54 GM094618 (target GPCR-235) and ShanghaiTech University to R.C.S.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beard H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082849; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Chun J., 2013, LYSOPHOSPHOLIPID REC, pi; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; D.E. Shaw Research, 2014, DESM MOL DYN SYST VE; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Herr KJ, 2011, P NATL ACAD SCI USA, V108, P15444, DOI 10.1073/pnas.1106129108; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Justus CR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00354; KANOH H, 1986, J BIOL CHEM, V261, P5597; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kim KS, 2006, CANCER RES, V66, P7983, DOI 10.1158/0008-5472.CAN-05-4381; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mirendil H., 2013, LYSOPHOSPHOLIPID REC, P1; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Postma FR, 1996, EMBO J, V15, P63, DOI 10.1002/j.1460-2075.1996.tb00334.x; Salam NK, 2014, PROTEIN ENG DES SEL, V27, P365, DOI 10.1093/protein/gzu017; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schrodinger, 2014, MAESTR DESM INT TOOL; Schrodinger, 2014, JAG 8 6; Schrodinger, 2014, OPLS2 1; Schrodinger, 2013, BIOLUMINATE VERS 1 0; Schrodinger, 2014, BIOLUMINATE VERS 1 7; Shivakumar D, 2012, J CHEM THEORY COMPUT, V8, P2553, DOI 10.1021/ct300203w; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Sugiura T, 1997, J BIOCHEM-TOKYO, V122, P890; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M., 2011, US Patent, Patent No. 7875745; TANNOCK IF, 1989, CANCER RES, V49, P4373; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Van Durme J, 2006, MOL ENDOCRINOL, V20, P2247, DOI 10.1210/me.2006-0020; van Loenen PB, 2011, EUR J PHARMACOL, V667, P105, DOI 10.1016/j.ejphar.2011.05.071; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Weiner JA, 1998, J COMP NEUROL, V398, P587; Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	53	133	135	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1633	1643		10.1016/j.cell.2015.06.002	http://dx.doi.org/10.1016/j.cell.2015.06.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091040	Bronze, Green Accepted			2022-12-28	WOS:000356618200019
J	[Anonymous]				[Anonymous]			North America	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S4	S7		10.1038/522S4a	http://dx.doi.org/10.1038/522S4a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083861	Bronze			2022-12-28	WOS:000356425400003
J	[Anonymous]				[Anonymous]			Australasia & Pacific Islands	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S20	S21		10.1038/522S20a	http://dx.doi.org/10.1038/522S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083854	Bronze			2022-12-28	WOS:000356425400007
J	Berger, D				Berger, David			Australia's law to gag doctors with concerns about asylum seekers is a failure of democracy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Broome Hosp, Emergency Med, Broome, WA 6725, Australia		Berger, D (corresponding author), Broome Hosp, Emergency Med, Robinson St, Broome, WA 6725, Australia.	daveberger@gmail.com						Aston H, 2015, SYDNEY MORNING HERAL; Barns G, 2015, THE DRUM ABC    0528; Farnsworth S, 2015, PM ABC          0601; Hague W, 2013, A MARR SHOW     0609; Human Rights Law Centre, 2015, UN FINDS AUSTR TREAT; MacAskill E, 2000, GUARDIAN JUL; MOSS, 2015, REV RECENT ALLEGATIO; Talley N, 2015, SYDNEY MORNING HERAL; Whyte S, 2015, SYDNEY MORNING HERAL; Yuhas A, 2015, GUARDIAN	10	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2015	350								h3256	10.1136/bmj.h3256	http://dx.doi.org/10.1136/bmj.h3256			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2OZ	26084489				2022-12-28	WOS:000356785200005
J	Maruthappu, M; Keogh, B				Maruthappu, Mahiben; Keogh, Bruce			The future of health system leadership	LANCET			English	Editorial Material									[Maruthappu, Mahiben; Keogh, Bruce] NHS England, Chair & Chief Execut Off, London SE1 6LH, England		Maruthappu, M (corresponding author), NHS England, Chair & Chief Execut Off, London SE1 6LH, England.	mahiben.maruthappu@nhs.net						Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Davies K, 2014, MIRROR MIRROR WALL P; NHS England Care Quality Commission Public Health England Monitor NHS Trust Development Authority Health Education England, 2014, NHS 5 YEAR FORW VIEW; Stevens S, 2014, HLTH SERV J; Timmins N., 2015, PRACTICE SYSTEM LEAD; WALPORT M, 2005, MED DENT QUALIFIED A	6	4	4	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2325	2326		10.1016/S0140-6736(15)60990-4	http://dx.doi.org/10.1016/S0140-6736(15)60990-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1XV	26088627				2022-12-28	WOS:000356003700005
J	Watts, G				Watts, Geoff			Susan Jebb: nutritionist with a scientific passion about food	LANCET			English	Biographical-Item																		JEBB S, PUBLICATION LIST	1	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2245	2245		10.1016/S0140-6736(15)61054-6	http://dx.doi.org/10.1016/S0140-6736(15)61054-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	26088488				2022-12-28	WOS:000355943500015
J	Hofbauer, LC; Rachner, TD				Hofbauer, Lorenz C.; Rachner, Tilman D.			More DATA to guide sequential osteoporosis therapy	LANCET			English	Editorial Material							POSTMENOPAUSAL OSTEOPOROSIS; PARATHYROID-HORMONE; ZOLEDRONIC ACID; WOMEN; TERIPARATIDE; DENOSUMAB; FRACTURES; TRIAL		[Hofbauer, Lorenz C.; Rachner, Tilman D.] Tech Univ Dresden, Med Ctr, Div Endocrinol Diabet & Bone Dis, D-01307 Dresden, Germany; [Hofbauer, Lorenz C.] Ctr Regenerat Therapies, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Hofbauer, LC (corresponding author), Tech Univ Dresden, Med Ctr, Div Endocrinol Diabet & Bone Dis, D-01307 Dresden, Germany.	lorenz.hofbauer@uniklinikum-dresden.de	Hofbauer, Lorenz C/G-2490-2010	Hofbauer, Lorenz C/0000-0002-8691-8423				Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Cosman F, 2014, CURR OSTEOPOROS REP, V12, P385, DOI 10.1007/s11914-014-0237-9; Cosman F, 2011, J BONE MINER RES, V26, P503, DOI 10.1002/jbmr.238; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Leder BZ, 2014, J CLIN ENDOCR METAB, V99, P1694, DOI 10.1210/jc.2013-4440; Leder BZ, 2015, LANCET; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Tsai JN, 2013, LANCET, V382, P50, DOI 10.1016/S0140-6736(13)60856-9	10	10	14	2	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1116	1118		10.1016/S0140-6736(15)61175-8	http://dx.doi.org/10.1016/S0140-6736(15)61175-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5GE	26144907				2022-12-28	WOS:000361368000010
J	Harper, CC; Rocca, CH; Thompson, KM; Morfesis, J; Goodman, S; Darney, PD; Westhoff, CL; Speidel, JJ				Harper, Cynthia C.; Rocca, Corinne H.; Thompson, Kirsten M.; Morfesis, Johanna; Goodman, Suzan; Darney, Philip D.; Westhoff, Carolyn L.; Speidel, J. Joseph			Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial	LANCET			English	Article							UNITED-STATES; INTRAUTERINE CONTRACEPTION; UNINTENDED PREGNANCIES; NATIONAL-SURVEY; KNOWLEDGE; IMMEDIATE; PROVISION; INSERTION; ABORTION; HEALTH	Background Unintended pregnancy remains a serious public health challenge in the USA. We assessed the effects of an intervention to increase patients' access to long-acting reversible contraceptives (LARCs) on pregnancy rates. Methods We did a cluster randomised trial in 40 reproductive health clinics across the USA in 2011-13. 20 clinics were randomly assigned to receive evidence-based training on providing counselling and insertion of intrauterine devices (IUDs) or progestin implants and 20 to provide standard care. Usual costs for contraception were maintained at all sites. We recruited women aged 18-25 years attending family planning or abortion care visits and not desiring pregnancy in the next 12 months. The primary outcome was selection of an IUD or implant at the clinic visit and secondary outcome was pregnancy within 12 months. We used generalised estimating equations for clustered data to measure the intervention effect on contraceptive selection, and used survival analysis to assess pregnancy rates. Findings Of 1500 women enrolled, more at intervention than control sites reported receiving counselling on IUDs or implants (565 [71%] of 797 vs 271 [39%] of 693, odds ratio 3.8, 95% CI 2.8-5.2) and more selected LARCs during the clinic visit (224 [28%] vs 117 [17%], 1.9, 1.3-2.8). The pregnancy rate was lower in intervention group than in the control group after family planning visits (7.9 vs 15.4 per 100 person-years), but not after abortion visits (26.5 vs 22.3 per 100 person-years). We found a significant intervention effect on pregnancy rates in women attending family planning visits (hazard ratio 0.54, 95% CI 0.34-0.85). Interpretation The pregnancy rate can be reduced by provision of counselling on long-term reversible contraception and access to devices during family planning counselling visits.	[Harper, Cynthia C.; Rocca, Corinne H.; Thompson, Kirsten M.; Goodman, Suzan; Darney, Philip D.; Speidel, J. Joseph] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, San Francisco, CA 94143 USA; [Morfesis, Johanna; Westhoff, Carolyn L.] Planned Parenthood Federat Amer, New York, NY USA; [Westhoff, Carolyn L.] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA	University of California System; University of California San Francisco; Columbia University	Harper, CC (corresponding author), Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, 3333 Calif St,Suite 335,UCSF Box 0744, San Francisco, CA 94143 USA.	cynthia.harper@ucsf.edu		Thompson, Kirsten/0000-0002-1552-7257	William and Flora Hewlett Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	William and Flora Hewlett Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	William and Flora Hewlett Foundation.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2011, CLIN PREV SERV WOM C; [Anonymous], 2011, CONTRACEPTIVE TECHNO; Arrowsmith ME, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008896.pub2; Barnet B, 2009, ANN FAM MED, V7, P436, DOI 10.1370/afm.1014; Bednarek PH, 2011, NEW ENGL J MED, V364, P2208, DOI 10.1056/NEJMoa1011600; Ferreira ALCG, 2009, EUR J CONTRACEP REPR, V14, P1, DOI 10.1080/13625180802549970; Centers for Disease Control and Prevention, 2014, NAT SURV FAM GROWTH; Centers for Disease Control and Prevention, 2013, UN PREGN PREV; Cleland K, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1104373; Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, 2012, OBSTET GYNECOL, V120, P983, DOI DOI 10.1097/AOG.0B013E3182723B7D; Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416; Finer LB, 2012, FERTIL STERIL, V98, P893, DOI 10.1016/j.fertnstert.2012.06.027; Goodman S, 2008, CONTRACEPTION, V78, P143, DOI 10.1016/j.contraception.2008.03.003; Harper CC, 2013, PREV MED, V57, P883, DOI 10.1016/j.ypmed.2013.10.005; Harper CC, 2012, FAM MED, V44, P637; Hayes RJ, 2009, INTERD STAT, P3; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1; Kavanaugh ML, 2011, WOMEN HEALTH ISS, V21, pS26, DOI 10.1016/j.whi.2011.01.009; Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013; Langston AM, 2014, CONTRACEPTION, V89, P103, DOI 10.1016/j.contraception.2013.10.014; Lewis C, 2013, CONTRACEPTION, V88, P226, DOI 10.1016/j.contraception.2013.06.004; Lopez LM, 2013, COCHRANE DB SYST REV, V4; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Ott MA, 2014, PEDIATRICS, V134, pE1244, DOI 10.1542/peds.2014-2299; Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]; Raine TR, 2011, OBSTET GYNECOL, V117, P363, DOI 10.1097/AOG.0b013e31820563d3; Rocca CH, 2012, PERSPECT SEX REPRO H, V44, P150, DOI 10.1363/4415012; Stanwood NL, 2006, OBSTET GYNECOL, V108, P1417, DOI 10.1097/01.AOG.0000245447.56585.a0; Steiner MJ, 2007, AM J OBSTET GYNECOL, V197, P118, DOI 10.1016/j.ajog.2007.03.049; Thompson KMJ, 2011, CONTRACEPTION, V83, P41, DOI 10.1016/j.contraception.2010.06.008; Thomson A, 2009, STAT MED, V28, P1739, DOI 10.1002/sim.3582; United Nations Department of Economic and Social Affairs Population Division, WORLD CONTR US 2011; US. Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL 2020; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855	36	138	138	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					562	568		10.1016/S0140-6736(14)62460-0	http://dx.doi.org/10.1016/S0140-6736(14)62460-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8PG	26091743				2022-12-28	WOS:000359431900030
J	Rasmussen, M; Sikora, M; Albrechtsen, A; Korneliussen, TS; Moreno-Mayar, JV; Poznik, GD; Zollikofer, CPE; de Leon, MSP; Allentoft, ME; Moltke, I; Jonsson, K; Valdiosera, C; Malhi, RS; Orlando, L; Bustamante, CD; Stafford, TW; Meltzer, DJ; Nielsen, R; Willerslev, E				Rasmussen, Morten; Sikora, Martin; Albrechtsen, Anders; Korneliussen, Thorfinn Sand; Moreno-Mayar, J. Victor; Poznik, G. David; Zollikofer, Christoph P. E.; de Leon, Marcia S. Ponce; Allentoft, Morten E.; Moltke, Ida; Jonsson, Kon; Valdiosera, Cristina; Malhi, Ripan S.; Orlando, Ludovic; Bustamante, Carlos D.; Stafford, Thomas W., Jr.; Meltzer, David J.; Nielsen, Rasmus; Willerslev, Eske			The ancestry and affiliations of Kennewick Man	NATURE			English	Article							GORDON CREEK WOMAN; GENOME; POPULATION; AMERICA; HISTORY; DNA	Kennewick Man, referred to as the Ancient One by Native Americans, is a male human skeleton discovered in Washington state (USA) in 1996 and initially radiocarbon dated to 8,340-9,200 calibrated years before present (BP)(1). His population affinities have been the subject of scientific debate and legal controversy. Based on an initial study of cranial morphology it was asserted that Kennewick Man was neither Native American nor closely related to the claimant Plateau tribes of the Pacific Northwest, who claimed ancestral relationship and requested repatriation under the Native American Graves Protection and Repatriation Act (NAGPRA). The morphological analysis was important to judicial decisions that Kennewick Man was not Native American and that therefore NAGPRA did not apply. Instead of repatriation, additional studies of the remains were permitted(2). Subsequent craniometric analysis affirmed Kennewick Man to be more closely related to circumpacific groups such as the Ainu and Polynesians than he is to modern Native Americans(2). In order to resolve Kennewick Man's ancestry and affiliations, we have sequenced his genome to similar to 1x coverage and compared it to worldwide genomic data including for the Ainu and Polynesians. We find that Kennewick Man is closer to modern Native Americans than to any other population worldwide. Among the Native American groups for whom genome-wide data are available for comparison, several seem to be descended from a population closely related to that of Kennewick Man, including the Confederated Tribes of the Colville Reservation (Colville), one of the five tribes claiming Kennewick Man. We revisit the cranial analyses and find that, as opposed to genome-wide comparisons, it is not possible on that basis to affiliate Kennewick Man to specific contemporary groups. We therefore conclude based on genetic comparisons that Kennewick Man shows continuity with Native North Americans over at least the last eight millennia.	[Rasmussen, Morten; Sikora, Martin; Korneliussen, Thorfinn Sand; Moreno-Mayar, J. Victor; Allentoft, Morten E.; Jonsson, Kon; Valdiosera, Cristina; Orlando, Ludovic; Stafford, Thomas W., Jr.; Nielsen, Rasmus; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Rasmussen, Morten] Stanford Univ, Sch Med, Dept Genet, Littlefield Ctr, Stanford, CA 94305 USA; [Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen N, Denmark; [Poznik, G. David] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA; [Zollikofer, Christoph P. E.] Univ Zurich, Inst Anthropol, CH-8057 Zurich, Switzerland; [Valdiosera, Cristina] La Trobe Univ, Dept Archaeol & Hist, Melbourne, Vic 3086, Australia; [Malhi, Ripan S.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Malhi, Ripan S.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Bustamante, Carlos D.] Stanford Univ, Ctr Evolutionary & Human Genom, Littlefield Ctr, Stanford, CA 94305 USA; [Stafford, Thomas W., Jr.] Univ Aarhus, Dept Phys & Astron, C Dating Ctr, DK-8000 Aarhus C, Denmark; [Meltzer, David J.] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Copenhagen; Stanford University; University of Copenhagen; Stanford University; University of Zurich; La Trobe University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Stanford University; Aarhus University; Southern Methodist University; University of California System; University of California Berkeley	Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.	ewillerslev@snm.ku.dk	Korneliussen, Thorfinn Sand/F-6421-2014; Albrechtsen, Anders/K-4281-2013; Moreno-Mayar, J. Víctor/AAB-3732-2022; Orlando, Ludovic/A-8932-2013; Korneliussen, Thorfinn Sand/ABB-7656-2021; Sikora, Martin/C-8609-2015; Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011; Nielsen, Rasmus/D-4405-2009; Moltke, Ida/C-6158-2011	Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Albrechtsen, Anders/0000-0001-7306-031X; Moreno-Mayar, J. Víctor/0000-0002-7712-4496; Orlando, Ludovic/0000-0003-3936-1850; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Sikora, Martin/0000-0003-2818-8319; Willerslev, Eske/0000-0002-7081-6748; Nielsen, Rasmus/0000-0003-0513-6591; Moltke, Ida/0000-0001-7052-8554; Valdiosera, Cristina/0000-0003-4948-2226; Bustamante, Carlos D./0000-0002-4187-7920; Meltzer, David/0000-0001-8084-9802; Allentoft, Morten/0000-0003-4424-3568; Malhi, Ripan/0000-0002-1484-0292	Danish National Research Foundation; Lundbeck Foundation; Danish Council for Independent Research [12-131829]; 'Consejo Nacional de Ciencia y Tecnologia' (Mexico); National Science Foundation Graduate Research Fellowship [DGE-1147470]; DFF-YDUN grant from the Danish Council for Independent Research; Marie Curie Intra-European Fellowship [FP7-People-PIEF-GA-2009-255503]; Lundbeck Foundation [R38-2008-3048, R70-2010-6286, R155-2013-16338, R109-2012-9995, R24-2008-2527] Funding Source: researchfish; Villum Fonden [00010120, 00007171] Funding Source: researchfish; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); 'Consejo Nacional de Ciencia y Tecnologia' (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); DFF-YDUN grant from the Danish Council for Independent Research; Marie Curie Intra-European Fellowship(European Commission); Lundbeck Foundation(Lundbeckfonden); Villum Fonden(Villum Fonden); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank the members of the Confederated Tribes of the Colville Reservation who provided their DNA for this study. We would like to also thank Nez Perce Tribe, Umatilla Tribe, Yakama Nation, and Wanapum Band for their consultation. We thank C. B. Pulliam and G. C. Celmer of the US Army Corps of Engineers, and the Burke Museum of the University of Washington, especially L. Phillips. We thank the Danish National Research Foundation and the Lundbeck Foundation for financial support and the Danish National Sequencing Centre for help with sequencing. M.R. was funded by grant 12-131829 from the Danish Council for Independent Research. J.V.M.-M. was supported by 'Consejo Nacional de Ciencia y Tecnologia' (Mexico). G.D.P. was supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1147470. I.M. was funded by a DFF-YDUN grant from the Danish Council for Independent Research. C.V. was funded by Marie Curie Intra-European Fellowship-FP7-People-PIEF-GA-2009-255503	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Brace CL, 2001, P NATL ACAD SCI USA, V98, P10017, DOI 10.1073/pnas.171305898; Chatters JC, 2000, AM ANTIQUITY, V65, P291, DOI 10.2307/2694060; CHATTERS JC, 2001, ANCIENT ENCOUNTERS; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Howells WW, 1996, AM J PHYS ANTHROPOL, V101, P441, DOI 10.1002/ajpa.1331010302; Jantz R. L., 2005, PALEOAMERICAN ORIGIN, P267; Jantz RL, 2001, AM J PHYS ANTHROPOL, V114, P146, DOI 10.1002/1096-8644(200102)114:2<146::AID-AJPA1014>3.0.CO;2-E; Jinam T, 2012, J HUM GENET, V57, P787, DOI 10.1038/jhg.2012.114; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Lawrence DM, 2010, HUM BIOL, V82, P157, DOI 10.3378/027.082.0203; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Owsley D. W., 2014, KENNEWICK MAN; Owsley DW, 2001, AM ANTIQUITY, V66, P565, DOI 10.2307/2694173; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Powell J. F., 2005, THE 1 AM; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Steele D. G., 2002, THE 1 AM; Swedlund A, 1999, AM ANTIQUITY, V64, P569, DOI 10.2307/2694205; Taylor RE, 1998, SCIENCE, V280, P1171; Thomas D.H., 2001, SKULL WARS KENNEWICK; Verdu P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004530; Wollstein A, 2010, CURR BIOL, V20, P1983, DOI 10.1016/j.cub.2010.10.040	28	131	135	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					455	U159		10.1038/nature14625	http://dx.doi.org/10.1038/nature14625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN4DD	26087396	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000358378900035
J	Striedter, GF; Srinivasan, S				Striedter, Georg F.; Srinivasan, Shyam			Knowing when to fold them	SCIENCE			English	Editorial Material									[Striedter, Georg F.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Srinivasan, Shyam] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Srinivasan, Shyam] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92037 USA	University of California System; University of California Irvine; Salk Institute; University of California System; University of California San Diego	Striedter, GF (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, 10010 North Torrey Pines Rd, Irvine, CA 92697 USA.	georg.striedter@gmail.com						Balankin AS, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061126; HOFMAN MA, 1991, J HIRNFORSCH, V32, P103; Manger PR, 2012, J COMP NEUROL, V520, P2430, DOI 10.1002/cne.23046; Mota B, 2015, SCIENCE, V349, P74, DOI 10.1126/science.aaa9101; PROTHERO JW, 1984, BRAIN BEHAV EVOLUT, V24, P152, DOI 10.1159/000121313; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ronan L, 2015, BRAIN STRUCT FUNCT, V220, P2475, DOI 10.1007/s00429-014-0961-z; Striedter G. F., 2015, ANNU REV NEUROSCI, DOI [10.1146/annurev-neuro-071714-034128, DOI 10.1146/ANNUREV-NEUR0-071714-034128]; Tallinen T, 2014, P NATL ACAD SCI USA, V111, P12667, DOI 10.1073/pnas.1406015111; Thompson D. W., 1917, GROWTH FORM; Toro R, 2005, CEREB CORTEX, V15, P1900, DOI 10.1093/cercor/bhi068; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Xu G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001683	13	3	3	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					31	32		10.1126/science.aac6531	http://dx.doi.org/10.1126/science.aac6531			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138965				2022-12-28	WOS:000357280800044
J	Guo, C; D'Ippolito, AM; Reddy, TE				Guo, Cong; D'Ippolito, Anthony M.; Reddy, Timothy E.			From Prescription to Transcription: Genome Sequence as Drug Target	CELL			English	Editorial Material								Personalizing treatments to account for genetically mediated differences in drug responses is an exciting opportunity to improve patient outcomes. In this issue, Soccio et al. reveal new mechanisms by which non-coding variants alter the activity of the anti-diabetic drug rosiglitazone.	[Guo, Cong; D'Ippolito, Anthony M.; Reddy, Timothy E.] Duke Univ, Sch Med, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [Guo, Cong; D'Ippolito, Anthony M.] Duke Univ, Sch Med, Univ Program Genet & Genom, Durham, NC 27708 USA; [Reddy, Timothy E.] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Reddy, TE (corresponding author), Duke Univ, Sch Med, Ctr Genom & Computat Biol, Durham, NC 27708 USA.	tim.reddy@duke.edu						Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Crowley JJ, 2015, NAT GENET, V47, P353, DOI 10.1038/ng.3222; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; HURLEY DM, 1991, J CLIN INVEST, V87, P680, DOI 10.1172/JCI115046; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025	10	6	6	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					16	17		10.1016/j.cell.2015.06.033	http://dx.doi.org/10.1016/j.cell.2015.06.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140587	Bronze			2022-12-28	WOS:000357542300003
J	Hsieh, THS; Weiner, A; Lajoie, B; Dekker, J; Friedman, N; Rando, OJ				Hsieh, Tsung-Han S.; Weiner, Assaf; Lajoie, Bryan; Dekker, Job; Friedman, Nir; Rando, Oliver J.			Mapping Nucleosome Resolution Chromosome Folding in Yeast by Micro-C	CELL			English	Article							CHROMATIN FIBER; HISTONE MODIFICATIONS; 30-NM FIBER; IN-VIVO; GENOME; ORGANIZATION; DROSOPHILA; PROMOTERS; REVEALS; CONFORMATION	We describe a Hi-C-based method, Micro-C, in which micrococcal nuclease is used instead of restriction enzymes to fragment chromatin, enabling nucleosome resolution chromosome folding maps. Analysis of Micro-C maps for budding yeast reveals abundant self-associating domains similar to those reported in other species, but not previously observed in yeast. These structures, far shorter than topologically associating domains in mammals, typically encompass one to five genes in yeast. Strong boundaries between self-associating domains occur at promoters of highly transcribed genes and regions of rapid histone turnover that are typically bound by the RSC chromatin-remodeling complex. Investigation of chromosome folding in mutants confirms roles for RSC, "gene looping'' factor Ssu72, Mediator, H3K56 acetyltransferase Rtt109, and the N-terminal tail of H4 in folding of the yeast genome. This approach provides detailed structural maps of a eukaryotic genome, and our findings provide insights into the machinery underlying chromosome compaction.	[Hsieh, Tsung-Han S.; Lajoie, Bryan; Dekker, Job; Rando, Oliver J.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA; [Weiner, Assaf; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; [Weiner, Assaf; Friedman, Nir] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Lajoie, Bryan; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Massachusetts System; University of Massachusetts Worcester	Rando, OJ (corresponding author), Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu	Friedman, Nir/H-9692-2012	Friedman, Nir/0000-0002-9678-3550; Hsieh, Tsung-Han Stanley/0000-0003-2094-0772; Rando, Oliver/0000-0003-1516-9397	NIH [GM079205, HG003143]; European Research Council (ERC) [340712]; Israeli Science Foundation I-CORE on "Chromatin and RNA in Gene Regulation''; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)); Israeli Science Foundation I-CORE on "Chromatin and RNA in Gene Regulation''; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the O.J.R. and N.F. laboratories for comments on this manuscript, and we thank C. Boone for the generous gift of temperature-sensitive yeast strains. Work was supported in part by the NIH grant GM079205 to O.J.R. and N.F., HG003143 to J.D., European Research Council (ERC) grant "ChromatinSys'' (340712) to N.F., and Israeli Science Foundation I-CORE on "Chromatin and RNA in Gene Regulation'' to N.F. T.-H.S.H. is a Howard Hughes Medical Institute (HHMI) international student research fellow.	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Feng SH, 2014, MOL CELL, V55, P694, DOI 10.1016/j.molcel.2014.07.008; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gheldof N, 2006, P NATL ACAD SCI USA, V103, P12463, DOI 10.1073/pnas.0605343103; Ghirlando R, 2008, J MOL BIOL, V376, P1417, DOI 10.1016/j.jmb.2007.12.051; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Grob S, 2014, MOL CELL, V55, P678, DOI 10.1016/j.molcel.2014.07.009; Hizume K, 2009, ULTRAMICROSCOPY, V109, P868, DOI 10.1016/j.ultramic.2009.03.014; Hughes AL, 2014, ANNU REV BIOPHYS, V43, P41, DOI 10.1146/annurev-biophys-051013-023114; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Kim TS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r75; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; MCDOWALL AW, 1986, EMBO J, V5, P1395, DOI 10.1002/j.1460-2075.1986.tb04373.x; Mizuguchi T, 2014, NATURE, V516, P432, DOI 10.1038/nature13833; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Weiner A, 2015, MOL CELL, V58, P371, DOI 10.1016/j.molcel.2015.02.002; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003	49	324	338	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					108	119		10.1016/j.cell.2015.05.048	http://dx.doi.org/10.1016/j.cell.2015.05.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26119342	Green Accepted, Bronze			2022-12-28	WOS:000357542300013
J	Wernet, MF; Desplan, C				Wernet, Mathias F.; Desplan, Claude			Brain Wiring in the Fourth Dimension	CELL			English	Editorial Material							DROSOPHILA VISUAL-SYSTEM; SPECIFICITY; CALLIPHORA; AXONS	In this issue of Cell, Langen et al. use time-lapse multiphoton microscopy to show how Drosophila photoreceptor growth cones find their targets. Based on the observed dynamics, they develop a simple developmental algorithm recapitulating the highly complex connectivity pattern of these neurons, suggesting a basic framework for establishing wiring specificity.	[Wernet, Mathias F.; Desplan, Claude] New York Univ Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi 129188, U Arab Emirates; [Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), New York Univ Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi 129188, U Arab Emirates.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413	NATIONAL EYE INSTITUTE [R01EY013012] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY013012] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; HORRIDGE GA, 1970, PROC R SOC SER B-BIO, V175, P69, DOI 10.1098/rspb.1970.0012; Langen M, 2015, CELL, V162, P120, DOI 10.1016/j.cell.2015.05.055; MEINERTZHAGEN IA, 1972, BRAIN RES, V41, P39, DOI 10.1016/0006-8993(72)90615-4; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schwabe T, 2014, CURR BIOL, V24, P1304, DOI 10.1016/j.cub.2014.04.047; Schwabe T, 2013, CELL, V154, P351, DOI 10.1016/j.cell.2013.06.011	9	1	1	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					20	22		10.1016/j.cell.2015.06.040	http://dx.doi.org/10.1016/j.cell.2015.06.040			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140589	Green Accepted, Bronze			2022-12-28	WOS:000357542300005
J	Holleman, F; Uijldert, M; Donswijk, LF; Gale, EAM				Holleman, Frits; Uijldert, Mick; Donswijk, Lennart F.; Gale, Edwin A. M.			Productivity of authors in the field of diabetes: bibliographic analysis of trial publications	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To determine whether trial publications of glucose lowering drugs are dominated by a small group of highly prolific authors ("supertrialists") and to identify some of their characteristics. DESIGN Bibliographic analysis of trial publications. DATA SOURCES AND REVIEW METHODS We searched PubMed for all randomised controlled trials (RCTs) relating to glucose lowering drugs published between 1 January 1993 and 31 December 2013. From these publications we identified the 110 most prolific authors using PubReMiner. The 991 RCTs they published were examined for various characteristics such as author number, commercial sponsorship, company authorship, conflicts of interest, etc. The track record of the top 11 authors was studied in more detail. MAIN OUTCOME MEASURE Proportion of articles published by the top 110 and the top 11 authors. RESULTS 3782 articles from 13 592 authors were identified. The top 110 authors were named in 1227 (32.4%) of all articles, and the top 11 authors in 397 (10.5%) of all articles. The top 110 authors published 991 RCTs for a median of 20 (range 4-77) RCTs per author; the top 11 published 354 RCTs for a median of 42 (36-77) RCTs per author. Of the 110 top authors, 48 were employed by a pharmaceutical company. Of the 991 RCTs, 906 were commercially sponsored. Of 704 articles that could be assessed for conflicts of interest, only 42 (6%) were considered fully independent. Medical writing assistance was acknowledged in 439 (44.3%) of 991 RCTs. CONCLUSION The past two decades have seen an explosive increase in the number of published clinical trials regarding glucose lowering treatment. Some authors have made a disproportionate contribution to the therapeutic evidence base; one third of the RCT evidence base on glucose lowering drug treatment for diabetes was generated by less than 1% of authors. Of these, 44% were company employees and 56% were academics who work closely with the pharmaceutical companies.	[Holleman, Frits; Uijldert, Mick] Univ Amsterdam, Acad Med Ctr, Dept Internal Med F4 112, NL-1105 AZ Amsterdam, Netherlands; [Donswijk, Lennart F.] Gelre Ziekenhuizen, Dept Internal Med, Apeldoorn, Netherlands; [Gale, Edwin A. M.] Univ Bristol, Dept Diabet & Metab, Bristol, Avon, England	University of Amsterdam; Academic Medical Center Amsterdam; Gelre Hospitals; University of Bristol	Holleman, F (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med F4 112, NL-1105 AZ Amsterdam, Netherlands.	f.holleman@amc.uva.nl			Sanofi; MSD; Eli Lilly; AstraZeneca; Janssen-Cilag	Sanofi; MSD; Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; FH has received speaker fees and research support from Sanofi, MSD, Eli Lilly, AstraZeneca and Janssen-Cilag in the past three years; no other relationships or activities that could appear to have influenced the submitted work.	International Committee of Medical Journal Editors, 2013, NEW ICMJE REC; Lenzer J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3830; Nathan DM, 2007, NEW ENGL J MED, V356, P437, DOI 10.1056/NEJMp068294; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Sismondo S, 2007, PLOS MED, V4, P1429, DOI 10.1371/journal.pmed.0040286; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128; Wren JD, 2007, EMBO REP, V8, P988, DOI 10.1038/sj.embor.7401095	7	14	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2015	351								h2638	10.1136/bmj.h2638	http://dx.doi.org/10.1136/bmj.h2638			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TQ	26136272	hybrid, Green Published			2022-12-28	WOS:000357607800001
J	Willyard, C				Willyard, Cassandra			PHARMACOTHERAPY Quest for the quitting pill	NATURE			English	Editorial Material							MORPHINE; AT-1001; RATS											Cippitelli A, 2015, NEUROPHARMACOLOGY, V93, P229, DOI 10.1016/j.neuropharm.2015.02.005; Dwoskin LP, 2002, BIOCHEM PHARMACOL, V63, P89, DOI 10.1016/S0006-2952(01)00899-1; Glick SD, 1996, BRAIN RES, V719, P29, DOI 10.1016/0006-8993(96)00056-X; Schlosburg JE, 2013, P NATL ACAD SCI USA, V110, P9036, DOI 10.1073/pnas.1219159110; Taraschenko OD, 2007, SYNAPSE, V61, P547, DOI 10.1002/syn.20396; Toll L, 2012, NEUROPSYCHOPHARMACOL, V37, P1367, DOI 10.1038/npp.2011.322	6	17	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					S53	S55		10.1038/522S53a	http://dx.doi.org/10.1038/522S53a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26107096	Bronze			2022-12-28	WOS:000356782900004
J	Friedman, AB; Saloner, B; Hsia, RY				Friedman, Ari B.; Saloner, Brendan; Hsia, Renee Y.			No Place to Call Home - Policies to Reduce ED Use in Medicaid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EMERGENCY-DEPARTMENT USE		[Friedman, Ari B.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Saloner, Brendan] Johns Hopkins Bloomberg Sch Publ Hlth, Hlth Policy Management Dept, Baltimore, MD USA; [Hsia, Renee Y.] Univ Calif San Francisco, Dept Emergency Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of Pennsylvania; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco	Friedman, AB (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.		Friedman, Ari/J-6528-2013	Friedman, Ari/0000-0003-0412-6754				Lee MH, 2013, ANN EMERG MED, V62, P498, DOI 10.1016/j.annemergmed.2013.03.029; Raven MC, 2013, JAMA-J AM MED ASSOC, V309, P1145, DOI 10.1001/jama.2013.1948; Reid RJ, 2013, ANN FAM MED, V11, pS19, DOI 10.1370/afm.1476; Siddiqui M, 2015, JAMA INTERN MED, V175, P393, DOI 10.1001/jamainternmed.2014.7582; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183	5	18	18	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2382	2385		10.1056/NEJMp1502627	http://dx.doi.org/10.1056/NEJMp1502627			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK6RF	26083205	Green Published			2022-12-28	WOS:000356354600004
J	Haas, NA; Zelle, M; Rosendahl, W; Zink, A; Preuss, R; Laser, KT; Gostner, P; Arens, S; Domik, G; Burchert, W				Haas, Nikolaus A.; Zelle, Michael; Rosendahl, Wilfried; Zink, Albert; Preuss, Rainer; Laser, Kai Thorsten; Gostner, Paul; Arens, Stephan; Domik, Gitta; Burchert, Wolfgang			Hypoplastic left heart in the 6500-year-old Detmold Child	LANCET			English	Editorial Material									[Haas, Nikolaus A.; Laser, Kai Thorsten] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Dept Congenital Heart Defects, D-32545 Bad Oeynhausen, Germany; [Preuss, Rainer; Burchert, Wolfgang] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Dept Radiol, D-32545 Bad Oeynhausen, Germany; [Zelle, Michael] Lipp Landesmuseum, Detmold, Germany; [Rosendahl, Wilfried] Reiss Engelhorn Museen Mannheim, Mannheim, Germany; [Arens, Stephan; Domik, Gitta] Univ Paderborn, Dept Comp Sci, D-33098 Paderborn, Germany; [Zink, Albert] EURAC Inst Mummies & Iceman, Bolzano, Italy; [Gostner, Paul] Cent Hosp, Dept Radiodiagnost, Bolzano, Italy	Ruhr University Bochum; Ruhr University Bochum; University of Paderborn; European Academy of Bozen-Bolzano; Krankenhaus Bozen	Haas, NA (corresponding author), Ruhr Univ Bochum, Dept Congenital Heart Defects Heart & Diabet, Ctr North Rhine Westphalia, D-32545 Bad Oeynhausen, Germany.	nhaas@hdz-nrw.de	Burchert, Wolfgang/ABF-4194-2020; Zink, Albert/P-4024-2015; Laser, Kai Thorsten/B-8698-2015	Zink, Albert/0000-0002-1461-747X; 				Gehrmann J, 2001, CHEST, V120, P1368, DOI 10.1378/chest.120.4.1368; Heath A, 2012, CATHETER CARDIO INTE, V79, P399, DOI 10.1002/ccd.23302; Meyer R, 2010, MUMMIES OF THE WORLD, P342; Miranda Chávez Irma, 2007, Arch. Cardiol. Méx., V77, P349; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X	5	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2432	2432		10.1016/S0140-6736(15)60770-X	http://dx.doi.org/10.1016/S0140-6736(15)60770-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	26088644				2022-12-28	WOS:000356003700037
J	Fee, E				Fee, Elizabeth			The first American medical school: the formative years	LANCET			English	Editorial Material									Natl Lib Med, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Fee, E (corresponding author), Natl Lib Med, Bethesda, MD 20894 USA.	feee@mail.nih.gov							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1940	1941		10.1016/S0140-6736(15)60950-3	http://dx.doi.org/10.1016/S0140-6736(15)60950-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1YR	26090632				2022-12-28	WOS:000354541700016
J	Mattila, JP; Shnyrova, AV; Sundborger, AC; Hortelano, ER; Fuhrmans, M; Neumann, S; Muller, M; Hinshaw, JE; Schmid, SL; Frolov, VA				Mattila, Juha-Pekka; Shnyrova, Anna V.; Sundborger, Anna C.; Rodriguez Hortelano, Eva; Fuhrmans, Marc; Neumann, Sylvia; Mueller, Marcus; Hinshaw, Jenny E.; Schmid, Sandra L.; Frolov, Vadim A.			A hemi-fission intermediate links two mechanistically distinct stages of membrane fission	NATURE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; DISSIPATIVE PARTICLE DYNAMICS; CRYSTAL-STRUCTURE; FUSION; MECHANICS; GTPASE; DOMAIN; SIMULATIONS; BILAYERS; BINDING	Fusion and fission drive all vesicular transport. Although topologically opposite, these reactions pass through the same hemi-fusion/fission intermediate1,2, characterized by a 'stalk' in which only the outer membrane monolayers of the two compartments have merged to form a localized non-bilayer connection(1-3). Formation of the hemi-fission intermediate requires energy input from proteins catalysing membrane remodelling; however, the relationship between protein conformational rearrangements and hemi-fusion/fission remains obscure. Here we analysed how the GTPase cycle of human dynamin 1, the prototypical membrane fission catalyst(4-6), is directly coupled to membrane remodelling. We used intramolecular chemical crosslinking to stabilize dynamin in its GDP.AlF4--bound transition state. In the absence of GTP this conformer produced stable hemi-fission, but failed to progress to complete fission, even in the presence of GTP. Further analysis revealed that the pleckstrin homology domain (PHD) locked in its membrane-inserted state facilitated hemi-fission. A second mode of dynamin activity, fuelled by GTP hydrolysis, couples dynamin disassembly with cooperative diminishing of the PHD wedging, thus destabilizing the hemi-fission intermediate to complete fission. Molecular simulations corroborate the bimodal character of dynamin action and indicate radial and axial forces as dominant, although not independent, drivers of hemi-fission and fission transformations, respectively. Mirrored in the fusion reaction(7,8), the force bimodality might constitute a general paradigm for leakage-free membrane remodelling.	[Mattila, Juha-Pekka; Schmid, Sandra L.] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75201 USA; [Shnyrova, Anna V.; Rodriguez Hortelano, Eva; Frolov, Vadim A.] Univ Basque Country, Biophys Unit, CSIC, Leioa 48940, Spain; [Shnyrova, Anna V.; Rodriguez Hortelano, Eva; Frolov, Vadim A.] Univ Basque Country, Dept Biochem & Mol Biol, Leioa 48940, Spain; [Sundborger, Anna C.; Hinshaw, Jenny E.] NIDDK, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Fuhrmans, Marc; Mueller, Marcus] Univ Gottingen, Inst Theoret Phys, D-37077 Gottingen, Germany; [Neumann, Sylvia] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Frolov, Vadim A.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	University of Texas System; University of Texas Southwestern Medical Center Dallas; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Gottingen; Scripps Research Institute; Basque Foundation for Science	Schmid, SL (corresponding author), UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75201 USA.	jennyh@helix.nih.gov; sandra.schmid@utsouthwestern.edu; vadim.frolov@ehu.eus	Frolov, Vadim/ABH-3889-2020; Müller, Marcus/B-9898-2009; Sundborger, Anna/J-6590-2014; Fuhrmans, Marc/E-2800-2015	Frolov, Vadim/0000-0002-0653-5669; Müller, Marcus/0000-0002-7472-973X; Schmid, Sandra/0000-0002-1690-7024; Sundborger, Anna/0000-0003-4696-7543; Shnyrova, Anna/0000-0002-5329-348X; Fuhrmans, Marc/0000-0002-9826-018X	National Institutes of Health [R01-GM42455]; Welch Foundation [I-1823]; Spanish Ministry of Economy and Competitiveness [BFU2012-34885]; Basque Government Program Etortek [IE12-332]; European FEDER; National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program; Volkswagen foundation; Academy of Finland;  [DFG-CRC803]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government Program Etortek; European FEDER(European Commission); National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Volkswagen foundation(Volkswagen); Academy of Finland(Academy of Finland); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Chappie for helpful discussions, A. Mohanakrishnan and D. Reed for technical assistance. S.L.S. was supported by National Institutes of Health grant R01-GM42455 and the Welch Foundation Grant I-1823. V.A.F. was supported by grants from the Spanish Ministry of Economy and Competitiveness BFU2012-34885, the Basque Government Program Etortek IE12-332 and European FEDER funds. J.E.H. was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program. M.F. and M.M. were supported by the Volkswagen foundation and the DFG-CRC803 "Functionality controlled by organization in and between membranes" (B03). Simulations were performed at the Julich Supercomputing Center and the North-German Supercomputer Alliance Hannover/Berlin. J.-P.M. was supported by a postdoctoral research grant from the Academy of Finland.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Daoulas KC, 2010, ADV POLYM SCI, V224, P197, DOI 10.1007/12_2008_7; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Frolov VA, 2015, CHEM PHYS LIPIDS, V185, P129, DOI 10.1016/j.chemphyslip.2014.07.006; Frolov VA, 2010, FEBS LETT, V584, P1824, DOI 10.1016/j.febslet.2010.01.039; Fuhrmans M, 2015, SOFT MATTER, V11, P1464, DOI 10.1039/c4sm02533d; Fuhrmans M, 2013, LANGMUIR, V29, P4335, DOI 10.1021/la400119e; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Grafmuller A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218101; Homberg M, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/68010; Homberg M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3369005; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Lee JY, 2008, BIOPHYS J, V94, P1699, DOI 10.1529/biophysj.107.119511; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Mehrotra N, 2014, MOL BIOL CELL, V25, P879, DOI 10.1091/mbc.E13-09-0548; Morlot S, 2013, ANNU REV BIOPHYS, V42, P629, DOI 10.1146/annurev-biophys-050511-102247; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Neumann S, 2013, NAT PROTOC, V8, P213, DOI 10.1038/nprot.2012.152; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Risselada HJ, 2014, P NATL ACAD SCI USA, V111, P11043, DOI 10.1073/pnas.1323221111; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sundborger AC, 2014, CELL REP, V8, P734, DOI 10.1016/j.celrep.2014.06.054; Trofimov SY, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2052667	39	65	65	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					109	U243		10.1038/nature14509	http://dx.doi.org/10.1038/nature14509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26123023	Green Accepted			2022-12-28	WOS:000359002300042
J	Kleinstiver, BP; Prew, MS; Tsai, SQ; Topkar, VV; Nguyen, NT; Zheng, ZL; Gonzales, APW; Li, ZY; Peterson, RT; Yeh, JRJ; Aryee, MJ; Joung, JK				Kleinstiver, Benjamin P.; Prew, Michelle S.; Tsai, Shengdar Q.; Topkar, Ved V.; Nguyen, Nhu T.; Zheng, Zongli; Gonzales, Andrew P. W.; Li, Zhuyun; Peterson, Randall T.; Yeh, Jing-Ruey Joanna; Aryee, Martin J.; Joung, J. Keith			Engineered CRISPR-Cas9 nucleases with altered PAM specificities	NATURE			English	Article							DIRECTED EVOLUTION; DUAL-RNA; CAS9; ENDONUCLEASE; RECOGNITION; CLEAVAGE	Although CRISPR-Cas9 nucleases are widely used for genome editing(1,2), the range of sequences that Cas9 can recognize is constrained by the need for a specific protospacer adjacent motif (PAM)(3-6). As a result, it can often be difficult to target double-stranded breaks (DSBs) with the precision that is necessary for various genome-editing applications. The ability to engineer Cas9 derivatives with purposefully altered PAM specificities would address this limitation. Here we show that the commonly used Streptococcus pyogenes Cas9 (SpCas9) can be modified to recognize alternative PAM sequences using structural information, bacterial selection-based directed evolution, and combinatorial design. These altered PAM specificity variants enable robust editing of endogenous gene sites in zebrafish and human cells not currently targetable by wild-type SpCas9, and their genome-wide specificities are comparable to wild-type SpCas9 as judged by GUIDE-seq analysis(7). In addition, we identify and characterize another SpCas9 variant that exhibits improved specificity in human cells, possessing better discrimination against off-target sites with non-canonical NAG and NGAPAMs and/or mismatched spacers. We also find that two smaller-size Cas9 orthologues, Streptococcus thermophilus Cas9 (St1Cas9) and Staphylococcus aureus Cas9 (SaCas9), function efficiently in the bacterial selection systems and in human cells, suggesting that our engineering strategies could be extended to Cas9s from other species. Our findings provide broadly useful SpCas9 variants and, more importantly, establish the feasibility of engineering a wide range of Cas9s with altered and improved PAM specificities.	[Kleinstiver, Benjamin P.; Prew, Michelle S.; Tsai, Shengdar Q.; Topkar, Ved V.; Nguyen, Nhu T.; Zheng, Zongli; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Prew, Michelle S.; Tsai, Shengdar Q.; Topkar, Ved V.; Nguyen, Nhu T.; Zheng, Zongli; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Prew, Michelle S.; Tsai, Shengdar Q.; Topkar, Ved V.; Nguyen, Nhu T.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Zheng, Zongli; Aryee, Martin J.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Zheng, Zongli] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Gonzales, Andrew P. W.; Li, Zhuyun; Peterson, Randall T.; Yeh, Jing-Ruey Joanna] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Gonzales, Andrew P. W.; Peterson, Randall T.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Gonzales, Andrew P. W.; Peterson, Randall T.] Broad Inst, Cambridge, MA 02142 USA; [Yeh, Jing-Ruey Joanna] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Aryee, Martin J.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Karolinska Institutet; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	jjoung@mgh.harvard.edu	zheng, zongli/C-7309-2008; Tsai, Shengdar Q./G-4600-2012; Li, Zhuyun/L-4792-2016; Aryee, Martin/AAC-8113-2020; Kleinstiver, Benjamin/K-4498-2014; Zheng, Zongli/B-2917-2011	Tsai, Shengdar Q./0000-0001-9161-3993; Kleinstiver, Benjamin/0000-0002-5469-0655; Peterson, Randall/0000-0003-0727-3469; Zheng, Zongli/0000-0003-4849-4903; Yeh, Jing-Ruey Joanna/0000-0002-7768-4901; Prew, Michelle/0000-0001-7247-3024	National Institutes of Health (NIH) [DP1 GM105378]; NIH [R01 GM107427, R01 GM088040]; Jim and Ann Orr Research Scholar Award; National Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107427, R01GM088040, DP1GM105378] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Research Scholar Award; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Edgell for providing the bacterial strain and plasmids related to the bacterial selection; J. Angstman and V. Pattanayak for discussion and comments on the manuscript. This work was supported by a National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378) and NIH R01 GM107427 to J.K.J., NIH R01 GM088040 to J.K.J. and R.T.P., The Jim and Ann Orr Research Scholar Award (to J.K.J.), and a National Sciences and Engineering Research Council of Canada Postdoctoral Fellowship (to B.P.K.).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Chen ZL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni148; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2010, NUCLEIC ACIDS RES, V38, P2411, DOI 10.1093/nar/gkp1223; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ran FA, 2015, NATURE; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	36	989	1173	26	447	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					481	U249		10.1038/nature14592	http://dx.doi.org/10.1038/nature14592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26098369	Green Accepted, Green Submitted			2022-12-28	WOS:000358378900041
J	Gavelis, GS; Hayakawa, S; White, RA; Gojobori, T; Suttle, CA; Keeling, PJ; Leander, BS				Gavelis, Gregory S.; Hayakawa, Shiho; White, Richard A., III; Gojobori, Takashi; Suttle, Curtis A.; Keeling, Patrick J.; Leander, Brian S.			Eye-like ocelloids are built from different endosymbiotically acquired components	NATURE			English	Article							DINOFLAGELLATE; PHYLOGENY; EVOLUTION; ERYTHROPSIDINIUM; WARNOWIIDAE; ALIGNMENT; LIGHT; FINE; GEN.; NOV	Multicellularity is often considered a prerequisite for morphological complexity, as seen in the camera-type eyes found in several groups of animals. A notable exception exists in single-celled eukaryotes called dinoflagellates, some of which have an eye-like 'ocelloid' consisting of subcellular analogues to a cornea, lens, iris, and retina(1). These planktonic cells are uncultivated and rarely encountered in environmental samples, obscuring the function and evolutionary origin of the ocelloid. Here we show, using a combination of electron microscopy, tomography, isolated-organelle genomics, and single-cell genomics, that ocelloids are built from pre-existing organelles, including a cornea-like layer made of mitochondria and a retinal body made of anastomosing plastids. We find that the retinal body forms the central core of a network of peridinin-type plastids, which in dinoflagellates and their relatives originated through an ancient endosymbiosis with a red alga(2). As such, the ocelloid is a chimaeric structure, incorporating organelles with different endosymbiotic histories. The anatomical complexity of single-celled organisms may be limited by the components available for differentiation, but the ocelloid shows that preexisting organelles can be assembled into a structure so complex that it was initially mistaken for a multicellular eye(3). Although mitochondria and plastids are acknowledged chiefly for their metabolic roles, they can also be building blocks for greater structural complexity.	[Gavelis, Gregory S.; Hayakawa, Shiho; Leander, Brian S.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Hayakawa, Shiho; Suttle, Curtis A.; Keeling, Patrick J.; Leander, Brian S.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Hayakawa, Shiho; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [White, Richard A., III; Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Gojobori, Takashi] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal 239556900, Saudi Arabia; [Suttle, Curtis A.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada; [Suttle, Curtis A.; Keeling, Patrick J.; Leander, Brian S.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	University of British Columbia; University of British Columbia; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of British Columbia; King Abdullah University of Science & Technology; University of British Columbia; Canadian Institute for Advanced Research (CIFAR)	Gavelis, GS (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	zoark0@gmail.com	White, Richard Allen/H-5142-2019; suttle, c/N-1144-2019	suttle, c/0000-0002-0372-0033; White III, Richard Allen/0000-0002-6292-5936; Keeling, Patrick/0000-0002-7644-0745	Natural Sciences and Engineering Research Council of Canada [2014-05258, 227301]; Tula Foundation (Centre for Microbial Diversity and Evolution)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Tula Foundation (Centre for Microbial Diversity and Evolution)	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (2014-05258 to B.S.L., and 227301 to P.J.K.) and the Tula Foundation (Centre for Microbial Diversity and Evolution). We thank G. Owen for his operation of the FIB-SEM and G. Martens for preparing our samples for tomography. G.S.G. thanks S. Maslakova, C. Young, A. Lehman, and D. Blackburn for training in developmental biology, marine systems, electron microscopy, and ultrastructure, respectively. C.A.S., P.J.K. and B.S.L. are Senior Fellows of the Canadian Institute for Advanced Research.	ABRAHAMS MV, 1993, ECOLOGY, V74, P258, DOI 10.2307/1939521; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dodge J.D., 1984, Biosystems, V16, P259; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Gomez F, 2009, J EUKARYOT MICROBIOL, V56, P440, DOI 10.1111/j.1550-7408.2009.00420.x; GREUET C, 1965, CR HEBD ACAD SCI, V261, P1904; GREUET C, 1977, PROTISTOLOGICA, V13, P127; Greuet C, 1968, PROTISTOLOGICA, P209; Hausmann K, 1978, Int Rev Cytol, V52, P197, DOI 10.1016/S0074-7696(08)60757-3; Hayakawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118415; Hofmann E, 1996, SCIENCE, V272, P1788, DOI 10.1126/science.272.5269.1788; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Kofoid C. A., 1921, Memoirs of the University of California, V5, P1; Kolisko M, 2014, CURR BIOL, V24, pR1081, DOI 10.1016/j.cub.2014.10.026; Kreimer G, 1999, PROTIST, V150, P311, DOI 10.1016/S1434-4610(99)70032-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Leander BS, 2008, TRENDS ECOL EVOL, V23, P481, DOI 10.1016/j.tree.2008.04.012; Lindberg K, 2005, PHYCOLOGIA, V44, P416, DOI 10.2216/0031-8884(2005)44[416:SOWDIW]2.0.CO;2; Liu JP, 2013, J QUANT SPECTROSC RA, V131, P24, DOI 10.1016/j.jqsrt.2013.02.012; Moestrup O, 2008, PHYCOLOGIA, V47, P54, DOI 10.2216/07-32.1; MORNIN L, 1967, J MICROSC-PARIS, V6, P759; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163	31	51	52	2	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					204	U155		10.1038/nature14593	http://dx.doi.org/10.1038/nature14593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26131935	Green Submitted			2022-12-28	WOS:000357695900033
J	Gattuso, JP; Magnan, A; Bille, R; Cheung, WWL; Howes, EL; Joos, F; Allemand, D; Bopp, L; Cooley, SR; Eakin, CM; Hoegh-Guldberg, O; Kelly, RP; Portner, HO; Rogers, AD; Baxter, JM; Laffoley, D; Osborn, D; Rankovic, A; Rochette, J; Sumaila, UR; Treyer, S; Turley, C				Gattuso, J-P; Magnan, A.; Bille, R.; Cheung, W. W. L.; Howes, E. L.; Joos, F.; Allemand, D.; Bopp, L.; Cooley, S. R.; Eakin, C. M.; Hoegh-Guldberg, O.; Kelly, R. P.; Poertner, H-O; Rogers, A. D.; Baxter, J. M.; Laffoley, D.; Osborn, D.; Rankovic, A.; Rochette, J.; Sumaila, U. R.; Treyer, S.; Turley, C.			Contrasting futures for ocean and society from different anthropogenic CO2 emissions scenarios	SCIENCE			English	Review							CLIMATE-CHANGE IMPACTS; CORAL-REEFS; ELEVATED-TEMPERATURE; CARBONATE CHEMISTRY; INFECTIOUS-DISEASES; COASTAL PROTECTION; ACIDIFICATION; FISHERIES; RESPONSES; SEA	The ocean moderates anthropogenic climate change at the cost of profound alterations of its physics, chemistry, ecology, and services. Here, we evaluate and compare the risks of impacts on marine and coastal ecosystems-and the goods and services they provide-for growing cumulative carbon emissions under two contrasting emissions scenarios. The current emissions trajectory would rapidly and significantly alter many ecosystems and the associated services on which humans heavily depend. A reduced emissions scenario-consistent with the Copenhagen Accord's goal of a global temperature increase of less than 2 degrees C-is much more favorable to the ocean but still substantially alters important marine ecosystems and associated goods and services. The management options to address ocean impacts narrow as the ocean warms and acidifies. Consequently, any new climate regime that fails to minimize ocean impacts would be incomplete and inadequate.	[Gattuso, J-P] Inst Natl Sci Univers, CNRS, Lab Oceanog Villefranche, F-06230 Villefranche Sur Mer, France; [Gattuso, J-P] Univ Paris 06, Sorbonne Univ, Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Gattuso, J-P; Magnan, A.; Rankovic, A.; Rochette, J.; Treyer, S.] Sci Po, Inst Sustainable Dev & Int Relat, F-75007 Paris, France; [Bille, R.] Secretariat Pacific Community, Noumea 98848, New Caledonia; [Cheung, W. W. L.] Univ British Columbia, Nippon Fdn UBC Nereus Program, Vancouver, BC V6T 1Z4, Canada; [Howes, E. L.; Poertner, H-O] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Joos, F.] Univ Bern, Inst Phys, Climate & Environm Phys, CH-3012 Bern, Switzerland; [Joos, F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Allemand, D.] Ctr Sci Monaco, MC-98000 Monaco, Monaco; [Allemand, D.] Prince Albert II Monaco Fdn, Sci & Tech Comm, MC-98000 Monaco, Monaco; [Bopp, L.] Univ Versailles St Quentin En Yvelines, Commissariat Energie Atom & Energies Alternat, Lab Sci Climat & Environm, Inst Pierre Simon Laplace,CNRS,UMR8212, Gif Sur Yvette, France; [Cooley, S. R.] Ocean Conservancy, Washington, DC 20036 USA; [Eakin, C. M.] NOAA, Coral Reef Watch, College Pk, MD 20740 USA; [Hoegh-Guldberg, O.] Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia; [Hoegh-Guldberg, O.] Univ Queensland, Australian Res Council Ctr Excellence Coral Reef, St Lucia, Qld 4072, Australia; [Kelly, R. P.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98105 USA; [Rogers, A. D.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Baxter, J. M.] Scottish Nat Heritage, Edinburgh EH12 7AT, Midlothian, Scotland; [Laffoley, D.] IUCN, CH-1196 Gland, Switzerland; [Osborn, D.] IAEA, Environm Labs, MC-98000 Monaco, Monaco; [Rankovic, A.] Harvard Univ, John F Kennedy Sch Govt, Program Sci Technol & Soc, Cambridge, MA 02138 USA; [Sumaila, U. R.] Univ British Columbia, Fisheries Econ Res Unit, Vancouver, BC V6T 1Z4, Canada; [Turley, C.] Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut d'Etudes Politiques Paris (Sciences Po); University of British Columbia; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bern; University of Bern; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Queensland; University of Queensland; University of Washington; University of Washington Seattle; University of Oxford; Harvard University; University of British Columbia; Plymouth Marine Laboratory	Gattuso, JP (corresponding author), Inst Natl Sci Univers, CNRS, Lab Oceanog Villefranche, F-06230 Villefranche Sur Mer, France.	gattuso@obs-vlfr.fr	Magnan, Alexandre K/I-3377-2017; Gattuso, Jean-Pierre/AAG-8643-2019; Cooley, Sarah R/K-7373-2012; /AAL-3738-2021; Hoegh-Guldberg, Ove/ABA-5420-2020; bopp, laurent/ABF-5302-2020; Joos, Fortunat/B-4118-2018; Sumaila, U. Rashid/ABE-6475-2020; Gattuso, Jean-Pierre/E-6631-2010; Pörtner, Hans-O./K-9429-2016; Eakin, C. Mark/F-5585-2010	Magnan, Alexandre K/0000-0001-7421-5184; Gattuso, Jean-Pierre/0000-0002-4533-4114; Cooley, Sarah R/0000-0002-1034-0653; Hoegh-Guldberg, Ove/0000-0001-7510-6713; bopp, laurent/0000-0003-4732-4953; Joos, Fortunat/0000-0002-9483-6030; Gattuso, Jean-Pierre/0000-0002-4533-4114; Pörtner, Hans-O./0000-0001-6535-6575; Kelly, Ryan/0000-0001-5037-2441; Eakin, C. Mark/0000-0002-5987-0858	Prince Albert II of Monaco Foundation; Ocean Acidification International Coordination Centre of the International Atomic Energy Agency; BNP Paribas Foundation; Monegasque Association for Ocean Acidification; French National Research Agency (CapAdapt project) [ANR-2011-JSH1-004 01]; RESCCUE project - French Development Agency; French Global Environment Facility [AFD CZZ 1647 01 F, FFEM CZZ 1667 01 H]; Nippon Foundation-UBC Nereus Program; Natural Science and Engineering Research Council of Canada; Social Sciences and Humanities Research Council; UK Ocean Acidification research program; Swiss National Science Foundation; Commission through the European Union Framework Programme 7 project CARBOCHANGE [264879]; University of Queensland; Australian Research Council Centre for Excellence; ARC Laureate Fellowship; PACES program; BIOACID program; National Oceanic and Atmospheric Administration (NOAA); NASA; government of the Principality of Monaco; Natural Environment Research Council [pml010005, pml010009] Funding Source: researchfish; NERC [pml010009, pml010005] Funding Source: UKRI	Prince Albert II of Monaco Foundation; Ocean Acidification International Coordination Centre of the International Atomic Energy Agency; BNP Paribas Foundation; Monegasque Association for Ocean Acidification; French National Research Agency (CapAdapt project)(French National Research Agency (ANR)); RESCCUE project - French Development Agency; French Global Environment Facility; Nippon Foundation-UBC Nereus Program; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); UK Ocean Acidification research program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission through the European Union Framework Programme 7 project CARBOCHANGE; University of Queensland(University of Queensland); Australian Research Council Centre for Excellence(Australian Research Council); ARC Laureate Fellowship(Australian Research Council); PACES program; BIOACID program; National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); NASA(National Aeronautics & Space Administration (NASA)); government of the Principality of Monaco; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This is a product of "The Oceans 2015 Initiative," an expert group supported by the Prince Albert II of Monaco Foundation, the Ocean Acidification International Coordination Centre of the International Atomic Energy Agency, the BNP Paribas Foundation, and the Monegasque Association for Ocean Acidification. This study is also a contribution to the international IMBER (Integrated Marine Biogeochemistry and Ecosystem Research) project. We are grateful for the considerable help of Y. Estrada (Technical Support Unit of IPCC WG II) and M. Khamla to finalize the illustrations and H. Flores for useful discussion. A. M. acknowledges support from the French National Research Agency (CapAdapt project, ANR-2011-JSH1-004 01). R.B. is supported by the RESCCUE project funded by the French Development Agency and the French Global Environment Facility (AFD CZZ 1647 01 F and FFEM CZZ 1667 01 H). W.W.L.C. acknowledges support from the Nippon Foundation-UBC Nereus Program and Natural Science and Engineering Research Council of Canada. U.R.S. and W.W.L.C. thank the Social Sciences and Humanities Research Council-sponsored OceanCanada Partnership for support. C.T. is supported by the UK Ocean Acidification research program. F.J. acknowledges support by the Swiss National Science Foundation and the European Commission through the European Union Framework Programme 7 project CARBOCHANGE (no. 264879). O.H.-G. is grateful for support from the University of Queensland, Australian Research Council Centre for Excellence, and his ARC Laureate Fellowship. H.-O.P. acknowledges support by the PACES and BIOACID programs. C.M.E. acknowledges support from the National Oceanic and Atmospheric Administration (NOAA) and NASA. The International Atomic Energy Agency is grateful to the government of the Principality of Monaco for the support provided to its Environment Laboratories. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for the Coupled Model Intercomparison Project (CMIP), and thank the climate modeling groups for producing and making available their model output. For CMIP, the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. The contents of this paper are solely the opinions of the authors and do not constitute a statement of policy, decision, or position on behalf of NOAA, NASA, the International Atomic Energy Agency, the U.S. government, or the Secretariat of the Pacific Community.	Ainsworth CH, 2011, ICES J MAR SCI, V68, P1217, DOI 10.1093/icesjms/fsr043; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; [Anonymous], 2009, DECISION 2 CP 15 COP; Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Barbier EB, 2015, ECOSYST SERV, V11, P32, DOI 10.1016/j.ecoser.2014.06.010; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Baudron AR, 2014, GLOBAL CHANGE BIOL, V20, P1023, DOI 10.1111/gcb.12514; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; Bednarsek N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109183; Bell JD, 2013, NAT CLIM CHANGE, V3, P591, DOI 10.1038/NCLIMATE1838; Bille R, 2013, ENVIRON MANAGE, V52, P761, DOI 10.1007/s00267-013-0132-7; Bjork MM, 2014, BIOGEOSCIENCES, V11, P57, DOI 10.5194/bg-11-57-2014; Boden T. A., 2013, GLOBAL REGIONAL AND; Bohnke-Henrichs A, 2013, J ENVIRON MANAGE, V130, P135, DOI 10.1016/j.jenvman.2013.08.027; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Borges AV, 2010, LIMNOL OCEANOGR, V55, P346, DOI 10.4319/lo.2010.55.1.0346; Boyd PW, 2015, NAT CLIM CHANGE, V5, P71, DOI [10.1038/NCLIMATE2441, 10.1038/nclimate2441]; Brander LM, 2012, CLIM CHANG ECON, V3, DOI 10.1142/S2010007812500029; Brodie J, 2014, ECOL EVOL, V4, P2787, DOI 10.1002/ece3.1105; Brown AK, 2015, J ROY ANTHROPOL INST, V21, P491, DOI 10.1111/1467-9655.12237; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Burke L., 2011, REEFS RISK REVISITED, P114; Cacciapaglia C, 2015, GLOBAL CHANGE BIOL, V21, P2272, DOI 10.1111/gcb.12851; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/NGEO1297, 10.1038/ngeo1297]; Callaway R, 2012, AQUAT CONSERV, V22, P389, DOI 10.1002/aqc.2247; Chambers LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075514; Chen PY, 2015, GLOBAL ENVIRON CHANG, V30, P12, DOI 10.1016/j.gloenvcha.2014.10.011; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2012, AQUAT CONSERV, V22, P368, DOI 10.1002/aqc.2248; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Christiansen JS, 2014, GLOBAL CHANGE BIOL, V20, P352, DOI 10.1111/gcb.12395; Church J.A., 2013, CLIMATE CHANGE 2013, P1137, DOI [10.1017/CBO9781107415324.026, DOI 10.1017/CBO9781107415324.026, DOI 10.1017/CB09781107415324.026]; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Clarkson MO, 2015, SCIENCE, V348, P229, DOI 10.1126/science.aaa0193; Cocco V, 2013, BIOGEOSCIENCES, V10, P1849, DOI 10.5194/bg-10-1849-2013; Comeau S, 2014, J EXP MAR BIOL ECOL, V453, P28, DOI 10.1016/j.jembe.2013.12.013; Committee on Geoengineering Climate, 2015, CLIMATE INTERVENTION; Cooley SR, 2013, OCEAN YEARB, V27, P29, DOI 10.1163/22116001-90000153; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Cyronak T, 2014, GLOBAL BIOGEOCHEM CY, V28, P398, DOI 10.1002/2013GB004598; de Suarez JM, 2014, OCEAN COAST MANAGE, V90, P27, DOI 10.1016/j.ocecoaman.2013.08.007; Deloitte Access Economics, 2013, ECONOMIC CONTRIBUTIO; DeSilva S. S, 2012, FARMING WATERS PEOPL, P75; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Gaitan-Espitia JD, 2014, J EXP MAR BIOL ECOL, V457, P51, DOI 10.1016/j.jembe.2014.03.018; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; Eakin CM, 2014, SCIENCE, V344, P798, DOI 10.1126/science.1254136; Eisaman MD, 2012, ENERG ENVIRON SCI, V5, P7346, DOI 10.1039/c2ee03393c; Emerson SR, 2014, OCEANOGRAPHY, V27, P168, DOI 10.5670/oceanog.2014.20; Endres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099228; FAO, 2014, THE STATE OF WORLD F; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Frieder CA, 2014, GLOBAL CHANGE BIOL, V20, P754, DOI 10.1111/gcb.12485; Friedrich T, 2012, NAT CLIM CHANGE, V2, P167, DOI [10.1038/NCLIMATE1372, 10.1038/nclimate1372]; Frolicher TL, 2010, CLIM DYNAM, V35, P1439, DOI 10.1007/s00382-009-0727-0; Garai J, 2014, INT PERSPECTIVES CLI, P151, DOI [DOI 10.1007/978-3-319-04489-7, DOI 10.1007/978-3-319-04489-7_11]; Garrard SL, 2014, J EXP MAR BIOL ECOL, V461, P31, DOI 10.1016/j.jembe.2014.07.011; Gattuso J. P., 2011, OCEAN ACIDIFICATION, P1, DOI DOI 10.1029/2006GB002898.BARCELOS; Gattuso J.-P., 2014, OCEAN ACIDIFICATION, P129; Gattuso JP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P97; Gehlen M, 2014, BIOGEOSCIENCES, V11, P6955, DOI 10.5194/bg-11-6955-2014; Gibert JP, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0473; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Govan H., 2009, STATUS AND POTENTIAL; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Harrould-Kolieb ER, 2012, CLIM POLICY, V12, P378, DOI 10.1080/14693062.2012.620788; Hiddink JG, 2015, GLOBAL CHANGE BIOL, V21, P117, DOI 10.1111/gcb.12726; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Hoegh-Guldberg O, 2012, SCI MAR, V76, P403, DOI 10.3989/scimar.03660.29A; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoppe CJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079890; Hume BCC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08562; IPCC, 2013, CLIMATE CHANGE 2022; Jones C, 2013, J CLIMATE, V26, P4398, DOI 10.1175/JCLI-D-12-00554.1; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Keller KM, 2014, BIOGEOSCIENCES, V11, P3647, DOI 10.5194/bg-11-3647-2014; Kelly RP, 2014, AMBIO, V43, P592, DOI 10.1007/s13280-013-0442-2; Kelly RP, 2013, HARVARD ENVIRON LAW, V37, P57; Keppel G, 2015, FRONT ECOL ENVIRON, V13, P106, DOI 10.1890/140055; Ko GWK, 2014, ENVIRON SCI TECHNOL, V48, P10079, DOI 10.1021/es501611u; Lam VWY, 2012, AFR J MAR SCI, V34, P103, DOI 10.2989/1814232X.2012.673294; Lam VWY, 2016, FISH FISH, V17, P335, DOI 10.1111/faf.12106; Leung TLF, 2013, J APPL ECOL, V50, P215, DOI 10.1111/1365-2644.12017; Levin LA, 2015, J MARINE SYST, V141, P3, DOI 10.1016/j.jmarsys.2014.04.016; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Lohbeck KT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0003; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Mackenzie CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086764; Madeira D, 2014, MAR ENVIRON RES, V98, P21, DOI 10.1016/j.marenvres.2014.03.011; Mastrandrea M. D., 2010, GUIDANCE NOTE FOR LE; Mathis JT, 2015, PROG OCEANOGR, V136, P71, DOI 10.1016/j.pocean.2014.07.001; Mcleod E, 2013, FRONT ECOL ENVIRON, V11, P20, DOI 10.1890/110240; Meier KJS, 2014, BIOGEOSCIENCES, V11, P2857, DOI 10.5194/bg-11-2857-2014; Meyer J, 2015, BIOGEOSCIENCES, V12, P1671, DOI 10.5194/bg-12-1671-2015; Miller KA, 2013, CAN J AGR ECON, V61, P309, DOI 10.1111/cjag.12011; Moffitt SE, 2015, P NATL ACAD SCI USA, V112, P4684, DOI 10.1073/pnas.1417130112; Montero-Serra I, 2015, GLOBAL CHANGE BIOL, V21, P144, DOI 10.1111/gcb.12747; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mukherjee J, 2013, J EXP BIOL, V216, P4580, DOI 10.1242/jeb.094516; Munday Philip L, 2014, F1000Prime Rep, V6, P99, DOI 10.12703/P6-99; Munoz NJ, 2015, NAT CLIM CHANGE, V5, P163, DOI 10.1038/NCLIMATE2473; Narita D, 2012, CLIMATIC CHANGE, V113, P1049, DOI 10.1007/s10584-011-0383-3; Ondiviela B, 2014, COAST ENG, V87, P158, DOI 10.1016/j.coastaleng.2013.11.005; Ordonez A, 2014, BIOL BULL-US, V226, P255, DOI 10.1086/BBLv226n3p255; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Perry RI, 2010, CURR OPIN ENV SUST, V2, P356, DOI 10.1016/j.cosust.2010.10.004; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Podvin K., 2014, SAFE HAVENS PROTECTE, P94; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Poloczanska E, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P123; Poulton AJ, 2014, BIOGEOSCIENCES, V11, P3919, DOI 10.5194/bg-11-3919-2014; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Richier S, 2014, BIOGEOSCIENCES, V11, P4733, DOI 10.5194/bg-11-4733-2014; Riebesell U, 2013, BIOGEOSCIENCES, V10, P5619, DOI 10.5194/bg-10-5619-2013; Riebesell U, 2015, NAT CLIM CHANGE, V5, P12; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Robbins LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073796; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rodgers KB, 2015, BIOGEOSCIENCES, V12, P3301, DOI 10.5194/bg-12-3301-2015; Rosa R, 2014, J EXP BIOL, V217, P518, DOI 10.1242/jeb.096081; Roy T, 2011, J CLIMATE, V24, P2300, DOI 10.1175/2010JCLI3787.1; Ruckelshaus M, 2013, MAR POLICY, V40, P154, DOI 10.1016/j.marpol.2013.01.009; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; Schluter L, 2014, NAT CLIM CHANGE, V4, P1024, DOI 10.1038/NCLIMATE2379; Schweinsberg M, 2015, MOL ECOL, V24, P2673, DOI 10.1111/mec.13200; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; Silbiger NJ, 2014, MAR ECOL PROG SER, V515, P33, DOI 10.3354/meps10999; Silverman J, 2014, GEOCHIM COSMOCHIM AC, V144, P72, DOI 10.1016/j.gca.2014.09.011; Silverstein RN, 2015, GLOBAL CHANGE BIOL, V21, P236, DOI 10.1111/gcb.12706; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Spalding MD, 2014, OCEAN COAST MANAGE, V90, P50, DOI 10.1016/j.ocecoaman.2013.09.007; Steinacher M, 2013, NATURE, V499, P197, DOI 10.1038/nature12269; Stewart JS, 2014, GLOBAL CHANGE BIOL, V20, P1832, DOI 10.1111/gcb.12502; Storch D, 2014, GLOBAL CHANGE BIOL, V20, P3059, DOI 10.1111/gcb.12645; Strassmann KM, 2009, CLIM DYNAM, V33, P737, DOI 10.1007/s00382-008-0505-4; Strong AL, 2014, BIOSCIENCE, V64, P581, DOI 10.1093/biosci/biu072; Suckling CC, 2014, INVERTEBR REPROD DEV, V58, P161, DOI 10.1080/07924259.2013.875951; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Sunday JM, 2014, TRENDS ECOL EVOL, V29, P117, DOI 10.1016/j.tree.2013.11.001; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; UN, 1992, UNITED NATIONS FRAME; van Oppen MJH, 2015, P NATL ACAD SCI USA, V112, P2307, DOI 10.1073/pnas.1422301112; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Weatherdon L., 2015, THE OCEANS 2015 INIT; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wisz MS, 2015, NAT CLIM CHANGE, V5, P261, DOI [10.1038/nclimate2500, 10.1038/NCLIMATE2500]; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Yemane D, 2014, REV FISH BIOL FISHER, V24, P463, DOI 10.1007/s11160-014-9357-7; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143	157	801	823	69	896	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243							aac4722	10.1126/science.aac4722	http://dx.doi.org/10.1126/science.aac4722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138982	Green Submitted, Green Accepted			2022-12-28	WOS:000357280800052
J	Dietlein, F; Kalb, B; Jokic, M; Noll, EM; Strong, A; Tharun, L; Ozretic, L; Kunstlinger, H; Kambartel, K; Randerath, WJ; Jungst, C; Schmitt, A; Torgovnick, A; Richters, A; Rauh, D; Siedek, F; Persigehl, T; Mauch, C; Bartkova, J; Bradley, A; Sprick, MR; Trumpp, A; Rad, R; Saur, D; Bartek, J; Wolf, J; Buttner, R; Thomas, RK; Reinhardt, HC				Dietlein, Felix; Kalb, Bastian; Jokic, Mladen; Noll, Elisa M.; Strong, Alexander; Tharun, Lars; Ozretic, Luka; Kuenstlinger, Helen; Kambartel, Kato; Randerath, Winfried J.; Juengst, Christian; Schmitt, Anna; Torgovnick, Alessandro; Richters, Andre; Rauh, Daniel; Siedek, Florian; Persigehl, Thorsten; Mauch, Cornelia; Bartkova, Jirina; Bradley, Allan; Sprick, Martin R.; Trumpp, Andreas; Rad, Roland; Saur, Dieter; Bartek, Jiri; Wolf, Juergen; Buettner, Reinhard; Thomas, Roman K.; Reinhardt, H. Christian			A Synergistic Interaction between Chk1-and MK2 Inhibitors in KRAS-Mutant Cancer	CELL			English	Article							CELL-CYCLE; REVEALS; MODEL	KRAS is one of the most frequently mutated oncogenes in human cancer. Despite substantial efforts, no clinically applicable strategy has yet been developed to effectively treat KRAS-mutant tumors. Here, we perform a cell-line-based screen and identify strong synergistic interactions between cell-cycle checkpoint-abrogating Chk1- and MK2 inhibitors, specifically in KRAS- and BRAF-driven cells. Mechanistically, we show that KRAS-mutant cancer displays intrinsic genotoxic stress, leading to tonic Chk1- and MK2 activity. We demonstrate that simultaneous Chk1- and MK2 inhibition leads to mitotic catastrophe in KRAS-mutant cells. This actionable synergistic interaction is validated using xenograft models, as well as distinct Kras- or Braf-driven autochthonous murine cancer models. Lastly, we show that combined checkpoint inhibition induces apoptotic cell death in KRAS- or BRAF-mutant tumor cells directly isolated from patients. These results strongly recommend simultaneous Chk1- and MK2 inhibition as a therapeutic strategy for the treatment of KRAS- or BRAF-driven cancers.	[Dietlein, Felix; Kalb, Bastian; Jokic, Mladen; Schmitt, Anna; Torgovnick, Alessandro; Wolf, Juergen; Reinhardt, H. Christian] Univ Hosp Cologne, Dept Internal Med, D-50931 Cologne, Germany; [Dietlein, Felix; Kalb, Bastian; Jokic, Mladen; Juengst, Christian; Schmitt, Anna; Torgovnick, Alessandro; Reinhardt, H. Christian] Univ Cologne, CECAD, D-50931 Cologne, Germany; [Noll, Elisa M.; Trumpp, Andreas] Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Noll, Elisa M.; Sprick, Martin R.; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med, D-69120 Heidelberg, Germany; [Strong, Alexander; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Tharun, Lars; Ozretic, Luka; Kuenstlinger, Helen; Buettner, Reinhard; Thomas, Roman K.] Univ Hosp Cologne, Inst Pathol, D-50937 Cologne, Germany; [Kambartel, Kato; Randerath, Winfried J.; Wolf, Juergen; Buettner, Reinhard] Univ Hosp Cologne, Network Genom Med, D-50937 Cologne, Germany; [Kambartel, Kato] Krankenhaus Bethanien Moers, Lungenklin, D-47441 Moers, Germany; [Randerath, Winfried J.] Krankenhaus Bethanien Solingen, Klin Pneumol, D-42699 Solingen, Germany; [Richters, Andre; Rauh, Daniel] Tech Univ Dortmund, Dept Chem & Biol Chem, D-44227 Dortmund, Germany; [Siedek, Florian; Persigehl, Thorsten] Univ Hosp Cologne, Dept Radiol, D-50937 Cologne, Germany; [Mauch, Cornelia] Univ Hosp Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc Res Ctr, DK-2100 Copenhagen, Denmark; [Bartkova, Jirina; Bartek, Jiri] Palacky Univ, Inst Mol & Translat Med, Olomouc 77900, Czech Republic; [Bartkova, Jirina; Bartek, Jiri] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17177 Stockholm, Sweden; [Trumpp, Andreas] German Canc Consortium, D-69120 Heidelberg, Germany; [Rad, Roland; Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-81675 Munich, Germany; [Thomas, Roman K.] Univ Cologne, Fac Med, Dept Translat Gen, D-50931 Cologne, Germany	University of Cologne; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); Wellcome Trust Sanger Institute; University of Cologne; University of Cologne; Dortmund University of Technology; University of Cologne; University of Cologne; Danish Cancer Society; Palacky University Olomouc; Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; University of Cologne	Dietlein, F (corresponding author), Univ Hosp Cologne, Dept Internal Med, Weyertal 115B, D-50931 Cologne, Germany.	fdietlei@smail.uni-koeln.de; christian.reinhardt@uk-koeln.de	Saur, Dieter/O-8355-2015; Trumpp, Andreas/Z-2141-2019; Sprick, Martin R./I-7995-2019	Saur, Dieter/0000-0001-5874-0210; Trumpp, Andreas/0000-0002-6212-3466; Sprick, Martin R./0000-0001-9691-7574; Rauh, Daniel/0000-0002-1970-7642; Bradley, Allan/0000-0002-2349-8839; Jungst, Christian/0000-0002-6586-7129	Volkswagenstiftung (Lichtenberg Program); Deutsche Forschungsgemeinschaft [KFO-286, RE2246/2-1]; Helmholtz-Gemeinschaft (Preclinical Comprehensive Cancer Center); Boehringer Ingelheim Foundation; German Cancer Aid [DKH-111112]; Federal Ministry for Research and Education (BMBF) [01ZX1303A]; Else Kroner-Fresenius Stiftung [EKFS-2014-A06]; Dietmar Hopp Foundation; Danish Cancer Society; Lundbeck Foundation [R93-A8990]; Czech National Program of Sustainability [LO1304]; Danish National Research Foundation; Lundbeck Foundation [R93-2011-8990] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002290] Funding Source: researchfish	Volkswagenstiftung (Lichtenberg Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz-Gemeinschaft (Preclinical Comprehensive Cancer Center); Boehringer Ingelheim Foundation(Boehringer Ingelheim); German Cancer Aid(Deutsche Krebshilfe); Federal Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Else Kroner-Fresenius Stiftung; Dietmar Hopp Foundation; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Czech National Program of Sustainability; Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Volkswagenstiftung (Lichtenberg Program, H.C.R.), the Deutsche Forschungsgemeinschaft (KFO-286, RE2246/2-1, H.C.R.), the Helmholtz-Gemeinschaft (Preclinical Comprehensive Cancer Center, H.C.R., D.S., R.R., and M.R.S.), the Boehringer Ingelheim Foundation (Exploration Grants Program to H.C.R.), the German Cancer Aid (DKH-111112 to H.C.R.), the Federal Ministry for Research and Education (BMBF, 01ZX1303A, R.T., H.C.R.), the Else Kroner-Fresenius Stiftung (EKFS-2014-A06, H.C.R.), the Dietmar Hopp Foundation (to A.T.), the Danish Cancer Society (J. Bartek), the Lundbeck Foundation (R93-A8990, J. Bartek), the Czech National Program of Sustainability (LO1304, J. Bartek), and the Danish National Research Foundation (project CARD, J. Bartkova).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Dietlein F, 2014, CANCER DISCOV, V4, P592, DOI 10.1158/2159-8290.CD-13-0907; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105	15	87	91	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					146	159		10.1016/j.cell.2015.05.053	http://dx.doi.org/10.1016/j.cell.2015.05.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140595	Bronze			2022-12-28	WOS:000357542300016
J	Wang, L				Wang, Ling			The Emerging Postdoc Culture in China	CELL			English	Editorial Material								Recent years have witnessed tremendous growth in investment toward building a strong scientific research base in China. Though the postdoctoral system in China was started 30 years ago, efforts to foster research there in the past few years have spurred on a new crop of scientists to pursue postdoctoral work in China.											0	2	2	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					9	10		10.1016/j.cell.2015.06.031	http://dx.doi.org/10.1016/j.cell.2015.06.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26140585	Bronze			2022-12-28	WOS:000357542300001
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The ethics of behavioural incentives	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FINANCIAL INCENTIVES					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bassani DG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S30; Cahill K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub5; Leahey T, 2014, JMIR SERIOUS GAMES, V2, P12, DOI 10.2196/games.2987; National Institute for Health and Care Excellence, 2007, DRUG MIS PSYCH INT; Relton C, 2014, LANCET, V384, P5; Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804	7	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2015	350								h3469	10.1136/bmj.h3469	http://dx.doi.org/10.1136/bmj.h3469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TH	26124502	Bronze			2022-12-28	WOS:000357606700002
J	D'Silva, J				D'Silva, Jeetha			BMJ AWARDS SOUTH ASIA 2015 Help us find and honour the stars of South Asian healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INDIA					j.dsilva@gmail.com						[Anonymous], 2015, BMJ              JUN; D'Silva J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5454; Hurley R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5803; Hurley R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4540	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2015	350								h3426	10.1136/bmj.h3426	http://dx.doi.org/10.1136/bmj.h3426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7NR	26104282	Bronze			2022-12-28	WOS:000357159400009
J	Weingarten, M; Ge, S; Godt, JW; Bekins, BA; Rubinstein, JL				Weingarten, M.; Ge, S.; Godt, J. W.; Bekins, B. A.; Rubinstein, J. L.			High-rate injection is associated with the increase in US mid-continent seismicity	SCIENCE			English	Article							WASTE-WATER INJECTION; EARTHQUAKE SEQUENCE; DENVER EARTHQUAKES; FLUID INJECTION; COLORADO; OKLAHOMA; ARKANSAS; PARADOX; BASIN; TEXAS	An unprecedented increase in earthquakes in the U.S. mid-continent began in 2009. Many of these earthquakes have been documented as induced by wastewater injection. We examine the relationship between wastewater injection and U.S. mid-continent seismicity using a newly assembled injection well database for the central and eastern United States. We find that the entire increase in earthquake rate is associated with fluid injection wells. High-rate injection wells (>300,000 barrels per month) are much more likely to be associated with earthquakes than lower-rate wells. At the scale of our study, a well's cumulative injected volume, monthly wellhead pressure, depth, and proximity to crystalline basement do not strongly correlate with earthquake association. Managing injection rates may be a useful tool to minimize the likelihood of induced earthquakes.	[Weingarten, M.; Ge, S.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Godt, J. W.] US Geol Survey, Denver, CO 80225 USA; [Bekins, B. A.; Rubinstein, J. L.] US Geol Survey, Menlo Pk, CA 94025 USA	University of Colorado System; University of Colorado Boulder; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Weingarten, M (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	matthew.weingarten@colorado.edu		Rubinstein, Justin/0000-0003-1274-6785; Godt, Jonathan/0000-0002-8737-2493	John Wesley Powell Center for Analysis and Synthesis - U.S. Geological Survey [G13AC00023]	John Wesley Powell Center for Analysis and Synthesis - U.S. Geological Survey	This work was conducted as a part of the Understanding Fluid Injection Induced Seismicity Project supported by the John Wesley Powell Center for Analysis and Synthesis, funded by the U.S. Geological Survey (grant G13AC00023). We thank J. Hardebeck and W. Ellsworth for their thoughtful comments. This project was aided by injection data contributed by A. Holland (OK), C. Eisenger (CO), T. Kropatsch (WY), J. Amrheim (IN), T. Tomastik (OH), S. Platt (PA), I. Allred (UT), M. Berry (UT), A. Wickert (TX), and I. Van-Vloten (CEUS). This project used earthquake data from the ANSS Comprehensive Catalog. The well data used in this study are available as supplementary materials on Science Online.	Ake J, 2005, B SEISMOL SOC AM, V95, P664, DOI 10.1785/0120040072; [Anonymous], 1995, SEISMOL RES LETT, DOI DOI 10.1785/GSSRL.66.4.8; Block LV, 2014, SEISMOL RES LETT, V85, P609, DOI 10.1785/0220130188; Davis S. D., 1993, Seismological Research Letters, V64, P207; Efron B., 1994, INTRO BOOTSTRAP; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Evans D. M., 1966, MT GEOL, V3, P23; Frohlich C, 2015, SEISMOL RES LETT, V86, P492, DOI 10.1785/0220140180; Frohlich C, 2014, J GEOPHYS RES-SOL EA, V119, P581, DOI 10.1002/2013JB010755; Frohlich C, 2012, P NATL ACAD SCI USA, V109, P13934, DOI 10.1073/pnas.1207728109; Frohlich C, 2011, B SEISMOL SOC AM, V101, P327, DOI 10.1785/0120100131; HEALY JH, 1968, SCIENCE, V161, P1301, DOI 10.1126/science.161.3848.1301; HERRMANN RB, 1981, B SEISMOL SOC AM, V71, P731; Horton S, 2012, SEISMOL RES LETT, V83, P250, DOI 10.1785/gssrl.83.2.250; HSIEH PA, 1981, J GEOPHYS RES, V86, P903, DOI 10.1029/JB086iB02p00903; Keranen KM, 2014, SCIENCE, V345, P448, DOI 10.1126/science.1255802; Keranen KM, 2013, GEOLOGY, V41, P699, DOI 10.1130/G34045.1; Kim WY, 2013, J GEOPHYS RES-SOL EA, V118, P3506, DOI 10.1002/jgrb.50247; Llenos AL, 2013, B SEISMOL SOC AM, V103, P2850, DOI 10.1785/0120130017; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; MCGARR A, 1976, J GEOPHYS RES, V81, P1487, DOI 10.1029/JB081i008p01487; Mooney WD, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB000866; Murray K. E., 2014, SHALE SHAKER, V65, P98; National Research Council, 2013, IND SEISM POT EN TEC; NICHOLSON C, 1988, B SEISMOL SOC AM, V78, P188; Petersen M.D., 2008, 081128 US GEOL SURV; Petersen M. D, 2015, 20151070 US GEOL SUR; RALEIGH CB, 1976, SCIENCE, V191, P1230, DOI 10.1126/science.191.4233.1230; Rubinstein JL, 2014, B SEISMOL SOC AM, V104, P2162, DOI 10.1785/0120140009; Rutqvist J, 2015, MATH GEOSCI, V47, P3, DOI 10.1007/s11004-013-9493-y; US EPA Environmental Protection Agency, 2004, EPA PUBL, VEPA-452/R-04-011; Zhang YP, 2013, GROUND WATER, V51, P525, DOI 10.1111/gwat.12071	32	345	353	7	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1336	1340		10.1126/science.aab1345	http://dx.doi.org/10.1126/science.aab1345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089509				2022-12-28	WOS:000356449500044
J	Germain, RN				Germain, Ronald N.			Healing the NIH-Funded Biomedical Research Enterprise	CELL			English	Editorial Material								Many feel that the R01 grant system supporting biomedical research in the U.S. is broken, discouraging entry of young investigators into the system and inadequately supporting more established investigators. Here, I argue for a "person-not-project"-based scheme that would permit creative, unfettered research by new investigators, better tie ongoing research contributions to continued funding, and help match the number of investigators seeking support with available funds.	NIAID, Lab Syst Biol, NIH, Bethesda, MD 20817 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Lab Syst Biol, NIH, Bethesda, MD 20817 USA.	rgermain@niaid.nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alberts B, 2015, P NATL ACAD SCI USA, V112, P1912, DOI 10.1073/pnas.1500969112; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Casadevall A, 2012, INFECT IMMUN, V80, P891, DOI 10.1128/IAI.06183-11; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Fang F.C., 2014, TAKING POWERBALL APP; HHMI, 2015, INV PROGR; Kaiser J, 2014, SCIENCE, V345, P366, DOI 10.1126/science.345.6195.366; Lorsch JR, 2015, MOL BIOL CELL, V26, P1578, DOI 10.1091/mbc.E14-06-1163; National Institutes of Health, 2015, OUR REV PROC STEP BY; National Institutes of Health, 2015, CRIT TEN NIH; Natl. Inst. Health (NIH), 2014, NIH GEN DAT SHAR POL; Rockey S., 2012, WHAT DOES BIOMEDICAL; Wadman M., 2012, NIH DIRECTOR GRILLED; Wellcome Trust, 2015, INV AW	14	17	17	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1485	1491		10.1016/j.cell.2015.05.052	http://dx.doi.org/10.1016/j.cell.2015.05.052			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091028	Green Accepted, Bronze			2022-12-28	WOS:000356618200002
J	Marx, V				Marx, Vivien			TECHNOLOGY FEATURE ORGANS FROM THE LAB	NATURE			English	Editorial Material																		Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Hashmi B, 2014, ADV MATER, V26, P3253, DOI 10.1002/adma.201304995; Komae H, 2015, J TISSUE ENG REGEN M; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Mustard J, 2014, SOFT ROBOT, V1, P169, DOI 10.1089/soro.2014.0011; Vacanti C. A., 1991, MRS P, V252, P367; Wikswo JP, 2014, EXP BIOL MED, V239, P1061, DOI 10.1177/1535370214542068	8	70	74	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					373	376		10.1038/522373a	http://dx.doi.org/10.1038/522373a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085275				2022-12-28	WOS:000356425400060
J	Sharma, N; Gabel, HW; Greenberg, ME				Sharma, Nikhil; Gabel, Harrison W.; Greenberg, Michael E.			A Shortcut to Activity-Dependent Transcription	CELL			English	Editorial Material							DOUBLE-STRAND BREAKS; DNA	Neuronal activity results in the rapid induction of gene transcription through a series of defined molecular events. Madabhushi et al. describe an unexpected role for the cutting of promoter DNA by topoisomerase IIB to facilitate transcription of activity-induced genes.	[Sharma, Nikhil; Gabel, Harrison W.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	meg@hms.harvard.edu						Alvarez-Quilon A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4347; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Gomez-Herreros F, 2014, NAT GENET, V46, P516, DOI 10.1038/ng.2929; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744	9	6	6	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1496	1498		10.1016/j.cell.2015.06.009	http://dx.doi.org/10.1016/j.cell.2015.06.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091031	Bronze			2022-12-28	WOS:000356618200005
J	Klein, M				Klein, Marije			Excuse me, doctor: I can still hear you	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2015	350								h2647	10.1136/bmj.h2647	http://dx.doi.org/10.1136/bmj.h2647			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2OZ	26085079	Bronze			2022-12-28	WOS:000356785200001
J	Aman, J; van Koppenhagen, L; Snoek, AM; van der Hoeven, JG; van der Lely, AJ				Aman, Jurjan; van Koppenhagen, Laurien; Snoek, Alexander M.; van der Hoeven, Johannes G.; van der Lely, Ary-Jan			Cerebral fat embolism after bone fractures	LANCET			English	Editorial Material									[Aman, Jurjan; van Koppenhagen, Laurien; van der Lely, Ary-Jan] Sint Antonius Ziekenhuis, Dept Intens Care, Nieuwegein, Netherlands; [Aman, Jurjan] Sint Antonius Ziekenhuis, Dept Internal Med, Nieuwegein, Netherlands; [van Koppenhagen, Laurien; van der Lely, Ary-Jan] Sint Antonius Ziekenhuis, Dept Anaesthesiol, Nieuwegein, Netherlands; [Snoek, Alexander M.] Sint Antonius Ziekenhuis, Dept Radiol, Nieuwegein, Netherlands; [van der Hoeven, Johannes G.] Radboudumc, Dept Intens Care, Nijmegen, Netherlands	Radboud University Nijmegen	Aman, J (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	j.aman@vumc.nl							0	13	14	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					E16	E16		10.1016/S0140-6736(15)60064-2	http://dx.doi.org/10.1016/S0140-6736(15)60064-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	26119840	Bronze			2022-12-28	WOS:000362316200002
J	Le Page, E; Veillard, D; Laplaud, DA; Hamonic, S; Wardi, R; Lebrun, C; Zagnoli, F; Wiertlewski, S; Deburghgraeve, VR; Coustans, M; Edan, G				Le Page, Emmanuelle; Veillard, David; Laplaud, David A.; Hamonic, Stephanie; Wardi, Rasha; Lebrun, Christine; Zagnoli, Fabien; Wiertlewski, Sandrine; Deburghgraeve, V. Ronique; Coustans, Marc; Edan, Gilles		COPOUSEP Investigators West	Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial	LANCET			English	Article							OPTIC NEURITIS; BIOAVAILABILITY	Background High doses of intravenous methylprednisolone are recommended to treat relapses in patients with multiple sclerosis, but can be inconvenient and expensive. We aimed to assess whether oral administration of high-dose methylprednisolone was non-inferior to intravenous administration. Methods We did this multicentre, double-blind, randomised, controlled, non-inferiority trial at 13 centres for multiple sclerosis in France. We enrolled patients aged 18-55 years with relapsing-remitting multiple sclerosis who reported a relapse within the previous 15 days that caused an increase of at least one point in one or more scores on the Kurtzke Functional System Scale. With use of a computer-generated randomisation list and in blocks of four, we randomly assigned (1: 1) patients to either oral or intravenous methylprednisolone, 1000 mg, once a day for 3 days. Patients, treating physicians and nurses, and data and outcome assessors were all masked to treatment allocation, which was achieved with the use of saline solution and placebo capsules. The primary endpoint was the proportion of patients who had improved by day 28 (decrease of at least one point in most affected score on Kurtzke Functional System Scale), without need for retreatment with corticosteroids, in the per-protocol population. The trial was powered to assess non-inferiority of oral compared with intravenous methylprednisolone with a predetermined non-inferiority margin of 15%. This trial is registered with ClinicalTrials.gov, number NCT00984984. Findings Between Jan 29, 2008, and June 14, 2013, we screened 200 patients and enrolled 199. We randomly assigned 100 patients to oral methylprednisolone and 99 patients to intravenous methylprednisolone with a mean time from relapse onset to treatment of 7.0 days (SD 3.6) and 7.4 days (3.9), respectively. In the per-protocol population, 66 (81%) of 82 patients in the oral group and 72 (80%) of 90 patients in the intravenous group achieved the primary endpoint (absolute treatment difference 0.5%, 90% CI -9.5 to 10.4). Rates of adverse events were similar, but insomnia was more frequently reported in the oral group (77 [77%]) than in the intravenous group (63 [64%]). Interpretation Oral administration of high-dose methylprednisolone for 3 days was not inferior to intravenous administration for improvement of disability scores 1 month after treatment and had a similar safety profile. This finding could have implications for access to treatment, patient comfort, and cost, but indication should always be properly considered by clinicians.	[Le Page, Emmanuelle; Deburghgraeve, V. Ronique; Edan, Gilles] Rennes Univ Hosp, INSERM, Clin Neurosci Ctr, CIC P 1414, Rennes, France; [Veillard, David; Hamonic, Stephanie] Rennes Univ Hosp, Epidemiol & Publ Hlth Dept, Rennes, France; [Laplaud, David A.] INSERM, UMR1064, Nantes, France; [Laplaud, David A.] INSERM, CIC015, Nantes, France; [Wardi, Rasha] St Brieuc Hosp, Dept Neurol, St Brieuc, France; [Lebrun, Christine] Nice Univ Hosp, Dept Neurol, Nice, France; [Zagnoli, Fabien] Mil Hosp, Dept Neurol, Brest, France; [Wiertlewski, Sandrine] Nantes Univ Hosp, Dept Neurol, Nantes, France; [Coustans, Marc] Quimper Hosp, Dept Neurol, Quimper, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; Nantes Universite; CHU de Nantes	Edan, G (corresponding author), CHU Pontchaillou, Serv Neurol, F-35033 Rennes, France.	gilles.edan@chu-rennes.fr	LAPLAUD, David/AAG-4367-2020; lebrun-frenay, christine/AAP-9539-2021; Edan, Gilles/AAI-5944-2020	lebrun-frenay, christine/0000-0002-3713-2416; Wiertlewki, Sandrine/0000-0002-8678-3661; Laplaud, David/0000-0001-6113-6938; Cohen, Mikael/0000-0002-3985-1297	French Health Ministry; Ligue Francaise contre la SEP; Teva	French Health Ministry; Ligue Francaise contre la SEP; Teva(Teva Pharmaceutical Industries)	French Health Ministry, Ligue Francaise contre la SEP, Teva.	ALAM SM, 1993, J NEUROL NEUROSUR PS, V56, P1219, DOI 10.1136/jnnp.56.11.1219; Barnes D, 1997, LANCET, V349, P902, DOI 10.1016/S0140-6736(96)06453-7; BECK RW, 1994, OPHTHALMOLOGY, V101, P1771; Beck RW, 1997, LANCET, V349, P1696, DOI 10.1016/S0140-6736(05)62663-3; BECK RW, 1995, OPHTHALMOLOGY, V102, P1504; Brochet B, 2001, REV NEUROL-FRANCE, V157, P988; Burton JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006921.pub3; Citterio A, 2000, COCHRANE DB SYST REV, V4; DUNNETT CW, 1977, BIOMETRICS, V33, P593, DOI 10.2307/2529457; Dunnett CW, 1996, STAT MED, V15, P1729; DURELLI L, 1986, NEUROLOGY, V36, P238, DOI 10.1212/WNL.36.2.238; GROENEWOUD G, 1994, INT J CLIN PHARM TH, V32, P652; *INT C HARM, ICH HARM TRIP GUID G; Kapoor N, 1992, Prog Clin Biol Res, V377, P49; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Lublin FD, 2003, NEUROLOGY, V61, P1528, DOI 10.1212/01.WNL.0000096175.39831.21; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Martinelli V, 2009, NEUROLOGY, V73, P1842, DOI 10.1212/WNL.0b013e3181c3fd5b; MILLER H, 1961, LANCET, V2, P1120; MILLIGAN NM, 1987, J NEUROL NEUROSUR PS, V50, P511, DOI 10.1136/jnnp.50.5.511; Morrow SA, 2004, NEUROLOGY, V63, P1079, DOI 10.1212/01.WNL.0000138572.82125.F5; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramo-Tello C, 2014, MULT SCLER J, V20, P717, DOI 10.1177/1352458513508835; Sellebjerg F, 1999, NEUROLOGY, V52, P1479, DOI 10.1212/WNL.52.7.1479; Sellebjerg F, 1998, NEUROLOGY, V51, P529, DOI 10.1212/WNL.51.2.529; World Medical Association, DECL HELS ETH PRINC	27	87	87	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					974	981		10.1016/S0140-6736(15)61137-0	http://dx.doi.org/10.1016/S0140-6736(15)61137-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26135706	Green Submitted			2022-12-28	WOS:000361182700029
J	Buenostro, JD; Wu, BJ; Litzenburger, UM; Ruff, D; Gonzales, ML; Snyder, MP; Chang, HY; Greenleaf, WJ				Buenostro, Jason D.; Wu, Beijing; Litzenburger, Ulrike M.; Ruff, Dave; Gonzales, Michael L.; Snyder, Michael P.; Chang, Howard Y.; Greenleaf, William J.			Single-cell chromatin accessibility reveals principles of regulatory variation	NATURE			English	Article							RNA-SEQ; DYNAMICS; HETEROGENEITY	Cell-to-cell variation is a universal feature of life that affects a wide range of biological phenomena, from developmental plasticity(1,2) to tumour heterogeneity(3). Although recent advances have improved our ability to document cellular phenotypic variation(4-8), the fundamental mechanisms that generate variability from identical DNA sequences remain elusive. Here we reveal the landscape and principles of mammalian DNA regulatory variation by developing a robust method for mapping the accessible genome of individual cells by assay for transposase-accessible chromatin using sequencing (ATAC-seq)(9) integrated into a programmable microfluidics platform. Single-cell ATAC-seq (scATAC-seq) maps from hundreds of single cells in aggregate closely resemble accessibility profiles from tens of millions of cells and provide insights into cell-to-cell variation. Accessibility variance is systematically associated with specific trans-factors and cis-elements, and we discover combinations of trans-factors associated with either induction or suppression of cell-to-cell variability. We further identify sets of trans-factors associated with cell-type-specific accessibility variance across eight cell types. Targeted perturbations of cell cycle or transcription factor signalling evoke stimulus-specific changes in this observed variability. The pattern of accessibility variation in cis across the genome recapitulates chromosome compartments(10) de novo, linking single-cell accessibility variation to three-dimensional genome organization. Single-cell analysis of DNA accessibility provides new insight into cellular variation of the 'regulome'.	[Buenostro, Jason D.; Wu, Beijing; Snyder, Michael P.; Greenleaf, William J.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Buenostro, Jason D.; Litzenburger, Ulrike M.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Buenostro, Jason D.; Litzenburger, Ulrike M.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ruff, Dave; Gonzales, Michael L.] Fluidigm Corp, San Francisco, CA 94080 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94025 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Greenleaf, WJ (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	howchang@stanford.edu; wjg@stanford.edu	wang, edwin/G-5372-2010; McErlean, Peter/O-5187-2016	Snyder, Michael/0000-0003-0784-7987	National Institutes of Health (NIH) [P50HG007735]; Lifespan Extension Foundation; Rita Allen Foundation; Baxter Foundation Faculty Scholar Grant; National Science Foundation; NIH [T32HG000044]; National Human Genome Research Institute (NHGRI) [5U54HG00455805];  [UH2 AR067676];  [U19AI057266]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558, P50HG007735, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lifespan Extension Foundation; Rita Allen Foundation; Baxter Foundation Faculty Scholar Grant; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) P50HG007735 (to H.Y.C. and W.J.G.), UH2 AR067676 and Lifespan Extension Foundation (H.Y.C.), U19AI057266 (to W.J.G.) and the Rita Allen Foundation (to W.J.G.) and the Baxter Foundation Faculty Scholar Grant (to W.J.G); H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. J.D.B. acknowledges support from the National Science Foundation Graduate Research Fellowships and NIH training grant T32HG000044 for support. M.P.S. acknowledges the NIH and the National Human Genome Research Institute (NHGRI) for funding through 5U54HG00455805. We thank members of Greenleaf and Chang laboratories, as well as the Fluidigm team, including L. Xi for discussions. We acknowledge the S. Kim laboratory for assistance with FACS sorting and the C. Bustamante laboratory for help with sequencing. We also thank R. Nichols, C. Mazumdar, V. Sebastiano and V. Risca for cells.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	28	992	1058	24	360	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					486	U264		10.1038/nature14590	http://dx.doi.org/10.1038/nature14590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26083756	Green Accepted			2022-12-28	WOS:000358378900042
J	Chen, J; Kovacs, JM; Peng, HQ; Rits-Volloch, S; Lu, JM; Park, D; Zablowsky, E; Seaman, MS; Chen, B				Chen, Jia; Kovacs, James M.; Peng, Hanqin; Rits-Volloch, Sophia; Lu, Jianming; Park, Donghyun; Zablowsky, Elise; Seaman, Michael S.; Chen, Bing			Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; TRIMER; GP41; ENV; MEMBRANE; SURFACE; FUSION; ECTODOMAIN; ELICITS	Amajor goal for HIV-1 vaccine development is the production of an immunogen tomimic native, functional HIV-1 envelope trimeric spikes (Env) on the virion surface. We lack a reliable description of a native, functional trimer, however, because of inherent instability and heterogeneity in most preparations. We describe here two conformationally homogeneous Envs derived fromdifficult-to-neutralize primary isolates. All their non-neutralizing epitopes are fully concealed and independent of their proteolytic processing. Most broadly neutralizing antibodies (bnAbs) recognize these native trimers. Truncation of their cytoplasmic tail has little effect on membrane fusion, but it diminishes binding to trimer-specific bnAbs while exposing non-neutralizing epitopes. These results yield a more accurate antigenic picture than hitherto possible of a genuinely untriggered and functional HIV-1 Env; they can guide effective vaccine development.	[Chen, Jia; Kovacs, James M.; Peng, Hanqin; Rits-Volloch, Sophia; Park, Donghyun; Chen, Bing] Boston Childrens Hosp, Div Mol Med, Boston, MA 02115 USA; [Chen, Jia; Kovacs, James M.; Chen, Bing] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Lu, Jianming] Codex BioSolut Inc, Gaithersburg, MD 20879 USA; [Zablowsky, Elise; Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Chen, B (corresponding author), Boston Childrens Hosp, Div Mol Med, Boston, MA 02115 USA.	bchen@crystal.harvard.edu	Park, Donghyun/AAA-5338-2022	Park, Donghyun/0000-0003-2048-6004	NIH [AI084794, GM083680, AI106488]; Collaboration for AIDS Vaccine Discovery (CAVD) [OPP1040741]; Center for HIV/AIDS Vaccine Immunology-Immunogen Design [AI-100645]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, R01AI106488, R01AI084794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083680] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaboration for AIDS Vaccine Discovery (CAVD); Center for HIV/AIDS Vaccine Immunology-Immunogen Design; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Harrison, H. Ha, and G. Frey for generous advice and assistance; D. Barouch, B. Haynes, and A. Carfi for critical reading of the manuscript; and the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH for reagents. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by NIH grants AI084794 (to B.C. and Dan H. Barouch), GM083680 (to B.C.), AI106488 (to B.C.), Collaboration for AIDS Vaccine Discovery (CAVD) grant OPP1040741 (to Dan H. Barouch from the Bill and Melinda Gates Foundation), and the Center for HIV/AIDS Vaccine Immunology-Immunogen Design AI-100645 (to Barton F. Haynes).	Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Beaumont T, 2001, J VIROL, V75, P2246, DOI 10.1128/JVI.75.5.2246-2252.2001; Bricault CA, 2015, J VIROL, V89, P2507, DOI 10.1128/JVI.03331-14; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Guenaga J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004570; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Kovacs JM, 2014, P NATL ACAD SCI USA, V111, P18542, DOI 10.1073/pnas.1422269112; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Liu PH, 2014, J VIROL, V88, P5165, DOI 10.1128/JVI.03765-13; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Schiffner T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-72; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Ye YJ, 2000, J VIROL, V74, P11955, DOI 10.1128/JVI.74.24.11955-11962.2000; York J, 2001, J VIROL, V75, P2741, DOI 10.1128/JVI.75.6.2741-2752.2001	29	84	87	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					191	195		10.1126/science.aaa9804	http://dx.doi.org/10.1126/science.aaa9804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26113642	Green Accepted			2022-12-28	WOS:000357664300045
J	Geller, BJ; Stone, RM; Merola, JF; Levy, BD; Loscalzo, J				Geller, Bram J.; Stone, Richard M.; Merola, Joseph F.; Levy, Bruce D.; Loscalzo, Joseph			A Man with Fever, Cough, and Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HAIRY-CELL LEUKEMIA; FEBRILE NEUTROPHILIC DERMATOSIS; SWEETS-SYNDROME; PRESENTING SYMPTOM; INFECTION	A 67-year-old man with hairy-cell leukemia presented to the clinic with a 3-day history of fevers (with temperatures as high as 38.7 degrees C), night sweats, arthralgias, and an erythematous, vesicular-appearing rash on his back. He had had no sick contacts, had not traveled outside the United States for more than 20 years, and had no pets at home. He reported no headaches, shortness of breath, cough, rhinorrhea, bleeding episodes, nausea, vomiting, or diarrhea.	[Geller, Bram J.; Stone, Richard M.; Merola, Joseph F.; Levy, Bruce D.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Merola, Joseph F.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Merola, Joseph F.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	blevy@partners.org	Geller, Bram/GOG-8532-2022; Loscalzo, Joseph/ABD-8980-2021					BENNETT C, 1986, AM J MED, V80, P891, DOI 10.1016/0002-9343(86)90634-0; Cheng VCC, 2002, EUR J CLIN MICROBIOL, V21, P803, DOI 10.1007/s10096-002-0821-2; Cohen PR, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-34; Hawkey CR, 2005, CLIN INFECT DIS, V40, P1368, DOI 10.1086/429317; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; KRAMERS C, 1992, ANN HEMATOL, V65, P55, DOI 10.1007/BF01715129; Levy RM, 2002, ARCH DERMATOL, V138, P1551, DOI 10.1001/archderm.138.12.1551; Netea MG, 2008, NETH J MED, V66, P340; SU WPD, 1986, CUTIS, V37, P167; Thaker H, 2001, J INFECTION, V42, P213, DOI 10.1053/jinf.2001.0816; Ventura Filipa, 2009, Dermatol Online J, V15, P12; VONDENDRIESCH P, 1994, J AM ACAD DERMATOL, V31, P535, DOI 10.1016/S0190-9622(94)70215-2	12	4	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					74	80		10.1056/NEJMcps1404270	http://dx.doi.org/10.1056/NEJMcps1404270			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL8IS	26132944				2022-12-28	WOS:000357218700011
J	Gardham, D				Gardham, Duncan			DOCTORS AND ISLAMIC STATE Time for tighter checks on medical schools?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												duncan.gardham@gmail.com						[Anonymous], 2015, AFRICA CONFIDEN 0403	1	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2015	350								h3511	10.1136/bmj.h3511	http://dx.doi.org/10.1136/bmj.h3511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TN	26130228				2022-12-28	WOS:000357607400016
J	Harshaw, C				Harshaw, Christopher			Comment on "Number-space mapping in the newborn chick resembles humans' mental number line"	SCIENCE			English	Editorial Material							ASYMMETRICAL HATCHING BEHAVIORS; PRENATAL VISUAL EXPERIENCE; GALLUS-GALLUS; TURNING BIAS; LATERALIZATION; CHOICE	Rugani et al. (Reports, 30 January 2015, p. 534) presented evidence that domestic chicks employ a "mental number line." I argue that the hypothesis testing used to support this claim unjustifiably assumes that domestic chicks are unbiased when choosing between identical stimuli presented to their left and right.	Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Harshaw, C (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	charshaw@indiana.edu	Harshaw, Christopher/O-2586-2013	Harshaw, Christopher/0000-0002-1400-7356				Andrew RJ, 2004, BEHAV BRAIN RES, V155, P67, DOI 10.1016/j.bbr.2004.04.016; Casey MB, 2005, DEV PSYCHOBIOL, V47, P123, DOI 10.1002/dev.20078; Casey MB, 1998, DEV PSYCHOBIOL, V32, P327, DOI 10.1002/(SICI)1098-2302(199805)32:4<327::AID-DEV7>3.3.CO;2-8; Casey MB, 1999, PSYCHOL REC, V49, P67, DOI 10.1007/BF03395307; Casey MB, 2000, DEV PSYCHOBIOL, V37, P13, DOI 10.1002/1098-2302(200007)37:1<13::AID-DEV3>3.0.CO;2-M; Deng C, 2002, BEHAV BRAIN RES, V134, P375, DOI 10.1016/S0166-4328(02)00050-5; Koshiba M, 2003, NEUROSCI LETT, V336, P81, DOI 10.1016/S0304-3940(02)01162-X; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; Rogers LJ, 2008, BRAIN RES BULL, V76, P235, DOI 10.1016/j.brainresbull.2008.02.001; ROGERS LJ, 1993, ANIM BEHAV, V45, P409, DOI 10.1006/anbe.1993.1049; Rugani R, 2015, SCIENCE, V347, P534, DOI 10.1126/science.aaa1379; Tommasi L, 1999, Laterality, V4, P89, DOI 10.1080/713754325; Vallortigara G, 1996, BEHAV BRAIN RES, V74, P135, DOI 10.1016/0166-4328(95)00037-2	13	4	4	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242								10.1126/science.aaa9565	http://dx.doi.org/10.1126/science.aaa9565			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113714				2022-12-28	WOS:000356869100031
J	Smith, JE; Rockett, M; Creanor, SS; Squire, R; Hayward, C; Ewings, P; Barton, A; Pritchard, C; Eyre, V; Cocking, L; Benger, J				Smith, Jason E.; Rockett, Mark; Creanor, Siobhan S.; Squire, Rosalyn; Hayward, Chris; Ewings, Paul; Barton, Andy; Pritchard, Colin; Eyre, Victoria; Cocking, Laura; Benger, Jonathan		PASTIES Res Team	PAin SoluTions In the Emergency Setting (PASTIES)-patient controlled analgesia versus routine care in emergency department patients with pain from traumatic injuries: randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE POSTOPERATIVE PAIN; MANAGEMENT; GUIDELINES; VARIABLES; EFFICACY; SAFETY	OBJECTIVE To determine whether patient controlled analgesia (PCA) is better than routine care in patients presenting to emergency departments with moderate to severe pain from traumatic injuries. DESIGN Pragmatic, multicentre, parallel group, randomised controlled trial. SETTING Five English hospitals. PARTICIPANTS 200 adults (71% (n=142) male), aged 18 to 75 years, who presented to the emergency department requiring intravenous opioid analgesia for the treatment of moderate to severe pain from traumatic injuries and were expected to be admitted to hospital for at least 12 hours. INTERVENTIONS PCA (n=99) or nurse titrated analgesia (treatment as usual; n=101). MAIN OUTCOME MEASURES The primary outcome was total pain experienced over the 12 hour study period, derived by standardised area under the curve (scaled from 0 to 100) of each participant's hourly pain scores, captured using a visual analogue scale. Pre-specified secondary outcomes included total morphine use, percentage of study period in moderate/severe pain, percentage of study period asleep, length of hospital stay, and satisfaction with pain management. RESULTS 200 participants were included in the primary analyses. Mean total pain experienced was 47.2 (SD 21.9) for the treatment as usual group and 44.0 (24.0) for the PCA group. Adjusted analyses indicated slightly (but not statistically significantly) lower total pain experienced in the PCA group than in the routine care group (mean difference 2.7, 95% confidence interval-2.4 to 7.8). Participants allocated to PCA used more morphine in total than did participants in the treatment as usual group (mean 44.3 (23.2) v 27.2 (18.2) mg; mean difference 17.0, 11.3 to 22.7). PCA participants spent, on average, less time in moderate/severe pain (36.2% (31.0) v 44.1% (31.6)), but the difference was not statistically significant. A higher proportion of PCA participants reported being perfectly or very satisfied compared with the treatment as usual group (86% (78/91) v 76% (74/98)), but this was also not statistically significant. CONCLUSIONS PCA provided no statistically significant reduction in pain compared with routine care for emergency department patients with traumatic injuries.	[Smith, Jason E.; Rockett, Mark; Squire, Rosalyn] Derriford Hosp, Plymouth PL6 8DH, Devon, England; [Smith, Jason E.] Med Directorate, Acad Dept Mil Emergency Med, Royal Ctr Def Med Res & Academia, Birmingham, W Midlands, England; [Smith, Jason E.; Rockett, Mark] Plymouth Univ Peninsula, Ctr Clin Trials & Populat Studies, Sch Med, Plymouth, Devon, England; [Smith, Jason E.; Rockett, Mark] Plymouth Univ Peninsula, Ctr Clin Trials & Populat Studies, Sch Dent, Plymouth, Devon, England; [Creanor, Siobhan S.] Plymouth Univ Peninsula, Ctr Biostat Bioinformat & Biomarkers, Sch Med, Plymouth, Devon, England; [Creanor, Siobhan S.] Plymouth Univ Peninsula, Ctr Biostat Bioinformat & Biomarkers, Sch Dent, Plymouth, Devon, England; [Hayward, Chris; Eyre, Victoria; Cocking, Laura] Plymouth Univ Peninsula, Peninsula Clin Trials Unit, Sch Med, Plymouth, Devon, England; [Hayward, Chris; Eyre, Victoria; Cocking, Laura] Plymouth Univ Peninsula, Peninsula Clin Trials Unit, Sch Dent, Plymouth, Devon, England; [Ewings, Paul; Barton, Andy; Pritchard, Colin] NIHR Res Design Serv South West, Bristol, Avon, England; [Benger, Jonathan] Univ W England, Fac Hlth & Appl Sci, Bristol BS16 1QY, Avon, England	Derriford Hospital; Royal Centre for Defence Medicine; University of West England	Smith, JE (corresponding author), Derriford Hosp, Plymouth PL6 8DH, Devon, England.	jasonesmith@nhs.net	Skene, Imogen/D-6153-2018; Coats, Timothy/AAW-1254-2021; Rockett, Mark/A-9465-2012; Creanor, Siobhan/A-9985-2018; Smith, Jason Edward/H-9380-2013	Skene, Imogen/0000-0001-5215-2899; Coats, Timothy/0000-0003-2736-2784; Rockett, Mark/0000-0001-8907-4396; Creanor, Siobhan/0000-0002-7373-8263; Smith, Jason Edward/0000-0002-6143-0421; barton, andy/0000-0003-2245-1446; Hayward, Christopher/0000-0002-2666-5073; Cocking, Laura/0000-0002-1371-6978	National Institute for Health Research (NIHR) [PB-PG-0909-20048]; National Institute for Health Research [PB-PG-0909-20048] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by the National Institute for Health Research (NIHR)'s research for patient benefit programme, grant reference number PB-PG-0909-20048. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Ab Rahman NHN, 2012, EUR J EMERG MED, V19, P241, DOI 10.1097/MEJ.0b013e32834bfc17; [Anonymous], 1979, Pain, V6, P249; Arendts G, 2006, J PAIN, V7, P682, DOI 10.1016/j.jpain.2006.03.003; Birnbaum A, 2012, ACAD EMERG MED, V19, DOI 10.1111/j.1553-2712.2012.01322.x; Camu F, 1998, ANESTH ANALG, V87, P890, DOI 10.1097/00000539-199810000-00027; Care Quality Commission, 2012, ACC EM 2012; CHOINIERE M, 1992, ANAESTHESIA, V47, P467, DOI 10.1111/j.1365-2044.1992.tb02266.x; College of Emergency Medicine, 2014, CLIN STAND EM DEP; Dolin SJ, 2002, BRIT J ANAESTH, V89, P409, DOI 10.1093/bja/aef207; Evans E, 2005, EMERG MED J, V22, P25, DOI 10.1136/emj.2002.004614; Hudcova J, 2006, COCHRANE DB SYST REV, DOI 10.1002/146518583.CD003348.pub2; Lvovschi V, 2008, AM J EMERG MED, V26, P676, DOI 10.1016/j.ajem.2007.10.025; Macintyre PE, 2001, BRIT J ANAESTH, V87, P36, DOI 10.1093/bja/87.1.36; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; OWEN H, 1989, ANAESTHESIA, V44, P11, DOI 10.1111/j.1365-2044.1989.tb11088.x; OWEN H, 1989, ANAESTHESIA, V44, P7, DOI 10.1111/j.1365-2044.1989.tb11087.x; Plummer JL, 1997, ANESTH ANALG, V84, P794, DOI 10.1097/00000539-199704000-00018; Rahman NHNA, 2012, J EMERG MED, V43, P951, DOI 10.1016/j.jemermed.2012.02.069; Rees DC, 2003, BRIT J HAEMATOL, V120, P744, DOI 10.1046/j.1365-2141.2003.04193.x; Smith JE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002577; Todd KH, 2007, J PAIN, V8, P460, DOI 10.1016/j.jpain.2006.12.005; Walder B, 2001, ACTA ANAESTH SCAND, V45, P795, DOI 10.1034/j.1399-6576.2001.045007795.x; WHITE PF, 1988, JAMA-J AM MED ASSOC, V259, P243, DOI 10.1001/jama.259.2.243	24	20	20	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2015	350								h2988	10.1136/bmj.h2988	http://dx.doi.org/10.1136/bmj.h2988			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3WK	26094763	Green Published, hybrid			2022-12-28	WOS:000377712900001
J	Hsu, HT; Chen, HM; Yang, Z; Wang, J; Lee, NK; Burger, A; Zaret, K; Liu, T; Levine, E; Mango, SE				Hsu, H. -T.; Chen, H. -M.; Yang, Z.; Wang, J.; Lee, N. K.; Burger, A.; Zaret, K.; Liu, T.; Levine, E.; Mango, S. E.			Recruitment of RNA polymerase II by the pioneer transcription factor PHA-4	SCIENCE			English	Article							ELEGANS FOREGUT; C-ELEGANS; GENES; ORGANIZATION; EXPRESSION; CHROMATIN; HOMOLOG; GROWTH; EMBRYO	Pioneer transcription factors initiate cell-fate changes by binding to silent target genes. They are among the first factors to bind key regulatory sites and facilitate chromatin opening. Here, we identify an additional role for pioneer factors. In early Caenorhabditis elegans foregut development, the pioneer factor PHA-4/FoxA binds promoters and recruits RNA polymerase II (Pol II), often in a poised configuration in which Pol II accumulates near transcription start sites. At a later developmental stage, PHA-4 promotes chromatin opening. We found many more genes with poised RNA polymerase than had been observed previously in unstaged embryos, revealing that early embryos accumulate poised Pol II and that poising is dynamic. Our results suggest that Pol II recruitment, in addition to chromatin opening, is an important feature of PHA-4 pioneer factor activity.	[Hsu, H. -T.; Chen, H. -M.; Lee, N. K.; Mango, S. E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Yang, Z.; Zaret, K.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Wang, J.; Liu, T.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Burger, A.; Levine, E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Burger, A.; Levine, E.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA; [Liu, T.] SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA	Harvard University; University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Mango, SE (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	smango@mcb.harvard.edu	Liu, Tao/G-3585-2010; Liu, Tao/AAO-6310-2021	Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0002-8818-8313; Mango, Susan/0000-0002-2146-3237; Lee, Nicholas/0000-0002-2756-1102; Liu, Tao/0000-0003-0446-9001	MacArthur Foundation;  [NIHP40OD010440];  [NIHR37GM056264];  [NSFMCB-1413134];  [NIHR37GM36477]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036477, R01GM036477, R01GM056264, R37GM056264] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	MacArthur Foundation; ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Whetstine for ChIP advice, A. Schier and S. von Stetina for comments, and G. Marnellos and M. Clamp for informatics. Some strains were obtained from the Caenorhabditis Genetics Center (CGC), funded by NIHP40OD010440. S.E.M. received support from the MacArthur Foundation and grant NIHR37GM056264, E.L. received support from grant NSFMCB-1413134, and K.S.Z. received support from grant NIHR37GM36477. Sequencing data are accessible from the National Center for Biotechnology Information Gene Expression Omnibus: GSM1666978 R1.CE.8E.ChIP GSM1666979, R1.CE.8E.Input GSM1666980, R2.CE.8E.ChIP GSM1666981, R2.CE.8E.Input GSM1666982, R1.CE.BE.ChIP GSM1666983, and R1.CE.BE.Input.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; Fakhouri THI, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001060; Gaertner B, 2012, CELL REP, V2, P1670, DOI 10.1016/j.celrep.2012.11.024; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Kalb JM, 1998, DEVELOPMENT, V125, P2171; Kiefer JC, 2007, DEV BIOL, V303, P611, DOI 10.1016/j.ydbio.2006.11.042; Kuchenthal Craig A., 2001, Genesis The Journal of Genetics and Development, V31, P156, DOI 10.1002/gene.10018; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; Mango SE, 2009, ANNU REV CELL DEV BI, V25, P597, DOI 10.1146/annurev.cellbio.24.110707.175411; Maxwell CS, 2014, CELL REP, V6, P455, DOI 10.1016/j.celrep.2014.01.008; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	19	47	48	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1372	1376		10.1126/science.aab1223	http://dx.doi.org/10.1126/science.aab1223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089518	Green Accepted			2022-12-28	WOS:000356449500054
J	Cutter, SL; Ismail-Zadeh, A; Alcantara-Ayala, I; Altan, O; Baker, DN; Briceno, S; Gupta, H; Holloway, A; Johnston, D; McBean, GA; Ogawa, Y; Paton, D; Porio, E; Silbereisen, RK; Takeuchi, K; Valsecchi, GB; Vogel, C; Wu, GX				Cutter, Susan L.; Ismail-Zadeh, Alik; Alcantara-Ayala, Irasema; Altan, Orhan; Baker, Daniel N.; Briceno, Salvano; Gupta, Harsh; Holloway, Ailsa; Johnston, David; McBean, Gordon A.; Ogawa, Yujiro; Paton, Douglas; Porio, Emma; Silbereisen, Rainer K.; Takeuchi, Kuniyoshi; Valsecchi, Giovanni B.; Vogel, Coleen; Wu, Guoxiong			Pool knowledge to stem losses from disasters	NATURE			English	Editorial Material							MANAGEMENT		[Cutter, Susan L.] Univ S Carolina, Geog, Columbia, SC 29208 USA; [Cutter, Susan L.] Univ S Carolina, Hazards & Vulnerabil Res Inst, Columbia, SC 29208 USA; [Ismail-Zadeh, Alik] Karlsruhe Inst Technol, Appl Geosci, D-76021 Karlsruhe, Germany; [Ismail-Zadeh, Alik] Russian Acad Sci, Inst Earthquake Predict Theory & Math Geophys, Moscow 117997, Russia; [Alcantara-Ayala, Irasema] Univ Nacl Autonoma Mexico, Inst Geog, Mexico City, DF, Mexico; [Altan, Orhan] Istanbul Tech Univ, Istanbul, Turkey; [Baker, Daniel N.] Univ Colorado, Lab Atmospher Space Phys, Boulder, CO 80309 USA; [Briceno, Salvano] UN Off Disaster Risk Reduct, Divonne Les Bains, France; [Gupta, Harsh] Natl Geophys Res Inst, Hyderabad 500007, Andhra Pradesh, India; [Holloway, Ailsa] Univ Stellenbosch, Res Alliance Disaster & Risk Reduct, ZA-7600 Stellenbosch, South Africa; [Johnston, David] Massey Univ, Joint Ctr Disaster Res, Wellington, New Zealand; [Johnston, David] GNS Sci, Wellington, New Zealand; [McBean, Gordon A.] Univ Western Ontario, Ctr Environm & Sustainabil, Res & External Relat, London, ON N6A 3K7, Canada; [McBean, Gordon A.] Univ Western Ontario, Inst Catastroph Loss Reduct, Policy Studies, London, ON N6A 3K7, Canada; [Ogawa, Yujiro] Univ Tsukuba, Inst Geosci, Tsukuba, Ibaraki 305, Japan; [Paton, Douglas] Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT, Australia; [Porio, Emma] Ateneo Manila Univ, Dept Sociol & Anthropol, Quezon City, Philippines; [Silbereisen, Rainer K.] Univ Jena, Ctr Appl Dev Sci, D-6900 Jena, Germany; [Takeuchi, Kuniyoshi] Univ Yamanashi, Dept Civil & Environm Engn, Kofu, Yamanashi, Japan; [Takeuchi, Kuniyoshi] Int Ctr Water Hazard Risk Management, Tsukuba, Ibaraki, Japan; [Valsecchi, Giovanni B.] Natl Inst Astrophys, Rome, Italy; [Valsecchi, Giovanni B.] CNR, Sesto Fiorentino, Italy; [Vogel, Coleen] Univ Witwatersrand, Johannesburg, South Africa; [Wu, Guoxiong] Chinese Acad Sci, Inst Atmospher Phys, Beijing 100864, Peoples R China	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Helmholtz Association; Karlsruhe Institute of Technology; Russian Academy of Sciences; Institute of Earthquake Prediction Theory & Mathematical Geophysics; Universidad Nacional Autonoma de Mexico; Istanbul Technical University; University of Colorado System; University of Colorado Boulder; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Geophysical Research Institute (NGRI); Stellenbosch University; Massey University; GNS Science - New Zealand; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Tsukuba; Charles Darwin University; Ateneo de Manila University; Friedrich Schiller University of Jena; University of Yamanashi; Istituto Nazionale Astrofisica (INAF); Consiglio Nazionale delle Ricerche (CNR); University of Witwatersrand; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Cutter, SL (corresponding author), Univ S Carolina, Geog, Columbia, SC 29208 USA.	scutter@sc.edu	Altan, Orhan/AAD-4550-2022; Cutter, Susan/R-8849-2019; Alcántara-Ayala, Irasema/G-8639-2017; Alcantara, Irasema/GPW-8040-2022; Ismail-Zadeh, Alik/ABF-2022-2021	Cutter, Susan/0000-0002-7005-8596; Alcántara-Ayala, Irasema/0000-0003-0794-1201; Valsecchi, Giovanni/0000-0002-2915-1465; Johnston, David/0000-0001-5114-5355; Paton, Douglas/0000-0002-8673-2178; Ismail-Zadeh, Alik/0000-0002-5607-4530	Russian Science Foundation [14-17-00520] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF))		Boaz A., 2002, EVALUATION-US, V8, P440, DOI [10.1177/13563890260620630, DOI 10.1177/13563890260620630]; Burton I., 2001, ENV HAZARD, V3, P139; Cutter S. L. J., 2014, EXTREM EVENTS, V1, P1; Cutter SL, 2013, CHALL SUSTAIN, V1, P72, DOI 10.12924/cis2013.01020072; Erisman JW, 2015, NATURE, V519, P151, DOI 10.1038/519151a; Gall M, 2015, INT J DISAST RISK RE, V12, P255, DOI 10.1016/j.ijdrr.2015.01.010; Ismail-Zadeh A., 2014, EXTREME NATURAL EVEN, P47, DOI DOI 10.1017/CBO9781139523905.007; Ismail-Zadeh A, 2007, NAT HAZARDS, V42, P459, DOI 10.1007/s11069-006-9075-0; McBean GA, 2012, CURR OPIN ENV SUST, V4, P122, DOI 10.1016/j.cosust.2012.01.002; Palmer L, 2013, NAT CLIM CHANGE, V3, P857, DOI 10.1038/nclimate2016	10	111	115	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					277	279		10.1038/522277a	http://dx.doi.org/10.1038/522277a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26085255	Bronze			2022-12-28	WOS:000356425400026
J	Halland, M; Saito, YA				Halland, Magnus; Saito, Yuri A.			Irritable bowel syndrome: new and emerging treatments	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FUNCTIONAL GASTROINTESTINAL DISORDERS; INTESTINAL BACTERIAL OVERGROWTH; PLACEBO-CONTROLLED TRIAL; GLUTEN-FREE DIET; DOUBLE-BLIND; CLINICAL-TRIAL; PHYSICAL-ACTIVITY; CELIAC-DISEASE; SYMPTOMS; DIARRHEA	Irritable bowel syndrome is one of the most common gastrointestinal disorders in developed nations. It is characterized by abdominal pain, altered bowel habits, and bloating. Several non-pharmacological and pharmacological agents, which target the peripheral gastrointestinal system and central nervous system, are used to treat the syndrome. The individual and societal impact of investigating and managing the syndrome is substantial, and despite newer treatments, many patients have unmet needs. Intense research at many international sites has improved the understanding of pathophysiology of the syndrome, but developing treatments that are effective, safe, and that have tolerable side effects remains a challenge. This review briefly summarizes the currently available treatments for irritable bowel syndrome then focuses on newer non-pharmacological and pharmacological therapies and recent evidence for older treatments. Recent guidelines on the treatment of irritable bowel syndrome are also discussed.	[Halland, Magnus; Saito, Yuri A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic	Saito, YA (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	saito.yuri@mayo.edu			Salix Pharmaceuticals; Pfizer Pharmaceuticals; Ironwood Pharmaceuticals	Salix Pharmaceuticals; Pfizer Pharmaceuticals(Pfizer); Ironwood Pharmaceuticals	We have read and understood BMJ policy on declaration of interests and declare the following interests: YAS's institution has received fees for her participation on an advisory board for Salix Pharmaceuticals and receives research funding from Pfizer Pharmaceuticals and Ironwood Pharmaceuticals for investigator initiated clinical studies in which she is principal investigator. YAS was a member of the American College of Gastroenterology Institute for Clinical Research and Education task force on the management of functional bowel disorders.	Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; Atkinson W, 2004, GUT, V53, P1459, DOI 10.1136/gut.2003.037697; Bajor A, 2015, GUT, V64, P84, DOI 10.1136/gutjnl-2013-305965; Bengtson MB, 2006, GUT, V55, P1754, DOI 10.1136/gut.2006.097287; Bengtsson M, 2006, PATIENT EDUC COUNS, V62, P118, DOI 10.1016/j.pec.2005.06.015; Bensoussan A, 1998, JAMA-J AM MED ASSOC, V280, P1585, DOI 10.1001/jama.280.18.1585; Beyder A, 2014, GASTROENTEROLOGY, V146, P1659, DOI 10.1053/j.gastro.2014.02.054; Bharucha AE, 2014, GASTROENTEROLOGY, V146, P37, DOI 10.1053/j.gastro.2013.10.062; Biesiekierski JR, 2013, GASTROENTEROLOGY, V145, P320, DOI 10.1053/j.gastro.2013.04.051; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; BORODY TJ, 1989, MED J AUSTRALIA, V150, P604, DOI 10.5694/j.1326-5377.1989.tb136704.x; Brandt L, 2002, AM J GASTROENTEROL S, V97, P26; Brenner DM, 2009, AM J GASTROENTEROL, V104, P1033, DOI 10.1038/ajg.2009.25; Camilleri M, 2015, ALIMENT PHARM THER, V41, P438, DOI 10.1111/apt.13065; Camilleri M, 2014, NEUROGASTROENT MOTIL, V26, P1677, DOI 10.1111/nmo.12421; Camilleri M, 2014, AM J PHYSIOL, V306, P26; Camilleri M, 2014, AM J GASTROENTEROL, V109, P1621, DOI 10.1038/ajg.2014.215; Camilleri M, 2014, GASTROENTEROLOGY, V146, P1829, DOI 10.1053/j.gastro.2014.01.071; Canavan C, 2014, ALIMENT PHARM THER, V40, P1023, DOI 10.1111/apt.12938; Carroll SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084718; Chang JY, 2010, AM J GASTROENTEROL, V105, P822, DOI 10.1038/ajg.2010.40; Chang L, 2002, GASTROENTEROLOGY, V123, P1686, DOI 10.1053/gast.2002.36603; Chang L, 2014, GASTROENTEROLOGY, V147, P1149, DOI 10.1053/j.gastro.2014.09.002; Chey WD, 2008, AM J GASTROENTEROL, V103, P1217, DOI 10.1111/j.1572-0241.2008.01808.x; Chey WD, 2012, AM J GASTROENTEROL, V107, P1702, DOI 10.1038/ajg.2012.254; Chey WY, 2001, AM J GASTROENTEROL, V96, P1499; Chiarioni G, 2014, CLIN GASTROENTEROL H, V12, P2049, DOI 10.1016/j.cgh.2014.03.013; Colwell LJ, 1998, AM J GASTROENTEROL, V93, P901; Dainese R, 2004, AM J MED, V116, P536, DOI 10.1016/j.amjmed.2003.12.018; de Roest RH, 2013, INT J CLIN PRACT, V67, P895, DOI 10.1111/ijcp.12128; Dean BB, 2005, AM J MANAG CARE, V11, pS17; Didari T, 2015, WORLD J GASTROENTERO, V21, P3072, DOI 10.3748/wjg.v21.i10.3072; Dove LS, 2013, GASTROENTEROLOGY, V145, P329, DOI 10.1053/j.gastro.2013.04.006; Drossman DA, 2009, ALIMENT PHARM THER, V29, P329, DOI 10.1111/j.1365-2036.2008.03881.x; Drossman DA, 1997, GASTROENTEROLOGY, V112, P2120, DOI 10.1053/gast.1997.v112.agast972120; Drossman DA, 2009, J CLIN GASTROENTEROL, V43, P541, DOI 10.1097/MCG.0b013e318189a7f9; Emmanuel A, 2014, AM J GASTROENTEROL, V109, P887, DOI 10.1038/ajg.2014.74; Eswaran Shanti, 2013, Gastroenterol Hepatol (N Y), V9, P85; Eswaran S, 2011, GASTROENTEROL CLIN N, V40, P141, DOI 10.1016/j.gtc.2010.12.012; Fassov JL, 2014, ANN SURG, V260, P31, DOI 10.1097/SLA.0000000000000559; Ford AC, 2014, AM J GASTROENTEROL, V109, P1547, DOI 10.1038/ajg.2014.202; Ford AC, 2014, AM J GASTROENTEROL, V109, P1350, DOI 10.1038/ajg.2014.148; Ford AC, 2014, AM J GASTROENTEROL, V109, pS2, DOI 10.1038/ajg.2014.187; Ford AC, 2009, CLIN GASTROENTEROL H, V7, P1279, DOI 10.1016/j.cgh.2009.06.031; Fukudo S, 2011, NEUROGASTROENT MOTIL, V23, P544; Fukudo S, 2014, CLIN GASTROENTEROL H, V12, P953, DOI 10.1016/j.cgh.2013.11.024; Furman DL, 2011, GASTROENTEROL CLIN N, V40, P105, DOI 10.1016/j.gtc.2010.12.001; Garsed K, 2014, GUT, V63, P1617, DOI 10.1136/gutjnl-2013-305989; Grudell ABM, 2008, NEUROGASTROENT MOTIL, V20, P213, DOI 10.1111/j.1365-2982.2007.01026.x; Halland M, 2014, NEUROGASTROENT MOTIL, V26, P990, DOI 10.1111/nmo.12353; Halmos EP, 2014, GASTROENTEROLOGY, V146, P67, DOI [10.1053/j.gastro.2013.09.046, 10.1053/j.gastro.2014.04.034]; HARVEY RF, 1989, LANCET, V1, P424; HARVEY RF, 1983, LANCET, V1, P632; Hoveyda N, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-15; Howard RA, 2008, CANCER CAUSE CONTROL, V19, P939, DOI 10.1007/s10552-008-9159-0; Hungin APS, 2013, ALIMENT PHARM THER, V38, P864, DOI 10.1111/apt.12460; Hungin APS, 2005, ALIMENT PHARM THER, V21, P1365, DOI 10.1111/j.1365-2036.2005.02463.x; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Johannesson E, 2011, AM J GASTROENTEROL, V106, P915, DOI 10.1038/ajg.2010.480; Johanson JF, 2008, ALIMENT PHARM THER, V27, P685, DOI 10.1111/j.1365-2036.2008.03629.x; Johnston JM, 2010, GASTROENTEROLOGY, V139, P1877, DOI 10.1053/j.gastro.2010.08.041; Jones MP, 2014, ALIMENT PHARM THER, V39, P426, DOI 10.1111/apt.12608; KELLOW JE, 1987, GASTROENTEROLOGY, V92, P1885, DOI 10.1016/0016-5085(87)90620-2; Khanna R, 2014, J CLIN GASTROENTEROL, V48, P505, DOI 10.1097/MCG.0b013e3182a88357; Klaus J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-61; Klooker TK, 2010, GUT, V59, P1213, DOI 10.1136/gut.2010.213108; Ko SJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/824605; Koloski NA, 2012, GUT, V61, P1284, DOI 10.1136/gutjnl-2011-300474; Koloski NA, 2000, AM J GASTROENTEROL, V95, P67; Krogius-Kurikka L, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-95; Krueger D, 2009, NEUROGASTROENT MOTIL, V21, P1203, DOI 10.1111/j.1365-2982.2008.01242.x; Lackner JA, 2004, J CONSULT CLIN PSYCH, V72, P1100, DOI 10.1037/0022-006X.72.6.1100; Lackner JM, 2008, CLIN GASTROENTEROL H, V6, P899, DOI 10.1016/j.cgh.2008.03.004; Lembo AJ, 2004, CLIN GASTROENTEROL H, V2, P675, DOI 10.1016/S1542-3565(04)00284-8; Leong SA, 2003, ARCH INTERN MED, V163, P929, DOI 10.1001/archinte.163.8.929; Lindfors P, 2012, AM J GASTROENTEROL, V107, P276, DOI 10.1038/ajg.2011.340; Liu JP, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004116.PUB2; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, AM J GASTROENTEROL, V107, P991, DOI 10.1038/ajg.2012.131; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Madisch A, 2004, ALIMENT PHARM THER, V19, P271, DOI 10.1111/j.1365-2036.2004.01859.x; Mangel AW, 2008, ALIMENT PHARM THER, V28, P239, DOI 10.1111/j.1365-2036.2008.03730.x; Mangel AW, 2012, CLIN EXP GASTROENTER, V5, P1, DOI 10.2147/CEG.S23274; Mannerkorpi K, 2005, CURR OPIN RHEUMATOL, V17, P190, DOI 10.1097/01.bor.0000154202.56962.85; McKenzie YA, 2012, J HUM NUTR DIET, V25, P260, DOI 10.1111/j.1365-277X.2012.01242.x; Menees SB, 2012, AM J GASTROENTEROL, V107, P28, DOI 10.1038/ajg.2011.355; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Moayyedi P, 2014, AM J GASTROENTEROL, V109, P1367, DOI 10.1038/ajg.2014.195; Mohammed I, 2005, AM J GASTROENTEROL, V100, P1340, DOI 10.1111/j.1572-0241.2005.41700.x; National Institute for Health and Care Excellence, 2013, IRR BOW SYNDR AD DIA; Nayak A K, 1997, Indian J Gastroenterol, V16, P137; Ong DK, 2010, J GASTROEN HEPATOL, V25, P1366, DOI 10.1111/j.1440-1746.2010.06370.x; Ottillinger B, 2013, WIEN MED WOCHENSCHR, V163, P65, DOI 10.1007/s10354-012-0169-x; Park MI, 2006, NEUROGASTROENT MOTIL, V18, P595, DOI 10.1111/j.1365-2982.2005.00745.x; Patcharatrakul T, 2011, J CLIN GASTROENTEROL, V45, P593, DOI 10.1097/MCG.0b013e31820c6001; Pavlidis P, 2013, SCAND J GASTROENTERO, V48, P1048, DOI 10.3109/00365521.2013.816771; Pilichiewicz AN, 2007, AM J GASTROENTEROL, V102, P1276, DOI 10.1111/j.1572-0241.2007.01142.x; Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6; Pimentel M, 2006, ANN INTERN MED, V145, P557, DOI 10.7326/0003-4819-145-8-200610170-00004; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; Posserud I, 2004, GUT, V53, P1102, DOI 10.1136/gut.2003.017962; Posserud I, 2007, GUT, V56, P802, DOI 10.1136/gut.2006.108712; Quigley EMM, 2007, J DIGEST DIS, V8, P2, DOI 10.1111/j.1443-9573.2007.00277.x; Quigley EMM, 2014, CURR OPIN GASTROEN, V30, P141, DOI 10.1097/MOG.0000000000000040; Quigley EMM, 2012, J CLIN GASTROENTEROL, V46, P356, DOI 10.1097/MCG.0b013e318247157c; Quigley EMM, 2012, THER ADV GASTROENTER, V5, P23, DOI 10.1177/1756283X11423706; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Rao S, 2012, AM J GASTROENTEROL, V107, P1714, DOI 10.1038/ajg.2012.255; Rao S, 2012, AM J GASTROENTEROL, V107, pS236, DOI 10.14309/00000434-201210001-00572; Ringstrom G, 2010, EUR J GASTROEN HEPAT, V22, P420, DOI 10.1097/MEG.0b013e3283333b61; Roos AM, 2012, INT UROGYNECOL J, V23, P755, DOI 10.1007/s00192-011-1609-7; Saito YA, 2002, AM J GASTROENTEROL, V97, P1910; Saito YA, 2004, CLIN GASTROENTEROL H, V2, P576, DOI 10.1016/S1542-3565(04)00241-1; Saito YA, 2011, GASTROENTEROL CLIN N, V40, P45, DOI 10.1016/j.gtc.2010.12.011; Saito YA, 2010, AM J GASTROENTEROL, V105, P833, DOI 10.1038/ajg.2010.116; Sallon S, 2002, DIGESTION, V65, P161, DOI 10.1159/000064936; Shailubhai K, 2013, DIGEST DIS SCI, V58, P2580, DOI 10.1007/s10620-013-2684-z; Sharara AI, 2006, AM J GASTROENTEROL, V101, P326, DOI 10.1111/j.1572-0241.2006.00458.x; Shepherd SJ, 2008, CLIN GASTROENTEROL H, V6, P765, DOI 10.1016/j.cgh.2008.02.058; Shepherd SJ, 2006, J AM DIET ASSOC, V106, P1631, DOI 10.1016/j.jada.2006.07.010; Shin A, 2014, ALIMENT PHARM THER, V39, P239, DOI 10.1111/apt.12571; Simmen U, 2006, PHYTOMEDICINE, V13, P51, DOI 10.1016/j.phymed.2006.03.012; Simren M, 2001, DIGESTION, V63, P108, DOI 10.1159/000051878; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Spiegel B, 2008, AM J GASTROENTEROL, V103, P2536, DOI 10.1111/j.1572-0241.2008.01997.x; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Staudacher HM, 2012, J NUTR, V142, P1510, DOI 10.3945/jn.112.159285; Sweetser S, 2009, AM J PHYSIOL-GASTR L, V296, pG295, DOI 10.1152/ajpgi.90558.2008; Tack JF, 2011, ALIMENT PHARM THER, V34, P868, DOI 10.1111/j.1365-2036.2011.04818.x; Tanitiphlachiva K, 2010, CLIN GASTROENTEROL H, V8, P955, DOI 10.1016/j.cgh.2010.06.031; Thabane M, 2007, ALIMENT PHARM THER, V26, P535, DOI 10.1111/j.1365-2036.2007.03399.x; Van Outryve M, 2006, GASTROENTEROLOGY, V131, P333, DOI 10.1053/j.gastro.2006.05.031; Vazquez-Roque MI, 2013, GASTROENTEROLOGY, V144, P903, DOI 10.1053/j.gastro.2013.01.049; Villani AC, 2010, GASTROENTEROLOGY, V138, P1502, DOI 10.1053/j.gastro.2009.12.049; Wacklin P, 2013, INFLAMM BOWEL DIS, V19, P934, DOI 10.1097/MIB.0b013e31828029a9; Waehrens R, 2015, GUT, V64, P215, DOI 10.1136/gutjnl-2013-305705; Wahnschaffe U, 2007, CLIN GASTROENTEROL H, V5, P844, DOI 10.1016/j.cgh.2007.03.021; Whelan K, 2008, JPEN-PARENTER ENTER, V32, P160, DOI 10.1177/0148607108314769; Wong BS, 2012, CLIN GASTROENTEROL H, V10, P1009, DOI 10.1016/j.cgh.2012.05.006; Wong RK, 2013, CLIN GASTROENTEROL H, V11, P151, DOI 10.1016/j.cgh.2012.07.019; Zijdenbos IL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006442.pub2; ZWETCHKENBAUM J, 1988, ANN ALLERGY, V61, P47	144	15	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2015	350								h1622	10.1136/bmj.h1622	http://dx.doi.org/10.1136/bmj.h1622			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2PK	26088265				2022-12-28	WOS:000356786300001
J	[Anonymous]				[Anonymous]			Central & East Europe	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S18	S19		10.1038/522S18a	http://dx.doi.org/10.1038/522S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083852	Bronze			2022-12-28	WOS:000356425400006
J	[Anonymous]				[Anonymous]			Latin America & Caribbean Islands	NATURE			English	Editorial Material																			0	0	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					S26	S27		10.1038/522S26a	http://dx.doi.org/10.1038/522S26a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7PU	26083857	Bronze			2022-12-28	WOS:000356425400010
J	Saal, D				Saal, Daniel			Rewriting the Script	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC NONCANCER PAIN; OPIOIDS		Kaiser Permanente, Cupertino, CA 95051 USA	Kaiser Permanente	Saal, D (corresponding author), Kaiser Permanente, Cupertino, CA 95051 USA.	dsaal@yahoo.com						Chaparro LE, 2014, SPINE, V39, P556, DOI 10.1097/BRS.0000000000000249; Cialdini R.B, 2001, INFLUENCE SCI PRACTI; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Gaskell H, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010692.pub2; Manchikanti L, 2014, PAIN PHYSICIAN, V17, pE1; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P60; Welsch P, 2015, SCHMERZ, V29, P85, DOI 10.1007/s00482-014-1436-0	8	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2323	2324		10.1001/jama.2015.2653	http://dx.doi.org/10.1001/jama.2015.2653			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080335				2022-12-28	WOS:000356300200014
J	Sutton, P				Sutton, Philip			At last, vaccine-induced protection against Helicobacter pylori	LANCET			English	Editorial Material							INFECTION		[Sutton, Philip] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Sutton, Philip] Univ Melbourne, Sch Vet & Agr Sci, Ctr Anim Biotechnol, Parkville, Vic 3010, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Sutton, P (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	phil.sutton@mcri.edu.au		Sutton, Philip/0000-0003-3129-1800				Aebischer T, 2008, GUT, V57, P1065, DOI 10.1136/gut.2007.145839; Herrero R, 2014, BEST PRACT RES CL GA, V28, P1107, DOI 10.1016/j.bpg.2014.10.003; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Michetti P, 1999, GASTROENTEROLOGY, V116, P804, DOI 10.1016/S0016-5085(99)70063-6; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; Sutton P, 2013, EXPERT REV VACCINES, V12, P433, DOI [10.1586/erv.13.20, 10.1586/ERV.13.20]; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Weyermann M, 2009, AM J GASTROENTEROL, V104, P182, DOI 10.1038/ajg.2008.61; Zeng M, 2015, LANCET, V386, P1457, DOI 10.1016/S0140-6736(15)60310-5	9	19	21	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1424	1425		10.1016/S0140-6736(15)60579-7	http://dx.doi.org/10.1016/S0140-6736(15)60579-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5UU	26142047				2022-12-28	WOS:000362877300007
J	Manokaran, G; Finol, E; Wang, CL; Gunaratne, J; Bahl, J; Ong, EZ; Tan, HC; Sessions, OM; Ward, AM; Gubler, DJ; Harris, E; Garcia-Blanco, MA; Ooi, EE				Manokaran, Gayathri; Finol, Esteban; Wang, Chunling; Gunaratne, Jayantha; Bahl, Justin; Ong, Eugenia Z.; Tan, Hwee Cheng; Sessions, October M.; Ward, Alex M.; Gubler, Duane J.; Harris, Eva; Garcia-Blanco, Mariano A.; Ooi, Eng Eong			Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness	SCIENCE			English	Article							UBIQUITIN LIGASE; VIRUS TYPE-2; PUERTO-RICO; RESISTANT; EVOLUTION; TARGETS; EVASION	The global spread of dengue virus (DENV) infections has increased viral genetic diversity, some of which appears associated with greater epidemic potential. The mechanisms governing viral fitness in epidemiological settings, however, remain poorly defined. We identified a determinant of fitness in a foreign dominant (PR-2B) DENV serotype 2 (DENV-2) clade, which emerged during the 1994 epidemic in Puerto Rico and replaced an endemic (PR-1) DENV-2 clade. The PR-2B DENV-2 produced increased levels of subgenomic flavivirus RNA (sfRNA) relative to genomic RNA during replication. PR-2B sfRNA showed sequence-dependent binding to and prevention of tripartite motif 25 (TRIM25) deubiquitylation, which is critical for sustained and amplified retinoic acid-inducible gene 1 (RIG-I)-induced type I interferon expression. Our findings demonstrate a distinctive viral RNA-host protein interaction to evade the innate immune response for increased epidemiological fitness.	[Manokaran, Gayathri; Finol, Esteban; Ong, Eugenia Z.; Tan, Hwee Cheng; Sessions, October M.; Ward, Alex M.; Gubler, Duane J.; Garcia-Blanco, Mariano A.; Ooi, Eng Eong] Duke Natl Univ Singapore, Program Emerging Infect Dis, Grad Sch Med, Singapore, Singapore; [Manokaran, Gayathri] Def Med & Environm Res Inst, DSO Natl Labs, Singapore, Singapore; [Manokaran, Gayathri; Finol, Esteban; Gunaratne, Jayantha; Ooi, Eng Eong] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Finol, Esteban] Univ Basel, Swiss Trop & Publ Hlth Inst, CH-4003 Basel, Switzerland; [Wang, Chunling; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Gunaratne, Jayantha] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Bahl, Justin] Univ Texas Sch Publ Hlth, Ctr Infect Dis, Houston, TX USA; [Garcia-Blanco, Mariano A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Garcia-Blanco, Mariano A.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Garcia-Blanco, Mariano A.] Duke Univ, Ctr RNA Biol, Durham, NC USA; [Ooi, Eng Eong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Ooi, Eng Eong] Singapore Massachusetts Inst Technol Alliance Res, Singapore, Singapore	National University of Singapore; National University of Singapore; University of Basel; Swiss Tropical & Public Health Institute; University of California System; University of California Berkeley; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Medical Branch Galveston; Duke University; Duke University; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Ooi, EE (corresponding author), Duke Natl Univ Singapore, Program Emerging Infect Dis, Grad Sch Med, Singapore, Singapore.	engeong.ooi@duke-nus.edu.sg	Berrueta, Esteban Andres Finol/ABA-5146-2020; Bahl, Justin/A-4728-2011	Berrueta, Esteban Andres Finol/0000-0002-9830-439X; Ooi, Eng Eong/0000-0002-0520-1544; Bahl, Justin/0000-0001-7572-4300; Ong, Eugenia/0000-0003-2187-7058	Singapore National Medical Research Council; Duke-National University of Singapore Signature Research Program - Ministry of Health, Singapore; Institute of Molecular and Cell Biology, Agency of Science, Technology and Research, Singapore; U.S. National Institutes of Health [R01 GM087405, R01 AI089526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087405] Funding Source: NIH RePORTER	Singapore National Medical Research Council(National Medical Research Council, Singapore); Duke-National University of Singapore Signature Research Program - Ministry of Health, Singapore(Ministry of Health-SingaporeNational University of Singapore); Institute of Molecular and Cell Biology, Agency of Science, Technology and Research, Singapore; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Singapore National Medical Research Council; the Duke-National University of Singapore Signature Research Program funded by the Ministry of Health, Singapore; the Institute of Molecular and Cell Biology, Agency of Science, Technology and Research, Singapore; and grants R01 GM087405 and R01 AI089526 from the U.S. National Institutes of Health (E.H. and M.A.G.-B., respectively). We thank K. Bidet and V. Dhanasekaran for their invaluable advice throughout this work. We thank Y. Chandran and S. M. Cave for technical assistance and M. Krishnan for the IRF-3 knockdown protocol. We also thank the anonymous reviewers for their helpful suggestions.	Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242; Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456; Buckley TR, 2001, MOL BIOL EVOL, V18, P223, DOI 10.1093/oxfordjournals.molbev.a003796; Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897; Choudhury NR, 2014, CELL REP, V9, P1265, DOI 10.1016/j.celrep.2014.10.017; Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004; McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961; Messer WB, 2003, EMERG INFECT DIS, V9, P800; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Pauli EK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004577; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67; Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23; Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836; Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015	27	247	253	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					217	221		10.1126/science.aab3369	http://dx.doi.org/10.1126/science.aab3369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26138103	Green Accepted			2022-12-28	WOS:000362405600041
J	Hackey, RB; May, EL				Hackey, Robert B.; May, Erika L.			Measuring the Performance of Health Insurance Marketplaces	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hackey, Robert B.; May, Erika L.] Providence Coll, Hlth Policy & Management Program, Providence, RI 02918 USA	Providence College	Hackey, RB (corresponding author), Providence Coll, Hlth Policy & Management, One Cunningham Sq, Providence, RI 02918 USA.	rhackey@providence.edu						Holahan John, 2015, MARKETPLACE PREMIUM; Kaiser Family Foundation, 2015, MARK ENR SHAR POT MA; Mach Annie L., 2014, FEDERAL FUNDING HLTH; Pearson CF, 2015, STATE BASED EXCHANGE; Radnofsky L., 2015, WALL STREET J   0223, pA3; US Department of Health and Human Services, 2015, HLTH INS MARK 2015 O	6	3	3	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2015	314	7					667	668		10.1001/jama.2015.7248	http://dx.doi.org/10.1001/jama.2015.7248			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SS	26121390				2022-12-28	WOS:000360019100011
J	Strathdee, SA; Beyrer, C				Strathdee, Steffanie A.; Beyrer, Chris			Threading the Needle - How to Stop the HIV Outbreak in Rural Indiana	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INJECTION-DRUG USERS; INFECTION		[Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Beyrer, Chris] Int AIDS Soc, Geneva, Switzerland	University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.		Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X				[Anonymous], 2015, MMWR MORB MORTAL WKL, V64, P453; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; O'Shaughnessy MV, 2012, CURR HIV-AIDS REP, V9, P394, DOI 10.1007/s11904-012-0130-z; Vlahov D, 2010, CLIN INFECT DIS, V50, pS114, DOI 10.1086/651482; 2015, MMWR MORB MORTAL WKL, V64, P443	5	91	92	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					397	399		10.1056/NEJMp1507252	http://dx.doi.org/10.1056/NEJMp1507252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN8BO	26106947				2022-12-28	WOS:000358662200001
J	Palm, W; Park, Y; Wright, K; Pavlova, NN; Tuveson, DA; Thompson, CB				Palm, Wilhelm; Park, Youngkyu; Wright, Kevin; Pavlova, Natalya N.; Tuveson, David A.; Thompson, Craig B.			The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1	CELL			English	Article							TUMOR-CELLS; AMINO-ACIDS; MACROPINOCYTOSIS; FIBROBLASTS; INHIBITION; METABOLISM; AUTOPHAGY; RAPTOR	Despite being surrounded by diverse nutrients, mammalian cells preferentially metabolize glucose and free amino acids. Recently, Ras-induced macropinocytosis of extracellular proteins was shown to reduce a transformed cell's dependence on extracellular glutamine. Here, we demonstrate that protein macropinocytosis can also serve as an essential amino acid source. Lysosomal degradation of extracellular proteins can sustain cell survival and induce activation of mTORC1 but fails to elicit significant cell accumulation. Unlike its growth-promoting activity under amino-acid-replete conditions, we discovered that mTORC1 activation suppresses proliferation when cells rely on extracellular proteins as an amino acid source. Inhibiting mTORC1 results in increased catabolism of endocytosed proteins and enhances cell proliferation during nutrient-depleted conditions in vitro and within vascularly compromised tumors in vivo. Thus, by preventing nutritional consumption of extracellular proteins, mTORC1 couples growth to availability of free amino acids. These results may have important implications for the use of mTOR inhibitors as therapeutics.	[Palm, Wilhelm; Pavlova, Natalya N.; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Park, Youngkyu; Wright, Kevin; Tuveson, David A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory	Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	thompsonc@mskcc.org	Palm, Wilhelm/AAS-6255-2021	Pavlova, Natalya/0000-0002-5120-4404	EMBO Long-Term Fellowship; Genentech Foundation Hope Funds for Cancer Research Fellowship; Cancer Center Support Grants [P30 CA008748, 5P30CA045508]; NCI [P01 CA104838]; NIH [5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-01, 5U01CA168409-3, 1R01CA190092-01]; DOD [W81XWH-13-PRCRP-IA]; Cold Spring Harbor Laboratory Association; David Rubinstein Center for Pancreatic Cancer Research at MSKCC; NATIONAL CANCER INSTITUTE [U01CA168409, R01CA201318, P50CA101955, R01CA190092, P01CA104838, U10CA180944, P30CA008748, P30CA045508] Funding Source: NIH RePORTER	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Genentech Foundation Hope Funds for Cancer Research Fellowship; Cancer Center Support Grants; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Cold Spring Harbor Laboratory Association; David Rubinstein Center for Pancreatic Cancer Research at MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge Michael Hall and Scott Lowe for providing reagents. We thank Dea Filippini and the Molecular Cytology Core of MSKCC for technical assistance. We are grateful to members of the Thompson laboratory for critical discussions and comments on the manuscript. W.P. is the recipient of an EMBO Long-Term Fellowship and the Genentech Foundation Hope Funds for Cancer Research Fellowship. This work was performed with assistance from the MSKCC Molecular Cytology Core and CSHL Laboratory Animal Shared Resources, which are supported by Cancer Center Support Grants P30 CA008748 and 5P30CA045508. This work was supported by grants from NCI (P01 CA104838 for C.B.T.), NIH (5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-01, 5U01CA168409-3, and 1R01CA190092-01 for D.A.T.), and DOD (W81XWH-13-PRCRP-IA for Y.P. and D.A.T.). D.A.T. is an investigator of the Lustgarten Foundation for Pancreatic Cancer Research and is supported by the Cold Spring Harbor Laboratory Association and the David Rubinstein Center for Pancreatic Cancer Research at MSKCC. C.B.T. is a founder of Agios Pharmaceuticals and a member of its scientific advisory board. C.B.T. also serves on the board of directors of Merck.	Amyere M, 2002, INT J MED MICROBIOL, V291, P487; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cybulski N, 2012, METHODS MOL BIOL, V821, P267, DOI 10.1007/978-1-61779-430-8_16; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kim E, 2008, JPN J PHYS FIT SPORT, V57, P207, DOI 10.7600/jspfsm.57.207; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Reis RCM, 1998, EUR J CELL BIOL, V75, P192, DOI 10.1016/S0171-9335(98)80061-7; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	26	282	288	0	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					259	270		10.1016/j.cell.2015.06.017	http://dx.doi.org/10.1016/j.cell.2015.06.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26144316	Green Accepted, Bronze			2022-12-28	WOS:000358087700008
J	Boseley, S				Boseley, Sarah			Michel Sidibe: working to end AIDS as a public health threat	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					127	127		10.1016/S0140-6736(15)61143-6	http://dx.doi.org/10.1016/S0140-6736(15)61143-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM5QC	26117720				2022-12-28	WOS:000357742200016
J	Cohen, JP; Dong, JH; Lu, CY; Chakravarthy, R				Cohen, Joshua P.; Dong, Jinghui; Lu, Christine Y.; Chakravarthy, Ranjana			Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STRUGGLE		[Cohen, Joshua P.; Dong, Jinghui; Chakravarthy, Ranjana] Tufts Univ, Boston, MA 02111 USA; [Lu, Christine Y.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Tufts University; Harvard University; Harvard Medical School	Cohen, JP (corresponding author), Tufts Univ, 75 Kneeland St,Suite 1100, Boston, MA 02111 USA.	joshua.cohen@tufts.edu						Bach PB, 2011, HEALTH AFFAIR, V30, P500, DOI 10.1377/hlthaff.2010.0752; Centers for Medicare and Medicaid Services, COV EV DEV DAT; Centers for Medicare and Medicaid Services, PROP DEC MEM BET AM; Chambers JD, 2013, HEALTH AFFAIR, V32, P1109, DOI 10.1377/hlthaff.2012.1073; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; Food and Drug Administration, AM INF; Foster NL, 2014, ALZHEIMERS DEMENT, V10, P503, DOI 10.1016/j.jalz.2014.05.003; Garrison LP, 2006, HEALTH AFFAIR, V25, P1281, DOI 10.1377/hlthaff.25.5.1281; Neumann PJ, 2012, NEW ENGL J MED, V367, P1775, DOI 10.1056/NEJMp1208386; NICE, 2011, DIAGN ASS PROGR MAN; Otero HJ, 2012, ACAD RADIOL, V19, P1060, DOI 10.1016/j.acra.2012.05.005; Tappenden P, 2009, VALUE HEALTH, V12, P657, DOI 10.1111/j.1524-4733.2008.00485.x; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tunis SR, 2011, IMPR QUAL EFF MED PR; Williams SCP, 2013, NAT MED, V19, P1551, DOI 10.1038/nm1213-1551	15	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2015	351								h3333	10.1136/bmj.h3333	http://dx.doi.org/10.1136/bmj.h3333			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM3UA	26141315				2022-12-28	WOS:000357609000002
J	Koberlin, MS; Snijder, B; Heinz, LX; Baumann, CL; Fauster, A; Vladimer, GI; Gavin, AC; Superti-Furga, G				Koeberlin, Marielle S.; Snijder, Berend; Heinz, Leonhard X.; Baumann, Christoph L.; Fauster, Astrid; Vladimer, Gregory I.; Gavin, Anne-Claude; Superti-Furga, Giulio			A Conserved Circular Network of Coregulated Lipids Modulates Innate Immune Responses	CELL			English	Article							PROTEINS MEDIATE; CERAMIDE; INFLAMMATION; RECOGNITION; LIPIDOMICS; RECEPTORS; MAP	Lipid composition affects the biophysical properties of membranes that provide a platform for receptor-mediated cellular signaling. To study the regulatory role of membrane lipid composition, we combined genetic perturbations of sphingolipid metabolism with the quantification of diverse steps in Toll-like receptor (TLR) signaling and mass spectrometry-based lipidomics. Membrane lipid composition was broadly affected by these perturbations, revealing a circular network of coregulated sphingolipids and glycerophospholipids. This evolutionarily conserved network architecture simultaneously reflected membrane lipid metabolism, subcellular localization, and adaptation mechanisms. Integration of the diverse TLR-induced inflammatory phenotypes with changes in lipid abundance assigned distinct functional roles to individual lipid species organized across the network. This functional annotation accurately predicted the inflammatory response of cells derived from patients suffering from lipid storage disorders, based solely on their altered membrane lipid composition. The analytical strategy described here empowers the understanding of higher-level organization of membrane lipid function in diverse biological systems.	[Koeberlin, Marielle S.; Snijder, Berend; Heinz, Leonhard X.; Baumann, Christoph L.; Fauster, Astrid; Vladimer, Gregory I.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Gavin, Anne-Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; European Molecular Biology Laboratory (EMBL); Medical University of Vienna	Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Snijder, Berend/M-2998-2017; Snijder, Berend/O-9206-2019; Vladimer, Gregory/X-4547-2018; Superti-Furga, Giulio/AAE-5681-2019	Snijder, Berend/0000-0003-3386-6583; Vladimer, Gregory/0000-0003-4205-7585; Gavin, Anne-Claude/0000-0003-4917-2340; Heinz, Leonhard/0000-0002-6921-1493; Fauster, Astrid/0000-0003-4608-5604	Swiss National Science Foundation [P300P3_147897]; EMBO [1543-2012]; Austrian Academy of Sciences; ERC i-FIVE advanced investigator grant; Telethon Italy [GTB12001]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Austrian Academy of Sciences; ERC i-FIVE advanced investigator grant; Telethon Italy(Fondazione Telethon)	We thank Manuela Bruckner for technical assistance and Omar Sharif, Rudiger Klein, and the entire G.S.-F. lab for feedback. We gratefully acknowledge funding from the Swiss National Science Foundation (P300P3_147897, to B.S.), EMBO (1543-2012, to G.I.V.), the Austrian Academy of Sciences (to Research Center for Molecular Medicine of the Austrian Academy of Sciences), and the ERC i-FIVE advanced investigator grant (to G.S.-F.). "Cell Line and DNA Biobank from Patients Affected by Genetic Diseases,'' member of the Telethon Network of Genetic Biobanks (project GTB12001), funded by Telethon Italy, provided us with specimens. We thank Mirella Filocamo from the Instituto G. Gaslini for assistance and feedback.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; dos Santosa AXD, 2014, MOL BIOL CELL, V25, P3234, DOI 10.1091/mbc.E14-03-0851; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gallegos CE, 2008, BBA-BIOMEMBRANES, V1778, P917, DOI 10.1016/j.bbamem.2007.10.019; Guan XL, 2010, METHOD ENZYMOL, V470, P369, DOI 10.1016/S0076-6879(10)70015-X; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Heinz L. X., 2015, CELL REP; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Jozefowski S, 2010, J IMMUNOL, V185, P6960, DOI 10.4049/jimmunol.0902926; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Memon RA, 1998, ARTERIOSCL THROM VAS, V18, P1257, DOI 10.1161/01.ATV.18.8.1257; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Parker LC, 2008, J IMMUNOL, V181, P5606, DOI 10.4049/jimmunol.181.8.5606; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Snijder B, 2014, NAT BIOTECHNOL, V32, P755, DOI 10.1038/nbt.2974; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0212-7; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wijesinghe DS, 2009, J LIPID RES, V50, P1986, DOI 10.1194/jlr.M800367-JLR200	43	126	126	1	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					170	183		10.1016/j.cell.2015.05.051	http://dx.doi.org/10.1016/j.cell.2015.05.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26095250	hybrid, Green Published			2022-12-28	WOS:000357542300018
J	Luo, ZQ; Jiang, YW; Myers, BD; Isheim, D; Wu, JS; Zimmerman, JF; Wang, ZG; Li, QQ; Wang, YC; Chen, XQ; Dravid, VP; Seidman, DN; Tian, BZ				Luo, Zhiqiang; Jiang, Yuanwen; Myers, Benjamin D.; Isheim, Dieter; Wu, Jinsong; Zimmerman, John F.; Wang, Zongan; Li, Qianqian; Wang, Yucai; Chen, Xinqi; Dravid, Vinayak P.; Seidman, David N.; Tian, Bozhi			Atomic gold-enabled three-dimensional lithography for silicon mesostructures	SCIENCE			English	Article							CATALYST ATOMS; SI NANOWIRES; GROWTH; MORPHOLOGY; DIFFUSION; PARTICLE; COMPLEX; MODEL	Three-dimensional (3D) mesostructured semiconductors show promising properties and applications; however, to date, few methods exist to synthesize or fabricate such materials. Metal can diffuse along semiconductor surfaces, and even trace amounts can change the surface behavior. We exploited the phenomena for 3D mesoscale lithography, by showing one example where iterated deposition-diffusion-incorporation of gold over silicon nanowires forms etchant-resistant patterns. This process is facet-selective, producing mesostructured silicon spicules with skeletonlike morphology, 3D tectonic motifs, and reduced symmetries. Atom-probe tomography, coupled with other quantitative measurements, indicates the existence and the role of individual gold atoms in forming 3D lithographic resists. Compared to other more uniform silicon structures, the anisotropic spicule requires greater force for detachment from collagen hydrogels, suggesting enhanced interfacial interactions at the mesoscale.	[Luo, Zhiqiang; Jiang, Yuanwen; Zimmerman, John F.; Wang, Zongan; Tian, Bozhi] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Myers, Benjamin D.; Isheim, Dieter; Wu, Jinsong; Li, Qianqian; Chen, Xinqi; Dravid, Vinayak P.; Seidman, David N.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Myers, Benjamin D.; Wu, Jinsong; Li, Qianqian; Chen, Xinqi; Dravid, Vinayak P.] Northwestern Univ, Northwestern Univ Atom & Nanoscale Characterizat, Evanston, IL 60208 USA; [Isheim, Dieter; Seidman, David N.] Northwestern Univ, Northwestern Univ Ctr Atom Probe Tomog NUCAPT, Evanston, IL 60208 USA; [Wang, Yucai; Tian, Bozhi] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Tian, Bozhi] Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; Northwestern University; Northwestern University; Northwestern University; University of Chicago	Tian, BZ (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	btian@uchicago.edu	Dravid, Vinayak/B-6688-2009; LUO, ZHIQIANG/G-8410-2015; Seidman, David/B-6697-2009; Wang, Yucai/A-1098-2017; Jiang, Yuanwen/B-6584-2018	Wang, Yucai/0000-0001-6046-2934; Jiang, Yuanwen/0000-0002-2056-2639; Luo, Zhiqiang/0000-0003-3867-6607; Zimmerman, John/0000-0003-4099-8699	NSF [NSF CAREER] [DMR-1254637]; NSF Materials Research Science and Engineering Centers (MRSEC) [DMR-0820054]; Searle Scholars Foundation; Air Force Office of Scientific Research [AFOSR FA9550-14-1-0175]; University of Chicago; NSF-Major Research Instrumentation Program [DMR-0420532]; Office of Naval Research-Defense University Research Instrumentation Program [N00014-0400798, N00014-0610539, N00014-0910781]; NSF MRSEC program at the Materials Research Center [NSF DMR-1121262]; International Institute for Nanotechnology (IIN); State of Illinois, through the IIN; Air Force Research Laboratory [FA9550-12-1-0280]	NSF [NSF CAREER]; NSF Materials Research Science and Engineering Centers (MRSEC)(National Science Foundation (NSF)); Searle Scholars Foundation; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); University of Chicago(University of Chicago); NSF-Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office of Naval Research-Defense University Research Instrumentation Program; NSF MRSEC program at the Materials Research Center; International Institute for Nanotechnology (IIN); State of Illinois, through the IIN; Air Force Research Laboratory	This work is supported by NSF [NSF CAREER, grant DMR-1254637; and NSF Materials Research Science and Engineering Centers (MRSEC), grant DMR-0820054], the Searle Scholars Foundation, the Air Force Office of Scientific Research (grant AFOSR FA9550-14-1-0175), and the University of Chicago startup fund. APT was performed at NUCAPT, whose APT was purchased and upgraded with funding from NSF-Major Research Instrumentation Program (grant DMR-0420532) and the Office of Naval Research-Defense University Research Instrumentation Program (grants N00014-0400798, N00014-0610539, and N00014-0910781). Instrumentation at NUCAPT was further upgraded by the Initiative for Sustainability and Energy at Northwestern. This work also made use of the EPIC facility (NUANCE Center-Northwestern University), which has received support from the NSF MRSEC program (grant NSF DMR-1121262) at the Materials Research Center and from the International Institute for Nanotechnology (IIN); and the State of Illinois, through the IIN. Part of this research is sponsored by the Air Force Research Laboratory (grant FA9550-12-1-0280). The authors thank L. Yu, Q. Guo, J. Jureller, J. Austin II, Y. Chen, S.-I. Baik, and T. A. Witten for technical support and stimulating discussion.	Algra RE, 2008, NATURE, V456, P369, DOI 10.1038/nature07570; Allen JE, 2008, NAT NANOTECHNOL, V3, P168, DOI 10.1038/nnano.2008.5; CHEN LC, 1995, J ELECTROCHEM SOC, V142, P170, DOI 10.1149/1.2043860; Chen WH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5134; Christesen JD, 2013, NANO LETT, V13, P6281, DOI 10.1021/nl403909r; Cusack M, 2008, CHEM REV, V108, P4433, DOI 10.1021/cr078270o; Day RW, 2015, NAT NANOTECHNOL, V10, P345, DOI [10.1038/NNANO.2015, 10.1038/nnano.2015.23]; den Hertog MI, 2008, NANO LETT, V8, P1544, DOI 10.1021/nl073356i; Dick KA, 2008, NANO LETT, V8, P4087, DOI 10.1021/nl8027153; Ferralis N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.256102; Hannon JB, 2006, NATURE, V440, P69, DOI 10.1038/nature04574; Hellman OC, 2000, MICROSC MICROANAL, V6, P437, DOI 10.1007/s100050010051; Hemesath ER, 2012, NANO LETT, V12, P167, DOI 10.1021/nl203259f; Lim SK, 2013, NANO LETT, V13, P331, DOI 10.1021/nl300121p; Madras P, 2010, NANO LETT, V10, P1759, DOI 10.1021/nl100249j; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Mehta B, 2005, J ELECTROCHEM SOC, V152, pG309, DOI 10.1149/1.1864452; Moutanabbir O, 2013, NATURE, V496, P78, DOI 10.1038/nature11999; Musin IR, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4792660; Naik GV, 2013, ADV MATER, V25, P3264, DOI 10.1002/adma.201205076; Ozel T, 2015, NAT NANOTECHNOL, V10, P319, DOI [10.1038/NNANO.2015.33, 10.1038/nnano.2015.33]; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Ross FM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146104; SEIDEL H, 1990, J ELECTROCHEM SOC, V137, P3612, DOI 10.1149/1.2086277; Shenoy VB, 2012, MRS BULL, V37, P847, DOI 10.1557/mrs.2012.184; STOLWIJK NA, 1983, PHYSICA B & C, V116, P335, DOI 10.1016/0378-4363(83)90271-1; Tawfick S, 2012, ADV MATER, V24, P1628, DOI 10.1002/adma.201103796; Xu S, 2015, SCIENCE, V347, P154, DOI 10.1126/science.1260960; Zhao LY, 2007, J AM CHEM SOC, V129, P5730, DOI 10.1021/ja070441j	29	77	77	3	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1451	1455		10.1126/science.1257278	http://dx.doi.org/10.1126/science.1257278			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113718				2022-12-28	WOS:000356869100036
J	Payne, KAP; White, MD; Fisher, K; Khara, B; Bailey, SS; Parker, D; Rattray, NJW; Trivedi, DK; Goodacre, R; Beveridge, R; Barran, P; Rigby, SEJ; Scrutton, NS; Hay, S; Leys, D				Payne, Karl A. P.; White, Mark D.; Fisher, Karl; Khara, Basile; Bailey, Samuel S.; Parker, David; Rattray, Nicholas J. W.; Trivedi, Drupad K.; Goodacre, Royston; Beveridge, Rebecca; Barran, Perdita; Rigby, Stephen E. J.; Scrutton, Nigel S.; Hay, Sam; Leys, David			New cofactor supports alpha,beta-unsaturated acid decarboxylation via 1,3-dipolar cycloaddition	NATURE			English	Article							ESCHERICHIA-COLI; SORBIC ACID; COENZYME-Q; BIOSYNTHESIS; UBIX; ENZYME; GENES; CARBOXYLASES; ASPERGILLUS; EVOLUTION	The bacterial ubiD and ubiX or the homologous fungal fdc1 and pad1 genes have been implicated in the non-oxidative reversible decarboxylation of aromatic substrates, and play a pivotal role in bacterial ubiquinone (also known as coenzyme Q) biosynthesis(1-3) or microbial biodegradation of aromatic compounds(4-6), respectively. Despite biochemical studies on individual gene products, the composition and cofactor requirement of the enzyme responsible for in vivo decarboxylase activity remained unclear(7-9). Here we show that Fdc1 is solely responsible for the reversible decarboxylase activity, and that it requires a new type of cofactor: a prenylated flavin synthesized by the associated UbiX/Pad1(10). Atomic resolution crystal structures reveal that two distinct isomers of the oxidized cofactor can be observed, an isoalloxazine N5-iminium adduct and a N5 secondary ketimine species with markedly altered ring structure, both having azomethine ylide character. Substrate binding positions the dipolarophile enoic acid group directly above the azomethine ylide group. The structure of a covalent inhibitor-cofactor adduct suggests that 1,3-dipolar cycloaddition chemistry supports reversible decarboxylation in these enzymes. Although 1,3-dipolar cycloaddition is commonly used in organic chemistry(11,12), we propose that this presents the first example, to our knowledge, of an enzymatic 1,3-dipolar cycloaddition reaction. Our model for Fdc1/UbiD catalysis offers new routes in alkene hydrocarbon production or aryl (de) carboxylation.	[Payne, Karl A. P.; White, Mark D.; Fisher, Karl; Khara, Basile; Bailey, Samuel S.; Rattray, Nicholas J. W.; Trivedi, Drupad K.; Goodacre, Royston; Beveridge, Rebecca; Barran, Perdita; Rigby, Stephen E. J.; Scrutton, Nigel S.; Hay, Sam; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Ctr Synthet Biol Fine & Special Chem, Manchester M1 7DN, Lancs, England; [Parker, David] Westhollow Technol Ctr, Innovat Biodomain Shell Int Explorat & Prod, Houston, TX 77082 USA	University of Manchester	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Ctr Synthet Biol Fine & Special Chem, 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Trivedi, Drupad/I-3904-2017; Barran, Perdita/AAY-6303-2021; Goodacre, Roy/J-1600-2012; Hay, Sam/D-5974-2012; Goodacre, Roy/AAO-3194-2021; Rattray, Nicholas/AAX-7283-2021; Fisher, Karl/A-5956-2013	Trivedi, Drupad/0000-0001-7969-0195; Goodacre, Roy/0000-0003-2230-645X; Hay, Sam/0000-0003-3274-0938; Goodacre, Roy/0000-0003-2230-645X; Fisher, Karl/0000-0003-3539-8939; White, Mark/0000-0002-1431-0339; Barran, Perdita/0000-0002-7720-586X; Rattray, Nicholas/0000-0002-3528-6905; Beveridge, Rebecca/0000-0003-0320-6496; payne, karl/0000-0002-6331-6374	BBSRC [BB/K017802/1, BB/M/017702/1]; EU [FP-7 256808]; Royal Society; BBSRC [BB/M017702/1, BB/H021523/1, BB/E013007/1] Funding Source: UKRI; EPSRC [EP/J020192/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013007/1, BB/K017802/1, 1482350, BB/H021523/1, BB/M017702/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The main part of this work was supported by BBSRC grants (BB/K017802/1 with Shell and BB/M/017702/1). Early studies were supported by EU grant FP-7 256808 to D.L. and N.S.S. S.H. is a BBSRC David Phillips research fellow. N.S.S. is an EPSRC Established Career Fellow and Royal Society Wolfson Award holder. We thank Diamond Light Source for access to MX beamlines (proposal number MX8997), which helped to contribute to the results presented here. We thank D. Procter (University of Manchester) for discussions. The authors acknowledge the assistance given by IT Services and the use of the Computational Shared Facility at The University of Manchester.	Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Boll M, 2014, ENVIRON MICROBIOL, V16, P612, DOI 10.1111/1462-2920.12328; Christendat D, 2000, NAT STRUCT BIOL, V7, P903; de Gonzalo G, 2011, CHEM COMMUN, V47, P11050, DOI 10.1039/c1cc14039f; de Villers MM, 2000, DRUG DEV IND PHARM, V26, P539, DOI 10.1081/DDC-100101265; Desai BJ, 2014, P NATL ACAD SCI USA, V111, P15066, DOI 10.1073/pnas.1411772111; Erb TJ, 2011, APPL ENVIRON MICROB, V77, P8466, DOI 10.1128/AEM.05702-11; Ess DH, 2008, J AM CHEM SOC, V130, P10187, DOI 10.1021/ja800009z; Frisch X.M.J., 2010, GAUSSIAN 09; Fu GX, 2011, BIOCHEMISTRY-US, V50, P6292, DOI 10.1021/bi200831a; Guex Y. N, 1997, ELECTROPHORESIS, V18, P2714; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Imada Y, 2011, CHEM-EUR J, V17, P5908, DOI 10.1002/chem.201003278; Jacewicz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063161; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KALGHATGI KK, 1975, BIOCHEM J, V149, P65, DOI 10.1042/bj1490065; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; Kopec J, 2011, ACTA CRYSTALLOGR F, V67, P1184, DOI 10.1107/S174430911102923X; LEPPIK RA, 1976, BIOCHIM BIOPHYS ACTA, V436, P800, DOI 10.1016/0005-2736(76)90407-7; Li TF, 2012, BIOORG CHEM, V43, P2, DOI 10.1016/j.bioorg.2012.03.001; Lin FM, 2015, ACS CHEM BIOL, V10, P1137, DOI 10.1021/cb5008103; Lupa B, 2005, GENOMICS, V86, P342, DOI 10.1016/j.ygeno.2005.05.002; Mukai N, 2010, J BIOSCI BIOENG, V109, P564, DOI 10.1016/j.jbiosc.2009.11.011; Okrasa K, 2009, ANGEW CHEM INT EDIT, V48, P7691, DOI 10.1002/anie.200904112; Pellissier H, 2007, TETRAHEDRON, V63, P3235, DOI 10.1016/j.tet.2007.01.009; Plumridge A, 2010, FUNGAL GENET BIOL, V47, P683, DOI 10.1016/j.fgb.2010.04.011; Prantz K, 2010, CHEM REV, V110, P3741, DOI 10.1021/cr900386h; Preiswerk N, 2014, P NATL ACAD SCI USA, V111, P8013, DOI 10.1073/pnas.1401073111; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; Richter M, 2013, NAT PROD REP, V30, P1324, DOI 10.1039/c3np70045c; Stratford M, 2012, INT J FOOD MICROBIOL, V157, P375, DOI 10.1016/j.ijfoodmicro.2012.06.007; Waller MP, 2006, J COMPUT CHEM, V27, P491, DOI 10.1002/jcc.20363; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; White M. D., 2015, NATURE; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu ST, 2013, CELL RES, V23, P1296, DOI 10.1038/cr.2013.107; Zhang HT, 2003, FEMS MICROBIOL LETT, V223, P67, DOI 10.1016/S0378-1097(03)00343-4	37	137	148	5	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					497	+		10.1038/nature14560	http://dx.doi.org/10.1038/nature14560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26083754	Green Accepted			2022-12-28	WOS:000356782900054
J	Hill, KP				Hill, Kevin P.			Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANNABIS-BASED MEDICINE; GUIDELINE DEVELOPMENT SUBCOMMITTEE; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; MULTIPLE-SCLEROSIS; NEUROPATHIC PAIN; AMERICAN ACADEMY; MENTAL-HEALTH; EFFICACY; TOLERABILITY	IMPORTANCE As of March 2015, 23 states and the District of Columbia had medical marijuana laws in place. Physicians should know both the scientific rationale and the practical implications for medical marijuana laws. OBJECTIVE To review the pharmacology, indications, and laws related to medical marijuana use. EVIDENCE REVIEW The medical literature on medical marijuana was reviewed from 1948 to March 2015 via MEDLINE with an emphasis on 28 randomized clinical trials of cannabinoids as pharmacotherapy for indications other than those for which there are 2 US Food and Drug Administration-approved cannabinoids (dronabinol and nabilone), which include nausea and vomiting associated with chemotherapy and appetite stimulation in wasting illnesses. FINDINGS Use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high-quality evidence. Six trials that included 325 patients examined chronic pain, 6 trials that included 396 patients investigated neuropathic pain, and 12 trials that included 1600 patients focused on multiple sclerosis. Several of these trials had positive results, suggesting that marijuana or cannabinoids may be efficacious for these indications. CONCLUSIONS AND RELEVANCE Medical marijuana is used to treat a host of indications, a few of which have evidence to support treatment with marijuana and many that do not. Physicians should educate patients about medical marijuana to ensure that it is used appropriately and that patients will benefit from its use.	[Hill, Kevin P.] McLean Hosp, Subst Abuse Consultat Serv, Belmont, MA 02478 USA; [Hill, Kevin P.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Hill, KP (corresponding author), McLean Hosp, Div Alcohol & Drug Abuse, 115 Mill St, Belmont, MA 02478 USA.	khill@mclean.harvard.edu	Hill, Kevin/GLQ-8874-2022		Brain and Behavior Research Foundation; American Lung Association; National Institute on Drug Abuse [K99/R00DA029115]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA029115] Funding Source: NIH RePORTER	Brain and Behavior Research Foundation; American Lung Association; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hill reports receiving honoraria from multiple academic institutions for talks related to medical marijuana, grants from the Brain and Behavior Research Foundation and the American Lung Association, and earnings from Hazelden Publishing for a book on marijuana. His major funding is from the National Institute on Drug Abuse (grant K99/R00DA029115).	Abrams DI, 2007, NEUROLOGY, V68, P515, DOI 10.1212/01.wnl.0000253187.66183.9c; Aggarwal Sunil K, 2007, MedGenMed, V9, P52; Amar MB, 2006, J ETHNOPHARMACOL, V105, P1, DOI 10.1016/j.jep.2006.02.001; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2008, CES PROD INF; [Anonymous], 2008, MAR PROD INF; Aragona M, 2009, CLIN NEUROPHARMACOL, V32, P41, DOI 10.1097/WNF.0b013e3181633497; Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Berman JS, 2004, PAIN, V112, P299, DOI 10.1016/j.pain.2004.09.013; Bhattacharyya S, 2010, NEUROPSYCHOPHARMACOL, V35, P764, DOI 10.1038/npp.2009.184; Blake DR, 2006, RHEUMATOLOGY, V45, P50, DOI 10.1093/rheumatology/kei183; Brook JS, 2013, SUBST ABUS, V34, P298, DOI 10.1080/08897077.2013.775092; Carroll CB, 2004, NEUROLOGY, V63, P1245, DOI 10.1212/01.WNL.0000140288.48796.8E; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Center for Behavioral Health Statistics and Quality, 2013, NAT SURV DRUG US HLT, V2015; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Crippa JA, 2009, HUM PSYCHOPHARM CLIN, V24, P515, DOI 10.1002/hup.1048; Degenhardt L, 2003, ADDICTION, V98, P1493, DOI 10.1046/j.1360-0443.2003.00437.x; Di Forti M, 2015, LANCET PSYCHIAT, V2, P233, DOI 10.1016/S2215-0366(14)00117-5; Ellis RJ, 2009, NEUROPSYCHOPHARMACOL, V34, P672, DOI 10.1038/npp.2008.120; Fergusson DM, 2008, ADDICTION, V103, P969, DOI 10.1111/j.1360-0443.2008.02221.x; Fox P, 2004, NEUROLOGY, V62, P1105, DOI 10.1212/01.WNL.0000118203.67138.3E; Frank B, 2008, BRIT MED J, V336, P199, DOI 10.1136/bmj.39429.619653.80; Freeman RM, 2006, INT UROGYNECOL J, V17, P636, DOI 10.1007/s00192-006-0086-x; Gilman JM, 2014, J NEUROSCI, V34, P5529, DOI 10.1523/JNEUROSCI.4745-13.2014; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hartman RL, 2013, CLIN CHEM, V59, P478, DOI 10.1373/clinchem.2012.194381; Hazekamp A., 2010, CANNABINOIDS, V5, P1, DOI DOI 10.1007/978-3-319-56645-0_; Hill KP, 2014, J PSYCHIATR PRACT, V20, P389, DOI 10.1097/01.pra.0000454786.97976.96; Johnston L.D., 2013, MONITORING FUTURE NA; Joy JE, 1999, MARIJUANA MED ASSESS; Kavia RBC, 2010, MULT SCLER J, V16, P1349, DOI 10.1177/1352458510378020; Killestein J, 2002, NEUROLOGY, V58, P1404, DOI 10.1212/WNL.58.9.1404; Kleber HD, 2012, AM J PSYCHIAT, V169, P564, DOI 10.1176/appi.ajp.2012.12030373; Koppel BS, 2014, NEUROLOGY, V82, P1556, DOI 10.1212/WNL.0000000000000363; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Lopez-Quintero C, 2011, DRUG ALCOHOL DEPEN, V115, P120, DOI 10.1016/j.drugalcdep.2010.11.004; Lynskey M, 2000, ADDICTION, V95, P1621, DOI 10.1046/j.1360-0443.2000.951116213.x; Massachusetts Executive Office of Health and Human Services, MED MAR INF PHYS; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Naftali T, 2013, CLIN GASTROENTEROL H, V11, P1276, DOI 10.1016/j.cgh.2013.04.034; Narang S, 2008, J PAIN, V9, P254, DOI 10.1016/j.jpain.2007.10.018; Nurmikko TJ, 2007, PAIN, V133, P210, DOI 10.1016/j.pain.2007.08.028; OCEBM Levels of Evidence Working Group, OCEBM LEV EV; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Pinsger M, 2006, WIEN KLIN WOCHENSCHR, V118, P327, DOI 10.1007/s00508-006-0611-4; ProCon.org, 2015, 23 LEG MED MAR STAT; Programme on Substance Abuse, 1997, CANN HLTH PERSP RES; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Skrabek RQ, 2008, J PAIN, V9, P164, DOI 10.1016/j.jpain.2007.09.002; Smith MJ, 2014, SCHIZOPHRENIA BULL, V40, P287, DOI 10.1093/schbul/sbt176; Svendsen KB, 2004, BMJ-BRIT MED J, V329, P253, DOI 10.1136/bmj.38149.566979.AE; Thomas G, 2014, AM J CARDIOL, V113, P187, DOI 10.1016/j.amjcard.2013.09.042; UNGERLEIDER J T, 1987, Advances in Alcohol and Substance Abuse, V7, P39; Vaney C, 2004, MULT SCLER, V10, P417, DOI 10.1191/1352458504ms1048oa; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Wade DT, 2003, CLIN REHABIL, V17, P21, DOI 10.1191/0269215503cr581oa; Weber M, 2010, J NEUROL NEUROSUR PS, V81, P1135, DOI 10.1136/jnnp.2009.200642; Wilkinson ST, 2014, JAMA-J AM MED ASSOC, V311, P2377, DOI 10.1001/jama.2014.6175; Wilsey B, 2008, J PAIN, V9, P506, DOI 10.1016/j.jpain.2007.12.010; Wissel J, 2006, J NEUROL, V253, P1337, DOI 10.1007/s00415-006-0218-8; Yadav V, 2014, NEUROLOGY, V82, P1083, DOI 10.1212/WNL.0000000000000250; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1; Zajicek JP, 2012, J NEUROL NEUROSUR PS, V83, P1125, DOI 10.1136/jnnp-2012-302468	68	337	347	10	245	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2474	2483		10.1001/jama.2015.6199	http://dx.doi.org/10.1001/jama.2015.6199			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103031				2022-12-28	WOS:000356663600016
J	Maselli, DJ; Peters, JI				Maselli, Diego J.; Peters, Jay I.			Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthma	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Maselli, Diego J.; Peters, Jay I.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Maselli, DJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.							Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Meurs H, 2013, CURR OPIN PHARMACOL, V13, P316, DOI 10.1016/j.coph.2013.04.004; Wise RA, 2013, NEW ENGL J MED, V369, P1491, DOI 10.1056/NEJMoa1303342	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC5	10.7326/ACPJC-2015-162-12-005	http://dx.doi.org/10.7326/ACPJC-2015-162-12-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075782				2022-12-28	WOS:000356516300006
J	Schectman, JM				Schectman, Joel M.			Incretin use was not associated with increased risk for acute pancreatitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Virginia, Charlottesville, VA 22904 USA	University of Virginia	Schectman, JM (corresponding author), Univ Virginia, Charlottesville, VA 22904 USA.			Thomsen, Reimar/0000-0001-9135-3474				Faillie JL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2780; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC12	10.7326/ACPJC-2015-162-12-012	http://dx.doi.org/10.7326/ACPJC-2015-162-12-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075777				2022-12-28	WOS:000356516300013
J	Ronco, P; Debiec, H				Ronco, Pierre; Debiec, Hanna			Pathophysiological advances in membranous nephropathy: time for a shift in patient's care	LANCET			English	Article							PHOSPHOLIPASE A(2) RECEPTOR; NEPHROTIC SYNDROME; EXPERIMENTAL GLOMERULONEPHRITIS; ANTI-PLA2R ANTIBODIES; SPONTANEOUS REMISSION; PLA2R AUTOANTIBODIES; REPLACEMENT THERAPY; HEYMANN NEPHRITIS; DE-NOVO; ANTIGEN	Membranous nephropathy is a major cause of nephrotic syndrome of non-diabetic origin in adults. It is the second or third leading cause of end-stage renal disease in patients with primary glomerulonephritis, and is the leading glomerulopathy that recurs after kidney transplantation (occurring in about 40% of patients). Treatment with costly and potentially toxic drugs remains controversial and challenging, partly because of insufficient insight into the pathogenesis of the disease and absence of sensitive biomarkers of disease activity. The disease is caused by the formation of immune deposits on the outer aspect of the glomerular basement membrane, which contain podocyte or planted antigens and circulating antibodies specific to those antigens, resulting in complement activation. In 2002, podocyte neutral endopeptidase was identified as an antigenic target of circulating antibodies in alloimmune neonatal nephropathy, and in 2009, podocyte phospholipase A(2) receptor (PLA(2)R) was reported as an antigenic target in autoimmune adult membranous nephropathy. These major breakthroughs were translated to clinical practice very quickly. Measurement of anti-PLA(2)R antibodies in serum and detection of PLA(2)R antigen in glomerular deposits can now be done routinely. Anti-PLA(2)R antibodies have high specificity (close to 100%), sensitivity (70-80%), and predictive value. PLA(2)R detection in immune deposits allows for retrospective diagnosis of PLA(2)R-related membranous nephropathy in archival kidney biopsies. These tests already have a major effect on diagnosis and monitoring of treatment, including after transplantation.	[Ronco, Pierre; Debiec, Hanna] Univ Paris 06, UMR S 1155, Sorbonne Univ, Paris, France; [Ronco, Pierre; Debiec, Hanna] INSERM, UMR S 1155, Paris, France; [Ronco, Pierre] Hop Tenon, AP HP, Dept Nephrol & Dialysis, F-75020 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Ronco, P (corresponding author), Hop Tenon, Nephrol & Dialysis, 4 Rue Chine, F-75020 Paris, France.	pierreronco@yahoo.fr	Debiec, Hanna/AAL-8144-2021; Ronco, Pierre/AAC-8390-2022	Debiec, Hanna/0000-0002-8946-8245; 	European Research Council Grant [ERC-2012-ADG_20120314, 322947]; Agence Nationale pour la Recherche Programme Blanc SVSE1 [ANR-12-BSE1-0002-01]; Fondation pour la Recherche Medicale Equipe FRM grant; 7th Framework Programme of the European Community (European Consortium for High-Throughput Research in Rare Kidney Diseases) [2012-305608]	European Research Council Grant(European Research Council (ERC)); Agence Nationale pour la Recherche Programme Blanc SVSE1(French National Research Agency (ANR)); Fondation pour la Recherche Medicale Equipe FRM grant; 7th Framework Programme of the European Community (European Consortium for High-Throughput Research in Rare Kidney Diseases)	The research of PR and HD is supported by the European Research Council Grant ERC-2012-ADG_20120314 (Grant Agreement 322947), Agence Nationale pour la Recherche Programme Blanc SVSE1 (2012) Decision ANR-12-BSE1-0002-01, Fondation pour la Recherche Medicale Equipe FRM 2012 grant, and the 7th Framework Programme of the European Community Contract 2012-305608 (European Consortium for High-Throughput Research in Rare Kidney Diseases). None of the funding sources had a role in the writing of the Series paper or the decision to submit it for publication.	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; ADLER SG, 1983, J CLIN INVEST, V71, P487, DOI 10.1172/JCI110793; Akiyama S, 2015, CLIN EXP NEPHROL, V19, P653, DOI 10.1007/s10157-014-1054-2; Augert A, 2009, EMBO REP, V10, P271, DOI 10.1038/embor.2008.255; Bech AP, 2014, CLIN J AM SOC NEPHRO, V9, P1386, DOI 10.2215/CJN.10471013; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Behnert A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061669; Bhimma R, 2004, AM J NEPHROL, V24, P198, DOI 10.1159/000077065; Blosser CD, 2012, AM J TRANSPLANT, V12, P1637, DOI 10.1111/j.1600-6143.2011.03957.x; BORDER WA, 1982, J CLIN INVEST, V69, P451, DOI 10.1172/JCI110469; Bullich G, 2014, CLIN J AM SOC NEPHRO, V9, P335, DOI 10.2215/CJN.05310513; Cattran D, 2005, J AM SOC NEPHROL, V16, P1188, DOI 10.1681/ASN.2005010028; Coenen MJH, 2013, J AM SOC NEPHROL, V24, P677, DOI 10.1681/ASN.2012070730; COUSER WG, 1978, J CLIN INVEST, V62, P1275, DOI 10.1172/JCI109248; Cravedi P, 2014, NEPHRON CLIN PRACT, V128, P261, DOI 10.1159/000368589; Cybulsky AV, 2013, KIDNEY INT, V84, P25, DOI 10.1038/ki.2012.390; Dahnrich C, 2013, CLIN CHIM ACTA, V421, P213, DOI 10.1016/j.cca.2013.03.015; Debiec H, 2004, LANCET, V364, P1252, DOI 10.1016/S0140-6736(04)17142-0; Debiec H, 2011, AM J TRANSPLANT, V11, P2144, DOI 10.1111/j.1600-6143.2011.03643.x; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Debiec H, 2014, J AM SOC NEPHROL, V25, P675, DOI 10.1681/ASN.2013030290; Debiec H, 2012, J AM SOC NEPHROL, V23, P1949, DOI 10.1681/ASN.2012060577; Debiec H, 2011, NAT REV NEPHROL, V7, P496, DOI 10.1038/nrneph.2011.106; Debiec H, 2011, NEW ENGL J MED, V364, P2101, DOI 10.1056/NEJMoa1013792; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Du Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104936; Ehrenreich T, 1968, PATHOL ANNU, P145; ELSHIHABI I, 1993, J PEDIATR-US, V123, P940, DOI 10.1016/S0022-3476(05)80391-9; Fervenza FC, 2008, CLIN J AM SOC NEPHRO, V3, P905, DOI 10.2215/CJN.04321007; Fresquet M, 2015, J AM SOC NEPHROL, V26, P302, DOI 10.1681/ASN.2014050502; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Glassock RJ, 2003, SEMIN NEPHROL, V23, P324, DOI 10.1016/S0270-9295(03)00049-4; Hayashi N, 2015, CLIN EXP NEPHROL, V19, P797, DOI 10.1007/s10157-014-1064-0; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Hladunewich MA, 2009, CLIN J AM SOC NEPHRO, V4, P1417, DOI 10.2215/CJN.01330209; Hofstra JM, 2013, NAT REV NEPHROL, V9, P443, DOI 10.1038/nrneph.2013.125; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110681; Hoxha E, 2014, CLIN J AM SOC NEPHRO, V9, P1883, DOI 10.2215/CJN.03850414; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Hunley TE, 2004, PEDIATRICS, V114, pE532, DOI 10.1542/peds.2003-0988-L; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; Kao LY, 2015, J AM SOC NEPHROL, V26, P291, DOI 10.1681/ASN.2013121315; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; Kerjaschki D, 2004, LANCET, V364, P1194, DOI 10.1016/S0140-6736(04)17154-7; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; Kim S, 2011, NEPHRON CLIN PRACT, V117, pC253, DOI 10.1159/000320194; Knehtl M, 2011, AM J KIDNEY DIS, V57, P140, DOI 10.1053/j.ajkd.2010.09.015; Larsen C, 2013, FORTUNE, V167, P26; Larsen CP, 2013, TRANSPLANTATION, V95, P1259, DOI 10.1097/TP.0b013e31828a947b; Lhotta K, 1999, NEPHROL DIAL TRANSPL, V14, P881, DOI 10.1093/ndt/14.4.881; Liu YH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-81; Lv JC, 2013, J AM SOC NEPHROL, V24, P1323, DOI 10.1681/ASN.2012080771; Ma H, 2013, SEMIN NEPHROL, V33, P531, DOI 10.1016/j.semnephrol.2013.08.004; Maisonneuve P, 2000, AM J KIDNEY DIS, V35, P157, DOI 10.1016/S0272-6386(00)70316-7; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Menon S, 2010, PEDIATR NEPHROL, V25, P1419, DOI 10.1007/s00467-009-1324-5; Naik A, 2013, SEMIN NEPHROL, V33, P575, DOI 10.1016/j.semnephrol.2013.08.008; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; Ohtani H, 2004, NEPHROL DIAL TRANSPL, V19, P574, DOI 10.1093/ndt/gfg616; Pan YB, 2014, SCI REP-UK, V4, DOI 10.1038/srep06660; Polanco N, 2012, NEPHROL DIAL TRANSPL, V27, P231, DOI 10.1093/ndt/gfr285; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; Ponticelli C, 2007, J NEPHROL, V20, P268; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Qu Z, 2012, NEPHROL DIAL TRANSPL, V27, P1931, DOI 10.1093/ndt/gfr534; Ronco P, 2012, NAT REV NEPHROL, V8, P203, DOI 10.1038/nrneph.2012.35; Ruggenenti P, 2015, J AM SOC NEPHROL; SACKS SH, 1993, KIDNEY INT, V43, pS13; Segawa Y, 2010, PEDIATR NEPHROL, V25, P1091, DOI 10.1007/s00467-009-1439-8; Seitz-Polski B, 2014, NEPHROL DIAL TRANSPL, V29, P2334, DOI 10.1093/ndt/gfu252; Sis B, 2007, KIDNEY INT, V71, P218, DOI 10.1038/sj.ki.5002039; Stahl R, 2010, NEW ENGL J MED, V363, P496, DOI 10.1056/NEJMc1003066; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; VANDAMME BJC, 1978, LAB INVEST, V38, P502; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; VANGELISTA A, 1988, NEPHRON, V50, P79, DOI 10.1159/000185130; VAUGHAN RW, 1989, TISSUE ANTIGENS, V34, P261, DOI 10.1111/j.1399-0039.1989.tb01741.x; Vivarelli M, 2015, KIDNEY INT, V87, P602, DOI 10.1038/ki.2014.381; Wang B, 2011, J INT MED RES, V39, P86, DOI 10.1177/147323001103900111; Wasserstein AG, 1997, J AM SOC NEPHROL, V8, P664	87	199	228	4	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1983	1992		10.1016/S0140-6736(15)60731-0	http://dx.doi.org/10.1016/S0140-6736(15)60731-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	26090644				2022-12-28	WOS:000354541700032
J	Watts, G				Watts, Geoff			Peng Gong: remote sensing of near climate change	LANCET			English	Biographical-Item																		GONG P, PUBLICATION LIST	1	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1815	1815		10.1016/S0140-6736(15)60723-1	http://dx.doi.org/10.1016/S0140-6736(15)60723-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26111437	Bronze			2022-12-28	WOS:000364194700019
J	Carrier, M; Lazo-Langner, A; Shivakumar, S; Tagalakis, V; Zarychanski, R; Solymoss, S; Routhier, N; Douketis, J; Danovitch, K; Lee, AY; Le Gal, G; Wells, PS; Corsi, DJ; Ramsay, T; Coyle, D; Chagnon, I; Kassam, Z; Tao, H; Rodger, MA				Carrier, Marc; Lazo-Langner, Alejandro; Shivakumar, Sudeep; Tagalakis, Vicky; Zarychanski, Ryan; Solymoss, Susan; Routhier, Nathalie; Douketis, James; Danovitch, Kim; Lee, Agnes Y.; Le Gal, Gregoire; Wells, Philip S.; Corsi, Daniel J.; Ramsay, Timothy; Coyle, Doug; Chagnon, Isabelle; Kassam, Zahra; Tao, Hardy; Rodger, Marc A.		SOME Investigators	Screening for Occult Cancer in Unprovoked Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; RISK; POPULATION; DIAGNOSIS	BACKGROUND Venous thromboembolism may be the earliest sign of cancer. Currently, there is a great diversity in practices regarding screening for occult cancer in a person who has an unprovoked venous thromboembolism. We sought to assess the efficacy of a screening strategy for occult cancer that included comprehensive computed tomography (CT) of the abdomen and pelvis in patients who had a first unprovoked venous thromboembolism. METHODS We conducted a multicenter, open-label, randomized, controlled trial in Canada. Patients were randomly assigned to undergo limited occult-cancer screening (basic blood testing, chest radiography, and screening for breast, cervical, and prostate cancer) or limited occult-cancer screening in combination with CT. The primary outcome measure was confirmed cancer that was missed by the screening strategy and detected by the end of the 1-year follow-up period. RESULTS Of the 854 patients who underwent randomization, 33 (3.9%) had a new diagnosis of occult cancer between randomization and the 1-year follow-up: 14 of the 431 patients (3.2%) in the limited-screening group and 19 of the 423 patients (4.5%) in the limited-screening-plus-CT group (P = 0.28). In the primary outcome analysis, 4 occult cancers (29%) were missed by the limited screening strategy, whereas 5 (26%) were missed by the strategy of limited screening plus CT (P = 1.0). There was no significant difference between the two study groups in the mean time to a cancer diagnosis (4.2 months in the limited-screening group and 4.0 months in the limited-screening-plus-CT group, P = 0.88) or in cancer-related mortality (1.4% and 0.9%, P = 0.75). CONCLUSIONS The prevalence of occult cancer was low among patients with a first unprovoked venous thromboembolism. Routine screening with CT of the abdomen and pelvis did not provide a clinically significant benefit. (Funded by the Heart and Stroke Foundation of Canada;	[Carrier, Marc; Danovitch, Kim; Le Gal, Gregoire; Wells, Philip S.; Rodger, Marc A.] Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada; [Corsi, Daniel J.; Ramsay, Timothy; Coyle, Doug] Univ Ottawa, Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON K1H 8L6, Canada; [Tao, Hardy] Univ Ottawa, Dept Diagnost Imaging, Ottawa, ON K1H 8L6, Canada; [Lazo-Langner, Alejandro] Univ Western Ontario, Dept Med, London, ON, Canada; [Lazo-Langner, Alejandro] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Lazo-Langner, Alejandro] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Kassam, Zahra] Univ Western Ontario, Dept Med Imaging, London, ON, Canada; [Shivakumar, Sudeep] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Tagalakis, Vicky] Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada; [Solymoss, Susan] McGill Univ, Montreal Gen Hosp, Dept Med, Montreal, PQ H3A 2T5, Canada; [Routhier, Nathalie; Chagnon, Isabelle] Univ Montreal, Hosp Sacre Coeur, Dept Med, Montreal, PQ, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Douketis, James] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Lee, Agnes Y.] Univ British Columbia, Dept Med, Vancouver, BC, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Dalhousie University; McGill University; McGill University; Universite de Montreal; University of Manitoba; McMaster University; University of British Columbia	Carrier, M (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa Hosp Gen Campus,501 Smyth Rd,Box 201a, Ottawa, ON K1H 8L6, Canada.	mcarrier@toh.on.ca	Tagalakis, Vicky/E-1932-2015; Lazo-Langner, Alejandro/E-6993-2011; Douketis, James/AAO-5659-2021; Zarychanski, Ryan/AAB-6369-2022; Corsi, Daniel J/S-4689-2018; Lazo-Langner, Alejandro/G-3318-2011	Lazo-Langner, Alejandro/0000-0001-6869-8431; Corsi, Daniel J/0000-0001-7063-3354; Lazo-Langner, Alejandro/0000-0001-6869-8431; Ramsay, Tim/0000-0001-8478-8170; Gandara, Esteban/0000-0003-0313-9174; Rodger, Marc/0000-0001-8166-3487; Coyle, Doug/0000-0003-3492-2268; Zarychanski, Ryan/0000-0001-9455-6138	Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	Funded by the Heart and Stroke Foundation of Canada; SOME ClinicalTrials.gov number, NCT00773448.	ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Community Preventive Services Task Force, 2021, GUID COMM PREV SERV; Cornuz J, 1996, ANN INTERN MED, V125, P785, DOI 10.7326/0003-4819-125-10-199611150-00001; Monreal M, 2004, J THROMB HAEMOST, V2, P876, DOI 10.1111/j.1538-7836.2004.00721.x; NORDSTROM M, 1994, BRIT MED J, V308, P891, DOI 10.1136/bmj.308.6933.891; Piccioli A, 2004, J THROMB HAEMOST, V2, P884, DOI 10.1111/j.1538-7836.2004.00720.x; Prandoni P, 2010, J THROMB HAEMOST, V8, P1126, DOI 10.1111/j.1538-7836.2010.03797.x; Public Health Agency of Canada, 2010, CAN TASK FORC PREV H; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; van Doormaal FF, 2011, J THROMB HAEMOST, V9, P79, DOI 10.1111/j.1538-7836.2010.04101.x; White RH, 2005, ARCH INTERN MED, V165, P1782, DOI 10.1001/archinte.165.15.1782; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	15	184	189	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					697	704		10.1056/NEJMoa1506623	http://dx.doi.org/10.1056/NEJMoa1506623			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26095467	Bronze			2022-12-28	WOS:000359709400006
J	Kronke, J; Fink, EC; Hollenbach, PW; MacBeth, KJ; Hurst, SN; Udeshi, ND; Chamberlain, PP; Mani, DR; Man, HW; Gandhi, AK; Svinkina, T; Schneider, RK; McConkey, M; Jaras, M; Griffiths, E; Wetzler, M; Bullinger, L; Cathers, BE; Carr, SA; Chopra, R; Ebert, BL				Kroenke, Jan; Fink, Emma C.; Hollenbach, Paul W.; MacBeth, Kyle J.; Hurst, Slater N.; Udeshi, Namrata D.; Chamberlain, Philip P.; Mani, D. R.; Man, Hon Wah; Gandhi, Anita K.; Svinkina, Tanya; Schneider, Rebekka K.; McConkey, Marie; Jaeras, Marcus; Griffiths, Elizabeth; Wetzler, Meir; Bullinger, Lars; Cathers, Brian E.; Carr, Steven A.; Chopra, Rajesh; Ebert, Benjamin L.			Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS	NATURE			English	Article							COMMONLY DELETED REGION; CASEIN KINASE; MYELODYSPLASTIC SYNDROMES; MULTIPLE-MYELOMA; GENE; IDENTIFICATION; THALIDOMIDE; COMPLEX; EFFICACY; THERAPY	Lenalidomide is a highly effective treatment for myelodysplastic syndrome (MDS) with deletion of chromosome 5q (del(5q)). Here, we demonstrate that lenalidomide induces the ubiquitination of casein kinase 1A1 (CK1 alpha) by the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4(CRBN)), resulting in CK1 alpha degradation. CK1 alpha is encoded by a gene within the common deleted region for del(5q) MDS and haploin sufficient expression sensitizes cells to lenalidomide therapy, providing a mechanistic basis for the therapeutic window of lenalidomide in del(5q) MDS. We found that mouse cells are resistant to lenalidomide but that changing a single amino acid in mouse Crbn to the corresponding human residue enables lenalidomide-dependent degradation of CK1 alpha. We further demonstrate that minor side chain modifications in thalidomide and a novel analogue, CC-122, can modulate the spectrum of substrates targeted by CRL4(CRBN). These findings have implications for the clinical activity of lenalidomide and related compounds, and demonstrate the therapeutic potential of novel modulators of E3 ubiquitin ligases.	[Kroenke, Jan; Fink, Emma C.; Hurst, Slater N.; Schneider, Rebekka K.; McConkey, Marie; Jaeras, Marcus; Ebert, Benjamin L.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Kroenke, Jan; Bullinger, Lars] Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Kroenke, Jan; Fink, Emma C.; Udeshi, Namrata D.; Mani, D. R.; Svinkina, Tanya; Carr, Steven A.; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hollenbach, Paul W.; MacBeth, Kyle J.; Chamberlain, Philip P.; Man, Hon Wah; Gandhi, Anita K.; Cathers, Brian E.; Chopra, Rajesh] Celgene Corp, San Diego, CA 92121 USA; [Griffiths, Elizabeth; Wetzler, Meir] Roswell Pk Canc Inst, Buffalo, NY 14263 USA	Harvard University; Brigham & Women's Hospital; Ulm University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Bristol-Myers Squibb; Celgene Corporation; Roswell Park Cancer Institute	Ebert, BL (corresponding author), Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA.	bebert@partners.org	Bullinger, Lars/AAL-7965-2020; Carr, Steven A./AAH-8366-2019	Fink, Emma/0000-0002-6589-8558; Mani, D. R./0000-0003-3914-133X; Jaras, Marcus/0000-0003-4080-7055; Cathers, Brian/0000-0003-2793-7533; Bullinger, Lars/0000-0002-5890-5510; Kronke, Jan/0000-0002-4649-0506	NIH [R01HL082945, P01CA108631]; Edward P. Evans Foundation; Gabrielle's Angel Foundation; Leukemia and Lymphoma Society Scholar Award; German Research Foundation (DFG, Emmy Noether Fellowship) [Kr3886/2-1, Kr3886/1-1, SFB1074]; Else-Kroner Fresenius Foundation; National Institute of General Medical Sciences [T32GM007753]; NATIONAL CANCER INSTITUTE [P01CA108631, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; Cancer Research UK [11566] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation; Gabrielle's Angel Foundation; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); German Research Foundation (DFG, Emmy Noether Fellowship)(German Research Foundation (DFG)); Else-Kroner Fresenius Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK)	We thank D. Heckl for cloning of the EGI vector and technical advice, R. Mathieu and M. Paktinat for help with FACS sorting, M. Chen for help with colony management and animal care, S. Kopff for technical support, and C. Fontanillo for proteomic analysis computational support. Patient samples were provided by the Stem Cell and Xenograft Core of the University of Pennsylvania. This work was supported by the NIH (R01HL082945 and P01CA108631), the Edward P. Evans Foundation, the Gabrielle's Angel Foundation, and a Leukemia and Lymphoma Society Scholar Award to B.L.E.; J.K. was supported by the German Research Foundation (DFG, Emmy Noether Fellowship Kr3886/2-1, Kr3886/1-1, and SFB1074) and the Else-Kroner Fresenius Foundation. E.C.F. was supported by award T32GM007753 from the National Institute of General Medical Sciences.	Benjamini Y, 1995, J R STAT SOC B; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Boultwood J, 2007, BRIT J HAEMATOL, V139, P578, DOI 10.1111/j.1365-2141.2007.06833.x; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chesi M, 2012, BLOOD, V120, P376, DOI 10.1182/blood-2012-02-412783; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Fenaux P, 2011, BLOOD, V118, P3765, DOI 10.1182/blood-2011-01-330126; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; FRATTA ID, 1965, TOXICOL APPL PHARM, V7, P268, DOI 10.1016/0041-008X(65)90095-5; FREI E, 1993, LANCET, V342, P662, DOI 10.1016/0140-6736(93)91764-D; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Graubert TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004583; Heckl D., 2014, NATURE BIOTECHNOL; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Rauniyar N, 2014, J PROTEOME RES, V13, P5293, DOI 10.1021/pr500880b; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Venerando A, 2014, BIOCHEM J, V460, P141, DOI 10.1042/BJ20140178; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; Wei S, 2009, P NATL ACAD SCI USA, V106, P12974, DOI 10.1073/pnas.0811267106; Wu SF, 2012, MOL CELL BIOL, V32, P4821, DOI 10.1128/MCB.00851-12; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024	38	480	517	5	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					183	U102		10.1038/nature14610	http://dx.doi.org/10.1038/nature14610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26131937	Green Accepted			2022-12-28	WOS:000357695900028
J	Lin, HC; Ho, SC; Chen, YY; Khoo, KH; Hsu, PH; Yen, HCS				Lin, Hsiu-Chuan; Ho, Szu-Chi; Chen, Yi-Yun; Khoo, Kay-Hooi; Hsu, Pang-Hung; Yen, Hsueh-Chi S.			CRL2 aids elimination of truncated selenoproteins produced by failed UGA/Sec decoding	SCIENCE			English	Article							MAMMALIAN THIOREDOXIN REDUCTASE; NONSENSE-MEDIATED DECAY; MESSENGER-RNA LEVELS; UBIQUITIN LIGASES; GENETIC-CODE; SELENOCYSTEINE INCORPORATION; CUL5-RBX2 MODULES; SELENIUM; IDENTIFICATION; CUL2-RBX1	Selenocysteine (Sec) is translated from the codon UGA, typically a termination signal. Codon duality extends the genetic code; however, the coexistence of two competing UGA-decoding mechanisms immediately compromises proteome fidelity. Selenium availability tunes the reassignment of UGA to Sec. We report a CRL2 ubiquitin ligase-mediated protein quality-control system that specifically eliminates truncated proteins that result from reassignment failures. Exposing the peptide immediately N-terminal to Sec, a CRL2 recognition degron, promotes protein degradation. Sec incorporation destroys the degron, protecting read-through proteins from detection by CRL2. Our findings reveal a coupling between directed translation termination and proteolysis-assisted protein quality control, as well as a cellular strategy to cope with fluctuations in organismal selenium intake.	[Lin, Hsiu-Chuan; Ho, Szu-Chi; Yen, Hsueh-Chi S.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lin, Hsiu-Chuan; Khoo, Kay-Hooi; Yen, Hsueh-Chi S.] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei, Taiwan; [Chen, Yi-Yun; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Dept Life Sci, Inst Biosci & Biotechnol, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; National Taiwan Ocean University	Yen, HCS (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	hyen@imb.sinica.edu.tw	Khoo, Kay-Hooi/E-1989-2019; Hsu, Pang-Hung/C-5587-2018; Yen, Hsueh-Chi Sherry/AAA-3907-2021	Khoo, Kay-Hooi/0000-0003-2906-406X; Hsu, Pang-Hung/0000-0001-6873-6434; Yen, Hsueh-Chi Sherry/0000-0003-3511-4414; Lin, Hsiu-Chuan/0000-0001-9587-6483	Career Development Award from Academia Sinica [101-CDA-L05]; Ministry of Science and Technology (MOST) [103-2311-B-001-034-MY3, 102-2113-M-019-003-MY2]; NIH [AG011085]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Career Development Award from Academia Sinica; Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. H. Chuang, M. D. Tsai, C. H. Yeang, L. Y. Chen, J. Y. Leu, and A. Pena for suggestions; Y. F. Chen, P. Y. Hsieh, T. T. Lee, S. Y. Lin, C. Y. Tai, and M. C. Tsai for technical assistance; S. J. Elledge, D. E. Hill, and M. Vidal for reagents. The CRL2 GPS screen was initiated at S.J.E.'s laboratory and completed in H. C.Y.'s laboratory. Orbitrap data were acquired at the Academia Sinica Common Mass Spectrometry Facilities located at the Institute of Biological Chemistry. This work was supported by Career Development Award 101-CDA-L05 from Academia Sinica and Ministry of Science and Technology (MOST) grant 103-2311-B-001-034-MY3 awarded to H. C. Y., MOST grant 102-2113-M-019-003-MY2 to P. H. H., and NIH grant AG011085 to S.J.E.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Donovan J, 2010, ANTIOXID REDOX SIGN, V12, P881, DOI 10.1089/ars.2009.2878; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Howard MT, 2013, J BIOL CHEM, V288, P19401, DOI 10.1074/jbc.M113.481051; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Lobanov AV, 2010, CRIT REV BIOCHEM MOL, V45, P257, DOI 10.3109/10409231003786094; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Okumura F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Seyedali A, 2014, RNA, V20, P1248, DOI 10.1261/rna.043463.113; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	22	42	45	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					91	95		10.1126/science.aab0515	http://dx.doi.org/10.1126/science.aab0515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138980	Green Accepted			2022-12-28	WOS:000357280800066
J	D'Souza, N				D'Souza, Nigel			PERSONAL VIEW Patients may prefer radiation risk to surgical risk in diagnosing appendicitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOWER QUADRANT PAIN; COMPUTED-TOMOGRAPHY; ULTRASONOGRAPHY; OUTCOMES		Queen Alexandra Hosp, Dept Gen Surg, Gen Surg, Portsmouth PO6 3LY, Hants, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	D'Souza, N (corresponding author), Queen Alexandra Hosp, Dept Gen Surg, Gen Surg, Portsmouth PO6 3LY, Hants, England.	mrnigeldsouza@gmail.com	D'Souza, Nigel/AAW-8195-2021					Akbar F, 2010, ANN ROY COLL SURG, V92, P65, DOI 10.1308/003588410X12518836439920; Barger RL, 2010, ACAD RADIOL, V17, P1211, DOI 10.1016/j.acra.2010.05.003; Bhangu A, 2013, BRIT J SURG, V100, P1240, DOI 10.1002/bjs.9201; D'Souza N, 2015, INT J SURG, V13, P165, DOI 10.1016/j.ijsu.2014.11.039; Drake FT, 2012, ANN SURG, V256, P586, DOI 10.1097/SLA.0b013e31826a9602; Jones GE, 2012, COLORECTAL DIS, V14, P237, DOI 10.1111/j.1463-1318.2011.02576.x; Kim K, 2012, NEW ENGL J MED, V366, P1596, DOI 10.1056/NEJMoa1110734; Krajewski S, 2011, CAN J SURG, V54, P43, DOI 10.1503/cjs.023509; Lahaye MJ, 2015, EUR RADIOL, V25, P1464, DOI 10.1007/s00330-014-3531-0; Lee CC, 2007, ACAD EMERG MED, V14, P117, DOI 10.1197/j.aem.2006.08.007; Phillips AW, 2009, SURG LAPARO ENDO PER, V19, P392, DOI 10.1097/SLE.0b013e3181b71957; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Shapter SL, 2012, ANAESTHESIA, V67, P474, DOI 10.1111/j.1365-2044.2011.07046.x; Slotboom T, 2014, SCAND J SURG, V103, P245, DOI 10.1177/1457496913519771; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; Walker S, 2000, AM J SURG, V180, P450, DOI 10.1016/S0002-9610(00)00540-7	16	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2015	350								h3493	10.1136/bmj.h3493	http://dx.doi.org/10.1136/bmj.h3493			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3TN	26130055				2022-12-28	WOS:000357607400012
J	Dixon, GB; Davies, SW; Aglyamova, GA; Meyer, E; Bay, LK; Matz, MV				Dixon, Groves B.; Davies, Sarah W.; Aglyamova, Galina A.; Meyer, Eli; Bay, Line K.; Matz, Mikhail V.			Genomic determinants of coral heat tolerance across latitudes	SCIENCE			English	Article							RAPID CLIMATE-CHANGE; GREAT-BARRIER-REEF; RESILIENCE	As global warming continues, reef-building corals could avoid local population declines through "genetic rescue" involving exchange of heat-tolerant genotypes across latitudes, but only if latitudinal variation in thermal tolerance is heritable. Here, we show an up-to-10-fold increase in odds of survival of coral larvae under heat stress when their parents come from a warmer lower-latitude location. Elevated thermal tolerance was associated with heritable differences in expression of oxidative, extracellular, transport, andmitochondrial functions that indicated a lack of prior stress. Moreover, two genomic regions strongly responded to selection for thermal tolerance in interlatitudinal crosses. These results demonstrate that variation in coral thermal tolerance across latitudes has a strong genetic basis and could serve as raw material for natural selection.	[Dixon, Groves B.; Davies, Sarah W.; Aglyamova, Galina A.; Matz, Mikhail V.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Meyer, Eli] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Bay, Line K.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	University of Texas System; University of Texas Austin; Oregon State University; Australian Institute of Marine Science	Bay, LK (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	l.bay@aims.gov.au; matz@utexas.edu	Dixon, Groves/O-1502-2013; Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819; Aglyamova, Galina/0000-0001-6105-6399; Bay, Line/0000-0002-9760-2977	NSF [DEB-1054766]; Australian Institute of Marine Science; Division Of Environmental Biology [1054766] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Australian Institute of Marine Science; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank B. Willis (James Cook University) and group for logistical support during coral spawning. The bioinformatics analysis was performed with computational resources of the Texas Advanced Computer Center. This study was supported by grants from NSF (DEB-1054766) to M.V.M. and the Australian Institute of Marine Science to L.K.B. Sequencing data have been deposited to National Center for Biotechnology Information's Short Reads Archive (accession numbers PRJNA279192 and PRJNA279420); data sets and scripts have been deposited to Dryad (http://dx.doi.org/10.5061/dryad.g75nq).	Ayre DJ, 2000, EVOLUTION, V54, P1590; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoekstra LA, 2013, GENETICS, V195, P1129, DOI 10.1534/genetics.113.154914; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Ingvarsson PK, 2001, TRENDS ECOL EVOL, V16, P62, DOI 10.1016/S0169-5347(00)02065-6; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; van Oppen MJH, 2011, MOL ECOL, V20, P4899, DOI 10.1111/j.1365-294X.2011.05328.x; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]	14	280	282	9	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1460	1462		10.1126/science.1261224	http://dx.doi.org/10.1126/science.1261224			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113720				2022-12-28	WOS:000356869100038
J	Jiang, FG; Zhou, KH; Ma, LL; Gressel, S; Doudna, JA				Jiang, Fuguo; Zhou, Kaihong; Ma, Linlin; Gressel, Saskia; Doudna, Jennifer A.			A Cas9-guide RNA complex preorganized for target DNA recognition	SCIENCE			English	Article							GUIDED SURVEILLANCE COMPLEX; CRISPR RNA; CRYSTAL-STRUCTURE; ENDONUCLEASE CAS9; STRUCTURAL BASIS; SEED SEQUENCE; SYSTEMS; BACTERIA; IMMUNITY	Bacterial adaptive immunity uses CRISPR (clustered regularly interspaced short palindromic repeats)-associated (Cas) proteins together with CRISPR transcripts for foreign DNA degradation. In type II CRISPR-Cas systems, activation of Cas9 endonuclease for DNA recognition upon guide RNA binding occurs by an unknown mechanism. Crystal structures of Cas9 bound to single-guide RNA reveal a conformation distinct from both the apo and DNA-bound states, in which the 10-nucleotide RNA "seed" sequence required for initial DNA interrogation is preordered in an A-form conformation. This segment of the guide RNA is essential for Cas9 to form a DNA recognition-competent structure that is poised to engage double-stranded DNA target sequences. We construe this as convergent evolution of a "seed" mechanism reminiscent of that used by Argonaute proteins during RNA interference in eukaryotes.	[Jiang, Fuguo; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zhou, Kaihong; Ma, Linlin; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Gressel, Saskia] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Doudna, Jennifer A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu	JIANG, FUGUO/G-6581-2012	JIANG, FUGUO/0000-0003-4469-1803; Gressel, Saskia/0000-0003-0261-675X	NSF [1244557]	NSF(National Science Foundation (NSF))	Atomic coordinates of Cas9-sgRNA and dCas9-sgRNA structures have been deposited in the Protein Data Bank with accession codes 4ZT0 and 4ZT9. We thank G. Meigs, J. Holton (beamline 8.3.1 of the Advanced Light Source, Lawrence Berkeley National Laboratory), and M. Miller for helpful discussion about data collection and processing; D. King and A. Iavarone for mass spectrometric data analysis; and S. H. Sternberg, M. L. Hochstrasser, M. Jinek, and C. Anders for critical reading of the manuscript. Supported by NSF grant 1244557 (J. A. D.). F.J. is a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2201-14); J. A. D. is a Howard Hughes Medical Institute Investigator.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ren XJ, 2014, G3-GENES GENOM GENET, V4, P1955, DOI 10.1534/g3.114.013821; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	27	326	366	10	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1477	1481		10.1126/science.aab1452	http://dx.doi.org/10.1126/science.aab1452			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113724				2022-12-28	WOS:000356869100043
J	Smith, JM				Smith, Jeanette M.			The Church Supper James Baare Turnbull	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2408	2409		10.1001/jama.2014.11821	http://dx.doi.org/10.1001/jama.2014.11821			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103012				2022-12-28	WOS:000356663600032
J	Siegel, M; Buschman, TJ; Miller, EK				Siegel, Markus; Buschman, Timothy J.; Miller, Earl K.			Cortical information flow during flexible sensorimotor decisions	SCIENCE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; EXECUTIVE CONTROL; VISUAL-ATTENTION; PARIETAL CORTEX; ABSTRACT RULES; TOP-DOWN; NEURONS; DYNAMICS; SIGNALS; REPRESENTATION	During flexible behavior, multiple brain regions encode sensory inputs, the current task, and choices. It remains unclear how these signals evolve. We simultaneously recorded neuronal activity from six cortical regions [middle temporal area (MT), visual area four (V4), inferior temporal cortex (IT), lateral intraparietal area (LIP), prefrontal cortex (PFC), and frontal eye fields (FEF)] of monkeys reporting the color or motion of stimuli. After a transient bottom-up sweep, there was a top-down flow of sustained task information from frontoparietal to visual cortex. Sensory information flowed from visual to parietal and prefrontal cortex. Choice signals developed simultaneously in frontoparietal regions and travelled to FEF and sensory cortex. This suggests that flexible sensorimotor choices emerge in a frontoparietal network from the integration of opposite flows of sensory and task information.	[Siegel, Markus] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Siegel, Markus] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Siegel, Markus; Buschman, Timothy J.; Miller, Earl K.] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Siegel, Markus; Buschman, Timothy J.; Miller, Earl K.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Buschman, Timothy J.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Buschman, Timothy J.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Princeton University; Princeton University	Siegel, M (corresponding author), Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany.	markus.siegel@uni-tuebingen.de	Siegel, Markus/H-5225-2012; Buschman, Timothy J/B-3056-2009; Miller, Earl K./AAE-8187-2019	Siegel, Markus/0000-0001-5115-936X; Buschman, Timothy J/0000-0003-1298-2761; Miller, Earl K./0000-0002-0582-6958	National Institute for Mental Health (NIMH) [5R37MH087027]; MIT Picower Innovation Fund; National Institutes of Health (NIH) [R00 MH092715]; Centre for Integrative Neuroscience (Deutsche Forschungsgemeinschaft) [EXC 307]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH087027, R00MH092715] Funding Source: NIH RePORTER	National Institute for Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MIT Picower Innovation Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Integrative Neuroscience (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Roy, C. von Nicolai, and J. Hipp for helpful discussions. This work was supported by National Institute for Mental Health (NIMH) grant 5R37MH087027 (E.K.M.), MIT Picower Innovation Fund (E.K.M.), National Institutes of Health (NIH) grant R00 MH092715 (T.J.B.), and the Centre for Integrative Neuroscience (Deutsche Forschungsgemeinschaft, EXC 307) (M.S.). All behavioral and electrophysiological data are archived at the Centre for Integrative Neuroscience, University of Tubingen, Germany.	Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Crowe DA, 2013, NAT NEUROSCI, V16, P1484, DOI 10.1038/nn.3509; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donahue CH, 2015, NAT NEUROSCI, V18, P295, DOI 10.1038/nn.3918; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Goodwin SJ, 2012, J NEUROSCI, V32, P3499, DOI 10.1523/JNEUROSCI.3585-11.2012; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Merten K, 2012, P NATL ACAD SCI USA, V109, P6289, DOI 10.1073/pnas.1121084109; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Siegel M, 2000, J COMPUT NEUROSCI, V8, P161, DOI 10.1023/A:1008973215925; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Singer W, 2013, TRENDS COGN SCI, V17, P616, DOI 10.1016/j.tics.2013.09.006; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wimmer K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7177	28	207	207	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1352	1355		10.1126/science.aab0551	http://dx.doi.org/10.1126/science.aab0551			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089513	Green Submitted, Green Accepted			2022-12-28	WOS:000356449500048
J	Dobbs, K; Conde, CD; Zhang, SY; Parolini, S; Audry, M; Chou, J; Haapaniemi, E; Keles, S; Bilic, I; Okada, S; Massaad, MJ; Rounioja, S; Alwahadneh, AM; Serwas, NK; Capuder, K; Ciftci, E; Felgentreff, K; Ohsumi, TK; Pedergnana, V; Boisson, B; Haskologlu, S; Ensari, A; Schuster, M; Moretta, A; Itan, Y; Patrizi, O; Rozenberg, F; Lebon, P; Saarela, J; Knip, M; Petrovski, S; Goldstein, DB; Parrott, RE; Savas, B; Schambach, A; Tabellini, G; Bock, C; Chatila, TA; Comeau, AM; Geha, RS; Abel, L; Buckley, RH; Ikinciogullari, A; Al-Herz, W; Helminen, M; Dogu, F; Casanova, JL; Boztug, K; Notarangelo, LD				Dobbs, K.; Conde, C. Dominguez; Zhang, S. -Y.; Parolini, S.; Audry, M.; Chou, J.; Haapaniemi, E.; Keles, S.; Bilic, I.; Okada, S.; Massaad, M. J.; Rounioja, S.; Alwahadneh, A. M.; Serwas, N. K.; Capuder, K.; Ciftci, E.; Felgentreff, K.; Ohsumi, T. K.; Pedergnana, V.; Boisson, B.; Haskologlu, S.; Ensari, A.; Schuster, M.; Moretta, A.; Itan, Y.; Patrizi, O.; Rozenberg, F.; Lebon, P.; Saarela, J.; Knip, M.; Petrovski, S.; Goldstein, D. B.; Parrott, R. E.; Savas, B.; Schambach, A.; Tabellini, G.; Bock, C.; Chatila, T. A.; Comeau, A. M.; Geha, R. S.; Abel, L.; Buckley, R. H.; Ikinciogullari, A.; Al-Herz, W.; Helminen, M.; Dogu, F.; Casanova, J. -L.; Boztug, K.; Notarangelo, L. D.			Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMACYTOID DENDRITIC CELLS; RAC ACTIVATOR DOCK2; INBORN-ERRORS; IMMUNODEFICIENCY; IMMUNITY; LYMPHOCYTE; MUTATIONS; DEDICATOR; MICE; WASP	BACKGROUND Combined immunodeficiencies are marked by inborn errors of T-cell immunity in which the T cells that are present are quantitatively or functionally deficient. Impaired humoral immunity is also common. Patients have severe infections, auto-immunity, or both. The specific molecular, cellular, and clinical features of many types of combined immunodeficiencies remain unknown. METHODS We performed genetic and cellular immunologic studies involving five unrelated children with early-onset invasive bacterial and viral infections, lymphopenia, and defective T-cell, B-cell, and natural killer (NK)-cell responses. Two patients died early in childhood; after allogeneic hematopoietic stem-cell transplantation, the other three had normalization of T-cell function and clinical improvement. RESULTS We identified biallelic mutations in the dedicator of cytokinesis 2 gene (DOCK2) in these five patients. RAC1 activation was impaired in the T cells. Chemokine-induced migration and actin polymerization were defective in the T cells, B cells, and NK cells. NK-cell degranulation was also affected. Interferon-a and interferon-lambda production by peripheral-blood mononuclear cells was diminished after viral infection. Moreover, in DOCK2-deficient fibroblasts, viral replication was increased and virus-induced cell death was enhanced; these conditions were normalized by treatment with interferon alfa-2b or after expression of wild-type DOCK2. CONCLUSIONS Autosomal recessive DOCK2 deficiency is a new mendelian disorder with pleiotropic defects of hematopoietic and nonhematopoietic immunity. Children with clinical features of combined immunodeficiencies, especially with early-onset, invasive infections, may have this condition.	[Dobbs, K.; Chou, J.; Keles, S.; Massaad, M. J.; Capuder, K.; Felgentreff, K.; Chatila, T. A.; Geha, R. S.; Notarangelo, L. D.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Notarangelo, L. D.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Ohsumi, T. K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Notarangelo, L. D.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Comeau, A. M.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Conde, C. Dominguez; Bilic, I.; Serwas, N. K.; Schuster, M.; Bock, C.; Boztug, K.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Boztug, K.] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Boztug, K.] CeRUD Vienna Ctr Rare & Undiagnosed Dis, Vienna, Austria; [Zhang, S. -Y.; Audry, M.; Okada, S.; Boisson, B.; Itan, Y.; Abel, L.; Casanova, J. -L.] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Petrovski, S.; Goldstein, D. B.] Columbia Univ, Inst Genom Med, New York, NY USA; [Zhang, S. -Y.; Pedergnana, V.; Abel, L.; Casanova, J. -L.] INSERM, U1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Zhang, S. -Y.; Rozenberg, F.; Lebon, P.; Abel, L.; Casanova, J. -L.] Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst, Paris, France; [Casanova, J. -L.] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, Paris, France; [Casanova, J. -L.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Parolini, S.; Patrizi, O.; Tabellini, G.] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Moretta, A.] Univ Genoa, Dept Expt Med, Genoa, Italy; [Haapaniemi, E.] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Haapaniemi, E.] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Saarela, J.] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Knip, M.] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Knip, M.] Univ Helsinki, Res Programs Unit, Diabet & Obes Res Program, Helsinki, Finland; [Knip, M.] Univ Helsinki, Folkhalsan Res Ctr, Helsinki, Finland; Helsinki Univ Cent Hosp, Helsinki, Finland; [Rounioja, S.; Knip, M.; Helminen, M.] Tampere Univ Hosp, Tampere Ctr Child Hlth Res, Tampere, Finland; [Rounioja, S.] Tampere Univ Hosp, Fimlab Labs, Tampere, Finland; [Keles, S.] Necmettin Erbakan Univ, Meram Fac Med, Div Pediat Immunol & Allergy, Konya, Turkey; [Ciftci, E.] Ankara Univ, Sch Med, Dept Pediat Infect Dis, TR-06100 Ankara, Turkey; [Haskologlu, S.; Ikinciogullari, A.; Dogu, F.] Ankara Univ, Sch Med, Dept Immunol & Allergy, TR-06100 Ankara, Turkey; [Ensari, A.; Savas, B.] Ankara Univ, Sch Med, Dept Pathol, TR-06100 Ankara, Turkey; [Alwahadneh, A. M.] Queen Rania Pediat Hosp, King Hussein Med Ctr, Pediat Allergy Immunol & Rheumatol Sect, Amman, Jordan; [Schambach, A.] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Petrovski, S.; Goldstein, D. B.] Duke Univ, Sch Med, Duke Ctr Human Genome Variat, Durham, NC USA; [Parrott, R. E.; Buckley, R. H.] Duke Univ, Dept Pediat, Sch Med, Div Allergy & Immunol, Durham, NC 27706 USA; [Buckley, R. H.] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA; [Al-Herz, W.] Kuwait Univ, Fac Med, Dept Pediat, Safat, Kuwait	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Rockefeller University; Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; University of Brescia; University of Genoa; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Necmettin Erbakan University; Ankara University; Ankara University; Ankara University; Hannover Medical School; Duke University; Duke University; Duke University; Kuwait University	Notarangelo, LD (corresponding author), Boston Childrens Hosp, Div Immunol, Karp Res Bldg,Rm 10217,1 Blackfan Circle, Boston, MA 02115 USA.	shzh289@mail.rockefeller.edu; casanova@rockefeller.edu; kboztug@cemm.oeaw.ac.at; luigi.notarangelo@childrens.harvard.edu	Knip, Mikael/AAL-3773-2020; Dogu, Figen/AAI-1316-2020; Boztug, Kaan/AAM-4161-2021; Savas, Berna/AAQ-3666-2020; Patrizi, Ornella/ABC-5102-2020; Rounioja, Samuli/D-4195-2014; Boisson, Bertrand/I-2485-2017; Rozenberg, Flore/O-8854-2017; Notarangelo, Luigi D/F-9718-2016; Zhang, Shen-Ying/I-2685-2017; Casanova, Jean-Laurent/I-3418-2017; ensari, arzu/AAQ-2826-2020; Okada, Satoshi/B-8901-2011; Bock, Christoph/AAE-7618-2019; İkinciogullari, Aydan/AAQ-3841-2020; Ciftci, Ergin/W-2756-2017; Abel, Laurent/H-8888-2017; Boisson, Bertrand/AAC-6058-2019; Goldstein, David/AAY-8125-2020; Schambach, Axel/C-5491-2011; Dominguez Conde, Cecilia/U-4890-2017	Dogu, Figen/0000-0002-7869-4941; Boztug, Kaan/0000-0001-8387-9185; Savas, Berna/0000-0003-3971-1419; Boisson, Bertrand/0000-0001-5240-3555; Notarangelo, Luigi D/0000-0002-8335-0262; Zhang, Shen-Ying/0000-0002-9449-3672; ensari, arzu/0000-0001-7036-4457; Okada, Satoshi/0000-0002-4622-5657; Bock, Christoph/0000-0001-6091-3088; İkinciogullari, Aydan/0000-0003-1145-0843; Ciftci, Ergin/0000-0002-4955-160X; Abel, Laurent/0000-0001-7016-6493; Boisson, Bertrand/0000-0001-5240-3555; Knip, Mikael/0000-0003-0474-0033; Casanova, Jean-Laurent/0000-0002-7782-4169; Rounioja, Samuli/0000-0001-7713-0610; Schuster, Michael/0000-0003-2975-8969; Haapaniemi, Emma/0000-0002-6693-8208; Petrovski, Slave/0000-0002-1527-961X; PAROLINI, Silvia/0000-0003-1968-7765; Dominguez Conde, Cecilia/0000-0002-8684-4655; Pedergnana, Vincent/0000-0002-7852-5339; Dobbs, Kerry/0000-0002-3432-3137; Chatila, Talal/0000-0001-7439-2762; Serwas, Nina/0000-0003-2243-5446; Saarela, Janna/0000-0002-0853-6219	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100887] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [Y 595] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Supported by the National Institutes of Health and others.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Biassoni Roberto, 2009, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1410s84; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Casanova JL, 2013, COLD SH Q B, V78, P157, DOI 10.1101/sqb.2013.78.019968; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Conley ME, 2014, CURR OPIN IMMUNOL, V30, P17, DOI 10.1016/j.coi.2014.05.004; Crawford G, 2013, BLOOD, V122, P2052, DOI 10.1182/blood-2013-02-482331; Crequer A, 2012, J CLIN INVEST, V122, P3239, DOI 10.1172/JCI62949; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Janssen E, 2014, J ALLERGY CLIN IMMUN, V134, P1365, DOI 10.1016/j.jaci.2014.07.042; Janssen E, 2014, CLIN IMMUNOL, V150, P220, DOI 10.1016/j.clim.2013.12.006; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Kunisaki Y, 2006, J IMMUNOL, V176, P4640, DOI 10.4049/jimmunol.176.8.4640; Lanzi G, 2012, J EXP MED, V209, P29, DOI 10.1084/jem.20110896; McGhee SA, 2010, DIS MARKERS, V29, P151, DOI [10.1155/2010/397291, 10.3233/DMA-2010-0740]; Mizesko MC, 2013, J ALLERGY CLIN IMMUN, V131, P840, DOI 10.1016/j.jaci.2012.12.1568; Montaldo E, 2013, CYTOM PART A, V83A, P702, DOI 10.1002/cyto.a.22302; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nishikimi A, 2012, CHEM BIOL, V19, P488, DOI 10.1016/j.chembiol.2012.03.008; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Notarangelo LD, 2013, ANNU REV IMMUNOL, V31, P195, DOI 10.1146/annurev-immunol-032712-095927; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Sakai Y, 2013, BLOOD, V122, P386, DOI 10.1182/blood-2012-12-475897; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tassi I, 2006, IMMUNOL REV, V214, P92, DOI 10.1111/j.1600-065X.2006.00463.x; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x; Zhang SY, 2013, CURR OPIN IMMUNOL, V25, P19, DOI 10.1016/j.coi.2012.11.001	42	120	122	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2409	2422		10.1056/NEJMoa1413462	http://dx.doi.org/10.1056/NEJMoa1413462			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK6RF	26083206	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000356354600007
J	Dranovsky, A; Leonardo, ED				Dranovsky, Alex; Leonardo, E. David			Neuroscience: The power of positivity	NATURE			English	Editorial Material							COGNITIVE BIAS; DEPRESSION		[Dranovsky, Alex; Leonardo, E. David] Columbia Univ, Dept Psychiat, Div Integrat Neurosci, New York, NY 10032 USA; [Dranovsky, Alex; Leonardo, E. David] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Dranovsky, A (corresponding author), Columbia Univ, Dept Psychiat, Div Integrat Neurosci, New York, NY 10032 USA.	ad722@cumc.columbia.edu; el367@cumc.columbia.edu	Dranovsky, Alex/P-4357-2018; Leonardo, Eduardo/AAH-1525-2020	Dranovsky, Alex/0000-0001-7896-3243; Leonardo, Eduardo/0000-0001-7426-0217	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091427, R01MH091844] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH091844, R01 MH091427] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blackwell SE, 2015, CLIN PSYCHOL SCI, V3, P91, DOI 10.1177/2167702614560746; Cheung WY, 2013, PERS SOC PSYCHOL B, V39, P1484, DOI 10.1177/0146167213499187; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Joormann J, 2007, J ABNORM PSYCHOL, V116, P484, DOI 10.1037/0021-843X.116.3.484; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Ramirez S, 2015, NATURE, V522, P335, DOI 10.1038/nature14514; Ramirez S, 2014, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00226; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005	8	2	2	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					294	295		10.1038/522294a	http://dx.doi.org/10.1038/522294a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085266				2022-12-28	WOS:000356425400041
J	Grinnell, F				Grinnell, Frederick			Rethink our approach to assessing risk	NATURE			English	Editorial Material									Univ Texas Dallas, Dept Cell Biol, UT Southwestern Med Ctr, Dallas, TX 75230 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Grinnell, F (corresponding author), Univ Texas Dallas, Dept Cell Biol, UT Southwestern Med Ctr, Dallas, TX 75230 USA.	frederick.grinnell@utsouthwestern.edu		grinnell, frederick/0000-0001-5337-3087				FUNTOWICZ SO, 1993, FUTURES, V25, P739, DOI 10.1016/0016-3287(93)90022-L; Shah S, 2004, JAMA-J AM MED ASSOC, V291, P476, DOI 10.1001/jama.291.4.476	2	6	6	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					257	257		10.1038/522257a	http://dx.doi.org/10.1038/522257a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085235	Bronze			2022-12-28	WOS:000356425400017
J	Jontof-Hutter, D; Rowe, JF; Lissauer, JJ; Fabrycky, DC; Ford, EB				Jontof-Hutter, Daniel; Rowe, Jason F.; Lissauer, Jack J.; Fabrycky, Daniel C.; Ford, Eric B.			The mass of the Mars-sized exoplanet Kepler-138 b from transit timing	NATURE			English	Article							LOW-DENSITY PLANETS; SUN-LIKE STAR; 1ST 16 MONTHS; DIFFERENTIAL EVOLUTION; CANDIDATES; SYSTEM; ORBITS; RADII; II.; ECCENTRICITY	Extrasolar planets that pass in front of their host star (transit) cause a temporary decrease in the apparent brightness of the star, providing a direct measure of the planet's size and orbital period. In some systems with multiple transiting planets, the times of the transits are measurably affected by the gravitational interactions between neighbouring planets(1,2). In favourable cases, the departures from Keplerian orbits (that is, unaffected by gravitational effects) implied by the observed transit times permit the planetary masses to be measured, which is key to determining their bulk densities(3). Characterizing rocky planets is particularly difficult, because they are generally smaller and less massive than gaseous planets. Therefore, few exoplanets near the size of Earth have had their masses measured. Here we report the sizes and masses of three planets orbiting Kepler-138, a star much fainter and cooler than the Sun. We determine that the mass of the Mars-sized inner planet, Kepler-138 b, is 0.066(-0.037)(+0.059) Earth masses. Its density is 2.6(-1.5)(+2.4) grams per cubic centimetre. The middle and outer planets are both slightly larger than Earth. The middle planet's density (6.2(-3.4)(+5.8) grams per cubic centimetre) is similar to that of Earth, and the outer planet is less than half as dense at 2.1(-1.2)(+2.2) grams per cubic centimetre, implying that it contains a greater portion of low-density components such as water and hydrogen.	[Jontof-Hutter, Daniel; Ford, Eric B.] Penn State Univ, Dept Astron, Davey Lab, University Pk, PA 16802 USA; [Jontof-Hutter, Daniel; Rowe, Jason F.; Lissauer, Jack J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Rowe, Jason F.] SETI Inst, Mountain View, CA 94043 USA; [Fabrycky, Daniel C.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Chicago	Jontof-Hutter, D (corresponding author), Penn State Univ, Dept Astron, Davey Lab, University Pk, PA 16802 USA.	dxj14@psu.edu	Ford, Eric B./AAB-5479-2019	Ford, Eric B./0000-0001-6545-639X; Rowe, Jason/0000-0002-5904-1865; Fabrycky, Daniel/0000-0003-3750-0183	NASA Postdoctoral Program; Center for Exoplanets and Habitable Worlds; Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; NASA [NNX14AB92G]; Kepler Participating Scientist Program award [NNX14AB87G]; NASA Kepler Participating Scientist Program award [NNX14AN76G]; NASA Exoplanet Research Program award [NNX15AE21G]	NASA Postdoctoral Program(National Aeronautics & Space Administration (NASA)); Center for Exoplanets and Habitable Worlds; Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; NASA(National Aeronautics & Space Administration (NASA)); Kepler Participating Scientist Program award; NASA Kepler Participating Scientist Program award; NASA Exoplanet Research Program award	D.J-H. acknowledges support through the NASA Postdoctoral Program and funding from the Center for Exoplanets and Habitable Worlds. The Center for Exoplanets and Habitable Worlds is supported by the Pennsylvania State University, the Eberly College of Science and the Pennsylvania Space Grant Consortium. J.F.R. acknowledges NASA grant NNX14AB92G issued through the Kepler Participating Scientist Program. D.C.F. is an Alfred P. Sloane Fellow and was supported by the Kepler Participating Scientist Program award NNX14AB87G. E.B.F. was supported in part by NASA Kepler Participating Scientist Program award NNX14AN76G and NASA Exoplanet Research Program award NNX15AE21G, as well as the Center for Exoplanets and Habitable Worlds.	Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Batalha NM, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/2/24; Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Bodenheimer P, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/103; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Boyajian TS, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/112; Burke CJ, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/19; Chiang EI, 2000, ASTROPHYS J, V540, P1084, DOI 10.1086/309372; Chiang EI, 2001, ASTRON J, V122, P1607, DOI 10.1086/322115; Claret A, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116451; Cochran WD, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/7; Delfosse X, 2000, ASTRON ASTROPHYS, V364, P217; Dotter A, 2008, ASTROPHYS J SUPPL S, V178, P89, DOI 10.1086/589654; Fabrycky DC, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/146; Ferraz-Mello S, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201016059; Ford EB, 2005, ASTRON J, V129, P1706, DOI 10.1086/427962; Ford EB, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/185; Fressin F, 2012, NATURE, V482, P195, DOI 10.1038/nature10780; Gautier TN, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/15; GOLDREICH P, 1979, ASTRON J, V84, P1638, DOI 10.1086/112587; Hadden S, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/80; Holman MJ, 2010, SCIENCE, V330, P51, DOI 10.1126/science.1195778; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Howard AW, 2013, NATURE, V503, P381, DOI 10.1038/nature12767; Jontof-Hutter D, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/15; Kipping DM, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/28; Lissauer JJ, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/131; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Lissauer JJ, 2011, NATURE, V470, P53, DOI 10.1038/nature09760; Lopez ED, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/2; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Marcy GW, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/20; Masuda K, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/53; Moorhead AV, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/1; Muirhead PS, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/2/L37; Nelson B, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/1/11; Nelson BE, 2014, MON NOT R ASTRON SOC, V441, P442, DOI 10.1093/mnras/stu450; Ofir A, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201220935; Pepe F, 2013, NATURE, V503, P377, DOI 10.1038/nature12768; Pineda JS, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/28; Rauch K. P., 2012, ASTROPHYSICS SOURCE; Rivera EJ, 2010, ASTROPHYS J, V719, P890, DOI 10.1088/0004-637X/719/1/890; Rowe JF, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/45; Steffen JH, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/186; Steffen JH, 2012, MON NOT R ASTRON SOC, V421, P2342, DOI 10.1111/j.1365-2966.2012.20467.x; Tegmark M, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.103501; VERDINELLI I, 1995, J AM STAT ASSOC, V90, P614, DOI 10.2307/2291073; Weiss LM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/14; Wu YQ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/74; Zeng L, 2013, PUBL ASTRON SOC PAC, V125, P227, DOI 10.1086/669163	56	69	70	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					321	+		10.1038/nature14494	http://dx.doi.org/10.1038/nature14494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26085271	Green Submitted			2022-12-28	WOS:000356425400048
J	Hirsch, C				Hirsch, Calvin			In open-angle glaucoma, latanoprost improved visual field preservation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.							Connor AJ, 2014, EYE, V28, P863, DOI 10.1038/eye.2014.114; Krupin T, 2011, AM J OPHTHALMOL, V151, P671, DOI 10.1016/j.ajo.2010.09.026; Novack GD, 2002, J AM GERIATR SOC, V50, P956, DOI 10.1046/j.1532-5415.2002.50226.x; Roughead EE, 2012, OPHTHAL EPIDEMIOL, V19, P74, DOI 10.3109/09286586.2011.638743	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12							JC10	10.7326/ACPJC-2015-162-12-010	http://dx.doi.org/10.7326/ACPJC-2015-162-12-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075775				2022-12-28	WOS:000356516300011
J	Dhaliwal, HS; Singh, A; Sinha, SK; Nampoothiri, RV; Goyal, A; Chatterjee, D; Dewana, SK; Lal, A; Das, A; Gupta, KL; Kochhar, R				Dhaliwal, Harpal S.; Singh, Anupam; Sinha, Saroj K.; Nampoothiri, Ram V.; Goyal, Ajay; Chatterjee, Debajyoti; Dewana, Sudheer K.; Lal, Anupam; Das, Ashim; Gupta, K. L.; Kochhar, Rakesh			Diagnosed only if considered: isolated renal mucormycosis	LANCET			English	Editorial Material									[Dhaliwal, Harpal S.; Sinha, Saroj K.; Kochhar, Rakesh] Postgrad Inst Med Educ & Res, Dept Gastroenterol, Chandigarh 160012, India; [Singh, Anupam; Nampoothiri, Ram V.] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India; [Goyal, Ajay; Gupta, K. L.] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India; [Chatterjee, Debajyoti; Das, Ashim] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh 160012, India; [Dewana, Sudheer K.] Postgrad Inst Med Educ & Res, Dept Urol, Chandigarh 160012, India; [Lal, Anupam] Postgrad Inst Med Educ & Res, Dept Radiodiag & Imaging, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Sinha, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Gastroenterol, Chandigarh 160012, India.	sarojksinha@hotmail.com		Dhaliwal, Harpal S./0000-0001-8252-4876				CHUGH KS, 1993, AM J KIDNEY DIS, V22, P393, DOI 10.1016/S0272-6386(12)70141-5; Gupta KL, 1999, NEPHROL DIAL TRANSPL, V14, P2720, DOI 10.1093/ndt/14.11.2720; L Gupta Krishan, 2012, J Nephropathol, V1, P155, DOI 10.5812/nephropathol.8111; Piccoli GB, 2014, AM J KIDNEY DIS, V64, P311, DOI 10.1053/j.ajkd.2014.02.027; SOULEN MC, 1989, RADIOLOGY, V171, P703, DOI 10.1148/radiology.171.3.2655002	5	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2322	2322		10.1016/S0140-6736(15)60730-9	http://dx.doi.org/10.1016/S0140-6736(15)60730-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	26088500				2022-12-28	WOS:000355943500036
J	Sandoe, JAT; Barlow, G; Chambers, JB; Gammage, M; Guleri, A; Howard, P; Olson, E; Perry, JD; Prendergast, BD; Spry, MJ; Steeds, RP; Tayebjee, MH; Watkin, R				Sandoe, Jonathan A. T.; Barlow, Gavin; Chambers, John B.; Gammage, Michael; Guleri, Achyut; Howard, Philip; Olson, Ewan; Perry, John D.; Prendergast, Bernard D.; Spry, Michael J.; Steeds, Richard P.; Tayebjee, Muzahir H.; Watkin, Richard			New guidelines for prevention and management of implantable cardiac electronic device-related infection	LANCET			English	Editorial Material							TRENDS		[Sandoe, Jonathan A. T.; Howard, Philip; Tayebjee, Muzahir H.] Univ Leeds, Leeds Teaching Hosp NHS Trust, Leeds LS1 3EX, W Yorkshire, England; [Barlow, Gavin] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England; [Chambers, John B.] Guys & St Thomas NHS Fdn Trust, London, England; [Gammage, Michael] Univ Birmingham, Birmingham, W Midlands, England; [Guleri, Achyut] Lancashire Cardiac Ctr, Blackpool, England; [Olson, Ewan] Royal Infirm, Edinburgh, Midlothian, Scotland; [Perry, John D.] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Prendergast, Bernard D.] Oxford Univ Hosp NHS Trust, Oxford, England; [Spry, Michael J.] Countess Chester Hosp NHS Fdn Trust, Chester, Cheshire, England; [Steeds, Richard P.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Watkin, Richard] Heart England NHS Fdn Trust, Birmingham, W Midlands, England	University of Leeds; Guy's & St Thomas' NHS Foundation Trust; University of Birmingham; Royal Infirmary of Edinburgh; Newcastle Freeman Hospital; Newcastle University - UK; Oxford University Hospitals NHS Foundation Trust; University of Birmingham; Heart of England NHS Foundation Trust	Sandoe, JAT (corresponding author), Univ Leeds, Leeds Teaching Hosp NHS Trust, Leeds LS1 3EX, W Yorkshire, England.	j.sandoe@leeds.ac.uk	Sandoe, Jonathan/AAL-2117-2020; Howard, Philip/I-8217-2014	Sandoe, Jonathan/0000-0003-0193-8677; Steeds, Richard/0000-0001-5687-2535; Howard, Philip/0000-0002-5096-0240				Cunningham D, 2011, CARDIAC RHYTHM MANAG; Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033; Sandoe JAT, 2015, J ANTIMICROB CHEMOTH, V70, P325, DOI 10.1093/jac/dku383; Voigt A, 2010, PACE, V33, P414, DOI 10.1111/j.1540-8159.2009.02569.x	4	10	10	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2225	2226		10.1016/S0140-6736(14)62249-2	http://dx.doi.org/10.1016/S0140-6736(14)62249-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	26088482	Green Accepted			2022-12-28	WOS:000355943500004
J	Wang, H; Horton, R				Wang, Helena; Horton, Richard			Tackling climate change: the greatest opportunity for global health	LANCET			English	Editorial Material									[Wang, Helena] The Lancet, Beijing 100738, Peoples R China; [Horton, Richard] The Lancet, London, England		Wang, H (corresponding author), The Lancet, Beijing 100738, Peoples R China.							Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6	2	45	46	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1798	1799		10.1016/S0140-6736(15)60931-X	http://dx.doi.org/10.1016/S0140-6736(15)60931-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3VO	26111438				2022-12-28	WOS:000364194700009
J	Fibriansah, G; Ibarra, KD; Ng, TS; Smith, SA; Tan, JL; Lim, XN; Ooi, JSG; Kostyuchenko, VA; Wang, JQ; de Silva, AM; Harris, E; Crowe, JE; Lok, SM				Fibriansah, Guntur; Ibarra, Kristie D.; Thiam-Seng Ng; Smith, Scott A.; Tan, Joanne L.; Lim, Xin-Ni; Ooi, Justin S. G.; Kostyuchenko, Victor A.; Wang, Jiaqi; de Silva, Aravinda M.; Harris, Eva; Crowe, James E., Jr.; Lok, Shee-Mei			Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers	SCIENCE			English	Article							VACCINE	There are four closely-related dengue virus (DENV) serotypes. Infection with one serotype generates antibodies that may cross-react and enhance infection with other serotypes in a secondary infection. We demonstrated that DENV serotype 2 (DENV2)-specific human monoclonal antibody (HMAb) 2D22 is therapeutic in a mouse model of antibody-enhanced severe dengue disease. We determined the cryo-electron microscopy (cryo-EM) structures of HMAb 2D22 complexed with two different DENV2 strains. HMAb 2D22 binds across viral envelope (E) proteins in the dimeric structure, which probably blocks the E protein reorganization required for virus fusion. HMAb 2D22 "locks" two-thirds of or all dimers on the virus surface, depending on the strain, but neutralizes these DENV2 strains with equal potency. The epitope defined by HMAb 2D22 is a potential target for vaccines and therapeutics.	[Fibriansah, Guntur; Thiam-Seng Ng; Tan, Joanne L.; Lim, Xin-Ni; Ooi, Justin S. G.; Kostyuchenko, Victor A.; Wang, Jiaqi; Lok, Shee-Mei] Duke Natl Univ Singapore Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Fibriansah, Guntur; Thiam-Seng Ng; Tan, Joanne L.; Lim, Xin-Ni; Ooi, Justin S. G.; Kostyuchenko, Victor A.; Wang, Jiaqi; Lok, Shee-Mei] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117548, Singapore; [Ibarra, Kristie D.; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Smith, Scott A.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Smith, Scott A.; Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, Nashville, TN 37235 USA; [de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN USA	National University of Singapore; University of California System; University of California Berkeley; Vanderbilt University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Vanderbilt University; Vanderbilt University	Lok, SM (corresponding author), Duke Natl Univ Singapore Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.	james.crowe@vanderbilt.edu; sheemei.lok@duke-nus.edu.sg	Fibriansah, Guntur/P-1201-2015; Crowe, James/B-5549-2009; , PEP-MX Core/AGV-4051-2022; desilva, Aravinda/ABE-6260-2020; Geap, Justin Ooi Seng/AAS-3483-2021	Fibriansah, Guntur/0000-0002-9990-3335; Crowe, James/0000-0002-0049-1079; desilva, Aravinda/0000-0003-3317-5950; Geap, Justin Ooi Seng/0000-0003-4899-8255; Lim, Xin-Ni/0000-0001-8117-3613; Lok, Shee-Mei/0000-0003-4631-8041; Wang, Jiaqi/0000-0001-8399-188X; Kostyuchenko, Victor/0000-0001-9751-307X	Ministry of Education Tier 3 [R-913-301-146-112]; U.S. NIH [U54 AI057157]; NIH (National Institute of Allergy and Infectious Diseases) [R01 AI107731]; NIH [K08 AI103038, U54 AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107731, U54AI065359, K08AI103038, U54AI057157] Funding Source: NIH RePORTER	Ministry of Education Tier 3; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Shresta (La Jolla Institute for Allergy and Immunology, La Jolla, CA) and E.-E. Ooi (Duke-National University of Singapore Graduate Medical School) for providing DENV2 strains S221 and PVP94/07, respectively. The data presented in this paper are tabulated in the main paper and in the supplementary materials. Coordinates of 4 degrees C-2D22-PVP94/07, 37 degrees C-2D22-PVP94/07 and BF-37 degrees C-2D22-NGC class II were deposited in the Protein Data Bank under accession codes 4UIF, 5A1Z, and 4UIH, respectively The cryo-EM maps of 4 degrees C-2D22-PVP94/07, 37 degrees C-2D22-PVP94/07, 4 degrees C-2D22-NGC, BF-37 degrees C-2D22-NGC Class I, BF-37 degrees C-2D22-NGC Class II, AF-37 degrees C-2D22-NGC Class I, and AF-37 degrees-2D22-NGC Class II were deposited in the Electron Microscopy Database under accession numbers EMD-2967, EMD-2996, EMD-2997, EMD-2999, EMD-2968, EMD-2998, and EMD-2969, respectively. This study was supported by Ministry of Education Tier 3 (R-913-301-146-112) grants awarded to S.-M.L., U.S. NIH grant U54 AI057157 awarded to J.E.C., NIH (National Institute of Allergy and Infectious Diseases) grant R01 AI107731 awarded to A.M.dS. and J.E.C., NIH grant K08 AI103038 awarded to S. A. S., and grant U54 AI065359 awarded to E.H.. We acknowledge the Cryo-Electron Microscopy Facility at the Center for Bio-imaging Science, Department of Biological Science, National University of Singapore for their scientific and technical assistance.	Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brien JD, 2013, J VIROL, V87, P7747, DOI 10.1128/JVI.00327-13; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Thomas SJ, 2011, CURR OPIN INFECT DIS, V24, P442, DOI 10.1097/QCO.0b013e32834a1b0b; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110	17	160	165	4	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					88	91		10.1126/science.aaa8651	http://dx.doi.org/10.1126/science.aaa8651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138979	Green Accepted, Green Submitted			2022-12-28	WOS:000357280800065
J	Hoelzel, AR				Hoelzel, A. Rus			Can DNA foil the poachers?	SCIENCE			English	Editorial Material							GENETIC-EVIDENCE; CONSERVATION; ELEPHANTS		Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Durham University	Hoelzel, AR (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	a.r.hoelzel@durham.ac.uk						Baker CS, 2010, BIOL LETTERS, V6, P647, DOI 10.1098/rsbl.2010.0239; Busch Briton Cooper, 1987, WAR SEALS HIST N AM; Eggert LS, 2014, CONSERV BIOL, V28, P107, DOI 10.1111/cobi.12161; Hoelzel AR, 2001, CONSERV GENET, V2, P69, DOI 10.1023/A:1011590517389; Ivashchenko Yulia V., 2011, U S National Marine Fisheries Service Marine Fisheries Review, V73, P1; Kraus RHS, 2015, MOL ECOL RESOUR, V15, P295, DOI 10.1111/1755-0998.12307; Okello JBA, 2008, J HERED, V99, P443, DOI 10.1093/jhered/esn028; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	10	1	1	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					34	35		10.1126/science.aac6301	http://dx.doi.org/10.1126/science.aac6301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL9FG	26089356				2022-12-28	WOS:000357280800046
J	Mackenzie, RB; Dewberry, CT; Leopold, KR				Mackenzie, Rebecca B.; Dewberry, Christopher T.; Leopold, Kenneth R.			Gas phase observation and microwave spectroscopic characterization of formic sulfuric anhydride	SCIENCE			English	Article							PARTICLE FORMATION; ATMOSPHERIC NUCLEATION; ACETIC-ANHYDRIDE; ORGANIC VAPORS; ACID; MECHANISM; AEROSOL; NANOPARTICLES; HYDROLYSIS; GROWTH	We report the observation of a covalently bound species, formic sulfuric anhydride (FSA), that is produced from formic acid and sulfur trioxide under supersonic jet conditions. FSA has been structurally characterized by means of microwave spectroscopy and further investigated by using density functional theory and ab initio calculations. Theory indicates that a pi(2) + pi(2) + sigma(2) cycloaddition reaction between SO3 and HCOOH is a plausible pathway to FSA formation and that such a mechanism would be effectively barrierless. We speculate on the possible role that FSA may play in the Earth's atmosphere.	[Mackenzie, Rebecca B.; Dewberry, Christopher T.; Leopold, Kenneth R.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Leopold, KR (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	kleopold@umn.edu			National Science Foundation [CHE-1266320]; Minnesota Supercomputing Institute	National Science Foundation(National Science Foundation (NSF)); Minnesota Supercomputing Institute	This work was supported by the National Science Foundation (grant CHE-1266320) and the Minnesota Supercomputing Institute. We are grateful to P. McMurry, T. Hoye, and M. Canagaratna for helpful conversations. We also thank W. Isley for assistance with the CCSD(T) calculations and J. Mendez and the Tektronix Corporation for invaluable aid in construction of the broadband spectrometer. The authors of this work are unaware of any conflicts of interest.	BENKOVIC SJ, 1970, J AM CHEM SOC, V92, P4971, DOI 10.1021/ja00719a034; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Berndt T, 2008, ATMOS CHEM PHYS, V8, P6365, DOI 10.5194/acp-8-6365-2008; Brown GG, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2919120; Burdick D. C., 2002, INT PUBLICATION; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Elm J, 2014, J PHYS CHEM A, V118, P7892, DOI 10.1021/jp503736s; Fiacco DL, 2002, J AM CHEM SOC, V124, P4504, DOI 10.1021/ja012724w; Gordy W., 1984, MICROWAVE MOL SPECTR; Hazra MK, 2011, J AM CHEM SOC, V133, P17444, DOI 10.1021/ja207393v; Keller JW, 2010, J PHYS CHEM A, V114, P13182, DOI 10.1021/jp1076214; KOLB CE, 1994, J AM CHEM SOC, V116, P10314, DOI 10.1021/ja00101a067; Kulmala M, 2014, ANNU REV PHYS CHEM, V65, P21, DOI 10.1146/annurev-physchem-040412-110014; Metzger A, 2010, P NATL ACAD SCI USA, V107, P6646, DOI 10.1073/pnas.0911330107; MOROKUMA K, 1994, J AM CHEM SOC, V116, P10316, DOI 10.1021/ja00101a068; Nadykto AB, 2007, CHEM PHYS LETT, V435, P14, DOI 10.1016/j.cplett.2006.12.050; Neese F, 2011, J CHEM THEORY COMPUT, V7, P33, DOI 10.1021/ct100396y; O'Dowd CD, 2002, NATURE, V416, P497, DOI 10.1038/416497a; Paasonen P, 2010, ATMOS CHEM PHYS, V10, P11223, DOI 10.5194/acp-10-11223-2010; Phillips JA, 1995, J AM CHEM SOC, V117, P12549, DOI 10.1021/ja00155a018; PHILLIPS JA, 1995, J PHYS CHEM-US, V99, P501, DOI 10.1021/j100002a008; Pitts Jr J. N., 2000, CHEM UPPER LOWER ATM; Riipinen I, 2012, NAT GEOSCI, V5, P453, DOI 10.1038/ngeo1499; Russell J, 1938, J AM CHEM SOC, V60, P1345, DOI 10.1021/ja01273a020; Schobesberger S, 2013, P NATL ACAD SCI USA, V110, P17223, DOI 10.1073/pnas.1306973110; Sedo G, 2009, J PHYS CHEM A, V113, P11301, DOI 10.1021/jp9063033; Smith JN, 2010, P NATL ACAD SCI USA, V107, P6634, DOI 10.1073/pnas.0912127107; TANGHE LJ, 1968, ANAL CHEM, V40, P350, DOI 10.1021/ac60258a057; van Peski AJ, 1921, RECL TRAV CHIM PAY-B, V40, P103; Zhang RY, 2009, P NATL ACAD SCI USA, V106, P17650, DOI 10.1073/pnas.0910125106; Zhang RY, 2004, SCIENCE, V304, P1487, DOI 10.1126/science.1095139	31	33	34	2	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					58	61		10.1126/science.aaa9704	http://dx.doi.org/10.1126/science.aaa9704			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26138972				2022-12-28	WOS:000357280800057
J	Spaldin, N				Spaldin, Nicola			Find your most interesting question	SCIENCE			English	Editorial Material								It started with a casual remark over coffee. It was the late 1990s, and I was a postdoc in Karin Rabe's ferroelectrics research group, then at Yale University. Ferroelectrics are materials that exhibit a spontaneous electric polarization that can be reversed by applying an electric field. Although they were named after an analogous magnetic phenomenon-ferromagnetism-ferroelectrics were generally thought to not have magnetic properties, which made me, a budding magnetism researcher, an apparently odd fit for the laboratory. That odd juxtaposition, though, turned out to be crucial to my career. "It's a pity there are no magnetic ferroelectrics," my labmate said to me as we guzzled espresso, "because then we could collaborate."	Swiss Fed Inst Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Spaldin, N (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.		Spaldin, Nicola A/A-1017-2010	Spaldin, Nicola A/0000-0003-0709-9499					0	1	1	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					110	110		10.1126/science.349.6243.110	http://dx.doi.org/10.1126/science.349.6243.110			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL9FG	26138981				2022-12-28	WOS:000357280800069
J	Bier, E; De Robertis, EM				Bier, Ethan; De Robertis, Edward M.			BMP gradients: A paradigm for morphogen-mediated developmental patterning	SCIENCE			English	Review							NERVOUS-SYSTEM CENTRALIZATION; SHORT GASTRULATION GENE; DROSOPHILA SOG PROTEIN; EXTRACELLULAR REGULATION; SPIDER EMBRYO; DPP; XENOPUS; TRANSPORT; EVOLUTION; GROWTH	Bone morphogenetic proteins (BMPs) act in dose-dependent fashion to regulate cell fate choices in a myriad of developmental contexts. In early vertebrate and invertebrate embryos, BMPs and their antagonists establish epidermal versus central nervous system domains. In this highly conserved system, BMP antagonists mediate the neural-inductive activities proposed by Hans Spemann and Hilde Mangold nearly a century ago. BMPs distributed in gradients subsequently function as morphogens to subdivide the three germ layers into distinct territories and act to organize body axes, regulate growth, maintain stem cell niches, or signal inductively across germ layers. In this Review, we summarize the variety of mechanisms that contribute to generating reliable developmental responses to BMP gradients and other morphogen systems.	[Bier, Ethan] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92095 USA; [De Robertis, Edward M.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [De Robertis, Edward M.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bier, E (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92095 USA.	ebier@ucsd.edu; ederobertis@mednet.ucla.edu		De Robertis, Edward/0000-0002-7843-1869	NIH [NS29870]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS029870, R01NS029870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Gantz for kindly providing the illustrations of organisms depicted in Fig. 6 and for the schematics of wing growth and BMP-mediated patterning shown in Fig. 5B. E.B. acknowledges funding support from NIH grant NS29870, and E.M.D.R. is a Howard Hughes Medical Institute Investigator.	Akiyama-Oda Y, 2003, DEVELOPMENT, V130, P1735, DOI 10.1242/dev.00390; Akiyama-Oda Y, 2006, DEVELOPMENT, V133, P2347, DOI 10.1242/dev.02400; Aleman A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06927; Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Ambrosio AL, 2008, DEV CELL, V15, P248, DOI 10.1016/j.devcel.2008.06.013; Appel T. A., 1987, CUVIER GEOFFROV DEBA; Araujo H, 2003, DEVELOPMENT, V130, P3851, DOI 10.1242/dev.00613; Araujo H, 2011, GENESIS, V49, P698, DOI 10.1002/dvg.20778; Arendt D, 2008, PHILOS T R SOC B, V363, P1523, DOI 10.1098/rstb.2007.2242; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Baena-Lopez LA, 2012, CURR OPIN CELL BIOL, V24, P166, DOI 10.1016/j.ceb.2011.12.010; Ben-Zvi D, 2014, BIOESSAYS, V36, P151, DOI 10.1002/bies.201300136; Biehs B, 1996, GENE DEV, V10, P2922, DOI 10.1101/gad.10.22.2922; Bier E, 2000, CURR OPIN GENET DEV, V10, P393, DOI 10.1016/S0959-437X(00)00102-7; Bier E, 1999, NATURE, V398, P375, DOI 10.1038/18778; Bier E., 2000, COILED SPRING LIFE B; Bier E, 2011, CURR BIOL, V21, pR591, DOI 10.1016/j.cub.2011.06.037; Carneiro K, 2006, DEV BIOL, V296, P203, DOI 10.1016/j.ydbio.2006.04.453; Cowden J, 2003, DEV BIOL, V262, P335, DOI 10.1016/S0012-1606(03)00395-6; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Decotto E, 2001, DEVELOPMENT, V128, P3831; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Molina MD, 2011, CURR BIOL, V21, P300, DOI 10.1016/j.cub.2011.01.016; Dworkin I, 2011, GENETICS, V187, P1171, DOI 10.1534/genetics.110.125922; Erickson JL, 2011, FLY, V5, P266, DOI 10.4161/fly.5.3.16542; Esteves FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004625; Ferguson EL, 1996, CURR OPIN GENET DEV, V6, P424, DOI 10.1016/S0959-437X(96)80063-3; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Gavin-Smyth J, 2013, CURR BIOL, V23, P2296, DOI 10.1016/j.cub.2013.09.055; Gavino MA, 2011, CURR BIOL, V21, P294, DOI 10.1016/j.cub.2011.01.017; Genikhovich G, 2015, CELL REP, V10, P1646, DOI 10.1016/j.celrep.2015.02.035; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Goltsev Y, 2007, DEVELOPMENT, V134, P2415, DOI 10.1242/dev.02863; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Hamaratoglu F, 2014, SEMIN CELL DEV BIOL, V32, P128, DOI 10.1016/j.semcdb.2014.04.036; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; Hamburger V, 1988, HERITAGE EXPT EMBRYO; Holland PWH, 2013, WIRES DEV BIOL, V2, P31, DOI 10.1002/wdev.78; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Illes JC, 2009, DEV DYNAM, V238, P194, DOI 10.1002/dvdy.21816; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Kang KH, 2010, DEV BIOL, V346, P1, DOI 10.1016/j.ydbio.2010.06.024; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kornberg TB, 2014, DEVELOPMENT, V141, P729, DOI 10.1242/dev.086223; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kuo DH, 2011, CURR BIOL, V21, P1282, DOI 10.1016/j.cub.2011.06.024; Kutejova E, 2009, CURR OPIN GENET DEV, V19, P315, DOI 10.1016/j.gde.2009.05.004; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Lander AD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002022; Lapraz F, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000248; Lauri A, 2014, SCIENCE, V345, P1365, DOI 10.1126/science.1253396; Lee HX, 2009, GENE DEV, V23, P2551, DOI 10.1101/gad.1839309; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lek M, 2010, DEVELOPMENT, V137, P4051, DOI 10.1242/dev.054288; Liang HL, 2012, DEVELOPMENT, V139, P1956, DOI 10.1242/dev.079772; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Marjoram L, 2011, DEVELOPMENT, V138, P475, DOI 10.1242/dev.056010; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; McHale P, 2011, DEV BIOL, V360, P230, DOI 10.1016/j.ydbio.2011.08.016; Mizutani CM, 2008, NAT REV GENET, V9, P663, DOI 10.1038/nrg2417; Mizutani CM, 2006, PLOS BIOL, V4, P1777, DOI 10.1371/journal.pbio.0040313; Mizutani CM, 2005, DEV CELL, V8, P915, DOI 10.1016/j.devcel.2005.04.009; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Nahmad M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000202; Negreiros E, 2010, GENESIS, V48, P31, DOI 10.1002/dvg.20579; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Nuzhdin SV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-124; PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905; Patten I, 2002, CURR BIOL, V12, P47, DOI 10.1016/S0960-9822(01)00631-5; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Plouhinec JL, 2013, P NATL ACAD SCI USA, V110, P20372, DOI 10.1073/pnas.1319745110; Rafiqi AM, 2012, DEVELOPMENT, V139, P3373, DOI 10.1242/dev.083873; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Restrepo S, 2014, CURR BIOL, V24, pR245, DOI 10.1016/j.cub.2014.01.055; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Roy S, 2014, SCIENCE, V343, P852, DOI 10.1126/science.1244624; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Sawala A, 2012, P NATL ACAD SCI USA, V109, P11222, DOI 10.1073/pnas.1202781109; Schmidt J, 1995, DEVELOPMENT, V121, P4319; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; SPEMANN H, 1924, WILHELM ROUX ARCH EN, V100, P599; Srinivasan S, 2002, DEV CELL, V2, P91, DOI 10.1016/S1534-5807(01)00097-1; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; Surowiecki James, 2004, WISDOM CROWDS; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Ulmulis DM, 2010, DEV CELL, V18, P260, DOI 10.1016/j.devcel.2010.01.006; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Umulis DM, 2006, P NATL ACAD SCI USA, V103, P11613, DOI 10.1073/pnas.0510398103; VALENTINE JW, 2004, ORIGIN PHYLA; van der Zee M, 2006, P NATL ACAD SCI USA, V103, P16307, DOI 10.1073/pnas.0605154103; Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Xu PF, 2014, SCIENCE, V344, P87, DOI 10.1126/science.1248252; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472; Yu K, 2000, DEVELOPMENT, V127, P2143; Yu K, 2004, GENETICS, V166, P1323, DOI 10.1534/genetics.166.3.1323; Zakin L, 2010, CURR BIOL, V20, pR89, DOI 10.1016/j.cub.2009.11.021; Zhang YT, 2007, J THEOR BIOL, V248, P579, DOI 10.1016/j.jtbi.2007.05.026; Zhou SH, 2012, CURR BIOL, V22, P668, DOI 10.1016/j.cub.2012.02.065	118	171	174	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242							aaa5838	10.1126/science.aaa5838	http://dx.doi.org/10.1126/science.aaa5838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE9NO	26113727	Green Published			2022-12-28	WOS:000370964800001
J	Garcia-Garcia, C; Frieda, KL; Feoktistova, K; Fraser, CS; Block, SM				Garcia-Garcia, Cuauhtemoc; Frieda, Kirsten L.; Feoktistova, Kateryna; Fraser, Christopher S.; Block, Steven M.			Factor-dependent processivity in human eIF4A DEAD-box helicase	SCIENCE			English	Article							INITIATION-FACTOR 4A; RNA HELICASE; TRANSLATION INITIATION; MESSENGER-RNA; ATPASE ACTIVITY; CHAPERONES; PROTEINS; MODULATION; MECHANISM; FAMILY	During eukaryotic translation initiation, the small ribosomal subunit, assisted by initiation factors, locates the messenger RNA start codon by scanning from the 5' cap. This process is powered by the eukaryotic initiation factor 4A (eIF4A), a DEAD-box helicase. eIF4A has been thought to unwind structures formed in the untranslated 5' region via a nonprocessive mechanism. Using a single-molecule assay, we found that eIF4A functions instead as an adenosine triphosphate-dependent processive helicase when complexed with two accessory proteins, eIF4G and eIF4B. Translocation occurred in discrete steps of 11 +/- 2 base pairs, irrespective of the accessory factor combination. Our findings support a memory-less stepwise mechanism for translation initiation and suggest that similar factor-dependent processivity may be shared by other members of the DEAD-box helicase family.	[Garcia-Garcia, Cuauhtemoc; Block, Steven M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Frieda, Kirsten L.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Feoktistova, Kateryna; Fraser, Christopher S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California Davis; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	sblock@stanford.edu			National Institute of General Medical Sciences [R37GM057035, R01GM092927, T32 GM-007377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377, R01GM092927, R37GM057035] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Landick for providing RNAP and J. Hershey, E. Abrash, and members of the Fraser and Block labs for helpful comments. This work was supported by National Institute of General Medical Sciences grants R37GM057035 (S.M.B.) and R01GM092927 (C.S.F.), an Alejandro and Lisa Zaffaroni Graduate Fellowship (C.G.G.), a Stanford Graduate Fellowship (K.L.F.), and training grant T32 GM-007377 (K.F.).	ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Andreou AZ, 2013, RNA BIOL, V10, P19, DOI 10.4161/rna.21966; Andreou AZ, 2014, J MOL BIOL, V426, P51, DOI 10.1016/j.jmb.2013.09.027; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nielsen KH, 2011, NUCLEIC ACIDS RES, V39, P2678, DOI 10.1093/nar/gkq1206; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Peck ML, 1999, RNA, V5, P1210, DOI 10.1017/S1355838299990817; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sun YJ, 2014, STRUCTURE, V22, P941, DOI 10.1016/j.str.2014.04.014; Sun YJ, 2012, NUCLEIC ACIDS RES, V40, P6199, DOI 10.1093/nar/gks278; Woodson SA, 2010, RNA BIOL, V7, P677, DOI 10.4161/rna.7.6.13615	30	58	58	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1486	1488		10.1126/science.aaa5089	http://dx.doi.org/10.1126/science.aaa5089			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113725	Green Accepted			2022-12-28	WOS:000356869100045
J	Knudson, MD; Desjarlais, MP; Becker, A; Lemke, RW; Cochrane, KR; Savage, ME; Bliss, DE; Mattsson, TR; Redmer, R				Knudson, M. D.; Desjarlais, M. P.; Becker, A.; Lemke, R. W.; Cochrane, K. R.; Savage, M. E.; Bliss, D. E.; Mattsson, T. R.; Redmer, R.			Direct observation of an abrupt insulator-to-metal transition in dense liquid deuterium	SCIENCE			English	Article							HIGH-PRESSURE; HYDROGEN; DISSOCIATION; JUPITER	Eighty years ago, it was proposed that solid hydrogen would becomemetallic at sufficiently high density. Despite numerous investigations, this transition has not yet been experimentally observed. More recently, there has been much interest in the analog of this predicted metallic transition in the dense liquid, due to its relevance to planetary science. Here, we show direct observation of an abrupt insulator-to-metal transition in dense liquid deuterium. Experimental determination of the location of this transition provides a much-needed benchmark for theory and may constrain the region of hydrogen-helium immiscibility and the boundary-layer pressure in standard models of the internal structure of gas-giant planets.	[Knudson, M. D.; Desjarlais, M. P.; Lemke, R. W.; Cochrane, K. R.; Savage, M. E.; Bliss, D. E.; Mattsson, T. R.] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Becker, A.; Redmer, R.] Univ Rostock, Inst Phys, D-18055 Rostock, Germany	United States Department of Energy (DOE); Sandia National Laboratories; University of Rostock	Knudson, MD (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	mdknuds@sandia.gov	Redmer, Ronald/F-3046-2013		Deutsche Forschungsgemeinschaft [SFB 652, Re 882/11-2]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	We acknowledge the crew of the Sandia Z facility for their contributions to these experiments; L. Shulenburger, J. Benage, and W. Lorenzen for numerous insightful discussions; and support from the Deutsche Forschungsgemeinschaft via SFB 652 and grant Re 882/11-2. A. Becker performed calculations at the North-German Supercomupting Alliance (HLRN). The experiments were performed as part of the Z Fundamental Science Program. Sandia National Laboratories is a multiprogram laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. Data are available in the supplementary materials and upon request to mdknuds@sandia.gov.	Bailey JE, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.144107; BARKER LM, 1972, J APPL PHYS, V43, P4669, DOI 10.1063/1.1660986; Clay RC, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.184106; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; Dzyabura V, 2013, P NATL ACAD SCI USA, V110, P8040, DOI 10.1073/pnas.1300718110; EBELING W, 1985, PHYS STATUS SOLIDI B, V128, P467, DOI 10.1002/pssb.2221280211; Fortov VE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.185001; Geballe ZM, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729905; Goncharov AF, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024101; Guillot T, 1999, SCIENCE, V286, P72, DOI 10.1126/science.286.5437.72; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Holmes NC, 1995, PHYS REV B, V52, P15835, DOI 10.1103/PhysRevB.52.15835; KERLEY GI, 2003, SAND20033613 SAND NA; Landau LD., 1943, ACTA PHYS CHIM USSR, V18, P380; Lee K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081101; Lorenzen W., 2014, FRONTIERS CHALLENGES, P203; Lorenzen W, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235109; Lorenzen W, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195107; Loubeyre P, 2004, HIGH PRESSURE RES, V24, P25, DOI 10.1080/08957950310001635792; Loubeyre P, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.144115; Matzen MK, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1891746; Mazzola G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4487; Morales MA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.065702; Morales MA, 2010, P NATL ACAD SCI USA, V107, P12799, DOI 10.1073/pnas.1007309107; Nellis WJ, 1999, PHYS REV B, V59, P3434, DOI 10.1103/PhysRevB.59.3434; Nettelmann N, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/52; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; SALPETER EE, 1973, ASTROPHYS J, V181, pL83, DOI 10.1086/181190; SMOLUCHO.R, 1967, NATURE, V215, P691, DOI 10.1038/215691a0; Tamblyn I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.065702; Weir ST, 1996, PHYS REV LETT, V76, P1860, DOI 10.1103/PhysRevLett.76.1860; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590	33	199	214	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1455	1460		10.1126/science.aaa7471	http://dx.doi.org/10.1126/science.aaa7471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113719	Green Submitted			2022-12-28	WOS:000356869100037
J	Leverenz, RL; Sutter, M; Wilson, A; Gupta, S; Thurotte, A; de Carbon, CB; Petzold, CJ; Ralston, C; Perreau, F; Kirilovsky, D; Kerfeld, CA				Leverenz, Ryan L.; Sutter, Markus; Wilson, Adjele; Gupta, Sayan; Thurotte, Adrien; de Carbon, Celine Bourcier; Petzold, Christopher J.; Ralston, Corie; Perreau, Francois; Kirilovsky, Diana; Kerfeld, Cheryl A.			A 12 angstrom carotenoid translocation in a photoswitch associated with cyanobacterial photoprotection	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PROTEIN; MECHANISM; IDENTIFICATION; PHOTOPHYSICS; CHARGE; PLANTS; SITE	Pigment-protein and pigment-pigment interactions are of fundamental importance to the light-harvesting and photoprotective functions essential to oxygenic photosynthesis. The orange carotenoid protein (OCP) functions as both a sensor of light and effector of photoprotective energy dissipation in cyanobacteria. We report the atomic-resolution structure of an active form of the OCP consisting of the N-terminal domain and a single noncovalently bound carotenoid pigment. The crystal structure, combined with additional solution-state structural data, reveals that OCP photoactivation is accompanied by a 12 angstrom translocation of the pigment within the protein and a reconfiguration of carotenoid-protein interactions. Our results identify the origin of the photochromic changes in the OCP triggered by light and reveal the structural determinants required for interaction with the light-harvesting antenna during photoprotection.	[Leverenz, Ryan L.; Sutter, Markus; Kerfeld, Cheryl A.] Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA; [Sutter, Markus; Petzold, Christopher J.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Wilson, Adjele; Thurotte, Adrien; de Carbon, Celine Bourcier; Kirilovsky, Diana] CEA, Inst Biol & Technol Saclay iBiTec S, F-91191 Gif Sur Yvette, France; [Wilson, Adjele; Thurotte, Adrien; de Carbon, Celine Bourcier; Kirilovsky, Diana] CNRS, I2BC, UMR 9198, F-91191 Gif Sur Yvette, France; [Gupta, Sayan; Ralston, Corie] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Perreau, Francois] Saclay Plant Sci, Inst Jean Pierre Bourgin, CNRS, INRA,UMR 1318,ERL 3559,RD10, F-78026 Versailles, France; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Michigan State University; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Berkeley	Kerfeld, CA (corresponding author), Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA.	ckerfeld@lbl.gov	Thurotte, Adrien/L-6340-2019; Kirilovsky, Diana/I-2359-2014	Thurotte, Adrien/0000-0002-3808-1913; Wilson, Adjele Flore/0000-0003-2622-3600; Perreau, Francois/0000-0001-7873-9866; Kirilovsky, Diana/0000-0003-2146-3103; Petzold, Christopher/0000-0002-8270-5228; Sutter, Markus/0000-0001-6290-4820	U.S. Department of Energy (DOE), Basic Energy Sciences [DE-FG02-91ER20021]; Office of Science, Office of Basic Energy Sciences, of the U.S. DOE [DE-AC02-05CH11231]; Office of Science of the U.S. DOE [DE-AC02-05CH11231]; Office of Science, Office of Biological and Environmental Research, of the U.S. DOE [DE-AC02-05CH11231]; Agence Nationale de la Recherche (ANR, project CYANOPROTECT)	U.S. Department of Energy (DOE), Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the U.S. DOE(United States Department of Energy (DOE)); Office of Science of the U.S. DOE(United States Department of Energy (DOE)); Office of Science, Office of Biological and Environmental Research, of the U.S. DOE(United States Department of Energy (DOE)); Agence Nationale de la Recherche (ANR, project CYANOPROTECT)(French National Research Agency (ANR))	Supported by the U.S. Department of Energy (DOE), Basic Energy Sciences, award DE-FG02-91ER20021. We thank the staff at the Berkeley Center for Structural Biology, which is supported in part by the National Institute of General Medical Sciences and the Howard Hughes Medical Institute. We thank R. Celestre for assistance at beamline 5.3.1. The Advanced Light Source at Lawrence Berkeley National Laboratory is supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. DOE under contract no. DE-AC02-05CH11231. This research used resources of the National Energy Research Scientific Computing Center, a DOE Office of Science User Facility supported by the Office of Science of the U.S. DOE under contract no. DE-AC02-05CH11231 and of the Joint BioEnergy Institute supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. DOE under contract DE-AC02-05CH11231. A.W., A.T., C.B., and D.K. are supported by a grant from the Agence Nationale de la Recherche (ANR, project CYANOPROTECT), and used resources of CNRS and the Commissariat a l'Energie Atomique (CEA). We thank S. Cot for technical assistance. Coordinates have been deposited in the RCSB Protein Data Bank under accession codes 4XB4 (RCP<INF>CAN</INF>) and 4XB5 (OCP<INF>CAN</INF>).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Berera R, 2012, J PHYS CHEM B, V116, P2568, DOI 10.1021/jp2108329; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; FRANK HA, 1994, PHOTOSYNTH RES, V41, P389, DOI 10.1007/BF02183041; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; Gupta S, 2012, P NATL ACAD SCI USA, V109, P14882, DOI 10.1073/pnas.1209060109; Gwizdala M, 2011, PLANT CELL, V23, P2631, DOI 10.1105/tpc.111.086884; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Jallet D, 2014, PLANT PHYSIOL, V164, P790, DOI 10.1104/pp.113.229997; Jallet D, 2012, BBA-BIOENERGETICS, V1817, P1418, DOI 10.1016/j.bbabio.2011.11.020; Kerfeld CA, 2003, STRUCTURE, V11, P55, DOI 10.1016/S0969-2126(02)00936-X; Kerfeld CA, 2010, CAROTENOIDS: PHYSICAL, CHEMICAL, AND BIOLOGICAL FUNCTIONS AND PROPERTIES, P3; King JD, 2014, FEBS LETT, V588, P4561, DOI 10.1016/j.febslet.2014.10.024; Kirilovsky D, 2007, PHOTOSYNTH RES, V93, P7, DOI 10.1007/s11120-007-9168-y; Leverenz RL, 2014, PLANT CELL, V26, P426, DOI 10.1105/tpc.113.118588; Liu HJ, 2014, BBA-BIOENERGETICS, V1837, P1955, DOI 10.1016/j.bbabio.2014.09.004; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Punginelli C, 2009, BBA-BIOENERGETICS, V1787, P280, DOI 10.1016/j.bbabio.2009.01.011; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; SCHOLES GD, 1994, J PHYS CHEM-US, V98, P4580, DOI 10.1021/j100068a017; Staleva H, 2015, NAT CHEM BIOL, V11, P287, DOI [10.1038/nchembio.1755, 10.1038/NCHEMBIO.1755]; Sutter M, 2013, P NATL ACAD SCI USA, V110, P10022, DOI 10.1073/pnas.1303673110; Tian LJ, 2011, J AM CHEM SOC, V133, P18304, DOI 10.1021/ja206414m; Walla PJ, 2014, ADV PHOTOSYNTH RESP, V40, P229, DOI 10.1007/978-94-017-9032-1_9; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Wilson A, 2012, PLANT CELL, V24, P1972, DOI 10.1105/tpc.112.096909; Wilson A, 2010, J BIOL CHEM, V285, P18364, DOI 10.1074/jbc.M110.115709; Zhang H, 2014, BIOCHEMISTRY-US, V53, P13, DOI 10.1021/bi401539w	30	132	134	2	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1463	1466		10.1126/science.aaa7234	http://dx.doi.org/10.1126/science.aaa7234			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113721				2022-12-28	WOS:000356869100039
J	George, A; Phillips, M; Sweeney, L; Colombo, C				George, Amaya; Phillips, Michael; Sweeney, Lori; Colombo, Christopher			CASE REVIEW A 56 year old woman with syncope, weakness, and refractory hypotension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[George, Amaya] Dwight D Eisenhower Army Med Ctr, Dept Internal Med, Ft Gordon, GA 30905 USA; [Phillips, Michael] Brooke Army Med Ctr, Dept Cardiol, Ft Sam Houston, TX 78234 USA; [Sweeney, Lori] Virginia Commonwealth Univ Hlth Syst, Dept Endocrinol, Richmond, VA USA; [Colombo, Christopher] Dwight D Eisenhower Army Med Ctr, Dept Crit Care, Ft Gordon, GA USA	United States Department of Defense; United States Army; San Antonio Military Medical Center; United States Department of Defense; United States Army; Virginia Commonwealth University; United States Department of Defense; United States Army	George, A (corresponding author), Dwight D Eisenhower Army Med Ctr, Dept Internal Med, Ft Gordon, GA 30905 USA.	amaya.d.george.mil@mail.mil		Colombo, Christopher/0000-0001-5499-3368				Darzy Ken H, 2005, Pituitary, V8, P203, DOI 10.1007/s11102-006-6042-4; Darzy KH, 2009, PITUITARY, V12, P40, DOI 10.1007/s11102-008-0088-4; Fernandez A, 2009, ENDOCR-RELAT CANCER, V16, P733, DOI 10.1677/ERC-08-0231; LITTLEY MD, 1989, Q J MED, V70, P145; Sheehan JP, 2005, J NEUROSURG, V102, P678, DOI 10.3171/jns.2005.102.4.0678	5	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2015	350								h3387	10.1136/bmj.h3387	http://dx.doi.org/10.1136/bmj.h3387			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL7OB	26113625				2022-12-28	WOS:000357160500003
J	Thompson, C				Thompson, Charis			CRISPR: Move beyond differences	NATURE			English	Editorial Material									[Thompson, Charis] Univ Calif Berkeley, Dept Gender & Womens Studies, Berkeley, CA 94720 USA; [Thompson, Charis] London Sch Econ, Dept Sociol, London, England	University of California System; University of California Berkeley; University of London; London School Economics & Political Science	Thompson, C (corresponding author), Univ Calif Berkeley, Dept Gender & Womens Studies, Berkeley, CA 94720 USA.	charis@berkeley.edu		Thompson, Charis/0000-0002-1330-0964				European Commission, 2013, SHE FIG 2012 GEND RE; Grzanka Patrick R., 2014, INTERSECTIONALITY FD; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5	3	6	6	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					414	414		10.1038/522415a	http://dx.doi.org/10.1038/522415a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2OC	26108837	Bronze			2022-12-28	WOS:000356782900023
J	Loeb, S; Folkvaljon, Y; Lambe, M; Robinson, D; Garmo, H; Ingvar, C; Stattin, P				Loeb, Stacy; Folkvaljon, Yasin; Lambe, Mats; Robinson, David; Garmo, Hans; Ingvar, Christian; Stattin, Par			Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSTATE-CANCER; UNITED-STATES; INCIDENT MELANOMA; SILDENAFIL; SWEDEN; DIAGNOSIS; SURVIVAL; REGISTER; COHORT; MEN	IMPORTANCE The target for the oral erectile dysfunction drugs, phosphodiesterase type 5 (PDE5) inhibitors, is part of a pathway implicated in the development of malignant melanoma. An increased risk of melanoma in sildenafil users was recently reported. OBJECTIVE To examine the association between use of PDE5 inhibitors and melanoma risk, including data on specific PDE5 inhibitors, number of prescriptions, and melanoma stage. DESIGN, SETTING, AND PARTICIPANTS Nationwide, population-based, nested case-control study in the Swedish Prescribed Drug Register, the Swedish Melanoma Register, and other health care registers and demographic databases in Sweden, including 4065 melanoma cases diagnosed from 2006 through 2012 and 5 randomly selected controls per case with matching year of birth. EXPOSURES Number of filled prescriptions for the PDE5 inhibitors sildenafil and vardenafil or tadalafil. MAIN OUTCOMES AND MEASURES Risk of melanoma; overall and by stage and risk of basal cell carcinoma in multivariable logistic regression analyses. RESULTS Of 4065 melanoma cases, 435 men (11%) had filled prescriptions for PDE5 inhibitors, as did 1713 men of 20 325 controls (8%). In multivariable analysis, there was an increased risk of melanoma in men taking PDE5 inhibitors (OR, 1.21 [95% CI, 1.08-1.36]). The most pronounced increase in risk was observed in men who had filled a single prescription (OR, 1.32 [95% CI, 1.10-1.59]; exposure rate, 4% for cases vs 3% for controls), but was not significant among men with multiple filled prescriptions (for 2-5 prescriptions: OR, 1.14 [95% CI, 0.95-1.37], 4% for cases and 3% for controls; for >= 6 prescriptions: OR, 1.17 [95% CI, 0.95-1.44], 3% for cases vs 2% for controls). PDE5 inhibitors were significantly associated with melanoma stage 0 (OR, 1.49 [95% CI, 1.22-1.83], 13% for cases vs 8% for controls) and stage I (OR, 1.21 [95% CI, 1.02-1.43], 12% for cases vs 10% for controls), but not stage II through IV (OR, 0.83 [95% CI, 0.63-1.09], 6% for cases vs 7% for controls). The risk estimates were similar for sildenafil and vardenafil or tadalafil. PDE5 inhibitor use was also associated with an increased risk of basal cell carcinoma (OR, 1.19 [95% CI, 1.14-1.25], 9% for cases vs 8% for controls). Men taking PDE5 inhibitors had a higher educational level and annual income, factors that were also significantly associated with melanoma risk. CONCLUSIONS AND RELEVANCE In a Swedish cohort of men, the use of PDE5 inhibitors was associated with a modest but statistically significant increased risk of malignant melanoma. However, the pattern of association (eg, the lack of association with multiple filled prescriptions) raises questions about whether this association is causal.	[Loeb, Stacy] NYU, Dept Urol, Populat Hlth, New York, NY USA; [Loeb, Stacy] NYU, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA; [Folkvaljon, Yasin; Lambe, Mats] Univ Uppsala Hosp, Reg Canc Ctr, Uppsala, Sweden; [Lambe, Mats] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Robinson, David; Stattin, Par] Umea Univ Hosp, Dept Surg & Perioperat Sci, Urol & Androl, S-90185 Umea, Sweden; [Garmo, Hans] Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England; [Ingvar, Christian] Univ Lund Hosp, Dept Surg Melanoma & Breast, S-22185 Lund, Sweden	New York University; New York University; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Umea University; University of London; King's College London; Lund University; Skane University Hospital	Loeb, S (corresponding author), 550 First Ave,VZ30,Sixth Floor 612, New York, NY 10016 USA.	stacyloeb@gmail.com	Ingvar, Christian/AAE-9841-2019	Loeb, Stacy/0000-0003-3933-9207; Lambe, Mats/0000-0002-4624-3767	Swedish Research Council [825-2012-5047]; Swedish Cancer Foundation [11 0471]; Vasterbotten County Council; Lion's Cancer Research Foundation at Umea University; Louis Feil Charitable Lead Trust; Laura and Isaac Perlmutter NYU Cancer Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Vasterbotten County Council; Lion's Cancer Research Foundation at Umea University; Louis Feil Charitable Lead Trust; Laura and Isaac Perlmutter NYU Cancer Institute	This work was supported by the Swedish Research Council (825-2012-5047) and the Swedish Cancer Foundation (11 0471), Vasterbotten County Council, the Lion's Cancer Research Foundation at Umea University, the Louis Feil Charitable Lead Trust (Dr Loeb), and the Laura and Isaac Perlmutter NYU Cancer Institute (Dr Loeb).	Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Aytac IA, 1999, BJU INT, V84, P50; Berglund A, 2011, J UROLOGY, V185, P833, DOI 10.1016/j.juro.2010.10.061; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Doggrell S, 2007, INT J IMPOT RES, V19, P281, DOI 10.1038/sj.ijir.3901525; Eriksson H, 2014, J CLIN ONCOL, V32, P1356, DOI 10.1200/JCO.2013.52.7564; Frederick LR, 2014, J SEX MED, V11, P2546, DOI 10.1111/jsm.12647; Grichnik JM, 2014, DERMATOL THER, V27, P313, DOI 10.1111/dth.12162; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jiang AJ, 2015, BRIT J DERMATOL, V172, P885, DOI 10.1111/bjd.13500; Li WQ, 2014, JAMA INTERN MED, V174, P964, DOI 10.1001/jamainternmed.2014.594; Li WQ, 2013, J CLIN ONCOL, V31, P4394, DOI 10.1200/JCO.2013.51.1915; Nordin M, 2013, SOC SCI MED, V77, P106, DOI 10.1016/j.socscimed.2012.11.013; Plym A, 2014, J SEX MED, V11, P2100, DOI 10.1111/jsm.12586; Pollack LA, 2011, J AM ACAD DERMATOL, V65, pS78, DOI 10.1016/j.jaad.2011.05.030; Robinson JK, 2014, JAMA INTERN MED, V174, P970, DOI 10.1001/jamainternmed.2014.157; Shaeer O, 2013, J SEX MED, V10, P532, DOI 10.1111/j.1743-6109.2012.02972.x; Socialstyrelson, STAT CANC; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068	19	63	64	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2449	2455		10.1001/jama.2015.6604	http://dx.doi.org/10.1001/jama.2015.6604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26103029	Bronze			2022-12-28	WOS:000356663600014
J	Urbach, DR; Bell, CM				Urbach, David R.; Bell, Chaim M.			A Revised Quality Measure for Surgical Care More Alpha Testing for Perioperative beta-Blockers?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MYOCARDIAL-INFARCTION; BLOCKADE; SURGERY		[Urbach, David R.] Univ Toronto, Dept Surg, 200 Elizabeth St,Room 10-214, Toronto, ON M5G 2C4, Canada; [Urbach, David R.; Bell, Chaim M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5G 2C4, Canada; [Urbach, David R.; Bell, Chaim M.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Urbach, David R.] Toronto Gen Res Inst, Div Support Syst & Outcomes, Toronto, ON, Canada; [Bell, Chaim M.] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Urbach, DR (corresponding author), Univ Toronto, Dept Surg, 200 Elizabeth St,Room 10-214, Toronto, ON M5G 2C4, Canada.	david.urbach@uhn.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469				Bell CM, 2011, JAMA-J AM MED ASSOC, V306, P840, DOI 10.1001/jama.2011.1206; Dawood MM, 1996, INT J CARDIOL, V57, P37, DOI 10.1016/S0167-5273(96)02769-6; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Landesberg G, 2001, J AM COLL CARDIOL, V37, P1839, DOI 10.1016/S0735-1097(01)01265-7; McGory ML, 2005, SURGERY, V138, P171, DOI 10.1016/j.surg.2005.03.022; Richman JS, 2014, JAMA SURG, V149, P1031, DOI 10.1001/jamasurg.2014.351; The Joint Commission, 2014, SURG CAR IMPR PROJ	7	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2369	+		10.1001/jama.2015.0798	http://dx.doi.org/10.1001/jama.2015.0798			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	26080341				2022-12-28	WOS:000356300200022
J	Jamtvedt, G; Klemp, M; Morland, B; Nylenna, M				Jamtvedt, Gro; Klemp, Marianne; Morland, Berit; Nylenna, Magne			Responsibility and accountability for well informed health-care decisions: a global challenge	LANCET			English	Editorial Material							INFORMATION; NETWORK		[Jamtvedt, Gro; Klemp, Marianne; Morland, Berit; Nylenna, Magne] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway	Norwegian Knowledge Centre for Health Services	Jamtvedt, G (corresponding author), Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway.	Gro.Jamtvedt@kunnskapssenteret.no	Klemp, Marianne/AAQ-5652-2021	Klemp, Marianne/0000-0002-9530-8344				Booth A, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-111; Boozary AS, 2014, JAMA-J AM MED ASSOC, V312, P1859, DOI 10.1001/jama.2014.14387; Chalmers I, 2014, LANCET, V384, P1903, DOI 10.1016/S0140-6736(14)62252-2; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Corallo AN, 2014, HEALTH POLICY, V114, P5, DOI 10.1016/j.healthpol.2013.08.002; Del Fiol G, 2014, JAMA INTERN MED, V174, P710, DOI 10.1001/jamainternmed.2014.368; Eisenberg JM, 2002, HEALTH AFFAIR, V21, P166, DOI 10.1377/hlthaff.21.3.166; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Kristensen FB, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5236; Kristensen FB, 2009, INT J TECHNOL ASSESS, V25, P1, DOI 10.1017/S0266462309990626; Kristiansen A, 2014, CHEST, V146, P735, DOI 10.1378/chest.13-2993; Lavis JN, 2009, HEALTH RES POLICY SY, V7, DOI [10.1186/1478-4505-7-S1-S1, 10.1186/1478-4505-7-S1-11, 10.1186/1478-4505-7-S1-S15, 10.1186/1478-4505-7-S1-I1]; Morahan-Martin JM, 2004, CYBERPSYCHOL BEHAV, V7, P497, DOI 10.1089/1094931042403082; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Rada G, 2013, STUD HEALTH TECHNOL, V192, P486, DOI 10.3233/978-1-61499-289-9-486; Runciman WB, 2012, MED J AUSTRALIA, V197, P100, DOI 10.5694/mja12.10510; Santesso N, 2015, J CLIN EPIDEMIOL, V68, P182, DOI 10.1016/j.jclinepi.2014.04.009; Siontis KC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4501; Stewart R, 2008, SYSTEMATIC MAP STUDI; Treweek S, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-6	21	2	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					826	828		10.1016/S0140-6736(15)60855-8	http://dx.doi.org/10.1016/S0140-6736(15)60855-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LR	26085031				2022-12-28	WOS:000360287900028
J	Han, JB; Li, EW; Chen, LQ; Zhang, YY; Wei, FC; Liu, JY; Deng, HT; Wang, YG				Han, Jinbo; Li, Erwei; Chen, Liqun; Zhang, Yuanyuan; Wei, Fangchao; Liu, Jieyuan; Deng, Haiteng; Wang, Yiguo			The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1	NATURE			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; COPII VESICLES; ENERGY-BALANCE; ER-STRESS; SENSITIVITY; LIPOGENESIS; GLUCONEOGENESIS; PATHWAY; LIVER	Abnormal accumulation of triglycerides in the liver, caused in part by increasedde novo lipogenesis, results in non-alcoholic fatty liver disease and insulin resistance(1,2). Sterol regulatory element-binding protein 1 (SREBP1), an important transcriptional regulator of lipogenesis, is synthesized as an inactive precursor that binds to the endoplasmic reticulum (ER). In response to insulin signalling, SREBP1 is transported from the ER to the Golgi in a COPII-dependent manner, processed by proteases in the Golgi, and then shuttled to the nucleus to induce lipogenic gene expression(3-5); however, the mechanisms underlying enhanced SREBP1 activity in insulin-resistant obesity and diabetes remain unclear. Here we show in mice that CREB regulated transcription coactivator 2 (CRTC2)(6) functions as a mediator of mTOR(7) signalling to modulate COPII-dependent SREBP1 processing. CRTC2 competes with Sec23A, a subunit of the COPII complex(8), to interact with Sec31A, another COPII subunit, thus disrupting SREBP1 transport. During feeding, mTOR phosphorylates CRTC2 and attenuates its inhibitory effect on COPII-dependent SREBP1 maturation. As hepatic overexpression of an mTOR-defective CRTC2 mutant in obese mice improved the lipogenic program and insulin sensitivity, these results demonstrate how the transcriptional coactivator CRTC2 regulates mTOR-mediated lipid homeostasis in the fed state and in obesity.	[Han, Jinbo; Li, Erwei; Chen, Liqun; Zhang, Yuanyuan; Wei, Fangchao; Wang, Yiguo] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Liu, Jieyuan; Deng, Haiteng] Tsinghua Univ, Sch Life Sci, Prote Facil, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Wang, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	wangyiguo@biomed.tsinghua.edu.cn		Deng, Haiteng/0000-0001-9496-1280	1000 Talents Program for Young Scholars; National Science Foundation of China [31322027, 31321003, 31471127]	1000 Talents Program for Young Scholars; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank M. Montminy, W. E. Balch, L. Yu, S. Fu, P. Li, J. Wu and D. Li for discussion, and X. Liu and P. Li for technical help with lipogenesis analyses and clamp studies, respectively. This work was supported by grants from 1000 Talents Program for Young Scholars and the National Science Foundation of China (31322027, 31321003 and 31471127) to Y.W.	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	29	167	181	5	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					243	+		10.1038/nature14557	http://dx.doi.org/10.1038/nature14557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26147081				2022-12-28	WOS:000359386900037
J	Winzer, T; Kern, M; King, AJ; Larson, TR; Teodor, RI; Donninger, SL; Li, Y; Dowle, AA; Cartwright, J; Bates, R; Ashford, D; Thomas, J; Walker, C; Bowser, TA; Graham, IA				Winzer, Thilo; Kern, Marcelo; King, Andrew J.; Larson, Tony R.; Teodor, Roxana I.; Donninger, Samantha L.; Li, Yi; Dowle, Adam A.; Cartwright, Jared; Bates, Rachel; Ashford, David; Thomas, Jerry; Walker, Carol; Bowser, Tim A.; Graham, Ian A.			Morphinan biosynthesis in opium poppy requires a P450-oxidoreductase fusion protein	SCIENCE			English	Article							BENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS; PAPAVER-SOMNIFERUM; MOLECULAR-CLONING; DIOXYGENASES CATALYZE; COPTIS-JAPONICA; O-DEMETHYLATION; ENZYME; SYNTHASE; CYTOCHROME-P450; PURIFICATION	Morphinan alkaloids from the opium poppy are used for pain relief. The direction of metabolites to morphinan biosynthesis requires isomerization of (S)-to (R)-reticuline. Characterization of high-reticuline poppy mutants revealed a genetic locus, designated STORR [(S)-to (R)-reticuline] that encodes both cytochrome P450 and oxidoreductase modules, the latter belonging to the aldo-keto reductase family. Metabolite analysis of mutant alleles and heterologous expression demonstrate that the P450 module is responsible for the conversion of (S)-reticuline to 1,2-dehydroreticuline, whereas the oxidoreductase module converts 1,2-dehydroreticuline to (R)-reticuline rather than functioning as a P450 redox partner. Proteomic analysis confirmed that these two modules are contained on a single polypeptide in vivo. This modular assembly implies a selection pressure favoring substrate channeling. The fusion protein STORR may enable microbial-based morphinan production.	[Winzer, Thilo; Kern, Marcelo; King, Andrew J.; Larson, Tony R.; Teodor, Roxana I.; Donninger, Samantha L.; Li, Yi; Graham, Ian A.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England; [Dowle, Adam A.; Cartwright, Jared; Bates, Rachel; Ashford, David; Thomas, Jerry] Univ York, Dept Biol, Biosci Technol Facil, York YO10 5DD, N Yorkshire, England; [Walker, Carol; Bowser, Tim A.] GlaxoSmithKline, Boronia, Vic 3155, Australia	University of York - UK; University of York - UK; GlaxoSmithKline	Graham, IA (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	ian.graham@york.ac.uk	Dowle, Adam/AAW-6410-2021; TEODOR, Roxana/R-6929-2018; Larson, Tony/AAI-4782-2020; King, Andrew/A-9887-2011	Dowle, Adam/0000-0002-6501-5444; TEODOR, Roxana/0000-0003-2652-1894; Larson, Tony/0000-0003-1337-3482; King, Andrew/0000-0002-2388-6081; Bowser, Tim/0000-0002-2126-8538	UK Biotechnology and Biological Sciences Research Council [BB/K018809/1]; Garfield Weston Foundation; Biotechnology and Biological Sciences Research Council [BB/L004917/1, BB/K018809/1] Funding Source: researchfish; BBSRC [BB/K018809/1, BB/L004917/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Garfield Weston Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the laboratory and horticultural staff at GlaxoSmithKline Australia and the University of York for valuable technical assistance; J. Mitchell for administrative support; T. Davis for providing high-(S)reticuline poppy straw; A. Bridges for providing DNA constructs; and D. Nelson for naming the P450 module. We acknowledge financial support from the UK Biotechnology and Biological Sciences Research Council (grant BB/K018809/1) and The Garfield Weston Foundation. The STORR cDNA sequence is available through the National Centre for Biotechnology Information under GenBank accession number KP998574. The University of York and GlaxoSmithKline have filed a patent application relating to this work. The supplementary materials contain additional data.	Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; [Anonymous], 2013, FORM SAL OP MOL; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; Choi KB, 2001, PHYTOCHEMISTRY, V56, P649, DOI 10.1016/S0031-9422(00)00481-7; DEEKNAMKUL W, 1992, PHYTOCHEMISTRY, V31, P813, DOI 10.1016/0031-9422(92)80020-F; Farrow SC, 2013, J BIOL CHEM, V288, P28997, DOI 10.1074/jbc.M113.488585; GATES M, 1956, J AM CHEM SOC, V78, P1380, DOI 10.1021/ja01588a033; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hansen BG, 2012, APPL ENVIRON MICROB, V78, P4908, DOI 10.1128/AEM.07955-11; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hirata K, 2004, PHYTOCHEMISTRY, V65, P1039, DOI 10.1016/j.phytochem.2004.02.015; Hoffmann I, 2014, J LIPID RES, V55, P2113, DOI 10.1194/jlr.M051755; Lenz R, 1995, J BIOL CHEM, V270, P31091, DOI 10.1074/jbc.270.52.31091; Morishige T, 2000, J BIOL CHEM, V275, P23398, DOI 10.1074/jbc.M002439200; Nakagawa A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06695; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; Ounaroon A, 2003, PLANT J, V36, P808, DOI 10.1046/j.1365-313X.2003.01928.x; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; Samanani N, 2004, PLANT J, V40, P302, DOI 10.1111/j.1365-313X.2004.02210.x; Serturner F, 1806, J PHARMACIE ARZTE AP, V14, P47; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x	27	90	107	6	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		309	312		10.1126/science.aab1852	http://dx.doi.org/10.1126/science.aab1852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26113639				2022-12-28	WOS:000358218600052
J	Payne, D				Payne, David			THEBMJ.COM AT 20 Twenty top papers to mark The BMJ's two digital decades	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCTOR; HEALTH; CHILDREN					dpayne@bmj.com						ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Berger D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3169; Chalmers I, 1998, BMJ-BRIT MED J, V317, P1167, DOI 10.1136/bmj.317.7167.1167; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Deer Brian, 2011, BMJ, V342, pc5347, DOI 10.1136/bmj.c5347; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Haines A, 1998, BMJ-BRIT MED J, V317, P72, DOI 10.1136/bmj.317.7150.72; Ham C, 2002, BRIT MED J, V324, P838, DOI 10.1136/bmj.324.7341.838; Hastings G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5124; Hurwitz B, 2002, BMJ-BRIT MED J, V325, P667, DOI 10.1136/bmj.325.7366.667; Kaczorowski J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d442; Kai J, 1996, BRIT MED J, V313, P983; McCormack J, 2000, BMJ-BRIT MED J, V320, P1720, DOI 10.1136/bmj.320.7251.1720; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Seehusen DA, 2006, BMJ-BRIT MED J, V333, P171, DOI 10.1136/bmj.38888.588519.55; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Swarte NB, 2003, BMJ-BRIT MED J, V327, P189, DOI 10.1136/bmj.327.7408.189; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Yudkin JS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4485	20	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2015	351								h3660	10.1136/bmj.h3660	http://dx.doi.org/10.1136/bmj.h3660			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MA	26149853				2022-12-28	WOS:000357954200004
J	Hilton, D				Hilton, Douglas			Practical policies can combat gender inequality	NATURE			English	Editorial Material									Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Hilton, D (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	hilton@wehi.edu.au	Hilton, Douglas J/C-7250-2013	Hilton, Douglas J/0000-0002-7698-2392					0	1	1	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					7	7		10.1038/523007a	http://dx.doi.org/10.1038/523007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL7RN	26135413	Bronze			2022-12-28	WOS:000357169500004
J	Luzzatto, L; Pandolfi, PP				Luzzatto, Lucio; Pandolfi, Pier Paolo			Causality and Chance in the Development of Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLORECTAL-CANCER; SOMATIC MUTATIONS; IN-VIVO; CARCINOGENESIS; CELL; RISK; LUNG; HEPATITIS; DISEASE; WATSON		[Luzzatto, Lucio] Ist Toscano Tumori, Florence, Italy; [Luzzatto, Lucio] Univ Florence, Florence, Italy; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Florence; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Luzzatto, L (corresponding author), Ist Toscano Tumori, Florence, Italy.			Pandolfi, Pier Paolo/0000-0002-5352-5295				ALBERTINI RJ, 1990, ANNU REV GENET, V24, P305; Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; ARMITAGE P, 1985, ENVIRON HEALTH PERSP, V63, P195, DOI 10.2307/3430046; Bebenek K, 2011, P NATL ACAD SCI USA, V108, P1862, DOI 10.1073/pnas.1012825108; Bodmer W, 2010, CURR OPIN GENET DEV, V20, P262, DOI 10.1016/j.gde.2010.04.016; BUESCHER ES, 1985, J CLIN INVEST, V76, P1581, DOI 10.1172/JCI112140; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Feinberg AP, 2014, J INTERN MED, V276, P5, DOI 10.1111/joim.12224; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fotouhi A, 2013, MUTAT RES-FUND MOL M, V751, P8, DOI 10.1016/j.mrfmmm.2013.10.001; Hecht SS, 2012, INT J CANCER, V131, P2724, DOI 10.1002/ijc.27816; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Larsen MJ, 2014, BREAST CANCER-BASIC, V8, P145, DOI 10.4137/BCBCR.S18715; Lindberg N, 2014, J NEUROSCI, V34, P14644, DOI 10.1523/JNEUROSCI.2977-14.2014; Luzzatto L, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S12; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miller YE, 2007, CANCER EPIDEM BIOMAR, V16, P2425, DOI 10.1158/1055-9965.EPI-07-0220; Peruzzi B, 2010, MUTAT RES-REV MUTAT, V705, P3, DOI 10.1016/j.mrrev.2009.12.004; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Riviere L, 2014, RECENT RESULTS CANC, V193, P59, DOI 10.1007/978-3-642-38965-8_4; Rondelli T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054046; Santen R, 2009, ANN NY ACAD SCI, V1155, P132, DOI 10.1111/j.1749-6632.2008.03685.x; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Serero A, 2014, P NATL ACAD SCI USA, V111, P1897, DOI 10.1073/pnas.1314423111; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; Steliga MA, 2010, EXPERT REV ANTICANC, V10, P1513, DOI [10.1586/era.10.149, 10.1586/ERA.10.149]; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Tetteh PW, 2015, TRENDS CELL BIOL, V25, P100, DOI 10.1016/j.tcb.2014.09.003; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Tomasetti C, 2015, SCIENCE, V347, P729, DOI 10.1126/science.aaa6592; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Weinberg RA, 2007, BIOL CANC; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zhang XB, 1996, CARCINOGENESIS, V17, P2259, DOI 10.1093/carcin/17.10.2259	43	27	28	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					84	88		10.1056/NEJMsb1502456	http://dx.doi.org/10.1056/NEJMsb1502456			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL8IS	26132946				2022-12-28	WOS:000357218700013
J	Slack, C; Alic, N; Foley, A; Cabecinha, M; Hoddinott, MP; Partridge, L				Slack, Cathy; Alic, Nazif; Foley, Andrea; Cabecinha, Melissa; Hoddinott, Matthew P.; Partridge, Linda			The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity	CELL			English	Article							LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; TRANSCRIPTION FACTORS; I RECEPTOR; INSULIN; YEAST; MICE; RAPAMYCIN; INHIBITOR	Identifying the molecular mechanisms that underlie aging and their pharmacological manipulation are key aims for improving lifelong human health. Here, we identify a critical role for Ras-Erk-ETS signaling in aging in Drosophila. We show that inhibition of Ras is sufficient for lifespan extension downstream of reduced insulin/IGF-1 (IIS) signaling. Moreover, direct reduction of Ras or Erk activity leads to increased lifespan. We identify the E-twenty six (ETS) transcriptional repressor, Anterior open (Aop), as central to lifespan extension caused by reduced IIS or Ras attenuation. Importantly, we demonstrate that adult-onset administration of the drug trametinib, a highly specific inhibitor of Ras-Erk-ETS signaling, can extend lifespan. This discovery of the Ras-Erk-ETS pathway as a pharmacological target for animal aging, together with the high degree of evolutionary conservation of the pathway, suggests that inhibition of Ras-Erk-ETS signaling may provide an effective target for anti-aging interventions in mammals.	[Slack, Cathy; Alic, Nazif; Foley, Andrea; Cabecinha, Melissa; Hoddinott, Matthew P.; Partridge, Linda] UCL, Inst Hlth Ageing, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Slack, Cathy; Cabecinha, Melissa; Hoddinott, Matthew P.; Partridge, Linda] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany	University of London; University College London; Max Planck Society	Partridge, L (corresponding author), UCL, Inst Hlth Ageing, Dept Genet Evolut & Environm, Darwin Bldg,Gower St, London WC1E 6BT, England.	l.partridge@ucl.ac.uk	Alic, Nazif/B-4665-2009	Alic, Nazif/0000-0003-0356-6600; Slack, Cathy/0000-0002-7949-4079; Partridge, Linda/0000-0001-9615-0094	Wellcome Trust Strategic Award [WT081394]; Max Planck Society; European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC grant [268739]; Bloomington Drosophila Stock Center [NIH P40OD018537]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Wellcome Trust Strategic Award(Wellcome Trust); Max Planck Society(Max Planck Society); European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC grant(European Research Council (ERC)); Bloomington Drosophila Stock Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Foukas and D. Withers for useful discussion and S. Pletcher and M. Ziehm for assistance with mortality analysis. Reagents were provided by E. Hafen, H. Stocker, S. Bogdan, V. Monnier, and B. Ohlstein. Stocks from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. We acknowledge funding from a Wellcome Trust Strategic Award (WT081394) and the Max Planck Society. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement number 268739 to L.P.	Alic N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004619; Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Borras C, 2011, AGING-US, V3, P262, DOI 10.18632/aging.100279; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Ehninger D, 2014, CELL MOL LIFE SCI, V71, P4325, DOI 10.1007/s00018-014-1677-1; Elbourkadi N, 2014, AGING CELL, V13, P283, DOI 10.1111/acel.12172; Enns LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005963; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fernandez-Medarde A, 2011, BBA-REV CANCER, V1815, P170, DOI 10.1016/j.bbcan.2010.11.001; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goitre L, 2014, METHODS MOL BIOL, V1120, P1, DOI 10.1007/978-1-62703-791-4_1; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Matheu A, 2009, AGING CELL, V8, P152, DOI 10.1111/j.1474-9726.2009.00458.x; Mirisola MG, 2011, AGING-US, V3, P340, DOI 10.18632/aging.100320; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; Oldham S, 2002, DEVELOPMENT, V129, P4103; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Poirier L, 2008, AGING CELL, V7, P758, DOI 10.1111/j.1474-9726.2008.00421.x; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; SUN JY, 1994, J BIOL CHEM, V269, P18638; Sun LY, 2009, FREE RADICAL BIO MED, V47, P1753, DOI 10.1016/j.freeradbiomed.2009.09.021; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Wu J, 2013, ONCOGENE, V32, P78, DOI 10.1038/onc.2012.26; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yang YC, 2014, J THORAC ONCOL, V9, P1305, DOI 10.1097/JTO.0000000000000240	53	111	117	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 2	2015	162	1					72	83		10.1016/j.cell.2015.06.023	http://dx.doi.org/10.1016/j.cell.2015.06.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CM2WF	26119340	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000357542300010
J	Alcolombri, U; Ben-Dor, S; Feldmesser, E; Levin, Y; Tawfik, DS; Vardi, A				Alcolombri, Uria; Ben-Dor, Shifra; Feldmesser, Ester; Levin, Yishai; Tawfik, Dan S.; Vardi, Assaf			Identification of the algal dimethyl sulfide-releasing enzyme: A missing link in the marine sulfur cycle	SCIENCE			English	Article							DMSP-LYASE; EMILIANIA-HUXLEYI; DIMETHYLSULFONIOPROPIONATE LYASE; OCEANIC PHYTOPLANKTON; ATMOSPHERIC SULFUR; PURIFICATION; CATABOLISM; PLANKTON; CLIMATE; GENES	Algal blooms produce large amounts of dimethyl sulfide (DMS), a volatile with a diverse signaling role in marine food webs that is emitted to the atmosphere, where it can affect cloud formation. The algal enzymes responsible for forming DMS from dimethylsulfoniopropionate (DMSP) remain unidentified despite their critical role in the global sulfur cycle. We identified and characterized Alma1, a DMSP lyase from the bloom-forming algae Emiliania huxleyi. Alma1 is a tetrameric, redox-sensitive enzyme of the aspartate racemase superfamily. Recombinant Alma1 exhibits biochemical features identical to the DMSP lyase in E. huxleyi, and DMS released by various E. huxleyi isolates correlates with their Alma1 levels. Sequence homology searches suggest that Alma1 represents a gene family present in major, globally distributed phytoplankton taxa and in other marine organisms.	[Alcolombri, Uria; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Alcolombri, Uria; Vardi, Assaf] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel; [Ben-Dor, Shifra] Weizmann Inst Sci, Bioinformat & Biol Comp Unit, Biol Serv, IL-76100 Rehovot, Israel; [Feldmesser, Ester; Levin, Yishai] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	dan.tawfik@weizmann.ac.il; assaf.vardi@weizmann.ac.il	BEN-DOR, SHIFRA/M-6718-2019	BEN-DOR, SHIFRA/0000-0001-9604-1939; Alcolombri, Uria/0000-0003-3561-5091; Vardi, Assaf/0000-0002-7079-0234	Sasson and Marjorie Peress Philanthropic Fund; European Research Council (ERC) StG (INFOTROPHIC grant) [280991]; BioProjectID [PRJNA283462]	Sasson and Marjorie Peress Philanthropic Fund; European Research Council (ERC) StG (INFOTROPHIC grant)(European Research Council (ERC)); BioProjectID	We thank S. Albeck for assistance with the gel filtration analysis, S. Rosenwasser for important insights regarding the transcriptome de novo construction, U. Sheyn for assistance with the experimental setup for the transcriptome, A. Admon for mass spectrometry, P. Laurino for the nuclear magnetic resonance analysis, R. Hashayev for technical assistance with fractionation, and S. Graff for the graphic design. We gratefully acknowledge financial support from the Sasson and Marjorie Peress Philanthropic Fund to D.S.T. and from the European Research Council (ERC) StG (INFOTROPHIC grant 280991) to A.V. All data are available in the supplementary materials. Transcriptome sequences are deposited in NCBI's Sequence Read Archive, BioProjectID PRJNA283462. Author contributions: U. A., D.S.T, and A.V. conceived the project, designed the experiments, analyzed the data, and wrote the paper. U. A. performed the experiments. S.B.-D. and E.F. performed the transcriptome analyses. Y.L. performed the shotgun proteomics.	Acolombri U, 2014, BIOCHEMISTRY-US, V53, P5473, DOI 10.1021/bi500853s; Alcolombri U, 2014, P NATL ACAD SCI USA, V111, pE2078, DOI 10.1073/pnas.1401685111; BALCH WM, 1991, LIMNOL OCEANOGR, V36, P629, DOI 10.4319/lo.1991.36.4.0629; CANTONI GL, 1956, J BIOL CHEM, V222, P171; Caruana AMN, 2014, PROG OCEANOGR, V120, P410, DOI 10.1016/j.pocean.2013.10.014; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Decelle J, 2012, P NATL ACAD SCI USA, V109, P18000, DOI 10.1073/pnas.1212303109; deSouza MP, 1996, PLANTA, V199, P433, DOI 10.1007/BF00195736; Garces E, 2013, ISME J, V7, P1065, DOI 10.1038/ismej.2012.173; Garren M, 2014, ISME J, V8, P999, DOI 10.1038/ismej.2013.210; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Lyon BR, 2011, PLANT PHYSIOL, V157, P1926, DOI 10.1104/pp.111.185025; Mohapatra BR, 2013, AQUAT BIOL, V18, P185, DOI 10.3354/ab00504; Moran MA, 2012, ANNU REV MAR SCI, V4, P523, DOI 10.1146/annurev-marine-120710-100827; NISHIGUCHI MK, 1995, J PHYCOL, V31, P567, DOI 10.1111/j.1529-8817.1995.tb02551.x; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; Raina JB, 2013, NATURE, V502, P677, DOI 10.1038/nature12677; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Reisch CR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00172; Rokitta SD, 2011, J PHYCOL, V47, P829, DOI 10.1111/j.1529-8817.2011.01014.x; Savoca MS, 2014, P NATL ACAD SCI USA, V111, P4157, DOI 10.1073/pnas.1317120111; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Stefels J, 1996, MAR ECOL PROG SER, V131, P307, DOI 10.3354/meps131307; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168	32	134	151	3	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1466	1469		10.1126/science.aab1586	http://dx.doi.org/10.1126/science.aab1586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113722				2022-12-28	WOS:000356869100040
J	Schadt, CW; Rosling, A				Schadt, Christopher W.; Rosling, Anna			Comment on "Global diversity and geography of soil fungi"	SCIENCE			English	Editorial Material								Tedersoo et al. (Research Article, 28 November 2014, p. 1078) present a compelling study regarding patterns of biodiversity of fungi, carried out at a scale unprecedented to date for fungal biogeographical studies. The study demonstrates strong global biogeographic patterns in richness and community composition of soil fungi. What concerns us with the study is what we do not see. Unfortunately, this study underestimates the fungal diversity of one key group of soil fungi due to reliance on a single primer with known flaws.	[Schadt, Christopher W.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Schadt, Christopher W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Rosling, Anna] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; Uppsala University	Schadt, CW (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	schadtcw@ornl.gov; anna.rosling@ebc.uu.se	Schadt, Christopher W./B-7143-2008; Rosling, Anna/D-1984-2012; Schadt, Christopher/M-8746-2019	Schadt, Christopher W./0000-0001-8759-2448; Schadt, Christopher/0000-0001-8759-2448; Rosling, Anna/0000-0002-7003-5941				Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; GARDES M, 1991, CAN J BOT, V69, P180, DOI 10.1139/b91-026; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Menkis A, 2014, FUNGAL BIOL-UK, V118, P943, DOI 10.1016/j.funbio.2014.08.005; Porter TM, 2008, MOL PHYLOGENET EVOL, V46, P635, DOI 10.1016/j.ympev.2007.10.002; Rosling A., 2013, GENOMICS SOIL AND PL, VVolume 3, P333, DOI [10.1007/978-3-642-39339-6_14, DOI 10.1007/978-3-642-39339-6_14, 10.1007/978-3-642-39339-6, DOI 10.1007/978-3-642-39339-6]; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	12	16	19	12	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242								10.1126/science.aaa4269	http://dx.doi.org/10.1126/science.aaa4269			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26113712	Green Submitted			2022-12-28	WOS:000356869100029
J	Avinoam, O; Schorb, M; Beese, CJ; Briggs, JAG; Kaksonen, M				Avinoam, Ori; Schorb, Martin; Beese, Carsten J.; Briggs, John A. G.; Kaksonen, Marko			Endocytic sites mature by continuous bending and remodeling of the clathrin coat	SCIENCE			English	Article							MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; DYNAMICS; CARGO; PIT; MICROSCOPY	During clathrin-mediated endocytosis (CME), plasma membrane regions are internalized to retrieve extracellular molecules and cell surface components. Whether endocytosis occurs by direct clathrin assembly into curved lattices on the budding vesicle or by initial recruitment to flat membranes and subsequent reshaping has been controversial. To distinguish between these models, we combined fluorescence microscopy and electron tomography to locate endocytic sites and to determine their coat and membrane shapes during invagination. The curvature of the clathrin coat increased, whereas the coated surface area remained nearly constant. Furthermore, clathrin rapidly exchanged at all stages of CME. Thus, coated vesicle budding appears to involve bending of a dynamic preassembled clathrin coat.	[Avinoam, Ori; Beese, Carsten J.; Briggs, John A. G.; Kaksonen, Marko] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Avinoam, Ori; Schorb, Martin; Briggs, John A. G.; Kaksonen, Marko] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Schorb, Martin] European Mol Biol Lab, Electron Microscopy Core Facil, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Briggs, JAG (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.	john.briggs@embl.de; marko.kaksonen@unige.ch	Avinoam, Ori/AAX-7382-2020	Avinoam, Ori/0000-0003-3543-168X; Kaksonen, Marko/0000-0003-3645-7689; Briggs, John/0000-0003-3990-6910; Beese, Carsten Jorn/0000-0002-0437-6764; Schorb, Martin/0000-0003-4910-1868	Marie Curie Actions COFUND (European Commission Cofunding of Regional, National, and International Programme) [229597]	Marie Curie Actions COFUND (European Commission Cofunding of Regional, National, and International Programme)	We thank members of the Kaksonen and Briggs laboratories for helpful discussion; B. Podbilewicz, J. Ries, and P. Lenart for critically reading the manuscript; the EMBL electron and advanced light microscopy facilities; and A. Politi and J. Ellenberg for single-site FRAP software. O.A was supported by the Marie Curie Actions COFUND (European Commission Cofunding of Regional, National, and International Programme) [grant no. 229597; EMBL Interdisciplinary Postdoc (EIPOD)]. Computer codes used are available upon request.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Grassart A, 2014, J CELL BIOL, V205, P721, DOI 10.1083/jcb.201403041; Grove J, 2014, MOL BIOL CELL, V25, P3581, DOI 10.1091/mbc.E14-06-1154; Henry AG, 2012, DEV CELL, V23, P519, DOI 10.1016/j.devcel.2012.08.003; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; KIRCHHAUSEN T, 1993, CURR OPIN STRUC BIOL, V3, P182, DOI 10.1016/S0959-440X(05)80150-2; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; Kukulski W, 2012, CELL, V150, P508, DOI 10.1016/j.cell.2012.05.046; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Loerke D, 2005, TRAFFIC, V6, P918, DOI 10.1111/j.1600-0854.2005.00329.x; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Morlot S, 2013, ANNU REV BIOPHYS, V42, P629, DOI 10.1146/annurev-biophys-050511-102247; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085	24	145	147	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1369	1372		10.1126/science.aaa9555	http://dx.doi.org/10.1126/science.aaa9555			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26089517				2022-12-28	WOS:000356449500053
J	Fuentealba, LC; Rompani, SB; Parraguez, JI; Obernier, K; Romero, R; Cepko, CL; Alvarez-Buylla, A				Fuentealba, Luis C.; Rompani, Santiago B.; Parraguez, Jose I.; Obernier, Kirsten; Romero, Ricardo; Cepko, Constance L.; Alvarez-Buylla, Arturo			Embryonic Origin of Postnatal Neural Stem Cells	CELL			English	Article							ADULT OLFACTORY-BULB; SUBVENTRICULAR ZONE; CEREBRAL-CORTEX; LINEAGE PROGRESSION; FATE DETERMINATION; PROGENITOR CELLS; MAMMALIAN BRAIN; NEUROGENESIS; INTERNEURONS; SUBPOPULATION	Adult neural stem/progenitor (B1) cells within the walls of the lateral ventricles generate different types of neurons for the olfactory bulb (OB). The location of B1 cells determines the types of OB neurons they generate. Here we show that the majority of mouse B1 cell precursors are produced between embryonic days (E) 13.5 and 15.5 and remain largely quiescent until they become reactivated postnatally. Using a retroviral library carrying over 100,000 genetic tags, we found that B1 cells share a common progenitor with embryonic cells of the cortex, striatum, and septum, but this lineage relationship is lost before E15.5. The regional specification of B1 cells is evident as early as E11.5 and is spatially linked to the production of neurons that populate different areas of the forebrain. This study reveals an early embryonic regional specification of postnatal neural stem cells and the lineage relationship between them and embryonic progenitor cells.	[Fuentealba, Luis C.; Parraguez, Jose I.; Obernier, Kirsten; Romero, Ricardo; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Fuentealba, Luis C.; Parraguez, Jose I.; Obernier, Kirsten; Romero, Ricardo; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, San Francisco, CA 94143 USA; [Rompani, Santiago B.; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Rompani, Santiago B.; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Rompani, Santiago B.; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Obernier, Kirsten/O-4967-2015	Obernier, Kirsten/0000-0002-4025-1299; Rompani, Santiago/0000-0002-3994-3052; Alvarez-Buylla, Arturo/0000-0003-4426-8925	Chilean Government (Becas Chile); Deutsche Forschungsgemeinschaft; NIH [HD 32116, NS 28478]; John G. Bowes Research Fund; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478, R29NS028478, R01NS028478] Funding Source: NIH RePORTER	Chilean Government (Becas Chile); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John G. Bowes Research Fund; HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank William Walantus for outstanding technical assistance with in utero procedures; Ernesto Guerra (UC Berkeley) for writing scripts for statistical analyses; Amelia J. Eisch (UT Southwestern Medical Center) and Nicoletta Kessaris (University College London) for generously sharing the Nestin::CreER and Emx1::CreER mice, respectively; Arnold R. Kriegstein for providing the 293 gp NIT-GFP cell line; Shawn Sorrells, Corey Harwell, and members of the Alvarez-Buylla laboratory for helpful discussions that improved this study. L.C.F. is a HHMI fellow of the Helen Hay Whitney Foundation. J.I.P. is supported by the Chilean Government (Becas Chile). K.O. is supported by the Deutsche Forschungsgemeinschaft. A.A.-B. is the Heather and Melanie Muss Endowed Chair. This study was supported by grants from the NIH (HD 32116 and NS 28478), the John G. Bowes Research Fund, and HHMI (C.L.C.)	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Benitah SA, 2012, J MOL MED, V90, P783, DOI 10.1007/s00109-012-0908-x; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; BAYER SA, 1983, EXP BRAIN RES, V50, P329; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cai YQ, 2013, STEM CELLS, V31, P1193, DOI 10.1002/stem.1363; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Cepko CL, 1998, CURR TOP DEV BIOL, V36, P51; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Conover JC, 2011, AGING DIS, V2, P49; Costa G, 2012, TRENDS IMMUNOL, V33, P215, DOI 10.1016/j.it.2012.01.012; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Garcia-Marques J, 2013, CEREB CORTEX, V23, P1463, DOI 10.1093/cercor/bhs134; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; GOLDEN JA, 1995, P NATL ACAD SCI USA, V92, P5704, DOI 10.1073/pnas.92.12.5704; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lopez-Juarez A, 2013, GENE DEV, V27, P1272, DOI 10.1101/gad.217539.113; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merkle FT, 2014, NAT NEUROSCI, V17, P207, DOI 10.1038/nn.3610; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Reid CB, 2002, J NEUROSCI, V22, P4002, DOI 10.1523/JNEUROSCI.22-10-04002.2002; Reid CB, 1999, J COMP NEUROL, V403, P106; Rompani SB, 2008, P NATL ACAD SCI USA, V105, P192, DOI 10.1073/pnas.0709979104; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Waclaw RR, 2009, NEURON, V63, P451, DOI 10.1016/j.neuron.2009.07.015; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	48	274	279	6	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1644	1655		10.1016/j.cell.2015.05.041	http://dx.doi.org/10.1016/j.cell.2015.05.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26091041	Bronze, Green Accepted			2022-12-28	WOS:000356618200020
J	O'Sullivan, S				O'Sullivan, Suzanne			The art of medicine First, do no harm	LANCET			English	Editorial Material									Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	O'Sullivan, S (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	drsosullivan@aol.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2246	2247		10.1016/S0140-6736(15)61055-8	http://dx.doi.org/10.1016/S0140-6736(15)61055-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1CR	26088489				2022-12-28	WOS:000355943500016
J	Reese, PP; Boudville, N; Garg, AX				Reese, Peter P.; Boudville, Neil; Garg, Amit X.			Living kidney donation: outcomes, ethics, and uncertainty	LANCET			English	Review							QUALITY-OF-LIFE; STAGE RENAL-DISEASE; LONG-TERM CONSEQUENCES; CARDIOVASCULAR-DISEASE; MEDICAL OUTCOMES; ORGAN DONATION; UNITED-STATES; FOLLOW-UP; DONOR KIDNEYS; TRANSPLANTATION	Since the first living-donor kidney transplantation in 1954, more than half a million living kidney donations have occurred and research has advanced knowledge about long-term donor outcomes. Donors in developed countries have a similar life expectancy and quality of life as healthy non-donors. Living kidney donation is associated with an increased risk of end-stage renal disease, although this outcome is uncommon (<0.5% increase in incidence at 15 years). Kidney donation seems to elevate the risks of gestational hypertension and pre-eclampsia. Many donors incur financial expenses due to factors such as lost wages, need for sick days, and travel expenses. Yet, most donors have no regrets about donation. Living kidney donation is practised ethically when informed consent incorporates information about risks, uncertainty about outcomes is acknowledged when it exists, and a donor's risks are proportional to benefits for the donor and recipient. Future research should determine whether outcomes are similar for donors from developing countries and donors with pre-existing conditions such as obesity.	[Reese, Peter P.] Univ Penn, Perelman Sch Med, Dept Med, Renal Elect & Hypertens Div, Philadelphia, PA 19104 USA; [Reese, Peter P.] Univ Penn, Dept Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Boudville, Neil] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Garg, Amit X.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Western Australia; Western University (University of Western Ontario)	Reese, PP (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	peter.reese@uphs.upenn.edu	Garg, Amit X/G-3295-2011; Boudville, Neil/H-8864-2014	Boudville, Neil/0000-0002-5884-640X	Astellas; Roche	Astellas(Astellas Pharmaceuticals); Roche(Roche Holding)	AXG declares receipt of an investigator initiated grant from Astellas and Roche to support a Canadian Institutes of Health Research study in living kidney donors. PPR and NB declare no competing interests.	Abraham G, 2010, CLIN KIDNEY J, V3, P203, DOI 10.1093/ndtplus/sfp178; Abraham G, 2010, KIDNEY INT, V77, P378, DOI 10.1038/ki.2009.494; Abramowicz D, 2015, NEPHROL DIAL TRANSPL, V30, P1790, DOI 10.1093/ndt/gfu216; [Anonymous], 2013, NEPHROL DIAL TRANSPL, V28, P1, DOI 10.1093/ndt/gft218; Australian Government National Health and Medical Research Council, 2000, ORG TISS DON LIV DON, P23; Axelrod DA, 2010, AM J TRANSPLANT, V10, P987, DOI 10.1111/j.1600-6143.2010.03022.x; Bal MM, 2007, TRANSPL P, V39, P2961, DOI 10.1016/j.transproceed.2007.08.089; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Berger JC, 2011, CLIN J AM SOC NEPHRO, V6, P2887, DOI 10.2215/CJN.04160511; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Boudville N, 2010, NEPHROLOGY, V15, pS133, DOI 10.1111/j.1440-1797.2009.01222.x; Boyarsky BJ, 2014, AM J TRANSPLANT, V14, P2168, DOI 10.1111/ajt.12819; Briancon S, 2011, NEPHROL THER, V7, pS1, DOI 10.1016/S1769-7255(11)70007-4; Chen CH, 2004, TRANSPL P, V36, P1920, DOI 10.1016/j.transproceed.2004.08.016; Cherikh WS, 2011, AM J TRANSPLANT, V11, P1650, DOI 10.1111/j.1600-6143.2011.03609.x; Clarke KS, 2006, NEPHROL DIAL TRANSPL, V21, P1952, DOI 10.1093/ndt/gfl069; Clayton Philip, 2013, ANZDATA REG 2012 REP, P1; Clemens K, 2011, AM J TRANSPLANT, V11, P463, DOI 10.1111/j.1600-6143.2010.03424.x; Clemens KK, 2006, AM J TRANSPLANT, V6, P2965, DOI 10.1111/j.1600-6143.2006.01567.x; Danovitch GM, 2014, KIDNEY INT, V85, P248, DOI 10.1038/ki.2013.466; Davis CL, 2010, CLIN J AM SOC NEPHRO, V5, P1873, DOI 10.2215/CJN.01510210; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; Dew MA, 2013, AM J TRANSPLANT, V13, P2672, DOI 10.1111/ajt.12393; Dew MA, 1997, TRANSPLANTATION, V64, P1261, DOI 10.1097/00007890-199711150-00006; Doshi MD, 2013, AM J TRANSPLANT, V13, P111, DOI 10.1111/j.1600-6143.2012.04303.x; Ethics Comm Transplantat Soc, 2004, TRANSPLANTATION, V78, P491, DOI 10.1097/01.TP.0000136654.85459.1E; Garcia MFFM, 2013, CLIN TRANSPLANT, V27, P9, DOI 10.1111/j.1399-0012.2012.01687.x; Fehrman-Ekholm I, 2000, TRANSPLANTATION, V69, P2067, DOI 10.1097/00007890-200005270-00016; Fehrman-Ekholm I, 2001, TRANSPLANTATION, V72, P444, DOI 10.1097/00007890-200108150-00015; Fehrman-Ekholm I, 2006, TRANSPLANTATION, V82, P1646, DOI 10.1097/01.tp.0000250728.73268.e3; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Garg AX, 2008, TRANSPLANTATION, V86, P399, DOI 10.1097/TP.0b013e31817ba9e3; Garg AX, 2015, NEW ENGL J MED, V372, P124, DOI 10.1056/NEJMoa1408932; Garg AX, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1203; Garonzik-Wang JM, 2012, TRANSPLANTATION, V93, P1147, DOI 10.1097/TP.0b013e31824e75a5; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gibney EM, 2007, TRANSPLANTATION, V84, P647, DOI 10.1097/01.tp.0000277288.78771.c2; Gordon EJ, 2010, AM J TRANSPLANT, V10, P2701, DOI 10.1111/j.1600-6143.2010.03304.x; Gore JL, 2009, AM J TRANSPLANT, V9, P1124, DOI 10.1111/j.1600-6143.2009.02620.x; Gossmann J, 2005, AM J TRANSPLANT, V5, P2417, DOI 10.1111/j.1600-6143.2005.01037.x; Grace BS, 2013, KIDNEY INT, V83, P138, DOI 10.1038/ki.2012.304; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; Gross CR, 2013, AM J TRANSPLANT, V13, P2924, DOI 10.1111/ajt.12434; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Ibrahim HN, 2009, AM J TRANSPLANT, V9, P825, DOI 10.1111/j.1600-6143.2009.02548.x; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Isotani S, 2002, UROLOGY, V60, P588, DOI 10.1016/S0090-4295(02)01865-4; Iyer HS, 2013, CURR OPIN NEPHROL HY, V22, P681, DOI 10.1097/MNH.0b013e328365b3b9; Johnson EM, 1999, TRANSPLANTATION, V67, P717, DOI 10.1097/00007890-199903150-00013; Joint Working Party of The British Transplantation Society and The Renal Association, UK GUID LIV DON KIDN; Klarenbach S, 2014, AM J TRANSPLANT, V14, P916, DOI 10.1111/ajt.12662; Lennerling A, 2004, NEPHROL DIAL TRANSPL, V19, P1600, DOI 10.1093/ndt/gfh138; Lentine KL, 2013, TRANSPL INT, V26, P853, DOI 10.1111/tri.12088; Lentine KL, 2010, NEW ENGL J MED, V363, P724, DOI 10.1056/NEJMoa1000950; Lima DX, 2006, NEPHROL DIAL TRANSPL, V21, P3238, DOI 10.1093/ndt/gfl433; Mandelbrot DA, 2007, AM J TRANSPLANT, V7, P2333, DOI 10.1111/j.1600-6143.2007.01932.x; Matas AJ, 2014, AM J TRANSPLANT, V14, P11, DOI 10.1111/ajt.12579; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Moazam F., 2006, BIOETHICS ORGAN TRAN; Montgomery RA, 2006, LANCET, V368, P419, DOI 10.1016/S0140-6736(06)69115-0; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Murray JE, 2001, SURG SOUL REFLECTION; Muzaale A, 2013, AM J TRANSPLANT, V13, P204; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; Nanidis TG, 2008, ANN SURG, V247, P58, DOI 10.1097/SLA.0b013e318153fd13; Nevis IF, 2009, AM J TRANSPLANT, V9, P661, DOI 10.1111/j.1600-6143.2009.02623.x; Oien CM, 2005, NEPHROL DIAL TRANSPL, V20, P783, DOI 10.1093/ndt/gfh696; Okamoto M, 2009, TRANSPLANTATION, V87, P419, DOI 10.1097/TP.0b013e318192dc95; Organ procurement and transplantation network, POL 172 LIV DON; Port FK, 2005, AM J TRANSPLANT, V5, P843, DOI 10.1111/j.1600-6135.2005.00831.x; Rahmel A., ANN REPORT 2013; Rees MA, 2009, NEW ENGL J MED, V360, P1096, DOI 10.1056/NEJMoa0803645; Reese PP, 2008, AM J TRANSPLANT, V8, P2062, DOI 10.1111/j.1600-6143.2008.02361.x; Reese PP, 2014, AM J TRANSPLANT, V14, P1853, DOI 10.1111/ajt.12822; Reisaeter AV, 2009, AM J TRANSPLANT, V9, P820, DOI 10.1111/j.1600-6143.2008.02427.x; Rodrigue JR, 2014, TRANSPLANTATION, V98, P979, DOI 10.1097/TP.0000000000000165; Rodrigue JR, 2014, TRANSPLANTATION, V97, P762, DOI 10.1097/01.TP.0000437560.23588.ef; Rodrigue JR, 2013, TRANSPLANTATION, V96, P767, DOI 10.1097/TP.0b013e318298fa61; Rook M, 2006, AM J TRANSPLANT, V6, P1653, DOI 10.1111/j.1600-6143.2006.01359.x; Sack K, NY TIMES; Sanner MA, 2005, NEPHROL DIAL TRANSPL, V20, P1707, DOI 10.1093/ndt/gfh861; Segev DL, 2011, AM J TRANSPLANT, V11, P356, DOI 10.1111/j.1600-6143.2010.03386.x; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Sickand M, 2009, AM J TRANSPLANT, V9, P2825, DOI 10.1111/j.1600-6143.2009.02829.x; Spital A, 2001, AM J KIDNEY DIS, V38, P189, DOI 10.1053/ajkd.2001.25213; Steiner RW, 2014, AM J TRANSPLANT, V14, P538, DOI 10.1111/ajt.12625; Storsley LJ, 2010, TRANSPLANTATION, V90, P401, DOI 10.1097/TP.0b013e3181e6e79b; Taler SJ, 2013, AM J TRANSPLANT, V13, P390, DOI 10.1111/j.1600-6143.2012.04321.x; The Canadian Organ Replacement Register (CORR), CORR ANN REP; Tong A, 2012, AM J KIDNEY DIS, V60, P15, DOI 10.1053/j.ajkd.2011.11.043; US renal data system, 2012, USRDS 2013 ANN DAT R; Waterman AD, 2009, PROG TRANSPLANT, V19, P7, DOI 10.7182/prtr.19.1.d2441w863vr16812; Weng FL, 2010, CLIN J AM SOC NEPHRO, V5, P2338, DOI 10.2215/CJN.03040410; Wiedebusch S, 2009, TRANSPL P, V41, P1483, DOI 10.1016/j.transproceed.2009.02.102; Yang R, 2009, AM J TRANSPLANT, V9, P1585, DOI 10.1111/j.1600-6143.2009.02679.x; Young A, 2007, NEPHRON CLIN PRACT, V107, pC82, DOI 10.1159/000108648; Young A, 2012, AM J KIDNEY DIS, V59, P761, DOI 10.1053/j.ajkd.2011.09.019	97	130	139	1	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					2003	2013		10.1016/S0140-6736(14)62484-3	http://dx.doi.org/10.1016/S0140-6736(14)62484-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	26090646				2022-12-28	WOS:000354541700034
J	Mitchell, SL				Mitchell, Susan L.			Advanced Dementia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NURSING-HOME RESIDENTS; LONG-TERM-CARE; OF-LIFE CARE; FEEDING OPTIONS; HOSPICE CARE; END; SURVIVAL; PNEUMONIA; IMPACT; DEATH	An 89-year-old male nursing home resident with a 10-year history of Alzheimer's disease presents with a temperature of 38.3 degrees C, a productive cough, and a respiratory rate of 28 breaths per minute. Nurses report that for the past 6 months he has been coughing at breakfast and having trouble swallowing. He has profound memory deficits, no longer recognizes his daughter (who is his health care proxy), is bed-bound, is able to mumble a couple of words, and is unable to perform any activities of daily living. The nurse asks whether he should be hospitalized. How should this patient be evaluated and treated?	[Mitchell, Susan L.] Beth Israel Deaconess Med Ctr, Dept Med, Hebrew SeniorLife Inst Aging Res, Boston, MA 02215 USA; [Mitchell, Susan L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Hebrew SeniorLife; Harvard University; Harvard Medical School	Mitchell, SL (corresponding author), Hebrew SeniorLife Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	smitchell@hsl.harvard.edu			NIA NIH HHS [K24 AG033640] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K24AG033640] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2013, FEED TUB PEOPL ALZH; [Anonymous], HOSPICE J; Arrighi HM, 2010, ALZ DIS ASSOC DIS, V24, P90, DOI 10.1097/WAD.0b013e31819fe7d1; BUCHANAN A, 1986, MILBANK Q, V64, P17, DOI 10.2307/3349960; Cegelka A, 2014, J AM GERIATR SOC, V62, P1590, DOI 10.1111/jgs.12924; Chen JH, 2006, J AM GERIATR SOC, V54, P290, DOI 10.1111/j.1532-5415.2005.00524.x; D'Agata E, 2008, ARCH INTERN MED, V168, P357, DOI 10.1001/archinternmed.2007.104; D'Agata E, 2013, J AM GERIATR SOC, V61, P62, DOI 10.1111/jgs.12070; Fischberg D, 2013, J PAIN SYMPTOM MANAG, V45, P595, DOI 10.1016/j.jpainsymman.2012.12.002; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Givens JL, 2012, J AM GERIATR SOC, V60, P905, DOI 10.1111/j.1532-5415.2012.03919.x; Givens JL, 2010, ARCH INTERN MED, V170, P1102, DOI 10.1001/archinternmed.2010.181; Givens JL, 2009, J AM GERIATR SOC, V57, P1149, DOI 10.1111/j.1532-5415.2009.02304.x; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Hanson LC, 2011, J AM GERIATR SOC, V59, P2009, DOI 10.1111/j.1532-5415.2011.03629.x; Hanson LC, 2011, J AM GERIATR SOC, V59, P463, DOI 10.1111/j.1532-5415.2011.03320.x; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hendriks SA, 2014, J PAIN SYMPTOM MANAG, V47, P710, DOI 10.1016/j.jpainsymman.2013.05.015; Holmes HM, 2008, J AM GERIATR SOC, V56, P1306, DOI 10.1111/j.1532-5415.2008.01741.x; Huskamp HA, 2012, MED CARE RES REV, V69, P3, DOI 10.1177/1077558711418518; Jayes RL, 2012, J PAIN SYMPTOM MANAG, V44, P750, DOI 10.1016/j.jpainsymman.2012.08.004; Kiely DK, 2010, J AM GERIATR SOC, V58, P2284, DOI 10.1111/j.1532-5415.2010.03185.x; Loeb M, 2001, INFECT CONT HOSP EP, V22, P120, DOI 10.1086/501875; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Miller SC, 2001, AM J MED, V111, P38, DOI 10.1016/S0002-9343(01)00747-1; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Mitchell SL, 1997, ARCH INTERN MED, V157, P327, DOI 10.1001/archinte.157.3.327; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mitchell SL, 2014, JAMA INTERN MED, V174, P1660, DOI 10.1001/jamainternmed.2014.3918; Mitchell SL, 2010, JAMA-J AM MED ASSOC, V304, P1929, DOI 10.1001/jama.2010.1572; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; National Hospice and Palliative Care Organization, 2014, NHPCOS FACTS FIG HOS; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Sampson EL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007209.pub2; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Shega JW, 2008, J PAIN SYMPTOM MANAG, V35, P499, DOI 10.1016/j.jpainsymman.2007.06.011; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Teno JM, 2012, J AM GERIATR SOC, V60, P1918, DOI 10.1111/j.1532-5415.2012.04148.x; Teno JM, 2012, ARCH INTERN MED, V172, P697, DOI 10.1001/archinternmed.2012.1200; Tjia J, 2014, JAMA INTERN MED, V174, P1763, DOI 10.1001/jamainternmed.2014.4103; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Unroe KT, 2013, J AM GERIATR SOC, V61, P1212, DOI 10.1111/jgs.12318; Volicer L, 2001, ALZ DIS ASSOC DIS, V15, P194, DOI 10.1097/00002093-200110000-00005; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Weuve Jennifer, 2014, Alzheimers Dement, V10, pe40, DOI 10.1016/j.jalz.2014.01.004; 2011, NATL VITAL STAT REP, V86, P1	48	102	113	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2533	2540		10.1056/NEJMcp1412652	http://dx.doi.org/10.1056/NEJMcp1412652			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2QD	26398084	Green Accepted			2022-12-28	WOS:000356788200009
